FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Karuppan, MKM
   Ojha, CR
   Rodriguez, M
   Nair, M
   El-Hage, N
AF Karuppan, Mohan Kumar Muthu
   Ojha, Chet Raj
   Rodriguez, Myosotys
   Nair, Madhavan
   El-Hage, Nazira
TI Different mechanisms implicated in ZIKV-induced inflammatory molecules
   in human microglial cells
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Karuppan, Mohan Kumar Muthu; Ojha, Chet Raj; Rodriguez, Myosotys; Nair, Madhavan; El-Hage, Nazira] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA.
EM mmuthuka@fiu.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P206
BP S60
EP S60
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400207
DA 2020-07-08
ER

PT J
AU Leda, A
   Andras, I
   El-Hage, N
   Nair, M
   Toborek, M
AF Leda, Ana
   Andras, Ibolya
   El-Hage, Nazira
   Nair, Madhavan
   Toborek, Michal
TI The role of the blood-brain barrier in Zika virus infection
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Leda, Ana; Andras, Ibolya; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Coral Gables, FL 33124 USA.
   [El-Hage, Nazira; Nair, Madhavan] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA.
EM aleda@miami.edu
FU Florida Department of Health [7ZK09]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01MH098891]
FX Supported in part by the Florida Department of Health 7ZK09 and NIH
   R01MH098891.
NR 0
TC 0
Z9 0
U1 1
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P154
BP S45
EP S45
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400155
DA 2020-07-08
ER

PT J
AU Sariyer, IK
   Wollebo, H
   Cicalese, S
   Donadoni, M
   Bellizzi, A
   Robinson, JA
   Burdo, TH
   Gordon, J
   Khalili, K
AF Sariyer, Ilker Kudret
   Wollebo, Hassen
   Cicalese, Stephanie
   Donadoni, Martina
   Bellizzi, Anna
   Robinson, Jake Arthur
   Burdo, Tricia Helen
   Gordon, Jennifer
   Khalili, Kamel
TI Non-Nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine
   suppresses Zika virus (ZIKV) in glial cells.
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Sariyer, Ilker Kudret; Wollebo, Hassen; Cicalese, Stephanie; Donadoni, Martina; Bellizzi, Anna; Robinson, Jake Arthur; Burdo, Tricia Helen; Gordon, Jennifer; Khalili, Kamel] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.
EM isariyer@temple.edu
RI Sariyer, Ilker/AAE-7677-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P264
BP S77
EP S77
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400265
DA 2020-07-08
ER

PT J
AU Seth, P
   Bhagat, R
AF Seth, Pankaj
   Bhagat, Reshma
TI Role of WNT signaling in Zika Virus Envelope protein induced quiescence
   in primary human neural stem cells
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Seth, Pankaj; Bhagat, Reshma] Natl Brain Res Ctr, Mol & Cellular Neurosci, Manesar, Haryana, India.
EM pseth@nbrc.ac.in
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P269
BP S78
EP S78
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400270
DA 2020-07-08
ER

PT J
AU Whelan, J
   Li, YZ
   Weiss, S
AF Whelan, Jillian
   Li, Yize
   Weiss, Susan
TI Zika virus resistance to the antiviral 2 ',5 '-oligoadenylate
   synthetase/ribonuclease L (OAS/RNase L) pathway
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Whelan, Jillian; Li, Yize; Weiss, Susan] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
EM jwhelan732@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P311
BP S90
EP S91
PG 2
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400312
DA 2020-07-08
ER

PT J
AU Perez-Avila, J
   Guzman-Tirado, MG
   Fraga-Nodarse, J
   Handley, FG
   Meegan, J
   de la Cotera, JLPM
   Fauci, AS
AF Perez-Avila, Jorge
   Guzman-Tirado, Maria G.
   Fraga-Nodarse, Jorge
   Handley, F. Gray
   Meegan, James
   Pelegrino-Martinez de la Cotera, Jose L.
   Fauci, Anthony S.
TI US and Cuban Scientists Forge Collaboration on Arbovirus Research
SO MEDICC REVIEW
LA English
DT Article
DE Arboviruses; flavivirus; Zika virus; chikungunya virus; dengue virus;
   research; disease vectors; Cuba; USA
AB After December 17, 2014, when the US and Cuban governments announced their intent to restore relations, the two countries participated in various exchange activities in an effort to encourage cooperation in public health, health research and biomedical sciences. The conference entitled Exploring Opportunities for Arbovirus Research Collaboration, hosted at Havana's Hotel Nacional, was part of these efforts and was the first major US-Cuban scientific conference in over 50 years. Its purpose was to share information about current arbovirus research and recent findings, and to explore opportunities for future joint research. The nearly 100 participants included leading arbovirus and vector transmission experts from ten US academic institutions, NIH, CDC, FDA and the US Department of Defense. Cuban participants included researchers, clinicians and students from Cuba's Ministry of Public Health, Pedro Kouri Tropical Medicine Institute, Center for Genetic Engineering and Biotechnology, Center for State Control of Medicines and Medical Devices and other health research and regulatory organizations. Topics highlighted at the three-day meeting included surveillance, research and epidemiology; pathogenesis, immunology and virology; treatment and diagnosis; vector biology and control; vaccine development and clinical trials; and regulatory matters. Concurrent breakout discussions focused on novel vector control, nonvector transmission, community engagement, Zika in pregnancy, and workforce development. Following the conference, the Pedro Kouri Tropical Medicine Institute and the US National Institute of Allergic and Infectious Diseases have continued to explore ways to encourage and support scientists in Cuba and the USA who wish to pursue arbovirus research cooperation to advance scientific discovery to improve disease prevention and control.
C1 [Perez-Avila, Jorge] Pedro Kouri Trop Med Inst IPK, Havana, Cuba.
   [Guzman-Tirado, Maria G.; Pelegrino-Martinez de la Cotera, Jose L.] IPK, Havana, Cuba.
   [Guzman-Tirado, Maria G.] IPK, PAHO WHO Collaborating Ctr Study & Control Dengue, Havana, Cuba.
   [Fraga-Nodarse, Jorge] IPK, Parasitol Dept, Havana, Cuba.
   [Handley, F. Gray] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Handley, F. Gray] NIAID, Off Global Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Fauci, Anthony S.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Perez-Avila, J (corresponding author), Pedro Kouri Trop Med Inst IPK, Havana, Cuba.
EM jorge.perez@ipk.sld.cu
FU MINSAP; PAHO; IPK
FX The authors thank MINSAP, PAHO and IPK for sponsorship and support of
   the November 2016 conference; as well as the organizing committee,
   speakers and participants who contributed to its successful outcomes.
CR American Society of Tropical Medicine and Hygiene, 2018, CUB US BUILD BRIDG S
   Bausch DG, 2017, AM J TROP MED HYG, V96, P1267, DOI 10.4269/ajtmh.17-0136
   Burwell SM, 2016, PROMISE STRONG US CU
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Pan American Health Organization, 2018, HLTH LEAD DISC ACT M
   Puderbaugh A., 2015, US SCI EXPLORE RES P
   The White House, 2018, PRESIDENTIAL POLICY
   U.S. Department of Treasury, 2018, U S DEPARTMENT OF TR
   Wern K., 2014, SCI DIPLOMACY VISIT
NR 9
TC 0
Z9 0
U1 1
U2 2
PU MEDICC-MED EDUC COOPERATION CUBA
PI DECATUR
PA 1902 CLAIRMONT RD, STE 250, DECATUR, GEORGIA 30033-3406 USA
SN 1555-7960
J9 MEDICC REV
JI MEDICC Rev.
PD APR
PY 2018
VL 20
IS 2
BP 32
EP 34
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GI3ZY
UT WOS:000434311900007
PM 29773774
DA 2020-07-08
ER

PT J
AU Carran, S
   Ferrari, M
   Reluga, T
AF Carran, Spencer
   Ferrari, Matthew
   Reluga, Timothy
TI Unintended consequences and the paradox of control: Management of
   emerging pathogens with age-specific virulence
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS-INFECTION; SEXUAL TRANSMISSION; RUBELLA; VACCINE;
   ERADICATION; EPIDEMICS; PREGNANCY; COLOMBIA; HISTORY
AB We project forward total Zika virus disease (ZVD) under varying hazards of infection and consider how the age distribution of disease burden varies between these scenarios. Pathogens with age structured disease outcomes, such as rubella and Zika virus, require that management decisions consider their impact not only on total disease incidence but also on distribution of disease burden within a population. Some situations exhibit a "paradox of control" in which reductions of overall transmission decrease the total incidence but increase the incidence of severe disease. This happens because of corresponding increases in the average age of infection. Beginning with the current population structure and demographic rates of Brazil, we project forward total ZVD burden as measured by cases occurring in pregnant women and document the scenarios under which a paradox of control for ZVD management emerges. We conclude that while a paradox of control can occur for ZVD, the higher total costs from increasing the average age of infection will only be realized after several decades and vanish under conservative discounting of future costs. This indicates that managers faced with an emerging pathogen are justified to prioritize current disease incidence over potential increases in severe disease outcomes in the endemic state.
C1 [Carran, Spencer] Penn State Univ, Ecol IGDP, University Pk, PA 16802 USA.
   [Ferrari, Matthew] Penn State Univ, Dept Biol, University Pk, PA 16802 USA.
   [Reluga, Timothy] Penn State Univ, Dept Math, University Pk, PA 16802 USA.
RP Carran, S (corresponding author), Penn State Univ, Ecol IGDP, University Pk, PA 16802 USA.
EM spencercarran@gmail.com
FU National Science FoundationNational Science Foundation (NSF)
   [CCF-1215682]
FX The research was supported in part by National Science Foundation grant
   CCF-1215682. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Barrett S, 2007, ENVIRON DEV ECON, V12, P627, DOI 10.1017/S1355770X07003816
   Bastos L., 2016, BIORXIV, DOI DOI 10.1101/055475
   Benelli G, 2016, PARASITOL RES, P1
   Bewick S., 2016, BIORXIV
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carlson C, 2016, BIORXIV
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X
   COOPER LZ, 1985, REV INFECT DIS, V7, pS2
   Costa e Castro M, 2016, PROTOCOLO VIGILANCIA
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Fefferman NH, 2015, LANCET INFECT DIS, V15, P922, DOI 10.1016/S1473-3099(15)00053-5
   Ferguson NM, 2016, SCIENCE
   Gao D, 2016, ARXIV160404008QBIO
   GRENFELL BT, 1989, PROC R SOC SER B-BIO, V236, P213, DOI 10.1098/rspb.1989.0022
   Harrison M., 2010, VALUING FUTURE SOCIA
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Honein MA, 2016, JAMA
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Khan MM, 2003, VACCINE, V21, P702, DOI 10.1016/S0264-410X(02)00584-4
   Lebreton JD, 1996, THEOR POPUL BIOL, V49, P291, DOI 10.1006/tpbi.1996.0015
   Lessler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067639
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   Martinez-Bakker M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2438
   McKendrick AG, 1926, P EDINBURGH MATH SOC, V44, P98, DOI DOI 10.1017/S0013091500034428
   Miller E, 1997, BIOLOGICALS, V25, P137, DOI 10.1006/biol.1997.0072
   MILLER E, 1982, LANCET, V2, P781
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Neumann PJ, 2016, COST EFFECTIVENESS H
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Panagiotopoulos T, 1999, BRIT MED J, V319, P1462, DOI 10.1136/bmj.319.7223.1462
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pitzer VE, 2009, J THEOR BIOL, V260, P175, DOI 10.1016/j.jtbi.2009.06.008
   Reluga TC, 2007, B MATH BIOL, V69, P2711, DOI 10.1007/s11538-007-9238-5
   Reluga TC, 2013, J MATH BIOL, V66, P1527, DOI 10.1007/s00285-012-0543-8
   Tebbens RJD, 2010, VACCINE, V29, P334, DOI 10.1016/j.vaccine.2010.10.026
   Thompson KM, 2006, RISK ANAL, V26, P1423, DOI 10.1111/j.1539-6924.2006.00831.x
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   United Nations DoE Social Affairs PD, 2013, WORLD FERT DAT 2012
   Vynnycky E, 2003, VACCINE, V21, P2708, DOI 10.1016/S0264-410X(03)00229-9
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wesolowski A, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1101
   Woog V, 2015, ADOLESCENT WOMENS NE
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 51
TC 1
Z9 1
U1 2
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2018
VL 12
IS 4
AR e0005997
DI 10.1371/journal.pntd.0005997
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH5QP
UT WOS:000433487700001
PM 29630603
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gunning, CE
   Okamoto, KW
   Astete, H
   Vasquez, GM
   Erhardt, E
   Del Aguila, C
   Pinedo, R
   Cardenas, R
   Pacheco, C
   Chalco, E
   Rodriguez-Ferruci, H
   Scott, TW
   Lloyd, AL
   Gould, F
   Morrison, AC
AF Gunning, Christian E.
   Okamoto, Kenichi W.
   Astete, Helvio
   Vasquez, Gissella M.
   Erhardt, Erik
   Del Aguila, Clara
   Pinedo, Raul
   Cardenas, Roldan
   Pacheco, Carlos
   Chalco, Enrique
   Rodriguez-Ferruci, Hugo
   Scott, Thomas W.
   Lloyd, Alun L.
   Gould, Fred
   Morrison, Amy C.
TI Efficacy of Aedes aegypti control by indoor Ultra Low Volume (ULV)
   insecticide spraying in Iquitos, Peru
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CULICIDAE PRODUCTION; EMERGENCY CONTROL; DENGUE VECTOR; PUERTO-RICO;
   DIPTERA; TRANSMISSION; POPULATIONS; INFECTION; PATTERNS; THAILAND
AB Background
   Aedes aegypti is a primary vector of dengue, chikungunya, Zika, and urban yellow fever viruses. Indoor, ultra low volume (ULV) space spraying with pyrethroid insecticides is the main approach used for Ae. aegypti emergency control in many countries. Given the widespread use of this method, the lack of large-scale experiments or detailed evaluations of municipal spray programs is problematic.
   Methodology/Principal findings
   Two experimental evaluations of non-residual, indoor ULV pyrethroid spraying were conducted in Iquitos, Peru. In each, a central sprayed sector was surrounded by an unsprayed buffer sector. In 2013, spray and buffer sectors included 398 and 765 houses, respectively. Spraying reduced the mean number of adults captured per house by -83 percent relative to the pre-spray baseline survey. In the 2014 experiment, sprayed and buffer sectors included 1,117 and 1,049 houses, respectively. Here, the sprayed sector's number of adults per house was reduced -64 percent relative to baseline. Parity surveys in the sprayed sector during the 2014 spray period indicated an increase in the proportion of very young females. We also evaluated impacts of a 2014 citywide spray program by the local Ministry of Health, which reduced adult populations by -60 percent. In all cases, adult densities returned to near-baseline levels within one month.
   Conclusions/Significance
   Our results demonstrate that densities of adult Ae. aegypti can be reduced by experimental and municipal spraying programs. The finding that adult densities return to approximately pre-spray densities in less than a month is similar to results from previous, smaller scale experiments. Our results demonstrate that ULV spraying is best viewed as having a shortterm entomological effect. The epidemiological impact of ULV spraying will need evaluation in future trials that measure capacity of insecticide spraying to reduce human infection or disease.
C1 [Gunning, Christian E.; Okamoto, Kenichi W.; Gould, Fred] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC USA.
   [Astete, Helvio; Vasquez, Gissella M.; Morrison, Amy C.] Naval Med Res Unit 6, 3230 Lima Pl, Washington, DC USA.
   [Erhardt, Erik] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA.
   [Del Aguila, Clara; Pinedo, Raul; Cardenas, Roldan; Pacheco, Carlos; Chalco, Enrique] Peruvian Minist Hlth, Dept Environm Sanitat, Iquitos, Peru.
   [Rodriguez-Ferruci, Hugo] Loreto Reg Hlth Directorate, Iquitos, Peru.
   [Scott, Thomas W.; Morrison, Amy C.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
   [Lloyd, Alun L.] North Carolina State Univ, Biomath Grad Program, Raleigh, NC USA.
   [Lloyd, Alun L.] North Carolina State Univ, Dept Math, Raleigh, NC USA.
   [Gunning, Christian E.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.
RP Morrison, AC (corresponding author), Naval Med Res Unit 6, 3230 Lima Pl, Washington, DC USA.; Morrison, AC (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
EM amy.aegypti@gmail.com
RI Lloyd, Alun/AAN-6639-2020; Lloyd, Alun L/H-4944-2012
OI Lloyd, Alun/0000-0002-6389-6321; Erhardt, Erik/0000-0002-9817-4011;
   Gunning, Christian/0000-0001-6403-6553
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01-AI091980];
   W. M. Keck FoundationW.M. Keck Foundation; National Science
   FoundationNational Science Foundation (NSF) [RTG/DMS - 1246991,
   NSF-IGERT - 1068676]
FX This research was funded by the National Institutes of Health (NIH)
   grant R01-AI091980, the W. M. Keck Foundation, and the National Science
   Foundation (RTG/DMS - 1246991 and NSF-IGERT - 1068676). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Castro Mirley, 2007, Rev. salud pública, V9, P106, DOI 10.1590/S0124-00642007000100011
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Hayes CG, 1996, AM J TROP MED HYG, V55, P459, DOI 10.4269/ajtmh.1996.55.459
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   James S, 2011, SCIENCE, V334, P771, DOI 10.1126/science.1213798
   Koenraadt CJM, 2007, J MED ENTOMOL, V44, P65, DOI 10.1603/0022-2585(2007)44[65:SATPIT]2.0.CO;2
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   Legros M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022701
   Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Morrison A. C., 2003, American Journal of Tropical Medicine and Hygiene, V69, P539
   Morrison AC, 2006, ANN TROP MED PARASIT, V100, pS73, DOI 10.1179/136485906X105534
   Morrison AC, 2004, J MED ENTOMOL, V41, P502, DOI 10.1603/0022-2585-41.3.502
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Morrison A, 2005, AM J TROP MED HYG, V73, P326
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709
   Palomino-Salcedo M., 2014, ESTADO SUSCEPTIBILID
   PANT CP, 1974, B WORLD HEALTH ORGAN, V51, P409
   Paz-Soldan VA, 2011, AM J TROP MED HYG, V84, P208, DOI 10.4269/ajtmh.2011.09-0615
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Perich MJ, 2003, J AM MOSQUITO CONTR, V19, P58
   Perich MJ, 2001, J AM MOSQUITO CONTR, V17, P221
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiter P, 2001, GUIDELINES ASSESSING
   Reiter P, 2003, GUIAS EVALUACION EFI
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   Rocha C, 2009, AM J TROP MED HYG, V80, P656, DOI 10.4269/ajtmh.2009.80.656
   Runge-Ranzinger S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004916
   Schneider JR, 2004, J MED ENTOMOL, V41, P634, DOI 10.1603/0022-2585-41.4.634
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Scott TW, 1997, AM J TROP MED HYG, V57, P235, DOI 10.4269/ajtmh.1997.57.235
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilder-Smith A, 2016, LANCET INFECT DIS, V16, P629, DOI 10.1016/S1473-3099(16)00076-1
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
   Wolbers M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001937
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2009, GUID EFF TEST INS IN
   World Health Organization Regional Office for South East Asia, 2011, COMPR GUID PREV CONT
   Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08
NR 59
TC 8
Z9 8
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2018
VL 12
IS 4
AR e0006378
DI 10.1371/journal.pntd.0006378
PG 26
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH5QP
UT WOS:000433487700025
PM 29624581
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kuo, YP
   Tsai, KN
   Luo, YC
   Chung, PJ
   Su, YW
   Teng, Y
   Wu, MS
   Lin, YF
   Lai, CY
   Chuang, TH
   Dai, SS
   Tseng, FC
   Hsieh, CH
   Tsai, DJ
   Tsai, WT
   Chen, CH
   Yu, GY
AF Kuo, Yi-Ping
   Tsai, Kuen-Nan
   Luo, Yin-Chiu
   Chung, Pei-Jung
   Su, Yu-Wen
   Teng, Yu
   Wu, Ming-Sian
   Lin, Yu-Feng
   Lai, Chao-Yang
   Chuang, Tsung-Hsien
   Dai, Shih-Syong
   Tseng, Fan-Chen
   Hsieh, Cheng-Han
   Tsai, De-Jiun
   Tsai, Wan-Ting
   Chen, Chun-Hong
   Yu, Guann-Yi
TI Establishment of a mouse model for the complete mosquito-mediated
   transmission cycle of Zika virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID NECROSIS-FACTOR-ALPHA; DENGUE; INFECTION; COMPETENCE; CELLS
AB Zika virus (ZIKV) is primarily transmitted by Aedes mosquitoes in the subgenus Stegomyia but can also be transmitted sexually and vertically in humans. STAT1 is an important downstream factor that mediates type I and II interferon signaling. In the current study, we showed that mice with STAT1 knockout (Stat1(-/-)) were highly susceptible to ZIKV infection. As low as 5 plaque-forming units of ZIKV could cause viremia and death in Stat1(-/-) mice. ZIKV replication was initially detected in the spleen but subsequently spread to the brain with concomitant reduction of the virus in the spleen in the infected mice. Furthermore, ZIKV could be transmitted from mosquitoes to Stat1(-/-) mice back to mosquitoes and then to naive Stat1(-/-) mice. The 50% mosquito infectious dose of viremic Statl(-/-) mouse blood was close to 810 focus-forming units (ffu)/ml. Our further studies indicated that the activation of macrophages and conventional dendritic cells were likely critical for the resolution of ZIKV infection. The newly developed mouse and mosquito transmission models for ZIKV infection will be useful for the evaluation of antiviral drugs targeting the virus, vector, and host.
C1 [Kuo, Yi-Ping; Luo, Yin-Chiu; Chung, Pei-Jung; Wu, Ming-Sian; Lin, Yu-Feng; Dai, Shih-Syong; Tsai, De-Jiun; Tsai, Wan-Ting; Yu, Guann-Yi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.
   [Tsai, Kuen-Nan; Hsieh, Cheng-Han; Chen, Chun-Hong] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Taiwan.
   [Tsai, Kuen-Nan; Teng, Yu; Chen, Chun-Hong] Natl Hlth Res Inst, Natl Mosquitoborne Dis Control Res Ctr, Zhunan, Taiwan.
   [Su, Yu-Wen; Lai, Chao-Yang; Chuang, Tsung-Hsien] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Taiwan.
   [Tseng, Fan-Chen] Natl Taipei Univ Nursing & Hlth Sci, Coll Nursing, Taipei, Taiwan.
RP Yu, GY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.; Chen, CH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Taiwan.; Chen, CH (corresponding author), Natl Hlth Res Inst, Natl Mosquitoborne Dis Control Res Ctr, Zhunan, Taiwan.
EM chunhong@nhri.org.tw; guannyiy@nhri.org.tw
RI Tsai, Kuen-Nan/G-4606-2019; Su, Yu-Wen/E-8804-2010; Chuang,
   Tsung-Hsien/F-9679-2010; Yu, Guann-Yi/O-5139-2019
OI Yu, Guann-Yi/0000-0002-0580-8282; CHEN, CHUN-HONG/0000-0002-3028-5508
FU National Health Research Institutes (NHRI)National Health Research
   Institutes - Taiwan [IV-105-SP-03, MOHW105-TDU-M-212-000006,
   MR-106-PP-01]; Ministry of Science and Technology from Taiwan [MOST
   105-2321-B-400-006]
FX This study was supported by grants from the National Health Research
   Institutes (NHRI) (IV-105-SP-03, MOHW105-TDU-M-212-000006 and
   MR-106-PP-01) and the Ministry of Science and Technology (MOST
   105-2321-B-400-006) from Taiwan to GYY. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Secundino NFC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2286-2
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324
   Hsu AYH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17990
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11
   Zhu YB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01244-6
NR 37
TC 7
Z9 7
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2018
VL 12
IS 4
AR e0006417
DI 10.1371/journal.pntd.0006417
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH5QP
UT WOS:000433487700051
PM 29668683
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Katzelnick, LC
   Harris, E
AF Katzelnick, Leah C.
   Harris, Eva
TI The use of longitudinal cohorts for studies of dengue viral pathogenesis
   and protection
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID PRIMARY-SCHOOL CHILDREN; ANTIBODY-DEPENDENT ENHANCEMENT; ORIGINAL
   ANTIGENIC SIN; ZIKA VIRUS-INFECTION; KAMPHAENG-PHET; SYMPTOMATIC DENGUE;
   HEMORRHAGIC-FEVER; AEDES-AEGYPTI; RISK-FACTORS; NEUTRALIZING ANTIBODIES
AB In this review, we describe how longitudinal prospective community-based, school-based, and household-based cohort studies contribute to improving our knowledge of viral disease, focusing specifically on contributions to understanding and preventing dengue. We describe how longitudinal cohorts enable measurement of essential disease parameters and risk factors; provide insights into biological correlates of protection and disease risk; enable rapid application of novel biological and statistical technologies; lead to development of new interventions and inform vaccine trial design; serve as sentinels in outbreak conditions and facilitate development of critical diagnostic assays; enable holistic studies on disease in the context of other infections, comorbidities, and environmental risk factors; and build research capacity that strengthens national and global public health response and disease surveillance.
C1 [Katzelnick, Leah C.; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, 185 Li Ka Shing Ctr,1951 Oxford St, Berkeley, CA 94720 USA.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, 185 Li Ka Shing Ctr,1951 Oxford St, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P01AI106695]
FX This work was supported by National Institutes of Health grant
   P01AI106695. The funders had no involvement in the writing of this
   manuscript.
CR Ackerman ME, 2017, IMMUNOL REV, V275, P262, DOI 10.1111/imr.12503
   Alera MT, 2016, PLOS NEGLECT TROP D, V10, P1
   Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0
   Andrade DV, 2017, MBIO, V8, DOI [10.1128/mBio.01205-17, 10.1128/mbio.01205-17]
   Andrade P, 2018, HDB ELISPOT METHODS
   Arguello DF, 2015, AM J TROP MED HYG, V92, P486, DOI 10.4269/ajtmh.14-0231
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, P6
   Biswas HH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001562
   Buddhari D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003230
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331
   Cauchemez S, 2012, J R SOC INTERFACE, V9, P456, DOI 10.1098/rsif.2011.0379
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Clapham HE, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004951
   Clapham HE, 2016, J INFECT DIS, V213, P1428, DOI 10.1093/infdis/jiv759
   Clapham HE, 2017, PLOS NEGLECT TROP D, V11, P1, DOI DOI 10.1371/J0URNAL.PNTD
   Coloma J, 2008, ANN NY ACAD SCI, V1136, P358, DOI 10.1196/annals.1425.014
   Comach G, 2009, VECTOR-BORNE ZOONOT, V9, P87, DOI 10.1089/vbz.2007.0213
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Dayan G, 2015, AM J TROP MED HYG, V93, P18, DOI 10.4269/ajtmh.13-0663
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P785, DOI 10.1038/ni0715-785a
   Dhar-Chowdhury P, 2017, PLOS NEGLECT TROP D, V11, P1, DOI DOI 10.1371/J0URNAL.PNTD.0005475
   Endy TP, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00183
   Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975
   Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Fauci AS, 2015, NEW ENGL J MED, V373, P2197, DOI 10.1056/NEJMp1502020
   Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428
   FISCHER DB, 1970, YALE J BIOL MED, V42, P329
   Forshey BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004398
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gallichotte EN, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00380-16, 10.1128/msphere.00380-16]
   Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350
   Gibbons RV, 2013, VACCINE, V31, P4487, DOI 10.1016/j.vaccine.2013.07.082
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Gordon A, 2010, CLIN INFECT DIS, V50, P1462, DOI 10.1086/652647
   Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hadjilaou A, 2015, J IMMUNOL, V195, P3490, DOI 10.4049/jimmunol.1500918
   HALL CE, 1973, AM J EPIDEMIOL, V98, P365, DOI 10.1093/oxfordjournals.aje.a121566
   Halstead S.B., 1980, TOGAVIRUSES BIOL STR, p107e173
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead Scott B, 2002, Rev Cubana Med Trop, V54, P171
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   Helb DA, 2015, P NATL ACAD SCI USA, V112, pE4438, DOI 10.1073/pnas.1501705112
   Henein S, 2016, J INFECT DIS, V7292, P351
   Imai N, 2015, PLOS NEGLECT TROP D, V9, P1
   Jarman RG, 2008, J VIROL, V82, P5494, DOI 10.1128/JVI.02728-07
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Khuntirat B, 2015, J CLIN VIROL, V69, P78, DOI 10.1016/j.jcv.2015.05.025
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Kochel TJ, 2002, LANCET, V360, P310, DOI 10.1016/S0140-6736(02)09522-3
   Kosasih H, 2016, PLOS NEGLECT TROP D, V10, P1
   Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   L'Azou M, 2016, NEW ENGL J MED, V374, P1155, DOI 10.1056/NEJMoa1503877
   Lai CY, 2013, PLONEGL TROP DIS, V7, P1
   Laoprasopwattana K, 2005, J INFECT DIS, V192, P510, DOI 10.1086/431520
   Laoprasopwattana K, 2007, J INFECT DIS, V195, P1108, DOI 10.1086/512860
   Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702
   Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472
   Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822
   Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607
   Messer WB, 2016, J VIROL, V90, P5090, DOI 10.1128/JVI.00155-16
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   Mishra N, 2018, MBIO, V9, DOI 10.1128/mBio.00095-18
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Moodie Z, 2018, J INFECT DIS, V217, P742, DOI 10.1093/infdis/jix609
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Nguyen TKT, 2010, T ROY SOC TROP MED H, V104, P592, DOI 10.1016/j.trstmh.2010.06.003
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008
   Pasteur S, 2017, NEW ANAL LONG TERM D
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Porter KR, 2005, AM J TROP MED HYG, V72, P60, DOI 10.4269/ajtmh.2005.72.60
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Puschnik A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002274
   Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, P1
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Restrepo BN, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/120496
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333
   RUSSELL PK, 1968, AM J TROP MED HYG, V17, P600, DOI 10.4269/ajtmh.1968.17.600
   Sabchareon A, 2012, PLOS NEGLECT TROP D, V6, P2006
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015
   Shao J, 2017, AM SOC TROP MED HYG
   Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103
   Simon-Loriere E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5088
   Sirivichayakul C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-48
   Sirivichayakul C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001520
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Standish K, 2010, PLOS NEGLECT TROP D, V4, P2
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tam CC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002259
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   Tissera H, 2014, AM J TROP MED HYG, V91, P132, DOI 10.4269/ajtmh.13-0540
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Undurraga EA, 2017, AM J TROP MED HYG, V96, P887, DOI 10.4269/ajtmh.16-0488
   van Panhuis WG, 2010, J INFECT DIS, V202, P1002, DOI 10.1086/656141
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vong S, 2010, PLOS NEGLECT TROP D, V4, P2006
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, J INFECT DIS, V214, P986, DOI 10.1093/infdis/jiw099
   Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821
   Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wichmann O, 2011, PLOS NEGLECT TROP D, V5, P1
   Yoksan S, 2009, J CLIN VIROL, V46, pS13, DOI 10.1016/S1386-6532(09)70289-6
   Yoon IK, 2013, AM J TROP MED HYG, V89, P1081, DOI 10.4269/ajtmh.13-0424
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
   Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357
   Zompi S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001568
NR 139
TC 3
Z9 3
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD APR
PY 2018
VL 29
BP 51
EP 61
DI 10.1016/j.coviro.2018.03.004
PG 11
WC Virology
SC Virology
GA GG7LT
UT WOS:000432880400009
PM 29597086
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Davidson, RB
   Hendrix, J
   Geiss, BJ
   McCullagh, M
AF Davidson, Russell B.
   Hendrix, Josie
   Geiss, Brian J.
   McCullagh, Martin
TI Allostery in the dengue virus NS3 helicase: Insights into the NTPase
   cycle from molecular simulations
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID HEPATITIS-C VIRUS; RNA-STIMULATED NTPASE; YELLOW-FEVER VIRUS; ATP
   HYDROLYSIS; DYNAMICS SIMULATIONS; ZIKA VIRUS; PCRA HELICASE;
   NUCLEIC-ACID; SERINE-PROTEASE; MECHANISM
AB The C-terminus domain of non-structural 3 (NS3) protein of the Flaviviridae viruses (e.g. HCV, dengue, West Nile, Zika) is a nucleotide triphosphatase (NTPase) -dependent super-family 2 (SF2) helicase that unwinds double-stranded RNA while translocating along the nucleic polymer. Due to these functions, NS3 is an important target for antiviral development yet the biophysics of this enzyme are poorly understood. Microsecond-long molecular dynamic simulations of the dengue NS3 helicase domain are reported from which allosteric effects of RNA and NTPase substrates are observed. The presence of a bound single-stranded RNA catalytically enhances the phosphate hydrolysis reaction by affecting the dynamics and positioning of waters within the hydrolysis active site. Coupled with results from the simulations, electronic structure calculations of the reaction are used to quantify this enhancement to be a 150-fold increase, in qualitative agreement with the experimental enhancement factor of 10-100. Additionally, protein-RNA interactions exhibit NTPase substrate-induced allostery, where the presence of a nucleotide (e.g. ATP or ADP) structurally perturbs residues in direct contact with the phosphodiester backbone of the RNA. Residue-residue network analyses highlight pathways of short ranged interactions that connect the two active sites. These analyses identify motif V as a highly connected region of protein structure through which energy released from either active site is hypothesized to move, thereby inducing the observed allosteric effects. These results lay the foundation for the design of novel allosteric inhibitors of NS3.
C1 [Davidson, Russell B.; Hendrix, Josie; McCullagh, Martin] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
   [Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Geiss, Brian J.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
   [Hendrix, Josie] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
RP McCullagh, M (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
EM martin.mccullagh@colostate.edu
OI McCullagh, Martin/0000-0002-8603-4388; Davidson, Russell
   B./0000-0003-2364-4039
FU Colorado State University; National Science FoundationNational Science
   Foundation (NSF) [ACI-1548562];  [CHE160008]
FX This project was funded by start-up funds to Martin McCullagh from
   Colorado State University. This work used the Extreme Science and
   Engineering Discovery Environment (XSEDE), which is supported by
   National Science Foundation grant number ACI-1548562. We would
   specifically like to acknowledge the San Diego Supercomputer Center
   Comet and Pittsburgh Super Computing Bridges resources used under XSEDE
   allocation CHE160008 awarded to MM. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akola J, 2006, J PHYS CHEM B, V110, P8121, DOI 10.1021/jp054921d
   Akola J, 2003, J PHYS CHEM B, V107, P11774, DOI 10.1021/jp035538g
   Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034
   Banas P, 2010, J CHEM THEORY COMPUT, V6, P3836, DOI 10.1021/ct100481h
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004
   Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Borowski P, 2002, ACTA BIOCHIM POL, V49, P597
   Borowski P, 2001, J VIROL, V75, P3220, DOI 10.1128/JVI.75.7.3220-3229.2001
   Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167
   Case D.A., 2014, AMBER
   Cecchini M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000129
   Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045
   Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023
   Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908
   Dittrich M, 2007, TOP CURR CHEM, V268, P319, DOI 10.1007/128_2006_086
   Dittrich M, 2006, STRUCTURE, V14, P1345, DOI 10.1016/j.str.2006.06.017
   Doshi U, 2016, P NATL ACAD SCI USA, V113, P4735, DOI 10.1073/pnas.1523573113
   Duarte F, 2016, J AM CHEM SOC, V138, P10664, DOI 10.1021/jacs.6b06277
   Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331
   Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011
   Flechsig H, 2010, P NATL ACAD SCI USA, V107, P20875, DOI 10.1073/pnas.1014631107
   Freedman H, 2012, J CHEM THEORY COMPUT, V8, P3373, DOI 10.1021/ct3003282
   Frisch M.J., 2009, GAUSSIAN 09 REVISION
   Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412
   Gesell JJ, 2001, PROTEIN ENG, V14, P573, DOI 10.1093/protein/14.8.573
   Glaves R, 2012, J AM CHEM SOC, V134, P6995, DOI 10.1021/ja2101533
   Grigorenko BL, 2007, P NATL ACAD SCI USA, V104, P7057, DOI 10.1073/pnas.0701727104
   Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107
   Harrison CB, 2012, J CHEM THEORY COMPUT, V8, P2328, DOI 10.1021/ct200886j
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   Hopfner KP, 2007, CURR OPIN STRUC BIOL, V17, P87, DOI 10.1016/j.sbi.2006.11.003
   Hsu WL, 2016, J PHYS CHEM B, V120, P11102, DOI 10.1021/acs.jpcb.6b07332
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Kadare G, 1997, J VIROL, V71, P2583
   Kim MC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.073003
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   Kuo MD, 1996, J GEN VIROL, V77, P2077, DOI 10.1099/0022-1317-77-9-2077
   Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920
   Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200
   Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200
   Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Liu DJ, 2001, J BIOMOL NMR, V19, P283, DOI 10.1023/A:1011228507343
   Liu DJ, 2001, J MOL BIOL, V314, P543, DOI 10.1006/jmbi.2001.5146
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Ma W, 2015, J AM CHEM SOC, V137, P3031, DOI 10.1021/ja512605w
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Mastrangelo E, 2012, BIOCHEM BIOPH RES CO, V417, P84, DOI 10.1016/j.bbrc.2011.11.060
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   McCullagh M, 2014, J AM CHEM SOC, V136, P13053, DOI 10.1021/ja507169f
   McGrath MJ, 2013, J AM CHEM SOC, V135, P8908, DOI 10.1021/ja401540g
   Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262
   Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130
   Ndjomou J, 2015, ACS CHEM BIOL, V10, P1887, DOI 10.1021/acschembio.5b00101
   Okimoto N, 2001, BIOPHYS J, V81, P2786, DOI 10.1016/S0006-3495(01)75921-8
   Perez-Villa A, 2015, NUCLEIC ACIDS RES, V43, P8725, DOI 10.1093/nar/gkv872
   Pervushin KV, 1999, P NATL ACAD SCI USA, V96, P9607, DOI 10.1073/pnas.96.17.9607
   Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449
   Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908
   Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Rosta E, 2008, BIOCHEMISTRY-US, V47, P3725, DOI 10.1021/bi702106m
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Saeedi BJ, 2013, WIRES RNA, V4, P723, DOI 10.1002/wrna.1191
   Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05
   Schenker S, 2011, J CHEM THEORY COMPUT, V7, P3586, DOI 10.1021/ct2002013
   Sengupta D, 2005, STRUCTURE, V13, P849, DOI 10.1016/j.str.2005.03.010
   Seo MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4724
   Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704
   Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106
   Shadrick WR, 2013, BIOCHEMISTRY-US, V52, P6151, DOI 10.1021/bi4006495
   Smith SA, 2013, J COMPUT CHEM, V34, P558, DOI 10.1002/jcc.23165
   Stone J., 1998, EFFICIENT LIB PARALL
   Sun R, 2017, J CHEM THEORY COMPUT, V13, P2332, DOI 10.1021/acs.jctc.7b00077
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   TAO JS, 1992, P NATL ACAD SCI USA, V89, P2723, DOI 10.1073/pnas.89.7.2723
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Utama A, 2000, FEBS LETT, V465, P74, DOI 10.1016/S0014-5793(99)01705-6
   Van Wart AT, 2014, J CHEM THEORY COMPUT, V10, P511, DOI 10.1021/ct4008603
   VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a
   Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008
   WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993
   WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M
   Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107
   Yoshimoto K, 2010, BIOPHYS J, V98, P1449, DOI 10.1016/j.bpj.2009.12.4315
   Yu J, 2007, BIOPHYS J, V93, P3783, DOI 10.1529/biophysj.107.109546
   Yu J, 2006, BIOPHYS J, V91, P2097, DOI 10.1529/biophysj.106.088203
   Zalatan JG, 2006, J AM CHEM SOC, V128, P1293, DOI 10.1021/ja056528r
   Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x
   Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005
   Zheng WJ, 2007, PROTEINS, V67, P886, DOI 10.1002/prot.21326
NR 106
TC 9
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD APR
PY 2018
VL 14
IS 4
AR e1006103
DI 10.1371/journal.pcbi.1006103
PG 28
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA GF7SX
UT WOS:000432169600041
PM 29659571
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schiess, N
   Saylor, D
   Zunt, J
AF Schiess, Nicoline
   Saylor, Deanna
   Zunt, Joseph
TI Global Neurology: Navigating Career Possibilities
SO SEMINARS IN NEUROLOGY
LA English
DT Review
DE global neurology; global health neurology
ID EDUCATION; PROGRAM; AFRICA
AB Neurology has not typically been associated with international relief work; however, with the growth of chronic cardiovascular disease and stroke associated with unhealthy eating and sedentary ways, the appearance of new neurologic diseases, such as the Zika and West Nile viruses, and the high numbers of seizure disorders resulting from neuroinfectious diseases, more opportunities are arising for international and globally oriented neurologists. Multiple opportunities exist for developing a global clinician-educator career pathway, including private institutions, nongovernmental organizations, government-funded opportunities such as Medical Education Partnership Initiative, Fogarty and Fulbright Scholarships, and the American Academy of Neurology's Global Health Section. Furthermore, increasing research capacity in developing countries and increased funding opportunities for global health research have led to new opportunities for neurologists to establish global health research careers. These opportunities could not have come at a better time, as many faculty members have noted a particularly strong interest in global neurology from medical students and residents. Career categories and opportunities for neurologists desiring to work globally are discussed along with the emerging global neurologist academic pathway.
C1 [Schiess, Nicoline; Saylor, Deanna] Johns Hopkins Univ, Dept Neurol, 600 N Wolfe St,Meyer 6-113, Baltimore, MD 21287 USA.
   [Zunt, Joseph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
RP Schiess, N (corresponding author), Johns Hopkins Univ, Dept Neurol, 600 N Wolfe St,Meyer 6-113, Baltimore, MD 21287 USA.
EM nschies1@jhmi.edu
OI Saylor, Deanna/0000-0002-9297-0244; Schiess,
   Nicoline/0000-0002-0121-8453
CR Aarli JA, 2007, NEUROLOGY, V69, P1715, DOI 10.1212/01.wnl.0000285102.47543.02
   Birbeck GL, 2014, ANN NEUROL, V75, P805, DOI 10.1002/ana.24197
   Consortium of Universities for Global Health, GLOB HLTH ED RES
   Dhaliwal G, 2009, J GEN INTERN MED, V24, P771, DOI 10.1007/s11606-009-0967-z
   Fleisher Jori E, 2014, Neurol Clin Pract, V4, P239
   Fogarty International Center, INT RES SCI DEV AW I
   Fogarty International Center, GLOB BRAIN DIS RES
   Howlett WP, 2014, NEUROLOGY, V83, P654, DOI 10.1212/WNL.0000000000000682
   Lyons JL, 2014, NEUROLOGY, V82, P119, DOI 10.1212/WNL.0000000000000019
   MEPI coordinating center, MED ED PARTN IN SUMM
   Mullan F, 2012, HEALTH AFFAIR, V31, P1561, DOI 10.1377/hlthaff.2012.0219
   MURRAY CJL, 1996, GLOBAL BURDEN DIS, V1
   Olapade-Olaopa EO, 2014, ACAD MED, V89, pS19, DOI 10.1097/ACM.0000000000000345
   Panosian C, 2006, NEW ENGL J MED, V354, P1771, DOI 10.1056/NEJMp068035
   Roberts David H, 2014, Ann Am Thorac Soc, V11, P254, DOI 10.1513/AnnalsATS.201309-322OT
   Roberts M, 2006, JAMA-J AM MED ASSOC, V295, P1491, DOI 10.1001/jama.295.13.1491
   Schiess N, 2015, APPL CLIN RES CLIN T, V2, P2020
   Schiess N, 2017, ACAD PSYCHIATR, V41, P551, DOI 10.1007/s40596-016-0616-x
   Sheikh J I, 2013, INNOVATIONS GLOBAL M, P3
   Siddiqi OK, 2017, ANN NEUROL, V81, P167, DOI 10.1002/ana.24863
   WHO, MENT HLTH NEUR ATL R
   WHO, MENT HLTH NEUR PUBL
NR 22
TC 1
Z9 1
U1 0
U2 0
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0271-8235
EI 1098-9021
J9 SEMIN NEUROL
JI Semin. Neurol.
PD APR
PY 2018
VL 38
IS 2
BP 145
EP 151
DI 10.1055/s-0038-1647245
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA GG8AA
UT WOS:000432918700004
PM 29791940
DA 2020-07-08
ER

PT J
AU Munoz, LS
   Garcia, MA
   Gordon-Lipkin, E
   Parra, B
   Pardo, CA
AF Munoz, Laura S.
   Garcia, Maria A.
   Gordon-Lipkin, Eliza
   Parra, Beatriz
   Pardo, Carlos A.
TI Emerging Viral Infections and Their Impact on the Global Burden of
   Neurological Disease
SO SEMINARS IN NEUROLOGY
LA English
DT Review
DE emerging viral infection; viral diseases; encephalitis; myelitis
ID WEST-NILE-VIRUS; CENTRAL-NERVOUS-SYSTEM; RIFT-VALLEY FEVER;
   GUILLAIN-BARRE-SYNDROME; LA-CROSSE ENCEPHALITIS; NEW-YORK-CITY; ZIKA
   VIRUS; DENGUE VIRUS; CHIKUNGUNYA VIRUS; HENIPAVIRUS ENCEPHALITIS
AB Emerging viral infections of the nervous system represent a major global public health concern in the 21st century. They are caused primarily by RNA viruses and are mostly associated with acute or subacute encephalitis. The spectrum of associated central or peripheral nervous system disorders is broad, and results either from a direct viral effect or due to the host immune responses against the infection. Emerging viral infections impose substantial neurological morbidity and mortality, particularly in low- and middle-income regions. In the past five decades, vector-borne viruses primarily transmitted by arthropods, or arboviruses, have been responsible for epidemics with a high burden of neurological disease, like the 2015-2016 Zika virus epidemic in the Americas. Viruses that have become neurovirulent for humans after geographical expansion include West Nile, Dengue, and Zika viruses. Factors such as animal migration, disruption of ecological niches, and cross-species contact have caused old viruses to reappear and cause neurological disease, as is the case of Ebola virus. In addition to these biological challenges, current preventive strategies, vaccination, and diagnostic and therapeutic approaches remain limited. We review the clinical-virological features and global impact of the most relevant emerging viral infections of the nervous system as they are projected over the 21st century.
C1 [Munoz, Laura S.; Garcia, Maria A.; Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Munoz, Laura S.; Parra, Beatriz; Pardo, Carlos A.] NEAS, Sydney, NSW, Australia.
   [Garcia, Maria A.] Univ Los Andes, Hosp Univ Santa Fe Bogota, Sch Med, Bogota, Colombia.
   [Gordon-Lipkin, Eliza] Kennedy Krieger Inst, Dept Neurol & Dev Med, Baltimore, MD USA.
   [Parra, Beatriz] Univ Valle, Dept Microbiol, Cali, Colombia.
   [Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
RP Pardo, CA (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Pathol 627,600 N Wolfe St, Baltimore, MD 21287 USA.
EM cpardov1@jhmi.edu
RI Pardo, Carlos A./A-5192-2008
OI Pardo, Carlos A./0000-0002-4128-5335; Gordon-Lipkin,
   Eliza/0000-0003-3134-2591; Munoz Arcos, Laura Sofia/0000-0002-0229-9056
FU Bart McLean Fund for Neuroimmunology Research; Johns Hopkins Project
   Restore; European Union's Horizon Research and Innovation Programme
   [734584]
FX The Neuroviruses Emerging in the Americas Study (NEAS) is supported by
   the Bart McLean Fund for Neuroimmunology Research and the Johns Hopkins
   Project Restore. This work was partially funded by the European Union's
   Horizon 2020 Research and Innovation Programme under Grant Agreement no.
   734584.
CR Abdullah S, 2014, HAND CLINIC, V123, P663, DOI 10.1016/B978-0-444-53488-0.00032-8
   Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Alrajhi AA, 2004, EMERG INFECT DIS, V10, P554, DOI 10.3201/eid1003.020817
   BALFOUR HH, 1973, PEDIATRICS, V52, P680
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoi SK, 2014, J NEUROL SCI, V342, P36, DOI 10.1016/j.jns.2014.04.018
   Billioux B, 2015, ACCOUNTS LIBERIA REP
   Billioux BJ, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0573-x
   Breman JG, 2016, J INFECT DIS, V214, pS93, DOI 10.1093/infdis/jiw207
   Brilla R, 2004, J NEUROL SCI, V220, P37, DOI 10.1016/j.jns.2004.01.013
   Broder CC, 2012, CURR OPIN VIROL, V2, P176, DOI 10.1016/j.coviro.2012.02.016
   Burrow JNC, 1998, AUST NZ J MED, V28, P590, DOI 10.1111/j.1445-5994.1998.tb00653.x
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CDC, NONP ENT 2016
   Ceausu Em., 1997, Romanian Journal of Virology, V48, P3
   Centers for Disease Control and Prevention (CDC), PREV CONTR SEAS INFL
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chertow DS, 2016, ANN INTERN MED, V165, P301, DOI 10.7326/M15-3066
   Chowers MY, 2001, EMERG INFECT DIS, V7, P675
   Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Dando SJ, 2014, CLIN MICROBIOL REV, V27, P691, DOI 10.1128/CMR.00118-13
   DeBiasi RL, 2006, NAT CLIN PRACT NEURO, V2, P264, DOI 10.1038/ncpneuro0176
   Dennehy JJ, 2017, ANN NY ACAD SCI, V1389, P124, DOI 10.1111/nyas.13304
   Dhillon Paul, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-211062
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekstrand JJ, 2012, SEMIN PEDIATR NEUROL, V19, P96, DOI 10.1016/j.spen.2012.02.004
   Ekstrand JJ, 2010, ANN NEUROL, V68, P762, DOI 10.1002/ana.22184
   Eldridge BF, 2001, EMERG INFECT DIS, V7, P451, DOI 10.3201/eid0703.017316
   Erasmus JH, 2016, J INFECT DIS, V214, pS488, DOI 10.1093/infdis/jiw271
   GASSMANN M, 1988, BIOCHIM BIOPHYS ACTA, V951, P280, DOI 10.1016/0167-4781(88)90098-X
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701
   Goldsmith CS, 2013, EMERG INFECT DIS, V19, P886, DOI 10.3201/eid1906.130173
   Gonzales-Scarano F, 2014, HDB CLIN NEUROLOGY N, P123
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   HALL RA, 1995, J VIROL METHODS, V51, P201, DOI 10.1016/0166-0934(94)00105-P
   Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003709
   Hayes CG, 2001, ANN NY ACAD SCI, V951, P25
   Hazelton PR, 2003, EMERG INFECT DIS, V9, P294, DOI 10.3201/eid0903.020327
   Hemachudha T, 2013, LANCET NEUROL, V12, P498, DOI 10.1016/S1474-4422(13)70038-3
   Holmes EC, 2013, CURR OPIN VIROL, V3, P180, DOI 10.1016/j.coviro.2012.12.003
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182
   Howlett P, 2016, EMERG INFECT DIS, V22, P150, DOI 10.3201/eid2201.151212
   Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302
   Huang HI, 2015, VIRUSES-BASEL, V7, P6051, DOI 10.3390/v7112920
   Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jonhson R T, 1998, MENINGITIS ENCEPHALI
   Kanagarajan K, 2003, SOUTH MED J, V96, P600, DOI 10.1097/01.SMJ.0000054912.04257.DC
   Knipe D.M., 2013, FIELDS VIROLOGY
   Knox J, 2012, MED J AUSTRALIA, V196, P322, DOI 10.5694/mja11.11026
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Kramer T, 2013, VIRUSES-BASEL, V5, P678, DOI 10.3390/v5020678
   Kunishige M, 2004, NEUROLOGY, V63, P1980, DOI 10.1212/01.WNL.0000144194.29643.D0
   Lafon M, 2004, ARCH VIROL, P149
   Laine RF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6980
   Laothamatas J, 2003, AM J NEURORADIOL, V24, P1102
   Lecuit M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00025
   Lee N, 2010, EMERG INFECT DIS, V16, P139, DOI [10.3201/eid1601.090077, 10.3201/eid1601.090007]
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   Li J, 2003, ANN NEUROL, V53, P703, DOI 10.1002/ana.10575
   Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09
   Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Liu Kun, 2012, Zhonghua Yi Xue Za Zhi, V92, P1742
   Lyons J, 2013, CURR INFECT DIS REP, V15, P576, DOI 10.1007/s11908-013-0377-6
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747
   Mandell RB, 2010, HUM VACCINES, V6, P597, DOI 10.4161/hv.6.7.11761
   Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020
   Martin P, 2015, INTENS CARE MED, V41, P895, DOI 10.1007/s00134-015-3671-y
   McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971
   McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medicine, 2015, EM VIR DIS EM VIR DI
   MILES J. A. R., 1951, MED JOUR AUSTRALIA, V1, P799
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Neilson DE, 2010, CURR OPIN PEDIATR, V22, P751, DOI 10.1097/MOP.0b013e3283402bfe
   NIAID & NIH, 2016, NIAID EM INF DIS PAT
   NNDSS Annual Report Writing Grp, 2015, COMMUN DIS INTELL, V39, pE387
   Okumura A, 2011, EMERG INFECT DIS, V17, P1993, DOI 10.3201/eid1711.110649
   Olival KJ, 2005, J NEUROVIROL, V11, P441, DOI 10.1080/13550280591002450
   Ong KC, 2015, BRAIN PATHOL, V25, P605, DOI 10.1111/bpa.12278
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08
   Patrick S., 2010, Morbidity and Mortality Weekly Report, V59, P869
   Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Petrova VN, 2018, NAT REV MICROBIOL, V16, P47, DOI 10.1038/nrmicro.2017.118
   Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Prevention CfDCa, CROSS ENC 2016
   Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015
   RATNAM S, 1995, J CLIN MICROBIOL, V33, P811, DOI 10.1128/JCM.33.4.811-815.1995
   Rewar S, 2014, ANN GLOB HEALTH, V80, P444, DOI 10.1016/j.aogh.2015.02.005
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Sahu R, 2014, NEUROLOGY, V83, P1601, DOI 10.1212/WNL.0000000000000935
   Salzberg SL, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000251
   Samaan Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158364
   Sayao AL, 2004, CAN J NEUROL SCI, V31, P194, DOI 10.1017/S031716710005383X
   SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304
   Seet RCS, 2006, J CLIN VIROL, V35, P310, DOI 10.1016/j.jcv.2005.08.006
   Sejvar JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0021-2016
   Sejvar JJ, 2016, CLIN INFECT DIS, V63, P737, DOI 10.1093/cid/ciw372
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129
   Selvey LA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002656
   Shen WC, 1999, AM J NEURORADIOL, V20, P1889
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Smits SL, 2013, EMERG INFECT DIS, V19, P1511, DOI 10.3201/eid1909.130404
   Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Suryawanshi SD, 2009, INDIAN J MED RES, V129, P438
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tan V, 2013, MBIO, V4
   Taylor KG, 2014, J NEUROVIROL, V20, P150, DOI 10.1007/s13365-013-0186-6
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Teleron ALA, 2016, AM J MED, V129, P881, DOI 10.1016/j.amjmed.2016.03.021
   THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   Tilley PAG, 2006, J INFECT DIS, V193, P1361, DOI 10.1086/503577
   Tsai JP, 2013, NEUROCRIT CARE, V18, P118, DOI 10.1007/s12028-012-9796-8
   van Riel D, 2015, J PATHOL, V235, P277, DOI 10.1002/path.4461
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Wang SH, 2005, J CLIN NEUROSCI, V12, P822, DOI 10.1016/j.jocn.2004.10.010
   Wasay M, 2008, CLIN NEUROL NEUROSUR, V110, P635, DOI 10.1016/j.clineuro.2008.03.011
   WHO, RAB EP BURD DIS 2017
   WHO, HUM RAB 2016 UPD CAL
   WHO/PAHO, REG ZIK EP UPD AM MA
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Willoughby RE, 2015, INFECT DIS CLIN N AM, V29, P637, DOI 10.1016/j.idc.2015.07.006
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   World Health Organization, EFF TRIALS ZIKV VACC
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, RIFT VALL FEV WHO ME
   World Health Organization (WHO), UPD QUEST ANSW REL D
NR 155
TC 3
Z9 3
U1 1
U2 8
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0271-8235
EI 1098-9021
J9 SEMIN NEUROL
JI Semin. Neurol.
PD APR
PY 2018
VL 38
IS 2
BP 163
EP 175
DI 10.1055/s-0038-1647247
PG 13
WC Clinical Neurology
SC Neurosciences & Neurology
GA GG8AA
UT WOS:000432918700006
PM 29791942
DA 2020-07-08
ER

PT J
AU Reid, S
   Thompson, H
   Thakur, KT
AF Reid, Savina
   Thompson, Haley
   Thakur, Kiran T.
TI Nervous System Infections and the Global Traveler
SO SEMINARS IN NEUROLOGY
LA English
DT Review
DE emerging neurological infections; neurotropic infections in travelers;
   central nervous system infections; encephalitis; meningitis
ID ZIKA VIRUS-INFECTION; LONG-TERM SEQUELAE; JAPANESE ENCEPHALITIS;
   CEREBRAL MALARIA; PLASMODIUM-FALCIPARUM; BACTERIAL-MENINGITIS;
   NEUROLOGICAL COMPLICATIONS; MOLECULAR EPIDEMIOLOGY; CLIMATE-CHANGE;
   BIRTH-DEFECTS
AB Neurological complications of infectious diseases are associated with high rates of morbidity and mortality. It is imperative that neurologists be up-to-date on current developments including typical and atypical presentations of neurological infections in travelers, diagnostic and treatment recommendations, and emerging pathogen resistance patterns to avoid fatal outcomes and long-term sequelae. This article will address concepts of emerging and reemerging infectious diseases, and will provide updates on the neurological manifestations of select emerging and reemerging infections, including Ebola virus, bacterial meningitis, enterovirus 71, Zika virus, cerebral malaria, and Japanese encephalitis. Emerging and reemerging neurotropic infectious diseases, including Zika virus, have recently been major global health threats. Factors contributing to the emergence of infectious diseases include closer contact with zoonoses, population growth in cities, globalization, environmental changes, and the rise in antibiotic resistance. Serotype replacement of bacterial meningitis, the possibility of viral persistence in the central nervous system in Ebola virus, antibiotic resistance of malaria, and the evolution of neurovirulent strains of Zika virus display some of the developing challenges that accompany various neurotropic infectious diseases. Neurologists should be aware of the factors contributing to the emergence and reemergence of neurotropic infectious diseases. As emerging and reemerging neurotropic infectious continue to be a major global health security threat, clinicians should be aware of the risks to travelers and current guidelines on prevention and management.
C1 [Reid, Savina; Thakur, Kiran T.] Columbia Univ, Med Ctr, Dept Neurol, Div Crit Care & Hospitalist Neurol, New York, NY USA.
   [Thompson, Haley] New York Med Coll, Valhalla, NY 10595 USA.
RP Thakur, KT (corresponding author), Columbia Univ, Milstein Hosp, Med Ctr, Dept Neurol,Div Crit Care & Hospitalist Neurol, 177 Ft Washington Ave,8GS-300, New York, NY 10032 USA.
EM ktt2115@cumc.columbia.edu
CR Adriani KS, 2015, NETH J MED, V73, P53
   Agier L, 2017, INT J INFECT DIS, V54, P103, DOI 10.1016/j.ijid.2016.10.032
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Beare NAV, 2011, FUTURE MICROBIOL, V6, P349, DOI [10.2217/FMB.11.3, 10.2217/fmb.11.3]
   Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Billioux BJ, 2017, JAMA NEUROL, V74, P1141, DOI 10.1001/jamaneurol.2017.1460
   Billioux BJ, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0573-x
   Billioux BJ, 2016, NEUROTHERAPEUTICS, V13, P461, DOI 10.1007/s13311-016-0457-z
   Birbeck GL, 2010, LANCET NEUROL, V9, P1173, DOI 10.1016/S1474-4422(10)70270-2
   Bowen L, 2016, NEUROLOGY S, V86, pS53
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Burton M, 2004, TROP DOCT, V34, P214, DOI 10.1177/004947550403400409
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461
   Casas-Alba D, 2017, CLIN MICROBIOL INFEC, V23, P874, DOI 10.1016/j.cmi.2017.03.016
   Caswell RJ, 2017, INT J STD AIDS, V28, P1352, DOI 10.1177/0956462417703572
   Centers for Disease Control and Prevention, 2017, ADV TRAV SPEC NEEDS
   Centers for Disease Control and Prevention, 2016, NONP ENT OUTBR SURV
   Centers for Disease Control and Prevention, 2017, DIAGN TESTS ZIK VIR
   Centers for Disease Control and Prevention, 2017, INF DIS REL TRAV TUB
   Centers for Disease Control and Prevention, 2017, PREGN WOM
   Centers for Disease Control and Prevention, 2017, INF DIS REL TRAV JAP
   Centers for Disease Control and Prevention, 2017, VACC MED ADV
   Centers for Disease Control and Prevention, 2017, ZIK TRAV INF
   Centers for Disease Control and Prevention, 2015, JAP ENC VACC
   Centers for Disease Control and Prevention, 2017, 1 10 US PREGN WOM CO
   Centers for Disease Control and Prevention, 2017, INF DIS REL TRAV MAL
   Centers for Disease Control and Prevention, 2017, ZIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, 2015, EB FACT SHEET
   Centers for Disease Control and Prevention, 2015, EB DIAGN
   Centers for Disease Control and Prevention, 2016, EB VIR DIS DISTR MAP
   Centers for Disease Control and Prevention Zoonotic Diseases, ZOON DIS
   Centers for Disease Control and Prevetion-CDC, 2017, UPD GUID US LAB TEST
   Chandran A, 2011, PEDIATR INFECT DIS J, V30, P3, DOI 10.1097/INF.0b013e3181ef25f7
   Chang PC, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090890
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Chow FC, 2014, NEUROHOSPITALIST, V4, P173, DOI 10.1177/1941874414540685
   Chung CC, 2007, INFECTION, V35, P30, DOI 10.1007/s15010-007-6038-7
   Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0
   Cleaveland S, 2007, CURR TOP MICROBIOL, V315, P85
   Daily JP, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0583-8
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   de Crom SCM, 2016, EUR J PEDIATR, V175, P1023, DOI 10.1007/s00431-016-2725-7
   Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287
   Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1
   Dung NM, 2009, J NEUROL, V256, P2052, DOI 10.1007/s00415-009-5249-5
   Ellerbrok H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005570
   Engering A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.5
   EPA, 1996, SAN SEW OV
   Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939
   Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007
   Fischer WA, 2016, CLIN INFECT DIS, V62, P1272, DOI 10.1093/cid/ciw123
   Freedman DO, 2016, NEW ENGL J MED, V375, P247, DOI 10.1056/NEJMra1508815
   Graham JP, 2007, PUBLIC HEALTH REP, V122, P79, DOI 10.1177/003335490712200111
   Heckenberg Sebastiaan G B, 2014, Handb Clin Neurol, V121, P1361, DOI 10.1016/B978-0-7020-4088-7.00093-6
   HOKE CH, 1992, J INFECT DIS, V165, P631, DOI 10.1093/infdis/165.4.631
   Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7
   Idro R, 2010, PEDIATR RES, V68, P267, DOI [10.1203/PDR.0b013e3181eee738, 10.1203/00006450-201011001-00524]
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Jakka SR, 2006, FLUIDS BARRIERS CNS, V3, DOI 10.1186/1743-8454-3-8
   Johnson BW, 2016, AM J TROP MED HYG, V94, P820, DOI 10.4269/ajtmh.15-0631
   Kampondeni SD, 2013, AM J TROP MED HYG, V88, P542, DOI 10.4269/ajtmh.12-0538
   Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575
   Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3
   Ku LC, 2015, CLIN PERINATOL, V42, P29, DOI 10.1016/j.clp.2014.10.004
   Lee Kyung Yeon, 2016, Korean J Pediatr, V59, P395
   Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63
   Leibovitch EC, 2016, NEUROTHERAPEUTICS, V13, P562, DOI 10.1007/s13311-016-0453-3
   Liang L, 2017, ENVIRON INT, V103, P99, DOI 10.1016/j.envint.2017.03.011
   Mailand MT, 2017, J NEUROL, V264, P1035, DOI 10.1007/s00415-016-8263-4
   Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]
   Mandl JN, 2015, CELL, V160, P20, DOI 10.1016/j.cell.2014.12.003
   Maude RJ, 2009, T ROY SOC TROP MED H, V103, P665, DOI 10.1016/j.trstmh.2009.03.001
   McGill F, 2016, LANCET, V388, P3036, DOI 10.1016/S0140-6736(16)30654-7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modlin J F, 1987, Adv Pediatr Infect Dis, V2, P57
   Mohammed I, 2017, PATHOG GLOB HEALTH, V111, P1, DOI 10.1080/20477724.2016.1274068
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Morris G, 2018, MOL NEUROBIOL, V55, P4160, DOI 10.1007/s12035-017-0635-y
   Morse S. S., 2001, PLAGUES AND POLITICS, P8, DOI [DOI 10.1057/9780230524248_2, 10.1057/9780230524248_2]
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Mung'Ala-Odera V, 2004, AM J TROP MED HYG, V71, P64, DOI 10.4269/ajtmh.2004.71.64
   Namutangula B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-138
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   Ong KC, 2015, BRAIN PATHOL, V25, P614, DOI 10.1111/bpa.12279
   Ostfeld RS, 2009, CLIN MICROBIOL INFEC, V15, P40, DOI 10.1111/j.1469-0691.2008.02691.x
   Pan American Health Organization, 2017, REG ZIK EP UPD AM AU
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   ProMED, 2017, MOST REC AL
   Racaniello VR, 2004, J CLIN INVEST, V113, P796, DOI [10.1172/JCI21370, 10.1172/JCI200421370]
   Reed Z, 2016, VACCINE, V34, P2967, DOI 10.1016/j.vaccine.2016.02.077
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sahu PK, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00075
   Sarkari NBS, 2012, J NEUROL, V259, P47, DOI 10.1007/s00415-011-6118-6
   Schwartz E, 2003, NEW ENGL J MED, V349, P1510, DOI 10.1056/NEJMoa021592
   Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116
   Sinclair D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005967.pub4
   Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342
   Solomon T, 2002, BRAIN, V125, P1084, DOI 10.1093/brain/awf116
   Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2
   Sullivan KE, 2017, J CLIN IMMUNOL, V37, P650, DOI 10.1007/s10875-017-0426-2
   Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X
   Teoh HL, 2016, JAMA NEUROL, V73, P300, DOI 10.1001/jamaneurol.2015.4388
   UNWTO, 2016, UNWTO TOUR HIGHL
   UNWTO (U. nited N. ations W. orld T. ourism O. rganization), 2017, TOURISM HIGHLIGHTS
   Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7
   van de Beek D, 2016, CLIN MICROBIOL INFEC, V22, pS37, DOI 10.1016/j.cmi.2016.01.007
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Wei MW, 2017, J INFECT DIS, V215, P56, DOI 10.1093/infdis/jiw502
   WHO, 2015, GUID TREATM MAL
   Wilson MR, 2013, CURR OPIN NEUROL, V26, P301, DOI 10.1097/WCO.0b013e328360dd2b
   World Health Organization, 2012, HAND FOOT MOUTH DIS
   World Health Organization, 2011, GUID CLIN MAN PUBL H
   World Health Organization, 2017, MAL RESP ANT DRUG RE
   World Health Organization, 2017, TUB FACT SHEET
   World Health Organization, 2017, ZIK VIR
   World Health Organization, 2015, PREL REP 21 MAY 2015
   World Health Organization, 2017, DIS OUTBR NEWS DONS
   World Health Organization, 2017, INT TRAV HLTH JAP EN
   World Health Organization, 2017, EP MEN CONTR COUNTR
   World Health Organization, 2015, MEN MEN
   Yi EJ, 2017, CLIN EXP VACCINE RES, V6, P4, DOI [10.7774/cevr.2017.6.1.4, 10.7774/cevr.2017.6.1.4.]
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhang QL, 2014, PEDIATR INFECT DIS J, V33, P482, DOI 10.1097/INF.0000000000000194
NR 131
TC 0
Z9 0
U1 2
U2 7
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0271-8235
EI 1098-9021
J9 SEMIN NEUROL
JI Semin. Neurol.
PD APR
PY 2018
VL 38
IS 2
BP 247
EP 261
DI 10.1055/s-0038-1649335
PG 15
WC Clinical Neurology
SC Neurosciences & Neurology
GA GG8AA
UT WOS:000432918700015
PM 29791951
DA 2020-07-08
ER

PT J
AU Britt, WJ
AF Britt, William J.
TI Adverse outcomes of pregnancy-associated Zika virus infection
SO SEMINARS IN PERINATOLOGY
LA English
DT Review
DE Zika virus; Congenital Zika virus infection; Zika associated adverse
   outcomes of pregnancy
ID SMALL-MOLECULE INHIBITORS; FDA-APPROVED DRUG; DENGUE VIRUS; OPHTHALMIC
   MANIFESTATIONS; NEURAL PROGENITORS; CEREBRAL ORGANOIDS;
   CROSS-REACTIVITY; DIAGNOSTIC ASSAY; HUMAN-ANTIBODIES; VIRAL DYNAMICS
AB The spread of Zika virus to the Americas was accompanied by surge in the number of infants with CNS abnormalities leading to a declaration of a health emergency by the WHO. This was accompanied by significant responses from governmental health agencies in the United States and Europe that resulted in significant new information described in the natural history of this perinatal infection in a very short period of time. Although much has been learned about Zika virus infection during pregnancy, limitations of current diagnostics and the challenges for accurate serologic diagnosis of acute Zika virus infection has restricted our understanding of the natural history of this perinatal infection to infants born to women with clinical disease during pregnancy and to Zika exposed infants with obvious clinical stigmata of disease. Thus, the spectrum of disease in infants exposed to Zika virus during pregnancy remains to be defined. In contrast, observations in informative animal models of Zika virus infections have provided rational pathways for vaccine development and existing antiviral drug development programs for other flaviviruses have resulted in accelerated development for potential antiviral therapies. This brief review will highlight some of the current concepts of the natural history of Zika virus during pregnancy. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Britt, William J.] Univ Alabama Birmingham, Sch Med, Dept Pediat, Childrens Hosp Harbor Bldg 160, Birmingham, AL 35233 USA.
RP Britt, WJ (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Pediat, Childrens Hosp Harbor Bldg 160, Birmingham, AL 35233 USA.
EM wbritt@peds.uab.edu
FU NIH (NICHD)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [HD61959]
FX Supported in part by the NIH (NICHD) HD61959 (WJB).
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003
   Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   [Anonymous], 2015, EP AL NEUR SYNDR CON
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Araujo E, 2017, CURR OPIN OBSTET GYN, V29, P95, DOI 10.1097/GCO.0000000000000345
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brainer-Lima AM, BMJ CLIN RES ED, V353, pi1901
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Chimelli L, 2017, ACTA NEUROPATHOL
   Chimelli L, 2017, CHILDS NERV SYST
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva Pone MV, 2017, CHILDS NERV SYST
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   deSouza AS, 2017, CHILDS NERV SYST
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dreher AM, 2014, J PEDIATR-US, V164, P855, DOI 10.1016/j.jpeds.2013.12.007
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Driggers RW, 2016, N ENGL J MED
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   EYROLLEGUIGNOT D, 2016, LANCET, V387, P2125, DOI DOI 10.1016/50140-6736(16)00651-6.PUBMED
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gao GF, 2017, J VIROL, V91
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Joob B, 2017, AM J OBSTET GYNECOL, V217, P91, DOI 10.1016/j.ajog.2017.02.045
   Julu B, 2017, EMERG INFECT DIS J, V23
   Jurgens I, 2017, ACTA OPHTHALMOL
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Katzelnick LC, 2017, SCIENCE NEW YORK NY
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Leyser M, 2017, J NEUROL SCI, V372, P73, DOI 10.1016/j.jns.2016.11.030
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Ljungman P, 2017, CLIN INFECT DIS, V64, P87, DOI 10.1093/cid/ciw668
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Lustig Y, 2016, EUR SURVEILL, V21
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Marquezan MC, 2017, SURV OPHTHALMOL
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Mulkey SB, 2017, PEDIAT NEUROL
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2017, LANCET INFECT DIS
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Newman C, 2017, CURR OPIN VIROL, V25, P34, DOI 10.1016/j.coviro.2017.06.011
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Pessoa R, 2016, EUR SURVEILL, V21
   Petribu NCL, BR MED J, V359, pj4188
   Poretti A, 2016, AJNR AM J NEURORADIO
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ramalho FS, 2017, CLIN INFECT DIS, V65, P687, DOI 10.1093/cid/cix374
   Ramalho Rocha YR, 2016, PLOS CURR, V8
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Saad T, 2017, CHILDS NERV SYST
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Smith DE, 2016, NEUROL-CLIN PRACT, V6, P515, DOI 10.1212/CPJ.0000000000000307
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
   Sung C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004851
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vesnaver TV, 2017, BJOG-INT J OBSTET GY, V124, P521, DOI 10.1111/1471-0528.14423
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 172
TC 4
Z9 4
U1 0
U2 5
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0146-0005
EI 1558-075X
J9 SEMIN PERINATOL
JI Semin. Perinatol.
PD APR
PY 2018
VL 42
IS 3
BP 155
EP 167
DI 10.1053/j.semperi.2018.02.003
PG 13
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA GF4NI
UT WOS:000431939200003
PM 29523447
DA 2020-07-08
ER

PT J
AU Szaba, FM
   Tighe, M
   Kummer, LW
   Lanzer, KG
   Ward, JM
   Lanthier, P
   Kim, IJ
   Kuki, A
   Blackman, MA
   Thomas, SJ
   Lin, JS
AF Szaba, Frank M.
   Tighe, Michael
   Kummer, Lawrence W.
   Lanzer, Kathleen G.
   Ward, Jerrold M.
   Lanthier, Paula
   Kim, In-Jeong
   Kuki, Atsuo
   Blackman, Marcia A.
   Thomas, Stephen J.
   Lin, Jr-Shiuan
TI Zika virus infection in immunocompetent pregnant mice causes fetal
   damage and placental pathology in the absence of fetal infection
SO PLOS PATHOGENS
LA English
DT Article
ID EMERGENCE; PATHOGENESIS; PROTECTION; DISEASE; MODEL; TORCH; LEADS
AB Zika virus (ZIKV) infection during human pregnancy may cause diverse and serious congenital defects in the developing fetus. Previous efforts to generate animal models of human ZIKV infection and clinical symptoms often involved manipulating mice to impair their Type I interferon (IFN) signaling, thereby allowing enhanced infection and vertical transmission of virus to the embryo. Here, we show that even pregnant mice competent to generate Type I IFN responses that can limit ZIKV infection nonetheless develop profound placental pathology and high frequency of fetal demise. We consistently found that maternal ZIKV exposure led to placental pathology and that ZIKV RNA levels measured in maternal, placental or embryonic tissues were not predictive of the pathological effects seen in the embryos. Placental pathology included trophoblast hyperplasia in the labyrinth, trophoblast giant cell necrosis in the junctional zone, and loss of embryonic vessels. Our findings suggest that, in this context of limited infection, placental pathology rather than embryonic/fetal viral infection may be a stronger contributor to adverse pregnancy outcomes in mice. Our finding demonstrates that in immunocompetent mice, direct viral infection of the embryo is not essential for fetal demise. Our immunologically unmanipulated pregnancy mouse model provides a consistent and easily measurable congenital abnormality readout to assess fetal outcome, and may serve as an additional model to test prophylactic and therapeutic interventions to protect the fetus during pregnancy, and for studying the mechanisms of ZIKV congenital immunopathogenesis.
C1 [Szaba, Frank M.; Tighe, Michael; Kummer, Lawrence W.; Lanzer, Kathleen G.; Lanthier, Paula; Kim, In-Jeong; Kuki, Atsuo; Blackman, Marcia A.; Lin, Jr-Shiuan] Trudeau Inst, Saranac Lake, NY 12983 USA.
   [Ward, Jerrold M.] Global VetPathol, Montgomery Village, MD USA.
   [Thomas, Stephen J.] SUNY Upstate Med Univ, Syracuse, NY USA.
RP Lin, JS (corresponding author), Trudeau Inst, Saranac Lake, NY 12983 USA.
EM jslin@trudeauinstitute.org
FU Trudeau Institute
FX This work was supported by funding from Trudeau Institute. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pawitwar SS, 2017, J NEUROIMMUNE PHARM, V12, P371, DOI 10.1007/s11481-017-9743-8
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wenzel PL, 2007, GENE DEV, V21, P85, DOI 10.1101/gad.1485307
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 46
TC 34
Z9 34
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD APR
PY 2018
VL 14
IS 4
AR e1006994
DI 10.1371/journal.ppat.1006994
PG 26
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GE3TI
UT WOS:000431135400035
PM 29634758
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ruckert, C
   Ebel, GD
AF Ruckert, Claudia
   Ebel, Gregory D.
TI How Do Virus-Mosquito Interactions Lead to Viral Emergence?
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID WEST-NILE-VIRUS; VENEZUELAN EQUINE ENCEPHALITIS; SUBGENOMIC FLAVIVIRUS
   RNA; AEDES-ALBOPICTUS; ZIKA VIRUS; VECTOR COMPETENCE; MAYARO VIRUS;
   ARBOVIRUS INFECTION; SINGLE MUTATION; HUMAN-DISEASE
AB Arboviruses such as West Nile, Zika, chikungunya, dengue, and yellow fever viruses have become highly significant global pathogens through unexpected, explosive outbreaks. While the rapid progression and frequency of recent arbovirus outbreaks is associated with long-term changes in human behavior (globalization, urbanization, climate change), there are direct mosquito-virus interactions which drive shifts in host range and alter virus transmission. This review summarizes how virus-mosquito interactions are critical for these viruses to become global pathogens at molecular, physiological, evolutionary, and epidemiological scales. Integrated proactive approaches are required in order to effectively manage the emergence of mosquito-borne arboviruses, which appears likely to continue into the indefinite future.
C1 [Ruckert, Claudia; Ebel, Gregory D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
RP Ruckert, C; Ebel, GD (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM claudia.rueckert@colostate.edu; gregory.ebel@colostate.edu
OI Ruckert, Claudia/0000-0003-3732-6752
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI067380]
CR Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Alkan C, 2013, ANTIVIR RES, V100, P54, DOI 10.1016/j.antiviral.2013.07.005
   Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Attarzadeh-Yazdi G, 2009, J VIROL, V83, P5735, DOI 10.1128/JVI.02440-08
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bennett KE, 2005, GENETICS, V170, P185, DOI 10.1534/genetics.104.035634
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Brackney DE, 2015, J VIROL, V89, P4035, DOI 10.1128/JVI.02612-14
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brault AC, 2002, J VIROL, V76, P1718, DOI 10.1128/JVI.76.4.1718-1730.2002
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Carpenter S, 2013, ANTIVIR RES, V100, P102, DOI 10.1016/j.antiviral.2013.07.020
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   Danforth ME, 2016, J MED ENTOMOL, V53, P681, DOI 10.1093/jme/tjw013
   Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022
   Deardorff ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002335
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   Dong SZ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3775-6
   Eastwood G, 2017, AM J TROP MED HYG, V97, P1399, DOI 10.4269/ajtmh.17-0126
   Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   GRIMSTAD PR, 1991, J MED ENTOMOL, V28, P378, DOI 10.1093/jmedent/28.3.378
   Grubaugh ND, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew033
   Grubaugh ND, 2017, CELL REP, V19, P709, DOI 10.1016/j.celrep.2017.03.076
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Mansfield KL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00298
   Matysiak A, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8947067
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Mbaika S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0566-7
   Mercado-Curiel RF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-118
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   O'Neal ST, 2014, VIRUSES-BASEL, V6, P4314, DOI 10.3390/v6114314
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   PAULSON SL, 1991, J AM MOSQUITO CONTR, V7, P170
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Powers AM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005421
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Terradas G, 2017, CURR OPIN INSECT SCI, V22, P37, DOI 10.1016/j.cois.2017.05.005
   THOMAS RE, 1993, J MED ENTOMOL, V30, P326, DOI 10.1093/jmedent/30.2.326
   Trobaugh DW, 2014, NATURE, V506, P245, DOI 10.1038/nature12869
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Xiao FZ, 2014, ARCH VIROL, V159, P3053, DOI 10.1007/s00705-014-2051-1
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zellweger RELM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005471
NR 79
TC 16
Z9 17
U1 4
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD APR
PY 2018
VL 34
IS 4
BP 310
EP 321
DI 10.1016/j.pt.2017.12.004
PG 12
WC Parasitology
SC Parasitology
GA GF7QR
UT WOS:000432163800008
PM 29305089
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Becker, W
   Adams, LA
   Graham, B
   Wagner, GE
   Zangger, K
   Otting, G
   Nitsche, C
AF Becker, Walter
   Adams, Luke A.
   Graham, Bim
   Wagner, Gabriel E.
   Zangger, Klaus
   Otting, Gottfried
   Nitsche, Christoph
TI Trimethylsilyl tag for probing protein-ligand interactions by NMR
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE Dissociation constant; Lead discovery; Protein-ligand interactions; Slow
   exchange; Trimethylsilyl group
ID VIRUS NS2B-NS3 PROTEASE; BINDING; DENGUE; FK506; ZIKA; DISCOVERY;
   RESONANCE; PATHWAYS; DISTINCT
AB Protein-ligand titrations can readily be monitored with a trimethylsilyl (TMS) tag. Owing to the intensity, narrow line shape and unique chemical shift of a TMS group, dissociation constants can be determined from straightforward 1D H-1-NMR spectra not only in the fast but also in the slow exchange limit. The tag is easily attached to cysteine residues and a sensitive reporter of ligand binding also at sites where it does not interfere with ligand binding or catalytic efficiency of the target protein. Its utility is demonstrated for the Zika virus NS2B-NS3 protease and the human prolyl isomerase FK506 binding protein.
C1 [Becker, Walter; Otting, Gottfried; Nitsche, Christoph] Australian Natl Univ, Res Sch Chem, GPO Box 4, Canberra, ACT 2601, Australia.
   [Becker, Walter; Zangger, Klaus] Karl Franzens Univ Graz, Inst Chem, A-8010 Graz, Austria.
   [Adams, Luke A.; Graham, Bim] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.
   [Wagner, Gabriel E.] Med Univ Graz, Inst Hyg Microbiol & Environm Med, A-8010 Graz, Austria.
RP Nitsche, C (corresponding author), Australian Natl Univ, Res Sch Chem, GPO Box 4, Canberra, ACT 2601, Australia.
EM christoph.nitsche@anu.edu.au
RI Otting, Gottfried/H-8413-2014
OI Otting, Gottfried/0000-0002-0563-0146; Wagner, Gabriel
   E./0000-0002-5704-3955; Becker, Walter/0000-0002-4511-0698; Adams,
   Luke/0000-0002-8481-9819
FU Alexander von Humboldt FoundationAlexander von Humboldt Foundation;
   Australian Research CouncilAustralian Research Council; Austrian Science
   Fund (FWF)Austrian Science Fund (FWF) [W901]; NAWI Graz
FX x We thank Mr Mithun Chamikara Mahawaththa for mass spectrometry
   measurements and Professor Rolf Hilgenfeld for providing a sample of the
   substrate Bz-Nle-Lys-Lys-Arg-AMC. C.N. and G.O. thank the Alexander von
   Humboldt Foundation for a Feodor Lynen Fellowship and the Australian
   Research Council for a Laureate Fellowship, respectively. Financial
   project support by the Australian Research Council, the Austrian Science
   Fund (FWF) (DK Molecular Enzymology W901 to K.Z.) and by NAWI Graz is
   gratefully acknowledged.
CR Arntson KE, 2016, J MED CHEM, V59, P5158, DOI 10.1021/acs.jmedchem.5b01447
   BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bonner JM, 2017, CELL SIGNAL, V38, P97, DOI 10.1016/j.cellsig.2017.06.013
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Cellitti SE, 2008, J AM CHEM SOC, V130, P9268, DOI 10.1021/ja801602q
   Chen WN, 2016, J AM CHEM SOC, V138, P4539, DOI 10.1021/jacs.6b00416
   Chen WN, 2015, J AM CHEM SOC, V137, P4581, DOI 10.1021/jacs.5b01918
   Loh CT, 2018, J BIOMOL NMR, V71, P287, DOI 10.1007/s10858-017-0157-y
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Doak BC, 2016, PHARMACOL THERAPEUT, V167, P28, DOI 10.1016/j.pharmthera.2016.07.003
   Gossert AD, 2016, PROG NUCL MAG RES SP, V97, P82, DOI 10.1016/j.pnmrs.2016.09.001
   Jabar S, 2017, CHEM-EUR J, V23, P13033, DOI 10.1002/chem.201703531
   Jackson JC, 2007, J AM CHEM SOC, V129, P1160, DOI 10.1021/ja064661t
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lim L., 2016, BIORXIV
   Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w
   Nitsche C, 2018, CURR OPIN STRUC BIOL, V48, P16, DOI 10.1016/j.sbi.2017.09.001
   Nitsche C, 2017, CHEM COMMUN, V53, P10894, DOI 10.1039/c7cc06155b
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531
   SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0
NR 24
TC 3
Z9 3
U1 1
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD APR
PY 2018
VL 70
IS 4
BP 211
EP 218
DI 10.1007/s10858-018-0173-6
PG 8
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA GF9VQ
UT WOS:000432327600002
PM 29564580
DA 2020-07-08
ER

PT J
AU Raymond, A
   Jakus, J
AF Raymond, Adam
   Jakus, Jonathan
TI CEREBRAL INFARCTION AND REFRACTORY SEIZURES IN A NEONATE WITH SUSPECTED
   ZIKA VIRUS INFECTION
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE Zika; virus; stroke; seizures; congenital Zika syndrome
AB Congenital Zika syndrome is a set of congenital anomalies associated with Zika virus infection during pregnancy. We present the unique case of a neonate born to a suspected Zika virus-positive mother that developed an embolic stroke and medication-resistant seizures. This report may impact the evolving definition of congenital Zika syndrome.
C1 Touro Coll Med, New York, NY USA.
   Montefiore Nyack Hosp, Nyack, NY USA.
RP Raymond, A (corresponding author), Montefiore Nyack Hosp, Dept Obstet & Gynecol, 160 Midland Ave, Nyack, NY 10960 USA.
EM adam.raymond3@student.touro.edu
CR [Anonymous], 2015, PREGN BREASTF
   Baskin HJ, 2007, PEDIATR RADIOL, V37, P949, DOI 10.1007/s00247-007-0506-1
   Elbers J, 2011, PEDIATRICS, V127, pE722, DOI 10.1542/peds.2010-1490
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kang SK, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00173
   Pridjian G, 2016, BIRTH DEFECTS RES A, V106, P716, DOI 10.1002/bdra.23523
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Westerman MP, 2002, AM J HEMATOL, V69, P89, DOI 10.1002/ajh.10021
NR 8
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD APR
PY 2018
VL 37
IS 4
BP E112
EP E114
DI 10.1097/INF.0000000000001832
PG 4
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA GF1RP
UT WOS:000431713300007
PM 29140935
DA 2020-07-08
ER

PT J
AU Andres, JB
   Pezzuto, P
   Higa, LM
   Dias, AA
   Gomes, JCC
   Lopes, RT
   Dos Santos, TMP
   Barbosa, RV
   Lent, R
   Bellio, M
   Tanuri, A
   Garcez, PP
AF Andres, Jimena Barbeito
   Pezzuto, Paula
   Higa, Luiza M.
   Dias, Andre A.
   Gomes, Jessica C. C.
   Lopes, Ricardo T.
   Pires Dos Santos, Thais M.
   Barbosa, Rodrigo V.
   Lent, Roberto
   Bellio, Maria
   Tanuri, Amilcar
   Garcez, Patricia P.
TI Exploring brain phenotypic outcomes when Zika virus and protein
   undernutrition interact during early development
SO AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY
LA English
DT Meeting Abstract
CT 87th Annual Meeting of the
   American-Association-of-Physical-Anthropologists (AAPA)
CY APR 11-14, 2018
CL Austin, TX
SP Amer Assoc Phys Anthropologists
C1 [Andres, Jimena Barbeito; Gomes, Jessica C. C.; Barbosa, Rodrigo V.; Lent, Roberto; Garcez, Patricia P.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Pezzuto, Paula; Higa, Luiza M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Dias, Andre A.; Bellio, Maria] Univ Fed Rio de Janeiro, Microbiol Inst Paulo de Goes, Rio De Janeiro, Brazil.
   [Lopes, Ricardo T.; Pires Dos Santos, Thais M.] Univ Fed Rio de Janeiro, Ctr Technol, Nucl Instrumentat Lab, Rio De Janeiro, Brazil.
RI Bellio, Maria/N-8525-2018; Lopes, Ricardo T/O-8840-2014
OI Lopes, Ricardo T/0000-0001-7250-824X
FU AAPA Professional Development Award
FX This study was partially supported by the AAPA Professional Development
   Award received by Jimena Barbeito Andres
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-9483
EI 1096-8644
J9 AM J PHYS ANTHROPOL
JI Am. J. Phys. Anthropol.
PD APR
PY 2018
VL 165
SU 66
BP 18
EP 19
PG 2
WC Anthropology; Evolutionary Biology
SC Anthropology; Evolutionary Biology
GA GD6ZA
UT WOS:000430656800055
DA 2020-07-08
ER

PT J
AU Howells, ME
   Lynn, CD
AF Howells, Michaela E.
   Lynn, Christopher D.
TI Zika Virus and maternal stigmatization: Supporting maternal and child
   health through religious engagement in American Samoa
SO AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY
LA English
DT Meeting Abstract
CT 87th Annual Meeting of the
   American-Association-of-Physical-Anthropologists (AAPA)
CY APR 11-14, 2018
CL Austin, TX
SP Amer Assoc Phys Anthropologists
C1 [Howells, Michaela E.] Univ N Carolina, Anthropol, Wilmington, NC USA.
   [Lynn, Christopher D.] Univ Alabama, Anthropol, Tuscaloosa, AL 35487 USA.
FU University of North Carolina Wilmington
FX Funding was provided from the University of North Carolina Wilmington.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-9483
EI 1096-8644
J9 AM J PHYS ANTHROPOL
JI Am. J. Phys. Anthropol.
PD APR
PY 2018
VL 165
SU 66
BP 126
EP 126
PG 1
WC Anthropology; Evolutionary Biology
SC Anthropology; Evolutionary Biology
GA GD6ZA
UT WOS:000430656801216
DA 2020-07-08
ER

PT J
AU Lynn, CD
   Howells, M
   Sesepesara, M
AF Lynn, Christopher D.
   Howells, Michaela
   Sesepesara, Margaret
TI Fight the bite: Zika Virus, personal responsibility, maternal
   stigmatization, and disabled children in American Samoa
SO AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY
LA English
DT Meeting Abstract
CT 87th Annual Meeting of the
   American-Association-of-Physical-Anthropologists (AAPA)
CY APR 11-14, 2018
CL Austin, TX
SP Amer Assoc Phys Anthropologists
C1 [Lynn, Christopher D.] Univ Alabama, Anthropol, Tuscaloosa, AL 35487 USA.
   [Howells, Michaela] Univ N Carolina, Anthropol, Wilmington, NC USA.
   [Sesepesara, Margaret] Amer Samoa Dept Hlth, Nursing, Apia, Samoa.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-9483
EI 1096-8644
J9 AM J PHYS ANTHROPOL
JI Am. J. Phys. Anthropol.
PD APR
PY 2018
VL 165
SU 66
BP 163
EP 163
PG 1
WC Anthropology; Evolutionary Biology
SC Anthropology; Evolutionary Biology
GA GD6ZA
UT WOS:000430656802140
DA 2020-07-08
ER

PT J
AU Milich, KM
   Koestler, BJ
   Simmons, JH
   Di Fiore, A
   Williams, LE
   Dudley, JP
   Vanchiere, J
   Payne, SM
AF Milich, Krista M.
   Koestler, Benjamin J.
   Simmons, Joe H.
   Di Fiore, Anthony
   Williams, Lawrence E.
   Dudley, Jaquelin P.
   Vanchiere, John
   Payne, Shelley M.
TI Developing a fecal detection method for monitoring Zika virus in
   Neotropical primates
SO AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY
LA English
DT Meeting Abstract
CT 87th Annual Meeting of the
   American-Association-of-Physical-Anthropologists (AAPA)
CY APR 11-14, 2018
CL Austin, TX
SP Amer Assoc Phys Anthropologists
C1 [Milich, Krista M.] Washington Univ, Anthropol, St Louis, MO USA.
   [Milich, Krista M.; Di Fiore, Anthony] Univ Texas Austin, Anthropol, Austin, TX 78712 USA.
   [Koestler, Benjamin J.; Dudley, Jaquelin P.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.
   [Simmons, Joe H.; Williams, Lawrence E.; Payne, Shelley M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
   [Vanchiere, John] LSU Hlth Sci Ctr, Pediat, Shreveport, LA USA.
RI Vanchiere, John/AAD-8979-2019; Williams, Lawrence/AAD-6685-2020
OI Williams, Lawrence/0000-0003-2267-9918
FU National Science FoundationNational Science Foundation (NSF) [BCS
   1638822]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [P40OD010938]; University of Texas at Austin; University of Texas MD
   Anderson Cancer Research Center
FX Funding was provided by the National Science Foundation (BCS 1638822),
   the National Institutes of Health (P40OD010938), University of Texas at
   Austin, and University of Texas MD Anderson Cancer Research Center.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-9483
EI 1096-8644
J9 AM J PHYS ANTHROPOL
JI Am. J. Phys. Anthropol.
PD APR
PY 2018
VL 165
SU 66
BP 178
EP 178
PG 1
WC Anthropology; Evolutionary Biology
SC Anthropology; Evolutionary Biology
GA GD6ZA
UT WOS:000430656802198
DA 2020-07-08
ER

PT J
AU Foob, B
   Wiwanitkit, V
AF Foob, Beuy
   Wiwanitkit, Viroj
TI THE EYES AS A WINDOW TO IMPROVED UNDERSTANDING OF THE PRENATAL EFFECTS
   OF ZIKA VIRUS INFECTION
SO JOURNAL OF AAPOS
LA English
DT Letter
C1 [Foob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Foob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
CR Prakalapakorn SG, 2017, J AAPOS, V21, P259, DOI 10.1016/j.jaapos.2017.07.001
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V., 2017, EUR J INTERN MED
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD APR
PY 2018
VL 22
IS 2
BP 165
EP 166
DI 10.1016/j.jaapos.2017.07.219
PG 2
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA GE5TM
UT WOS:000431285000027
PM 29305314
OA Bronze
DA 2020-07-08
ER

PT J
AU Dong, SP
   Liang, QM
AF Dong, Shupeng
   Liang, Qiming
TI Recent Advances in Animal Models of Zika Virus Infection
SO VIROLOGICA SINICA
LA English
DT Review
DE Zika virus; Flavivirus; Rodent models; Non-human primate models
ID GUILLAIN-BARRE-SYNDROME; TOLL-LIKE RECEPTORS; MICE; LEADS; INOCULATION;
   DEFICIENT; MACAQUES; EXPOSURE; IMMUNITY; EMBRYOS
AB An infection by Zika virus (ZIKV), a mosquito-borne flavivirus, broke out in South American regions in 2015, and recently showed a tendency of spreading to North America and even worldwide. ZIKV was first detected in 1947 and only 14 human infection cases were reported until 2007. This virus was previously observed to cause only mild flu-like symptoms. However, recent ZIKV infections might be responsible for the increasing cases of neurological disorders such as Guillain-Barr, syndrome and congenital defects, including newborn microcephaly. Therefore, researchers have established several animal models to study ZIKV transmission and pathogenesis, and test therapeutic candidates. This review mainly summarizes the reported animal models of ZIKV infection, including mice and non-human primates.
C1 [Dong, Shupeng; Liang, Qiming] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai 200025, Peoples R China.
RP Liang, QM (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, Sch Med, Shanghai 200025, Peoples R China.
EM liangqiming@shsmu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31770176]; Program for Professor of Special
   Appointment (Eastern Scholar) at Shanghai Institutions of Higher
   learning; Shanghai Rising-Star Program [17QA1403200]
FX This work was supported by the National Natural Science Foundation of
   China (31770176), the Program for Professor of Special Appointment
   (Eastern Scholar) at Shanghai Institutions of Higher learning, and the
   Shanghai Rising-Star Program (17QA1403200) for QL.
CR Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Drake VJ, 2006, BIRTH DEFECTS RES A, V76, P66, DOI 10.1002/bdra.20202
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900
   Ko MSH, 2001, TRENDS BIOTECHNOL, V19, P511, DOI 10.1016/S0167-7799(01)01806-6
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Lugo-Roman LA, 2010, J MED PRIMATOL, V39, P41, DOI 10.1111/j.1600-0684.2009.00394.x
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thibodeaux BA, 2012, VACCINE, V30, P3180, DOI 10.1016/j.vaccine.2012.03.003
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Woodruff AM, 1931, AM J PATHOL, V7, P209
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 40
TC 4
Z9 4
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD APR
PY 2018
VL 33
IS 2
BP 125
EP 130
DI 10.1007/s12250-018-0007-4
PG 6
WC Virology
SC Virology
GA GE7KW
UT WOS:000431413000002
PM 29541942
OA Green Published
DA 2020-07-08
ER

PT J
AU Paixao, ES
   Leong, WY
   Rodrigues, LC
   Wilder-Smith, A
AF Paixao, Enny S.
   Leong, Wei-Yee
   Rodrigues, Laura C.
   Wilder-Smith, Annelies
TI Asymptomatic Prenatal Zika Virus Infection and Congenital Zika Syndrome
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE asymptomatic prenatal infection; congenital Zika syndrome; maternal
   infection; microcephaly; Zika
ID BIRTH-DEFECTS; PREGNANCY; INFANTS; BRAZIL; JANUARY
AB To investigate to what extent asymptomatic vs symptomatic prenatal Zika virus infections contribute to birth defects, we identified 3 prospective and 8 retrospective studies. The ratio varied greatly in the retrospective studies, most likely due to recruitment and recall bias. The prospective studies revealed a ratio of 1: 1 for asymptomatic vs symptomatic maternal Zika infections resulting in adverse fetal outcomes.
C1 [Paixao, Enny S.; Rodrigues, Laura C.; Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Infect Dis Epidemiol & Dept Dis Control, London, England.
   [Leong, Wei-Yee; Wilder-Smith, Annelies] Lee Kong Chian Sch Med, Singapore, Singapore.
   [Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.
RP Paixao, ES (corresponding author), London Sch Hyg & Trop Med, London, England.
EM enny.cruz@lshtm.ac.uk
FU European Union's Horizon Research and Innovation Programme under the
   ZikaPLAN [734584]; National Council for Scientific and Technological
   Development (CNPq-Brazil)National Council for Scientific and
   Technological Development (CNPq)
FX This study was partially funded by the European Union's Horizon 2020
   Research and Innovation Programme under the ZikaPLAN grant agreement No
   734584. E.P. was funded by the National Council for Scientific and
   Technological Development (CNPq-Brazil).
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Runge-Ranzinger S, 2016, TROP MED INT HEALTH, V19, P1116
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
NR 15
TC 12
Z9 12
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD APR
PY 2018
VL 5
IS 4
DI 10.1093/ofid/ofy073
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GE3XK
UT WOS:000431146000025
PM 29732381
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Raghunath, P
AF Raghunath, Pendru
TI Does Zika Virus Really Causes Microcephaly in Children Whose Mothers
   Became Infected with the Virus during Their Pregnancy?
SO IRANIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Letter
C1 [Raghunath, Pendru] Texila Amer Univ, Sch Med, Dept Microbiol, Georgetown, Guyana.
RP Raghunath, P (corresponding author), Texila Amer Univ, Sch Med, Dept Microbiol, Georgetown, Guyana.
EM gyraghunathreddyp@gmail.com
RI Pendru, Raghunath/A-5282-2017
OI Pendru, Raghunath/0000-0002-2852-5357
CR Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Nogueira FCS, 2016, ZIKA VIRUS MAY NOT B
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 2251-6085
EI 2251-6093
J9 IRAN J PUBLIC HEALTH
JI Iran J. Public Health
PD APR
PY 2018
VL 47
IS 4
BP 613
EP 614
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GE4MD
UT WOS:000431189100022
PM 29900151
DA 2020-07-08
ER

PT J
AU Gomez, MM
   de Abreu, FVS
   dos Santos, AAC
   de Mello, IS
   Santos, MP
   Ribeiro, IP
   Ferreira-de-Brito, A
   de Miranda, RM
   de Castro, MG
   Ribeiro, MS
   Laterriere, RD
   Aguiar, SF
   Meira, GLS
   Antunes, D
   Torres, PHM
   Mir, D
   Vicente, ACP
   Guimaraes, ACR
   Caffarena, ER
   Bello, G
   Lourenco-de-Oliveira, R
   Bonaldo, MC
AF Gomez, Mariela Martinez
   Santos de Abreu, Filipe Vieira
   Cunha dos Santos, Alexandre Araujo
   de Mello, Iasmim Silva
   Santos, Marta Pereira
   Ribeiro, Ieda Pereira
   Ferreira-de-Brito, Anielly
   de Miranda, Rafaella Moraes
   de Castro, Marcia Goncalves
   Ribeiro, Mario Sergio
   Laterriere Junior, Roberto da Costa
   Aguiar, Shirlei Ferreira
   Silva Meira, Guilherme Louzada
   Antunes, Deborah
   Monteiro Torres, Pedro Henrique
   Mir, Daiana
   Paulo Vicente, Ana Carolina
   Ramos Guimaraes, Ana Carolina
   Caffarena, Ernesto Raul
   Bello, Gonzalo
   Lourenco-de-Oliveira, Ricardo
   Bonaldo, Myrna Cristina
TI Genomic and structural features of the yellow fever virus from the
   2016-2017 Brazilian outbreak
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE yellow fever virus; 2016-2017 Brazilian outbreak; amino acid changes;
   genetic diversity; evolution
ID NS2B-NS3 PROTEASE; MOSAIC STRUCTURE; ZIKA VIRUS; NS3; RECOMBINATION;
   EMERGENCE; PROTEINS; ELECTROSTATICS; EVOLUTIONARY; PROTECTION
AB Southeastern Brazil has been suffering a rapid expansion of a severe sylvatic yellow fever virus (YFV) outbreak since late 2016, which has reached one of the most populated zones in Brazil and South America, heretofore a yellow fever-free zone for more than 70 years. In the current study, we describe the complete genome of 12 YFV samples from mosquitoes, humans and non-human primates from the Brazilian 2017 epidemic. All of the YFV sequences belong to the modern lineage (sub-lineage 1E) of South American genotype I, having been circulating for several months prior to the December 2016 detection. Our data confirm that viral strains associated with the most severe YF epidemic in South America in the last 70 years display unique amino acid substitutions that are mainly located in highly conserved positions in non-structural proteins. Our data also corroborate that YFV has spread southward into Rio de Janeiro state following two main sylvatic dispersion routes that converged at the border of the great metropolitan area comprising nearly 12 million unvaccinated inhabitants. Our original results can help public health authorities to guide the surveillance, prophylaxis and control measures required to face such a severe epidemiological problem. Finally, it will also inspire other workers to further investigate the epidemiological and biological significance of the amino acid polymorphisms detected in the Brazilian 2017 YFV strains.
C1 [Gomez, Mariela Martinez; Cunha dos Santos, Alexandre Araujo; de Mello, Iasmim Silva; Santos, Marta Pereira; Ribeiro, Ieda Pereira; Bonaldo, Myrna Cristina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Santos de Abreu, Filipe Vieira; Ferreira-de-Brito, Anielly; de Miranda, Rafaella Moraes; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Santos de Abreu, Filipe Vieira] Inst Fed Norte Minas Gerais, Salinas, MG, Brazil.
   [Ribeiro, Mario Sergio] Secretaria Estadual Saude, Superintendencia Vigilancia Epidemiol & Ambiental, Rio De Janeiro, Brazil.
   [Laterriere Junior, Roberto da Costa] Secretaria Estadual Saude Espirito Santo, Nucleo Especial Vigilancia Ambiental, Vitoria, Brazil.
   [Aguiar, Shirlei Ferreira; Silva Meira, Guilherme Louzada] Lab Cent Saude Publ Noel Nutels LACEN RJ, Rio De Janeiro, Brazil.
   [Antunes, Deborah; Monteiro Torres, Pedro Henrique; Caffarena, Ernesto Raul] Fundacao Oswaldo Cruz, Programa Computacao Cient PROCC, Rio De Janeiro, Brazil.
   [Mir, Daiana; Bello, Gonzalo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS Imunol Mol, Rio De Janeiro, Brazil.
   [Paulo Vicente, Ana Carolina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genet Mol Microorganismos, Rio De Janeiro, Brazil.
   [Ramos Guimaraes, Ana Carolina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, Rio De Janeiro, Brazil.
RP Bonaldo, MC (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.; Lourenco-de-Oliveira, R (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
EM lourenco@ioc.fiocruz; mbonaldo@ioc.fiocruz.br
RI Antunes, Deborah/O-2505-2019; Caffarena, Ernesto/O-5920-2019; Antunes,
   Deborah/P-5615-2018; Torres, Pedro Henrique Monteiro/C-7657-2015;
   Caffarena, Ernesto/G-4467-2011; , daiana/J-5515-2019; Guimaraes, Ana
   Carolina Ramos/P-7914-2018; Bello, Gonzalo/E-6842-2013
OI Antunes, Deborah/0000-0002-2927-0800; Caffarena,
   Ernesto/0000-0002-8353-3034; Antunes, Deborah/0000-0002-2927-0800;
   Torres, Pedro Henrique Monteiro/0000-0002-0945-1495; Caffarena,
   Ernesto/0000-0002-8353-3034; , daiana/0000-0002-3172-4867; Guimaraes,
   Ana Carolina Ramos/0000-0003-1260-543X; Ribeiro, Ivonizete
   Pires/0000-0003-0737-5430
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro [E-26/102.351/2013, E-26/201.335/2016]; Conselho Nacional
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [309577/2013-6, 440865/2016-6];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [88881130684/2016-00]; Institut Pasteur, Transversal Research Program
   (PTR) [528]
FX This work was funded by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (grants nos E-26/102.351/2013 and
   E-26/201.335/2016 to R.L.O.), Conselho Nacional Desenvolvimento
   Cientifico e Tecnologico [grants nos 309577/2013-6 (to R.L.O.) and
   440865/2016-6 (to M.C.B.)], Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (grant no. 88881130684/2016-00 to M.C.B.) and the
   Institut Pasteur, Transversal Research Program (PTR grant no. 528 to
   R.L.O.). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835
   Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Carpp LN, 2011, MICROBES INFECT, V13, P85, DOI 10.1016/j.micinf.2010.10.010
   Carrington CVF, 2013, INFECT GENET EVOL, V13, P198, DOI 10.1016/j.meegid.2012.08.015
   CAUSEY OR, 1950, AM J TROP MED, V30, P301
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cumberworth SL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12737
   de Souza RP, 2010, J MED VIROL, V82, P175, DOI 10.1002/jmv.21606
   Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   Dorigatti I, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.28.30572
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Environment BMot, 2017, MON BIOM
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fioravanti C., 2018, REV PESQUISA FAPESP
   Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573
   Health BMo, 2017, EM EP FEBR AM NO BRA
   (IBGE) BIoGaS, 2017, MAPAS
   Jung L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129789
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   Mathew A, 2014, FUTURE MICROBIOL, V9, P411, DOI 10.2217/fmb.13.171
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056
   Pan American Health Organization, 2017, EP UPD YELL FEV
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SMITH JM, 1992, J MOL EVOL, V34, P126
   Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Teramoto T, 2017, J BIOL CHEM, V292, P9465, DOI [10.1074/jbc.M117.775643, 10.1074/jbc.m117.775643]
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Wu RH, 2017, J VIROL, V91, DOI [10.1128/JVI.01836-16, 10.1128/jvi.01836-16]
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
NR 69
TC 16
Z9 16
U1 0
U2 3
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD APR
PY 2018
VL 99
IS 4
BP 536
EP 548
DI 10.1099/jgv.0.001033
PG 13
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GE2CH
UT WOS:000431022600011
PM 29469689
OA Bronze
DA 2020-07-08
ER

PT J
AU Neto, NNM
   Maia, JTD
   Zacarkim, MR
   Queiroz, I
   Labeaud, AD
   Aronoff, DM
AF Mendes Neto, Nilson N.
   da Silva Maia, Jessika Thais
   Zacarkim, Marcelo Rodrigues
   Queiroz, Igor
   Labeaud, Angelle Desiree
   Aronoff, David M.
TI Perinatal Case Fatality Rate Related to Congenital Zika Syndrome in
   Brazil: A Cross-Sectional Study
SO PEDIATRIC NEUROLOGY
LA English
DT Editorial Material
C1 [Mendes Neto, Nilson N.; da Silva Maia, Jessika Thais; Queiroz, Igor] UnP Laureate Int Univ, Dept Med, Natal, RN, Brazil.
   [Mendes Neto, Nilson N.] Univ Calif Davis, Extens Ctr, Davis, CA 95616 USA.
   [Zacarkim, Marcelo Rodrigues] Harvard Med Sch, Dept Med, Boston, MA USA.
   [Labeaud, Angelle Desiree] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.
   [Aronoff, David M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN USA.
RP Neto, NNM (corresponding author), Ave Gov Tarcisio Maia,1798 Bloco C,Ap 104, BR-59066035 Natal, RN, Brazil.
EM nmendes@ucdavis.edu
RI Neto, Nilson Nogueira Mendes/V-6717-2019
OI Neto, Nilson Nogueira Mendes/0000-0002-3626-189X; Aronoff,
   David/0000-0003-4587-6121
CR Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Neto NN, 2017, NEUROLOGY S, V88, pS40
NR 2
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD APR
PY 2018
VL 81
BP 47
EP 48
DI 10.1016/j.pediatrneurol.2017.11.012
PG 2
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA GE1RY
UT WOS:000430995600010
PM 29526344
OA Green Published
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Neuroimaging Findings in Normocephalic Zika Virus Infection
SO PEDIATRIC NEUROLOGY
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Orantes LD, 2020, NEUROLOGIA, V35, P160, DOI 10.1016/j.nrl.2017.07.019
   Landais A., 2017, J NEUROL SCI
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD APR
PY 2018
VL 81
BP 54
EP 54
DI 10.1016/j.pediatrneurol.2017.12.001
PG 1
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA GE1RY
UT WOS:000430995600014
PM 29661493
DA 2020-07-08
ER

PT J
AU Mulkey, SB
   Vezina, G
   Bulas, DI
   Khademian, Z
   Blask, A
   Kousa, Y
   Cristante, C
   Pesacreta, L
   du Plessis, AJ
   DeBiasi, RL
AF Mulkey, Sarah B.
   Vezina, Gilbert
   Bulas, Dorothy I.
   Khademian, Zarir
   Blask, Anna
   Kousa, Youssef
   Cristante, Caitlin
   Pesacreta, Lindsay
   du Plessis, Adre J.
   DeBiasi, Roberta L.
TI Neuroimaging Findings in Normocephalic Zika Virus Infection Response
SO PEDIATRIC NEUROLOGY
LA English
DT Letter
ID MRI
C1 [Mulkey, Sarah B.; Bulas, Dorothy I.; Cristante, Caitlin; Pesacreta, Lindsay; du Plessis, Adre J.] Childrens Natl Hlth Syst, Div Fetal & Transit Med, Washington, DC 20010 USA.
   [Mulkey, Sarah B.; du Plessis, Adre J.; DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Mulkey, Sarah B.; du Plessis, Adre J.] George Washington Univ, Sch Med & Hlth Sci, Dept Neurol, Washington, DC 20052 USA.
   [Vezina, Gilbert; Bulas, Dorothy I.; Khademian, Zarir; Blask, Anna] Childrens Natl Hlth Syst, Div Radiol, Washington, DC USA.
   [Kousa, Youssef] Childrens Natl Hlth Syst, Div Neurol, Washington, DC USA.
   [DeBiasi, Roberta L.] Childrens Natl Hlth Syst, Div Infect Dis, Washington, DC USA.
   [DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.
RP Mulkey, SB (corresponding author), Childrens Natl Hlth Syst, Div Fetal & Transit Med, Washington, DC 20010 USA.; Mulkey, SB (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.; Mulkey, SB (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Neurol, Washington, DC 20052 USA.
EM sbmulkey@childrensnational.org
RI Youssef A Kousa/AAR-3064-2020
OI Youssef A Kousa/0000-0001-6049-8144
CR Beslow LA, 2008, PEDIATR RADIOL, V38, P694, DOI 10.1007/s00247-008-0763-7
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Jaremko JL, 2011, EUR J RADIOL, V80, P821, DOI 10.1016/j.ejrad.2010.10.017
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Saremi F, 2005, AM J ROENTGENOL, V185, P1487, DOI 10.2214/AJR.04.1518
NR 5
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD APR
PY 2018
VL 81
BP 55
EP 56
DI 10.1016/j.pediatrneurol.2018.01.006
PG 2
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA GE1RY
UT WOS:000430995600015
PM 29661494
DA 2020-07-08
ER

PT J
AU Sood, SK
   Mahajan, I
AF Sood, Sandeep K.
   Mahajan, Isha
TI A Fog-Based Healthcare Framework for Chikungunya
SO IEEE INTERNET OF THINGS JOURNAL
LA English
DT Article
DE Chikungunya; cloud computing (CC); decision tree; fog computing (FOC);
   temporal network analysis (TNA)
ID VIRUSES; DENGUE; ZIKA
AB Chikungunya virus is an infection which is transmitted to humans by the bite of Aedes agypti and Aedes albopictis mosquitoes. It causes deterioration in health leading to multiorgan failure. Diagnostic tests for this virus are not easily available and affordable in developing countries. The medical technologies are not so efficient in diagnosing and preventing the outbreak of Chikungunya virus. Healthcare services based on a fog-cloud technology are emerging as a proactive and effective solution to provide remote detection and monitoring of users. A fog assisted healthcare system can be used to diagnose users infected by Chikungunya virus in an initial state of their infection so that proper treatment can be given to them on time to enable fast recovery. In this paper, a fog assisted cloud-based healthcare system is designed to diagnose and prevent the outbreak of this virus. Initially, a decision tree is used to classify the category of user's infection depending on his/her health symptoms and diagnostic alerts are immediately generated on the user's mobile phone from fog layer. Furthermore, the state of Chikungunya virus outbreak is represented using temporal network analysis (TNA) on cloud layer using proximity data. Various outbreak metrics from TNA graph are calculated which indicate the probability to receive or transmit Chikungunya infection to human beings. Results depict that J48 decision tree classifier has higher accuracy and lower response time in determining the level of Chikungunya virus infection as compared to other classification algorithms. Moreover, alert generation based on real-time healthcare data further enhances the utility of the proposed system.
C1 [Sood, Sandeep K.; Mahajan, Isha] Guru Nanak Dev Univ Reg Campus, Dept Comp Sci & Engn, Gurdaspur 143521, India.
RP Mahajan, I (corresponding author), Guru Nanak Dev Univ Reg Campus, Dept Comp Sci & Engn, Gurdaspur 143521, India.
EM san1198@gmail.com; isha_3883@yahoo.co.in
OI Singh, Kiran Deep/0000-0002-8154-0986
CR Ahmad M, 2016, J SUPERCOMPUT, V72, P3677, DOI 10.1007/s11227-016-1634-x
   Beltran-Silva S. L., 2018, REV MED HOSP GEN MEX, V81, P146, DOI [10.1016/j.hgmx.2016.09.011, DOI 10.1016/J.HGMX.2016.09.011]
   Blonder B, 2012, METHODS ECOL EVOL, V3, P958, DOI 10.1111/j.2041-210X.2012.00236.x
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Chen HL, 2018, IEEE INTERNET THINGS, V5, P2915, DOI 10.1109/JIOT.2017.2752239
   Data Catalog, SURF AIR TEMP
   DHS Program Demographic and Health Surveys, SURV DAT FIL
   Fu JC, 2016, PHYSICA A, V444, P428, DOI 10.1016/j.physa.2015.09.091
   Hall M., 2009, ACM SIGKDD EXPLOR NE, V38, P10
   Jain J, 2016, ACTA TROP, V162, P46, DOI 10.1016/j.actatropica.2016.06.004
   Moosavi SR, 2016, FUTURE GENER COMP SY, V64, P108, DOI 10.1016/j.future.2016.02.020
   Murugan SB, 2016, ASIAN PAC J TROP MED, V9, P910, DOI 10.1016/j.apjtm.2016.07.020
   Nandyala C., 2016, INT J SMART HOME, V10, P187, DOI DOI 10.14257/IJSH.2016.10.2.18
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Rahmani AM, 2018, FUTURE GENER COMP SY, V78, P641, DOI 10.1016/j.future.2017.02.014
   Socio Patterns, PRIM SCH TEMP NETW D
   Gia TN, 2015, CIT/IUCC/DASC/PICOM 2015 IEEE INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION TECHNOLOGY - UBIQUITOUS COMPUTING AND COMMUNICATIONS - DEPENDABLE, AUTONOMIC AND SECURE COMPUTING - PERVASIVE INTELLIGENCE AND COMPUTING, P356, DOI 10.1109/CIT/IUCC/DASC/PICOM.2015.51
   W.H.O, CHIK
   World Health Organization: Media Center, CHIK
   Xu BY, 2017, ENTERP INF SYST-UK, V11, P17, DOI 10.1080/17517575.2015.1053416
   Zhao YH, 2008, ADV SPACE RES, V41, P1955, DOI 10.1016/j.asr.2007.07.020
NR 21
TC 27
Z9 27
U1 0
U2 8
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 2327-4662
J9 IEEE INTERNET THINGS
JI IEEE Internet Things J.
PD APR
PY 2018
VL 5
IS 2
SI SI
BP 794
EP 801
DI 10.1109/JIOT.2017.2768407
PG 8
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA GC7KD
UT WOS:000429971100033
DA 2020-07-08
ER

PT J
AU Boama, V
   Guinto, VT
   Sosa, CG
AF Boama, Vincent
   Guinto, Valerie T.
   Sosa, Claudio G.
TI Contemporary Issues in Women's Health Abstracts
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Editorial Material
ID ZIKA VIRUS-INFECTION; TRANEXAMIC ACID; ULTRASOUND
C1 [Boama, Vincent] Sidra Med & Res Ctr, Dept Obstet & Gynecol, Doha, Qatar.
   [Guinto, Valerie T.] Univ Philippines, St Lukes Med Ctr Global City, Dept Obstet & Gynaecol, Philippine Gen Hosp, Manila, Philippines.
   [Sosa, Claudio G.] Univ Uruguay, Dept Obstet & Gynecol, Sch Med, Montevideo, Uruguay.
RP Boama, V (corresponding author), Sidra Med & Res Ctr, Dept Obstet & Gynecol, Doha, Qatar.; Guinto, VT (corresponding author), Univ Philippines, St Lukes Med Ctr Global City, Dept Obstet & Gynaecol, Philippine Gen Hosp, Manila, Philippines.; Sosa, CG (corresponding author), Univ Uruguay, Dept Obstet & Gynecol, Sch Med, Montevideo, Uruguay.
EM vincent.boama2015@gmail.com; laireguinto@gmail.com; sosaclau@gmail.com
CR Bultez T, 2016, ULTRASOUND OBST GYN, V48, P86, DOI 10.1002/uog.14951
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Hehir MP, 2013, EUR J OBSTET GYN R B, V171, P40, DOI 10.1016/j.ejogrb.2013.08.015
   Kahrs BH, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.03.009
   Kasbaoui S, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.007
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4
   Vogel JP, 2018, LANCET GLOB HEALTH, V6, pE18, DOI 10.1016/S2214-109X(17)30428-X
NR 8
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD APR
PY 2018
VL 141
IS 1
BP 2
EP 4
DI 10.1002/ijgo.12437
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FY5HM
UT WOS:000426857900002
PM 29388219
OA Bronze
DA 2020-07-08
ER

PT J
AU Alyahya, SA
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Mothana, RA
   Al-anbr, MN
   Vaseeharan, B
   Ishwarya, R
   Yazhiniprabha, M
   Benelli, G
AF Alyahya, Sarni A.
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Mothana, Ramzi A.
   Al-anbr, Mohammed N.
   Vaseeharan, Baskaralingam
   Ishwarya, Ramachandran
   Yazhiniprabha, Mariappan
   Benelli, Giovanni
TI Swift fabrication of Ag nanostructures using a colloidal solution of
   Holostemma ada-kodien (Apocynaceae) - Antibiofilm potential,
   insecticidal activity against mosquitoes and non-target impact on water
   bugs
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Antimicrobial drugs; Dengue; Zika virus; Malaria; SEM; TEM; XRD;
   Non-target toxicity
ID ZINC-OXIDE NANOPARTICLES; SILVER NANOPARTICLES; AEDES-AEGYPTI; GREEN
   SYNTHESIS; ANOPHELES-STEPHENSI; LARVICIDAL ACTIVITY; VECTOR CONTROL;
   FRUIT EXTRACT; LEAF EXTRACT; ZIKA VIRUS
AB Recent research in entomology and parasitology focused on the efficacy of green fabricated nanomaterials as novel insecticides. In this study, we synthesized poly-dispersed and stable silver nanoparticles (AgNPs) using the leaf extract of Holostemma ada-kodien. The nanostructures were characterized by ultraviolet-visible spectroscopy, Fourier-transform infrared spectroscopy, scanning electron microscopy, transmission electron microscopy, energy dispersive X-ray, and X-ray diffraction analysis. The efficacy of H. ada-kodien leaf extract and AgNPs in vector control was evaluated against the mosquitoes Anopheles stephensi, Aedes aegypti, and Culex quinque-fasciatus, which act as major vectors of important parasitic and arboviral diseases. AgNPs showed higher toxicity if compared to the H. ada-kodien leaf aqueous extract, LC50 towards larvae of A. stephensi, A. aegypti, and C. quinquefasciatus were 12.18, 13.30, and 14.70 mu g/mL, respectively. When the AgNPs were tested on non-target water bugs, Diplonychus indicus, the LC50 value was 623.48 mu g/mL. Furthermore, 100 mu l/mL of AgNPs achieved significant antimicrobial activity against Bacillus pumilus, Enterococcus faecalis, Pseudomonas aeruginosa, Proteus vulgaris, and Candida albicans. Light and confocal laser scanning microscopy highlighted a major impact of the H. ada-kodien-synthesized AgNPs on the external topography and architecture of microbial biofilms, both on Gram-positive and Gram-negative bacteria. Overall, this study sheds light on the insecticidal and antibiofilm potential of H. ada-kodien-synthesized AgNPs, a potential green resource for the rapid synthesis of polydispersed and highly stable AgNPs.
C1 [Alyahya, Sarni A.] King Abdulaziz City Sci & Technol, Natl Ctr Biotechnol, Riyadh 11442, Saudi Arabia.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Govt Coll Women, Dept Zool, Kumbakonam 612001, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.; Al-anbr, Mohammed N.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Mothana, Ramzi A.] King Saud Univ, Dept Pharmacognosy, Coll Pharm, Riyadh 11451, Saudi Arabia.
   [Vaseeharan, Baskaralingam; Ishwarya, Ramachandran; Yazhiniprabha, Mariappan] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Block,6th Floor, Karaikkudi 630003, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI Mothana, Ramzi Ahmed/D-8740-2015; /L-2836-2013; GOVINDARAJAN,
   MARIMUTHU/A-8070-2019; Khaled, Jamal/D-8188-2017; Alharbi, Naiyf
   S/B-9402-2019
OI Mothana, Ramzi Ahmed/0000-0003-4220-7854; /0000-0001-7018-5379;
   GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; 
FU King Saud UniversityDeanship of Scientific Research at King Saud
   University [RG-1438-091]
FX The authors extend their appreciation to the Deanship of Scientific
   Research at King Saud University for funding this work through research
   group No. RG-1438-091.
CR AlQahtani FS, 2017, J ASIA-PAC ENTOMOL, V20, P157, DOI 10.1016/j.aspen.2016.12.004
   Amer A, 2006, PARASITOL RES, V99, P478, DOI 10.1007/s00436-006-0184-1
   Azarudeen RMST, 2017, J CLUST SCI, V28, P369, DOI 10.1007/s10876-016-1103-y
   Ba Y, 2005, J MED ENTOMOL, V42, P739, DOI 10.1603/0022-2585(2005)042[0739:AOBOTR]2.0.CO;2
   Banumathi B, 2017, J CLUST SCI, V28, P2857, DOI 10.1007/s10876-017-1263-4
   Banumathi B, 2017, PARASITOL RES, V116, P1637, DOI 10.1007/s00436-017-5438-6
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10283, DOI 10.1007/s11356-017-8898-4
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10184, DOI 10.1007/s11356-017-9752-4
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P637, DOI 10.1007/s10876-017-1159-3
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bernhard L, 2003, ALTERN APPROACH PHYS, V89, P743, DOI DOI 10.1016/S0031-9406(05)60500-7
   Bhuvaneswari R, 2016, J KING SAUD UNIV SCI, V28, P318, DOI 10.1016/j.jksus.2015.10.006
   Dharumadurai Dhanasekaran, 2013, Asian Pacific Journal of Tropical Disease, V3, P174
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Elemike EE, 2017, MAT SCI ENG C-MATER, V75, P980, DOI 10.1016/j.msec.2017.02.161
   Elumalai D., 2016, ENG AGR ENV FOOD EAE, V9, P1, DOI [DOI 10.1016/j.eaef.2015.08.002, DOI 10.1016/J.EAEF.2015.08.002]
   Elumalai Devan, 2017, Parasite Epidemiol Control, V2, P15, DOI 10.1016/j.parepi.2017.09.001
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Feng Y, 2016, NANOSCALE, V8, P13223, DOI 10.1039/c6nr03317b
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Gopinath K, 2016, MICROB PATHOGENESIS, V101, P1, DOI 10.1016/j.micpath.2016.10.011
   Govindarajan M, 2005, Trop Biomed, V22, P1
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2011, PARASITOL RES, V109, P93, DOI 10.1007/s00436-010-2224-0
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hao Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01332
   Huber H., 1983, REVISED HDB FLORA CE, P81
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Ishwarya R, 2018, J PHOTOCH PHOTOBIO B, V178, P249, DOI 10.1016/j.jphotobiol.2017.11.006
   Jiang GM, 2013, J HAZARD MATER, V250, P91, DOI 10.1016/j.jhazmat.2013.01.047
   Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014
   Lee SE, 2001, AGR CHEM BIOTECHNOL, V44, P105
   Liu Nannan, 2006, Insect Science, V13, P159, DOI 10.1111/j.1744-7917.2006.00078.x
   Malaikozhundan B, 2017, MICROB PATHOGENESIS, V111, P316, DOI 10.1016/j.micpath.2017.08.039
   Malaikozhundan B, 2017, MICROB PATHOGENESIS, V104, P268, DOI 10.1016/j.micpath.2017.01.029
   Malaikozhundan B, 2016, BIOCATAL AGR BIOTECH, V8, P189, DOI 10.1016/j.bcab.2016.09.007
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Mohapatra B, 2015, J ALLOY COMPD, V637, P119, DOI 10.1016/j.jallcom.2015.02.206
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Nagaraja B.M., 2004, J MOL CATAL A-CHEM, V223, P313, DOI DOI 10.1016/j.molcata.2003.09.047
   Pallavicini P, 2017, J COLLOID INTERF SCI, V498, P271, DOI 10.1016/j.jcis.2017.03.062
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Philip D, 2011, SPECTROCHIM ACTA A, V78, P899, DOI 10.1016/j.saa.2010.12.060
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Soni N, 2012, PARASITOL RES, V110, P175, DOI 10.1007/s00436-011-2467-4
   Subarani S, 2013, PARASITOL RES, V112, P487, DOI 10.1007/s00436-012-3158-5
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Thirunavukkarasu S., 2012, PARASITOL RES, V110, P1815
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   WHO, 2005, WHOCDSWHOPESGCDPP13
   World Health Organization, 2010, DENG TRANSM RES WHO
   Yang YC, 2002, J AGR FOOD CHEM, V50, P3765, DOI 10.1021/jf011708f
NR 68
TC 4
Z9 4
U1 2
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD APR
PY 2018
VL 181
BP 70
EP 79
DI 10.1016/j.jphotobiol.2018.02.019
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA GE0JC
UT WOS:000430899100008
PM 29510358
DA 2020-07-08
ER

PT J
AU Adams, Z
   Morris, G
   Campbell, T
   Mostert, K
   Dibdin, N
   Fearon, M
   Elmoazzen, H
   Mercer, D
   Young, K
   Allan, D
AF Adams, Zachary
   Morris, Gail
   Campbell, Todd
   Mostert, Karen
   Dibdin, Nicholas
   Fearon, Margaret
   Elmoazzen, Heidi
   Mercer, Dena
   Young, Kimberly
   Allan, David
TI Risk of Exposure to Zika Virus and Impact on Cord Blood Banking and
   Adult Unrelated Donors in Hematopoietic Cell Transplantation: The
   Canadian Blood Services Experience
SO BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
LA English
DT Article
DE Donor; Hematopoietic; Transplantation; Unrelated; Cord blood banking;
   Zika virus; Transmission risk
ID TRANSFUSION; OUTBREAK; BRAZIL
AB Zika virus has emerged as a potential threat to the Canadian blood supply system. Stem cell donors within Canadian Blood Services' Cord Blood Bank (CBB) and OneMatch Stem Cell and Marrow Network (OM) now undergo screening measures designed to reduce the risk of Zika virus transmission. The impact these screening measures have on cord blood and unrelated adult stem cell donations is currently unknown. Among 146 donor workups initiated by OM between July 2016 and May 2017, 102 were completed and 44 workups were canceled. There were 17 potential donors (11.6%) with a risk of Zika virus exposure identified by the donor questionnaire (13 completed, 4 canceled workups). None of the workups involved a donor diagnosed with confirmed Zika virus within the past 6 months. Only 1 of the 44 canceled workups (and only 1 of 4 cases with a risk of Zika transmission) was canceled because of the risk of Zika transmission, and a backup donor was selected. Canadian Blood Services' CBB identified 25 of 875 cord blood units (2.9%) from women who donated their infants' cord blood and underwent screening that otherwise met the initial cell number thresholds for banking and had at least 1 risk factor for exposure to Zika virus. No women were diagnosed with Zika virus at any point of their pregnancy. All 25 units were discarded. Unrelated donors at OM have a higher incidence of a risk of exposure to Zika virus compared with cord blood donors. Only rarely did transplant centers cancel donor workups due to potential Zika virus exposure. The impact of screening for Zika virus exposure risk on cord blood banking was minor. Continued vigilance and surveillance is recommended. (C) 2017 American Society for Blood and Marrow Transplantation.
C1 [Adams, Zachary; Allan, David] Ottawa Hosp, Res Inst, 501 Smyth Rd,Box 704, Ottawa, ON K1H 8L6, Canada.
   [Morris, Gail; Mercer, Dena; Young, Kimberly; Allan, David] OneMatch Stem Cell & Marrow Network, Ottawa, ON, Canada.
   [Campbell, Todd; Mostert, Karen; Dibdin, Nicholas; Elmoazzen, Heidi; Allan, David] Cord Blood Bank, Ottawa, ON, Canada.
   [Fearon, Margaret] Canadian Blood Serv, Med Microbiol, Toronto, ON, Canada.
   [Allan, David] Ottawa Hosp, Ctr Transfus Res, Ottawa, ON, Canada.
   [Allan, David] Univ Ottawa, Dept Med, Ottawa, ON, Canada.
RP Allan, D (corresponding author), Ottawa Hosp, Res Inst, 501 Smyth Rd,Box 704, Ottawa, ON K1H 8L6, Canada.
EM daallan@ohri.ca
OI Allan, David/0000-0003-3261-8289
FU Faculty of Medicine Summer Student Award; Department of Medicine at the
   University of Ottawa
FX Z.A. was a recipient of a Faculty of Medicine Summer Student Award. D.A.
   is supported by the Department of Medicine at the University of Ottawa.
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   [Anonymous], 2017, ZIKA VIRUS SEXUAL TR
   [Anonymous], 2017, ZIKA SITUATION REPOR
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Germain M, 2017, TRANSFUSION, V57, P2463, DOI 10.1111/trf.14247
   Government of Canada, SURV ZIK VIR
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Musso D, 2014, EURO SURVEIL, V19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Sher G, 2016, CANADIAN BLOOD SERVI
   WHO, 2016, GEN SUMM OUTC EM COM
NR 18
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1083-8791
EI 1523-6536
J9 BIOL BLOOD MARROW TR
JI Biol. Blood Marrow Transplant.
PD APR
PY 2018
VL 24
IS 4
BP 861
EP 865
DI 10.1016/j.bbmt.2017.11.032
PG 5
WC Hematology; Immunology; Transplantation
SC Hematology; Immunology; Transplantation
GA GD6TH
UT WOS:000430640800030
PM 29253552
OA Other Gold
DA 2020-07-08
ER

PT J
AU Benelli, G
   Rajeswary, M
   Vijayan, P
   Senthilmurugan, S
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Govindarajan, M
AF Benelli, Giovanni
   Rajeswary, Mohan
   Vijayan, Periasamy
   Senthilmurugan, Sengamalai
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Govindarajan, Marimuthu
TI Boswellia ovalifoliolata (Burseraceae) essential oil as an eco-friendly
   larvicide? Toxicity against six mosquito vectors of public health
   importance, non-target mosquito fishes, backswimmers, and water bugs
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Dengue fever; Filariasis; Malaria; Japanese encephalitis; Yellow fever;
   Zika virus
ID LEAF ESSENTIAL OILS; CHEMICAL-COMPOSITION; AEDES-AEGYPTI;
   CULEX-TRITAENIORHYNCHUS; ANOPHELES-SUBPICTUS; CINNAMOMUM-OSMOPHLOEUM;
   ACARICIDAL ACTIVITY; PLANT OILS; DIPTERA; ALBOPICTUS
AB The use of synthetic pesticides to control vector populations is detrimental to human health and the environment and may lead to the development of resistant strains. Plants can be alternative sources of safer compounds effective on mosquito vectors. In this study, the mosquito larvicidal activity of Boswellia ovalifoliolata leaf essential oil (EO) was evaluated against Anopheles stephensi, Anopheles subpictus, Aedes aegypti, Aedes albopictus, Culex quinquefasciatus, and Culex tritaeniorhynchus. GC-MS revealed that the B. ovalifoliolata EO contained at least 20 compounds. The main constituents were beta-pinene, alpha-terpineol, and caryophyllene. In acute toxicity assays, the EO was toxic to larvae of An. stephensi, Ae. aegypti, Cx. quinquefasciatus, An. subpictus, Ae. albopictus, and Cx. tritaeniorhynchus with LC50 values of 61.84, 66.24, 72.47, 82.26, 89.80, and 97.95 mu g/ml, respectively. B. ovalifoliolata EO was scarcely toxic to mosquito fishes, backswimmers, and water bugs predating mosquito larvae with LC50 from 4186 to 14,783 mu g/ml. Overall, these results contribute to develop effective and affordable instruments to magnify the reliability of Culicidae control programs.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Rajeswary, Mohan; Vijayan, Periasamy; Senthilmurugan, Sengamalai; Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
EM benelli.giovanni@gmail.com; drgovind1979@gmail.com
RI Khaled, Jamal/D-8188-2017; /L-2836-2013; GOVINDARAJAN,
   MARIMUTHU/A-8070-2019; Alharbi, Naiyf S/B-9402-2019; S,
   Senthilmurugan/AAB-4374-2019; Benelli, Giovanni/A-9100-2013
OI /0000-0001-7018-5379; GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931;
   Benelli, Giovanni/0000-0001-8971-6010
FU Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [PRG-1437-36]
FX The authors extend their sincere appreciations to the Deanship of
   Scientific Research at King Saud University for funding this Prolific
   Research Group (PRG-1437-36). Also thanks to the Professor and Head,
   Department of Zoology, Annamalai University for the laboratory
   facilities provided.
CR Afoulous S, 2013, FOOD CHEM TOXICOL, V56, P352, DOI 10.1016/j.fct.2013.02.008
   Ansari M. A., 2005, Journal of Vector Borne Diseases, V42, P95
   Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10218, DOI 10.1007/s11356-016-8146-3
   Benelli G, 2017, PARASITOL RES, V116, P1175, DOI 10.1007/s00436-017-5395-0
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Campolo O, 2016, J ECON ENTOMOL, V109, P360, DOI 10.1093/jee/tov270
   Chantraine JM, 1998, PHYTOTHER RES, V12, P350, DOI 10.1002/(SICI)1099-1573(199808)12:5&lt;350::AID-PTR311&gt;3.0.CO;2-7
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P457, DOI 10.1016/j.biortech.2008.02.030
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038
   Cheng SS, 2004, J AGR FOOD CHEM, V52, P4395, DOI 10.1021/jf0497152
   Conti B, 2014, PARASITOL RES, V113, P251, DOI 10.1007/s00436-013-3651-5
   DEO P G, 1988, International Pest Control, V30, P118
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Giatropoulos A, 2012, PARASITOL RES, V111, P2253, DOI 10.1007/s00436-012-3074-8
   Govindarajan M, 2013, EXP PARASITOL, V134, P7, DOI 10.1016/j.exppara.2013.01.018
   Govindarajan M, 2012, PARASITOL RES, V110, P2023, DOI 10.1007/s00436-011-2731-7
   Govindarajan M, 2016, ENVIRON SCI POLLUT R, V23, P23228, DOI 10.1007/s11356-016-7568-2
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, COMB CHEM HIGH T SCR, V19, P565, DOI 10.2174/1386207319666160506123520
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2013, PARASITOL RES, V112, P3713, DOI 10.1007/s00436-013-3557-2
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P106, DOI 10.1016/S1995-7645(11)60047-3
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   Habeeb S. M., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V5, P196
   Kamalakannan S, 2010, VECTOR-BORNE ZOONOT, V10, P817, DOI 10.1089/vbz.2009.0081
   Khandagle AJ, 2011, PARASITOL RES, V109, P339, DOI 10.1007/s00436-011-2261-3
   Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003
   Lee HS, 2006, J AM MOSQUITO CONTR, V22, P292, DOI 10.2987/8756-971X(2006)22[292:MLAOAM]2.0.CO;2
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Magalhaes LAM, 2010, MOLECULES, V15, P5734, DOI 10.3390/molecules15085734
   Milet-Pinheiro P, 2015, PLOS ONE, V9, P1
   Morais F.D., 2010, PEST MANAG SCI, V5, P965
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Pavarini DP, 2012, ANIM FEED SCI TECH, V176, P5, DOI 10.1016/j.anifeedsci.2012.07.002
   Pavela R, 2007, J ESSENT OIL BEAR PL, V10, P346, DOI 10.1080/0972060X.2007.10643566
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2017, J PEST SCI, V90, P369, DOI 10.1007/s10340-016-0763-6
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2014, PLANT PROTECT SCI, V50, P36, DOI 10.17221/48/2013-PPS
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   Pontes WJT, 2007, J ESSENT OIL RES, V19, P379, DOI 10.1080/10412905.2007.9699310
   Pontes WJT, 2010, J ESSENT OIL RES, V22, P279, DOI 10.1080/10412905.2010.9700324
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Prasanna ARL, 2015, INT J PHARM CLIN RES, V7, P96
   Regnault-Roger C., 1997, INTEGR PEST MANAG RE, V2, P25, DOI DOI 10.1023/A:1018472227889
   da Silva MFR, 2016, EXP PARASITOL, V165, P64, DOI 10.1016/j.exppara.2016.03.017
   Rodrigues KAD, 2013, PHARM BIOL, V51, P1293, DOI 10.3109/13880209.2013.789536
   Saxena RC, 1998, CRITICAL ISSUES INSE, P155
   Seo SM, 2012, J AGR FOOD CHEM, V60, P5909, DOI 10.1021/jf301296d
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Sivaji K, 2008, FLOWERING PLANTS CHI, P162
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   Traboulsi AF, 2002, PEST MANAG SCI, V58, P491, DOI 10.1002/ps.486
   Turek C, 2013, COMPR REV FOOD SCI F, V12, P40, DOI 10.1111/1541-4337.12006
   Ward M, 2017, PARASITOL RES, V116, P839, DOI 10.1007/s00436-016-5352-3
   WHO, 2005, WHOCDSWHOPESGCDPP13
   Younoussa Lame, 2016, Int J Insect Sci, V8, P23, DOI 10.4137/IJIS.S37188
   ZOGHBI MGB, 2005, J ESSENT OIL BEAR PL, V8, P312
NR 67
TC 10
Z9 10
U1 2
U2 16
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2018
VL 25
IS 11
SI SI
BP 10264
EP 10271
DI 10.1007/s11356-017-8820-0
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GC5FC
UT WOS:000429810200010
PM 28332087
DA 2020-07-08
ER

PT J
AU Rajeswary, M
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Benelli, G
AF Rajeswary, Mohan
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Benelli, Giovanni
TI Zingiber cernuum (Zingiberaceae) essential oil as effective larvicide
   and oviposition deterrent on six mosquito vectors, with little
   non-target toxicity on four aquatic mosquito predators
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Aquatic toxicology; Biosafety; Dengue; Japanese encephalitis; Malaria;
   Neglected tropical disease; Zika virus
ID ECO-FRIENDLY LARVICIDES; AEDES-AEGYPTI DIPTERA; LEAF ESSENTIAL OILS;
   CHEMICAL-COMPOSITION; INSECTICIDAL PROPERTIES; CINNAMOMUM-OSMOPHLOEUM;
   CRYPTOMERIA-JAPONICA; VOLATILE OILS; HOUSE-FLY; PLANT
AB Mosquitoes are responsible for the transmission of many pathogens and parasites, which cause serious diseases in humans and animals. Currently, botanical products have been suggested as alternative tools in the fight against arthropod vectors. In this study, the essential oil (EO) extracted from Zingiber cernuum was tested as larvicide and oviposition deterrent on six mosquito species of public health relevance, including malaria and Zika virus vectors. The EO showed high toxicity on third instar larvae of Anopheles stephensi (LC50 = 41.34 mu g/ml), Aedes aegypti (LC50 = 44.88 mu g/ml), Culex quinquefasciatus (LC50 = 48.44 mu g/ml), Anopheles subpictus (LC50 = 51.42 mu g/ml), Aedes albopictus (LC50 = 55.84 mu g/ml), and Culex tritaeniorhynchus (LC50 = 60.20 mu g/ml). In addition, low doses of Z. cernuum EO reduced oviposition rates in six mosquito species. The acute toxicity of Z. cernuum EO on four mosquito predators was scarce; LC50 ranged from 3119 to 11,233 mu g/ml. Overall, our results revealed that the Z. cernuum EO can be considered for the development of effective and environmental-friendly mosquito larvicides and oviposition deterrents.
C1 [Rajeswary, Mohan; Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013; /L-2836-2013; Khaled, Jamal/D-8188-2017;
   GOVINDARAJAN, MARIMUTHU/A-8070-2019; Alharbi, Naiyf S/B-9402-2019
OI Benelli, Giovanni/0000-0001-8971-6010; /0000-0001-7018-5379;
   GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; 
FU Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [RG-1438-074]
FX The authors extend their appreciation to the Deanship of Scientific
   Research at King Saud University for funding this work through research
   group No RG-1438-074.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Ansari M. A., 2005, Journal of Vector Borne Diseases, V42, P95
   Ansari MA, 2000, BIORESOURCE TECHNOL, V71, P267, DOI 10.1016/S0960-8524(99)00079-6
   Ansari MA, 2000, BIORESOURCE TECHNOL, V73, P207, DOI 10.1016/S0960-8524(99)00180-7
   Araujo ECC, 2003, J AGR FOOD CHEM, V51, P3760, DOI 10.1021/jf021074s
   Astani A, 2010, PHYTOTHER RES, V24, P673, DOI 10.1002/ptr.2955
   Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055
   Barnard DR, 1999, J MED ENTOMOL, V36, P625, DOI 10.1093/jmedent/36.5.625
   Bendjeddou D, 2003, J ETHNOPHARMACOL, V88, P155, DOI 10.1016/S0378-8741(03)00226-5
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhuiyan MNI, 2009, BANGL J PHARMACOL, V4, P9, DOI 10.3329/bjp.v4i1.845
   BURKILL IH, 1966, DICT EC PRODUCTS MAL, V2
   BURKILL IH, 1966, DICT EC PRODUCTS MAL, V1
   Campbell CJ, 2009, ANAL ESSENTIAL EDIBL
   Campbell C, 2011, ENTOMOL EXP APPL, V138, P21, DOI 10.1111/j.1570-7458.2010.01072.x
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   Champakaew D, 2007, PARASITOL RES, V100, P729, DOI 10.1007/s00436-006-0350-5
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P465, DOI 10.1016/j.biortech.2007.11.060
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P457, DOI 10.1016/j.biortech.2008.02.030
   Cheng SS, 2008, BIORESOURCE TECHNOL, V99, P3617, DOI 10.1016/j.biortech.2007.07.038
   Cheng SS, 2009, PEST MANAG SCI, V65, P339, DOI 10.1002/ps.1693
   Cheng SS, 2004, J AGR FOOD CHEM, V52, P4395, DOI 10.1021/jf0497152
   Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7
   Chericoni S, 2004, BIOCHEM SYST ECOL, V32, P423, DOI 10.1016/j.bse.2003.10.002
   Coria C, 2008, BIORESOURCE TECHNOL, V99, P3066, DOI 10.1016/j.biortech.2007.06.012
   Dargahi Leila, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS589
   de Almeida RN, 2011, MOLECULES, V16, P2726, DOI 10.3390/molecules16032726
   Dekker T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-183
   DEO P G, 1988, International Pest Control, V30, P118
   Dharmagadda VSS, 2005, BIORESOURCE TECHNOL, V96, P1235, DOI 10.1016/j.biortech.2004.10.020
   do Nascimento JC, 2013, PEST MANAG SCI, V69, P1267, DOI 10.1002/ps.3495
   El-Akhal Eouad, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P746
   El-Akhal F, 2015, J MAT ENV SCI, V1, P214
   Elango G, 2009, PARASITOL RES, V105, P1567, DOI 10.1007/s00436-009-1593-8
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Foko GA, 2011, J ENTOMOLOGY, V8, P152
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Jain N, 2001, FLAVOUR FRAG J, V16, P408, DOI 10.1002/ffj.1024
   Jantan I, 2003, PHARM BIOL, V41, P234, DOI 10.1076/phbi.41.4.234.15665
   Jirovetz Leopold, 2003, Acta Pharmaceutica (Zagreb), V53, P73
   Kamaraj C, 2010, PARASITOL RES, V107, P1337, DOI 10.1007/s00436-010-2006-8
   Kamsuk K, 2007, PARASITOL RES, V100, P339, DOI 10.1007/s00436-006-0256-2
   Kasarkar A. R., 2011, International Journal of Research in Ayurveda and Pharmacy (IJRAP), V2, P648
   Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003
   KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111
   Li YW, 2012, PARASITOL RES, V110, P2197, DOI [10.1007/s00436-011-2749-x, 10.1007/s00436-012-3251-9]
   Liu XC, 2015, PEST MANAG SCI, V71, P1582, DOI 10.1002/ps.3964
   Liu ZL, 2012, PARASITOL RES, V110, P2125, DOI 10.1007/s00436-011-2738-0
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Menon A. N., 2007, Journal of Medicinal and Aromatic Plant Sciences, V29, P78
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d
   Nguefack J, 2004, INT J FOOD MICROBIOL, V94, P329, DOI 10.1016/j.ijfoodmicro.2004.02.017
   Ogbonna C. U., 2014, Journal of Biopesticides, V7, P177
   Opender Koul, 2008, Biopesticides International, V4, P63
   Padmakumari KP, 2009, INDIAN PERFUM, V53, P16
   Park YU, 2012, J AM MOSQUITO CONTR, V28, P192, DOI 10.2987/12-6250R.1
   PATHAK A K, 1988, Fitoterapia, V59, P211
   Pavela R, 2008, PARASITOL RES, V102, P555, DOI 10.1007/s00436-007-0821-3
   Pavela R, 2008, PHYTOTHER RES, V22, P274, DOI 10.1002/ptr.2300
   Pavela R, 2017, J PEST SCI, V90, P683, DOI [10.1007/s10340-016-0828-6, 10.1007/s10340-016-0763-6]
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pitasawat B, 2007, FITOTERAPIA, V78, P205, DOI 10.1016/j.fitote.2007.01.003
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Pushpanathan T, 2008, PARASITOL RES, V102, P1289, DOI 10.1007/s00436-008-0907-6
   Rahuman AA, 2008, PARASITOL RES, V102, P981, DOI 10.1007/s00436-007-0864-5
   Rana V. S., 2008, INDIAN PERFUMER, V52, P17
   Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008
   Sanjay J, 2015, J ACAD IND RES, V4, P56
   Santos RP, 2006, J BRAZIL CHEM SOC, V17, P1027, DOI 10.1590/S0103-50532006000500030
   Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0
   Sekiwa Y, 2000, J AGR FOOD CHEM, V48, P373, DOI 10.1021/jf990674x
   Senthilkumar A, 2008, PARASITOL RES, V103, P959, DOI 10.1007/s00436-008-1085-2
   SHARMA R N, 1992, Indian Journal of Experimental Biology, V30, P244
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   SOMANABANDHU AO, 1992, J SCI SOC THAILAND, V18, P181
   Srivastava AK, 2000, J ESSENT OIL RES, V12, P595, DOI 10.1080/10412905.2000.9712165
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   Sutthanont N, 2010, J VECTOR ECOL, V35, P106, DOI 10.1111/j.1948-7134.2010.00036.x
   Tawatsin A, 2001, J VECTOR ECOL, V26, P76
   Tewtrakul S., 1998, J SCI TECHNOL, V20, P183
   Thomas TG, 2004, JPN J INFECT DIS, V57, P176
   Tiwary Mohini, 2007, Journal of Vector Borne Diseases, V44, P198
   Traboulsi AF, 2002, PEST MANAG SCI, V58, P491, DOI 10.1002/ps.486
   Urzua A, 2010, J CHIL CHEM SOC, V55, P392, DOI 10.4067/S0717-97072010000300026
   Ward M, 2017, PARASITOL RES, V116, P839, DOI 10.1007/s00436-016-5352-3
   WHO, 2005, WHOCDSWHOPESGCDPP13
   Xue RD, 2001, MED VET ENTOMOL, V15, P126, DOI 10.1046/j.0269-283x.2001.00301.x
NR 93
TC 9
Z9 9
U1 3
U2 16
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2018
VL 25
IS 11
SI SI
BP 10307
EP 10316
DI 10.1007/s11356-017-9093-3
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GC5FC
UT WOS:000429810200014
PM 28497331
DA 2020-07-08
ER

PT J
AU Aarthi, C
   Govindarajan, M
   Rajaraman, P
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Mothana, RA
   Siddiqui, NA
   Benelli, G
AF Aarthi, Chinnadurai
   Govindarajan, Marimuthu
   Rajaraman, Pichaimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Mothana, Ramzi A.
   Siddiqui, Nasir A.
   Benelli, Giovanni
TI Eco-friendly and cost-effective Ag nanocrystals fabricated using the
   leaf extract of Habenaria plantaginea: toxicity on six mosquito vectors
   and four non-target species
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Biofabrication; Biosafety; Biopesticide; AFM, SEM, TEM; Zika virus
ID SYNTHESIZED SILVER NANOPARTICLES; GREEN SYNTHESIS;
   CULEX-QUINQUEFASCIATUS; ANOPHELES-STEPHENSI; ESSENTIAL OILS;
   PLANT-EXTRACT; AEDES-AEGYPTI; LARVICIDAL EFFICACY; CATALYTIC-ACTIVITY;
   AQUEOUS EXTRACT
AB Recently, the biofabrication of metal nanoparticles has gained wide interest owing to its inherent features such as swift, simplicity, eco-friendliness, and cheaper costs. Different green-reducing agents led to the production of nanoparticles with varying toxicity on insects. In the current study, silver nanoparticles (AgNPs) were successfully synthesized using Habenaria plantaginea leaf extract. Ag nanoparticles were studied by UV-Vis spectroscopy (UV-Vis), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), atomic force microscopy (AFM), scanning electron microscopy (SEM) coupled with energy-dispersive spectroscopy (EDS), and transmission electron microscopy (TEM). H. plantaginea extract and AgNPs were tested for mosquito larvicidal activity on Anopheles stephensi, Aedes aegypti, Culex quinquefasciatus, An. subpictus, Ae. albopictus, and Cx. tritaeniorhynchus. LC50 values were 102.51, 111.99, 123.47, 123.96, 136.56, 149.42 mu g/ml and 12.23, 13.38, 14.78, 14.37, 15.39, 16.89 mu g/ml, respectively. Moreover, H. plantaginea aqueous extract and AgNPs were tested against the non-target species Anisops bouvieri, Diplonychus indicus, Poecilia reticulata, and Gambusia affinis obtaining LC50 values ranging from 831.82 to 36,212.67 mu g/ml. Overall, this study showed the effectiveness of H. plantaginea-fabricated nanoparticles on a wide range of important mosquito vectors, highlighting their scarce toxicity on four natural enemies predating mosquito larvae and pupae.
C1 [Aarthi, Chinnadurai; Govindarajan, Marimuthu; Rajaraman, Pichaimuthu] Thiru Vi Ka Govt Arts Coll, Dept Zool, Tiruvarur 610003, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Mothana, Ramzi A.; Siddiqui, Nasir A.] King Saud Univ, Dept Pharmacognosy, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Thiru Vi Ka Govt Arts Coll, Dept Zool, Tiruvarur 610003, Tamil Nadu, India.; Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI Siddiqui, Nasir/AAF-7267-2019; GOVINDARAJAN, MARIMUTHU/A-8070-2019;
   Mothana, Ramzi Ahmed/D-8740-2015; Khaled, Jamal/D-8188-2017; Benelli,
   Giovanni/A-9100-2013; Alharbi, Naiyf S/B-9402-2019; /L-2836-2013
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; Mothana, Ramzi
   Ahmed/0000-0003-4220-7854; Benelli, Giovanni/0000-0001-8971-6010;
   /0000-0001-7018-5379
FU Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [RGP-073]
FX The authors extend their sincere appreciations to the Deanship of
   Scientific Research at King Saud University for funding the work through
   the research group project no. (RGP-073). The authors would like to
   thank the Principal and Head of the Department of Zoology, Thiru. Vi. Ka
   Government Arts College and the Professor and Head, Department of
   Zoology, Annamalai University for the laboratory facilities provided.
CR Ajitha B, 2014, SPECTROCHIM ACTA A, V121, P164, DOI 10.1016/j.saa.2013.10.077
   AlQahtani FS, 2017, J ASIA-PAC ENTOMOL, V20, P157, DOI 10.1016/j.aspen.2016.12.004
   Antony JJ, 2013, COLLOID SURFACE B, V108, P185, DOI 10.1016/j.colsurfb.2013.02.041
   Ashokkumar S, 2014, SPECTROCHIM ACTA A, V121, P88, DOI 10.1016/j.saa.2013.10.073
   Balavigneswaran CK, 2014, APPL NANOSCI, V4, P367, DOI 10.1007/s13204-013-0203-3
   Banumathi B, 2017, J CLUST SCI, V28, P2027, DOI 10.1007/s10876-017-1201-5
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10218, DOI 10.1007/s11356-016-8146-3
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Chowdhery H.J., 2009, J ORCHID SOC INDIA, V23, P19
   DEO P G, 1988, International Pest Control, V30, P118
   Dharumadurai Dhanasekaran, 2013, Asian Pacific Journal of Tropical Disease, V3, P174
   Dhiman RC, 2010, PARASITOL RES, V106, P763, DOI 10.1007/s00436-010-1767-4
   Edison TJI, 2012, PROCESS BIOCHEM, V47, P1351, DOI 10.1016/j.procbio.2012.04.025
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Geethalakshmi R, 2012, INT J NANOMED, V7, P5375, DOI 10.2147/IJN.S36516
   Govindarajan M, 2008, PARASITOL RES, V103, P691, DOI 10.1007/s00436-008-1032-2
   Govindarajan M, 2012, EUR REV MED PHARMACO, V16, P386
   Govindarajan M, 2011, PARASITOL RES, V109, P353, DOI 10.1007/s00436-011-2263-1
   Govindarajan M, 2010, EUR REV MED PHARMACO, V14, P107
   Govindarajan M, 2009, EUR REV MED PHARMACO, V13, P99
   Govindarajan M, 2018, PHYSIOL MOL PLANT P, V101, P219, DOI 10.1016/j.pmpp.2017.01.003
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2014, PARASITOL RES, V113, P777, DOI 10.1007/s00436-013-3709-4
   Hossain MM, 2011, FITOTERAPIA, V82, P102, DOI 10.1016/j.fitote.2010.09.007
   Kathiravan V, 2014, SPECTROCHIM ACTA A, V130, P116, DOI 10.1016/j.saa.2014.03.107
   Khan M, 2014, INT J NANOMED, V9, P3551, DOI 10.2147/IJN.S61983
   Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008
   Kumar PPNV, 2014, IND CROP PROD, V52, P562, DOI 10.1016/j.indcrop.2013.10.050
   Kumar R, 2012, SPECTROCHIM ACTA A, V90, P173, DOI 10.1016/j.saa.2012.01.029
   Mabberley DJ, 2008, MABBERLEYS PLANT BOO, V3, P606
   Madhumitha G, 2015, J SOL-GEL SCI TECHN, V73, P476, DOI 10.1007/s10971-014-3591-2
   Maity D, 2012, CARBOHYD POLYM, V90, P1818, DOI 10.1016/j.carbpol.2012.07.082
   Maity D, 2011, J APPL POLYM SCI, V122, P2189, DOI 10.1002/app.34266
   Maridassa M., 2008, ETHANOBOTANICAL LEAF, V12, P705
   Medhi RP, 2009, INDIAN J TRADIT KNOW, V8, P11
   Mishra A, 2012, SCI ADV MATER, V4, P143, DOI 10.1166/sam.2012.1263
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Naik BR, 2014, ADV ENTOMOL, P293
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nazeruddin GM, 2014, J ALLOY COMPD, V583, P272, DOI 10.1016/j.jallcom.2013.07.111
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Perni S, 2014, COLLOID SURFACE A, V460, P219, DOI 10.1016/j.colsurfa.2013.09.034
   Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017
   Prathna TC, 2011, COLLOID SURFACE B, V82, P152, DOI 10.1016/j.colsurfb.2010.08.036
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Rajeswary M, 2013, J VECTOR DIS, V50, P141
   Raman N, 2012, SPECTROCHIM ACTA A, V96, P1031, DOI 10.1016/j.saa.2012.08.011
   Rastogi L, 2011, MATER CHEM PHYS, V129, P558, DOI 10.1016/j.matchemphys.2011.04.068
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Roopan SM, 2013, IND CROP PROD, V43, P631, DOI 10.1016/j.indcrop.2012.08.013
   Sathiya CK, 2014, SPECTROCHIM ACTA A, V128, P337, DOI 10.1016/j.saa.2014.02.172
   Singh A, 2009, ETHNOBOTAN LEAFL, V13, P399
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Suganya A, 2013, PARASITOL RES, V112, P1385, DOI 10.1007/s00436-012-3269-z
   Suganya G, 2014, PARASITOL RES, V113, P1673, DOI 10.1007/s00436-014-3811-2
   Suman TY, 2013, COLLOID SURFACE B, V106, P74, DOI 10.1016/j.colsurfb.2013.01.037
   Tamboli DP, 2013, J HAZARD MATER, V260, P878, DOI 10.1016/j.jhazmat.2013.06.003
   Tamuly C, 2013, COLLOID SURFACE B, V102, P627, DOI 10.1016/j.colsurfb.2012.09.007
   Vijayakumar M, 2013, IND CROP PROD, V41, P235, DOI 10.1016/j.indcrop.2012.04.017
   *WHO, 1980, WHO TECHN REP SER, V646, P12
   WHO, 2005, WHOCDSWHOPESGCDPP13
   World Health Organization, 2014, WHODCOWHD20141
   Zaheer Z, 2013, COLLOID SURFACE B, V108, P90, DOI 10.1016/j.colsurfb.2013.02.023
NR 70
TC 5
Z9 5
U1 0
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2018
VL 25
IS 11
SI SI
BP 10317
EP 10327
DI 10.1007/s11356-017-9203-2
PG 11
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GC5FC
UT WOS:000429810200015
PM 28523613
DA 2020-07-08
ER

PT J
AU Thandapani, K
   Kathiravan, M
   Namasivayam, E
   Padiksan, IA
   Natesan, G
   Tiwari, M
   Giovanni, B
   Perumal, V
AF Thandapani, Keerthika
   Kathiravan, Manikandan
   Namasivayam, Elangovan
   Padiksan, Indira Arulselvi
   Natesan, Geetha
   Tiwari, Manish
   Giovanni, Benelli
   Perumal, Venkatachalam
TI Enhanced larvicidal, antibacterial, and photocatalytic efficacy of TiO2
   nanohybrids green synthesized using the aqueous leaf extract of
   Parthenium hysterophorus
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Dengue; Malaria; Filariasis; Larvicidal activity; Microbial pathogens;
   Photocatalytic activity
ID METALLIC SILVER NANOPARTICLES; AEDES-AEGYPTI; OPTICAL-PROPERTIES;
   METHYL-ORANGE; DEGRADATION; WATER; DYE; DIPTERA; ANATASE; BIOSYNTHESIS
AB Titanium dioxide nanoparticles are emerging as a biocompatible nanomaterial with multipurpose bioactivities. In this study, titanium dioxide (TiO2) nanoparticles were effectively synthesized using the aqueous leaf extracts of Parthenium hysterophorus prepared by microwave irradiation. TiO2 nanoparticles were fabricated by treating the P. hysterophorus leaf extracts with the TiO4 solution. Biologically active compounds such as alcohols, phenols, alkanes, and fluoroalkanes were involved in bioreduction of TiO4 into TiO2. The formation of green-engineered TiO2 nanoparticles was confirmed by UV-vis spectroscopy, Fourier transform infrared spectroscopy (FTIR), field emission scanning electron microscopy (FESEM), and energy-dispersive X-ray (EDX) spectroscopy and further characterized by X-ray diffraction (XRD) studies. UV-vis spectroscopy analysis showed maximum absorbance at 420 nm due to surface plasmon resonance of synthesized TiO2 NPs. FTIR spectrum of the engineered TiO2 NPs showed the presence of bioactive compounds in the leaf extract, which acted as capping and reducing agents. FESEM exhibited an average size of 20-50 nm and a spherical shape of TiO2 NPs. EDX analysis indicated the presence of TiO2 NPs by observing the peaks of titanium ions. XRD results pointed out the crystalline nature of engineered TiO2 NPs. The larvicidal activity of TiO2 NPs was studied on fourth instar larvae of dengue, Zika virus, and filariasis mosquito vectors Aedes aegypti and Culex quinquefasciatus. Antimicrobial efficacy of TiO2 NPs was assessed on clinically isolated pathogens Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus vulgaris, and Staphylococcus epidermidis. Besides, we found that TiO2 NPs are able to quickly degrade the industrially harmful pigments methylene blue, methyl orange, crystal violet, and alizarin red dyes under sunlight illumination. Overall, this novel, simple, and eco-friendly approach can be of interest for the control of vector-borne diseases, as well as to formulate new bactericidal agents and to efficiently degrade dye solutions in the polluted areas.
C1 [Thandapani, Keerthika; Kathiravan, Manikandan; Namasivayam, Elangovan; Padiksan, Indira Arulselvi; Perumal, Venkatachalam] Periyar Univ, Dept Biotechnol, Sch Biosci, Salem 636011, Tamil Nadu, India.
   [Natesan, Geetha] Bharathiar Univ, Dept Bot, Coimbatore 641046, Tamil Nadu, India.
   [Tiwari, Manish] Ghent Univ VIB, Dept Plant Syst Biol, B-9000 Ghent, Belgium.
   [Giovanni, Benelli] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Perumal, V (corresponding author), Periyar Univ, Dept Biotechnol, Sch Biosci, Salem 636011, Tamil Nadu, India.
EM pvenkat67@yahoo.com
RI P, Venkatachalam/AAC-2222-2019
OI Tiwari, Manish/0000-0002-0546-0757
CR Akurati KK, 2007, SOLID STATE SCI, V9, P247, DOI 10.1016/j.solidstatesciences.2006.12.004
   Alaton IA, 2001, J PHOTOCH PHOTOBIO A, V141, P247, DOI 10.1016/S1010-6030(01)00440-3
   Begum NA, 2009, COLLOID SURFACE B, V71, P113, DOI 10.1016/j.colsurfb.2009.01.012
   Behnajady MA, 2011, PHOTOCHEM PHOTOBIOL, V87, P1002, DOI 10.1111/j.1751-1097.2011.00954.x
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Bhuvaneswari T, 2014, ACTA TROP, V135, P55, DOI 10.1016/j.actatropica.2014.03.009
   Chong MN, 2010, WATER RES, V44, P2997, DOI 10.1016/j.watres.2010.02.039
   Daneshvar N, 2003, J PHOTOCH PHOTOBIO A, V157, P111, DOI 10.1016/S1010-6030(03)00015-7
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Duran Nelson, 2005, J Nanobiotechnology, V3, P8, DOI 10.1186/1477-3155-3-8
   Faisal M, 2007, DYES PIGMENTS, V72, P233, DOI 10.1016/j.dyepig.2005.08.020
   FINNEY D J, 1971, P333
   FRANK SN, 1977, J AM CHEM SOC, V99, P303, DOI 10.1021/ja00443a081
   Garcia M. A., 2012, J PHYS D, V44, P28
   Hameed BH, 2007, DYES PIGMENTS, V75, P143, DOI 10.1016/j.dyepig.2006.05.039
   Jeeva K, 2014, IND CROP PROD, V52, P714, DOI 10.1016/j.indcrop.2013.11.037
   Jinu U, 2017, J CLUST SCI, V28, P489, DOI 10.1007/s10876-016-1125-5
   Jinu U, 2017, MICROB PATHOGENESIS, V105, P86, DOI 10.1016/j.micpath.2017.02.019
   Kalaiarasi K, 2015, TURK J BIOL, V39, P223, DOI 10.3906/biy-1406-10
   Kannan RRR, 2013, S AFR J BOT, V86, P1, DOI 10.1016/j.sajb.2013.01.003
   Kayalvizhi T, 2016, J ENVIRON ENG, V142, DOI 10.1061/(ASCE)EE.1943-7870.0001098
   Krishna V, 2006, J COLLOID INTERF SCI, V304, P166, DOI 10.1016/j.jcis.2006.08.041
   Kumar Kaushal, 2008, Journal of Vector Borne Diseases, V45, P157
   Kumar P, 2013, COLLOID SURFACE B, V103, P658, DOI 10.1016/j.colsurfb.2012.11.022
   Kwan JL, 2010, AM J TROP MED HYG, V83, P400, DOI 10.4269/ajtmh.2010.10-0076
   Lee KH, 2011, ACS APPL MATER INTER, V3, P3697, DOI 10.1021/am200872c
   Li XY, 2016, J CLUST SCI, V27, P1877, DOI 10.1007/s10876-016-1049-0
   Macwan DP, 2011, J MATER SCI, V46, P3669, DOI 10.1007/s10853-011-5378-y
   MAISHI AI, 1998, BRIT HOMOEOPATH J, V87, P17, DOI DOI 10.1016/S0007-0785(98)80005-7
   Marimuthu S, 2013, ASIAN PAC J TROP MED, V6, P682, DOI 10.1016/S1995-7645(13)60118-2
   Mohamed RM, 2012, J NANOTECHNOL, V2012, DOI 10.1155/2012/329082
   Mohanpuria P, 2008, J NANOPART RES, V10, P507, DOI 10.1007/s11051-007-9275-x
   Murugan K, 2012, PARASITOL RES, V111, P1757, DOI 10.1007/s00436-012-3021-8
   Noginov M.A., 2006, APPL PHYS B, V86, P458
   Patel S, 2011, 3 BIOTECH, V1, P1, DOI 10.1007/s13205-011-0007-7
   Quadros ME, 2011, ENVIRON SCI TECHNOL, V45, P10713, DOI 10.1021/es202770m
   Rajasekaran Anitha, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1578
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Sakthivel S, 2006, APPL CATAL B-ENVIRON, V63, P31, DOI 10.1016/j.apcatb.2005.08.011
   Sankar R, 2015, APPL NANOSCI, V5, P731, DOI 10.1007/s13204-014-0369-3
   Santhoshkumar T, 2014, ASIAN PAC J TROP MED, V7, P968, DOI 10.1016/S1995-7645(14)60171-1
   Shekshavali T., 2012, Indian Journal of Natural Products and Resources, V3, P128
   Sosa IO, 2003, J PHYS CHEM B, V107, P6269, DOI 10.1021/jp0274076
   Suman Thodhal Yoganandham, 2015, Asian Pacific Journal of Tropical Disease, V5, P224
   Sundaravadivelan C, 2013, PARASITOL RES, V112, P303, DOI [10.1007/s00436-012-3138-9, 10.100]
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Tarafdar A., 2013, Advanced Science, Engineering and Medicine (ASEM), V5, P943
   Tayade RJ, 2007, SCI TECHNOL ADV MAT, V8, P455, DOI 10.1016/j.stam.2007.05.006
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   Vanaja M, 2013, APPL NANOSCI, V3, P217, DOI 10.1007/s13204-012-0121-9
   Venkatachalam P, 2017, J CLUST SCI, V28, P607, DOI 10.1007/s10876-016-1141-5
   Wanyonyi WC, 2014, ENRGY PROCED, V50, P862, DOI 10.1016/j.egypro.2014.06.105
   Williams D, 2008, BIOMATERIALS, V29, P1737, DOI 10.1016/j.biomaterials.2008.01.003
   Yang HM, 2006, J ALLOY COMPD, V413, P302, DOI 10.1016/j.jallcom.2005.06.061
   Zeman P, 2003, THIN SOLID FILMS, V433, P57, DOI 10.1016/S0040-6090(03)00311-0
   Zhao Y, 2007, MATER LETT, V61, P79, DOI 10.1016/j.matlet.2006.04.010
NR 56
TC 12
Z9 12
U1 3
U2 23
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2018
VL 25
IS 11
SI SI
BP 10328
EP 10339
DI 10.1007/s11356-017-9177-0
PG 12
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GC5FC
UT WOS:000429810200016
PM 28537028
DA 2020-07-08
ER

PT J
AU Thanigaivel, A
   Vasantha-Srinivasan, P
   Edwin, ES
   Ponsankar, A
   Selin-Rani, S
   Chellappandian, M
   Kalaivani, K
   Senthil-Nathan, S
   Benelli, G
AF Thanigaivel, Annamalai
   Vasantha-Srinivasan, Prabhakaran
   Edwin, Edward-Sam
   Ponsankar, Athirstam
   Selin-Rani, Selvaraj
   Chellappandian, Muthiah
   Kalaivani, Kandaswamy
   Senthil-Nathan, Sengottayan
   Benelli, Giovanni
TI Development of an eco-friendly mosquitocidal agent from Alangium
   salvifolium against the dengue vector Aedes aegypti and its biosafety on
   the aquatic predator
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Biocontrol agent; Larvicides; GST; CYP450; Oxidative stress;
   Detoxification; Yellow fever
ID STEPHENSI LISTON DIPTERA; ESSENTIAL OILS; ANOPHELES-STEPHENSI;
   DYSOXYLUM-MALABARICUM; ENZYME-ACTIVITIES; CULICIDAE; EXTRACT; TOXICITY;
   PRODUCTS; LARVAE
AB Plant extracts with their enriched chemical constituents have established potential alternative mosquito control agents. In this research, we developed an eco-friendly mosquitocidal agent from Alangium salvifolium leaves against the dengue and Zika virus vector Aedes aegypti and we investigated its biosafety on the mosquito aquatic predator Toxorhynchites splendens. Results showed that the methanolic extract of A. salvifolium leaves was composed by eight main compounds, with major peak area for hexadecenoic acid (21.74%). LC50 and LC90 values calculated on Ae. aegypti fourth instar larvae were 104.80 and 269.15 ppm respectively. The methanolic extract tested at 100 ppm decreased the alpha-beta carboxylesterase and SOD ratio significantly and upregulated the GST and CYP450 level. The A. salvifolium methanolic extract displayed significant repellent and adulticidal activity at 100 and 400 ppm respectively. The treatment with 100 ppm of the methanolic extract led to 210 min of protection from Ae. aegypti bites. Four hundred parts per million of the extract showed 98% adult mortality within 30 min from the treatment. Lastly, biosafety assays on the mosquito aquatic predator Tx. splendens showed that the toxicity of the A. salvifolium extract was significantly lower if compared to the cypermethrin-based treatments. The methanolic extract of A. salvifolium showed a maximum of 47.3% mortality rate at the concentration of 1000 ppm, while 0.7 ppm of cypermethrin achieved 91.3% mortality rate on Tx. splendens. Overall, our study enhances basic knowledge on how to improve natural larvicidal agents against dengue and Zika virus mosquito vector with harmless responses on non-target aquatic predators.
C1 [Thanigaivel, Annamalai; Vasantha-Srinivasan, Prabhakaran; Edwin, Edward-Sam; Ponsankar, Athirstam; Selin-Rani, Selvaraj; Chellappandian, Muthiah; Senthil-Nathan, Sengottayan] Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticides & Environm Toxicol, Tirunelveli 627412, Tamil Nadu, India.
   [Kalaivani, Kandaswamy] Sri Parasakthi Coll Women, Dept Zool, Post Grad & Res Ctr, Tirunelveli 627802, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via 23 Borghetto 80, I-56124 Pisa, Italy.
RP Senthil-Nathan, S (corresponding author), Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticides & Environm Toxicol, Tirunelveli 627412, Tamil Nadu, India.
EM senthil@msuniv.ac.in
RI Sengottayan, Senthil-Nathan/D-8979-2012; Muthiah,
   Chellappandian/AAB-4521-2020; Benelli, Giovanni/A-9100-2013;
   Prabhakaran, Vasantha-Srinivasan/R-8135-2019
OI Sengottayan, Senthil-Nathan/0000-0003-0839-2021; Muthiah,
   Chellappandian/0000-0002-4172-5863; Benelli,
   Giovanni/0000-0001-8971-6010; Prabhakaran,
   Vasantha-Srinivasan/0000-0003-3415-3315
FU Indian Council of Medical Research (ICMR), Government of IndiaIndian
   Council of Medical Research (ICMR) [45/32/2013/BMS/TRM]
FX Author Annamalai Thanigaivel was supported by the Indian Council of
   Medical Research (ICMR), Government of India (45/32/2013/BMS/TRM).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Agra-Neto AC, 2014, PARASITOL RES, V113, P175, DOI 10.1007/s00436-013-3640-8
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Boyer S, 2006, ENVIRON TOXICOL CHEM, V25, P470, DOI 10.1897/05-267R2.1
   Caballero C, 2008, SPAN J AGRIC RES, V6, P177, DOI 10.5424/sjar/200806S1-386
   Cheng SS, 2013, IND CROP PROD, V47, P310, DOI 10.1016/j.indcrop.2013.03.016
   Choochote Wej, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P33, DOI 10.1590/S0036-46652006000100007
   CLARK AG, 1990, GLUTATHIONE S-TRANSFERASES AND DRUG RESISTANCE, P369
   David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174
   Dua VK, 2008, J AM MOSQUITO CONTR, V24, P315, DOI 10.2987/5642.1
   Edwin ES, 2016, ACTA TROP, V163, P167, DOI 10.1016/j.actatropica.2016.07.009
   Erland LAE, 2015, CROP PROT, V78, P20, DOI 10.1016/j.cropro.2015.08.013
   Finney D.T., 1971, PROBIT ANAL
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Gillij YG, 2008, BIORESOURCE TECHNOL, V99, P2507, DOI 10.1016/j.biortech.2007.04.066
   Govindarajan M, 2012, PARASITOL RES, V110, P1607, DOI 10.1007/s00436-011-2669-9
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hung TM, 2009, BIOORG MED CHEM LETT, V19, P4389, DOI 10.1016/j.bmcl.2009.05.070
   Kalaivani K, 2012, PARASITOL RES, V110, P1261, DOI 10.1007/s00436-011-2623-x
   Koodalingam A, 2011, ACTA TROP, V118, P27, DOI 10.1016/j.actatropica.2011.01.003
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Larson RT, 2010, J MED ENTOMOL, V47, P249, DOI 10.1603/ME09160
   Lee SE, 2001, PEST MANAG SCI, V57, P548, DOI 10.1002/ps.322
   Lek-Uthai U, 2011, ASIA J PUBLIC HLTH, V2, P67
   Lija-Escaline J, 2015, PARASITOL RES, V114, P4239, DOI 10.1007/s00436-015-4662-1
   Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005
   Napoleao TH, 2012, PARASITOL RES, V110, P609, DOI 10.1007/s00436-011-2529-7
   Nathan SS, 2008, FITOTERAPIA, V79, P106, DOI 10.1016/j.fitote.2007.07.013
   Nathan SS, 2007, BIORESOURCE TECHNOL, V98, P1856, DOI 10.1016/j.biortech.2006.07.044
   Nathan SS, 2004, PHYTOPARASITICA, V32, P433, DOI 10.1007/BF02980437
   Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439
   Pavela R, 2016, CHALLENGES CONSTRAIN, DOI [10.1016/j.tplants.2016.10.005, DOI 10.1016/J.TPLANTS.2016.10.005]
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Ponsankar A, 2016, ECOTOX ENVIRON SAFE, V133, P260, DOI 10.1016/j.ecoenv.2016.06.043
   Pratt HD, 1959, P NEW JERS MOSQ EXT, V46, P148
   Ravindran J., 2012, ASIAN PAC J TROP DIS, V2, P177
   Reegan Appadurai Daniel, 2015, Osong Public Health Res Perspect, V6, P64, DOI 10.1016/j.phrp.2014.08.009
   Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554
   Rehman JU, 2014, FITOTERAPIA, V95, P65, DOI 10.1016/j.fitote.2014.03.002
   Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625
   Sasaki NY, 2015, BIOCHIMIE, V112, P172, DOI 10.1016/j.biochi.2015.03.011
   Selin-Rani S, 2016, PESTIC BIOCHEM PHYS, V126, P92, DOI 10.1016/j.pestbp.2015.08.003
   Nathan SS, 2006, BIORESOURCE TECHNOL, V97, P2077, DOI 10.1016/j.biortech.2005.09.034
   Senthil-Nathan S., 2015, ENV SUSTAINABILITY, P49, DOI 10.1007/978-81-322-2056-5_3.
   Senthil-Nathan S, 2005, ACTA TROP, V96, P47, DOI DOI 10.1016/J.ACTATROPICA.2005.07.002
   Senthil-Nathan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00359
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Tan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102725
   Thanigaivel A, 2017, ECOTOX ENVIRON SAFE, V137, P210, DOI 10.1016/j.ecoenv.2016.11.004
   Thanigaivel A, 2012, PARASITOL RES, V110, P1993, DOI 10.1007/s00436-011-2728-2
   Vasantha-Srinivasan P, 2016, CHEMOSPHERE, V155, P336, DOI 10.1016/j.chemosphere.2016.03.139
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   World Health Organisation, 1981, WHOVBC, V81, P1
   World Health Organization, 2009, WHOCDSNTDWHOPES20094, P4
   World Health Organization, 2014, GLOB BRIEF VECT BORN
NR 56
TC 5
Z9 5
U1 1
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2018
VL 25
IS 11
SI SI
BP 10340
EP 10352
DI 10.1007/s11356-017-9102-6
PG 13
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GC5FC
UT WOS:000429810200017
PM 28580548
DA 2020-07-08
ER

PT J
AU Vasantha-Srinivasan, P
   Thanigaivel, A
   Edwin, ES
   Ponsankar, A
   Senthil-Nathan, S
   Selin-Rani, S
   Kalaivani, K
   Hunter, WB
   Duraipandiyan, V
   Al-Dhabi, NA
AF Vasantha-Srinivasan, Prabhakaran
   Thanigaivel, Annamalai
   Edwin, Edward-Sam
   Ponsankar, Athirstam
   Senthil-Nathan, Sengottayan
   Selin-Rani, Selvaraj
   Kalaivani, Kandaswamy
   Hunter, Wayne B.
   Duraipandiyan, Veeramuthu
   Al-Dhabi, Naif Abdullah
TI Toxicological effects of chemical constituents from Piper against the
   environmental burden Aedes aegypti Liston and their impact on non-target
   toxicity evaluation against biomonitoring aquatic insects
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Volatile; Pb-CVO; Vector; Gut-histology; Enzyme; Beneficial insects;
   Non-target
ID VECTOR ANOPHELES-STEPHENSI; EISENIA-FOETIDA SAVIGNY; SPODOPTERA-LITURA
   FAB.; DIPTERA-CULICIDAE; ESSENTIAL OILS; CNAPHALOCROCIS-MEDINALIS;
   DYSOXYLUM-MALABARICUM; INHIBITORY PROPERTIES; GENERALIST HERBIVORE;
   LARVICIDAL ACTIVITY
AB Dengue is the most rapidly spreading mosquito-borne viral disease in the world. The mosquito, Aedes aegypti, also spreads Yellow fever, Chikungunya, and Zika virus. As the primary vector for dengue, Ae. aegypti now occurs in over 20 countries and is a serious concern with reports of increasing insecticide resistance. Developing new treatments to manage mosquitoes are needed. Formulation of crude volatile oil from Piper betle leaves (Pb-CVO) was evaluated as a potential treatment which showed larvicidal, ovipositional, and repellency effects. Gut-histology and enzyme profiles were analyzed post treatment under in-vitro conditions. The Pb-CVO from leaves of field collected plants was obtained by steam distillation and separated through rotary evaporation. The Pb-CVO were evaluated for chemical constituents through GC-MS analyses revealed 20 vital compounds. The peak area was establish to be superior in Eudesm-7(11)-en-4-ol (14.95%). Pb-CVO were determined and tested as four different concentrations (0.25, 0.5, 1.0, and 1.5 mg/L) of Pb-CVO towards Ae. aegypti. The larvicidal effects exhibited dose dependent mortality being greatest at 1.5 mg Pb-CVO/10 g leaves. The LC50 occurred at 0.63 mg Pb-CVO/L. Larva of Ae. aegypti exposed to Pb-CVO showed significantly reduced digestive enzyme actions of alpha- and beta-carboxylesterases. In contrast, GST and CYP450 enzyme levels increased significantly as concentration increased. Correspondingly, oviposition deterrence index and egg hatch of Ae. aegypti exposed to sub-lethal doses of Pb-CVO demonstrated a strong effect suitable for population suppression. Repellency at 0.6 mg Pb-CVO applied as oil had a protection time of 15-210 min. Mid-gut histological of Ae. aegypti larvae showed severe damage when treated with 0.6 mg of Pb-CVO treatment compared to the control. Non-toxic effects against aquatic beneficial insects, such as Anisops bouvieri and Toxorhynchites splendens, were observed at the highest concentrations, exposed for 3 h. These results suggest that the Pb-CVO may contain effective constituents suitable for development of new vector control agents against Ae.aegypti.
C1 [Vasantha-Srinivasan, Prabhakaran; Thanigaivel, Annamalai; Edwin, Edward-Sam; Ponsankar, Athirstam; Senthil-Nathan, Sengottayan; Selin-Rani, Selvaraj] Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticides & Environm Toxicol, Tirunelveli 627412, Tamil Nadu, India.
   [Kalaivani, Kandaswamy] Sri Parasakthi Coll Women, Dept Zool, Post Grad & Res Ctr, Tirunelveli 627802, Tamil Nadu, India.
   [Hunter, Wayne B.] USDA, US Hort Res Lab, 2001 South Rock Rd, Ft Pierce, FL 34945 USA.
   [Duraipandiyan, Veeramuthu; Al-Dhabi, Naif Abdullah] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Addiriyah Res Chair Environm Studies, POB 2455, Riyadh 11451, Saudi Arabia.
RP Senthil-Nathan, S (corresponding author), Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticides & Environm Toxicol, Tirunelveli 627412, Tamil Nadu, India.
EM senthil@msuniv.ac.in
RI Sengottayan, Senthil-Nathan/D-8979-2012; Prabhakaran,
   Vasantha-Srinivasan/R-8135-2019; hunter, wayne/AAB-9096-2020;
   Veeramuthu, Duraipandiyan/D-9924-2012
OI Sengottayan, Senthil-Nathan/0000-0003-0839-2021; Prabhakaran,
   Vasantha-Srinivasan/0000-0003-3415-3315; hunter,
   wayne/0000-0001-8603-3337; Veeramuthu, Duraipandiyan/0000-0002-2107-3503
FU Deanship of Scientific Research, King Saud UniversityDeanship of
   Scientific Research at King Saud University
FX The authors are grateful to the Deanship of Scientific Research, King
   Saud University for Partial funding through Vice Deanship of Scientific
   Research Chairs.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Adams R.P., 2007, IDENTIFICATION ESSEN, P804
   Agra-Neto AC, 2014, PARASITOL RES, V113, P175, DOI 10.1007/s00436-013-3640-8
   Allinson G, 2015, ENVIRON SCI POLLUT R, V22, P10214, DOI 10.1007/s11356-015-4206-3
   Arambewela LSR, 2005, J ETHNOPHARMACOL, V102, P239, DOI 10.1016/j.jep.2005.06.016
   Arokiyaraj S, 2015, ENVIRON SCI POLLUT R, V22, P9759, DOI 10.1007/s11356-015-4148-9
   Bilal H, 2012, AFR ENTOMOL, V20, P8, DOI 10.4001/003.020.0102
   Boyer S, 2006, ENVIRON TOXICOL CHEM, V25, P470, DOI 10.1897/05-267R2.1
   Breuer M, 2003, PESTIC BIOCHEM PHYS, V76, P99, DOI 10.1016/S0048-3575(03)00067-1
   Caburian AB, 2010, E INT SCI RES J, V2
   Champakaew D, 2015, PARASITOL RES, V114, P2187, DOI 10.1007/s00436-015-4409-z
   Chellappandian M, 2018, ENVIRON SCI POLLUT R, V25, P10294, DOI 10.1007/s11356-017-8952-2
   Cheng SS, 2013, IND CROP PROD, V47, P310, DOI 10.1016/j.indcrop.2013.03.016
   Dammini-Premachandra W. T. S., 2014, CROP PROT, V65, P1, DOI DOI 10.1016/J.CR0PR0.2014.06.004
   Edwin E, 2016, ISJ-INVERT SURVIV J, V13, P153
   Edwin ES, 2016, ACTA TROP, V163, P167, DOI 10.1016/j.actatropica.2016.07.009
   Fayemiwo Kehinde Adenike, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P30, DOI 10.1016/S2221-1691(14)60204-5
   Gleiser RM, 2011, PARASITOL RES, V108, P69, DOI 10.1007/s00436-010-2042-4
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hummelbrunner LA, 2001, J AGR FOOD CHEM, V49, P715, DOI 10.1021/jf000749t
   HWANG YS, 1982, ENVIRON ENTOMOL, V11, P223, DOI 10.1093/ee/11.1.223
   Jukic M, 2007, PHYTOTHER RES, V21, P259, DOI 10.1002/ptr.2063
   Kalaivani K, 2012, PARASITOL RES, V110, P1261, DOI 10.1007/s00436-011-2623-x
   Khan A. A., 2013, Pharmacognosy Journal, V5, P176, DOI 10.1016/j.phcgj.2013.07.002
   Koodalingam A, 2011, ACTA TROP, V118, P27, DOI 10.1016/j.actatropica.2011.01.003
   Laranja AT, 2003, GENET MOL BIOL, V26, P419, DOI 10.1590/S1415-47572003000400004
   Larson RT, 2010, J MED ENTOMOL, V47, P249, DOI 10.1603/ME09160
   Lija-Escaline J, 2015, PARASITOL RES, V114, P4239, DOI 10.1007/s00436-015-4662-1
   Mohottalage S, 2007, FLAVOUR FRAG J, V22, P130, DOI 10.1002/ffj.1770
   Nathan SS, 2008, FITOTERAPIA, V79, P106, DOI 10.1016/j.fitote.2007.07.013
   Nathan SS, 2007, BIORESOURCE TECHNOL, V98, P1856, DOI 10.1016/j.biortech.2006.07.044
   Nathan SS, 2006, CHEMOSPHERE, V62, P1381, DOI 10.1016/j.chemosphere.2005.07.051
   Nathan SS, 2005, PHYTOPARASITICA, V33, P187, DOI 10.1007/BF03029978
   Nouri L, 2014, IND CROP PROD, V62, P47, DOI 10.1016/j.indcrop.2014.08.015
   Park HM, 2011, J MED ENTOMOL, V48, P405, DOI 10.1603/ME10108
   Parthasarathy U, 2008, CURR SCI INDIA, V94, P1632
   Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x
   Pitasawat B, 2007, FITOTERAPIA, V78, P205, DOI 10.1016/j.fitote.2007.01.003
   Ponsankar A, 2018, PHYSIOL MOL PLANT P, V101, P16, DOI 10.1016/j.pmpp.2016.12.006
   Ponsankar A, 2016, ECOTOX ENVIRON SAFE, V133, P260, DOI 10.1016/j.ecoenv.2016.06.043
   Pradeepa V, 2016, PESTIC BIOCHEM PHYS, V134, P84, DOI 10.1016/j.pestbp.2016.04.001
   Pradeepa V, 2015, EXP PARASITOL, V153, P8, DOI 10.1016/j.exppara.2015.01.017
   Pradeepa V, 2014, PARASITOL RES, V113, P3105, DOI 10.1007/s00436-014-4015-5
   Pradhan D., 2013, J PHARMACOGNOSY PHYT, V1, P147
   Rehman JU, 2014, FITOTERAPIA, V95, P65, DOI 10.1016/j.fitote.2014.03.002
   Rey D, 1999, J INVERTEBR PATHOL, V73, P173, DOI 10.1006/jipa.1998.4810
   Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625
   RUDIN W, 1989, PARASITOL RES, V75, P268, DOI 10.1007/BF00931811
   Safaei-Ghomi J, 2016, J ESSENT OIL BEAR PL, V19, P885, DOI 10.1080/0972060X.2016.1195292
   Selin-Rani S, 2016, CHEMOSPHERE, V165, P257, DOI 10.1016/j.chemosphere.2016.08.136
   Selin-Rani S, 2016, PESTIC BIOCHEM PHYS, V126, P92, DOI 10.1016/j.pestbp.2015.08.003
   Nathan SS, 2006, BIORESOURCE TECHNOL, V97, P2077, DOI 10.1016/j.biortech.2005.09.034
   Senthil-Nathan S., 2015, ENV SUSTAINABILITY, P49, DOI 10.1007/978-81-322-2056-5_3.
   Senthil-Nathan S, 2005, ACTA TROP, V96, P47, DOI DOI 10.1016/J.ACTATROPICA.2005.07.002
   Senthil-Nathan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00359
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Stark JD, 2001, BIOSCIENCE, V51, P980, DOI 10.1641/0006-3568(2001)051[0980:SPATLH]2.0.CO;2
   Stark J, 2005, DECIS ENG, P1
   Su TY, 1999, ENTOMOL EXP APPL, V91, P337, DOI 10.1023/A:1003630714731
   Thanigaivel A, 2017, ARCH INSECT BIOCHEM, V94, DOI 10.1002/arch.21384
   Thanigaivel A, 2017, ECOTOX ENVIRON SAFE, V137, P210, DOI 10.1016/j.ecoenv.2016.11.004
   Thanigaivel A, 2012, PARASITOL RES, V110, P1993, DOI 10.1007/s00436-011-2728-2
   van Lexmond MB, 2015, ENVIRON SCI POLLUT R, V22, P1, DOI 10.1007/s11356-014-3220-1
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   Vasantha-Srinivasan P, 2017, ECOTOX ENVIRON SAFE, V139, P439, DOI 10.1016/j.ecoenv.2017.01.026
   Vasantha-Srinivasan P, 2016, CHEMOSPHERE, V155, P336, DOI 10.1016/j.chemosphere.2016.03.139
   *WHO, 2009, GUID EFF TEST MOSQ R, P4
   World Health Organisation, 1981, WHOVBC, V81, P1
NR 69
TC 6
Z9 6
U1 3
U2 10
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2018
VL 25
IS 11
SI SI
BP 10434
EP 10446
DI 10.1007/s11356-017-9714-x
PG 13
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GC5FC
UT WOS:000429810200025
PM 28852982
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Vaseeharan, B
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Al-Anbr, MN
   Alyahya, SA
   Maggi, F
   Benelli, G
AF Govindarajan, Marimuthu
   Vaseeharan, Baskaralingam
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Al-Anbr, Mohammed N.
   Alyahya, Sami A.
   Maggi, Filippo
   Benelli, Giovanni
TI High efficacy of (Z)-gamma-bisabolene from the essential oil of
   Galinsoga parviflora (Asteraceae) as larvicide and oviposition deterrent
   against six mosquito vectors
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Culicidae; Dengue; Japanese encephalitis; Malaria; Vector control; Zika
   virus (Z)-gamma-bisabolene
ID ECO-FRIENDLY LARVICIDES; LEAF ESSENTIAL OILS; AEDES-AEGYPTI;
   CHEMICAL-COMPOSITION; AERIAL PARTS; CULEX-QUINQUEFASCIATUS; INSECTICIDAL
   ACTIVITY; BOTANICAL INSECTICIDES; CINNAMOMUM-OSMOPHLOEUM; BORNE
   COMPOUNDS
AB The eco-friendly management of mosquitoes with novel and effective larvicides and oviposition deterrents is a crucial challenge to prevent outbreaks of mosquito-borne diseases. However, most of the herbal formulations tested in these years showed LC50 values higher of 40 ppm, and significant oviposition deterrent activity only when tested at relatively higher doses (> 50 mu g/ml). Herein, we studied the chemical composition of the Galinsoga parviflora essential oil (EO). This plant is an annual herb native to South America naturalized all over the world. We tested the EO larvicidal and oviposition deterrent action on 6 mosquito species. Totally 37 compounds were identified in the EO of G. parviflora by GC and GC-MS analyses. The major constituent was (Z)-gamma-bisabolene (38.9%). The G. parviflora EO and (Z)-gamma-bisabolene showed acute toxicity on An. stephensi (LC50 = 31.04 and 2.04 mu g/ml, respectively), Ae. aegypti (LC50 = 34.22 and 2.26 mu g/ml, respectively), Cx. quinquefasciatus (LC50 = 37.10 and 2.47 mu g/ml, respectively), An. subpictus (LC50 = 40.97 and 4.09 mu g/ml, respectively), Ae. albopictus (LC50 = 45.55 and 4.50 mu g/ml, respectively) and Cx. tritaeniorhynchus (LC50 = 49.56 and 4.87 mu g/ml, respectively) larvae. Furthermore, the oviposition deterrent potential of the G. parviflora EO and (Z)-gamma-bisabolene was studied on six mosquito vectors, showing that 25 mu g/ml of (Z)-gamma-bisabolene led to an Oviposition Activity Index lower of -0.79 in all tested mosquito vectors. Overall, all larvicidal LC50 values estimated for (Z)-gamma-bisabolene were lower than 5 mu g/ml. This result far encompasses current evidences of toxicity reported for the large majority of botanical products currently tested against mosquito young instars, allowing us to propose this compound as an highly effective mosquito larvicide and oviposition deterrent.
C1 [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Vaseeharan, Baskaralingam] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Karaikkudi 630004, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.; Al-Anbr, Mohammed N.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Alyahya, Sami A.] King Abdulaziz City Sci & Technol, Natl Biotechnol Ctr, Riyadh 11442, Saudi Arabia.
   [Maggi, Filippo] Univ Camerino, Sch Pharm, Via St Agostino 1, I-62032 Camerino, Italy.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, Biorobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Benelli, G (corresponding author), St Anna Sch Adv Studies, Biorobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI /L-2836-2013; Alharbi, Naiyf S/B-9402-2019; Benelli,
   Giovanni/A-9100-2013; GOVINDARAJAN, MARIMUTHU/A-8070-2019; Khaled,
   Jamal/D-8188-2017
OI /0000-0001-7018-5379; Benelli, Giovanni/0000-0001-8971-6010;
   GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; 
FU Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [RG-1438-091]
FX The authors are grateful to the Professor and Head of the Department of
   Zoology, Annamalai University for laboratory provisions granted. The
   authors extend their appreciation to the Deanship of Scientific Research
   at King Saud University for funding this work through research group no.
   RG-1438-091.
CR Adams RP, 2007, CAROL STREAM ILLINOI
   Ali A, 2016, REC NAT PROD, V10, P137
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Atiko R, 2016, INT J SCI ENG RES, V7, P888
   Bazylko A, 2015, J PHOTOCH PHOTOBIO B, V149, P189, DOI 10.1016/j.jphotobiol.2015.06.010
   Bazylko A, 2012, NAT PROD RES, V26, P1584, DOI 10.1080/14786419.2011.582469
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10264, DOI 10.1007/s11356-017-8820-0
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, IND CROP PROD, V103, P19, DOI 10.1016/j.indcrop.2017.03.032
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10218, DOI 10.1007/s11356-016-8146-3
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2017, PARASITOL RES, V116, P1175, DOI 10.1007/s00436-017-5395-0
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Boulos L, 2002, FLORA EGYPT, VIII, P233
   Boussaada O, 2008, B INSECTOL, V61, P283
   Chen XB, 2013, TROP J PHARM RES, V12, P799, DOI 10.4314/tjpr.v12i5.21
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P465, DOI 10.1016/j.biortech.2007.11.060
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P457, DOI 10.1016/j.biortech.2008.02.030
   Cheng SS, 2009, PEST MANAG SCI, V65, P339, DOI 10.1002/ps.1693
   Cheng SS, 2004, J AGR FOOD CHEM, V52, P4395, DOI 10.1021/jf0497152
   Chericoni S, 2004, BIOCHEM SYST ECOL, V32, P423, DOI 10.1016/j.bse.2003.10.002
   de Omena MC, 2007, BIORESOURCE TECHNOL, V98, P2549, DOI 10.1016/j.biortech.2006.09.040
   Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440
   Dharmagadda VSS, 2005, BIORESOURCE TECHNOL, V96, P1235, DOI 10.1016/j.biortech.2004.10.020
   do Nascimento JC, 2013, PEST MANAG SCI, V69, P1267, DOI 10.1002/ps.3495
   Dudek MK, 2016, PHYTOCHEM LETT, V16, P303, DOI 10.1016/j.phytol.2016.05.007
   Euro+Med, 2006, EURO MED PLANTBASE T
   Ferheen S, 2009, J ENZYM INHIB MED CH, V24, P1128, DOI 10.1080/14756360802667688
   Ferreira PE, 2013, TRENDS PARASITOL, V29, P318, DOI 10.1016/j.pt.2013.05.002
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Gairola S, 2014, J ETHNOPHARMACOL, V155, P925, DOI 10.1016/j.jep.2014.06.029
   Gonzalez-Coloma A, 2005, Z NATURFORSCH C, V60, P855
   Govindarajan M, 2018, ENVIRON SCI POLLUT R, V25, P10272, DOI 10.1007/s11356-017-8822-y
   Govindarajan M, 2016, ENVIRON SCI POLLUT R, V23, P23228, DOI 10.1007/s11356-016-7568-2
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Haider SZ, 2017, ENTOMOL RES, V47, P318, DOI 10.1111/1748-5967.12228
   Ibrahim MA, 2008, PLANT BIOLOGY, V10, P97, DOI 10.1111/j.1438-8677.2007.00013.x
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470
   Isman MB, 2015, PEST MANAG SCI, V71, P1587, DOI 10.1002/ps.4088
   Jain N, 2001, FLAVOUR FRAG J, V16, P408, DOI 10.1002/ffj.1024
   Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003
   KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111
   Lawal OA, 2014, J OLEO SCI, V63, P629, DOI 10.5650/jos.ess13179
   Lee HS, 2006, J AM MOSQUITO CONTR, V22, P292, DOI 10.2987/8756-971X(2006)22[292:MLAOAM]2.0.CO;2
   Li YW, 2012, PARASITOL RES, V110, P2197, DOI [10.1007/s00436-011-2749-x, 10.1007/s00436-012-3251-9]
   LIU XC, 2014, J ENTOMOL ZOOL STU G, V2, P345
   Liu XC, 2015, PEST MANAG SCI, V71, P1582, DOI 10.1002/ps.3964
   Liu XC, 2014, TROP J PHARM RES, V13, P399, DOI 10.4314/tjpr.v13i3.13
   Lomonaco D, 2009, GREEN CHEM, V11, P31, DOI 10.1039/b811504d
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Mancini E, 2011, MOLECULES, V16, P7725, DOI 10.3390/molecules16097725
   Marques MMM, 2011, J AM MOSQUITO CONTR, V27, P156, DOI 10.2987/10-6056.1
   Mehlhorn H, 2015, ENCY PARASITOLOGY
   Miyazawa M, 2000, J AGR FOOD CHEM, V48, P3639, DOI 10.1021/jf000325z
   Morshedloo MR, 2017, PLANT PHYSIOL BIOCH, V111, P119, DOI 10.1016/j.plaphy.2016.11.023
   MOSSA JS, 1992, PHYTOCHEMISTRY, V31, P575, DOI 10.1016/0031-9422(92)90041-N
   Mostafa I, 2013, Z NATURFORSCH C, V68, P285, DOI 10.5560/ZNC.2013.68c0285
   Namukobe J, 2011, J ETHNOPHARMACOL, V136, P236, DOI 10.1016/j.jep.2011.04.044
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Ochwang'i DO, 2014, J ETHNOPHARMACOL, V151, P1040, DOI 10.1016/j.jep.2013.11.051
   [潘争红 PAN Zhenghong], 2007, [云南大学学报. 自然科学版, Journal of Yunnan University. Natural Science], V29, P613
   Pavela Roman, 2008, Journal of Biopesticides, V1, P81
   Pavela R, 2016, RES VET SCI, V109, P1, DOI 10.1016/j.rvsc.2016.09.001
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2009, PARASITOL RES, V105, P1365, DOI 10.1007/s00436-009-1571-1
   PICOT S, 2009, MALARIA J, V8
   Pignatti S, 1982, FLORA DITALIA, VIII, P63
   Pino JA, 2010, NAT PROD COMMUN, V5, P1831
   Raal A, 2012, NAT PROD RES, V26, P1173, DOI 10.1080/14786419.2010.535154
   Rawani A, 2014, PARASITOL RES, V113, P4423, DOI 10.1007/s00436-014-4120-5
   Ro DK, 2006, ARCH BIOCHEM BIOPHYS, V448, P104, DOI 10.1016/j.abb.2005.09.019
   Ruiz C, 2011, PLANTA MED, V77, P1300
   Sakthivadivel M, 2008, APPL ENTOMOL ZOOL, V43, P57, DOI 10.1303/aez.2008.57
   Schmidt C, 2009, J ETHNOPHARMACOL, V122, P523, DOI 10.1016/j.jep.2009.01.022
   Sefidkon F, 2004, FOOD CHEM, V88, P325, DOI 10.1016/j.foodchem.2003.12.044
   Senthilkumar A, 2008, PARASITOL RES, V103, P959, DOI 10.1007/s00436-008-1085-2
   Shaalan EAS, 2005, ENVIRON INT, V31, P1149, DOI 10.1016/j.envint.2005.03.003
   Sivakumar R, 2011, EUR REV MED PHARMACO, V15, P1172
   Vera SS, 2014, PARASITOL RES, V113, P2647, DOI 10.1007/s00436-014-3917-6
   Sulaiman S, 2008, IRAN J ARTHROPOD-BOR, V2, P7
   Tariq S, 2008, J CHEM SOC PAKISTAN, V30, P762
   Tavares WD, 2009, IND CROP PROD, V30, P384, DOI 10.1016/j.indcrop.2009.07.007
   Tene V, 2007, J ETHNOPHARMACOL, V111, P63, DOI 10.1016/j.jep.2006.10.032
   Tiwary Mohini, 2007, Journal of Vector Borne Diseases, V44, P198
   Tolossa K, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-32
   Turek C, 2013, COMPR REV FOOD SCI F, V12, P40, DOI 10.1111/1541-4337.12006
   VIGNESH A, 2016, INT J MOSQ RES A, V3, P62
   WHO, 2005, WHOCDSWHOPESGCDPP13
   World Health Organization, 2012, HDB INT VECT MAN
   Xue RD, 2001, MED VET ENTOMOL, V15, P126, DOI 10.1046/j.0269-283x.2001.00301.x
   Zhu L, 2013, PARASITOL RES, V112, P1137, DOI 10.1007/s00436-012-3243-9
   Zhu L, 2011, PARASITOL RES, V109, P1417, DOI 10.1007/s00436-011-2388-2
   Zhu L, 2011, ASIAN PAC J TROP MED, V4, P371, DOI 10.1016/S1995-7645(11)60106-5
NR 105
TC 8
Z9 7
U1 2
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2018
VL 25
IS 11
SI SI
BP 10555
EP 10566
DI 10.1007/s11356-018-1203-3
PG 12
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GC5FC
UT WOS:000429810200035
PM 29372518
DA 2020-07-08
ER

PT J
AU Li, L
   Wang, J
   Jia, ZH
   Shaw, N
AF Li, Lei
   Wang, Jin
   Jia, Zhihui
   Shaw, Neil
TI Structural view of the helicase reveals that Zika virus uses a conserved
   mechanism for unwinding RNA
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
DE Zika virus; helicase; crystal structure; ligands
ID NS3 HELICASE; HELICASE/NUCLEOSIDE TRIPHOSPHATASE; CRYSTAL-STRUCTURE;
   CATALYTIC DOMAIN; TRANSLOCATION; INFECTION; PROTEIN; RESOLUTION;
   INSIGHTS; THREAT
AB Recent studies suggest a link between infection by Zika virus (ZIKV) and the development of neurological complications. The lack of ZIKV-specific therapeutics has alarmed healthcare professionals worldwide. Here, crystal structures of apo and AMPPNP- and Mn2+-bound forms of the essential helicase of ZIKV refined to 1.78 and 1.3 angstrom resolution, respectively, are reported. The structures reveal a conserved trimodular topology of the helicase. ATP and Mn2+ are tethered between two RecA-like domains by conserved hydrogen-bonding interactions. The binding of ligands induces the movement of backbone C alpha and side-chain atoms. Numerous solvent molecules are observed in the vicinity of the AMPPNP, suggesting a role in catalysis. These high-resolution structures could be useful for the design of inhibitors targeting the helicase of ZIKV for the treatment of infections caused by ZIKV.
C1 [Li, Lei; Wang, Jin] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.
   [Li, Lei; Wang, Jin] Sichuan Univ, West China Hosp, Canc Ctr, Natl Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China.
   [Li, Lei; Wang, Jin; Jia, Zhihui] Tsinghua Univ, Sch Med, Lab Struct Biol, Beijing 100084, Peoples R China.
   [Li, Lei; Wang, Jin; Jia, Zhihui] Tsinghua Univ, Sch Med, MOE Lab Prot Sci, Beijing 100084, Peoples R China.
   [Shaw, Neil] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100101, Peoples R China.
RP Li, L (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.; Li, L (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Natl Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China.; Li, L (corresponding author), Tsinghua Univ, Sch Med, Lab Struct Biol, Beijing 100084, Peoples R China.; Li, L (corresponding author), Tsinghua Univ, Sch Med, MOE Lab Prot Sci, Beijing 100084, Peoples R China.; Shaw, N (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100101, Peoples R China.
EM leiliby@163.com; neilshaw@moon.ibp.ac.cn
OI Shaw, Neil/0000-0003-2722-9967
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31000332, 31100208, 31100877, 31170782,
   31110103915]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 31000332, 31100208, 31100877, 31170782 and
   31110103915).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034
   Aziz H, 2017, J MED VIROL, V89, P943, DOI 10.1002/jmv.24731
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DeLano WL, 2002, PYMOL, P700
   Dub T, 2017, REV NEUROL-FRANCE, V173, P361, DOI 10.1016/j.neurol.2017.03.033
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007
   Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1
   Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Matlock DL, 2010, BIOCHEMISTRY-US, V49, P2097, DOI 10.1021/bi901977k
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miller E, 2017, J NEUROL SCI, V375, P367, DOI 10.1016/j.jns.2017.02.029
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yamashita T, 2008, VIROLOGY, V373, P426, DOI 10.1016/j.virol.2007.12.018
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 37
TC 4
Z9 5
U1 0
U2 4
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD APR
PY 2018
VL 74
BP 205
EP 213
DI 10.1107/S2053230X18003813
PN 4
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA GC1QS
UT WOS:000429557300004
PM 29633968
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Theel, ES
   Hata, DJ
AF Theel, Elitza S.
   Hata, D. Jane
TI Diagnostic Testing for Zika Virus: a Postoutbreak Update
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Review
DE diagnostic assays; RT-PCR; serology; Zika virus
ID LINKED IMMUNOSORBENT ASSAYS; WHOLE-BLOOD SPECIMENS; UNITED-STATES;
   INFECTION; DENGUE; RNA; URINE; IGM; TRANSMISSION; SPECIFICITY
AB Since the emergence and dissemination of Zika virus (ZIKV) in late 2015, our understanding of the biology, transmission, clinical disease, and potential sequelae associated with infection has markedly expanded. Over the past 2 years, the number of diagnostic assays for ZIKV has increased from none in 2015 to 5 serological assays and 14 molecular assays in 2017, all with emergency use authorization granted through the U. S. Food and Drug Administration. Here we provide an update on ZIKV, addressing what we have collectively learned since the outbreak began, including a summary of currently available diagnostic assays for this virus.
C1 [Theel, Elitza S.] Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA.
   [Hata, D. Jane] Mayo Clin, Lab Med & Pathol, Jacksonville, FL 32224 USA.
RP Theel, ES (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA.
EM theel.elitza@mayo.edu
CR [Anonymous], 2016, TRIOPL REAL TIM RT P
   Assistant Secretary for Preparedness and Response, 2016, DET PUBL HLTH EM EX
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, CDCHAN00399
   Centers for Disease Control and Prevention, 2017, ZIK CAS US
   Centers for Disease Control and Prevention, 2017, ZIK MAC ELISA US EM
   Centres for Disease Control and Prevention, 2017, WORLD MAP AR RISK ZI
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Food and Drug Administration, 2017, EM US AUTH MED PROD
   Frankel MB, 2017, J VIROL METHODS, V246, P117, DOI 10.1016/j.jviromet.2017.05.002
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Olschlager S, 2017, AM J TROP MED HYG, V97, P1070, DOI 10.4269/ajtmh.17-0268
   Pan American Health Organization, 2017, ZIK CAS CONG SYNDR A
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   St George K, 2018, REV MED MICROBIOL, V29, P8, DOI 10.1097/MRM.0000000000000125
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 71
TC 17
Z9 17
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD APR
PY 2018
VL 56
IS 4
AR UNSP e01972-17
DI 10.1128/JCM.01972-17
PG 12
WC Microbiology
SC Microbiology
GA GC3YC
UT WOS:000429718700036
PM 29386264
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Letter to "Knowledge and perceptions of Zika virus among
   reproductive-aged women after public announcement of local
   mosquito-borne transmission'
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Med Ctr Dept, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Med Ctr Dept, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Curry CL, 2017, J OBSTET GYNAECOL RE, DOI 10. 1111/jog. 13533
   Joob B, 2017, CASE STUDY CASE REP, V7, P29
   Wiwanitkit S, 2016, ANN TROP MED PUBLIC, V9, P361, DOI 10.4103/1755-6783.190206
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 4
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1341-8076
EI 1447-0756
J9 J OBSTET GYNAECOL RE
JI J. Obstet. Gynaecol. Res.
PD APR
PY 2018
VL 44
IS 4
BP 806
EP 806
DI 10.1111/jog.13587
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GC1QP
UT WOS:000429557000028
PM 29359481
DA 2020-07-08
ER

PT J
AU Prins, JR
   Eskandar, S
   Eggen, BJL
   Scherjon, SA
AF Prins, Jelmer R.
   Eskandar, Sharon
   Eggen, Bart J. L.
   Scherjon, Sicco A.
TI Microglia, the missing link in maternal immune activation and fetal
   neurodevelopment; and a possible link in preeclampsia and disturbed
   neurodevelopment?
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE Microglia; Macrophages; Pregnancy; Preeclampsia; Maternal immune
   activation (MIA)
ID AUTISM SPECTRUM DISORDERS; REGULATORY T-CELLS; BLOOD-BRAIN-BARRIER; ZIKA
   VIRUS; PERIPHERAL-BLOOD; EARLY-PREGNANCY; SEMINAL PLASMA; MACROPHAGES;
   SCHIZOPHRENIA; INFECTION
AB Disturbances in fetal neurodevelopment have extensively been related to neurodevelopmental disorders in early and later life. Fetal neurodevelopment is dependent on adequate functioning of the fetal immune system. During pregnancy, the maternal immune system is challenged to both tolerate the semi-allogenic fetus and to protect the mother and fetus from microbes. The fetal immune system is influenced by maternal immune disturbances; therefore, perturbations in maternal immunity likely do not only alter pregnancy outcome but also alter fetal neurodevelopment. A possible common pathway could be modulating the functioning of tissue macrophages in the placenta and brain.
   Maternal immune tolerance towards the fetus involves several complex adaptations. In this active maternal immune state, the fetus develops its own immunity. As cytokines and other players of the immune system-which can pass the placenta-are involved in neurodevelopment, disruptions in immune balance influence fetal neurodevelopment. Several studies reported an association between maternal immune activation, complications of pregnancy as preeclampsia, and altered neonatal neurodevelopment. A possible pathway involves dysfunctioning of microglia cells, the immune cells of the brain. Functionality of microglia cells during normal pregnancy is, however, poorly understood. The recent outbreak of ZIKA virus (ZKV), but also the literature on virus infections in general and its consequences on microglial cell function and fetal neurodevelopment show the devastating effects a virus infection during pregnancy can have.
C1 [Prins, Jelmer R.; Eskandar, Sharon; Scherjon, Sicco A.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, POB 30001, NL-9700 RB Groningen, Netherlands.
   [Prins, Jelmer R.] Med Spectrum Twente, Dept Obstet & Gynecol, POB 50000, NL-7500 KA Enschede, Netherlands.
   [Eskandar, Sharon; Eggen, Bart J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Sect Med Physiol, POB 30001, NL-9700 RB Groningen, Netherlands.
RP Prins, JR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, POB 30001, NL-9700 RB Groningen, Netherlands.
EM j.r.prins@umcg.nl; s.eskandar@umcg.nl; b.j.l.eggen@umcg.nl;
   s.a.scherjon@umcg.nl
CR Adhyatmika A, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00081
   Aractingi S, 1998, LANCET, V352, P1898, DOI 10.1016/S0140-6736(98)05121-6
   Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572
   Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y
   Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445
   Bilbo SD, 2012, FRONT NEUROENDOCRIN, V33, P267, DOI 10.1016/j.yfrne.2012.08.006
   Bloise E, 2017, CELL PHYSIOL BIOCHEM, V41, P1044, DOI 10.1159/000461569
   Brown AS, 2014, MOL PSYCHIATR, V19, P259, DOI 10.1038/mp.2012.197
   Chan WFN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045592
   Ciernia AV, 2018, GLIA, V66, P505, DOI 10.1002/glia.23261
   Dangat K, 2014, INT J DEV NEUROSCI, V33, P115, DOI 10.1016/j.ijdevneu.2013.12.007
   Debost JCPG, 2017, SCHIZOPHRENIA BULL, V43, P171, DOI 10.1093/schbul/sbw083
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Filiano AJ, 2015, BRAIN RES, V1617, P18, DOI 10.1016/j.brainres.2014.07.050
   Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630
   Franken L, 2016, CELL MICROBIOL, V18, P475, DOI 10.1111/cmi.12580
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gardner RM, 2015, INT J EPIDEMIOL, V44, P870, DOI 10.1093/ije/dyv081
   Guerin LR, 2009, HUM REPROD UPDATE, V15, P517, DOI 10.1093/humupd/dmp004
   Hamidzadeh K, 2017, ANNU REV PHYSIOL, V79, P567, DOI 10.1146/annurev-physiol-022516-034348
   Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004
   Johnson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133953
   Johnson AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113670
   Kallikourdis M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000382
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kinder JM, 2017, NAT REV IMMUNOL, V17, P483, DOI 10.1038/nri.2017.38
   Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187
   Kowal C, 2015, IMMUNOL RES, V63, P18, DOI 10.1007/s12026-015-8714-5
   Koyama R, 2015, NEUROSCI RES, V100, P1, DOI 10.1016/j.neures.2015.06.005
   Lee BK, 2015, BRAIN BEHAV IMMUN, V44, P100, DOI 10.1016/j.bbi.2014.09.001
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Marques AH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00120
   Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670
   Mattei D, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.80
   McGrath KE, 2015, SEMIN IMMUNOL, V27, P379, DOI 10.1016/j.smim.2016.03.013
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mori M, 2016, SEMIN IMMUNOPATHOL, V38, P635, DOI 10.1007/s00281-016-0574-0
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nardone S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3339/fnins.2016.00329, 10.3389/fnins.2016.00329]
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529
   Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rijnink EC, 2015, MOL HUM REPROD, V21, P857, DOI 10.1093/molehr/gav047
   Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3
   Sasaki Y, 2007, CLIN EXP IMMUNOL, V149, P139, DOI 10.1111/j.1365-2249.2007.03397.x
   Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044
   Schaafsma W, 2017, NEUROBIOL DIS, V106, P291, DOI 10.1016/j.nbd.2017.07.017
   Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026
   Schonkeren D, 2011, AM J PATHOL, V178, P709, DOI 10.1016/j.ajpath.2010.10.011
   Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549
   Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028
   Simamura E, 2010, ENDOCRINOLOGY, V151, P1853, DOI 10.1210/en.2009-0985
   Svensson-Arvelund J, 2015, AM J REPROD IMMUNOL, V74, P100, DOI 10.1111/aji.12357
   Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737
   Tsukada T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129011
   Vieau D, 2007, PSYCHONEUROENDOCRINO, V32, pS16, DOI 10.1016/j.psyneuen.2007.03.014
   Walker CK, 2015, JAMA PEDIATR, V169, P154, DOI 10.1001/jamapediatrics.2014.2645
   Warshafsky C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010884
   Whitehouse AJO, 2012, PAEDIATR PERINAT EP, V26, P101, DOI 10.1111/j.1365-3016.2011.01257.x
   Yue X., 2015, CANC CELL MICROENVIR, V2
NR 63
TC 11
Z9 11
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD APR
PY 2018
VL 126
BP 18
EP 22
DI 10.1016/j.jri.2018.01.004
PG 5
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA GC8HH
UT WOS:000430033900003
PM 29421625
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Raude, J
   Peretti-Watel, P
   Ward, J
   Flamand, C
   Verger, P
AF Raude, Jocelyn
   Peretti-Watel, Patrick
   Ward, Jeremy
   Flamand, Claude
   Verger, Pierre
TI Are Perceived Prevalences of Infection also Biased and How? Lessons from
   Large Epidemics of Mosquito-Borne Diseases in Tropical Regions
SO MEDICAL DECISION MAKING
LA English
DT Article
DE perceived prevalence; primary bias; probability weighting function;
   white male effect
ID RISK PERCEPTIONS; JUDGED FREQUENCY; LETHAL EVENTS; BEHAVIOR;
   UNCERTAINTY; JUDGMENTS; ACCURACY; NUMERACY; PEOPLE; VIRUS
AB Background. Although people are likely to underestimate the frequencies of risks to health from common diseases and overestimate those from rare diseases, we still do not know much about reasons for this systematic bias, which is also referred to as primary bias in the literature. In this study, we take advantage of a series of large epidemics of mosquito-borne diseases to examine the accuracy of judgments of risk frequencies. In this aim, we assessed the perceived v. observed prevalence of infection by Zika, chikungunya or dengue fever during these outbreaks, as well as their variations among different subpopulations and epidemiological settings. Methods. We used data drawn from 4 telephone surveys, conducted between 2006 and 2016, among representative samples of the adult population in tropical regions (Reunion, Martinique, and French Guiana). The participants were asked to estimate the prevalence of these infections by using a natural frequency scale. Results. The surveys showed that 1) most people greatly overestimated the prevalence of infection by arbovirus, 2) these risk overestimations fell considerably as the actual prevalence of these diseases increased, 3) the better-educated and male participants consistently yielded less inaccurate risk estimates across epidemics, and 4) these biases in the perception of prevalence of these infectious diseases are relatively well predicted by the probability weighting function developed in the field of behavioral decision making. Conclusions. These findings suggest that the primary bias, which has been found in laboratory experiments to characterize a variety of probabilistic judgments, equally affects perception of prevalence of acute infectious diseases in epidemic settings. They also indicate that numeracy may play a considerable role in people's ability to transform epidemiological observations from their social environment to more accurate risk estimates.
C1 [Raude, Jocelyn] Univ Sorbonne Paris Cite, EHESP Rennes, Paris, France.
   [Raude, Jocelyn] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, UMR Emergence Pathol Virales D 190, Marseille, France.
   [Raude, Jocelyn] Univ La Reunion, Plateforme Technol CYROI, UMR PIMIT, INSERM 1187,CNRS 9192,IRD 249, St Denis, Reunion, France.
   [Peretti-Watel, Patrick; Ward, Jeremy; Verger, Pierre] Aix Marseille Univ, IHU Mediterrane Infect, AP HM, IRD,SSA,VITROME, Marseille, France.
   [Flamand, Claude] Inst Pasteur Guyane, Unite Epidemiol, Cayenne, France.
   [Peretti-Watel, Patrick; Ward, Jeremy; Verger, Pierre] ORS PACA, Southeastern Hlth Reg Observ, Marseille, France.
   [Ward, Jeremy] Univ Paris Diderot, CNRS, LIED, Interdisciplinary Lab Tomorrows Energies, Paris, France.
RP Raude, J (corresponding author), EHESP French Sch Publ Hlth, Dept Social & Behav Sci, 15 Ave Prof Leon Bernard,CS 74312, F-35043 Rennes, France.
EM Jocelyn.Raude@ehesp.fr
RI Peretti-Watel, Patrick/P-4535-2017
OI ward, jeremy/0000-0003-3389-6870; Flamand, Claude/0000-0002-8064-445X
CR Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746
   Althaus CE, 2005, RISK ANAL, V25, P567, DOI 10.1111/j.1539-6924.2005.00625.x
   [Anonymous], 2015, RAPP 2015
   Blalock SJ, 2016, HEALTH PSYCHOL, V35, P781, DOI 10.1037/hea0000384
   Bodemer N., 2015, SAGE HDB RISK COMMUN, P10
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Campbell S, 2006, J RISK RES, V9, P225, DOI 10.1080/13669870600603147
   Chandon P, 2007, J MARKETING RES, V44, P84, DOI 10.1509/jmkr.44.1.84
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cosmides L, 1996, COGNITION, V58, P1, DOI 10.1016/0010-0277(95)00664-8
   DIEFENBACH MA, 1993, HEALTH EDUC RES, V8, P181, DOI 10.1093/her/8.2.181
   Finucane ML, 2000, HEALTH RISK SOC, V2, P159, DOI 10.1080/713670162
   Frijling BD, 2004, PATIENT EDUC COUNS, V52, P47, DOI 10.1016/S0738-3991(02)00248-3
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gaskell G., 2010, EUROPEANS BIOTECHNOL
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Gigerenzer G., 2012, ECOLOGICAL RATIONALI, P80, DOI DOI 10.1093/ACPROF:OSO/9780195315448.003.0025
   GIGERENZER G, 1991, EUROPEAN REV SOCIAL, V2, P83, DOI DOI 10.1080/14792779143000033
   Gilovich T., 2002, HEURISTICS BIASES PS
   Hakes JK, 2004, RISK ANAL, V24, P651, DOI 10.1111/j.0272-4332.2004.00465.x
   Heggenhougen HK, 2003, WORLD HLTH ORG BEHAL
   Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725
   Hertwig R, 2005, J EXP PSYCHOL LEARN, V31, P621, DOI 10.1037/0278-7393.31.4.621
   Ioannidis J, 2013, J ECON SURV, V27, P997, DOI 10.1111/joes.12032
   JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20
   Kpanake L, 2008, RISK ANAL, V28, P193, DOI 10.1111/j.1539-6924.2008.01008.x
   LICHTENSTEIN S, 1978, J EXP PSYCHOL-HUM L, V4, P551, DOI 10.1037/0278-7393.4.6.551
   Lundborg P, 2004, J RISK UNCERTAINTY, V28, P261, DOI 10.1023/B:RISK.0000026098.84109.62
   Lundborg P, 2002, J RISK UNCERTAINTY, V25, P165, DOI 10.1023/A:1020695730192
   NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308
   Noppert GA, 2017, J EPIDEMIOL COMMUN H, V71, P350, DOI 10.1136/jech-2016-207967
   Pachur T, 2004, P COGNIT SCI SOC, P26
   Palmer CGS, 2003, HEALTH RISK SOC, V5, P71, DOI 10.1080/1369857031000066014
   Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P531, DOI 10.1177/1745691612463401
   Pattanayak S, 2006, 0604 RTI RES TRIANGL
   Payyappilly RJ, 2017, J INT MED DENT, V4, P27
   Peters E, 2008, ANN NY ACAD SCI, V1128, P1, DOI 10.1196/annals.1399.001
   Philipson T, 2000, HANDB ECON, V17, P1761
   Picone G, 2013, MALARIA PREVALENCE I
   Prelec D, 1998, ECONOMETRICA, V66, P497, DOI 10.2307/2998573
   Raude J, 2005, J RISK RES, V8, P663, DOI 10.1080/13669870500194825
   Reyna VF, 2009, PSYCHOL BULL, V135, P943, DOI 10.1037/a0017327
   Rivers L, 2010, RISK ANAL, V30, P65, DOI 10.1111/j.1539-6924.2009.01313.x
   Rosine J, 2011, BVS ANTILLES GUYANE, P2
   Rothman Alexander J., 1999, Journal of the National Cancer Institute Monographs, P44
   SAVAGE I, 1993, RISK ANAL, V13, P413, DOI 10.1111/j.1539-6924.1993.tb00741.x
   Seban J, 2013, HEALTH PLACE, V24, P275, DOI 10.1016/j.healthplace.2013.09.001
   SHANTEAU J, 1978, J EXP PSYCHOL-HUM L, V4, P579, DOI 10.1037/0278-7393.4.6.579
   Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   SLOVIC P, 1979, ENVIRONMENT, V21, P14, DOI 10.1080/00139157.1979.9933091
   Slovic P, 1999, RISK ANAL, V19, P689, DOI 10.1023/A:1007041821623
   Slovic P, 1999, J RISK RES, V2, P281, DOI DOI 10.1080/136698799376727
   Sutton SR, 1999, RISK SOC, V1, P223, DOI DOI 10.1080/13698579908407020
   TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574
   VISCUSI WK, 1990, J POLIT ECON, V98, P1253, DOI 10.1086/261733
   Viscusi WK, 2003, J RISK RES, V6, P23, DOI 10.1080/1366987032000047789
   Weinstein ND, 1998, ANN BEHAV MED, V20, P135, DOI 10.1007/BF02884459
   Xu J, 2015, PLOS ONE
NR 60
TC 2
Z9 2
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0272-989X
EI 1552-681X
J9 MED DECIS MAKING
JI Med. Decis. Mak.
PD APR
PY 2018
VL 38
IS 3
BP 377
EP 389
DI 10.1177/0272989X17750845
PG 13
WC Health Care Sciences & Services; Health Policy & Services; Medical
   Informatics
SC Health Care Sciences & Services; Medical Informatics
GA GC6JO
UT WOS:000429896800008
PM 29436309
DA 2020-07-08
ER

PT J
AU Jin, L
   Guo, XM
   Shen, CB
   Hao, X
   Sun, P
   Li, PP
   Xu, T
   Hu, CM
   Rose, O
   Zhou, HN
   Yang, MD
   Qin, CF
   Guo, JY
   Peng, H
   Zhu, MZ
   Cheng, G
   Qi, XP
   Lai, R
AF Jin, Lin
   Guo, Xiaomin
   Shen, Chuanbin
   Hao, Xue
   Sun, Peng
   Li, Pengpeng
   Xu, Tao
   Hu, Chunmiao
   Rose, Ombati
   Zhou, Hongning
   Yang, Mingdong
   Qin, Cheng-Feng
   Guo, Jingya
   Peng, Hua
   Zhu, Mingzhao
   Cheng, Gong
   Qi, Xiaopeng
   Lai, Ren
TI Salivary factor LTRIN from Aedes aegypti facilitates the transmission of
   Zika virus by interfering with the lymphotoxin-beta receptor
SO NATURE IMMUNOLOGY
LA English
DT Article
ID FLY LUTZOMYIA-LONGIPALPIS; PLATELET-AGGREGATION; BINDING PROTEIN;
   MOSQUITO; VECTOR; DISEASE; ENHANCEMENT; ACTIVATION; INHIBITOR; IMMUNITY
AB Pathogens have co-evolved with mosquitoes to optimize transmission to hosts. Mosquito salivary-gland extract is known to modulate host immune responses and facilitate pathogen transmission, but the underlying molecular mechanisms of this have remained unknown. In this study, we identified and characterized a prominent 15-kilodalton protein, LTRIN, obtained from the salivary glands of the mosquito Aedes aegypti. LTRIN expression was upregulated in blood-fed mosquitoes, and LTRIN facilitated the transmission of Zika virus (ZIKV) and exacerbated its pathogenicity by interfering with signaling through the lymphotoxin-beta receptor (LT beta R). Mechanically, LTRIN bound to LT beta R and 'preferentially' inhibited signaling via the transcription factor NF-kappa B and the production of inflammatory cytokines by interfering with the dimerization of LT beta R during infection with ZIKV. Furthermore, treatment with antibody to LTRIN inhibited mosquito-mediated infection with ZIKV, and abolishing LT beta R potentiated the infectivity of ZIKV both in vitro and in vivo. This study provides deeper insight into the transmission of mosquito-borne diseases in nature and supports the therapeutic potential of inhibiting the action of LTRIN to disrupt ZIKV transmission.
C1 [Jin, Lin; Guo, Xiaomin; Shen, Chuanbin; Hao, Xue; Li, Pengpeng; Xu, Tao; Hu, Chunmiao; Rose, Ombati; Qi, Xiaopeng; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming, Yunnan, Peoples R China.
   [Jin, Lin; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Sinoafrica Joint Res Ctr, Kunming, Yunnan, Peoples R China.
   [Sun, Peng; Cheng, Gong] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China.
   [Li, Pengpeng] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.
   [Rose, Ombati] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China.
   [Zhou, Hongning; Yang, Mingdong] Yunnan Inst Parasit Dis, Puer, Yunnan, Peoples R China.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Guo, Jingya; Peng, Hua; Zhu, Mingzhao] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing, Peoples R China.
RP Qi, XP; Lai, R (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming, Yunnan, Peoples R China.; Lai, R (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Sinoafrica Joint Res Ctr, Kunming, Yunnan, Peoples R China.; Cheng, G (corresponding author), Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China.
EM gongcheng@mail.tsinghua.edu.cn; qixiaopeng@mail.kiz.ac.cn;
   rlai@mail.kiz.ac.cn
RI Qin, Cheng-Feng/I-6839-2019; Zhu, Mingzhao/L-8662-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Jin, Lin/0000-0001-6273-9140
CR Anisuzzaman, 2014, J CLIN INVEST, V124, P4429, DOI 10.1172/JCI74917
   Anisuzzaman, 2013, Methods Mol Biol, V963, P127, DOI 10.1007/978-1-62703-230-8_9
   Arca B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3579-8
   Assumpcao TCF, 2013, J BIOL CHEM, V288, P14341, DOI 10.1074/jbc.M113.466995
   Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200
   Caraballo Hector, 2014, Emerg Med Pract, V16, P1
   Chagas AC, 2014, P NATL ACAD SCI USA, V111, P6946, DOI 10.1073/pnas.1404179111
   Collin N, 2012, ARTERIOSCL THROM VAS, V32, P2185, DOI 10.1161/ATVBAHA.112.253906
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Coutinho-Abreu IV, 2015, CURR OPIN INSECT SCI, V10, P98, DOI 10.1016/j.cois.2015.04.014
   Ge JN, 2012, P NATL ACAD SCI USA, V109, P6193, DOI 10.1073/pnas.1117490109
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86
   Jones AV, 2017, HUM MOL GENET, V26, P1391, DOI 10.1093/hmg/ddx036
   Juhn J., 2011, AEDES AEGYPTI PARASI, V4, P1, DOI DOI 10.1186/1756-3305-4-1
   Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Ma DY, 2012, THROMB HAEMOSTASIS, V107, P111, DOI 10.1160/TH11-10-0685
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Macho-Fernandez E, 2015, MUCOSAL IMMUNOL, V8, P403, DOI 10.1038/mi.2014.78
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Qi XP, 2013, IMMUNITY, V39, P97, DOI 10.1016/j.immuni.2013.06.012
   Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024
   Spahn TW, 2005, INFECT IMMUN, V73, P7077, DOI 10.1128/IAI.73.11.7077-7088.2005
   Sudhamsu J, 2013, P NATL ACAD SCI USA, V110, P19896, DOI 10.1073/pnas.1310838110
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819
   Upadhyay V, 2013, NAT REV IMMUNOL, V13, P270, DOI 10.1038/nri3406
   Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011
   Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719
   Wolf MJ, 2010, ONCOGENE, V29, P5006, DOI 10.1038/onc.2010.260
   Xu XQ, 2013, ACTA CRYSTALLOGR D, V69, P105, DOI 10.1107/S0907444912043326
   Xu XQ, 2011, J BIOL CHEM, V286, P32383, DOI 10.1074/jbc.M111.268904
   Yang S, 2012, MOL CELL PROTEOMICS, V11, P640, DOI 10.1074/mcp.M112.018853
   Zhang ZY, 2015, IMMUNITY, V43, P1137, DOI 10.1016/j.immuni.2015.10.018
NR 42
TC 23
Z9 24
U1 3
U2 26
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD APR
PY 2018
VL 19
IS 4
BP 342
EP +
DI 10.1038/s41590-018-0063-9
PG 14
WC Immunology
SC Immunology
GA GA2KJ
UT WOS:000428151000014
PM 29507355
DA 2020-07-08
ER

PT J
AU Brixner, V
   Kiessling, AH
   Madlener, K
   Muller, MM
   Leibacher, J
   Dombos, S
   Weber, I
   Pfeiffer, HU
   Geisen, C
   Schmidt, M
   Henschler, R
   North, A
   Huang, N
   Mufti, N
   Erickson, A
   Ernst, C
   Rico, S
   Benjamin, RJ
   Corash, LM
   Seifried, E
AF Brixner, Veronika
   Kiessling, Arndt-Holger
   Madlener, Katharina
   Mueller, Markus M.
   Leibacher, Johannes
   Dombos, Sarah
   Weber, Iuliia
   Pfeiffer, Hans-Ulrich
   Geisen, Christof
   Schmidt, Michael
   Henschler, Reinhard
   North, Anne
   Huang, Norman
   Mufti, Nina
   Erickson, Anna
   Ernst, Christine
   Rico, Salvador
   Benjamin, Richard J.
   Corash, Laurence M.
   Seifried, Erhard
TI Red blood cells treated with the amustaline (S-303) pathogen reduction
   system: a transfusion study in cardiac surgery
SO TRANSFUSION
LA English
DT Article
ID ACUTE KIDNEY INJURY; ZIKA VIRUS; INACTIVATION; RISK; CRITERIA; RIFLE;
   COMPONENTS; MORTALITY; VIABILITY; PLASMA
AB BACKGROUNDNucleic acid-targeted pathogen inactivation technology using amustaline (S-303) and glutathione (GSH) was developed to reduce the risk of transfusion-transmitted infectious disease and transfusion-associated graft-versus-host disease with red blood cell (RBC) transfusion.
   STUDY DESIGN AND METHODSA randomized, double-blind, controlled study was performed to assess the in vitro characteristics of amustaline-treated RBCs (test) compared with conventional (control) RBCs and to evaluate safety and efficacy of transfusion during and after cardiac surgery. The primary device efficacy endpoint was the postproduction hemoglobin (Hb) content of RBCs. Exploratory clinical outcomes included renal and hepatic failure, the 6-minute walk test (a surrogate for cardiopulmonary function), adverse events (AEs), and the immune response to amustaline-treated RBCs.
   RESULTSA total of 774 RBC unis were produced. Mean treatment difference in Hb content was -2.27 g/unit (95% confidence interval, -2.61 to -1.92 g/unit), within the prespecified equivalence margins (5 g/unit) to declare noninferiority. Amustaline-treated RBCs met European guidelines for Hb content, hematocrit, and hemolysis. Fifty-one (25 test and 26 control) patients received study RBCs. There were no significant differences in RBC usage or other clinical outcomes. Observed AEs were within the spectrum expected for patients of similar age undergoing cardiovascular surgery requiring RBCs transfusion. No patients exhibited an immune response specific to amustaline-treated RBCs.
   CONCLUSIONAmustaline-treated RBCs demonstrated equivalence to control RBCs for Hb content, have appropriate characteristics for transfusion, and were well tolerated when transfused in support of acute anemia. Renal impairment was characterized as a potential efficacy endpoint for pivotal studies of RBC transfusion in cardiac surgery.
C1 [Brixner, Veronika; Mueller, Markus M.; Leibacher, Johannes; Dombos, Sarah; Weber, Iuliia; Pfeiffer, Hans-Ulrich; Geisen, Christof; Schmidt, Michael; Seifried, Erhard] Goethe Univ Frankfurt, Inst Transfus Med & Immunohematol, Frankfurt, Germany.
   [Brixner, Veronika; Mueller, Markus M.; Leibacher, Johannes; Dombos, Sarah; Weber, Iuliia; Pfeiffer, Hans-Ulrich; Geisen, Christof; Schmidt, Michael; Seifried, Erhard] German Red Cross Blood Donor Serv, Frankfurt, Germany.
   [Kiessling, Arndt-Holger] Johann Wolfgang Goethe Univ Hosp Frankfurt, Dept Thorac & Cardiovasc Surg, Frankfurt, Germany.
   [Madlener, Katharina] Kerckhoff Klin, Dept Haemostaseol & Transfus Med, Bad Nauheim, Germany.
   [Henschler, Reinhard] Swiss Red Cross, Blood Ctr Zurich, Schlieren, Switzerland.
   [Henschler, Reinhard] Red Cross Blood Serv Graubunden, Chur, Switzerland.
   [North, Anne; Huang, Norman; Mufti, Nina; Erickson, Anna; Ernst, Christine; Rico, Salvador; Benjamin, Richard J.; Corash, Laurence M.] Cerus Corp, Concord, CA USA.
RP Brixner, V (corresponding author), DRK Blutspendedienst Baden Wurttemberg Hessen gGm, Sandhofstr 1, D-60528 Frankfurt, Germany.
EM v.brixner@blutspende.de
RI Kiessling, Arndt/AAI-7261-2020
OI Kiessling, Arndt/0000-0003-0472-755X; Schmidt,
   Michael/0000-0001-9338-0900; Rico, Salvador/0000-0002-1508-8717
FU Cerus Corporation
FX The study was supported with funding from Cerus Corporation.
CR Alghamdi AA, 2006, TRANSFUSION, V46, P1120, DOI 10.1111/j.1537-2995.2006.00860.x
   [Anonymous], 2016, GUIDANCE IND
   Arora P, 2012, J CARDIOTHOR VASC AN, V26, P687, DOI 10.1053/j.jvca.2012.03.001
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Benjamin RJ, 2005, TRANSFUSION, V45, P1739, DOI 10.1111/j.1537-2995.2005.00583.x
   Bundesarztekammer, 2010, RICHTL GEW BLUT BLUT
   Cancelas JA, 2017, VOX SANG, V112, P210, DOI 10.1111/vox.12500
   Cancelas JA, 2011, TRANSFUSION, V51, P2367, DOI 10.1111/j.1537-2995.2011.03163.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHUNG MK, 2000, CRIT CARE MED S, V28
   Conlan M. G. C., 2005, Vox Sanguinis, V89, P121
   Corash L, 2011, EXPERT REV HEMATOL, V4, P509, DOI [10.1586/EHM.11.53, 10.1586/ehm.11.53]
   Corredor C, 2016, J CARDIOTHOR VASC AN, V30, P69, DOI 10.1053/j.jvca.2015.07.013
   Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8
   Gayda M, 2004, ARCH PHYS MED REHAB, V85, P1538, DOI 10.1016/j.apmr.2003.11.037
   Haase M, 2009, J THORAC CARDIOV SUR, V138, P1370, DOI 10.1016/j.jtcvs.2009.07.007
   HARBOE M, 1959, SCAND J CLIN LAB INV, V11, P66, DOI 10.3109/00365515909060410
   Heim MU, 2010, ANAESTHESIST, V59, P80, DOI 10.1007/s00101-009-1654-5
   Henschler R, 2011, TRANSFUS MED HEMOTH, V38, P33, DOI 10.1159/000324458
   Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011
   Kleinman S, 2015, TRANSFUSION, V55, P2983, DOI 10.1111/trf.13259
   Kleinman S, 2010, TRANSFUSION, V50, P2592, DOI 10.1111/j.1537-2995.2010.02724.x
   Knotzer Hans, 2004, Curr Opin Crit Care, V10, P330, DOI 10.1097/01.ccx.0000135512.18753.bc
   Kopolovic I, 2015, BLOOD, V126, P406, DOI 10.1182/blood-2015-01-620872
   Lagny MG, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0066-9
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Lustig Y, 2016, EURO SURVEILL, V21
   Mastronardi C, 2010, CLIN CHEM LAB MED, V48, P1179, DOI 10.1515/CCLM.2010.240
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moritz ED, 2016, NEW ENGL J MED, V375, P2236, DOI 10.1056/NEJMoa1600897
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   North A, 2011, TRANSFUSION, V51, P2208, DOI 10.1111/j.1537-2995.2011.03132.x
   Oliveira GU, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-95
   Olper L, 2011, PHYS THER, V91, P566, DOI 10.2522/ptj.20100156
   Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743
   Sadikot RT, 2000, ARCH INTERN MED, V160, P2665, DOI 10.1001/archinte.160.17.2665
   Salunkhe V, 2015, TRANSFUS APHER SCI, V52, P19, DOI 10.1016/j.transci.2014.12.016
   Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646
   Seltsam A, 2013, BRIT J HAEMATOL, V162, P442, DOI 10.1111/bjh.12403
   Sockalingam S, 2005, J CARDIAC SURG, V20, P560, DOI 10.1111/j.1540-8191.2005.00134.x
   Steiner ME, 2015, NEW ENGL J MED, V372, P1419, DOI 10.1056/NEJMoa1414219
   Stramer SL, 2013, TRANSFUSION, V53, P2375, DOI 10.1111/trf.12371
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932
   Walther-Wenke G, 2010, ANN HEMATOL, V89, P83, DOI 10.1007/s00277-009-0762-2
   Zhou JJ, 2016, INT UROL NEPHROL, V48, P125, DOI 10.1007/s11255-015-1150-6
NR 48
TC 11
Z9 11
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD APR
PY 2018
VL 58
IS 4
BP 905
EP 916
DI 10.1111/trf.14528
PG 12
WC Hematology
SC Hematology
GA GC2BE
UT WOS:000429586200014
PM 29498049
OA Other Gold
DA 2020-07-08
ER

PT J
AU Aubry, M
   Laughhunn, A
   Maria, FS
   Lanteri, MC
   Stassinopoulos, A
   Musso, D
AF Aubry, M.
   Laughhunn, A.
   Maria, F. Santa
   Lanteri, M. C.
   Stassinopoulos, A.
   Musso, D.
TI Amustaline (S-303) treatment inactivates high levels of Chikungunya
   virus in red-blood-cell components
SO VOX SANGUINIS
LA English
DT Article
DE NAT testing; pathogen inactivation; red cell components;
   Transfusion-transmissible infections
ID PATHOGEN REDUCTION TECHNOLOGY; RT-PCR ASSAY; ZIKA VIRUS; PHOTOCHEMICAL
   INACTIVATION; PLATELET COMPONENTS; DENGUE VIRUSES; REUNION ISLAND;
   PUERTO-RICO; LA-REUNION; TRANSFUSION
AB Background and objectives Chikungunya virus (CHIKV) infections have been reported in all continents, and the potential risk for CHIKV transfusion-transmitted infections (TTIs) was demonstrated by the detection of CHIKV RNA-positive donations in several countries. TTIs can be reduced by pathogen inactivation (PI) of blood products. In this study, we evaluated the efficacy of amustaline and glutathione (S-303/GSH) to inactivate CHIKV in red-blood-cell concentrates (RBCs).
   Material and Methods Red-blood-cells were spiked with high level of CHIKV. Infectious titres and RNA loads were measured before and after PI treatment. Residual CHIKV infectivity was also assessed after five successive cell culture passages.
   Results The mean CHIKV titres in RBCs before inactivation was 581 018 log(10) 50% tissue culture infectious dose (TCID50)/mL, and the mean viral RNA load was 1049 +/- 015 log(10) genome equivalent (GEq)/mL. No CHIKV TCID was detected after S-303 treatment nor was replicative CHIKV particles and viral RNA present after five cell culture passages of samples obtained immediately after S-303 treatment.
   Conclusion Chikungunya virus was previously shown to be inactivated by the PI technology using amotosalen and ultraviolet A light for the treatment of plasma and platelets. This new study demonstrates that S-303/GSH can inactivate high titres of CHIKV in RBCs.
C1 [Aubry, M.; Musso, D.] Inst Louis Malarde, Pole Rech & Veille Sur Malad Infect Emergentes, Tahiti, French Polynesi, France.
   [Aubry, M.; Musso, D.] Aix Marseille Univ, IRD Dakar Marseille Papeete, UMR Vecteurs Infect Trop & Mediterraneennes VITRO, AP HM,IHU Mediterranee Infect, Marseille, France.
   [Laughhunn, A.; Maria, F. Santa; Lanteri, M. C.; Stassinopoulos, A.] Cerus Corp, Concord, CA USA.
RP Aubry, M (corresponding author), Inst Louis Malarde, POB 30, F-98713 Tahiti, French Polynesi, France.
EM maubry@ilm.pf
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Aubry, Maite/0000-0002-9913-5794
FU Cerus Corporation (USA)
FX This work was partially funded by Cerus Corporation (USA).
CR Allain JP, 2005, TRANSFUS MED REV, V19, P110, DOI 10.1016/j.tmrv.2004.11.005
   Appassakij H, 2016, TRANSFUSION, V56, P2100, DOI 10.1111/trf.13675
   Aubry M, 2017, TRANSFUSION, V57, P2888, DOI 10.1111/trf.14318
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Bakkour S, 2014, VOX SANG, V107, P351, DOI 10.1111/vox.12173
   Bakkour S, 2016, TRANSFUSION, V56, P410, DOI 10.1111/trf.13360
   Brouard C, 2007, ESTIMATION QUANTITAT
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   CORDEL H, 2006, EURO SURVEILL, V11, P3
   Donalisio M.R., 2017, REV SAUDE PUBL, V51
   Dupuis K, 2012, TRANSFUSION, V52, P2012
   Epstein JS, 2003, TRANSFUSION, V43, P1347, DOI 10.1046/j.1537-2995.2003.00584.x
   Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519
   Foissac M, 2015, EMERG INFECT DIS, V21, P530, DOI 10.3201/eid2103.141397
   Fryk JJ, 2016, TRANSFUSION, V56, P2278, DOI 10.1111/trf.13729
   Gallian P, 2015, TRANSFUSION, V55, p17A
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Kessler CM, 2016, CLIN ADV HEMATOL ONC, V14, P677
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Lederman E., 2010, Morbidity and Mortality Weekly Report, V59, P34
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   Nhan TX, 2015, CLIN MICROBIOL INFEC, V21, pE47, DOI 10.1016/j.cmi.2015.02.018
   Oei W, 2013, TRANSFUSION, V53, P1421, DOI 10.1111/j.1537-2995.2012.03941.x
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Petersen LR, 2010, TRANSFUS MED REV, V24, P15, DOI 10.1016/j.tmrv.2009.09.002
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Rasongles P, 2009, TRANSFUSION, V49, P1083, DOI 10.1111/j.1537-2995.2009.02111.x
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Freitas ARR, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658024
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Staples JE, 2016, CDC HLTH INFORM INT, P161
   Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tan LK, 2013, ADV INFECT DIS, V3, P1
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2013, AM J TROP MED HYG, V88, P1163, DOI 10.4269/ajtmh.12-0603
   Vanlandingham DL, 2013, TRANSFUSION, V53, P284, DOI 10.1111/j.1537-2995.2012.03717.x
   Venkat H, 2017, TRANSFUSION, V57, P2987, DOI 10.1111/trf.14314
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   WAHLBERG P, 1989, J INTERN MED, V225, P173, DOI 10.1111/j.1365-2796.1989.tb00059.x
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
NR 68
TC 0
Z9 0
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0042-9007
EI 1423-0410
J9 VOX SANG
JI Vox Sang.
PD APR
PY 2018
VL 113
IS 3
BP 232
EP 241
DI 10.1111/vox.12626
PG 10
WC Hematology
SC Hematology
GA GC4CA
UT WOS:000429729600003
PM 29314033
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Clancy, CS
   Van Wettere, AJ
   Siddharthan, V
   Morrey, JD
   Julander, JG
AF Clancy, Chad S.
   Van Wettere, Arnaud J.
   Siddharthan, Venkatraman
   Morrey, John D.
   Julander, Justin G.
TI Comparative Histopathologic Lesions of the Male Reproductive Tract
   during Acute Infection of Zika Virus in AG129 and Ifnar(-/-) Mice
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID SEXUAL TRANSMISSION; MOUSE MODEL; ANTIVIRAL DEFENSE; INTERFERONS;
   ORCHITIS; SEMEN
AB An understanding of the pathogenesis of infection with the Zika virus in the male reproductive tract is vital for the development of vaccines and antivirals that will limit or prevent sexual transmission. Two common immunocompromised mouse strains used in transmission studies-male with genes encoding interferon types I and II receptor gene knockout (IFNAR/IFNGR; AG129) and with interferon type 1 receptor knockout (Ifnar(-/-)) were infected with a Puerto Rican Zika virus isolate (PRVABC59), and pathology was assessed 5 to 11 days after infection. Virus was detected by immunohistochemistry and quantitative RT-PCR in the testicle and epididymis of AG129 and Ifnar(-/-) mice, and by immunohistochemistry in the prostate and seminal vesicle of infected AG129 mice. Severe disease manifestations initiating as epididymitis and progressing to orchitis were observed in both models, with more severe inflammation noted in the AG129 mouse strain. Significant inflammation was not observed in any evaluated accessory sex gland at any point during infection. Time course analysis of infection revealed an increase in the severity of disease within the epididymis of both strains, indicating a potential route of sexual transmission. Male mice with Ifnarl(-/-) may better recapitulate Zika virus in humans and provide insight into the mechanism of sexual transmission, due to milder histopathologic lesions, the presence of histologically normal sperm in epididymal tubules, and an ability to survive the acute phase of disease.
C1 [Clancy, Chad S.; Van Wettere, Arnaud J.] Utah State Univ, Sch Vet Med, Utah Vet Diagnost Lab, Logan, UT 84322 USA.
   [Clancy, Chad S.; Siddharthan, Venkatraman; Morrey, John D.; Julander, Justin G.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.
   [Clancy, Chad S.; Siddharthan, Venkatraman; Morrey, John D.; Julander, Justin G.] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.
RP Clancy, CS (corresponding author), Utah State Univ, Utah Vet Diagnost Lab, 950 E 1400 N, Logan, UT 84341 USA.
EM chad.clancy@lusu.edu
OI Clancy, Chad/0000-0002-5354-9270
FU NIH/Public Health Service grant [5R33AI101483]; National Institute of
   Allergy and Infectious Diseases Virology Branch
   [HHSN272201000039I/HHSN27200004]
FX Supported by NIH/Public Health Service grant 5R33AI101483 and National
   Institute of Allergy and Infectious Diseases Virology Branch contract
   HHSN272201000039I/HHSN27200004 (J.D.M.).
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, P1
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUID CAR US LAB AN
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P3
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Knoblaugh S, 2011, COMPARATIVE ANATOMY AND HISTOLOGY: A MOUSE AND HUMAN ATLAS, P285
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Maclachlan NJ, 2010, FENNERS VET VIROLOGY, P467
   Mann PC, 2012, TOXICOL PATHOL, V40, P7, DOI 10.1177/0192623312438738
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   OAKBERG EF, 1957, NATURE, V180, P1137, DOI 10.1038/1801137a0
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Suwa T, 2002, TOXICOL PATHOL, V30, P228, DOI 10.1080/019262302753559560
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Trojian TH, 2009, AM FAM PHYSICIAN, V79, P583
   VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995
   White BA, 2010, BERNE LEVY PHYSL, P758
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 48
TC 13
Z9 14
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD APR
PY 2018
VL 188
IS 4
BP 904
EP 915
DI 10.1016/j.ajpath.2017.12.019
PG 12
WC Pathology
SC Pathology
GA GB6NH
UT WOS:000429185400008
PM 29378173
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Griffin, I
   White, SL
   Algarin, A
   Ibanez, GE
AF Griffin, Isabel
   White, Stephen L.
   Algarin, Angel
   Ibanez, Gladys E.
TI Panic in a (Zika) hot zone
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Editorial Material
DE health behaviour; health promotion; epidemics
C1 [Griffin, Isabel; White, Stephen L.; Algarin, Angel; Ibanez, Gladys E.] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA.
RP Griffin, I (corresponding author), Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA.
EM Igrif005@fiu.edu
OI White, Stephen/0000-0002-2112-1560
CR Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 2
TC 1
Z9 1
U1 4
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
EI 1470-2738
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD APR
PY 2018
VL 72
IS 4
BP 269
EP 269
DI 10.1136/jech-2017-210198
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GB9XL
UT WOS:000429428000002
PM 29367282
DA 2020-07-08
ER

PT J
AU Bhagat, R
   Seth, P
AF Bhagat, Reshma
   Seth, Pankaj
TI Zika Virus E protein alters properties of human fetal neural stem cells
   by disruption of microRNA circuitry
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Bhagat, Reshma; Seth, Pankaj] Natl Brain Res Ctr, Gurgaon, Haryana, India.
EM reshuubhagat@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P19
BP S6
EP S6
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100020
DA 2020-07-08
ER

PT J
AU Bidokhti, M
   Dutta, D
   Madduri, L
   Knight, L
   Giavedoni, L
   Byrareddy, S
AF Bidokhti, Mehdi
   Dutta, Debashis
   Madduri, Lepakshe
   Knight, Lindsey
   Giavedoni, Luis
   Byrareddy, Siddappa
TI Rhesus Macaque Model of Zika and SIV/HIV Co-infection
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Bidokhti, Mehdi; Dutta, Debashis; Madduri, Lepakshe; Knight, Lindsey; Byrareddy, Siddappa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.
   [Giavedoni, Luis] Texas Biomed Res Inst, San Antonio, TX 78245 USA.
EM mehdi.bidokhti@unmc.edu
RI Dutta, Debashis/L-4685-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P22
BP S7
EP S7
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100023
DA 2020-07-08
ER

PT J
AU Caobi, A
   Yndart, A
   El-Hage, N
   Nair, M
   Raymond, A
AF Caobi, Allen
   Yndart, Adriana
   El-Hage, Nazira
   Nair, Madhavan
   Raymond, Andrea
TI Pathogenic strains of ZIKV induce gene expression promoting inflammation
   and apoptosis in primary human placental trophoblasts
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Caobi, Allen; Yndart, Adriana; El-Hage, Nazira; Nair, Madhavan; Raymond, Andrea] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA.
EM adraymon@fiu.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P40
BP S12
EP S12
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100041
DA 2020-07-08
ER

PT J
AU Cicalese, S
   Donadoni, M
   Sariyer, I
AF Cicalese, Stephanie
   Donadoni, Martina
   Sariyer, Ilker
TI Regulation of ZIKV infection by SRSF1 and IFN-gamma in human astrocytes
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Cicalese, Stephanie; Donadoni, Martina; Sariyer, Ilker] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.
EM isariyer@temple.edu
RI Sariyer, Ilker/AAE-7677-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P56
BP S16
EP S17
PG 2
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100057
DA 2020-07-08
ER

PT J
AU Cisneros, I
   Dineley, K
   Paessler, S
AF Cisneros, Irma
   Dineley, Kelly
   Paessler, Slobodan
TI Cocaine promotes astrocyte mitochondrial toxicity to regulate activation
   of antiviral innate immune responses to HIV-1 and Zika virus
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Cisneros, Irma; Dineley, Kelly] Univ Texas Med Branch, Dept Pathol, Ctr Addict Res, Galveston, TX 77555 USA.
   [Paessler, Slobodan] Univ Texas Med Branch, Galveston Natl Lab, Inst Human Infect & Immun, Dept Pathol, Galveston, TX 77555 USA.
EM ircisner@utmb.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P58
BP S17
EP S17
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100059
DA 2020-07-08
ER

PT J
AU GeurtsvanKessel, C
   Islam, Z
   Islam, MB
   Kamga, S
   Koopmans, M
   Jacobs, B
   Endtz, H
AF GeurtsvanKessel, Corine
   Islam, Zhahirul
   Islam, Md Badrul
   Kamga, Sandra
   Koopmans, Marion
   Jacobs, Bart
   Endtz, Hubert
TI Zika virus infection and Guillain-Barre syndrome in Bangladesh: a
   prospective case-control study
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [GeurtsvanKessel, Corine; Kamga, Sandra; Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Islam, Zhahirul] Int Ctr Diarrhoeal Dis Res, Sci & Serv Div 2Lab, Icddr B, Dhaka, Bangladesh.
   [Jacobs, Bart] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Jacobs, Bart] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
   [Endtz, Hubert] Fdn Merieux, Lyon, France.
   [Endtz, Hubert] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.
EM c.geurtsvankessel@erasmusmc.nl
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P101
BP S30
EP S30
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100102
DA 2020-07-08
ER

PT J
AU He, M
   Zhang, HN
   Li, YJ
   Wang, GS
   Tang, BS
   Zhao, J
   Huang, YL
   Zheng, JL
AF He, Miao
   Zhang, Hainan
   Li, Yuju
   Wang, Guangshun
   Tang, Beisha
   Zhao, Jeffrey
   Huang, Yunlong
   Zheng, Jialin
TI Cathelicidin-derived antimicrobial peptides suppress Zika virus through
   direct inactivation and interferon pathway
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [He, Miao; Zhang, Hainan; Li, Yuju; Zhao, Jeffrey; Huang, Yunlong; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.
   [Wang, Guangshun] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA.
   [Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.
EM yhuan1@unmc.edu
RI Huang, Yunlong/J-6554-2015
OI Huang, Yunlong/0000-0002-3328-1924
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P117
BP S34
EP S34
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100118
DA 2020-07-08
ER

PT J
AU Jimenez, O
   Narasipura, S
   Al-Harthi, L
AF Jimenez, Oscar
   Narasipura, Srinivas
   Al-Harthi, Lena
TI Zika virus, in a strain specific manner, induces human fetal astrocyte
   cell death through beta-catenin inhibition
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Jimenez, Oscar; Narasipura, Srinivas; Al-Harthi, Lena] Rush Univ, Coll Med, Dept Microbial Pathogens & Immun, Chicago, IL 60612 USA.
EM oscar_a_jimenez@rush.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P134
BP S39
EP S39
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100135
DA 2020-07-08
ER

PT J
AU Karuppan, MKM
   Ojha, CR
   Rodriguez, M
   Nair, M
   El-Hage, N
AF Karuppan, Mohan Kumar Muthu
   Ojha, Chet Raj
   Rodriguez, Myosotys
   Nair, Madhavan
   El-Hage, Nazira
TI Different mechanisms implicated in ZIKV-induced inflammatory molecules
   in human microglial cells
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Karuppan, Mohan Kumar Muthu; Ojha, Chet Raj; Rodriguez, Myosotys; Nair, Madhavan; El-Hage, Nazira] Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.
EM mmuthuka@fiu.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P206
BP S60
EP S60
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100207
DA 2020-07-08
ER

PT J
AU Leda, A
   Andras, I
   El-Hage, N
   Nair, M
   Toborek, M
AF Leda, Ana
   Andras, Ibolya
   El-Hage, Nazira
   Nair, Madhavan
   Toborek, Michal
TI The role of the blood-brain barrier in Zika virus infection
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Leda, Ana; Andras, Ibolya; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Coral Gables, FL 33124 USA.
   [El-Hage, Nazira; Nair, Madhavan] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA.
EM aleda@miami.edu
FU Florida Department of Health [7ZK09]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01MH098891]
FX Supported in part by the Florida Department of Health 7ZK09 and NIH
   R01MH098891.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P154
BP S45
EP S45
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100155
DA 2020-07-08
ER

PT J
AU Sariyer, IK
   Wollebo, H
   Cicalese, S
   Donadoni, M
   Bellizzi, A
   Robinson, JA
   Burdo, TH
   Gordon, J
   Khalili, K
AF Sariyer, Ilker Kudret
   Wollebo, Hassen
   Cicalese, Stephanie
   Donadoni, Martina
   Bellizzi, Anna
   Robinson, Jake Arthur
   Burdo, Tricia Helen
   Gordon, Jennifer
   Khalili, Kamel
TI Non-Nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine
   suppresses Zika virus (ZIKV) in glial cells.
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Sariyer, Ilker Kudret; Wollebo, Hassen; Cicalese, Stephanie; Donadoni, Martina; Bellizzi, Anna; Robinson, Jake Arthur; Burdo, Tricia Helen; Gordon, Jennifer; Khalili, Kamel] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.
EM isariyer@temple.edu
RI Sariyer, Ilker/AAE-7677-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P264
BP S77
EP S77
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100265
DA 2020-07-08
ER

PT J
AU Seth, P
   Bhagat, R
AF Seth, Pankaj
   Bhagat, Reshma
TI Role of WNT signaling in Zika Virus Envelope protein induced quiescence
   in primary human neural stem cells
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Seth, Pankaj; Bhagat, Reshma] Natl Brain Res Ctr, Mol & Cellular Neurosci, Gurgaon, Haryana, India.
EM pseth@nbrc.ac.in
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P269
BP S78
EP S78
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100270
DA 2020-07-08
ER

PT J
AU Whelan, J
   Li, YZ
   Weiss, S
AF Whelan, Jillian
   Li, Yize
   Weiss, Susan
TI Zika virus resistance to the antiviral 2 ',5 '-oligoadenylate
   synthetase/ribonuclease L (OAS/RNase L) pathway
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Whelan, Jillian; Li, Yize; Weiss, Susan] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
EM jwhelan732@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2018
VL 13
SU 1
MA P311
BP S90
EP S91
PG 2
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GB6AH
UT WOS:000429149100312
DA 2020-07-08
ER

PT J
AU Vasudevan, J
   Skandhan, A
   Skandhan, AKP
   Balakrishnan, S
   Skandhan, KP
AF Vasudevan, Jaya
   Skandhan, Amith
   Skandhan, Avni K. P.
   Balakrishnan, Sumangala
   Skandhan, Kalangot P.
TI Zika virus
SO REVIEWS IN MEDICAL MICROBIOLOGY
LA English
DT Article
DE congenital Zika syndrome; Guillain-Barre syndrome; sexual transmission;
   Zika (fever); Zika virus
ID PUBLIC-HEALTH EMERGENCY; GUILLAIN-BARRE-SYNDROME; SEXUAL TRANSMISSION;
   PREGNANT-WOMEN; UNITED-STATES; INFECTION; BRAZIL; OUTBREAK; CONTACT;
   FETUSES
AB In this review, the authors present current knowledge and research on the Zika virus, including epidemiology, symptom manifestations (collectively referred as Zika fever'), modes of transmission, as well as Zika-related complications including Guillain-Barre syndrome and congenital Zika syndrome. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Vasudevan, Jaya; Skandhan, Amith] Southeast Alabama Med Ctr, Dept Internal Med, Dothan, AL USA.
   [Skandhan, Avni K. P.] Aster Malabar Inst Med Sci, Dept Radiol, Kottakal, Kerala, India.
   [Balakrishnan, Sumangala] MVR Canc Ctr & Res Ctr, Calicut, Kerala, India.
   [Skandhan, Kalangot P.] KLE Univ, Shri BMK Ayurveda Mahavidyalaya, Belgaum 590005, India.
RP Skandhan, KP (corresponding author), KLE Univ, Shri BMK Ayurveda Mahavidyalaya, Belgaum 590005, India.
EM kpskandhan@gmail.com
OI Skandhan, Avni K P/0000-0002-4797-8634
CR [Anonymous], 2017, LANCET, V389, P573, DOI 10.1016/S0140-6736(17)30325-2
   [Anonymous], 2017, WHO DIS OUTBREAK NEW
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blanchard K, 2017, LANCET, V389, P1603, DOI 10.1016/S0140-6736(17)31010-3
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevetion-CDC, 2017, UPD GUID US LAB TEST
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Onis M, 2008, LANCET, V371, P204, DOI 10.1016/S0140-6736(08)60131-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gubler DJ, 2016, TOP MED HLTH, V39, P3
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huits RMHG, 2016, B WHO UNPUB
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578
   Kuhn JH, 2015, HARRISONS PRINCIPLES, P1314
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vouga M, 2017, LANCET, V389, P151, DOI 10.1016/S0140-6736(17)30013-2
   Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4
   WHO, 2016, WHO ZIK VIR INF DIS
   World Health Organization, 2016, SAUDI MED J, V37, P334
   World Health Organization, 2015, EPID AL
   Zucca C, 2003, NEUROLOGY, V61, P710, DOI 10.1212/WNL.61.5.710
NR 105
TC 1
Z9 1
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-139X
EI 1473-5601
J9 REV MED MICROBIOL
JI Rev. Med. Microbiol.
PD APR
PY 2018
VL 29
IS 2
BP 43
EP 50
DI 10.1097/MRM.0000000000000126
PG 8
WC Microbiology
SC Microbiology
GA GC0CB
UT WOS:000429443100001
DA 2020-07-08
ER

PT J
AU Darrigo, LG
   Carvalho, AMD
   Machado, CM
AF Darrigo, Luiz Guilherme, Jr.
   de Sant'Anna Carvalho, Alexandre Machado
   Machado, Clarisse Martins
TI Chikungunya, Dengue, and Zika in Immunocompromised Hosts
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Chikungunya; Zika; Dengue; Transplantation; Immunocompromised hosts;
   Arboviruses
ID VIRUS TRANSMISSION; TRANSPLANT RECIPIENTS; BLOOD-DONATIONS; LIVING
   DONOR; INFECTION; OUTBREAK; BRAZIL; AMERICA; VIREMIA; REGION
AB Purpose of Review Describe the characteristics of chikungunya, dengue, and Zika in transplant recipients and immunocompromised hosts.
   Recent Findings Stem cell/bone marrow grafts, organs, and blood transfusions can transmit CHIKV/DENV/ZIKV infections, which are clinically similar, resembling influenza-like illness. Laboratory confirmation is necessary. In the acute phase, RT-PCR is preferred. DENV and ZIKV serology may cross-react. Delayed engraftment and extended viruria is observed in ZIKV+/HSCT recipients, while longer viremia is observed in DENV+/HSCT patients. Arbovirus persistence in organ tissues is generally unknown. Vaccine development is in early stages for CHIKV/ZIKV. No data is available to recommend the licensed DENV vaccine in transplant recipients.
   Summary In endemic areas, the assessment of epidemiological risk is mandatory. Donor deferral for 120 days in suspected or confirmed ZIKV+ has been recommended, while CHIKV+ donors should wait 30 days. No deferral is recommended for DENV+ donors. CHIKV/DENV/ZIKV tests should be included in the differential of febrile neutropenia and other transplant syndromes. Reassessment of DENV serology is urgently needed. Prospective studies are necessary to determine the impact of CHIKV/DENV/ZIKV in this special population.
C1 [Darrigo, Luiz Guilherme, Jr.] Univ Sao Paulo, Ribeirao Preto Med Sch, Bone Marrow Transplant Unit, Ribeirao Preto, SP, Brazil.
   [de Sant'Anna Carvalho, Alexandre Machado; Machado, Clarisse Martins] Univ Sao Paulo, Inst Trop Med, Virol Lab, Av Dr Eneasde de Carvalho Aguiar 470,2nd Floor, BR-05403000 Sao Paulo, SP, Brazil.
   [Machado, Clarisse Martins] Amaral Carvalho Fdn, HSCT Program, Jahu, SP, Brazil.
RP Machado, CM (corresponding author), Univ Sao Paulo, Inst Trop Med, Virol Lab, Av Dr Eneasde de Carvalho Aguiar 470,2nd Floor, BR-05403000 Sao Paulo, SP, Brazil.; Machado, CM (corresponding author), Amaral Carvalho Fdn, HSCT Program, Jahu, SP, Brazil.
EM clarimm@usp.br
RI Darrigo Junior, Luiz/A-2686-2019; JUNIOR, LUIZ GUILHERME
   DARRIGO/AAH-1776-2019
OI Darrigo Junior, Luiz/0000-0001-6007-8908; JUNIOR, LUIZ GUILHERME
   DARRIGO/0000-0001-6007-8908
CR Abdelnabi R, 2017, CURR OPIN VIROL, V24, P25, DOI 10.1016/j.coviro.2017.03.016
   Alfaro A, 2016, DENGUE GUIDELINES PA
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Appassakij H, 2014, TRANSFUSION, V54, P1945, DOI 10.1111/trf.12575
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Collucci C, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4560
   Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Pereira BBSD, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12721
   Dias LL, 2012, TRANSFUSION, V52, P1667, DOI 10.1111/j.1537-2995.2012.03729.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, PLOS CURRENTS OUTBRE
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Fernandes Paula Frassinetti Castelo Branco Camurca, 2017, World J Transplant, V7, P57, DOI 10.5500/wjt.v7.i1.57
   Gasperina DD, 2015, TRANSPL INFECT DIS, V17, P876, DOI 10.1111/tid.12453
   Girao ES, 2017, TRANSPL P, V49, P2076, DOI 10.1016/j.transproceed.2017.07.004
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805
   Gupta RK, 2016, J CLIN EXP HEPATOL, V6, P59, DOI 10.1016/j.jceh.2016.01.005
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Heald-Sargent T, 2017, PEDIATR ANN, V46, pE428, DOI 10.3928/19382359-20171025-01
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jimenez A, 2017, TRANSFUSION, V57, P2077, DOI 10.1111/trf.14252
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kee ACL, 2010, EMERG INFECT DIS, V16, P1038, DOI 10.3201/eid1606.091115
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Levi JE, 2015, TRANSFUSION, V55, P961, DOI 10.1111/trf.12944
   Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x
   Machado CM, 2017, BLOOD ADV, V1, P624, DOI 10.1182/bloodadvances.2016003285
   Machado CM, 2016, TRANSPLANT INFECT, P129
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Magnani DM, 2017, J VIROL, V91, DOI 10.1128/JVI.00867-17
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mathew AJ, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0680-7
   McCarthy MK, 2016, FUTURE MICROBIOL, V11, P331, DOI 10.2217/fmb.15.147
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nasim A, 2013, TRANSPL INFECT DIS, V15, P516, DOI 10.1111/tid.12114
   Nhan TX, 2014, EMERG INFECT DIS, V20, P1773, DOI 10.3201/eid2010.141060
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petersen LR, 2012, TRANSFUSION, V52, P1647, DOI 10.1111/j.1537-2995.2011.03529.x
   Pierrotti LC, 2017, INT J INFECT DIS, V64, P96, DOI 10.1016/j.ijid.2017.09.009
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Punzel M, 2014, EMERG INFECT DIS, V20, P1366, DOI 10.3201/eid2008.140508
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   Raboni SM, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12700
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Salvador FS, 2015, TRAVEL MED INFECT DI, V2015, P1
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Shirley DAT, 2017, PEDIATR CLIN N AM, V64, P937, DOI 10.1016/j.pcl.2017.03.012
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   Simkins J, 2017, AM J TRANSPLANT
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Styczynski J, 2017, BONE MARROW TRANSPL, V52, P1345, DOI 10.1038/bmt.2017.145
   Tan FLS, 2005, NEPHROL DIAL TRANSPL, V20, P447, DOI 10.1093/ndt/gfh601
   Thiery G, 2016, INTENS CARE MED, V42, P1485, DOI 10.1007/s00134-016-4364-x
   U. S. Department of Health and Human Services, 2016, REV REC RED RISK ZIK
   UNOS, 2016, GUID ORG DON TRANSPL
   US Department of Health and Human Services, 2016, GUID ZIK VIR ORG PRO
   Wang YM, 2016, ANTIVIR RES, V135, P81, DOI 10.1016/j.antiviral.2016.10.003
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weerakkody RM, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-016-0428-y
   Weerakkody Ranga Migara, 2014, J Med Case Rep, V8, P378, DOI 10.1186/1752-1947-8-378
   WHO PAHO, 2017, DENG CAS AM, V2017, P1
   Wichmann O, 2017, VACCINE, V35, P5535, DOI 10.1016/j.vaccine.2017.08.066
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, WHO POS PAP JUL 2016, V30
NR 87
TC 9
Z9 9
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD APR
PY 2018
VL 20
IS 4
AR 5
DI 10.1007/s11908-018-0612-2
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA GB4RR
UT WOS:000429048900002
PM 29551005
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Sloan, A
   Safronetz, D
   Makowski, K
   Barairo, N
   Ranadheera, C
   Dimitrova, K
   Holloway, K
   Mendoza, E
   Wood, H
   Drebot, M
   Gretchen, A
   Kadkhoda, K
AF Sloan, Angela
   Safronetz, David
   Makowski, Kai
   Barairo, Nicole
   Ranadheera, Charlene
   Dimitrova, Kristina
   Holloway, Kimberly
   Mendoza, Emelissa
   Wood, Heidi
   Drebot, Mike
   Gretchen, Ainsley
   Kadkhoda, Kamran
TI Evaluation of the Diasorin Liaison (R) XL Zika Capture IgM CMIA for Zika
   virus serological testing
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika; Immunoassay; Diagnostics; Arbovirus; Emerging pathogens
ID SPECIFICITY; ELISA
AB Due to the increase of Zika virus (ZIKV) transmission throughout the world, many commercial kits have recently become available to aid in laboratory diagnosis of ZIKV infections in clinical samples. Here, we analyze the fully automated Liaison (R) XL Zika Capture immunoglobulin M (IgM) assay against the recommended IgM-capture enzyme-linked immunosorbent assay. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Sloan, Angela; Safronetz, David; Makowski, Kai; Barairo, Nicole; Ranadheera, Charlene; Dimitrova, Kristina; Holloway, Kimberly; Mendoza, Emelissa; Wood, Heidi; Drebot, Mike] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada.
   [Safronetz, David; Wood, Heidi; Drebot, Mike; Kadkhoda, Kamran] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, 745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.
   [Gretchen, Ainsley; Kadkhoda, Kamran] Cadham Prov Lab, 750 William Ave, Winnipeg, MB R3C 3Y1, Canada.
   [Kadkhoda, Kamran] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Immunol, 750 McDermot Ave, Winnipeg, MB R3E 0T5, Canada.
RP Kadkhoda, K (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, 745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.; Kadkhoda, K (corresponding author), Cadham Prov Lab, 750 William Ave, Winnipeg, MB R3C 3Y1, Canada.; Kadkhoda, K (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Immunol, 750 McDermot Ave, Winnipeg, MB R3E 0T5, Canada.
EM angela.sloan@canada.ca; david.safronetz@canada.ca;
   kai.makowski@canada.ca; nicole.barairo@canada.ca;
   charlene.ranadheera@canada.ca; dimitrova@canada.ca;
   emelissa.mendoza@canada.ca; heidi.wood@canada.ca; mike.drebot@canada.ca;
   ainsley.gretchen@gov.mb.ca; kamran.kadkhoda@gov.mb.ca
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   WHO, 2017, SIT REP
NR 16
TC 6
Z9 6
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD APR
PY 2018
VL 90
IS 4
BP 264
EP 266
DI 10.1016/j.diagmicrobio.2017.11.018
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GB3PO
UT WOS:000428970100006
PM 29310948
OA Bronze
DA 2020-07-08
ER

PT J
AU Uncini, A
   Gonzalez-Bravo, DC
   Acosta-Ampudia, YY
   Ojeda, EC
   Rodriguez, Y
   Monsalve, DM
   Ramirez-Santana, C
   Vega, DA
   Paipilla, D
   Torres, L
   Molano-Gonzalez, N
   Osorio, JE
   Anaya, JM
AF Uncini, A.
   Gonzalez-Bravo, D. C.
   Acosta-Ampudia, Y. Y.
   Ojeda, E. C.
   Rodriguez, Y.
   Monsalve, D. M.
   Ramirez-Santana, C.
   Vega, D. A.
   Paipilla, D.
   Torres, L.
   Molano-Gonzalez, N.
   Osorio, J. E.
   Anaya, J. -M.
TI Clinical and nerve conduction features in Guillain-Barre syndrome
   associated with Zika virus infection in Cucuta, Colombia
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE acute inflammatory demyelinating polyneuropathy; clinical features;
   electrodiagnosis; Guillain-Barre syndrome; Zika virus
ID SYNDROME SUBTYPES; CRITERIA; POLYNEUROPATHY
AB Background and purposeZika virus (ZIKV) infection has been associated with an increased incidence of Guillain-Barre syndrome (GBS) but the relative frequency of acute inflammatory demyelinating polyradiculoneuropathy (AIDP) and axonal GBS subtypes is controversial.
   MethodsTwenty GBS patients diagnosed according to the Brighton criteria during the ZIKV outbreak in Cucuta, Colombia, were evaluated clinically and electrophysiologically. The electrodiagnosis of GBS subtypes was made according to a recently described criteria set that demonstrated a high diagnostic accuracy on the basis of a single test. The electrophysiological features of 34 Italian AIDP patients were used as control.
   ResultsAll patients had symptoms compatible with ZIKV infection before the onset of GBS and ZIKV infection was laboratory confirmed through a plaque reduction neutralization test (PRNT90) in 100% of patients. The median time from onset of ZIKV infection symptoms to GBS was 5 days (interquartile range 1-6 days). Cranial nerve palsy was present in 85% of patients (facial palsy in 75%, bulbar nerve involvement in 60%), autonomic dysfunction in 85%, and 50% of patients required invasive mechanical ventilation. AIDP was diagnosed in 70% of patients. 40% of nerves of AIDP patients showed a prevalent distal demyelinating involvement but this pattern was not different from the Italian AIDP patients without ZIKV infection.
   ConclusionsGuillain-Barre syndrome associated with ZIKV infection in Cucuta is characterized by a high frequency of cranial nerve involvement, autonomic dysfunction and requirement of mechanical ventilation indicating an aggressive and severe course. AIDP is the most frequent electrophysiological subtype. Demyelination is prevalent distally but this pattern is not specific for ZIKV infection.
C1 [Uncini, A.] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Via Luigi Polacchi, I-66100 Chieti, Italy.
   [Gonzalez-Bravo, D. C.; Acosta-Ampudia, Y. Y.; Ojeda, E. C.; Rodriguez, Y.; Monsalve, D. M.; Ramirez-Santana, C.; Vega, D. A.; Molano-Gonzalez, N.; Anaya, J. -M.] Univ Rosario, Ctr Autoimmune Dis Res CREA, Sch Med & Hlth Sci, Bogota, Colombia.
   [Paipilla, D.; Torres, L.] SOMEFYR Clin, Neurophysiol Lab, Cucuta, Colombia.
   [Osorio, J. E.] Univ Wisconsin Madison, Dept Pathobiol Sci, Madison, WI USA.
RP Uncini, A (corresponding author), Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Via Luigi Polacchi, I-66100 Chieti, Italy.
EM uncini@unich.it
RI Monsalve, Diana M./J-2374-2016; Anaya, Juan-Manuel/J-1960-2016;
   Acosta-Ampudia, Yeny/J-2401-2016; Ramirez-Santana, Carolina/J-2363-2016
OI Monsalve, Diana M./0000-0002-1145-1312; Anaya,
   Juan-Manuel/0000-0002-6444-1249; Acosta-Ampudia,
   Yeny/0000-0001-8491-9134; Ramirez-Santana, Carolina/0000-0003-2137-4899
FU Universidad del Rosario, Bogota, Colombia [ABN011]; Colciencias, Bogota,
   ColombiaDepartamento Administrativo de Ciencia, Tecnologia e Innovacion
   Colciencias [747-2016]
FX The authors are grateful to James Lewis of Natus Neurology and to all
   the members of the Centre for Autoimmune Diseases Research (CREA) for
   their fruitful discussions and comments. Supported by Universidad del
   Rosario (ABN011) and Colciencias (747-2016), Bogota, Colombia.
CR Al-Shekhlee A, 2007, MUSCLE NERVE, V35, P246, DOI 10.1002/mus.20660
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Mahecha MP, 2017, IMMUNOL RES, V65, P72, DOI 10.1007/s12026-016-8816-8
   Padilla JC, 2012, DENGUE COLOMBIA EPID
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   R Core Team, 2016, LANG ENV STAT COMP
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Sharma S, 2017, J MED VIROL, V89, P1693, DOI 10.1002/jmv.24822
   Uncini A, 2017, CLIN NEUROPHYSIOL, V128, P1176, DOI 10.1016/j.clinph.2017.03.048
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025
   Uncini A, 2010, J NEUROL NEUROSUR PS, V81, P1157, DOI 10.1136/jnnp.2010.208538
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 26
TC 7
Z9 9
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD APR
PY 2018
VL 25
IS 4
BP 644
EP 650
DI 10.1111/ene.13552
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GA5TQ
UT WOS:000428397200013
PM 29266602
OA Bronze
DA 2020-07-08
ER

PT J
AU Martins, MA
   Watkins, DI
AF Martins, Mauricio A.
   Watkins, David I.
TI What Is the Predictive Value of Animal Models for Vaccine Efficacy in
   Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be
   Instructive
SO COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY
LA English
DT Article
ID HIGHLY PATHOGENIC SIV; HIV-1 VACCINE; DOUBLE-BLIND; ZIKA VIRUS;
   NEUTRALIZING ANTIBODIES; GAG/POL/NEF VACCINE; DISEASE PROGRESSION;
   PROTECTIVE EFFICACY; RHESUS MACAQUES; REPLICATION
AB Simian immunodeficiency virus (SIV) challenge of rhesus macaques provides an invaluable tool to evaluate the clinical prospects of HIV-1 vaccine concepts. However, as with any animal model of human disease, it is crucial to understand the advantages and limitations of this system to maximize the translational value of SIV vaccine studies. Here, we discuss the importance of assessing the efficacy of vaccine prototypes using stringent SIV challenge regimens that mimic HIV-1 transmission and pathogenesis. We also review some of the cautionary tales of HIV-1 vaccine research because they provide general lessons for the preclinical assessment of vaccine candidates.
C1 [Martins, Mauricio A.; Watkins, David I.] Univ Miami, Dept Pathol, Miami, FL 33136 USA.
RP Watkins, DI (corresponding author), Univ Miami, Dept Pathol, Miami, FL 33136 USA.
EM dwatkins@med.miami.edu
OI Martins, Mauricio/0000-0001-8336-216X
FU NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [K01 OD023032]
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886
   Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766
   Bilello JP, 2011, J VIROL, V85, P12708, DOI 10.1128/JVI.00865-11
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005
   Dang Q, 2008, ADV PHARMACOL, V56, P369, DOI 10.1016/S1054-3589(07)56012-6
   Del Prete GQ, 2014, CELL HOST MICROBE, V16, P412, DOI 10.1016/j.chom.2014.08.003
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207
   Flynn MN, 2005, J INFECT DIS, V191, P654
   Friedlander AM, 2013, VACCINES, P127
   Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794
   Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441
   Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152
   Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6
   Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566
   Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475
   Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519
   Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874
   Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003
   Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911
   Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302
   HORSTMANN DM, 1985, YALE J BIOL MED, V58, P79
   Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, GAP REP JOINT UN PRO
   Joseph SB, 2015, NAT REV MICROBIOL, V13, P414, DOI 10.1038/nrmicro3471
   Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296
   Langlois AJ, 1998, J VIROL, V72, P6950, DOI 10.1128/JVI.72.8.6950-6955.1998
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Letvin NL, 2004, J VIROL, V78, P7490, DOI 10.1128/JVI.78.14.7490-7497.2004
   Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351
   Lopker M, 2013, J VIROL, V87, P5477, DOI 10.1128/JVI.03419-12
   Martins MA, 2014, J VIROL, V88, P7493, DOI 10.1128/JVI.00601-14
   Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695
   Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254
   Montefiori DC, 1998, J VIROL, V72, P3427, DOI 10.1128/JVI.72.4.3427-3431.1998
   Moore J P, 1995, AIDS, V9 Suppl A, pS117
   NIAID, 2016, NIH FUND STUD WILL T
   Nishimura Y, 2010, J VIROL, V84, P4769, DOI 10.1128/JVI.02279-09
   Norrby E, 2007, J EXP MED, V204, P2779, DOI 10.1084/jem.20072290
   Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87
   Parker RA, 2001, J VIROL, V75, P11234, DOI 10.1128/JVI.75.22.11234-11238.2001
   Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298
   Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110
   Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748
   Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11
   Reimann KA, 1999, VIROLOGY, V256, P15, DOI 10.1006/viro.1999.9632
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Reynolds MR, 2012, VACCINE, V30, P4465, DOI 10.1016/j.vaccine.2012.04.082
   Robb ML, 2016, NEW ENGL J MED, V374, P2120, DOI 10.1056/NEJMoa1508952
   Roederer M, 2014, NATURE, V505, P502, DOI 10.1038/nature12893
   SAWYER LSW, 1994, J VIROL, V68, P1342, DOI 10.1128/JVI.68.3.1342-1349.1994
   Shaw GM, 2012, COLD SPRING HARB PER, V2, P1, DOI DOI 10.1101/CSHPERSPECT.A006965
   Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344
   Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a
   Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105
   Vaccari M, 2013, J VIROL, V87, P3538, DOI 10.1128/JVI.02863-12
   Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759
   Wieland SF, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021469
   Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06
   Zhang YJ, 2000, J VIROL, V74, P6893, DOI 10.1128/JVI.74.15.6893-6910.2000
NR 62
TC 4
Z9 4
U1 0
U2 1
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1943-0264
J9 CSH PERSPECT BIOL
JI Cold Spring Harbor Perspect. Biol.
PD APR
PY 2018
VL 10
IS 4
AR a029504
DI 10.1101/cshperspect.a029504
PG 10
WC Cell Biology
SC Cell Biology
GA GB3UP
UT WOS:000428985000009
PM 28348034
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Howard, A
   Visintine, J
   Fergie, J
   Deleon, M
AF Howard, Ashley
   Visintine, John
   Fergie, Jaime
   Deleon, Miguel
TI Two Infants with Presumed Congenital Zika Syndrome, Brownsville, Texas,
   USA, 2016-2017
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; VIRUS-INFECTION; UNITED-STATES; PREGNANT-WOMEN;
   BIRTH-DEFECTS; OUTCOMES; TERRITORIES; EXPOSURE; FETAL
AB Since 2007, Zika virus has spread through the Pacific Islands and the Americas. Beginning in 2016, women in Brownsville, Texas, USA, were identified as possibly being exposed to Zika virus during pregnancy. We identified 18 pregnant women during 2016-2017 who had supportive serologic or molecular test results indicating Zika virus or flavivirus infection. Two infants were evaluated for congenital Zika syndrome after identification of prenatal microcephaly. Despite standard of care testing of mothers and neonates, comparative results were unreliable for mothers and infants, which highlights the need for clinical and epidemiologic evidence for an accurate diagnosis. A high index of suspicion for congenital Zika syndrome for at-risk populations is useful because of current limitations of testing.
C1 [Howard, Ashley; Visintine, John; Fergie, Jaime; Deleon, Miguel] Driscoll Childrens Hosp, 3533 S Alameda St, Corpus Christi, TX 78411 USA.
   [Fergie, Jaime] Texas A&M Univ, Coll Med, Bryan, TX USA.
RP Howard, A (corresponding author), Driscoll Childrens Hosp, 3533 S Alameda St, Corpus Christi, TX 78411 USA.
EM ashley.howard@dchstx.org
CR Alves Lucas Victor, 2016, Rev. Bras. Saude Mater. Infant., V16, pS27, DOI 10.1590/1806-9304201600s100003
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CDC, CDC CONCL ZIK CAUS M
   CDC, 2015, CUM ZIK VIR DIS CAS
   CDC, 2016, PREGN WOM AN LAB EV
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   WHO, 2016, ZIK OR SPREAD MOSQ B
   World Health Organization, 2016, DEF SYNDR ASS CONG Z
NR 25
TC 3
Z9 3
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2018
VL 24
IS 4
BP 625
EP 630
DI 10.3201/eid2404.171545
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GA2QC
UT WOS:000428167600002
PM 29553331
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mutebi, JP
   Hughes, HR
   Burkhalter, KL
   Kothera, L
   Vasquez, C
   Kenney, JL
AF Mutebi, John-Paul
   Hughes, Holly R.
   Burkhalter, Kristen L.
   Kothera, Linda
   Vasquez, Chalmers
   Kenney, Joan L.
TI Zika Virus MB16-23 in Mosquitoes, Miami-Dade County, Florida, USA, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB We isolated a strain of Zika virus, MB16-23, from Aedes aegypti mosquitoes collected in Miami Beach, Florida, USA, on September 2, 2016. Phylogenetic analysis suggests that MB16-23 most likely originated from the Caribbean region.
C1 [Mutebi, John-Paul] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
   [Hughes, Holly R.; Burkhalter, Kristen L.; Kothera, Linda; Kenney, Joan L.] Ctr Dis Control & Prevent, 3150 Rampart Rd, Ft Collins, CO 80521 USA.
   [Vasquez, Chalmers] Miami Dade Cty Mosquito Control, Miami, FL USA.
RP Mutebi, JP (corresponding author), Ctr Dis Control & Prevent, 3150 Rampart Rd, Ft Collins, CO 80521 USA.
EM grv0@cdc.gov
RI Kenney, Joan L./AAE-7416-2019
OI Kenney, Joanie/0000-0002-6761-4272
CR Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miller MA, 2010, GAT COMP ENV WORKSH
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
NR 8
TC 7
Z9 8
U1 0
U2 6
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2018
VL 24
IS 4
BP 808
EP 810
DI 10.3201/eid2404.171919
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GA2QC
UT WOS:000428167600036
PM 29400646
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Herrera, BB
   Tsai, WY
   Chang, CA
   Hamel, DJ
   Wang, WK
   Lu, YC
   Mboup, S
   Kanki, PJ
AF Herrera, Bobby Brooke
   Tsai, Wen-Yang
   Chang, Charlotte A.
   Hamel, Donald J.
   Wang, Wei-Kung
   Lu, Yichen
   Mboup, Souleymane
   Kanki, Phyllis J.
TI Sustained Specific and Cross-Reactive T Cell Responses to Zika and
   Dengue Virus NS3 in West Africa
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE ZIKV; DENV; flavivirus; T cells; Senegal; West Africa; T cell immunity
ID ORIGINAL ANTIGENIC SIN; INFECTION; TRANSMISSION; ANTIBODIES; IMMUNITY;
   OUTBREAK; PROTEIN; BRAZIL; PATHOGENESIS; ENHANCEMENT
AB Recent studies on the role of T cells in Zika virus (ZIKV) infection have shown that T cell responses to Asian ZIKV infection are important for protection, and that previous dengue virus (DENV) exposure amplifies the protective T cell response to Asian ZIKV. Human T cell responses to African ZIKV infection, however, remain unexplored. Here, we utilized the modified anthrax toxin delivery system to develop a flavivirus enzyme-linked immunosorbent spot (ELISPOT) assay. Using human ZIKV and DENV samples from Senegal, West Africa, our results demonstrate specific and cross-reactive T cell responses to nonstructural protein 3 (NS3). Specifically, we found that T cell responses to NS3 protease are ZIKV and DENV specific, but responses to NS3 helicase are cross-reactive. Sequential sample analyses revealed immune responses sustained many years after infection. These results have important implications for African ZIKV/DENV vaccine development, as well as for potential flavivirus diagnostics based on T cell responses.
   IMPORTANCE The recent Zika virus (ZIKV) epidemic in Latin America and the associated congenital microcephaly and Guillain-Barre syndrome have raised questions as to why we have not recognized these distinct clinical diseases in Africa. The human immunologic response to ZIKV and related flaviviruses in Africa represents a research gap that may shed light on the mechanisms contributing to protection. The goal of our study was to develop an inexpensive assay to detect and characterize the T cell response to African ZIKV and DENV. Our data show long-term specific and cross-reactive human immune responses against African ZIKV and DENV, suggesting the usefulness of a diagnostic based on the T cell response. Additionally, we show that prior flavivirus exposure influences the magnitude of the T cell response. The identification of immune responses to African ZIKV and DENV is of relevance to vaccine development.
C1 [Herrera, Bobby Brooke; Chang, Charlotte A.; Hamel, Donald J.; Kanki, Phyllis J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Tsai, Wen-Yang; Wang, Wei-Kung] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA.
   [Lu, Yichen] Haikou VTI Biol Inst, Haikou, Hainan, Peoples R China.
   [Mboup, Souleymane] Inst Hlth Res Epidemiol Surveillance & Training, Dakar, Senegal.
   [Mboup, Souleymane] Anta Diop Univ, Dept Parasitol & Mycol, Dakar, Senegal.
   [Mboup, Souleymane] Le Dantec Hosp, Dakar, Senegal.
RP Kanki, PJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
EM pkanki@hsph.harvard.edu
OI Herrera, Bobby Brooke/0000-0002-2438-6716
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI301795,
   CA39805]; U.S. Department of DefenseUnited States Department of Defense
   [DAMD-17-87-7072]; National Institutes of Allergy and Infectious
   Diseases, NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI110769-01]
FX The Senegalese FSW cohort was supported in part by the National
   Institutes of Health (NIH) (grant numbers AI301795 and CA39805 to
   P.J.K.) and the U.S. Department of Defense (grant number DAMD-17-87-7072
   to P.J.K.). This work was supported in part by the National Institutes
   of Allergy and Infectious Diseases, NIH (grant number R01AI110769-01 to
   W.-K.W.).
CR Alm E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003416
   Ballard JD, 1996, P NATL ACAD SCI USA, V93, P12531, DOI 10.1073/pnas.93.22.12531
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Goletz TJ, 1997, HUM IMMUNOL, V54, P129, DOI 10.1016/S0198-8859(97)00081-5
   Goletz TJ, 1997, P NATL ACAD SCI USA, V94, P12059, DOI 10.1073/pnas.94.22.12059
   Grifoni A, 2017, J VIROL
   Grifoni A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01309
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5
   Knipe D.M., 2013, FIELDS VIROLOGY
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liao Q, 2012, VACCINE, V30, P1601, DOI 10.1016/j.vaccine.2011.12.117
   Lu YC, 2000, P NATL ACAD SCI USA, V97, P8027, DOI 10.1073/pnas.97.14.8027
   MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sarr AD, 2001, AIDS RES HUM RETROV, V17, P1257, DOI 10.1089/088922201750461311
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P623, DOI 10.1093/jmedent/31.4.623
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xu X, 2016, PLOS CURR, V8
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 54
TC 12
Z9 12
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2018
VL 92
IS 7
AR e01992-17
DI 10.1128/JVI.01992-17
PG 20
WC Virology
SC Virology
GA GA5YL
UT WOS:000428409800021
PM 29321308
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Panayiotou, C
   Lindqvist, R
   Kurhade, C
   Vonderstein, K
   Pasto, J
   Edlund, K
   Upadhyay, AS
   Overby, AK
AF Panayiotou, Christakis
   Lindqvist, Richard
   Kurhade, Chaitanya
   Vonderstein, Kirstin
   Pasto, Jenny
   Edlund, Karin
   Upadhyay, Arunkumar S.
   Overby, Anna K.
TI Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus
   Replication by Targeting NS3 for Proteasomal Degradation
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE ISG; viperin; NS3; flavivirus; proteasomal degradation; interferons
ID HEPATITIS-C VIRUS; INTERFERON-STIMULATED GENES; WEST NILE VIRUS; PROTEIN
   VIPERIN; PATHOGENESIS; IDENTIFICATION; INFECTION; INHIBIT; RNA; COMPLEX
AB Flaviviruses are arthropod-borne viruses that constitute a major global health problem, with millions of human infections annually. Their pathogenesis ranges from mild illness to severe manifestations such as hemorrhagic fever and fatal encephalitis. Type I interferons (IFNs) are induced in response to viral infection and stimulate the expression of interferon-stimulated genes (ISGs), including that encoding viperin (virus-inhibitory protein, endoplasmic reticulum associated, IFN inducible), which shows antiviral activity against a broad spectrum of viruses, including several flaviviruses. Here we describe a novel antiviral mechanism employed by viperin against two prominent flaviviruses, tick-borne encephalitis virus (TBEV) and Zika virus (ZIKV). Viperin was found to interact and colocalize with the structural proteins premembrane (prM) and envelope (E) of TBEV, as well as with nonstructural (NS) proteins NS2A, NS2B, and NS3. Interestingly, viperin expression reduced the NS3 protein level, and the stability of the other interacting viral proteins, but only in the presence of NS3. We also found that although viperin interacted with NS3 of mosquito-borne flaviviruses (ZIKV, Japanese encephalitis virus, and yellow fever virus), only ZIKV was sensitive to the antiviral effect of viperin. This sensitivity correlated with viperin's ability to induce proteasome-dependent degradation of NS3. ZIKV and TBEV replication was rescued completely when NS3 was overexpressed, suggesting that the viral NS3 is the specific target of viperin. In summary, we present here a novel antiviral mechanism of viperin that is selective for specific viruses in the genus Flavivirus, affording the possible availability of new drug targets that can be used for therapeutic intervention.
   IMPORTANCE Flaviviruses are a group of enveloped RNA viruses that cause severe diseases in humans and animals worldwide, but no antiviral treatment is yet available. Viperin, a host protein produced in response to infection, effectively restricts the replication of several flaviviruses, but the exact molecular mechanisms have not been elucidated. Here we have identified a novel mechanism employed by viperin to inhibit the replication of two flaviviruses: tick-borne encephalitis virus (TBEV) and Zika virus (ZIKV). Viperin induced selective degradation via the proteasome of TBEV and ZIKV non-structural 3 (NS3) protein, which is involved in several steps of the viral life cycle. Furthermore, viperin also reduced the stability of several other viral proteins in a NS3-dependent manner, suggesting a central role of NS3 in viperin's antiflavivirus activity. Taking the results together, our work shows important similarities and differences among the members of the genus Flavivirus and could lead to the possibility of therapeutic intervention.
C1 [Panayiotou, Christakis; Lindqvist, Richard; Kurhade, Chaitanya; Vonderstein, Kirstin; Pasto, Jenny; Edlund, Karin; Upadhyay, Arunkumar S.; Overby, Anna K.] Umea Univ, Virol, Dept Clin Microbiol, Umea, Sweden.
   [Panayiotou, Christakis; Lindqvist, Richard; Kurhade, Chaitanya; Vonderstein, Kirstin; Pasto, Jenny; Edlund, Karin; Upadhyay, Arunkumar S.; Overby, Anna K.] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.
   [Vonderstein, Kirstin] Univ Helsinki, Biomedicum Imaging Unit, Fac Med, Helsinki, Finland.
   [Vonderstein, Kirstin] Univ Helsinki, HiLIFE, Helsinki, Finland.
RP Overby, AK (corresponding author), Umea Univ, Virol, Dept Clin Microbiol, Umea, Sweden.; Overby, AK (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.
EM anna.overby@umu.se
OI Upadhyay, Arunkumar/0000-0003-1608-2736; Overby Wernstedt,
   Anna/0000-0001-6553-0940; Kurhade, Chaitanya/0000-0002-6139-2461
FU Kempe Foundations; Laboratory for Molecular Medicine Sweden (MIMS); Umea
   Center for Microbial Research (UCMR); Linneus Support; Swedish Research
   Council (VR)Swedish Research Council [2011-2795, 2017-02438]; Swedish
   Foundation for Strategic Research (SSF)Swedish Foundation for Strategic
   Research [ICA10-0059, FFL12-0089]; Vasterbotten County Hospital
FX This work was supported by the Kempe Foundations, the Laboratory for
   Molecular Medicine Sweden (MIMS), the Umea Center for Microbial Research
   (UCMR), Linneus Support, the Swedish Research Council (VR) (2011-2795,
   2017-02438), the Swedish Foundation for Strategic Research (SSF)
   (ICA10-0059, FFL12-0089), and Vasterbotten County Hospital (A.K.O.). The
   funding bodies had no role in study design, data collection or
   interpretation, or the decision to submit the work for publication.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Asghar N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39265
   BARTHOLOMEUSZ AI, 1993, ARCH VIROL, V128, P111, DOI 10.1007/BF01309792
   Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Eldin P, 2009, J GEN VIROL, V90, P536, DOI 10.1099/vir.0.006288-0
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Gebhard LG, 2016, J VIROL, V90, P5451, DOI 10.1128/JVI.00206-16
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Jumat MR, 2015, ANTIVIR RES, V114, P11, DOI 10.1016/j.antiviral.2014.11.007
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Liu WJ, 2002, J VIROL, V76, P10766, DOI 10.1128/JVI.76.21.10766-10775.2002
   McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395
   NIEDRIG M, 1994, ACTA VIROL, V38, P141
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Carcamo JRP, 2018, VIROLOGY, V514, P216, DOI 10.1016/j.virol.2017.10.012
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006
   Sen Tan K, 2012, J GEN VIROL, V93, P1269, DOI 10.1099/vir.0.040824-0
   Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11
   Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241
   Upadhyay AS, 2017, J BIOL CHEM
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Vonderstein K., 2017, J VIROL
   Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0
   Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009
   Xue BB, 2016, J VIROL, V90, P6832, DOI 10.1128/JVI.00352-16
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07
NR 42
TC 24
Z9 26
U1 1
U2 21
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2018
VL 92
IS 7
AR UNSP e02054-17
DI 10.1128/JVI.02054-17
PG 13
WC Virology
SC Virology
GA GA5YL
UT WOS:000428409800027
PM 29321318
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Poonsiri, T
   Wright, GSA
   Diamond, MS
   Turtle, L
   Solomon, T
   Antonyuk, SV
AF Poonsiri, Thanalai
   Wright, Gareth S. A.
   Diamond, Michael S.
   Turtle, Lance
   Solomon, Tom
   Antonyuk, Svetlana V.
TI Structural Study of the C-Terminal Domain of Nonstructural Protein 1
   from Japanese Encephalitis Virus
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Japanese encephalitis virus; protein crystallography; neutralizing
   antibodies; nonstructural protein 1; protein structure-function
ID WEST-NILE-VIRUS; SMALL-ANGLE SCATTERING; NS1 PROTEIN; YELLOW-FEVER;
   COMPLEMENT ACTIVATION; GLYCOSYLATION SITES; RNA REPLICATION; CELLS;
   INFECTION; ANTIBODY
AB Japanese encephalitis virus (JEV) is a mosquito-transmitted flavivirus that is closely related to other emerging viral pathogens, including dengue virus (DENV), West Nile virus (WNV), and Zika virus (ZIKV). JEV infection can result in meningitis and encephalitis, which in severe cases cause permanent brain damage and death. JEV occurs predominantly in rural areas throughout Southeast Asia, the Pacific Islands, and the Far East, causing around 68,000 cases of infection worldwide each year. In this report, we present a 2.1-angstrom-resolution crystal structure of the C-terminal beta-ladder domain of JEV nonstructural protein 1 (NS1-C). The surface charge distribution of JEV NS1-C is similar to those of WNV and ZIKV but differs from that of DENV. Analysis of the JEV NS1-C structure, with in silico molecular dynamics simulation and experimental solution small-angle X-ray scattering, indicates extensive loop flexibility on the exterior of the protein. This, together with the surface charge distribution, indicates that flexibility influences the proteinprotein interactions that govern pathogenicity. These factors also affect the interaction of NS1 with the 22NS1 monoclonal antibody, which is protective against West Nile virus infection. Liposome and heparin binding assays indicate that only the N-terminal region of NS1 mediates interaction with membranes and that sulfate binding sites common to NS1 structures are not glycosaminoglycan binding interfaces. This report highlights several differences between flavivirus NS1 proteins and contributes to our understanding of their structurepathogenic function relationships.
   IMPORTANCE JEV is a major cause of viral encephalitis in Asia. Despite extensive vaccination, epidemics still occur. Nonstructural protein 1 (NS1) plays a role in viral replication, and, because it is secreted, it can exhibit a wide range of interactions with host proteins. NS1 sequence and protein folds are conserved within the Flavivirus genus, but variations in NS1 protein-protein interactions among viruses likely contribute to differences in pathogenesis. Here, we compared characteristics of the C-terminal beta-ladder domain of NS1 between flaviviruses, including surface charge, loop flexibility, epitope cross-reactivity, membrane adherence, and glycosaminoglycan binding. These structural features are central to NS1 functionality and may provide insight into the development of diagnostic tests and therapeutics.
C1 [Poonsiri, Thanalai; Wright, Gareth S. A.; Antonyuk, Svetlana V.] Univ Liverpool, Inst Integrat Biol, Fac Hlth & Life Sci, Mol Biophys Grp, Liverpool, Merseyside, England.
   [Turtle, Lance] Univ Liverpool, Inst Infect & Global Hlth, Ctr Global Vaccine Res, Liverpool, Merseyside, England.
   [Poonsiri, Thanalai; Turtle, Lance; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
RP Antonyuk, SV (corresponding author), Univ Liverpool, Inst Integrat Biol, Fac Hlth & Life Sci, Mol Biophys Grp, Liverpool, Merseyside, England.
EM S.Antonyuk@liverpool.ac.uk
RI Antonyuk, Svetlana/W-5159-2019; Diamond, Michael/AAH-1733-2019
OI Antonyuk, Svetlana/0000-0002-2779-9946; Diamond,
   Michael/0000-0002-8791-3165; Turtle, Lance/0000-0002-0778-1693; Wright,
   Gareth/0000-0002-3756-9634; Solomon, Tom/0000-0001-7266-6547
FU Mahidol-Liverpool Stang Mongkolsuk Ph.D. scholarship; European
   Community's Seventh Framework Programme (FP7) under BioStruct-X [283570,
   6714]; Wellcome TrustWellcome Trust [205228/Z/16/Z]; National Institute
   for Health Research (NIHR) Health Protection Research Unit in Emerging
   and Zoonotic Infections;  [HHSN272201400018C]
FX This work was supported by a Mahidol-Liverpool Stang Mongkolsuk Ph.D.
   scholarship. We acknowledge help from the following colleagues at the
   University of Liverpool: Richard Strange for assistance with the
   electrostatic surface map; Sujitra Keadsanti for assistance with Western
   blotting; Kangsa Amporndanai for providing bovine cytochrome bc1;
   Varunya Chantadul for providing human SOD3; and Pawin Ngamlert for
   assistance with the heparin binding assay. We also thank Samar Hasnain
   for support and interest in the project throughout and for extensive
   discussions of the results. We acknowledge Synchrotron Soleil for
   provision of the Proxima 1 beamline and SAXS facilities.; Use of Soleil
   was funded by the European Community's Seventh Framework Programme
   (FP7/2007-2013) under BioStruct-X (grant agreement number 283570 and
   proposal number 6714). We gratefully acknowledge the Diamond Synchrotron
   for providing support at the I02 beamline. M.S.D. acknowledges support
   from HHSN272201400018C, L.T. from The Wellcome Trust (grant number
   205228/Z/16/Z), and T.S. and L.T. from the National Institute for Health
   Research (NIHR; www.nihr.ac.uk) Health Protection Research Unit in
   Emerging and Zoonotic Infections.
CR Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Blitvich BJ, 2001, J GEN VIROL, V82, P2251, DOI 10.1099/0022-1317-82-9-2251
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Fan Jingjing, 2014, Virologica Sinica, V29, P162, DOI 10.1007/s12250-014-3459-1
   Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Han YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004319
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Julkowska Magdalena M, 2013, Methods Mol Biol, V1009, P261, DOI 10.1007/978-1-62703-401-2_24
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370
   LEE JM, 1989, J GEN VIROL, V70, P335, DOI 10.1099/0022-1317-70-2-335
   Li YZ, 2012, J VIROL METHODS, V179, P8, DOI 10.1016/j.jviromet.2011.06.008
   Li YZ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-135
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Liu JW, 2016, ADV COMPUT SCI TECH, P1
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   MANDL CW, 1989, VIROLOGY, V173, P291, DOI 10.1016/0042-6822(89)90246-8
   MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X
   Melian EB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004447
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Modhiran N, 2017, IMMUNOL CELL BIOL, V95, P491, DOI 10.1038/icb.2017.5
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Morrison CR, 2014, VIROLOGY, V456, P96, DOI 10.1016/j.virol.2014.03.017
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Noisakran S, 2008, J GEN VIROL, V89, P2492, DOI 10.1099/vir.0.83620-0
   Noisakran S, 2007, J VIROL METHODS, V142, P67, DOI 10.1016/j.jviromet.2007.01.008
   Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   SCHLESINGER JJ, 1990, J GEN VIROL, V71, P593, DOI 10.1099/0022-1317-71-3-593
   Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020
   Smith JL, 2015, US patent, Patent No. [WO 2015095735 A2, 2015095735]
   Solomon T, 1998, J CLIN MICROBIOL, V36, P2030, DOI 10.1128/JCM.36.7.2030-2034.1998
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   Takamatsu Y, 2014, J GEN VIROL, V95, P373, DOI 10.1099/vir.0.057968-0
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   Xu X, 2016, EMBO J
   Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0
   Youn S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-339
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Young LB, 2013, J VIROL, V87, P9384, DOI 10.1128/JVI.01101-13
NR 68
TC 5
Z9 5
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2018
VL 92
IS 7
AR UNSP e01868-17
DI 10.1128/JVI.01868-17
PG 19
WC Virology
SC Virology
GA GA5YL
UT WOS:000428409800014
PM 29343583
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Scott, JM
   Lebratti, TJ
   Richner, JM
   Jiang, XP
   Fernandez, E
   Zhao, HY
   Fremont, DH
   Diamond, MS
   Shin, HN
AF Scott, Jason M.
   Lebratti, Tania J.
   Richner, Justin M.
   Jiang, Xiaoping
   Fernandez, Estefania
   Zhao, Haiyan
   Fremont, Daved H.
   Diamond, Michael S.
   Shin, Haina
TI Cellular and Humoral Immunity Protect against Vaginal Zika Virus
   Infection in Mice
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika; sexual transmission; immunity; Zika virus
ID MALE SEXUAL TRANSMISSION; RESIDENT MEMORY; T-CELLS; HUMAN-ANTIBODIES;
   STRUCTURAL BASIS; GENITAL HERPES; MOUSE MODEL; VACCINE; RHESUS; IGG
AB Zika virus (ZIKV), which can cause devastating disease in fetuses of infected pregnant women, can be transmitted by mosquito inoculation and sexual routes. Little is known about immune protection against sexually transmitted ZIKV. In this study, we show that previous infection through intravaginal or subcutaneous routes with a contemporary Brazilian strain of ZIKV can protect against subsequent intravaginal challenge with a homologous strain. Both routes of inoculation induced high titers of ZIKV-specific and neutralizing antibody in serum and the vaginal lumen. Virus-specific T cells were recruited to and retained in the female reproductive tract after intravaginal and subcutaneous ZIKV infection. Studies in mice with genetic or acquired deficiencies in B and/or T cells demonstrated that both lymphocyte populations redundantly protect against intravaginal challenge in ZIKV-immune animals. Passive transfer of ZIKV-immune IgG or T cells significantly limited intravaginal infection of naive mice, although antibody more effectively prevented dissemination throughout the reproductive tract. Collectively, our experiments begin to establish the immune correlates of protection against intravaginal ZIKV infection, which should inform vaccination strategies in nonpregnant and pregnant women.
   IMPORTANCE The recent ZIKV epidemic resulted in devastating outcomes in fetuses and may affect reproductive health. Unlike other flaviviruses, ZIKV can be spread by sexual contact as well as a mosquito vector. While previous studies have identified correlates of protection for mosquito-mediated infection, few have focused on immunity against sexual transmission. As exposure to ZIKV via mosquito bite has likely occurred to many living in areas where ZIKV is endemic, our study addresses whether this route of infection can protect against subsequent sexual exposure. We demonstrate that subcutaneous ZIKV infection can protect against subsequent vaginal infection by generating both local antiviral T cell and antibody responses. Our research begins to define the immune correlates of protection for ZIKV infection in the vagina and provides a foundation for testing ZIKV vaccines against sexual transmission.
C1 [Scott, Jason M.; Richner, Justin M.; Jiang, Xiaoping; Diamond, Michael S.; Shin, Haina] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.
   [Lebratti, Tania J.; Fernandez, Estefania; Zhao, Haiyan; Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Fremont, Daved H.] Washington Univ, Sch Med, Dept Biochem & Biophys, St Louis, MO USA.
   [Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA.
   [Richner, Justin M.] IIT, Res Inst, Chicago, IL 60616 USA.
RP Shin, HN (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.
EM haina.shin@wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Shin, Haina/0000-0002-1014-1451;
   Richner, Justin/0000-0002-5344-118X
FU NIH NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21 AI132133, R01 AI104972, P01 AI106695,
   R01 AI073755]; NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272201400018C,
   HHSN272201200026C]
FX This work was supported by grants from the NIH NIAID (R21 AI132133 to
   H.S., R01 AI104972 and P01 AI106695 to M.S.D., and R01 AI073755 to
   M.S.D. and D.H.F.) and by NIAID contracts (HHSN272201400018C and
   HHSN272201200026C [CSGID] to D.H.F.).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaudinski MR, 2017, LANCET
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Iijima N, 2007, P NATL ACAD SCI USA, V104, P19061, DOI 10.1073/pnas.0707179104
   Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kumamoto Y, 2012, CURR OPIN IMMUNOL, V24, P411, DOI 10.1016/j.coi.2012.05.006
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108
   Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008
   Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858
   MCDERMOTT MR, 1990, J GEN VIROL, V71, P1497, DOI 10.1099/0022-1317-71-7-1497
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Modjarrad K, 2017, LANCET
   Morrison LA, 2001, J VIROL, V75, P1195, DOI 10.1128/JVI.75.3.1195-1204.2001
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Parr EL, 1997, J VIROL, V71, P8109, DOI 10.1128/JVI.71.11.8109-8115.1997
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shin H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13346
   Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087
   Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522
   Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tebas P, 2017, N ENGL J MED
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Turmel J. M., 2016, LANCET, V6736, P30775, DOI DOI 10.1016/S0140-6736(16)30775-9
   Turner LH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006684
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   USALA SJ, 1989, J REPROD MED, V34, P292
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 78
TC 19
Z9 19
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2018
VL 92
IS 7
AR e00038-18
DI 10.1128/JVI.00038-18
PG 17
WC Virology
SC Virology
GA GA5YL
UT WOS:000428409800004
PM 29343577
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Cortes, MS
   Rivera, AM
   Yepez, M
   Guimaraes, CV
   Yunes, ID
   Zarutskie, A
   Davila, I
   Shetty, A
   Mahadev, A
   Serrano, SM
   Castillo, N
   Lee, W
   Valentine, G
   Belfort, M
   Parra, G
   Mohila, C
   Aagaard, K
   Saavedra, MP
AF Cortes, Magdalena Sanz
   Maria Rivera, Ana
   Yepez, Mayel
   Guimaraes, Carolina V.
   Diaz Yunes, Israel
   Zarutskie, Alexander
   Davila, Ivan
   Shetty, Anil
   Mahadev, Arun
   Maria Serrano, Saray
   Castillo, Nicolas
   Lee, Wesley
   Valentine, Gregory
   Belfort, Michael
   Parra, Guido
   Mohila, Carrie
   Aagaard, Kjersti
   Parra Saavedra, Miguel
TI Clinical assessment and brain findings in a cohort of mothers, fetuses
   and infants infected with ZIKA virus
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE calcification; congenital infection; fetal brain MRI; microcephaly;
   neurodevelopment; neuroimaging; pregnancy; ventriculomegaly; Zika virus
ID INTERNATIONAL STANDARDS; PULSATILITY INDEX; FETAL-GROWTH; ULTRASOUND;
   BRAZIL; PREGNANCY; MALFORMATIONS; ASSOCIATION; BIOMETRY; WEIGHT
AB BACKGROUND: Congenital Zika virus (ZIKV) infection can be detected in both the presence and absence of microcephaly and manifests as a number of signs and symptoms that are detected clinically and by neuroimaging. However, to date, qualitative and quantitative measures for the purpose of diagnosis and prognosis are limited.
   OBJECTIVES: Main objectives of this study conducted on fetuses and infants with confirmed congenital Zika virus infection and detected brain abnormalities were (1) to assess the prevalence of microcephaly and the frequency of the anomalies that include a detailed description based on ultrasound and magnetic resonance imaging in fetuses and ultrasound, magnetic resonance imaging, and computed tomography imaging postnatally, (2) to provide quantitative measures of fetal and infant brain findings by magnetic resonance imaging with the use of volumetric analyses and diffusion-weighted imaging, and (3) to obtain additional information from placental and fetal histopathologic assessments and postnatal clinical evaluations.
   STUDY DESIGN: This is a longitudinal cohort study of Zika viruseinfected pregnancies froma single institution in Colombia. Clinical and imaging findings of patients with laboratory-confirmed Zika virus infection and fetal brain anomalies were the focus of this study. Patients underwent monthly fetal ultrasound scans, neurosonography, and a fetal magnetic resonance imaging. Postnatally, infant brain assessment was offered by the use of ultrasound imaging, magnetic resonance imaging, and/or computed tomography. Fetal head circumference measurements were compared with different reference ranges with <2 or <3 standard deviations below the mean for the diagnosis of microcephaly. Fetal and infantmagnetic resonance imaging images were processed to obtain a quantitative brain volumetric assessment. Diffusion weighted imaging sequences were processed to assess brain microstructure. Anthropometric, neurologic, auditory, and visual assessments were performed postnatally. Histopathologic assessment was included if patients opted for pregnancy termination.
   RESULTS: All women (n = 214) had been referred for Zika virus symptoms during pregnancy that affected themselves or their partners or if fetal anomalies that are compatible with congenital Zika virus syndrome were detected. A total of 12 pregnant patients with laboratory confirmation of Zika virus infection were diagnosed with fetal brain malformations. Most common findings that were assessed by prenatal and postnatal imaging were brain volume loss (92%), calcifications (92%), callosal anomalies (100%), cortical malformations (89%), and ventriculomegaly (92%). Results from fetal brain volumetric assessment by magnetic resonance imaging showed that 1 of the most common findings associated with microcephaly was reduced supratentorial brain parenchyma and increased subarachnoid cerebrospinal fluid. Diffusion weighted imaging analyses of apparent diffusion coefficient values showed microstructural changes. Microcephaly was present in 33.3-58.3% of the cases at referral and was present at delivery in 55.6-77.8% of cases. At birth, most of the affected neonates (55.6-77.8%) had head circumference measurements >3 standard deviations below the mean. Postnatal imaging studies confirmed brain malformations that were detected prenatally. Auditory screening results were normal in 2 cases that were assessed. Visual screening showed different anomalies in 2 of the 3 cases that were examined. Pathologic results that were obtained from 2 of the 3 cases who opted for termination showed similar signs of abnormalities in the central nervous system and placental analyses, including brain microcalcifications.
   CONCLUSION: Congenital microcephaly is not an optimal screening method for congenital Zika virus syndrome, because it may not accompany other evident and preceding brain findings; microcephaly could be an endpoint of the disease that results from progressive changes that are related to brain volume loss. Long-term studies are needed to understand the clinical and developmental relevance of these findings.
C1 [Cortes, Magdalena Sanz; Yepez, Mayel; Zarutskie, Alexander; Davila, Ivan; Shetty, Anil; Mahadev, Arun; Lee, Wesley; Belfort, Michael; Aagaard, Kjersti] Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA.
   [Guimaraes, Carolina V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA.
   [Valentine, Gregory] Baylor Coll Med, Dept Pediat, Div Neonatal Med, Houston, TX 77030 USA.
   [Mohila, Carrie] Baylor Coll Med, Dept Pathol & Lab Med, Houston, TX 77030 USA.
   Texas Childrens Hosp, Houston, TX 77030 USA.
   [Maria Rivera, Ana; Diaz Yunes, Israel; Castillo, Nicolas; Parra, Guido; Parra Saavedra, Miguel] Cediul Cedifetal, Dept Obstet & Gynecol, Div Maternal Fetal Med, Barranquilla, Colombia.
   [Maria Serrano, Saray] Cediul Cedifetal, Dept Radiol, Barranquilla, Colombia.
RP Cortes, MS (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA.
EM magdalec@bcm.edu
OI Valentine, Gregory/0000-0002-3055-2987; DAVILA ESCAMILLA, IVAN
   VLADIMIR/0000-0002-4776-5049
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01NR014792]; March
   of Dimes Prematurity Research InitiativeMarch of Dimes
FX Supported in part by the National Institutes of Health (grant number
   R01NR014792 to K.M.A) and the March of Dimes Prematurity Research
   Initiative (K.M.A.).
CR Achiron R, 2001, ULTRASOUND OBST GYN, V18, P343, DOI 10.1046/j.0960-7692.2001.00512.x
   Adachi Y, 2011, AM J NEURORADIOL, V32, P1123, DOI 10.3174/ajnr.A2440
   Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   [Anonymous], 2016, N Engl J Med, V375, P498, DOI 10.1056/NEJMx160025
   [Anonymous], 2016, PRACT ADV ZIK VIR
   [Anonymous], 2015, PROT VIG RESP OC MIC
   ARDUINI D, 1990, J PERINAT MED, V18, P165, DOI 10.1515/jpme.1990.18.3.165
   Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d
   Baschat AA, 2003, ULTRASOUND OBST GYN, V21, P124, DOI 10.1002/uog.20
   Besnard M, 2014, EURO SURVEILL, V19
   Besnard M, 2016, EURO SURVEILL, V21
   Bosnjak VM, 2011, COLLEGIUM ANTROPOL, V35, P229
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brouwer MJ, 2012, RADIOLOGY, V262, P224, DOI 10.1148/radiol.11110334
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gomez O, 2008, ULTRASOUND OBST GYN, V32, P128, DOI 10.1002/uog.5315
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kurmanavicius J, 1999, BRIT J OBSTET GYNAEC, V106, P126, DOI 10.1111/j.1471-0528.1999.tb08212.x
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller-Oehring EM, 2010, NEUROPSYCHOLOGIA, V48, P1133, DOI 10.1016/j.neuropsychologia.2009.12.015
   Natale V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003735
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organization, 2015, ZIK VIR ZIKV SURV AM
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Righini A, 2003, AM J NEURORADIOL, V24, P799
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sari A, 2005, ACTA RADIOL, V46, P631, DOI 10.1080/02841850510021715
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Soares de Araujo J, 2016, B WORLD HEALTH ORGAN, V94, P835
   Soares de Oliveira-Szejnfeld P, 2016, RADIOLOGY, V281, P1
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V62, P1
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Wolf RL, 2001, RADIOLOGY, V218, P825, DOI 10.1148/radiology.218.3.r01fe47825
   Yaniv G, 2016, ULTRASOUND OBST GYN, V47, P600, DOI 10.1002/uog.14737
NR 64
TC 21
Z9 24
U1 0
U2 18
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD APR
PY 2018
VL 218
IS 4
AR 440.e1-e36
DI 10.1016/j.ajog.2018.01.012
PG 36
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GA5XD
UT WOS:000428406300016
PM 29353032
OA Bronze
DA 2020-07-08
ER

PT J
AU Blohm, GM
   Lednicky, JA
   Marquez, M
   White, SK
   Loeb, JC
   Pacheco, CA
   Nolan, DJ
   Paisie, T
   Salemi, M
   Rodriguez-Morales, AJ
   Morris, JG
   Pulliam, JRC
   Paniz-Mondolfi, AE
AF Blohm, Gabriela M.
   Lednicky, John A.
   Marquez, Marilianna
   White, Sarah K.
   Loeb, Julia C.
   Pacheco, Carlos A.
   Nolan, David J.
   Paisie, Taylor
   Salemi, Marco
   Rodriguez-Morales, Alfonso J.
   Morris, J. Glenn, Jr.
   Pulliam, Juliet R. C.
   Paniz-Mondolfi, Alberto E.
TI Evidence for Mother-to-Child Transmission of Zika Virus Through Breast
   Milk
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE Zika virus; Venezuela; asymptomatic; breast milk; breastfeeding
   transmission
AB Zika virus (ZIKV) is an emerging viral pathogen that continues to spread throughout different regions of the world. Herein we report a case that provides further evidence that ZIKV transmission can occur through breastfeeding by providing a detailed clinical, genomic, and virological case-based description.
C1 [Blohm, Gabriela M.; Lednicky, John A.; White, Sarah K.; Loeb, Julia C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA.
   [Blohm, Gabriela M.; Lednicky, John A.; White, Sarah K.; Loeb, Julia C.; Nolan, David J.; Paisie, Taylor; Salemi, Marco; Morris, J. Glenn, Jr.; Pulliam, Juliet R. C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Blohm, Gabriela M.; Marquez, Marilianna; Paniz-Mondolfi, Alberto E.] Univ Centroccidental Lisandro Alvarado, Infect Dis Res Incubator & Zoonosis & Emerging Pa, Lara, Venezuela.
   [Marquez, Marilianna] Univ Centroccidental Lisandro Alvarado, Coll Med, Hlth Sci Dept, Lara, Venezuela.
   [Pacheco, Carlos A.] Policlin Barquisimeto, Lara, Venezuela.
   [Nolan, David J.; Paisie, Taylor; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA.
   [Nolan, David J.] Bioinfoexperts LLC, Thibodaux, LA USA.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Dept Internal Med,Div Infect Dis & Global Med, Gainesville, FL USA.
   [Pulliam, Juliet R. C.] DST NRF Ctr Excellence Epidemiol Modelling & Anal, Stellenbosch, South Africa.
   [Paniz-Mondolfi, Alberto E.] Biomed Res Inst, IDB, Dept Infect Dis & Trop Med, Lara, Barquisimeto, Venezuela.
RP Paniz-Mondolfi, AE (corresponding author), Hosp Int Barquisimeto, Dept Pathol & Lab Med, Lara, Barquisimeto, Venezuela.; Paniz-Mondolfi, AE (corresponding author), Av Intercomunal Barquisimeto Cabudare, Las Mercedes 3023, Cabudare, Venezuela.
EM albertopaniz@yahoo.com
RI Lednicky, John A/C-5678-2012; AJ, Rodriguez-Morales/R-9765-2016;
   Pulliam, Juliet/A-6516-2008
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Pulliam,
   Juliet/0000-0003-3314-8223
FU National Science FoundationNational Science Foundation (NSF) [1515734];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI126357-01S1]
FX Components of the work were supported by grants from the National
   Science Foundation (award number 1515734) and the National Institutes of
   Health (grant number R01 AI126357-01S1).
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blohm G.M., 2017, GENOME ANNOUNC, V5
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   World Health Organization, ZIK VIR MICR GUILL B
NR 8
TC 30
Z9 30
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 1
PY 2018
VL 66
IS 7
BP 1120
EP 1121
DI 10.1093/cid/cix968
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FZ8YP
UT WOS:000427897000024
PM 29300859
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Romero, DM
   Bahi-Buisson, N
   Francis, F
AF Romero, Delfina M.
   Bahi-Buisson, Nadia
   Francis, Fiona
TI Genetics and mechanisms leading to human cortical malformations
SO SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE Neuronal migration; Cortical malformations; Lissencephaly;
   Tubulinopathies; Heterotopia; Microcephaly; Polymicrogyria; Atypical
   rare mutations; Exome sequencing; Human in vitro cultures; ZIKV
ID DOUBLECORTIN-LIKE-KINASE; NEURONAL MIGRATION DISORDERS; PLURIPOTENT
   STEM-CELLS; WARBURG MICRO SYNDROME; DE-NOVO MUTATIONS; PERIVENTRICULAR
   NODULAR HETEROTOPIA; CONGENITAL MUSCULAR-DYSTROPHY;
   BARAITSER-WINTER-SYNDROME; SIMPLIFIED GYRAL PATTERN; FUKUTIN-RELATED
   PROTEIN
AB Cerebral cortical development involves a complex series of highly regulated steps to generate the laminated structure of the adult neocortex. Neuronal migration is a key part of this process. We provide here a detailed review of cortical malformations thought to be linked to abnormal neuronal migration. We have focused on providing updated views related to perturbed mechanisms based on the wealth of genetic information currently available, as well as the study of mutant genes in animal models. We discuss mainly type 1 lissencephaly, periventricular heterotopia, type II lissencephaly and polymicrogyria. We also discuss functional classifications such as the tubulinopathies, and emphasize how modern genetics is revealing genes mutated in atypical cases, as well as unexpected genes for classical cases. A role in neuronal migration is revealed for many mutant genes, although progenitor abnormalities also predominate, depending on the disorder. We finish by describing the advantages of human in vitro cell culture models, to examine human-specific cells and transcripts, and further mention non-genetic mechanisms leading to cortical malformations. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Romero, Delfina M.; Francis, Fiona] INSERM, UMR S 839, 17 Rue Fer A Moulin, F-75005 Paris, France.
   [Romero, Delfina M.; Francis, Fiona] Univ Paris 06, Sorbonne Univ, 4 Pl Jussieu, F-75005 Paris, France.
   [Romero, Delfina M.; Francis, Fiona] Inst Fer A Moulin, 17 Rue Fer A Moulin, F-75005 Paris, France.
   [Bahi-Buisson, Nadia] Sorbonne Paris Cite Univ, Paris Descartes, Imagine Inst, Paris, France.
   [Bahi-Buisson, Nadia] INSERM, UMR 1163, Embryol & Genet Congenital Malformat, Paris, France.
RP Francis, F (corresponding author), INSERM, Inst Fer A Moulin, UMR S 839, 17 Rue Fer A Moulin, F-75005 Paris, France.
EM fiona.francis@inserm.fr
RI Francis, Fiona/B-5854-2016; Bahi-Buisson, Nadia/H-5207-2017
OI Bahi-Buisson, Nadia/0000-0002-5352-0929; Francis,
   Fiona/0000-0001-8542-7537
FU INSERMInstitut National de la Sante et de la Recherche Medicale
   (Inserm); CNRSCentre National de la Recherche Scientifique (CNRS);
   UPMCUniversity of Pittsburgh; European UnionEuropean Union (EU);
   ANRFrench National Research Agency (ANR) [13-BSV4-0008-01,
   ANR-16-CE16-0011-03]; JTC Neurodevelopmental Disorders; ANRFrench
   National Research Agency (ANR); Region Ile-de-FranceRegion Ile-de-France
FX We are grateful for financial support from INSERM, the CNRS and UPMC,
   the European Union (EU-HEALTH-2013), the ANR (13-BSV4-0008-01,
   ANR-16-CE16-0011-03), the JTC 2015 Neurodevelopmental Disorders and the
   ANR for NEURON8-Full-815-006 STEM-MCD and the Region Ile-de-France. FF's
   group is associated with the BioPsy Labex project and the Ecole des
   Neurosciences de Paris Ile-de-France network.
CR Abdel-Salam GMH, 2012, AM J MED GENET A, V158A, P2788, DOI 10.1002/ajmg.a.35583
   Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Ackroyd MR, 2009, BRAIN, V132, P439, DOI 10.1093/brain/awn335
   Adams M, 2012, HUM MOL GENET, V21, P1272, DOI 10.1093/hmg/ddr557
   AICARDI J, 1991, BRAIN DEV-JPN, V13, P1
   Alders M, 2014, HUM GENET, V133, P1161, DOI 10.1007/s00439-014-1456-y
   Aligianis IA, 2006, AM J HUM GENET, V78, P702, DOI 10.1086/502681
   Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517
   Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003
   Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439
   Araque A, 2010, PHILOS T R SOC B, V365, P2375, DOI 10.1098/rstb.2009.0313
   Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408
   Astrea G, 2016, NEUROMUSCULAR DISORD, V26, P459, DOI 10.1016/j.nmd.2016.05.003
   Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021
   Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108
   Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993
   Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392
   Baek ST, 2015, NAT MED, V21, P1445, DOI 10.1038/nm.3982
   Bahi-Buisson N, 2008, J MED GENET, V45, P647, DOI 10.1136/jmg.2008.058073
   Bahi-Buisson N., 1993, GENEREVIEWS
   Bahi-Buisson N, 2014, BRAIN, V137, P1676, DOI 10.1093/brain/awu082
   Bahi-Buisson N, 2013, BRAIN, V136, P223, DOI 10.1093/brain/aws323
   Bahi-Buisson N, 2010, BRAIN, V133, P3194, DOI 10.1093/brain/awq259
   Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153
   Bakircioglu M, 2011, AM J HUM GENET, V88, P523, DOI 10.1016/j.ajhg.2011.03.019
   Bamiou DE, 2007, ARCH PEDIAT ADOL MED, V161, P463, DOI 10.1001/archpedi.161.5.463
   Banne E, 2013, J MED GENET, V50, P772, DOI 10.1136/jmedgenet-2013-101752
   Barak T, 2011, NAT GENET, V43, P590, DOI 10.1038/ng.836
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Barkovich AJ, 2010, NEURORADIOLOGY, V52, P479, DOI 10.1007/s00234-009-0644-2
   Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003
   Bassuk AG, 2015, J NEUROGENET, V29, P174, DOI 10.3109/01677063.2015.1088847
   Baulac S, 2014, NEUROLOGY, V82, P1068, DOI 10.1212/WNL.0000000000000241
   Bazelot M, 2012, EUR J NEUROSCI, V35, P244, DOI 10.1111/j.1460-9568.2011.07962.x
   Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4
   Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975
   Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106
   Bem D, 2011, AM J HUM GENET, V88, P499, DOI 10.1016/j.ajhg.2011.03.012
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511
   Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981
   Biesecker LG, 2014, CURR OPIN PEDIATR, V26, P639, DOI 10.1097/MOP.0000000000000150
   Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424
   Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327
   Bizzotto S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00030
   Blaeser A, 2013, HUM GENET, V132, P923, DOI 10.1007/s00439-013-1302-7
   Bock HH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00166
   Bonneau D, 2002, ANN NEUROL, V51, P340, DOI 10.1002/ana.10119
   Booler HS, 2016, BRAIN PATHOL, V26, P465, DOI 10.1111/bpa.12306
   Borrell V, 1999, J NEUROSCI, V19, P1345
   Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007
   Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400
   Boyd JL, 2015, CURR BIOL, V25, P772, DOI 10.1016/j.cub.2015.01.041
   Bradshaw NJ, 2017, CELL MOL LIFE SCI, V74, P1191, DOI 10.1007/s00018-016-2395-7
   Breuss M, 2016, DEVELOPMENT, V143, P1126, DOI 10.1242/dev.131516
   Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017
   Broix L, 2016, NAT GENET, V48, P1349, DOI 10.1038/ng.3676
   Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582
   Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021
   Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Campeau PM, 2013, AM J HUM GENET, V92, P781, DOI 10.1016/j.ajhg.2013.03.020
   Cappello S, 2013, NAT GENET, V45, P1300, DOI 10.1038/ng.2765
   Cappello S, 2012, NEURON, V73, P911, DOI 10.1016/j.neuron.2011.12.030
   Carpanini SM, 2014, DIS MODEL MECH, V7, P711, DOI 10.1242/dmm.015222
   Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885
   Cho G, 2014, DEV BIOL, V393, P137, DOI 10.1016/j.ydbio.2014.06.012
   Colasante G, 2015, CEREB CORTEX, V25, P322, DOI 10.1093/cercor/bht222
   Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003
   Colombo E, 2007, J NEUROSCI, V27, P4786, DOI 10.1523/JNEUROSCI.0417-07.2007
   Conti V, 2013, BRAIN, V136, P3378, DOI 10.1093/brain/awt249
   Corbo JC, 2002, J NEUROSCI, V22, P7548
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cushion TD, 2014, AM J HUM GENET, V94, P634, DOI 10.1016/j.ajhg.2014.03.009
   Cushion TD, 2013, BRAIN, V136, P536, DOI 10.1093/brain/aws338
   D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0
   de Juan Romero C, 2015, EMBO J, V34, P1859, DOI 10.15252/embj.201591176
   de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524
   deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6
   Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514
   des Portes V, 1998, CELL, V92, P51
   Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038
   Di Costanzo S, 2014, HUM MOL GENET, V23, P5781, DOI 10.1093/hmg/ddu296
   Di Donato N, 2014, EUR J HUM GENET, V22, P179, DOI 10.1038/ejhg.2013.130
   Di Donato N, 2016, AM J HUM GENET, V99, P1117, DOI 10.1016/j.ajhg.2016.09.010
   Dillon GM, 2017, NEURON, V93, P1344, DOI 10.1016/j.neuron.2017.02.039
   DOBYNS WB, 1991, AM J HUM GENET, V48, P584
   Dobyns WB, 1993, GENEREVIEWS
   Doobin DJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12551
   Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681
   Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101
   Eksioglu YZ, 2011, EPILEPSIA, V52, P984, DOI 10.1111/j.1528-1167.2011.02980.x
   Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208
   Endo Y, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000033
   Fallet-Bianco C, 2008, BRAIN, V131, P2304, DOI 10.1093/brain/awn155
   Faria LC, 2017, NEUROBIOL DIS, V102, P70, DOI 10.1016/j.nbd.2017.01.009
   Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020
   Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104
   Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023
   Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377
   Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109
   Filges I, 2016, HUM MUTAT, V37, P711, DOI 10.1002/humu.22997
   Flores-Sarnat L, 2003, J CHILD NEUROL, V18, P776, DOI 10.1177/08830738030180111101
   Florio M, 2017, CURR OPIN NEUROBIOL, V42, P33, DOI 10.1016/j.conb.2016.11.004
   Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975
   Forman MS, 2005, J NEUROPATH EXP NEUR, V64, P847, DOI 10.1097/01.jnen.0000182978.56612.41
   Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0
   Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x
   Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1
   Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003
   Freeman MR, 2013, NEURON, V80, P613, DOI 10.1016/j.neuron.2013.10.034
   Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620
   Friocourt G, 2007, J NEUROSCI, V27, P3875, DOI 10.1523/JNEUROSCI.4530-06.2007
   Friocourt G, 2011, ACTA NEUROPATHOL, V121, P149, DOI 10.1007/s00401-010-0768-9
   Fry AE, 2014, AM J MED GENET C, V166, P198, DOI 10.1002/ajmg.c.31402
   Fujii Y, 2014, BRAIN DEV-JPN, V36, P528, DOI 10.1016/j.braindev.2013.07.015
   Fujimori A, 2014, BRAIN DEV-JPN, V36, P661, DOI 10.1016/j.braindev.2013.10.006
   Fullston T, 2011, CLIN GENET, V80, P510, DOI 10.1111/j.1399-0004.2011.01685.x
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gambello MJ, 2003, J NEUROSCI, V23, P1719
   Gao P, 2013, DEVELOPMENT, V140, P2645, DOI 10.1242/dev.087668
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130
   Geis T, 2013, NEUROGENETICS, V14, P205, DOI 10.1007/s10048-013-0374-9
   Gelineau-Morel R, 2016, GENES-BASEL, V7, DOI 10.3390/genes7100085
   Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12
   Germanaud D, 2014, NEUROIMAGE, V102, P317, DOI 10.1016/j.neuroimage.2014.07.057
   Gil-Sanz C, 2014, J NEUROSCI, V34, P10475, DOI 10.1523/JNEUROSCI.1793-14.2014
   GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463
   Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043
   Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5
   GOFFINET AM, 1992, INT J DEV BIOL, V36, P101
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Grandone A, 2016, CLIN GENET, V90, P445, DOI 10.1111/cge.12771
   Grewal PK, 2002, BBA-GEN SUBJECTS, V1573, P216, DOI 10.1016/S0304-4165(02)00387-2
   Grzmil P, 2010, INT J DEV BIOL, V54, P1259, DOI 10.1387/ijdb.092959pg
   Guerrini R, 2005, J CHILD NEUROL, V20, P287, DOI 10.1177/08830738050200040401
   Guerrini R, 2014, LANCET NEUROL, V13, P710, DOI 10.1016/S1474-4422(14)70040-7
   Guerrini R, 2012, EUR J HUM GENET, V20, P995, DOI 10.1038/ejhg.2012.21
   Guven A, 2012, NEUROGENETICS, V13, P189, DOI 10.1007/s10048-012-0326-9
   Ha S, 2017, J NEUROSCI, V37, P960, DOI 10.1523/JNEUROSCI.1826-16.2016
   Hamada N, 2017, J NEUROCHEM, V140, P82, DOI 10.1111/jnc.13878
   Handley MT, 2013, HUM MUTAT, V34, P686, DOI 10.1002/humu.22296
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939
   Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168
   HATTORI M, 1994, J BIOL CHEM, V269, P23150
   Haverfield EV, 2009, EUR J HUM GENET, V17, P911, DOI 10.1038/ejhg.2008.213
   He SJ, 2015, NEURON, V86, P1159, DOI 10.1016/j.neuron.2015.05.002
   Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0
   Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2
   Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027
   Hirotsune S, 1998, NAT GENET, V19, P333
   Holzfeind PJ, 2002, HUM MOL GENET, V11, P2673, DOI 10.1093/hmg/11.21.2673
   Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1
   Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246
   Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9
   Houlihan SL, 2016, ELIFE, V5, DOI 10.7554/eLife.17823
   Hu WF, 2014, NEURON, V84, P1240, DOI 10.1016/j.neuron.2014.12.017
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117
   Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721
   Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003
   Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380
   Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709
   Jamuar SS, 2014, NEW ENGL J MED, V371, P2038, DOI 10.1056/NEJMc1411784
   Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432
   Jamuar SS, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0031-5
   Jayaraman D, 2016, NEURON, V92, P813, DOI 10.1016/j.neuron.2016.09.056
   Jerber J, 2016, AM J HUM GENET, V99, P1181, DOI 10.1016/j.ajhg.2016.09.007
   Jin MY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39902
   Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980
   Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063
   Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062
   Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170
   Kato M, 2005, J CHILD NEUROL, V20, P392, DOI 10.1177/08830738050200042001
   Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310
   Kato M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00181
   Kawano H, 1999, J COMP NEUROL, V408, P147, DOI 10.1002/(SICI)1096-9861(19990531)408:2<147::AID-CNE1>3.0.CO;2-L
   Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017
   Kerjan G, 2009, P NATL ACAD SCI USA, V106, P6766, DOI 10.1073/pnas.0812687106
   Khalaf-Nazzal R, 2017, HUM MOL GENET, V26, P90, DOI 10.1093/hmg/ddw370
   Khalifa O, 2015, EUR J MED GENET, V58, P293, DOI 10.1016/j.ejmg.2014.12.008
   Kia SK, 2012, AM J HUM GENET, V91, P533, DOI 10.1016/j.ajhg.2012.07.008
   Kielar M, 2014, NAT NEUROSCI, V17, P923, DOI 10.1038/nn.3729
   Kielbinski M, 2016, NEUROPATH APPL NEURO, V42, P593, DOI 10.1111/nan.12331
   Kim MH, 2004, STRUCTURE, V12, P987, DOI 10.1016/j.str.2004.03.024
   Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009
   Kobayashi K, 1998, NATURE, V394, P388
   Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040
   Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704
   Komuro H, 1998, J NEUROSCI, V18, P1478
   Kortum F, 2011, J MED GENET, V48, P396, DOI 10.1136/jmg.2010.087528
   Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001
   Kumar RA, 2010, HUM MOL GENET, V19, P2817, DOI 10.1093/hmg/ddq182
   Labelle-Dumais C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002062
   Lambert de Rouvroit C, 1998, CELL BIOL, V150
   LaMonica BE, 2012, CURR OPIN NEUROBIOL, V22, P747, DOI 10.1016/j.conb.2012.03.006
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lange L, 2016, CLIN GENET, V90, P258, DOI 10.1111/cge.12773
   Laquerriere A, 2016, EUR J MED GENET, V59, P249, DOI 10.1016/j.ejmg.2015.12.007
   Lee GH, 2014, J BIOL CHEM, V289, P20307, DOI 10.1074/jbc.M114.576249
   Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329
   Leemhuis J, 2010, J NEUROSCI, V30, P14759, DOI 10.1523/JNEUROSCI.4036-10.2010
   Leventer Richard J, 2008, Dialogues Clin Neurosci, V10, P47
   Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li J, 2005, NAT CELL BIOL, V7, P686, DOI 10.1038/ncb1273
   Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008
   Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449
   Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003
   LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157
   Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108
   Lysko DE, 2014, J NEUROSCI, V34, P4941, DOI 10.1523/JNEUROSCI.4351-12.2014
   Lysko DE, 2011, J NEUROSCI, V31, P1739, DOI 10.1523/JNEUROSCI.3118-10.2011
   Maeta K, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0142-16.2016
   Magen D, 2015, HUM GENET, V134, P305, DOI 10.1007/s00439-014-1522-5
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P178, DOI 10.1002/uog.3906
   Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110
   Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009
   Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006
   Marcorelles P, 2010, ACTA NEUROPATHOL, V120, P503, DOI 10.1007/s00401-010-0692-z
   Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058
   Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155
   MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920
   Marques I, 2015, MOL GENET GENOM MED, V3, P203, DOI 10.1002/mgg3.133
   Marsh E, 2009, BRAIN, V132, P1563, DOI 10.1093/brain/awp107
   Marsh ED, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0265-8
   Matsumoto N, 2001, EUR J HUM GENET, V9, P5, DOI 10.1038/sj.ejhg.5200548
   McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035
   Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062
   Meyer G, 2000, J NEUROSCI, V20, P1858
   Meyer KA, 2017, MOL BIOL EVOL, V34, P1217, DOI 10.1093/molbev/msx076
   Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837
   Mirzaa GM, 2016, JAMA NEUROL, V73, P836, DOI 10.1001/jamaneurol.2016.0363
   Mirzaa GM, 2015, LANCET NEUROL, V14, P1182, DOI 10.1016/S1474-4422(15)00278-1
   Mirzaa GM, 2014, NAT GENET, V46, P510, DOI 10.1038/ng.2948
   Mishra-Gorur K, 2014, NEURON, V84, P1226, DOI 10.1016/j.neuron.2014.12.014
   Miyata R, 2009, BRAIN DEV-JPN, V31, P456, DOI 10.1016/j.braindev.2008.08.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moey C, 2016, EUR J HUM GENET, V24, P681, DOI 10.1038/ejhg.2015.176
   Moller RS, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000118
   Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151
   Moon HM, 2014, HUM MOL GENET, V23, P449, DOI 10.1093/hmg/ddt436
   Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838
   Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919
   Mori N, 2012, AM J PATHOL, V180, P314, DOI 10.1016/j.ajpath.2011.09.014
   Morris-Rosendahl DJ, 2008, CLIN GENET, V74, P425, DOI 10.1111/j.1399-0004.2008.01093.x
   Morris-Rosendahl DJ, 2010, EUR J HUM GENET, V18, P1100, DOI 10.1038/ejhg.2010.79
   Muller M, 2011, NEURON, V69, P749, DOI 10.1016/j.neuron.2011.01.025
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Murdock DR, 2011, AM J MED GENET A, V155A, P2071, DOI 10.1002/ajmg.a.34165
   Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967
   Nakagawa N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11163
   Nakamura Kazuyuki, 2015, Pediatr Neurol, V52, pe7, DOI 10.1016/j.pediatrneurol.2015.01.019
   Nakayama T, 2015, DEV BIOL, V408, P328, DOI 10.1016/j.ydbio.2015.02.012
   Nellist M, 2015, MOL GENET METAB, V114, P467, DOI 10.1016/j.ymgme.2014.11.018
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682
   Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1
   Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005
   Nosten-Bertrand M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002473
   Novorol C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130065
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Donnell L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002698
   Oda H, 2016, EUR J HUM GENET, V24, P408, DOI 10.1038/ejhg.2015.119
   Oegema R, 2012, AM J MED GENET A, V158A, P1472, DOI 10.1002/ajmg.a.35365
   Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173
   Okazaki S, 2008, ACTA NEUROPATHOL, V116, P453, DOI 10.1007/s00401-008-0382-2
   Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pancoast M, 2005, ACTA NEUROPATHOL, V109, P400, DOI 10.1007/s00401-004-0979-z
   Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125
   Pawlisz AS, 2008, HUM MOL GENET, V17, P2441, DOI 10.1093/hmg/ddn144
   Peddibhotla S, 2015, EUR J HUM GENET, V23, P54, DOI 10.1038/ejhg.2014.51
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petit LF, 2014, ANN NEUROL, V76, P428, DOI 10.1002/ana.24237
   Philbert M, 2017, AM J MED GENET A, V173, P561, DOI 10.1002/ajmg.a.38041
   Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780
   Pilz DT, 1999, HUM MOL GENET, V8, P1757, DOI 10.1093/hmg/8.9.1757
   Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524
   Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010
   Poirier K, 2008, EPILEPSY RES, V80, P224, DOI 10.1016/j.eplepsyres.2008.03.019
   Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572
   Poirier K, 2015, EUR J MED GENET, V58, P416, DOI 10.1016/j.ejmg.2015.06.006
   Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613
   Poirier K, 2013, EUR J HUM GENET, V21, P381, DOI 10.1038/ejhg.2012.195
   Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Poulton CJ, 2011, AM J HUM GENET, V89, P265, DOI 10.1016/j.ajhg.2011.07.006
   Pramparo T, 2010, J NEUROSCI, V30, P3002, DOI 10.1523/JNEUROSCI.4851-09.2010
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ramalho F.S., 2017, CLIN INFECT DIS
   REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0
   Reiner O, 2013, CURR OPIN NEUROBIOL, V23, P951, DOI 10.1016/j.conb.2013.08.001
   Riemersma M, 2015, NEUROLOGY, V84, P2177, DOI 10.1212/WNL.0000000000001615
   Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331
   Rodan LH, 2017, J CHILD NEUROL, V32, P127, DOI 10.1177/0883073816672998
   Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035
   Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640
   Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253
   Ross ME, 2001, NEUROPEDIATRICS, V32, P256, DOI 10.1055/s-2001-19120
   Rossi M, 2003, NEUROPEDIATRICS, V34, P287
   Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611
   Royer-Zemmour B, 2008, HUM MOL GENET, V17, P3617, DOI 10.1093/hmg/ddn256
   RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143
   Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601
   Ruzzo EK, 2013, NEURON, V80, P429, DOI 10.1016/j.neuron.2013.08.013
   Saillour Y, 2014, HUM MOL GENET, V23, P1516, DOI 10.1093/hmg/ddt538
   Saillour Y, 2009, ARCH NEUROL-CHICAGO, V66, P1007, DOI 10.1001/archneurol.2009.149
   Sakane A, 2006, P NATL ACAD SCI USA, V103, P10029, DOI 10.1073/pnas.0600304103
   Salmi M, 2013, BRAIN, V136, P2457, DOI 10.1093/brain/awt161
   Sanchez J.D., 2017, REGIONAL ZIKA EPIDEM
   Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024
   Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X
   Satyanarayana A, 2010, BLOOD, V116, P2921, DOI 10.1182/blood-2010-01-262964
   Schlotawa L, 2013, J NEUROL, V260, P1678, DOI 10.1007/s00415-013-6941-z
   Schmahl W., 1997, DEV CAMB ENGL, V124, P5087
   Schmid MT, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00215
   Seidahmed MZ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0633-0
   Senturk A, 2011, NATURE, V472, P356, DOI 10.1038/nature09874
   Sgourdou P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43708
   Shaheen R, 2013, NEUROGENETICS, V14, P243, DOI 10.1007/s10048-013-0367-8
   Shamseldin H, 2015, AM J HUM GENET, V97, P862, DOI 10.1016/j.ajhg.2015.10.012
   Shawlot W, 1998, TRANSGENIC RES, V7, P95, DOI 10.1023/A:1008816308171
   Sheeman B., 2005, CURR BIOL CB, V13, P686
   Sheen VL, 2003, NEUROLOGY, V60, P1108, DOI 10.1212/01.WNL.0000055898.00349.02
   Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276
   Sheen VL, 2014, TISSUE BARRIERS, V2, DOI 10.1523/JNEUROSCI.1939-13.2013
   Sheridan E, 2013, LANCET, V382, P1350, DOI 10.1016/S0140-6736(13)61132-0
   Sherr EH, 2003, CURR OPIN PEDIATR, V15, P567, DOI 10.1097/00008480-200312000-00004
   Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041
   Shibata M, 2015, TRENDS GENET, V31, P77, DOI 10.1016/j.tig.2014.12.004
   Shoubridge Cheryl, 2010, Pathogenetics, V3, P1, DOI 10.1186/1755-8417-3-1
   Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030
   Simonet JC, 2015, CEREB CORTEX, V25, P2939, DOI 10.1093/cercor/bhu090
   Sisodiya SM, 2000, BRAIN, V123, P1075, DOI 10.1093/brain/123.6.1075
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010
   Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016
   Stottmann RW, 2013, HUM MOL GENET, V22, P4053, DOI 10.1093/hmg/ddt255
   Stouffer MA, 2016, NEUROBIOL DIS, V92, P18, DOI 10.1016/j.nbd.2015.08.003
   Tabata H, 2003, J NEUROSCI, V23, P9996
   Tabata H, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00114
   Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418
   Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tao H, 2011, AM J HUM GENET, V88, P138, DOI 10.1016/j.ajhg.2010.12.012
   Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801
   Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200
   Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011
   Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113
   Tokuda S, 2011, HUM MOL GENET, V20, P988, DOI 10.1093/hmg/ddq544
   Toropova K, 2014, ELIFE, V3, DOI 10.7554/eLife.03372
   Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169
   Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934
   Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166
   Ueki K, 2002, P NATL ACAD SCI USA, V99, P419, DOI 10.1073/pnas.012581799
   Valence S, 2016, CLIN GENET, V90, P545, DOI 10.1111/cge.12779
   van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963
   van Reeuwijk J, 2007, HUM GENET, V121, P685, DOI 10.1007/s00439-007-0362-y
   vanderKnaap MS, 1997, ANN NEUROL, V42, P50, DOI 10.1002/ana.410420110
   Vandervore L., 2017, J MED GENET
   Vergult S, 2015, EUR J HUM GENET, V23, P628, DOI 10.1038/ejhg.2014.141
   Verloes A, 2015, EUR J HUM GENET, V23, P292, DOI 10.1038/ejhg.2014.95
   Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708
   von Renesse A, 2014, J MED GENET, V51, P275, DOI 10.1136/jmedgenet-2013-102236
   Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009
   Wallerstein R, 2008, CLIN NEUROL NEUROSUR, V110, P631, DOI 10.1016/j.clineuro.2008.03.007
   Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807
   Waters AM, 2015, J MED GENET, V52, P147, DOI 10.1136/jmedgenet-2014-102691
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
   Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542
   Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101
   Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252
   Wright KM, 2012, NEURON, V76, P931, DOI 10.1016/j.neuron.2012.10.009
   Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x
   Xu D, 2014, CELL REP, V6, P104, DOI 10.1016/j.celrep.2013.12.016
   Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182
   Yamamoto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080356
   Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005
   Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601
   Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555
   Yanpallewar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32957
   Yap CC, 2016, J BIOL CHEM, V291, P26613, DOI 10.1074/jbc.M116.760777
   Yokoi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15165
   Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3
   Youn YH, 2009, J NEUROSCI, V29, P15520, DOI 10.1523/JNEUROSCI.4630-09.2009
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683
   Yuba-Kubo A, 2005, DEV BIOL, V282, P361, DOI 10.1016/j.ydbio.2005.03.031
   Yun EJ, 2012, ANAT REC, V295, P167, DOI 10.1002/ar.21475
   Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714
   Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhang XC, 2016, CELL, V166, P1147, DOI 10.1016/j.cell.2016.07.025
NR 403
TC 31
Z9 32
U1 1
U2 22
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-9521
J9 SEMIN CELL DEV BIOL
JI Semin. Cell Dev. Biol.
PD APR
PY 2018
VL 76
BP 33
EP 75
DI 10.1016/j.semcdb.2017.09.031
PG 43
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA GA0SR
UT WOS:000428025000005
PM 28951247
DA 2020-07-08
ER

PT J
AU Duerinckx, S
   Abramowicz, M
AF Duerinckx, Sarah
   Abramowicz, Marc
TI The genetics of congenitally small brains
SO SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE Intellectual disability; Congenital malformation; Brain development;
   Centriole; Complex inheritance
ID DNA-DAMAGE RESPONSE; WD40-REPEAT PROTEIN 62; CITRON KINASE; CHROMATID
   SEPARATION; DIGENIC INHERITANCE; PRIMORDIAL DWARFISM; BIALLELIC
   MUTATIONS; NEURAL PROGENITORS; PROLONGED MITOSIS; SECKEL-SYNDROME
AB Primary microcephaly (PM) refers to a congenitally small brain, resulting from insufficient prenatal production of neurons, and serves as a model disease for brain volumic development. Known PM genes delineate several cellular pathways, among which the centriole duplication pathway, which provide interesting clues about the cellular mechanisms involved. The general interest of the genetic dissection of PM is illustrated by the convergence of Zika virus infection and PM gene mutations on congenital microcephaly, with CENPJ/CPAP emerging as a key target. Physical (protein-protein) and genetic (digenic inheritance) interactions of Wdr62 and Aspm have been demonstrated in mice, and should now be sought in humans using high throughput parallel sequencing of multiple PM genes in PM patients and control subjects, in order to categorize mutually interacting genes, hence delineating functional pathways in vivo in humans. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Duerinckx, Sarah; Abramowicz, Marc] Univ Libre Bruxelles, IRIBHM, Campus Erasme,CP602,Route Lennik 808, B-1070 Brussels, Belgium.
   [Abramowicz, Marc] Univ Libre Bruxelles, Hop Erasme, Dept Med Genet, Route Lennik 808, B-1070 Brussels, Belgium.
RP Duerinckx, S (corresponding author), Univ Libre Bruxelles, IRIBHM, Campus Erasme,CP602,Route Lennik 808, B-1070 Brussels, Belgium.
EM saduerin@ulb.ac.be; marcabra@ulb.ac.be
OI Abramowicz, Marc/0000-0003-0623-8768
FU ERA-net E-Rare; Fonds de la Recherche Scientifique fnrs-frs,
   BelgiumFonds de la Recherche Scientifique - FNRS; Fonds Erasme
   convention Jean Van Damme
FX This work is supported by ERA-net E-Rare, the Fonds de la Recherche
   Scientifique fnrs-frs, Belgium, and the Fonds Erasme convention Jean Van
   Damme.
CR Abdel-Salam GMH, 2012, AM J MED GENET A, V158A, P2788, DOI 10.1002/ajmg.a.35583
   Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313
   Awad S, 2013, HUM MOL GENET, V22, P2200, DOI 10.1093/hmg/ddt072
   Barbelanne M, 2014, BIOMED RES INT, DOI 10.1155/2014/547986
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bianchi FT, 2017, CELL REP, V18, P1674, DOI 10.1016/j.celrep.2017.01.054
   Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776
   Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327
   Bober M. B., 2017, CURR OSTEOPOROS REP, P1
   Bogoyevitch MA, 2012, J CELL SCI, V125, P5096, DOI 10.1242/jcs.107326
   Bohers E, 2008, HUM GENET, V124, P473, DOI 10.1007/s00439-008-0572-y
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Brooks SS, 2014, GENETICS, V198, P723, DOI 10.1534/genetics.114.168211
   BROWN AI, 2014, PLOS COMPUT BIOL, V10, DOI DOI 10.1371/JOURNAL.PONE.0091222
   Brown NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069986
   Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036
   Capecchi MR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9763
   Carvalho CMB, 2014, AM J HUM GENET, V95, P565, DOI 10.1016/j.ajhg.2014.10.006
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Cottee MA, 2013, ELIFE, V2, DOI 10.7554/eLife.01071
   de Munnik SA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0322-x
   Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059
   Delepine M, 2000, NAT GENET, V25, P406
   Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103
   Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gabriel E, 2016, EMBO J, V35, P803, DOI 10.15252/embj.201593679
   Gazzo AM, 2016, NUCLEIC ACIDS RES, V44, pD900, DOI 10.1093/nar/gkv1068
   Genin A, 2012, HUM MOL GENET, V21, P5306, DOI 10.1093/hmg/dds386
   Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091
   Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80
   Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342
   Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311
   Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449
   Harley ME, 2016, NAT GENET, V48, P36, DOI 10.1038/ng.3451
   Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006
   Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016
   Igoillo-Esteve M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003888
   Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831
   Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909
   Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640
   Jayaraman D, 2016, NEURON, V92, P813, DOI 10.1016/j.neuron.2016.09.056
   Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595
   Julier C, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-29
   Kakar N, 2015, HUM GENET, V134, P45, DOI 10.1007/s00439-014-1487-4
   Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725
   Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156
   Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525
   Khan MA, 2014, HUM MOL GENET, V23, P5940, DOI 10.1093/hmg/ddu318
   Kim HT, 2011, BIOCHEM BIOPH RES CO, V409, P640, DOI 10.1016/j.bbrc.2011.05.056
   Kodani A, 2015, ELIFE, V4, DOI 10.7554/eLife.07519
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, AM J HUM GENET, V99, P501, DOI 10.1016/j.ajhg.2016.07.004
   Li Y, 2017, ACCIDENT ANAL PREV, V104, P137, DOI 10.1016/j.aap.2017.04.025
   Lim NR, 2016, CELL CYCLE, V15, P413, DOI 10.1080/15384101.2015.1127472
   Lim NR, 2015, J CELL SCI, V128, P527, DOI 10.1242/jcs.157537
   Lin Y.-C., 2013, SCI WORLD J, V2013, P10, DOI DOI 10.1109/TKDE.2013.19
   Liu XQ, 2016, ACTA BIOCH BIOPH SIN, V48, P678, DOI 10.1093/abbs/gmw048
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Lupski JR, 2012, NAT GENET, V44, P1291, DOI 10.1038/ng.2479
   Maciejczyk M, 2017, REDOX BIOL, V11, P375, DOI 10.1016/j.redox.2016.12.030
   Marthiens V, 2014, CURR BIOL, V24, pR162, DOI 10.1016/j.cub.2013.12.054
   Martin CA, 2016, GENE DEV, V30, P2158, DOI 10.1101/gad.286351.116
   Matsuura S, 2006, AM J MED GENET A, V140A, P358, DOI 10.1002/ajmg.a.31069
   Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007
   Mirzaa GM, 2014, HUM GENET, V133, P1023, DOI 10.1007/s00439-014-1443-3
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mouden C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117418
   Murray JE, 2014, HUM MUTAT, V35, P76, DOI 10.1002/humu.22461
   Nair AR, 2016, CELL REP, V14, P1100, DOI 10.1016/j.celrep.2015.12.097
   Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518
   Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241
   Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682
   Novorol C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130065
   O'Driscoll M., MOL CELL, V8
   Ogi T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002945
   Olmezer G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13157
   OMIM-Online Mendelian Inheritance in Man OMIM, MCKUSICK NATH I GEN
   Pagan JK, 2015, NAT CELL BIOL, V17, P31, DOI 10.1038/ncb3076
   Paridaen JTML, 2013, CELL, V155, P333, DOI 10.1016/j.cell.2013.08.060
   Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910
   Payne F, 2014, J CLIN INVEST, V124, P4028, DOI 10.1172/JCI73264
   Pilaz LJ, 2016, NEURON, V89, P83, DOI 10.1016/j.neuron.2015.12.007
   Poulton CJ, 2011, AM J HUM GENET, V89, P265, DOI 10.1016/j.ajhg.2011.07.006
   Pulvers J. N., 2015, FRONT CELL NEUROSCI, V9
   Qvist P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002310
   Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174
   Reynolds JJ, 2017, NAT GENET, V49, P537, DOI 10.1038/ng.3790
   Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718
   Rollins JD, 2010, J PEDIATR-US, V156, P907, DOI 10.1016/j.jpeds.2010.01.009
   Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431
   Schaffer AA, 2013, J MED GENET, V50, P641, DOI 10.1136/jmedgenet-2013-101713
   Schawalder J, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-15
   Sgourdou P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43708
   Sgro F, 2016, CELL DEATH DIFFER, V23, P801, DOI 10.1038/cdd.2015.142
   Shalev SA, 2014, PEDIATR DIABETES, V15, P252, DOI 10.1111/pedi.12086
   Shanske A, 1997, AM J MED GENET, V70, P155, DOI 10.1002/(SICI)1096-8628(19970516)70:2<155::AID-AJMG10>3.0.CO;2-I
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Singh N, 2012, P NATL ACAD SCI USA, V109, P14381, DOI 10.1073/pnas.1212366109
   Singh N, 2012, J BIOL CHEM, V287, P2854, DOI 10.1074/jbc.M111.307868
   Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971
   Stiff T, 2016, HUM MOL GENET, V25, P1574, DOI 10.1093/hmg/ddw034
   Szczepanski S, 2016, HUM GENET, V135, P157, DOI 10.1007/s00439-015-1619-5
   Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TOLMIE JL, 1987, AM J MED GENET, V27, P583, DOI 10.1002/ajmg.1320270311
   Verloes A., 1993, GENEREVIEWS
   Vertii A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a025049
   Wilsch-Brauninger M, 2016, CURR OPIN NEUROBIOL, V39, P122, DOI 10.1016/j.conb.2016.05.004
   Woods CG, 2014, CURR BIOL, V24, pR1109, DOI 10.1016/j.cub.2014.09.063
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002
   Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128
   Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043
   Yin Linlin, 2015, Methods Mol Biol, V1332, P205, DOI 10.1007/978-1-4939-2917-7_16
   Yiu WH, 2004, GENE, V337, P37, DOI 10.1016/j.gene.2004.04.033
   Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897
   Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005
NR 122
TC 14
Z9 14
U1 2
U2 15
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-9521
J9 SEMIN CELL DEV BIOL
JI Semin. Cell Dev. Biol.
PD APR
PY 2018
VL 76
BP 76
EP 85
DI 10.1016/j.semcdb.2017.09.015
PG 10
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA GA0SR
UT WOS:000428025000006
PM 28912110
DA 2020-07-08
ER

PT J
AU de Souza, LEC
   de Lima, TJS
   Ribeiro, E
   Pessoa, ALS
   Figueiredo, TC
   Lima, LBP
AF Cunha de Souza, Luana Elayne
   Souza de Lima, Tiago Jesse
   Ribeiro, Erlane Marques
   Santos Pessoa, Andre Luiz
   Figueiredo, Thamyres Costa
   Porto Lima, Luiza Barbosa
TI Mental Health of Parents of Children with Congenital Zika Virus Syndrome
   in Brazil
SO JOURNAL OF CHILD AND FAMILY STUDIES
LA English
DT Article
DE Parents; Mental health; Fatigue; Microcephaly; Zika virus congenital
   syndrome
ID QUALITY-OF-LIFE; AUTISM SPECTRUM DISORDER; DEPRESSIVE SYMPTOMS;
   CEREBRAL-PALSY; MOTHERS; FATIGUE; FATHERS; STRESS; PROGRAM
AB This study aims to analyze the potential impact of taking care of a child with congenital Zika virus syndrome (CZS) on the mental health of parents. Specifically, three objectives were formulated: (a) to assess the level of mental health of the parents; (b) to examine the influence of subjective well-being and fatigue as predictors of parents' mental health; and (c) to identify the impact of sociodemographic variables on parents' mental health. Sixty-nine mothers (M-age = 26.38; SD = 6.23) and 17 fathers (M-age = 31.41; SD = 7.57) of children diagnosed with CZS took part in this study. They answered a questionnaire containing measures of positive and negative affects, life satisfaction, fatigue, mental health, as well as sociodemographic questions. The results indicated that approximately 7% of the participants had low levels of mental health and probable emotional disorder. In addition, higher levels of fatigue and negative affects and lower levels of life satisfaction significantly predict a lower level of mental health. Finally, comparative analysis showed significant differences between fathers and mothers: mothers reported experiencing fewer positive and more negative affects, a lower level of satisfaction with life, a higher level of fatigue and worse mental health. In summary, this article presents an overview of the mental health of mothers and fathers of children with CZS and points the way to devising strategies for psychological intervention that promote the adaptation of parents to this kind of developmental disability in the family.
C1 [Cunha de Souza, Luana Elayne; Souza de Lima, Tiago Jesse; Figueiredo, Thamyres Costa; Porto Lima, Luiza Barbosa] Univ Fortaleza, Fortaleza, Ceara, Brazil.
   [Ribeiro, Erlane Marques; Santos Pessoa, Andre Luiz] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Ribeiro, Erlane Marques] UNICHRISTUS, Fac Med, Fortaleza, Ceara, Brazil.
RP de Lima, TJS (corresponding author), Univ Fortaleza, Fortaleza, Ceara, Brazil.
EM tiago.souzalima@hotmail.com
RI Lima, Tiago Jesse Sousa/F-9845-2011
OI Lima, Tiago Jesse Sousa/0000-0001-8840-4285
FU Institutional Review Board of Albert Sabin Children's Hospital in
   Fortaleza, Brazil [1.743.023]
FX All procedures performed in this study involving human participants were
   in accordance with the ethical standards of the institutional and/or
   national research committee and with the 1964 Helsinki declaration and
   its later amendments or comparable ethical standards. This study is part
   of a larger project that has been approved by the Institutional Review
   Board of Albert Sabin Children's Hospital in Fortaleza, Brazil
   (registration number: 1.743.023).
CR Barlow JH, 2006, EARLY CHILD DEV CARE, V176, P421, DOI 10.1080/0300443042000313403
   Borsa JC, 2011, PSICOLOGIA ARGUMENTO, V29, P31
   Cheshire A, 2010, DISABIL REHABIL, V32, P1673, DOI 10.3109/09638281003649920
   Cohen J., 1988, STAT POWER ANAL BEHA
   Dabrowska A, 2010, J INTELL DISABIL RES, V54, P266, DOI 10.1111/j.1365-2788.2010.01258.x
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Freitas P. M, 2014, ESTUDOS PESQUISAS PS, V14, P453
   Garip Y, 2017, DISABIL REHABIL, V39, P757, DOI 10.3109/09638288.2016.1161837
   Gatzoyia D, 2014, DISABIL HEALTH J, V7, P173, DOI 10.1016/j.dhjo.2013.10.008
   Gerardin P, 2017, LANCET, V389, P151, DOI 10.1016/S0140-6736(17)30014-4
   Giacomoni C. H, 1997, SIP AN 26 C INT PSIC, P313
   Giallo R, 2010, J REPROD, V29, P69, DOI DOI 10.1080/02646838.2010
   Giallo R, 2013, AUTISM, V17, P465, DOI 10.1177/1362361311416830
   GOLDBERG DP, 1988, USERS GUIDE GEN HLTH
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   Gouveia V. V, 2015, REV PSICOLOGIA ORG T, V15, P246, DOI DOI 10.17652/RPOT/2015.3.594
   Gouveia VV, 2012, CAD SAUDE PUBLICA, V28, P375, DOI 10.1590/S0102-311X2012000200016
   Guillamon N, 2013, J CLIN NURS, V22, P1579, DOI 10.1111/jocn.12124
   Hastings RP, 2003, J INTELL DISABIL RES, V47, P231, DOI 10.1046/j.1365-2788.2003.00485.x
   Hox J, 2010, MULTILEVEL ANAL TECH
   Khayamim Nafiseh, 2016, Iran J Nurs Midwifery Res, V21, P385, DOI 10.4103/1735-9066.185580
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Mak WWS, 2010, SOC SCI MED, V70, P2045, DOI 10.1016/j.socscimed.2010.02.023
   McCarthy A, 2006, RES DEV DISABIL, V27, P688, DOI 10.1016/j.ridd.2005.10.002
   Michielsen HJ, 2004, EUR J PSYCHOL ASSESS, V20, P39, DOI 10.1027/1015-5759.20.1.39
   Michielsen HJ, 2003, J PSYCHOSOM RES, V54, P345, DOI 10.1016/S0022-3999(02)00392-6
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CM, 2016, JAMA PEDIAT, V2016, pE1, DOI DOI 10.1001/JAMAPEDIA
   Pozo P, 2014, J INTELL DISABIL RES, V58, P442, DOI 10.1111/jir.12042
   Runquist JJ, 2007, ARCH WOMEN MENT HLTH, V10, P267, DOI 10.1007/s00737-007-0208-6
   Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68
   de Souza LAS, 2014, CAD SAUDE PUBLICA, V30, P2309, DOI 10.1590/0102-311X00177513
   Seltzer MM, 2009, J HEALTH SOC BEHAV, V50, P1, DOI 10.1177/002214650905000101
   Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593
   Smith LE, 2010, J AUTISM DEV DISORD, V40, P167, DOI 10.1007/s10803-009-0844-y
   Tonge B, 2006, J AM ACAD CHILD PSY, V45, P561, DOI 10.1097/01.chi.0000205701.48324.26
   Totsika V, 2011, J CHILD PSYCHOL PSYC, V52, P91, DOI 10.1111/j.1469-7610.2010.02295.x
   Van Der Veek SMC, 2009, J INTELLECT DEV DIS, V34, P216, DOI 10.1080/13668250903093133
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   Wood W., 2010, HDB SOCIAL PSYCHOL, V1, P629, DOI DOI 10.1002/9780470561119.S0CPSY001017
   Woyciekoski C, 2012, PSICO, V43, P280
   Yang CM, 2005, QUAL LIFE RES, V14, P1357, DOI 10.1007/s11136-004-5680-0
NR 46
TC 2
Z9 3
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1062-1024
EI 1573-2843
J9 J CHILD FAM STUD
JI J. Child Fam. Stud.
PD APR
PY 2018
VL 27
IS 4
BP 1207
EP 1215
DI 10.1007/s10826-017-0969-0
PG 9
WC Family Studies; Psychology, Developmental; Psychiatry
SC Family Studies; Psychology; Psychiatry
GA FZ6AG
UT WOS:000427677600018
DA 2020-07-08
ER

PT J
AU Kuszpit, K
   Hollidge, BS
   Zeng, XK
   Stafford, RG
   Daye, S
   Zhang, X
   Basuli, F
   Golden, JW
   Swenson, RE
   Smith, DR
   Bocan, TM
AF Kuszpit, Kyle
   Hollidge, Bradley S.
   Zeng, Xiankun
   Stafford, Robert G.
   Daye, Sharon
   Zhang, Xiang
   Basuli, Falguni
   Golden, Joseph W.
   Swenson, Rolf E.
   Smith, Darci R.
   Bocan, Thomas M.
TI [F-18]DPA-714 PET Imaging Reveals Global Neuroinflammation in Zika
   Virus-Infected Mice
SO MOLECULAR IMAGING AND BIOLOGY
LA English
DT Article
DE Zika virus; Animal model; Mice; Pathology; Neuroinflammation; TSPO;
   DPA-714; PET imaging; Therapeutics
ID POSITRON-EMISSION-TOMOGRAPHY; PROTEIN 18 KDA; TSPO; INFLAMMATION;
   RADIOSYNTHESIS; MICROGLIA; TARGET; MODEL
AB The association of Zika virus (ZIKV) infection and development of neurological sequelae require a better understanding of the pathogenic mechanisms causing severe disease. The purpose of this study was to evaluate the ability and sensitivity of positron emission tomography (PET) imaging using [F-18]DPA-714, a translocator protein (TSPO) 18 kDa radioligand, to detect and quantify neuroinflammation in ZIKV-infected mice.
   We assessed ZIKV-induced pathogenesis in wild-type C57BL/6 mice administered an antibody to inhibit type I interferon (IFN) signaling. [F-18]DPA-714 PET imaging was performed on days 3, 6, and 10 post-infection (PI), and tissues were subsequently processed for histological evaluation, quantification of microgliosis, and detection of viral RNA by in situ hybridization (ISH).
   In susceptible ZIKV-infected mice, viral titers in the brain increased from days 3 to 10 PI. Over this span, these mice showed a two- to sixfold increase in global brain neuroinflammation using [F-18]DPA-714 PET imaging despite limited, regional detection of viral RNA. No measurable increase in ionized calcium binding adaptor molecule 1 (Iba-1) expression was noted at day 3 PI; however, there was a modest increase at day 6 PI and an approximately significant fourfold increase in Iba-1 expression at day 10 PI in the susceptible ZIKV-infected group relative to controls.
   The results of the current study demonstrate that global neuroinflammation plays a significant role in the progression of ZIKV infection and that [F-18]DPA-714 PET imaging is a sensitive tool relative to histology for the detection of neuroinflammation. [F-18]DPA-714 PET imaging may be useful in dynamically characterizing the pathology associated with neurotropic viruses and the evaluation of therapeutics being developed for treatment of infectious diseases.
C1 [Kuszpit, Kyle; Stafford, Robert G.; Bocan, Thomas M.] US Army Med Res Inst Infect Dis, Mol & Translat Sci Div, 1425 Porter St, Frederick, MD 21702 USA.
   [Hollidge, Bradley S.; Golden, Joseph W.; Smith, Darci R.] US Army Med Res Inst Infect Dis, Virol Div, 1425 Porter St, Frederick, MD 21702 USA.
   [Zeng, Xiankun; Daye, Sharon] US Army Med Res Inst Infect Dis, Pathol Div, 1425 Porter St, Frederick, MD 21702 USA.
   [Zhang, Xiang; Basuli, Falguni; Swenson, Rolf E.] NHLBI, Imaging Probe Dev Ctr, NIH, 9800 Med Ctr Dr,Bldg B 2034, Bethesda, MD 20892 USA.
RP Bocan, TM (corresponding author), US Army Med Res Inst Infect Dis, Mol & Translat Sci Div, 1425 Porter St, Frederick, MD 21702 USA.; Smith, DR (corresponding author), US Army Med Res Inst Infect Dis, Virol Div, 1425 Porter St, Frederick, MD 21702 USA.
EM darci.r.smith.ctr@mail.mil; thomas.m.bocan.ctr@mail.mil
OI Zeng, Xiankun (Kevin)/0000-0003-3526-8755; Golden,
   Joseph/0000-0002-9709-313X
FU Department of Defense through Defense Advanced Research Projects Agency
   (DARPA) under US Army Medical Research Institute of Infectious Diseases
   (USAMRIID) project [15094637]; NRC Research Associateship award at
   USAMRIID
FX The authors would like to thank Dr. Sarah Norris for her assistance in
   performing the statistical analysis and Ms. Tara Kenny for preparation
   of the ZIKV strain DAK AR D 41525 stocks used in the study. The authors
   would also like to thank Drs. Christopher Kane and Sina Bavari and LTC
   Todd Kijek for their assistance in securing funding for performance of
   the study. Funding for performance of the study was provided by the
   Department of Defense through the Defense Advanced Research Projects
   Agency (DARPA) under the US Army Medical Research Institute of
   Infectious Diseases (USAMRIID) project number 15094637. Dr. Bradley S.
   Hollidge participated in this research while holding an NRC Research
   Associateship award at USAMRIID. Opinions, interpretations, conclusions,
   and recommendations stated within the article are those of the authors
   and are not necessarily endorsed by the US Army.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Bird JLE, 2010, ATHEROSCLEROSIS, V210, P388, DOI 10.1016/j.atherosclerosis.2009.11.047
   Bocan TM, 2015, MOL IMAGING BIOL, V17, P4, DOI 10.1007/s11307-014-0759-7
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x
   Damont A, 2008, J LABELLED COMPD RAD, V51, P286, DOI 10.1002/jlcr.1523
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Gaemperli O, 2012, EUR HEART J, V33, P1902, DOI 10.1093/eurheartj/ehr367
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Griffin DE, 2016, NEUROTHERAPEUTICS, V13, P455, DOI 10.1007/s13311-016-0434-6
   Hannestad J, 2012, NEUROIMAGE, V63, P232, DOI 10.1016/j.neuroimage.2012.06.055
   Hatori A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045065
   Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0
   Kuhnast B, 2012, APPL RADIAT ISOTOPES, V70, P489, DOI 10.1016/j.apradiso.2011.10.015
   Ladner JT, 2016, GENOME ANNOUNC, V4
   Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oh U, 2011, J NEUROIMMUNE PHARM, V6, P354, DOI 10.1007/s11481-010-9243-6
   Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   PROPHET EB, 1992, LAB METHODS HISTOTEC
   Roeda D, 2012, J FLUORINE CHEM, V134, P107, DOI 10.1016/j.jfluchem.2011.03.020
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wu CX, 2013, THERANOSTICS, V3, P448, DOI 10.7150/thno.6592
NR 35
TC 6
Z9 6
U1 1
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1536-1632
EI 1860-2002
J9 MOL IMAGING BIOL
JI Mol. Imaging. Biol.
PD APR
PY 2018
VL 20
IS 2
BP 275
EP 283
DI 10.1007/s11307-017-1118-2
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA GA1GU
UT WOS:000428064400014
PM 28900831
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Carod-Artal, FJ
AF Javier Carod-Artal, Francisco
TI Autonomic dysfunction: a novel neurological phenotype associated with
   Zika virus infection?
SO CLINICAL AUTONOMIC RESEARCH
LA English
DT Editorial Material
C1 [Javier Carod-Artal, Francisco] NHS Highlands, Dept Neurol, Raigmore Hosp, Old Perth Rd, Inverness IV2 3UJ, Inverness, Scotland.
   [Javier Carod-Artal, Francisco] Univ Int Catalunya, Int Master Trop Neurol, Barcelona, Spain.
RP Carod-Artal, FJ (corresponding author), NHS Highlands, Dept Neurol, Raigmore Hosp, Old Perth Rd, Inverness IV2 3UJ, Inverness, Scotland.; Carod-Artal, FJ (corresponding author), Univ Int Catalunya, Int Master Trop Neurol, Barcelona, Spain.
EM fjcarod-artal@hotmail.com
CR Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carod-Artal FJ, 2018, CLIN AUTON RES, V28, P67, DOI 10.1007/s10286-017-0452-4
   Carod-Artal FJ, 2017, CLIN AUTON RES, V27, P137, DOI 10.1007/s10286-017-0422-x
   Kummer W, 2009, MOVEMENT DISORD, V25, P205
   Martinez ARM, 2018, MUSCLE NERVE, V57, pE100, DOI 10.1002/mus.25958
   Pan American Health Organization (PAHO), 2016, GUID SURV ZIK VIR DI
   Robinson-Papp J, 2017, CLIN AUTON RES, V27, P25, DOI 10.1007/s10286-016-0384-4
   Rodriguez Y, 2018, CLIN AUTON RES
   Swartout K, 2017, PATHOGENS
   Versace V, 2017, CLIN AUTON RES, V27, P205, DOI 10.1007/s10286-017-0419-5
NR 11
TC 2
Z9 2
U1 0
U2 10
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0959-9851
EI 1619-1560
J9 CLIN AUTON RES
JI Clin. Auton. Res.
PD APR
PY 2018
VL 28
IS 2
BP 161
EP 163
DI 10.1007/s10286-018-0516-0
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FZ8SN
UT WOS:000427880500001
PM 29500738
OA Bronze
DA 2020-07-08
ER

PT J
AU Rodriguez, Y
   Rojas, M
   Ramirez-Santana, C
   Acosta-Ampudia, Y
   Monsalve, DM
   Anaya, JM
AF Rodriguez, Yhojan
   Rojas, Manuel
   Ramirez-Santana, Carolina
   Acosta-Ampudia, Yeny
   Monsalve, Diana M.
   Anaya, Juan-Manuel
TI Autonomic symptoms following Zika virus infection
SO CLINICAL AUTONOMIC RESEARCH
LA English
DT Article
DE Autonomic symptoms; Dysautonomia; Zika virus; Flavivirus; COMPASS 31
ID COMPASS 31; DYSFUNCTION; DISEASE; SCORE
AB To determine if autonomic symptoms are associated with previous Zika virus infection.
   Case-control study including 35 patients with Zika virus infection without evidence of neurological disease and 105 controls. Symptoms of autonomic dysfunction were assessed with the composite autonomic symptom scale 31 (COMPASS-31).
   Patients with previous Zika virus infection had significantly higher COMPASS-31 score than controls regardless of age and sex (p = 0.007). The main drivers for the higher scores where orthostatic intolerance (p = 0.003), secretomotor (p = 0.04) and bladder symptoms (p < 0.001).
   Zika virus infection is associated with autonomic dysfunction. The mechanisms remain to be elucidated.
C1 [Rodriguez, Yhojan; Rojas, Manuel; Ramirez-Santana, Carolina; Acosta-Ampudia, Yeny; Monsalve, Diana M.; Anaya, Juan-Manuel] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 26-63-B-51, Bogota 110010, Colombia.
RP Anaya, JM (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 26-63-B-51, Bogota 110010, Colombia.
EM juan.anaya@urosario.edu.co
RI ; Acosta-Ampudia, Yeny/J-2401-2016; Ramirez-Santana,
   Carolina/J-2363-2016; Monsalve, Diana M./J-2374-2016; Anaya,
   Juan-Manuel/J-1960-2016
OI Rojas, Manuel/0000-0002-8604-4658; Acosta-Ampudia,
   Yeny/0000-0001-8491-9134; Ramirez-Santana, Carolina/0000-0003-2137-4899;
   Monsalve, Diana M./0000-0002-1145-1312; Anaya,
   Juan-Manuel/0000-0002-6444-1249
FU Universidad del Rosario [ABN011]; Colciencias, Bogota,
   ColombiaDepartamento Administrativo de Ciencia, Tecnologia e Innovacion
   Colciencias [747-2016]
FX This study was supported by Universidad del Rosario (ABN011), and
   Colciencias (747-2016), Bogota, Colombia.
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   FREEMAN R, 1993, J CLIN NEUROPHYSIOL, V10, P61, DOI 10.1097/00004691-199301000-00007
   Gonzalez P, 2016, NEUROLOGIA, V31, P389, DOI 10.1016/j.nrl.2014.09.004
   ICTV. International comittee on taxonomy of viruses, 2014, VIRUS TAXONOMY
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Carod-Artal FJ, 2018, CLIN AUTON RES, V28, P67, DOI 10.1007/s10286-017-0452-4
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Mohammed J, 2017, ACTA CLIN BELG
   Morrey JD, 2013, ANTIVIR RES, V100, P535, DOI 10.1016/j.antiviral.2013.09.010
   Pierangeli G, 2015, NEUROL SCI, V36, P1897, DOI 10.1007/s10072-015-2278-y
   Sletten DM, 2012, MAYO CLIN PROC, V87, P1196, DOI 10.1016/j.mayocp.2012.10.013
   Stokic DS, 2012, FRONT NEUROL, V3, P1
   Versace V, 2017, CLIN AUTON RES, V27, P205, DOI 10.1007/s10286-017-0419-5
   Wang H, 2014, CLIN AUTON RES, V24, P15, DOI 10.1007/s10286-013-0213-y
   Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019575
   Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 19
TC 4
Z9 4
U1 0
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0959-9851
EI 1619-1560
J9 CLIN AUTON RES
JI Clin. Auton. Res.
PD APR
PY 2018
VL 28
IS 2
BP 211
EP 214
DI 10.1007/s10286-018-0515-1
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FZ8SN
UT WOS:000427880500010
PM 29497887
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika virus infection and autonomic symptoms
SO CLINICAL AUTONOMIC RESEARCH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Carod-Artal FJ, 2018, CLIN AUTON RES
   Rodriguez Y, 2018, CELL MOL IMMUNOL
   Rodriguez Y, 2018, CLIN AUTON RES
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 4
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0959-9851
EI 1619-1560
J9 CLIN AUTON RES
JI Clin. Auton. Res.
PD APR
PY 2018
VL 28
IS 2
BP 251
EP 251
DI 10.1007/s10286-018-0520-4
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FZ8SN
UT WOS:000427880500016
PM 29532283
OA Bronze
DA 2020-07-08
ER

PT J
AU Petersen, E
   Petrosillo, N
   Koopmans, M
AF Petersen, E.
   Petrosillo, N.
   Koopmans, M.
CA ESCMID Emerging Infections Task Fo
TI Emerging infections-an increasingly important topic: review by the
   Emerging Infections Task Force
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Review
DE Emerging infections; Food borne; New virus; Outbreaks; Prediction;
   Surveillance
ID RESPIRATORY SYNDROME CORONAVIRUS; NIPAH VIRUS; ZIKA VIRUS; ONE HEALTH;
   EPIDEMIC; DISEASES; TRANSMISSION; EMERGENCE; FEVER; RISK
AB Objectives: This paper review trends in emerging infections and the need for increased clinical and laboratory surveillance.
   Methods: Factors that contributed to the emergence of recent outbreaks have been reviewed. Known, major outbreaks over the past two decades were reviewed.
   Results: We identified at least four major drivers of emergent infections: (i) increasing density of the human population; (ii) stress from farmland expansion on the environment; (iii) globalization of the food market and manufacturing; (iv) environmental contamination. The factors creating new opportunities for emerging infections include: (i) population growth; (ii) spread in health care facilities; (iii) an ageing population; (iv) international travel; (v) changing and expanding vector habitats.
   Conclusions: Emerging infections are unpredictable. In this review we argue that to discover new trends in infectious diseases, the clinicians have to look for the unusual and unexpected and ensure proper diagnostics and that syndromic surveillance must be supported by highly specialized laboratory services. Mathematical modeling has not been able to predict outbreaks More emphasis on the biology of evolution is needed. EID rarely stands out as unusual, and the continuous pressure on health care budgets forces clinicians and laboratories to prioritize their diagnostic work-up to common and treatable conditions. The European Society for Infectious Diseases and Clinical Microbiology, ESCMID, has established an Emerging Infections Task Force, EITaF, to strengthen the activities of the society on emerging infections and ensure that emerging infections is included in differential diagnostic considerations in everyday clinical practice. (C) 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Petersen, E.] Univ Aarhus, Inst Clin Med, Aarhus, Denmark.
   [Petersen, E.] Royal Hosp, Dept Infect Dis, Muscat, Oman.
   [Petrosillo, N.] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Clin & Res Dept, Rome, Italy.
   [Koopmans, M.] Erasmus Univ, Virosci Dept, Rotterdam, Netherlands.
RP Petersen, E (corresponding author), Aarhus Univ, Inst Clin Med, Fac Hlth Sci, Aarhus, Denmark.
EM eskild.petersen@gmail.com
RI Rossen, John W/G-7564-2011; Di Caro, Antonino/K-6854-2016; Koopmans,
   Marion/Y-9170-2019
OI Rossen, John W/0000-0002-7167-8623; Di Caro,
   Antonino/0000-0001-6027-3009; Koopmans, Marion/0000-0002-5204-2312;
   Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; Beeching,
   Nicholas/0000-0002-7019-8791; Laufenberg, Rebekka/0000-0003-4317-1347;
   Storgaard, Merete/0000-0001-6110-5963
FU Wellcome TrustWellcome Trust
CR Aarestrup FM, 2016, TRENDS MICROBIOL, V24, P241, DOI 10.1016/j.tim.2016.01.009
   Aarestrup Frank M, 2012, Emerg Infect Dis, V18, pe1, DOI 10.3201/eid/1811.120453
   Breitling LP, 2016, DIABETES-METAB RES, V32, P111, DOI 10.1002/dmrr.2681
   Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482
   Buss BF, 2016, EPIDEMIOL INFECT, V144, P2709, DOI 10.1017/S0950268815002320
   *CDC, 1999, MMWR-MORBID MORTAL W, V48, P265
   Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686
   Daszak P, 2013, P NATL ACAD SCI USA, V110, P3681, DOI 10.1073/pnas.1201243109
   der MS, 2014, PLOS CURR, V114, P6
   Fruth A, 2015, INT J MED MICROBIOL, V305, P697, DOI 10.1016/j.ijmm.2015.08.020
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Girardi E, 2017, INT J INFECT DIS, V56, P45, DOI 10.1016/j.ijid.2017.01.018
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Hope J, 2013, CURR TOP MICROBIOL, V366, P37, DOI 10.1007/82_2012_264
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kantele A, 2016, CLIN MICROBIOL INFEC, V22, P658, DOI 10.1016/j.cmi.2016.07.004
   Kantele A, 2011, CLIN INFECT DIS, V52, P1356, DOI 10.1093/cid/cir180
   Khyatti M, 2014, EUR J PUBLIC HEALTH, V24, P47, DOI 10.1093/eurpub/cku109
   Kinsella K, 2001, IN AN AGEING WORLD
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Launders N, 2016, EPIDEMIOL INFECT, V144, P171, DOI 10.1017/S0950268815001016
   Lee S, 2005, SOC SCI MED, V61, P2038, DOI 10.1016/j.socscimed.2005.04.010
   Lipsitch M, 2016, ELIFE, V5, DOI 10.7554/eLife.18491
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Lo MK, 2008, J CLIN VIROL, V43, P396, DOI 10.1016/j.jcv.2008.08.007
   McKinney KR, 2006, J ENVIRON HEALTH, V68, P26
   McNamara LA, 2017, MMWR-MORBID MORTAL W, V66, P734, DOI 10.15585/mmwr.mm6627e1
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Nam HS, 2017, INT J INFECT DIS, V58, P37, DOI 10.1016/j.ijid.2017.02.008
   Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021
   Nishiura H, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0061-x
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107
   Rockx B, 2014, PATHOG DIS, V71, P197, DOI 10.1111/2049-632X.12149
   Schieppati A, 2015, SEMIN DIALYSIS, V28, P193, DOI 10.1111/sdi.12328
   Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X
   Sigfrid L, 2018, CLIN MICROBIOL INFEC, V24, P229, DOI 10.1016/j.cmi.2017.05.029
   Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4
   Smith KM, 2012, PLOS ONE, V7, P71, DOI 10.1371/journal.pone.0029505
   Soares RR, 2007, POPUL DEV REV, V33, P247, DOI 10.1111/j.1728-4457.2007.00169.x
   Tahden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164508
   Torres A, 2015, THORAX, V70, P984, DOI 10.1136/thoraxjnl-2015-206780
   van der Hoek W, 2012, ADV EXP MED BIOL, V984, P329, DOI 10.1007/978-94-007-4315-1_17
   Velkers FC, 2017, VET QUART, V37, P182, DOI 10.1080/01652176.2017.1325537
   Vince G, 2011, SCIENCE, V334, P32, DOI 10.1126/science.334.6052.32
   Ward MP, 2009, EPIDEMIOL INFECT, V137, P219, DOI 10.1017/S0950268808000885
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wolf N, 2011, THE VIRAL STORM
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Ypma RJF, 2013, J INFECT DIS, V207, P730, DOI 10.1093/infdis/jis757
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zumla A, 2016, INT J INFECT DIS, V47, P5, DOI 10.1016/j.ijid.2016.06.012
NR 55
TC 7
Z9 7
U1 1
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD APR
PY 2018
VL 24
IS 4
BP 369
EP 375
DI 10.1016/j.cmi.2017.10.035
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FZ8AG
UT WOS:000427826500009
PM 29155018
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Neuberger, I
   Garcia, J
   Meyers, ML
   Feygin, T
   Bulas, DI
   Mirsky, DM
AF Neuberger, Ilana
   Garcia, Jacquelyn
   Meyers, Mariana L.
   Feygin, Tamara
   Bulas, Dorothy I.
   Mirsky, David M.
TI Imaging of congenital central nervous system infections
SO PEDIATRIC RADIOLOGY
LA English
DT Article; Proceedings Paper
CT 4th Meeting on Advances in Fetal and Neonatal Imaging
CY JAN 27-29, 2017
CL Soc Pediat Radiol, Orlando, FL
HO Soc Pediat Radiol
DE Brain; Central nervous system; Computed tomography; Congenital; Fetus;
   Infant; Infection; Magnetic resonance imaging; Virus
ID CHORIOMENINGITIS VIRUS-INFECTION; ZIKA VIRUS; CYTOMEGALOVIRUS-INFECTION;
   MATERNAL RUBELLA; TOXOPLASMOSIS; INFANTS; CHILDREN; SYPHILIS; DISEASE;
   MRI
AB Congenital central nervous system (CNS) infections are a cause of significant morbidity and mortality. The recent Zika virus outbreak raised awareness of congenital CNS infections. Imaging can be effective in diagnosing the presence and severity of infection. In this paper we review the clinical presentations and imaging characteristics of several common and less common congenital CNS infections.
C1 [Neuberger, Ilana; Garcia, Jacquelyn; Meyers, Mariana L.; Mirsky, David M.] Univ Colorado, Sch Med, Dept Radiol, Childrens Hosp Colorado, 13123 E 16th Ave,Box B125, Aurora, CO 80045 USA.
   [Feygin, Tamara] Univ Penn, Dept Radiol, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Bulas, Dorothy I.] George Washington Sch Med & Hlth Sci, Dept Radiol, Childrens Natl Hlth Syst, Washington, DC USA.
RP Mirsky, DM (corresponding author), Univ Colorado, Sch Med, Dept Radiol, Childrens Hosp Colorado, 13123 E 16th Ave,Box B125, Aurora, CO 80045 USA.
EM David.Mirsky@childrenscolorado.org
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Alkalay A L, 1987, J Perinatol, V7, P69
   ALKALAY AL, 1987, J PEDIATR-US, V111, P320, DOI 10.1016/S0022-3476(87)80447-X
   ALTSHULER G, 1973, AM J DIS CHILD, V125, P251, DOI 10.1001/archpedi.1973.04160020073014
   Amir J, 2016, ARCH DIS CHILD-FETAL, V101, pF428, DOI 10.1136/archdischild-2015-308357
   Averill LW, 2015, SEMIN ULTRASOUND CT, V36, P476, DOI 10.1053/j.sult.2015.04.001
   Barton LL, 2001, CLIN INFECT DIS, V33, P370, DOI 10.1086/321897
   Baskin HJ, 2007, PEDIATR RADIOL, V37, P949, DOI 10.1007/s00247-007-0506-1
   Benoist G, 2008, ULTRASOUND OBST GYN, V32, P900, DOI 10.1002/uog.6129
   BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007
   BRION LP, 1991, PEDIATRICS, V88, P1037
   Cannie MM, 2016, EUR RADIOL, V26, P3760, DOI 10.1007/s00330-015-4187-0
   Cantey JB, 2015, EARLY HUM DEV, V91, P427, DOI 10.1016/j.earlhumdev.2015.04.005
   Centers for Disease Control and Prevention, 2013, HIV SURV REP, V25
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Cherry JD, 2014, FEIGIN CHERRYS TXB P
   CIVITELLO LA, 1992, PEDIATR NEUROSURG, V17, P104, DOI 10.1159/000120576
   COOPER LZ, 1985, REV INFECT DIS, V7, pS2
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   DAABOUL JJ, 1993, J PEDIATR-US, V123, P983, DOI 10.1016/S0022-3476(05)80398-1
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Deasy NP, 1999, NEURORADIOLOGY, V41, P205, DOI 10.1007/s002340050736
   Dhawan A, 2006, J PAEDIATR CHILD H, V42, P824, DOI 10.1111/j.1440-1754.2006.00986.x
   DIEBLER C, 1985, NEURORADIOLOGY, V27, P125, DOI 10.1007/BF00343783
   Doneda C, 2010, RADIOLOGY, V255, P613, DOI 10.1148/radiol.10090749
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   DUDGEON JA, 1975, J PEDIATR-US, V87, P1078, DOI 10.1016/S0022-3476(75)80119-3
   Dworkin MS, 2002, CURR CLIN TOPICS INF, V22, P181
   Enders G, 1999, PEDIATR INFECT DIS J, V18, P652, DOI 10.1097/00006454-199907000-00020
   Flagg EW, 2011, PEDIATRICS, V127, pE1, DOI 10.1542/peds.2010-0134
   Fowler MG, 2007, AM J OBSTET GYNECOL, V197, pS3, DOI 10.1016/j.ajog.2007.06.048
   FRENKEL JK, 1974, B NEW YORK ACAD MED, V50, P182
   GUERINA NG, 1994, NEW ENGL J MED, V330, P1858, DOI 10.1056/NEJM199406303302604
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   HARDING B, 1988, ACTA NEUROPATHOL, V76, P311, DOI 10.1007/BF00687781
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   ISTAS AS, 1995, CLIN INFECT DIS, V20, P665, DOI 10.1093/clinids/20.3.665
   Johann-Liang R, 1998, PEDIATR INFECT DIS J, V17, P753, DOI 10.1097/00006454-199808000-00019
   Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2012, GLOB REP UNAIDS REP
   KIEBURTZ KD, 1993, ARCH NEUROL-CHICAGO, V50, P430, DOI 10.1001/archneur.1993.00540040082019
   Kimberlin DW, 2007, SEMIN PERINATOL, V31, P19, DOI 10.1053/j.semperi.2007.01.003
   Kimberlin DW, 2004, CLIN MICROBIOL REV, V17, P1, DOI 10.1128/CMR.17.1.1-13.2004
   Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230
   Kubota T, 2007, BRAIN DEV-JPN, V29, P171, DOI 10.1016/j.braindev.2006.08.003
   Lane B, 1996, AM J NEURORADIOL, V17, P99
   Lazzarotto T, 2008, J CLIN VIROL, V41, P192, DOI 10.1016/j.jcv.2007.10.015
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Mayer M, 1996, ANN OTO RHINOL LARYN, V105, P242, DOI 10.1177/000348949610500312
   McLeod R, 2006, CLIN INFECT DIS, V42, P1383, DOI 10.1086/501360
   MILLER E, 1982, LANCET, V2, P781
   Moyer VA, 1998, ARCH PEDIAT ADOL MED, V152, P353
   Nolt D, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e63
   Pacheco O, 2016, N ENGL J MED
   PARK YD, 1990, ANN NEUROL, V28, P303, DOI 10.1002/ana.410280302
   Paruthikunnan S, 2014, JPN J RADIOL, V32, P664, DOI 10.1007/s11604-014-0352-7
   Patel DV, 1996, RADIOLOGY, V199, P433, DOI 10.1148/radiology.199.2.8668790
   PERLMAN JM, 1992, ANN NEUROL, V31, P64, DOI 10.1002/ana.410310112
   Picone O, 2008, PRENATAL DIAG, V28, P753, DOI 10.1002/pd.2037
   PIZZO P, 1998, PEDIAT AIDS CHALLENG
   QURESHI F, 1993, HUM PATHOL, V24, P779, DOI 10.1016/0046-8177(93)90016-A
   Remington JS, 2014, INFECT DIS FETUS NEW
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Sanchez TR, 2016, NEURORADIOL J, V29, P314, DOI 10.1177/1971400916665372
   SHEINBERGAS MM, 1976, INFECTION, V4, P185, DOI 10.1007/BF01638922
   Smith CK, 2009, SEMIN FETAL NEONAT M, V14, P209, DOI 10.1016/j.siny.2008.11.008
   Thiebaut R, 2007, LANCET, V369, P115
   UEDA K, 1986, AM J EPIDEMIOL, V124, P807, DOI 10.1093/oxfordjournals.aje.a114457
   Van Rie A, 2007, EUR J PAEDIATR NEURO, V11, P1, DOI 10.1016/j.ejpn.2006.10.006
   Varella IS, 2009, MEM I OSWALDO CRUZ, V104, P383, DOI 10.1590/S0074-02762009000200037
   Vesnaver TV, 2017, BJOG-INT J OBSTET GY, V124, P521, DOI 10.1111/1471-0528.14423
   Vossough A, 2008, NEURORADIOLOGY, V50, P355, DOI 10.1007/s00234-007-0349-3
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   WILSON CB, 1980, PEDIATRICS, V66, P767
   Woods Charles R, 2005, Semin Pediatr Infect Dis, V16, P245
   Wright R, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e9
   Yoshimura Masaki, 1996, No To Hattatsu, V28, P385
NR 79
TC 1
Z9 1
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0301-0449
EI 1432-1998
J9 PEDIATR RADIOL
JI Pediatr. Radiol.
PD APR
PY 2018
VL 48
IS 4
BP 513
EP 523
DI 10.1007/s00247-018-4092-1
PG 11
WC Pediatrics; Radiology, Nuclear Medicine & Medical Imaging
SC Pediatrics; Radiology, Nuclear Medicine & Medical Imaging
GA FZ7SB
UT WOS:000427800100007
PM 29550865
DA 2020-07-08
ER

PT J
AU Chakhtoura, N
   Hazra, R
   Spong, CY
AF Chakhtoura, Nahida
   Hazra, Rohan
   Spong, Catherine Y.
TI Zika virus: a public health perspective
SO CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
LA English
DT Review
DE anomaly; child; microcephaly; pregnancy; Zika virus
ID BIRTH-DEFECTS; INFECTION; INFANTS; CONSEQUENCES; EXPOSURE; FETUSES;
   UPDATE; WOMEN
AB Purpose of reviewZika virus' impact on pregnancy became widely known in 2015 with a dramatic increase in the number of babies born with microcephaly in Recife, Brazil. A mosquito-borne virus resulting in congenital anomalies is unique, and Zika's ability to cause neurological defects on a large scale was a grim reminder of the Rubella epidemic in the 1950s. Over the past 2 years, studies have provided insight on how Zika virus (ZIKV) infects cells and causes disease, but much remains unknown about the long-term risks of Zika exposure on infant growth and development.Recent findingsThe impact of ZIKV on pregnancy extends beyond microcephaly and may only first be identified in infancy. The virus has a long latency in semen and can be transmitted sexually. Transplacental passage occurs through infection of Hofbauer cells in the trophoblast. A major difficulty in management of ZIKV disease is that most infections are asymptomatic and the diagnostic methods are not ideal, making both diagnosis and ascertainment of timing of infection problematic. Several different types of vaccines are in development. Large studies are ongoing to determine the risk and total spectrum of anomalies based on the timing of infection and other environmental exposures.SummaryThis review will summarize the epidemic, what we have learned, what we hope to learn, and current recommendations for care and management.
C1 [Chakhtoura, Nahida; Hazra, Rohan; Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.
RP Spong, CY (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.
EM spongc@mail.nih.gov
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [Z99 HD999999]
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Barzon L., 2016, EURO SURVEILL, V21
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Pone MVD, 2018, CHILD NERV SYST, V34, P63, DOI 10.1007/s00381-017-3635-3
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faden RR, 2017, VACCINE, V35, P6819, DOI 10.1016/j.vaccine.2017.09.065
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li Y., 2017, CELL STEM CELL, V20
   Medina MT, 2017, J NEUROL SCI, V383, P214, DOI 10.1016/j.jns.2017.10.046
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nogueira ML, 2017, CLIN MICROBIOL INFEC
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Plotkin SA, 2018, ZIKA VIRUS
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Ribeiro Bruno Niemeyer de Freitas, 2017, Radiol Bras, V50, P314, DOI 10.1590/0100-3984.2017.0098
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 37
TC 3
Z9 3
U1 0
U2 31
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-872X
EI 1473-656X
J9 CURR OPIN OBSTET GYN
JI Curr. Opin. Obstet. Gynecol.
PD APR
PY 2018
VL 30
IS 2
BP 116
EP 122
DI 10.1097/GCO.0000000000000440
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GA0EH
UT WOS:000427985300006
PM 29406461
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Burdino, E
   Milia, MG
   Allice, T
   Gregori, G
   Ruggiero, T
   Calleri, G
   Lipani, F
   Lucchini, A
   Venturi, G
   Di Perri, G
   Ghisetti, V
AF Burdino, Elisa
   Milia, Maria Grazia
   Allice, Tiziano
   Gregori, Gabriella
   Ruggiero, Tina
   Calleri, Guido
   Lipani, Filippo
   Lucchini, Anna
   Venturi, Giulietta
   Di Perri, Giovanni
   Ghisetti, Valeria
TI Laboratory findings in Zika infection: The experience of a reference
   centre in North-West Italy
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; Travelers; Real time RT-PCR; Blood; Urine
ID VIRUS
AB Background: Zika virus (ZIKV) remains a public health concern due to its association with fetal malformation and neurologic disease.
   Objective: To report a reference centre experience on ZIKA virus (ZIKV) infection in travelers from epidemic countries from January 1 to September, 30, 2016 in Italy North-West (a geographic area covering 4.424 million inhabitants, corresponding to almost 73% of Italy North-West area).
   Study design: One hundred and twelve febrile travelers were studied to rule out a tropical fever [e. g. malaria, dengue (DENV), chikungunya (CHIKV), West Nile (WNV) and ZIKV]. Molecular tests for detecting ZIKV RNA were applied on serum or urine as well as IgG and IgM specific serology.
   Results: ZIKV was the most frequent "tropical infection (11.6%) with 12 infected travelers and one sexual partner of an infected traveler. At the time of the diagnosis, ZIKV RNA was detected in the blood from 9 patients (69%) within 7 days from symptom onset; afterwards, the virus was detected only in urine (5 patients) and ZIKV IgM was reactive in 9 patients (69%). Travelers with ZIKV infection tested negative for DENV, CHIKV, WNV and malaria and completely recovered. Other infections identified in travelers were DENV (5 patients, 4.5%), CHIKV (1, 0.9%), malaria (Plasmodium vivax, 1, 0.9%), measles (1, 0.9%) and tuberculosis (1, 0.9%).
   Conclusions: The etiologic diagnosis of a febrile illness in travelers where ZIKV is endemic is highly desirable as they are sentinel of a challenging epidemiology including the risk of autochthonous transmission in non endemic countries where the competent or carrier vector is present.
C1 [Burdino, Elisa; Milia, Maria Grazia; Allice, Tiziano; Gregori, Gabriella; Ruggiero, Tina; Ghisetti, Valeria] Amedeo di Savoia Hosp, Lab Microbiol & Virol, Turin, Italy.
   [Calleri, Guido] Amedeo di Savoia Hosp, Unit Infect & Trop Dis A, Turin, Italy.
   [Lipani, Filippo; Lucchini, Anna; Di Perri, Giovanni] Amedeo di Savoia Hosp, Dept Infect Dis, Turin, Italy.
   [Venturi, Giulietta] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Natl Reference Lab Arboviruses, Rome, Italy.
RP Burdino, E (corresponding author), Amedeo di Savoia Hosp, Dept Infect Dis, Lab Microbiol & Virol, Corso Svizzera 164, I-10149 Turin, Italy.
EM elisa.burdino@libero.it
RI Di Perri, Giovanni/AAC-1882-2019; VENTURI, GIULIETTA/O-8123-2015
OI VENTURI, GIULIETTA/0000-0002-9078-8350
CR BARZON L, 2016, EUROSURVEILLANCE, V21, P2
   BINGHAM AM, 2018, MMWR MORB MORTAL WKL, V2
   Burdino E, 2011, J CLIN VIROL, V51, P255, DOI 10.1016/j.jcv.2011.05.011
   Cao-Lormeau V. M., 2014, EMERG INFECT DIS, V20, P1960
   CORMAN VM, BULL WORLD HEALTH OR, P879
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diaz-Menendez M., 2016, ENFERM INFEC MICR CL, P8
   DUFFY M, 1956, N ENGL J MED
   European Centre for Disease Prevention and Control (ECDC), 2017, RAPID RISK ASSESSMEN
   FORTUNA C, 2017, BMC INFECT DIS, V17
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   LANCIOTTI RS, 2008, EMERG INFECT DIS
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P10
   MUSSO D, 2010, CLIN MICROBIOL INFEC, V1111, P1469
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Paz-Bailey G, 2017, N ENGL J MED
   Tappe D, 2014, EUROSURVEILLANCE, V19, DOI [10.2807/1560-7917.ES2014.19.4.20685, DOI 10.2807/1560-7917.ES2014.19.4.20685]
   van G. E., 2016, SFD, V21, P30251
   VAN GE, 2016, EUROSURVEILLANCE, V21, P23
   Veasna D., 2016, INT J INFECT DIS, V54, P121
   World Health Organization, 2016, ZIKA VIRUS DISEASE I
   World Health Organization (WHO), 2016, ZIKA VIRUS AND COMPL
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P21153, DOI 10.2807/1560-7917.ES2015.20.23.21153
NR 25
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD APR
PY 2018
VL 101
BP 18
EP 22
DI 10.1016/j.jcv.2018.01.010
PG 5
WC Virology
SC Virology
GA FZ4SJ
UT WOS:000427581900004
PM 29414182
DA 2020-07-08
ER

PT J
AU Esposito, DLA
   de Moraes, JB
   da Fonseca, BAL
AF Esposito, Danillo L. A.
   de Moraes, Jonathan B.
   Lopes da Fonseca, Benedito Antonio
TI Current priorities in the Zika response
SO IMMUNOLOGY
LA English
DT Review
DE comparative immunology; evolution; vaccination; viral; zika virus and
   infection
ID VIRUS-INFECTION; PROFILE
AB Zika virus (ZIKV), a single-stranded RNA virus of the Flaviviridae family, is an arbovirus (viruses transmitted by arthropods) transmitted to humans and non-human primates through the bites of infected female Aedes sp. mosquitoes. Although first isolated in 1947, it only recently emerged as a global threat, present in several countries resulting in a pandemic scenario. ZIKV infections may have severe outcomes, such as neurological impairment, and with the intrinsic ability of inducing microcephaly in fetuses of infected pregnant women, the virus has become a major public health problem. This review discusses some advances in diagnosis; vaccine development and the problems associated with their administration; the importance of the cross-reactivity with other flaviviruses in protecting or worsening the disease; the implications of the recent outbreak caused by the virus in the world; and future prospects for the complete understanding of this disease.
C1 [Esposito, Danillo L. A.; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Dept Internal Med, Ribeirao Preto Med Sch, Sao Paulo, Brazil.
   [de Moraes, Jonathan B.] Univ Sao Paulo, Grad Studies Programme Basic & Appl Immunol Ribei, Ribeirao Preto Med Sch, Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Disciplina Molestias Infecciosas, Dept Clin Med, Fac Med Ribeirao Preto, Ave Bandeirantes 3900, Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687; Moraes, Jonathan/0000-0002-0021-3714
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505
   ANDRADE DV, 2017, VIRUS RES, P462, DOI DOI 10.4049/JIMMUNOL.1601949
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   BOWEN JR, 2017, PLOS PATHOG, V13, P6164, DOI DOI 10.1016/J.IT.2006.06.003
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMPTON T, 2016, JAMA J AM MED ASSOC, V316, P1755
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jin Jill, 2016, JAMA, V315, P2482, DOI 10.1001/jama.2016.4741
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   KRAUSS MJ, AM J OBSTET GYNECOL, DOI DOI 10.1038/NI.3849
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kuwabara S, 2007, CURR NEUROL NEUROSCI, V7, P57, DOI 10.1007/s11910-007-0022-6
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Millichap J Gordon, 2016, Pediatr Neurol Briefs, V30, P8, DOI 10.15844/pedneurbriefs-30-1-7
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E, 2013, EUROSURVEILLANCE, V19, P20720
   PARDY RD, 2017, PLOS PATHOG, V13, P6184, DOI DOI 10.1016/J.CHOM.2016.04.019
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rios A, 1996, Pediatr Rev, V17, P386
   Saude SdVe, 2017, B EP
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   Thiery G, 2016, INTENS CARE MED, V42, P1485, DOI 10.1007/s00134-016-4364-x
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vogel G, 2016, SCIENCE, V351, P1377, DOI 10.1126/science.351.6280.1377
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   *WHO, 2017, PREV SEX TRANSM ZIK, V29, DOI DOI 10.1016/J.CELREP.2016.08.079
   WHO, 2017, ZIK VIR SIT REP
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
NR 64
TC 2
Z9 2
U1 3
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD APR
PY 2018
VL 153
IS 4
BP 435
EP 442
DI 10.1111/imm.12878
PG 8
WC Immunology
SC Immunology
GA FY3OD
UT WOS:000426728600004
PM 29243225
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Winkler, CW
   Peterson, KE
AF Winkler, Clayton W.
   Peterson, Karin E.
TI Using immunocompromised mice to identify mechanisms of Zika virus
   transmission and pathogenesis
SO IMMUNOLOGY
LA English
DT Review
DE innate receptors; neuroinflammation; reproductive Immunology; T cell;
   viral
ID NECROSIS-FACTOR-ALPHA; SEXUAL TRANSMISSION; VIRAL-INFECTION; DENGUE
   VIRUS; MOUSE MODEL; BRAIN; INFLAMMATION; MICROGLIA; INJURY; CELLS
AB Zika virus (ZIKV) is responsible for a recent global epidemic that has been associated with congenital brain malformations in fetuses and with Guillain-Barre syndrome in adults. Within the last 2years, a major effort has been made to develop murine models to study the mechanism of viral transmission, pathogenesis and the host immune response. Here, we discuss the findings from these models regarding the role that the innate and adaptive immune responses have in controlling ZIKV infection and pathogenesis. Additionally, we examine how innate and adaptive immune responses influence sexual and vertical transmission of ZIKV infection as well as how these responses can influence the ability of ZIKV to cross the placenta and to induce damage in the developing brain.
C1 [Winkler, Clayton W.; Peterson, Karin E.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.
RP Winkler, CW (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.
EM clayton.winkler@nih.gov
RI Winkler, Clayton/F-8031-2018
OI Winkler, Clayton/0000-0002-4460-3378
FU NIAID Division of Intramural ResearchUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID)
FX Thanks to Ryan Kissinger for his excellent illustrative work on the
   figures in this review. CWW and KEP are supported by the NIAID Division
   of Intramural Research.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Babri S, 2014, BEHAV BRAIN RES, V261, P305, DOI 10.1016/j.bbr.2013.12.037
   Blaszczyk K, 2016, CYTOKINE GROWTH F R, V29, P71, DOI 10.1016/j.cytogfr.2016.02.010
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cai ZW, 2004, PEDIATR RES, V56, P377, DOI 10.1203/01.PDR.0000134249.92944.14
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087420
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Du LY, 2017, EXPERT REV VACCINES, V16, P951, DOI 10.1080/14760584.2017.1363648
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Gilmore JH, 2004, NEUROPSYCHOPHARMACOL, V29, P1221, DOI 10.1038/sj.npp.1300446
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Kneeland RE, 2013, PROG NEURO-PSYCHOPH, V42, P35, DOI 10.1016/j.pnpbp.2012.02.001
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Ma W, 2016, CELL, V167, pe10
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670
   Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417
   Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rostovsky I, 2015, J VIROL, V89, P2182, DOI 10.1128/JVI.02908-14
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Souza INO, 2017, BIORXIV
   Swartwout BK, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6040049
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wang J, 2017, CELL, V171, pe15
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 78
TC 6
Z9 6
U1 1
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD APR
PY 2018
VL 153
IS 4
BP 443
EP 454
DI 10.1111/imm.12883
PG 12
WC Immunology
SC Immunology
GA FY3OD
UT WOS:000426728600005
PM 29266213
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Goellner, E
   Schmitt, AT
   Couto, JL
   Muller, ND
   Pilz, HL
   Schrekker, HS
   Silva, CE
   da Silva, OS
AF Goellner, Emanuelle
   Schmitt, Ademir Tramontini
   Couto, Julia Lacerda
   Mueller, Nicolas Drumm
   Pilz-Junior, Harry Luiz
   Schrekker, Henri Stephan
   Silva, Carlos Eugenio
   da Silva, Onilda Santos
TI Larvicidal and residual activity of imidazolium salts against Aedes
   aegypti (Diptera: Culicidae)
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE dengue virus; zika virus; chemical control; imidazolium ionic liquids;
   mosquito control; Aedes aegypti
ID MAMMALIAN-CELLS; IONIC LIQUIDS; MOSQUITO; INFECTION; BIOFILM; IMPACT;
   LARVAE; VIRUS
AB BACKGROUNDAedes aegypti is an important mosquito species that can transmit several arboviruses such as dengue fever, yellow fever, chikungunya and zika. Because these mosquitoes are becoming resistant to most chemical insecticides used around the world, studies with new larvicides should be prioritized. Based on the known biological profile of imidazolium salts (IS), the objective of this study was to evaluate the potential of six IS as larvicides against Ae. aegypti, as tested against Ae. aegypti larvae. Larval mortality was measured after 24 and 48h, and residual larvicidal activity was also evaluated.
   RESULTSPromising results were obtained with aqueous solutions of two IS: 1-n-octadecyl-3-methylimidazolium chloride (C(18)MImCl) and 1-n-hexadecyl-3-methylimidazolium methanesulfonate (C(16)MImMeS), showing up to 90% larval mortality after 48h exposure. C(18)MImCl was more effective than C(16)mIMeS, causing mortality until day 15 after exposure. An application of C(18)MImCl left to dry under ambient conditions for at least 2months and then dissolved in water showed a more pronounced residual effect (36days with 95% mortality and 80% mortality up to 78days).
   CONCLUSIONThis is the first study to show the potential of IS in the control of Ae. aegypti. Further studies are needed to understand the mode of action of these compounds in the biological development of this mosquito species. (c) 2017 Society of Chemical Industry
C1 [Goellner, Emanuelle; Schmitt, Ademir Tramontini; Mueller, Nicolas Drumm; Pilz-Junior, Harry Luiz; Silva, Carlos Eugenio; da Silva, Onilda Santos] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Microbiol Immunol & Parasitol, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.
   [Couto, Julia Lacerda; Schrekker, Henri Stephan] Univ Fed Rio Grande do Sul, Inst Chem, Lab Technol Proc & Catalysis, Ave Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
RP da Silva, OS (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Microbiol Immunol & Parasitol, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.; Schrekker, HS (corresponding author), Univ Fed Rio Grande do Sul, Inst Chem, Lab Technol Proc & Catalysis, Ave Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM henri.schrekker@ufrgs.br; onilda.silva@ufrgs.br
RI Schrekker, Henri Stephan/B-8292-2008; da Silva, Onilda
   Santos/AAE-7457-2020; da Silva, Onilda Santos/K-3606-2013; Junior, Harry
   Luiz Pilz/AAC-8425-2020; Couto, Julia Lacerda/U-1197-2019
OI Schrekker, Henri Stephan/0000-0002-8173-3841; Junior, Harry Luiz
   Pilz/0000-0002-3379-4885; Couto, Julia Lacerda/0000-0001-6608-9261
FU Brazilian agency 'Conselho Nacional de Desenvolvimento Cientfico e
   Tecnologico' (CNPq)National Council for Scientific and Technological
   Development (CNPq); CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX EG acknowledges the Brazilian agency 'Conselho Nacional de
   Desenvolvimento Cientfico e Tecnologico' (CNPq) for the scholarship. HSS
   is grateful to CNPq for the PQ fellowship.
CR Akhter H, 2017, COMP BIOCHEM PHYS A, V203, P144, DOI 10.1016/j.cbpa.2016.09.008
   Bergamo VZ, 2015, LETT APPL MICROBIOL, V61, P504, DOI 10.1111/lam.12488
   Borowiecki P, 2013, EUR J ORG CHEM, V2013, P712, DOI 10.1002/ejoc.201201245
   BRADLEY TJ, 1977, J EXP BIOL, V66, P83
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Cassol CC, 2006, ADV SYNTH CATAL, V348, P243, DOI 10.1002/adsc.200505295
   Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409
   Costa SAL, 2017, PLOS NEGLECT TROP D, V14
   Dalla Lana DF, 2015, J APPL MICROBIOL, V119, P377, DOI 10.1111/jam.12862
   Diallo M, 2000, AM J TROP MED HYG, V62, P151, DOI 10.4269/ajtmh.2000.62.151
   Donato RK, 2010, J APPL POLYM SCI, V116, P304, DOI 10.1002/app.31531
   Dos Santos TP, 2017, ACTA TROP
   Fang B, 2010, EUR J MED CHEM, V45, P4388, DOI 10.1016/j.ejmech.2010.06.012
   Forattini OP, 2002, REV SAUDE PUBL, V36, P257, DOI 10.1590/S0034-89102002000300001
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Huang SM, 2007, J MED ENTOMOL, V44, P705, DOI 10.1603/0022-2585(2007)44[705:EOSOTT]2.0.CO;2
   Huang Y, 2017, CHEM MATER, V29, P6389, DOI 10.1021/acs.chemmater.7b01796
   Lapinski MK, 2015, SOC SCI MED, V129, P51, DOI 10.1016/j.socscimed.2014.09.048
   Liu LH, 2013, BIOMATERIALS, V34, P1018, DOI 10.1016/j.biomaterials.2012.10.050
   Maestre-Serrano R, 2014, PESTIC BIOCHEM PHYS, V116, P63, DOI 10.1016/j.pestbp.2014.09.014
   MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315
   McCann M, 2013, POLYHEDRON, V56, P180, DOI 10.1016/j.poly.2013.03.057
   Monnerat R., 2012, BIOASSAY, V7, P1, DOI DOI 10.14295/BA.V7.0.73
   Pendleton JN, 2015, INT J ANTIMICROB AG, V46, P131, DOI 10.1016/j.ijantimicag.2015.02.016
   Phophiro JS, 2013, REV SOC BRAS MED TRO, V44, P300
   Pontes RJS, 2005, REV SOC BRAS MED TRO, V38, P316, DOI 10.1590/S0037-86822005000400007
   Prud'homme SM, 2017, ENVIRON POLLUT, V220, P242, DOI 10.1016/j.envpol.2016.09.056
   Ranke J., 2006, Toxicological and Environmental Chemistry, V88, P273, DOI 10.1080/02772240600589505
   Riduan SN, 2013, CHEM SOC REV, V42, P9055, DOI 10.1039/c3cs60169b
   Schrekker HS, 2008, J BRAZIL CHEM SOC, V19, P426, DOI 10.1590/S0103-50532008000300009
   Schrekker HS, 2007, J COLLOID INTERF SCI, V316, P189, DOI 10.1016/j.jcis.2007.08.018
   Schrekker HS, 2013, MEDCHEMCOMM, V4, P1457, DOI 10.1039/c3md00222e
   Sivan A, 2015, PARASITOL RES, V114, P4693, DOI 10.1007/s00436-015-4717-3
   Smiglak M, 2014, CHEM COMMUN, V50, P9228, DOI 10.1039/c4cc02021a
   Pontes RJS, 2010, MEM I OSWALDO CRUZ, V105, P220, DOI 10.1590/S0074-02762010000200019
   Trilla A, 2016, MED CLIN-BARCELONA, V146, P308, DOI 10.1016/j.medcli.2016.02.004
   WHO, 1981, CRIT MEAN TESTS DET
   World Health Organization Pyriproxyfen in drinking water, 2004, WHOSDEWSH0304113
   Yang ZX, 2017, COMP BIOCHEM PHYS B, V204, P35, DOI 10.1016/j.cbpb.2016.11.003
NR 40
TC 8
Z9 8
U1 0
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD APR
PY 2018
VL 74
IS 4
BP 1013
EP 1019
DI 10.1002/ps.4803
PG 7
WC Agronomy; Entomology
SC Agriculture; Entomology
GA FY0SI
UT WOS:000426521600028
PM 29193680
OA Bronze
DA 2020-07-08
ER

PT J
AU Farinelli, EC
   Baquero, OS
   Stephan, C
   Chiaravalloti-Neto, F
AF Farinelli, Elaine Cristina
   Baquero, Oswaldo Santos
   Stephan, Celso
   Chiaravalloti-Neto, Francisco
TI Low socioeconomic condition and the risk of dengue fever: A direct
   relationship
SO ACTA TROPICA
LA English
DT Article
DE Dengue; Socioeconomic conditions; Spatial analysis; GIS
ID AEDES-AEGYPTI; SPATIAL-DISTRIBUTION; URBAN LOCALITY; BRAZIL; DYNAMICS;
   VIRUS; PATTERNS; SOUTHEASTERN; TRANSMISSION; CIRCULATION
AB This study aimed to characterize the first dengue fever epidemic in Varzea Paulista, Sao Paulo, Brazil, and its spatial and spatio-temporal distribution in order to assess the association of socioeconomic factors with dengue occurrence. We used autochthonous dengue cases confirmed in a 2007 epidemic, the first reported in the city, available in the Information System on Diseases of Compulsory Declaration database. These cases where geocoded by address. We identified spatial and spatio-temporal clusters of high- and low-risk dengue areas using scan statistics. To access the risk of dengue occurrence and to evaluate its relationship with socioeconomic level we used a population-based case-control design. Firstly, we fitted a generalized additive model (GAM) to dengue cases and controls without considering the non-spatial covariates to estimate the odds ratios of the occurrence of the disease. The controls were drawn considering the spatial distribution of the household of the study area and represented the source population of the dengue cases. After that, we assessed the relationship between socioeconomic variables and dengue using the GAM and obtained the effect of these covariates in the occurrence of dengue adjusted by the spatial localization of the cases and controls. Cluster analysis and GAM indicated that northeastern area of Varzea Paulista was the most affected area during the epidemic. The study showed a positive relationship between low socioeconomic condition and increased risk of dengue. We studied the first dengue epidemic in a highly susceptible population at the beginning of the outbreak and therefore it may have allowed to identify an association between low socioeconomic conditions and increased risk of dengue. These results may be useful to predict the occurrence and to identify priority areas to develop control measures for dengue, and also for Zika and Chikungunya; diseases that recently reached Latin America, especially Brazil.
C1 [Farinelli, Elaine Cristina] Unidade Basica Saude Jardim Promeca, Rua Dinamarca 41, BR-13223290 Varzea Paulista, SP, Brazil.
   [Baquero, Oswaldo Santos] Univ Sao Paulo, Fac Med Vet & Zootecnia, Ave Prof Doutor Orlando Marques de Paiva 87, BR-05508270 Sao Paulo, SP, Brazil.
   [Stephan, Celso] Univ Estadual Campinas, Fac Ciencias Med, Rua Tessalia Vieira de Camargo 126, BR-13083887 Campinas, SP, Brazil.
   [Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Fac Saude Publ, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
RP Chiaravalloti-Neto, F (corresponding author), Univ Sao Paulo, Fac Saude Publ, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM ecfarinelli@usp.br; baquero@usp.br; stephan@fcm.unicamp.br;
   franciscochiara@usp.br
RI Neto, Francisco Chiaravalloti/F-8006-2012; Stephan, Celso/D-6472-2015;
   Baquero, Oswaldo/R-4265-2016
OI Neto, Francisco Chiaravalloti/0000-0003-2686-8740; Stephan,
   Celso/0000-0001-5725-4130; Baquero, Oswaldo/0000-0003-2695-7946
CR Ali M, 2003, AM J TROP MED HYG, V69, P634, DOI 10.4269/ajtmh.2003.69.634
   Bailey TC, 2007, RISK ANAL, V27, P421, DOI 10.1111/j.1539-6924.2007.00894.x
   Barbosa GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002873
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bohra A, 2001, APPL GIS MODELING DE
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Institute of Geography and Statistics [IBGE], 2012, CENS 2010
   Wilke ABB, 2017, ACTA TROP, V166, P343, DOI 10.1016/j.actatropica.2016.10.025
   Carbajo AE, 2006, MED VET ENTOMOL, V20, P209, DOI 10.1111/j.1365-2915.2006.00625.x
   Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x
   Chaves LF, 2014, ACTA TROP, V129, P15, DOI 10.1016/j.actatropica.2013.02.025
   Chiaravalloti-Neto F, 2015, ACTA TROP, V142, P167, DOI 10.1016/j.actatropica.2014.11.017
   Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290
   Cordeiro R, 2016, CAD SAUDE PUBLICA, V32, DOI [10.1590/0102-311X00069516, 10.1590/0102-311x00069516]
   Costa JV, 2013, CAD SAUDE PUBLICA, V29, P1522, DOI [10.1590/S0102-311X2013001200005, 10.1590/0102-311X00110912]
   da Costa AIP, 1998, REV SAUDE PUBL, V32, P232, DOI 10.1590/S0034-89101998000300005
   Resendes APD, 2010, REV SAUDE PUBL, V44, P274, DOI 10.1590/s0034-89102010000200007
   Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028
   Delmelle E, 2013, INT J APPL GEOSPAT R, V4, P58, DOI 10.4018/jagr.2013100104
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Duarte HHP, 2006, REV SAUDE PUBL, V40, P134, DOI 10.1590/S0034-89102006000100021
   Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feldstein LR, 2015, T ROY SOC TROP MED H, V109, P303, DOI 10.1093/trstmh/trv012
   Gil JF, 2016, ACTA TROP, V158, P24, DOI 10.1016/j.actatropica.2016.02.003
   Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Hastie T.J., 1990, GEN ADDITIVE MODELS, V9
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Hu WB, 2012, ENVIRON HEALTH PERSP, V120, P260, DOI 10.1289/ehp.1003270
   IBGE Instituto Brasileiro de Geografia e Estatistica, 2011, CENS 2010
   Jeefoo P, 2011, INT J ENV RES PUB HE, V8, P51, DOI 10.3390/ijerph8010051
   Kabacoff R., 2015, R ACTION DATA ANAL G
   Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059
   Kulldorff M., 2015, SATSCAN USER GUIDE V
   Lian CW, 2006, TROP BIOMED, V23, P85
   Lin CH, 2011, INT J ENV RES PUB HE, V8, P2798, DOI 10.3390/ijerph8072798
   Lowe R, 2011, COMPUT GEOSCI-UK, V37, P371, DOI 10.1016/j.cageo.2010.01.008
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010
   Mondini A, 2007, REV SAUDE PUBL, V41, P922
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Moreno-Madrinan MJ, 2014, ISPRS INT J GEO-INF, V3, P732, DOI 10.3390/ijgi3020732
   Nakhapakorn Kanchana, 2005, Int J Health Geogr, V4, P13
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   PAHO, 1991, DIR REL AO CONTR PRE
   Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007
   PONTES RJS, 1994, REV SAUDE PUBL, V28, P218, DOI 10.1590/S0034-89101994000300010
   PONTES RJS, 1991, REV SAUDE PUBL, V25, P315, DOI 10.1590/S0034-89101991000400011
   Qi X, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/289404
   Quinn G. P., 2002, EXPT DESIGN DATA ANA
   Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009
   R Core Team, 2015, R LANG ENV STAT COMP
   Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325
   Revelle W., 2016, PSYCH PROCEDURES PER
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   SES, 1991, PLAN EM CONTR DENG F
   SES, 2013, PLAN AC CONTR DENG E
   SES, 2011, PLAN INT AC VIG CONT
   SES, 2016, ZIK VIR
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Siqueira JB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-361
   Stephan C., 2016, AMOSTRABRASIL GENERA
   Stephan C., 2016, EPIGAM MULTINOMIAL G
   Szklo M., 2014, EPIDEMIOLOGY
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Teurlai M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004211
   Thammapalo S, 2008, EPIDEMIOL INFECT, V136, P135, DOI 10.1017/S0950268807008126
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5
   Vargas WP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2097-3
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Vikram K, 2015, J VECTOR DIS, V52, P129
   WHO, 2012, DENG DENG HAEM FEV F
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
NR 81
TC 5
Z9 5
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD APR
PY 2018
VL 180
BP 47
EP 57
DI 10.1016/j.actatropica.2018.01.005
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FX6XY
UT WOS:000426231800008
PM 29352990
DA 2020-07-08
ER

PT J
AU Zheng, B
   Gu, WL
   Hu, LC
   Huang, MG
   Yu, JS
AF Zheng, Bo
   Gu, Wenliang
   Hu, Linchao
   Huang, Mugen
   Yu, Jianshe
TI COMPLEX WOLBACHIA INFECTION DYNAMICS IN MOSQUITOES WITH IMPERFECT
   MATERNAL TRANSMISSION
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
ID INDUCED CYTOPLASMIC INCOMPATIBILITY; SHORTENING WOLBACHIA;
   DROSOPHILA-SIMULANS; AEDES; POPULATIONS; EVOLUTION; SPREAD; DENGUE;
   ESTABLISHMENT; MECHANISM
AB Dengue, malaria, and Zika are dangerous diseases primarily transmitted by Aedes aegypti, Aedes albopictus, and Anopheles stephensi. In the last few years, a new disease control method, besides pesticide spraying to kill mosquitoes, has been developed by releasing mosquitoes carrying bacterium Wolbachia into the natural areas to infect the wild population of mosquitoes and block disease transmission. The bacterium is transmitted by infected mothers and the maternal transmission was assumed to be perfect in virtually all previous models. However, recent experiments on Aedes aegypti and Anopheles stephensi showed that the transmission can be imperfect. In this work, we develop a model to describe how the imperfect maternal transmission affects the dynamics of Wolbachia spread. We establish two useful identities and employ them to find sufficient and necessary conditions under which the system exhibits monomorphic, bistable, and polymorphic dynamics. These analytical results may help find a plausible explanation for the recent observation that the Wolbachia strain wMelPop failed to establish in the natural populations in Australia and Vietnam.
C1 [Zheng, Bo; Gu, Wenliang; Huang, Mugen; Yu, Jianshe] Guangzhou Univ, Coll Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China.
   [Hu, Linchao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510080, Guangdong, Peoples R China.
   [Hu, Linchao] Minist Educ, Key Lab Trop Dis Control SYSU, Guangzhou 510080, Guangdong, Peoples R China.
RP Yu, JS (corresponding author), Guangzhou Univ, Coll Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China.
EM zhengbo611@outlook.com; 2111415035@e.gzhu.edu.cn; linchaohu@outlook.com;
   mghuang@gzhu.edu.cn; jsyu@gzhu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11631005, 11626246, 11571084]; Program for
   Changjiang Scholars and Innovative Research Team in UniversityProgram
   for Changjiang Scholars & Innovative Research Team in University
   (PCSIRT) [IRT_16R16]; National Research and Development Plan of China
   [2016YFC1200500]
FX This work was supported by National Natural Science Foundation of China
   (11631005, 11626246, 11571084), Program for Changjiang Scholars and
   Innovative Research Team in University (IRT_16R16), and National
   Research and Development Plan of China (2016YFC1200500). We thank the
   anonymous reviewers for their careful reading of our manuscript and
   stimulating comments.
CR Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Carrington LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022565
   CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138
   Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876
   Farkas JZ, 2010, B MATH BIOL, V72, P2067, DOI 10.1007/s11538-010-9528-1
   FINE PEM, 1978, J INVERTEBR PATHOL, V31, P10, DOI 10.1016/0022-2011(78)90102-7
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Hamm CA, 2014, MOL ECOL, V23, P4871, DOI 10.1111/mec.12901
   Haygood R, 2009, EVOLUTION, V63, P432, DOI 10.1111/j.1558-5646.2008.00550.x
   Hirsch M. W., 2004, PURE APPL MATH, V60
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1988, GENETICS, V119, P435
   HOFFMANN AA, 1990, GENETICS, V126, P933
   Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hu LC, 2015, THEOR POPUL BIOL, V106, P32, DOI 10.1016/j.tpb.2015.09.003
   Huang MG, 2016, SCI CHINA MATH, V59, P1249, DOI 10.1007/s11425-016-5149-y
   Huang MG, 2015, SCI CHINA MATH, V58, P77, DOI 10.1007/s11425-014-4934-8
   Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343
   Kriesner P, 2016, EVOLUTION, V70, P979, DOI 10.1111/evo.12923
   Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Schraiber JG, 2012, J THEOR BIOL, V297, P26, DOI 10.1016/j.jtbi.2011.12.006
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x
   Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x
   TURELLI M, 1995, GENETICS, V140, P1319
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114
   Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405
   Xi ZY, 2005, APPL ENVIRON MICROB, V71, P3199, DOI 10.1128/AEM.71.6.3199-3204.2005
   Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
NR 41
TC 6
Z9 6
U1 0
U2 224
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PD APR
PY 2018
VL 15
IS 2
BP 523
EP 541
DI 10.3934/mbe.2018024
PG 19
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA FI5DL
UT WOS:000412001800010
PM 29161848
OA Other Gold
DA 2020-07-08
ER

PT J
AU Shang, ZF
   Son, H
   Shi, Y
   Qi, JX
   Gao, GF
AF Shang, Zifang
   Son, Hao
   Shi, Yi
   Qi, Jianxun
   Gao, George F.
TI Crystal Structure of the Capsid Protein from Zika Virus
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE Zika virus; capsid (C); RNA binding protein; virus assembly;
   protein-lipid interaction
ID MALE SEXUAL TRANSMISSION; DENGUE VIRUS; CORE PROTEIN;
   NUCLEAR-LOCALIZATION; BINDING PROPERTY; HELICASE; REVEALS; SYSTEM; SEMEN
AB Recently, Zika virus (ZIKV) emerged as a global public health concern and is distinct from other flaviviruses in many aspects, for example, causing transplacental infection, fetal abnormalities and vector-independent transmission through body fluids in humans. The capsid (C) protein is a multifunctional protein, since it binds to viral RNA in the process of nucleocapsid assembly and plays important roles in virus infection processes by interacting with cellular proteins, modulating cellular metabolism, apoptosis and immune response. Here we solved the crystal structure of ZIKV C protein at a resolution of 1.9 angstrom. The ZIKV C protein structure contains four alpha helices with a long pre-alpha 1 loop and forms dimers. The unique long pre-alpha 1 loop in ZIKV C contributes to the tighter association of dimeric assembly and renders a divergent hydrophobic feature at the lipid bilayer interface in comparison with the known C structures of West Nile and dengue viruses. We reported the interaction between the ZIKV C protein and lipid droplets through confocal microscopy analysis. Substitutions of key amino acids in the pre-alpha 1 loop of ZIKV C disrupted the interaction with lipid droplets, indicating that the loop is critical for membrane association. We also recognized that ZIKV C protein possesses broad binding capability to different nucleotide types, including single-stranded and double-stranded RNAs or DNAs. Furthermore, the highly positively charged interface, mainly formed by alpha 4 helix, is proposed to be responsible for nucleotide binding. These findings will greatly enhance our understanding of ZIKV C protein, providing information for anti-ZIKV drug design targeting the C protein. (C) 2018 Published by Elsevier Ltd.
C1 [Shang, Zifang; Son, Hao; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China.
   [Shang, Zifang; Shi, Yi; Gao, George F.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Shi, Yi; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Shi, Yi; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing 100101, Peoples R China.
   [Shi, Yi; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
RP Qi, JX; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China.
EM jxqi@im.ac.cn; gaof@im.ac.cn
FU CASDefence Research & Development Organisation (DRDO)Chinese Academy of
   Sciences [XDPB0301]; National Key Plan for Scientific Research and
   Development of China [2016YFD0500300]; National Science and Technology
   Major Project [2017ZX10303403]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [81622031]; CASDefence
   Research & Development Organisation (DRDO)Chinese Academy of Sciences;
   Youth Innovation Promotion Association CAS [2015078, 2017117]; China
   Association for Science Technology [2016QNRC001]; National Natural
   Science Foundation of China Innovative Research Group [81621091]
FX We thank the staff of BL17U beamline at Shanghai Synchrotron Radiation
   Facility. We are grateful to Yuanyuan Chen, Zhenwei Yang and Yihui Xu
   from the Institute of Biophysics, Chinese Academy of Sciences (CAS) for
   technical assistance with ITC and the confocal microscope experiments,
   respectively. We thank Zhennan Zhao (Institute of Microbiology CAS) for
   help with virus infection experiment. This work was supported by
   Strategic Priority Research Program of CAS (XDPB0301), the National Key
   Plan for Scientific Research and Development of China (2016YFD0500300)
   and the National Science and Technology Major Project (2017ZX10303403).
   Y.S. is supported by the Excellent Young Scientist Program from the
   National Natural Science Foundation of China (81622031), the Excellent
   Young Scientist Program of CAS and the Youth Innovation Promotion
   Association CAS (2015078). H.S. is supported by the Young Elite
   Scientist Sponsorship Program of China Association for Science &
   Technology (2016QNRC001) and the Youth Innovation Promotion Association
   CAS (2017117). G.F.G. is a leading principal investigator of the
   National Natural Science Foundation of China Innovative Research Group
   (Grant No. 81621091).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Cheong YK, 2011, MICROBES INFECT, V13, P76, DOI 10.1016/j.micinf.2010.10.014
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Debreczeni JE, 2012, ACTA CRYSTALLOGR D, V68, P425, DOI 10.1107/S0907444912000200
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Freire JM, 2015, FEBS J, V282, P2267, DOI 10.1111/febs.13274
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li HT, 2005, J IMMUNOL, V174, P195, DOI 10.4049/jimmunol.174.1.195
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Nemesio H, 2013, MOL MEMBR BIOL, V30, P273, DOI 10.3109/09687688.2013.805835
   Ni P, 2013, VIROLOGY, V446, P123, DOI 10.1016/j.virol.2013.07.023
   Noda M, 2012, BIOL-TARGETS THER, V6, P409, DOI 10.2147/BTT.S37792
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pong WL, 2011, FEBS LETT, V585, P2575, DOI 10.1016/j.febslet.2011.06.038
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Sharma S, 2017, J MED VIROL, V89, P1693, DOI 10.1002/jmv.24822
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tseng HN, 2007, VIRUS GENES, V35, P483, DOI 10.1007/s11262-006-0075-7
   Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x
   [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 59
TC 28
Z9 29
U1 3
U2 23
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAR 30
PY 2018
VL 430
IS 7
BP 948
EP 962
DI 10.1016/j.jmb.2018.02.006
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GC4LE
UT WOS:000429755200005
PM 29454707
DA 2020-07-08
ER

PT J
AU Schreur, PJW
   van Keulen, L
   Anjema, D
   Kant, J
   Kortekaas, J
AF Schreur, P. J. Wichgers
   van Keulen, L.
   Anjema, D.
   Kant, J.
   Kortekaas, J.
TI Microencephaly in fetal piglets following in utero inoculation of Zika
   virus
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID PLACENTAL PATHOLOGY; VIRAL-INFECTION; BIRTH-DEFECTS; MOUSE MODEL;
   PROLIFERATION; PREGNANCY; RHESUS; BRAIN; MICE; TRANSMISSION
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that became associated with microcephaly in newborns and Guillain-Barre syndrome in adults after its emergence in the Pacific and the Americas in 2015. Newly developed rodent and nonhuman primate models have already revealed important insights into ZIKV-induced neuropathology. Nonhuman primates are phylogenetically closely related to humans and are therefore preferred human surrogates in ZIKV research. However, the use of nonhuman primates, particularly during gestation, raises ethical issues. Considering that pigs also share many anatomical and physiological features with humans, this species may be an attractive alternative human surrogate for ZIKV research. Here, we inoculated 20 porcine fetuses in utero and assessed the effect of ZIKV on brain development 4 weeks later. All inoculated fetuses presented mild to severe neuropathology, characterized by a depletion of neurons in the cerebral cortex. In most cases, neuronal depletion was confined to specific cerebral lobes without affecting brain size, whereas in severe cases a more generalized depletion resulted in microencephaly. Although the virus was widespread in the sows' placenta at the time of necropsy only low levels of viral RNA were detected in fetal brain samples, thereby preventing the identification of primary target cells. Our findings suggest that pigs can be used to study ZIKV-induced neurodevelopmental defects as currently observed in human neonates, varying from stunted brain growth to localized cortical neuronal depletion in the absence of major macroscopic abnormalities.
C1 [Schreur, P. J. Wichgers; van Keulen, L.; Anjema, D.; Kant, J.; Kortekaas, J.] Wageningen Biovet Res, Houtribweg 39, NL-8221 RA Lelystad, Netherlands.
RP Schreur, PJW (corresponding author), Wageningen Biovet Res, Houtribweg 39, NL-8221 RA Lelystad, Netherlands.
EM paul.wichgersschreur@wur.nl
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Griffin DE, 2017, SCIENCE, V357, P33, DOI 10.1126/science.aan8626
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002
   Miner JJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3438
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Newman C, 2017, CURR OPIN VIROL, V25, P34, DOI 10.1016/j.coviro.2017.06.011
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Roberts DJ, 2016, LANCET, V388, P847, DOI 10.1016/S0140-6736(16)30930-8
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
NR 41
TC 13
Z9 13
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAR 29
PY 2018
VL 7
AR 42
DI 10.1038/s41426-018-0044-y
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GB5CQ
UT WOS:000429080400001
PM 29593256
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barzallo, DP
   Barzallo, AP
   Narvaez, E
AF Barzallo, Diana Pacheco
   Pacheco Barzallo, Andrea
   Narvaez, Eulalia
TI The 2016 Earthquake in Ecuador: Zika Outbreak After a Natural Disaster
SO HEALTH SECURITY
LA English
DT Article
DE Public health; Epidemics; Disaster risk management; Infectious diseases;
   Zika virus
ID GUILLAIN-BARRE-SYNDROME; COMMUNITY RESILIENCE; VIRUS-INFECTION;
   EPIDEMICS; RISK
AB The objective of this work was to examine the spread of the Zika virus after the destructive impact of the earthquake of April 2016 along the coast of Ecuador. Using a difference-in-difference estimation method and a unique dataset to track Zika cases at the national level, we estimated the impact of the earthquake on the reported cases of Zika in the affected region. Our results suggest that the earthquake increased the reported cases of Zika by 0.509 per epidemiologic week (data per 10,000 population), and we argue that the destroyed built environment along with other factors created a disease focus, where the virus spread easily. Because of its potential complications and devastating long-term effects, Zika represents a national threat. After a natural disaster, the health authorities, together with a multidisciplinary team and the wider community, all have an urgent responsibility to collaborate to minimize the health risks to the population.
C1 [Barzallo, Diana Pacheco] Swiss Parapleg Res, Hlth Serv Stat & Econ Unit, Nottwil, Switzerland.
   [Barzallo, Diana Pacheco] Univ Neuchatel, Fac Econ, Neuchatel, Switzerland.
   [Pacheco Barzallo, Andrea] Int Univ Ecuador, Quito, Ecuador.
   [Pacheco Barzallo, Andrea] Univ Politecn Madrid, Town & Reg Planning Dept, Madrid, Spain.
   [Narvaez, Eulalia] Publ Hlth Minist Ecuador, Epidemiol & Surveillance Dept, Quito, Ecuador.
RP Barzallo, DP (corresponding author), Swiss Parapleg Res, Hlth Serv Stat & Econ Unit, Nottwil, Switzerland.; Barzallo, DP (corresponding author), Univ Neuchatel, Fac Econ, Neuchatel, Switzerland.
EM diana.pachecobarzallo@paraplegie.ch
OI Pacheco Barzallo, Andrea Cecilia/0000-0002-0930-5148; Pacheco Barzallo,
   Diana/0000-0002-8816-4071
CR Ainuddin S, 2012, INT J DISAST RISK RE, V2, P25, DOI 10.1016/j.ijdrr.2012.07.003
   [Anonymous], 2016, EL COMERCIO
   [Anonymous], 2016, LA REPUBLICA
   Arziman I, 2015, TURK J EMERG MED, V15, P11, DOI 10.5505/1304.7361.2015.79923
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cash RA, 2013, LANCET, V382, P2094, DOI 10.1016/S0140-6736(13)61948-0
   Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013
   Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483
   Floret N, 2006, EMERG INFECT DIS, V12, P543, DOI 10.3201/eid1204.051569
   Ginige K, 2009, DISASTER PREV MANAG, V18, P23, DOI 10.1108/09653560910938510
   Haigh R., 2010, INT J DISASTER RESIL, V1, P11, DOI DOI 10.1108/17595901011026454
   Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/ERI.11.155, 10.1586/eri.11.155]
   Lemonick DM, 2011, AM J CLIN MED, V8
   Ministerio de Salud Publica del Ecuador, 2016, ENF TRANSM VECT ZIK
   Ministerio de Salud Publica del Ecuador, 2016, INF SIT ACT
   Noji Eric K, 2005, Crit Care Med, V33, pS29, DOI 10.1097/01.CCM.0000151064.98207.9C
   Organizacion Panamericana de la Salud, 2016, PUBLIC HLTH
   Organizacion Panamericana de la Salud, 2016, GUIA VIG ENF VIR ZIK
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paul BK, 1997, GEOFORUM, V28, P121, DOI 10.1016/S0016-7185(97)00004-3
   Pearce L, 2003, NAT HAZARDS, V28, P211, DOI 10.1023/A:1022917721797
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ortiz MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15706-w
   Saenz R, 1995, Prehosp Disaster Med, V10, P154
   Salazar MA, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31320
   Secretaria de Gestion de Riesgos, 2016, INF SIT GEN DESD CRI
   Secretaria de Gestion de Riesgos, 2016, INF SIT 65 TERR 7 8
   Secretaria de Vigilancia em Saude, 2015, SIT EP OC MICR BRAS
   Stewart-Ibarra AM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121516
   Taveau J, 2010, J LOSS PREVENT PROC, V23, P813, DOI 10.1016/j.jlp.2010.04.003
   Vasquez D, 2017, AM J PUBLIC HEALTH, V107, P1137, DOI 10.2105/AJPH.2017.303769
   Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779
   World Health Organization and others, 2006, WMMR WEEKLY MORBIDIT, P23
NR 34
TC 1
Z9 1
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD APR
PY 2018
VL 16
IS 2
BP 127
EP 134
DI 10.1089/hs.2017.0099
EA MAR 2018
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GB8MF
UT WOS:000428782800001
PM 29596013
DA 2020-07-08
ER

PT J
AU Ma, CP
   Jing, H
   Zhang, PS
   Han, LZ
   Zhang, ML
   Wang, FX
   Niu, SY
   Shi, C
AF Ma, Cuiping
   Jing, Hao
   Zhang, Pansong
   Han, Lingzhi
   Zhang, Meiling
   Wang, Fuxin
   Niu, Shuyan
   Shi, Chao
TI An ultrafast one-step assay for the visual detection of RNA virus
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID DNA-POLYMERASE; AMPLIFICATION; OUTBREAK; DISEASE; PCR
AB A one-step, rapid, and visual method was developed for the detection of RNA viruses and a few copies of the Zika RNA virus were directly detected within 25 min by naked-eye observation. This method will prove to be promising for point-of-care testing in out-of-lab and inconvenient settings.
C1 [Ma, Cuiping; Jing, Hao; Zhang, Pansong; Han, Lingzhi; Zhang, Meiling; Wang, Fuxin; Niu, Shuyan] Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Minist Educ, Coll Marine Sci & Biol Engn,Key Lab Sensor Anal T, Qingdao 266042, Peoples R China.
   [Shi, Chao] Qingdao Univ, Coll Life Sci, Qingdao 266071, Peoples R China.
RP Shi, C (corresponding author), Qingdao Univ, Coll Life Sci, Qingdao 266071, Peoples R China.
EM sc169@163.com
OI Ma, Cuiping/0000-0001-5491-7269
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31670868, 21675094]; Shandong Province Natural
   Science Fund Major Basic Research Project [ZR2017ZC0123]
FX We would like to express our thanks to Prof. Yuhai Bi for providing
   extracted Zika virus RNA. This study was financially supported by grants
   from the National Natural Science Foundation of China (31670868,
   21675094) and the Shandong Province Natural Science Fund Major Basic
   Research Project (ZR2017ZC0123).
CR Altan-Bonnet G, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLEtt.90.138101
   Beer NR, 2008, ANAL CHEM, V80, P1854, DOI 10.1021/ac800048k
   Bhadra S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123126
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443
   Du Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11039
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gootenberg J. S., 2017, SCIENCE
   Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065
   Jia HX, 2010, ANGEW CHEM INT EDIT, V49, P5498, DOI 10.1002/anie.201001375
   Jiang YS, 2015, ANAL CHEM, V87, P3314, DOI 10.1021/ac504387c
   Kaushik A, 2016, BIOSENS BIOELECTRON, V75, P254, DOI 10.1016/j.bios.2015.08.040
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   Liang XG, 2004, BIOCHEMISTRY-US, V43, P13459, DOI 10.1021/bi0489614
   Ma Y, 2017, ANALYST, V142, P147, DOI [10.1039/C6AN02192A, 10.1039/c6an02192a]
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Schmitt MW, 2015, NAT METHODS, V12, P423, DOI [10.1038/NMETH.3351, 10.1038/nmeth.3351]
   Shi C, 2016, CHEM COMMUN, V52, P11551, DOI 10.1039/c6cc05906f
   Shi C, 2015, J AM CHEM SOC, V137, P13804, DOI 10.1021/jacs.5b08144
   Tan E, 2008, BIOCHEMISTRY-US, V47, P9987, DOI 10.1021/bi800746p
   Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100
   Wang Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00753
   Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
NR 24
TC 2
Z9 2
U1 8
U2 35
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PD MAR 28
PY 2018
VL 54
IS 25
BP 3118
EP 3121
DI 10.1039/c8cc00150b
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA GB1XT
UT WOS:000428845500009
PM 29517791
DA 2020-07-08
ER

PT J
AU Liang, HB
   Yang, RH
   Liu, Z
   Li, M
   Liu, HT
   Jin, X
AF Liang, Huabin
   Yang, Ruoheng
   Liu, Zhihua
   Li, Min
   Liu, Haitao
   Jin, Xia
TI Recombinant Zika virus envelope protein elicited protective immunity
   against Zika virus in immunocompetent mice
SO PLOS ONE
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE VIRUS; MOUSE MODEL; SEXUAL TRANSMISSION;
   DOMAIN-III; VACCINE; EFFICACY; IMMUNOGENICITY; ANTIBODIES; INFECTION
AB Zika virus (ZIKV) has caused great public concerns due to its recent large outbreaks and a close association with microcephaly in fetus and Guillain-Barre syndrome in adults. Rapid development of vaccines against ZIKV is a public health priority. To this end, we have constructed and purified recombinant ZIKV envelope protein using both prokaryotic and eukaryotic expression systems, and then tested their immunogenicity and protective efficacy in immune competent mice. Both protein immunogens elicited humoral and cellular immune responses, and protected immune competent mice from ZIKV challenge in vivo. These products could be further evaluated either as stand-alone vaccine candidate, or used in a prime-and-boost regimen with other forms of ZIKV vaccine.
C1 [Liang, Huabin; Yang, Ruoheng; Liu, Zhihua; Li, Min; Liu, Haitao; Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.
   [Liang, Huabin; Yang, Ruoheng; Liu, Zhihua; Li, Min; Jin, Xia] Univ Chinese Acad Sci, Beijing, Peoples R China.
RP Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Jin, X (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.
EM xjin@ips.a.c.cn
OI liu, zhihua/0000-0002-8959-2350
FU National Key Program Project Grant from the Ministry of Science and
   Technology China [2016YFC1201000]; National Science Foundation of
   ChinaNational Natural Science Foundation of China [31670941]; Strategic
   Priority Research Program of the Chinese Academy of SciencesChinese
   Academy of Sciences [XDPB030405]
FX This study was supported in part by a National Key Program Project Grant
   from the Ministry of Science and Technology China
   (2016YFC1201000)(http://www.most.gov.cn/), a National Science Foundation
   of China grant (31670941)(http://www.nsfc.gov.cn/), and The Strategic
   Priority Research Program of the Chinese Academy of Sciences
   (XDPB030405)(http://www.cas.cn/). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   Chambers TJ, 2003, J VIROL, V77, P3655, DOI 10.1128/JVI.77.6.3655-3668.2003
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li DP, 2016, J VIROL, V90, P10486, DOI 10.1128/JVI.01462-16
   Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT MED
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   SRIVASTAVA AK, 1995, VACCINE, V13, P1251, DOI 10.1016/0264-410X(94)00059-V
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tebas P, 2017, N ENGL J MED
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yang M, 2017, VACCINE
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086573
   Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6
NR 62
TC 14
Z9 14
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 28
PY 2018
VL 13
IS 3
AR e0194860
DI 10.1371/journal.pone.0194860
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA8PV
UT WOS:000428603100081
PM 29590178
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fitzgerald, B
   Boyle, C
   Honein, MA
AF Fitzgerald, Brenda
   Boyle, Coleen
   Honein, Margaret A.
TI Birth Defects Potentially Related to Zika Virus Infection During
   Pregnancy in the United States
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
ID INFANTS; BRAZIL; BORN
C1 [Fitzgerald, Brenda; Boyle, Coleen; Honein, Margaret A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Honein, MA (corresponding author), Ctr Dis Control & Prevent, Birth Defects Branch, 1600 Clifton Rd,Mailstop E-86, Atlanta, GA 30333 USA.
EM mrh7@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Center for Disease Control and Prevention, 2015, PREGN WOM AN LAB EV
   Delaney A, 2016, MMWR MORB MORTAL WKL
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 8
TC 8
Z9 8
U1 1
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAR 27
PY 2018
VL 319
IS 12
BP 1195
EP 1196
DI 10.1001/jama.2018.0126
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GA5VW
UT WOS:000428403000007
PM 29372233
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Lai, HF
   Paul, AM
   Sun, HY
   He, JY
   Yang, M
   Bai, FW
   Chen, Q
AF Lai, Huafang
   Paul, Amber M.
   Sun, Haiyan
   He, Junyun
   Yang, Ming
   Bai, Fengwei
   Chen, Qiang
TI A plant-produced vaccine protects mice against lethal West Nile virus
   infection without enhancing Zika or dengue virus infectivity
SO VACCINE
LA English
DT Article
DE West Nile virus (WNV); Vaccine; Envelope protein; Domain Ill (Dill);
   Antibody-dependent enhancement (ADE); Zika virus (ZIKV); Dengue virus
   (DENV); Plant-produced vaccine; Plant-made pharmaceuticals
ID ANTIBODY-DEPENDENT ENHANCEMENT; MONOCLONAL-ANTIBODY; DOMAIN-III;
   STRUCTURAL BASIS; IMMUNIZATION; NANOPARTICLES; PATHOGENESIS; CHALLENGE
AB West Nile virus (WNV) has caused multiple global outbreaks with increased frequency of neuroinvasive disease in recent years. Despite many years of research, there are no licensed therapeutics or vaccines available for human use. One of the major impediments of vaccine development against WNV is the potential enhancement of infection by related flaviviruses in vaccinated subjects through the mechanism of antibody-dependent enhancement of infection (ADE). For instance, the recent finding of enhancement of Zika virus (ZIKV) infection by pre-exposure to WNV further complicates the development of WNV vaccines. Epidemics of WNV and the potential risk of ADE by current vaccine candidates demand the development of effective and safe vaccines. We have previously reported that the domain Ill (DIII) of the WNV envelope protein can be readily expressed in Nicotiana benthamiana leaves, purified to homogeneity, and promote antigen-specific antibody response in mice. Herein, we further investigated the in vivo potency of a plant-made DIII (plant-Dill) in providing protective immunity against WNV infection. Furthermore, we examined if vaccination with plant-Dill would enhance the risk of a subsequent infection by ZIKV and Dengue virus (DENV). Plant-DIII vaccination evoked antigen-specific cellular immune responses as well as humoral responses. Dill-specific antibodies were neutralizing and the neutralization titers met the threshold correlated with protective immunity by vaccines against multiple flaviviruses. Furthermore, passive administration of anti-plant Dill mouse serum provided full protection against a lethal challenge of WNV infection in mice. Notably, plant Dill-induced antibodies did not enhance ZIKV and DENV infection in Fc gamma receptor-expressing cells, addressing the concern of WNV vaccines in inducing cross-reactive antibodies and sensitizing subjects to subsequent infection by heterologous flavivirus. This study provides the first report of a WNV subunit vaccine that induces protective immunity, while circumventing induction of antibodies with enhancing activity for ZIKV and DENV infection. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Lai, Huafang; Sun, Haiyan; He, Junyun; Yang, Ming; Chen, Qiang] Arizona State Univ, Biodesign Inst, 1001 S McAllister Ave, Tempe, AZ 85287 USA.
   [Lai, Huafang; Sun, Haiyan; He, Junyun; Yang, Ming; Chen, Qiang] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.
   [Paul, Amber M.; Bai, Fengwei] Univ Southern Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.
RP Chen, Q (corresponding author), Arizona State Univ, Biodesign Inst, 1001 S McAllister Ave, Tempe, AZ 85287 USA.
EM qiang.chen.4@asu.edu
RI Yang, Ming/J-9215-2019
OI chen, qiang/0000-0003-1498-7013; Paul, Amber/0000-0002-1657-3618
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U01 AI075549, R33AI101329]
FX The authors thank Dr. J. Anderson at the Connecticut Agricultural
   Experiment Station for providing WNV-CT2741. We also thank E. Cheng for
   providing the graphic of a mouse in the figure. This work was supported
   in part by grants from National Institute of Allergy and Infectious
   Diseases (NIAID) # U01 AI075549 and # R33AI101329 to QC.
CR Alonso-Padilla J, 2011, VACCINE, V29, P1830, DOI 10.1016/j.vaccine.2010.12.081
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Chen Q., 2008, BIOL ENG, V1, P291, DOI DOI 10.13031/201326854
   Chen Q, 2016, POTENTIAL PLANTS SYS, V5, DOI [10.12688/f1000research.8010.1, DOI 10.12688/F1000RESEARCH.8010.1]
   Chen Q, 2018, ADV BOT RES, V86, P207, DOI 10.1016/bs.abr.2017.11.006
   Chen Q, 2016, METHODS MOL BIOL, V1385, P55, DOI 10.1007/978-1-4939-3289-4_4
   Chen Q, 2014, BIOMED RES INT, DOI 10.1155/2014/418064
   Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dejnirattisai W, 2016, NAT IMMUNOL
   Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768
   Dent M, 2016, J GEN VIROL, V97, P3280, DOI 10.1099/jgv.0.000635
   Diamond MS, 2006, TRENDS MICROBIOL, V14, P287, DOI 10.1016/j.tim.2006.05.004
   Firbas C, 2015, HUM VACC IMMUNOTHER, V11, P411, DOI 10.4161/21645515.2014.983412
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248
   He JY, 2014, BIOMED RES INT, DOI 10.1155/2014/952865
   He JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093541
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Lai HF, 2014, PLANT BIOTECHNOL J, V12, P1098, DOI 10.1111/pbi.12217
   Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521
   Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447
   Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x
   Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Minke JM, 2004, ARCH VIROL, P221
   Monath T. P., 2006, P NATL ACAD SCI US
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Paul AM, 2014, J GEN VIROL, V95, P1712, DOI 10.1099/vir.0.066084-0
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108
   Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun HY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010054
   Tuse D, 2014, BIOMED RES INT, DOI 10.1155/2014/256135
   Vogt MR, 2009, J VIROL, V83, P6494, DOI 10.1128/JVI.00286-09
   Yang M, 2017, PLANT BIOTECHNOL J, DOI [10.1111/nhi.12796, DOI 10.1111/NHI.12796]
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 53
TC 7
Z9 7
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAR 27
PY 2018
VL 36
IS 14
BP 1846
EP 1852
DI 10.1016/j.vaccine.2018.02.073
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GB9KQ
UT WOS:000429393100009
PM 29490880
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wang, HB
   Li, Z
   Niu, JL
   Xu, YF
   Ma, L
   Lu, AL
   Wang, X
   Qian, ZK
   Huang, Z
   Jin, X
   Leng, QB
   Wang, JH
   Zhong, J
   Sun, B
   Meng, GX
AF Wang, Hongbin
   Li, Zheng
   Niu, Junling
   Xu, Yongfen
   Ma, Li
   Lu, Ailing
   Wang, Xun
   Qian, Zhikang
   Huang, Zhong
   Jin, Xia
   Leng, Qibin
   Wang, Jianhua
   Zhong, Jin
   Sun, Bing
   Meng, Guangxun
TI Antiviral effects of ferric ammonium citrate
SO CELL DISCOVERY
LA English
DT Article
ID PHOSPHATE BINDER; ENTEROVIRUS 71; ZIKA VIRUS; IRON; HYPERPHOSPHATEMIA;
   IDENTIFICATION; VIRULENCE; JTT-751
AB Iron is an essential nutrient for cell survival and is crucial for DNA replication, mitochondrial function and erythropoiesis. However, the immunological role of iron in viral infections has not been well defined. Here we found the iron salt ferric ammonium citrate (FAC) inhibited Influenza A virus, HIV virus, Zika virus, and Enterovirus 71 (EV71) infections. Of note, both iron ion and citrate ion were required for the antiviral capability of FAC, as other iron salts and citrates did not exhibit viral inhibition. Mechanistically, FAC inhibited viral infection through inducing viral fusion and blocking endosomal viral release. These were further evidenced by the fact that FAC induced liposome aggregation and intracellular vesicle fusion, which was associated with a unique iron-dependent cell death. Our results demonstrate a novel antiviral function of FAC and suggest a therapeutic potential for iron in the control of viral infections.
C1 [Wang, Hongbin; Li, Zheng; Niu, Junling; Xu, Yongfen; Ma, Li; Lu, Ailing; Qian, Zhikang; Huang, Zhong; Jin, Xia; Leng, Qibin; Wang, Jianhua; Zhong, Jin; Sun, Bing; Meng, Guangxun] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
   [Wang, Xun] Shanghai Blood Ctr, Shanghai 200051, Peoples R China.
RP Meng, GX (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
EM gxmeng@ips.ac.cn
FU National Key Basic Research Programs of ChinaNational Basic Research
   Program of China [2015CB554302, 2014CB541905, 2016YFC1201000,
   2016YFE0133500]; Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [31570895, 31600146, 81761128012]; Strategic
   Priority Research Program Grant [XDPB0303]; International Partnership
   Program of Chinese Academy of Sciences [153831KYSB20160009]; Shanghai
   Sailing Program [16YF1412400]; Shanghai Natural Science
   FoundationNatural Science Foundation of Shanghai [16ZR1439900]; China
   Postdoctoral Science FoundationChina Postdoctoral Science Foundation
   [2016M601659]; TOTAL foundation for HFMD
FX This work was supported by grants from National Key Basic Research
   Programs of China (2015CB554302, 2014CB541905, 2016YFC1201000,
   2016YFE0133500), Natural Science Foundation of China (31570895,
   31600146, 81761128012), Strategic Priority Research Program Grant
   (XDPB0303), and International Partnership Program (153831KYSB20160009)
   of Chinese Academy of Sciences, Shanghai Sailing Program (16YF1412400),
   Shanghai Natural Science Foundation (16ZR1439900), China Postdoctoral
   Science Foundation (2016M601659), as well as the TOTAL foundation for
   HFMD.
CR Bek EJ, 2010, FUTURE VIROL, V5, P453, DOI 10.2217/FVL.10.22
   Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517
   Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010
   Crielaard BJ, 2017, NAT REV DRUG DISCOV, V16, P400, DOI 10.1038/nrd.2016.248
   Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930
   Esan MO, 2013, CLIN INFECT DIS, V57, P1626, DOI 10.1093/cid/cit528
   Fukushima T, 2012, P NATL ACAD SCI USA, V109, P16829, DOI 10.1073/pnas.1210131109
   Gallin John I, 2007, Trans Am Clin Climatol Assoc, V118, P175
   Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5
   Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6
   Gruenberg J, 2009, CURR OPIN CELL BIOL, V21, P582, DOI 10.1016/j.ceb.2009.03.008
   Hider RC, 2002, EUR J CLIN INVEST, V32, P50, DOI 10.1046/j.1365-2362.2002.0320s1050.x
   Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001
   Hsu CH, 1999, J AM SOC NEPHROL, V10, P1274
   Hu WB, 2015, VACCINE, V33, P374, DOI 10.1016/j.vaccine.2014.11.007
   Knipe D.M., 2006, FIELDS VIROLOGY
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liu QW, 2013, J VIROL METHODS, V187, P127, DOI 10.1016/j.jviromet.2012.09.024
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005
   Matsuo A, 2014, RENAL FAILURE, V36, P1291, DOI 10.3109/0886022X.2014.930491
   Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034
   Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X
   Patel M, 2012, INDIAN J CLIN BIOCHE, V27, P322, DOI 10.1007/s12291-012-0250-7
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Qin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027609
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rellan-Alvarez R, 2010, PLANT CELL PHYSIOL, V51, P91, DOI 10.1093/pcp/pcp170
   Ren RR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07384-5
   Silva AMN, 2009, DALTON T, P8616, DOI 10.1039/b910970f
   Thompson CA, 2014, AM J HEALTH-SYST PH, V71, P1822, DOI 10.2146/news140072
   Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947
   UNAIDS, 2017, UNAIDS DATA 2017
   Wang HB, 2015, CELL REP, V12, P42, DOI 10.1016/j.celrep.2015.05.047
   Yagil Y, 2015, THER ADV CHRONIC DIS, V6, P252, DOI 10.1177/2040622315589934
   Yokoyama K, 2014, NEPHRON CLIN PRACT, V128, P135, DOI 10.1159/000366482
NR 36
TC 10
Z9 10
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2056-5968
J9 CELL DISCOV
JI Cell Discov.
PD MAR 27
PY 2018
VL 4
AR UNSP 14
DI 10.1038/s41421-018-0013-6
PG 11
WC Cell Biology
SC Cell Biology
GA GB6OT
UT WOS:000429191200001
PM 29619244
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Thackray, LB
   Handley, SA
   Gorman, MJ
   Poddar, S
   Bagadia, P
   Briseno, CG
   Theisen, DJ
   Tan, Q
   Hykes, BL
   Lin, H
   Lucas, TM
   Desai, C
   Gordon, JI
   Murphy, KM
   Virgin, HW
   Diamond, MS
AF Thackray, Larissa B.
   Handley, Scott A.
   Gorman, Matthew J.
   Poddar, Subhajit
   Bagadia, Prachi
   Briseno, Carlos G.
   Theisen, Derek J.
   Tan, Qing
   Hykes, Barry L., Jr.
   Lin, Hueylie
   Lucas, Tiffany M.
   Desai, Chandni
   Gordon, Jeffrey I.
   Murphy, Kenneth M.
   Virgin, Herbert W.
   Diamond, Michael S.
TI Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of
   Multiple Flavivirus Infections
SO CELL REPORTS
LA English
DT Article
ID WEST-NILE-VIRUS; CD8(+) T-CELLS; DENDRITIC CELLS; GUT MICROBIOTA;
   UNITED-STATES; I INTERFERONS; MOUSE; BACTERIA; DENGUE; REPLICATION
AB Although the outcome of flavivirus infection can vary from asymptomatic to lethal, environmental factors modulating disease severity are poorly defined. Here, we observed increased susceptibility of mice to severe West Nile (WNV), Dengue, and Zika virus infections after treatment with oral antibiotics (Abx) that depleted the gut microbiota. Abx treatment impaired the development of optimal T cell responses, with decreased levels of WNV-specific CD8(+) T cells associated with increased infection and immunopathology. Abx treatments that resulted in enhanced WNV susceptibility generated changes in the overall structure of the gut bacterial community and in the abundance of specific bacterial taxa. As little as 3 days of treatment with ampicillin was sufficient to alter host immunity and WNV outcome. Our results identify oral Abx therapy as a potential environmental determinant of systemic viral disease, and they raise the possibility that perturbation of the gut microbiota may have deleterious consequences for subsequent flavivirus infections.
C1 [Thackray, Larissa B.; Gorman, Matthew J.; Poddar, Subhajit; Tan, Qing; Lin, Hueylie; Lucas, Tiffany M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Handley, Scott A.; Bagadia, Prachi; Briseno, Carlos G.; Theisen, Derek J.; Hykes, Barry L., Jr.; Desai, Chandni; Murphy, Kenneth M.; Virgin, Herbert W.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.
   [Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA.
   [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.
   [Virgin, Herbert W.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019; Desai, Chandni/AAA-5477-2020
OI Diamond, Michael/0000-0002-8791-3165; Desai,
   Chandni/0000-0002-3708-3634; Virgin, Herbert/0000-0001-8580-7628;
   Poddar, Subhajit/0000-0002-9764-3242
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI106772, AI07375, RO1DK30292,
   RO1DK101354, U19AI109725, RFAAI12027]; cWIDR at Washington University
   School of Medicine
FX NIH grants (U19AI106772 and AI07375 to M.S.D., RO1DK30292 to J.I.G.,
   RO1DK101354 and U19AI109725 to H.W.V., and RFAAI12027 to L.B.T.) and a
   pilot grant from cWIDR at Washington University School of Medicine to
   L.B.T. supported this work. K.M.M. is a Howard Hughes Medical Institute
   Investigator. We thank J. White for preliminary data, G. Zhao for data
   analysis, and L. Droit, J. Govero, J. Hong, M. Karlsson, C. Liu, M.
   Noll, D. O'Donnell, and S. Venkatesh for technical assistance.
CR Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011
   Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474
   Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025
   Balmer ML, 2014, J IMMUNOL, V193, P5273, DOI 10.4049/jimmunol.1400762
   Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745
   Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494
   Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568
   Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033
   Burrows MP, 2015, P NATL ACAD SCI USA, V112, P9973, DOI 10.1073/pnas.1508740112
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244
   De Burghgraeve T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037244
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223
   Ebel GD, 2001, EMERG INFECT DIS, V7, P650
   Fricke WF, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0103-8
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hand TW, 2016, TRENDS IMMUNOL, V37, P647, DOI 10.1016/j.it.2016.08.007
   Hicks LA, 2015, CLIN INFECT DIS, V60, P1308, DOI 10.1093/cid/civ076
   Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206
   Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147
   Josefsdottir KS, 2017, BLOOD, V129, P729, DOI 10.1182/blood-2016-03-708594
   Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599
   Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718
   Kaptein SJF, 2010, ANTIMICROB AGENTS CH, V54, P5269, DOI 10.1128/AAC.00686-10
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006
   Kim S, 2014, EUR J IMMUNOL, V44, P1936, DOI 10.1002/eji.201444450
   Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507
   Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597
   Kuhn KA, 2013, SEMIN IMMUNOL, V25, P364, DOI 10.1016/j.smim.2013.10.002
   Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057
   Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lim JK, 2010, J INFECT DIS, V201, P178, DOI 10.1086/649426
   Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321
   Lindsey NP, 2012, AM J TROP MED HYG, V87, P179, DOI 10.4269/ajtmh.2012.12-0113
   Loeb M, 2013, PUBLIC HEALTH GENOM, V16, P4, DOI 10.1159/000345934
   Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06
   Makhluf H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054220
   McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Michaelis M, 2007, J ANTIMICROB CHEMOTH, V60, P981, DOI 10.1093/jac/dkm307
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Pfeiffer JK, 2016, SCIENCE, V351, DOI 10.1126/science.aad5872
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Racsa L, 2014, DIAGN MICR INFEC DIS, V78, P132, DOI 10.1016/j.diagmicrobio.2013.11.006
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005027
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Sanchez MB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00658
   Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679
   Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08
   Shrestha B, 2007, J VIROL, V81, P11749, DOI 10.1128/JVI.01136-07
   Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06
   Shrestha B, 2012, J VIROL, V86, P8937, DOI 10.1128/JVI.00673-12
   Suda KJ, 2014, ANTIMICROB AGENTS CH, V58, P2763, DOI 10.1128/AAC.02239-13
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7
   Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004
   Williams JH, 2015, VET PATHOL, V52, P140, DOI 10.1177/0300985813520246
   Wu S, 2013, CURR MICROBIOL, V67, P414, DOI 10.1007/s00284-013-0380-z
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
   Zhang XCG, 2009, ANTIVIR RES, V83, P21, DOI 10.1016/j.antiviral.2009.02.204
NR 80
TC 24
Z9 26
U1 3
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD MAR 27
PY 2018
VL 22
IS 13
BP 3440
EP +
DI 10.1016/j.celrep.2018.03.001
PG 20
WC Cell Biology
SC Cell Biology
GA GA5TJ
UT WOS:000428396300008
PM 29590614
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Lambert, B
   Sikulu-Lord, MT
   Mayagaya, VS
   Devine, G
   Dowell, F
   Churcher, TS
AF Lambert, Ben
   Sikulu-Lord, Maggy T.
   Mayagaya, Vale S.
   Devine, Greg
   Dowell, Floyd
   Churcher, Thomas S.
TI Monitoring the Age of Mosquito Populations Using Near-Infrared
   Spectroscopy
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LEAST-SQUARES REGRESSION; ANOPHELES-GAMBIAE
AB Mosquito control with bednets, residual sprays or fumigation remains the most effective tool for preventing vector-borne diseases such as malaria, dengue and Zika, though there are no widely used entomological methods for directly assessing its efficacy. Mosquito age is the most informative metric for evaluating interventions that kill adult mosquitoes but there is no simple or reliable way of measuring it in the field. Near-Infrared Spectroscopy (NIRS) has been shown to be a promising, high-throughput method that can estimate the age of mosquitoes. Currently the ability of NIRS to measure mosquito age is biased, and has relatively high individual mosquito measurement error, though its capacity to rigorously monitor mosquito populations in the field has never been assessed. In this study, we use machine learning methods from the chemometric literature to generate more accurate, unbiased estimates of individual mosquito age. These unbiased estimates produce precise population-level measurements, which are relatively insensitive to further increases in NIRS accuracy when feasible numbers of mosquitoes are sampled. The utility of NIRS to directly measure the impact of pyrethroid resistance on mosquito control is illustrated, showing how the technology has potential as a highly valuable tool for directly assessing the efficacy of mosquito control interventions.
C1 [Lambert, Ben] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
   [Lambert, Ben; Churcher, Thomas S.] Imperial Coll London, MRC Ctr Outbreak Anal & Modelling, Infect Dis Epidemiol, London W2 1PG, England.
   [Sikulu-Lord, Maggy T.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia.
   [Mayagaya, Vale S.] Ifakara Hlth Inst, Ifakara Branch, Biomed Unit, Ifakara, Tanzania.
   [Mayagaya, Vale S.] Ifakara Hlth Inst, Dar Es Salaam Branch, Biomed Unit, Dar Es Salaam, Tanzania.
   [Devine, Greg] QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia.
   [Dowell, Floyd] ARS, USDA, Ctr Grain & Anim Hlth Res, 1515 Coll Ave, Manhattan, KS 66502 USA.
RP Lambert, B (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.; Lambert, B (corresponding author), Imperial Coll London, MRC Ctr Outbreak Anal & Modelling, Infect Dis Epidemiol, London W2 1PG, England.
EM ben.c.lambert@gmail.com
RI Devine, Gregor J/H-1141-2014
OI Devine, Gregor J/0000-0001-6312-0390; Churcher,
   Thomas/0000-0002-8442-0525
FU UK Medical Research Council (MRC)Medical Research Council UK (MRC)
   [MR/P01111X/1]; EPSRC scholarshipEngineering & Physical Sciences
   Research Council (EPSRC) [EP/F500394/1]; MRC/UK Department for
   International Development (DFID) under the MRC/DFID Concordat agreement
FX The work was supported by UK Medical Research Council (MRC) Project
   Grant (MR/P01111X/1), an EPSRC scholarship (EP/F500394/1), and the
   MRC/UK Department for International Development (DFID) under the
   MRC/DFID Concordat agreement. Mention of trade names or commercial
   products in this publication is solely for the purpose of providing
   specific information and does not imply recommendation or endorsement by
   the U.S. Department of Agriculture. USDA is an equal opportunity
   provider and employer.
CR Balabin RM, 2011, ANALYST, V136, P1703, DOI 10.1039/c0an00387e
   Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Charlwood J. D., 2004, ECOLOGICAL ASPECTS A, P47
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Churcher TS, 2016, ELIFE, V5, DOI 10.7554/eLife.16090
   Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103
   Desena ML, 1999, J MED ENTOMOL, V36, P811, DOI 10.1093/jmedent/36.6.811
   DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13
   Dowell FE, 2011, AM J TROP MED HYG, V85, P1093, DOI 10.4269/ajtmh.2011.11-0438
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   GILLIES MT, 1965, B ENTOMOL RES, V56, P237, DOI 10.1017/S0007485300056339
   Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324
   Kleinschmidt I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0782-4
   LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539
   Li HD, 2009, CHEMOMETR INTELL LAB, V95, P188, DOI 10.1016/j.chemolab.2008.10.007
   Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516
   Liebman K, 2015, AM J TROP MED HYG, V92, P1070, DOI 10.4269/ajtmh.14-0790
   Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192
   Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010
   Norgaard L, 2000, APPL SPECTROSC, V54, P413, DOI 10.1366/0003702001949500
   Ntamatungiro AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-298
   Penny MA, 2016, LANCET, V387, P367, DOI 10.1016/S0140-6736(15)00725-4
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Rohani A., 2009, SE ASIAN J TROP MED, V40, P5
   Scientific Thermo, 2018, GRAMS SUIT SOL VIS P
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Sikulu M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-186
   Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49
   Sikulu MT, 2015, J PROTEOMICS, V126, P234, DOI 10.1016/j.jprot.2015.06.008
   Sikulu MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090657
   Sikulu-Lord M. T., 2016, PLOS NEGLECT TROP D, V10, P10
   Viana M, 2016, P NATL ACAD SCI USA, V113, P8975, DOI 10.1073/pnas.1603431113
   WHO, 2016, WORLD MAL REP 2016
   Wold H., 1985, ENCY STAT SCI
   Yao F, 2005, ANN STAT, V33, P2873, DOI 10.1214/009053605000000660
   Zou XB, 2010, ANAL CHIM ACTA, V667, P14, DOI 10.1016/j.aca.2010.03.048
NR 37
TC 9
Z9 9
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 27
PY 2018
VL 8
AR 5274
DI 10.1038/s41598-018-22712-z
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA5IS
UT WOS:000428367600005
PM 29588452
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Borges, ALV
   Moreau, C
   Burke, A
   dos Santos, OA
   Chofakian, CB
AF Borges, A. L., V
   Moreau, C.
   Burke, A.
   dos Santos, O. A.
   Chofakian, C. B.
TI Women's reproductive health knowledge, attitudes and practices in
   relation to the Zika virus outbreak in northeast Brazil (vol 13,
   e0190024, 2018)
SO PLOS ONE
LA English
DT Correction
C1 [Borges, A. L., V; dos Santos, O. A.; Chofakian, C. B.] Univ Sao Paulo, Sch Nursing, Dept Publ Hlth Nursing, Sao Paulo, SP, Brazil.
   [Moreau, C.; Burke, A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA.
   [Burke, A.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21205 USA.
   [Moreau, C.] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Gender Sexual & Reprod Hlth, Le Kremlin Bicetre, France.
RP Borges, ALV (corresponding author), Univ Sao Paulo, Sch Nursing, Dept Publ Hlth Nursing, Sao Paulo, SP, Brazil.
RI santos, osmara/AAH-6719-2020; Moreau, Caroline/A-8989-2019; Chofakian,
   Christiane Borges do Nascimento/S-2179-2017
OI Moreau, Caroline/0000-0002-8637-6249; Chofakian, Christiane Borges do
   Nascimento/0000-0002-5953-3296
CR Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024
NR 1
TC 0
Z9 0
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 26
PY 2018
VL 13
IS 3
AR e0195150
DI 10.1371/journal.pone.0195150
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA5DH
UT WOS:000428351800081
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Eskildsen, GA
   Rovira, JR
   Smith, O
   Miller, MJ
   Bennett, KL
   McMillan, WO
   Loaiza, J
AF Eskildsen, Gilberto A.
   Rovira, Jose R.
   Smith, Octavio
   Miller, Matthew J.
   Bennett, Kelly L.
   McMillan, W. Owen
   Loaiza, Jose
TI Maternal invasion history of Aedes aegypti and Aedes albopictus into the
   Isthmus of Panama: Implications for the control of emergent viral
   disease agents
SO PLOS ONE
LA English
DT Article
ID YELLOW-FEVER MOSQUITO; POPULATION-GENETICS; VECTOR; CULICIDAE; DIPTERA;
   PHYLOGEOGRAPHY; SOFTWARE; SPREAD; DENGUE; TIGER
AB Despite an increase in dengue outbreaks and the arrival of chikungunya and Zika disease in Panama, studies on the demographic history of the invasive Aedes mosquitoes that are the principle vectors of these diseases are still lacking in this region. Here, we assess the genetic diversity of these mosquitoes in order to decipher their invasion histories into the Isthmus of Panama. DNA sequences from the mitochondrial cytochrome C oxidase I gene obtained from 30 localities in 10 provinces confirmed the presence of more than one mitochondrial haplogroup (i.e., maternal lineage) in each species. The invasion of Aedes albopictus was likely from temperate European countries, as the most frequent and widespread haplogroup in Panama harbored variants that are uncommon elsewhere in the Americas. Two infrequent and geographically restricted Ae. albopictus haplotypes appear to have subsequently invaded Panama from neighboring Costa Rica and the USA, respectively. In addition, we recovered two deeply divergent mitochondrial clades in Panamanian Aedes aegypti. The geographic origins of these clades is unknown, given that divergence in the mitochondrial genome is probably due to ancient population processes within the native range of Ae. aegypti, rather than due to its global expansion out of Africa. However, Panamanian Ae. aegypti mitochondrial sequences within the first Glade were closely related to others from Colombia, Bolivia, Brazil, Mexico and the USA, suggesting two separate invasions from Western Hemisphere source populations. The pattern of increased genetic diversity in Aedes mosquitoes in Panama is likely facilitated by the numerous land and water inter-connections across the country, which allows them to enter via sea- and land-transportation from Europe, North, Central and South America. Our results here should be considered in disease mitigation programs if emergent arboviruses are to be effectively diminished in Panama through vector suppression.
C1 [Eskildsen, Gilberto A.; Rovira, Jose R.; Miller, Matthew J.; Loaiza, Jose] Inst Invest Cient & Serv Alta Tecnol, Panama City, Panama.
   [Eskildsen, Gilberto A.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, India.
   [Rovira, Jose R.; Bennett, Kelly L.; McMillan, W. Owen; Loaiza, Jose] Smithsonian Trop Res Inst, Unit 0948, Panama City, Panama.
   [Smith, Octavio] Ctr Agua Trop Humedo Amer Latina & El Caribe, Panama City, Panama.
   [Miller, Matthew J.] Univ Oklahoma, Sam Noble Oklahoma Museum Nat Hist, Norman, OK 73019 USA.
   [Miller, Matthew J.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.
   [Loaiza, Jose] Univ Panama, Programa Ctr Amer Maestria Entomol, Panama City, Panama.
RP Loaiza, J (corresponding author), Inst Invest Cient & Serv Alta Tecnol, Panama City, Panama.; Loaiza, J (corresponding author), Smithsonian Trop Res Inst, Unit 0948, Panama City, Panama.; Loaiza, J (corresponding author), Univ Panama, Programa Ctr Amer Maestria Entomol, Panama City, Panama.
EM jloaiza@indicasat.org.pa
RI ; Miller, Matthew/B-4560-2008
OI Bennett, Kelly/0000-0003-0330-5275; Miller, Matthew/0000-0002-2939-0239
FU Secretaria Nacional de Ciencia, Tecnologia e Innovacion de Panama
   [SENACYT- IDDS15_047]
FX This work was supported by Secretaria Nacional de Ciencia, Tecnologia e
   Innovacion de Panama (SENACYT- IDDS15_047). http:/www.senacyt.gob.pa/.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Battaglia V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00208
   Bell Jonathan, 2008, Biotechniques, V44, P834, DOI 10.2144/000112890
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bennett KL, 2016, MOL ECOL, V25, P4337, DOI 10.1111/mec.13762
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Brown L, 2014, PUBLIC HEALTH, V128, P29, DOI 10.1016/j.puhe.2013.09.006
   Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002
   CORNEL AJ, 1991, J AM MOSQUITO CONTR, V7, P107
   da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   Futami K, 2015, J ECON ENTOMOL, V108, P761, DOI 10.1093/jee/tou028
   Gorman K, 2016, PEST MANAG SCI, V72, P618, DOI 10.1002/ps.4151
   Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008
   Jaimes-Duenez J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003553
   KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Miller MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003383
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   ROGERS AR, 1992, MOL BIOL EVOL, V9, P552
   Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1
   Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895
   Shaikevich E, 2013, ISRN ENTOMOL, V2013, P1, DOI DOI 10.1155/2013/157426
   Shi QM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2213-6
   TABACHNICK WJ, 1979, GENET RES, V34, P215, DOI 10.1017/S0016672300019467
   TAJIMA F, 1989, GENETICS, V123, P585
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Usmani- Brown S, 2009, BIOMED CENTRAL, V102, P144, DOI [https:// doi. org/ 10. 1603/ 008. 102. 0116, 10. 1603/ 008. 102. 0116, DOI 10.1186/313071016-1505-6]
   Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Zhang RL, 2018, MITOCHONDRIAL DNA A, V29, P594, DOI 10.1080/24701394.2017.1325481
NR 50
TC 6
Z9 6
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 26
PY 2018
VL 13
IS 3
AR e0194874
DI 10.1371/journal.pone.0194874
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA5DH
UT WOS:000428351800063
PM 29579112
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Prow, NA
   Liu, L
   Nakayama, E
   Cooper, TH
   Yan, KX
   Eldi, P
   Hazlewood, JE
   Tang, B
   Le, TT
   Setoh, YX
   Khromykh, AA
   Hobson-Peters, J
   Diener, KR
   Howley, PM
   Hayball, JD
   Suhrbier, A
AF Prow, Natalie A.
   Liu, Liang
   Nakayama, Eri
   Cooper, Tamara H.
   Yan, Kexin
   Eldi, Preethi
   Hazlewood, Jessamine E.
   Tang, Bing
   Le, Thuy T.
   Setoh, Yin Xiang
   Khromykh, Alexander A.
   Hobson-Peters, Jody
   Diener, Kerrilyn R.
   Howley, Paul M.
   Hayball, John D.
   Suhrbier, Andreas
TI A vaccinia-based single vector construct multi-pathogen vaccine protects
   against both Zika and chikungunya viruses
SO NATURE COMMUNICATIONS
LA English
DT Article
ID AEDES-AEGYPTI MOSQUITOS; HUMORAL IMMUNITY; IN-VIVO; INFECTION; MICE;
   CELL; DNA; VACCINATIONS; TRANSMISSION; REPLICATION
AB Zika and chikungunya viruses have caused major epidemics and are transmitted by Aedes aegypti and/or Aedes albopictus mosquitoes. The "Sementis Copenhagen Vector" (SCV) system is a recently developed vaccinia-based, multiplication-defective, vaccine vector technology that allows manufacture in modified CHO cells. Herein we describe a single-vector construct SCV vaccine that encodes the structural polyprotein cassettes of both Zika and chikungunya viruses from different loci. A single vaccination of mice induces neutralizing antibodies to both viruses in wild-type and IFNAR(-/-) mice and protects against (i) chikungunya virus viremia and arthritis in wild-type mice, (ii) Zika virus viremia and fetal/placental infection in female IFNAR(-/-) mice, and (iii) Zika virus viremia and testes infection and pathology in male IFNAR(-/-) mice. To our knowledge this represents the first single-vector construct, multi-pathogen vaccine encoding large polyproteins, and offers both simplified manufacturing and formulation, and reduced "shot burden" for these often co-circulating arboviruses.
C1 [Prow, Natalie A.; Nakayama, Eri; Yan, Kexin; Hazlewood, Jessamine E.; Tang, Bing; Le, Thuy T.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia.
   [Prow, Natalie A.; Khromykh, Alexander A.; Suhrbier, Andreas] Australian Infect Dis Res Ctr, Brisbane, Qld 4029, Australia.
   [Prow, Natalie A.; Khromykh, Alexander A.; Suhrbier, Andreas] Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.
   [Liu, Liang; Cooper, Tamara H.; Eldi, Preethi; Diener, Kerrilyn R.; Hayball, John D.] Univ South Australia, Inst Hlth Res, Sch Pharm & Med Sci, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
   [Nakayama, Eri] Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan.
   [Setoh, Yin Xiang; Khromykh, Alexander A.; Hobson-Peters, Jody] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.
   [Diener, Kerrilyn R.; Hayball, John D.] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia.
   [Diener, Kerrilyn R.; Hayball, John D.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5005, Australia.
   [Howley, Paul M.] Sementis Ltd, Berwick, Vic 3806, Australia.
RP Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia.; Suhrbier, A (corresponding author), Australian Infect Dis Res Ctr, Brisbane, Qld 4029, Australia.; Suhrbier, A (corresponding author), Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.; Hayball, JD (corresponding author), Univ South Australia, Inst Hlth Res, Sch Pharm & Med Sci, Expt Therapeut Lab, Adelaide, SA 5000, Australia.; Hayball, JD (corresponding author), Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia.; Hayball, JD (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5005, Australia.; Howley, PM (corresponding author), Sementis Ltd, Berwick, Vic 3806, Australia.
EM Paul.Howley@sementis.com.au; john.hayball@unisa.edu.au;
   Andreas.Suhrbier@qimrberghofer.edu.au
RI Cooper, Tamara/F-3702-2013; Khromykh, Alexander/X-7200-2018; Setoh, Yin
   Xiang/K-4503-2012; Liu, Liang/F-4519-2013; Hayball, John/F-4137-2013
OI Khromykh, Alexander/0000-0001-6206-6935; Setoh, Yin
   Xiang/0000-0002-1683-3555; Yan, Kexin/0000-0003-2203-217X; Liu,
   Liang/0000-0002-6272-2565; Hayball, John/0000-0002-3089-4506; Diener,
   Kerrilyn/0000-0001-8417-5542
FU Queensland Government, Australia; National Health and Medical Research
   Council of AustraliaNational Health and Medical Research Council of
   Australia; Sementis Ltd. via Australian Department of Industry,
   Enterprise Connect Researchers in Business Fellowships; Sementis Ltd.
   via Science Industry Endowment Fund, STEM+ Business Fellowship; Sementis
   Ltd. via Australian Research Council [LP160100633]; Daiichi Sankyo
   Foundation of Life Science
FX We thank the QIMR B animal house staff for their assistance and supply
   of GMO mice, and Clay Winterford and his team at QIMR B for their help
   with histology and immunohistochemistry. We thank Dr I Anraku for his
   assistance in managing the BSL3 facility at QIMR B. Thanks also to
   Caitlin O'Brien (UQ) for help with the ZIKV antigen preparations. N.A.P.
   was supported by an Advance Queensland Research Fellowship from the
   Queensland Government, Australia. A.S. holds a Principal Research
   Fellowship from the National Health and Medical Research Council of
   Australia. This work was also supported in part by Sementis Ltd. via (i)
   Australian Department of Industry, Enterprise Connect Researchers in
   Business Fellowships for L.L. and T.H.C., (ii) a Science Industry
   Endowment Fund, STEM+ Business Fellowship for T.H.C and L.L. and (iii)
   an Australian Research Council Linkage grant LP160100633 awarded to
   J.D.H. and P.M.H. E.N. was supported in part by the Daiichi Sankyo
   Foundation of Life Science.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Alcock R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000490
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092
   Ansarah-Sobrinho C, 2004, J VIROL, V78, P6855, DOI 10.1128/JVI.78.13.6855-6863.2004
   Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Eldi P, 2017, MOL THER, V25, P2332, DOI 10.1016/j.ymthe.2017.06.017
   ETLINGER HM, 1990, SCIENCE, V249, P423, DOI 10.1126/science.1696030
   Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Greenberg RN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138348
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Halle S, 2016, IMMUNITY, V44, P233, DOI 10.1016/j.immuni.2016.01.010
   Hugo LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1838-1
   Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200
   JOKLIK WK, 1964, J MOL BIOL, V10, P452, DOI 10.1016/S0022-2836(64)80066-8
   Kannanganat S, 2010, J IMMUNOL, V185, P7262, DOI 10.4049/jimmunol.1000751
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2017, J INFECT CHEMOTHER, V23, P114, DOI 10.1016/j.jiac.2016.08.003
   LALINN M, 1995, J VIROL METHODS, V52, P51
   Lauer K. B., 2017, PREPRINT
   Lauer KB, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00298-16
   Lee AW, 2017, EXPERT REV VACCINES, V16, P85, DOI 10.1080/14760584.2017.1268920
   Liu L, 2017, BIOTECHNIQUES, V62, P183, DOI 10.2144/000114537
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Nichols DB, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080215
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Overton ET, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv040
   PERKUS ME, 1985, SCIENCE, V229, P981, DOI 10.1126/science.2992092
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Prabakaran M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107316
   Price N, 2000, VIROLOGY, V267, P65, DOI 10.1006/viro.1999.0116
   Prow NA, 2014, J VIROL, V88, P9947, DOI 10.1128/JVI.01304-14
   Rattanasena P, 2011, IMMUNOL CELL BIOL, V89, P426, DOI 10.1038/icb.2010.99
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   SALZMAN NP, 1960, VIROLOGY, V10, P150, DOI 10.1016/0042-6822(60)90015-5
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Sherritt MA, 2000, EUR J IMMUNOL, V30, P671, DOI 10.1002/1521-4141(200002)30:2<671::AID-IMMU671>3.3.CO;2-8
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   SMITH GL, 1983, GENE, V25, P21, DOI 10.1016/0378-1119(83)90163-4
   Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x
   Suhrbier A, 2016, AUST NZ J PUBL HEAL, V40, P207, DOI 10.1111/1753-6405.12515
   Suhrbier Andreas, 2002, Expert Rev Vaccines, V1, P207, DOI 10.1586/14760584.1.2.207
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Tree JA, 2016, HUM VACC IMMUNOTHER, V12, P1795, DOI 10.1080/21645515.2015.1134070
   Verardi PH, 2001, J VIROL, V75, P11, DOI 10.1128/JVI.75.1.11-18.2001
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108
   Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006
   Wilson JAC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006155
   Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 64
TC 25
Z9 25
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 26
PY 2018
VL 9
AR 1230
DI 10.1038/s41467-018-03662-6
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA3OB
UT WOS:000428237700009
PM 29581442
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tavares, M
   da Silva, MRM
   de Siqueira, LBD
   Rodrigues, RAS
   Bodjolle-d'Almeida, L
   dos Santos, EP
   Ricci, E
AF Tavares, Melanie
   Mattos da Silva, Marcio Robert
   de Oliveira de Siqueira, Luciana Betzler
   Schuenck Rodrigues, Raphaela Aparecida
   Bodjolle-d'Almeida, Lolita
   dos Santos, Elisabete Pereira
   Ricci-Junior, Eduardo
TI Trends in insect repellent formulations: A review
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Review
DE Formulation; Repellent; Safety; Efficacy; Toxicity
ID SOLID LIPID NANOPARTICLES; ESSENTIAL OILS; AEDES-AEGYPTI; CITRONELLA
   OIL; MOSQUITO REPELLENTS; CONTROLLED-RELEASE; PERSONAL PROTECTION; SKIN
   ABSORPTION; IXODES-RICINUS; DIPTERA
AB The use of natural and synthetic repellents, marketed in different pharmaceutical forms, is growing in the world due to the emerging vector-borne viral diseases as Dengue, Zika, Chikungunya, Yellow Fever and Malaria. The choice of the ideal formulation will depend on a series of factors to be analyzed: type of repellent active (natural or synthetic), pharmaceutical forms (spray, lotion, cream, gel), action time duration (short or long), environment of exposure and the user (adult, pregnant women, children, newborn). The most used repellents are DEET, IR3535 (Ethyl Butylacetylaminopropionate) (EB), Icaridin (Picaridin) and essential oils, each of them presenting advantages and disadvantages. DEET is the oldest and the most powerful repellent available in the market, thus being the reference standard. For this reason, there are many classic formulations available in the market containing the chemical component DEET in spray forms and lotions. However, due to its toxicity, DEET is not recommended for children up to 6 months and pregnant women. DEET has been an option along with other market-shared products as IR3535 and Icaridin (Picaridin), which present less toxicity in their composition. IR3535 is the less toxic and may be prescribed for children over 6 months of age and pregnant women so that they have been the best option because of the lower toxicity levels presented. IR3535 is the one that has the lowest toxicity level among the three options and may be prescribed for children above 6 months of age and pregnant women.
   Icaridin is as potent as DEET, but less toxic, and has the advantage of having the long-lasting action among the aforementioned repellents. The new formulations have been based on controlled release systems (CRS). The CRSs for repellents comprise polymer micro/nanocapsules, micro/solid lipid nanoparticles, nanoemulsions/microemulsions, liposomes/niosomes, nanostructured hydrogels and cyclodextrins. There are many formulations based on micro and nanocapsules containing DEET and essential oils to increase repellent action time duration and decrease permeation and consequently, systemic toxicity. The development of new formulations for the IR3535 and Icaridin is a research field yet to be explored. The current trend is the use of natural repellent actives such as essential oils, which present low toxicity, do not harm the environment, but present reduced repellent action time due to rapid evaporation after skin application. CRSs have been used as vehicle of natural repellents to improve long-lasting repellent action, reduce skin permeation and systemic effects.
C1 [Tavares, Melanie; Mattos da Silva, Marcio Robert; de Oliveira de Siqueira, Luciana Betzler; Schuenck Rodrigues, Raphaela Aparecida; dos Santos, Elisabete Pereira; Ricci-Junior, Eduardo] Univ Fed Rio de Janeiro, Dept Med, Lab Desenvolvimento Galenico LADEG, Fac Pharm, Carlos Chagas Filho Ave, BR-21941590 Rio De Janeiro, Brazil.
   [Bodjolle-d'Almeida, Lolita] Aix Marseille Univ, Fac Pharm, Marseille, France.
RP Tavares, M (corresponding author), Univ Fed Rio de Janeiro, Dept Med, Lab Desenvolvimento Galenico LADEG, Fac Pharm, Carlos Chagas Filho Ave, BR-21941590 Rio De Janeiro, Brazil.
EM mel.tavares@ufrj.br
RI Tavares, Melanie/E-8109-2018; Betzler, Luciana/AAE-3345-2019; amsalu,
   ribka/G-8780-2019; Santos, Elisabete P/D-3710-2015
OI Tavares, Melanie/0000-0003-1903-6751; Santos,
   Elisabete/0000-0002-6712-0643
CR Abagli AZ, 2012, J AM MOSQUITO CONTR, V28, P15, DOI 10.2987/11-6181.1
   Agrawal N, 2017, ULTRASON SONOCHEM, V36, P367, DOI 10.1016/j.ultsonch.2016.11.037
   Akhtar Y, 2012, PHYSIOL ENTOMOL, V37, P81, DOI 10.1111/j.1365-3032.2011.00824.x
   Anjali CH, 2010, ECOTOX ENVIRON SAFE, V73, P1932, DOI 10.1016/j.ecoenv.2010.08.039
   [Anonymous], 2016, MED LETT DRUGS THER, V58, P83
   [Anonymous], 2016, NAN
   [Anonymous], 1996, TRI NEWS
   [Anonymous], 2009, NPIC GEN FACT SHEETS
   Anvisa. Cosmetics Tehcnical Group - Catec, 2006, COSM TEHCN GROUP CAT
   Appel KE, 2008, INT J HYG ENVIR HEAL, V211, P88, DOI 10.1016/j.ijheh.2007.10.005
   Ashitani T, 2015, EXP APPL ACAROL, V67, P595, DOI 10.1007/s10493-015-9965-5
   Balaji APB, 2017, J KING SAUD UNIV SCI, V29, P517, DOI 10.1016/j.jksus.2016.12.005
   Balaji APB, 2015, COLLOID SURFACE B, V128, P370, DOI 10.1016/j.colsurfb.2015.02.034
   Banerjee S, 2013, CARBOHYD POLYM, V93, P691, DOI 10.1016/j.carbpol.2013.01.028
   Barnard DR, 1999, J MED ENTOMOL, V36, P625, DOI 10.1093/jmedent/36.5.625
   Barradas TN, 2013, INT J PHARMACEUT, V454, P633, DOI 10.1016/j.ijpharm.2013.05.050
   Brazil Healthy Ministry, 2016, EP REP, V47
   Broschard TH, 2013, TOXICOL LETT, V218, P246, DOI 10.1016/j.toxlet.2013.02.002
   Cal K, 2008, EUR J PHARM BIOPHARM, V68, P467, DOI 10.1016/j.ejpb.2007.08.002
   Casida J.E., 1980, ENV HLTH PERSPECT, DOI [10.1289/ehp.8034189, DOI 10.1289/EHP.8034189]
   Castillo RM, 2017, J AM MOSQUITO CONTR, V33, P25, DOI 10.2987/16-6585.1
   Champakaew D, 2015, PARASITOL RES, V114, P2187, DOI 10.1007/s00436-015-4409-z
   Chang CP, 2003, COLLOID SURFACE B, V32, P257, DOI 10.1016/j.colsurfb.2003.07.002
   Chittiteeranon P, 2007, J INCL PHENOM MACRO, V57, P69, DOI 10.1007/s10847-006-9219-6
   Cilek JE, 2004, J AM MOSQUITO CONTR, V20, P299
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   COMBEMALE P, 1992, ANN DERMATOL VENER, V119, P411
   Conti B, 2012, PARASITOL RES, V110, P2013, DOI 10.1007/s00436-011-2730-8
   de Compos VEB, 2012, J NANOSCI NANOTECHNO, V12, P2881, DOI 10.1166/jnn.2012.5690
   Debboun M., 2014, INSECT REPELLENTS HD, P409
   DeGennaro M, 2015, FLY, V9, P45, DOI 10.1080/19336934.2015.1079360
   Diaz JH, 2016, WILD ENVIRON MED, V27, P153, DOI 10.1016/j.wem.2015.11.007
   DOME AJ, 1995, J AM MOSQUITO CONTR, V11, P29
   Drapeau J, 2009, CHEM BIODIVERS, V6, P934, DOI 10.1002/cbdv.200800225
   Drug Bank, PERM
   Dua VK, 2010, INDIAN J MED RES, V131, P434
   EPA. U.S. Environmental Protection Agency, 2012, REG REV METH NON KET
   EPA. U.S. Environmental Protection Agency, 1999, FACT SHEET CITR
   EPA. U.S. Environmental Protection Agency, 1998, REGR EL DEC DEET
   EPA. U.S. Environmental Protection Agency, 2005, FACT SHEET PIC
   EPA. U.S. Environmental Protection Agency, 2012, FACT SHEET COLD PRES
   EPA. U.S. Environmental Protection Agency, 2000, FACT SHEET P MENTH 3
   EPA. U.S. Environmental Protection Agency, 2007, SCI REV PROD PERF SU
   EPA. US Environmental Protection Agency, 1984, PEST ASS GUID SUBD F
   EPA. US Environmental Protection Agency, 2008, PROD PERF TEST GUID
   Forgearini JC, 2016, J NANOSCI NANOTECHNO, V16, P1301, DOI 10.1166/jnn.2016.11665
   Frances SP, 2005, J AM MOSQUITO CONTR, V21, P1, DOI 10.2987/8756-971X(2005)21[1:RPPAF]2.0.CO;2
   Frances SP, 2002, J MED ENTOMOL, V39, P541, DOI 10.1603/0022-2585-39.3.541
   Gatehouse J.A., 2002, NEW PHYTOL
   Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5
   Ghisalberti E.L., 2000, FITOTERAPIA
   Gillij YG, 2008, BIORESOURCE TECHNOL, V99, P2507, DOI 10.1016/j.biortech.2007.04.066
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P106, DOI 10.1016/S1995-7645(11)60047-3
   Gu XC, 2009, PHARM DEV TECHNOL, V14, P332, DOI 10.1080/10837450802647318
   Hao HL, 2008, J MED ENTOMOL, V45, P533, DOI 10.1603/0022-2585(2008)45[533:HABBOA]2.0.CO;2
   Hsieh WC, 2006, COLLOID SURFACE B, V53, P209, DOI 10.1016/j.colsurfb.2006.09.008
   Hu J, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40182
   Hughes MF, 2010, TOXICOL APPL PHARM, V246, P29, DOI 10.1016/j.taap.2010.04.003
   Ichiura H, 2014, CHEM ENG J, V245, P17, DOI 10.1016/j.cej.2014.02.019
   Innocent E., 2015, Journal of Herbs, Spices & Medicinal Plants, V21, P219, DOI 10.1080/10496475.2014.949997
   Iscan Y, 2005, PHARMAZIE, V60, P905
   Islam J., 2017, ACTA TROP
   Jaenson TGT, 2006, J MED ENTOMOL, V43, P113, DOI 10.1603/0022-2585(2006)043[0113:EOEAOO]2.0.CO;2
   Jantan I, 1998, ASEAN REV BIODIVERS
   KALYANASUNDARAM M, 1982, INDIAN J MED RES, V76, P190
   Kalyanasundaram M, 2006, J MED ENTOMOL, V43, P518, DOI 10.1603/0022-2585(2006)43[518:NPDASA]2.0.CO;2
   Karr JI, 2012, J CONTROL RELEASE, V160, P502, DOI 10.1016/j.jconrel.2012.04.023
   Kasting GB, 2008, TOXICOL IN VITRO, V22, P548, DOI 10.1016/j.tiv.2007.11.003
   Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005
   Kiran SR, 2007, PARASITOL RES, V101, P413, DOI 10.1007/s00436-007-0485-z
   Kohler W., 2007, WHO TECHNICAL REPORT, V8, P249
   Li Y, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40053
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]
   Llusia J, 2010, GLOBAL ECOL BIOGEOGR, V19, P863, DOI 10.1111/j.1466-8238.2010.00557.x
   Lukwa N., 1994, Central African Journal of Medicine, V40, P306
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   Maji TK, 2009, J APPL POLYM SCI, V111, P779, DOI 10.1002/app.29001
   Makhaik M, 2005, J SCI IND RES INDIA, V64, P129
   Mendki J.M., 2015, INT J MOSQ RES A, V2, P17
   Merck, 2001, WHOISTC6672001, P1
   Merck, GEN INF SAF DAT SHEE
   Misni N, 2017, J VECTOR DIS, V54, P44
   Muller GC, 2009, J VECTOR ECOL, V34, P2, DOI [10.3376/038.034.0102, 10.1111/j.1948-7134.2009.00002.x]
   N'Guessan R, 2008, T ROY SOC TROP MED H, V102, P259, DOI 10.1016/j.trstmh.2007.10.012
   Nasci R.S., 2016, PROTECTION MOSQUITOE, P1
   Nortje JM, 2015, J ETHNOPHARMACOL, V171, P205, DOI 10.1016/j.jep.2015.04.049
   Nuchuchua O, 2009, AAPS PHARMSCITECH, V10, P1234, DOI 10.1208/s12249-009-9323-1
   Omolo MO, 2005, PHYTOMEDICINE, V12, P241, DOI 10.1016/j.phymed.2003.10.004
   Omolo MO, 2004, PHYTOCHEMISTRY, V65, P2797, DOI 10.1016/j.phytochem.2004.08.035
   Padhy PK, 2005, CHEMOSPHERE, V59, P1643, DOI 10.1016/j.chemosphere.2005.01.046
   Palsson K, 1999, ACTA TROP, V72, P39, DOI 10.1016/S0001-706X(98)00083-7
   Pardeike J, 2009, INT J PHARMACEUT, V366, P170, DOI 10.1016/j.ijpharm.2008.10.003
   Park BS, 2005, J AM MOSQUITO CONTR, V21, P80, DOI 10.2987/8756-971X(2005)21[80:MFTTVA]2.0.CO;2
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Peterson Christopher John, 2001, THESIS
   Phasomkusolsil S, 2010, SE ASIAN J TROP MED, V41, P831
   Picaridin A., 2005, MED LETT DRUGS THER, V47, P46
   Pinto IC, 2017, DRUG DEV IND PHARM, V43, P67, DOI 10.1080/03639045.2016.1220564
   Pirmohammadi M, 2016, J ARTHROPOD-BORNE DI, V10, P201
   Place LW, 2017, COLLOID SURFACE A, V530, P76, DOI 10.1016/j.colsurfa.2017.07.004
   Plapp FW, 1999, ARCH ENVIRON HEALTH, V54, P312, DOI 10.1080/00039899909602492
   Prakash S., 2007, INSECT REPELLENTS PR, P341
   Puglia C, 2009, J PHARM PHARMACOL, V61, P1013, DOI 10.1211/jpp/61.08.0004
   Quantum Inc, 2017, BUZZ AW EXTR PLANT B
   RAJA ASM, 2015, INT J MOSQ RES A, V2, P49
   Rakkiyappan C, 2012, INT J POLYM MATER, V61, P1154, DOI 10.1080/00914037.2011.641635
   Ramkumar G, 2015, PARASITOL RES, V114, P167, DOI 10.1007/s00436-014-4173-5
   RAO SS, 1991, J MED ENTOMOL, V28, P303, DOI 10.1093/jmedent/28.3.303
   Rattan R.S., 2010, CROP PROT
   Rehman JU, 2014, FITOTERAPIA, V95, P65, DOI 10.1016/j.fitote.2014.03.002
   Ribas J, 2010, AN BRAS DERMATOL, V85, P33, DOI 10.1590/S0365-05962010000100004
   Ribeiro AD, 2016, APPL MATER TODAY, V5, P90, DOI 10.1016/j.apmt.2016.09.003
   Milhomem-Paixao SSR, 2017, J NANOMATER, V2017, DOI 10.1155/2017/4362046
   Paumgartten FJR, 2016, VIGIL SANIT DEBATE, V4, P97, DOI 10.3395/2317-269x.00736
   Romi R, 2005, BIOTECHNOL PROGR, V21, P1724, DOI 10.1021/bp050276g
   Rust RS, 2012, SEMIN PEDIATR NEUROL, V19, P130, DOI 10.1016/j.spen.2012.03.002
   Sakulku U, 2009, INT J PHARMACEUT, V372, P105, DOI 10.1016/j.ijpharm.2008.12.029
   Sawyer, 2015, EXT REL INS REP
   SCHRECK CE, 1978, J ECON ENTOMOL, V71, P397, DOI 10.1093/jee/71.3.397
   Solomon B, 2012, EUR J PHARM BIOPHARM, V80, P61, DOI 10.1016/j.ejpb.2011.08.003
   Songkro S, 2012, J INCL PHENOM MACRO, V72, P339, DOI 10.1007/s10847-011-9985-7
   Souza JM, 2014, REV BRAS FARMACOGN, V24, P691, DOI 10.1016/j.bjp.2014.11.007
   Sritabutra D., 2011, ASIAN PAC J TROP BIO, P1
   Stashenko EE, 2004, J CHROMATOGR A, V1025, P93, DOI 10.1016/j.chroma.2003.10.058
   Stefani, 2009, REV PAUL PEDIATR, V27, P81
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   Substances T., 1998, REREGISTRATION ELIGI, V25, P170
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   Sundaramoorthy R, 2016, CHEM-BIOL INTERACT, V257, P119, DOI 10.1016/j.cbi.2016.08.001
   Thavara U, 2001, J AM MOSQUITO CONTR, V17, P190
   Thomas J, 2009, J MED ENTOMOL, V46, P1387, DOI 10.1603/033.046.0619
   Trongtokit Y, 2005, PHYTOTHER RES, V19, P303, DOI 10.1002/ptr.1637
   Trongtokit Yuwadee, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1423
   Tunon H, 2006, FITOTERAPIA, V77, P257, DOI 10.1016/j.fitote.2006.02.009
   U.S. Environmental Protection Agency Office of Prevention, 2009, REG EL DEC REF COPP
   United Industries Corp, 2017, REP PLANT BAS OIL LE
   USDA, 1967, MAT EV INS REP CHEM
   Van Wyk B.-E., 1997, MED PLANTS S AFRICA
   Venkatachalam MR, 2001, BIORESOURCE TECHNOL, V76, P287, DOI 10.1016/S0960-8524(00)00096-1
   Vongsombath C, 2012, J MED ENTOMOL, V49, P1398, DOI 10.1603/ME12025
   Webb CE, 2007, J AM MOSQUITO CONTR, V23, P351, DOI 10.2987/8756-971X(2007)23[351:ITEFTP]2.0.CO;2
   WHO, 2009, WHO TECH REP SER, V958, P1
   Who. World Health Organization, 2005, 6672005 WHO
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
   Yoon Jong Kwang, 2015, J Parasitol Res, V2015, P361021, DOI 10.1155/2015/361021
NR 147
TC 18
Z9 18
U1 4
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD MAR 25
PY 2018
VL 539
IS 1-2
BP 190
EP 209
DI 10.1016/j.ijpharm.2018.01.046
PG 20
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FZ4TJ
UT WOS:000427584500021
PM 29410208
DA 2020-07-08
ER

PT J
AU Gong, DY
   Zhang, TH
   Zhao, DW
   Du, YS
   Chapa, TJ
   Shi, Y
   Wang, L
   Contreras, D
   Zeng, G
   Shi, PY
   Wu, TT
   Arumugaswami, V
   Sun, R
AF Gong, Danyang
   Zhang, Tian-Hao
   Zhao, Dawei
   Du, Yushen
   Chapa, Travis J.
   Shi, Yuan
   Wang, Laurie
   Contreras, Deisy
   Zeng, Gang
   Shi, Pei-Yong
   Wu, Ting-Ting
   Arumugaswami, Vaithilingaraja
   Sun, Ren
TI High-Throughput Fitness Profiling of Zika Virus E Protein Reveals
   Different Roles for Glycosylation during Infection of Mammalian and
   Mosquito Cells
SO ISCIENCE
LA English
DT Article
ID WEST-NILE-VIRUS; HUMAN DENDRITIC CELLS; AEDES-AEGYPTI MOSQUITOS;
   N-LINKED GLYCOSYLATION; DENGUE VIRUS; ENVELOPE PROTEIN; MEMBRANE-FUSION;
   CONFORMATIONAL-CHANGES; PRODUCTIVE INFECTION; ENDOTHELIAL-CELLS
AB Zika virus (ZIKV) infection causes Guillain-Barre syndrome and severe birth defects. ZIKV envelope (E) protein is the major viral protein involved in cell receptor binding and entry and is therefore considered one of the major determinants in ZIKV pathogenesis. Here we report a gene-wide mapping of functional residues of ZIKV E protein using a mutant library, with changes covering every nucleotide position. By comparing the replication fitness of every viral mutant between mosquito and human cells, we identified that mutations affecting glycosylation display the most divergence. By characterizing individual mutants, we show that ablation of glycosylation selectively benefits ZIKV infection of mosquito cells by enhancing cell entry, whereas it either has little impact on ZIKV infection on certain human cells or leads to decreased infection through the entry factor DC-SIGN. In conclusion, we define the roles of individual residues of ZIKV envelope protein, which contribute to ZIKV replication fitness in human and mosquito cells.
C1 [Gong, Danyang; Zhang, Tian-Hao; Zhao, Dawei; Du, Yushen; Chapa, Travis J.; Shi, Yuan; Wu, Ting-Ting; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Zeng, Gang] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA.
   [Contreras, Deisy; Arumugaswami, Vaithilingaraja] Cedars Sinai Med Ctr, Board Governors, Regenerat Med Inst, Los Angeles, CA 90048 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Wang, Laurie] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.
RP Sun, R (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
EM rsun@mednet.ucla.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [DE023591, CA177322]
FX We thank Dr. Ralph Baric for sharing data and comments and members of
   the R.S. and T.-T.W. laboratories for discussions. This work was
   supported by NIH grants DE023591 and CA177322.
CR Al-Mawsawi LQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0124-6
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo E, 1996, FASEB J, V10, P859
   Doud MB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006271
   Drake JW, 1998, GENETICS, V148, P1667
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081
   Fulton BO, 2017, J VIROL, V91, DOI 10.1128/JVI.00698-17
   Gong DY, 2016, CELL HOST MICROBE, V20, P642, DOI 10.1016/j.chom.2016.10.004
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Heinz FX, 2003, ADV VIRUS RES, V59, P63, DOI 10.1016/S0065-3527(03)59003-0
   Heinz FX, 2004, ARCH VIROL, P133
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Lin TY, 2012, J VIROL, V86, P3501, DOI 10.1128/JVI.06435-11
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x
   May M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161355
   Meyerhans A., 1999, ORIGIN EVOLUTION VIR, P87
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   POST PR, 1992, VIROLOGY, V188, P160, DOI 10.1016/0042-6822(92)90745-B
   Prakash MK, 2010, BIOPHYS J, V99, P588, DOI 10.1016/j.bpj.2010.04.024
   Qi HF, 2017, P NATL ACAD SCI USA, V114, P2018, DOI 10.1073/pnas.1614623114
   Qi HF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004064
   Qi J, 2015, J VIROL, V89, P5788, DOI 10.1128/JVI.00406-15
   Ramirez B. C., 1995, MOL BASIS VIRUS EVOL, P105
   Remenyi R, 2014, MBIO, V5, DOI 10.1128/mBio.01469-14
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roehrig JT, 2007, AM J TROP MED HYG, V77, P1
   Scherret JH, 2001, ANN NY ACAD SCI, V951, P361, DOI 10.1111/j.1749-6632.2001.tb02719.x
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Taylor ME, 2011, INTRO GLYCOBIOLOGY
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   Wu NC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2358-7
   Wu NC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005310
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
NR 60
TC 13
Z9 13
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2589-0042
J9 ISCIENCE
JI iScience
PD MAR 23
PY 2018
VL 1
BP 97
EP +
DI 10.1016/j.isci.2018.02.005
PG 36
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ8FA
UT WOS:000449721300009
PM 30227960
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bharucha, T
   Sengvilaipaseuth, O
   Vongsouvath, M
   Vongsouvath, M
   Davong, V
   Panyanouvong, P
   Piorkowski, G
   Garson, JA
   Newton, PN
   de Lamballerie, X
   Dubot-Peres, A
AF Bharucha, Tehmina
   Sengvilaipaseuth, Onanong
   Vongsouvath, Manivanh
   Vongsouvath, Malavanh
   Davong, Viengmon
   Panyanouvong, Phonepasith
   Piorkowski, Geraldine
   Garson, Jeremy A.
   Newton, Paul N.
   de Lamballerie, Xavier
   Dubot-Peres, Audrey
TI Development of an improved RT-qPCR Assay for detection of Japanese
   encephalitis virus (JEV) RNA including a systematic review and
   comprehensive comparison with published methods
SO PLOS ONE
LA English
DT Review
ID POLYMERASE CHAIN-REACTION; REAL-TIME PCR; CEREBROSPINAL-FLUID; GENOTYPE
   I; ZIKA VIRUS; WEST-NILE; IGM; EPIDEMIOLOGY; DIAGNOSIS; SURVEILLANCE
AB Background
   Japanese encephalitis virus (JEV) is a major cause of encephalitis in Asia, and the commonest cause of mosquito-borne encephalitis worldwide. Detection of JEV RNA remains challenging due to the characteristic brief and low viraemia, with 0-25% of patients positive, and the mainstay of diagnosis remains detection of anti-JEV IgM antibody.
   Methods
   We performed a systematic review of published RT-PCR protocols, and evaluated them in silico and in vitro alongside new primers and probes designed using a multiple genome alignment of all JEV strains >9,000nt from GenBank, downloaded from the NCBI website (November 2016). The new assays included pan-genotype and genotype specific assays targeting genotypes 1 and 3.
   Results
   Ten RT-qPCR assays were compared, a pre-existing in-house assay, three published assays and six newly designed assays, using serial RNA dilutions. We selected three assays, one published and two novel assays, with the lowest limit of detection (LOD) for further optimisation and validation. One of the novel assays, detecting NS2A, showed the best results, with LOD approximately 4 copies/reaction, and no cross-reaction on testing closely related viruses in the JEV serocomplex, West Nile Virus and St. Louis Virus. The optimised assays were validated in consecutive patients with central nervous system infections admitted to hospitals in Laos, testing paired CSF and serum samples.
   Conclusions
   We succeeded in developing a JEV specific RT-qPCR assay with at least 1 log(10) improved sensitivity as compared to existing assays. Further evaluation is required, field-testing the assay in a larger group of patients.
C1 [Bharucha, Tehmina; Sengvilaipaseuth, Onanong; Vongsouvath, Manivanh; Vongsouvath, Malavanh; Davong, Viengmon; Panyanouvong, Phonepasith; Newton, Paul N.; Dubot-Peres, Audrey] Mahosot Hosp, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit LOMWRU, Microbiol Lab, Viangchan, Laos.
   [Bharucha, Tehmina; Garson, Jeremy A.] UCL, Div Infect & Immun, London, England.
   [Bharucha, Tehmina] Royal Free Hosp, Dept Infect Dis, London, England.
   [Bharucha, Tehmina] Royal Free Hosp, Dept Microbiol, London, England.
   [Piorkowski, Geraldine; de Lamballerie, Xavier; Dubot-Peres, Audrey] Aix Marseille Univ, INSERM 1207, IRD 190, UMR Unite Virus Emergents,UVE,IHU Mediterranee In, Marseille, France.
   [Garson, Jeremy A.; Dubot-Peres, Audrey] NHS Blood & Transplant, Natl Transfus Microbiol Labs, London, England.
   [Newton, Paul N.] Univ Oxford, Churchill Hosp, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Oxford, England.
   [Newton, Paul N.] London Sch Hyg & Trop Med, London, England.
RP Bharucha, T (corresponding author), Mahosot Hosp, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit LOMWRU, Microbiol Lab, Viangchan, Laos.; Bharucha, T (corresponding author), UCL, Div Infect & Immun, London, England.; Bharucha, T (corresponding author), Royal Free Hosp, Dept Infect Dis, London, England.; Bharucha, T (corresponding author), Royal Free Hosp, Dept Microbiol, London, England.
EM t.bharucha@doctors.org.uk
RI Garson, Jeremy A/C-5357-2008
OI Garson, Jeremy/0000-0003-0553-0126; Newton, Paul/0000-0002-4608-6431
FU Wellcome Trust of Great BritainWellcome Trust; IRD; European Union's
   Horizon 2020 research and innovation programme EVAg [653316]
FX This study was supported by the Wellcome Trust of Great Britain, IRD to
   PNN and by the European Union's Horizon 2020 research and innovation
   programme EVAg under grant agreement No 653316 to XdL. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Aubry F., 2013, GENOME ANNOUNC, V1, P1
   Barros SC, 2013, J VIROL METHODS, V193, P554, DOI 10.1016/j.jviromet.2013.07.025
   Bharucha T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004516
   Boucher A, 2017, MED MAL INFECT
   BURKE DS, 1985, B WORLD HEALTH ORGAN, V63, P1037
   BURKE DS, 1985, J INFECT DIS, V151, P1093, DOI 10.1093/infdis/151.6.1093
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao Yu-Xi, 2009, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V23, P248
   Chen SP, 2012, EPIDEMIOL INFECT, V140, P1637, DOI 10.1017/S095026881100255X
   Chen YY, 2014, TRANSBOUND EMERG DIS, V61, P37, DOI 10.1111/j.1865-1682.2012.01369.x
   Cherian SS, 2015, ARCH VIROL, V160, P3097, DOI 10.1007/s00705-015-2599-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dubot-Peres A, 2015, LANCET INFECT DIS, V15, P1376, DOI 10.1016/S1473-3099(15)00405-3
   ELDADAH ZA, 1991, J MED VIROL, V33, P260, DOI 10.1002/jmv.1890330410
   Fang MY, 1997, MICROBIOL IMMUNOL, V41, P209, DOI 10.1111/j.1348-0421.1997.tb01192.x
   Gao XY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0270-z
   Gao XY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002459
   Granerod J, 2010, NEUROLOGY, V75, P924, DOI 10.1212/WNL.0b013e3181f11d65
   Granerod J, 2007, NEUROPSYCHOL REHABIL, V17, P406, DOI 10.1080/09602010600989620
   Han N, 2015, VIROL SIN, V30, P277, DOI 10.1007/s12250-015-3621-4
   Huang GKL, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx203
   Huang JL, 2004, J MED VIROL, V74, P589, DOI 10.1002/jmv.20218
   Johnson BW, 2016, AM J TROP MED HYG, V94, P820, DOI 10.4269/ajtmh.15-0631
   Kakkar M, 2016, INDIAN PEDIATR, V53, P33, DOI 10.1007/s13312-016-0785-4
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Khalakdina A, 2010, INT J INFECT DIS, V14, pE79, DOI 10.1016/j.ijid.2009.11.020
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Do LP, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0278-4
   Mishra B, 2016, J POSTGRAD MED, V62, P249, DOI 10.4103/0022-3859.191006
   Moore CE, 2012, AM J TROP MED HYG, V87, P171, DOI 10.4269/ajtmh.2012.11-0729
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Mai NTH, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx046
   Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142
   Nitatpattana N, 2008, EMERG INFECT DIS, V14, P1762, DOI 10.3201/eid1411.080542
   Organization WH, 2007, MAN LAB DIAGN JAP EN
   Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198
   Pyke AT, 2004, J VIROL METHODS, V117, P161, DOI 10.1016/j.jviromet.2004.01.007
   Read SJ, 2001, J CLIN PATHOL-MOL PA, V54, P86
   Robinson JS, 2010, AM J TROP MED HYG, V83, P1146, DOI 10.4269/ajtmh.2010.10-0212
   Saito M, 2015, THESCIENTIFICWORLDJO, V2015
   Santhosh SR, 2007, J VIROL METHODS, V143, P73, DOI 10.1016/j.jviromet.2007.02.011
   Sarkar A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-271
   Shirato K, 2005, J VIROL METHODS, V126, P119, DOI 10.1016/j.jviromet.2005.02.001
   Solomon TW. R., 2014, INFECT CENTRAL NERVO, P210
   Swami R, 2008, SCAND J INFECT DIS, V40, P815, DOI 10.1080/00365540802227102
   Touch S, 2009, TROP MED INT HEALTH, V14, P1365, DOI 10.1111/j.1365-3156.2009.02380.x
   van den Hurk AF, 2014, VECTOR-BORNE ZOONOT, V14, P66, DOI 10.1089/vbz.2013.1373
   VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   World Health Organization S-EAatWP, WHO REC STAND SURV S
   Yang Dong Kun, 2016, Journal of Bacteriology and Virology, V46, P231, DOI 10.4167/jbv.2016.46.4.231
   Yang Dong-Kun, 2004, J Vet Sci, V5, P345
   Zhao H, 2013, CLIN INFECT DIS, V57, P157, DOI 10.1093/cid/cit169
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 57
TC 7
Z9 7
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 23
PY 2018
VL 13
IS 3
AR e0194412
DI 10.1371/journal.pone.0194412
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA2QK
UT WOS:000428168400018
PM 29570739
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Whiten, SR
   Ray, WK
   Helm, RF
   Adelman, ZN
AF Whiten, Shavonn R.
   Ray, W. Keith
   Helm, Richard F.
   Adelman, Zach N.
TI Characterization of the adult Aedes aegypti early midgut peritrophic
   matrix proteome using LC-MS
SO PLOS ONE
LA English
DT Article
ID DENGUE HEMORRHAGIC-FEVER; LATE TRYPSIN GENE; ANOPHELES-GAMBIAE;
   SALIVARY-GLANDS; BLOOD MEAL; MOSQUITO; PROTEINS; CLONING; HEME;
   IDENTIFICATION
AB The Aedes aegypti mosquito is the principal vector of arboviruses such as dengue, chikungunya, yellow fever, and Zika virus. These arboviruses are transmitted during adult female mosquito bloodfeeding. While these viruses must transverse the midgut to replicate, the blood meal must also reach the midgut to be digested, absorbed, or excreted, as aggregation of blood meal metabolites can be toxic to the female mosquito midgut. The midgut peritrophic matrix (PM), a semipermeable extracellular layer comprised of chitin fibrils, glycoproteins, and proteoglycans, is one such mechanism of protection for the mosquito midgut. However, this structure has not been characterized for adult female Ae. aegypti. We conducted a mass spectrometry based proteomic analysis to identify proteins that comprise or are associated with the adult female Ae. aegypti early midgut PM. Altogether, 474 unique proteins were identified, with 115 predicted as secreted. GO-term enrichment analysis revealed an abundance of serine-type proteases and several known and novel intestinal mucins. In addition, approximately 10% of the peptides identified corresponded to known salivary proteins, indicating Ae. aegypti mosquitoes extensively swallow their own salivary secretions. However, the physiological relevance of this remains unclear, and further studies are needed to determine PM proteins integral for midgut protection from blood meal derived toxicity and pathogen protection. Finally, we describe substantial discordance between previously described transcriptionally changes observed in the midgut in response to a bloodmeal and the presence of the corresponding protein in the PM. Data are available via ProteomeXchange with identifier PXD007627.
C1 [Whiten, Shavonn R.; Adelman, Zach N.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
   [Ray, W. Keith; Helm, Richard F.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.
RP Adelman, ZN (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
EM zachadel@tamu.edu
RI Helm, Richard/N-6249-2018
OI Helm, Richard/0000-0001-5317-0925; Adelman, Zach/0000-0001-5901-7171
FU Fralin Life Science Institute; Agricultural Experiment Station Hatch
   Program; McIntire-Stennis Program at Virginia Tech; Agrilife Research;
   National Institute of Allergies and Infectious Diseases of the National
   Institutes of Health [AI115138]
FX The mass spectrometry resources used in this work are maintained in part
   through funding by the Fralin Life Science Institute, the Agricultural
   Experiment Station Hatch Program, and the McIntire-Stennis Program at
   Virginia Tech. This study was supported in part by Agrilife Research, as
   well as by the National Institute of Allergies and Infectious Diseases
   of the National Institutes of Health under award number AI115138. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR AFT RL, 1984, J BIOL CHEM, V259, P301
   Barillas-Mury C., 1993, Insect Molecular Biology, V2, P7, DOI 10.1111/j.1365-2583.1993.tb00119.x
   BARILLASMURY CV, 1995, INSECT BIOCHEM MOLEC, V25, P241, DOI 10.1016/0965-1748(94)00061-L
   BEIER MS, 1992, AM J TROP MED HYG, V47, P195
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82
   Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003
   CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694
   Conus S, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13042
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Devenport M, 2006, BIOCHEMISTRY-US, V45, P9540, DOI 10.1021/bi0605991
   Dinglasan RR, 2009, INSECT BIOCHEM MOLEC, V39, P125, DOI 10.1016/j.ibmb.2008.10.010
   Distler U, 2014, NAT METHODS, V11, P167, DOI [10.1038/NMETH.2767, 10.1038/nmeth.2767]
   Edwards MJ, 2000, INSECT MOL BIOL, V9, P33, DOI 10.1046/j.1365-2583.2000.00159.x
   Freyvogel T. A., 1965, Acta Tropica Basle, V22, P148
   GALUN R, 1963, SCIENCE, V142, P1674, DOI 10.1126/science.142.3600.1674
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882
   HAWKINS RI, 1966, NATURE, V212, P738, DOI 10.1038/212738a0
   HUDSON A, 1964, CAN J ZOOLOG, V42, P113, DOI 10.1139/z64-011
   Jiang QJ, 1997, INSECT BIOCHEM MOLEC, V27, P283, DOI 10.1016/S0965-1748(97)00001-5
   Juhn J., 2011, AEDES AEGYPTI PARASI, V4, P1, DOI DOI 10.1186/1756-3305-4-1
   KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709
   Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006
   Liao ZP, 2012, ANAL CHEM, V84, P4535, DOI 10.1021/ac300510t
   Lowenberger C, 2001, INSECT BIOCHEM MOLEC, V31, P219, DOI 10.1016/S0965-1748(00)00141-7
   Marquardt WC, 2005, BIOL DIS VECTORS, pxxiii
   Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130
   MELLINK JJ, 1981, MOSQ NEWS, V41, P115
   Moskalyk LA, 1996, INSECT MOL BIOL, V5, P261, DOI 10.1111/j.1365-2583.1996.tb00100.x
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Noriega FG, 1999, J INSECT PHYSIOL, V45, P613, DOI 10.1016/S0022-1910(99)00052-9
   Noriega FG, 1996, INSECT MOL BIOL, V5, P25, DOI 10.1111/j.1365-2583.1996.tb00037.x
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8
   PETERS W, 1992, PERITROPHIC MEMBRANE
   Rayms-Keller A, 2000, INSECT MOL BIOL, V9, P419, DOI 10.1046/j.1365-2583.2000.00202.x
   Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226
   Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Ribeiro JMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151400
   RICHARDS AG, 1977, ANNU REV ENTOMOL, V22, P219, DOI 10.1146/annurev.en.22.010177.001251
   Rodgers FH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006391
   Rose C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002691
   Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656
   Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3
   Schorderet S, 1998, INSECT BIOCHEM MOLEC, V28, P99, DOI 10.1016/S0965-1748(97)00103-3
   Shao L, 2005, INSECT BIOCHEM MOLEC, V35, P947, DOI 10.1016/j.ibmb.2005.03.012
   Shao L, 2001, ARCH INSECT BIOCHEM, V47, P119, DOI 10.1002/arch.1042.abs
   Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665
   Stohler H. R., 1961, Acta Tropica Basle, V18, P263
   TAPPEL AL, 1955, J BIOL CHEM, V217, P721
   Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4
   Toprak U., 2010, TRENDS ENTOMOL, V6, P23
   Vincent S, 1989, SEMINARS HEMATOLOGY
   VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2
   Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145
   Whiten SR, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01134
   Wilder-Smith A, 2015, SCIENCE, V350, P626, DOI 10.1126/science.aab4047
   Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e
   YORKE Warrington, 1924, Annals of Tropical Medicine and Parasitology, V18, P103
NR 61
TC 4
Z9 4
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 23
PY 2018
VL 13
IS 3
AR e0194734
DI 10.1371/journal.pone.0194734
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA2QK
UT WOS:000428168400028
PM 29570734
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bueno-Mari, R
   Saiz, JC
   Salomon, OD
   Villamil-Jimenez, LC
   Heukelbach, J
   Alencar, CH
   Armstrong, PK
   Rosado-de-Castro, PH
   Pimentel-Coelho, PM
AF Bueno-Mari, Ruben
   Saiz, Juan-Carlos
   Salomon, Oscar D.
   Villamil-Jimenez, Luis C.
   Heukelbach, Jorg
   Alencar, Carlos H.
   Armstrong, Paul K.
   Rosado-de-Castro, Paulo H.
   Pimentel-Coelho, Pedro M.
TI Editorial: Zika Virus Research
SO FRONTIERS IN NEUROLOGY
LA English
DT Editorial Material
DE Zika virus; arbovirus; public health; mosquitoes; epidemiology;
   microcephaly; Guillain-Barre syndrome; flavivirus
C1 [Bueno-Mari, Ruben] Labs Lokimica, Dept Invest & Desarrollo ID, Valencia, Spain.
   [Saiz, Juan-Carlos] Inst Nacl Invest & Tecnol Agr & Alimentar, Dept Biotechnol, Madrid, Spain.
   [Salomon, Oscar D.] Inst Nacl Med Trop, Puerto Iguazu, Argentina.
   [Villamil-Jimenez, Luis C.] Univ La Salle, Grp Epidemiol & Salud Publ, Bogota, Colombia.
   [Heukelbach, Jorg; Alencar, Carlos H.] Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil.
   [Heukelbach, Jorg] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia.
   [Armstrong, Paul K.] Western Australia Dept Hlth, Communicable Dis Control Directorate, Perth, WA, Australia.
   [Rosado-de-Castro, Paulo H.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Rosado-de-Castro, Paulo H.] Inst DOr Pesquisa & Ensino, Rio De Janeiro, Brazil.
   [Pimentel-Coelho, Pedro M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Bueno-Mari, R (corresponding author), Labs Lokimica, Dept Invest & Desarrollo ID, Valencia, Spain.
EM rbueno@lokimica.es
RI de Castro, Paulo Henrique Rosado/F-9310-2013; Pimentel-Coelho, Pedro
   M/K-1994-2015; Pimentel-Coelho, Pedro Moreno/AAM-9106-2020
OI de Castro, Paulo Henrique Rosado/0000-0003-0091-9714; Pimentel-Coelho,
   Pedro M/0000-0002-2414-3386; Pimentel-Coelho, Pedro
   Moreno/0000-0002-2414-3386; Alencar, Carlos
   Henrique/0000-0003-2967-532X; Heukelbach, Jorg/0000-0002-7845-5510
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   ECDC, 2017, ZIK TRANSM S E AS
   Graham BS, 2018, NAT IMMUNOL, V19, P20, DOI 10.1038/s41590-017-0007-9
   PAHO/WHO PAHOWHO, 2018, ZIK SUSP CONF CAS RE
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
NR 5
TC 1
Z9 1
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD MAR 23
PY 2018
VL 9
AR 168
DI 10.3389/fneur.2018.00168
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GA2XH
UT WOS:000428189900001
PM 29628908
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wiratsudakul, A
   Suparit, P
   Modchang, C
AF Wiratsudakul, Anuwat
   Suparit, Parinya
   Modchang, Charin
TI Dynamics of Zika virus outbreaks: an overview of mathematical modeling
   approaches
SO PEERJ
LA English
DT Article
DE Deterministic; Intervention; Import risk; Stochastic; Epidemic model;
   Zika
ID RIO-DE-JANEIRO; TRANSMISSION DYNAMICS; REPRODUCTION NUMBER; HUMAN
   MOVEMENT; OLYMPIC GAMES; INFECTION; EPIDEMIC; RISK; DISEASE; NETWORK
AB Background. The Zika virus was first discovered in 1947. It was neglected until a major outbreak occurred on Yap Island, Micronesia, in 2007. Teratogenic effects resulting in microcephaly in newborn infants is the greatest public health threat. In 2016, the Zika virus epidemic was declared as a Public Health Emergency of International Concern (PHEIC). Consequently, mathematical models were constructed to explicitly elucidate related transmission dynamics.
   Survey Methodology. In this review article, two steps of journal article searching were performed. First, we attempted to identify mathematical models previously applied to the study of vector-borne diseases using the search terms dynamics, mathematical model, modeling, and vector-borne together with the names of vector-borne diseases including chikungunya, dengue, malaria, West Nile, and Zika. Then the identified types of model were further investigated. Second, we narrowed down our survey to focus on only Zika virus research. The terms we searched for were compartmental, spatial, metapopulation, network, individual-based, agent-based AND Zika. All relevant studies were included regardless of the year of publication. We have collected research articles that were published before August 2017 based on our search criteria. In this publication survey, we explored the Google Scholar and PubMed databases.
   Results. We found five basic model architectures previously applied to vector-borne virus studies, particularly in Zika virus simulations. These include compartmental, spatial, metapopulation, network, and individual-based models. We found that Zika models carried out for early epidemics were mostly fit into compartmental structures and were less complicated compared to the more recent ones. Simple models are still commonly used for the timely assessment of epidemics. Nevertheless, due to the availability of large-scale real-world data and computational power, recently there has been growing interest in more complex modeling frameworks.
   Discussion. Mathematical models are employed to explore and predict how an infectious disease spreads in the real world, evaluate the disease importation risk, and assess the effectiveness of intervention strategies. As the trends in modeling of infectious diseases have been shifting towards data-driven approaches, simple and complex models should be exploited differently. Simple models can be produced in a timely fashion to provide an estimation of the possible impacts. In contrast, complex models integrating real-world data require more time to develop but are far more realistic. The preparation of complicated modeling frameworks prior to the outbreaks is recommended, including the case of future Zika epidemic preparation.
C1 [Wiratsudakul, Anuwat] Mahidol Univ, Fac Vet Sci, Dept Clin Sci & Publ Hlth, Phutthamonthon, Nakhon Pathom, Thailand.
   [Wiratsudakul, Anuwat] Mahidol Univ, Monitoring & Surveillance Ctr Zoonot Dis Wildlife, Fac Vet Sci, Phutthamonthon, Nakhon Pathom, Thailand.
   [Suparit, Parinya; Modchang, Charin] Mahidol Univ, Dept Phys, Biophys Grp, Fac Sci, Bangkok, Thailand.
   [Modchang, Charin] CHE, Ctr Excellence Math, Bangkok, Thailand.
RP Modchang, C (corresponding author), Mahidol Univ, Dept Phys, Biophys Grp, Fac Sci, Bangkok, Thailand.; Modchang, C (corresponding author), CHE, Ctr Excellence Math, Bangkok, Thailand.
EM charin.mod@mahidol.edu
RI Wiratsudakul, Anuwat/V-2619-2019
OI Wiratsudakul, Anuwat/0000-0002-1112-3220; Modchang,
   Charin/0000-0002-0739-006X
FU National Science and Technology Development Agency, Thailand
   [P-16-50695]; Centre of Excellence in Mathematics, the Commission on
   Higher Education, ThailandOffice of Higher Education Commission (OHEC)
FX This review study was financially supported by the National Science and
   Technology Development Agency, Thailand (Project ID P-16-50695) and the
   Centre of Excellence in Mathematics, the Commission on Higher Education,
   Thailand. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abdulla S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-213
   Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Akpa OM, 2010, J INFECT DEV COUNTR, V4, P597, DOI 10.3855/jidc.542
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Alaniz AJ, 2017, INT J EPIDEMIOL, V46, P966, DOI 10.1093/ije/dyw366
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Andronico A, 2017, AM J EPIDEMIOL, V186, P1194, DOI 10.1093/aje/kwx008
   Asher J, 2018, EPIDEMICS-NETH, V22, P50, DOI 10.1016/j.epidem.2017.02.009
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002
   Banos A, 2015, SYSTEMS, V3, P309, DOI 10.3390/systems3040309
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Bellazzi R, 2014, Yearb Med Inform, V9, P8, DOI 10.15265/IY-2014-0024
   Bernoulli D, 1766, MEM MATH PHYS ACAD R, V1, P1
   Bisanzio D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013796
   Browne C, 2015, J THEOR BIOL, V384, P33, DOI 10.1016/j.jtbi.2015.08.004
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Chao DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076044
   Chen TM, 2014, TRAVEL MED INFECT DI, V12, P650, DOI 10.1016/j.tmaid.2014.10.015
   Coburn BJ, 2013, LANCET GLOB HEALTH, V1, pE251, DOI 10.1016/S2214-109X(13)70084-6
   Craft ME, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0107
   Crowder DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055006
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   de Jong MCM, 2009, REV SCI TECH OIE, V28, P371
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   DeAngelis Donald L, 2014, F1000Prime Rep, V6, P39, DOI 10.12703/P6-39
   Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   Dommar CJ, 2014, ACTA TROP, V129, P61, DOI 10.1016/j.actatropica.2013.08.004
   Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106
   Eichner M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-365
   El-Sayed Abdulrahman M, 2012, Epidemiol Perspect Innov, V9, P1, DOI 10.1186/1742-5573-9-1
   Ellingson KD, 2017, TRANSFUSION, V57, P1625, DOI 10.1111/trf.14164
   Emmanuel F, 2013, EXPERT REV ANTI-INFE, V11, P451, DOI [10.1586/ERI.13.33, 10.1586/eri.13.33]
   Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405
   Fitzgibbon WE, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0051-z
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Furqan HT, 2017, L N INST COMP SCI SO, V185, P205, DOI 10.1007/978-3-319-51207-5_21
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098
   Goeijenbier M, 2016, NETH J MED, V74, P104
   Goubar A, 2009, EPIDEMIOL INFECT, V137, P1019, DOI 10.1017/S0950268808001635
   Rodrigues CCG, 2015, PHYSICA A, V428, P52, DOI 10.1016/j.physa.2015.02.027
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Harrigan RJ, 2014, GLOBAL CHANGE BIOL, V20, P2417, DOI 10.1111/gcb.12534
   Hashimoto T, 2017, EMERG INFECT DIS, V23, P1222, DOI 10.3201/eid2307.170519
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051
   Kermack WO, 1933, P R SOC LOND A-CONTA, V141, P94, DOI 10.1098/rspa.1933.0106
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Khan A, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0043-3
   Khengwa C, 2017, ANIM PROD SCI, V57, P152, DOI 10.1071/AN15043
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kiti MC, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0084-2
   Koch T, 2015, DISASTER MED PUBLIC, V9, P66, DOI 10.1017/dmp.2015.14
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lanzas C, 2015, PREV VET MED, V118, P207, DOI 10.1016/j.prevetmed.2014.09.012
   Lawson A. B., 2013, STAT METHODS SPATIAL
   Lee S, 2015, J THEOR BIOL, V374, P152, DOI 10.1016/j.jtbi.2015.03.005
   Lee SY, 2013, IFAC P VOLUMES, V46, P176, DOI [10.3182/20130327-3-JP-3017.00040, DOI 10.3182/20130327-3-JP-3017.00040]
   Lessler Justin, 2016, Curr Epidemiol Rep, V3, P212, DOI 10.1007/s40471-016-0078-4
   Lessler J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155249
   LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237
   Lewis N, 2017, TRANSBOUND EMERG DIS, V64, P938, DOI 10.1111/tbed.12461
   Lin ZG, 2017, J MATH BIOL, V75, P1381, DOI 10.1007/s00285-017-1124-7
   Lopes MH, 2016, REV ASSOC MED BRAS, V62, P4, DOI 10.1590/1806-9282.62.01.4
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Luo ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126893
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Machens A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-185
   Mackey TK, 2012, J PUBLIC HEALTH POL, V33, P119, DOI 10.1057/jphp.2011.51
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Matheson T, 2017, SPORA J BIOMATHEMATI, V3, P29
   McVernon J, 2007, INFLUENZA OTHER RESP, V1, P43, DOI 10.1111/j.1750-2659.2007.00008.x
   Metcalf C Jessica E, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.873427b89ab9c75eb90c8ddb8d8c7c90
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan AJ, 2016, PLOS CURRENTS
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nah K, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1675-z
   Nishiura H, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.27.21181
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pyke AT, 2014, PLOS CURRENTS
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Rock K, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026602
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Ross R, 1911, PREVENTION MALARIA, P651
   Rossi G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02567-6
   Saad-Roy CM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2076-z
   Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108
   Santermans E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147172
   Sardar T, 2017, MATH BIOSCI, V288, P109, DOI 10.1016/j.mbs.2017.03.004
   Scata M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37105
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Sornbundit K, 2017, COMPUT BIOL MED, V87, P162, DOI 10.1016/j.compbiomed.2017.05.031
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741
   Tabachnick WJ, 2016, CURR OPIN VIROL, V21, P124, DOI 10.1016/j.coviro.2016.09.008
   TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802
   Vest KG, 2016, DISASTER MED PUBLIC, V10, P707, DOI 10.1017/dmp.2016.43
   Vincenti-Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005317
   Wang L, 2014, CHINESE SCI BULL, V59, P3511, DOI 10.1007/s11434-014-0499-8
   Wesolowski A, 2014, PLOS CURRENTS OUTBRE
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11114, DOI 10.1073/pnas.1423542112
   White PJ, 2014, J INFECT DIS, V210, pS594, DOI 10.1093/infdis/jiu470
   WHO, 2017, ZIK SIT REP
   Wiratsudakul A, 2016, TRAVEL MED INFECT DI, V14, P481, DOI 10.1016/j.tmaid.2016.06.011
   Wiratsudakul A, 2014, TROP ANIM HEALTH PRO, V46, P845, DOI 10.1007/s11250-014-0575-8
   Xiang B, 2017, J INFECTION, V74, P328, DOI 10.1016/j.jinf.2017.01.004
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 136
TC 12
Z9 14
U1 4
U2 26
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD MAR 22
PY 2018
VL 6
AR e4526
DI 10.7717/peerj.4526
PG 30
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA9XI
UT WOS:000428694900002
PM 29593941
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chuchuy, A
   Rodriguero, MS
   Ferrari, W
   Ciota, AT
   Kramer, LD
   Micieli, MV
AF Chuchuy, Ailen
   Rodriguero, Marcela S.
   Ferrari, Walter
   Ciota, Alexander T.
   Kramer, Laura D.
   Micieli, Maria V.
TI Biological characterization of Aedes albopictus (Diptera: Culicidae) in
   Argentina: implications for arbovirus transmission
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CYTOPLASMIC INCOMPATIBILITY; CHIKUNGUNYA VIRUS; VECTOR COMPETENCE;
   WOLBACHIA; AEGYPTI; SKUSE; INFECTION; MOSQUITO; POPULATIONS; SUPERGROUP
AB Aedes albopictus (Diptera: Culicidae) is an invasive mosquito, native to Asia, that has expanded its range worldwide. It is considered to be a public health threat as it is a competent vector of viruses of medical importance, including dengue, chikungunya, and Zika. Despite its medical importance there is almost no information on biologically important traits of Ae. albopictus in Argentina. We studied life cycle traits, demographic parameters and analyzed the competence of this mosquito as a virus vector. In addition, we determined the prevalence of Wolbachia strains in Ae. albopictus as a first approach to investigate the potential role of this bacteria in modulating vector competence for arboviruses. We observed low hatch rates of eggs, which led to a negative growth rate. We found that Ae. albopictus individuals were infected with Wolbachia in the F1 but while standard superinfection with wAlbA and wAlbB types was found in 66.7% of the females, 16.7% of the females and 62.5% of the males were single-infected with the wAlbB strain. Finally, despite high levels of infection and dissemination, particularly for chikungunya virus, Ae. albopictus from subtropical Argentina were found to be relatively inefficient vectors for transmission of both chikungunya and dengue viruses.
C1 [Chuchuy, Ailen; Ferrari, Walter; Micieli, Maria V.] UNLP, CONICET, CCT La Plata, Ctr Estudios Parasitol & Vectores,CEPAV, Blvd 120 E-61y 62, RA-1900 La Plata, Buenos Aires, Argentina.
   [Rodriguero, Marcela S.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, IEGEBA,CONICET, Intendente Guiraldes & Av Costanera Norte S-N, Buenos Aires, DF, Argentina.
   [Ciota, Alexander T.; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Arbovirus Lab, Slingerlands, NY USA.
   [Ciota, Alexander T.; Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.
RP Chuchuy, A (corresponding author), UNLP, CONICET, CCT La Plata, Ctr Estudios Parasitol & Vectores,CEPAV, Blvd 120 E-61y 62, RA-1900 La Plata, Buenos Aires, Argentina.
EM chuchuyailen@gmail.com
RI ; Ciota, Alexander/E-1634-2017
OI Micieli, Maria Victoria/0000-0003-0616-2214; Rodriguero,
   Marcela/0000-0001-5967-2045; Ciota, Alexander/0000-0001-6589-4728
FU Fulbright Visiting Scholar Program; Agencia Nacional de Promocion
   Cientifica y Tecnica, Argentina (PICT)ANPCyT [2662014-1536, 2015-0665];
   University La Plata; Consejo Nacional de Investigaciones Cientificas y
   Tecnicas (CONICET)Consejo Nacional de Investigaciones Cientificas y
   Tecnicas (CONICET) [PIP 2015-0288]
FX The authors would like to thank the financial support of the Fulbright
   Visiting Scholar Program, Agencia Nacional de Promocion Cientifica y
   Tecnica, Argentina (PICT No 2662014-1536, 2015-0665), University La
   Plata and Consejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET) (PIP 2015-0288). We acknowledge Graciela Minardi for her
   assistance in statistical analyses, Maria Laura Morote for helping in
   the figures design, Pamela Chin and the New York State Arbovirus
   Laboratory Insectary staff for assistance with vector competence
   studies.
CR Afizah AN, 2015, INDIAN J MED RES, V142, P205, DOI 10.4103/0971-5916.164259
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Baldo L, 2007, CURR MICROBIOL, V55, P81, DOI 10.1007/s00284-007-0055-8
   Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   BLACK WC, 1989, J MED ENTOMOL, V26, P260, DOI 10.1093/jmedent/26.4.260
   Bordenstein SR, 2009, MOL BIOL EVOL, V26, P231, DOI 10.1093/molbev/msn243
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   DARSIE R F JR, 1985, Mosquito Systematics, V17, P153
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458
   Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876
   dos Santos RL, 2003, REV SAUDE PUBL, V37, P671
   Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493
   Rabinovich JE, 2011, J MED ENTOMOL, V48, P775, DOI 10.1603/ME10277
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   Gavotte L, 2010, J INVERTEBR PATHOL, V105, P341, DOI 10.1016/j.jip.2010.08.005
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Islam MS, 2006, J MED ENTOMOL, V43, P689, DOI 10.1603/0022-2585(2006)43[689:WEOAAD]2.0.CO;2
   KAMBHAMPATI S, 1993, EVOLUTION, V47, P673, DOI [10.2307/2410079, 10.1111/j.1558-5646.1993.tb02121.x]
   Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Maimusa HA, 2016, J AM MOSQUITO CONTR, V32, P1, DOI 10.2987/moco-32-01-1-11.1
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   RAI KS, 1991, ANNU REV ENTOMOL, V36, P459, DOI 10.1146/annurev.en.36.010191.002331
   Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Rodriguero MS, 2010, INSECT MOL BIOL, V19, P631, DOI 10.1111/j.1365-2583.2010.01018.x
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Rossi GC, 1999, J AM MOSQUITO CONTR, V15, P422
   Rossi Gustavo C., 2006, Rev. Soc. Entomol. Argent., V65, P51
   Schweigmann N, 2004, REV SAUDE PUBL, V38, P136, DOI 10.1590/S0034-89102004000100020
   SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tortosa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009700
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsuda Yoshio, 1994, Tropical Medicine, V36, P15
   TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x
   TURELLI M, 1995, GENETICS, V140, P1319
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Zhang DJ, 2014, PARASITOL RES, V113, P399, DOI 10.1007/s00436-013-3668-9
   Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324
NR 58
TC 3
Z9 3
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 22
PY 2018
VL 8
AR 5041
DI 10.1038/s41598-018-23401-7
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA0VU
UT WOS:000428033500009
PM 29568046
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nazerai, L
   Scholler, AS
   Rasmussen, POS
   Buus, S
   Stryhn, A
   Christensen, JP
   Thomsen, AR
AF Nazerai, Loulieta
   Scholler, Amalie Skak
   Rasmussen, Peter Overbeck Sharma
   Buus, Soren
   Stryhn, Anette
   Christensen, Jan Pravsgaard
   Thomsen, Allan Randrup
TI A New In Vivo Model to Study Protective Immunity to Zika Virus Infection
   in Mice With Intact Type I Interferon Signaling
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika virus; mouse model; adaptive immunity; T cells; B cells; memory;
   protection
ID LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CD8(+) T-CELLS; VIRAL-INFECTION;
   RESPONSES; ANTIBODIES; EFFECTOR; INNATE; LIFE; IGG
AB The association between recent Zika virus (ZIKV) infection and neurological complications, microcephaly in the fetus, and Guillain-Barre syndrome in adults underscores the necessity for a protective vaccine. Rational vaccine development requires an in-depth understanding of the mechanisms which could protect against infection with this virus. However, so far, such an analysis has been hampered by the absence of a suitable small animal model. Unlike the situation in humans, ZIKV only replicates effectively in the peripheral organs of mice, if type I IFN signaling is interrupted. As type I IFN also impacts the adaptive immune response, mice with such a defect are not optimal for a comprehensive immunological analysis. In this report, we show that even in wild-type (WT) mice i.c. infection with low doses of virus causes marked local virus replication and lethal encephalitis in naive mice. Furthermore, peripheral infection of WT mice with low doses of virus induces a significant immune response, which provides long-lasting protection of WT mice from a fatal outcome of subsequent i.c. challenge. Therefore, combining peripheral priming with later i.c. challenge represents a new approach for studying the adaptive immune response to ZIKV in mice with an intact type I IFN response. In this study, we focused on the mechanisms underlying resistance to reinfection. Using a combination of adoptive transfer, antibody-based cell depletion, and gene targeting, we show that the key protective factor in type I IFN replete mice is humoral immunity. CD8 T cells are not essential in mice with preformed specific antibodies, but under conditions where initial antibody levels are low, effector CD8 T cells may play a role as a back-up system. These results have important implications for our understanding of natural immunity to ZIKV infection and for Zika vaccine design.
C1 [Nazerai, Loulieta; Scholler, Amalie Skak; Rasmussen, Peter Overbeck Sharma; Buus, Soren; Stryhn, Anette; Christensen, Jan Pravsgaard; Thomsen, Allan Randrup] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark.
RP Thomsen, AR (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark.
EM athomsen@sund.ku.dk
RI ; Christensen, Jan/I-4782-2017
OI Nazerai, Loulieta/0000-0002-1090-9029; Christensen,
   Jan/0000-0002-4299-9479; Stryhn, Anette/0000-0002-4581-3553; Thomsen,
   Allan Randrup/0000-0002-2392-9803
FU Lundbeck FoundationLundbeckfonden; Faculty of Health and Medical
   Sciences, University of Copenhagen
FX This work was supported by the Lundbeck Foundation. LN is the recipient
   of a Ph.D. scholarship partly funded by the Lundbeck Foundation and
   partly by the Faculty of Health and Medical Sciences, University of
   Copenhagen.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Belnoue E, 2007, J VIROL, V81, P7338, DOI 10.1128/JVI.00062-07
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   COBBOLD S, 1986, TRANSPLANTATION, V42, P239, DOI 10.1097/00007890-198609000-00003
   Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dub T, 2017, REV NEUROL-FRANCE, V173, P361, DOI 10.1016/j.neurol.2017.03.033
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Moseman EA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3565
   Mouchacca P, 2015, IMMUNOLOGY, V145, P24, DOI 10.1111/imm.12420
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nansen A, 1999, J IMMUNOL, V163, P6114
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SPRIGGS MK, 1992, P NATL ACAD SCI USA, V89, P6070, DOI 10.1073/pnas.89.13.6070
   THOMSEN AR, 1988, IMMUNOLOGY, V65, P9
   Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757
   Voigt I, 2000, EUR J IMMUNOL, V30, P560, DOI 10.1002/1521-4141(200002)30:2<560::AID-IMMU560>3.0.CO;2-T
   WHO, 2017, ZIK VIR SIT REP 29 D
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
NR 47
TC 11
Z9 11
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAR 22
PY 2018
VL 9
AR 593
DI 10.3389/fimmu.2018.00593
PG 15
WC Immunology
SC Immunology
GA GA1EU
UT WOS:000428059100003
PM 29623081
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gianfredi, V
   Bragazzi, NL
   Nucci, D
   Martini, M
   Rosselli, R
   Minelli, L
   Moretti, M
AF Gianfredi, Vincenza
   Bragazzi, Nicola Luigi
   Nucci, Daniele
   Martini, Mariano
   Rosselli, Roberto
   Minelli, Liliana
   Moretti, Massimo
TI Harnessing Big Data for Communicable Tropical and Sub-Tropical
   Disorders: Implications From a Systematic Review of the Literature
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Review
DE big data; Zika; Ebola; Chikungunya; West Nile virus; dengue; Mayaro
   virus; communicable tropical diseases
ID FOR-DISEASE-CONTROL; ZIKA-VIRUS; SOCIAL MEDIA; EBOLA; INFORMATION;
   TWITTER; NEWS; WEB; MISINFORMATION; OUTBREAKS
AB Aim: According to the World Health Organization (WHO), communicable tropical and sub-tropical diseases occur solely, or mainly in the tropics, thriving in hot, and humid conditions. Some of these disorders termed as neglected tropical diseases are particularly overlooked. Communicable tropical/sub-tropical diseases represent a diverse group of communicable disorders occurring in 149 countries, favored by tropical and sub-tropical conditions, affecting more than one billion people and imposing a dramatic societal and economic burden.
   Methods: A systematic review of the extant scholarly literature was carried out, searching in PubMed/MEDLINE and Scopus. The search string used included proper keywords, like big data, nontraditional data sources, social media, social networks, infodemiology, infoveillance, novel data streams (NDS), digital epidemiology, digital behavior, Google Trends, Twitter, Facebook, YouTube, Instagram, Pinterest, Ebola, Zika, dengue, Chikungunya, Chagas, and the other neglected tropical diseases.
   Results: 47 original, observational studies were included in the current systematic review: 1 focused on Chikungunya, 6 on dengue, 19 on Ebola, 2 on Malaria, 1 on Mayaro virus, 2 on West Nile virus, and 16 on Zika. Fifteen were dedicated on developing and validating forecasting techniques for real-time monitoring of neglected tropical diseases, while the remaining studies investigated public reaction to infectious outbreaks. Most studies explored a single nontraditional data source, with Twitter being the most exploited tool (25 studies).
   Conclusion: Even though some studies have shown the feasibility of utilizing NDS as an effective tool for predicting epidemic outbreaks and disseminating accurate, high-quality information concerning neglected tropical diseases, some gaps should be properly underlined. Out of the 47 articles included, only 7 were focusing on neglected tropical diseases, while all the other covered communicable tropical/sub-tropical diseases, and the main determinant of this unbalanced coverage seems to be the media impact and resonance. Furthermore, efforts in integrating diverse NDS should be made. As such, taking into account these limitations, further research in the field is needed.
C1 [Gianfredi, Vincenza] Univ Perugia, Post Grad Sch Hyg & Prevent Med, Dept Expt Med, Perugia, Italy.
   [Bragazzi, Nicola Luigi] Univ Genoa, Dept Hlth Sci DISSAL, Genoa, Italy.
   [Nucci, Daniele] Veneto Inst Oncol IOV IRCCS, Digest Endoscopy Unit, Padua, Italy.
   [Martini, Mariano] Univ Genoa, Dept Hlth Sci DISSAL, Sect Hist Med & Eth, Genoa, Italy.
   [Rosselli, Roberto] Local Hlth Unit 3 Genoa, Hyg & Publ Hlth Unit, Genoa, Italy.
   [Minelli, Liliana] Univ Perugia, Dept Expt Med, Perugia, Italy.
   [Moretti, Massimo] Univ Perugia, Unit Publ Hlth, Dept Pharmaceut Sci, Perugia, Italy.
RP Gianfredi, V (corresponding author), Univ Perugia, Post Grad Sch Hyg & Prevent Med, Dept Expt Med, Perugia, Italy.
EM vincenza.gianfredi@studenti.unipg.it
RI Moretti, Massimo/H-6885-2017; Bragazzi, Nicola Luigi/G-1672-2011; Nucci,
   Daniele/Q-3089-2016; Gianfredi, Vincenza/W-1408-2017
OI Moretti, Massimo/0000-0002-5038-8619; Bragazzi, Nicola
   Luigi/0000-0001-8409-868X; Nucci, Daniele/0000-0003-4546-213X;
   Gianfredi, Vincenza/0000-0003-3848-981X
CR Adawi Mohammad, 2017, JMIR Public Health Surveill, V3, pe93, DOI 10.2196/publichealth.9136
   Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9
   Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0
   Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505
   Basch Corey H, 2017, J Prev Med Public Health, V50, P133, DOI 10.3961/jpmph.16.107
   Basch CH, 2015, DISASTER MED PUBLIC, V9, P531, DOI 10.1017/dmp.2015.77
   Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263
   Bragazzi NL, 2016, DATA BRIEF, V9, P839, DOI 10.1016/j.dib.2016.10.022
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Cooper Kathryn M, 2016, AMIA Annu Symp Proc, V2016, P431
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Eysenbach G, 2002, AM J MED, V113, P763, DOI 10.1016/S0002-9343(02)01473-0
   Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Fung ICH, 2017, DISASTER MED PUBLIC, V11, P656, DOI 10.1017/dmp.2017.23
   Fung ICH, 2017, ANN GLOB HEALTH, V83, P682, DOI 10.1016/j.aogh.2017.09.006
   Fung ICH, 2016, PUBLIC HEALTH REP, V131, P461, DOI 10.1177/003335491613100312
   Fung ICH, 2014, LANCET, V384, P2207, DOI 10.1016/S0140-6736(14)62418-1
   Ghosh S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40841
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Gomide J., 2011, P ACM WEBSCI 11 JUN, P1, DOI [10.1145/2527031.2527049, DOI 10.1145/2527031.2527049]
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Guo P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005973
   Hotez PJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004186
   Househ M, 2016, HEALTH INFORM J, V22, P470, DOI 10.1177/1460458214568037
   Jin F, 2014, COMPUTER, V47, P90, DOI 10.1109/MC.2014.361
   Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   Lehnert JD, 2017, J PUBLIC HEALTH MAN, V23, P608, DOI 10.1097/PHH.0000000000000537
   Li ZhongWu, 2017, Soil & Tillage Research, V166, P1, DOI 10.1016/j.still.2016.10.004
   Liu K, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080780
   Mackey TK, 2014, CLIN MICROBIOL REV, V27, P949, DOI 10.1128/CMR.00045-14
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Marques-Toledo CD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005729
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Nagpal SJS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1251-9
   Nii-Trebi NI, 2017, BIOMED RES INT, V2017, P1, DOI 10.1155/2017/5245021
   Nsoesie Elaine O, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.cc09a42586e16dc7dd62813b7ee5d6b6
   Ocampo AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-390
   Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023
   Pathak R, 2015, N AM J MED SCI, V7, P306, DOI 10.4103/1947-2714.161244
   Peeling RW, 2017, COMPUT STRUCT BIOTEC, V15, P271, DOI 10.1016/j.csbj.2017.02.003
   Roberts H, 2017, J HEALTH COMMUN, V22, P51, DOI 10.1080/10810730.2016.1209598
   Roche B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05957-y
   Sastry S, 2017, HEALTH COMMUN, V32, P329, DOI 10.1080/10410236.2016.1138380
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Strekalova YA, 2017, HEALTH EDUC BEHAV, V44, P332, DOI 10.1177/1090198116660310
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   van Lent LGG, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7219
   Vijaykumar S, 2017, J AM MED INFORM ASSN, V24, P1155, DOI 10.1093/jamia/ocx028
   Watad A, 2018, EPJ DATA SCIENCE IN
   Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]
   Wong R, 2017, J PUBLIC HEALTH MAN, V23, pE16, DOI 10.1097/PHH.0000000000000342
   World Health Organization, 2017, NEGLECTED TROPICAL D
NR 60
TC 7
Z9 7
U1 2
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD MAR 21
PY 2018
VL 6
AR UNSP 90
DI 10.3389/fpubh.2018.00090
PG 15
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GC1RQ
UT WOS:000429559800001
PM 29619364
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carlson, CJ
   Dougherty, E
   Boots, M
   Getz, W
   Ryan, SJ
AF Carlson, Colin J.
   Dougherty, Eric
   Boots, Mike
   Getz, Wayne
   Ryan, Sadie J.
TI Consensus and conflict among ecological forecasts of Zika virus
   outbreaks in the United States
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SEXUAL TRANSMISSION; SAMPLE-SIZE; DISEASE; MODELS; TEMPERATURE;
   INFECTIONS; SELECTION; WOMEN; RISK
AB Ecologists are increasingly involved in the pandemic prediction process. In the course of the Zika outbreak in the Americas, several ecological models were developed to forecast the potential global distribution of the disease. Conflicting results produced by alternative methods are unresolved, hindering the development of appropriate public health forecasts. We compare ecological niche models and experimentally-driven mechanistic forecasts for Zika transmission in the continental United States. We use generic and uninformed stochastic county-level simulations to demonstrate the downstream epidemiological consequences of conflict among ecological models, and show how assumptions and parameterization in the ecological and epidemiological models propagate uncertainty and produce downstream model conflict. We conclude by proposing a basic consensus method that could resolve conflicting models of potential outbreak geography and seasonality. Our results illustrate the usually-undocumented margin of uncertainty that could emerge from using any one of these predictions without reservation or qualification. In the short term, ecologists face the task of developing better post hoc consensus that accurately forecasts spatial patterns of Zika virus outbreaks. Ultimately, methods are needed that bridge the gap between ecological and epidemiological approaches to predicting transmission and realistically capture both outbreak size and geography.
C1 [Carlson, Colin J.] Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA.
   [Carlson, Colin J.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA.
   [Dougherty, Eric; Getz, Wayne] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.
   [Boots, Mike] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.
   [Getz, Wayne] Univ KwaZulu, Sch Math Sci, Natal, South Africa.
   [Ryan, Sadie J.] Univ KwaZulu, Sch Life Sci, Natal, South Africa.
   [Ryan, Sadie J.] Univ Florida, Dept Geog, Gainesville, FL 32601 USA.
   [Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.
RP Carlson, CJ (corresponding author), Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA.; Carlson, CJ (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.
EM ccarlson@sesync.org
RI Carlson, Colin/I-2736-2019; Getz, Wayne/I-4521-2013
OI Carlson, Colin/0000-0001-6960-8434; Dougherty, Eric/0000-0001-5140-1646;
   Ryan, Sadie/0000-0002-4308-6321; Getz, Wayne/0000-0001-8784-9354
FU National Socio-Environmental Synthesis Center (SESYNC) from the National
   Science FoundationNational Science Foundation (NSF)NSF - Directorate for
   Biological Sciences (BIO) [DBI-1639145]; Rutgers University Center for
   Discrete Mathematics Theoretical Computational Science (DIMACS)
   Mathematics of Planet Earth 2013+ Workshop on Zika DIMACS MPE 2013+
   Workshop on Appropriate Complexity Modeling of the Impacts of Global
   Change on Ecosystem; Centers for Disease Control and Prevention Epidemic
   Predictions Initiative (CDC EPI); NSFNational Science Foundation (NSF)
   [EF-0553768]; NSF DEB EEID [1518681]; NSF DEB RAPID [1641145]; CDC grant
   [1U01CK000510-01]; Centers for Disease Control and PreventionUnited
   States Department of Health & Human ServicesCenters for Disease Control
   & Prevention - USA
FX We thank Lewis Bartlett, Eva Harris, and others for helpful comments and
   guidance. This work was supported by the National Socio-Environmental
   Synthesis Center (SESYNC) under funding received from the National
   Science Foundation DBI-1639145; the Rutgers University Center for
   Discrete Mathematics & Theoretical Computational Science (DIMACS)
   Mathematics of Planet Earth 2013+ Workshop on Zika & DIMACS MPE 2013+
   Workshop on Appropriate Complexity Modeling of the Impacts of Global
   Change on Ecosystem; and the Centers for Disease Control and Prevention
   Epidemic Predictions Initiative (CDC EPI), a Center funded by NSF
   (EF-0553768). SJR was also supported by NSF DEB EEID 1518681, NSF DEB
   RAPID 1641145, and CDC grant 1U01CK000510-01: Southeastern Regional
   Center of Excellence in Vector-Borne Diseases: the Gateway Program. This
   publication was supported by the Cooperative Agreement Number above from
   the Centers for Disease Control and Prevention. Its contents are solely
   the responsibility of the authors and do not necessarily represent the
   official views of the Centers for Disease Control and Prevention.
CR Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Allard A., 2016, BIORXIV
   Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6
   Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45
   Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x
   Blinder A, NY TIMES
   Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   Cattan P. E., 2017, INT J EPIDEMIOL
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Colon-Gonzalez F. D. J., 2017, PLOS NEGLECTED TROPI
   Dickey-Collas M, 2014, ICES J MAR SCI, V71, P2300, DOI 10.1093/icesjms/fst215
   Escobar LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01174
   Evans MV, 2017, ELIFE, V6, DOI 10.7554/eLife.22053
   Folkers KM, 2017, PUBLIC HEALTH, V148, P66, DOI 10.1016/j.puhe.2017.02.018
   Gao D., 2016, SCI REPORTS, V6
   Golding N., 2017, METHODS ECOLOGY EVOL
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x
   Hijmans R., 2004, WORLDCLIM INTERPOLAT
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Johnson LR, 2015, ECOLOGY, V96, P203, DOI 10.1890/13-1964.1
   Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x
   Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x
   Kracalik IT, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005885
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   LEVINS R, 1966, AM SCI, V54, P421
   Lindstrom N, TRIBUNE LIVE
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005698
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Marcius Chelsia Rose, NEW YORK DAILY NEWS
   Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Merow C, 2014, ECOGRAPHY, V37, P1267, DOI 10.1111/ecog.00845
   Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Naucke TJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-67
   Ogden NH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1977-z
   PAHO/WHO, 2017, TECH REP
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004
   Pigott D. M., 2017, LANCET
   Pozzi F, 2003, EARTH OBSERVATION MA, V12, P24
   Qiao HJ, 2015, METHODS ECOL EVOL, V6, P1126, DOI 10.1111/2041-210X.12397
   R Core Team, 2018, R LANG ENV STAT COMP
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   Redding DW, 2016, METHODS ECOL EVOL, V7, P646, DOI 10.1111/2041-210X.12549
   Regan DG, 2008, T ROY SOC TROP MED H, V102, P207, DOI 10.1016/j.trstmh.2007.08.009
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x
   Shacham E., 2017, AM J PUBLIC HEALTH, pe1
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Zacharias N, 2017, AJP REP, V7, P68, DOI 10.1055/s-0037-1601890
NR 68
TC 11
Z9 11
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 21
PY 2018
VL 8
AR 4921
DI 10.1038/s41598-018-22989-0
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ9IV
UT WOS:000427925000001
PM 29563545
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abdulkareem, SA
   Augustijn, EW
   Mustafa, YT
   Filatova, T
AF Abdulkareem, Shaheen A.
   Augustijn, Ellen-Wien
   Mustafa, Yaseen T.
   Filatova, Tatiana
TI Intelligent judgements over health risks in a spatial agent-based model
SO INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS
LA English
DT Article
DE Protection motivation theory; Disease diffusion; Emergent behavior;
   Learning; Cholera; Bayesian networks
ID PERCEPTIONS; INFORMATION; LANDSCAPE; NETWORKS; BEHAVIOR; CHOLERA;
   SPREAD; IMPACT
AB Background: Millions of people worldwide are exposed to deadly infectious diseases on a regular basis. Breaking news of the Zika outbreak for instance, made it to the main media titles internationally. Perceiving disease risks motivate people to adapt their behavior toward a safer and more protective lifestyle. Computational science is instrumental in exploring patterns of disease spread emerging from many individual decisions and interactions among agents and their environment by means of agent-based models. Yet, current disease models rarely consider simulating dynamics in risk perception and its impact on the adaptive protective behavior. Social sciences offer insights into individual risk perception and corresponding protective actions, while machine learning provides algorithms and methods to capture these learning processes. This article presents an innovative approach to extend agent-based disease models by capturing behavioral aspects of decision-making in a risky context using machine learning techniques. We illustrate it with a case of cholera in Kumasi, Ghana, accounting for spatial and social risk factors that affect intelligent behavior and corresponding disease incidents. The results of computational experiments comparing intelligent with zero-intelligent representations of agents in a spatial disease agent-based model are discussed.
   Methods: We present a spatial disease agent-based model (ABM) with agents' behavior grounded in Protection Motivation Theory. Spatial and temporal patterns of disease diffusion among zero-intelligent agents are compared to those produced by a population of intelligent agents. Two Bayesian Networks (BNs) designed and coded using R and are further integrated with the NetLogo-based Cholera ABM. The first is a one-tier BN1 (only risk perception), the second is a two-tier BN2 (risk and coping behavior).
   Results: We run three experiments (zero-intelligent agents, BN1 intelligence and BN2 intelligence) and report the results per experiment in terms of several macro metrics of interest: an epidemic curve, a risk perception curve, and a distribution of different types of coping strategies over time.
   Conclusions: Our results emphasize the importance of integrating behavioral aspects of decision making under risk into spatial disease ABMs using machine learning algorithms. This is especially relevant when studying cumulative impacts of behavioral changes and possible intervention strategies.
C1 [Abdulkareem, Shaheen A.; Filatova, Tatiana] Univ Twente, Fac Behav Management & Social Sci BMS, Dept Governance & Technol Sustainabil CSTM, Enschede, Netherlands.
   [Abdulkareem, Shaheen A.] Univ Duhok UoD, Coll Sci, Dept Comp Sci, Duhok, Kurdistan Regio, Iraq.
   [Augustijn, Ellen-Wien] Univ Twente, Dept Geo Informat Proc GIP, Fac Geo Informat Sci & Earth Observat ITC, Enschede, Netherlands.
   [Mustafa, Yaseen T.] Univ Zakho UoZ, Fac Sci, Duhok, Kurdistan Regio, Iraq.
   [Filatova, Tatiana] Univ Technol Sydney, Sch Syst Management & Leadership, Fac Engn & Informat Technol, Ultimo, Australia.
RP Abdulkareem, SA (corresponding author), Univ Twente, Fac Behav Management & Social Sci BMS, Dept Governance & Technol Sustainabil CSTM, Enschede, Netherlands.
EM s.a.abdulkareem@utwente.nl
RI Mustafa, Yaseen T./F-8144-2013; Abdulkareem, Shaheen A./K-8301-2018;
   Filatova, Tatiana/K-8233-2016
OI Mustafa, Yaseen T./0000-0003-0634-3170; Abdulkareem, Shaheen
   A./0000-0002-9837-0207; Filatova, Tatiana/0000-0002-3546-6930
FU split-site PhD program of the Iraqi Kurdistan-region government (KRG);
   NWO DID MIRACLE project [640-006-012]
FX The financial support of this research comes from the split-site PhD
   program of the Iraqi Kurdistan-region government (KRG) represented by
   ministry of higher education and scientific research, and the NWO DID
   MIRACLE project (640-006-012).
CR Asase M, 2009, WASTE MANAGE, V29, P2779, DOI 10.1016/j.wasman.2009.06.019
   Asgari S, 2016, AUTOMAT CONSTR, V65, P9, DOI 10.1016/j.autcon.2016.01.004
   Augustijn EW, 2016, STOCH ENV RES RISK A, V30, P2079, DOI 10.1007/s00477-015-1199-x
   Bassett RL, 2011, DISABIL HEALTH J, V4, P165, DOI 10.1016/j.dhjo.2010.12.001
   Bauch CT, 2013, BEHAV EPIDEMIOLOGY I
   Bieberstein A., 2014, INVESTIGATION WOMENS, P25
   Crooks AT, 2014, ENVIRON MODELL SOFTW, V62, P164, DOI 10.1016/j.envsoft.2014.08.027
   Danquah L., 2011, Journal of Sustainable Development, V4, P103
   Filatova T, 2011, AGR RESOURCE EC REV, V40, P405
   Frias-martinez V., 2012, PERVASIVE URBAN APPL
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Ghana Statistical Service, 2014, 2010 POP HOUS CENS, DOI [DOI 10.1371/JOURNAL.PONE.0104053, 10.1371/journal.pone.0104053]
   Gotteland C, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-45
   Haer T, 2017, RISK ANAL, V37, P1977, DOI 10.1111/risa.12740
   Heckerman D., 1995, INNOVATIONS BAYESIAN
   Jensen F. V., 2007, BAYESIAN NETWORKS DE
   Kim DJ, 2008, DECIS SUPPORT SYST, V44, P544, DOI 10.1016/j.dss.2007.07.001
   Kocabas V, 2013, J GEOGR SYST, V15, P403, DOI 10.1007/s10109-012-0171-2
   Lei Z, 2005, SIMUL-T SOC MOD SIM, V81, P503, DOI 10.1177/0037549705058067
   Manfredi P., 2013, MODELING INTERPLAY H
   Melegaro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170459
   Miezah K, 2015, WASTE MANAGE, V46, P15, DOI 10.1016/j.wasman.2015.09.009
   Mitchell T., 1997, MACHINE LEARNING
   Pablo AL, 1996, J MANAGE, V22, P723, DOI 10.1177/014920639602200503
   Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50
   Rogers RW, 1983, SOCIAL PSYCHOPHYSIOL, P1, DOI DOI 10.1002/9780470479216.CORPSY0897
   Seidl R, 2016, REGIONAL ASSESSMENT, P347
   Sitkin SB, 1995, ACAD MANAGE J, V38, P1573, DOI 10.2307/256844
   van Duinen R, 2016, ANN REGIONAL SCI, V57, P335, DOI 10.1007/s00168-015-0699-4
   Williams DJ, 2007, THEOR ISS ERGON SCI, V8, P1, DOI 10.1080/14639220500484419
   Wise Sarah, 2014, USING SOCIAL MEDIA C
   Zhang MW, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION WORKSHOP: IITA 2008 WORKSHOPS, PROCEEDINGS, P859, DOI 10.1109/IITA.Workshops.2008.144
NR 32
TC 5
Z9 5
U1 4
U2 24
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1476-072X
J9 INT J HEALTH GEOGR
JI Int. J. Health Geogr.
PD MAR 20
PY 2018
VL 17
AR 8
DI 10.1186/s12942-018-0128-x
PG 19
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GA4AX
UT WOS:000428273000001
PM 29558944
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shabani, F
   Tehrany, MS
   Solhjouy-fard, S
   Kumar, L
AF Shabani, Farzin
   Tehrany, Mahyat Shafapour
   Solhjouy-fard, Samaneh
   Kumar, Lalit
TI A comparative modeling study on non-climatic and climatic risk
   assessment on Asian Tiger Mosquito (Aedes albopictus)
SO PEERJ
LA English
DT Article
DE Mosquito; Ae. albopicus and Aedes albopictus; MaxEnt; USA; GIS;
   Evidential Belief Function
ID DEMPSTER-SHAFER THEORY; DIPTERA-CULICIDAE; AEGYPTI; SUITABILITY; MAXENT;
   SPREAD; EGGS
AB Aedes albopictus, the Asian Tiger Mosquito, vector of Chikungunya, Dengue Fever and Zika viruses, has proven its hardy adaptability in expansion from its natural Asian, forest edge, tree hole habitat on the back of international trade transportation, re-establishing in temperate urban surrounds, in a range of water receptacles and semi-enclosures of organic matter. Conventional aerial spray mosquito vector controls focus on wetland and stagnant water expanses proven to miss the protected hollows and crevices favoured by Ae. albopictus. New control or eradication strategies are thus essential, particular in light of potential expansions in the southeastern and eastern USA. Successful regional vector control strategies require risk level analysis. Should strategies prioritize regions with non-climatic or climatic suitability parameters for Ae. albopictus? Our study used current Ae. albopictus distribution data to develop two independent models: (i) regions with suitable non-climatic factors, and (ii) regions with suitable climate for Ac. albopictus in southeastern USA. Non-climatic model processing used Evidential Belief Function (EBF), together with six geographical conditioning factors (raster data layers), to establish the probability index. Validation of the analysis results was estimated with area under the curve (AUC) using Ae. albopictus presence data. Climatic modeling was based on two General Circulation Models (GCMs), Miroc3.2 and CSIRO-MK30 running the RCP 8.5 scenario in MaxEnt software. EBF non climatic model results achieved a 0.70 prediction rate and 0.73 success rate, confirming suitability of the study site regions for Ae. albopictus establishment. The climatic model results showed the best-fit model comprised Coldest Quarter Mean Temp, Precipitation of Wettest Quarter and Driest Quarter Precipitation factors with mean AUC value of 0.86. Both GCMs showed that the whole study site is highly suitable and will remain suitable climatically, according to the prediction for 2055, for Ae. albopictus expansion.
C1 [Shabani, Farzin; Solhjouy-fard, Samaneh] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.
   [Tehrany, Mahyat Shafapour] RMIT Univ, Coll Sci, Geospatial Sci, Melbourne, Vic, Australia.
   [Kumar, Lalit] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.
RP Shabani, F (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.
EM farzin.shabani@flinders.edu.au
RI shabani, Farzin/P-1033-2019; Kumar, Lalit/A-6397-2011
OI shabani, Farzin/0000-0002-5100-8921; Kumar, Lalit/0000-0002-9205-756X
CR Althuwaynee OF, 2012, COMPUT GEOSCI-UK, V44, P120, DOI 10.1016/j.cageo.2012.03.003
   Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104
   Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010
   Awasthi A, 2011, ENVIRON MODELL SOFTW, V26, P787, DOI 10.1016/j.envsoft.2010.11.010
   Beyer HL, 2004, HAWTHS ANAL TOOLS AR
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Carranza EJM, 2008, ORE GEOL REV, V33, P536, DOI 10.1016/j.oregeorev.2007.07.001
   Carranza E. J. M., 2005, NAT RESOUR RES, V14, DOI [DOI 10.1007/S11053-005-4678-9, 10.1007/s11053-005-4678-9]
   Carranza EJM, 2003, ORE GEOL REV, V22, P117, DOI 10.1016/S0169-1368(02)00111-7
   da Silva RS, 2018, THEOR APPL CLIMATOL, V132, P135, DOI 10.1007/s00704-017-2072-2
   da Silva RS, 2017, INT J BIOMETEOROL, V61, P785, DOI 10.1007/s00484-016-1256-2
   DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950
   Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x
   Guillera-Arroita G, 2014, METHODS ECOL EVOL, V5, P1192, DOI 10.1111/2041-210X.12252
   HANSON SM, 1995, J MED ENTOMOL, V32, P599, DOI 10.1093/jmedent/32.5.599
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Holder P, 2010, J MED ENTOMOL, V47, P600, DOI 10.1603/ME09111
   Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x
   Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y
   Kraemer M, 2015, GLOBAL COMPENDIUM AE
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lamsal P, 2017, GLOBAL PLANET CHANGE, V159, P77, DOI 10.1016/j.gloplacha.2017.09.010
   Li H, 2010, J EARTH SCI-CHINA, V21, P941, DOI 10.1007/s12583-010-0147-4
   Malpica JA, 2007, EXPERT SYST APPL, V32, P47, DOI 10.1016/j.eswa.2005.11.011
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Nihei N, 2014, GEOSPATIAL HEALTH, V8, P417, DOI 10.4081/gh.2014.30
   Paterson RRM, 2017, J AGR SCI-CAMBRIDGE, V155, P689, DOI 10.1017/S0021859616000605
   PEARL J, 1989, ANNU REV COMPUT SCI, V4, P37, DOI 10.1146/annurev.cs.04.060190.000345
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x
   Pimentel D., 2011, BIOL INVASIONS EC EN, P463
   Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548
   RAI KS, 1991, ANNU REV ENTOMOL, V36, P459, DOI 10.1146/annurev.en.36.010191.002331
   Ramirez-Cabral NYZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05804-0
   RAMIREZCABRAL NYZ, 2017, J PHYTOPATHOL, V7, DOI DOI 10.1038/S41598-017-05804-0
   Randall DA, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589
   Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rochlin I, 2013, BIOL INVASIONS, V15, P991, DOI 10.1007/s10530-012-0345-3
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Shabani F, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6040058
   Shabani F, 2016, ECOL EVOL, V6, P5973, DOI 10.1002/ece3.2332
   Shabani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048021
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Srivastava RP, 2011, AUST ACCOUNT REV, V21, P282, DOI 10.1111/j.1835-2561.2011.00135.x
   Stocker T., 2013, IPCC 2013 SUMMARY PO
   Tehrany MS, 2013, J HYDROL, V504, P69, DOI 10.1016/j.jhydrol.2013.09.034
   Thiam A. K., 2005, Transactions in GIS, V9, P507, DOI 10.1111/j.1467-9671.2005.00232.x
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Umar Z, 2014, CATENA, V118, P124, DOI 10.1016/j.catena.2014.02.005
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Walker M., 2016, ENTOMOLOGYTODAY
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wittenberg R., 2001, INVASIVE ALIEN SPECI
NR 58
TC 5
Z9 5
U1 0
U2 9
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD MAR 19
PY 2018
VL 6
AR e4474
DI 10.7717/peerj.4474
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ7NG
UT WOS:000427787500004
PM 29576954
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dzaki, N
   Azzam, G
AF Dzaki, Najat
   Azzam, Ghows
TI Assessment of Aedes albopictus reference genes for quantitative PCR at
   different stages of development
SO PLOS ONE
LA English
DT Article
ID REAL-TIME PCR; ELONGATION-FACTOR 1A; RT-PCR; INSECTICIDE RESISTANCE;
   ACTIN CYTOSKELETON; CHIKUNGUNYA VIRUS; BETA-ACTIN; NORMALIZATION;
   AEGYPTI; VECTOR
AB Members of the Aedes genus of mosquitoes are widely recognized as vectors of viral diseases. Ae. albopictus is its most invasive species, and are known to carry viruses such as Dengue, Chikugunya and Zika. Its emerging importance puts Ae. albopictus on the forefront of genetic interaction and evolution studies. However, a panel of suitable reference genes specific for this insect is as of now undescribed. Nine reference genes, namely ACT, eEF1-gamma, eIF2 alpha, PP2A, RPL32, RPS17, PGK1, ILK and STK were evaluated. Expression patterns of the candidate reference genes were observed in a total of seventeen sample types, separated by stage of development and age. Gene stability was inferred from obtained quantification data through three widely cited evaluation algorithms i. e. BestKeeper, geNorm, and NormFinder. No single gene showed a satisfactory degree of stability throughout all developmental stages. Therefore, we propose combinations of PGK and ILK for early embryos; RPL32 and RPS17 for late embryos, all four larval instars, and pupae samples; eEF1-gamma with STK for adult males; eEF1-gamma with RPS17 for non-blood fed females; and eEF1-gamma with eIF2 alpha for both blood-fed females and cell culture. The results from this study should be able to provide a more informed selection of normalizing genes during qPCR in Ae. albopictus.
C1 [Dzaki, Najat; Azzam, Ghows] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia.
   [Azzam, Ghows] Univ Sains Malaysia, Sch Biol Sci, Vector Control & Res Unit, George Town, Malaysia.
RP Azzam, G (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia.; Azzam, G (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Vector Control & Res Unit, George Town, Malaysia.
EM ghows@usm.my
RI Azzam, Ghows/C-5592-2013
OI Azzam, Ghows/0000-0001-5352-8675; Dzaki, Najat/0000-0001-9661-6827
FU Fundamental Research Grant Scheme [203/PBIOLOGI/6711457]; Universiti
   Sains Malaysia Research University GrantUniversiti Sains Malaysia
   [1001/PBIOLOGI/811320];  [304/PBIOLOGI/6313195];  [305/PBIOLOGI/613238]
FX This work was supported by Fundamental Research Grant Scheme
   (203/PBIOLOGI/6711457) http://mygrants.gov.my/main.php; Universiti Sains
   Malaysia Research University Grant (1001/PBIOLOGI/811320)
   http://www.research.usm.my/default.asp?tag=3& Short Term Grant
   (304/PBIOLOGI/6313195) http://www.research.usm.my/default.asp?tag=3&
   ScienceFund grant (305/PBIOLOGI/613238)
   https://ernd.mosti.gov.my/site/login. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahn K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-78
   Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bogaert L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-24
   Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82
   Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22
   Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023
   Bustin Stephen A, 2004, J Biomol Tech, V15, P155
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049
   Clemens MJ, 2001, PROG MOLEC, V27, P57
   CRAVEN RB, 1988, J AM MOSQUITO CONTR, V4, P138
   Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743
   Dzaki N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43618
   Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208
   Fischer M, 2005, J MOL DIAGN, V7, P89, DOI 10.1016/S1525-1578(10)60013-X
   Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862
   Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360
   Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979
   Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6
   Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369
   Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986
   Hildyard JC, 2014, PLOS CURRENTS MUSCUL, V1
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Huang X, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003724
   Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Khanlou KM, 2012, PLANTA, V236, P1381, DOI 10.1007/s00425-012-1682-2
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kriegova E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-69
   Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   Munshi R, 2001, GENETICS, V157, P1425
   Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285
   Padmanabha H, 2011, MED VET ENTOMOL, V25, P445, DOI 10.1111/j.1365-2915.2011.00950.x
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Perez-Rico A, 2014, ANIM REPROD SCI, V149, P204, DOI 10.1016/j.anireprosci.2014.08.007
   Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143
   Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573
   Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177
   Raquin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125066
   Ray Debashree L, 2014, BMC Res Notes, V7, P304, DOI 10.1186/1756-0500-7-304
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X
   Rey JR, 2009, AQUAT ECOL, V43, P987, DOI 10.1007/s10452-009-9232-0
   Riemer AB, 2012, EXP DERMATOL, V21, P625, DOI 10.1111/j.1600-0625.2012.01537.x
   Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118
   Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376
   Sgamma T, 2016, SELECTION REFERENCE, V12, P21, DOI DOI 10.1186/S13007-016-0121-Y
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Socolovschi C, 2012, EMERG INFECT DIS, V18, P1687, DOI 10.3201/eid1810.120178
   Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979
   Tortosa P, 2008, INSECT MOL BIOL, V17, P677, DOI 10.1111/j.1365-2583.2008.00842.x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Usarek E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174317
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yeung AT, 2004, BIOTECHNIQUES, V36, P266, DOI 10.2144/04362RR01
   Zhai YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106800
   Zhang MC, 2010, AM J TROP MED HYG, V83, P700, DOI 10.4269/ajtmh.2010.10-0193
   Zhao XT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3089584
   Zheng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093624
   Zhou Y., 2014, PARASITE VECTOR, V7, P1
NR 73
TC 2
Z9 2
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2018
VL 13
IS 3
AR e0194664
DI 10.1371/journal.pone.0194664
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ7QU
UT WOS:000427796800048
PM 29554153
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Guan, H
   Wang, MY
   Liao, CH
   Liang, J
   Mehere, P
   Tian, ML
   Liu, HR
   Robinson, H
   Li, JY
   Han, Q
AF Guan, Huai
   Wang, Maoying
   Liao, Chenghong
   Liang, Jing
   Mehere, Prajwalini
   Tian, Meiling
   Liu, Hairong
   Robinson, Howard
   Li, Jianyong
   Han, Qian
TI Identification of aaNAT5b as a spermine N-acetyltransferase in the
   mosquito, Aedes aegypti
SO PLOS ONE
LA English
DT Article
ID YELLOW-FEVER MOSQUITO; STRUCTURAL-ANALYSIS; POLYAMINES; CRYSTALLOGRAPHY;
   SEQUENCE
AB Mosquitoes transmit a number of diseases in animals and humans, including Dengue, Chikungunya and Zika viruses that affect millions of people each year. Controlling the disease-transmitting mosquitoes has proven to be a successful strategy to reduce the viruses transmission. Polyamines are required for the life cycle of the RNA viruses, Chikungunya virus and Zika virus, and a depletion of spermidine and spermine in the host via induction of spermine N-acetyltransferase restricts their replication. Spermine N-acetyltransferase is a key catabolic enzyme in the polyamine pathway, however there is no information of the enzyme identification in any insects. Aliphatic polyamines play a fundamental role in tissue growth and development in organisms. They are acetylated by spermidine/spermine N-1-acetyl-transferase (SAT). In this study we provided a molecular and biochemical identification of SAT from Aedes aegypti mosquitoes. Screening of purified recombinant proteins against polyamines established that aaNAT5b, named previously based on sequence similarity with identified aaNAT1 in insects, is active to spermine and spermidine. A crystal structure was determined and used in molecular docking in this study. Key residues were identified to be involved in spermine binding using molecular docking and simulation. In addition, SAT transcript was down regulated by blood feeding using a real time PCR test. Based on its substrate profile and transcriptional levels after blood feeding, together with previous reports for polyamines required in arboviruses replication, SAT might be potentially used as a target to control arboviruses with human interference.
C1 [Guan, Huai; Wang, Maoying; Liao, Chenghong; Han, Qian] Hainan Univ, Minist Educ, Key Lab Trop Biol Resources, Haikou, Hainan, Peoples R China.
   [Guan, Huai; Wang, Maoying; Liao, Chenghong; Tian, Meiling; Liu, Hairong; Han, Qian] Hainan Univ, Inst Trop Agr & Forestry, Lab Trop Vet Med & Vector Biol, Haikou, Hainan, Peoples R China.
   [Liang, Jing; Li, Jianyong] Krantisinh Nana Patil Coll Vet Sci, Shirval, India.
   [Mehere, Prajwalini] Virginia Tech, Dept Biochem, Blacksburg, VA USA.
   [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.
RP Han, Q (corresponding author), Hainan Univ, Minist Educ, Key Lab Trop Biol Resources, Haikou, Hainan, Peoples R China.; Han, Q (corresponding author), Hainan Univ, Inst Trop Agr & Forestry, Lab Trop Vet Med & Vector Biol, Haikou, Hainan, Peoples R China.
EM qianhan@hainu.edu.cn
RI Han, Qian/J-8696-2014; Han, Qian/AAS-2134-2020
OI Han, Qian/0000-0001-6245-5252; Han, Qian/0000-0001-6245-5252
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31472186]
FX This work was supported by National Natural Science Foundation of China
   [Grant Number 31472186] (QH). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Bembenek J, 2005, ARCH INSECT BIOCHEM, V59, P219, DOI 10.1002/arch.20070
   CASERO RA, 1991, J BIOL CHEM, V266, P810
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Delano W.L., 2002, PYMOL MOL GRAPHICS S
   Dempsey DR, 2015, BIOCHEMISTRY-US, V54, P2644, DOI 10.1021/acs.biochem.5b00113
   Dzaki N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43618
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Han Q, 2012, P NATL ACAD SCI USA, V109, P11669, DOI 10.1073/pnas.1206828109
   Hegde SS, 2007, BIOCHEMISTRY-US, V46, P7187, DOI 10.1021/bi700256z
   Kawamura A, 2005, BIOCHEM PHARMACOL, V69, P347, DOI 10.1016/j.bcp.2004.09.014
   Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91
   Li MMH, 2016, CELL HOST MICROBE, V20, P123, DOI 10.1016/j.chom.2016.07.012
   Mehere P, 2011, INSECT BIOCHEM MOLEC, V41, P707, DOI 10.1016/j.ibmb.2011.05.002
   Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008
   Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661
   Ramani D, 2014, CLIN NUTR, V33, P14, DOI 10.1016/j.clnu.2013.09.019
   Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Yerra A, 2017, BIOPOLYMERS, V107, P20, DOI 10.1002/bip.22980
NR 26
TC 0
Z9 0
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2018
VL 13
IS 3
AR e0194499
DI 10.1371/journal.pone.0194499
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ7QU
UT WOS:000427796800043
PM 29554129
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vani, JM
   Monreal, MTFD
   Auharek, SA
   Cunha-Laura, AL
   de Arruda, EJ
   Limas, AR
   da Silva, CM
   Antoniolli-Silva, ACMB
   de Lima, DP
   Beatriz, A
   Oliveira, RJ
AF Vani, Juliana Miron
   Ferreira Duenhas Monreal, Maria Tereza
   Auharek, Sarah Alves
   Cunha-Laura, Andrea Luiza
   de Arruda, Eduardo Jose
   Limas, Alessandra Ramos
   da Silva, Cicera Maria
   Milan Brochado Antoniolli-Silva, Andreia Conceicao
   de Lima, Denis Pires
   Beatriz, Adilson
   Oliveira, Rodrigo Juliano
TI The mixture of cashew nut shell liquid and castor oil results in an
   efficient larvicide against Aedes aegypti that does not alter
   embryo-fetal development, reproductive performance or DNA integrity
SO PLOS ONE
LA English
DT Article
ID ANACARDIUM-OCCIDENTALE; ZIKA VIRUS; IN-VITRO; EXPOSURE; TOXICITY;
   TERATOGENICITY; ISOFLURANE; ASSAY; CNSL
AB Dengue fever, chikungunya fever and Zika virus are epidemics in Brazil that are transmitted by mosquitoes, such as Aedes aegypti or Aedes albopictus. The liquid from shells of cashew nuts is attractive for its important biological and therapeutic activities, which include toxicity to mosquitoes of the genus Aedes. The present study evaluated the effects of a mixture of surfactants from natural cashew nutshell liquid and castor oil (named TaLCC-20) on the mortality of larvae and on the reproductive performance, embryonic and fetal development and genetic stability of Swiss mice. A total of 400 Ae. aegypti larvae (third larval stage) were treated with TaLCC-20 concentrations of 0.05 mg/L, 0.5 mg/L, or 5 mg/L (ppm). Twenty pregnant female mice were also orally administered TaLCC-20 at doses of 5 mg/kg and 50 mg/kg body weight (b.w.), and 10 animals were given only drinking water at 0.1 mL/10 g b. w. (orally). The results of a larvicide test demonstrated that 5 mg/mL TaLCC-20 killed 100% of larvae within three hours, which is comparable to the gold standard indicated by the Ministry of Health. Overall, these results show that TaLCC-20 is an efficient larvicide that does not induce genetic damage. In addition, changes in reproductive performance and embryo-fetal development appear positive, and the formulation is cost effective. Therefore, TaLCC-20 is an important product in the exploration of natural larvicides and can assist in fighting mosquitos as vectors for dengue fever, chikungunya fever and Zika virus, which are emerging/re-emerging and require proper management to ensure minimal harm to the human population. Therefore, TaLCC-20 can be considered a key alternative to commercial products, which are effective yet toxigenic.
C1 [Vani, Juliana Miron; Milan Brochado Antoniolli-Silva, Andreia Conceicao; Oliveira, Rodrigo Juliano] Univ Fed Mato Grosso do Sul UFMS, HUMAP, Ctr Estudos Celulas Tronco Terapia Celular & Gene, Campo Grande, MS, Brazil.
   [Vani, Juliana Miron; Ferreira Duenhas Monreal, Maria Tereza; Cunha-Laura, Andrea Luiza; de Lima, Denis Pires; Beatriz, Adilson; Oliveira, Rodrigo Juliano] Univ Fed Mato Grosso do Sul UFMS, Programa Mestrado Farm, Fac Ciencias Farmaceut Alimentos & Nutr FACFAN, Campo Grande, MS, Brazil.
   [Vani, Juliana Miron; Milan Brochado Antoniolli-Silva, Andreia Conceicao; Oliveira, Rodrigo Juliano] Univ Fed Mato Grosso do Sul UFMS, Programa Posgrad Saude & Desenvolvimento Regiao C, Fac Med Dr Helio Mandetta FAMED, Campo Grande, MS, Brazil.
   [Auharek, Sarah Alves] UFVJM, Fac Med Mucuri, Teofilo Otoni, MG, Brazil.
   [de Arruda, Eduardo Jose; Limas, Alessandra Ramos; da Silva, Cicera Maria] UFGD, Fac Ciencias Exatas & Tecnol FACET, Dourados, MS, Brazil.
   [de Lima, Denis Pires; Beatriz, Adilson] Univ Fed Mato Grosso do Sul UFMS, Inst Quim INQUI, Campo Grande, MS, Brazil.
   [Oliveira, Rodrigo Juliano] Univ Estadual Londrina, CCB, Programa Posgrad Genet & Biol Mol, Londrina, PR, Brazil.
RP Oliveira, RJ (corresponding author), Univ Fed Mato Grosso do Sul UFMS, HUMAP, Ctr Estudos Celulas Tronco Terapia Celular & Gene, Campo Grande, MS, Brazil.; Beatriz, A; Oliveira, RJ (corresponding author), Univ Fed Mato Grosso do Sul UFMS, Programa Mestrado Farm, Fac Ciencias Farmaceut Alimentos & Nutr FACFAN, Campo Grande, MS, Brazil.; Oliveira, RJ (corresponding author), Univ Fed Mato Grosso do Sul UFMS, Programa Posgrad Saude & Desenvolvimento Regiao C, Fac Med Dr Helio Mandetta FAMED, Campo Grande, MS, Brazil.; Beatriz, A (corresponding author), Univ Fed Mato Grosso do Sul UFMS, Inst Quim INQUI, Campo Grande, MS, Brazil.; Oliveira, RJ (corresponding author), Univ Estadual Londrina, CCB, Programa Posgrad Genet & Biol Mol, Londrina, PR, Brazil.
EM adilson.beatriz@ufms.br; rodrigo.oliveira@ufms.br
RI Monreal, Maria Tereza/D-4987-2019; de Arruda, Eduardo
   Jose/AAJ-9834-2020; AR, Lima/AAP-6642-2020; de Lima, Denis
   P./I-4607-2013; amsalu, ribka/G-8780-2019; Oliveira, Rodrigo
   Juliano/M-3151-2018
OI de Arruda, Eduardo Jose/0000-0002-9835-467X; AR,
   Lima/0000-0001-5810-5137; de Lima, Denis P./0000-0002-6023-4867;
   Oliveira, Rodrigo Juliano/0000-0003-3514-3346; Monreal, Maria
   Tereza/0000-0002-7472-6504; Cunha-Laura, Andrea
   Luiza/0000-0002-1246-5513
FU Fundacao de apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do
   Estado de Mato Grosso do Sul (FUNDECT-MS)Fundect; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Kardol Ind.
   Quimica Ltda; Fundacao de apoio ao Desenvolvimento do Ensino, Ciencia e
   Tecnologia do Estado de Mato Grosso do Sul (FUNDECT-MS)Fundect
   [134/2016, FUNDECT 25894]; Kardol Ind
FX We are grateful to the financial support by the Brazilian Foundation:
   Fundacao de apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do
   Estado de Mato Grosso do Sul (FUNDECT-MS) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Kardol Ind.
   Quimica Ltda.; The authors are grateful to the financial support by the
   Brazilian Foundation: Fundacao de apoio ao Desenvolvimento do Ensino,
   Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT-MS)
   (Numero outorga 134/2016 Numero FUNDECT 25894) to MTFDM and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and
   Kardol Ind. Quimica Ltda. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aiub Claudia Alessandra Fortes, 2002, Genetics and Molecular Research, V1, P159
   Auharek SA, 2013, J ETHNOPHARMACOL, V148, P341, DOI 10.1016/j.jep.2013.04.010
   BARROW MV, 1969, J MORPHOL, V127, P291, DOI 10.1002/jmor.1051270303
   Beatriz A, 2015, Brasil. Patente: Privile A gio de Inovac E ao. Nu A mero do registro, Patent No. [BR10201500723, 10201500723]
   Bilenky T., 2015, EM MESE INSS REGISTR
   BRASIL, 2010, GUIA COND EST NAO CL
   Brasil D Secretaria de Vigila A ncia Sanita A ria/ Ministe A rio da Sau A de, 2016, B EPIDEMIOLOGICO, V47
   Brasil-Ministerio da Saude, 2014, OR TECN UT LARV PYR
   Brent RL, 1999, TERATOLOGY, V59, P261
   Bretveld R, 2007, SCAND J WORK ENV HEA, V33, P13, DOI 10.5271/sjweh.1060
   Carbajal-Lopez Y, 2016, ENVIRON SCI POLLUT R, V23, P2513, DOI 10.1007/s11356-015-5474-7
   Carvalho ALN, 2013, EVID-BASED COMPL ALT, V2013
   Colet Jean-Marie, 2015, Drug Discov Today Technol, V13, P3, DOI 10.1016/j.ddtec.2015.01.002
   Oliveira MSC, 2011, ACTA TROP, V117, P165, DOI 10.1016/j.actatropica.2010.08.003
   Cunha-Laura AL, 2013, REV BRAS FARMACOGN, V23, P374, DOI 10.1590/S0102-695X2013005000005
   DAMASCENO DC, 2008, ANOMALIAS CONGENITAS
   Danesi R, 2004, TRANSPL P, V36, P705, DOI 10.1016/j.transproceed.2004.03.017
   de Barros AL, 2016, ENVIRON TOXICOL, V31, P407, DOI 10.1002/tox.22054
   de Barros AL, 2013, J TOXICOL ENV HEAL A, V76, P1003, DOI 10.1080/15287394.2013.830585
   de David N, 2014, J ETHNOPHARMACOL, V154, P370, DOI 10.1016/j.jep.2014.04.005
   Deeba F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv119
   desouza KM, 2016, AVALIACAO DANOS MAT
   ERIKSSON RSM, 1989, DIABETES, V38, P764, DOI 10.2337/diabetes.38.6.764
   ERIKSSON U, 1982, DIABETES, V31, P1, DOI 10.2337/diabetes.31.1.1
   Evans L., 2010, DIAS FALTA AO TRABAL
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Farias DF, 2009, J AM MOSQUITO CONTR, V25, P386, DOI 10.2987/08-5851.1
   Galdino TG, 2013, FEIRA BRASILEIRA CIE
   Gandhi TS, 2013, POL J CHEM TECHNOL, V15, P24, DOI 10.2478/pjct-2013-0062
   Gardner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139481
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   George L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004006
   Ghisi ND, 2016, CHEMOSPHERE, V145, P42, DOI 10.1016/j.chemosphere.2015.11.044
   Goncalves CA, 2014, GENET MOL RES, V13, P4392, DOI 10.4238/2014.June.11.3
   Goncalves CA, 2013, J ETHNOPHARMACOL, V150, P843, DOI 10.1016/j.jep.2013.09.012
   Guissoni A.C.P., 2013, Rev. bras. plantas med., V15, P363, DOI 10.1590/S1516-05722013000300008
   Hamad FB, 2015, INT J MOL SCI, V16, P8569, DOI 10.3390/ijms16048569
   HAYASHI M, 1990, MUTAT RES, V245, P245, DOI 10.1016/0165-7992(90)90153-B
   Heine J, 2000, BRIT J ANAESTH, V85, P424, DOI 10.1093/bja/85.3.424
   Hoerauf KH, 1999, BRIT J ANAESTH, V82, P268, DOI 10.1093/bja/82.2.268
   Jeronimo CE, 2012, MONOGRAFIAS AMBIENTA, V9, P2021
   Julis J, 2014, GREEN CHEM, V16, P2846, DOI 10.1039/c4gc00111g
   Kotani N, 1998, ANESTHESIOLOGY, V89, P1125, DOI 10.1097/00000542-199811000-00012
   Lomonaco D, 2009, GREEN CHEM, V11, P31, DOI 10.1039/b811504d
   Madariaga M, 2016, BRAZ J INFECT DIS, V20, P91, DOI 10.1016/j.bjid.2015.10.004
   Manson J. M., 1994, PRINCIPLES METHODS T
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   MATHEW G, 1990, MUTAGENESIS, V5, P147, DOI 10.1093/mutage/5.2.147
   Mazzetto SE, 2009, QUIM NOVA, V32, P732, DOI 10.1590/S0100-40422009000300017
   Melo KM, 2014, MUTAGENESIS, V29, P215, DOI 10.1093/mutage/geu005
   Mukhopadhyay AK, 2010, J VECTOR DIS, V47, P257
   Neal A, 2015, TOXICOL SCI, V148, P594, DOI 10.1093/toxsci/kfv208
   Ni Z, 1993, Hua Xi Yi Ke Da Xue Xue Bao, V24, P82
   OECD, 2001, OECD GUIDELINES TEST
   OECD, 2012, OECD GUIDELINES TEST
   OECD-Guidelines for Testing of Chemicals, 1997, OECD GUIDELINES TEST
   OECD-Guidelines for Testing of Chemicals, 2009, OECD GUIDEL IN PRESS
   Oliveira RJ, 2015, GENET MOL RES, V14, P834, DOI 10.4238/2015.February.2.8
   Oliveira RJ, 2014, GENET MOL RES, V13, P5606, DOI 10.4238/2014.July.25.16
   Oliveira RJ, 2009, REGUL TOXICOL PHARM, V53, P164, DOI 10.1016/j.yrtph.2008.12.007
   Patil RD, 2006, REPROD TOXICOL, V22, P679, DOI 10.1016/j.reprotox.2006.04.022
   Pereira BB, 2015, J TOXICOL ENV HEAL A, V78, P1033, DOI 10.1080/15287394.2015.1050566
   Raheja KL, 1998, REPROD TOXICOL, V2, P291
   Raraswati GR, 2014, BIOL MED NATURAL PRO, V3, P59
   Rodrigues FHA, 2011, POLIMEROS, V21, P156, DOI 10.1590/S0104-14282011005000028
   Sally EOF, 2013, CIENC SAUDE COLETIVA, P18
   Staples RE, 1964, STAIN TECHNOL
   Taylor P., 1986, PRATICAL TERATOLOGY
   Thavara Usavadee, 2013, Southeast Asian J Trop Med Public Health, V44, P753
   Torres RC, 2015, PARASITOL RES, V114, P3699, DOI 10.1007/s00436-015-4598-5
   Vargas MHM, 2014, REV ATENCAO SAUDE, V12
   Machado AAV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003104
   WHO-Recommended Classification of Pesticides by Hazard, 2000, WHO RECOMMENDED CLAS
   WILSON JC, 1965, TERATOLOGY PRINCIPLE
   Yu Y, 2017, ENVIRON TOXICOL, P32139
   Zhang C, 2014, TOXICOLOGY, V325, P74, DOI 10.1016/j.tox.2014.08.015
NR 77
TC 5
Z9 5
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2018
VL 13
IS 3
AR e0193509
DI 10.1371/journal.pone.0193509
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ7QU
UT WOS:000427796800011
PM 29554095
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abdullah, AM
   O'Shea, K
AF Abdullah, A. M.
   O'Shea, Kevin
TI Hydrolysis of the Zika pesticide naled: Kinetics and mechanistic
   investigation
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 255th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nexus of Food, Energy, and Water
CY MAR 18-22, 2018
CL New Orleans, LA
C1 [Abdullah, A. M.] Florida Int Univ, Chem, Miami, FL 33199 USA.
   [O'Shea, Kevin] Florida Int Univ, Miami, FL 33199 USA.
EM aabdu040@fiu.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 18
PY 2018
VL 255
MA 261
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GJ7BN
UT WOS:000435539900813
DA 2020-07-08
ER

PT J
AU Abdullah, AM
   O'Shea, K
AF Abdullah, A. M.
   O'Shea, Kevin
TI Ultrasonic degradation of the Zika pesticide naled in aqueous solution:
   Kinetics and mechanistic investigation
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 255th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nexus of Food, Energy, and Water
CY MAR 18-22, 2018
CL New Orleans, LA
C1 [Abdullah, A. M.] Florida Int Univ, Chem, Miami, FL 33199 USA.
   [O'Shea, Kevin] Florida Int Univ, Miami, FL 33199 USA.
EM aabdu040@fiu.edu
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 18
PY 2018
VL 255
MA 675
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GJ7BN
UT WOS:000435539901352
DA 2020-07-08
ER

PT J
AU Raubenolt, B
   Wong, K
   Rick, S
AF Raubenolt, Bryan
   Wong, Katy
   Rick, Steve
TI Allosteric inhibition of the Zika virus NS3 helicase
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 255th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nexus of Food, Energy, and Water
CY MAR 18-22, 2018
CL New Orleans, LA
C1 [Raubenolt, Bryan] Univ New Orleans, Chem, New Orleans, LA 70148 USA.
   [Wong, Katy] Tulane Univ, Chem & Biomol Engn, New Orleans, LA 70118 USA.
   [Rick, Steve] Univ New Orleans, New Orleans, LA 70148 USA.
EM braubeno@uno.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 18
PY 2018
VL 255
MA 78
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA GJ7AU
UT WOS:000435537706495
DA 2020-07-08
ER

PT J
AU Reed, A
   Connelly, R
   Williams, A
   Choe, H
   Gerasimova, Y
AF Reed, Adam
   Connelly, Ryan
   Williams, Allison
   Choe, Hyeryun
   Gerasimova, Yulia
TI Deoxyribozyme cascade for visual detection of Zika virus RNA
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 255th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nexus of Food, Energy, and Water
CY MAR 18-22, 2018
CL New Orleans, LA
C1 [Reed, Adam; Connelly, Ryan; Williams, Allison] Univ Cent Florida, Chem, Ft Myers, FL USA.
   [Gerasimova, Yulia] Univ Cent Florida, Chem, Orlando, FL 32816 USA.
   [Choe, Hyeryun] Scripps Res Inst, Immunol & Microbiol, Jupiter, FL USA.
EM Adam.Reed@ucf.edu
FU Florida Department of Health, Biomedical research Program [7ZK33]
FX This work is supported by the Florida Department of Health, Biomedical
   research Program (7ZK33).
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 18
PY 2018
VL 255
MA 399
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GJ7AU
UT WOS:000435537701513
DA 2020-07-08
ER

PT J
AU Santos, J
   Silveira, R
   Toma, S
   Araki, K
   Brolo, A
   Corio, P
AF Santos, Jonnatan
   Silveira, Raisa
   Toma, Sergio
   Araki, Koiti
   Brolo, Alexandre
   Corio, Paola
TI Surface plasmons to Zika virus detection: Detection of NS1 protein
   utilizing localized surface plasmon resonance and surface plasmon
   resonance spectroscopy
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 255th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nexus of Food, Energy, and Water
CY MAR 18-22, 2018
CL New Orleans, LA
C1 [Santos, Jonnatan; Silveira, Raisa; Toma, Sergio; Araki, Koiti; Corio, Paola] Univ Sao Paulo, Sao Paulo, SP, Brazil.
   [Brolo, Alexandre] Univ Victoria, Dept Chem, Victoria, BC, Canada.
EM jonnatan@iq.usp.br
RI , Sergio/V-3812-2019; Santos, Jonnatan/K-1862-2013
OI Santos, Jonnatan/0000-0003-3789-6229
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 18
PY 2018
VL 255
MA 230
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA GJ7AU
UT WOS:000435537705793
DA 2020-07-08
ER

PT J
AU Silveira, R
   Santos, J
   Rubim, J
   Corio, P
AF Silveira, Raisa
   Santos, Jonnatan
   Rubim, Joel
   Corio, Paola
TI Spectroscopy nanosensors based on Zika Virus Sn1 Antibodies linked to
   gold nanoparticles: A system optimization study
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 255th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nexus of Food, Energy, and Water
CY MAR 18-22, 2018
CL New Orleans, LA
C1 [Corio, Paola] Univ Sao Paulo, So Paulo, Brazil.
   [Silveira, Raisa; Santos, Jonnatan] Univ Sao Paulo, Sao Paulo, SP, Brazil.
   [Rubim, Joel] Univ Brasilia, Brasilia, DF, Brazil.
EM raisalacerda@gmail.com
RI Santos, Jonnatan/K-1862-2013
OI Santos, Jonnatan/0000-0003-3789-6229
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 18
PY 2018
VL 255
MA 66
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA GJ7AU
UT WOS:000435537705631
DA 2020-07-08
ER

PT J
AU Zakrzewski, M
   Rasic, G
   Darbro, J
   Krause, L
   Poo, YS
   Filipovic, I
   Parry, R
   Asgari, S
   Devine, G
   Suhrbier, A
AF Zakrzewski, Martha
   Rasic, Gordana
   Darbro, Jonathan
   Krause, Lutz
   Poo, Yee S.
   Filipovic, Igor
   Parry, Rhys
   Asgari, Sassan
   Devine, Greg
   Suhrbier, Andreas
TI Mapping the virome in wild-caught Aedes aegypti from Cairns and Bangkok
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FUSING AGENT VIRUS; WEST NILE VIRUS; INSECT-SPECIFIC FLAVIVIRUSES;
   VECTOR COMPETENCE; DENGUE VECTOR; MOSQUITOS; TRANSMISSION; RNA;
   SEQUENCE; RESISTANCE
AB Medically important arboviruses such as dengue, Zika, and chikungunya viruses are primarily transmitted by the globally distributed mosquito Aedes aegypti. Increasing evidence suggests that transmission can be influenced by mosquito viromes. Herein RNA-Seq was used to characterize RNA metaviromes of wild-caught Ae. aegypti from Bangkok (Thailand) and from Cairns (Australia). The two mosquito populations showed a high degree of similarity in their viromes. BLAST searches of assembled contigs suggest up to 27 insect-specific viruses may infect Ae. aegypti, with up to 23 of these currently uncharacterized and up to 16 infecting mosquitoes from both Cairns and Bangkok. Three characterized viruses dominated, Phasi Charoen-like virus, Humaita-Tubiacanga virus and Cell fusing agent virus, and comparisons with other available RNA-Seq datasets suggested infection levels with these viruses may vary in laboratory-reared mosquitoes. As expected, mosquitoes from Bangkok showed higher mitochondrial diversity and carried alleles associated with knock-down resistance to pyrethroids. Blood meal reads primarily mapped to human genes, with a small number also showing homology with rat/mouse and dog genes. These results highlight the wide spectrum of data that can be obtained from such RNA-Seq analyses, and suggests differing viromes may need to be considered in arbovirus vector competence studies.
C1 [Zakrzewski, Martha; Krause, Lutz] QIMR Berghofer Med Res Inst, Med Genom, Brisbane, Qld 4029, Australia.
   [Rasic, Gordana; Darbro, Jonathan; Filipovic, Igor; Devine, Greg] QIMR Berghofer Med Res Inst, Mosquito Control, Brisbane, Qld 4029, Australia.
   [Poo, Yee S.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol, Brisbane, Qld 4029, Australia.
   [Parry, Rhys; Asgari, Sassan] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4029, Australia.
   [Darbro, Jonathan] Metro North Publ Hlth Unit, Bryden St, Windsor, Qld 4030, Australia.
   [Krause, Lutz] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia.
RP Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Inflammat Biol, Brisbane, Qld 4029, Australia.
EM Andreas.Suhrbier@qimrberghofer.edu.au
RI Asgari, Sassan/G-2678-2011; Devine, Gregor J/H-1141-2014; Parry,
   Rhys/L-5804-2019; Rasic, Gordana/AAO-4360-2020; Krause, Lutz/G-6283-2013
OI Asgari, Sassan/0000-0001-7885-6544; Devine, Gregor
   J/0000-0001-6312-0390; Parry, Rhys/0000-0001-9238-1952; Rasic,
   Gordana/0000-0002-3057-0093; Zakrzewski, Martha/0000-0003-1436-5070;
   Krause, Lutz/0000-0003-3806-0845
FU Australian Infectious Disease Research Centre; National Health and
   Medical Research Council of AustraliaNational Health and Medical
   Research Council of Australia
FX We would like to thank R. Adamczyk and A. Giblin (Queensland Health
   Tropical Public Health Services, Cairns) for mosquito collection. The
   work was supported by a seed grant from the Australian Infectious
   Disease Research Centre. AS hold a fellowship from the National Health
   and Medical Research Council of Australia.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Contreras-Gutierrez MA, 2017, AM J TROP MED HYG, V97, P299, DOI 10.4269/ajtmh.16-0987
   Audsley MD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005426
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Calzolari M, 2016, INFECT GENET EVOL, V40, P381, DOI 10.1016/j.meegid.2015.07.032
   Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Chandler JA, 2014, VIROLOGY, V464, P312, DOI 10.1016/j.virol.2014.06.036
   Cholleti H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162751
   Cooper D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00539
   da Costa GL, 1998, J BASIC MICROB, V38, P343, DOI 10.1002/(SICI)1521-4028(199811)38:5/6&lt;343::AID-
   David MR, 2016, MEM I OSWALDO CRUZ, V111, P577, DOI 10.1590/0074-02760160238
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duncan AB, 2015, J ANIM ECOL, V84, P498, DOI 10.1111/1365-2656.12302
   Endersby-Harshman N. M, 2017, J MED ENTOMOL
   Faucon F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005526
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Fauver JR, 2016, VIROLOGY, V498, P288, DOI 10.1016/j.virol.2016.07.031
   FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gotting M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12284
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hang J, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01644-15
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Komalamisra N, 2011, SE ASIAN J TROP MED, V42, P814
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900
   Muturi EJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005377
   Nasar F, 2015, VIROLOGY, V484, P51, DOI 10.1016/j.virol.2015.05.009
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579
   Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rodrigues J, 2017, J INVERTEBR PATHOL, V146, P7, DOI 10.1016/j.jip.2017.03.012
   Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Segoli M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003294
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Sivaram A, 2009, INTERVIROLOGY, V52, P1, DOI 10.1159/000210044
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Terenius O, 2012, FEMS MICROBIOL ECOL, V80, P556, DOI 10.1111/j.1574-6941.2012.01317.x
   ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0
   Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020
   Vaidyanathan R, 2008, VECTOR-BORNE ZOONOT, V8, P727, DOI 10.1089/vbz.2007.0189
   Vasilakis N, 2015, CURR OPIN VIROL, V15, P69, DOI 10.1016/j.coviro.2015.08.007
   Williams CR, 2013, MED VET ENTOMOL, V27, P313, DOI 10.1111/j.1365-2915.2012.01051.x
   Yamanaka A, 2013, INFECT GENET EVOL, V19, P188, DOI 10.1016/j.meegid.2013.07.012
   Yeap HL, 2016, HEREDITY, V116, P265, DOI 10.1038/hdy.2015.97
   Yeap HL, 2013, AM J TROP MED HYG, V89, P78, DOI 10.4269/ajtmh.12-0719
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
   Zhang GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07279-5
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
NR 70
TC 21
Z9 21
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 16
PY 2018
VL 8
AR 4690
DI 10.1038/s41598-018-22945-y
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ4UN
UT WOS:000427587600003
PM 29549363
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Suphatrakul, A
   Duangchinda, T
   Jupatanakul, N
   Prasittisa, K
   Onnome, S
   Pengon, J
   Siridechadilok, B
AF Suphatrakul, Amporn
   Duangchinda, Thaneeya
   Jupatanakul, Natapong
   Prasittisa, Kanjanawadee
   Onnome, Suppachoke
   Pengon, Jutharat
   Siridechadilok, Bunpote
TI Multi-color fluorescent reporter dengue viruses with improved stability
   for analysis of a multi-virus infection
SO PLOS ONE
LA English
DT Article
ID MONOMERIC RED; ZIKA VIRUS; PROTEINS; GENE; THROUGHPUT; BIOSENSORS;
   EFFECTORS; AMERICA; RANGE; FEVER
AB Reporter virus is a versatile tool to visualize and to analyze virus infections. However, for flaviviruses, it is difficult to maintain the inserted reporter genes on the viral genome, limiting its use in several studies that require homogeneous virus particles and several rounds of virus replication. Here, we showed that flanking inserted GFP genes on both sides with ribosome-skipping 2A sequences improved the stability and the consistency of their fluorescent signals for dengue-virus-serotype 2 (DENV2) reporter viruses. The reporter viruses can infect known susceptible mammalian cell lines and primary CD14+ human monocytes. This design can accommodate several fluorescent protein genes, enabling the generation of multi-color DENV2-16681 reporter viruses with comparable replication capabilities, as demonstrated by their abilities to maintain their fluorescent intensities during co-infections and to exclude superinfections regardless of the fluorescent tags. The reported design of multi-color DENV2 should be useful for high-throughput analyses, single-cell analysis, and characterizations of interference and superinfection in animal models.
C1 [Suphatrakul, Amporn; Duangchinda, Thaneeya; Jupatanakul, Natapong; Prasittisa, Kanjanawadee; Onnome, Suppachoke; Pengon, Jutharat; Siridechadilok, Bunpote] Natl Ctr Genet Engn & Biotechnol, Klongluang, Pathumthani, Thailand.
RP Siridechadilok, B (corresponding author), Natl Ctr Genet Engn & Biotechnol, Klongluang, Pathumthani, Thailand.
EM bunpote.sir@biotec.or.th
FU Grand Challenges Canada, Stars in Global Health Program Round 5
FX This work is funded by a grant from Grand Challenges Canada, Stars in
   Global Health Program Round 5 to BS.
CR Ai HW, 2008, NAT METHODS, V5, P401, DOI 10.1038/NMETH.1207
   Bomati EK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05469
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529
   Chu J, 2014, NAT METHODS, V11, P572, DOI [10.1038/NMETH.2888, 10.1038/nmeth.2888]
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006
   Descours B, 2017, NATURE, V94, P13193
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556
   Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/nmeth.2171, 10.1038/NMETH.2171]
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Mehle A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005081
   Park A, 2016, J GEN VIROL, V97, P839, DOI 10.1099/jgv.0.000405
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107
   Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021
   Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Shan C, 2016, CELL HOST MICROBE
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   Shcherbakova DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12405
   Shepard DS, 2016, LANCET INFECT DIS
   Simmons CP, 2015, NEW ENGL J MED, V373, P1263, DOI 10.1056/NEJMe1509442
   Siridechadilok B, 2013, J VIROL, V87, P12667, DOI 10.1128/JVI.02261-13
   Srikiatkhachorn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051335
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Wilder- Smith A, 2016, LANCET INFECT DIS
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
   Zou G, 2009, J VIROL, V83, P11765, DOI 10.1128/JVI.01205-09
NR 37
TC 2
Z9 2
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 16
PY 2018
VL 13
IS 3
AR e0194399
DI 10.1371/journal.pone.0194399
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ6JH
UT WOS:000427703500040
PM 29547653
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chan, K
   Wong, PY
   Parikh, C
   Wong, S
AF Chan, Kamfai
   Wong, Pui-Yan
   Parikh, Chaitanya
   Wong, Season
TI Moving toward rapid and low-cost point-of-care molecular diagnostics
   with a repurposed 3D printer and RPA
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE 3D printers; Low-resource settings; Nucleic acid extraction; Recombinase
   polymerase amplification; Foodbome pathogens; Zika virus
ID NUCLEIC-ACID EXTRACTION; DNA EXTRACTION; ZIKA VIRUS; AMPLIFICATION; RNA;
   PURIFICATION; DEVICE; ASSAY
AB Traditionally, the majority of nucleic acid amplification-based molecular diagnostic tests are done in centralized settings. In recent years, point-of-care tests have been developed for use in low-resource settings away from central laboratories. While most experts agree that point-of-care molecular tests are greatly needed, their availability as cost-effective and easy-to-operate tests remains an unmet goal. In this article, we discuss our efforts to develop a recombinase polymerase amplification reaction-based test that will meet these criteria. First, we describe our efforts in repurposing a low-cost 3D printer as a platform that can carry out medium-throughput, rapid, and high-performing nucleic acid extraction. Next, we address how these purified templates can be rapidly amplified and analyzed using the 3D printer's heated bed or the deconstructed, low-cost thermal cycler we have developed. In both approaches, real-time isothermal amplification and detection of template DNA or RNA can be accomplished using a low-cost portable detector or smartphone camera. Last, we demonstrate the capability of our technologies using foodborne pathogens and the Zika virus. Our low-cost approach does not employ complicated and high-cost components, making it suitable for resource-limited settings. When integrated and commercialized, it will offer simple sample-to-answer molecular diagnostics.
C1 [Chan, Kamfai; Wong, Pui-Yan; Parikh, Chaitanya; Wong, Season] AI Biosci Inc, 1902 Pinon Dr,Suite C, College Stn, TX 77845 USA.
RP Wong, S (corresponding author), AI Biosci Inc, 1902 Pinon Dr,Suite C, College Stn, TX 77845 USA.
EM season.wong@aibiosciences.com
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [1R43AI129061,
   2R44AI106239]
FX Funding was provided by the National Institutes of Health (NIH) through
   the Small Business Innovative Research program (NIH grants No.
   1R43AI129061 and 2R44AI106239). The content is solely the responsibility
   of the authors and does not necessarily represent or reflect views of
   the NIH or the federal government. We thank Dr. Scott C. Weaver for
   kindly providing us the Zika virus sample.
CR Berry SM, 2011, LAB CHIP, V11, P1747, DOI 10.1039/c1lc00004g
   Bordelon H, 2011, ACS APPL MATER INTER, V3, P2161, DOI 10.1021/am2004009
   Byrnes S, 2013, ANAL METHODS-UK, V5, P3177, DOI 10.1039/c3ay40162f
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158502
   Chan KF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149150
   Choi JR, 2015, BIOSENS BIOELECTRON, V74, P427, DOI 10.1016/j.bios.2015.06.065
   Connelly JT, 2015, ANAL CHEM, V87, P7595, DOI 10.1021/acs.analchem.5b00411
   Dineva MA, 2007, ANALYST, V132, P1193, DOI 10.1039/b705672a
   Dundas N, 2008, J MOL DIAGN, V10, P311, DOI 10.2353/jmoldx.2008.070149
   Euler M, 2012, J CLIN VIROL, V54, P308, DOI 10.1016/j.jcv.2012.05.006
   Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17
   Jangam SR, 2013, BIOSENS BIOELECTRON, V42, P69, DOI 10.1016/j.bios.2012.10.024
   Jangam SR, 2009, J CLIN MICROBIOL, V47, P2363, DOI 10.1128/JCM.r00092-09
   Jungkind D, 2001, J CLIN VIROL, V20, P1, DOI 10.1016/S1386-6532(00)00148-7
   Kim J, 2009, INTEGR BIOL-UK, V1, P574, DOI 10.1039/b905844c
   KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0
   LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lillis L, 2016, MOL CELL PROBE, V30, P74, DOI 10.1016/j.mcp.2016.01.009
   Lillis L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108189
   Linnes JC, 2014, RSC ADV, V4, P42245, DOI 10.1039/c4ra07911f
   Liu CC, 2011, LAB CHIP, V11, P2686, DOI 10.1039/c1lc20345b
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Patel P, 2012, J CLIN VIROL, V54, P42, DOI 10.1016/j.jcv.2012.01.022
   Price CW, 2009, LAB CHIP, V9, P2484, DOI 10.1039/b907652m
   Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611
   Shah KG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139449
   Shi X, 2015, LAB CHIP, V15, P1059, DOI 10.1039/c4lc01111b
   Singleton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113693
   Strotman L, 2013, ANAL CHEM, V85, P9764, DOI 10.1021/ac402162r
   Strotman LN, 2012, ANALYST, V137, P4023, DOI 10.1039/c2an35506j
   Sur K, 2010, J MOL DIAGN, V12, P620, DOI 10.2353/jmoldx.2010.090190
   Tang YW, 2005, J CLIN MICROBIOL, V43, P4830, DOI 10.1128/JCM.43.9.4830-4833.2005
   Taub IA, 2002, J PHYS CHEM A, V106, P8070, DOI 10.1021/jp0143847
   Vandeventer PE, 2011, J CLIN MICROBIOL, V49, P2533, DOI 10.1128/JCM.02171-10
   Waters RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105630
   Wong G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131701
   Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079975
   Xu GL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00246
   Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524
   Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018
   Zhang M, 2013, ANAL CHEM, V85, P75, DOI 10.1021/ac301640p
NR 43
TC 9
Z9 9
U1 7
U2 33
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
EI 1096-0309
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD MAR 15
PY 2018
VL 545
BP 4
EP 12
DI 10.1016/j.ab.2018.01.008
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA GA5GR
UT WOS:000428361700002
PM 29339059
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Hoen, B
   Schaub, B
   Funk, AL
   Ardillon, V
   Boullard, M
   Cabie, A
   Callier, C
   Carles, G
   Cassadou, S
   Cesaire, R
   Douine, M
   Herrmann-Storck, C
   Kadhel, P
   Laouenan, C
   Madec, Y
   Monthieux, A
   Nacher, M
   Najioullah, F
   Rousset, D
   Ryan, C
   Schepers, K
   Stegmann-Planchard, S
   Tressieres, B
   Volumenie, JL
   Yassinguezo, S
   Janky, E
   Fontanet, A
AF Hoen, Bruno
   Schaub, Bruno
   Funk, Anna L.
   Ardillon, Vanessa
   Boullard, Manon
   Cabie, Andre
   Callier, Caroline
   Carles, Gabriel
   Cassadou, Sylvie
   Cesaire, Raymond
   Douine, Maylis
   Herrmann-Storck, Cecile
   Kadhel, Philippe
   Laouenan, Cedric
   Madec, Yoann
   Monthieux, Alice
   Nacher, Mathieu
   Najioullah, Fatiha
   Rousset, Dominique
   Ryan, Catherine
   Schepers, Kinda
   Stegmann-Planchard, Sofia
   Tressieres, Benoit
   Volumenie, Jean-Luc
   Yassinguezo, Samson
   Janky, Eustase
   Fontanet, Arnaud
TI Pregnancy Outcomes after ZIKV Infection in French Territories in the
   Americas
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID VIRUS-INFECTION; BIRTH-DEFECTS; INFANTS; FETUSES
AB BACKGROUND
   The risk of congenital neurologic defects related to Zika virus (ZIKV) infection has ranged from 6 to 42% in various reports. The aim of this study was to estimate this risk among pregnant women with symptomatic ZIKV infection in French territories in the Americas.
   METHODS
   From March 2016 through November 2016, we enrolled in this prospective cohort study pregnant women with symptomatic ZIKV infection that was confirmed by polymerase-chain-reaction (PCR) assay. The analysis included all data collected up to April 27, 2017, the date of the last delivery in the cohort.
   RESULTS
   Among the 555 fetuses and infants in the 546 pregnancies included in the analysis, 28 (5.0%) were not carried to term or were stillborn, and 527 were born alive. Neurologic and ocular defects possibly associated with ZIKV infection were seen in 39 fetuses and infants (7.0%; 95% confidence interval, 5.0 to 9.5); of these, 10 were not carried to term because of termination of pregnancy for medical reasons, 1 was stillborn, and 28 were live-born. Microcephaly (defined as head circumference more than 2 SD below the mean for sex and gestational age) was detected in 32 fetuses and infants (5.8%), of whom 9 (1.6%) had severe microcephaly (more than 3 SD below the mean). Neurologic and ocular defects were more common when ZIKV infection occurred during the first trimester (24 of 189 fetuses and infants [12.7%]) than when it occurred during the second trimester (9 of 252 [3.6%]) or third trimester (6 of 114 [5.3%]) (P = 0.001).
   CONCLUSIONS
   Among pregnant women with symptomatic, PCR-confirmed ZIKV infection, birth defects possibly associated with ZIKV infection were present in 7% of fetuses and infants. Defects occurred more frequently in fetuses and infants whose mothers had been infected early in pregnancy. Longer-term follow-up of infants is required to assess any manifestations not detected at birth.
C1 [Hoen, Bruno; Callier, Caroline; Tressieres, Benoit] Ctr Hosp Univ CHU Pointe A Pitre Abymes, INSERM, Ctr Invest Clin 1424, Pointe a Pitre, Guadeloupe, France.
   [Hoen, Bruno; Schepers, Kinda] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Serv Malad Infect & Trop, Dermatol, Med Interne, Pointe a Pitre, Guadeloupe, France.
   [Cassadou, Sylvie] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Cellule Intervent Reg CIRE Antilles, Sante Publ France, Pointe a Pitre, Guadeloupe, France.
   [Herrmann-Storck, Cecile] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Lab Microbiol, Pointe a Pitre, Guadeloupe, France.
   [Kadhel, Philippe] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Serv Gynecol Obstet, Pointe a Pitre, Guadeloupe, France.
   [Ryan, Catherine] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Ctr Pluridisciplinaire Diagnost Prenatal, Pointe a Pitre, Guadeloupe, France.
   [Janky, Eustase] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Pole Parent Enfant, Pointe a Pitre, Guadeloupe, France.
   [Hoen, Bruno] Univ Antilles Guyane, Fac Med Hyacinthe Bastaraud, Pointe a Pitre, Guadeloupe, France.
   [Schaub, Bruno] CHU Martinique, Ctr Pluridisciplinaire Diagnost Prenatal, Maison Femme Mere & Enfant, Martinique, France.
   CHU Martinique, INSERM, Ctr Invest Clin, Martinique, France.
   CHU Martinique, Ctr Ressources Biol, Martinique, France.
   [Monthieux, Alice; Volumenie, Jean-Luc] CHU Martinique, Maison Femme Mere & Enfant, Unit Obstet & Gynecol, Martinique, France.
   [Najioullah, Fatiha] CHU Martinique, Lab Virol, Martinique, France.
   [Funk, Anna L.; Madec, Yoann; Fontanet, Arnaud] Paris Diderot Univ, Emerging Dis Epidemiol Unit, Paris, France.
   [Laouenan, Cedric] Paris Diderot Univ, Ctr Global Hlth, Paris, France.
   [Laouenan, Cedric] Paris Diderot Univ, Inst Pasteur, INSERM, IAME, Paris, France.
   [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Unite Pasteur Cnam Risques Infectieux & Emergents, Paris, France.
   [Ardillon, Vanessa] CIRE Guyane, Sante Publ France, French Guiana, France.
   [Carles, Gabriel] Ctr Hosp Ouest Guyanais, Pole Mere Enfant, French Guiana, France.
   [Douine, Maylis; Nacher, Mathieu] Ctr Hosp Cayenne, INSERM, Ctr Invest Clin 1424, French Guiana, France.
   [Rousset, Dominique] Ctr Hosp Cayenne, Inst Pasteur Guyane, Lab Virol, French Guiana, France.
   [Yassinguezo, Samson] Ctr Hosp Cayenne, Serv Gynecol Obstet, French Guiana, France.
   [Stegmann-Planchard, Sofia] Ctr Hosp Louis Constant Fleming, Unite Malad Infect, St Martin Dheres, France.
RP Hoen, B (corresponding author), Univ Med Ctr Guadeloupe, Dept Infect Dis Dermatol & Internal Med, BP 465, F-97159 Pointe a Pitre, Guadeloupe, France.
EM bruno.hoen@inserm.fr
RI Rousset, Dominique/S-5400-2019; Laouenan, Cedric/E-1157-2019
OI Rousset, Dominique/0000-0002-1473-3147; Laouenan,
   Cedric/0000-0002-3681-6314; Cabie, Andre/0000-0003-0117-3061; Douine,
   Maylis/0000-0003-4616-6690
FU French Ministry of Health (Soutien Exceptionnel a la Recherche et a
   l'Innovation); ZIKAlliance consortium (the European Union's Horizon
   Research and Innovation Program); INSERMInstitut National de la Sante et
   de la Recherche Medicale (Inserm); Institut Carnot-Pasteur Maladies
   Infectieuses through the Pasteur-Paris University International Ph.D.
   program [ANR 11-CARN 017-01]; Laboratoire d'Excellence Integrative
   Biology of Emerging Infectious Diseases project [ANR-10-LABX-62-IBEID]
FX Supported by the French Ministry of Health (Soutien Exceptionnel a la
   Recherche et a l'Innovation), by a grant (ANR-10-LABX-62-IBEID) from
   Laboratoire d'Excellence Integrative Biology of Emerging Infectious
   Diseases project, by the ZIKAlliance consortium (the European Union's
   Horizon 2020 Research and Innovation Program), and by INSERM. This study
   is part of the ZIKAlliance consortium project.r Ms. Funk reports
   receiving salary from Institut Carnot-Pasteur Maladies Infectieuses (ANR
   11-CARN 017-01) through the Pasteur-Paris University International Ph.D.
   program. No other potential conflict of interest relevant to this
   article was reported.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Conseil National Professionnel de Gynecologie et Obstetrique, 2016, VIR ZIK FEMM ENC AG
   de Jong EP, 2013, ARCH DIS CHILDHOOD-E, V98, P93, DOI 10.1136/archdischild-2012-303327
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Haut Conseil de la Sante Publique, 2016, AV REL ACT AV HCSP 2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Mejdoubi M, 2017, NEW ENGL J MED, V377, P1399, DOI 10.1056/NEJMc1612813
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Tolan RJ, 2008, INFEC DIS CLIN PRAC, V16, P4
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 18
TC 95
Z9 98
U1 2
U2 16
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAR 15
PY 2018
VL 378
IS 11
BP 985
EP 994
DI 10.1056/NEJMoa1709481
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA FZ2HT
UT WOS:000427399000004
PM 29539287
OA Bronze
DA 2020-07-08
ER

PT J
AU de Castro, DB
   Sampaio, VS
   de Albuquerque, BC
   Pinto, RC
   Sadahiro, M
   dos Passos, RA
   da Costa, CF
   Braga, JU
AF de Castro, Daniel Barros
   Sampaio, Vanderson Souza
   de Albuquerque, Bernardino Claudio
   Pinto, Rosemary Costa
   Sadahiro, Megumi
   dos Passos, Ricardo Augusto
   da Costa, Cristiano Fernandes
   Braga, Jose Ueleres
TI Dengue epidemic typology and risk factors for extensive epidemic in
   Amazonas state, Brazil, 2010-2011
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Dengue epidemics classification; Socioeconomic; Environment; Climate;
   Amazon
ID HEMORRHAGIC-FEVER; CLIMATE; TRANSMISSION; URBANIZATION; THAILAND;
   HISTORY; AREAS; MODEL
AB Background: Dengue is the most prevalent arboviral disease affecting humans. The frequency and magnitude of dengue epidemic have significantly increased over recent decades. This study aimed to identify dengue epidemic types and risk factors for the extensive epidemics that occurred in 2010-2011, across the municipalities of Amazonas state, Brazil.
   Methods: Using an ecological approach, secondary data were obtained from the dengue fever surveillance system. Epidemic waves were classified according to three indices: duration, intensity, and coverage. A hierarchical model of multiple logistic regression was used for the identification of risk factors, with the occurrence of extensive dengue epidemic.
   Results: During the study period, dengue virus affected 49 of the 62 Amazonas municipalities. In 22 of these, the epidemics were of high intensity, wide range, and long time span, and therefore categorized as "extensive epidemics". The final multivariable model revealed a significant association between extensive dengue epidemics occurrence and the average number of days with precipitation (adjusted OR = 1.40, 95% CI: 1.01-1.94) and the number of years with infestation (adjusted OR = 1.53, 95% CI: 1.18-1.98).
   Conclusions: Our results indicate that it is crucial to integrate vector control, case management, epidemiological investigation, and health education, in order to respond to the growing threat of multiple mosquito-borne diseases, such as dengue, Zika and chikungunya, which are highly prevalent in the South America region.
C1 [de Castro, Daniel Barros; Sampaio, Vanderson Souza; de Albuquerque, Bernardino Claudio; Pinto, Rosemary Costa; Sadahiro, Megumi; dos Passos, Ricardo Augusto; da Costa, Cristiano Fernandes] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.
   [de Castro, Daniel Barros; Braga, Jose Ueleres] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
   [Sampaio, Vanderson Souza] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Manaus, Amazonas, Brazil.
   [dos Passos, Ricardo Augusto] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Fundacao Amparo Pesquisa Estado Amazonas, PECTI SAUDE, Manaus, Amazonas, Brazil.
RP Braga, JU (corresponding author), Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio De Janeiro, Inst Med Social, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Fundacao Amparo Pesquisa Estado Amazonas, PECTI SAUDE, Manaus, Amazonas, Brazil.
EM ueleres@gmail.com
RI Sampaio, Vanderson/AAQ-1418-2020; Sampaio, Vanderson/M-4337-2015
OI Sampaio, Vanderson/0000-0001-7307-8851; Sampaio,
   Vanderson/0000-0001-7307-8851; Dos Passos/0000-0002-2155-9351
FU state of Amazonas, through the Fundacao de Amparo a Pesquisa do Estado
   do Amazonas, FAPEAM (Research Foundation of the State of Amazonas);
   National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq) [440856 /
   2016-7]; Coordination for the Improvement of Higher Education
   PersonnelCAPES [88881.130825 / 2016-00, 88887.130823 / 2016-00]
FX This study was supported by government of the state of Amazonas, through
   the Fundacao de Amparo a Pesquisa do Estado do Amazonas, FAPEAM
   (Research Foundation of the State of Amazonas), for granting
   scholarships. DBC is a fellow of the RH-Doctoral Program at FAPEAM. This
   work was funded by the National Council for Scientific and Technological
   Development (http://www.cnpq.br, grant 440856 / 2016-7) and Coordination
   for the Improvement of Higher Education Personnel
   (http://www.capes.gov.br, grants 88881.130825 / 2016-00 and 88887.130823
   / 2016-00).
CR Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681
   Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Barcellos C, 2014, TROP MED INT HEALTH, V19, P159, DOI 10.1111/tmi.12227
   Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brazilian Ministry of Health, 2009, DIR NAC PREV CONTR E, P160
   Camara FP, 2009, REV SOC BRAS MED TRO, V42, P137, DOI 10.1590/S0037-86822009000200008
   Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106
   COBRA C, 1995, AM J EPIDEMIOL, V142, P1204, DOI 10.1093/oxfordjournals.aje.a117579
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Fan J, 2014, EPIDEMIOL INFECT, V142, P634, DOI 10.1017/S0950268813001519
   Galli B, 2008, REV SAUDE PUBL, V42, P656, DOI [10.1590/S0034-89102008005000032, 10.1590/s0034-89102008000400011]
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hopp MJ, 2003, CLIM RES, V25, P85, DOI 10.3354/cr025085
   IBGE. Instituto Brasileiro de Geografia e Estatistica, 2013, PROJ POP BRAS UN FED
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, CENS DEM 2010 CAR PO
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047
   KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1168, DOI 10.1093/oxfordjournals.aje.a115829
   Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549
   Pan American Health Organization, 1994, DENG DENG HEM FEV AM, P548
   Parker D, 2012, INT J INFECT DIS, V16, pE793, DOI 10.1016/j.ijid.2012.07.002
   PINHEIRO Valéria Cristina Soares, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P245, DOI 10.1590/S0036-46652002000500002
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rios-Velasquez CM, 2007, MEM I OSWALDO CRUZ, V102, P617, DOI 10.1590/S0074-02762007005000076
   Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137
   Vargas WP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2097-3
   Wen TH, 2006, SCI TOTAL ENVIRON, V367, P631, DOI 10.1016/j.scitotenv.2006.02.009
NR 32
TC 4
Z9 4
U1 0
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAR 15
PY 2018
VL 18
AR 356
DI 10.1186/s12889-018-5251-x
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FZ6ZI
UT WOS:000427748700003
PM 29544456
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lindqvist, R
   Kurhade, C
   Gilthorpe, JD
   Overby, AK
AF Lindqvist, Richard
   Kurhade, Chaitanya
   Gilthorpe, Jonathan D.
   Overby, Anna K.
TI Cell-type- and region-specific restriction of neurotropic flavivirus
   infection by viperin
SO JOURNAL OF NEUROINFLAMMATION
LA English
DT Article
DE Viperin; Interferon; Flavivirus; Neurons; Astrocytes
ID BORNE ENCEPHALITIS-VIRUS; WEST NILE VIRUS; INTERFERON-INDUCIBLE PROTEIN;
   OLFACTORY-BULB; STRANDED-RNA; NS5 PROTEIN; IDENTIFICATION; BRAIN;
   REPLICATION; ASTROCYTES
AB Background: Flaviviruses are a group of diverse and emerging arboviruses and an immense global health problem. A number of flaviviruses are neurotropic, causing severe encephalitis and even death. Type I interferons (IFNs) are the first line of defense of the innate immune system against flavivirus infection. IFNs elicit the concerted action of numerous interferon-stimulated genes (ISGs) to restrict both virus infection and replication. Viperin (virus-inhibitory protein, endoplasmic reticulum-associated, IFN-inducible) is an ISG with broad-spectrum antiviral activity against multiple flaviviruses in vitro. Its activity in vivo restricts neurotropic infections to specific regions of the central nervous system (CNS). However, the cell types in which viperin activity is required are unknown. Here we have examined both the regional and cell-type specificity of viperin in the defense against infection by several model neurotropic flaviviruses.
   Methods: Viral burden and IFN induction were analyzed in vivo in wild-type and viperin(-/-) mice infected with Langat virus (LGTV). The effects of IFN pretreatment were tested in vitro in primary neural cultures from different brain regions in response to infection with tick-borne encephalitis virus (TBEV), West Nile virus (WNV), and Zika virus (ZIKV).
   Results: Viperin activity restricted nonlethal LGTV infection in the spleen and the olfactory bulb following infection via a peripheral route. Viperin activity was also necessary to restrict LGTV replication in the olfactory bulb and the cerebrum following CNS infection, but not in the cerebellum. In vitro, viperin could restrict TBEV replication in primary cortical neurons, but not in the cerebellar granule cell neurons. Interferon-induced viperin was also very important in primary cortical neurons to control TBEV, WNV, and ZIKV.
   Conclusions: Our findings show that viperin restricts replication of neurotropic flaviviruses in the CNS in a region- and cell-type-specific manner. The most important sites of activity are the olfactory bulb and cerebrum. Activity within the cerebrum is required in the cortical neurons in order to restrict spread. This study exemplifies cell type and regional diversity of the IFN response within the CNS and shows the importance of a potent broad-spectrum antiviral ISG.
C1 [Lindqvist, Richard; Kurhade, Chaitanya; Overby, Anna K.] Umea Univ, Dept Clin Microbiol Virol, S-90185 Umea, Sweden.
   [Lindqvist, Richard; Kurhade, Chaitanya; Overby, Anna K.] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.
   [Gilthorpe, Jonathan D.] Umea Univ, Dept Pharmacol & Clin Neurosci, S-90187 Umea, Sweden.
RP Overby, AK (corresponding author), Umea Univ, Dept Clin Microbiol Virol, S-90185 Umea, Sweden.; Overby, AK (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.
EM anna.overby@umu.se
OI Gilthorpe, Jonathan/0000-0002-6884-4774; Kurhade,
   Chaitanya/0000-0002-6139-2461
FU Kempe Foundations; Laboratory for Molecular Medicine Sweden (MIMS); Umea
   Center for Microbial Research (UCMR) and Linneus Support; Swedish
   Research Council (VR)Swedish Research Council [2011-2795, 2017-02438];
   Swedish Foundation for Strategic Research (SSF)Swedish Foundation for
   Strategic Research [ICA10-0059, FFL12-0089]
FX This work was supported by the Kempe Foundations (RL, CK, AKO), the
   Laboratory for Molecular Medicine Sweden (MIMS), the Umea Center for
   Microbial Research (UCMR) and Linneus Support (AKO), The Swedish
   Research Council (VR) 2011-2795, 2017-02438, and the Swedish Foundation
   for Strategic Research (SSF) ICA10-0059, FFL12-0089 (AKO). The funders
   had no role in the study design, data collection and interpretation, or
   the decision to submit the work for publication.
CR Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Cargnelutti JF, 2011, BRAZ J MICROBIOL, V42, P1160
   Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08
   Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298
   Cho H, 2013, J VIROL, V87, P8363, DOI 10.1128/JVI.01097-13
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623
   Detje CN, 2015, J VIROL, V89, P2731, DOI 10.1128/JVI.02044-14
   Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596
   Dunning CJ, 2016, ACS CHEM NEUROSCI, V7, P161, DOI 10.1021/acschemneuro.5b00262
   Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712
   Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hee JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172236
   Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   HORISBERGER MA, 1987, J GEN VIROL, V68, P945, DOI 10.1099/0022-1317-68-3-945
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Kallfass C, 2012, J VIROL, V86, P11223, DOI 10.1128/JVI.01093-12
   Kurhade C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0487-9
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lee Hae Young, 2009, J Vis Exp, DOI 10.3791/990
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Lucas TM, 2016, J VIROL, V90, P2600, DOI 10.1128/JVI.02463-15
   Mattijssen S, 2012, MICROBES INFECT, V14, P419, DOI 10.1016/j.micinf.2011.11.015
   McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473
   Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395
   NIEDRIG M, 1994, ACTA VIROL, V38, P141
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Panayiotou C, 2018, J VIROL, VJVI, P02054
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010
   Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079
   Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3
   Sen Tan K, 2012, J GEN VIROL, V93, P1269, DOI 10.1099/vir.0.040824-0
   Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004
   Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264
   Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11
   Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241
   van den Pol AN, 2014, J VIROL, V88, P3695, DOI 10.1128/JVI.03509-13
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Vonderstein K, 2018, J VIROL, V92, DOI 10.1128/JVI.01751-17
   Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0
   Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009
   Weber E, 2014, J VIROL, V88, P12202, DOI 10.1128/JVI.01215-14
   Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x
   Zegenhagen L, 2016, CYTOKINE GROWTH F R, V30, P95, DOI 10.1016/j.cytogfr.2016.03.006
   Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07
NR 54
TC 14
Z9 15
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-2094
J9 J NEUROINFLAMM
JI J. Neuroinflamm.
PD MAR 15
PY 2018
VL 15
AR 80
DI 10.1186/s12974-018-1119-3
PG 11
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA FZ9BL
UT WOS:000427904500001
PM 29544502
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Honein, MA
AF Honein, Margaret A.
TI Recognizing the Global Impact of Zika Virus Infection during Pregnancy
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID BIRTH-DEFECTS; SURVEILLANCE; TERRITORIES; INFANTS; UPDATE; STATES
C1 [Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30322 USA.
RP Honein, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30322 USA.
FU Intramural CDC HHS [CC999999]
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Chu V, 2017, OPEN FORUM INFECT S1, pS696, DOI [10.1093/ofid/ofx163.1867, DOI 10.1093/OFID/OFX163.1867]
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Gilboa SM, 2017, BIRTH DEFECTS RES, V109, P372, DOI 10.1002/bdr2.1007
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
NR 11
TC 10
Z9 10
U1 0
U2 2
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAR 15
PY 2018
VL 378
IS 11
BP 1055
EP 1056
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FZ2HT
UT WOS:000427399000012
PM 29539290
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Hoyt, AT
   Canfield, MA
   Langlois, PH
   Waller, DK
   Agopian, AJ
   Shumate, CJ
   Hall, NB
   Marengo, LK
   Ethen, MK
   Scheuerle, AE
AF Hoyt, Adrienne T.
   Canfield, Mark A.
   Langlois, Peter H.
   Waller, Dorothy K.
   Agopian, A. J.
   Shumate, Charles J.
   Hall, Noemi B.
   Marengo, Lisa K.
   Ethen, Mary K.
   Scheuerle, Angela E.
TI Pre-Zika descriptive epidemiology of microcephaly in Texas, 2008-2012
SO BIRTH DEFECTS RESEARCH
LA English
DT Article
DE congenital microcephaly; head circumference; occipitofrontal
   circumference; Texas Birth Defects Registry; Zika virus; ZIKV
ID UNITED-STATES; HEAD CIRCUMFERENCE; BIRTH-DEFECTS; WEIGHT; PREVALENCE;
   PREGNANCY; STANDARDS; OUTCOMES; RISK; RACE
AB BackgroundThere are limited population-based studies on microcephaly. We characterized the epidemiology of microcephaly in Texas during a 5-year period (2008-2012), prior to the Zika epidemic in the Western hemisphere (2015). The associations of suspected risk factors were compared across four clearly defined case groups.
   MethodsData from the Texas Birth Defects Registry were used to calculate the prevalence of congenital microcephaly and crude and adjusted prevalence ratios using Poisson regression. Twelve maternal and infant factors were assessed across case groups, which included total (explained+unexplained), explained (e.g., syndromic), unexplained, and severe unexplained microcephaly (head circumference <3(rd) percentile).
   ResultsThe birth prevalence for total and total severe microcephaly were 14.7 and 4.8 per 10,000 livebirths, respectively. For explained and unexplained cases, significantly elevated risks were noted for mothers who were older (35+), less educated (12 years), diabetic (pre-pregnancy or gestational), or had a preterm delivery. Unlike explained cases, however, mothers who were non-White or smoked had an increased risk for unexplained microcephaly. Furthermore, young maternal age (<20), multiparity, and higher BMI reduced the risk for unexplained microcephaly. For severe unexplained cases, the risk profile was similar to that for all unexplained caseswith the exception of null associations noted for diabetes and birth year.
   ConclusionsWe found that risk patterns for microcephaly varied across case groupings. Risk factors included maternal race/ethnicity, age, and smoking during pregnancy. Among severe unexplained cases, notable positive associations were seen among mothers who were non-Hispanic Black or less educated, while inverse associations were noted for obesity.
C1 [Hoyt, Adrienne T.; Canfield, Mark A.; Langlois, Peter H.; Shumate, Charles J.; Hall, Noemi B.; Marengo, Lisa K.; Ethen, Mary K.; Scheuerle, Angela E.] Texas Dept State Hlth Serv, Birth Defects Epidemiol & Surveillance Branch, POB 149347, Austin, TX 78714 USA.
   [Waller, Dorothy K.; Agopian, A. J.] UT Hlth Sch Publ Hlth, Houston, TX USA.
   [Scheuerle, Angela E.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA.
RP Hoyt, AT (corresponding author), Texas Dept State Hlth Serv, Birth Defects Epidemiol & Surveillance Branch, POB 149347, Austin, TX 78714 USA.
EM adrienne.hoyt@dshs.texas.gov
OI Waller, Dorothy/0000-0003-2211-4773
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [CDC-RFA-DD16-1605]; Title V Maternal and Child Health Block Grant Funds
   from the Office of Title V and Family Health, Texas Department of State
   Health Services; State of Texas
FX This analysis was supported in part through a cooperative agreement
   (CDC-RFA-DD16-1605) from the Centers for Disease Control and Prevention
   to the Texas Department of State Health Services. Its contents are
   solely the responsibility of the authors and do not necessarily
   represent the official view of the CDC. Work was also supported in part
   by Title V Maternal and Child Health Block Grant Funds from the Office
   of Title V and Family Health, Texas Department of State Health Services,
   and by general revenue from the State of Texas.
CR Allen CL, 2005, AM J PERINAT, V22, P245, DOI 10.1055/s-2005-867089
   Ananth CV, 2005, OBSTET GYNECOL, V105, P1084, DOI 10.1097/01.AOG.0000158124.96300.c7
   [Anonymous], 2016, EUROCAT PREVALENCE D
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Bianchi DW, 2010, FETOLOGY DIAGNOSIS M, P166
   BRAY PF, 1969, J PEDIATR, V75, P303, DOI 10.1016/S0022-3476(69)80404-X
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gold KJ, 2010, J WOMENS HEALTH, V19, P767, DOI 10.1089/jwh.2009.1561
   Graham KA, 2017, MMWR-MORBID MORTAL W, V66, P125, DOI 10.15585/mmwr.mm6605a1
   Gray P., 1993, J DIAGNOSTIC MED SON, V9, P3
   Hansen M, 2017, MED J AUSTRALIA, V206, P351, DOI 10.5694/mja16.00966
   Holden KR, 2014, DEV MED CHILD NEUROL, V56, P705, DOI 10.1111/dmcn.12449
   HUGHES HE, 1986, PEDIATRICS, V78, P85
   Kistka ZAF, 2007, AM J OBSTET GYNECOL, V196, P241, DOI 10.1016/j.ajog.2006.10.873
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   MacDorman Marian F, 2007, Natl Vital Stat Rep, V55, P1
   McElrath T., 2010, AM J OBSTET GYNECOL
   McInerny T. K., 2017, AM ACAD PEDIAT TXB P, P1514
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Negrato CA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-41
   Nyberg D. A., 2003, DIAGNOSTIC IMAGING F, P275
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   OPITZ JM, 1990, J CRAN GENET DEV BIO, V10, P175
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rios A, 1996, Pediatr Rev, V17, P386
   Sheeder Jeanelle, 2006, J Pediatr Adolesc Gynecol, V19, P385, DOI 10.1016/j.jpag.2006.09.012
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vintzileos AM, 2002, OBSTET GYNECOL, V99, P483, DOI 10.1016/S0029-7844(01)01758-6
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zhang S, 2013, MATERN CHILD HLTH J, V17, P1518, DOI 10.1007/s10995-012-1162-0
NR 38
TC 4
Z9 4
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAR 15
PY 2018
VL 110
IS 5
BP 395
EP 405
DI 10.1002/bdr2.1164
PG 11
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA FY8KL
UT WOS:000427113200001
PM 29171191
OA Bronze
DA 2020-07-08
ER

PT J
AU Somerville, NJ
   Chen, XL
   Heinke, D
   Stone, SL
   Higgins, C
   Manning, SE
   Pagnano, S
   Yazdy, MM
   Anderka, M
AF Somerville, Nicholas J.
   Chen, Xiaoli
   Heinke, Dominique
   Stone, Sarah L.
   Higgins, Cathleen
   Manning, Susan E.
   Pagnano, Sharon
   Yazdy, Mahsa M.
   Anderka, Marlene
TI Accuracy of birth certificate head circumference measurements:
   Massachusetts, 2012-2013
SO BIRTH DEFECTS RESEARCH
LA English
DT Article
DE birth certificate; birth defects surveillance; head circumference;
   microcephaly; vital records; Zika virus
ID NORTH-CAROLINA; DELIVERY; PRETERM; INTERGROWTH-21ST; RELIABILITY;
   VALIDATION; VALIDITY; WEIGHT
AB BackgroundZika virus has recently emerged as a novel cause of microcephaly. CDC has asked states to rapidly ascertain and report cases of Zika-linked birth defects, including microcephaly. Massachusetts added head circumference to its birth certificate (BC) in 2011. The accuracy of head circumference measurements from state vital records data has not been reported.
   MethodsWe sought to assess the accuracy of Massachusetts BC head circumference measurements by comparing them to measurements for 2,217 infants born during 2012-2013 captured in the Massachusetts Birth Defects Monitoring Program (BDMP) data system. BDMP contains information abstracted directly from infant medical records and served as the true head circumference value (i.e., gold standard) for analysis. We calculated the proportion of head circumference measurements in agreement between the BC and BDMP data. We assigned growth chart head circumference percentile categories to each BC and BDMP measurement, and calculated the sensitivity and specificity of BC-based categories to predict BDMP-based categories.
   ResultsNo difference was found in head circumference measurements between the two sources in 77.9% (n=1,727) of study infants. The sensitivity of BC-based head circumference percentile categories ranged from 85.6% (<3rd percentile) to 92.7% (90th percentile) and the specificity ranged from 97.6% (90th percentile) to 99.3% (<3rd percentile).
   ConclusionsBC head circumference measurements agreed with those abstracted from the medical chart the majority of the time. Head circumference measurements on the BC were more specific than sensitive across all standardized growth chart percentile categories.
C1 [Somerville, Nicholas J.] CDC, Div Sci Educ & Profess Dev, Epidem Intelligence Serv, Boston, MA USA.
   [Somerville, Nicholas J.; Chen, Xiaoli; Stone, Sarah L.; Higgins, Cathleen; Manning, Susan E.; Yazdy, Mahsa M.; Anderka, Marlene] Massachusetts Dept Publ Hlth, 250 Washington St 5th Floor, Boston, MA 02108 USA.
   [Heinke, Dominique] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Manning, Susan E.] CDC, Div Reprod Hlth, Atlanta, GA 30333 USA.
   [Pagnano, Sharon] Massachusetts Registry Vital Records & Stat, Dorchester, MA USA.
RP Yazdy, MM (corresponding author), Massachusetts Dept Publ Hlth, 250 Washington St 5th Floor, Boston, MA 02108 USA.
EM mahsa.yazdy@state.ma.us
RI Heinke, Dominique/J-4593-2019
OI Heinke, Dominique/0000-0001-9217-3723
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U50 DD000011]
FX Centers for Disease Control and Prevention, Award/grant number: U50
   DD000011.
CR Anderka M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2223-2
   Andrade SE, 2013, PHARMACOEPIDEM DR S, V22, P7, DOI 10.1002/pds.3319
   Bodnar LM, 2014, PAEDIATR PERINAT EP, V28, P203, DOI 10.1111/ppe.12120
   CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   Clayton HB, 2013, MATERN CHILD HLTH J, V17, P869, DOI 10.1007/s10995-012-1065-0
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Dietz P, 2015, PUBLIC HEALTH REP, V130, P60, DOI 10.1177/003335491513000108
   Dietz PM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.875
   DiGiuseppe David L, 2002, Matern Child Health J, V6, P169, DOI 10.1023/A:1019726112597
   Hackney DN, 2012, MATERN CHILD HLTH J, V16, P1241, DOI 10.1007/s10995-011-0882-x
   Kane DJ, 2014, MATERN CHILD HLTH J, V18, P970, DOI 10.1007/s10995-013-1325-7
   Krstev S, 2013, MATERN CHILD HLTH J, V17, P1591, DOI 10.1007/s10995-012-1169-6
   Liberman RF, 2014, PEDIATRICS, V134, pE373, DOI 10.1542/peds.2013-3949
   Martin Joyce A, 2013, Natl Vital Stat Rep, V62, P1
   Massachusetts Department of Public Health, 2014, MASS BIRTHS
   Mujugira A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-106
   National Birth Defects Prevention Network, 2017, NBDPN BIRTH DEF SURV
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reichman NE, 2001, ANN EPIDEMIOL, V11, P186, DOI 10.1016/S1047-2797(00)00209-X
   Salemi JL, 2017, PAEDIATR PERINAT EP, V31, P67, DOI 10.1111/ppe.12326
   Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vinikoor LC, 2010, PAEDIATR PERINAT EP, V24, P102, DOI 10.1111/j.1365-3016.2009.01087.x
   Zollinger TW, 2006, ANN EPIDEMIOL, V16, P1, DOI 10.1016/j.annepidem.2005.03.005
NR 24
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAR 15
PY 2018
VL 110
IS 5
BP 413
EP 420
DI 10.1002/bdr2.1174
PG 8
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA FY8KL
UT WOS:000427113200003
PM 29195030
OA Bronze
DA 2020-07-08
ER

PT J
AU Santos, MCD
   Nascimento, YM
   Monteiro, JD
   Alves, BEB
   Melo, MF
   Paiva, AAP
   Pereira, HWB
   Medeiros, LG
   Morais, IC
   Neto, JCF
   Fernandes, JV
   Araujo, JMG
   Lima, KMG
AF Santos, Marfran C. D.
   Nascimento, Yasmin M.
   Monteiro, Joelma D.
   Alves, Brenda E. B.
   Melo, Marilia F.
   Paiva, Anne A. P.
   Pereira, Hannaly W. B.
   Medeiros, Leandro G.
   Morais, Ingryd C.
   Fagundes Neto, Joao Ciro
   Fernandes, Jose V.
   Araujo, Joselio M. G.
   Lima, Kassio M. G.
TI ATR-FTIR spectroscopy with chemometric algorithms of multivariate
   classification in the discrimination between healthy vs. dengue vs.
   chikungunya vs. zika clinical samples
SO ANALYTICAL METHODS
LA English
DT Article
ID ENHANCED RAMAN-SPECTROSCOPY; COMPUTATIONAL ANALYSIS;
   INFRARED-SPECTROSCOPY; VARIABLE SELECTION; IR SPECTROSCOPY; VIRUS;
   IDENTIFICATION; BLOOD
AB Dengue, zika and chikungunya are arboviruses transmitted by mosquitoes of genus Aedes. In clinical diagnostic routines, cross reactions between dengue and zika may occur because they are viruses of the same family (Flaviviridae); on the other hand, chikungunya is an alphavirus. In this study we suggest the use of FTIR spectroscopy in conjunction with PCA-LDA, SPA-LDA and GA-LDA multivariate classification algorithms as a tool sensitive to biochemical variations caused by the presence of different viruses in the blood. We used 45 blood samples from patients diagnosed with dengue, 30 blood samples from patients diagnosed with zika, 10 samples from patients diagnosed with chikungunya and 45 blood samples from people without these viruses. The objective of the study was to evaluate, mainly, the specificity of the technique in discriminating the blood samples based only on the presence or absence of different viruses and to compare it with some standard diagnostic methods. The results showed sensitivity and specificity values of 100% for the healthy, dengue and chikungunya classes and values close to 90% for zika, suggesting that spectroscopic techniques have great potential for detecting the biochemical variations that the presence of the virus causes in the blood, through a fast methodology.
C1 [Santos, Marfran C. D.; Lima, Kassio M. G.] Univ Fed Rio Grande do Norte, Biol Chem & Chemometr, Inst Chem, BR-59072970 Natal, RN, Brazil.
   [Nascimento, Yasmin M.; Monteiro, Joelma D.; Alves, Brenda E. B.; Melo, Marilia F.; Paiva, Anne A. P.; Pereira, Hannaly W. B.; Medeiros, Leandro G.; Fagundes Neto, Joao Ciro; Fernandes, Jose V.; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Lab Mol Biol Infect Dis & Canc, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   [Nascimento, Yasmin M.; Monteiro, Joelma D.; Alves, Brenda E. B.; Melo, Marilia F.; Paiva, Anne A. P.; Pereira, Hannaly W. B.; Medeiros, Leandro G.; Morais, Ingryd C.; Fagundes Neto, Joao Ciro; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Lab Virol, Inst Trop Med, BR-59072970 Natal, RN, Brazil.
RP Lima, KMG (corresponding author), Univ Fed Rio Grande do Norte, Biol Chem & Chemometr, Inst Chem, BR-59072970 Natal, RN, Brazil.
EM kassiolima@gmail.com
RI Lima, kassio M G/Q-7042-2019; Araujo, Joselio M G/B-5502-2013
OI Lima, kassio M G/0000-0002-3827-3800; Araujo, Joselio M
   G/0000-0003-3548-2786; Fernandes, Jose Verissimo/0000-0002-5169-6496
FU CAPESCAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPqNational Council for Scientific and Technological
   Development (CNPq) [305962/2014-0, 400328/2014-3]
FX Marfran C. D. Santos would like to thank CAPES for its financial support
   and the PPGQ-UFRN for its scientific support. The authors thank the
   Unidade de Pronto Atendimento - UPA - Pajucara (Natal-RN) in the person
   of Samara B. S. Silveira for the supply of samples from healthy people.
   This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq (grant no. 305962/2014-0
   and 400328/2014-3).
CR Baia TC, 2016, ANAL METHODS-UK, V8, P968, DOI 10.1039/c5ay02342d
   Baker MJ, 2014, NAT PROTOC, V9, P1771, DOI 10.1038/nprot.2014.110
   Byrne HJ, 2016, CHEM SOC REV, V45, P1865, DOI 10.1039/c5cs00440c
   Cialla D, 2009, J RAMAN SPECTROSC, V40, P240, DOI 10.1002/jrs.2123
   Costa FSL, 2016, ANAL METHODS-UK, V8, P7107, DOI [10.1039/C6AY01893A, 10.1039/c6ay01893a]
   Cui L, 2016, ANAL METHODS-UK, V8, P481, DOI 10.1039/c5ay02638e
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Fan C, 2010, J FOOD SCI, V75, pM302, DOI 10.1111/j.1750-3841.2010.01619.x
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Hermann P, 2011, ANALYST, V136, P1148, DOI 10.1039/c0an00531b
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kazarian SG, 2006, BBA-BIOMEMBRANES, V1758, P858, DOI 10.1016/j.bbamem.2006.02.011
   Kelly JG, 2011, J PROTEOME RES, V10, P1437, DOI 10.1021/pr101067u
   KENNARD RW, 1969, TECHNOMETRICS, V11, P137, DOI 10.2307/1266770
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lim JY, 2015, ANAL CHEM, V87, P11652, DOI 10.1021/acs.analchem.5b02661
   Marques AD, 2014, J MICROBIOL METH, V98, P26, DOI 10.1016/j.mimet.2013.12.015
   Marques AS, 2015, TALANTA, V134, P126, DOI 10.1016/j.talanta.2014.11.006
   Martin FL, 2010, NAT PROTOC, V5, P1748, DOI 10.1038/nprot.2010.133
   Misra A. K., 2011, P SOC PHOTO-OPT INS, V8025
   Nikiforov VN, 2016, B EXP BIOL MED+, V161, P88, DOI 10.1007/s10517-016-3352-z
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sakudo A, 2012, CLIN CHIM ACTA, V414, P130, DOI 10.1016/j.cca.2012.08.022
   Santos MCD, 2017, RSC ADV, V7, P25640, DOI 10.1039/c7ra03361c
   Taylor SE, 2011, BRIT J CANCER, V104, P790, DOI 10.1038/sj.bjc.6606094
   Trevisan J, 2012, ANALYST, V137, P3202, DOI 10.1039/c2an16300d
   Vargis E, 2012, TRANSL ONCOL, V5, P172, DOI 10.1593/tlo.12106
NR 31
TC 5
Z9 5
U1 4
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9660
EI 1759-9679
J9 ANAL METHODS-UK
JI Anal. Methods
PD MAR 14
PY 2018
VL 10
IS 10
BP 1280
EP 1285
DI 10.1039/c7ay02784b
PG 6
WC Chemistry, Analytical; Food Science & Technology; Spectroscopy
SC Chemistry; Food Science & Technology; Spectroscopy
GA GE1ES
UT WOS:000430960200019
DA 2020-07-08
ER

PT J
AU Duggal, NK
   McDonald, EM
   Ritter, JM
   Brault, AC
AF Duggal, Nisha K.
   McDonald, Erin M.
   Ritter, Jana M.
   Brault, Aaron C.
TI Sexual transmission of Zika virus enhances in utero transmission in a
   mouse model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HUMAN PLACENTAL TROPHOBLASTS; INFECTION; SPERM; BRAIN; EXPRESSION;
   CYTOKINE; VIREMIA; WOMEN; LEADS
AB Zika virus (ZIKV) is an emerging mosquito-borne virus that can cause ZIKV congenital syndrome when a pregnant woman is infected. Sexual transmission has also been described for ZIKV, though the relationship between sexual transmission and vertical transmission has not been investigated. Here, viral dissemination to the female reproductive tract and fetuses was assessed in immunodeficient (AG129) female mice that were exposed to ZIKV by subcutaneous (s.c.) inoculation, intravaginal (ivag.) inoculation, or sexual transmission from infected male AG129 mice. Pregnant females had significantly increased ZIKV dissemination to the female reproductive tract compared to non-pregnant females when exposed by s.c. or ivag. inoculation. Sexual transmission resulted in significantly greater morbidity and mortality in females and higher ZIKV titers in the female reproductive tract than s.c. or ivag. inoculation. Ovaries from females infected sexually contained ZIKV RNA within the ovarian follicles. Furthermore, ZIKV titers were significantly higher in fetuses from dams exposed sexually compared to fetuses from dams exposed by s.c. or ivag. inoculation. These results demonstrate that sexual transmission enhances dissemination of ZIKV to the female reproductive tract and developing fetuses in a mouse model.
C1 [Duggal, Nisha K.; McDonald, Erin M.; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
   [Ritter, Jana M.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA.
RP Brault, AC (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
EM abrault@cdc.gov
FU Office of Infectious Disease, Bureau for Global Health, U.S. Agency for
   International DevelopmentUnited States Agency for International
   Development (USAID)
FX The findings and conclusions in this report are those of the authors and
   do not necessarily represent the official position of the Centers for
   Disease Control and Prevention. We thank DVBD staff members Jason Velez
   for cell culture support and Sean Masters for animal husbandry and
   animal care needs throughout this study. We thank Heather Hayes for
   histology and immunohistochemistry support. This research was made
   possible through support provided by the Office of Infectious Disease,
   Bureau for Global Health, U.S. Agency for International Development,
   under the terms of an Interagency Agreement with CDC. The opinions
   expressed herein are those of the authors and do not necessarily reflect
   the views of the U.S. Agency for International Development.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BEDFORD JM, 1992, J ANDROL, V13, P444
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kawano N, 2014, P NATL ACAD SCI USA, V111, P4145, DOI 10.1073/pnas.1320715111
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Meaney-Delman D, 2016, OBSTET GYNECOL
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Paz-Bailey G, 2017, N ENGL J MED
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028
   Sharkey DJ, 2012, J IMMUNOL, V188, P2445, DOI 10.4049/jimmunol.1102736
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tabata T, 2017, J INFECT DIS
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Terzian ACB, 2017, EMERG INFECT DIS, V23, P1891, DOI 10.3201/eid2311.170078
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 44
TC 18
Z9 19
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 14
PY 2018
VL 8
AR 4510
DI 10.1038/s41598-018-22840-6
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ1VS
UT WOS:000427366200040
PM 29540804
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Levi, JE
AF Levi, Jose Eduardo
TI Emerging Infectious Agents and Blood Safety in Latin America
SO FRONTIERS IN MEDICINE
LA English
DT Article
DE blood transfusion; arboviruses; Latin America; Zika; Dengue; Chikungunya
ID WEST NILE VIRUS; ZIKA VIRUS; DENGUE VIRUS; CHIKUNGUNYA VIRUS;
   PUERTO-RICO; TRANSFUSION; DONORS; TRANSMISSION; MULTICENTER; EXPERIENCE
AB Historically, emerging infectious agents have been an important driving force toward the enhancement of blood safety, illustrated by the sharp reduction in the transmission of infectious agents by blood transfusion after human immunodeficiency virus (HIV) epidemics. In general, Latin American (LATAM) countries have introduced screening for microorganisms with proven blood transmission with some delay in comparison to developed countries, but, nowadays, all LATAM countries comply with a minimum standard of screening which includes Hepatitis B, C, HIV, Treponema pallidum, and Trypanosoma cruzi. Noticeably, all those agents, in addition to HTLV, cause chronic infections. By contrast, in the last decade, the region has witnessed explosive outbreaks of arboviral diseases, representing a new challenge to the blood system, threatening not only blood safety but also availability. So far, the clinical impact of transfusion-transmitted Dengue, Chikungunya, or Zika has not been evident, precluding immediate reaction from the authorities. A number of other arboviruses are endemic in the region and may, unpredictably, originate new epidemics. Several measures must be taken in preparedness for the potential emergence of another arbodisease.
C1 [Levi, Jose Eduardo] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
RP Levi, JE (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
EM jose.levi@einstein.br
FU Sao Paulo State Research Agency (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/50093-8];  [CNPq 444961/2014-3]
FX This work was partially supported by Sao Paulo State Research Agency
   (FAPESP) Grant # 2014/50093-8, and the grant CNPq 444961/2014-3.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Allain JP, 2017, TRANSFUSION MED, V27, P320, DOI 10.1111/tme.12456
   Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   [Anonymous], 2016, WHOZIKVHS161
   de Brito CAA, 2017, REV SOC BRAS MED TRO, V50, P585, DOI 10.1590/0037-8682-0479-2016
   Arellanos-Soto D, 2015, TRANSFUSION MED, V25, P122, DOI 10.1111/tme.12198
   Aubry M, 2018, VOX SANG, DOI [10.1111/vox, DOI 10.1111/VOX]
   Bajak A, 2014, NATURE, V512, P124, DOI 10.1038/512124a
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   BRAZIL, 2017, B EP MON CAS DENG FE
   BRUCECHW.LJ, 1974, B WORLD HEALTH ORGAN, V50, P337
   Chen RB, 2016, J VIROL, V90, P10600, DOI 10.1128/JVI.01166-16
   de Almeida-Neto C, 2013, VOX SANG, V105, P91, DOI 10.1111/vox.12028
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dias LL, 2012, TRANSFUSION, V52, P1667, DOI 10.1111/j.1537-2995.2012.03729.x
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Elizondo-Quiroga D, 2013, J GLOB INFECT DIS, V5, P168, DOI 10.4103/0974-777X.122014
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Levi JE, 2017, TRANSFUSION MED, V27, P286, DOI 10.1111/tme.12427
   Levi JE, 2016, J INFECT DIS, V213, P689, DOI 10.1093/infdis/jiv322
   Levi JE, 2015, TRANSFUSION, V55, P961, DOI 10.1111/trf.12944
   Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x
   Lye DC, 2017, LANCET, V389, P1611, DOI 10.1016/S0140-6736(17)30269-6
   Matos D, 2016, TRANSFUSION, V56, P215, DOI 10.1111/trf.13288
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Schmunis GA, 2001, AM J TROP MED HYG, V65, P924, DOI 10.4269/ajtmh.2001.65.924
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Stansbury LG, 2009, TRANSFUS MED REV, V23, P232, DOI 10.1016/j.tmrv.2009.03.007
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   WHO/ PAHO, 2015, SUPPL BLOOD TRANSF L
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 44
TC 1
Z9 1
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-858X
J9 FRONT MED-LAUSANNE
JI Front. Med.
PD MAR 14
PY 2018
VL 5
AR 71
DI 10.3389/fmed.2018.00071
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA FZ2QH
UT WOS:000427424900001
PM 29594126
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Caires, LC
   Goulart, E
   Melo, US
   Araujo, BHS
   Alvizi, L
   Soares-Schanoski, A
   de Oliveira, DF
   Kobayashi, GS
   Griesi-Oliveira, K
   Musso, CM
   Amaral, MS
   daSilva, LF
   Astray, RM
   Suarez-Patino, SF
   Ventini, DC
   da Silva, SG
   Yamamoto, GL
   Ezquina, S
   Naslavsky, MS
   Telles-Silva, KA
   Weinmann, K
   van der Linden, V
   van der Linden, H
   de Oliveira, JRM
   Arrais, NMR
   Melo, A
   Figueiredo, T
   Santos, S
   Meira, JGC
   Passos, SD
   de Almeida, RP
   Bispo, AJB
   Cavalheiro, EA
   Kalil, J
   Cunha-Neto, E
   Nakaya, H
   Andreata-Santos, R
   Ferreira, LCD
   Verjovski-Almeida, S
   Ho, PL
   Passos-Bueno, MR
   Zatz, M
AF Caires-Junior, Luiz Carlos
   Goulart, Ernesto
   Melo, Uira Souto
   Silva Araujo, Bruno Henrique
   Alvizi, Lucas
   Soares-Schanoski, Alessandra
   de Oliveira, Danyllo Felipe
   Kobayashi, Gerson Shigeru
   Griesi-Oliveira, Karina
   Musso, Camila Manso
   Amaral, Murilo Sena
   daSilva, Lucas Ferreira
   Astray, Renato Mancini
   Suarez-Patino, Sandra Fernanda
   Ventini, Daniella Cristina
   da Silva, Sergio Gomes
   Yamamoto, Guilherme Lopes
   Ezquina, Suzana
   Naslavsky, Michel Satya
   Telles-Silva, Kayque Alves
   Weinmann, Karina
   van der Linden, Vanessa
   van der Linden, Helio
   Mendes de Oliveira, Joao Ricardo
   Rodrigues Arrais, Nivia Maria
   Melo, Adriana
   Figueiredo, Thalita
   Santos, Silvana
   Castro Meira, Joanna Goes
   Passos, Saulo Duarte
   de Almeida, Roque Pacheco
   Barreto Bispo, Ana Jovina
   Cavalheiro, Esper Abrao
   Kalil, Jorge
   Cunha-Neto, Edecio
   Nakaya, Helder
   Andreata-Santos, Robert
   de Souza Ferreira, Luis Carlos
   Verjovski-Almeida, Sergio
   Ho, Paulo Lee
   Passos-Bueno, Maria Rita
   Zatz, Mayana
TI Discordant congenital Zika syndrome twins show differential in vitro
   viral susceptibility of neural progenitor cells (vol 9, 2018)
SO NATURE COMMUNICATIONS
LA English
DT Correction
C1 [Caires-Junior, Luiz Carlos; Goulart, Ernesto; Melo, Uira Souto; Alvizi, Lucas; de Oliveira, Danyllo Felipe; Kobayashi, Gerson Shigeru; Griesi-Oliveira, Karina; Musso, Camila Manso; Yamamoto, Guilherme Lopes; Ezquina, Suzana; Naslavsky, Michel Satya; Telles-Silva, Kayque Alves; Weinmann, Karina; Figueiredo, Thalita; Passos-Bueno, Maria Rita; Zatz, Mayana] Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Res Ctr, Dept Genet & Evolutionary Biol, BR-05508900 Sao Paulo, SP, Brazil.
   [Silva Araujo, Bruno Henrique] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, BR-13083970 Campinas, SP, Brazil.
   [Silva Araujo, Bruno Henrique; Cavalheiro, Esper Abrao] Fed Univ Sao Paulo UNIFESP, EPM, Dept Neurol & Neurosurg, Neurosci Lab, BR-04039002 Sao Paulo, SP, Brazil.
   [Soares-Schanoski, Alessandra; Amaral, Murilo Sena; Astray, Renato Mancini; Suarez-Patino, Sandra Fernanda; Ventini, Daniella Cristina; Kalil, Jorge; Verjovski-Almeida, Sergio; Ho, Paulo Lee] Butantan Inst, BR-05503900 Sao Paulo, SP, Brazil.
   [Griesi-Oliveira, Karina; da Silva, Sergio Gomes] Albert Einstein Hosp, BR-05652900 Sao Paulo, SP, Brazil.
   [daSilva, Lucas Ferreira; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508900 Sao Paulo, SP, Brazil.
   [da Silva, Sergio Gomes] Univ Mogi das Cruzes, BR-08780911 Mogi Das Cruzes, SP, Brazil.
   [van der Linden, Vanessa] AACD, BR-50080810 Recife, PE, Brazil.
   [van der Linden, Helio] Rehabil Ctr Dr Henrique Santillo, BR-74653230 Goiania, Go, Brazil.
   [Mendes de Oliveira, Joao Ricardo] Fed Univ Pernambuco UFPE, Neuropsychiat Dept, BR-50670901 Recife, PE, Brazil.
   [Mendes de Oliveira, Joao Ricardo] Fed Univ Pernambuco UFPE, KeizoAsami Lab, BR-50670901 Recife, PE, Brazil.
   [Rodrigues Arrais, Nivia Maria] Fed Univ Rio Grande do Norte UFRN, Dept Pediat, BR-59010180 Natal, RN, Brazil.
   [Melo, Adriana] ISEA, BR-58400220 Campina Grande, PB, Brazil.
   [Santos, Silvana] Paraiba State Univ UEPB, Dept Biol, BR-58429500 Campina Grande, PB, Brazil.
   [Castro Meira, Joanna Goes] Fed Univ Bahia UFBA, BR-40170115 Salvador, BA, Brazil.
   [Passos, Saulo Duarte] Med Sch Jundiai, Infect Pediat Lab, BR-40170115 Jundiai, SP, Brazil.
   [de Almeida, Roque Pacheco; Barreto Bispo, Ana Jovina] Fed Univ Sergipe UFS, Div Immunol, BR-49100000 Aracaju, SP, Brazil.
   [de Almeida, Roque Pacheco; Barreto Bispo, Ana Jovina] Fed Univ Sergipe UFS, Mol Biol Lab, BR-49100000 Aracaju, SP, Brazil.
   [Cunha-Neto, Edecio] Univ Sao Paulo, Fac Med, Heart Inst, BR-05403900 Sao Paulo, SP, Brazil.
   [Nakaya, Helder] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508900 Sao Paulo, SP, Brazil.
   [Andreata-Santos, Robert; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Vaccine Dev Lab, BR-05508900 Sao Paulo, SP, Brazil.
RP Zatz, M (corresponding author), Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Res Ctr, Dept Genet & Evolutionary Biol, BR-05508900 Sao Paulo, SP, Brazil.
EM mayazatz@usp.br
RI Kobayashi, Gerson/H-4017-2013; Zatz, Mayana/M-5338-2015; KALIL,
   JORGE/C-8029-2012; Goulart, Ernesto/AAC-3713-2020; Schanoski,
   Alessandra/H-8144-2014; Passos-Bueno, Maria Rita/I-6796-2016;
   Verjovski-Almeida, Sergio/E-4082-2012; Amaral, Murilo S/G-5769-2013;
   Melo, Adriana S O/H-5650-2016; Cunha-Neto, Edecio/B-4157-2009;
   Kobayashi, Gerson Shigeru/AAB-9113-2019; Nakaya, Helder/AAF-1738-2020;
   Naslavsky, Michel/L-1772-2015; Cavalheiro, Esper/I-3084-2016
OI Kobayashi, Gerson/0000-0002-6520-5774; Zatz, Mayana/0000-0003-3970-8025;
   KALIL, JORGE/0000-0001-8415-4274; Schanoski,
   Alessandra/0000-0002-6514-8458; Passos-Bueno, Maria
   Rita/0000-0002-9248-3008; Verjovski-Almeida, Sergio/0000-0002-6356-2401;
   Cunha-Neto, Edecio/0000-0002-3699-3345; Kobayashi, Gerson
   Shigeru/0000-0002-6520-5774; Nakaya, Helder/0000-0001-5297-9108;
   Naslavsky, Michel/0000-0002-9068-1713; Goulart,
   Ernesto/0000-0001-9526-8701; Cavalheiro, Esper/0000-0002-0854-3582;
   Santos, Silvana/0000-0002-5252-0206
FU CAPESCAPES; DECIT-MS
FX Financial support from CAPES and DECIT-MS
CR CAIRESJUNIOR LC, 2018, NAT COMM, V0009
NR 1
TC 4
Z9 4
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 13
PY 2018
VL 9
AR 1114
DI 10.1038/s41467-018-03497-1
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ0HK
UT WOS:000427248800003
PM 29535311
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kuehn, B
AF Kuehn, Bridget
TI Zika-Associated Birth Defects Increasing
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAR 13
PY 2018
VL 319
IS 10
BP 973
EP 973
DI 10.1001/jama.2018.1611
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FZ0HS
UT WOS:000427249700006
PM 29536104
DA 2020-07-08
ER

PT J
AU Di Guardo, G
AF Di Guardo, Giovanni
TI Commentary: Zika Virus in the Americas-Yet Another Arbovirus Threat
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Editorial Material
DE Zika virus; arthropod-borne viruses; mosquitoes; Aedes aegypti; Aedes
   albopictus; Wolbachia spp.; Dirofilaria immitis
ID TRANSMISSION
C1 [Di Guardo, Giovanni] Univ Teramo, Fac Vet Med, Teramo, Italy.
RP Di Guardo, G (corresponding author), Univ Teramo, Fac Vet Med, Teramo, Italy.
EM gdiguardo@unite.it
CR Aznar-Alemany O, 2017, ENVIRON POLLUT, V225, P346, DOI 10.1016/j.envpol.2017.02.060
   Di Guardo G, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.103
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Frank Kristen, 2010, Compend Contin Educ Vet, V32, pE4
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1086
   Ligios C, 2011, J VIROL, V85, P1136, DOI 10.1128/JVI.02022-10
   Morchon R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00196
   Waltz E., 2017, NATURE NEWS
   Zafar MA, 2017, CELL HOST MICROBE, V21, P73, DOI 10.1016/j.chom.2016.12.005
NR 10
TC 1
Z9 1
U1 2
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAR 12
PY 2018
VL 9
AR 435
DI 10.3389/fmicb.2018.00435
PG 2
WC Microbiology
SC Microbiology
GA FY9BU
UT WOS:000427161000001
PM 29593683
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sen Kwek, S
   Watanabe, S
   Chan, KR
   Ong, EZ
   Tan, HC
   Ng, WC
   Nguyen, MTX
   Gan, ES
   Zhang, SL
   Chan, KWK
   Tan, JH
   Sessions, OM
   Manuel, M
   Pompon, J
   Chua, C
   Hazirah, S
   Tryggvason, K
   Vasudevan, SG
   Ooi, EE
AF Sen Kwek, Swee
   Watanabe, Satoru
   Chan, Kuan Rong
   Ong, Eugenia Z.
   Tan, Hwee Cheng
   Ng, Wy Ching
   Nguyen, Mien T. X.
   Gan, Esther S.
   Zhang, Summer L.
   Chan, Kitti W. K.
   Tan, Jun Hao
   Sessions, October M.
   Manuel, Menchie
   Pompon, Julien
   Chua, Camillus
   Hazirah, Sharifah
   Tryggvason, Karl
   Vasudevan, Subhash G.
   Ooi, Eng Eong
TI A systematic approach to the development of a safe live attenuated Zika
   vaccine
SO NATURE COMMUNICATIONS
LA English
DT Article
ID YELLOW-FEVER VACCINE; T-CELL IMMUNITY; MEMBRANE ASSOCIATION; MEDIATED
   PROTECTION; VIRUS; DENGUE; INFECTION; IMMUNOGENICITY; EPIDEMIC; BIOLOGY
AB Zika virus (ZIKV) is a flavivirus that can cause congenital disease and requires development of an effective long-term preventative strategy. A replicative ZIKV vaccine with properties similar to the yellow fever 17D (YF17D) live-attenuated vaccine (LAV) would be advantageous, as a single dose of YF17D produces lifelong immunity. However, a replicative ZIKV vaccine must also be safe from causing persistent organ infections. Here we report an approach to ZIKV LAV development. We identify a ZIKV variant that produces small plaques due to interferon (IFN)-restricted viral propagation and displays attenuated infection of endothelial cells. We show that these properties collectively reduce the risk of organ infections and vertical transmission in a mouse model but remain sufficiently immunogenic to prevent wild-type ZIKV infection. Our findings suggest a strategy for the development of a safe but efficacious ZIKV LAV.
C1 [Sen Kwek, Swee; Watanabe, Satoru; Chan, Kuan Rong; Ong, Eugenia Z.; Tan, Hwee Cheng; Ng, Wy Ching; Gan, Esther S.; Zhang, Summer L.; Chan, Kitti W. K.; Tan, Jun Hao; Sessions, October M.; Manuel, Menchie; Pompon, Julien; Vasudevan, Subhash G.; Ooi, Eng Eong] Duke Natl Univ Singapore, Programme Emerging Infect Dis, Med Sch, Singapore 169857, Singapore.
   [Nguyen, Mien T. X.; Tryggvason, Karl] Duke Natl Univ Singapore, Programme Cardiovasc & Metab Disorders, Med Sch, Singapore 169857, Singapore.
   [Chan, Kitti W. K.; Vasudevan, Subhash G.; Ooi, Eng Eong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117597, Singapore.
   [Pompon, Julien] Univ Montpellier, CNRS, IRD, MIVEGEC, F-34394 Montpellier, France.
   [Chua, Camillus; Hazirah, Sharifah] SingHealth, SingHlth Translat Immunol & Inflammat Ctr, Singapore 169856, Singapore.
   [Tryggvason, Karl] Karolinska Inst, Div Matrix Biol, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
   [Ooi, Eng Eong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore.
   [Ooi, Eng Eong] Singapore MIT Alliance Res & Technol, Infect Dis Interdisciplinary Grp, Singapore 138602, Singapore.
RP Ooi, EE (corresponding author), Duke Natl Univ Singapore, Programme Emerging Infect Dis, Med Sch, Singapore 169857, Singapore.; Ooi, EE (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117597, Singapore.; Ooi, EE (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore.; Ooi, EE (corresponding author), Singapore MIT Alliance Res & Technol, Infect Dis Interdisciplinary Grp, Singapore 138602, Singapore.
EM engeong.ooi@duke-nus.edu.sg
OI Gan, Esther/0000-0003-4992-424X; Ong, Eugenia/0000-0003-2187-7058; Ooi,
   Eng Eong/0000-0002-0520-1544
FU National Medical Research Council of SingaporeNational Medical Research
   Council, Singapore [NMRC/BNIG/2032/2015, NMRC/CBRG/0074/2014,
   NMRC/CSA/0060/2014, NMRC/STaR/020/2013, NMRC/MOHIAFCA T2/005/2015,
   MOHIAFCAT2001, CIRG13nov032, NMRC MOHIAFCAT1-6003]; Duke-NUS Medical
   School
FX We thank Karin Sundstrom for the design of primers used in Gibson
   assembly, Katell Bidet for providing the vector for infectious clone
   generation, and also Amanda Bifani for help during the manuscript
   preparation process. We also thank Nicole Wei Wen Tan for providing help
   in the pregnant mice work. We thank the Duke-NUS Genome Biology Facility
   for providing NGS and microarray services. J.P. received support from
   National Medical Research Council of Singapore (NMRC/BNIG/2032/2015 and
   NMRC/CBRG/0074/2014). C.C. and S.H. are supported in STIIC with grants
   from National Medical Research Council of Singapore (NMRC/STaR/020/2013,
   NMRC/MOHIAFCA T2/005/2015, MOHIAFCAT2001, CIRG13nov032, and NMRC
   MOHIAFCAT1-6003). This study was funded by the National Medical Research
   Council of Singapore (NMRC/CSA/0060/2014) and internal support from the
   Duke-NUS Medical School.
CR Andrade DV, 2017, VIRUS RES
   Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barr J, 2010, J GEN VIROL, V91, P1373, DOI 10.1099/vir.0.020818-0
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   Chan KR, 2011, P NATL ACAD SCI USA, V108, P12479, DOI 10.1073/pnas.1106568108
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   Douam F, 2017, MBIO, V8, DOI [10.1128/mBio.00819-17, 10.1128/mbio.00819-17]
   Duncan CJA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4227
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fehres CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00157
   Fensterl V, 2015, ANNU REV VIROL, V2, P549, DOI 10.1146/annurev-virology-100114-055249
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Goh KCM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26100
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hambleton S, 2013, P NATL ACAD SCI USA, V110, P3053, DOI 10.1073/pnas.1220098110
   Hou J, 2017, J IMMUNOL, V199, P1476, DOI 10.4049/jimmunol.1700083
   Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kanesa-thasan N, 2001, VACCINE, V19, P3179, DOI 10.1016/S0264-410X(01)00020-2
   Kato F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16475-2
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Khou C, 2017, INTERVIROLOGY, V60, P8, DOI 10.1159/000479966
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211
   Meeting of the Strategic Advisory Group of Experts on immunization, 2013, WKLY EPIDEMIOL REC, V88, P201
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Nemesio H, 2014, BIOCHEMISTRY-US, V53, P5280, DOI 10.1021/bi500724k
   Nguyen MTX, 2016, STEM CELL REP, V7, P802, DOI 10.1016/j.stemcr.2016.08.017
   Nice T. J., 2017, TRENDS MICROBIOL
   Plotkin SA, 2006, CLIN INFECT DIS, V43, pS164, DOI 10.1086/505950
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Siridechadilok B, 2013, J VIROL, V87, P12667, DOI 10.1128/JVI.02261-13
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Torresi J, 2017, J INFECT DIS, V216, P834, DOI 10.1093/infdis/jix314
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Vynnycky E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149160
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   WHO, 2016, YELLOW FEVER
   World Health Organization, 2017, TICK BORNE ENCEPHALI
   World Health Organization, 2017, JAPANESE ENCEPHALITI
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387
NR 68
TC 14
Z9 15
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 12
PY 2018
VL 9
AR 1031
DI 10.1038/s41467-018-03337-2
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FY8NL
UT WOS:000427121700006
PM 29531213
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Leal, W
   Bonecke, J
   Spielmann, H
   Azeiteiro, UM
   Alves, F
   de Carvalho, ML
   Nagy, GJ
AF Leal Filho, Walter
   Boenecke, Juliane
   Spielmann, Hannah
   Azeiteiro, Ulisses M.
   Alves, Fatima
   de Carvalho, Mauren Lopes
   Nagy, Gustavo J.
TI Climate change and health: An analysis of causal relations on the spread
   of vector-borne diseases in Brazil
SO JOURNAL OF CLEANER PRODUCTION
LA English
DT Article
DE Health; Extreme events; Arbovirus infections; Brazil; Zika;
   Policy-making
ID RIO-DE-JANEIRO; DISASTER RISK REDUCTION; ZIKA VIRUS; EL-NINO;
   TRADITIONAL COMMUNITIES; PUBLIC-HEALTH; CHALLENGES; IMPACTS;
   CHIKUNGUNYA; RESILIENCE
AB The increases in greenhouse gas concentrations caused by anthropogenic activities such as industrial emissions, transport and burning of forests and other resources, recorded over the past decades, are known to have an impact on the global environment. In particular, this paper reviews the evidence that climate change has an impact on human health as a whole and on the spread of vector-borne diseases in particular. It offers an analysis of previous research on the connections between climate change and health, with a case study from Brazil, and lists some areas which may guide future policy-making. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Leal Filho, Walter; Boenecke, Juliane; Spielmann, Hannah] Hamburg Univ Appl Sci, Res & Transfer Ctr Sustaiinable Dev & Climate Cha, Hamburg, Germany.
   [Leal Filho, Walter] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester, Lancs, England.
   [Azeiteiro, Ulisses M.] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal.
   [Azeiteiro, Ulisses M.] Univ Aveiro, CESAM Ctr Environm & Marine Studies, P-3810193 Aveiro, Portugal.
   [Alves, Fatima] UnversidadeAberta, Lisbon, Portugal.
   [Alves, Fatima] Univ Coimbra, Ctr Funct Ecol, Lisbon, Portugal.
   [de Carvalho, Mauren Lopes] Inst Fed Educ, Brasilia, DF, Brazil.
   [Nagy, Gustavo J.] UdelaR, Fac Ciencias, Montevideo, Uruguay.
RP Leal, W (corresponding author), Hamburg Univ Appl Sci, Res & Transfer Ctr Sustaiinable Dev & Climate Cha, Hamburg, Germany.
EM walter.leal2@haw-hamburg.de
RI Alves, Fatima/P-2895-2019; de Miranda Azeiteiro, Ulisses
   Manuel/C-5933-2008; Alves, Fatima/R-3494-2016
OI Alves, Fatima/0000-0003-2600-8652; de Miranda Azeiteiro, Ulisses
   Manuel/0000-0002-5252-1700; Alves, Fatima/0000-0003-2600-8652
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Al-Amin AQ, 2011, INT J GLOBAL WARM, V3, P390, DOI 10.1504/IJGW.2011.044402
   Alderman K, 2012, ENVIRON INT, V47, P37, DOI 10.1016/j.envint.2012.06.003
   Ali H, 2016, CLIM CHANG MANAG, P151, DOI 10.1007/978-3-319-24660-4_10
   Alpino TA, 2016, CIENC SAUDE COLETIVA, V21, P809, DOI 10.1590/1413-81232015213.21392015
   Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507
   Alves F, 2014, INT J CLIM CHANG STR, V6, P2, DOI 10.1108/IJCCSM-10-2013-0121
   [Anonymous], 2016, LANCET GLOB HEALTH, V4, pE427, DOI 10.1016/S2214-109X(16)30109-7
   Aparicio-Effen M, 2016, CLIM CHANG MANAG, P449, DOI 10.1007/978-3-319-24660-4_26
   Aparicio-Effen M, 2016, CLIM CHANG MANAG, P231, DOI 10.1007/978-3-319-24660-4_14
   Basagana X, 2011, EPIDEMIOLOGY, V22, P765, DOI 10.1097/EDE.0b013e31823031c5
   Becker Norbert, 2012, P31
   Benmarhnia T, 2015, EPIDEMIOLOGY, V26, P781, DOI 10.1097/EDE.0000000000000375
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Butler CD, 2010, POSTGRAD MED J, V86, P230, DOI 10.1136/pgmj.2009.082727
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111
   Carraro C., 2015, REV ENV ENERGY EC, V3
   Castro P, 2016, WORLD SUSTAIN SER, P1, DOI 10.1007/978-3-319-32318-3
   Central Intelligence Agency, 2017, S AM BRAZ
   Jabbour CJC, 2013, RESOUR CONSERV RECY, V74, P144, DOI 10.1016/j.resconrec.2012.12.017
   Chirebvu E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0139843
   Confalonieri U., 2007, CLIMATE CHANGE 2007, P391, DOI DOI 10.1016/J.JHYDR0L.2011.05.013
   Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541
   de Freitas CM, 2012, CIENC SAUDE COLETIVA, V17, P1601, DOI 10.1590/S1413-81232012000600023
   de Freitas LE, 2016, CLIM CHANG MANAG, P353, DOI 10.1007/978-3-319-24660-4_20
   de Lucena AJ, 2013, THEOR APPL CLIMATOL, V111, P497, DOI 10.1007/s00704-012-0668-0
   de Mendonca MB, 2016, CLIM CHANG MANAG, P279, DOI 10.1007/978-3-319-24660-4_16
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Field C. B., 2012, MANAGING RISKS EXTRE, P1, DOI DOI 10.1017/CB09781139177245
   Figueiredo P, 2013, J CLEAN PROD, V60, P188, DOI 10.1016/j.jclepro.2012.02.025
   Setti AFF, 2016, CLIM CHANG MANAG, P329, DOI 10.1007/978-3-319-24660-4_19
   Gallo E, 2016, CLIM CHANG MANAG, P515, DOI 10.1007/978-3-319-24660-4_28
   Gaziulusoy AI, 2016, J CLEAN PROD, V123, P55, DOI 10.1016/j.jclepro.2015.08.049
   Goorhuis A, 2016, LANCET INFECT DIS, V16, P1204, DOI 10.1016/S1473-3099(16)30316-4
   Gronlund Carina J, 2014, Curr Epidemiol Rep, V1, P165
   Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012
   Gumel A., 2015, PHILOS T R SOC B, V370
   Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364
   Hales S., 2014, QUANTITATIVE RISK AS
   Haque MM, 2016, J CLEAN PROD, V137, P60, DOI 10.1016/j.jclepro.2016.07.038
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Huang LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155166
   Hulme M, 2014, PROG PHYS GEOG, V38, P499, DOI 10.1177/0309133314538644
   Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x
   Institute of Medicine, 2008, CLIM CLIM CHANG EXTR
   IPCC, 2014, CLIM CHANG 2014 IMP
   Nehama FPJ, 2016, CLIM CHANG MANAG, P369, DOI 10.1007/978-3-319-24660-4_21
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Leal Filho W, 2014, INT PERSPECTIVES CLI
   Leal Filho W., 2011, EC SOCIAL POLITICAL
   Leal W, 2018, J CLEAN PROD, V170, P269, DOI 10.1016/j.jclepro.2017.09.105
   Leal W, 2016, CLIM CHANG MANAG, P1, DOI 10.1007/978-3-319-24660-4_1
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Amui LBL, 2017, J CLEAN PROD, V142, P308, DOI 10.1016/j.jclepro.2016.07.103
   McMichael AJ, 2015, PUBLIC HEALTH, V129, P1361, DOI 10.1016/j.puhe.2014.11.013
   McMichael A. J., 2003, CLIMATE CHANGE HUMAN
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
   Meason B, 2014, HEALTH HUM RIGHTS, V16, P105
   Favaro AKMD, 2016, CLIM CHANG MANAG, P419, DOI 10.1007/978-3-319-24660-4_24
   Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389
   Munoz AG, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0146-1
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Nagy GJ, 2016, CLIM CHANG MANAG, P475, DOI 10.1007/978-3-319-24660-4_27
   Naidoo S, 2014, INT J ENV RES PUB HE, V11, P249, DOI 10.3390/ijerph110100249
   National Research Council - NRC, 2001, WEATH CLIM EC INF DI
   Nazareth T, 2016, CLIM CHANG MANAG, P187, DOI 10.1007/978-3-319-24660-4_12
   Ojeh VN, 2016, CLIM CHANG MANAG, P171, DOI 10.1007/978-3-319-24660-4_11
   Oliveira B, 2016, CLIM CHANG MANAG, P117, DOI 10.1007/978-3-319-24660-4_8
   Oliver SL, 2016, CLIM CHANG MANAG, P433, DOI 10.1007/978-3-319-24660-4_25
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Pereda PC, 2016, CLIM CHANG MANAG, P201
   REEVES WC, 1994, J MED ENTOMOL, V31, P323, DOI 10.1093/jmedent/31.3.323
   Schuck-Paim C., 2016, PLOS CURR
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709
   Stanke C, 2012, PLOS CURR
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Stott PA, 2014, B AM METEOROL SOC, V95, pS1
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   The Lancet Infectious Diseases, 2017, DENG EX SUMM
   Viegas V, 2016, CLIM CHANG MANAG, P305, DOI 10.1007/978-3-319-39880-8_19
   Watts N, 2018, LANCET, V391, P581, DOI 10.1016/S0140-6736(17)32464-9
   Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6
   WHO, 2016, NIN MAY INCR BREED G
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   Wilbanks T.J., 2007, CLIMATE CHANGE 2007, P357
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   World Health Organization, 2015, CLIM HLTH COUNTR PRO
   World Health Organization, 2016, VECT BORN DIS
   Wu XX, 2016, ENVIRON INT, V86, P14, DOI 10.1016/j.envint.2015.09.007
   Yuan XC, 2017, J CLEAN PROD, V166, P1169, DOI 10.1016/j.jclepro.2017.07.209
   Zahouli JBZ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1778-9
NR 98
TC 6
Z9 6
U1 2
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-6526
EI 1879-1786
J9 J CLEAN PROD
JI J. Clean Prod.
PD MAR 10
PY 2018
VL 177
BP 589
EP 596
DI 10.1016/j.jclepro.2017.12.144
PG 8
WC Green & Sustainable Science & Technology; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA FU9OY
UT WOS:000424186600053
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Marques, JA
   Mendoza, I
   Carta, KG
   Morr, I
   Meza, Y
   Flores, VF
   Mendoza-Britto, IJ
   Martinez, N
AF Marques, Juan A.
   Mendoza, Ivan
   Gonzalez Carta, Karina
   Morr, Igor
   Meza, Yolimar
   Finizola Flores, Vicente
   Mendoza-Britto, Ivan J.
   Martinez, Nahir
TI ZIKA AND HEART FAILURE: PRIOR DENGUE MAY BRING OUT THE WORST
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Meeting Abstract
CT 67th Annual Scientific Session and Expo of the
   American-College-of-Cardiology (ACC)
CY MAR 10-12, 2018
CL Orlando, FL
SP Amer Coll Cardiol
C1 [Marques, Juan A.; Mendoza, Ivan; Gonzalez Carta, Karina; Morr, Igor; Meza, Yolimar; Finizola Flores, Vicente; Mendoza-Britto, Ivan J.; Martinez, Nahir] Cent Univ Venezuela, Caracas, Venezuela.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD MAR 10
PY 2018
VL 71
IS 11
SU S
MA A730
BP 730
EP 730
DI 10.1016/S0735-1097(18)31271-3
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC3BT
UT WOS:000429659701580
OA Bronze
DA 2020-07-08
ER

PT J
AU Nico, D
   Conde, L
   Rivera-Correa, JL
   Vasconcelos-dos-Santos, A
   Mesentier-Louro, L
   Freire-de-Lima, L
   Arruda, MB
   Freire-de-Lima, CG
   Ferreira, OD
   Moreira, MEL
   Zin, AA
   Vasconcelos, ZFM
   Otero, RM
   Palatnik-de-Sousa, CB
   Tanuri, A
   Todeschini, AR
   Savino, W
   Rodriguez, A
   Morrot, A
AF Nico, Dirlei
   Conde, Luciana
   Rivera-Correa, Juan L.
   Vasconcelos-dos-Santos, Andreia
   Mesentier-Louro, Louise
   Freire-de-Lima, Leonardo
   Arruda, Monica Barcellos
   Freire-de-Lima, Celio Geraldo
   Ferreira, Orlando da Costa, Jr.
   Lopes Moreira, Maria Elisabeth
   Zin, Andrea Araujo
   Meira Vasconcelos, Zilton Farias
   Otero, Rosalia Mendez
   Palatnik-de-Sousa, Clarisa Beatriz
   Tanuri, Amilcar
   Todeschini, Adriane Regina
   Savino, Wilson
   Rodriguez, Ana
   Morrot, Alexandre
TI Prevalence of IgG Autoantibodies against GD3 Ganglioside in Acute Zika
   Virus Infection
SO FRONTIERS IN MEDICINE
LA English
DT Article
DE Zika virus; gangliosides; autoimmunity; autoantibody; infectious
   diseases
ID NEURAL STEM-CELLS; ANTIBODY-RESPONSE; EXPRESSION; RETINA; BRAIN
AB Zika virus (ZIKV) disease has become a global health emergency with devastating effects on public health. Recent evidences implicate the virus as an emergent neuropathological agent promoting serious pathologies of the human nervous system, that include destructive and malformation consequences such as development of ocular and fetal brain lesions, microcephaly in neonates, and Guillain-Barre syndrome (GBS) in adults. These neurological disorders of both central and peripheral nervous systems are thought to be associated to the neurotropic properties of the virus that has ability to infect neural stem cells as well as peripheral neurons, a hallmark of its pathogenicity. The presence of autoantibodies against gangliosides plays a pivotal role in the etiogenesis of GBS and a variety of neurological disorders. Gangliosides are a class of galactose -containing cerebrosides mainly expressed in nervous system tissues playing a critical role in the physiology of neural cells and neurogenesis. Herein, our findings indicate that patients at acute phase of ZIKV infection without any neurological signs show increased levels of IgG autoantibody against GD3 gangliosides, a class of glycolipid found to be highly expressed in neural stem cell acting in the maintenance of their self -renewal cellular capacity. It is possible that a pathological threshold of these antibodies is only acquired in secondary or subsequent infections. In the light of these evidences, we propose that the target of GD3 by autoimmune responses may possibly has an effect in the neuropathy and neurogenesis disorder seen during ZIKV infection.
C1 [Nico, Dirlei; Conde, Luciana; Palatnik-de-Sousa, Clarisa Beatriz] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
   [Rivera-Correa, Juan L.; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
   [Vasconcelos-dos-Santos, Andreia; Mesentier-Louro, Louise; Freire-de-Lima, Leonardo; Freire-de-Lima, Celio Geraldo; Otero, Rosalia Mendez; Todeschini, Adriane Regina] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Arruda, Monica Barcellos; Ferreira, Orlando da Costa, Jr.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.
   [Lopes Moreira, Maria Elisabeth; Zin, Andrea Araujo; Meira Vasconcelos, Zilton Farias] Fiocruz MS, Inst Oswaldo Cruz, Unidade Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Savino, Wilson] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Savino, Wilson] Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro, Brazil.
   [Morrot, Alexandre] Univ Fed Rio de Janeiro, Ctr Pesquisas TB, Fac Med, Rio De Janeiro, Brazil.
   [Morrot, Alexandre] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunopatol, Rio De Janeiro, Brazil.
RP Rodriguez, A (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.; Morrot, A (corresponding author), Univ Fed Rio de Janeiro, Ctr Pesquisas TB, Fac Med, Rio De Janeiro, Brazil.; Morrot, A (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Imunopatol, Rio De Janeiro, Brazil.
EM Ana.Rodriguez@nyumc.org; alexandre.lima@ioc.fiocruz.br
RI de Lima, Celio Geraldo Freire/A-9057-2012; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; Todeschini, Adriane/AAG-8128-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Vasconcelos,
   Zilton/0000-0002-2193-2224; Palatnik-de-Sousa, Clarisa
   B./0000-0002-6231-0608; Freire-de-Lima, Leonardo/0000-0003-3013-3173;
   Mendez-Otero, Rosalia/0000-0002-1798-9930; Rodriguez,
   Ana/0000-0002-0060-3405; Rivera-Correa, Juan/0000-0003-4822-0005
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)
   fellowshipNational Council for Scientific and Technological Development
   (CNPq) [310977/2014-2, 404400/2012-4]; Focem/Mercosur; Fundacao Carlos
   Chagas de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26-201.583/2014]; FaperjCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
    [E-26/ 201747/2015]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPQ) fellowship 310977/2014-2 and grant
   404400/2012-4 (to CP-d-S); Focem/Mercosur (WS); and by Fundacao Carlos
   Chagas de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) grants
   E-26-201.583/2014 (to CP-d-S), Zika-related networks funded by Faperj
   (AT and WS) and fellowships E-26/ 201747/2015 (to DN).
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Ang CW, 2002, INFECT IMMUN, V70, P5081, DOI 10.1128/IAI.70.9.5081-5085.2002
   Bowes T, 2002, INFECT IMMUN, V70, P5008, DOI 10.1128/IAI.70.9.5008-5018.2002
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DANIOTTI JL, 1990, J NEUROSCI RES, V26, P436, DOI 10.1002/jnr.490260406
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Fujio K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00028
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goldman JE, 1996, GLIA, V16, P291, DOI 10.1002/(SICI)1098-1136(199604)16:4<291::AID-GLIA1>3.0.CO;2-3
   Gomez-Nicola D, 2006, J NEUROSCI RES, V83, P754, DOI 10.1002/jnr.20777
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Horwacik I, 2015, APOPTOSIS, V20, P679, DOI 10.1007/s10495-015-1103-7
   Huijbers MG, 2015, EUR J NEUROL, V22, P1151, DOI 10.1111/ene.12758
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Ilyas AA, 2001, RES COMMUN MOL PATH, V109, P115
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179
   Malisan F, 2002, BBA-MOL CELL BIOL L, V1585, P179, DOI 10.1016/S1388-1981(02)00339-6
   Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209
   Morris G, 2018, MOL NEUROBIOL, V55, P4160, DOI 10.1007/s12035-017-0635-y
   Nakatani Y, 2010, GLYCOBIOLOGY, V20, P78, DOI 10.1093/glycob/cwp149
   Pan QJ, 2017, DISCOV MED, V23, P169
   Park JE, 2008, CYTOTHERAPY, V10, P38, DOI 10.1080/14653240701762380
   Pisetsky DS, 2009, LUPUS, V18, P1176, DOI 10.1177/0961203309106492
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01740
   Ryu JS, 2009, BIOCHEM BIOPH RES CO, V387, P266, DOI 10.1016/j.bbrc.2009.07.005
   Schnaar RL, 2016, J MOL BIOL, V428, P3325, DOI 10.1016/j.jmb.2016.05.020
   Schwerer B, 1999, INFECT IMMUN, V67, P2414, DOI 10.1128/IAI.67.5.2414-2420.1999
   SPARROW JR, 1988, J NEUROSCI RES, V21, P398, DOI 10.1002/jnr.490210231
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tyler KL, 2017, JAMA NEUROL, V74, P1169, DOI 10.1001/jamaneurol.2017.1471
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Wang J, 2014, J NEUROSCI, V34, P13790, DOI 10.1523/JNEUROSCI.2275-14.2014
   Wang J, 2013, P NATL ACAD SCI USA, V110, P19137, DOI 10.1073/pnas.1307224110
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537
NR 45
TC 5
Z9 5
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-858X
J9 FRONT MED-LAUSANNE
JI Front. Med.
PD MAR 9
PY 2018
VL 5
DI 10.3389/fmed2018.00025
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA FY7SZ
UT WOS:000427064700001
PM 29594116
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hall, V
   Walker, WL
   Lindsey, NP
   Lehman, JA
   Kolsin, J
   Landry, K
   Rabe, IB
   Hills, SL
   Fischer, M
   Staples, JE
   Gould, CV
   Martin, SW
AF Hall, Victoria
   Walker, William L.
   Lindsey, Nicole P.
   Lehman, Jennifer A.
   Kolsin, Jonathan
   Landry, Kimberly
   Rabe, Ingrid B.
   Hills, Susan L.
   Fischer, Marc
   Staples, J. Erin
   Gould, Carolyn V.
   Martin, Stacey W.
TI Update: Noncongenital Zika Virus Disease Cases-50 US States and the
   District of Columbia, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES; INTERIM GUIDANCE
C1 [Hall, Victoria; Walker, William L.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Hall, Victoria; Walker, William L.; Lindsey, Nicole P.; Lehman, Jennifer A.; Kolsin, Jonathan; Landry, Kimberly; Rabe, Ingrid B.; Hills, Susan L.; Fischer, Marc; Staples, J. Erin; Gould, Carolyn V.; Martin, Stacey W.] CDC, Arboviral Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Martin, SW (corresponding author), CDC, Arboviral Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM smartin4@cdc.gov
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS ZIK VIR
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Pan American Health Organization, 2017, REG ZIK EP UPD AM AU
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   US Geological Survey; CDC, 2017, DIS MAPS
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
NR 10
TC 9
Z9 9
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 9
PY 2018
VL 67
IS 9
BP 265
EP 269
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FY6MF
UT WOS:000426960900001
PM 29518067
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Grubaugh, ND
   Faria, NR
   Andersen, KG
   Pybus, OG
AF Grubaugh, Nathan D.
   Faria, Nuno R.
   Andersen, Kristian G.
   Pybus, Oliver G.
TI Genomic Insights into Zika Virus Emergence and Spread
SO CELL
LA English
DT Editorial Material
ID INFECTIVITY; BRAZIL
AB The emergence and spread of Zika virus in the Americas continues to challenge our disease surveillance systems. Virus genome sequencing during the epidemic uncovered the timescale of Zika virus transmission and spread. Yet, we are only beginning to explore how genomics can enhance our responses to emerging viruses.
C1 [Grubaugh, Nathan D.; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
RP Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
EM andersen@scripps.edu; oliver.pybus@zoo.ox.ac.uk
RI Faria, Nuno/I-2975-2012; Pybus, Oliver g/B-2640-2012
OI Faria, Nuno/0000-0001-8839-2798; Pybus, Oliver g/0000-0002-8797-2667;
   Grubaugh, Nathan/0000-0003-2031-1933
FU NIH training grantUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5T32AI007244-33];
   Wellcome TrustWellcome Trust; Royal Society Sir Henry Dale Fellowship
   [204311/Z/16/Z]; NIH NCATS CTSAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Advancing Translational Sciences (NCATS) [UL1TR001114]; Ray
   Thomas Foundation; European Union's Seventh Framework Programme
   (FP7)/European Research Council [614725-PATHPHYLODYN]; Oxford Martin
   School
FX We thank the clinicians, epidemiologists, and biologists at the front
   lines of the epidemic and the many laboratories worldwide that shared
   protocols and data ahead of print. N.D.G. is supported by NIH training
   grant 5T32AI007244-33. N.R.F. is funded by a Wellcome Trust and Royal
   Society Sir Henry Dale Fellowship (grant 204311/Z/16/Z). K.G.A. is a Pew
   Biomedical Scholar and is supported by NIH NCATS CTSA UL1TR001114 and
   The Ray Thomas Foundation. O.G.P. is supported by the European Union's
   Seventh Framework Programme (FP7/2007-2013)/European Research Council
   (614725-PATHPHYLODYN) and by the Oxford Martin School.
CR de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Souza AD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064615
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 15
TC 18
Z9 19
U1 2
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAR 8
PY 2018
VL 172
IS 6
BP 1160
EP 1162
DI 10.1016/j.cell.2018.02.027
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA FZ3IX
UT WOS:000427482100017
PM 29522736
OA Bronze
DA 2020-07-08
ER

PT J
AU Dolley, S
AF Dolley, Shawn
TI Big Data's Role in Precision Public Health
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Review
DE precision public health; big data; computational epidemiology;
   infectious disease surveillance; precision population health
ID GENOME-WIDE ASSOCIATION; INFECTIOUS-DISEASE SURVEILLANCE; LATENT CLASS
   ANALYSIS; DATA ANALYTICS; ANTIMICROBIAL RESISTANCE; PERSONALIZED
   MEDICINE; DATA RESOURCE; SOCIAL MEDIA; ZIKA VIRUS; REAL-TIME
AB Precision public health is an emerging practice to more granularly predict and understand public health risks and customize treatments for more specific and homogeneous subpopulations, often using new data, technologies, and methods. Big data is one element that has consistently helped to achieve these goals, through its ability to deliver to practitioners a volume and variety of structured or unstructured data not previously possible. Big data has enabled more widespread and specific research and trials of stratifying and segmenting populations at risk for a variety of health problems. Examples of success using big data are surveyed in surveillance and signal detection, predicting future risk, targeted interventions, and understanding disease. Using novel big data or big data approaches has risks that remain to be resolved. The continued growth in volume and variety of available data, decreased costs of data capture, and emerging computational methods mean big data success will likely be a required pillar of precision public health into the future. This review article aims to identify the precision public health use cases where big data has added value, identify classes of value that big data may bring, and outline the risks inherent in using big data in precision public health efforts.
C1 [Dolley, Shawn] Cloudera Inc, Palo Alto, CA 94306 USA.
RP Dolley, S (corresponding author), Cloudera Inc, Palo Alto, CA 94306 USA.
EM shawn.dolley@gmail.com
OI Dolley, Shawn/0000-0003-1266-1722
CR Aarestrupt FM, 2016, TRENDS MICROBIOL, V24, P241, DOI 10.1016/j.tim.2016.01.009
   Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642
   Alajajian SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168893
   Altaf-Ul-Amin M, 2014, BIOMED RES INT, DOI 10.1155/2014/428570
   Althani A., 2015, J TISSUE SCI ENG, V6, P157, DOI DOI 10.4172/2157-7552.1000157
   Alyass A, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0108-y
   Andrejevic M, 2014, INT J COMMUN-US, V8, P1673
   Andreu-Perez J, 2015, IEEE J BIOMED HEALTH, V19, P1193, DOI 10.1109/JBHI.2015.2450362
   Anney RJL, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0137-9
   Arnett DK, 2016, DIABETES CARE, V39, P1870, DOI 10.2337/dc16-1763
   ARZBERGER P, 2004, DATA SCI J, V3, P135, DOI DOI 10.2481/DSJ.3.135
   Bansal S, 2016, J INFECT DIS, V214, pS375, DOI 10.1093/infdis/jiw400
   Bar-Or A., 2004, ENG MED BIOL SOC 200, V2, P3101
   Barber MF, 2014, SCIENCE, V346, P1362, DOI 10.1126/science.1259329
   Barral MFM, 2017, AIDS RES HUM RETROV, V33, P465, DOI [10.1089/aid.2015.0376, 10.1089/AID.2015.0376]
   Barrett MA, 2013, BIG DATA-US, V1, P168, DOI 10.1089/big.2013.0027
   Baynam G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00031
   Belgrave D, 2017, J ALLERGY CLIN IMMUN, V139, P400, DOI 10.1016/j.jaci.2016.11.003
   Belle A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/370194
   Ben-Menachem E, 2016, LANCET NEUROL, V15, P6, DOI 10.1016/S1474-4422(15)00356-7
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bonner S, 2015, PROCEEDINGS 2015 IEEE INTERNATIONAL CONFERENCE ON BIG DATA, P737, DOI 10.1109/BigData.2015.7363818
   Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Braem B., 2016, P IEEE INT SMART CIT, P1
   Bragazzi NL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166051
   Brennan PF, 2015, J NURS SCHOLARSHIP, V47, P477, DOI 10.1111/jnu.12159
   Burke-Garcia A, 2014, J PUBLIC HEALTH-UK, V36, P527, DOI 10.1093/pubmed/fdt125
   Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147
   Bustamante M, 2016, HUM MOL GENET, V25, P4127, DOI 10.1093/hmg/ddw264
   Carreiro S, 2017, J MED TOXICOL, V13, P166, DOI 10.1007/s13181-017-0611-y
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   Celi LA, 2013, AM J RESP CRIT CARE, V187, P1157, DOI 10.1164/rccm.201212-2311ED
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27
   Chen CY, 2017, BIOL PSYCHIAT, V81, pS91, DOI 10.1016/j.biopsych.2017.02.236
   Chen JY, 2017, INFORM SYST, V64, P281, DOI 10.1016/j.is.2016.03.011
   Chen M, 2015, IEEE WIREL COMMUN, V22, P20, DOI 10.1109/MWC.2015.7054715
   Chuang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046882
   Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597
   Claesson A, 2017, RESUSCITATION, V114, P152, DOI 10.1016/j.resuscitation.2017.01.003
   Clark A, 2016, SURV OPHTHALMOL, V61, P443, DOI 10.1016/j.survophthal.2016.01.003
   Cochran G, 2017, RES SOC ADMIN PHARM, V13, P1055, DOI 10.1016/j.sapharm.2016.11.005
   Colijn C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00136
   Collyer ML, 2015, HEREDITY, V115, P357, DOI 10.1038/hdy.2014.75
   Consolvo S, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1797
   Correia RB, 2016, BIOCOMPUT-PAC SYM, P492
   Croes K, 2014, INT J HYG ENVIR HEAL, V217, P239, DOI 10.1016/j.ijheh.2013.06.004
   Cukier K, 2013, FOREIGN AFF, V92, P28
   Daley D, 2016, CHILD ABUSE NEGLECT, V62, P29, DOI 10.1016/j.chiabu.2016.09.014
   Danaei G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002164
   Davis JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27930
   De Mauro A, 2015, AIP CONF PROC, V1644, P97, DOI 10.1063/1.4907823
   Dilsizian SE, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0441-8
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a
   Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667
   Escott-Price V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094661
   Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Findley K, 2016, TRENDS MICROBIOL, V24, P847, DOI 10.1016/j.tim.2016.08.001
   Finger F, 2016, P NATL ACAD SCI USA, V113, P6421, DOI 10.1073/pnas.1522305113
   Finlayson SG, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.32
   Fradkin JE, 2016, DIABETES CARE, V39, P1080, DOI 10.2337/dc16-0541
   Fraenkel L, 2016, PATIENT, V9, P241, DOI 10.1007/s40271-015-0147-7
   Franke J, 2015, GEOSPATIAL HEALTH, V10, P117, DOI 10.4081/gh.2015.335
   Freifeld CC, 2014, DRUG SAFETY, V37, P343, DOI 10.1007/s40264-014-0155-x
   Frisby J, 2017, J BIOMED INFORM, V65, P97, DOI 10.1016/j.jbi.2016.11.008
   Fu Q, 2016, J COMMUN HEALTH, V41, P850, DOI 10.1007/s10900-016-0163-0
   Gandon S, 2016, TRENDS ECOL EVOL, V31, P776, DOI 10.1016/j.tree.2016.07.010
   Geethanjali C, 2016, INDIAN J SCI TECHNOL, V9, P99620, DOI DOI 10.17485/ijst/2016/v9i33/99620
   Ghosh S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40841
   Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116
   Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169
   Gligorijevic V, 2016, PROTEOMICS, V16, P741, DOI 10.1002/pmic.201500396
   Glymour MM, 2013, AM J EPIDEMIOL, V178, P858, DOI 10.1093/aje/kwt145
   Godman B, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-179
   Gomez SL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-201
   Gomide J., 2011, P 3 INT WEB SCI C
   Gorenshteyn D, 2015, IMMUNITY, V43, P605, DOI 10.1016/j.immuni.2015.08.014
   Gu DX, 2017, INT J MED INFORM, V98, P22, DOI 10.1016/j.ijmedinf.2016.11.006
   Gubler D J, 1989, Bull Pan Am Health Organ, V23, P397
   Hall ES, 2014, MATERN CHILD HLTH J, V18, P316, DOI 10.1007/s10995-013-1236-7
   Hamada T, 2017, J GASTROENTEROL, V52, P265, DOI 10.1007/s00535-016-1272-3
   HAMMOND EC, 1967, AM J PUBLIC HEALTH N, V57, P1979, DOI 10.2105/AJPH.57.11.1979
   Hansen M, 2015, HUM REPROD, V30, P2956, DOI 10.1093/humrep/dev247
   Hay SI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001413
   Hemingway H, 2017, PROGRAMME GRANTS APP, V5, DOI [10.3310/pgfar05040, DOI 10.3310/PGFAR05040]
   HETHCOTE HW, 1982, MATH BIOSCI, V58, P93, DOI 10.1016/0025-5564(82)90053-0
   Hood L, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0238-7
   Hose AJ, 2017, J ALLERGY CLIN IMMUN, V139, P1935, DOI 10.1016/j.jaci.2016.08.046
   Hripcsak G, 2016, P NATL ACAD SCI USA, V113, P7329, DOI 10.1073/pnas.1510502113
   Hu H, 2014, IEEE ACCESS, V2, P652, DOI 10.1109/ACCESS.2014.2332453
   Huff A, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.711379ace737b7c04c89765342a9a8c9, DOI 10.1371/CURRENTS.OTBREAKS.711379ACE737B7C04C89765342A9A8C9]
   Ireland ME, 2015, HEALTH PSYCHOL, V34, P1252, DOI 10.1037/hea0000279
   Isdory A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142805
   ISHAM V, 1988, J ROY STAT SOC A STA, V151, P5, DOI 10.2307/2982179
   Ji X, 2017, J INF SCI, V43, P221, DOI 10.1177/0165551515625029
   Jiang P, 2016, IEEE SYST J, V10, P1147, DOI 10.1109/JSYST.2014.2308324
   Johnson SB, 2017, ANN EPIDEMIOL, V27, P361, DOI 10.1016/j.annepidem.2017.05.008
   Johnstone IM, 2009, PHILOS T R SOC A, V367, P4237, DOI 10.1098/rsta.2009.0159
   Joseph W, 2016, BIOELECTROMAGNETICS, V37, P195, DOI 10.1002/bem.21964
   Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x
   Justice AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14977
   Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011
   Kent EE, 2016, J AM GERIATR SOC, V64, P186, DOI 10.1111/jgs.13888
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031
   Koning M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3757-7
   Kostkova P, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00007
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kringel D, 2017, PHARMACOGENOMICS J, V17, P419, DOI 10.1038/tpj.2016.28
   Lal A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020186
   LALONDE M, 1974, NEW PERSPECTIVE HLTH
   LANGMUIR AD, 1976, INT J EPIDEMIOL, V5, P13, DOI 10.1093/ije/5.1.13
   Lardon J, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4304
   Lavalle S, 2011, MIT SLOAN MANAGE REV, V52, P21
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   Li Cai, 2015, DATA SCI J, V14, P2, DOI DOI 10.5334/DSJ-2015-002
   Lin KJ, 2016, CLIN PHARMACOL THER, V100, P147, DOI 10.1002/cpt.359
   Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397
   Liu X, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1137-3
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Lohr S., 2012, NY TIMES
   Lopez AD, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-5
   Lupton D, 2015, HEALTH PROMOT INT, V30, P174, DOI 10.1093/heapro/dau091
   MacFadden DR, 2016, J INFECT DIS, V214, pS393, DOI 10.1093/infdis/jiw343
   Mari L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00493-1
   Martinez P, 2016, COMPUT IND, V78, P43, DOI 10.1016/j.compind.2015.10.006
   Mascalzoni D, 2015, EUR J HUM GENET, V23, P721, DOI 10.1038/ejhg.2014.197
   Maxmen A, 2017, NATURE, V549, P15, DOI 10.1038/nature.2017.22545
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   McIntyre RS, 2014, BIPOLAR DISORD, V16, P531, DOI 10.1111/bdi.12162
   Miani Celine, 2014, Rand Health Q, V4, P15
   Millett ERC, 2016, J CLIN EPIDEMIOL, V75, P66, DOI 10.1016/j.jclinepi.2016.01.005
   Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866
   Mooney SJ, 2015, EPIDEMIOLOGY, V26, P390, DOI 10.1097/EDE.0000000000000274
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Nandy A., 2017, J MOL PATHOL EPIDEMI, V2, pS1
   Narayanan A, 2010, COMMUN ACM, V53, P24, DOI 10.1145/1743546.1743558
   Newnham JP, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00066
   Nguyen KA, 2017, 170400148 ARXIV, DOI [10.1109/IPIN.2017.8115963, DOI 10.1109/IPIN.2017.8115963]
   Nimmesgern E, 2017, CTS-CLIN TRANSL SCI, V10, P61, DOI 10.1111/cts.12446
   Nishi A, 2016, EXPERT REV MOL DIAGN, V16, P11, DOI 10.1586/14737159.2016.1115346
   NIST, 2015, NIST SPEC PUBL, V1
   Nsoesie EO, 2015, CELL HOST MICROBE, V17, P275, DOI 10.1016/j.chom.2015.02.004
   Nsoesie EO, 2014, INFLUENZA OTHER RESP, V8, P309, DOI 10.1111/irv.12226
   O'Shea J, 2017, INT J MED INFORM, V101, P15, DOI 10.1016/j.ijmedinf.2017.01.019
   Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181
   Ohm P, 2010, UCLA LAW REV, V57, P1701
   Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689
   Ozcaglar C, 2012, MATH BIOSCI, V236, P77, DOI 10.1016/j.mbs.2012.02.003
   Passos IC, 2016, LANCET PSYCHIAT, V3, P13, DOI 10.1016/S2215-0366(15)00549-0
   Pellegrino P, 2016, PHARMACOGENOMICS J, V16, P96, DOI 10.1038/tpj.2015.21
   Pesala Samuli, 2017, JMIR Public Health Surveill, V3, pe19, DOI 10.2196/publichealth.6764
   Peterson TA, 2013, J MOL BIOL, V425, P4047, DOI 10.1016/j.jmb.2013.08.008
   Phan TP, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000012
   Phillips RL, 2015, FAM MED, V47, P628
   Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415
   Poland GA, 2017, NAT VACC ADV COMM M
   Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI 10.2217/PGS.09.25
   Predic B, 2013, INT CONF PERVAS COMP, P303
   Pugach O, 2017, NICOTINE TOB RES, V19, P410, DOI 10.1093/ntr/ntw197
   Qi BS, 2015, 2015 INTERNATIONAL CONFERENCE ON ICT CONVERGENCE (ICTC), P1297, DOI 10.1109/ICTC.2015.7354800
   Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815
   RICHERT CA, 1993, AM J PUBLIC HEALTH, V83, P520, DOI 10.2105/AJPH.83.4.520
   Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427
   Ross MC, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0072-y
   Roth AM, 2015, SUBST USE MISUSE, V50, P205, DOI 10.3109/10826084.2014.962661
   Rozek LS, 2014, ANNU REV PUBL HEALTH, V35, P105, DOI 10.1146/annurev-publhealth-032013-182513
   Rujirojindakul Pairaya, 2015, Adv Hematol, V2015, P543027, DOI 10.1155/2015/543027
   Sadler RC, 2017, AM J PUBLIC HEALTH, V107, P763, DOI 10.2105/AJPH.2017.303692
   Salathe M, 2016, J INFECT DIS, V214, pS399, DOI 10.1093/infdis/jiw281
   Saleheen D, 2017, CIRCULATION, V135, P2336, DOI 10.1161/CIRCULATIONAHA.116.022069
   Sanmartin C, 2016, HEALTH REP, V27, P10
   Santillana M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25732
   Schneeweiss S, 2016, CLIN PHARMACOL THER, V99, P262, DOI 10.1002/cpt.316
   Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253
   Setiawan VW, 2015, AM J EPIDEMIOL, V181, P917, DOI 10.1093/aje/kwv055
   Severi G, 2014, BREAST CANCER RES TR, V148, P665, DOI 10.1007/s10549-014-3209-y
   Shaikh AR, 2014, J MED INTERNET RES, V16, P143, DOI 10.2196/jmir.2496
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Simonsen L, 2016, J INFECT DIS, V214, pS380, DOI 10.1093/infdis/jiw376
   Slobogean Gerard P, 2015, J Orthop Trauma, V29 Suppl 12, pS43, DOI 10.1097/BOT.0000000000000463
   Smith AH, 2017, MOL PSYCHIATR, V22, P346, DOI 10.1038/mp.2016.257
   Speybroeck N, 2013, INT J ENV RES PUB HE, V10, P5750, DOI 10.3390/ijerph10115750
   Stein P, 2016, FERTIL STERIL, V106, pE113, DOI 10.1016/j.fertnstert.2016.07.339
   Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Strohbach M., 2016, NEW HORIZONS DATA DR, P119, DOI [10.1007/978-3-319-21569-3_7, DOI 10.1007/978-3-319-21569-3_7]
   Sweeney L, 1997, J LAW MED ETHICS, V25, P98, DOI 10.1111/j.1748-720X.1997.tb01885.x
   Tatem AJ, 2014, INT HEALTH, V6, P5, DOI 10.1093/inthealth/ihu006
   Triantafyllidis AK, 2017, IEEE J BIOMED HEALTH, V21, P218, DOI 10.1109/JBHI.2015.2483902
   US Department of Health and Human Services, 2010, MULT CHRON COND STRA
   Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56
   Vayena E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003904
   Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802
   Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029
   Wesolowski A, 2016, J INFECT DIS, V214, pS414, DOI 10.1093/infdis/jiw273
   Wesolowski Amy, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Westra Bonnie L, 2015, Nurs Adm Q, V39, P304, DOI 10.1097/NAQ.0000000000000130
   White SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167846
   Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319
   WILSON ME, 1995, EMERG INFECT DIS, V1, P39, DOI 10.3201/eid0102.950201
   Wooden B, 2017, GASTROENTEROLOGY, V152, P53, DOI 10.1053/j.gastro.2016.09.065
   Xiao JG, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00064
   Xie L, 2017, ANNU REV PHARMACOL, V57, P245, DOI 10.1146/annurev-pharmtox-010716-104659
   Yang SH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2424-7
   Zawati MH, 2015, J MED GENET, V52, P566, DOI 10.1136/jmedgenet-2014-102640
   Zhang XZ, 2017, ETHNIC DIS, V27, P95, DOI 10.18865/ed.27.2.95
   Zheng Y, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P1436, DOI 10.1145/2487575.2488188
   Zinszer K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001992
NR 212
TC 22
Z9 22
U1 6
U2 22
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD MAR 7
PY 2018
VL 6
AR 68
DI 10.3389/fpubh.2018.00068
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FY8BQ
UT WOS:000427088300001
PM 29594091
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zapletal, J
   Erraguntla, M
   Adelman, ZN
   Myles, KM
   Lawley, MA
AF Zapletal, Josef
   Erraguntla, Madhav
   Adelman, Zach N.
   Myles, Kevin M.
   Lawley, Mark A.
TI Impacts of diurnal temperature and larval density on aquatic development
   of Aedes aegypti
SO PLOS ONE
LA English
DT Article
ID ANOPHELES-GAMBIAE; POPULATION-MODEL; CULICIDAE; DIPTERA; ALBOPICTUS;
   MOSQUITO; VECTOR; DENGUE; VIRUS; FLUCTUATIONS
AB The increasing range of Aedes aegypti, vector for Zika, dengue, chikungunya, and other viruses, has brought attention to the need to understand the population and transmission dynamics of this mosquito. It is well understood that environmental factors and breeding site characteristics play a role in organismal development and the potential to transmit pathogens. In this study, we observe the impact of larval density in combination with diurnal temperature on the time to pupation, emergence, and mortality of Aedes aegypti. Experiments were conducted at two diurnal temperature ranges based on 10 years of historical temperatures of Houston, Texas (21-32 degrees C and 26.5-37.5 degrees C). Experiments at constant temperatures (26.5 degrees C, 32 degrees C) were also conducted for comparison. At each temperature setting, five larval densities were observed (0.2, 1, 2, 4, 5 larvae per mL of water). Data collected shows significant differences in time to first pupation, time of first emergence, maximum rate of pupation, time of maximum rate of pupation, maximum rate of emergence, time of maximum rate of emergence, final average proportion of adult emergence, and average proportion of larval mortality. Further, data indicates a significant interactive effect between temperature fluctuation and larval density on these measures. Thus, wild population estimates should account for temperature fluctuations, larval density, and their interaction in low-volume containers.
C1 [Zapletal, Josef; Erraguntla, Madhav; Lawley, Mark A.] Texas A&M Univ, Dept Ind & Syst Engn, College Stn, TX 77843 USA.
   [Adelman, Zach N.; Myles, Kevin M.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
RP Zapletal, J (corresponding author), Texas A&M Univ, Dept Ind & Syst Engn, College Stn, TX 77843 USA.
EM jozinzapletal@tamu.edu
OI Adelman, Zach/0000-0001-5901-7171
FU Scowcroft Institute of International Affairs in the Bush School of
   Government and Public Service at Texas AM University
FX Josef Zapletal was supported by the Scowcroft Institute of International
   Affairs in the Bush School of Government and Public Service at Texas A&M
   University.
CR BAKER F. C., 1935, CANADIAN ENL, V67, P149
   Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x
   Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x
   Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468
   de Almeida SJ, 2010, ENVIRON MODELL SOFTW, V25, P1490, DOI 10.1016/j.envsoft.2010.04.021
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018
   Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   HAWLEY WA, 1985, J ANIM ECOL, V54, P955, DOI 10.2307/4389
   Hemme RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000634
   HOLZAPFEL CM, 1981, CAN J ZOOL, V59, P1014, DOI 10.1139/z81-141
   Jia PF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1448-y
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009
   LOVE GJ, 1955, ECOLOGY, V36, P340, DOI 10.2307/1933243
   LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775
   MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   MORI A, 1979, Tropical Medicine, V21, P85
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   PETERS TM, 1977, ANNU REV ENTOMOL, V22, P431, DOI 10.1146/annurev.en.22.010177.002243
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Scott TW, 1997, AM J TROP MED HYG, V57, P235, DOI 10.4269/ajtmh.1997.57.235
   The Weather Company LLC, 2016, HOUST TX 77001 FOR
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Wada Y., 1965, QUAEST ENTOMOL, V1
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yang HM, 2011, BIOSYSTEMS, V103, P360, DOI 10.1016/j.biosystems.2010.11.002
NR 43
TC 3
Z9 3
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 7
PY 2018
VL 13
IS 3
AR e0194025
DI 10.1371/journal.pone.0194025
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FY5TA
UT WOS:000426896800098
PM 29513751
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Huang, MG
   Luo, JW
   Hu, LC
   Zheng, B
   Yu, JS
AF Huang, Mugen
   Luo, Jiaowan
   Hu, Linchao
   Zheng, Bo
   Yu, Jianshe
TI Assessing the efficiency of Wolbachia driven Aedes mosquito suppression
   by delay differential equations
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE Dengue fever; Wolbachia; Cytoplasmic incompatibility; Population
   suppression; Delay differential equation
ID POPULATION-DYNAMICS; ABUNDANCE MODEL; SPREAD; INCOMPATIBILITY; INVASION
AB To suppress wild population of Aedes mosquitoes, the primary transmission vector of life-threatening diseases such as dengue, malaria, and Zika, an innovative strategy is to release male mosquitoes carrying the bacterium Wolbachia into natural areas to drive female sterility by cytoplasmic incompatibility. We develop a model of delay differential equations, incorporating the strong density restriction in the larval stage, to assess the delicate impact of life table parameters on suppression efficiency. Through mathematical analysis, we find the sufficient and necessary condition for global stability of the complete suppression state. This condition, combined with the experimental data for Aedes albopictus population in Guangzhou, helps us predict a large range of releasing intensities for suppression success. In particular, we find that if the number of released infected males is no less than four times the number of mosquitoes in wild areas, then the mosquito density in the peak season can be reduced by 95%. We introduce an index to quantify the dependence of suppression efficiency on parameters. The invariance of some quantitative properties of the index values under various perturbations of the same parameter justifies the applicability of this index, and the robustness of our modeling approach. The index yields a ranking of the sensitivity of all parameters, among which the adult mortality has the highest sensitivity and is considerably more sensitive than the natural larvae mortality. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Huang, Mugen] Guangdong Univ Finance & Econ, Sch Stat & Math, Guangzhou 510320, Guangdong, Peoples R China.
   [Luo, Jiaowan; Zheng, Bo; Yu, Jianshe] Guangzhou Univ, Sch Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China.
   [Huang, Mugen; Zheng, Bo; Yu, Jianshe] Guangzhou Univ, Ctr Appl Math, Guangzhou 510006, Guangdong, Peoples R China.
   [Hu, Linchao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510080, Guangdong, Peoples R China.
RP Luo, JW; Yu, JS (corresponding author), Guangzhou Univ, Sch Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China.
EM jluo@gzhu.edu.cn; jsyu@gzhu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11301103, 11631005, 11626246]; Program for
   Changjiang Scholars and Innovative Research Team in UniversityProgram
   for Changjiang Scholars & Innovative Research Team in University
   (PCSIRT) [IRT_16R16]; Natural Science Foundation of Guangdong
   ProvinceNational Natural Science Foundation of Guangdong Province
   [2017A030310597]
FX We thank Prof. Moxun Tang for his careful reading and important
   contribution on the improvement of this manuscript. We are also grateful
   to the reviewer's valuable and precious suggestions. This work was
   supported by National Natural Science Foundation of China (11301103,
   11631005, 11626246), Program for Changjiang Scholars and Innovative
   Research Team in University (IRT_16R16), and Natural Science Foundation
   of Guangdong Province (2017A030310597).
CR Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x
   Beretta E, 2002, SIAM J MATH ANAL, V33, P1144, DOI 10.1137/S0036141000376086
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cailly P, 2012, ECOL MODEL, V227, P7, DOI 10.1016/j.ecolmodel.2011.10.027
   CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138
   Hancock PA, 2016, J APPL ECOL, V53, P785, DOI 10.1111/1365-2664.12620
   Hirsch M. W., 2003, DIFFERENTIAL EQUATIO
   Hu LC, 2015, THEOR POPUL BIOL, V106, P32, DOI 10.1016/j.tpb.2015.09.003
   Huang MG, 2016, SCI CHINA MATH, V59, P1249, DOI 10.1007/s11425-016-5149-y
   Huang MG, 2015, SCI CHINA MATH, V58, P77, DOI 10.1007/s11425-014-4934-8
   Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Liu Fusheng, 1992, Acta Scientiarum Naturalium Universitatis Sunyatseni, V31, P84
   Liu Fusheng, 1990, Acta Scientiarum Naturalium Universitatis Sunyatseni, V29, P118
   LIU ZW, 1985, ACTA ENTOMOL SINICA, V28, P274
   Ross PA, 2014, AM J TROP MED HYG, V91, P198, DOI 10.4269/ajtmh.13-0576
   Smith H, 2011, INTRO DELAY DIFFEREN
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   TSUDA Y, 1991, Tropical Medicine, V33, P41
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walsh RK, 2011, J VECTOR ECOL, V36, P300, DOI 10.1111/j.1948-7134.2011.00170.x
   Walsh RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035959
   Waltz E, 2016, NATURE, V533, P450, DOI 10.1038/533450a
   Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
   Zhong Z, 1988, ZHONGSHAN YI KE DA X, V9, P35
   ZHONG Z-L, 1990, Acta Entomologica Sinica, V33, P64
   Zhu GH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004633
NR 33
TC 16
Z9 16
U1 2
U2 43
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD MAR 7
PY 2018
VL 440
BP 1
EP 11
DI 10.1016/j.jtbi.2017.12.012
PG 11
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA FV7AH
UT WOS:000424733100001
PM 29248525
DA 2020-07-08
ER

PT J
AU Judice, CC
   Tan, JJL
   Parise, PL
   Kam, YW
   Milanez, GP
   Leite, JA
   Caserta, LC
   Arns, CW
   Resende, MR
   Angerami, R
   Amaral, E
   Passini, R
   Freitas, ARR
   Costa, FTM
   Proenca-Modena, JL
   Ng, LFP
AF Judice, Carla Cristina
   Tan, Jeslin J. L.
   Parise, Pierina Lorencini
   Kam, Yiu-Wing
   Milanez, Guilherme Paier
   Leite, Juliana Almeida
   Caserta, Leonardo Cardia
   Arns, Clarice Weis
   Resende, Mariangela Ribeiro
   Angerami, Rodrigo
   Amaral, Eliana
   Passini Junior, Renato
   Ribas Freitas, Andre Ricardo
   Maranhao Costa, Fabio Trindade
   Proenca-Modena, Jose Luiz
   Ng, Lisa F. P.
CA Zika-Unicamp Network
TI Efficient detection of Zika virus RNA in patients' blood from the 2016
   outbreak in Campinas, Brazil
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EPIDEMIC; DISEASE
AB Infection with Zika virus (ZIKV), a mosquito-borne flavivirus has been casually linked with increased congenital microcephaly in Brazil from 2015 through 2016. Sensitive and specific diagnosis of patients with Zika fever (ZIKF) remains critical for patient management. We developed a ZIKV NS5 qRT-PCR assay by combining primers described by Balm et al. and a new Taqman probe. The assay was evaluated and compared with another assay described by Lanciotti et al. (ZIKV 1107) using 51 blood and 42 urine samples from 54 suspected ZIKV patients. ZIKV NS5 performed better in terms of sensitivity with more samples detected as ZIKV-positive (n = 37) than ZIKV 1107 (n = 34) for urine, and ZIKV-positive (n = 29) than ZIKV 1107 (n = 26) for blood. Both assays displayed good overall agreement for urine (kappa appa = 0.770) and blood (kappa appa = 0.825) samples. Improved availability of validated diagnostic tests, such ZIKV NS5 qRT-PCR, will be critical to ensure adequate and accurate ZIKV diagnosis.
C1 [Judice, Carla Cristina; Leite, Juliana Almeida; Maranhao Costa, Fabio Trindade; Proenca-Modena, Jose Luiz] Univ Estadual Campinas, UNICAMP, Dept Genet Evolut & Bioagents, Inst Biol,Lab Trop Dis, Campinas, SP, Brazil.
   [Tan, Jeslin J. L.; Kam, Yiu-Wing; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Parise, Pierina Lorencini; Milanez, Guilherme Paier; Proenca-Modena, Jose Luiz] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Lab Emerging Viruses, Campinas, SP, Brazil.
   [Caserta, Leonardo Cardia; Arns, Clarice Weis] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Lab Anim Viruses, Campinas, SP, Brazil.
   [Resende, Mariangela Ribeiro; Angerami, Rodrigo] Univ Estadual Campinas, Sch Med Sci, Clin Pathol Dept, Campinas, SP, Brazil.
   [Amaral, Eliana; Passini Junior, Renato] Univ Estadual Campinas, Sch Med Sci, Obstet & Gynecol Dept, Campinas, SP, Brazil.
   [Ribas Freitas, Andre Ricardo] Campinas Dept Publ Hlth Surveillance, Campinas, SP, Brazil.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Proenca-Modena, JL (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Genet Evolut & Bioagents, Inst Biol,Lab Trop Dis, Campinas, SP, Brazil.; Ng, LFP (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.; Proenca-Modena, JL (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Lab Emerging Viruses, Campinas, SP, Brazil.; Ng, LFP (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
EM jlmodena@unicamp.br; lisa_ng@immunol.a-star.edu.sg
RI Freitas, Andre Ricardo Ribas/L-1969-2016; Fertrin, Kleber/M-4175-2013;
   Angerami, Rodrigo Nogueira/A-8926-2013; Milanez, Guilherme/G-6457-2016;
   Modena, Jose Luiz Proenca/C-8231-2014; Costa, Fabio/E-1181-2012;
   Colella-Santos, Maria Francisca/A-6008-2013; de Toledo Teixeira, Daniel
   Augusto/C-6940-2017; Resende, Mariangela/U-9938-2019; Judice,
   Carla/P-4738-2014; Arns, Clarice/F-2762-2015
OI Freitas, Andre Ricardo Ribas/0000-0003-0291-7771; Fertrin,
   Kleber/0000-0003-2637-3297; Angerami, Rodrigo
   Nogueira/0000-0002-4976-9238; Milanez, Guilherme/0000-0002-8599-1098;
   Modena, Jose Luiz Proenca/0000-0002-4996-3153; Costa,
   Fabio/0000-0001-9969-7300; Colella-Santos, Maria
   Francisca/0000-0002-7456-9502; Vinolo, Marco
   Aurelio/0000-0003-1335-760X; Ribeiro-do-Valle,
   Carolina/0000-0002-2630-9909; Calil, Roseli/0000-0001-5120-6955; Judice,
   Carla/0000-0003-1839-053X; Ng, Lisa/0000-0003-4071-5222; Arns,
   Clarice/0000-0002-7308-460X; de Toledo Teixeira, Daniel
   Augusto/0000-0002-4055-058X
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR); BMRC A*STAR-led Zika Virus Consortium Fund
   [15/1/82/27/001]; Agency for Science, Technology and Research (A* STAR),
   SingaporeAgency for Science Technology & Research (ASTAR); Sao Paulo
   Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2016/00194-8]
FX We thank the study subjects for their participation and clinical teams
   within the network in patient recruitment, sample collection and data
   entry. This work is supported by core research grants provided to the
   Singapore Immunology Network by the Biomedical Research Council (BMRC),
   and also partially supported by the BMRC A*STAR-led Zika Virus
   Consortium Fund (project number: 15/1/82/27/001), Agency for Science,
   Technology and Research (A* STAR), Singapore. In addition, this work is
   supported by Sao Paulo Research Foundation (FAPESP - 2016/00194-8). FTMC
   is a research fellow from CNPq (Brazilian National Council for
   Scientific and Technological Development).
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   DYER O, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J707
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gibson G, 2013, CAD SAUDE PUBLICA, V29, P82, DOI 10.1590/S0102-311X2013000100010
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Maurer-Stroh S., 2016, EURO SURVEILL, V21
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oehler E, 2014, EURO SURVEILL, V19
   Ong SP, 2006, ANTIVIR RES, V72, P216, DOI 10.1016/j.antiviral.2006.06.005
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Verma R, 2013, HUM VACC IMMUNOTHER, V9, P1268, DOI 10.4161/hv.23950
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 39
TC 7
Z9 9
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 5
PY 2018
VL 8
AR 4012
DI 10.1038/s41598-018-22159-2
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FY0ZI
UT WOS:000426540800045
PM 29507368
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tchesnokov, EP
   Raeisimakiani, P
   Ngure, M
   Marchant, D
   Gotte, M
AF Tchesnokov, Egor P.
   Raeisimakiani, Parisa
   Ngure, Marianne
   Marchant, David
   Gotte, Matthias
TI Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VESICULAR STOMATITIS-VIRUS; DE-NOVO; INITIATION; REPLICATION;
   INHIBITION; IDENTIFICATION; FAVIPIRAVIR; PROTEIN; MOTIFS; GTP
AB Here we report on the expression, purification and characterization of recombinant ebola virus RNA-dependent RNA polymerase (EBOV RdRp). Active protein complexes composed of the large L protein and viral protein VP35 were isolated from insect cells and analyzed using a short primer/template substrate that allowed benchmarking against related enzymes. RNA synthesis by multiprotein complexes of EBOV, influenza B, respiratory syncytial virus (RSV) and monomeric enzymes of hepatitis C and Zika (ZIKV) viruses required a 5'-phosporylated primer. The minimum length of the primer varied between two and three nucleotides in this system. The EBOV enzyme utilizes Mg2+ as a co-factor and the D742A substitution provides an active site mutant that likely affects binding of the catalytic metal ions. Selectivity measurements with nucleotide analogues translate our assay into quantitative terms and facilitate drug discovery efforts. The related EBOV and RSV enzymes are not able to efficiently discriminate against ara-cytidine-5'-triphosphate. We demonstrate that this compound acts like a non-obligate chain-terminator.
C1 [Tchesnokov, Egor P.; Raeisimakiani, Parisa; Ngure, Marianne; Marchant, David; Gotte, Matthias] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.
   [Marchant, David; Gotte, Matthias] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.
RP Gotte, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Gotte, M (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.
EM gotte@ualberta.ca
FU Canadian Institutes of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR)
FX This study was supported by the Canadian Institutes of Health Research
   (CIHR) with grants to MG and DM. We thank Dr. Jack Moore at the Alberta
   Proteomics and Mass Spectrometry facility for prompt mass spectrometry
   analysis.
CR Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036
   Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51
   Connor JH, 2007, VIROLOGY, V362, P109, DOI 10.1016/j.virol.2006.12.026
   D'Abramo CM, 2006, J BIOL CHEM, V281, P24991, DOI 10.1074/jbc.M600474200
   Deval J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154097
   Deval J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004995
   Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200
   Fearns R, 2017, VIRUS RES, V234, P87, DOI 10.1016/j.virusres.2017.01.008
   Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999
   Fix Jenna, 2011, Open Virol J, V5, P103, DOI 10.2174/1874357901105010103
   Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16
   Harrus D, 2010, J BIOL CHEM, V285, P32906, DOI 10.1074/jbc.M110.151316
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Jacome R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139001
   Jin ZN, 2017, ANTIVIR RES, V143, P151, DOI 10.1016/j.antiviral.2017.04.005
   Jin ZN, 2015, ANTIMICROB AGENTS CH, V59, P7504, DOI 10.1128/AAC.01391-15
   Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347
   Katoh H., 2017, J VIROLOGY, V91
   Klumpp K, 2008, J BIOL CHEM, V283, P2167, DOI 10.1074/jbc.M708929200
   Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018
   Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Martin B., 2017, ANTIVIRAL RES
   Morin B, 2012, EMBO J, V31, P1320, DOI 10.1038/emboj.2011.483
   Muhlberger E, 1999, J VIROL, V73, P2333
   Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137
   Noton SL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002980
   Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008
   POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x
   Reich S, 2017, NUCLEIC ACIDS RES, V45, P3353, DOI 10.1093/nar/gkx043
   Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009
   Schmidt ML, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005996
   Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468
   Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015
   TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361
   Vazquez AL, 2000, J VIROL, V74, P3888, DOI 10.1128/JVI.74.8.3888-3891.2000
   Wang J, 2016, NUCLEIC ACIDS RES, V44, P8962, DOI 10.1093/nar/gkw572
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
NR 39
TC 12
Z9 14
U1 2
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 5
PY 2018
VL 8
AR 3970
DI 10.1038/s41598-018-22328-3
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FY0ZI
UT WOS:000426540800003
PM 29507309
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, J
   Liu, J
   Zhou, R
   Ding, X
   Zhang, QP
   Zhang, CY
   Li, L
AF Wang, Jin
   Liu, Jing
   Zhou, Rui
   Ding, Xin
   Zhang, Qipeng
   Zhang, Chenyu
   Li, Liang
TI Zika virus infected primary microglia impairs NPCs proliferation and
   differentiation
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika virus; Microglia; Neuroinflammation; Neural precursor cells;
   Proliferation; Differentiation
ID NEURAL PROGENITORS; BRAIN ORGANOIDS; GLIAL-CELLS; ACTIVATION;
   MICRONESIA; RESPONSES; MODELS; MICE
AB Zika virus (ZIKV) can lead to severe birth defects especially microcephaly in newborns by infecting human neural progenitors and impairing brain development. However, as the resident immune cells in the brain, the role of microglia in the ZIKV pathology is not clearly defined. To understand the interplay between immune response and neural cells, we investigate the interaction between microglia and NPCs during ZIKV infection. Our results demonstrate that primary microglia infected with ZIKV induces an inflammatory response similar to that in human, producing high level of tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), interleukin 10 (IL-10) and inducible nitric oxide synthase (iNOS). Furthermore, conditional medium (CM) of ZIKV infected microglia showed inhibitory effects on cell proliferation and neuronal differentiation of neural precursor cells (NPCs) derived from E14 mice brain. Blocking cytokines in the CM remarkably improved neurogenesis and decreased astrocytic differentiation of NPCs. Together, our results suggest that microglia mediated neuroinflammation plays an important role in neuropathogenesis during ZIKV infection. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Wang, Jin; Liu, Jing; Zhou, Rui; Ding, Xin; Zhang, Qipeng; Zhang, Chenyu; Li, Liang] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, NAILS,State Key Lab Pharmaceut Biotechnol, Nanjing 210046, Jiangsu, Peoples R China.
   [Li, Liang] Xianlin Rd 163, Nanjing 210046, Jiangsu, Peoples R China.
RP Li, L (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, NAILS,State Key Lab Pharmaceut Biotechnol, Nanjing 210046, Jiangsu, Peoples R China.; Li, L (corresponding author), Xianlin Rd 163, Nanjing 210046, Jiangsu, Peoples R China.
EM liangli@nju.edu.cn
FU National Science Foundation of ChinaNational Natural Science Foundation
   of China [31471019, 31741053]
FX This work was supported by grants from the National Science Foundation
   of China (31471019) and (31741053).
CR Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Costa F., 2017, LANCET INFECT DIS
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Fan XL, 2009, NEUROIMMUNOMODULAT, V16, P162, DOI 10.1159/000204229
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Kwak YD, 2010, NEUROTOX RES, V18, P328, DOI 10.1007/s12640-010-9170-6
   Lan XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050783
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mao SS, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0685-5
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 34
TC 12
Z9 12
U1 2
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 4
PY 2018
VL 497
IS 2
BP 619
EP 625
DI 10.1016/j.bbrc.2018.02.118
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA GA3LE
UT WOS:000428229400023
PM 29453985
DA 2020-07-08
ER

PT J
AU Lin, DC
   Li, LQ
   Xie, T
   Yin, QQ
   Saksena, N
   Wu, RK
   Li, WY
   Dai, GY
   Ma, JM
   Zhou, XH
   Chen, XG
AF Lin, Dechun
   Li, Liqiang
   Xie, Tian
   Yin, Qingqing
   Saksena, Nitin
   Wu, Rangke
   Li, Wanyu
   Dai, Geyang
   Ma, Jinmin
   Zhou, Xiaohong
   Chen, Xiaoguang
TI Codon usage variation of Zika virus: The potential roles of NS2B and
   NS4A in its global pandemic
SO VIRUS RESEARCH
LA English
DT Article
DE Zika virus; Codon usage bias; NS2B; NS4A; The African and Asian lineages
ID GENE-EXPRESSION LEVEL; PHYLOGENETIC ANALYSIS; TRANSFER-RNAS; GC CONTENT;
   BIAS; SELECTION; CPG; DINUCLEOTIDES; CORONAVIRUS; FREQUENCIES
AB A comprehensive demonstration of Zika virus (ZIKV) molecular evolution is essential for understanding its adaptation and expansion in its recent pandemics. Despite several studies on mutations and codon usage in ZIKVs, the variations in codon usage patterns across individual genes and their biological implication remains unclear. Here, we performed a gene-by-gene comparison of the codon usage variation in ZIKVs of the African and Asian lineages. We found that besides the evidence of positive selection (Ka/Ks > 1) in the Asian lineage of the ZIKV genome, codon usage patterns were gene-specific and codon usage variation of ZIKV genes, was possibly constrained by their individual functional features, such as transmembrane domains, or antigenicity. In particular, the NS2B and NS4A genes showed distinct codon usage patterns, clearly separating them from the clusters of other genes in the correspondence analysis (CA). In the Asian lineage, the NS2B and NS4A genes showed the highest codon usage bias (ENC values: 51.01 +/- 0.72 and 48.89 +/- 0.99 respectively), and were subjected to the highest translation selection (ENCobs/ENCexp ratio: 0.847 +/- 0.0297 and 0.828 +/- 0.0233 respectively) in comparison to the African lineages of ZIKV. The CpG frequency of the NS2B showed a gradual ascending trend in the Asian ZIKV lineages, while in NS4A it was constrained along with the expansion of the Asian lineage. Furthermore, between the African and Asian lineages, differentiated and specific over-represented codons were more prominent in the NS2B and NS4A. Together, our study implies that ZIKVs are in the process of evolutionary fine tuning their codon as seen in the recent pandemics, and NS2B and NS4A could have played a potential role in the molecular evolution of the Asian lineage and their establishment.
C1 [Lin, Dechun] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Guangdong, Peoples R China.
   [Lin, Dechun; Li, Liqiang; Saksena, Nitin; Ma, Jinmin] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China.
   [Lin, Dechun; Li, Liqiang; Saksena, Nitin; Ma, Jinmin] BGI Shenzhen, China Natl Genebank, Shenzhen 518083, Guangdong, Peoples R China.
   [Xie, Tian; Yin, Qingqing; Li, Wanyu; Dai, Geyang; Zhou, Xiaohong; Chen, Xiaoguang] Southern Med Univ, Sch Publ Hlth, Emerging Infect Dis Guangdong Higher Inst,Key Lab, Dept Pathogen Biol,Guangdong Prov Key Lab Trop Di, Guangzhou 510515, Guangdong, Peoples R China.
   [Wu, Rangke] Southern Med Univ, Sch Foreign Studies, Guangzhou 510515, Guangdong, Peoples R China.
   Univ Copenhagen, Dept Biol, Copenhagen, Denmark.
RP Li, LQ; Ma, JM (corresponding author), BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China.; Zhou, XH; Chen, XG (corresponding author), Southern Med Univ, Sch Publ Hlth, Emerging Infect Dis Guangdong Higher Inst,Key Lab, Dept Pathogen Biol,Guangdong Prov Key Lab Trop Di, Guangzhou 510515, Guangdong, Peoples R China.
EM lindechun@genomics.cn; liliqiang@genomics.cn; jimmy198360@163.com;
   2150071@i.smu.edu.cn; saksenanitinkumar@genomics.cn; fanglan@fimmu.com;
   wal034@ucsd.edu; daigeyang@fimmu.com; majinmin@genomics.cn;
   zhouxh@fimmu.com; xgchen2001@hotmail.com
RI Ma, Jinmin/L-8470-2019
OI Ma, Jinmin/0000-0002-7993-7001; Li, Liqiang/0000-0003-0180-7052
FU National Key Research and Development Program of China [2016YFC1200500];
   Science and Technology Planning Project of Guangdong Province of China
   [2016A020251001]; Research Team Program of the Natural Science
   Foundation of Guangdong Province Grant [2014A030312016]; Guangzhou
   Synergy Innovation Key Program for Health [201508020263]; Guangzhou
   International Science and Technology Cooperation Program [2012J5100026];
   Shenzhen Science and Technology Research and Development projects
   [JCYJ20150402111430617, JCYJ20160427151920801]
FX This study was supported by the National Key Research and Development
   Program of China (2016YFC1200500), the Science and Technology Planning
   Project of Guangdong Province of China (2016A020251001 to Xiao-Guang
   Chen), the Research Team Program of the Natural Science Foundation of
   Guangdong Province Grant (2014A030312016 to Xiao-Guang Chen), the
   Guangzhou Synergy Innovation Key Program for Health (201508020263 to
   Xiao-Guang Chen), the Guangzhou International Science and Technology
   Cooperation Program (2012J5100026 to Xiaohong Zhou), and the Shenzhen
   Science and Technology Research and Development projects
   (JCYJ20150402111430617 to Liqiang Li, JCYJ20160427151920801 to Jinmin
   Ma).
CR Martinez MA, 2016, TRENDS MICROBIOL, V24, P134, DOI 10.1016/j.tim.2015.11.002
   [Anonymous], 2017, ZIK SIT REP 20 JAN 2
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075
   Baker SF, 2015, FUTURE VIROL, V10, P715, DOI 10.2217/fvl.15.31
   Barahimipour R, 2015, PLANT J, V84, P704, DOI 10.1111/tpj.13033
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Biro JC, 2013, GENE, V515, P249, DOI 10.1016/j.gene.2012.12.048
   Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09
   Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ghosh TC, 2000, INT J PARASITOL, V30, P715, DOI 10.1016/S0020-7519(00)00042-4
   Goertz GP, 2017, VIRUS RES, V254, P41
   Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006
   Gu WY, 2004, NUCLEIC ACIDS RES, V32, P4448, DOI 10.1093/nar/gkh748
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Gupta SK, 2001, GENE, V273, P63, DOI 10.1016/S0378-1119(01)00576-5
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5
   Karniychuk UU, 2016, VIRUS RES, V223, P73, DOI 10.1016/j.virusres.2016.06.015
   Klitting R, 2016, INFECT GENET EVOL, V45, P332, DOI 10.1016/j.meegid.2016.09.017
   Knight R.D., 2001, GENOME BIOL, V2, P2001
   Krieg AM, 1998, TRENDS MICROBIOL, V6, P23, DOI 10.1016/S0966-842X(97)01145-1
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031
   Lau SKP, 2011, J VIROL, V85, P11325, DOI 10.1128/JVI.05512-11
   Lauring AS, 2012, CELL HOST MICROBE, V12, P623, DOI 10.1016/j.chom.2012.10.008
   Li JM, 2015, 2015 EIGHTH INTERNATIONAL CONFERENCE ON INTERNET COMPUTING FOR SCIENCE AND ENGINEERING (ICICSE), P5, DOI 10.1109/ICICSE.2015.10
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu JB, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081304
   Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Miranda I, 2013, MBIO, V4, DOI 10.1128/mBio.00285-13
   Mondal SK, 2016, J BIOMOL STRUCT DYN, V34, P1649, DOI 10.1080/07391102.2015.1087334
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Naya H, 2001, FEBS LETT, V501, P127, DOI 10.1016/S0014-5793(01)02644-8
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466
   Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100
   Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899
   Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035
   Ren LC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r35
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495
   SHARP PM, 1989, NUCLEIC ACIDS RES, V17, P5029, DOI 10.1093/nar/17.13.5029
   SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125
   SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Singh NK, 2017, ARCH VIROL, V162, P1963, DOI 10.1007/s00705-017-3324-2
   Singh NK, 2016, VIRUS RES, V221, P58, DOI 10.1016/j.virusres.2016.05.008
   Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166
   Supek F, 2016, J MOL EVOL, V82, P65, DOI 10.1007/s00239-015-9714-8
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031
   Ur Rahman S., 2017, GENES GENOM
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   van Hemert F, 2016, J GEN VIROL, V97, P2608, DOI 10.1099/jgv.0.000579
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Wang B., 2017, J INFECT
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang SF, 2016, J MICROBIOL IMMUNOL, V49, P477, DOI 10.1016/j.jmii.2014.08.011
   Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Zeidler JD, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030042
   Zhang J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-146
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 78
TC 0
Z9 0
U1 2
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD MAR 2
PY 2018
VL 247
BP 71
EP 83
DI 10.1016/j.virusres.2018.01.014
PG 13
WC Virology
SC Virology
GA FZ5VY
UT WOS:000427665600011
PM 29428601
DA 2020-07-08
ER

PT J
AU Camacho, SA
   Sobral, RG
   Aoki, PHB
   Constantino, CJL
   Brolo, AG
AF Camacho, Sabrina A.
   Sobral-Filho, Regivaldo Gomes
   Aoki, Pedro Henrique B.
   Constantino, Carlos Jose L.
   Brolo, Alexandre G.
TI Zika Immunoassay Based on Surface-Enhanced Raman Scattering Nanoprobes
SO ACS SENSORS
LA English
DT Article
DE gold shell-isolated nanoparticles; Raman reporter; SERS nanoprobes; Zika
   detection; cross-reactivity
ID LINKED-IMMUNOSORBENT-ASSAY; SILVER NANOPARTICLES; SINGLE MOLECULES;
   YELLOW-FEVER; VIRUS; SPECTROSCOPY; FLUORESCENCE; TAGS; DENGUE;
   QUANTIFICATION
AB Zika virus (ZIKV) was considered a public health emergency of international concern after the 2015 outbreak. Serological tests based on immunoassay platforms is one of the methods applied on the diagnosis of ZIKV and Dengue virus (DENV). However, the high limits of detection (LOD) and the cross-reactivity between ZIKV and DENV are still limitations in immunological tests. In order to tackle these issues, we have designed an immune-specific assay based on surface-enhanced Raman scattering (SERS) nanoprobes. Gold shell-isolated nanoparticles (Au-SHINs) were synthesized with 100 nm Au nanoparticles and 4 nm silica shell thickness coated with Nile Blue (Raman reporter). Then, the SERS nanoprobes were wrapped in a final silica shell and functionalized with monoclonal anti-ZIKV NS1 antibodies. Concentrations of ZIKV NS1 down to 10 ng/mL were probed free of cross-reactivity with DENV NS1 antigens.
C1 [Camacho, Sabrina A.; Constantino, Carlos Jose L.] Sao Paulo State Univ, UNESP, Sch Technol & Appl Sci, BR-19060900 Presidente Prudente, SP, Brazil.
   [Camacho, Sabrina A.; Sobral-Filho, Regivaldo Gomes; Aoki, Pedro Henrique B.; Brolo, Alexandre G.] Univ Victoria UVic, Dept Chem, Victoria, BC V8P 5C2, Canada.
   [Camacho, Sabrina A.; Sobral-Filho, Regivaldo Gomes; Aoki, Pedro Henrique B.; Brolo, Alexandre G.] Univ Victoria UVic, Ctr Adv Mat & Related Technol CAMTEC, Victoria, BC V8P 5C2, Canada.
   [Aoki, Pedro Henrique B.] Sao Paulo State Univ, UNESP, Sch Sci Humanities & Languages, BR-19806900 Assis, SP, Brazil.
RP Brolo, AG (corresponding author), Univ Victoria UVic, Dept Chem, Victoria, BC V8P 5C2, Canada.; Brolo, AG (corresponding author), Univ Victoria UVic, Ctr Adv Mat & Related Technol CAMTEC, Victoria, BC V8P 5C2, Canada.
EM agbrolo@uvic.ca
RI Camacho, Sabrina/AAF-1929-2020; Aoki, Pedro H. B./K-7964-2013
OI Aoki, Pedro H. B./0000-0003-4701-6408; Brolo,
   Alexandre/0000-0002-3162-0881
FU NSERCNatural Sciences and Engineering Research Council of Canada;
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX We acknowledge funding provided by NSERC and FAPESP. We thank Dr.
   Patrick Nahirney and Brent Gowen for their assistance and access to the
   transmission electron microscope.
CR Adungo F, 2016, CLIN VACCINE IMMUNOL, V23, P689, DOI 10.1128/CVI.00209-16
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Aroca R., 2007, SURFACE ENHANCED VIB
   Aroca RF, 2013, PHYS CHEM CHEM PHYS, V15, P5355, DOI 10.1039/c3cp44103b
   Aroca RF, 2011, J PHYS CHEM C, V115, P20419, DOI 10.1021/jp205997u
   Berger AG, 2017, ANAL CHIM ACTA, V949, P59, DOI 10.1016/j.aca.2016.10.035
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Camacho SA, 2017, ANALYST, V142, P2717, DOI 10.1039/c7an00639j
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chrispal A, 2010, TROP DOCT, V40, P230, DOI 10.1258/td.2010.100132
   Cialla-May D, 2017, CHEM SOC REV, V46, P3945, DOI 10.1039/c7cs00172j
   Cortes E, 2010, J AM CHEM SOC, V132, P18034, DOI 10.1021/ja108989b
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Etchegoin PG, 2010, ANAL CHEM, V82, P2888, DOI 10.1021/ac9028888
   Fan MK, 2015, CHEM COMMUN, V51, P1965, DOI 10.1039/c4cc07928k
   Fan MK, 2013, CHEM SCI, V4, P509, DOI 10.1039/c2sc21191b
   Fan MK, 2011, ANAL CHIM ACTA, V693, P7, DOI 10.1016/j.aca.2011.03.002
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feliu N, 2017, LANGMUIR, V33, P9711, DOI 10.1021/acs.langmuir.7b01567
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   Grandi S, 2007, J SOL-GEL SCI TECHN, V41, P57, DOI 10.1007/s10971-006-0119-4
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guerrero AR, 2012, SMALL, V8, P2964, DOI 10.1002/smll.201200750
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Homan J., 2016, BIORXIV, P44834
   Jiji SG, 2017, SPECTROCHIM ACTA A, V171, P499, DOI 10.1016/j.saa.2016.08.022
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kneipp K., 2006, SURFACE ENHANCED RAM, V103
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Lee S, 2012, NANOSCALE, V4, P124, DOI 10.1039/c1nr11243k
   Li JF, 2013, NAT PROTOC, V8, P52, DOI 10.1038/nprot.2012.141
   Li JF, 2010, NATURE, V464, P392, DOI 10.1038/nature08907
   Li M, 2015, CHEM SCI, V6, P3906, DOI 10.1039/c5sc01054c
   Li M, 2013, ACS NANO, V7, P4967, DOI 10.1021/nn4018284
   Li XK, 2017, BIOSENS BIOELECTRON, V92, P517, DOI 10.1016/j.bios.2016.10.070
   Ma Y, 2017, ACS APPL MATER INTER, V9, P10530, DOI 10.1021/acsami.7b01074
   Minghim R., 2006, P SOC PHOTO-OPT INS, V6060
   MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Osorio-Romin I. O., 2014, ANAL CHEM, V86
   Ozaki Y, 2014, FRONTIERS OF SURFACE-ENHANCED RAMAN SCATTERING: SINGLE NANOPARTICLES AND SINGLE CELLS, P1, DOI 10.1002/9781118703601
   Pallaoro A, 2015, NANO LETT, V15, P6745, DOI 10.1021/acs.nanolett.5b02594
   Paulovich FV, 2011, ANALYST, V136, P1344, DOI 10.1039/c0an00822b
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Sha MY, 2008, J AM CHEM SOC, V130, P17214, DOI 10.1021/ja804494m
   Tan YH, 2008, ACS NANO, V2, P2374, DOI 10.1021/nn800508f
   U. S. Food and Drug Administration, 2000, AN PROC METH VAL CHE
   Wang R, 2017, MICROCHIM ACTA, V184, P279, DOI 10.1007/s00604-016-1990-5
   Wang YQ, 2013, CHEM REV, V113, P1391, DOI 10.1021/cr300120g
   WHO, 2015, ZIK VIR ZIKV SURV AM
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang YY, 2016, ANAL CHEM, V88, P12502, DOI 10.1021/acs.analchem.6b04077
NR 56
TC 18
Z9 18
U1 19
U2 83
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2379-3694
J9 ACS SENSORS
JI ACS Sens.
PD MAR
PY 2018
VL 3
IS 3
BP 587
EP 594
DI 10.1021/acssensors.7b00639
PG 15
WC Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA GA8RW
UT WOS:000428608400009
PM 29411598
DA 2020-07-08
ER

PT J
AU Hersh, AM
   Gundacker, ND
   Boltax, J
AF Hersh, Andrew M.
   Gundacker, Nathan D.
   Boltax, Jonathan
TI Reply: Zika-associated Shock and Multiorgan Dysfunction
SO ANNALS OF THE AMERICAN THORACIC SOCIETY
LA English
DT Letter
C1 [Hersh, Andrew M.] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA.
   [Hersh, Andrew M.; Boltax, Jonathan] Univ Utah, Salt Lake City, UT 84112 USA.
   [Gundacker, Nathan D.] Med Coll Wisconsin, Milwaukee, WI 53226 USA.
RP Hersh, AM (corresponding author), Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA.; Hersh, AM (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.
CR Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Hersh AM, 2017, ANN AM THORAC SOC, V14, P1706, DOI 10.1513/AnnalsATS.201612-988CC
   Munoz-Jordan JL, 2009, J CLIN MICROBIOL, V47, P927, DOI 10.1128/JCM.01564-08
NR 3
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1546-3222
EI 2325-6621
J9 ANN AM THORAC SOC
JI Ann. Am. Thoracic Society
PD MAR
PY 2018
VL 15
IS 3
BP 391
EP 392
PG 4
WC Respiratory System
SC Respiratory System
GA FY7AT
UT WOS:000427014700026
PM 29232165
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika-associated Shock and Multiorgan Dysfunction: A Comment
SO ANNALS OF THE AMERICAN THORACIC SOCIETY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
CR Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Hersh AM, 2017, ANN AM THORAC SOC, V14, P1706, DOI 10.1513/AnnalsATS.201612-988CC
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sriwijitralai W, 2017, ANN TROP MED PUBLIC, V10, P475
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 5
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1546-3222
EI 2325-6621
J9 ANN AM THORAC SOC
JI Ann. Am. Thoracic Society
PD MAR
PY 2018
VL 15
IS 3
BP 391
EP 391
PG 1
WC Respiratory System
SC Respiratory System
GA FY7AT
UT WOS:000427014700025
PM 29232159
DA 2020-07-08
ER

PT J
AU Luo, HL
   Winkelmann, ER
   Fernandez-Salas, I
   Li, L
   Mayer, SV
   Danis-Lozano, R
   Sanchez-Casas, RM
   Vasilakis, N
   Tesh, R
   Barrett, AD
   Weaver, SC
   Wang, T
AF Luo, Huanle
   Winkelmann, Evandro R.
   Fernandez-Salas, Ildefonso
   Li, Li
   Mayer, Sandra V.
   Danis-Lozano, Rogelio
   Ma Sanchez-Casas, Rosa
   Vasilakis, Nikos
   Tesh, Robert
   Barrett, Alan D.
   Weaver, Scott C.
   Wang, Tian
TI Zika, dengue and yellow fever viruses induce differential anti-viral
   immune responses in human monocytic and first trimester trophoblast
   cells
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Immunity; Flavivirus; Trophoblast
ID NF-KAPPA-B; IMMUNIZATION; PATHOGENESIS; INFLAMMATION; ACTIVATION;
   INFECTION; TISSUE
AB Zika virus (ZIKV) is a mosquito-borne flavivirus associated with severe neonatal birth defects, but the causative mechanism is incompletely understood. ZIKV shares sequence homology and early clinical manifestations with yellow fever virus (YFV) and dengue virus (DENV) and are all transmitted in urban cycles by the same species of mosquitoes. However, YFV and DENV have been rarely reported to cause congenital diseases. Here, we compared infection with a contemporary ZIKV strain (FSS13025) to YFV17D and DENV-4 in human monocytic cells (THP-1) and first-trimester trophoblasts (HTR-8). Our results suggest that all three viruses have similar tropisms for both cells. Nevertheless, ZIKV induced strong type 1 IFN and inflammatory cytokine and chemokine production in monocytes and peripheral blood mononuclear cells. Furthermore, ZIKV infection in trophoblasts induced lower IFN and higher inflammatory immune responses. Placental inflammation is known to contribute to the risk of brain damage in preterm newborns. Inhibition of toll-like receptor (TLR)3 and TLR8 each abrogated the inflammatory cytokine responses in ZIKV-infected trophoblasts. Our findings identify a potential link between maternal immune activation and ZIKV-induced congenital diseases, and a potential therapeutic strategy that targets TLR-mediated inflammatory responses in the placenta.
C1 [Luo, Huanle; Winkelmann, Evandro R.; Weaver, Scott C.; Wang, Tian] Univ Texas Med Branch, Dept Microbiol & Immunol, Keiller 3-118B, Galveston, TX 77555 USA.
   [Fernandez-Salas, Ildefonso; Danis-Lozano, Rogelio] Inst Nacl Salud Publ, Ctr Reg Salud Publ, Tapachula, Mexico.
   [Li, Li; Mayer, Sandra V.; Vasilakis, Nikos; Tesh, Robert; Barrett, Alan D.; Weaver, Scott C.; Wang, Tian] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Ma Sanchez-Casas, Rosa] Univ Autonoma Nuevo Leon, FMVZ CIDICS, Monterrey, NL, Mexico.
   [Vasilakis, Nikos; Tesh, Robert; Barrett, Alan D.; Weaver, Scott C.; Wang, Tian] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Vasilakis, Nikos; Tesh, Robert; Barrett, Alan D.; Weaver, Scott C.; Wang, Tian] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Wang, T (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Keiller 3-118B, Galveston, TX 77555 USA.
EM ti1wang@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556; SANCHEZ CASAS, ROSA
   MARIA/0000-0002-2626-7227; Vasilakis, Nikos/0000-0002-0708-3289
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI099123, R24AI120942]
FX We thank Dr. Linsey Yeager for assisting in manuscript preparation. This
   work was supported in part by NIH grants R01 AI099123 (T.W.) and
   R24AI120942 (S.W.).
CR Aldo PB, 2010, AM J REPROD IMMUNOL, V64, P27, DOI 10.1111/j.1600-0897.2010.00817.x
   Benirschke K, 2006, PATHOLOGY HUMAN PLAC, P700
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Collins ND, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0566-9
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Gierman LM, 2015, PLACENTA, V36, P1246, DOI 10.1016/j.placenta.2015.09.004
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Indoh T, 2007, VIROLOGY, V361, P294, DOI 10.1016/j.virol.2006.11.002
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Milligan GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125476
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nakada E, 2009, PLACENTA, V30, P774, DOI 10.1016/j.placenta.2009.07.001
   Potter JA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Suzano CES, 2006, VACCINE, V24, P1421, DOI 10.1016/j.vaccine.2005.09.033
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Uehara A, 2007, MOL IMMUNOL, V44, P3552, DOI 10.1016/j.molimm.2007.03.010
   Verma R, 2014, J STEROID BIOCHEM, V141, P1, DOI 10.1016/j.jsbmb.2013.12.012
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Weaver S.C., 2017, ANN REV MED
   Welte T, 2011, FEMS IMMUNOL MED MIC, V63, P183, DOI 10.1111/j.1574-695X.2011.00840.x
   Xie GR, 2015, VACCINE, V33, P869, DOI 10.1016/j.vaccine.2014.12.056
   Xu Wei, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1559
   Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004
   Yang M, 2016, PLACENTA, V41, P62, DOI 10.1016/j.placenta.2016.03.007
   Yanni D, 2017, PEDIATR RES, V82, P691, DOI 10.1038/pr.2017.128
NR 46
TC 17
Z9 17
U1 2
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2018
VL 151
BP 55
EP 62
DI 10.1016/j.antiviral.2018.01.003
PG 8
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GA7BK
UT WOS:000428489400009
PM 29331320
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Auger, N
   Quach, C
   Healy-Profitos, J
   Lowe, AM
   Arbour, L
AF Auger, Nathalie
   Quach, Caroline
   Healy-Profitos, Jessica
   Lowe, Anne-Marie
   Arbour, Laura
TI Congenital microcephaly in Quebec: baseline prevalence, risk factors and
   outcomes in a large cohort of neonates
SO ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION
LA English
DT Article
ID ZIKA VIRUS; HEAD CIRCUMFERENCE; BIRTH
AB Objective We assessed baseline prevalence, risk factors and outcomes of microcephaly in a large population of neonates.
   Design Retrospective cohort study.
   Setting All hospitals in the province of Quebec, Canada.
   Participants 794 microcephalic and 1 944 010 non-microcephalic infants born between 1989 and 2012.
   Main outcome measures Baseline prevalence of microcephaly and occurrence of other congenital anomalies. We estimated the association of (1) pregnancy risk factors including TORCH infections (toxoplasmosis, rubella, cytomegalovirus, herpes, other), exposure to teratogens, diabetes and maternal congenital anomalies with risk of microcephaly, and (2) microcephaly with risk of infant mortality and severe morbidity, adjusted for maternal characteristics.
   Results The overall prevalence of microcephaly was 4.1 per 10 000, ranging between 3.0 and 5.3 per 10 000 over time. Only 37% of microcephalic infants presented with other congenital anomalies. Maternal infection during pregnancy was the strongest risk factor, with 32 times the risk of microcephaly (prevalence ratio 32.38; 95% CI 22.42 to 46.75) compared with no infection. Exposure to teratogens was the next most important risk factor, with three times greater risk (prevalence ratio 3.10; 95% CI 2.37 to 4.07). Microcephaly was associated with 20 times the risk of infant mortality compared with no microcephaly (prevalence ratio 20.52; 95% CI 15.57 to 27.04) and significantly greater infant morbidity.
   Conclusions In Canada, infectious exposure during pregnancy is a strong risk factor for microcephaly, and affected infants are at higher risk of poor birth outcomes. Better monitoring of microcephaly is needed in the event that Zika or other novel viruses affect future risk.
C1 [Auger, Nathalie; Healy-Profitos, Jessica] Univ Montreal Hosp Res Ctr, Montreal, PQ, Canada.
   [Auger, Nathalie; Quach, Caroline; Healy-Profitos, Jessica; Lowe, Anne-Marie] Inst Natl Sante Publ Quebec, 190 Cremazie E Blvd, Montreal, PQ H2P 1E2, Canada.
   [Quach, Caroline] Univ Montreal, St Justine Hosp Res Ctr, Montreal, PQ, Canada.
   [Arbour, Laura] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.
RP Auger, N (corresponding author), Inst Natl Sante Publ Quebec, 190 Cremazie E Blvd, Montreal, PQ H2P 1E2, Canada.
EM nathalie.auger@inspq.qc.ca
RI Auger, Nathalie/E-3736-2016
OI Auger, Nathalie/0000-0002-2412-0459; Arbour, Laura/0000-0002-9589-0880;
   Quach, Caroline/0000-0002-1170-9475
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [MOP-130452]; Fonds de recherche du Quebec-SanteFonds de
   la Recherche en Sante du Quebec [25128, 26873]
FX This study was funded by the Canadian Institutes of Health Research
   (MOP-130452) and the Fonds de recherche du Quebec-Sante (career grants
   awarded to Auger 25128 and Quach 26873).
CR Abeywardana S, 2008, CONGENITAL ANOMALIES
   Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   [Anonymous], 2015, ANN REP 2014
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Auger N, 2015, JAMA-J AM MED ASSOC, V314, P1588, DOI 10.1001/jama.2015.12505
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barbier A, 2013, PEDIATRICS, V131, pE1158, DOI 10.1542/peds.2011-3846
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Government of Canada, 2016, RAP RISK ASS RISK ZI
   Harris SR, 2015, CAN FAM PHYSICIAN, V61, P680
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Leroy Jules G, 2005, Adv Pediatr, V52, P261, DOI 10.1016/j.yapd.2005.04.003
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003
   National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention, 2013, MAJ BIRTH DEF DAT PO
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Public Health Agency Of Canada, 2013, CONG AN CAN 2013 PER
   Steele RW, 2016, CLIN PEDIATR, V55, P698, DOI 10.1177/0009922816638660
   Vargas JE, 2001, J PEDIATR-US, V139, P210, DOI 10.1067/mpd.2001.115314
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 29
TC 10
Z9 10
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1359-2998
EI 1468-2052
J9 ARCH DIS CHILD-FETAL
JI Arch. Dis. Child.-Fetal Neonatal Ed.
PD MAR
PY 2018
VL 103
IS 2
BP F167
EP F172
DI 10.1136/archdischild-2016-311199
PG 6
WC Pediatrics
SC Pediatrics
GA GB2OO
UT WOS:000428893100016
PM 28676560
DA 2020-07-08
ER

PT J
AU Barbi, L
   Coelho, AVC
   de Alencar, LCA
   Crovella, S
AF Barbi, Ludovica
   Campos Coelho, Antonio Victor
   Arraes de Alencar, Luiz Claudio
   Crovella, Sergio
TI Prevalence of Guillain-Barre syndrome among Zika virus infected cases: a
   systematic review and meta-analysis
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Arboviruses; Zika virus; Guillain-Barre syndrome; Epidemiology; Emergent
   diseases
ID DISORDERS
AB Zika virus (ZIKV) is an emergent flavivirus transmitted mainly through Aedes spp. mosquitoes that is posing challenge to healthcare services in countries experiencing an outbreak. Usually ZIKV infection is mild, but in some cases it has been reported to progress into neurological diseases such as microcephaly in infants and Guillain-Barre syndrome (GBS) in adults. GBS is a debilitating autoimmune disorder that affects peripheral nerves. Since ZIKV caused massive outbreaks in South America in the past few years, we aimed to systematically review the literature and perform a meta-analysis to estimate the prevalence of GBS among ZIKV-infected individuals. We searched PubMed and Cochrane databases and selected three studies for a meta-analysis. We estimated the prevalence of ZIKV-associated GBS to be 1.23% (95% CI = 1.17-1.29%). Limitations include paucity of data regarding previous flavivirus infections and ZIKV-infection confirmation issues. Our estimate seems to be low, but cannot be ignored, since ZIKV outbreaks affects an overwhelming number of individuals and GBS is a life-threatening debilitating condition, especially in pregnant women. ZIKV infection cases must be closely followed to assure prompt care to reduce the impact of GBS associated-sequelae on the quality of life of those affected. (C) 2018 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license.
C1 [Barbi, Ludovica] Kings Coll London, Dept Global Hlth & Social Med, London, England.
   [Campos Coelho, Antonio Victor] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Arraes de Alencar, Luiz Claudio] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [Arraes de Alencar, Luiz Claudio] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Crovella, Sergio] Sci Inst Res Hospitalizat & Care IRCCS, Inst Maternal & Child Hlth, Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, Dept Dev & Reprod Sci, Genet Unit, Trieste, Italy.
RP Crovella, S (corresponding author), Sci Inst Res Hospitalizat & Care IRCCS, Inst Maternal & Child Hlth, Trieste, Italy.; Crovella, S (corresponding author), Univ Trieste, Dept Dev & Reprod Sci, Genet Unit, Trieste, Italy.
EM crovella@burlo.trieste.it
RI Coelho, Antonio Victor C/E-6795-2015
OI Coelho, Antonio Victor C/0000-0003-2143-9701
FU Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES)CAPES
   [88881.130808/2016.1]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [440371/2016-3]; Brazilian public notice Chamada -
   Prevencao e Combate ao virus Zika [14/2016]; CAPESCAPES
   [88887.137992/2017-00]; Fundacao de Amparo a Ciencia e Tecnologia de
   Pernambuco (FACEPE) [BFP-0018-2.02/17]
FX This work was supported by grants 88881.130808/2016.1 from Comissao de
   Aperfeicoamento de Pessoal do Nivel Superior (CAPES) and 440371/2016-3
   from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq), from the Brazilian public notice Chamada 14/2016 - Prevencao e
   Combate ao virus Zika, both granted to SC. AVCC was supported by
   stipends by CAPES (88887.137992/2017-00) from the same public notice and
   by Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE -
   BFP-0018-2.02/17).
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coelho A. V. C, 2017, INT J MOL SCI, V18
   Critical Appraisal Skills Programme, 2018, CASP COH STUD CHECKL
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Flamand C, 2016, EURO SURVEILL, V22
   French Polynesia. Direction de la Sante. Bureau de Veille sanitaire, 2014, POINT SIT 7 FEVR 201
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Lozier MJ, 2016, J INFECT DIS, V2017
   Pacheco LD, 2016, OBSTET GYNECOL, V128, P1105, DOI 10.1097/AOG.0000000000001716
   R Core Team, 2017, R LANG ENV STAT COMP
   Schwarzer G, 2014, META METAANALYSIS R
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
NR 21
TC 18
Z9 18
U1 0
U2 1
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD MAR-APR
PY 2018
VL 22
IS 2
BP 137
EP 141
DI 10.1016/j.bjid.2018.02.005
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA GS0PO
UT WOS:000443206900009
PM 29545017
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Crino, JP
   Driggers, RW
AF Crino, Jude P.
   Driggers, Rita W.
TI Ultrasound Findings Associated With Antepartum Viral Infection
SO CLINICAL OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE fetal infection; obstetric ultrasound; prenatal diagnosis; TORCH; Zika
   virus; parvovirus
ID CONGENITAL VARICELLA SYNDROME; PARVOVIRUS B19 INFECTION; ZIKA
   VIRUS-INFECTION; PRENATAL SONOGRAPHIC DIAGNOSIS; FETAL ANEMIA;
   CYTOMEGALOVIRUS-INFECTION; IN-UTERO; INTRAUTERINE TRANSMISSION; DOPPLER
   ULTRASONOGRAPHY; NONINVASIVE DIAGNOSIS
AB This article reviews the sonographic manifestations of fetal infection and the role of ultrasound in the evaluation of the fetus at risk for congenital infection. Several ultrasound findings have been associated with in utero fetal infections. For the patient with a known or suspected fetal infection, sonographic identification of characteristic abnormalities can provide useful information for counseling and perinatal management. Demonstration of such findings in the low-risk patient may serve to identify the fetus with a previously unsuspected infection. The clinician should understand the limitations of ultrasound in the prenatal diagnosis of congenital infection and discuss them with the patient.
C1 [Crino, Jude P.; Driggers, Rita W.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Baltimore, MD 21205 USA.
RP Crino, JP (corresponding author), Phipps 228, Baltimore, MD 21287 USA.
EM jcrino1@jhmi.edu
CR Ahn KH, 2016, J OBSTET GYNAECOL, V36, P563, DOI 10.3109/01443615.2015.1127905
   ALEXANDER I, 1979, BRIT MED J, V2, P1074, DOI 10.1136/bmj.2.6197.1074
   Andrade JQ, 2006, J CLIN VIROL, V35, P285, DOI 10.1016/j.jcv.2005.09.007
   AOKI S, 1992, AM J PERINAT, V9, P361, DOI 10.1055/s-2007-999265
   Bailao Luiz Antonio, 2005, Ultrasound Q, V21, P295, DOI 10.1097/01.ruq.0000187025.61943.ff
   Bats AS, 2002, ULTRASOUND OBST GYN, V20, P502, DOI 10.1046/j.1469-0705.2002.00848.x
   BECKER LE, 1992, AM J NEURORADIOL, V13, P537
   BLAAKAER J, 1986, ACTA OBSTET GYN SCAN, V65, P653, DOI 10.3109/00016348609158405
   Carbonne B, 2008, J GYNECOL OBST BIO R, V37, P163, DOI 10.1016/j.jgyn.2007.08.008
   CARDOZA JD, 1988, RADIOLOGY, V169, P711, DOI 10.1148/radiology.169.3.3055034
   CARDOZA JD, 1988, AM J ROENTGENOL, V151, P767, DOI 10.2214/ajr.151.4.767
   Chisaka H, 2006, TOHOKU J EXP MED, V209, P277, DOI 10.1620/tjem.209.277
   Cluver C, 2013, ULTRASOUND OBST GYN, V42, P235, DOI 10.1002/uog.12399
   Cooper LZ, 2001, INFECT DIS FETUS NEW, P347
   Cordier AG, 2012, PRENATAL DIAG, V32, P496, DOI 10.1002/pd.2943
   Cosmi E, 2002, AM J OBSTET GYNECOL, V187, P1290, DOI 10.1067/mob.2002.128024
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Couto JC, 2006, FETAL TOXOPLASMOSIS
   Cullier F, 2006, CASE OF THE WEEK 168
   CUTHBERTSON G, 1987, J PEDIATR-US, V111, P592, DOI 10.1016/S0022-3476(87)80128-2
   DAFFOS F, 1984, LANCET, V2, P1
   Dhombres F, 2017, FETAL DIAGN THER, V41, P8, DOI 10.1159/000445113
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   DROSE JA, 1991, RADIOLOGY, V178, P369, DOI 10.1148/radiology.178.2.1846239
   Drose JA, 1998, FETAL ECHOCARDIOGRAP, P15
   Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8
   ELTABBAKH GH, 1994, J REPROD MED, V39, P412
   ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2
   ENDERS G, 1982, DEV BIOL STAND, V52, P221
   Enders M, 2017, PRENATAL DIAG, V37, P389, DOI 10.1002/pd.5025
   Enders M, 2004, PRENATAL DIAG, V24, P513, DOI 10.1002/pd.940
   FAKHRY J, 1991, J ULTRAS MED, V10, P51
   FARRELL TA, 1994, RADIOLOGY, V193, P409, DOI 10.1148/radiology.193.2.7972754
   FITZ CR, 1992, AM J NEURORADIOL, V13, P551
   FOWLER KB, 1993, J INFECT DIS, V168, P552, DOI 10.1093/infdis/168.3.552
   Friedman S, 1999, PRENATAL DIAG, V19, P330, DOI 10.1002/(SICI)1097-0223(199904)19:4&lt;330::AID-PD549&gt;3.0.CO;2-V
   Gay-Andrieu F, 2003, PRENAT DIAGN, V23, P1098
   Guerra B, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.052
   Harger JH, 2002, OBSTET GYNECOL, V100, P260, DOI 10.1016/S0029-7844(02)02059-8
   HILL LM, 1991, OBSTET GYNECOL, V78, P895
   HODDICK WK, 1985, J ULTRAS MED, V4, P479
   Hofmeyr GJ, 1996, PRENATAL DIAG, V16, P1148, DOI 10.1002/(SICI)1097-0223(199612)16:12<1148::AID-PD7>3.0.CO;2-J
   HOHLFELD P, 1991, ULTRASOUND OBST GYN, V1, P241, DOI 10.1046/j.1469-0705.1991.01040241.x
   Hollier LM, 1998, SEMIN PERINATOL, V22, P323, DOI 10.1016/S0146-0005(98)80021-9
   Hollier LM, 2001, OBSTET GYNECOL, V97, P947, DOI 10.1016/S0029-7844(01)01367-9
   HOLZGREVE W, 1993, CHILD NERV SYST, V9, P408, DOI 10.1007/BF00306194
   Jones J, 2003, AM FAM PHYSICIAN, V67, P2131
   JONES KL, 1994, TERATOLOGY, V49, P29, DOI 10.1002/tera.1420490106
   Junior E, 2012, INFECT DIS, V2012
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Koch WC, 1998, PEDIATR INFECT DIS J, V17, P489, DOI 10.1097/00006454-199806000-00011
   Koren G, 2003, CAN FAM PHYSICIAN, V49, P1445
   LECURU F, 1994, EUR J OBSTET GYN R B, V56, P67, DOI 10.1016/0028-2243(94)90156-2
   Levy R, 1997, Obstet Gynecol Surv, V52, P254, DOI 10.1097/00006254-199704000-00023
   Leyder M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.06.003
   Lilienfeld DE, 1989, FDN EPIDEMIOLOGY
   LYNCH L, 1991, AM J OBSTET GYNECOL, V165, P714, DOI 10.1016/0002-9378(91)90315-I
   Mace G, 2014, PRENATAL DIAG, V34, P1023, DOI 10.1002/pd.4413
   MACGREGOR SN, 1995, AM J OBSTET GYNECOL, V173, P1254, DOI 10.1016/0002-9378(95)91365-3
   MAHONY BS, 1984, RADIOLOGY, V151, P757, DOI 10.1148/radiology.151.3.6718738
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Mari G, 2005, ULTRASOUND OBST GYN, V25, P323, DOI 10.1002/uog.1882
   MARI G, 1995, ULTRASOUND OBST GYN, V5, P400, DOI 10.1046/j.1469-0705.1995.05060400.x
   Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102
   Markenson GR, 1998, SEMIN PERINATOL, V22, P309, DOI 10.1016/S0146-0005(98)80019-0
   Migliucci A, 2011, Minerva Ginecol, V63, P485
   MILLER E, 1982, LANCET, V2, P781
   Miller E, 1998, BRIT J OBSTET GYNAEC, V105, P174, DOI 10.1111/j.1471-0528.1998.tb10048.x
   Moise KJ, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.788
   MOORE TR, 1990, AM J OBSTET GYNECOL, V162, P1168, DOI 10.1016/0002-9378(90)90009-V
   NATHAN L, 1993, J ULTRAS MED, V12, P97
   Nathan L, 1997, PRENATAL DIAG, V17, P119, DOI 10.1002/(SICI)1097-0223(199702)17:2<119::AID-PD39>3.0.CO;2-T
   Nyberg DA, 1990, DIAGNOSTIC ULTRASOUN, P83
   PALADINI D, 1990, ARCH DIS CHILD-FETAL, V65, P20, DOI 10.1136/adc.65.1_Spec_No.20
   Pappalardo Elisa Maria, 2009, J Prenat Med, V3, P28
   PARISOT S, 1991, PEDIATR RADIOL, V21, P229, DOI 10.1007/BF02011057
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   PASTUSZAK AL, 1994, NEW ENGL J MED, V330, P901, DOI 10.1056/NEJM199403313301305
   PHELAN JP, 1987, J REPROD MED, V32, P540
   Picone O, 2014, PRENATAL DIAG, V34, P518, DOI 10.1002/pd.4340
   Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118
   PILU G, 1989, OBSTET GYNECOL, V73, P250
   PRETORIUS DH, 1992, J ULTRAS MED, V11, P459
   RAAFAT NA, 1993, J ULTRAS MED, V12, P783, DOI 10.7863/jum.1993.12.12.783
   Rac MWF, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.049
   RADNER M, 1993, J CLIN ULTRASOUND, V21, P346, DOI 10.1002/jcu.1870210511
   SATIN AJ, 1992, J ULTRAS MED, V11, P49
   SCHARF A, 1990, J PERINAT MED, V18, P317
   SCHMIDT W, 1985, J ULTRAS MED, V4, P667
   Seetoo K, 2013, MMWR-MORBID MORTAL W, V62, P226
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   SMFM Consult Series #39, 2016, AM J OBSTET GYNECOL, V214, pB9
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   STEIN B, 1995, RADIOLOGY, V197, P489, DOI 10.1148/radiology.197.2.7480699
   STRAYPEDERSEN B, 1993, BAILLIERE CLIN OB GY, V7, P107, DOI 10.1016/S0950-3552(05)80149-X
   Tongsong T, 2012, J CLIN ULTRASOUND, V40, P176, DOI 10.1002/jcu.21891
   VINTZILEOS AM, 1985, OBSTET GYNECOL, V66, P477
   Wannes S., 2013, J PEDIAT PUERICULTUR, V26, P171
   WATTMORSE ML, 1995, PRENATAL DIAG, V15, P567, DOI 10.1002/pd.1970150610
   Wendel GD, 2002, CLIN INFECT DIS, V35, pS200, DOI 10.1086/342108
   Yazigi A, 2017, J MATERN-FETAL NEO M, V30, P274, DOI 10.3109/14767058.2016.1169526
NR 103
TC 2
Z9 2
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-9201
EI 1532-5520
J9 CLIN OBSTET GYNECOL
JI Clin. Obstet. Gynecol.
PD MAR
PY 2018
VL 61
IS 1
BP 106
EP 121
DI 10.1097/GRF.0000000000000342
PG 16
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GA6XN
UT WOS:000428478100012
PM 29319590
DA 2020-07-08
ER

PT J
AU Judson, SD
   LeBreton, M
   Fuller, T
   Hoffman, RM
   Njabo, K
   Brewer, TF
   Dibongue, E
   Diffo, J
   Kameni, JMF
   Loul, S
   Nchinda, GW
   Njouom, R
   Nwobegahay, J
   Takuo, JM
   Torimiro, JN
   Wade, A
   Smith, TB
AF Judson, Seth D.
   LeBreton, Matthew
   Fuller, Trevon
   Hoffman, Risa M.
   Njabo, Kevin
   Brewer, Timothy F.
   Dibongue, Elsa
   Diffo, Joseph
   Kameni, Jean-Marc Feussom
   Loul, Severin
   Nchinda, Godwin W.
   Njouom, Richard
   Nwobegahay, Julius
   Takuo, Jean Michel
   Torimiro, Judith N.
   Wade, Abel
   Smith, Thomas B.
TI Translating Predictions of Zoonotic Viruses for Policymakers
SO ECOHEALTH
LA English
DT Article
DE Viruses; Risk; Virus diseases; Hemorrhagic fevers; Viral; Ebola virus;
   Bunyaviridae; Arenaviridae; Filoviridae
ID RIFT-VALLEY FEVER; CONGO HEMORRHAGIC-FEVER; LASSA FEVER; WEST-AFRICA;
   DISEASE; SURVEILLANCE; MARBURG; EBOLA; BATS; DIRECTIONS
AB Recent outbreaks of Ebola virus disease and Zika virus disease highlight the need for disseminating accurate predictions of emerging zoonotic viruses to national governments for disease surveillance and response. Although there are published maps for many emerging zoonotic viruses, it is unknown if there is agreement among different models or if they are concordant with national expert opinion. Therefore, we reviewed existing predictions for five high priority emerging zoonotic viruses with national experts in Cameroon to investigate these issues and determine how to make predictions more useful for national policymakers. Predictive maps relied primarily on environmental parameters and species distribution models. Rift Valley fever virus and Crimean-Congo hemorrhagic fever virus predictions differed from national expert opinion, potentially because of local livestock movements. Our findings reveal that involving national experts could elicit additional data to improve predictions of emerging pathogens as well as help repackage predictions for policymakers.
C1 [Judson, Seth D.; Hoffman, Risa M.; Brewer, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [LeBreton, Matthew] Mosaic, Yaounde, Cameroon.
   [Fuller, Trevon; Njabo, Kevin; Smith, Thomas B.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA.
   [Dibongue, Elsa] Minist Publ Hlth, Yaounde, Cameroon.
   [Diffo, Joseph; Takuo, Jean Michel] Metabiota Cameroon, Yaounde, Cameroon.
   [Kameni, Jean-Marc Feussom; Loul, Severin] Minist Livestock Fisheries & Anim Ind, Yaounde, Cameroon.
   [Kameni, Jean-Marc Feussom] Epidemiol Publ Hlth Vet Assoc ESPV, Yaounde, Cameroon.
   [Nchinda, Godwin W.; Torimiro, Judith N.] Chantal Biya Int Reference Ctr Res Prevent & Mana, Yaounde, Cameroon.
   [Njouom, Richard] Ctr Pasteur, Yaounde, Cameroon.
   [Nwobegahay, Julius] Mil Hlth Res Ctr, Yaounde, Cameroon.
   [Wade, Abel] Natl Vet Lab LANAVET Annex, Yaounde, Cameroon.
RP Judson, SD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
EM sethdjudson@gmail.com
RI Fuller, Trevon/B-8087-2014
OI Fuller, Trevon/0000-0001-9954-4267; Judson, Seth/0000-0001-9911-7839
FU NSF Partnerships for International Research and Education (PIRE)National
   Science Foundation (NSF)NSF - Office of the Director (OD) [1243524]
CR Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106
   Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010
   Clements Archie C A, 2006, Int J Health Geogr, V5, P57, DOI 10.1186/1476-072X-5-57
   Clements ACA, 2009, VET J, V182, P21, DOI 10.1016/j.tvjl.2008.05.010
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feldmann H, 2014, NEW ENGL J MED, V371, P1375, DOI 10.1056/NEJMp1405314
   Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388
   GONZALEZ JP, 1989, RES VIROLOGY, V140, P319, DOI 10.1016/S0923-2516(89)80112-8
   Hay SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0250
   Judson SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005780
   Kronmann KC, 2013, MIL MED, V178, P306, DOI 10.7205/MILMED-D-12-00273
   Kuhn J. H., 2008, FILOVIRUSES COMPENDI, P143, DOI DOI 10.1097/QCO.0B013E32833C3DA6
   LaBeaud AD, 2010, CURR OPIN INFECT DIS, V23, P403, DOI 10.1097/QCO.0b013e32833c3da6
   LeBreton M, 2006, EMERG INFECT DIS, V12, P702, DOI 10.3201/eid1204.051428
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819
   Maganga GD, 2011, J INFECT DIS, V204, pS800, DOI 10.1093/infdis/jir358
   Maurice Y, 1967, Rev Elev Med Vet Pays Trop, V20, P395
   Messina JP, 2015, T ROY SOC TROP MED H, V109, P503, DOI 10.1093/trstmh/trv050
   Monath TP, 1999, J INFECT DIS, V179, pS127, DOI 10.1086/514281
   Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088
   Muller MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26637
   Mylne AQN, 2015, T ROY SOC TROP MED H, V109, P483, DOI 10.1093/trstmh/trv047
   Olival KJ, 2014, VIRUSES-BASEL, V6, P1759, DOI 10.3390/v6041759
   Peeters M, 2014, AIDS REV, V16, P23
   Perry HN, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-24
   Peterson AT, 2016, ACTA TROP, V162, P114, DOI 10.1016/j.actatropica.2016.06.012
   Peterson AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100711
   Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024
   Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]
   Randolph Sarah E., 2007, P167, DOI 10.1007/978-1-4020-6106-6_14
   Redding DW, 2016, METHODS ECOL EVOL, V7, P646, DOI 10.1111/2041-210X.12549
   Rogers DJ, 2006, ADV PARASIT, V62, P1, DOI 10.1016/S0065-308X(05)62001-5
   Schmidt JP, 2017, SPATIOTEMPORAL FLUCT
   Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001
   WHO, 2015, BLUEPR R D PREP RESP
   Witt CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S2-S10
   Xiao NC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131697
NR 39
TC 2
Z9 2
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD MAR
PY 2018
VL 15
IS 1
BP 52
EP 62
DI 10.1007/s10393-017-1304-3
PG 11
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA GJ6XL
UT WOS:000435527600006
PM 29230614
OA Green Published
DA 2020-07-08
ER

PT J
AU Kuper, H
   Smythe, T
   Duttine, A
AF Kuper, Hannah
   Smythe, Tracey
   Duttine, Antony
TI Reflections on Health Promotion and Disability in Low and Middle-Income
   Countries: Case Study of Parent-Support Programmes for Children with
   Congenital Zika Syndrome
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE disability; health promotion; Zika; parent-support; low and middle
   income
ID SECONDARY CONDITIONS; REPRODUCTIVE HEALTH; HIV/AIDS KNOWLEDGE; PEOPLE;
   CARE; DISPARITIES; SERVICES; NIGERIA; BEHAVIORS; COVERAGE
AB Universal health coverage (UHC) has been adopted by many countries as a national target for 2030. People with disabilities need to be included within efforts towards UHC, as they are a large group making up 15% of the world's population and are more vulnerable to poor health. UHC focuses both on covering the whole population as well as providing all the services needed and must include an emphasis on health promotion, as well as disease treatment and cure. Health promotion often focusses on tackling individual behaviours, such as encouraging exercise or good nutrition. However, these activities are insufficient to improve health without additional efforts to address poverty and inequality, which are the underlying drivers of poor health. In this article, we identify common challenges, opportunities and examples for health promotion for people with disabilities, looking at both individual behaviour change as well as addressing the drivers of poor health. We present a case study of a carer support programme for parents of children with Congenital Zika Syndrome in Brazil as an example of a holistic programme for health promotion. This programme operates both through improving skills of caregivers to address the health needs of their child and tackling poverty and exclusion.
C1 [Kuper, Hannah; Smythe, Tracey; Duttine, Antony] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London WC1E 7HT, England.
RP Kuper, H (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London WC1E 7HT, England.
EM hannah.kuper@lshtm.ac.uk; tracey.smythe@lshtm.ac.uk;
   antony.duttine@lshtm.ac.uk
RI Smythe, Tracey/N-7699-2017
OI Smythe, Tracey/0000-0003-3408-7362
FU grant from Wellcome; Department for International Development
   [206719/Z/17/Z]
FX The development and testing of the intervention for children with
   Congenital Zika Syndrome is supported by a grant from Wellcome and the
   Department for International Development (grant code 206719/Z/17/Z).
CR AIHW, HLTH AUSTR DIS HLTH
   Altman B., 2008, DISABILITY HLTH US 2
   Arunakul M, 2012, SE ASIAN J TROP MED, V43, P1297
   Banks L.M, 2014, EC COSTS EXCLUSION G
   Best K, 1999, Netw Res Triangle Park N C, V19, P16
   Bisol CA, 2008, AM ANN DEAF, V153, P349
   Chun SM, 2012, ARCH PHYS MED REHAB, V93, P1161, DOI 10.1016/j.apmr.2012.02.012
   Coe G, 2014, GLOB HEALTH-SCI PRAC, V2, P10, DOI 10.9745/GHSP-D-13-00164
   Collins PY, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002393
   Diab ME, 2004, ARCH PHYS MED REHAB, V85, P749, DOI 10.1016/j.apmr.2003.06.028
   Eide AH, 2011, AIDS CARE, V23, P1595, DOI 10.1080/09540121.2011.575119
   Floud S, 2017, BRIT J CANCER, V117, P1711, DOI 10.1038/bjc.2017.331
   Froehlich-Grobe K, 2016, DISABIL HEALTH J, V9, P600, DOI 10.1016/j.dhjo.2016.04.007
   Gilson SF, 1996, AM J PUBLIC HEALTH, V86, P1613, DOI 10.2105/AJPH.86.11.1613
   Glazier RE, 2013, DISABIL HEALTH J, V6, P107, DOI 10.1016/j.dhjo.2013.01.007
   Groce N, 2011, J WATER HEALTH, V9, P617, DOI 10.2166/wh.2011.198
   Groce NE, 2007, DISABIL REHABIL, V29, P367, DOI 10.1080/09638280600834567
   Groce N, 2011, THIRD WORLD Q, V32, P1493, DOI 10.1080/01436597.2011.604520
   Horner-Johnson W, 2013, DISABIL HEALTH J, V6, P280, DOI 10.1016/j.dhjo.2013.04.006
   Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955
   J. U. N. P. o. H. AIDS, 2014, THE GAP REP
   Kassa TA, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0142-3
   Khan F., 2017, J REHABIL MED
   Kinne S, 2004, AM J PUBLIC HEALTH, V94, P443, DOI 10.2105/AJPH.94.3.443
   Ko KD, 2011, ARCH PHYS MED REHAB, V92, P1230, DOI 10.1016/j.apmr.2011.03.004
   Kuper H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107300
   Mactaggart I, 2016, DISABIL REHABIL, V38, P1757, DOI 10.3109/09638288.2015.1107765
   McConachie H, 2001, CHILD CARE HLTH DEV, V27, P1, DOI 10.1046/j.1365-2214.2001.00207.x
   Mitra S, 2013, WORLD DEV, V41, P1, DOI 10.1016/j.worlddev.2012.05.024
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morrison J, 2017, HEALTH PROMOT INT, V32, P464, DOI 10.1093/heapro/dav099
   Oredugba FA, 2010, SPEC CARE DENT, V30, P211, DOI 10.1111/j.1754-4505.2010.00155.x
   Otte WM, 2008, AIDS CARE, V20, P1093, DOI 10.1080/09540120701842787
   Ravesloot C, 2011, DISABIL HEALTH J, V4, P19, DOI 10.1016/j.dhjo.2010.05.006
   Reich MR, 2016, LANCET, V387, P811, DOI 10.1016/S0140-6736(15)60002-2
   Reichard A, 2011, DISABIL HEALTH J, V4, P59, DOI 10.1016/j.dhjo.2010.05.003
   Rotarou ES, 2017, HEALTH POLICY, V121, P495, DOI 10.1016/j.healthpol.2017.03.005
   Smeltzer Suzanne C, 2004, Online J Issues Nurs, V9, P11
   Stevens A, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140162
   Trani JF, 2011, SOC SCI MED, V73, P1477, DOI 10.1016/j.socscimed.2011.08.040
   United Nations, 2006, CONV RIGHTS PERS DIS
   White S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155043
   Wilber N, 2002, MILBANK Q, V80, P393, DOI 10.1111/1468-0009.00009
   2011, WORLD REP DIS, P1
NR 44
TC 7
Z9 7
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAR
PY 2018
VL 15
IS 3
AR 514
DI 10.3390/ijerph15030514
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GA7II
UT WOS:000428509200121
PM 29538291
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Balmaseda, A
   Zambrana, JV
   Collado, D
   Garcia, N
   Saborio, S
   Elizondo, D
   Mercado, JC
   Gonzalez, K
   Cerpas, C
   Nunez, A
   Corti, D
   Waggoner, JJ
   Kuan, G
   Burger-Calderon, R
   Harris, E
AF Balmaseda, Angel
   Victor Zambrana, Jose
   Collado, Damaris
   Garcia, Nadezna
   Saborio, Saira
   Elizondo, Douglas
   Carlos Mercado, Juan
   Gonzalez, Karla
   Cerpas, Cristhiam
   Nunez, Andrea
   Corti, Davide
   Waggoner, Jesse J.
   Kuan, Guillermina
   Burger-Calderon, Raquel
   Harris, Eva
TI Comparison of Four Serological Methods and Two Reverse Transcription-PCR
   Assays for Diagnosis and Surveillance of Zika Virus Infection
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE ELISA; RT-PCR; Zika virus; dengue virus; diagnosis; serological assay;
   surveillance
ID GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS; CROSS-REACTIVITY; ANTIBODIES;
   SALIVA; CHIKUNGUNYA; COHORT; BRAZIL; CHILD; SERUM
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that is responsible for recent explosive epidemics in the Americas. Notably, ZIKV infection during pregnancy has been found to cause congenital birth defects, including microcephaly, and ZIKV has been associated with Guillain-Barre syndrome in adults. Diagnosis and surveillance of Zika in the Americas have been challenging due to similar clinical manifestations and extensive antibody cross-reactivity with endemic flaviviral diseases, such as dengue. We evaluated four serological and two reverse transcription-PCR (RT-PCR) methods in acute-phase (mean day, 1.8), early-convalescent-phase (mean day, 16.7), and late-convalescent-phase (mean, similar to 7 months) samples from the same individuals in a long-term pediatric cohort study in Nicaragua. Well-characterized samples from 301 cases of Zika, dengue, or non-Zika, nondengue febrile illnesses were tested. Compared to a composite reference, an in-house IgM antibody capture enzymelinked immunosorbent assay (MAC-ELISA) and the NIAID-Biodefense and Emerging Infections (BEI) MAC-ELISA measuring IgM yielded sensitivities of 94.5% and 70.1% and specificities of 85.6% and 82.8%, respectively. The NS1 blockade-ofbinding ELISA measuring anti-ZIKV NS1 antibody levels yielded sensitivities of 85.0% and 96.5% and specificities of 91.4% and 92.6% at early and late convalescence, respectively. An inhibition ELISA detecting total anti-ZIKV antibodies had sensitivity and specificity values of 68.3% and 58.3% for diagnosis and 94.0% and 98.6% for measuring annual infection incidence. Finally, the ZCD and Trioplex real-time RT-PCR assays detecting Zika, chikungunya, and dengue viruses both yielded a sensitivity of 96.1% and specificity of 100%. Together, these assays resolve the urgent need for diagnostic and surveillance tools for countries affected by Zika virus infections.
C1 [Balmaseda, Angel; Garcia, Nadezna; Saborio, Saira; Carlos Mercado, Juan; Gonzalez, Karla; Cerpas, Cristhiam; Nunez, Andrea] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Balmaseda, Angel; Victor Zambrana, Jose; Collado, Damaris; Garcia, Nadezna; Saborio, Saira; Elizondo, Douglas; Carlos Mercado, Juan; Gonzalez, Karla; Cerpas, Cristhiam; Nunez, Andrea; Kuan, Guillermina; Burger-Calderon, Raquel; Harris, Eva] Sustainable Sci Inst, Managua, Nicaragua.
   [Corti, Davide] Humabs Biomed SA, Bellinzona, Switzerland.
   [Waggoner, Jesse J.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua, Nicaragua.
   [Burger-Calderon, Raquel; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Harris, E (corresponding author), Sustainable Sci Inst, Managua, Nicaragua.; Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
RI Zambrana, Jose Victor/Q-3214-2019
OI Zambrana, Jose Victor/0000-0003-0107-6173; COLLADO GARCIA, DAMARIS
   LISANGELES/0000-0002-0878-3260
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI099631, P01AI106695]; NIH
   grantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI118610]; Pediatric Dengue Vaccine
   Initiative grant from the Bill and Melinda Gates Foundation [VE-1];
   FIRST grant from the Bill and Melinda Gates Foundation
FX This research was funded by grants from the National Institute of
   Allergy and Infectious Diseases of the National Institutes of Health
   R01AI099631 (A.B.) and P01AI106695 (E.H.); the cohort study was also
   supported by NIH grant U19AI118610 (E.H.), as well as by Pediatric
   Dengue Vaccine Initiative grant VE-1 (E.H.) and a FIRST grant (E.H.),
   both from the Bill and Melinda Gates Foundation. The funders had no role
   in study design, data collection and interpretation, or the decision to
   submit the work for publication.
CR Aziz H, 2017, J MED VIROL, V89, P943, DOI 10.1002/jmv.24731
   Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003
   Balmaseda A, 2008, J CLIN VIROL, V43, P287, DOI 10.1016/j.jcv.2008.07.016
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   BEI Resources, 2016, NIAID ZIK VIR ZIKV M
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CDC, 2017, TRIOPL REAL TIM RT S
   Rocha NACF, 2017, INFANT BEHAV DEV, V49, P70, DOI 10.1016/j.infbeh.2017.07.002
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Pessoa R, 2016, EURO SURVEILL, V21
   Raboni SM, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12700
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Galo SS, 2017, REV PANAM SALUD PUBL, V41
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waggoner J, 2017, AM J TROP MED HYG, V97, P121, DOI 10.4269/ajtmh.17-0027
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13
NR 37
TC 25
Z9 25
U1 0
U2 18
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAR
PY 2018
VL 56
IS 3
AR UNSP e01785-17
DI 10.1128/JCM.01785-17
PG 13
WC Microbiology
SC Microbiology
GA FX1WJ
UT WOS:000425843200029
PM 29305550
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Baylis, SA
   McCulloch, E
   Wallace, P
   Mantke, OD
   Niedrig, M
   Blumel, J
   Yue, C
   Nubling, CM
AF Baylis, S. A.
   McCulloch, E.
   Wallace, P.
   Mantke, O. Donoso
   Niedrig, M.
   Bluemel, J.
   Yue, C.
   Nubling, C. M.
TI External Quality Assessment (EQA) of Molecular Detection of Zika Virus:
   Value of the 1st World Health Organization International Standard
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Letter
DE EQA; standard; WHO; Zika virus
C1 [Baylis, S. A.; Bluemel, J.; Yue, C.] Paul Ehrlich Inst, Div Virol, Langen, Germany.
   [McCulloch, E.; Wallace, P.; Mantke, O. Donoso] QCMD, Glasgow, Lanark, Scotland.
   [Niedrig, M.] Robert Koch Inst, Berlin, Germany.
   [Nubling, C. M.] WHO, Essential Med & Hlth Prod Dept, Geneva, Switzerland.
RP Baylis, SA (corresponding author), Paul Ehrlich Inst, Div Virol, Langen, Germany.
EM Sally.Baylis@pei.de
FU World Health OrganizationWorld Health Organization [001]
CR Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Baylis SA, 2015, TRANSFUS MED HEMOTH, V42, P211, DOI 10.1159/000435872
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   ISO, 2010, 170432010 ISOIEC
   Paul-Ehrlich-Institut, 2016, 1 WORLD HLTH ORG INT
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
NR 7
TC 3
Z9 3
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAR
PY 2018
VL 56
IS 3
AR UNSP e01997-17
DI 10.1128/JCM.01997-17
PG 2
WC Microbiology
SC Microbiology
GA FX1WJ
UT WOS:000425843200034
PM 29472437
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Lee, WT
   Wong, SJ
   Kulas, KE
   Dupuis, AP
   Payne, AF
   Kramer, LD
   Dean, AB
   George, KS
   White, JL
   Sommer, JN
   Ledizet, M
   Limberger, RJ
AF Lee, William T.
   Wong, Susan J.
   Kulas, Karen E.
   Dupuis, Alan P., II
   Payne, Anne F.
   Kramer, Laura D.
   Dean, Amy B.
   George, Kirsten St.
   White, Jennifer L.
   Sommer, Jamie N.
   Ledizet, Michel
   Limberger, Ronald J.
TI Development of Zika Virus Serological Testing Strategies in New York
   State
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE flavivirus; host response; immunology; serology; virus-host interactions
ID WEST-NILE-VIRUS; DENGUE VIRUS; MICROSPHERE IMMUNOASSAY; INFECTION; IGM;
   MICRONESIA; ANTIBODIES; DIAGNOSIS; RESPONSES
AB The recent outbreak of Zika virus (ZIKV) in the Americas has challenged diagnostic laboratory testing strategies. At the Wadsworth Center, ZIKV serological testing was performed for over 10,000 specimens, using a combination of an enzyme-linked immunosorbent assay (ELISA) for IgM antibodies (Abs) to ZIKV, a polyvalent microsphere immunoassay (MIA) to detect Abs broadly reactive with flaviviruses, and a plaque reduction neutralization test (PRNT) for further testing. Overall, 42% of patients showed serological evidence of flavivirus infection (primarily past dengue virus [DENV] infection), while 7% possessed IgM Abs to ZIKV and/or DENV. ZIKV IgM Abs typically arose within 3 to 4 days, with only one instance of duration beyond 100 days after reported symptoms. PRNT analysis of 826 IgM-positive specimens showed 7% positive neutralization to ZIKV alone, 9% to DENV alone, and 85% to both ZIKV and DENV. Thus, the extensive Ab cross-reactivity among flaviviruses significantly reduced the value of performing PRNT analysis, especially when a traditional paired serum algorithm with viral neutralization titering was used. Nevertheless, the finding of a negative ZIKV result by PRNT was invaluable for reassuring both physicians and patients. The MIA detected both IgM and IgG, which enabled us to identify patients who presented without IgM anti-ZIKV Abs but still had ZIKV-specific neutralizing Abs. On the basis of these results, a new algorithm, which included an IgM Ab capture (MAC)-ELISA to detect recent infection, a flavivirus MIA to identify patients no longer producing IgM, and a single-dilution PRNT for ZIKV exclusion and occasional discrimination of ZIKV and DENV, was implemented.
C1 [Lee, William T.; Wong, Susan J.; Kulas, Karen E.; Dupuis, Alan P., II; Payne, Anne F.; Kramer, Laura D.; Dean, Amy B.; George, Kirsten St.; Limberger, Ronald J.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.
   [Lee, William T.; Wong, Susan J.; Kramer, Laura D.; George, Kirsten St.] Univ Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.
   [White, Jennifer L.; Sommer, Jamie N.] New York State Dept Hlth, Div Epidemiol, Albany, NY 12237 USA.
   [Ledizet, Michel] L2 Diagnost LLC, New Haven, CT USA.
RP Lee, WT (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.; Lee, WT (corresponding author), Univ Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.
EM william.lee@health.ny.gov
OI Lee, William/0000-0003-2883-0391
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [NU50CK000423]; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R43 AI49646]
FX A portion of the work described in this publication was supported by
   cooperative agreement NU50CK000423 from the CDC. The contents of this
   publication are solely the responsibility of the authors and do not
   necessarily represent the official views of the CDC. Partial support was
   also provided by grant R43 AI49646 from the National Institute of
   Allergy and Infectious Diseases.
CR [Anonymous], 2016, MMWR Morb Mortal Wkly Rep, V65, P1304, DOI 10.15585/mmwr.mm6546a7
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Centers for Disease Control and Prevention, 2017, ZIK VIR 2016 CAS COU
   Centers for Disease Control and Prevention, 2016, ZIK MAC ELISA INSTR
   Chanama S, 2004, J CLIN VIROL, V31, P185, DOI 10.1016/j.jcv.2004.03.005
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Malan AK, 2003, AM J CLIN PATHOL, V119, P508, DOI 10.1309/WJJ7UE42DFHTTF1X
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR MORB MORTAL WKL
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sloan A, DIAGN MICRO IN PRESS
   Tsunoda Ikuo, 2016, Acta Med Kinki Univ, V41, P37
   U.S. Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wong SJ, 2004, J CLIN MICROBIOL, V42, P65, DOI 10.1128/JCM.42.1.65-72.2004
   Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
NR 37
TC 9
Z9 9
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAR
PY 2018
VL 56
IS 3
AR UNSP e01591-17
DI 10.1128/JCM.01591-17
PG 12
WC Microbiology
SC Microbiology
GA FX1WJ
UT WOS:000425843200016
PM 29263203
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Premkumar, L
   Collins, M
   Graham, S
   Liou, GJA
   Lopez, CA
   Jadi, R
   Balmaseda, A
   Brackbill, JA
   Dietze, R
   Camacho, E
   De Silva, AD
   Giuberti, C
   dos Reis, HL
   Singh, T
   Heimsath, H
   Weiskopf, D
   Sette, A
   Osorio, JE
   Permar, SR
   Miley, MJ
   Lazear, HM
   Harris, E
   de Silva, AM
AF Premkumar, Lakshmanane
   Collins, Matthew
   Graham, Stephen
   Liou, Guei-Jiun Alice
   Lopez, Cesar A.
   Jadi, Ramesh
   Balmaseda, Angel
   Brackbill, James A.
   Dietze, Reynaldo
   Camacho, Erwin
   De Silva, Aruna D.
   Giuberti, Camila
   dos Reis, Helena Lucia
   Singh, Tulika
   Heimsath, Holly
   Weiskopf, Daniela
   Sette, Alessandro
   Osorio, Jorge E.
   Permar, Sallie R.
   Miley, Michel J.
   Lazear, Helen M.
   Harris, Eva
   de Silva, Aravinda M.
TI Development of Envelope Protein Antigens To Serologically Differentiate
   Zika Virus Infection from Dengue Virus Infection
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE comparative epitope mapping; computational prediction; ELISA; Zika
   virus; antibody-binding region; cross-reactivity; dengue virus;
   flavivirus; serological diagnosis; surveillance
ID WEST-NILE-VIRUS; HUMAN NEUTRALIZING ANTIBODIES; STRUCTURAL BASIS;
   EVOLUTIONARY CONSERVATION; INTERIM GUIDANCE; RECOGNITION; PCR;
   DETERMINANTS; CHIKUNGUNYA; MECHANISM
AB Zika virus (ZIKV) is an emerging flavivirus that can cause birth defects and neurologic complications. Molecular tests are effective for diagnosing acute ZIKV infection, although the majority of infections produce no symptoms at all or present after the narrow window in which molecular diagnostics are dependable. Serology is a reliable method for detecting infections after the viremic period; however, most serological assays have limited specificity due to cross-reactive antibodies elicited by flavivirus infections. Since ZIKV and dengue virus (DENV) widely cocirculate, distinguishing ZIKV infection from DENV infection is particularly important for diagnosing individual cases or for surveillance to coordinate public health responses. Flaviviruses also elicit type-specific antibodies directed to non-cross-reactive epitopes of the infecting virus; such epitopes are attractive targets for the design of antigens for development of serological tests with greater specificity. Guided by comparative epitope modeling of the ZIKV envelope protein, we designed two recombinant antigens displaying unique antigenic regions on domain I (Z-EDI) and domain III (Z-EDIII) of the ZIKV envelope protein. Both the Z-EDI and Z-EDIII antigens consistently detected ZIKV-specific IgG in ZIKV-immune sera but not cross-reactive IgG in DENV-immune sera in late convalescence (>12 weeks postinfection). In contrast, during early convalescence (2 to 12 weeks postinfection), secondary DENV-immune sera and some primary DENV-immune sera cross-reacted with the Z-EDI and Z-EDIII antigens. Analysis of sequential samples from DENV-immune individuals demonstrated that Z-EDIII cross-reactivity peaked in early convalescence and declined steeply over time. The Z-EDIII antigen has much potential as a diagnostic antigen for populationlevel surveillance and for detecting past infections in patients.
C1 [Premkumar, Lakshmanane; Collins, Matthew; Graham, Stephen; Liou, Guei-Jiun Alice; Lopez, Cesar A.; Jadi, Ramesh; Lazear, Helen M.; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Brackbill, James A.; Miley, Michel J.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA.
   [Dietze, Reynaldo; Giuberti, Camila; dos Reis, Helena Lucia] Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Vitoria, Brazil.
   [Camacho, Erwin] Univ Sucre, Sincelejo, Sucre, Colombia.
   [De Silva, Aruna D.] Genetech Res Inst, Colombo, Sri Lanka.
   [De Silva, Aruna D.; Weiskopf, Daniela; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.
   [Singh, Tulika; Heimsath, Holly; Permar, Sallie R.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.
   [Singh, Tulika; Heimsath, Holly; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [De Silva, Aruna D.] Kotelawala Def Univ, Fac Med, Dept Paraclin Sci, Ratmalana, Sri Lanka.
RP Premkumar, L; de Silva, AM (corresponding author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
EM prem@med.unc.edu; aravinda_desilva@med.unc.edu
RI REIS, HELENA LUCIA BARROSO DOS/U-3347-2019
OI REIS, HELENA LUCIA BARROSO DOS/0000-0003-2018-2529; Dietze,
   Reynaldo/0000-0002-6995-8001; Lopez, Cesar/0000-0001-9301-4177;
   Weiskopf, Daniela/0000-0003-2968-7371; Camacho Burgos,
   Erwin/0000-0003-2411-1875
FU NIAID, NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI107731, R21AI134073, R01AI099631,
   R21/R33AI100186, P01AI106695, U19AI118610]; CDC contract
   [200-2017-93142]; ZIKAPLAN from the European Union's Horizon research
   and innovation program [734584]; FAPES [306/2016-74910132/16]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [HHSN272200900042C, HHSN27220140045C]
FX These studies were supported by NIAID, NIH, grants R01AI107731
   (A.M.D.S.), R21AI134073 (A.M.D.S. and L.P.), R01AI099631 (A.B.),
   R21/R33AI100186 (A.B.), P01AI106695 (E.H.), and U19AI118610 (E.H.) and
   by CDC contract 200-2017-93142 (A.M.D.S.). Further support was provided
   by ZIKAPLAN, which received funding from the European Union's Horizon
   2020 research and innovation program under grant agreement 734584. The
   Brazil pregnancy cohort was funded by FAPES grant 306/2016-74910132/16
   (S.R.P.). The Sri Lankan cohort study was funded by NIH contracts
   HHSN272200900042C and HHSN27220140045C (A.S.).
CR Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davis AC, 2017, DCS BOTCHED ZIKA TES
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Education CsDoICa, 2016, FDA WARNS HLTH CAR P
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fonseca BPF, 2011, CLIN VACCINE IMMUNOL, V18, P802, DOI 10.1128/CVI.00265-10
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Metz SW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005071
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Musso D, 2016, CLIN MICROBIOL INFEC, V22, P494, DOI 10.1016/j.cmi.2016.03.032
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   The National Academies of Sciences Engineering and Medicine., 2016, POT RES PRIOR INF PU
   U.S. Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 64
TC 20
Z9 20
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAR
PY 2018
VL 56
IS 3
AR UNSP e01504-17
DI 10.1128/JCM.01504-17
PG 13
WC Microbiology
SC Microbiology
GA FX1WJ
UT WOS:000425843200010
PM 29263206
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Reusken, CB
   Charrel, R
AF Reusken, Chantal B.
   Charrel, Remi
TI Reply to Baylis et al., "External Quality Assessment (EQA) of Molecular
   Detection of Zika Virus: Value of the 1st World Health Organization
   International Standard"
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Letter
C1 [Reusken, Chantal B.] Erasmus MC, Dept Virosci, WHO, Collaborating Ctr Arboviruses & Viral Haemorrhag, Rotterdam, Netherlands.
   [Charrel, Remi] Aix Marseille Univ, EPV, UMR, Marseille, France.
RP Reusken, CB (corresponding author), Erasmus MC, Dept Virosci, WHO, Collaborating Ctr Arboviruses & Viral Haemorrhag, Rotterdam, Netherlands.
EM c.reusken@erasmusmc.nl
CR Baylis SA, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01997-17
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Reusken CBEM, 2018, CLIN MICROBIOL INFEC
   WHO Expert Committee on Biological Standardization, 2017, COLL STUD EV CAND WO
NR 5
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAR
PY 2018
VL 56
IS 3
AR UNSP e02023-17
DI 10.1128/JCM.02023-17
PG 2
WC Microbiology
SC Microbiology
GA FX1WJ
UT WOS:000425843200035
PM 29472438
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Lima, ED
   Guerreiro, TM
   Melo, CFOR
   de Oliveira, DN
   Machado, D
   Lancelloti, M
   Catharino, RR
AF Lima, Estela de O.
   Guerreiro, Tatiane M.
   Melo, Carlos Fernando O. R.
   de Oliveira, Diogo N.
   Machado, Daisy
   Lancelloti, Marcelo
   Catharino, Rodrigo R.
TI MALDI imaging detects endogenous digoxin in glioblastoma cells infected
   by Zika virusWould it be the oncolytic key?
SO JOURNAL OF MASS SPECTROMETRY
LA English
DT Article
DE digoxin; MALDI imaging; mass spectrometry; metabolomics; Zika virus
ID CARDIAC-GLYCOSIDES; BREAST-CANCER; NA+/K+-ATPASE; DIGITALIS;
   IDENTIFICATION; VIRUSES; BRAIN
AB Recently, microcephaly cases have increased in Americas and have been matter of concern due to Zika virus (ZIKV) recent outbreak. Previous studies have shown that ZIKV-infected progenitor neuronal cells present morphological abnormalities and increased rates of cell death, which may be indicators of microcephaly causes. As recent studies indicate ZIKV' tropism for brain cells, how would a glioblastoma (GBM) lineage behave under ZIKV infection, considering GBM the most common and malignant brain tumor in adults, presenting extreme chemoresistance and high morbidity and mortality rates? The current trend of using genetically engineered oncolytic pathogens as a safe way to eliminate tumors is under development, with trials already in course. Therefore, the present study evaluated the possible oncolytic effects and metabolomic alterations of ZIKV infection at human malignant M059J GBM cells. Microscopic evaluation was performed by using optical microscopy, which showed cytopathic effects induced by ZIKV at GBM cells. For the metabolomics study, both control and infected cell cultures were submitted to matrix laser desorption/ionization mass spectrometry imaging analysis. Mass spectrometry data were submitted to partial least squares discriminant analysis statistical analysis, and distinct biomarkers were elected for each infected groups. This study brings light to unexpectedly induced metabolic changes, as endogenous digoxin as important biomarker for ZIKV-GBM group, associated with cytopathic effects induced by viral infection. These result evidences that genetically engineered ZIKV might be a potential new strategy for neural cancer management through the induction of endogenous digoxin synthesis in GBM cells.
C1 [Lima, Estela de O.; Guerreiro, Tatiane M.; Melo, Carlos Fernando O. R.; de Oliveira, Diogo N.; Catharino, Rodrigo R.] Univ Campinas UNICAMP, Sch Pharmaceut Sci, Innovare Biomarkers Lab, Campinas, SP, Brazil.
   [Machado, Daisy; Lancelloti, Marcelo] Univ Campinas UNICAMP, Sch Pharmaceut Sci, Biotechnol Lab, Campinas, SP, Brazil.
RP Catharino, RR (corresponding author), Univ Campinas UNICAMP, Sch Pharmaceut Sci, Innovare Biomarkers Lab, Campinas, SP, Brazil.
EM rrcatharino@gmail.com
RI de Oliveira, Diogo Noin/C-3939-2013; Lima, Estela/W-5105-2019; de
   Oliveira Lima, Estela/G-7375-2015; Machado, Daisy/A-4891-2013;
   Catharino, Rodrigo/G-1487-2013
OI de Oliveira, Diogo Noin/0000-0002-2725-476X; Lima,
   Estela/0000-0003-0479-0364; de Oliveira Lima,
   Estela/0000-0003-0479-0364; Machado, Daisy/0000-0002-6435-6159; Melo,
   Carlos/0000-0003-0334-1065; Catharino, Rodrigo/0000-0001-7219-2644
FU Plano Nacional de Enfrentamento ao Aedes aegypti e a Microcefalia
   [88887.137889/2017-00]; Sao Paulo Research Foundation (FAPESP)Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/50400-0,
   14/00302-0, 15/06809-1, 16/17066-2]; Coordination for the Improvement of
   Higher Level Personnel (CAPES)CAPES [PNPD: 1578388 PROEX: 1489740]
FX Plano Nacional de Enfrentamento ao Aedes aegypti e a Microcefalia,
   Grant/Award Number: 88887.137889/2017-00; Sao Paulo Research Foundation
   (FAPESP), Grant/Award Numbers: 11/50400-0, 14/00302-0, 15/06809-1 and
   16/17066-2; Coordination for the Improvement of Higher Level Personnel
   (CAPES), Grant/Award Number: PNPD: 1578388 PROEX: 1489740
CR Akimova Olga A, 2005, Pathophysiology, V12, P125, DOI 10.1016/j.pathophys.2005.03.003
   Bagrov AY, 1998, HYPERTENSION, V31, P1097, DOI 10.1161/01.HYP.31.5.1097
   Berens Michael E., 1999, Neoplasia (New York), V1, P208, DOI 10.1038/sj.neo.7900034
   Brunner M, 2004, CURR ORG CHEM, V8, P1629, DOI 10.2174/1385272043369638
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chavali PL, 2017, SCIENCE
   Cugola F. R., 2016, NATURE
   de Oliveira DN, 2013, MATERIALS, V6, P1000, DOI 10.3390/ma6031000
   Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364
   Gokhale MS, 2008, PHARMACOGNOSY
   Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200
   Hanners NW, 2016, CELL REP
   Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013
   Joshi AD, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-17
   Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218
   Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F
   Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302
   Kulikov A, 2007, BBA-BIOMEMBRANES, V1768, P1691, DOI 10.1016/j.bbamem.2007.04.012
   Ledford H, 2015, NATURE, V526, P622, DOI 10.1038/526622a
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200
   Liu J, 2000, J BIOL CHEM, V275, P27838
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   Lopez-Ladzaro M, 2005, J NAT PROD, V68, P1642, DOI 10.1021/np050226l
   Lutterbach J, 2001, RADIOTHER ONCOL, V61, P57, DOI 10.1016/S0167-8140(01)00415-7
   Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958
   MATHEWS WR, 1991, HYPERTENSION, V17, P930, DOI 10.1161/01.HYP.17.6.930
   Melero CP, 2000, MOLECULES, V5, P51, DOI 10.3390/50100051
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Newman RA, 2006, J EXP THER ONCOL, V5, P167
   Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837
   PAOWH Organization, 2016, ZIK SUSP CONF CAS RE
   Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682
   Qazzaz HMAM, 2004, CLIN CHEM, V50, P612, DOI 10.1373/clinchem.2003.022715
   Qazzaz HMAM, 1996, CLIN CHEM, V42, P1092
   Russell SJ, 2014, MAYO CLIN PROC, V89, P926, DOI 10.1016/j.mayocp.2014.04.003
   Saude Md, 2015, CONFIRMACAO ZIKA VIR
   Schatzmann H, 1965, HELV PHYSL PHARM ACT, V65
   Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007
   SHAIKH IM, 1991, J BIOL CHEM, V266, P13672
   Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128
   Stenkvist B, 1999, ONCOL REP, V6, P493
   STENKVIST B, 1982, NEW ENGL J MED, V306, P484
   STENKVIST B, 1980, ANAL QUANT CYTOL, V2, P49
   Stewart B, 2016, WORLD
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
   Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157
   Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 55
TC 3
Z9 3
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1076-5174
EI 1096-9888
J9 J MASS SPECTROM
JI J. Mass Spectrom.
PD MAR
PY 2018
VL 53
IS 3
BP 257
EP 263
DI 10.1002/jms.4058
PG 7
WC Biochemical Research Methods; Chemistry, Analytical; Spectroscopy
SC Biochemistry & Molecular Biology; Chemistry; Spectroscopy
GA FY2FR
UT WOS:000426631300009
PM 29285820
DA 2020-07-08
ER

PT J
AU Liu, SQ
   Li, X
   Deng, CL
   Yuan, ZM
   Zhang, B
AF Liu, Si-Qing
   Li, Xiao
   Deng, Cheng-Lin
   Yuan, Zhi-Ming
   Zhang, Bo
TI Development and evaluation of one-step multiplex real-time RT-PCR assay
   for simultaneous detection of Zika virus and Chikungunya virus
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE amplification; chikungunya virus; multiplex real-time RT-PCR assay; Zika
   virus
ID INFECTIOUS CDNA-CLONE; ENCEPHALITIS-VIRUS; DENGUE VIRUSES; FEVER VIRUS;
   TRANSMISSION; MUTATIONS; INSIGHTS; REVEALS; CHINA
AB Zika virus (ZIKV) and chikungunya virus (CHIKV) are important human pathogens and mosquito-borne arboviruses, which have resembling history, common vectors, circulating regions, and indistinguishable clinical symptoms. Wide geographical range that is suitable for ZIKV and CHIKV transmission underlines the concern about the impact of epidemic and endemic infections on burden of public health. In the present study, a highly sensitive and specific one-step multiplex real-time RT-PCR assay was developed and evaluated for simultaneous detection and quantification of ZIKV and CHIKV. The single reaction assay employs two pairs of primers and two TaqMan probes that differentiate ZIKV and CHIKV infections. The entire viral genomic RNA in vitro transcribed from full-length infectious clones were used to generate the standard curves for absolute quantification in subsequent tests. The detection limit of the one-step multiplex assay was 1 and 0.5 PFU for infectious ZIKV and CHIKV, respectively. The assessment of specificity indicated this assay is highly specific to targeted viruses showing no amplification of a variety of other flaviviruses. Our assay was able to detect geographically separated and phylogenetically diverse strains of ZIKV and CHIKV. On the applicability of monitoring viral multiplication in cells and testing clinical samples, the one-step multiplex assay provided efficient and accurate determination. The one-step multiplex real-time RT-PCR assay offers a valuable tool for detection of ZIKV and CHIKV and potentially contributes to general surveillance and clinical treatment.
C1 [Liu, Si-Qing; Li, Xiao; Deng, Cheng-Lin; Yuan, Zhi-Ming; Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430071, Hubei, Peoples R China.
   [Li, Xiao] Univ Chinese Acad Sci, Beijing, Peoples R China.
RP Zhang, B (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430071, Hubei, Peoples R China.
EM zhangbo@wh.iov.cn
OI Zhang, Bo/0000-0002-8895-3679
FU Major State Basic Research Development ProgramNational Basic Research
   Program of China [2013FY113500]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31600141, 81572003]
FX Major State Basic Research Development Program, Grant number:
   2013FY113500; National Natural Science Foundation of China, Grant
   numbers: 31600141, 81572003
CR Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen HX, 2015, J MOL DIAGN, V17, P722, DOI 10.1016/j.jmoldx.2015.06.008
   Chen RB, 2016, J VIROL, V90, P10600, DOI 10.1128/JVI.01166-16
   Deng CL, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070181
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Giry C, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1019-1
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li XD, 2014, J GEN VIROL, V95, P806, DOI 10.1099/vir.0.061838-0
   Liu SQ, 2016, VIROL SIN, V2, P1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pongsiri P, 2012, ASIAN PAC J TROP MED, V5, P342, DOI 10.1016/S1995-7645(12)60055-8
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Yang CF, 2010, J VIROL METHODS, V168, P147, DOI 10.1016/j.jviromet.2010.05.006
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Yoshii K, 2011, VIRUS RES, V155, P61, DOI 10.1016/j.virusres.2010.08.023
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang XW, 2016, VIRUS RES, V213, P6, DOI 10.1016/j.virusres.2015.11.006
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 40
TC 8
Z9 9
U1 0
U2 76
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAR
PY 2018
VL 90
IS 3
BP 389
EP 396
DI 10.1002/jmv.24970
PG 8
WC Virology
SC Virology
GA FS1CE
UT WOS:000419510600001
PM 28980717
OA Bronze
DA 2020-07-08
ER

PT J
AU Curry, CL
   Tse, C
   Billero, V
   Hellerstein, L
   Messore, M
   Fein, L
AF Curry, Christine L.
   Tse, Colette
   Billero, Victoria
   Hellerstein, Leah
   Messore, Marisa
   Fein, Lydia
TI Knowledge and perceptions of Zika virus among reproductive-aged women
   after public announcement of local mosquito-borne transmission
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
LA English
DT Article
DE pregnancy; prevention; public health; Zika
ID PREGNANT-WOMEN
AB AimThis study was conducted to ascertain the knowledge and perceptions of the Zika virus among reproductive-aged women living in the first affected area of the United States with local mosquito-borne transmission.
   MethodsReproductive-aged women were surveyed during the fourweeks immediately following the announcement of local Zika virus transmission. The survey evaluated the participant's knowledge of Zika pathogenesis and transmission, sequelae of infection, epidemiology and public health information.
   ResultsFifty-nine women (age range 18-45) completed the survey. Most patients (n=53, 89.8%) had received information about the Zika virus from the media rather than clinicians. In 93% of the questions, a high level of knowledge was demonstrated by the participants. Personal concern about becoming infected with the Zika virus was significantly higher in those considering pregnancy (n=13, 86.7% vs n=21, 47.7%; P=0.01).
   ConclusionIn the weeks following recognized local transmission of the Zika virus in the continental United States, reproductive-aged women had a high level of knowledge of the Zika virus, but those considering pregnancy harbored the greatest concern of personal risk of infection.
C1 [Curry, Christine L.; Tse, Colette; Billero, Victoria; Hellerstein, Leah; Fein, Lydia] Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Miami, FL 33136 USA.
   [Messore, Marisa] Mt Sinai Med Ctr, Dept Obstet & Gynecol, Miami, FL USA.
RP Curry, CL (corresponding author), 1611 NW 12th Ave 7007, Miami, FL 33136 USA.
EM clcurry@gmail.com
OI Curry, Christine L/0000-0003-4783-9623
CR Abramson D, 2016, 1 NYU
   Centers for Disease Control and Prevention, 2016, SYMPT TEST TREATM
   Centers for Disease Control and Prevention, 2016, AR RISK ZIK
   Centers for Disease Control and Prevention, 2016, AB ZIK
   Gidado S, 2015, PLOS CURR
   Goldschmidt D, 2016, FLORIDA HLTH OFFICIA
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1460
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
NR 18
TC 5
Z9 5
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1341-8076
EI 1447-0756
J9 J OBSTET GYNAECOL RE
JI J. Obstet. Gynaecol. Res.
PD MAR
PY 2018
VL 44
IS 3
BP 503
EP 508
DI 10.1111/jog.13533
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FY4KR
UT WOS:000426792400017
PM 29111579
DA 2020-07-08
ER

PT J
AU Colavita, F
   Musumeci, G
   Caglioti, C
AF Colavita, Francesca
   Musumeci, Giuseppina
   Caglioti, Claudia
TI Human Osteoblast-like Cells Are Permissive for Zika Virus Replication
SO JOURNAL OF RHEUMATOLOGY
LA English
DT Letter
ID INFECTION
C1 [Colavita, Francesca; Caglioti, Claudia] IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Virol, Via Portuense 292, Rome, Italy.
   [Musumeci, Giuseppina] Univ Bologna, Sch Med, Sect Dept Expt Diagnost & Specialty Med, Dept Microbiol, Bologna, Italy.
RP Caglioti, C (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Virol, Via Portuense 292, Rome, Italy.
EM claudia.caglioti@inmi.it
RI Colavita, Francesca/I-8848-2018
OI Colavita, Francesca/0000-0003-0640-8667
FU Italian Ministry of Health (Ricerca Corrente)Ministry of Health, Italy
FX Institute for Infectious Diseases L. Spallanzani, Istituto Di Ricovero e
   Cura a Carattere Scientifico (IRCCS), Rome; GIUSEPPINA MUSUMECI,
   Biologist, Department of Microbiology, Section of the Department of
   Experimental, Diagnostic and Specialty Medicine, School of Medicine,
   University of Bologna, Bologna; CLAUDIA CAGLIOTI, Biologist, Laboratory
   of Virology, National Institute for Infectious Diseases L. Spallanzani,
   IRCCS, Rome, Italy. This study was partly supported by the Italian
   Ministry of Health (Ricerca Corrente). The authors gratefully
   acknowledge the scientific support and the mentoring of Dr. Licia Bordi,
   Dr. Concetta Castilletti, and Dr. Eleonora Lalle (Rome); and the help
   and encouragement of Dr. Maria Rosaria Capobianchi, Dr. Giuseppe
   Ippolito (Rome), Prof. Maria Carla Re (Bologna), and Prof. Davide
   Gibellini (Verona). We also thank Dr. Serena Quartu and Dr. Mirella
   Biava (Rome) for technical support. Address correspondence to Dr. C.
   Caglioti, National Institute for Infectious Diseases L. Spallanzani,
   IRCCS, Laboratory of Virology, Via Portuense 292, Rome, Italy. E-mail:
   claudia.caglioti@inmi.it
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Roimicher L, 2017, J RHEUMATOL, V44, DOI 10.3899/jrheum.160722
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
NR 10
TC 4
Z9 4
U1 0
U2 0
PU J RHEUMATOL PUBL CO
PI TORONTO
PA 365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA
SN 0315-162X
EI 1499-2752
J9 J RHEUMATOL
JI J. Rheumatol.
PD MAR 1
PY 2018
VL 45
IS 3
BP 443
EP 443
DI 10.3899/jrheum.170835
PG 1
WC Rheumatology
SC Rheumatology
GA FX8TN
UT WOS:000426368000027
PM 29496921
OA Bronze
DA 2020-07-08
ER

PT J
AU Friedrich, S
   Engelmann, S
   Schmidt, T
   Szczepankiewicz, G
   Bergs, S
   Liebert, UG
   Kummerer, BM
   Golbik, RP
   Behrens, SE
AF Friedrich, Susann
   Engelmann, Susanne
   Schmidt, Tobias
   Szczepankiewicz, Grit
   Bergs, Sandra
   Liebert, Uwe G.
   Kuemmerer, Beate M.
   Golbik, Ralph P.
   Behrens, Sven-Erik
TI The Host Factor AUF1 p45 Supports Flavivirus Propagation by Triggering
   the RNA Switch Required for Viral Genome Cyclization
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE AUF1; dengue virus; flavivirus; RNA chaperone; RNA cyclization;
   RNA-protein interaction; RNA replication; West Nile virus; Zika virus;
   host factor
ID WEST-NILE-VIRUS; DENGUE VIRUS; IN-VITRO; CHAPERONE ACTIVITY;
   REPLICATION; PROTEIN; TRANSLATION; SEQUENCE; ELEMENTS; DECAY
AB In previous studies, we showed that the cellular RNA-binding protein AUF1 supports the replication process of the flavivirus West Nile virus. Here we demonstrate that the protein also enables effective proliferation of dengue virus and Zika virus, indicating that AUF1 is a general flavivirus host factor. Further studies demonstrated that the AUF1 isoform p45 significantly stimulates the initiation of viral RNA replication and that the protein's RNA chaperone activity enhances the interactions of the viral 5'UAR and 3'UAR genome cyclization sequences. Most interestingly, we observed that AUF1 p45 destabilizes not only the 3'-terminal stem-loop (3'SL) but also 5'-terminal stem-loop B (SLB) of the viral genome. RNA structure analyses revealed that AUF1 p45 increases the accessibility of defined nucleotides within the 3'SL and SLB and, in this way, exposes both UAR cyclization elements. Conversely, AUF1 p45 does not modulate the fold of stem-loop A (SLA) at the immediate genomic 5' end, which is proposed to function as a promoter of the viral RNA-dependent RNA polymerase (RdRp). These findings suggest that AUF1 p45, by destabilizing specific stem-loop structures within the 5' and 3' ends of the flaviviral genome, assists genome cyclization and concurrently enables the RdRp to initiate RNA synthesis. Our study thus highlights the role of a cellular RNA-binding protein inducing a flaviviral RNA switch that is crucial for viral replication.
   IMPORTANCE The genus Flavivirus within the Flaviviridae family includes important human pathogens, such as dengue, West Nile, and Zika viruses. The initiation of replication of the flaviviral RNA genome requires a transformation from a linear to a cyclized form. This involves considerable structural reorganization of several RNA motifs at the genomic 5' and 3' ends. Specifically, it needs a melting of stem structures to expose complementary 5' and 3' cyclization elements to enable their annealing during cyclization. Here we show that a cellular RNA chaperone, AUF1 p45, which supports the replication of all three aforementioned flaviviruses, specifically rearranges stem structures at both ends of the viral genome and in this way permits 5'-3' interactions of cyclization elements. Thus, AUF1 p45 triggers the RNA switch in the flaviviral genome that is crucial for viral replication. These findings represent an important example of how cellular (host) factors promote the propagation of RNA viruses.
C1 [Friedrich, Susann; Engelmann, Susanne; Schmidt, Tobias; Golbik, Ralph P.; Behrens, Sven-Erik] Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany.
   [Szczepankiewicz, Grit; Bergs, Sandra; Liebert, Uwe G.] Univ Leipzig, Inst Virol, Leipzig, Germany.
   [Kuemmerer, Beate M.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany.
   [Schmidt, Tobias] MRC, Toxicol Unit, Leicester, Leics, England.
RP Friedrich, S; Behrens, SE (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany.
EM susann.friedrich@biochemtech.uni-halle.de;
   sven.behrens@biochemtech.uni-halle.de
RI Schmidt, Tobias/V-4736-2019
OI Schmidt, Tobias/0000-0001-7230-1214; Friedrich,
   Susann/0000-0001-6378-2933
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [BE1885/7-1/2, BE1885/12-1, Graduiertenkolleg 1026, Graduiertenkolleg
   1591]
FX This work was supported by the Deutsche Forschungsgemeinschaft (grants
   BE1885/7-1/2 and BE1885/12-1 to S.F. and S.-E.B., Graduiertenkolleg 1026
   to T.S. and R.P.G., and Graduiertenkolleg 1591 to S.E. and S.-E.B.).
CR Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040
   Fernandez-Sanles A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00546
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289
   Friedrich S, 2016, RNA, V22, P1574, DOI 10.1261/rna.055269.115
   Friedrich S, 2014, J VIROL, V88, P11586, DOI 10.1128/JVI.01283-14
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Grohman JK, 2013, SCIENCE, V340, P190, DOI 10.1126/science.1230715
   Ivanyi-Nagy R, 2012, VIRUS RES, V167, P226, DOI 10.1016/j.virusres.2012.05.003
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499
   Lin JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094040
   Liu ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.17636
   Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003
   Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106
   Moore AE, 2014, WIRES RNA, V5, P549, DOI 10.1002/wrna.1230
   Nagy PD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005912
   Nomaguchi M, 2004, J BIOL CHEM, V279, P12141, DOI 10.1074/jbc.M310839200
   Paek KY, 2008, J VIROL, V82, P12082, DOI 10.1128/JVI.01405-08
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08
   Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Ullmer W, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120335
   Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142
   Waldsich C, 2014, RNA FOLDING
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   White EJF, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1393
   Yoon JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6248
   You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714
   Yu HY, 1999, J VIROL, V73, P3638, DOI 10.1128/JVI.73.5.3638-3648.1999
   Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182
NR 41
TC 9
Z9 9
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2018
VL 92
IS 6
AR e01647-17
DI 10.1128/JVI.01647-17
PG 15
WC Virology
SC Virology
GA FZ2XN
UT WOS:000427447100011
PM 29263261
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Xu, K
   Song, YF
   Dai, LP
   Zhang, YL
   Lu, XC
   Xie, YJ
   Zhang, HJ
   Cheng, T
   Wang, QH
   Huang, QR
   Bi, YH
   Liu, WJ
   Liu, WJ
   Li, XD
   Qin, C
   Shi, Y
   Yan, JH
   Zhou, DM
   Gao, GF
AF Xu, Kun
   Song, Yufeng
   Dai, Lianpan
   Zhang, Yongli
   Lu, Xuancheng
   Xie, Yijia
   Zhang, Hangjie
   Cheng, Tao
   Wang, Qihui
   Huang, Qingrui
   Bi, Yuhai
   Liu, William J.
   Liu, Wenjun
   Li, Xiangdong
   Qin, Chuan
   Shi, Yi
   Yan, Jinghua
   Zhou, Dongming
   Gao, George F.
TI Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika
   Virus Infection and Testis Damage
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; ZIKV; Zika vaccine; chimpanzee adenovirus vector; testis
   damage; sterilizing immunity
ID PLACEBO-CONTROLLED TRIAL; T-CELL RESPONSES; SEXUAL TRANSMISSION;
   STRUCTURAL BASIS; DNA VACCINE; EBOLA-VIRUS; MICE; CHALLENGE; INFLUENZA;
   EFFICACY
AB The recent outbreak of Zika virus (ZIKV) has emerged as a global health concern. ZIKV can persist in human semen and be transmitted by sexual contact, as well as by mosquitoes, as seen for classical arboviruses. We along with others have previously demonstrated that ZIKV infection leads to testis damage and infertility in mouse models. So far, no prophylactics or therapeutics are available; therefore, vaccine development is urgently demanded. Recombinant chimpanzee adenovirus has been explored as the preferred vaccine vector for many pathogens due to the low preexisting immunity against the vector among the human population. Here, we developed a ZIKV vaccine based on recombinant chimpanzee adenovirus type 7 (AdC7) expressing ZIKV M/E glycoproteins. A single vaccination of AdC7-M/E was sufficient to elicit potent neutralizing antibodies and protective immunity against ZIKV in both immunocompetent and immunodeficient mice. Moreover, vaccinated mice rapidly developed neutralizing antibody with high titers within 1 week postvaccination, and the elicited antiserum could crossneutralize heterologous ZIKV strains. Additionally, ZIKV M-and E-specific T cell responses were robustly induced by AdC7-M/E. Moreover, one-dose inoculation of AdC7-M/E conferred mouse sterilizing immunity to eliminate viremia and viral burden in tissues against ZIKV challenge. Further investigations showed that vaccination with AdC7-M/E completely protected against ZIKV-induced testicular damage. These data demonstrate that AdC7-M/E is highly effective and represents a promising vaccine candidate for ZIKV control.
   IMPORTANCE Zika virus (ZIKV) is a pathogenic flavivirus that causes severe clinical consequences, including congenital malformations in fetuses and Guillain-Barre syndrome in adults. Vaccine development is a high priority for ZIKV control. In this study, to avoid preexisting anti-vector immunity in humans, a rare serotype chimpanzee adenovirus (AdC7) expressing the ZIKV M/E glycoproteins was used for ZIKV vaccine development. Impressively, AdC7-M/E exhibited exceptional performance as a ZIKV vaccine, as follows: (i) protective efficacy by a single vaccination, (ii) rapid development of a robust humoral response, (iii) durable immune responses, (iv) robust T cell responses, and (v) sterilizing immunity achieved by a single vaccination. These advantages of AdC7-M/E strongly support its potential application as a promising ZIKV vaccine in the clinic.
C1 [Xu, Kun; Dai, Lianpan; Xie, Yijia; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing, Peoples R China.
   [Xu, Kun; Xie, Yijia; Liu, Wenjun; Shi, Yi; Yan, Jinghua; Gao, George F.] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Song, Yufeng; Cheng, Tao; Zhou, Dongming] Chinese Acad Sci, Inst Pasteur Shanghai, Vaccine Res Ctr, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.
   [Zhang, Yongli; Liu, William J.] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Peoples R China.
   [Lu, Xuancheng] Chinese Ctr Dis Control & Prevent, Lab Anim Ctr, Beijing, Peoples R China.
   [Zhang, Yongli; Zhang, Hangjie; Liu, William J.; Gao, George F.] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
   [Wang, Qihui; Huang, Qingrui; Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China.
   [Bi, Yuhai; Liu, Wenjun; Shi, Yi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Bi, Yuhai; Liu, Wenjun; Shi, Yi; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning, Beijing, Peoples R China.
   [Bi, Yuhai; Shi, Yi; Yan, Jinghua; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.
   [Li, Xiangdong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.
   [Qin, Chuan] Chinese Acad Med Sci, Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China.
   [Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China.
   [Gao, George F.] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.
RP Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing, Peoples R China.; Gao, GF (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Zhou, DM (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Vaccine Res Ctr, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Ctr Influenza Res & Early Warning, Beijing, Peoples R China.; Gao, GF (corresponding author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.; Gao, GF (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.
EM dmzhou@sibs.ac.cn; gaof@im.ac.cn
FU Chinese Academy of SciencesChinese Academy of Sciences [XDPB0301];
   MOSTMinistry of Science and Technology (MOST) Korea [2016YFC1201000];
   National Key R&D Program of China [2016YFE0205800]; National Science and
   Technology Major Project [2016ZX10004222-008]; CASDefence Research &
   Development Organisation (DRDO)Chinese Academy of Sciences
   [153211KYSB20160001]; NSFC Innovative Research Group [81621091]
FX This work was supported by the Strategic Priority Research Program of
   the Chinese Academy of Sciences (grant no. XDPB0301), a National Key
   Program Project Grant (grant no. 2016YFC1201000) from MOST, the National
   Key R&D Program of China (2016YFE0205800), the National Science and
   Technology Major Project (2016ZX10004222-008), and the External
   Cooperation Program of CAS (153211KYSB20160001). G.F.G. is partly
   supported as a leading principal investigator of the NSFC Innovative
   Research Group (grant no. 81621091).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   [Anonymous], 2016, WHO 1 M INT HLTH REG
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carnathan DG, 2015, P NATL ACAD SCI USA, V112, P518, DOI 10.1073/pnas.1407466112
   Chen TH, 2017, ANTIVIR RES, V146, P213, DOI 10.1016/j.antiviral.2017.09.014
   Cheng T, 2016, VACCINE, V34, P4875, DOI 10.1016/j.vaccine.2016.08.066
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Ertl HCJ, 2016, CURR OPIN VIROL, V21, P1, DOI 10.1016/j.coviro.2016.06.001
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Green CA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5745
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Kennedy SB, 2017, NEW ENGL J MED, V377, P1438, DOI 10.1056/NEJMoa1614067
   Kobinger GP, 2007, VACCINE, V25, P5220, DOI 10.1016/j.vaccine.2007.04.065
   Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HT, 2005, J IMMUNOL, V174, P195, DOI 10.4049/jimmunol.174.1.195
   Liu J, 2013, EUR J IMMUNOL, V43, P2055, DOI 10.1002/eji.201343417
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Rampling T, 2016, J INFECT DIS, V214, P772, DOI 10.1093/infdis/jiw244
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Roy S, 2007, VACCINE, V25, P6845, DOI 10.1016/j.vaccine.2007.07.035
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sharma A, 2014, VACCINE, V32, P5761, DOI [10.1016/j.vaccine.2014.08.049, 10.1016]
   Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185
   Tan SG, 2017, VACCINE, V35, P5644, DOI 10.1016/j.vaccine.2017.08.061
   Tapia MD, 2016, LANCET INFECT DIS, V16, P31, DOI 10.1016/S1473-3099(15)00362-X
   Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang X, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.30
   Wong G, 2017, CELL RES, V27, P1077, DOI 10.1038/cr.2017.53
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhi Y, 2006, HUM GENE THER, V17, P500, DOI 10.1089/hum.2006.17.500
   Zhou DM, 2010, NAT PROTOC, V5, P1775, DOI 10.1038/nprot.2010.134
NR 57
TC 29
Z9 30
U1 4
U2 30
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2018
VL 92
IS 6
AR e01722-17
DI 10.1128/JVI.01722-17
PG 16
WC Virology
SC Virology
GA FZ2XN
UT WOS:000427447100014
PM 29298885
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Krow-Lucal, ER
   de Andrade, MR
   Cananea, JNA
   Moore, CA
   Leite, PL
   Biggerstaff, BJ
   Cabral, CM
   Itoh, M
   Percio, J
   Wada, MY
   Powers, AM
   Barbosa, A
   Abath, RB
   Staples, JE
   Coelho, GE
AF Krow-Lucal, Elisabeth R.
   de Andrade, Marcia Regina
   Abath Cananea, Juliana Nunes
   Moore, Cynthia A.
   Leite, Priscila Leal
   Biggerstaff, Brad J.
   Cabral, Cibelle Mendes
   Itoh, Megumi
   Percio, Jadher
   Wada, Marcelo Y.
   Powers, Ann M.
   Barbosa, Aristides
   Abath, Roberta Batista
   Staples, J. Erin
   Coelho, Giovanini Evelim
CA Paraiba Microcephaly Work Grp
TI Association and birth prevalence of microcephaly attributable to Zika
   virus infection among infants in Paraiba, Brazil, in 2015-16: a
   case-control study
SO LANCET CHILD & ADOLESCENT HEALTH
LA English
DT Article
ID MICRONESIA; STATES
AB Background In 2015, the number of infants born with microcephaly increased in Paraiba, Brazil, after a suspected Zika virus outbreak. We did a retrospective case-control investigation to assess the association of microcephaly and Zika virus.
   Methods We enrolled cases reported to the national database for microcephaly and born between Aug 1, 2015, and Feb 1, 2016, on the basis of their birth head circumference and total body length. We identified controls from the national birth registry and matched them to cases by location, aiming to enrol a minimum of two controls per case. Mothers of both cases and controls were asked about demographics, exposures, and illnesses and infants were measured at a follow-up visit 1-7 months after birth. We took blood samples from mothers and infants and classified those containing Zika virus IgM and neutralising antibodies as evidence of recent infection. We calculated prevalence of microcephaly and odds ratios (ORs) using a conditional logistic regression model with maximum penalised conditional likelihood, and combined these ORs with exposure probability estimates to determine the attributable risk.
   Findings We enrolled 164 of 706 infants with complete information reported with microcephaly at birth, of whom we classified 91 (55%) as having microcephaly on the basis of their birth measurements, 36 (22%) as small, 21 (13%) as disproportionate, and 16 (10%) as not having microcephaly. 43 (26%) of the 164 infants had microcephaly at follow-up for an estimated prevalence of 5.9 per 1000 livebirths. We enrolled 114 control infants matched to the 43 infants classified as having microcephaly at follow-up. Infants with microcephaly at follow-up were more likely than control infants to be younger (OR 0.5, 95% CI 0.4-0.7), have recent Zika virus infection (21.9, 7.0-109.3), or a mother with Zika-like symptoms in the first trimester (6.2, 2.8-15.4). Once Zika virus infection and infant age were controlled for, we found no significant association between microcephaly and maternal demographics, medications, toxins, or other infections. Based on the presence of Zika virus antibodies in infants, we concluded that 35-87% of microcephaly occurring during the time of our investigation in northeast Brazil was attributable to Zika virus. We estimate 2-5 infants per 1000 livebirths in Paraiba had microcephaly attributable to Zika virus.
   Interpretation Time of exposure to Zika virus and evidence of infection in the infants were the only risk factors associated with microcephaly. This investigation has improved understanding of the outbreak of microcephaly in northeast Brazil and highlights the need to obtain multiple measurements after birth to establish if an infant has microcephaly and the need for further research to optimise testing criteria for congenital Zika virus infection.
C1 [Krow-Lucal, Elisabeth R.; Biggerstaff, Brad J.; Powers, Ann M.; Staples, J. Erin] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
   [Krow-Lucal, Elisabeth R.; Itoh, Megumi] Ctr Dis Control & Prevent, EIS Program Off, Atlanta, GA USA.
   [Moore, Cynthia A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Atlanta, GA USA.
   [de Andrade, Marcia Regina; Cabral, Cibelle Mendes; Percio, Jadher; Wada, Marcelo Y.] Epidemiol Aplicada Serv Sistema Unico Saude Eplsu, Brasilia, DF, Brazil.
   [Abath Cananea, Juliana Nunes; Abath, Roberta Batista] Secretariat Hlth, Joao Pessoa, Paraiba, Brazil.
   [Leite, Priscila Leal; Percio, Jadher; Wada, Marcelo Y.; Coelho, Giovanini Evelim] Brazil Minist Hlth, Natl Dengue Control Program, Brasilia, DF, Brazil.
   [Barbosa, Aristides] Ctr Dis Control & Prevent, Brazil Country Off, Brasilia, DF, Brazil.
RP Staples, JE (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
EM auv1@cdc.gov
OI PERCIO, JADHER/0000-0002-3641-8105
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX Centers for Disease Control and Prevention.
CR Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157
   Brasil Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Brasil Ministerio da Saude, 2015, EM SAUD PUBL IMP NAC
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Centers for Disease Control and Prevention, CONG ZIK SYNDR OTH B
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Heinze G, 2010, STAT MED, V29, P770, DOI 10.1002/sim.3794
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Martin D, 2000, J CLIN MICROBIOL, V73, P1407
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Ploner M, COX REGRESSION FIRTH
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   State Birth Defects Surveillance Program, MAJ BIRTH DEF DAT PO
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 27
TC 20
Z9 21
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-4642
J9 LANCET CHILD ADOLESC
JI Lancet Child. Adolesc. Health
PD MAR
PY 2018
VL 2
IS 3
BP 204
EP 213
DI 10.1016/S2352-4642(18)30020-8
PG 9
WC Pediatrics
SC Pediatrics
GA GI8HW
UT WOS:000434766300019
PM 30169255
OA Bronze
DA 2020-07-08
ER

PT J
AU Costa, F
   Ko, AI
AF Costa, Federico
   Ko, Albert I.
TI Zika virus and microcephaly: where do we go from here?
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID INFECTION; BRAZIL; PREGNANCY; JANUARY; INFANTS; BIRTH
C1 [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Costa, Federico; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
RP Ko, AI (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.; Ko, AI (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
EM albert.ko@yale.edu
RI Costa, Federico/G-1838-2015; Ko, Albert Icksang/P-2343-2015
OI Costa, Federico/0000-0001-6951-2336; Ko, Albert
   Icksang/0000-0001-9023-2339
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   deAraujo T.V.B, 2017, LANCET INFECT DIS
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 13
TC 4
Z9 4
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2018
VL 18
IS 3
BP 236
EP 237
DI 10.1016/S1473-3099(17)30697-7
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA FX2ZO
UT WOS:000425938000011
PM 29242092
OA Bronze
DA 2020-07-08
ER

PT J
AU de Araujo, TVB
   Ximenes, RADA
   Miranda, DD
   Souza, WV
   Montarroyos, UR
   de Melo, APL
   Valongueiro, S
   de Albuquerque, MDPM
   Braga, C
   Brandao, SP
   Cordeiro, MT
   Vazquez, E
   Cruz, DDS
   Henriques, CMP
   Bezerra, LCA
   Castanha, PMD
   Dhalia, R
   Marques, ETA
   Martelli, CMT
   Rodrigues, LC
AF Barreto de Araujo, Thalia Velho
   de Alencar Ximenes, Ricardo Arraes
   Miranda-Filho, Democrito de Barros
   Souza, Wayner Vieira
   Montarroyos, Ulisses Ramos
   Lopes de Melo, Ana Paula
   Valongueiro, Sandra
   Pessoa Militao de Albuquerque, Maria de Fatima
   Braga, Cynthia
   Brandao Filho, Sinval Pinto
   Cordeiro, Marli Tenorio
   Vazquez, Enrique
   Souza Cruz, Danielle di Cavalcanti
   Pessanha Henriques, Claudio Maierovitch
   Albuquerque Bezerra, Luciana Caroline
   da Silva Castanha, Priscila Mayrelle
   Dhalia, Rafael
   Azevedo Marques-Junior, Ernesto Torres
   Turchi Martelli, Celina Maria
   Rodrigues, Laura Cunha
CA Investigators Microcephaly Epidem
TI Association between microcephaly, Zika virus infection, and other risk
   factors in Brazil: final report of a case-control study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID BIRTH-DEFECTS; GESTATIONAL-AGE; PREGNANCY; INFANTS; FETUSES; SMOKING
AB Background A Zika virus epidemic emerged in northeast Brazil in 2015 and was followed by a striking increase in congenital microcephaly cases, triggering a declaration of an international public health emergency. This is the final report of the first case-control study evaluating the potential causes of microcephaly: congenital Zika virus infection, vaccines, and larvicides. The published preliminary report suggested a strong association between microcephaly and congenital Zika virus infection.
   Methods We did a case-control study in eight public maternity hospitals in Recife, Brazil. Cases were neonates born with microcephaly, defined as a head circumference of 2 SD below the mean. Two controls without microcephaly were matched to each case by expected date of delivery and area of residence. We tested the serum of cases and controls and the CSF of cases for detection of Zika virus genomes with quantitative RT-PCR and for detection of IgM antibodies with capture-IgM ELISA. We also tested maternal serum with plaque reduction neutralisation assays for Zika and dengue viruses. We estimated matched crude and adjusted odds ratios with exact conditional logistic regression to determine the association between microcephaly and Zika virus infection.
   Findings We screened neonates born between Jan 15 and Nov 30, 2016, and prospectively recruited 91 cases and 173 controls. In 32 (35%) cases, congenital Zika virus infection was confirmed by laboratory tests and no controls had confirmed Zika virus infections. 69 (83%) of 83 cases with known birthweight were small for gestational age, compared with eight (5%) of 173 controls. The overall matched odds ratio was 73.1 (95% CI 13.0-infinity) for microcephaly and Zika virus infection after adjustments. Neither vaccination during pregnancy or use of the larvicide pyriproxyfen was associated with microcephaly. Results of laboratory tests for Zika virus and brain imaging results were available for 79 (87%) cases; within these cases, ten were positive for Zika virus and had cerebral abnormalities, 13 were positive for Zika infection but had no cerebral abnormalities, and 11 were negative for Zika virus but had cerebral abnormalities.
   Interpretation The association between microcephaly and congenital Zika virus infection was confirmed. We provide evidence of the absence of an effect of other potential factors, such as exposure to pyriproxyfen or vaccines (tetanus, diphtheria, and acellular pertussis, measles and rubella, or measles, mumps, and rubella) during pregnancy, confirming the findings of an ecological study of pyriproxyfen in Pernambuco and previous studies on the safety of Tdap vaccine administration during pregnancy.
C1 [Barreto de Araujo, Thalia Velho; Valongueiro, Sandra] Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes; Miranda-Filho, Democrito de Barros; Montarroyos, Ulisses Ramos] Univ Pernambuco, Recife, PE, Brazil.
   [Souza, Wayner Vieira; Pessoa Militao de Albuquerque, Maria de Fatima; Braga, Cynthia; Brandao Filho, Sinval Pinto; Cordeiro, Marli Tenorio; da Silva Castanha, Priscila Mayrelle; Dhalia, Rafael; Azevedo Marques-Junior, Ernesto Torres; Turchi Martelli, Celina Maria] Oswaldo Cruz Fdn Fiocruz, Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [Lopes de Melo, Ana Paula] Univ Fed Pernambuco, Dept Community Hlth, Vitoria De Santo Antao, Brazil.
   [Vazquez, Enrique] Pan Amer Hlth Org, Brasilia, DF, Brazil.
   [Souza Cruz, Danielle di Cavalcanti] Inst Materno Infantil Fernando Figueira, Recife, PE, Brazil.
   [Pessanha Henriques, Claudio Maierovitch] Brazilian Minist Hlth, Brasilia, DF, Brazil.
   [Albuquerque Bezerra, Luciana Caroline] State Hlth Dept Pernambuco, Recife, PE, Brazil.
   [Azevedo Marques-Junior, Ernesto Torres] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP de Araujo, TVB (corresponding author), Univ Fed Pernambuco, BR-50670901 Recife, PE, Brazil.
EM thalia@ufpe.br
RI Dhalia, Rafael/AAD-5432-2020; Marques, Ernesto T. A/L-4967-2013; Souza,
   Wayner V/H-3798-2013; Braga, Maria Cynthia/A-8204-2013; Brandao-Filho,
   Sinval Pinto/AAP-4792-2020; Montarroyos, Ulisses/AAJ-7527-2020;
   CASTANHA, PRISCILA/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; Brandao-Filho, Sinval
   Pinto/0000-0003-3768-2810; CASTANHA, PRISCILA/0000-0002-1220-5308;
   Turchi Martelli, Celina Maria/0000-0002-2491-0688; Souza,
   Wayner/0000-0002-0939-9332
FU Brazilian Ministry of Health; Pan American Health Organization;
   Enhancing Research Activity in Epidemic Situations
FX Brazilian Ministry of Health, Pan American Health Organization, and
   Enhancing Research Activity in Epidemic Situations.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022
   HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Instituto de Pesquisa Economica Aplicada, 2014, SIT SOC POP NEGR EST
   Ko TJ, 2014, PEDIATR NEONATOL, V55, P20, DOI 10.1016/j.pedneo.2013.05.005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Ministerio da Saude, 2014, INF TECN IMPL VAC AD
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   STATA, EX LOG REGR REF MAN, P507
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Walls T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009536
   WHO, 2016, SCREEN ASS MAN NON I
NR 33
TC 94
Z9 96
U1 4
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2018
VL 18
IS 3
BP 328
EP 336
DI 10.1016/S1473-3099(17)30727-2
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA FX2ZO
UT WOS:000425938000040
PM 29242091
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Siedner, MJ
   Ryan, ET
   Bogoch, II
AF Siedner, Mark J.
   Ryan, Edward T.
   Bogoch, Isaac I.
TI Gone or forgotten? The rise and fall of Zika virus
SO LANCET PUBLIC HEALTH
LA English
DT Editorial Material
ID INFECTION
C1 [Siedner, Mark J.; Ryan, Edward T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.
   [Siedner, Mark J.; Ryan, Edward T.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA.
   [Siedner, Mark J.] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda.
   [Bogoch, Isaac I.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada.
RP Siedner, MJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Siedner, MJ (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Siedner, MJ (corresponding author), Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda.
EM msiedner@mgh.harvard.edu
CR Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
NR 7
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2468-2667
J9 LANCET PUBLIC HEALTH
JI Lancet Public Health
PD MAR
PY 2018
VL 3
IS 3
BP E109
EP E110
DI 10.1016/S2468-2667(18)30029-X
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GL5PF
UT WOS:000437219700006
PM 29519697
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mishra, N
   Caciula, A
   Price, A
   Thakkar, R
   Ng, J
   Chauhan, LV
   Jain, K
   Che, XY
   Espinosa, DA
   Cruz, MM
   Balmaseda, A
   Sullivan, EH
   Patel, JJ
   Jarman, RG
   Rakeman, JL
   Egan, CT
   Reusken, CBEM
   Koopmans, MPG
   Harris, E
   Tokarz, R
   Briese, T
   Lipkin, WI
AF Mishra, Nischay
   Caciula, Adrian
   Price, Adam
   Thakkar, Riddhi
   Ng, James
   Chauhan, Lokendra V.
   Jain, Komal
   Che, Xiaoyu
   Espinosa, Diego A.
   Cruz, Magelda Montoya
   Balmaseda, Angel
   Sullivan, Eric H.
   Patel, Jigar J.
   Jarman, Richard G.
   Rakeman, Jennifer L.
   Egan, Christina T.
   Reusken, Chantal B. E. M.
   Koopmans, Marion P. G.
   Harris, Eva
   Tokarz, Rafal
   Briese, Thomas
   Lipkin, W. Ian
TI Diagnosis of Zika Virus Infection by Peptide Array and Enzyme-Linked
   Immunosorbent Assay
SO MBIO
LA English
DT Article
DE arbovirus; emerging infectious diseases; flavivirus; serology; Zika
ID ANTIBODY-RESPONSES; DENGUE; CHIKUNGUNYA; TRANSMISSION; COHORT; PCR
AB Zika virus (ZIKV) is implicated in fetal stillbirth, microcephaly, intracranial calcifications, and ocular anomalies following vertical transmission from infected mothers. In adults, infection may trigger autoimmune inflammatory polyneuropathy. Transmission most commonly follows the bite of infected Aedes mosquitoes but may also occur through sexual intercourse or receipt of blood products. Definitive diagnosis through detection of viral RNA is possible in serum or plasma within 10 days of disease onset, in whole blood within 3 weeks of onset, and in semen for up to 3 months. Serological diagnosis is nonetheless critical because few patients have access to molecular diagnostics during the acute phase of infection and infection may be associated with only mild or inapparent disease that does not prompt molecular testing. Serological diagnosis is confounded by cross-reactivity of immune sera with other flaviviruses endemic in the areas where ZIKV has recently emerged. Accordingly, we built a high-density microarray comprising nonredundant 12-mer peptides that tile, with one-residue overlap, the proteomes of Zika, dengue, yellow fever, West Nile, Ilheus, Oropouche, and chikungunya viruses. Serological analysis enabled discovery of a ZIKV NS2B 20-residue peptide that had high sensitivity (96.0%) and specificity (95.9%) versus natural infection with or vaccination against dengue, chikungunya, yellow fever, West Nile, tick-borne encephalitis, or Japanese encephalitis virus in a microarray assay and an enzyme-linked immunosorbent assay (ELISA) of early-convalescent-phase sera (2 to 3 weeks after onset of symptomatic infection).
   IMPORTANCE The emergence of Zika virus (ZIKV) as a teratogen is a profound challenge to global public health. Molecular diagnosis of infection is straightforward during the 3-week period when patients are viremic. However, serological diagnosis thereafter of historical exposure has been confounded by cross-reactivity. Using high-density peptide arrays that tile the proteomes of a selection of flaviviruses to identify a ZIKV-specific peptide, we established two assays that enable sensitive and specific diagnosis of exposure to ZIKV. These assays may be useful in guiding clinical management of mothers at risk for potential exposure to ZIKV and enable insights into the epidemiology of ZIKV infections.
C1 [Mishra, Nischay; Caciula, Adrian; Price, Adam; Thakkar, Riddhi; Ng, James; Chauhan, Lokendra V.; Jain, Komal; Che, Xiaoyu; Tokarz, Rafal; Briese, Thomas; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.
   [Espinosa, Diego A.; Cruz, Magelda Montoya; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Sullivan, Eric H.; Patel, Jigar J.] Roche Madison, Madison, WI USA.
   [Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA.
   [Rakeman, Jennifer L.] New York City Dept Hlth & Mental Hyg, Publ Hlth Lab, New York, NY USA.
   [Egan, Christina T.] New York State Dept Hlth, Biodef Lab, Wadsworth Ctr, Albany, NY USA.
   [Reusken, Chantal B. E. M.; Koopmans, Marion P. G.] Erasmus Univ, Dept Virosci, WHO Collaborating Ctr Arbovirus & Viral Haemorrha, Med Ctr, Rotterdam, Netherlands.
RP Mishra, N; Lipkin, WI (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.
EM nm2641@cumc.columbia.edu; wil2001@cumc.columbia.edu
RI Price, Adam/AAA-3128-2019; Koopmans, Marion/Y-9170-2019
OI Price, Adam/0000-0001-6114-6298; Koopmans, Marion/0000-0002-5204-2312;
   Lipkin, W. Ian/0000-0002-8768-9386; Espinosa, Diego
   A./0000-0002-4364-5031
FU National Institutes of Health awardUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U19AI109761];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P01AI106695,
   U19AI118610, R01AI099631]; ZIKAlliance [73548]; Mailman School of Public
   Health, Columbia University
FX We are grateful for financial support from National Institutes of Health
   award U19AI109761 (CETR [Center for Research in Diagnostics and
   Discovery]). E.H. received funding support from National Institutes of
   Health grants P01AI106695, U19AI118610, and R01AI099631 (to A.B.).
   C.B.E.M.R. received funding support from ZIKAlliance H2020 (73548). N.M.
   was partially supported by 2016-2017 Calderone Junior Faculty Awards
   awarded by the Mailman School of Public Health, Columbia University.
CR [Anonymous], 2016, EL NUEVO DIARIO
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   CLASSEN DC, 1987, J CLIN MICROBIOL, V25, P600, DOI 10.1128/JCM.25.4.600-604.1987
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Gonzalez JP, 2018, METHODS MOL BIOL, V1604, P3, DOI 10.1007/978-1-4939-6981-4_1
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lipkin WI., 2016, WALL STREET J
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mattia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027252
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Oshlack A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r2
   Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   United Nations Development Programme, 2017, SOC EC COSTS ZIK CAN
   US Food and Drug Administration, 2017, CII ARBOVIROPLEX RRT
   Valentini D, 2017, INT J INFECT DIS, V56, P140, DOI 10.1016/j.ijid.2017.01.027
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   World Health Organization, 2016, WHOZIKVLAB161
NR 42
TC 17
Z9 17
U1 2
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2018
VL 9
IS 2
AR e00095-18
DI 10.1128/mBio.00095-18
PG 16
WC Microbiology
SC Microbiology
GA GE5RK
UT WOS:000431279600018
PM 29511073
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Evans, HC
   Elliot, SL
   Barreto, RW
AF Evans, Harry C.
   Elliot, Simon L.
   Barreto, Robert W.
TI Entomopathogenic fungi and their potential for the management of Aedes
   aegypti (Diptera: Culicidae) in the Americas
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Aedes mosquitoes; classical biological control; enemy release
   hypothesis; flaviviruses; infection strategies; pathogenic fungi
ID CLASSICAL BIOLOGICAL-CONTROL; ZIKA VIRUS; ENTOMOPHTHORA AQUATICA;
   MOSQUITO; HISTORY; RESISTANCE; DIVERSITY; MAIMAIGA; EFFICACY; RELEASE
AB Classical biological control has been used extensively for the management of exotic weeds and agricultural pests, but never for alien insect vectors of medical importance. This simple but elegant control strategy involves the introduction of coevolved natural enemies from the centre of origin of the target alien species. Aedes aegypti - the primary vector of the dengue, yellow fever and Zika flaviviruses - is just such an invasive alien in the Americas where it arrived accidentally from its West African home during the slave trade. Here, we introduce the concept of exploiting entomopathogenic fungi from Africa for the classical biological control of Ae. aegypti in the Americas. Fungal pathogens attacking arthropods are ubiquitous in tropical forests and are important components in the natural balance of arthropod populations. They can produce a range of specialised spore forms, as well as inducing a variety of bizarre behaviours in their hosts, in order to maximise infection. The fungal groups recorded as specialised pathogens of mosquito hosts worldwide are described and discussed. We opine that similar fungal pathogens will be found attacking and manipulating Ae. aegypti in African forests and that these could be employed for an economic, environmentally-safe and long-term solution to the flavivirus pandemics in the Americas.
C1 [Evans, Harry C.] Ctr Agr & Biosci Int, Egham, Surrey, England.
   [Evans, Harry C.; Elliot, Simon L.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.
   [Evans, Harry C.; Barreto, Robert W.] Univ Fed Vicosa, Dept Fitopatol, Vicosa, MG, Brazil.
RP Barreto, RW (corresponding author), Univ Fed Vicosa, Dept Fitopatol, Vicosa, MG, Brazil.
EM rbarreto@ufv.br
FU CAPESCAPES [88881.068090/2014-01]
FX CAPES (grant no. 88881.068090/2014-01).
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Alkhaibari AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005715
   ANDERSON JF, 1969, J INVERTEBR PATHOL, V13, P386, DOI 10.1016/0022-2011(69)90191-8
   ANDREADIS TG, 1983, J INVERTEBR PATHOL, V42, P277, DOI 10.1016/0022-2011(83)90073-3
   ANDREADIS TG, 1990, P NATL ACAD SCI USA, V87, P2461, DOI 10.1073/pnas.87.7.2461
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Araujo JPM, 2015, PHYTOTAXA, V220, P224, DOI 10.11646/phytotaxa.220.3.2
   Azevedo-Santos VM, 2016, SCIENCE, V351, P675, DOI 10.1126/science.351.6274.675
   Bellows TS, 2001, BIOL CONTROL, V21, P199, DOI 10.1006/bcon.2001.0936
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423
   Blanford S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-365
   Bokonon-Ganta AH, 2002, AGR ECOSYST ENVIRON, V93, P367, DOI 10.1016/S0167-8809(01)00337-1
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Butt TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081686
   CAMARGO S, 1967, B WORLD HEALTH ORGAN, V36, P602
   COST Action 842, 2007, 842 COST EU OFF
   COUCH JN, 1985, GENUS COELOMOMYCES
   Culliney TW, 2005, CRIT REV PLANT SCI, V24, P131, DOI 10.1080/07352680590961649
   Darbro JM, 2011, BIOCONTROL SCI TECHN, V21, P1027, DOI 10.1080/09583157.2011.597913
   de Bekker C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1812-x
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   dos Santos CND, 2016, TRENDS PARASITOL, V32, P508, DOI 10.1016/j.pt.2016.03.008
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Eilenberg J., 2000, MANUAL PALAEARCTIC D, P521
   Elton C. S., 1958, ECOLOGY INVASIONS AN
   Evans H. C., 2003, Clavicipitalean Fungi: evolutionary biology, chemistry, biocontrol and cultural impacts, P517
   Evans H. C., 2013, AGR APPL, P145, DOI DOI 10.1007/978-3-642-36821-9_6
   Evans Harry C., 2013, P107
   Evans HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017024
   EVANS HC, 1974, J APPL ECOL, V11, P37, DOI 10.2307/2402003
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Flores AE, 2013, J ECON ENTOMOL, V106, P959, DOI 10.1603/EC12284
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gryganskyi AP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006274
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hajek A. E., 2007, FIELD MANUAL TECHNIQ, P299
   Hajek AE, 1999, MICROBIOL MOL BIOL R, V63, P814, DOI 10.1128/MMBR.63.4.814-835.1999
   Hajek AE, 2007, BIOL CONTROL, V41, P1, DOI 10.1016/j.biocontrol.2006.11.003
   Hajek AE, 2010, BIOCONTROL, V55, P147, DOI 10.1007/s10526-009-9253-6
   Hajek AE, 2007, BIOLOGICAL CONTROL: A GLOBAL PERSPECTIVE, P53, DOI 10.1079/9781845932657.0053
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Henry LM, 2010, ECOL APPL, V20, P242, DOI 10.1890/08-1869.1
   HERREN HR, 1991, ANNU REV ENTOMOL, V36, P257, DOI 10.1146/annurev.en.36.010191.001353
   Hoddle MS, 2004, CONSERV BIOL, V18, P38, DOI 10.1111/j.1523-1739.2004.00249.x
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004765
   Hughes DP, 2016, ADV GENET, V94, P437, DOI 10.1016/bs.adgen.2016.01.004
   Hughes D, 2013, J EXP BIOL, V216, P142, DOI 10.1242/jeb.077461
   Hughes DP, 2006, TRENDS ECOL EVOL, V21, P533, DOI 10.1016/j.tree.2006.07.010
   Inglis G. D., 2001, Fungi as biocontrol agents: progress, problems and potential, P23, DOI 10.1079/9780851993560.0023
   Jenkins NE, 1998, BIOCONTROL NEWS INFO, V19, P21
   Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0
   Leewis RJ, 2007, BIOL GLOBALISATION B
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   MADDOX JV, 1992, THOM SAY P, P27
   McFadyen REC, 1998, ANNU REV ENTOMOL, V43, P369, DOI 10.1146/annurev.ento.43.1.369
   Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE D, 2004, BIOCONTROL NEWS INF, V25, P17
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NADEAU MP, 1994, J AM MOSQUITO CONTR, V10, P487
   Neuenschwander P, 1996, ENTOMOPHAGA, V41, P405, DOI 10.1007/BF02765793
   Osorio JE, 2011, VACCINE, V29, P7251, DOI 10.1016/j.vaccine.2011.07.020
   Pell J. K., 2001, Fungi as biocontrol agents: progress, problems and potential, P71, DOI 10.1079/9780851993560.0071
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   ROBERTS D W, 1970, Miscellaneous Publications of the Entomological Society of America, V7, P140
   Rodriguez-Perez MA, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P241
   Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   SAMSON R, 1988, ATLAS ENTOMOPATHOGEN
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639
   Scholte Ernst-Jan, 2008, Entomologische Berichten (Amsterdam), V68, P21
   Shah PA, 1999, BIOCONTROL SCI TECHN, V9, P19, DOI 10.1080/09583159929875
   Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8
   Shang YF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005037
   SIGLER L, 1987, MYCOLOGIA, V79, P493, DOI 10.2307/3807586
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Sylla M, 2013, J VECTOR ECOL, V38, P237, DOI 10.1111/j.1948-7134.2013.12036.x
   Trandem N, 2015, J INVERTEBR PATHOL, V128, P6, DOI 10.1016/j.jip.2015.04.002
   Vogel G, 2016, SCIENCE, V352, P1152, DOI 10.1126/science.352.6290.1152
   Warner KD, 2012, BIOCONTROL, V57, P307, DOI 10.1007/s10526-011-9419-x
   Weiser J., 1991, BIOL CONTROL VICTORS
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, 2009, DENG GUID TREATM PRE
   Wraight S.P., 2007, FIELD MANUAL TECHNIQ, P223
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yalwala S, 2015, J VECTOR ECOL, V40, P301, DOI 10.1111/jvec.12168
   Yaninek S, 2007, BIOLOGICAL CONTROL: A GLOBAL PERSPECTIVE, P28, DOI 10.1079/9781845932657.0028
NR 98
TC 1
Z9 2
U1 0
U2 23
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAR
PY 2018
VL 113
IS 3
BP 206
EP 214
DI 10.1590/0074-02760170369
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FV3TM
UT WOS:000424492000010
PM 29412361
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nitatpattana, N
   Chaiyo, K
   Rajakam, S
   Poolam, K
   Chansiprasert, K
   Pesirikan, N
   Buree, S
   Rodpai, E
   Yoksan, S
AF Nitatpattana, Narong
   Chaiyo, Kumchol
   Rajakam, Supoth
   Poolam, Kanya
   Chansiprasert, Kusuma
   Pesirikan, Norapath
   Buree, Supanat
   Rodpai, Ekkarat
   Yoksan, Sutee
TI Complete Genome Sequence of a Zika Virus Strain Isolated from the Serum
   of an Infected Patient in Thailand in 2006
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
ID RT-PCR; IDENTIFICATION
AB The complete genome of Zika virus (ZIKV) strain CVD_06-274 was isolated from the serum of an infected patient in Thailand in 2006. Phylogenetic analysis showed that this strain belongs to the Asian lineage and also high titers in Vero cells (RCB 10-87). It has potential for development as an inactivated ZIKV vaccine.
C1 [Nitatpattana, Narong; Chaiyo, Kumchol; Rajakam, Supoth; Poolam, Kanya; Chansiprasert, Kusuma; Buree, Supanat; Rodpai, Ekkarat; Yoksan, Sutee] Mahidol Univ, Inst Mol Biosci, Salaya, Nakhon Pathom, Thailand.
   [Pesirikan, Norapath] Minist Publ Hlth, Govt Pharmaceut Org, Bangkok, Thailand.
RP Nitatpattana, N (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya, Nakhon Pathom, Thailand.
EM narong.nit@mahidol.ac.th
FU National Vaccine Institute Ministry of Public Health, Thailand
   [2560.1/7]
FX This project was supported by the National Vaccine Institute Ministry of
   Public Health, Thailand (grant 2560.1/7).
CR Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Jirakanjanakit N, 1999, VACCINE, V17, P597, DOI 10.1016/S0264-410X(98)00239-4
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leguia M, 2017, J VIROL METHODS, V248, P77, DOI 10.1016/j.jviromet.2017.06.005
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
NR 11
TC 6
Z9 6
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD MAR
PY 2018
VL 6
IS 10
AR UNSP e00121-18
DI 10.1128/genomeA.00121-18
PG 2
WC Microbiology
SC Microbiology
GA HD2ES
UT WOS:000452324500014
PM 29519832
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Waldorf, KMA
   Nelson, BR
   Stencel-Baerenwald, JE
   Studholme, C
   Kapur, RP
   Armistead, B
   Walker, CL
   Merillat, S
   Vornhagen, J
   Tisoncik-Go, J
   Baldessari, A
   Coleman, M
   Dighe, MK
   Shaw, DWW
   Roby, JA
   Santana-Ufret, V
   Boldenow, E
   Li, JW
   Gao, XH
   Davis, MA
   Swanstrom, JA
   Jensen, K
   Widman, DG
   Baric, RS
   Medwid, JT
   Hanley, KA
   Ogle, J
   Gough, GM
   Lee, W
   English, C
   Durning, WM
   Thiel, J
   Gatenby, C
   Dewey, EC
   Fairgrieve, MR
   Hodge, RD
   Grant, RF
   Kuller, L
   Dobyns, WB
   Hevner, RF
   Gale, M
   Rajagopal, L
AF Waldorf, Kristina M. Adams
   Nelson, Branden R.
   Stencel-Baerenwald, Jennifer E.
   Studholme, Colin
   Kapur, Raj P.
   Armistead, Blair
   Walker, Christie L.
   Merillat, Sean
   Vornhagen, Jay
   Tisoncik-Go, Jennifer
   Baldessari, Audrey
   Coleman, Michelle
   Dighe, Manjiri K.
   Shaw, Dennis W. W.
   Roby, Justin A.
   Santana-Ufret, Veronica
   Boldenow, Erica
   Li, Junwei
   Gao, Xiaohu
   Davis, Michael A.
   Swanstrom, Jesica A.
   Jensen, Kara
   Widman, Douglas G.
   Baric, Ralph S.
   Medwid, Joseph T.
   Hanley, Kathryn A.
   Ogle, Jason
   Gough, G. Michael
   Lee, Wonsok
   English, Chris
   Durning, W. McIntyre
   Thiel, Jeff
   Gatenby, Chris
   Dewey, Elyse C.
   Fairgrieve, Marian R.
   Hodge, Rebecca D.
   Grant, Richard F.
   Kuller, LaRene
   Dobyns, William B.
   Hevner, Robert F.
   Gale, Michael, Jr.
   Rajagopal, Lakshmi
TI Congenital Zika virus infection as a silent pathology with loss of
   neurogenic output in the fetal brain
SO NATURE MEDICINE
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; NEURAL STEM-CELLS; DENGUE VIRUS;
   PROGENITORS; IMMUNITY; DISEASE; VACCINE; GROWTH; TBR2
AB Zika virus (ZIKV) is a flavivirus with teratogenic effects on fetal brain, but the spectrum of ZIKV-induced brain injury is unknown, particularly when ultrasound imaging is normal. In a pregnant pigtail macaque (Macaca nemestrina) model of ZIKV infection, we demonstrate that ZIKV-induced injury to fetal brain is substantial, even in the absence of microcephaly, and may be challenging to detect in a clinical setting. A common and subtle injury pattern was identified, including (i) periventricular T2-hyperintense foci and loss of fetal noncortical brain volume, (ii) injury to the ependymal epithelium with underlying gliosis and (iii) loss of late fetal neuronal progenitor cells in the subventricular zone (temporal cortex) and subgranular zone (dentate gyrus, hippocampus) with dysmorphic granule neuron patterning. Attenuation of fetal neurogenic output demonstrates potentially considerable teratogenic effects of congenital ZIKV infection even without microcephaly. Our findings suggest that all children exposed to ZIKV in utero should receive long-term monitoring for neurocognitive deficits, regardless of head size at birth.
C1 [Waldorf, Kristina M. Adams; Walker, Christie L.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams; Stencel-Baerenwald, Jennifer E.; Tisoncik-Go, Jennifer; Roby, Justin A.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gale, Michael, Jr.; Rajagopal, Lakshmi] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams; Armistead, Blair; Vornhagen, Jay; Gale, Michael, Jr.; Rajagopal, Lakshmi] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden.
   [Nelson, Branden R.; Dobyns, William B.; Hevner, Robert F.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA.
   [Stencel-Baerenwald, Jennifer E.; Tisoncik-Go, Jennifer; Roby, Justin A.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Studholme, Colin; Coleman, Michelle; Boldenow, Erica; Dobyns, William B.; Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Studholme, Colin; Li, Junwei; Gao, Xiaohu] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Studholme, Colin; Dighe, Manjiri K.; Shaw, Dennis W. W.; Thiel, Jeff; Gatenby, Chris] Univ Washington, Dept Radiol, Seattle, WA 98195 USA.
   [Kapur, Raj P.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Kapur, Raj P.] Seattle Childrens Hosp, Dept Pathol, Seattle, WA USA.
   [Armistead, Blair; Walker, Christie L.; Merillat, Sean; Vornhagen, Jay; Coleman, Michelle; Santana-Ufret, Veronica; Boldenow, Erica; Rajagopal, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.
   [Baldessari, Audrey; Ogle, Jason; Gough, G. Michael; Lee, Wonsok; English, Chris; Durning, W. McIntyre; Grant, Richard F.; Kuller, LaRene] Washington Natl Primate Res Ctr, Seattle, WA USA.
   [Shaw, Dennis W. W.] Seattle Childrens Hosp, Dept Radiol, Seattle, WA USA.
   [Swanstrom, Jesica A.; Jensen, Kara; Widman, Douglas G.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA.
   [Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.
   [Medwid, Joseph T.; Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Hodge, Rebecca D.] Allen Inst Brain Sci, Seattle, WA USA.
RP Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Waldorf, KMA; Rajagopal, L (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Waldorf, KMA; Rajagopal, L (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden.; Rajagopal, L (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Rajagopal, L (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.
EM adamsk@uw.edu; mgale@uw.edu; lakshmi.rajagopal@seattlechildrens.org
RI Vornahgen, Jay/AAI-1887-2019; amsalu, ribka/G-8780-2019; Gao,
   Xiaohu/C-8869-2009; Dobyns, William/AAI-2768-2020; Adams Waldorf,
   Kristina/F-2608-2013
OI Dobyns, William/0000-0002-7681-2844; Coleman,
   Michelle/0000-0002-6752-3266; Adams Waldorf,
   Kristina/0000-0002-6939-7224; Roby, Justin/0000-0003-2434-4273; Widman,
   Douglas/0000-0002-3585-6373
FU University of Washington Department of Obstetrics & Gynecology, Seattle
   Children's Research Institute; National Institutes of Health (NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01AI100989, AI083019, AI104002, AI100625, AI107731,
   R01NS092339, R01NS085081, R21OD023838]; Keck FoundationW.M. Keck
   Foundation; NIH training grantsUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [T32 HD007233,
   T32 AI07509]; A Perkins Coie Award; NIH Office of Research
   Infrastructure Programs [P51 OD010425]; Allen Institute for Brain
   Science founders
FX We thank C. Hughes and G. Gallardo for administrative assistance. This
   work was primarily supported by generous private philanthropic gifts,
   mainly from five donors in Florida, who wish to remain anonymous.
   Further support was obtained from the University of Washington
   Department of Obstetrics & Gynecology, Seattle Children's Research
   Institute and the National Institutes of Health (NIH), grant no.
   R01AI100989 (L.R. and K.M.A.W.), AI083019 (M. G.), AI104002 (M. G.),
   AI100625 (R.S.B.), AI107731 (R.S.B.), R01NS092339 (R.F.H.), R01NS085081
   (R.F.H.), R21OD023838 (B.R.N.), and the Keck Foundation (B.R.N.). The
   NIH training grants T32 HD007233 (principal investigator: L. Frenkel)
   and T32 AI07509 (principal investigator: L. Campbell) supported E.B. and
   J. V., respectively. A Perkins Coie Award for Discovery supported J.A.R.
   The NIH Office of Research Infrastructure Programs (P51 OD010425) also
   supported this project. The authors thank the Allen Institute for Brain
   Science founders, P. Allen and J. Allen, for their vision, encouragement
   and support. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the NIH or other
   funders. The funders had no role in study design, data collection and
   analysis, decision to publish or preparation of the manuscript.
CR Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4
   Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   CONRAD S, 1995, AM J PRIMATOL, V36, P15, DOI 10.1002/ajp.1350360103
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010
   Fogtmann M, 2014, IEEE T MED IMAGING, V33, P272, DOI 10.1109/TMI.2013.2284014
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021
   Habas PA, 2010, NEUROIMAGE, V53, P460, DOI 10.1016/j.neuroimage.2010.06.054
   Hodge RD, 2013, J NEUROSCI, V33, P4165, DOI 10.1523/JNEUROSCI.4185-12.2013
   Hodge RD, 2012, J NEUROSCI, V32, P6275, DOI 10.1523/JNEUROSCI.0532-12.2012
   Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906
   Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kim K, 2011, IEEE T MED IMAGING, V30, P1704, DOI 10.1109/TMI.2011.2143724
   Kim K, 2010, IEEE T MED IMAGING, V29, P146, DOI 10.1109/TMI.2009.2030679
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Miller JA, 2013, DEVELOPMENT, V140, P4633, DOI 10.1242/dev.097212
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573
   Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37
   Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/nmeth.3629, 10.1038/NMETH.3629]
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Woods SE, 2013, J AM ASSOC LAB ANIM, V52, P295
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 51
TC 44
Z9 44
U1 0
U2 30
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD MAR
PY 2018
VL 24
IS 3
BP 368
EP +
DI 10.1038/nm.4485
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA FY3EN
UT WOS:000426700900019
PM 29400709
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Qiu, XD
   Lei, YF
   Yang, P
   Gao, Q
   Wang, N
   Cao, L
   Yuan, S
   Huang, XF
   Deng, YQ
   Ma, WY
   Ding, TB
   Zhang, FL
   Wu, XG
   Hu, JJ
   Liu, SL
   Qin, CF
   Wang, XX
   Xu, ZK
   Rao, ZH
AF Qiu, Xiaodi
   Lei, Yingfeng
   Yang, Pan
   Gao, Qiang
   Wang, Nan
   Cao, Lei
   Yuan, Shuai
   Huang, Xiaofang
   Deng, Yongqiang
   Ma, Wenyu
   Ding, Tianbing
   Zhang, Fanglin
   Wu, Xingan
   Hu, Junjie
   Liu, Shan-Lu
   Qin, Chengfeng
   Wang, Xiangxi
   Xu, Zhikai
   Rao, Zihe
TI Structural basis for neutralization of Japanese encephalitis virus by
   two potent therapeutic antibodies
SO NATURE MICROBIOLOGY
LA English
DT Article
ID CRYO-EM STRUCTURE; WEST-NILE-VIRUS; DENGUE VIRUS; MONOCLONAL-ANTIBODY;
   VALIDATION; PROTECTION; PROTEIN; MODEL
AB Japanese encephalitis virus (JEV), closely related to dengue, Zika, yellow fever and West Nile viruses, remains neglected and not well characterized(1). JEV is the leading causative agent of encephalitis, and is responsible for thousands of deaths each year in Asia. Humoral immunity is essential for protecting against flavivirus infections and passive immunization has been demonstrated to be effective in curing disease(2,3). Here, we demonstrate that JEV-specific monoclonal antibodies, 2F2 and 2H4, block attachment of the virus to its receptor and also prevent fusion of the virus. Neutralization of JEV by these antibodies is exceptionally potent and confers clear therapeutic benefit in mouse models. A single 20 mu g dose of these antibodies resulted in 100% survival and complete clearance of JEV from the brains of mice. The 4.7 angstrom and 4.6 angstrom resolution cryo-electron microscopy structures of JEV-2F2-Fab and JEV-2H4-Fab complexes, together with the crystal structure of 2H4 Fab and our recent near-atomic structure of JEV4, unveil the nature and location of epitopes targeted by the antibodies. Both 2F2 and 2H4 Fabs bind quaternary epitopes that span across three adjacent envelope proteins. Our results provide a structural and molecular basis for the application of 2F2 and 2H4 to treat JEV infection.
C1 [Qiu, Xiaodi; Yang, Pan; Gao, Qiang; Wang, Nan; Cao, Lei; Yuan, Shuai; Huang, Xiaofang; Hu, Junjie; Wang, Xiangxi; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing, Peoples R China.
   [Qiu, Xiaodi; Yang, Pan; Wang, Nan] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Lei, Yingfeng; Ma, Wenyu; Ding, Tianbing; Zhang, Fanglin; Wu, Xingan; Xu, Zhikai] Fourth Mil Med Univ, Dept Microbiol, Xian, Shanxi, Peoples R China.
   [Gao, Qiang] Sinovac Biotech Co Ltd, Beijing, Peoples R China.
   [Cao, Lei] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.
   [Deng, Yongqiang; Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China.
   [Liu, Shan-Lu] Ohio State Univ, Program Viruses & Emerging Pathogens, Infect Dis Inst, Columbus, OH 43210 USA.
   [Liu, Shan-Lu] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci Microbial Infect & Immun & Microb, Columbus, OH 43210 USA.
   [Rao, Zihe] Tsinghua Univ, Sch Med, Lab Struct BiolspringDE 2017ogy, Beijing, Peoples R China.
RP Wang, XX; Rao, ZH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing, Peoples R China.; Xu, ZK (corresponding author), Fourth Mil Med Univ, Dept Microbiol, Xian, Shanxi, Peoples R China.; Rao, ZH (corresponding author), Tsinghua Univ, Sch Med, Lab Struct BiolspringDE 2017ogy, Beijing, Peoples R China.
EM xiangxi@ibp.ac.cn; zhikaixu@fmmu.edu.cn; raozh@tsinghua.edu.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Wang, Nan/0000-0002-9936-9179
FU Ministry of Science and Technology 973 ProjectNational Basic Research
   Program of China [2014CB542800]; National Key Research and Development
   Program of China [2016YFC1200400]; National Science FoundationNational
   Science Foundation (NSF) [81330036, 31570717, 81171557, 81520108019];
   Strategic Priority Research Program of the Chinese Academy of
   SciencesChinese Academy of Sciences [XDB08020200]; US NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 AI1 12381, R21 AI09464]; Young Elite Scientist sponsorship of
   CAST; program C of "One Hundred Talented People" of the Chinese Academy
   of Sciences
FX We thank Y. Chen, Z. Yang and B. Zhou for SPR technical support; X.
   Huang, B. Zhu and Z. Guo for cryo-EM technical support; and M.S.
   Diamond, S. Lok and D. Stuart for providing comments on the paper. The
   cryo-EM datasets were collected at the Center for Biological Imaging,
   Institute of Biophysics; the X-ray diffraction datasets were collected
   at beam line BL18U of the Shanghai Synchrotron Facility. Work was
   supported by the Ministry of Science and Technology 973 Project (grant
   no. 2014CB542800); the National Key Research and Development Program of
   China (no. 2016YFC1200400); the National Science Foundation, grant no.
   81330036, no. 31570717, no. 81171557 and no. 81520108019; the Strategic
   Priority Research Program of the Chinese Academy of Sciences, grant no.
   XDB08020200; and US NIH grants R01 AI1 12381 and R21 AI09464. X.W. is
   supported by the Young Elite Scientist sponsorship of CAST and program C
   of "One Hundred Talented People" of the Chinese Academy of Sciences.
CR Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Barad BA, 2015, NAT METHODS, V12, P943, DOI [10.1038/NMETH.3541, 10.1038/nmeth.3541]
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang MH, 2014, PROTEIN CELL, V5, P692, DOI 10.1007/s13238-014-0087-3
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Liu HQ, 2015, J STRUCT BIOL, V192, P14, DOI 10.1016/j.jsb.2015.09.001
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Roehrig JT, 2001, ANN NY ACAD SCI, V951, P286
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115
   Simhaev L, 2017, J CHEM INF MODEL, V57, P1932, DOI 10.1021/acs.jcim.7b00091
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Wang XX, 2017, P NATL ACAD SCI USA, V114, P770, DOI 10.1073/pnas.1616502114
   Xiao CA, 2007, J STRUCT BIOL, V158, P182, DOI 10.1016/j.jsb.2006.10.013
   ZHANG MJ, 1989, J MED VIROL, V29, P133, DOI 10.1002/jmv.1890290211
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 40
TC 13
Z9 14
U1 1
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD MAR
PY 2018
VL 3
IS 3
BP 287
EP 294
DI 10.1038/s41564-017-0099-x
PG 8
WC Microbiology
SC Microbiology
GA FX1WX
UT WOS:000425846200009
PM 29379207
DA 2020-07-08
ER

PT J
AU Chen, J
   Yang, YF
   Yang, Y
   Zou, P
   Chen, J
   He, YQ
   Shui, SL
   Cui, YR
   Bai, R
   Liang, YJ
   Hu, YW
   Jiang, B
   Lu, L
   Zhang, XY
   Liu, J
   Xu, JQ
AF Chen, Jian
   Yang, Yi-feng
   Yang, Yu
   Zou, Peng
   Chen, Jun
   He, Yongquan
   Shui, Sai-lan
   Cui, Yan-ru
   Bai, Ru
   Liang, Ya-jun
   Hu, Yunwen
   Jiang, Biao
   Lu, Lu
   Zhang, Xiaoyan
   Liu, Jia
   Xu, Jianqing
TI AXL promotes Zika virus infection in astrocytes by antagonizing type I
   interferon signalling
SO NATURE MICROBIOLOGY
LA English
DT Article
ID WEST NILE VIRUS; INNATE IMMUNE-RESPONSES; TAM RECEPTORS; BRAIN; CELLS;
   MICE; ORGANOIDS; ENTRY; IDENTIFICATION; PROTECTS
AB Zika virus (ZIKV) is associated with neonatal microcephaly and Guillain-Barre syndrome(1,2). While progress has been made in understanding the causal link between ZIKV infection and microcephaly(3-9), the life cycle and pathogenesis of ZIKV are less well understood. In particular, there are conflicting reports on the role of AXL, a TAM family kinase receptor that was initially described as the entry receptor for ZIKV(10-22). Here, we show that while genetic ablation of AXL protected primary human astrocytes and astrocytoma cell lines from ZIKV infection, AXL knockout did not block the entry of ZIKV. We found, instead, that the presence of AXL attenuated the ZIKV-induced activation of type I interferon (IFN) signalling genes, including several type I IFNs and IFN-stimulating genes. Knocking out type I IFN receptor alpha chain (IFNAR1) restored the vulnerability of AXL knockout astrocytes to ZIKV infection. Further experiments suggested that AXL regulates the expression of SOCS1, a known type I IFN signalling suppressor, in a STAT1/STAT2-dependent manner. Collectively, our results demonstrate that AXL is unlikely to function as an entry receptor for ZIKV and may instead promote ZIKV infection in human astrocytes by antagonizing type I IFN signalling.
C1 [Chen, Jian; Yang, Yu; Zou, Peng; He, Yongquan; Bai, Ru; Hu, Yunwen; Lu, Lu; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Sci Res Ctr, Shanghai, Peoples R China.
   [Chen, Jian; Yang, Yu; Zou, Peng; He, Yongquan; Bai, Ru; Hu, Yunwen; Lu, Lu; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Key Lab Med Mol Virol, Minist Educ Hlth,Shanghai Med Coll, Shanghai, Peoples R China.
   [Yang, Yi-feng; Shui, Sai-lan; Cui, Yan-ru; Liang, Ya-jun; Jiang, Biao; Liu, Jia] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China.
   [Chen, Jun] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, Uppsala, Sweden.
   [Zhang, Xiaoyan; Xu, Jianqing] China Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.
RP Zhang, XY; Xu, JQ (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Sci Res Ctr, Shanghai, Peoples R China.; Zhang, XY; Xu, JQ (corresponding author), Fudan Univ, Inst Biomed Sci, Key Lab Med Mol Virol, Minist Educ Hlth,Shanghai Med Coll, Shanghai, Peoples R China.; Liu, J (corresponding author), ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China.; Zhang, XY; Xu, JQ (corresponding author), China Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.
EM zhangxiaoyan@shaphc.org.cn; liujia@shanghaitech.edu.cn;
   xujianqing@shaphc.org.cn
RI Lu, Lu/K-7070-2014
OI Lu, Lu/0000-0002-2255-0391
FU National Science Foundation of ChinaNational Natural Science Foundation
   of China [81430030]; ShanghaiTech University Startup Fund; Shanghai
   Public Health Clinical Center; Developmental Center of Shanghai Shenkang
   Hospital [SHDC12014104]; Shanghai Advanced Biosafety and Pathogen
   Diagnostic Platform [15DZ2290200]
FX This work was supported by the National Science Foundation of China
   (81430030 to J.X.), the ShanghaiTech University Startup Fund (to B.J.
   and J.L.), the Shanghai Public Health Clinical Center (to X.Z.), the
   Developmental Center of Shanghai Shenkang Hospital (SHDC12014104 to
   X.Z.) and the Shanghai Advanced Biosafety and Pathogen Diagnostic
   Platform (15DZ2290200 to X.Z.).
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2
   Cho H, 2013, J VIROL, V87, P8363, DOI 10.1128/JVI.01097-13
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hussmann KL, 2014, J GEN VIROL, V95, P1991, DOI 10.1099/vir.0.065474-0
   Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 51
TC 42
Z9 46
U1 3
U2 52
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD MAR
PY 2018
VL 3
IS 3
BP 302
EP 309
DI 10.1038/s41564-017-0092-4
PG 8
WC Microbiology
SC Microbiology
GA FX1WX
UT WOS:000425846200011
PM 29379210
DA 2020-07-08
ER

PT J
AU Neufeldt, CJ
   Cortese, M
   Acosta, EG
   Bartenschlager, R
AF Neufeldt, Christopher J.
   Cortese, Mirko
   Acosta, Eliana G.
   Bartenschlager, Ralf
TI Rewiring cellular networks by members of the Flaviviridae family
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID HEPATITIS-C VIRUS; UNFOLDED PROTEIN RESPONSE; HOST-TARGETING AGENTS;
   DENGUE VIRUS; ZIKA VIRUS; VIRAL REPLICATION; RNA REPLICATION; HCV
   REPLICATION; ULTRASTRUCTURAL CHARACTERIZATION; 3-DIMENSIONAL
   ARCHITECTURE
AB Members of the Flaviviridae virus family comprise a large group of enveloped viruses with a single-strand RNA genome of positive polarity. Several genera belong to this family, including the Hepacivirus genus, of which hepatitis C virus (HCV) is the prototype member, and the Flavivirus genus, which contains both dengue virus and Zika virus. Viruses of these genera differ in many respects, such as the mode of transmission or the course of infection, which is either predominantly persistent in the case of HCV or acutely self-limiting in the case of flaviviruses. Although the fundamental replication strategy of Flaviviridae members is similar, during the past few years, important differences have been discovered, including the way in which these viruses exploit cellular resources to facilitate viral propagation. These differences might be responsible, at least in part, for the various biological properties of these viruses, thus offering the possibility to learn from comparisons. In this Review, we discuss the current understanding of how Flaviviridae viruses manipulate and usurp cellular pathways in infected cells. Specifically, we focus on comparing strategies employed by flaviviruses with those employed by hepaciviruses, and we discuss the importance of these interactions in the context of viral replication and antiviral therapies.
C1 [Neufeldt, Christopher J.; Cortese, Mirko; Acosta, Eliana G.; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, D-69120 Heidelberg, Germany.
   [Bartenschlager, Ralf] German Ctr Infect Res, Heidelberg Partner Site, D-69120 Heidelberg, Germany.
RP Bartenschlager, R (corresponding author), Heidelberg Univ, Dept Infect Dis, Mol Virol, D-69120 Heidelberg, Germany.; Bartenschlager, R (corresponding author), German Ctr Infect Res, Heidelberg Partner Site, D-69120 Heidelberg, Germany.
EM ralf.bartenschlager@med.uni-heidelberg.de
RI Neufeldt, Christopher/AAD-1702-2019
OI Neufeldt, Christopher/0000-0002-4551-1811; Cortese,
   Mirko/0000-0003-1786-4211
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB
   1129, SFB/TRR 83, SFB/TRR179]; Federal Ministry for Education and
   Research (BMBF) 'ERA-Net for Applied Systems Biology' (ERASysAPP)
   (SysVirDrug) [031A602B]; EU H project 'ANTIVIRALS' [642434]; European
   Molecular Biology Organization (EMBO)European Molecular Biology
   Organization (EMBO) [ALTF 466-2016]
FX The authors apologize to all colleagues whose work they could not cite
   due to space limitations. Research in the authors' laboratory is
   supported by the Deutsche Forschungsgemeinschaft (SFB 1129, TP 11;
   SFB/TRR 83, TP 13; SFB/TRR179, TP 9), the Federal Ministry for Education
   and Research (BMBF) 'ERA-Net for Applied Systems Biology' (ERASysAPP)
   (SysVirDrug, grant no. 031A602B) and the EU H2020 project 'ANTIVIRALS'
   (grant no. 642434), all to R.B. C.J.N. is supported by the European
   Molecular Biology Organization (EMBO) (ALTF 466-2016).
CR Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003
   Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Akil A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12203
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   [Anonymous], 2017, TAXONOMY
   [Anonymous], 2017, HEPATITIS C FACT SHE
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bankwitz D, 2017, J HEPATOL, V67, P480, DOI 10.1016/j.jhep.2017.04.010
   Barbier V, 2017, VIROLOGY, V500, P149, DOI 10.1016/j.virol.2016.10.022
   Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046
   Baugh JM, 2013, ANTIVIR RES, V100, P555, DOI 10.1016/j.antiviral.2013.09.020
   Berger C, 2014, GASTROENTEROLOGY, V147, P1094, DOI 10.1053/j.gastro.2014.07.019
   Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423
   Bonamassa B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00619
   Bost AG, 2003, J VIROL, V77, P4401, DOI 10.1128/JVI.77.7.4401-4408.2003
   Bozzacco L, 2016, J VIROL, V90, P3212, DOI 10.1128/JVI.03077-15
   Brewer J, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/738471
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Chan SW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00233
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chen W, 2008, ARCH VIROL, V153, P1777, DOI 10.1007/s00705-008-0183-x
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004227
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409
   Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719
   Diwaker D, 2015, ACTA BIOCH BIOPH SIN, V47, P960, DOI 10.1093/abbs/gmv108
   Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.4161/auto.5.8.10219
   Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002
   Ertel KJ, 2017, ELIFE, V6, DOI 10.7554/eLife.25940
   Esser-Nobis K, 2013, HEPATOLOGY, V57, P953, DOI 10.1002/hep.26260
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Fahmy AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40351
   Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10
   Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086
   Fukuhara T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006475
   Gagne B, 2017, TRAFFIC, V18, P362, DOI 10.1111/tra.12480
   Gao L, 2003, J VIROL, V77, P4149, DOI 10.1128/JVI.77.7.4149-4159.2003
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gonzalez O, 2009, HEPATOLOGY, V50, P1756, DOI 10.1002/hep.23232
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Harak C, 2014, J VIROL, V88, P9909, DOI 10.1128/JVI.01063-14
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108
   Hundt J, 2013, WORLD J GASTROENTERO, V19, P8929, DOI 10.3748/wjg.v19.i47.8929
   Idris F, 2016, ARCH VIROL, V161, P1751, DOI 10.1007/s00705-016-2855-2
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kallio K, 2016, J VIROL, V90, P1687, DOI 10.1128/JVI.02484-15
   Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474
   Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431
   Khachatoorian R, 2016, INT J ANTIMICROB AG, V47, P289, DOI 10.1016/j.ijantimicag.2016.01.012
   Khachatoorian R, 2014, VIROLOGY, V454, P118, DOI 10.1016/j.virol.2014.02.016
   Khan I, 2014, J VIROL, V88, P12276, DOI 10.1128/JVI.00970-14
   Khawaja A, 2015, WIRES RNA, V6, P211, DOI 10.1002/wrna.1268
   Kim SJ, 2014, P NATL ACAD SCI USA, V111, P6413, DOI 10.1073/pnas.1321114111
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Lee E, 2000, J VIROL, V74, P24, DOI 10.1128/JVI.74.1.24-32.2000
   Lee JY, 2014, J VIROL, V88, P12422, DOI 10.1128/JVI.01660-14
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Levin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114629
   Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190
   Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06
   Lin WY, 2005, GASTROENTEROLOGY, V128, P1034, DOI 10.1053/j.gastro.2005.02.006
   Lobigs M, 2004, J VIROL, V78, P178, DOI 10.1128/JVI.78.1.178-186.2004
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Lussignol M, 2016, P NATL ACAD SCI USA, V113, P2484, DOI 10.1073/pnas.1518934113
   Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055
   Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Mettenleiter TC, 2016, J MOL BIOL, V428, P1949, DOI 10.1016/j.jmb.2015.10.001
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200
   Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5
   Neufeldt CJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005428
   Neufeldt CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003744
   Overby AK, 2011, VIRULENCE, V2, P238, DOI 10.4161/viru.2.3.16162
   Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06
   Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13
   Paul D, 2011, J VIROL, V85, P6963, DOI 10.1128/JVI.00502-11
   Pawlotsky JM, 2015, HEPATOLOGY, V62, P1013, DOI 10.1002/hep.27960
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Peng ZG, 2010, HEPATOLOGY, V52, P845, DOI 10.1002/hep.23766
   Perera N, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12734
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Piver E, 2017, GUT, V66, P1487, DOI 10.1136/gutjnl-2016-311726
   Poenisch M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004573
   Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005
   Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002
   Romero-Brey I, 2015, MBIO, V6, DOI 10.1128/mBio.00759-15
   Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056
   Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013
   Ruggieri V, 2014, WORLD J GASTROENTERO, V20, P2624, DOI 10.3748/wjg.v20.i10.2624
   Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shao RX, 2010, J VIROL, V84, P6060, DOI 10.1128/JVI.02484-09
   Shrivastava S, 2016, J VIROL, V90, P1387, DOI 10.1128/JVI.02383-15
   Braga ACS, 2017, CELL STRESS CHAPERON, V22, P113, DOI 10.1007/s12192-016-0747-8
   Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085
   Siu GKY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23464
   Smith JA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00222
   Soto-Acosta R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006257
   Spuul P, 2011, J VIROL, V85, P4739, DOI 10.1128/JVI.00085-11
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Stevenson NJ, 2013, FEBS LETT, V587, P1571, DOI 10.1016/j.febslet.2013.03.041
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Stoeck IK, 2018, J VIROL, V92, DOI 10.1128/JVI.01196-17
   Sung C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004851
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Taguwa Shuhei, 2015, Virus (Nagoya), V65, P179
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243
   Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13
   Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014
   Viktorovskaya OV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004921
   Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655
   Wang HL, 2014, GASTROENTEROLOGY, V146, P1373, DOI 10.1053/j.gastro.2014.02.002
   Wang J, 2014, AUTOPHAGY, V10, P766, DOI 10.4161/auto.27954
   Wang LY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004764
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32243
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Yang ZL, 2016, J VIROL, V90, P9632, DOI 10.1128/JVI.01353-16
   Ye J, 2017, J VIROL, V91, DOI [10.1128/jvi.00039-17, 10.1128/JVI.00039-17]
   Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255
   Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200
   Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0
   Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4
   Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zamudio-Meza H, 2009, J GEN VIROL, V90, P2902, DOI 10.1099/vir.0.014159-0
   Zayas M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005376
   Zeisel MB, 2015, VIRUSES-BASEL, V7, P5659, DOI 10.3390/v7112898
   Zeuzem S, 2015, ALIMENT PHARM THER, V42, P829, DOI 10.1111/apt.13342
   Zhang JT, 2016, P NATL ACAD SCI USA, V113, pE1064, DOI 10.1073/pnas.1519730113
   Zhang J, 2016, SCI CHINA LIFE SCI, V59, P487, DOI 10.1007/s11427-016-5042-5
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zhang XW, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006321
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
NR 175
TC 62
Z9 62
U1 6
U2 27
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD MAR
PY 2018
VL 16
IS 3
BP 125
EP 142
DI 10.1038/nrmicro.2017.170
PG 18
WC Microbiology
SC Microbiology
GA FV7JY
UT WOS:000424760800005
PM 29430005
OA Green Published
DA 2020-07-08
ER

PT J
AU Koishi, AC
   Suzukawa, AA
   Zanluca, C
   Camacho, DE
   Comach, G
   dos Santos, CND
AF Koishi, Andrea Cristine
   Suzukawa, Andreia Akemi
   Zanluca, Camila
   Elena Camacho, Daria
   Comach, Guillermo
   Duarte dos Santos, Claudia Nunes
TI Development and evaluation of a novel high-throughput image-based
   fluorescent neutralization test for detection of Zika virus infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUSES; REAL-TIME; ASSAY; ANTIBODIES; MICRONESIA
AB Zika virus (ZIKV) is an emerging arbovirus belonging to the genus flavivirus that comprises other important public health viruses, such as dengue (DENV) and yellow fever (YFV). In general, ZIKV infection is a self-limiting disease, however cases of Guillain-Barre A syndrome and congenital brain abnormalities in newborn infants have been reported. Diagnosing ZIKV infection remains a challenge, as viral RNA detection is only applicable until a few days after the onset of symptoms. After that, serological tests must be applied, and, as expected, high cross-reactivity between ZIKV and other flavivirus serology is observed. Plaque reduction neutralization test (PRNT) is indicated to confirm positive samples for being more specific, however it is laborious intensive and time consuming, representing a major bottleneck for patient diagnosis. To overcome this limitation, we developed a high-throughput image-based fluorescent neutralization test for ZIKV infection by serological detection. Using 226 human specimens, we showed that the new test presented higher throughput than traditional PRNT, maintaining the correlation between results. Furthermore, when tested with dengue virus samples, it showed 50.53% less cross reactivity than MAC-ELISA. This fluorescent neutralization test could be used for clinical diagnosis confirmation of ZIKV infection, as well as for vaccine clinical trials and seroprevalence studies.
C1 [Koishi, Andrea Cristine; Suzukawa, Andreia Akemi; Zanluca, Camila; Duarte dos Santos, Claudia Nunes] Inst Carlos Chagas ICC Fiocruz PR, Lab Virol Mol, Curitiba, Parana, Brazil.
   [Elena Camacho, Daria; Comach, Guillermo] Univ Carabobo LARDIDEV BIOMED UC, Inst Invest Biomed, Lab Reg Diagnost & Invest Dengue & Otras Enfermed, Maracay, Venezuela.
RP dos Santos, CND (corresponding author), Inst Carlos Chagas ICC Fiocruz PR, Lab Virol Mol, Curitiba, Parana, Brazil.
EM clsantos@fiocruz.br
RI Santos, Claudia Duarte dos/P-4868-2019; Koishi, Andrea/N-2484-2013
OI Santos, Claudia Duarte dos/0000-0001-8707-6638; Koishi,
   Andrea/0000-0002-3542-1353; Zanluca, Camila/0000-0001-7350-9105
FU BNDES (Brazilian Governmental agency); Fundacao Araucaria (fellowships)
   (Brazilian Governmental agency); CNPq (Brazilian Governmental
   agency)National Council for Scientific and Technological Development
   (CNPq); CAPES (Brazilian Governmental agency)CAPES
FX CNDS received financial support from BNDES, Fundacao Araucaria
   (fellowships), CNPq and CAPES (all Brazilian Governmental agencies) for
   funding the research. Nevertheless, the funding for publication fees is
   very limited. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Centers for Disease Control and Prevention, 2016, ZIKA MAC ELISA
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   L'Huillier AG, 2017, J CLIN MICROBIOL JCM, DOI [10.1128/JCM.00442-17, DOI 10.1128/JCIM.00442-17]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Maistriau M, 2017, VIRUS RES, V237, P1, DOI 10.1016/j.virusres.2017.05.004
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   PAHO/ WHO, 2017, REG ZIK EP UPD AM AU
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Safronetz D, 2017, EMERG INFECT DIS J, V23
   Shan C., 2017, J CLIN MICROBIOL, DOI [10.1128/JCM.00975-17, DOI 10.1128/JCM.00975-17]
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Vorndam V, 2002, AM J TROP MED HYG, V66, P208, DOI 10.4269/ajtmh.2002.66.208
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilson HL, 2017, J CLIN MICROBIOL JCM, DOI [10.1128/JCM.00673-17, DOI 10.1128/JCM.00673-17]
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
NR 31
TC 8
Z9 9
U1 3
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2018
VL 12
IS 3
AR e0006342
DI 10.1371/journal.pntd.0006342
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GE5NI
UT WOS:000431268900063
PM 29543803
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Villarroel, PMS
   Nurtop, E
   Pastorino, B
   Roca, Y
   Drexler, JF
   Gallian, P
   Jaenisch, T
   Leparc-Goffart, I
   Priet, S
   Ninove, L
   de Lamballerie, X
AF Villarroel, Paola Mariela Saba
   Nurtop, Elif
   Pastorino, Boris
   Roca, Yelin
   Drexler, Jan Felix
   Gallian, Pierre
   Jaenisch, Thomas
   Leparc-Goffart, Isabelle
   Priet, Stephane
   Ninove, Laetitia
   de Lamballerie, Xavier
TI Zika virus epidemiology in Bolivia: A seroprevalence study in volunteer
   blood donors
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE; TRANSMISSION; VECTOR; FEVER
AB Background
   Zika virus (ZIKV), was widely reported in Latin America and has been associated with neuropathologies, as microcephaly, but only few seroprevalence studies have been published to date. Our objective was to determine the seroprevalence amongst Bolivian blood donors and estimate the future potential circulation of the virus.
   Methodology
   A ZIKV seroprevalence study was conducted between December 2016 and April 2017 in 814 asymptomatic Bolivian volunteer blood donors residing in various eco-environments corresponding to contrasting entomological activities. It was based on detection of IgG to ZIKV using NS1 ELISA screening, followed by a seroneutralisation test in case of positive or equivocal ELISA result.
   Conclusions/Significance
   Analysis revealed that ZIKV circulation occurred in tropical areas (Beni: 39%; Santa Cruz de la Sierra: 21.5%) but not in highlands (similar to 0% in Cochabamba, La Paz, Tarija). It was modulated by Aedes aegypti activity and the virus spread was not limited by previous immunity to dengue. Cases were geo-localised in a wide range of urban areas in Santa Cruz and Trinidad. No differences in seroprevalence related to gender or age-groups could be identified. It is concluded that ZIKV has been intensely circulating in the Beni region and has still a significant potential for propagating in the area of Santa Cruz.
C1 [Villarroel, Paola Mariela Saba; Nurtop, Elif; Pastorino, Boris; Priet, Stephane; Ninove, Laetitia; de Lamballerie, Xavier] Aix Marseille Univ, UMR EPV Emergence Pathol Virales, IHU Mediterranee Infect, EHESP,IRD 190,Inserm 1207, Marseille, France.
   [Villarroel, Paola Mariela Saba; Roca, Yelin] Ctr Nacl Enfermedades Trop CENETROP, Virol 2, Santa Cruz, Bolivia.
   [Drexler, Jan Felix] Charite, German Ctr Infect Res DZIF, Berlin, Germany.
   [Drexler, Jan Felix] Charite, Inst Virol, Berlin, Germany.
   [Gallian, Pierre] Etab Francais Sang Alpes Mediterranee EFS, Virol Lab, Marseille, France.
   [Jaenisch, Thomas] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [Leparc-Goffart, Isabelle] French Armed Forces Biomed Res Inst, Natl Reference Ctr Arboviruses, Marseille, France.
RP Villarroel, PMS (corresponding author), Aix Marseille Univ, UMR EPV Emergence Pathol Virales, IHU Mediterranee Infect, EHESP,IRD 190,Inserm 1207, Marseille, France.; Villarroel, PMS (corresponding author), Ctr Nacl Enfermedades Trop CENETROP, Virol 2, Santa Cruz, Bolivia.
EM marielasaba@gmail.com
RI Priet, Stephane/N-7952-2017
OI Priet, Stephane/0000-0001-7102-3654; Drexler, Jan
   Felix/0000-0002-3509-0232; pastorino, boris/0000-0001-5233-5193
FU European Union's Horizon research and innovation programm ZIKAlliance
   [734548]; European Union's Horizon research and innovation programm EVAg
   [653316]
FX This work was supported in part by the European Union's Horizon 2020
   research and innovation programmes ZIKAlliance and EVAg under grant
   agreements No 734548 and 653316, respectively. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2013, EMERG INFECT DIS, V20, DOI [10.3201/eid2006.140138, DOI 10.3201/EID2006.140138]
   Aquino Rojas Evelin, 2016, Gac Med Bol, V39, P83
   Baronti C, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomea.00500-14, DOI 10.1128/GENOMEA.0050]
   Bremond P, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0118337, DOI 10.1371/JOURNAL.P0NE.0118337]
   de Lamballerie X, 2017, 8 EUR M VIR ZOON OCT
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   L'Azou M, 2015, AM J TROP MED HYG, V92, P1137, DOI 10.4269/ajtmh.14-0211
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.prad.0004687, DOI 10.1371/JOURNAL.PRAD.0004687]
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   OMS, 2017, INF VIR ZIK BOL
   Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Roca Y, 2009, VECTOR-BORNE ZOONOT, V9, P337, DOI 10.1089/vbz.2008.0187
   Sanchez JD, 2017, PAHO WHO REGIONAL ZI
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   WPRO, EM DIS SURV RESP
NR 27
TC 20
Z9 20
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2018
VL 12
IS 3
AR e0006239
DI 10.1371/journal.pntd.0006239
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GE5NI
UT WOS:000431268900014
PM 29513667
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aliota, MT
   Dudley, DM
   Newman, CM
   Weger-Lucarelli, J
   Stewart, LM
   Koenig, MR
   Breitbach, ME
   Weiler, AM
   Semler, MR
   Barry, GL
   Zarbock, KR
   Haj, AK
   Moriarty, RV
   Mohns, MS
   Mohr, EL
   Venturi, V
   Schultz-Darken, N
   Peterson, E
   Newton, W
   Schotzko, ML
   Simmons, HA
   Mejia, A
   Hayes, JM
   Capuano, S
   Davenport, MP
   Friedrich, TC
   Ebel, GD
   O'Connor, SL
   O'Connor, DH
AF Aliota, Matthew T.
   Dudley, Dawn M.
   Newman, Christina M.
   Weger-Lucarelli, James
   Stewart, Laurel M.
   Koenig, Michelle R.
   Breitbach, Meghan E.
   Weiler, Andrea M.
   Semler, Matthew R.
   Barry, Gabrielle L.
   Zarbock, Katie R.
   Haj, Amelia K.
   Moriarty, Ryan V.
   Mohns, Martel S.
   Mohr, Emma L.
   Venturi, Vanessa
   Schultz-Darken, Nancy
   Peterson, Eric
   Newton, Wendy
   Schotzko, Michele L.
   Simmons, Heather A.
   Mejia, Andres
   Hayes, Jennifer M.
   Capuano, Saverio, III
   Davenport, Miles P.
   Friedrich, Thomas C.
   Ebel, Gregory D.
   O'Connor, Shelby L.
   O'Connor, David H.
TI Molecularly barcoded Zika virus libraries to probe in vivo evolutionary
   dynamics
SO PLOS PATHOGENS
LA English
DT Article
ID VERTICAL TRANSMISSION; CULEX-PIPIENS; INFECTION; STRAIN; RNA;
   BOTTLENECKS; VIREMIA; GENOME
AB Defining the complex dynamics of Zika virus (ZIKV) infection in pregnancy and during transmission between vertebrate hosts and mosquito vectors is critical for a thorough understanding of viral transmission, pathogenesis, immune evasion, and potential reservoir establishment. Within-host viral diversity in ZIKV infection is low, which makes it difficult to evaluate infection dynamics. To overcome this biological hurdle, we constructed a molecularly barcoded ZIKV. This virus stock consists of a "synthetic swarm" whose members are genetically identical except for a run of eight consecutive degenerate codons, which creates approximately 64,000 theoretical nucleotide combinations that all encode the same amino acids. Deep sequencing this region of the ZIKV genome enables counting of individual barcodes to quantify the number and relative proportions of viral lineages present within a host. Here we used these molecularly barcoded ZIKV variants to study the dynamics of ZIKV infection in pregnant and non-pregnant macaques as well as during mosquito infection/transmission. The barcoded virus had no discernible fitness defects in vivo, and the proportions of individual barcoded virus templates remained stable throughout the duration of acute plasma viremia. ZIKV RNA also was detected in maternal plasma from a pregnant animal infected with barcoded virus for 67 days. The complexity of the virus population declined precipitously 8 days following infection of the dam, consistent with the timing of typical resolution of ZIKV in non-pregnant macaques and remained low for the subsequent duration of viremia. Our approach showed that synthetic swarm viruses can be used to probe the composition of ZIKV populations over time in vivo to understand vertical transmission, persistent reservoirs, bottlenecks, and evolutionary dynamics.
C1 [Aliota, Matthew T.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Dudley, Dawn M.; Newman, Christina M.; Stewart, Laurel M.; Koenig, Michelle R.; Breitbach, Meghan E.; Semler, Matthew R.; Haj, Amelia K.; Mohns, Martel S.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Weger-Lucarelli, James; Ebel, Gregory D.] Colorado State Univ, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Weiler, Andrea M.; Barry, Gabrielle L.; Zarbock, Katie R.; Moriarty, Ryan V.; Schultz-Darken, Nancy; Peterson, Eric; Newton, Wendy; Schotzko, Michele L.; Simmons, Heather A.; Mejia, Andres; Hayes, Jennifer M.; Capuano, Saverio, III; Friedrich, Thomas C.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
   [Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Madison, WI USA.
   [Venturi, Vanessa; Davenport, Miles P.] Univ New South Wales, Kirby Inst Infect & Immun, Infect Analyt Program, Sydney, NSW, Australia.
   [Weger-Lucarelli, James] Inst Pasteur, Viral Populat & Pathogenesis Unit, Paris, France.
RP O'Connor, SL; O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.; O'Connor, SL; O'Connor, DH (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
EM slfeinberg@wisc.edu; dhoconno@wisc.edu
OI Davenport, Miles/0000-0002-4751-1831; Moriarty,
   Ryan/0000-0001-7100-1906; Weger-Lucarelli, James/0000-0002-9483-1694;
   Haj, Amelia/0000-0002-1453-341X; Aliota, Matthew/0000-0002-6902-9149
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21AI131454,
   R01AI132563, R56AI132563, R01AI067380, R21AI125996, R01AI116382,
   P51OD011106]; Research Facilities Improvement Program GrantsUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR)
   [RR15459-01, RR020141-01]
FX Funding for this project came from National Institutes of Health grants
   R21AI131454, R01AI132563, R56AI132563 to MTA; R01AI067380 and
   R21AI125996 to GDE; and R01AI116382 to DHO; and from P51OD011106 awarded
   to the Wisconsin National Primate Research Center, Madison, WI. This
   research was conducted in part at a facility that was constructed with
   support from Research Facilities Improvement Program Grants RR15459-01
   and RR020141-01. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The publication's contents are solely the responsibility of
   the authors and do not necessarily represent the official views of the
   Office of Research Infrastructure Program or the National Institutes of
   Health; https:www.nih.gov/, http://dpcpsi.nih.gov/orip/index.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   CHRISTENSEN BM, 1984, T AM MICROSC SOC, V103, P423, DOI 10.2307/3226478
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Ciota AT, 2012, INFECT GENET EVOL, V12, P557, DOI 10.1016/j.meegid.2012.01.022
   Dow N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131972
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Fabre F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003833
   Fennessey CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006359
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lauring AS, 2011, J VIROL, V85, P3780, DOI 10.1128/JVI.02217-10
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105
   Pfeiffer JK, 2006, P NATL ACAD SCI USA, V103, P5520, DOI 10.1073/pnas.0600834103
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Reiczigel J, 2005, AM STAT, V59, P156, DOI 10.1198/000313005X23526
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   ROSENBERG K, 2017, AM J NURS, V117, P71
   Rousseau E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006702
   Samleerat T, 2008, J INFECT DIS, V198, P868, DOI 10.1086/591251
   Simmons HE, 2013, VIRUS RES, V176, P259, DOI 10.1016/j.virusres.2013.06.016
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020
   Verhofstede C, 2003, J VIROL, V77, P3050, DOI 10.1128/JVI.77.5.3050-3057.2003
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Wu G, 2014, CELL HOST MICROBE, V16, P559, DOI 10.1016/j.chom.2014.10.016
   Zhou ST, 2015, J VIROL, V89, P8540, DOI 10.1128/JVI.00522-15
NR 46
TC 7
Z9 7
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAR
PY 2018
VL 14
IS 3
AR e1006964
DI 10.1371/journal.ppat.1006964
PG 25
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GD0LM
UT WOS:000430192300044
PM 29590202
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodrigues, KMD
   Moreira, BM
AF de Pinho Rodrigues, Karis Maria
   Moreira, Beatriz Meurer
TI Preventing diseases in round-the-world travelers: a contemporary
   challenge for travel medicine advice
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Round-the-world travelers; Long-term travelers; Infectious diseases;
   Malaria prophylaxis; Vaccines
ID LONG-TERM TRAVELERS; ESBL-PRODUCING ENTEROBACTERIACEAE; MENINGOCOCCAL
   DISEASE; INTERNATIONAL TRAVELERS; CURRENT RECOMMENDATIONS; JAPANESE
   ENCEPHALITIS; ANTIMICROBIAL DRUGS; MALARIA PROPHYLAXIS; TROPICAL
   COUNTRIES; ZIKA VIRUS
AB Providing advice for travelers embarking on long-term trips poses a challenge in travel medicine. A long duration of risk exposure is associated with underuse of protective measures and poor adherence to chemoprophylaxis, increasing the chances of acquiring infections. Recently, in our clinic, we observed an increase in the number of travelers undertaking round-the-world trips. These individuals are typically aged around 32 years and quit their jobs to embark on one-to-two-year journeys. Their destinations include countries in two or more continents, invariably Southeast Asia and Indonesia, and mostly involve land travel and visiting rural areas. Such trips involve flexible plans, increasing the challenge, especially with regard to malaria prophylaxis. Advising round-the-world travelers is time-consuming because of the amount of information that must be provided to the traveler. Advisors must develop strategies to commit the traveler to his/her own health, and verify their learnings on disease-prevention measures. Contacting the advisor after the appointment or during the trip can be helpful to clarify unclear instructions or diagnosis made and prescriptions given abroad. Infectious diseases are among the most frequent problems affecting travelers, many of which are preventable by vaccines, medicines, and precautionary measures. The dissemination of counterfeit medicines, particularly antibiotics and antimalarial medicines, emphasizes the need for travelers to carry medicines that they may possibly need on their trip. Additional advice on altitude, scuba diving, and other possible risks may also be given. Considering the difficulties in advising this group, we present a review of the main recommendations on advising these travelers.
C1 [de Pinho Rodrigues, Karis Maria] Univ Fed Rio de Janeiro, Dept Med Prevent, Ctr Informacao Saude Viajantes Cives, Fac Med, Rio De Janeiro, RJ, Brazil.
   [Moreira, Beatriz Meurer] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil.
RP Rodrigues, KMD (corresponding author), Univ Fed Rio de Janeiro, Dept Med Prevent, Ctr Informacao Saude Viajantes Cives, Fac Med, Rio De Janeiro, RJ, Brazil.
EM karis@cives.ufrj.br
RI Moreira, Beatriz M/G-3272-2012
CR Ahmed T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009029.pub2
   Aiello AE, 2010, AM J INFECT CONTROL, V38, P251, DOI 10.1016/j.ajic.2009.12.007
   Alpern JD, 2016, MED CLIN N AM, V100, P303, DOI 10.1016/j.mcna.2015.08.019
   Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X
   Arguin PM, 2016, CDC HLTH INFORM INT, P236
   Armand-Lefevre L, 2017, LANCET INFECT DIS, V17, P8, DOI [10.1016/S1473-3099(16)30417-0, 10.1016/s1473-3099(16)30417-0]
   Bauer IL, 2005, J TRAVEL MED, V12, P45, DOI 10.2310/7060.2005.00008
   Behrens RH, 2012, INFECT DIS CLIN N AM, V26, P791, DOI 10.1016/j.idc.2012.05.002
   Centers for Disease Control and Prevention, HIGHL PATH AS AV INF
   Centers for Disease Control and Prevention (CDC), INFL FLU AV INFL A H
   Centers for Disease Control and Prevention (CDC), MIDL E RESP SYNDR ME
   Chen HL, 2015, J CHIN MED ASSOC, V78, P271, DOI 10.1016/j.jcma.2014.12.009
   Chen LH, 2006, JAMA-J AM MED ASSOC, V296, P2234, DOI 10.1001/jama.296.18.2234
   Chen LH, 2009, EMERG INFECT DIS, V15, P1773, DOI 10.3201/eid1511.090945
   Chiodini PL, 2013, GUIDELINES MALARIA P
   Cockburn R, 2005, PLOS MED, V2, P302, DOI 10.1371/journal.pmed.0020100
   Cramer JP, 2012, CURR OPIN INFECT DIS, V25, P507, DOI 10.1097/QCO.0b013e3283574c06
   Cunningham J, 2014, TRAVEL MED INFECT DI, V12, P341, DOI 10.1016/j.tmaid.2013.12.006
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ganu Mohini A, 2011, J Assoc Physicians India, V59, P83
   Gautret P, 2012, VACCINE, V30, P126, DOI 10.1016/j.vaccine.2011.11.007
   Gautret P, 2010, TRAVEL MED INFECT DI, V8, P155, DOI 10.1016/j.tmaid.2010.02.007
   Genton B, 2012, INFECT DIS CLIN N AM, V26, P637, DOI 10.1016/j.idc.2012.05.003
   Goldstein I, 2015, J TRAVEL MED, V22, P130, DOI 10.1111/jtm.12156
   Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032
   Hanlon CA, 2016, CDC YELLOW BOOK 2016, P282
   Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063
   Herman J, 2014, MEDICINE, V42, P107
   Heywood AE, 2015, J TRAVEL MED, V22, P368, DOI 10.1111/jtm.12229
   Hills SL, 2016, CDC YELLOW BOOK 2016, P218
   Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014
   Jelinek T, 1999, J CLIN MICROBIOL, V37, P721, DOI 10.1128/JCM.37.3.721-723.1999
   Jelinek T, 2008, EXPERT REV VACCINES, V7, P561, DOI 10.1586/14760584.7.5.561
   Jelinek Tomas, 2004, Travel Med Infect Dis, V2, P143, DOI 10.1016/j.tmaid.2004.03.003
   Jelinek Tomas, 2017, MMW Fortschr Med, V159, P4, DOI 10.1007/s15006-017-9293-2
   Jentes ES, 2014, J TRAVEL MED, V21, P62, DOI 10.1111/jtm.12085
   Jungwirth D, 2017, HLTH INFORM J, V1, P1
   Kantele A, 2017, TRAVEL MED INFECT DI, V16, P23, DOI 10.1016/j.tmaid.2017.01.003
   Kantele A, 2016, EMERG INFECT DIS, V22, P117, DOI 10.3201/eid2201.151272
   Kelesidis T, 2015, CLIN MICROBIOL REV, V28, P443, DOI 10.1128/CMR.00072-14
   Korzeniewski K, 2015, INT MARIT HEALTH, V66, P238, DOI 10.5603/IMH.2015.0045
   Laaveri T, 2016, TRAVEL MED INFECT DI, V14, P299, DOI 10.1016/j.tmaid.2016.06.006
   Landman KZ, 2015, TRAVEL MED INFECT DI, V13, P61, DOI 10.1016/j.tmaid.2014.12.001
   Lee AW, 2016, CDC YELLOW BOOK 2016, P138
   Lim SK, 2016, CLIN EXP VACCINE RES, V5, P89, DOI 10.7774/cevr.2016.5.2.89
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martin LB, 2012, CURR OPIN INFECT DIS, V25, P489, DOI 10.1097/QCO.0b013e328356ffeb
   Matono T, 2015, J TRAVEL MED, V22, P422, DOI 10.1111/jtm.12241
   Matteelli A, 2001, CLIN INFECT DIS, V32, P1063, DOI 10.1086/319607
   Matteelli A, 2012, INFECT DIS CLIN N AM, V26, P625, DOI 10.1016/j.idc.2012.07.003
   Memish Ziad A, 2010, J Infect Public Health, V3, P143, DOI 10.1016/j.jiph.2010.09.008
   Muentener P, 1999, B WORLD HEALTH ORGAN, V77, P560
   Muller JM, 2013, J TRAVEL MED, V20, P78, DOI 10.1111/j.1708-8305.2012.00675.x
   Mutonga DM, 2009, AM J TROP MED HYG, V80, P619
   Nicolls DJ, 2008, AM J TROP MED HYG, V79, P729, DOI 10.4269/ajtmh.2008.79.729
   Noble LM, 2012, INFECT DIS CLIN N AM, V26, P575, DOI 10.1016/j.idc.2012.05.007
   O'Ryan M, 2015, HUM VACC IMMUNOTHER, V11, P601, DOI 10.1080/21645515.2015.1011578
   Olivero RM, 2016, AM J TROP MED HYG, V95, P1130, DOI 10.4269/ajtmh.16-0159
   Pan American Health Organization (PAHO), 2016, EP UPD
   Pavli A, 2015, J INFECT DEV COUNTR, V9, P917, DOI 10.3855/jidc.5108
   Riddle MS, 2017, J TRAVEL MED, V24, pS63, DOI 10.1093/jtm/tax026
   Sagui E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-232
   Schlagenhauf P, 2012, EXPERT REV ANTI-INFE, V10, P537, DOI [10.1586/ERI.12.42, 10.1586/eri.12.42]
   Schneider MC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000964
   Shepherd SM, 2011, PRIMARY CARE, V38, P643, DOI 10.1016/j.pop.2011.07.005
   Sing A, 2001, J TRAVEL MED, V8, P109
   Staples JE, 2015, MMWR-MORBID MORTAL W, V64, P647
   Steffen R, 2010, J TRAVEL MED, V17, P9, DOI 10.1111/j.1708-8305.2010.00449.x
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   The Green Book, 2013, INF PUBL HLTH PROF I, P313
   Toovey S, 2007, J TRAVEL MED, V14, P50, DOI 10.1111/j.1708-8305.2006.00092.x
   Toovey S, 2007, J TRAVEL MED, V14, P42, DOI 10.1111/j.1708-8305.2006.00091.x
   United Nations Office on Drugs and Crime (UNODC), 2003, GUID NAT REG TRAV TR
   Uwanyiligira M, 2012, CLIN INFECT DIS, V55, P201, DOI 10.1093/cid/cis384
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, 2016, PREV SEX TRANSM ZIK
   Wilder-Smith A, 2010, J TRAVEL MED, V17, P1, DOI 10.1111/j.1708-8305.2010.00451.x
   World Health Organization (WHO), 2016, CHOL CAS REP YEAR CO
   World Health Organization (WHO), 2016, YELL FEV VACC REQ RE
   World Health Organization (WHO), 2016, INT TRAV HLTH
   World Health Organization (WHO), 2016, CHOL U REP TANZ
NR 81
TC 0
Z9 0
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAR-APR
PY 2018
VL 51
IS 2
BP 125
EP 132
DI 10.1590/0037-8682-0418-2017
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GG0TA
UT WOS:000432390600002
PM 29768543
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Marquezan, MC
   Ventura, CV
   Sheffield, JS
   Golden, WC
   Omiadze, R
   Belfort, R
   May, W
AF Marquezan, Maria Carolina
   Ventura, Camila V.
   Sheffield, Jeanne S.
   Golden, William Christopher
   Omiadze, Revaz
   Belfort, Rubens, Jr.
   May, William
TI Ocular effects of Zika virus-a review
SO SURVEY OF OPHTHALMOLOGY
LA English
DT Review
DE Zika virus; ocular findings; congenital Zika syndrome; epidemic
ID GUILLAIN-BARRE-SYNDROME; BIRTH-DEFECTS; INFECTION; INFANTS;
   TRANSMISSION; OUTBREAK; DISEASE; BRAZIL; MANIFESTATIONS; ANTIBODIES
AB Zika virus was considered an innocent pathogen while restricted to the African and Asian population; however, after reaching the Americas in March 2015, it became a global threat. Despite usually causing mild or no symptoms in infected adults, Zika virus displays a different behavior toward fetuses. When infected during gestation, fetuses have their immature neural cells killed by the virus and consequently have devastating findings at birth. In the past year the drastic effects of Zika virus infection in newborns include neurological, ophthalmological, audiological, and skeletal abnormalities. These findings represent a new entity called congenital Zika syndrome. We summarize the ocular findings of congenital Zika Syndrome, as well as the current understanding of the illness, systemic manifestations, laboratory investigation, differential diagnosis, prophylaxis, and treatment for this disorder. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Marquezan, Maria Carolina; Ventura, Camila V.; Belfort, Rubens, Jr.] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Marquezan, Maria Carolina; Ventura, Camila V.; Belfort, Rubens, Jr.] Vis Inst, Sao Paulo, SP, Brazil.
   [Marquezan, Maria Carolina; Omiadze, Revaz; May, William] Johns Hopkins Univ Hosp, Wilmer Ophthalmol Inst, Baltimore, MD 21287 USA.
   [Ventura, Camila V.] Altino Ventura Fdn FAV, Recife, PE, Brazil.
   [Sheffield, Jeanne S.] Johns Hopkins Med, Dept Gynecol & Obstet, Baltimore, MD USA.
   [Golden, William Christopher] Johns Hopkins Med, Dept Pediat, Baltimore, MD USA.
RP Marquezan, MC (corresponding author), Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.; Marquezan, MC (corresponding author), Vis Inst, Sao Paulo, SP, Brazil.; Marquezan, MC (corresponding author), Johns Hopkins Univ Hosp, Wilmer Ophthalmol Inst, Baltimore, MD 21287 USA.
EM mcmarquezan@gmail.com
RI Ventura, Camila V/N-2654-2018
OI Ventura, Camila V/0000-0002-2927-4684; Golden,
   William/0000-0002-4834-6778
CR Aggarwal A, 2013, J NEUROSCI RURAL PRA, V4, P288, DOI 10.4103/0976-3147.118781
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   [Anonymous], 2016, PREGN WOM AN LAB EV
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, TRANSM RISKS
   Centers for Disease Control and Prevention, AB ZIK
   Centers for Disease Control and Prevention, 2016, OUTC COMPL PREGN US
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US 2015
   Centers for Disease Control and Prevention, TREATM
   Centers for Disease Control and Prevention, SYMPT TEST TREATM
   Centers for Disease Control and Prevention (CDC), ZIK VIR PREV
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cuturilo G, 2008, BIRTH DEFECTS RES A, V82, P166, DOI 10.1002/bdra.20441
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira Dias JR, 2017, RETIN CASES BRIEF RE
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dimantas Maria Angélica Pavão, 2003, Arq. Bras. Oftalmol., V66, P235, DOI 10.1590/S0004-27492003000200023
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   El-Ruby M, 2007, GENET COUNSEL, V18, P217
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Goyal R, 2008, EYE, V22, P273, DOI 10.1038/sj.eye.6702958
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jonas JB, 2003, EUR J OPHTHALMOL, V13, P209
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Rosa RFM, 2015, SAO PAULO MED J, V133, P377, DOI 10.1590/1516-3180.2013.7930003
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-35
   Man BL, 2014, BMJ CASE REP, V2014
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mulvihill AO, 2007, BRIT J OPHTHALMOL, V91, P613, DOI 10.1136/bjo.2006.105569
   Nascimento H, 2016, OCUL IMMUNOL INFLAMM, V25, P1, DOI [10.3109/09273948.2015.1132741, DOI 10.3109/09273948.2015.1132741]
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   O'Hara MF, 2002, TERATOLOGY, V65, P131, DOI 10.1002/tera.10028
   OLSHAN AF, 1989, INT J EPIDEMIOL, V18, P891, DOI 10.1093/ije/18.4.891
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasool N, 2016, JAMA OPHTHALMOL, V134, P1200, DOI 10.1001/jamaophthalmol.2016.2398
   Lyra PPR, 2016, AJP REP, V6, pE299, DOI 10.1055/s-0036-1587323
   Roze B, 2016, EUROSURVEILLANCE, V21, P1
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scripsema Nicole K, 2015, Retin Cases Brief Rep, V9, P352, DOI 10.1097/ICB.0000000000000232
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsay CH, 1996, J CHILD NEUROL, V11, P25, DOI 10.1177/088307389601100106
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 2017, SIT REP
   Wong CW, 2017, RETIN CASES BRIEF RE
   World Health Organization, 2016, REG ZIK EP UPD AM
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   World Health Organization. Programmes, 2016, 1 ZIK EM COMM
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 97
TC 7
Z9 7
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0039-6257
EI 1879-3304
J9 SURV OPHTHALMOL
JI Surv. Ophthalmol.
PD MAR-APR
PY 2018
VL 63
IS 2
BP 166
EP 173
DI 10.1016/j.survophthal.2017.06.001
PG 8
WC Ophthalmology
SC Ophthalmology
GA FX4EN
UT WOS:000426025600003
PM 28623165
DA 2020-07-08
ER

PT J
AU Sariol, CA
   Nogueira, ML
   Vasilakis, N
AF Sariol, Carlos A.
   Nogueira, Mauricio L.
   Vasilakis, Nikos
TI A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance
   Zika Disease?
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID ANTIBODY-DEPENDENT ENHANCEMENT; MEDIATED ENHANCEMENT; INFECTION;
   PATHOGENESIS; RHESUS; SPECIFICITY; MACAQUES; MONKEYS
AB The rise of Zika virus (ZIKV) and its unusual clinical manifestations provided ground for speculative debate. The clinical severity of secondary dengue virus (DENV) infections is associated with antibody-dependent enhancement (ADE), and it was recently suggested that previous exposure to DENV may worsen ZIKV clinical outcomes. In this Opinion article we analyze the relationship among different flaviviruses and ADE. We discuss new evidence obtained in non-human primates and human cohorts demonstrating that there is no correlation to ADE when ZIKV infection occurs in the presence of pre-existing DENV immunity. We propose a redefinition of ADE in the context of complex immunological flavivirus interactions to provide a more objective perspective when translating in vitro or in vivo observations into the clinical setting.
C1 [Sariol, Carlos A.] Univ Puerto Rico, Caribbean Primate Res Ctr, Unit Comparat Med, Med Sci Campus, San Juan, PR 00936 USA.
   [Sariol, Carlos A.] Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA.
   [Sariol, Carlos A.] Univ Puerto Rico, Dept Internal Med, Med Sci Campus, San Juan, PR 00936 USA.
   [Nogueira, Mauricio L.] Fac Med Sao Jose Do Rio Preto, Sao Jose Do Rio Preto, SP, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Sariol, CA (corresponding author), Univ Puerto Rico, Caribbean Primate Res Ctr, Unit Comparat Med, Med Sci Campus, San Juan, PR 00936 USA.; Sariol, CA (corresponding author), Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA.; Sariol, CA (corresponding author), Univ Puerto Rico, Dept Internal Med, Med Sci Campus, San Juan, PR 00936 USA.; Nogueira, ML (corresponding author), Fac Med Sao Jose Do Rio Preto, Sao Jose Do Rio Preto, SP, Brazil.; Vasilakis, N (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Vasilakis, N (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.; Vasilakis, N (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.; Vasilakis, N (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM carlos.sariol1@upr.edu; mnogueira@famerp.br; nivasila@utmb.edu
RI Sariol, Carlos A./W-6360-2019; Nogueira, Mauricio L/B-7599-2012
OI Sariol, Carlos A./0000-0001-7535-4303; Nogueira, Mauricio
   L/0000-0003-1102-2419
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U01 AI115577, R24AI120942, P40
   OD012217, U42OD021458]; FAPESPFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2013/21719-3, 2016/15021-1]
FX The authors' work on DENV and ZIKV is supported by NIH grants U01
   AI115577, R24AI120942 (NV), P40 OD012217 and U42OD021458, (CAS) and
   FAPESP Grants # 2013/21719-3 and 2016/15021-1 (MNL). We would also like
   to acknowledge Erick Perez Guzman for expert graphical design on Figure
   1. During the review of this manuscript a category 4 hurricane
   devastated Puerto Rico with an undetermined impact in the research
   activity. Authors want to deeply thank all collaborators and friends who
   expressed their sympathy and who were actively engaged in different
   supporting initiatives.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GC, 2016, BRAZ J INFECT DIS, V20, P227, DOI 10.1016/j.bjid.2016.05.001
   Cao-Lormeau V. M., 2016, LANCET
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Fust G, 1997, PARASITOLOGY, V115, pS127, DOI 10.1017/S0031182097001819
   GEORGE J, 2017, SCI REP UK, V7
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Grifoni A, 2017, J VIROL
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Jarasch-Althof N, 2010, VIRAL IMMUNOL, V23, P369, DOI 10.1089/vim.2010.0018
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   KING AA, 1984, J GEN VIROL, V65, P1091, DOI 10.1099/0022-1317-65-6-1091
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   PEIRIS JSM, 1982, J GEN VIROL, V58, P291, DOI 10.1099/0022-1317-58-2-291
   PETRALEIGH P, 2016, SECONDARY ZIKA VIRUS, P1
   Roze B, 2016, EURO SURVEILL
   Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Srikiatkhachorn A, 2017, SEMIN IMMUNOPATHOL, V39, P563, DOI 10.1007/s00281-017-0625-1
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Wang SF, 2014, BIOCHEM BIOPH RES CO, V451, P208, DOI 10.1016/j.bbrc.2014.07.090
NR 40
TC 14
Z9 14
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD MAR
PY 2018
VL 26
IS 3
BP 186
EP 190
DI 10.1016/j.tim.2017.10.004
PG 5
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA FX5WU
UT WOS:000426154100005
PM 29122447
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Bos, S
   Viranaicken, W
   Turpin, J
   El-Kalamouni, C
   Roche, M
   Krejbich-Trotot, P
   Despres, P
   Gadea, G
AF Bos, Sandra
   Viranaicken, Wildriss
   Turpin, Jonathan
   El-Kalamouni, Chaker
   Roche, Marjolaine
   Krejbich-Trotot, Pascale
   Despres, Philippe
   Gadea, Gilles
TI The structural proteins of epidemic and historical strains of Zika virus
   differ in their ability to initiate viral infection in human host cells
SO VIROLOGY
LA English
DT Article
DE Arbovirus; Flavivirus; Zika virus; Viral strains; Infectious cDNA;
   Chimeric virus; Viral infection; Virus binding; Host-cell activation;
   Structural proteins; Innate immunity
ID PRM PROTEIN; CLEAVAGE; GLYCOSYLATION; TRANSMISSION; SECRETION; MUTATION;
   AFRICAN
AB Mosquito-borne Zika virus (ZIKV) recently emerged in South Pacific islands and Americas where large epidemics were documented. In the present study, we investigated the contribution of the structural proteins C, prM and E in the permissiveness of human host cells to epidemic strains of ZIKV. To this end, we evaluated the capacity of the epidemic strain BeH819015 to infect epithelial A549 and neuronal SH-SY5Y cells in comparison to the African historical MR766 strain. For that purpose, we generated a molecular clone of BeH819015 and a chimeric clone of MR766 which contains the BeH819015 structural protein region. We showed that ZIKV containing BeH819015 structural proteins was much less efficient in cell-attachment leading to a reduced susceptibility of A549 and SH-SY5Y cells to viral infection. Our data illustrate a previously underrated role for C, prM, and E in ZIKV epidemic strain ability to initiate viral infection in human host cells.
C1 [Bos, Sandra; Viranaicken, Wildriss; Turpin, Jonathan; El-Kalamouni, Chaker; Roche, Marjolaine; Krejbich-Trotot, Pascale; Despres, Philippe; Gadea, Gilles] Univ Reunion, CNRS UMR 9192, Plateforme Technol CYROI,INSERM U1187, Unite Mixte Proc Infect Milieu Insulaire Trop,IRD, F-94791 St Clothilde, La Reunion, France.
RP Despres, P; Gadea, G (corresponding author), Univ Reunion, CNRS UMR 9192, Plateforme Technol CYROI,INSERM U1187, Unite Mixte Proc Infect Milieu Insulaire Trop,IRD, F-94791 St Clothilde, La Reunion, France.
EM philippe.despres@univ-reunion.fr; gilles.gadea@inserm.fr
RI Gilles, Gadea/M-9966-2015
OI Gilles, Gadea/0000-0001-6325-4866; Krejbich Trotot,
   Pascale/0000-0001-7329-1716; BOS, Sandra/0000-0001-5036-0336
FU European UnionEuropean Union (EU) [735548]; ZIKAlert project (POE FEDER)
   [SYNERGY:RE0001902]; La Reunion Island University; French ministry MEESR
FX We gratefully knowledge P. Mavingui and REACTing consortium for their
   support. We thank J-J. Hoarau for helpful discussions. This work was
   supported by the ZIKAlliance project (European Union-Horizon 2020
   programme under grant agreement no 735548) and the ZIKAlert project (POE
   FEDER 2014-2020 Ile de la Reunion action 1.05 under grant agreement no
   SYNERGY:RE0001902). SB has PhD degree scholarship from La Reunion Island
   University (Ecole Doctorale STS), funded by French ministry MEESR.
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Calvert AE, 2012, VIROLOGY, V433, P35, DOI 10.1016/j.virol.2012.07.011
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0
   Epelboin S, 2017, HUM REPROD UPDATE, V23, P629, DOI 10.1093/humupd/dmx024
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hsieh SC, 2014, J BIOL CHEM, V289, P33149, DOI 10.1074/jbc.M114.610428
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Setoh YX, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0303-7
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Viranaicken W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022296
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yoshii K, 2004, J GEN VIROL, V85, P3049, DOI 10.1099/vir.0.80169-0
   Yoshii K, 2012, J GEN VIROL, V93, P27, DOI 10.1099/vir.0.035964-0
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 47
TC 21
Z9 21
U1 0
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD MAR
PY 2018
VL 516
BP 265
EP 273
DI 10.1016/j.virol.2017.12.003
PG 9
WC Virology
SC Virology
GA GA0LP
UT WOS:000428004800028
PM 29395111
OA Other Gold
DA 2020-07-08
ER

PT J
AU Oh, SJ
   Choi, YK
   Shin, OS
AF Oh, Soo-Jin
   Choi, Young-Ki
   Shin, Ok Sarah
TI Systems Biology-Based Platforms to Accelerate Research of Emerging
   Infectious Diseases
SO YONSEI MEDICAL JOURNAL
LA English
DT Review
DE Emerging infectious diseases; systems biology; systems vaccinology;
   vaccines; immunity
ID YELLOW-FEVER VACCINE; INFLUENZA-VIRUS INFECTION; THROMBOCYTOPENIA
   SYNDROME; GENE-EXPRESSION; ZIKA VIRUS; SEASONAL INFLUENZA; SOUTH-KOREA;
   REEMERGING PATHOGENS; IMMUNE-RESPONSES; SAUDI-ARABIA
AB Emerging infectious diseases (EIDs) pose a major threat to public health and security. Given the dynamic nature and significant impact of EIDs, the most effective way to prevent and protect against them is to develop vaccines in advance. Systems biology approaches provide an integrative way to understand the complex immune response to pathogens. They can lead to a greater understanding of EID pathogenesis and facilitate the evaluation of newly developed vaccine-induced immunity in a timely manner. In recent years, advances in high throughput technologies have enabled researchers to successfully apply systems biology methods to analyze immune responses to a variety of pathogens and vaccines. Despite recent advances, computational and biological challenges impede wider application of systems biology approaches. This review highlights recent advances in the fields of systems immunology and vaccinology, and presents ways that systems biology- based platforms can be applied to accelerate a deeper understanding of the molecular mechanisms of immunity against EIDs.
C1 [Oh, Soo-Jin; Shin, Ok Sarah] Korea Univ, Guro Hosp, Coll Med, Dept Biomed Sci, Seoul, South Korea.
   [Choi, Young-Ki] Chungbuk Natl Univ, Coll Med, Cheongju, South Korea.
   [Choi, Young-Ki] Chungbuk Natl Univ, Med Res Inst, Cheongju, South Korea.
RP Shin, OS (corresponding author), Korea Univ, Guro Hosp, Coll Med, Dept Biomed Sci, Seoul, South Korea.
EM oshin@korea.ac.kr
OI Shin, Ok Sarah/0000-0002-3977-2492; Oh, Soo-jin/0000-0001-5423-0440
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2016R1C1B2006493]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF), funded by the
   Ministry of Science, ICT & Future Planning (grant number
   NRF-2016R1C1B2006493).
CR Aderem A, 2011, MBIO, V2, DOI 10.1128/mBio.00325-10
   Ahmed N, 2009, EXPERT REV VACCINES, V8, P543, DOI [10.1586/erv.09.26, 10.1586/ERV.09.26]
   Almeida SL, 2015, J EMERG NURS, V41, P104, DOI 10.1016/j.jen.2015.01.001
   Azhar EI, 2017, ADV EXP MED BIOL, V972, P49, DOI 10.1007/5584_2016_133
   Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732
   Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156
   Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84
   Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102
   Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7
   Choi YK, 2013, CURR TOP MICROBIOL, V370, P147, DOI 10.1007/82_2011_195
   Dash AP, 2013, J VECTOR DIS, V50, P77
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Ertl R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-52
   Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Grimm SK, 2013, CURR OPIN BIOTECH, V24, P1078, DOI 10.1016/j.copbio.2013.02.015
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Henn AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02327
   Hoek KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118528
   Howard CR, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.47
   Hwang GM, 2012, TRAVEL MED INFECT DI, V10, P32, DOI 10.1016/j.tmaid.2011.12.003
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Jones M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003896
   Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114
   Kim WY, 2015, CLIN INFECT DIS, V60, P1681, DOI 10.1093/cid/civ128
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071
   Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003
   Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026
   Li SZ, 2013, SEMIN IMMUNOL, V25, P209, DOI 10.1016/j.smim.2013.05.003
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lisnic VJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003611
   Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Mei B, 2014, GENE, V551, P255, DOI 10.1016/j.gene.2014.08.062
   Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172
   Miki Shinichiro, 2017, J Clin Med Res, V9, P650, DOI 10.14740/jocmr3022w
   Mizukami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101835
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morse SS, 1996, EPIDEMIOL REV, V18, P1, DOI 10.1093/oxfordjournals.epirev.a017912
   MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102
   MORSE SS, 1990, J INFECT DIS, V162, P1, DOI 10.1093/infdis/162.1.1
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113
   Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Nakaya HI, 2012, WIRES SYST BIOL MED, V4, P193, DOI 10.1002/wsbm.163
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Hagan DT, 2017, CURR OPIN IMMUNOL, V47, P93, DOI 10.1016/j.coi.2017.07.010
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Oh WS, 2017, YONSEI MED J, V58, P867, DOI 10.3349/ymj.2017.58.4.867
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Ostfeld RS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0051
   Park JH, 2012, EMERG INFECT DIS, V18, P1525, DOI 10.3201/eid1809.111811
   Park SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16512
   Park WB, 2013, COMP IMMUNOL MICROB, V36, P559
   Pulendran B, 2013, IMMUNOL REV, V255, P243, DOI 10.1111/imr.12099
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3
   Rappuoli R, 2011, LANCET, V378, P360, DOI 10.1016/S0140-6736(11)60440-6
   Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829
   Rossetto CC, 2013, J VIROL, V87, P5540, DOI 10.1128/JVI.03111-12
   Shin SY, 2016, YONSEI MED J, V57, P1286, DOI 10.3349/ymj.2016.57.5.1286
   Short KR, 2015, ONE HEALTH, V1, P1, DOI [10.1016/j.onehlt.2015.03.001, 10.1016/j.onehit.2015.03.001]
   Sievers SA, 2015, CURR OPIN HIV AIDS, V10, P151, DOI 10.1097/COH.0000000000000148
   Six A, 2012, MICROB BIOTECHNOL, V5, P295, DOI 10.1111/j.1751-7915.2011.00321.x
   Stone BL, 2017, VECTOR-BORNE ZOONOT, V17, P619, DOI 10.1089/vbz.2017.2127
   Su S, 2017, TRENDS MICROBIOL, V25, P713, DOI 10.1016/j.tim.2017.06.008
   Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603
   Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748
   Vesikari T, 2012, VACCINE, V30, P1388, DOI 10.1016/j.vaccine.2011.12.009
   Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331
   Wang XL, 2017, LANCET INFECT DIS, V17, P822, DOI [10.1016/S1473-3099(17)30323-7, 10.1016/s1473-3099(17)30323-7]
   Wang Y, 2014, POULTRY SCI, V93, P485, DOI 10.3382/ps.2013-03557
   WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992
   Westerhoff HV, 2009, FEBS LETT, V583, P3882, DOI 10.1016/j.febslet.2009.11.018
   WILSON ME, 1995, EMERG INFECT DIS, V1, P39, DOI 10.3201/eid0102.950201
   Wilson ME, 2003, J APPL MICROBIOL, V94, p1S
   Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
   Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9
   Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396
   Yun SM, 2014, EMERG INFECT DIS, V20, P1358, DOI 10.3201/eid2008.131857
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhan JB, 2017, VIROL SIN, V32, P51, DOI 10.1007/s12250-016-3931-1
NR 91
TC 3
Z9 3
U1 0
U2 5
PU YONSEI UNIV COLL MEDICINE
PI SEOUL
PA 50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA
SN 0513-5796
EI 1976-2437
J9 YONSEI MED J
JI Yonsei Med. J.
PD MAR
PY 2018
VL 59
IS 2
BP 176
EP 186
DI 10.3349/ymj.2018.59.2.176
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA FW5MQ
UT WOS:000425361900003
PM 29436184
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Makhluf, H
   Shresta, S
AF Makhluf, Huda
   Shresta, Sujan
TI Development of Zika Virus Vaccines
SO VACCINES
LA English
DT Review
DE Zika virus; dengue virus; vaccines
ID DNA VACCINE; TRANSMISSION; PROTECTION
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that emerged as a global threat following the most recent outbreak in Brazil in 2015. ZIKV infection of pregnant women is associated with fetal abnormalities such as microcephaly, and infection of adults can lead to Guillain-Barre syndrome, an autoimmune disease characterized by neurological deficits. Although there are currently licensed vaccines for other flaviviruses, there remains an urgent need for preventative vaccines against ZIKV infection. Herein we describe the current efforts to accelerate the development of ZIKV vaccines using various platforms, including live attenuated virus, inactivated virus, DNA and RNA, viral vectors, and in silico-predicted immunogenic viral epitopes. Many of these approaches have leveraged lessons learned from past experience with Dengue and other flavivirus vaccines.
C1 [Makhluf, Huda] Natl Univ, Dept Math & Nat Sci, La Jolla, CA 92037 USA.
   [Makhluf, Huda; Shresta, Sujan] La Jolla Inst, Ctr Infect Dis, La Jolla, CA 92037 USA.
RP Makhluf, H (corresponding author), Natl Univ, Dept Math & Nat Sci, La Jolla, CA 92037 USA.; Makhluf, H (corresponding author), La Jolla Inst, Ctr Infect Dis, La Jolla, CA 92037 USA.
EM hmakhluf@nu.edu; sujan@lji.org
RI amsalu, ribka/G-8780-2019
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI116813, R21 NS100477,
   R21AI127988]
FX Research in the Shresta laboratory is funded by NIH grants (R01
   AI116813, R21 NS100477, and R21AI127988).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaudinski M.R., 2017, LANCET, V6736, P1
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   PAHO, 2017, PAHO REP PAN AM HLTH
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Tebas P, 2017, N ENGL J MED
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xie X., 2017, MBIO AM SOC MICROBIO, V8
   Yang ML, 2017, SCI REP-UK, V7, DOI 10.1038/srep43829
NR 39
TC 13
Z9 15
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD MAR
PY 2018
VL 6
IS 1
AR 7
DI 10.3390/vaccines6010007
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GS7XK
UT WOS:000443917800006
PM 29346287
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yaren, O
   Alto, BW
   Bradley, KM
   Moussatche, P
   Glushakova, L
   Benner, SA
AF Yaren, Ozlem
   Alto, Barry W.
   Bradley, Kevin M.
   Moussatche, Patricia
   Glushakova, Lyudmyla
   Benner, Steven A.
TI Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect
   Zika, Chikungunya, and Dengue 1
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Biochemistry; Issue 133; Point-of-care diagnostics; multiplexed
   isothermal amplification; loop-mediated isothermal amplification; Zika
   detection; fluorescence read-out; no RNA extraction; mosquito
   surveillance; virus detection
ID VIRUS; INNOVATIONS; ARBOVIRUSES; LAMP; DNA
AB Zika, dengue, and chikungunya viruses are transmitted by mosquitoes, causing diseases with similar patient symptoms. However, they have different downstream patient-to-patient transmission potentials, and require very different patient treatments. Thus, recent Zika outbreaks make it urgent to develop tools that rapidly discriminate these viruses in patients and trapped mosquitoes, to select the correct patient treatment, and to understand and manage their epidemiology in real time.
   Unfortunately, current diagnostic tests, including those receiving 2016 emergency use authorizations and fast-track status, detect viral RNA by reverse transcription polymerase chain reaction (RT-PCR), which requires instrumentation, trained users, and considerable sample preparation. Thus, they must be sent to "approved" reference laboratories, requiring time. Indeed, in August 2016, the Center for Disease Control (CDC) was asking pregnant women who had been bitten by a mosquito and developed a Zika-indicating rash to wait an unacceptable 2 to 4 weeks before learning whether they were infected. We very much need tests that can be done on site, with few resources, and by trained but not necessarily licensed personnel.
   This video demonstrates an assay that meets these specifications, working with urine or serum (for patients) or crushed mosquito carcasses (for environmental surveillance), all without much sample preparation. Mosquito carcasses are captured on paper carrying quaternary ammonium groups (Q-paper) followed by ammonia treatment to manage biohazards. These are then directly, without RNA isolation, put into assay tubes containing freeze-dried reagents that need no chain of refrigeration. A modified form of reverse transcription loop-mediated isothermal amplification with target-specific fluorescently tagged displaceable probes produces readout, in 30 min, as a three-color fluorescence signal. This is visualized with a handheld, battery-powered device with an orange filter. Forward contamination is prevented with sealed tubes, and the use of thermolabile uracil DNA glycosylase (UDG) in the presence of dUTP in the amplification mixture.
C1 [Yaren, Ozlem; Benner, Steven A.] Fdn Appl Mol Evolut FfAME, Alachua, FL 32615 USA.
   [Alto, Barry W.] Univ Florida, Florida Med Entomol Lab, Gainesville, FL 32611 USA.
   [Bradley, Kevin M.; Moussatche, Patricia; Glushakova, Lyudmyla; Benner, Steven A.] Firebird Biomol Sci LLC, Gainesville, FL 32605 USA.
RP Benner, SA (corresponding author), Fdn Appl Mol Evolut FfAME, Alachua, FL 32615 USA.; Benner, SA (corresponding author), Firebird Biomol Sci LLC, Gainesville, FL 32605 USA.
EM manuscripts@ffame.org
RI amsalu, ribka/G-8780-2019
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1R21AI128188-01]; National Institutes of
   Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID); Biomedical Research
   Program of Florida Department of Health; Dynamic Combinatorial Chemistry
   LLC;  [FDOH-7ZK15]
FX The work was supported in part by FDOH-7ZK15 and NIAID 1R21AI128188-01.
   Research reported in this publication was supported in part by the
   National Institutes of Allergy and Infectious Diseases, and in part by
   Biomedical Research Program of Florida Department of Health. The content
   is solely the responsibility of the authors and does not necessarily
   represent the official views of the NIH or Florida Department of Health.
   Dynamic Combinatorial Chemistry LLC is acknowledged for their support
   and contribution to this project.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007
   DICK G.W.A., 1952, T R SOC TROP MED HYG, V46
   Edgar RC, 2004, NUCL ACIDS RES, V32
   Edwards T, 2014, J CLIN MICROBIOL, V52, P2163, DOI 10.1128/JCM.00314-14
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gasque P, 2016, J INFECT DIS, V214, pS446, DOI 10.1093/infdis/jiw362
   Glushakova LG, 2017, J VIROL METHODS, V246, P104, DOI 10.1016/j.jviromet.2017.04.013
   Glushakova LG, 2015, J VIROL METHODS, V214, P60, DOI 10.1016/j.jviromet.2015.01.003
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hsieh K, 2014, CHEM COMMUN, V50, P3747, DOI 10.1039/c4cc00540f
   Janis A. M., 2016, EMERG INFECT DIS J, V22
   Jones PHOC, 2015, J INFECT DIS THER, V3
   Kubota R, 2011, BIOL ENG T, V4, P81, DOI DOI 10.13031/2013.38509
   Kubota R, 2015, INT J MOL SCI, V16, P4786, DOI 10.3390/ijms16034786
   Li J, 2015, BIOSENS BIOELECTRON, V64, P196, DOI 10.1016/j.bios.2014.08.069
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nagamine K., 2002, MOL CELL PROBES, V16
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Reiskind MH, 2008, AM J TROP MED HYG, V78, P422, DOI 10.4269/ajtmh.2008.78.422
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27605
   Thomas A. H., 2002, PHOTOCHEM PHOTOBIOL, V1
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Wu D, 1999, MED VET ENTOMOL, V13, P48, DOI 10.1046/j.1365-2915.1999.00144.x
   Yaren O., 2016, US Provisional patent application, Patent No. 62381759
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
NR 39
TC 2
Z9 2
U1 3
U2 12
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAR
PY 2018
IS 133
AR e57051
DI 10.3791/57051
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS1XA
UT WOS:000443329500015
PM 29608170
OA Green Published
DA 2020-07-08
ER

PT J
AU Hoffman, SJ
   Silverberg, SL
AF Hoffman, Steven J.
   Silverberg, Sarah L.
TI Delays in Global Disease Outbreak Responses: Lessons from H1N1, Ebola,
   and Zika
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID EPIDEMIC
AB Inglobal disease outbreaks, there are significant time delays between the source of an outbreak and collective action. Some delay is necessary, but recent delays have been extended by insufficient surveillance capacity and time-consuming efforts to mobilize action.
   Three public health emergencies of international concern (PHEICs)-H1N1, Ebola, and Zika-allow us to identify and compare sources of delays and consider seven hypotheses about what influences the length of delays. These hypotheses can then motivate further research that empirically tests them. The three PHEICs suggest that deferred global mobilization is a greater source of delay than is poor surveillance capacity. These case study outbreaks support hypotheses that we see quicker responses for novel diseases when outbreaks do not coincide with holidays and when US citizens are infected. They do not support hypotheses that we see quicker responses for more severe outbreaks or those that threaten larger numbers of people.
   Better understanding the reason for delays can help target policy interventions and identify the kind of global institutional changes needed to reduce the spread and severity of future PHEICs.
C1 [Hoffman, Steven J.] York Univ, Fac Hlth, Dahdaleh Inst Global Hlth Res, Global Strategy Lab, Toronto, ON, Canada.
   [Hoffman, Steven J.] York Univ, Osgoode Hall Law Sch, Toronto, ON, Canada.
   [Hoffman, Steven J.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.
   [Silverberg, Sarah L.] Univ Toronto, Fac Med, Toronto, ON, Canada.
RP Hoffman, SJ (corresponding author), York Univ, Global Strategy Lab, 4700 Keele St, Toronto, ON M3J 1P3, Canada.
EM steven.hoffman@globalstrategylab.org
OI Hoffman, Steven/0000-0002-2064-3711
FU Research Council of Norway's Global Health & Vaccination Programme
   (GLOBVAC project) [234608]; Canadian Institutes of Health
   ResearchCanadian Institutes of Health Research (CIHR); Ontario
   government's Ministry of Research, Innovation and Science
FX This work was completed as part of the International Collaboration for
   Capitalizing on Cost-Effective and Life-Saving Commodities, which is
   funded by the Research Council of Norway's Global Health & Vaccination
   Programme (GLOBVAC project 234608). S. J. H. is additionally funded by
   the Canadian Institutes of Health Research and the Ontario government's
   Ministry of Research, Innovation and Science.
CR [Anonymous], 2015, MIN SAND DIV B EP
   Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467
   Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400
   Gopinathan U, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0128-6
   Hoffman SJ, 2016, J CLIN EPIDEMIOL, V75, P47, DOI 10.1016/j.jclinepi.2015.12.010
   Hoffman SJ, 2015, B WORLD HEALTH ORGAN, V93, P867, DOI 10.2471/BLT.15.153171
   Hoffman SJ, 2015, AM J PUBLIC HEALTH, V105, P1523, DOI 10.2105/AJPH.2015.302726
   Hoffman SJ, 2012, GLOB POLICY, V3, P421, DOI 10.1111/j.1758-5899.2011.00153.x
   Hoffman SJ, 2012, B WORLD HEALTH ORGAN, V90, P854, DOI 10.2471/BLT.12.109827
   Hoffman SJ, 2010, HEALTH POLICY PLANN, V25, P510, DOI 10.1093/heapol/czq037
   Hsieh YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023853
   Kalra S, 2014, J GLOB INFECT DIS, V6, P164, DOI 10.4103/0974-777X.145247
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Ottersen T, 2016, AM J LAW MED, V42, P356, DOI 10.1177/0098858816658273
   Pan-American Health Organization, 2015, NEUR SYNDR CONG MALF
   Tomori O, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0359-7
   United Nations, 2016, PROT HUM FUT HLTH CR
   Vetter P, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0112-9
   WHO, 2015, REP EB INT ASS PAN J
   World Health Organization (WHO), 2015, OR 2014 EB EP ON YEA
NR 23
TC 10
Z9 10
U1 16
U2 20
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD MAR
PY 2018
VL 108
IS 3
BP 329
EP 333
DI 10.2105/AJPH.2017.304245
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GO7LP
UT WOS:000440247400032
PM 29345996
OA Green Published
DA 2020-07-08
ER

PT J
AU Long, EF
   Nohdurft, E
   Spinler, S
AF Long, Elisa F.
   Nohdurft, Eike
   Spinler, Stefan
TI Spatial Resource Allocation for Emerging Epidemics: A Comparison of
   Greedy, Myopic, and Dynamic Policies
SO M&SOM-MANUFACTURING & SERVICE OPERATIONS MANAGEMENT
LA English
DT Article
DE healthcare operations; resource allocation; approximate dynamic
   programming; epidemiology
ID COMPARTMENTAL-MODELS; EBOLA; SPREAD; INTERVENTIONS; INFERENCE; DISEASE;
   LIBERIA; NUMBER; IMPACT; HIV
AB Rapidly evolving infectious disease epidemics, such as the 2014 West African Ebola outbreak, pose significant health threats and present challenges to the global health community because of their heterogeneous geographic spread. Policy makers must allocate limited intervention resources quickly, in anticipation of where the outbreak is moving next. We develop a two-stage model for optimizing when and where to assign Ebola treatment units across geographic regions during the outbreak's early phases. The first stage employs a novel dynamic transmission model to forecast the occurrence of new cases at the region level, capturing connectivity among regions. We introduce an empirically estimated coefficient for behavioral adaptation to changing epidemic conditions. The second stage compares four approaches to allocate units across affected regions: (i) a heuristic based on observed cases, (ii) a greedy policy that prioritizes regions based on the reproductive number, (iii) a myopic linear program that allocates resources in the next period based on an iterative estimation-optimization approach coupled with the underlying epidemic model, and (iv) an approximate dynamic programming algorithm that optimizes over all future periods. After testing the allocation schemes under different budgets and time periods, we find that the myopic policy performs best, even when limited data are available. Our methodology could be generalized to other disease outbreaks, including the Zika virus, and other interventions.
C1 [Long, Elisa F.] Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA 90095 USA.
   [Nohdurft, Eike; Spinler, Stefan] Kuhne Inst Logist Management, WHU Otto Beisheim Sch Management, D-56179 Vallendar, Germany.
RP Long, EF (corresponding author), Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA 90095 USA.
EM elisa.long@anderson.ucla.edu; eike.nohdurft@whu.edu;
   stefan.spinler@whu.edu
FU U.S. National Instituteon Drug AbuseUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Drug Abuse (NIDA) [R01-DA15612]; German Academic Exchange
   ServiceDeutscher Akademischer Austausch Dienst (DAAD) [91620716]
FX E. Long received support from the U.S. National Instituteon Drug Abuse
   [Grant R01-DA15612]. E. Nohdurft received support from the German
   Academic Exchange Service [Grant 91620716].
CR Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109
   ALLEN LJS, 1994, MATH BIOSCI, V124, P83, DOI 10.1016/0025-5564(94)90025-6
   Althaus CL, 2014, PLOS CURRENTS OUTBRE, V6, DOI [10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288, DOI 10.1371/CURRENTS.OUTBREAKS.91AFB5E0F279E7F29E7056095255B288.]
   ANDERSON R M, 1991
   Apolloni A, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-3
   Arino J, 2003, LECT NOTES CONTR INF, V294, P135
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Barz C, 2015, PROD OPER MANAG, V24, P1907, DOI 10.1111/poms.12395
   Bertsekas D. P., 1995, DYNAMIC PROGRAMMING, VII
   Blount S, 1997, APPL MATH COMPUT, V86, P123, DOI 10.1016/S0096-3003(96)00177-4
   Brandeau ML, 2005, INT SER OPER RES MAN, V70, P443, DOI 10.1007/1-4020-8066-2_17
   Brandeau ML, 2003, J HEALTH ECON, V22, P575, DOI 10.1016/S0167-6296(03)00043-2
   Butler D, 2014, NATURE, V515, P18, DOI 10.1038/515018a
   Butler D, 2014, NATURE, V513, P469, DOI 10.1038/513469a
   Carr S, 2010, WINT SIMUL C PROC, P2171, DOI 10.1109/WSC.2010.5678858
   Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006
   Currie CSM, 2007, J SIMUL, V1, P97, DOI 10.1057/palgrave.jos.4250014
   Dilorenzo S, 2014, NEWS HERALD     1113
   Doctors Without Borders, 2015, MSF OP NEW EB TREATM
   Ekici A, 2014, M&SOM-MANUF SERV OP, V16, P11, DOI 10.1287/msom.2013.0460
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferrari MJ, 2005, MATH BIOSCI, V198, P14, DOI 10.1016/j.mbs.2005.08.002
   Fisman D, 2014, PLOS CURRENTS OUTBRE, V6, DOI [10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571, DOI 10.1371/CURRENTS.OUTBREAKS.89C0D3783F36958D96EBBAE97348D571.]
   Funk S, 2014, NATURE, V515, P493, DOI 10.1038/515492b
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Gerberry DJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6454
   Gettleman Jeffrey, 2014, NY TIMES
   Gibson GJ, 1998, IMA J MATH APPL MED, V15, P19
   Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5
   GREENHALGH D, 1986, MATH BIOSCI, V80, P23, DOI 10.1016/0025-5564(86)90065-9
   Groseth A, 2007, TRENDS MICROBIOL, V15, P408, DOI 10.1016/j.tim.2007.08.001
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Hulshof PJ, 2015, FLEX SERV MANUF J, P1
   Humanitarian Data Exchange, 2015, SUB NAT TIM SER DAT
   Humanitarian Data Exchange, 2016, NUMB EB CAS DEATHS A
   Humanitarian Data Exchange, 2014, NUMB EX BEDS EB TREA
   Institut National de la Statistique, 2014, REP POP DENS REG PRE
   Khan A, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0043-3
   Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217
   Lekone PE, 2006, BIOMETRICS, V62, P1170, DOI 10.1111/j.1541-0420.2006.00609.x
   Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]
   Liberia Institute of Statistics and Geo-Information Service, 2008, POP HOUS CENS
   Mbah MLN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024577
   Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570
   Meltzer MI, 2014, MMWR-MORBID M      S, V63, p[2014, 1]
   Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6
   Powell W. B., 2011, APPROXIMATE DYNAMIC
   Richter A, 1999, MED DECIS MAKING, V19, P167, DOI 10.1177/0272989X9901900207
   Rivers C, 2014, PLOS CURRENTS OUTBRE
   Rowthorn RE, 2009, J R SOC INTERFACE, V6, P1135, DOI 10.1098/rsif.2008.0402
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   Sierra Leone Statistics, 2004, REP STAT SIERR LEON
   Sun L, 2014, COMPUT OPER RES, V51, P350, DOI 10.1016/j.cor.2013.12.001
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371
   WHO, 2015, EB VIR DIS
   Wilson DP, 2006, P NATL ACAD SCI USA, V103, P14228, DOI 10.1073/pnas.0509689103
   Woolhouse MEJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0191
   World Health Organization, 2017, STAT EB DEM REP CONG
   Wu JT, 2007, P ROY SOC B-BIOL SCI, V274, P2811, DOI 10.1098/rspb.2007.0893
   Zaric GS, 2002, IMA J MATH APPL MED, V19, P235
   Zaric GS, 2001, MATH BIOSCI, V171, P33, DOI 10.1016/S0025-5564(01)00050-5
NR 62
TC 2
Z9 2
U1 3
U2 8
PU INFORMS
PI CATONSVILLE
PA 5521 RESEARCH PARK DR, SUITE 200, CATONSVILLE, MD 21228 USA
SN 1523-4614
EI 1526-5498
J9 M&SOM-MANUF SERV OP
JI M&SOM-Manuf. Serv. Oper. Manag.
PD SPR
PY 2018
VL 20
IS 2
BP 181
EP 198
DI 10.1287/msom.2017.0681
PG 18
WC Management; Operations Research & Management Science
SC Business & Economics; Operations Research & Management Science
GA GN3VF
UT WOS:000438937400002
DA 2020-07-08
ER

PT J
AU Bradt, D
   Coburn, L
   Bradley, KK
   Noden, BH
AF Bradt, David
   Coburn, Lisa
   Bradley, Kristy K.
   Noden, Bruce H.
TI FIRST RECORD OF AEDES JAPONICUS JAPONICUS IN OKLAHOMA, 2017
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes japonicus japonicus; Asian bush mosquito; Culex coronator; rural
   surveillance; West Nile virus
ID OCHLEROTATUS-J.-JAPONICUS; WEST-NILE VIRUS; CULEX-CORONATOR DYAR;
   ENCEPHALITIS-VIRUS; EXPERIMENTAL TRANSMISSION; DIPTERA-CULICIDAE; USA;
   DISCOVERY; ALABAMA; BIOLOGY
AB In spring 2017, mosquito larvae were collected from 25 sites across eastern Oklahoma as part of a Zika virus vector surveillance effort. Aedes japonicus japonicus larvae were collected from horse troughs at 2 sites in Ottawa County, OK. Identification was made using 1 larva stored in 70% ethanol and 3 adult females reared from the larvae. Another invasive mosquito species, Culex coronator, was detected at 2 different sites, adding 2 additional counties to the 9 where the species had been previously reported. The presence of these invasive species in Oklahoma may have an impact on future regional arbovirus concerns.
C1 [Bradt, David; Coburn, Lisa; Noden, Bruce H.] Oklahoma State Univ, Dept Entomol & Plant Pathol, 127 Noble Res Ctr, Stillwater, OK 74078 USA.
   [Bradley, Kristy K.] Oklahoma Dept Hlth, Off State Epidemiologist, 1000 NE Tenth St, Oklahoma City, OK 73117 USA.
RP Noden, BH (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, 127 Noble Res Ctr, Stillwater, OK 74078 USA.
EM Bruce.Noden@okstate.edu
FU Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative
   Agreement - Centers for Disease Control and Prevention (CDC)
   [5-U50-CK000406]; National Institute of Food and Agriculture/US
   Department of Agriculture through the Oklahoma Agricultural Experiment
   Station [OKL-02909]
FX We thank Hassan Melouk and Wyatt Hoback for constructive comments on an
   earlier version of this manuscript. This project was funded through
   support from an Epidemiology and Laboratory Capacity for Infectious
   Diseases Cooperative Agreement (5-U50-CK000406), funded by the Centers
   for Disease Control and Prevention (CDC). Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the CDC or the Oklahoma Department of Health and Human
   Services. Partial funding for this project was also provided by National
   Institute of Food and Agriculture/US Department of Agriculture Hatch
   Grant funds through the Oklahoma Agricultural Experiment Station
   (OKL-02909).
CR Alto BW, 2014, VECTOR-BORNE ZOONOT, V14, P606, DOI 10.1089/vbz.2013.1501
   Andreadis TG, 2001, J MED ENTOMOL, V38, P774, DOI 10.1603/0022-2585-38.6.774
   Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031
   Bradt DL, 2017, THESIS
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Debboun M, 2005, J AM MOSQUITO CONTR, V21, P455, DOI 10.2987/8756-971X(2006)21[455:FROCCC]2.0.CO;2
   Dyar H. G., 1906, J NY ENTOMOL SOC, V14, P169
   Dyar HG, 1906, J N Y ENTOMOL SOC, V14, P242
   Gallitano S, 2005, J VECTOR ECOL, V30, P347
   Gaspar JP, 2012, J AM MOSQUITO CONTR, V28, P38, DOI 10.2987/11-6196.1
   Goddard J, 2006, J AM MOSQUITO CONTR, V22, P622, DOI 10.2987/8756-971X(2006)22[622:NOTEOC]2.0.CO;2
   Gray KM, 2008, J AM MOSQUITO CONTR, V24, P585, DOI 10.2987/08-5778.1
   KAMPEN H, 2014, PARASITE VECTOR, V7
   Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012
   McNelly JR, 2007, J AM MOSQUITO CONTR, V23, P473, DOI 10.2987/5575.1
   Moulis RA, 2008, J AM MOSQUITO CONTR, V24, P588, DOI 10.2987/5766.1
   Noden BH, 2015, J AM MOSQUITO CONTR, V31, P336, DOI 10.2987/moco-31-04-336-345.1
   Paras KL, 2014, MED VET ENTOMOL, V28, P60, DOI 10.1111/mve.12069
   Sardelis MR, 2003, J AM MOSQUITO CONTR, V19, P159
   Sardelis MR, 2002, J MED ENTOMOL, V39, P635, DOI 10.1603/0022-2585-39.4.635
   Sardelis MR, 2002, J MED ENTOMOL, V39, P480, DOI 10.1603/0022-2585-39.3.480
   Sardelis MR, 2001, J AM MOSQUITO CONTR, V17, P137
   Schaffner Francis, 2011, European Mosquito Bulletin, V29, P141
   Smith JP, 2006, J AM MOSQUITO CONTR, V22, P330, DOI 10.2987/8756-971X(2006)22[330:CCDAKA]2.0.CO;2
   TAKASHIMA I, 1989, J MED ENTOMOL, V26, P454, DOI 10.1093/jmedent/26.5.454
   Turell MJ, 2013, J AM MOSQUITO CONTR, V29, P133, DOI 10.2987/12-6316r.1
NR 26
TC 5
Z9 5
U1 0
U2 1
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD MAR
PY 2018
VL 34
IS 1
BP 38
EP 41
DI 10.2987/17-6690.1
PG 4
WC Entomology
SC Entomology
GA GM9LO
UT WOS:000438570200006
PM 31442116
OA Bronze
DA 2020-07-08
ER

PT J
AU Aldridge, RL
   Golden, FV
   Britch, SC
   Blersch, J
   Linthicum, KJ
AF Aldridge, Robert L.
   Golden, Frances, V
   Britch, Seth C.
   Blersch, Jessika
   Linthicum, Kenneth J.
TI TRUCK-MOUNTED NATULAR 2EC (SPINOSAD) ULV RESIDUAL TREATMENT IN A
   SIMULATED URBAN ENVIRONMENT TO CONTROL AEDES AEGYPTI AND AEDES
   ALBOPICTUS IN NORTH FLORIDA
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Biorational; container inhabiting; integrated vector management; urban;
   Zika virus
ID INSECTICIDE; HEALTH; VIRUS
AB Preemptive treatment of dry habitats with an ultra-low volume (ULV) residual larvicide may be effective in an integrated vector management program to control populations of container-inhabiting Aedes mosquitoes, key vectors of Zika, dengue, and chikungunya viruses. We exposed dry, artificial containers placed in exposed and protected locations to Natular 2EC (spinosad) larvicide applied with a truck-mounted ULV sprayer in a simulated urban setting in North Florida, and later introduced water and Ae. aegypti or Ae. albopictus larvae to conduct bioassays. Up to 50% mortality was observed in bioassays, indicating further analysis of spinosad as a residual treatment application.
C1 [Aldridge, Robert L.; Golden, Frances, V; Britch, Seth C.; Linthicum, Kenneth J.] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
   [Blersch, Jessika] Florida Army Natl Guard, Camp Blanding Joint Training Ctr, Starke, FL 32091 USA.
RP Aldridge, RL (corresponding author), ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
RI Aldridge, Robert L./J-9828-2019
OI Aldridge, Robert L./0000-0001-7656-365X
FU US Department of Agriculture (USDA)-Agricultural Research ServiceUnited
   States Department of Agriculture (USDA); US Department of Defense (DOD)
   Deployed War-Fighter Protection Program (DWFP)
FX We thank T. Carney, B. Smith, and C. Swain at the USDA-ARS-CMAVE
   insectary for providing immature mosquitoes. This research was supported
   by the US Department of Agriculture (USDA)-Agricultural Research Service
   and the US Department of Defense (DOD) Deployed War-Fighter Protection
   Program (DWFP). Mention of trade names or commercial products in this
   publication is solely for the purpose of providing specific information
   and does not imply recommendation or endorsement by USDA, DOD, CBJTC, or
   the DWFP. The USDA is an equal opportunity provider and employer.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Bibbs CS, 2016, J AM MOSQUITO CONTR, V32, P247, DOI 10.2987/15-6532.1
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Gerberg E. J., 1994, J AM MOSQUITO CONTR, V5, P98
   Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Kuehn BM, 2014, JAMA-J AM MED ASSOC, V312, P776, DOI 10.1001/jama.2014.9916
   Perez CM, 2007, J MED ENTOMOL, V44, P631, DOI 10.1603/0022-2585(2007)44[631:SANDIF]2.0.CO;2
   Pruszynski CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170079
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Williams GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110035
NR 11
TC 3
Z9 3
U1 0
U2 0
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD MAR
PY 2018
VL 34
IS 1
BP 53
EP 57
DI 10.2987/17-6697R.1
PG 5
WC Entomology
SC Entomology
GA GM9LO
UT WOS:000438570200010
PM 31442121
OA Bronze
DA 2020-07-08
ER

PT J
AU Alemayehu, D
   Reyes, T
   Haas-Stapleton, EJ
AF Alemayehu, Dereje
   Reyes, Trinidad
   Haas-Stapleton, Eric J.
TI FIELD EVALUATION OF A REDESIGNED OVIPOSITION TRAP TO MONITOR GRAVID
   INVASIVE AEDES MOSQUITOES IN A SUBURBAN ENVIRONMENT
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; eggs; oviposition trap
ID DIPTERA-CULICIDAE; AEGYPTI DIPTERA; ZIKA
AB Oviposition cup traps (OCT) arc commonly used to detect gravid invasive Aedes mosquitoes. Employing OCT during hot summer months or over broad geographic areas is labor intensive because the water in these small-volume traps must be frequently replenished to maintain their attractiveness to mosquitoes. We developed low-cost and simple-to-build oviposition bucket traps (OBT) that attract mosquitoes for more than 1 wk. Comparison of adjacently placed OCT and OBT in the city of Madera, CA, showed OBT captured significantly more Ae. aegypti eggs per trap-night relative to the OCT (8.8 +/- 2.6 and 4.1 +/- 1.1, respectively; paired t-test, P = 0.0076), and a significantly greater proportion of OBT contained Ae. aegypti eggs relative to OCT (83% of OBT and 65% of OCT; Fisher's exact test, P = 0.0214). The results suggest that OBT can collect larger quantities of Ae. aegypti eggs relative to OCT while potentially offering greater flexibility in scheduling trap inspections.
C1 [Alemayehu, Dereje; Haas-Stapleton, Eric J.] Alameda Cty Mosquito Abatement Dist, 23187 Connecticut St, Hayward, CA 94545 USA.
   [Reyes, Trinidad] Madera Cty Mosquito & Vector Control Dist, 3105 Airport Dr, Madera, CA 93637 USA.
RP Haas-Stapleton, EJ (corresponding author), Alameda Cty Mosquito Abatement Dist, 23187 Connecticut St, Hayward, CA 94545 USA.
FU Board of Trustees of the Alameda County Mosquito Abatement District
FX We thank Ryan Clausnitzer and the Board of Trustees of the Alameda
   County Mosquito Abatement District for supporting the funding of this
   research. Discussions of the study and data analysis with Jan Washburn
   of the Alameda County Mosquito Abatement District were highly valuable.
   Lastly, this study could not have been completed without the support of
   Lenard Irby and Alex Scalzo at MCMVCD.
CR CAREY DE, 1964, SCIENCE, V143, P131, DOI 10.1126/science.143.3602.131
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   Harrington LC, 2008, VECTOR-BORNE ZOONOT, V8, P415, DOI 10.1089/vbz.2007.0203
   Heringer L, 2016, J MED ENTOMOL, V53, P873, DOI 10.1093/jme/tjw051
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
NR 10
TC 0
Z9 0
U1 2
U2 4
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD MAR
PY 2018
VL 34
IS 1
BP 67
EP 69
DI 10.2987/17-6647.1
PG 3
WC Entomology
SC Entomology
GA GM9LO
UT WOS:000438570200013
PM 31442112
OA Bronze
DA 2020-07-08
ER

PT J
AU Brickley, EB
   Rodrigues, LC
AF Brickley, Elizabeth B.
   Rodrigues, Laura C.
TI Further pieces of evidence in the Zika virus and microcephaly puzzle
SO LANCET CHILD & ADOLESCENT HEALTH
LA English
DT Editorial Material
ID BRAZIL
C1 [Brickley, Elizabeth B.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
RP Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
EM laura.rodrigues@lshtm.ac.uk
RI Brickley, Elizabeth/U-3625-2017
OI Brickley, Elizabeth/0000-0003-0280-2288
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15088];
   Wellcome TrustWellcome Trust [201870, 107779, 205377/Z/16/Z, 205377,
   201870/Z/16/Z]
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Parens Raphael, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.5afb0bfb8cf31d9a4baba7b19b4edbac
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 10
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-4642
J9 LANCET CHILD ADOLESC
JI Lancet Child. Adolesc. Health
PD MAR
PY 2018
VL 2
IS 3
BP 162
EP 164
DI 10.1016/S2352-4642(18)30021-X
PG 4
WC Pediatrics
SC Pediatrics
GA GI8HW
UT WOS:000434766300006
PM 30169250
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Bisanzio, D
   Dzul-Manzanilla, F
   Gomez-Dantes, H
   Pavia-Ruz, N
   Hladish, TJ
   Lenhart, A
   Palacio-Vargas, J
   Roldan, JFG
   Correa-Morales, F
   Sanchez-Tejeda, G
   Morales, PK
   Manrique-Saide, P
   Longini, IM
   Halloran, ME
   Vazquez-Prokopec, GM
AF Bisanzio, Donal
   Dzul-Manzanilla, Felipe
   Gomez-Dantes, Hector
   Pavia-Ruz, Norma
   Hladish, Thomas J.
   Lenhart, Audrey
   Palacio-Vargas, Jorge
   Gonzalez Roldan, Jesus F.
   Correa-Morales, Fabian
   Sanchez-Tejeda, Gustavo
   Kuri Morales, Pablo
   Manrique-Saide, Pablo
   Longini, Ira M.
   Halloran, M. Elizabeth
   Vazquez-Prokopec, Gonzalo M.
TI Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in
   Merida, Mexico
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS; SURVEILLANCE; SPREAD
AB Response to Zika virus (ZIKV) invasion in Brazil lagged a year from its estimated February 2014 introduction, and was triggered by the occurrence of severe congenital malformations. Dengue (DENV) and chikungunya (CHIKV) invasions tend to show similar response lags. We analyzed geo-coded symptomatic case reports from the city of Merida, Mexico, with the goal of assessing the utility of historical DENV data to infer CHIKV and ZIKV introduction and propagation. About 42% of the 40,028 DENV cases reported during 2008-2015 clustered in 27% of the city, and these clustering areas were where the first CHIKV and ZIKV cases were reported in 2015 and 2016, respectively. Furthermore, the three viruses had significant agreement in their spatio-temporal distribution (Kendall W> 0.63; p< 0.01). Longitudinal DENV data generated patterns indicative of the resulting introduction and transmission patterns of CHIKV and ZIKV, leading to important insights for the surveillance and targeted control to emerging Aedes-borne viruses.
C1 [Bisanzio, Donal] RTI Int, Washington, DC USA.
   [Bisanzio, Donal] Sacro Cuore Don Calabria Hosp, Ctr Trop Dis, Verona, Italy.
   [Dzul-Manzanilla, Felipe; Gonzalez Roldan, Jesus F.; Correa-Morales, Fabian; Sanchez-Tejeda, Gustavo] Secretaria Salud Mexico, Ctr Nacl Programas Prevent & Control Enfermedades, Mexico City, DF, Mexico.
   [Gomez-Dantes, Hector] Natl Inst Publ Hlth, Hlth Syst Res Ctr, Cuernavaca, Morelos, Mexico.
   [Pavia-Ruz, Norma] Univ Autonoma Yucatan, Ctr Invest Reg Hideyo Noguchi, Merida, Mexico.
   [Hladish, Thomas J.] Univ Florida, Dept Biol, Gainesville, FL USA.
   [Hladish, Thomas J.; Longini, Ira M.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Lenhart, Audrey] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Palacio-Vargas, Jorge] Secretaria Salud Yucatan, Merida, Mexico.
   [Kuri Morales, Pablo] Subsecretarra Prevenc & Promoc Salud, Mexico City, DF, Mexico.
   [Manrique-Saide, Pablo] Univ Autonoma Yucatan, Unidad Colaborat Bioensayos Entomol, Campus Ciencias Biol & Agr, Merida, Mexico.
   [Longini, Ira M.] Univ Florida, Dept Biostat, Gainesville, FL USA.
   [Longini, Ira M.; Halloran, M. Elizabeth] Ctr Inference & Dynam Infect Dis, Seattle, WA USA.
   [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
RP Vazquez-Prokopec, GM (corresponding author), Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
EM gmvazqu@emory.edu
OI Hladish, Thomas/0000-0003-1819-6235; Dzul Manzanilla, Felipe
   Antonio/0000-0002-2085-9141; Correa Morales, Fabian/0000-0002-6193-1242
FU National Science Foundation (DEB/EEID award)National Science Foundation
   (NSF) [1640698]; Office of Infectious Disease, Bureau for Global Health,
   U.S. Agency for International DevelopmentUnited States Agency for
   International Development (USAID); US Centers for Disease Control and
   PreventionUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [CDC: OADS BAA 2016-N-17844];
   National Institutes of Health through the MIDAS research networkUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [U54 GM111274]; Canadian Institutes of Health
   Research (CIHR)Canadian Institutes of Health Research (CIHR); IDRC
   (Preventing Zika disease with novel vector control approaches) [108412];
   SANOFI Pasteur
FX Research funding was provided by the National Science Foundation
   (DEB/EEID award: 1640698), the Office of Infectious Disease, Bureau for
   Global Health, U.S. Agency for International Development, under the
   terms of an Interagency Agreement with the US Centers for Disease
   Control and Prevention (CDC: OADS BAA 2016-N-17844), and by partial
   support from the National Institutes of Health through the MIDAS
   research network (U54 GM111274) and the Canadian Institutes of Health
   Research (CIHR) and IDRC (Preventing Zika disease with novel vector
   control approaches, Project 108412). 'SANOFI Pasteur financed the cohort
   study (DNG25) for which HGD and NPR were PIs. The opinions expressed
   herein are those of the author(s) and do not necessarily reflect the
   views of the U.S. Agency for International Development or the Centers
   for Disease Control and Prevention. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Bowman LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157971
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Desmond-Hellmann S, 2016, SCIENCE, V353, P731, DOI 10.1126/science.aai7598
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a
   Hernandez-Avila JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070231
   Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105
   Hladish TJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004661
   Hladish TJ, EFFECTIVENESS UNPUB
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kieny MP, 2017, LANCET, V389, P2469, DOI 10.1016/S0140-6736(17)31635-5
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Maslow JN, 2017, VACCINE
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Ngono AE, 2018, ANN REV IMMUNOL
   ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x
   Pepin KM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0659-y
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Roth A, 2014, EURO SURVEILL, V19
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109
   Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Texier G, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0271-x
   Vanlerberghe V, 2017, REV PANAM SALUD PUBL, V41, DOI 10.26633/RPSP.2017.16
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Vazquez-Prokopec GM, 2016, T ROY SOC TROP MED H, V110, P567, DOI 10.1093/trstmh/trw070
   Vazquez-Prokopec GM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001788
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Vincenti-Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005317
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 47
TC 15
Z9 15
U1 2
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2018
VL 12
IS 3
AR e0006298
DI 10.1371/journal.pntd.0006298
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GE5NI
UT WOS:000431268900033
PM 29543910
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Che-Mendoza, A
   Medina-Barreiro, A
   Koyoc-Cardena, E
   Uc-Puc, V
   Contreras-Perera, Y
   Herrera-Bojorquez, J
   Dzul-Manzanilla, F
   Correa-Morales, F
   Ranson, H
   Lenhart, A
   McCall, PJ
   Kroeger, A
   Vazquez-Prokopec, G
   Manrique-Saide, P
AF Che-Mendoza, Azael
   Medina-Barreiro, Anuar
   Koyoc-Cardena, Edgar
   Uc-Puc, Valentin
   Contreras-Perera, Yamili
   Herrera-Bojorquez, Josue
   Dzul-Manzanilla, Felipe
   Correa-Morales, Fabian
   Ranson, Hilary
   Lenhart, Audrey
   McCall, Philip J.
   Kroeger, Axel
   Vazquez-Prokopec, Gonzalo
   Manrique-Saide, Pablo
TI House screening with insecticide-treated netting provides sustained
   reductions in domestic populations of Aedes aegypti in Merida, Mexico
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VECTOR CONTROL; TRANSMISSION; CURTAINS; NEIGHBORHOOD; RESISTANCE;
   TRIAL; NETS
AB Background
   There is a need for effective methods to control Aedes aegypti and prevent the transmission of dengue, chikungunya, yellow fever and Zika viruses. Insecticide treated screening (ITS) is a promising approach, particularly as it targets adult mosquitoes to reduce human-mosquito contact.
   Methodology/Principal findings
   A cluster-randomised controlled trial evaluated the entomological efficacy of ITS based intervention, which consisted of the installation of pyrethroid-impregnated long-lasting insecticide-treated netting material fixed as framed screens on external doors and windows. A total of 10 treatment and 10 control clusters (100 houses/cluster) were distributed throughout the city of Merida, Mexico. Cross-sectional entomological surveys quantified indoor adult mosquito infestation at baseline (pre-intervention) and throughout four post-intervention (PI) surveys spaced at 6-month intervals corresponding to dry/rainy seasons over two years (2012-2014). A total of 844 households from intervention clusters (86% coverage) were protected with ITS at the start of the trial. Significant reductions in the indoor presence and abundance of Ae. aegypti adults (OR = 0.48 and IRR = 0.45, P<0.05 respectively) and the indoor presence and abundance of Ae. aegypti female mosquitoes (OR = 0.47 and IRR = 0.44, P<0.05 respectively) were detected in intervention clusters compared to controls. This high level of protective effect was sustained for up to 24 months PI. Insecticidal activity of the ITS material declined with time, with similar to 70% mortality being demonstrated in susceptible mosquito cohorts up to 24 months after installation.
   Conclusions/Significance
   The strong and sustained entomological impact observed in this study demonstrates the potential of house screening as a feasible, alternative approach to a sustained long-term impact on household infestations of Ae. aegypti. Larger trials quantifying the effectiveness of ITS on epidemiological endpoints are warranted and therefore recommended.
C1 [Che-Mendoza, Azael; Ranson, Hilary; Lenhart, Audrey; McCall, Philip J.; Kroeger, Axel] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England.
   [Che-Mendoza, Azael; Medina-Barreiro, Anuar; Koyoc-Cardena, Edgar; Uc-Puc, Valentin; Contreras-Perera, Yamili; Herrera-Bojorquez, Josue; Manrique-Saide, Pablo] Univ Autonoma Yucatan, Unidad Colaborat Bioensayos Entomol, Merida, Yucatan, Mexico.
   [Che-Mendoza, Azael; Dzul-Manzanilla, Felipe; Correa-Morales, Fabian] Secretaria Salud Mexico, Ctr Nacl Programas Prevent & Control Enfermedades, Mexico City, DF, Mexico.
   [Lenhart, Audrey] Ctr Dis Control & Prevent, Entomol Branch, Atlanta, GA USA.
   [Kroeger, Axel] WHO, Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland.
   [Vazquez-Prokopec, Gonzalo] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
RP Manrique-Saide, P (corresponding author), Univ Autonoma Yucatan, Unidad Colaborat Bioensayos Entomol, Merida, Yucatan, Mexico.
EM msaide@correo.uady.mx
OI McCall, Philip/0000-0002-0007-3985; Ranson, Hilary/0000-0003-2332-8247;
   Correa Morales, Fabian/0000-0002-6193-1242
FU Consejo Nacional de Ciencia y TecnologiaConsejo Nacional de Ciencia y
   Tecnologia (CONACyT) [SALUD-2010-01-161551]; UNICEF/UNDP/VVorld Bank/WHO
   Special Programme for Research and Training in Tropical Diseases
   (TDR)/International Development Research Center (IDRC)
FX This study was funded by the Consejo Nacional de Ciencia y Tecnologia
   (Research project SALUD-2010-01-161551 FONDO SECTORIAL DE INVESTIGACION
   EN SALUD Y SEGURIDAD SOCIAL SSA/IMSS/ISSSTE-CONACYT Mexico),
   UNICEF/UNDP/VVorld Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR)/International Development Research Center
   (IDRC) (Research project "Innovative Community Based Ecosystem
   Management Interventions for Improved Dengue Prevention in Mexico"). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Lorono-Pino MA, 2013, AM J TROP MED HYG, V89, P385, DOI 10.4269/ajtmh.12-0772
   Andriessen R, 2015, P NATL ACAD SCI USA, V112, P12081, DOI 10.1073/pnas.1510801112
   Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x
   Barrera R, 2015, BIOMEDICA, V35, P297, DOI 10.7705/biomedica.v35i3.
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   CDC, 2010, GUID EV INS RES VECT
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   De Benedictis J, 2003, AM J TROP MED HYG, V68, P437, DOI 10.4269/ajtmh.2003.68.437
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Hernandez-Avila JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070231
   Garcia Gil G, 2012, INVESTIGACIONES GEOG, V77, P89
   Garcia-Rejon JE, 2011, J MED ENTOMOL, V48, P644, DOI 10.1603/ME10253
   Golding N, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0491-4
   Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Itoh T, 2005, TROP MED INT HEALTH, V10, P1321, DOI 10.1111/j.1365-3156.2005.01523.x
   Jones CH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-846
   Kirby MJ, 2013, BIOLOGICAL AND ENVIRONMENTAL CONTROL OF DISEASE VECTORS, P117, DOI 10.1079/9781845939861.0117
   Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0
   Knols BGJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1452-x
   Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76
   KO YC, 1992, AM J EPIDEMIOL, V136, P214, DOI 10.1093/oxfordjournals.aje.a116487
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423
   Liebman K, 2015, AM J TROP MED HYG, V92, P1070, DOI 10.4269/ajtmh.14-0790
   Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x
   Manrique-Saide P, 2008, J AM MOSQUITO CONTR, V24, P289, DOI 10.2987/5578.1
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   Manrique-Saide P, 2013, J AM MOSQUITO CONTR, V29, P164, DOI 10.2987/12-6320R.1
   Manrique-Saide P, 2012, J AM MOSQUITO CONTR, V28, P255, DOI 10.2987/12-6244R.1
   McBride WJH, 1998, AM J EPIDEMIOL, V148, P1111, DOI 10.1093/oxfordjournals.aje.a009589
   Mutuku FM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-356
   Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412
   Ngufor C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093603
   Official Regulations of Mexico, 2015, NOM032SSA22014
   Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773
   Paz-Soldan VA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004409
   Pilger D., 2010, TROPIKA, V1, P1
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Reimer LJ, 2013, NEW ENGL J MED, V369, P745, DOI 10.1056/NEJMoa1207594
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   Rizzo N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-931
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619
   Thomson Hilary, 2009, Am J Public Health, V99 Suppl 3, pS681, DOI 10.2105/AJPH.2008.143909
   Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P1067, DOI 10.1111/j.1365-3156.2010.02582.x
   Vanlerberghe V, 2013, AM J TROP MED HYG, V89, P93, DOI 10.4269/ajtmh.13-0015
   Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Vazquez-Prokopec GM, 2016, T ROY SOC TROP MED H, V110, P567, DOI 10.1093/trstmh/trw070
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   Viana M, 2016, P NATL ACAD SCI USA, V113, P8975, DOI 10.1073/pnas.1603431113
   Walker N, 2010, AM J TROP MED HYG, V83, P963, DOI 10.4269/ajtmh.2010.10-0405
   WHO, 2012, GLOB PLAN INS RES MA
   WHO, 2005, WHOCDSWHOPESGCDPP200, P11
   Wilson AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003228
   WINCH PJ, 1992, J AM MOSQUITO CONTR, V8, P193
NR 67
TC 6
Z9 6
U1 2
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2018
VL 12
IS 3
AR e0006283
DI 10.1371/journal.pntd.0006283
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GE5NI
UT WOS:000431268900027
PM 29543805
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Fauver, JR
   Weger-Lucarelli, J
   Fakoli, LS
   Bolay, K
   Bolay, FK
   Diclaro, JW
   Brackney, DE
   Foy, BD
   Stenglein, MD
   Ebel, GD
AF Fauver, Joseph R.
   Weger-Lucarelli, James
   Fakoli, Lawrence S., III
   Bolay, Kpehe
   Bolay, Fatorma K.
   Diclaro, Joseph W., II
   Brackney, Doug E.
   Foy, Brian D.
   Stenglein, Mark D.
   Ebel, Gregory D.
TI Xenosurveillance reflects traditional sampling techniques for the
   identification of human pathogens: A comparative study in West Africa
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HEPATITIS-B-VIRUS; INFECTED POULTRY FARM; PUBLIC-HEALTH; REAL-TIME;
   DISEASE OUTBREAK; HOST PREFERENCE; ZIKA VIRUS; SURVEILLANCE; INFLUENZA;
   GENOME
AB Background
   Novel surveillance strategies are needed to detect the rapid and continuous emergence of infectious disease agents. Ideally, new sampling strategies should be simple to implement, technologically uncomplicated, and applicable to areas where emergence events are known to occur. To this end, xenosurveillance is a technique that makes use of blood collected by hematophagous arthropods to monitor and identify vertebrate pathogens. Mosquitoes are largely ubiquitous animals that often exist in sizable populations. As well, many domestic or peridomestic species of mosquitoes will preferentially take blood-meals from humans, making them a unique and largely untapped reservoir to collect human blood.
   Methodology/Principal findings
   We sought to take advantage of this phenomenon by systematically collecting blood-fed mosquitoes during a field trail in Northern Liberia to determine whether pathogen sequences from blood engorged mosquitoes accurately mirror those obtained directly from humans. Specifically, blood was collected from humans via finger-stick and by aspirating bloodfed mosquitoes from the inside of houses. Shotgun metagenomic sequencing of RNA and DNA derived from these specimens was performed to detect pathogen sequences. Samples obtained from xenosurveillance and from finger-stick blood collection produced a similar number and quality of reads aligning to two human viruses, GB virus C and hepatitis B virus.
   Conclusions/Significance
   This study represents the first systematic comparison between xenosurveillance and more traditional sampling methodologies, while also demonstrating the viability of xenosurveillance as a tool to sample human blood for circulating pathogens.
C1 [Fauver, Joseph R.; Weger-Lucarelli, James; Brackney, Doug E.; Foy, Brian D.; Stenglein, Mark D.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Fakoli, Lawrence S., III; Bolay, Kpehe; Bolay, Fatorma K.] Liberian Inst Biomed Res, Charlesville, Liberia.
   [Diclaro, Joseph W., II] US Naval Med Res Unit 3, Cairo, Egypt.
   [Fauver, Joseph R.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.
   [Weger-Lucarelli, James] Inst Pasteur, Viral Populat & Pathogenesis Unit, Paris, France.
   [Brackney, Doug E.] Connecticut Agr Expt Stn, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06504 USA.
RP Fauver, JR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Fauver, JR (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.
EM josephfauver@wustl.edu
RI ; Foy, Brian/E-6230-2017
OI Weger-Lucarelli, James/0000-0002-9483-1694; Fauver,
   Joseph/0000-0001-8099-2991; Foy, Brian/0000-0002-9117-203X
FU CSU Infectious Disease Supercluster Grant
FX The projected was supported in part by the CSU Infectious Disease
   Supercluster Grant "Xenosurveillance: A novel approach for interrogating
   the human-pathogen landscape in sub-Saharan Africa" awarded to DEB, BDF,
   and GDE. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104
   Barbazan P, 2008, VECTOR-BORNE ZOONOT, V8, P105, DOI 10.1089/vbz.2007.0142
   Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007
   Bitome-Essono PY, 2017, ELIFE, V6, DOI [10.7554/eLife.22069, 10.7554/elife.22069]
   Bogus J, 2016, AM J TROP MED HYG, V94, P497, DOI 10.4269/ajtmh.15-0591
   Breman JG, 2001, AM J TROP MED HYG, V64, P1
   Brugman VA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1034-8
   Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06
   Castillo-Salgado C, 2010, EPIDEMIOL REV, V32, P93, DOI 10.1093/epirev/mxq008
   Center for Disease Control and Prevention, 2017, GLOB DIS DET GDD PRO
   Dixon MG, 2014, MMWR-MORBID MORTAL W, V63, P548
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauver JR, 2017, AM J TROP MED HYG, V97, P324, DOI 10.4269/ajtmh.17-0063
   Fauver JR, 2016, VIROLOGY, V498, P288, DOI 10.1016/j.virol.2016.07.031
   Gatherer D, 2014, J GEN VIROL, V95, P1619, DOI 10.1099/vir.0.067199-0
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grubaugh ND, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003628
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927
   Hijawi B, 2013, E MEDITERR HEALTH J, V19, pS12
   Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kassebaum NJ, 2016, LANCET, V388, P1603, DOI 10.1016/S0140-6736(16)31460-X
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Keusch GT, 2009, SUST GLOB SURV RESP
   Koutsovoulos G, 2016, P NATL ACAD SCI USA, V113, P5053, DOI 10.1073/pnas.1600338113
   Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045
   Kramvis A, 2007, HEPATOLOGY RES, V37
   Kraus RHS, 2011, JOVE-J VIS EXP, DOI 10.3791/2832
   Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lauck M, 2015, J VIROL, V89, P2425, DOI 10.1128/JVI.02752-14
   Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876
   Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462
   May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866
   Merchant S, 2014, PEERJ, V2, DOI 10.7717/peerj.675
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8
   Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579
   Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08
   Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439
   Peiris JSM, 2012, SCIENCE, V335, P1173, DOI 10.1126/science.1219936
   Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013
   Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114
   Pike BL, 2010, CLIN INFECT DIS, V50, P1636, DOI 10.1086/652860
   Quick J, 2017, BIORXIV, DOI [10.1101/098913, DOI 10.1101/098913]
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rueda L., 2015, ADULT IDENTIFICATION
   Sawabe K, 2006, AM J TROP MED HYG, V75, P327, DOI 10.4269/ajtmh.2006.75.327
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   University of California Davis, 2017, PREDICT 2017
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Wetterstrand KA, 2016, DNA SEQUENCING COSTS
   Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107
   Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789
   Wolfe ND, METABIOTA 2017
   World Health Organization, 2016, OV MAL TREATM 2016
   World Health Organization, 2017, FACT CONTR UND SPREA
   World Health Organization, MAL RAP DIAGN TEST P
   Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000
NR 69
TC 5
Z9 5
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2018
VL 12
IS 3
AR e0006348
DI 10.1371/journal.pntd.0006348
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GE5NI
UT WOS:000431268900069
PM 29561834
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Macoris, MD
   Martins, AJ
   Andrighetti, MTM
   Lima, JBP
   Valle, D
AF Macoris, Maria de Lourdes
   Martins, Ademir Jesus
   Macoris Andrighetti, Maria Teresa
   Pereira Lima, Jose Bento
   Valle, Denise
TI Pyrethroid resistance persists after ten years without usage against
   Aedes aegypti in governmental campaigns: Lessons from Sao Paulo State,
   Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID INSECTICIDE RESISTANCE; ZIKA VIRUS; SUSCEPTIBILITY; ORGANOPHOSPHATES;
   CYPERMETHRIN; POPULATIONS; VECTORS; DIPTERA; HISTORY
AB Background
   Aedes aegypti, vector of dengue, chikungunya and Zika viruses, is found at high densities in tropical urban areas. The dissemination of this vector is partially the consequence of failures in current vector control methods, still mainly relying upon insecticides. In the State of Sao Paulo (SP), Brazil, public health managers employed pyrethroids against Ae. aegypti adults from 1989 to 2000, when a robust insecticide resistance monitoring system detected resistance to pyrethroids in several Ae. aegypti populations. However, pyrethroids are also the preferred compounds engaged in household applications due to their rapid knockdown effect, lower toxicity to mammals and less irritating smell.
   Methodology/Principal findings
   We evaluated pyrethroid resistance in Ae. aegypti populations over the course of a decade, from 2004 to 2015, after interruption of pyrethroid public applications in SP. Qualitative bio-assays with papers impregnated with a deltamethrin diagnostic dose (DD) performed with insects from seven SP municipalities and evaluated yearly from 2006 to 2014, detected resistance in most of the cases. Quantitative bioassays were also carried out with four populations in 2011, suggesting a positive correlation between resistance level and survivorship in the DD bioassays. Biochemical tests conducted with seven insect populations in 2006 and 2015, detected increasing metabolic alterations of all major classes of detoxifying enzymes, mostly of mixed function oxidases. Genotyping of the voltage-gated sodium channel (AaNa(V), the pyrethroid target-site) with a TaqMan real time PCR based technique was performed from 2004 to 2014 in all seven localities. The two kdr mutations, Val1016Ile and Phe1534Cys, known to be spread throughout Brazil, were always present with a severe decrease of the susceptible allele over time.
   Conclusions/Significance
   These results are discussed in the context of public and domestic insecticide use, the necessity of implementation of a strong integrated vector control strategy and the conceptual misunderstanding between 'vector control' and 'chemical control of vectors'.
C1 [Macoris, Maria de Lourdes; Macoris Andrighetti, Maria Teresa] Sucen, Lab Entomol Aplicada, Marilia, SP, Brazil.
   [Martins, Ademir Jesus; Pereira Lima, Jose Bento] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetore, Rio De Janeiro, RJ, Brazil.
   [Martins, Ademir Jesus; Valle, Denise] INCT EM, Rio De Janeiro, Brazil.
   [Valle, Denise] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivitus, Rio De Janeiro, RJ, Brazil.
RP Martins, AJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetore, Rio De Janeiro, RJ, Brazil.; Martins, AJ; Valle, D (corresponding author), INCT EM, Rio De Janeiro, Brazil.; Valle, D (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivitus, Rio De Janeiro, RJ, Brazil.
EM ademirjr@ioc.fiocruz.br; dvalle@ioc.fiocruz.br
RI Martins, Ademir/W-3251-2019; Martins, Ademir J./B-4117-2009
OI Martins, Ademir/0000-0001-5739-1215; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [550116/2010-9]; Institute Nacional de Ciencia e Tecnologia em
   Entomologia Molecular (INCT-EM) [465678/2014-9]; Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/203.177/2016]; National Institute of Allergy and
   Infectious Diseases (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U01 AI115595]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq
   #550116/2010-9) supported the conception of this study, scholarships,
   data analyses and workshops. Laboratory maintenance, molecular biology
   reagents, scholarships and equipment were supported by Institute
   Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCT-EM
   #465678/2014-9), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ # E-26/203.177/2016) and National
   Institute of Allergy and Infectious Diseases (NIH # U01 AI115595). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andrighetti MTM, 2006, B EPIDEMIOL PAULI S1, V3, P50
   [Anonymous], 2009, DIR NAC PREV CONTR E
   [Anonymous], 2006, PEST THEIR APPL CONT
   [Anonymous], 2009, INF MUD US INS LARV
   Barbosa S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001387
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P295, DOI [10.5123/S1679-49742007000400007, DOI 10.5123/S1679-49742007000400007]
   Braga IA, 2015, DENGUE TEORIAS PRATI, P61
   Braga IA, 2015, DENGUE TEORIAS PRATI
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Macoris MDD, 2014, REV SOC BRAS MED TRO, V47, P573, DOI 10.1590/0037-8682-0141-2014
   Macoris MDD, 2007, MEM I OSWALDO CRUZ, V102, P895, DOI 10.1590/S0074-02762007000800001
   da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017
   David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Santos Veruska Marques dos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P99, DOI 10.1590/S0036-46652003000200009
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faucon F, 2015, GENOME RES
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Chapadense FGG, 2015, REV SOC BRAS MED TRO, V48, P607, DOI 10.1590/0037-8682-0046-2015
   Garcia GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006227
   Glasser CM, 2000, REV SAUDE PUBL, V34, P570, DOI 10.1590/S0034-89102000000600002
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hemingway J., 1998, TECHNIQUES DETECT IN
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   Luna JED, 2004, REV SAUDE PUBL, V38, P842, DOI [10.1590/S0034-89102004000600013, 10.1590/s0034-89102004000600013]
   Macoris MDG, 1999, REV SAUDE PUBL, V33, P521
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   Martins A.J., 2012, INSECTICIDES BASIC O, P17
   Mnzava AP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0693-4
   Montella IR, 2007, AM J TROP MED HYG, P77
   Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Cardim MFM, 2013, REV SAUDE PUBL, V47, P691, DOI 10.1590/S0034-8910.2013047004454
   PAHO, 2015, ANN REP 2014 EP AL U
   Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781
   Ranson H, 2010, TROPIKA NET J, V1, P1
   Raymond M., 1985, Cahiers O.R.S.T.O.M., Serie Entomologie Medicale et Parasitologie, V23, P117
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x
   Seixas G, 2013, MEM I OSWALDO CRUZ, V108, P3, DOI 10.1590/0074-0276130386
   Shorrocks B, 1978, GENESIS DIVERSITY
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Teixeira MG, 2015, DENGUE TEORIAS PRATI, P293
   Valle D., 2015, DENGUE TEORIAS PRATI, P93
   Valle D, 2006, QUANTIFICATION METOD
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   WHO, 2012, GLOB PLAN INS RES MA, V2012, P132
   WHO, 1981, INT COD MARK BREAST, P4
   WHO, 2016, TEST PROC INREMO, V2016, P48
   WHO, 2016, WHOZIKVVC161
   WHO, 1981, CRIT MEAN TESTS DET, P4
   WHO, 2005, SAF PYR PUBL HLTH US
   WHO, 2016, MON MAN INS RES AED
   WHO (World Health Organization), 1992, VECT RES PEST
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 68
TC 13
Z9 13
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2018
VL 12
IS 3
AR e0006390
DI 10.1371/journal.pntd.0006390
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GE5NI
UT WOS:000431268900085
PM 29601580
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Orofino, DHG
   Passos, SRL
   de Oliveira, RVC
   Farias, CVB
   Leite, MDMP
   Pone, SM
   Pone, MVD
   Mendes, HART
   Moreira, MEL
   Nielsen-Saines, K
AF Orofino, Dulce H. G.
   Passos, Sonia R. L.
   de Oliveira, Raquel V. C.
   Farias, Carla Verona B.
   Leite, Maria de Fatima M. P.
   Pone, Sheila M.
   Pone, Marcos V. da S.
   Teixeira Mendes, Helena A. R.
   Moreira, Maria Elizabeth L.
   Nielsen-Saines, Karin
TI Cardiac findings in infants with in utero exposure to Zika virus- a
   cross sectional study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CONGENITAL HEART-DISEASE; INFECTION; BRAZIL
AB Background
   Antenatal exposure to Zika virus (ZIKV) is related to severe neurological manifestations. A previous study in Brazil reported an increased incidence of non-severe congenital heart defects in infants with diagnosis of congenital Zika syndrome but without laboratory confirmation of ZIKV infection in the mother or infant. The objective of this study is to report echocardiographic (ECHO) findings in infants with laboratory confirmed antenatal exposure to ZIKV.
   Methodology
   Cross sectional study of cardiologic assessments of infants born between November 2015 and January 2017 with confirmed vertical exposure to ZIKV in Rio de Janeiro, Brazil.
   Results
   The study enrolled 120 children with a median age of 97 days (1 to 376 days). In utero exposure to ZIKV was confirmed in 97 children (80,8%) through positive maternal polymerase chain reaction (PCR) results during pregnancy or a positive PCR result at birth; 23 additional children (19.2%) had maternal positive PCR results during pregnancy and postnatally. Forty-eight infants (40%) had cardiac defects noted on ECHO. Thirteen infants (10.8%) had major cardiac defects (atrial septal defect, ventricular septal defect, patent ductus arteriosus). None of the defects were severe. The frequency of major defects was higher in infants whose mothers had a rash in the 2nd trimester of pregnancy, or who had altered Central Nervous System (CNS) imaging postnatally or were preterm.
   Conclusions
   Infants with in utero ZIKV exposure have a higher prevalence of major cardiac defects, however none were severe enough to require immediate intervention. For this reason, guidelines for performance of postnatal ECHO in this population should follow general newborn screening guidelines, which significantly reduces the burden of performing emergent fetal or neonatal ECHOs in a setting where resources are not available, such as most Brazilian municipalities.
C1 [Orofino, Dulce H. G.; Farias, Carla Verona B.; Leite, Maria de Fatima M. P.] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Pediat, Rio De Janeiro, Brazil.
   [Orofino, Dulce H. G.; Teixeira Mendes, Helena A. R.] Souza Marques Sch Med, Rio De Janeiro, Brazil.
   [Passos, Sonia R. L.; de Oliveira, Raquel V. C.; Teixeira Mendes, Helena A. R.] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infectol, Lab Clin Epidemiol, Rio De Janeiro, Brazil.
   [Pone, Sheila M.; Pone, Marcos V. da S.] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Infect Dis, Rio De Janeiro, Brazil.
   [Moreira, Maria Elizabeth L.] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Clin Res, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA.
RP Orofino, DHG (corresponding author), Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Pediat, Rio De Janeiro, Brazil.; Orofino, DHG (corresponding author), Souza Marques Sch Med, Rio De Janeiro, Brazil.
EM dulceorofino@yahoo.com.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019; DE FATIMA MONTEIRO PEREIRA
   LEITE, MARIA/AAO-9985-2020; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; Oliveira, Raquel de V C de/S-7443-2016
OI DE FATIMA MONTEIRO PEREIRA LEITE, MARIA/0000-0001-6244-3593; Moreira,
   Maria Elisabeth Lopes/0000-0002-2034-0294; Oliveira, Raquel de V C
   de/0000-0001-9387-8645; Passos, Sonia/0000-0001-9947-2291; Moura Pone,
   Sheila/0000-0002-6246-8915; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; orofino, dulce/0000-0002-0953-1831
FU MCTI Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440846/2016-1, 310765/2016-1]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES [88881130793/2016-01,
   88887130789/2016-00]; Universidade Estacio de Sa-Bolsa Produtividade
FX Sonia Regina Lambert Passos was supported by MCTI Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 440846/2016-1 and
   310765/2016-1; supported by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) Grant 88881130793/2016-01 and by Universidade
   Estacio de Sa-Bolsa Produtividade. Helena Alencar Rosa Teixeira Mendes
   was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) Grant 88887130789/2016-00. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abdulkadir M, 2016, AFR HEALTH SCI, V16, P367, DOI 10.4314/ahs.v16i2.5
   Brasil. Ministerio da SaCrde (MS), 2009, DIR MET EST AV LOG S
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Caneo LF, 2012, ARQ BRAS CARDIOL, V98, P390, DOI 10.1590/S0066-782X2012005000030
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   Di Cavalcanti D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175065
   HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pedra CAC, 2009, HEART, V95, P1385, DOI 10.1136/hrt.2008.152017
   Pinto VC, 2015, REV BRAS CIR CARDIOV, V30, P219, DOI 10.5935/1678-9741.20150018
   Qu YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159257
   Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 19
TC 6
Z9 6
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2018
VL 12
IS 3
AR e0006362
DI 10.1371/journal.pntd.0006362
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GE5NI
UT WOS:000431268900078
PM 29579059
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Uraki, R
   Hastings, AK
   Gloria-Soria, A
   Powell, JR
   Fikrig, E
AF Uraki, Ryuta
   Hastings, Andrew K.
   Gloria-Soria, Andrea
   Powell, Jeffrey R.
   Fikrig, Erol
TI Altered vector competence in an experimental mosquito-mouse transmission
   model of Zika infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI MOSQUITOS; ARBOVIRUS INFECTION; VIRUS TRANSMISSION; DENGUE
   VIRUS; SEVERITY; HOST
AB Few animal models of Zika virus (ZIKV) infection have incorporated arthropod-borne transmission. Here, we establish an Aedes aegypti mosquito model of ZIKV infection of mice, and demonstrate altered vector competency among three strains, (Orlando, ORL, Ho Chi Minh, HCM, and Patilas, PAT). All strains acquired ZIKV in their midguts after a blood meal from infected mice, but ZIKV transmission only occurred in mice fed upon by HCM, and to a lesser extent PAT, but not ORL, mosquitoes. This defect in transmission from ORL or PAT mosquitoes was overcome by intrathoracic injection of ZIKV into mosquito. Genetic analysis revealed significant diversity among these strains, suggesting a genetic basis for differences in ability for mosquito strains to transmit ZIKV. The intrathoracic injection mosquito-mouse transmission model is critical to understanding the influence of mosquitoes on ZIKV transmission, infectivity and pathogenesis in the vertebrate host, and represents a natural transmission route for testing vaccines and therapeutics.
C1 [Uraki, Ryuta; Hastings, Andrew K.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.
   [Gloria-Soria, Andrea; Powell, Jeffrey R.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.
   [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.; Fikrig, E (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM erol.fikrig@yale.edu
RI Gloria-Soria, Andrea/AAJ-3304-2020
OI Gloria-Soria, Andrea/0000-0002-5401-3988
FU JSPS Overseas Research Fellowships; NIH NIH/NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI101112]
FX This study was supported by grants from JSPS Overseas Research
   Fellowships (R.U.) and the NIH NIH/NIAID R01 AI101112 (JRP). E. F. is an
   investigator within the Howard Hughes Medical Institute. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Audsley MD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005426
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   COLEMAN JC, 1973, AM J TROP MED HYG, V22, P124, DOI 10.4269/ajtmh.1973.22.124
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   Secundino NFC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2286-2
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Fros JJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003956
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Heitmann A, 2017, EUROPEAN COMMUNICABL, V22, DOI [10.2807/156077917.ES.2017.222.30437, https://doi.org/10.2807/156077917.ES.2017.222.30437, DOI 10.2807/156077917.ES.2017.222.30437]
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292
   Joyce JD, 2011, J MED ENTOMOL, V48, P389, DOI 10.1603/ME09268
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Machain-Williams C, 2012, PARASITE IMMUNOL, V34, P15, DOI 10.1111/j.1365-3024.2011.01339.x
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Masotti A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00137
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E, 2014, EUROPEAN COMMUNICABL, V19
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Severson DW, 2016, INSECTS, V7, DOI 10.3390/insects7040058
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 46
TC 6
Z9 6
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2018
VL 12
IS 3
AR e0006350
DI 10.1371/journal.pntd.0006350
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GE5NI
UT WOS:000431268900070
PM 29505571
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stellmach, D
   Beshar, I
   Bedford, J
   du Cros, P
   Stringer, B
AF Stellmach, Darryl
   Beshar, Isabel
   Bedford, Juliet
   du Cros, Philipp
   Stringer, Beverley
TI Anthropology in public health emergencies: what is anthropology good
   for?
SO BMJ GLOBAL HEALTH
LA English
DT Article
ID EMERGING INFECTIOUS-DISEASES; LETHAL VIOLENCE; EPIDEMIC; DARFUR
AB Recent outbreaks of Ebola virus disease (2013-2016) and Zika virus (2015-2016) bring renewed recognition of the need to understand social pathways of disease transmission and barriers to care. Social scientists, anthropologists in particular, have been recognised as important players in disease outbreak response because of their ability to assess social, economic and political factors in local contexts. However, in emergency public health response, as with any interdisciplinary setting, different professions may disagree over methods, ethics and the nature of evidence itself. A disease outbreak is no place to begin to negotiate disciplinary differences. Given increasing demand for anthropologists to work alongside epidemiologists, clinicians and public health professionals in health crises, this paper gives a basic introduction to anthropological methods and seeks to bridge the gap in disciplinary expectations within emergencies. It asks: 'What can anthropologists do in a public health crisis and how do they do it?' It argues for an interdisciplinary conception of emergency and the recognition that social, psychological and institutional factors influence all aspects of care.
C1 [Stellmach, Darryl; du Cros, Philipp; Stringer, Beverley] Med Sans Frontieres, London, England.
   [Stellmach, Darryl] Univ Sydney, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.
   [Stellmach, Darryl] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.
   [Beshar, Isabel] Stanford Univ, Stanford Med Sch, Stanford, CA 94305 USA.
   [Bedford, Juliet] Anthrologica, Oxford, England.
RP Stellmach, D (corresponding author), Med Sans Frontieres, London, England.; Stellmach, D (corresponding author), Univ Sydney, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.; Stellmach, D (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.
EM darryl.stellmach@london.msf.org
OI Stellmach, Darryl/0000-0003-3845-6874
FU Medecins Sans Frontieres-UK; Marie Bashir Institute at the University of
   Sydney
FX We thank Sarah Venis (MSF, London, UK) for editing assistance. We thank
   our anonymous reviewers for their helpful comments on earlier versions
   of this submission. We thank Medecins Sans Frontieres-UK and The Marie
   Bashir Institute at the University of Sydney for covering the cost of
   Open Access publication.
CR Abramowitz S., 2014, 10 THINGS ANTHR CAN
   Abramowitz S, 2015, PA STUD HUM RIGHTS, P1
   Abramowitz Sharon, 2016, RESPONDING EBOLA CRE, DOI DOI 10.13140/RG.2.1.2152.0881
   Abramowitz SA, 2015, LANCET, V385, P330, DOI 10.1016/S0140-6736(15)60119-2
   Adams V, 2014, MED ANTHROPOL, V33, P179, DOI 10.1080/01459740.2013.858335
   American Anthropological Association, 2016, ADV KNOWL SOLV HUM P
   Association of Social Anthropologists of the UK and the Commonwealth (ASA), 2011, ETH GUID GOOD RES PR
   Atlani-Duault L, 2009, MED ANTHROPOL, V28, P207, DOI 10.1080/01459740903070519
   Bernard H.R., 2011, RES METHODS ANTHR QU
   Biran A, 2005, HEALTH POLICY PLANN, V20, P213, DOI 10.1093/heapol/czi024
   Biruk C, 2015, EBOLA EMERGENCY ANTH
   Bolten C, 2017, ANTHROPOL QUART, V90, P349, DOI 10.1353/anq.2017.0022
   Bourgois Philippe, 2002, INT J DRUG POLICY, V13, P259
   Briggs CL, 2009, MED ANTHROPOL, V28, P189, DOI 10.1080/01459740903070410
   Brown H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003651
   Cardoso JG, 2007, ANTROPOL ESCALA MEM, V2, P102
   Corrigan O, 2003, SOCIOL HEALTH ILL, V25, P768, DOI 10.1046/j.1467-9566.2003.00369.x
   de Waal A, 2015, PA STUD HUM RIGHTS, P77
   de Waal A, 2014, SOC SCI MED, V120, P368, DOI 10.1016/j.socscimed.2013.12.035
   Eyben R., 2004, WORKSH HELD I DEV ST
   Ezeome ER, 2010, DEV WORLD BIOETH, V10, P1, DOI 10.1111/j.1471-8847.2008.00239.x
   Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250
   Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402
   Farmer P., 2014, DIARY
   Farmer P., 2006, AIDS ACCUSATION HAIT, P372
   Garrett L., 2013, EXISTENTIAL CHALLENG
   Gellner D., 2001, INSIDE ORG ANTHR WOR, P1
   Harragin S., 2012, METHODOLOGY INFORM L
   HEWLETT B.S., 2007, EBOLA CULTURE POLITI
   Ingold T, 2014, HAU-J ETHNOGR THEORY, V4, P383, DOI 10.14318/hau4.1.021
   Jaffre Y, 2012, SOC ANTHROPOL, V20, P3, DOI 10.1111/j.1469-8676.2011.00190.x
   Janes CR, 2012, LANCET, V380, P1884, DOI 10.1016/S0140-6736(12)61725-5
   Joralemon D., 2017, EXPLORING MED ANTHR, P51
   Kirk J, 1986, RELIABILITY VALIDITY, DOI [10.4135/9781412985659.n2, DOI 10.4135/9781412985659.N2]
   Kovats-Bernat JC, 2002, AM ANTHROPOL, V104, P208, DOI 10.1525/aa.2002.104.1.208
   Lakoff A, 2015, INTRO EBOLAS ECOLOGI
   Leatherman TL, 1996, MED ANTHROPOL Q, V10, P476, DOI 10.1525/maq.1996.10.4.02a00040
   Lenzer J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4580
   Lowton K., 2016, J ANTHR SOC OXFORD O, V8, P44
   Lucas George., 2009, ANTHR ARMS ETHICS MI
   Manderson L, 1998, TROP MED INT HEALTH, V3, P1020, DOI 10.1046/j.1365-3156.1998.00334.x
   MANDERSON L, 1992, SOC SCI MED, V35, P839, DOI 10.1016/0277-9536(92)90098-B
   Mapedzahama V, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017720483
   Medecins Sans Frontieres (MSF), 2017, VULN ASS TOOLK PIL
   Medecins Sans Frontieres (MSF), RES TIM CRIS US COMB
   Moran Mary, 2014, EBOLA PERSPECTIVE
   Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2
   Ophir A., 2010, CONT STATES EMERGENC, P40
   Richards P, 2016, EBOLA PEOPLES SCI HE, P180
   Stellmach D., 2013, RES PROTOCOL PRACTIC
   Stevenson L., 2014, LIFE ITSELF IMAGININ, P272
   Venables E., 2017, ANTHR ACTION, V24
   WHO, 2015, REP EB INT ASS PAN
   Wilkinson A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0305
   Williams Holly Ann, 2001, NAPA B, V21, P1
NR 55
TC 10
Z9 10
U1 3
U2 26
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD MAR
PY 2018
VL 3
IS 2
DI 10.1136/bmjgh-2017-000534
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GH2RC
UT WOS:000433248400006
PM 29607097
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Estes, S
   Ulrich, E
   Ginty, J
AF Estes, Sandra
   Ulrich, Ethel
   Ginty, Joan
TI Implementation of a Zika Virus Education and Prevention Program for at
   Risk Individuals in Jamaica, West Indies
SO NURSING RESEARCH
LA English
DT Meeting Abstract
C1 [Estes, Sandra; Ulrich, Ethel; Ginty, Joan] Molloy Coll, New York, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-6562
EI 1538-9847
J9 NURS RES
JI Nurs. Res.
PD MAR-APR
PY 2018
VL 67
IS 2
BP E143
EP E143
PG 1
WC Nursing
SC Nursing
GA FZ7XA
UT WOS:000427817200374
DA 2020-07-08
ER

PT J
AU Fujita, DM
   Nali, LHD
   Salvador, FS
   Luna, EJD
AF Fujita, Dennis Minoru
   da Silva Nali, Luiz Henrique
   Salvador, Felipe Scassi
   de Albuquerque Luna, Expedito Jose
TI Additional travel recommendations for babies and pregnant women after
   the recent Zika and Chikungunya outbreaks
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
C1 [Fujita, Dennis Minoru] Univ Sao Paulo, Lab Protozool, Inst Med Trop Sao Paulo, Sao Paulo, Brazil.
   [da Silva Nali, Luiz Henrique] Univ Sao Paulo, Lab Virol, Inst Med Trop Sao Paulo, Sao Paulo, Brazil.
   [Salvador, Felipe Scassi] Univ Santo Amaro, Sao Paulo, Brazil.
   [de Albuquerque Luna, Expedito Jose] Univ Sao Paulo, Inst Med Trop Sao Paulo, Lab Epidemiol, Sao Paulo, Brazil.
RP Fujita, DM (corresponding author), Univ Sao Paulo, Lab Protozool, Inst Med Trop Sao Paulo, Sao Paulo, Brazil.
EM dmfujita@usp.br
RI Nali, Luiz/AAG-7253-2019; Nali, Luiz Henrique/AAE-1520-2020; Luna,
   Expedito J A/B-7948-2012; Fujita, Dennis/P-6578-2015
OI Luna, Expedito J A/0000-0002-1145-9672; Fujita,
   Dennis/0000-0003-0419-5338; NALI, LUIZ HENRIQUE da
   Silva/0000-0002-8365-9796
CR Brazilian Ministry of Health, 2017, MON CAS DENG FEBR CH, P19
   Duarte Maria do Carmo Menezes Bezerra, 2016, Rev. Bras. Saude Mater. Infant., V16, pS63, DOI 10.1590/1806-9304201600s100006
   Silva JVJ, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759021, 10.1590/s1678-9946201759021]
   PAHO Pan American Health Organization (PAHO), 2017, ZIK CUM CAS
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   WHO, 2011, TRAV MED COND SPEC N
   WHO Antibacterial Agents, 2017, ANT AG CLIN DEV AN A, P1
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAR-APR
PY 2018
VL 22
BP 75
EP 76
DI 10.1016/j.tmaid.2018.02.012
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GG0EV
UT WOS:000432352200014
PM 29505830
DA 2020-07-08
ER

PT J
AU Lee, AHF
   Gessert, SF
   Chen, YT
   Sergeev, NV
   Haghiri, B
AF Lee, Alex H. F.
   Gessert, Steven F.
   Chen, Yutao
   Sergeev, Nikolay, V
   Haghiri, Babak
TI Preparation of iron oxide silica particles for Zika viral RNA extraction
SO HELIYON
LA English
DT Article
DE Biomedical engineering; Nanotechnology; Materials science
ID MAGNETIC MICROSPHERES; NANOPARTICLES; PURIFICATION; IMMUNOASSAY;
   NANOSPHERES; SEPARATION; BINDING; SPHERES; DRUG
AB In this work, a robust synthetic pathway for magnetic core preparation and silica surface coating of magnetic microparticles is presented. Silica-coated magnetic particles are widely used to extract DNA and RNA from various biological samples. We present a novel route for the synthesis of iron oxide silica particles (Fe3O4@Silica) and demonstrate their performance for extracting ZIKA viral RNA from serum. The iron (II, III) oxide (Fe3O4), magnetite core is first prepared by ammonia neutralization of ferrous and ferric chloride aqueous solution under argon, followed by the addition of citrate salt to stabilize the surface of the resultant magnetic nanospheres. After this one-pot, two-step synthesis, the magnetic nanospheres are consumed during silica coating by hydrolysis of tetraethoxysilane (TEOS) under alkaline condition. The final product is a sphere-like magnetic aggregate with a size range of 1-2 micron. By simply suspending the magnetic aggregates in guanidinium chloride solution, the silica surface can be prepared for RNA binding. The RNA extraction efficiency was evaluated by extracting ZIKA viral RNA from serum followed by a PCR-based assay. The data indicate excellent recovery of target RNA and removal of PCR inhibitors. This manufacturing procedure for the silica coated microparticles provides a low-cost, effective and ready for scale-up method whose performance is equivalent to commercial alternatives such as magnetic silica surface particles for DNA and RNA sample preparations. The cost of the clinical assays could be largely decreased due to the 100 fold reduction in cost by replacing the commercially available magnetic particles with the developed material for RNA extraction.
C1 [Lee, Alex H. F.; Gessert, Steven F.; Chen, Yutao; Sergeev, Nikolay, V; Haghiri, Babak] Theranos Inc, 7333 Gateway Blvd, Newark, CA 94560 USA.
RP Lee, AHF (corresponding author), Theranos Inc, 7333 Gateway Blvd, Newark, CA 94560 USA.
EM alee@theranos.com
OI Haghiri, Babak/0000-0002-0375-7573
CR Adams NM, 2015, ACS APPL MATER INTER, V7, P6062, DOI 10.1021/am506374t
   Akerlof G, 1932, J AM CHEM SOC, V54, P4125, DOI 10.1021/ja01350a001
   Berensmeier S, 2006, APPL MICROBIOL BIOT, V73, P495, DOI 10.1007/s00253-006-0675-0
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Caruso F, 2001, CHEM MATER, V13, P109, DOI 10.1021/cm001164h
   Christy AA, 2005, ANALYST, V130, P738, DOI 10.1039/b501895c
   Cocker TM, 1997, BIOTECHNOL BIOENG, V53, P79
   Deng YH, 2003, ADV MATER, V15, P1729, DOI 10.1002/adma.200305459
   Digigow RG, 2014, J MAGN MAGN MATER, V362, P72, DOI 10.1016/j.jmmm.2014.03.026
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Frickel N, 2010, LANGMUIR, V26, P2839, DOI 10.1021/la902904f
   Huang SH, 2003, BIOTECHNOL PROGR, V19, P1095, DOI 10.1021/bp025587v
   Hyeon T, 2001, J AM CHEM SOC, V123, P12798, DOI 10.1021/ja016812s
   Kakar S, 2013, J ACUTE DIS, V2, P1, DOI 10.1016/S2221-6189(13)60087-6
   Kang K, 2009, J PHYS CHEM B, V113, P536, DOI 10.1021/jp807081b
   Kuhara M, 2004, ANAL CHEM, V76, P6207, DOI 10.1021/ac0493727
   Mahmoudi M, 2011, ADV DRUG DELIVER REV, V63, P24, DOI 10.1016/j.addr.2010.05.006
   MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086
   Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Patel D, 2008, COLLOID SURFACE A, V313, P91, DOI 10.1016/j.colsurfa.2007.04.078
   Qin GX, 2012, ANAL CHEM, V84, P2708, DOI 10.1021/ac202959d
   Rasmussen TB, 2009, J VIROL METHODS, V155, P87, DOI 10.1016/j.jviromet.2008.09.021
   Safarik I, 1999, J CHROMATOGR B, V722, P33, DOI 10.1016/S0378-4347(98)00338-7
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398
   Tanaka T, 2000, ANAL CHEM, V72, P3518, DOI 10.1021/ac9912505
   UGELSTAD J, 1980, ADV COLLOID INTERFAC, V13, P101, DOI 10.1016/0001-8686(80)87003-5
   UGELSTAD J, 1992, PROG POLYM SCI, V17, P87, DOI 10.1016/0079-6700(92)90017-S
   Xu H, 2007, J MAGN MAGN MATER, V311, P125, DOI 10.1016/j.jmmm.2006.11.173
   Xu H, 2006, J AM CHEM SOC, V128, P15582, DOI 10.1021/ja066165a
   Yoon TJ, 2005, ANGEW CHEM INT EDIT, V44, P1068, DOI 10.1002/anie.200461910
NR 32
TC 4
Z9 4
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD MAR
PY 2018
VL 4
IS 3
AR e00572
DI 10.1016/j.heliyon.2018.e00572
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GF5US
UT WOS:000432033900024
PM 29556569
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ribeiro, B
   Hartley, S
   Nerlich, B
   Jaspal, R
AF Ribeiro, Barbara
   Hartley, Sarah
   Nerlich, Brigitte
   Jaspal, Rusi
TI Media coverage of the Zika crisis in Brazil: The construction of a 'war'
   frame that masked social and gender inequalities
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE Brazil; Zika; Media; War frame; Social inequality; Gender inequality;
   Frame analysis; Social representations theory
ID FOR-DISEASE-CONTROL; WEST NILE VIRUS; EBOLA; REPRESENTATIONS; METAPHORS;
   TWITTER; RIGHTS; UK
AB Between 2015 and 2016, Zika became an epidemic of global concern and the focus of intense media coverage. Using a hybrid model of frame and social representations theory, we examine how the Zika outbreak was reported in two major newspapers in Brazil: 0 Globo and Polka de San Paulo. The analysis of 186 articles published between December 2015 and May 2016 reveals a dominant 'war' frame supported by two sub-frames: one focused on eradicating the vector (mosquito) and another on controlling microcephaly, placing the burden of prevention on women. Scientific uncertainties about the virus and its relationship to microcephaly coupled with political uncertainties in Brazil increased the power of the war frame. This frame gave prominence and legitimacy to certain representations of disease management during the crisis, masking social and gender inequalities. We show how the cartography of the disease overlaps with that of poverty and regional inequality in Brazil to argue that addressing socio-economic aspects is essential, but normally neglected, in media communications during disease outbreaks like Zika.
C1 [Ribeiro, Barbara] Univ Manchester, Alliance Manchester Business Sch, Manchester Inst Innovat Res, Oxford Rd, Manchester M13 9PL, Lancs, England.
   [Hartley, Sarah] Univ Exeter, Business Sch, Rennes Dr, Exeter EX4 4PU, Devon, England.
   [Nerlich, Brigitte] Univ Nottingham, Sch Sociol & Social Policy, Inst Sci & Soc, Univ Pk, Nottingham NG7 2RD, England.
   [Jaspal, Rusi] De Montfort Univ, Fac Hlth & Life Sci, Sch Appl Social Sci, Leicester LE1 9BH, Leics, England.
RP Ribeiro, B (corresponding author), Univ Manchester, Alliance Manchester Business Sch, Manchester Inst Innovat Res, Oxford Rd, Manchester M13 9PL, Lancs, England.
EM barbara.ribeiro@manchester.ac.uk; sarah.hartley@exeter.ac.uk;
   brigitte.nerlich@nottingham.ac.uk; rjaspal@dmu.ac.uk
OI Jaspal, Rusi/0000-0002-8463-9519
FU University of Nottingham's Governance and Public Policy Research
   Priority Area (GaPP-RPA); University of Manchester's Institutional Open
   Access Fund [005771]
FX This research has received financial support from the University of
   Nottingham's Governance and Public Policy Research Priority Area
   (GaPP-RPA) and from the University of Manchester's Institutional Open
   Access Fund (ID 005771). The authors would like to thank Prof Jonathan
   Ball for providing useful comments on an earlier version of the
   manuscript; to Prof Robespierre Ribeiro for insightful comments on the
   public health response to the Zika outbreak in Brazil; to Izabel
   Portocarrero for supporting data collection and analysis; and to the
   valuable suggestions of three anonymous reviewers who have significantly
   contributed to improve the text.
CR Almeida T, 2016, UNFPA DEBATE SURTO Z
   Atanasova D., 2016, ROUTLEDGE HDB METAPH, P296
   Azevedo Fernando Antônio, 2006, Opin. Publica, V12, P88, DOI 10.1590/S0104-62762006000100004
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [DOI 10.1191/1478088706QP0630A, 10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]
   Breakwell G. M., 2014, IDENTITY PROCESS THE, P118, DOI 10.1017/cbo9781139136983.010
   Bryman A, 2012, SOCIAL RES METHODS
   Cammaerts B, 2012, INT J MEDIA CULT POL, V8, P229, DOI 10.1386/macp.8.2-3.229_1
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Curson P., 2016, ABC NEWS        0203
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donalisio Maria Rita, 2015, Rev. bras. epidemiol., V18, P283, DOI 10.1590/1980-5497201500010022
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   GAMSON WA, 1989, AM J SOCIOL, V95, P1, DOI 10.1086/229213
   Garvin T, 2001, SOC SCI MED, V53, P1175, DOI 10.1016/S0277-9536(00)00418-4
   Gislason MK, 2013, SOCIOL HEALTH ILL, V35, P188, DOI 10.1111/j.1467-9566.2012.01535.x
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Greer SL, 2017, HEALTH ECON POLICY L, V12, P81, DOI [10.1017/S1744133116000244, 10.1017/s1744133116000244]
   Mondragon NI, 2017, J HEALTH PSYCHOL, V22, P951, DOI 10.1177/1359105315620294
   Jaspal R., 2016, HEALTH, V21, P478
   Joffe H, 2002, SOC SCI MED, V54, P955, DOI 10.1016/S0277-9536(01)00068-5
   Kott A, 2016, SOC SCI MED, V169, P42, DOI 10.1016/j.socscimed.2016.09.029
   Lakoff G, 1980, METAPHORS WE LIVE BY
   Macnamara J, 2005, ASIA PACIFIC PUBLIC, V6, P1, DOI DOI 10.1093/irap/lci133
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Markens S, 2012, SOC SCI MED, V74, P1745, DOI 10.1016/j.socscimed.2011.09.013
   Marques de Oliveira N, 2013, DESENVOLVIMENTO SODO, V179
   McCormick S, 2013, SOCIOL HEALTH ILL, V35, P268, DOI 10.1111/1467-9566.12002
   Ministerio da Saude, 2016, MIN SAAD INV 3 448 C
   Montgomery S. L., 1991, SCI CULTURE, V2, P341
   MOSCOVICI S, 1988, EUR J SOC PSYCHOL, V18, P211, DOI 10.1002/ejsp.2420180303
   Nerlich B, 2004, AGR HUM VALUES, V21, P15, DOI 10.1023/B:AHUM.0000014022.42425.a9
   Nerlich B., 2016, WAR ZIKA
   Nerlich B., 2002, METAPHORIK, V02, P90
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Philips D., 2016, WASHINGTON POST
   Portal Brasil, 2016, DILM POV BRAS CAP GA
   Rasanathan JJK, 2017, AM J PUBLIC HEALTH, V107, P525, DOI 10.2105/AJPH.2017.303658
   Ribeiro EM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0107-x
   Rossmann C, 2018, RISK ANAL, V38, P357, DOI 10.1111/risa.12841
   Salata André, 2016, Sociol. Antropol., V6, P181, DOI 10.1590/2238-38752016v618
   Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G
   Scheufele B, 2004, COMMUNICATIONS-GER, V29, P401, DOI 10.1515/comm.2004.29.4.401
   Schon Donald, 1979, METAPHOR THOUGHT, P137
   Semino E, 2018, APPL LINGUIST, V39, P625, DOI 10.1093/applin/amw028
   Osorio-De-Castro CGS, 2017, AM J PUBLIC HEALTH, V107, P960, DOI 10.2105/AJPH.2017.303705
   Sontag Susan, 1989, AIDS ITS METAPHORS
   Sontag Susan, 1979, ILLNESS METAPHOR
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Ungar S, 1998, BRIT J SOCIOL, V49, P36, DOI 10.2307/591262
   Valente PK, 2017, AM J PUBLIC HEALTH, V107, P1376, DOI 10.2105/AJPH.2017.303924
   Van Gorp B, 2012, SOC SCI MED, V74, P1274, DOI 10.1016/j.socscimed.2011.12.045
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Wallis P, 2005, SOC SCI MED, V60, P2629, DOI 10.1016/j.socscimed.2004.11.031
   Washer P, 2006, SOC SCI MED, V62, P457, DOI 10.1016/j.socscimed.2005.06.001
   Washer P., 2010, EMERGING INFECT DIS
   Watts J., 2016, ZIKA CRISIS EC WOES
   Wenham C., 2016, ZIKA WHY ITS WRONG C
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 64
TC 15
Z9 15
U1 5
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD MAR
PY 2018
VL 200
BP 137
EP 144
DI 10.1016/j.socscimed.2018.01.023
PG 8
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA GE4BS
UT WOS:000431159900017
PM 29421460
OA Green Accepted, Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Pettersson, JHO
   Eldholm, V
   Seligman, SJ
   Lundkvist, A
   Falconar, AK
   Gaunt, MW
   Musso, D
   Nougairede, A
   Charrel, R
   Gould, EA
   de Lamballerie, X
AF Pettersson, John H-O
   Eldholm, Vegard
   Seligman, Stephen J.
   Lundkvist, Ake
   Falconar, Andrew K.
   Gaunt, Michael W.
   Musso, Didier
   Nougairede, Antoine
   Charrel, Remi
   Gould, Ernest A.
   de Lamballerie, Xavier
TI How Did Zika Virus Emerge in the Pacific Islands and Latin America? (vol
   7, e01239-16, 2016)
SO MBIO
LA English
DT Correction
C1 [Pettersson, John H-O; Eldholm, Vegard] Norwegian Inst Publ Hlth, Domain Infect Control & Environm Hlth, Dept Infect Dis Epidemiol & Modelling Mol Biol, Oslo, Norway.
   [Pettersson, John H-O; Lundkvist, Ake] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol IMBIM, Uppsala, Sweden.
   [Seligman, Stephen J.] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.
   [Seligman, Stephen J.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.
   [Falconar, Andrew K.] Univ Norte, Dept Med, Barranquilla, Colombia.
   [Gaunt, Michael W.] London Sch Hyg & Trop Med, London, England.
   [Musso, Didier] Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, Tahiti, French Polynesi, France.
   [Nougairede, Antoine; Charrel, Remi; Gould, Ernest A.; de Lamballerie, Xavier] Aix Marseille Univ, UMR Emergence Pathol Virales EVP, EHESP, IRD 190,INSERM 1207, Marseille, France.
   [Nougairede, Antoine; Charrel, Remi; de Lamballerie, Xavier] Publ Hosp Marseille, AP HM, Inst Hospitalouniv Mediterranee Infect, Marseille, France.
RP Pettersson, JHO (corresponding author), Norwegian Inst Publ Hlth, Domain Infect Control & Environm Hlth, Dept Infect Dis Epidemiol & Modelling Mol Biol, Oslo, Norway.; Pettersson, JHO (corresponding author), Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol IMBIM, Uppsala, Sweden.
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Pettersson, John H.-O./0000-0001-6665-7492
FU European UnionEuropean Union (EU) [734548, 734584]
FX J.H.-O.P., V.E., D.M., A.N., R.C., E.A.G., and X.D.L. are members of the
   European Union's Horizon 2020 research and innovation program
   ZIKAlliance under grant agreement 734548, and A.K.F. and M.W.G. are
   members of ZikaPLAN under grant agreement 734584.
CR Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
NR 1
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2018
VL 9
IS 2
AR e00386-18
DI 10.1128/mBio.00386-18
PG 1
WC Microbiology
SC Microbiology
GA GE5RK
UT WOS:000431279600098
PM 29559572
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Ribeiro, BND
   Muniz, BC
   Gasparetto, EL
   Marchiori, E
AF de Freitas Ribeiro, Bruno Niemeyer
   Muniz, Bernardo Carvalho
   Gasparetto, Emerson Leandro
   Marchiori, Edson
TI Congenital involvement of the central nervous system by the Zika virus
   in a child without microcephaly - spectrum of congenital syndrome by the
   Zika virus
SO JOURNAL OF NEURORADIOLOGY
LA English
DT Letter
C1 [de Freitas Ribeiro, Bruno Niemeyer; Muniz, Bernardo Carvalho; Gasparetto, Emerson Leandro] Inst Estadual Cerebro Paulo Niemeyer, 156 Rua Rezende, BR-20231092 Rio De Janeiro, Brazil.
   [Marchiori, Edson] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RP Ribeiro, BND (corresponding author), Inst Estadual Cerebro Paulo Niemeyer, 156 Rua Rezende, BR-20231092 Rio De Janeiro, Brazil.
EM bruno.niemeyer@hotmail.com
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 8
TC 2
Z9 2
U1 1
U2 2
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0150-9861
EI 1773-0406
J9 J NEURORADIOLOGY
JI J. Neuroradiol.
PD MAR
PY 2018
VL 45
IS 2
BP 152
EP +
DI 10.1016/j.neurad.2017.11.007
PG 2
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA GE0MA
UT WOS:000430906700011
PM 29273529
DA 2020-07-08
ER

PT J
AU Lum, FM
   Lee, D
   Chua, TK
   Tan, JJL
   Lee, CYP
   Liu, X
   Fang, YX
   Lee, B
   Yee, WX
   Rickett, NY
   Chia, PY
   Lim, V
   Leo, YS
   Matthews, DA
   Hiscox, JA
   Ng, LFP
AF Lum, Fok-Moon
   Lee, David
   Chua, Tze-Kwang
   Tan, Jeslin J. L.
   Lee, Cheryl Y. P.
   Liu, Xuan
   Fang, Yongxiang
   Lee, Bernett
   Yee, Wearn-Xin
   Rickett, Natasha Y.
   Chia, Po-Ying
   Lim, Vanessa
   Leo, Yee-Sin
   Matthews, David A.
   Hiscox, Julian A.
   Ng, Lisa F. P.
TI Zika Virus Infection Preferentially Counterbalances Human Peripheral
   Monocyte and/or NK Cell Activity
SO MSPHERE
LA English
DT Article
DE NK cells; RNA-seq; Zika virus; immune response; monocytes;
   transcriptomes
ID NATURAL-KILLER-CELLS; CHEMOATTRACTANT PROTEIN-1; MACROPHAGE
   HETEROGENEITY; GENE-EXPRESSION; IMMUNE CELLS; ACTIVATION; MICE;
   CYTOTOXICITY; OUTBREAK; STRAINS
AB Zika virus (ZIKV) has reemerged in the population and caused unprecedented global outbreaks. Here, the transcriptomic consequences of ZIKV infection were studied systematically first in human peripheral blood CD14(+) monocytes and monocyte-derived macrophages with high-density RNA sequencing. Analyses of the ZIKV genome revealed that the virus underwent genetic diversification, and differential mRNA abundance was found in host cells during infection. Notably, there was a significant change in the cellular response, with cross talk between monocytes and natural killer (NK) cells as one of the highly identified pathways. Immunophenotyping of peripheral blood from ZIKV-infected patients further confirmed the activation of NK cells during acute infection. ZIKV infection in peripheral blood cells isolated from healthy donors led to the induction of gamma interferon (IFN-gamma) and CD107-atwo key markers of NK cell function. Depletion of CD14(+) monocytes from peripheral blood resulted in a reduction of these markers and reduced priming of NK cells during infection. This was complemented by the immunoproteomic changes observed. Mechanistically, ZIKV infection preferentially counterbalances monocyte and/or NK cell activity, with implications for targeted cytokine immunotherapies.
   IMPORTANCE ZIKV reemerged in recent years, causing outbreaks in many parts of the world. Alarmingly, ZIKV infection has been associated with neurological complications such as Guillain-Barre syndrome (GBS) in adults and congenital fetal growthassociated anomalies in newborns. Host peripheral immune cells are one of the first to interact with the virus upon successful transmission from an infected female Aedes mosquito. However, little is known about the role of these immune cells during infection. In this work, the immune responses of monocytes, known target cells of ZIKV infection, were investigated by high-density transcriptomics. The analysis saw a robust immune response being elicited. Importantly, it also divulged that monocytes prime NK cell activities during virus infection. Removal of monocytes during the infection changed the immune milieu, which in turn reduced NK cell stimulation. This study provides valuable insights into the pathobiology of the virus and allows for the possibility of designing novel targeted therapeutics.
C1 [Lum, Fok-Moon; Chua, Tze-Kwang; Tan, Jeslin J. L.; Lee, Cheryl Y. P.; Lee, Bernett; Yee, Wearn-Xin; Hiscox, Julian A.; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Lee, David; Matthews, David A.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.
   [Lee, Cheryl Y. P.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore.
   [Liu, Xuan; Fang, Yongxiang] Univ Liverpool, Inst Integrat Biol, Ctr Genom Res, Liverpool, Merseyside, England.
   [Liu, Xuan; Rickett, Natasha Y.; Hiscox, Julian A.; Ng, Lisa F. P.] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Rickett, Natasha Y.; Hiscox, Julian A.; Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Chia, Po-Ying; Lim, Vanessa; Leo, Yee-Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Singapore, Singapore.
   [Leo, Yee-Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Leo, Yee-Sin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.
RP Ng, LFP (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.; Ng, LFP (corresponding author), Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.; Ng, LFP (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.; Ng, LFP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
RI Chia, Po Ying/AAN-9657-2020
OI Chia, Po Ying/0000-0002-8797-9527; Lum, Fok Moon/0000-0002-5645-7048;
   Matthews, David/0000-0003-4611-8795; Hiscox, Julian/0000-0002-6582-0275;
   Rickett, Natasha/0000-0002-3172-1877
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR); BMRC A*STAR-led Zika Virus Consortium Fund, Agency for
   Science, Technology and Research (A*STAR), Singapore [15/1/82/27/001];
   Medical Research Council (MRC)Medical Research Council UK (MRC)
   [MC_PC_15094]; HPRU in Emerging and Zoonotic Infections Cross NIHR
   Strategic Research Fund, United Kingdom [ZLKN_11447]
FX This work was supported by core research grants provided to the
   Singapore Immunology Network (SIgN) by the Biomedical Research Council
   (BMRC) and by the BMRC A*STAR-led Zika Virus Consortium Fund (project
   number 15/1/82/27/001), Agency for Science, Technology and Research
   (A*STAR), Singapore. This work was also supported by funds provided by
   the Medical Research Council (MRC) (project number MC_PC_15094) and by
   the HPRU in Emerging and Zoonotic Infections Cross NIHR Strategic
   Research Fund (project number ZLKN_11447), United Kingdom.
CR Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008
   Beyersdorf N, 2015, IMMUNOTARGETS THER, V4, P111, DOI 10.2147/ITT.S61647
   Bosworth A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43144
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CARRASCO L, 1977, FEBS LETT, V76, P11, DOI 10.1016/0014-5793(77)80110-5
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Charron L, 2015, IMMUNOL CELL BIOL, V93, P796, DOI 10.1038/icb.2015.42
   CONTI P, 1991, IMMUNOLOGY, V73, P450
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Neves PCD, 2009, VACCINE, V27, P5543, DOI 10.1016/j.vaccine.2009.07.028
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0540-x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Eubank TD, 2003, J IMMUNOL, V171, P2637, DOI 10.4049/jimmunol.171.5.2637
   Fogel LA, 2013, J IMMUNOL, V190, P6269, DOI 10.4049/jimmunol.1202533
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   French AR, 2006, CYTOKINE, V35, P229, DOI 10.1016/j.cyto.2006.08.006
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223
   Gotlieb N, 2015, BRAIN BEHAV IMMUN, V45, P277, DOI 10.1016/j.bbi.2014.12.020
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758
   Kerdiles Y, 2013, J EXP MED, V210, P1065, DOI 10.1084/jem.20130960
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kim TJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07157
   KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Krylova NV, 2015, VIRAL IMMUNOL, V28, P272, DOI 10.1089/vim.2014.0083
   Kuroda T, 2005, CLIN CANCER RES, V11, P7629, DOI 10.1158/1078-0432.CCR-05-0798
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Liu Jianguo, 2005, Curr Immunol Rev, V1, P119, DOI 10.2174/1573395054065115
   Liu X, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1137-3
   Luenemann JD, 2012, NEUROLOGY, V78, P11, DOI 10.1212/WNL.0b013e318241f2b3
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Mamrut S, 2015, EPIGENETICS-US, V10, P943, DOI 10.1080/15592294.2015.1084462
   Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131
   Matsui M, 2009, CANCER RES, V69, P2523, DOI 10.1158/0008-5472.CAN-08-2793
   Metcalfe SM, 2011, GENES IMMUN, V12, P157, DOI 10.1038/gene.2011.9
   Michel T, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00403
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Montaldo E, 2013, CYTOM PART A, V83A, P702, DOI 10.1002/cyto.a.22302
   Morrison BE, 2003, J CLIN INVEST, V112, P1862, DOI 10.1172/JCI200318125
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Notario L, 2016, J VIROL, V90, P6464, DOI 10.1128/JVI.00550-16
   Park JY, 2011, MOL CELLS, V32, P265, DOI 10.1007/s10059-011-1057-8
   Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0
   Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rodpothong Patsarin, 2012, World J Virol, V1, P131, DOI 10.5501/wjv.v1.i5.131
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Sellers RS, 2012, VET PATHOL, V49, P32, DOI 10.1177/0300985811429314
   Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thapa M, 2008, J IMMUNOL, V180, P1098, DOI 10.4049/jimmunol.180.2.1098
   Tucker WG, 2008, MED HYPOTHESES, V71, P682, DOI 10.1016/j.mehy.2008.06.029
   van de Wetering D, 2009, INT IMMUNOL, V21, P145, DOI 10.1093/intimm/dxn132
   Warren HS, 1999, IMMUNOL CELL BIOL, V77, P64, DOI 10.1046/j.1440-1711.1999.00790.x
   Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402
   Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397
   Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355
   Wu D, 2012, EMERG INFECT DIS, V18, P493, DOI 10.3201/eid1803.110034
   Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491
   Zhang Q, 2008, CYTOKINE GROWTH F R, V19, P347, DOI 10.1016/j.cytogfr.2008.08.003
NR 80
TC 12
Z9 12
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD MAR-APR
PY 2018
VL 3
IS 2
AR e00120
DI 10.1128/mSphereDirect.00120-18
PG 18
WC Microbiology
SC Microbiology
GA GE0MK
UT WOS:000430907900038
PM 29600283
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Smith, JL
   Pugh, CL
   Cisney, ED
   Keasey, SL
   Guevara, C
   Ampuero, JS
   Comach, G
   Gomez, D
   Ochoa-Diaz, M
   Hontz, RD
   Ulrich, RG
AF Smith, Jessica L.
   Pugh, Christine L.
   Cisney, Emily D.
   Keasey, Sarah L.
   Guevara, Carolina
   Ampuero, Julia S.
   Comach, Guillermo
   Gomez, Doris
   Ochoa-Diaz, Margarita
   Hontz, Robert D.
   Ulrich, Robert G.
TI Human Antibody Responses to Emerging Mayaro Virus and Cocirculating
   Alphavirus Infections Examined by Using Structural Proteins from Nine
   New and Old World Lineages
SO MSPHERE
LA English
DT Article
DE alphavirus; humoral immunity; protein microarray; viral antigen
ID VENEZUELAN EQUINE ENCEPHALITIS; AEDES-ALBOPICTUS DIPTERA; CHIKUNGUNYA
   VIRUS; EXPERIMENTAL TRANSMISSION; ENCEPHALOMYELITIS VIRUS; CULICIDAE;
   VECTOR; SERODIAGNOSIS; EVOLUTIONARY; EXPRESSION
AB Mayaro virus (MAYV), Venezuelan equine encephalitis virus (VEEV), and chikungunya virus (CHIKV) are vector-borne alphaviruses that cocirculate in South America. Human infections by these viruses are frequently underdiagnosed or misdiagnosed, especially in areas with high dengue virus endemicity. Disease may progress to debilitating arthralgia (MAYV, CHIKV), encephalitis (VEEV), and death. Few standardized serological assays exist for specific human alphavirus infection detection, and antigen cross-reactivity can be problematic. Therefore, serological platforms that aid in the specific detection of multiple alphavirus infections will greatly expand disease surveillance for these emerging infections. In this study, serum samples from South American patients with PCR-and/or isolation-confirmed infections caused by MAYV, VEEV, and CHIKV were examined by using a protein microarray assembled with recombinant capsid, envelope protein 1 (E1), and E2 from nine New and Old World alphaviruses. Notably, specific antibody recognition of E1 was observed only with MAYV infections, whereas E2 was specifically targeted by antibodies from all of the alphavirus infections investigated, with evidence of cross-reactivity to E2 of o'nyong-nyong virus only in CHIKV-infected patient serum samples. Our findings suggest that alphavirus structural protein microarrays can distinguish infections caused by MAYV, VEEV, and CHIKV and that this multiplexed serological platform could be useful for high-throughput disease surveillance.
   IMPORTANCE Mayaro, chikungunya, and Venezuelan equine encephalitis viruses are closely related alphaviruses that are spread by mosquitos, causing diseases that produce similar influenza-like symptoms or more severe illnesses. Moreover, alphavirus infection symptoms can be similar to those of dengue or Zika disease, leading to underreporting of cases and potential misdiagnoses. New methods that can be used to detect antibody responses to multiple alphaviruses within the same assay would greatly aid disease surveillance efforts. However, possible antibody cross-reactivity between viruses can reduce the quality of laboratory results. Our results demonstrate that antibody responses to multiple alphaviruses can be specifically quantified within the same assay by using selected recombinant protein antigens and further show that Mayaro virus infections result in unique responses to viral envelope proteins.
C1 [Smith, Jessica L.; Pugh, Christine L.; Cisney, Emily D.; Keasey, Sarah L.; Ulrich, Robert G.] Army Med Res Inst Infect Dis, Mol & Translat Sci Div, Frederick, MD 21702 USA.
   [Keasey, Sarah L.] Univ Maryland Baltimore Cty, Dept Biol, Baltimore, MD 21228 USA.
   [Guevara, Carolina; Ampuero, Julia S.; Hontz, Robert D.] US Naval Med Res Unit 6 NAMRU 6, Lima, Peru.
   [Comach, Guillermo] Univ Carabobo BIOMED UC, Inst Invest Biomed, Lab Reg Diagnost & Invest Dengue & Otras Enfermed, Maracay, Aragua, Venezuela.
   [Gomez, Doris; Ochoa-Diaz, Margarita] Univ Cartagena, Doctorado Med Trop, Grp UNIMOL, Cartagena, Colombia.
   [Cisney, Emily D.] US Army Med Res & Mat Command, MIDRP, Ft Detrick, MD USA.
   [Hontz, Robert D.] Naval Med Res Ctr, Ft Detrick, MD USA.
RP Ulrich, RG (corresponding author), Army Med Res Inst Infect Dis, Mol & Translat Sci Div, Frederick, MD 21702 USA.
EM robert.g.ulrich.civ@mail.mil
FU National Academy of Sciences through a National Research Council;
   National Academy of Engineering through a National Research Council;
   National Academy of Medicine through a National Research Council;
   NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI096215]; Armed Forces Health
   Surveillance Center-Global Emerging Infections Surveillance (AFHSC-GEIS)
   [80000.82000.25GB.B0016, 847705.82000.25GB.B0016]
FX This research was supported in part by the National Academies of
   Sciences, Engineering, and Medicine through a National Research Council
   research associateship awarded to J.L.S. Grant support for this project
   was provided in part by the NIAID (R01AI096215 to R.G.U.). Collection of
   samples from patients in South America was performed with support from
   the Armed Forces Health Surveillance Center-Global Emerging Infections
   Surveillance (AFHSC-GEIS) (80000.82000.25GB.B0016 and
   847705.82000.25GB.B0016).
CR Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50
   Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   Arrigo NC, 2010, J VIROL, V84, P1014, DOI 10.1128/JVI.01586-09
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   BEAMAN JR, 1991, J MED ENTOMOL, V28, P161, DOI 10.1093/jmedent/28.1.161
   Bergren NA, 2014, J VIROL, V88, P9260, DOI 10.1128/JVI.01463-14
   Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101
   Brault AC, 2002, J VIROL, V76, P1718, DOI 10.1128/JVI.76.4.1718-1730.2002
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   CALISHER CH, 1986, J CLIN MICROBIOL, V23, P155, DOI 10.1128/JCM.23.1.155-159.1986
   CALISHER CH, 1980, INTERVIROLOGY, V14, P229, DOI 10.1159/000149190
   CALISHER CH, 1988, ARBOVIRUSES EPIDEMIO, V1, P19
   Carrera JP, 2013, NEW ENGL J MED, V369, P732, DOI 10.1056/NEJMoa1212628
   Cho B, 2008, YONSEI MED J, V49, P828, DOI 10.3349/ymj.2008.49.5.828
   Cho B, 2008, J VIROL METHODS, V154, P154, DOI 10.1016/j.jviromet.2008.07.031
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   DALRYMPL.JM, 1973, J VIROL, V12, P1034, DOI 10.1128/JVI.12.5.1034-1042.1973
   Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245
   Fernandez S, 2011, CLIN VACCINE IMMUNOL, V18, P523, DOI 10.1128/CVI.00016-11
   Fernandez Z, 2003, J MED ENTOMOL, V40, P522, DOI 10.1603/0022-2585-40.4.522
   Forrester NL, 2008, VIROLOGY, V380, P170, DOI 10.1016/j.virol.2008.08.012
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Gay N, 2016, AM J TROP MED HYG, V94, P393, DOI 10.4269/ajtmh.15-0308
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Hassing RJ, 2010, EUROSURVEILLANCE, V15, P22
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]
   Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12
   Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033
   Kamata T, 2014, CLIN VACCINE IMMUNOL, V21, P1605, DOI 10.1128/CVI.00484-14
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kowalzik S, 2008, MED MICROBIOL IMMUN, V197, P381, DOI 10.1007/s00430-008-0090-5
   Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   McClain DJ, 1998, J INFECT DIS, V177, P634, DOI 10.1086/514240
   Morrison AC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000349
   Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   *NAT COMM PROT HUM, 1979, BELM REP ETH PRINC G
   Natesan M, 2016, CLIN VACCINE IMMUNOL, V23, P717, DOI 10.1128/CVI.00107-16
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Ortiz DI, 2008, J MED ENTOMOL, V45, P1117, DOI 10.1603/0022-2585(2008)45[1117:SOAADC]2.0.CO;2
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Palmer Ira, 2004, Curr Protoc Protein Sci, VChapter 6, DOI [10.1002/0471140864.ps0603s70, 10.1002/0471140864.ps0603s38]
   Pan American Health Organization, 2017, CHIK DAT MAPS STAT
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Rivas F, 1997, J INFECT DIS, V175, P828, DOI 10.1086/513978
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Santiago FW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004104
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Talarmin A, 1998, AM J TROP MED HYG, V59, P452, DOI 10.4269/ajtmh.1998.59.452
   Torres JR, 2004, EMERG INFECT DIS, V10, P1304
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   TURELL MJ, 1992, J MED ENTOMOL, V29, P802, DOI 10.1093/jmedent/29.5.802
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 68
TC 9
Z9 9
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD MAR-APR
PY 2018
VL 3
IS 2
AR e00003-18
DI 10.1128/mSphere.00003-18
PG 14
WC Microbiology
SC Microbiology
GA GE0MK
UT WOS:000430907900019
PM 29577083
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Monitoring Zika virus infection associated cardiovascular problem
SO EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
LA English
DT Letter
ID COMPLICATIONS
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Joob B, 2016, ANATOL J CARDIOL, V16, P455, DOI 10.14744/AnatolJCardiol.2016.7140
   Krittanawong C, 2017, EUR J PREV CARDIOL, V24, P1988, DOI 10.1177/2047487317737182
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, INT J CARDIOL, V223, P53, DOI 10.1016/j.ijcard.2016.08.174
NR 4
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 2047-4873
EI 2047-4881
J9 EUR J PREV CARDIOL
JI Eur. J. Prev. Cardiol.
PD MAR
PY 2018
VL 25
IS 4
BP 388
EP 388
DI 10.1177/2047487317741986
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC5BM
UT WOS:000429800400007
PM 29110515
DA 2020-07-08
ER

PT J
AU Alkhaibari, AM
   Maffeis, T
   Bull, JC
   Butt, TM
AF Alkhaibari, Abeer M.
   Maffeis, Thierry
   Bull, James C.
   Butt, Tariq M.
TI Combined use of the entomopathogenic fungus, Metarhizium brunneum, and
   the mosquito predator, Toxorhynchites brevipalpis, for control of
   mosquito larvae: Is this a risky biocontrol strategy?
SO JOURNAL OF INVERTEBRATE PATHOLOGY
LA English
DT Article
DE Aedes; Metarhizium; Toxorhynchites; Predator; Fungal pathogen;
   Blastospores; Conidia; Risk assessment; Interaction
ID FRANKLINIELLA-OCCIDENTALIS; BACILLUS-THURINGIENSIS; INSECTICIDE
   RESISTANCE; BIOLOGICAL-CONTROL; DIPTERA-CULICIDAE; VECTOR;
   COMPATIBILITY; DESICCATION; AVOIDANCE; ANOPHELES
AB Mosquitoes transmit several diseases, which are of global significance (malaria, dengue, yellow fever, Zika). The geographic range of mosquitoes is increasing due to climate change, tourism and trade. Both conidial and blastospore formulations of the entomopathogenic fungus, Metarhiziwn brunnewn ARSEF 4556, are being investigated as mosquito larvicides. However, concerns have been raised over possible non-target impacts to arthropod mosquito predators such as larvae of Toxorhynchites brevipalpis which feed on larvae of mosquito vector species. Laboratory-based, small container bioassays showed, that T. bevipalpis larvae are susceptible to relatively high concentrations (i.e. >= 10(7) spores ml(-1)) of inoculum with blastospores being significantly more virulent than conidia. At lower concentrations (e.g. < 10(7) spores ml(-1)), it appears that M. brunnewn complements T. brevipalpis resulting in higher control than if either agent was used alone. At a concentration of 105 spores ml(-1), the LT50 of for conidia and blastospores alone was 5.64 days (95% CI: 4.79-6.49 days) and 3.89 days (95% CI: 3.53-4.25 days), respectively. In combination with T. brevipalpis, this was reduced to 3.15 days (95% CI: 2.82-3.48 days) and 2.82 days (95% CI: 2.55-3.08 days). Here, combined treatment with the fungus and predator was beneficial but weaker than additive. At 10(7) and 10(5) blastospores ml(-1), mosquito larval mortality was mostly due to the fungal pathogen when the predator was combined with blastospores. However, with conidia, the effects of combined treatment were additive/synergistic at these high concentrations. Optimisation of fungal concentration and formulation will reduce: (1) risk to the predator and (2) application rates and costs of M. bnumewn for control of mosquito larvae.
C1 [Alkhaibari, Abeer M.; Bull, James C.; Butt, Tariq M.] Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales.
   [Maffeis, Thierry] Swansea Univ, Coll Engn, Ctr Nanohlth, Swansea, W Glam, Wales.
   [Alkhaibari, Abeer M.] Tabuk Univ, Dept Biol, Fac Sci, Tabuk, Saudi Arabia.
RP Butt, TM (corresponding author), Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales.
EM t.butt@swansea.ac.uk
OI Bull, James/0000-0002-4373-6830
FU Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC); Department for
   Environment, Food and Rural AffairsDepartment for Environment, Food &
   Rural Affairs (DEFRA); Economic and Social Research CouncilEconomic &
   Social Research Council (ESRC); Forestry Commission; Natural Environment
   Research CouncilNERC Natural Environment Research Council; Scottish
   Government, under the Tree Health and Plant Biosecurity Initiative;
   Saudi Arabian Cultural Bureau in London (UKSACB); Tabuk University, KSA
FX TMB was supported by a grant funded jointly by the Biotechnology and
   Biological Sciences Research Council, the Department for Environment,
   Food and Rural Affairs, the Economic and Social Research Council, the
   Forestry Commission, the Natural Environment Research Council and the
   Scottish Government, under the Tree Health and Plant Biosecurity
   Initiative. We thank the Saudi Arabian Cultural Bureau in London
   (UKSACB) and Tabuk University, KSA, for funding AMA.
CR Alkhaibari A., 2017, J MED ENTOMOL, V1, P9
   Alkhaibari AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005715
   Ansari MA, 2008, ENTOMOL EXP APPL, V129, P340, DOI 10.1111/j.1570-7458.2008.00783.x
   Becker N., 2003, MOSQUITOES THEIR CON, V2, P405
   Behle RW, 2006, SOUTHWEST ENTOMOL, V31, P289
   Boyer S, 2012, BIOL CONTROL, V62, P75, DOI 10.1016/j.biocontrol.2012.02.001
   Butt TM, 2016, ADV GENET, V94, P307, DOI 10.1016/bs.adgen.2016.01.006
   Butt TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081686
   Ceretti W, 2016, J ARTHROPOD-BORNE DI, V10, P102
   Collins LE, 2000, BIOCONTROL NEWS INFO, V4, P105
   Crawley M, 2012, R BOOK, P869
   de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001
   Dogan Y., 2017, BIOL CONTROL
   Faull KJ, 2016, J VECTOR ECOL, V41, P55, DOI 10.1111/jvec.12194
   Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632
   Garrido-Jurado I., 2015, J PEST SCI, P1
   Gehman ALM, 2017, OECOLOGIA, V183, P919, DOI 10.1007/s00442-016-3784-1
   Greenfield BPJ, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140193
   Greenfield BPJ, 2015, BIOCONTROL SCI TECHN, V25, P487, DOI 10.1080/09583157.2014.989813
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Ippolito A, 2015, ENVIRON POLLUT, V198, P54, DOI 10.1016/j.envpol.2014.12.016
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Koppenhofer AM, 1997, BIOL CONTROL, V8, P131, DOI 10.1006/bcon.1996.0498
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Liess M, 2013, ENVIRON SCI TECHNOL, V47, P8862, DOI 10.1021/es401346d
   Meyling NV, 2006, ECOL ENTOMOL, V31, P162, DOI 10.1111/j.0307-6946.2006.00781.x
   Mohamad N, 2014, TROP BIOMED, V31, P166
   Morgan G.A., 2012, IBM SPSS INTRO STAT
   Mulla M. S., 1990, Bacterial control of mosquitoes & black flies: biochemistry, genetics & applications of Bacillus thuringiensis israelensis and Bacillus sphaericus., P134
   Nkya TE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0480-z
   Ormond EL, 2011, FEMS MICROBIOL ECOL, V77, P229, DOI 10.1111/j.1574-6941.2011.01100.x
   R Core Team, 2012, R LANG ENV STAT COMP
   Ravensberg WJ, 2011, PROG BIOL CONTROL, V10, P1, DOI 10.1007/978-94-007-0437-4
   Roy HE, 2000, BIOCONTROL SCI TECHN, V10, P737, DOI 10.1080/09583150020011708
   Saito T, 2016, BIOL CONTROL, V92, P92, DOI 10.1016/j.biocontrol.2015.10.003
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Shaalan EAS, 2009, TROP BIOMED, V26, P223
   Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8
   Tanada Y, 2012, INSECT PATHOLOGY
   Thomas M.B, 2017, BIOCONTROL, P1
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Wu SY, 2015, J INTEGR AGR, V14, P98, DOI 10.1016/S2095-3119(13)60731-5
NR 43
TC 4
Z9 4
U1 0
U2 17
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-2011
EI 1096-0805
J9 J INVERTEBR PATHOL
JI J. Invertebr. Pathol.
PD MAR
PY 2018
VL 153
BP 38
EP 50
DI 10.1016/j.jip.2018.02.003
PG 13
WC Zoology
SC Zoology
GA GC6ID
UT WOS:000429892400007
PM 29425967
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Khusro, A
   Aarti, C
   Barbabosa-Pilego, A
   Sanchez-Aparicio, P
AF Khusro, Ameer
   Aarti, Chirom
   Barbabosa-Pilego, Alberto
   Sanchez-Aparicio, Pedro
TI Outbreak of Zika virus pathogenesis and quest of its vaccine
   development: Where do we stand now?
SO MICROBIAL PATHOGENESIS
LA English
DT Review
DE Tropical infection; Vaccine; Viral infection; Zika virus
ID SEXUAL TRANSMISSION; INFECTION; DISEASE; BRAZIL
AB Zika virus (ZIKV) infection is a life-threatening tropical infection, mainly caused by mosquito bite. After a very long period of quietness, ZIKV infections have become a problematic issue again. Previously, the virus was limited to Africa and Asia only but later it emerged in Brazil, South America, and other parts of the world in 2015. In 2016, there are emerging new cases of sexually transmitted ZIKV infection as well. At present, there is no proper treatment and available pronounced vaccines for the treatment of ZIKV infection. The prime focal point of this review is not only to provide imperative epidemiological information on ZIKV infection in brief but also the current situation of vaccines testing on animal model as well as in clinical trial phases. Currently there is no human vaccine for this pestiferous viral infection. Therefore, prevention, proper management, and up-to-date recommendation are crucial to mitigate the possible risk of vector and non-vector transmission of ZIKV.
C1 [Khusro, Ameer; Aarti, Chirom] Loyola Coll, Res Dept Plant Biol & Biotechnol, Chennai 600034, Tamil Nadu, India.
   [Barbabosa-Pilego, Alberto] Univ Autonoma Estado Mexico, Fac Med Vet & Zootecnia, Toluca, Mexico.
   [Sanchez-Aparicio, Pedro] Univ Autonoma Estado Mexico, Fac Vet Med, Dept Pharmacol Anesthesia & Analgesia, Toluca, Mexico.
RP Khusro, A (corresponding author), Loyola Coll, Res Dept Plant Biol & Biotechnol, Chennai 600034, Tamil Nadu, India.
EM armankhan0301@gmail.com
OI sanchez aparicio, pedro/0000-0002-6511-6595
CR [Anonymous], 2016, EXPT ZIKA VACCINE IS
   [Anonymous], 2016, ZIKA VACCINE CLIN TR
   [Anonymous], 2017, ZIK VIR COUNTR CLASS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   ClinicalTrials.gov, 2016, STUD GLS 5700 HLTH V
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leo YS, 2016, LANCET INFECT DIS, V16, P1317, DOI 10.1016/S1473-3099(16)30448-0
   Mexico Secretariat of Health, 2017, ZIK VIR DIS CONF CAS
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, ZIK SUSP CONF CAS RE
   Pan American Health Organization WHO, 2017, ZIK EP UPD
   Pan American Health Organization/World Health Organization, 2017, ZIK EP REP MEX
   Pan-American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   SABBIR A, 2016, ASIAN PAC J TROP DIS, V6, P925, DOI DOI 10.1016/S2222-1808(16)61157-X
   Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Weissman D, 2015, EXPERT REV VACCINES, V14, P265, DOI 10.1586/14760584.2015.973859
   Wiwanitkit S., 2016, Asian Pacific Journal of Tropical Disease, V6, P757, DOI 10.1016/S2222-1808(16)61124-6
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
NR 31
TC 1
Z9 2
U1 0
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD MAR
PY 2018
VL 116
BP 289
EP 295
DI 10.1016/j.micpath.2018.02.001
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GB5EF
UT WOS:000429085200045
PM 29407238
OA Green Published
DA 2020-07-08
ER

PT J
AU Karesh, JW
   Mazzoli, RA
   Heintz, SK
AF Karesh, James W.
   Mazzoli, Robert A.
   Heintz, Shannon K.
TI Ocular Manifestations of Mosquito-Transmitted Diseases
SO MILITARY MEDICINE
LA English
DT Article; Proceedings Paper
CT Military Health System Research Symposium (MHSRS)
CY 2016
CL FL
ID RIFT-VALLEY FEVER; CHIKUNGUNYA VIRUS-INFECTION; CONGENITAL ZIKA
   SYNDROME; DERMATOBIA-HOMINIS; EXTERNAL OPHTHALMOMYIASIS; OPHTHALMIC
   MANIFESTATIONS; EQUINE ENCEPHALITIS; CEREBRAL MALARIA; DIROFILARIASIS;
   INVOLVEMENT
AB Of the 3,548 known mosquito species, about 100 transmit human diseases. Mosquitoes are distributed globally throughout tropical and temperate regions where standing water sources are available for egg laying and the maturation of larva. Female mosquitoes require blood meals for egg production. This is the main pathway for disease transmission. Mosquitoes carry several pathogenic organisms responsible for significant ocular pathology and vision loss including West Nile, Rift Valley, chikungunya, dengue viruses, various encephalitis viruses, malarial parasites, Francisella tularensis, microfilarial parasites, including Dirofilaria, Wuchereria, and Brugia spp., and human botfly larvae. Health care providers may not be familiar with many of these mosquito-transmitted diseases or their associated ocular findings delaying diagnosis, treatment, and recovery of visual function. This article aims to provide an overview of the ocular manifestations associated with mosquito-transmitted diseases.
C1 [Karesh, James W.; Mazzoli, Robert A.; Heintz, Shannon K.] Walter Reed Natl Mil Med Ctr, Vis Ctr Excellence, 8960 Brown Dr,Bldg 2,1st Floor,Room 1403-A, Bethesda, MD 20889 USA.
   [Mazzoli, Robert A.] Madigan Army Med Ctr, 9040 Jackson Ave, Tacoma, WA 98431 USA.
RP Karesh, JW (corresponding author), Walter Reed Natl Mil Med Ctr, Vis Ctr Excellence, 8960 Brown Dr,Bldg 2,1st Floor,Room 1403-A, Bethesda, MD 20889 USA.
FU Vision Center of Excellence
FX The Vision Center of Excellence supported this research.
CR Abu El-Asrar AM, 2009, MIDDLE EAST AFR J OP, V16, P202, DOI 10.4103/0974-9233.58423
   Abu Sayeed A, 2011, AM J TROP MED HYG, V84, P141, DOI 10.4269/ajtmh.2011.10-0205
   Al-Hazmi A, 2005, OPHTHALMOLOGY, V112, P313, DOI 10.1016/j.ophtha.2004.09.018
   Alsaif N, 2016, OPHTHAL PLAST RECONS, V32, pE113, DOI 10.1097/IOP.0000000000000286
   Armed Forces Health Surveillance Branch, 2016, MSMR, V23, P2
   Backman S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07793
   Bakken J., 2009, Morbidity and Mortality Weekly Report, V58, P737
   BEAVER PC, 1989, AM J TROP MED HYG, V40, P40, DOI 10.4269/ajtmh.1989.40.40
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biswas J, 1996, OPHTHALMOLOGY, V103, P1471, DOI 10.1016/S0161-6420(96)30481-8
   Boivin MJ, 2014, PEDIATR INFECT DIS J, V33, P821, DOI 10.1097/INF.0000000000000296
   BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   CDC, W NIL VIR DIS CAS DE
   CDC, W NIL VIR NEUR DIS C
   CDC Web Site, 2016, CHIK VIR GEOGR DISTR
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cholewinski Marcin, 2015, Annals of Parasitology, V61, P137, DOI 10.17420/ap6103.01
   Denion E, 2004, ACTA OPHTHALMOL SCAN, V82, P576, DOI 10.1111/j.1600-0420.2004.00315.x
   Dhasmana Renu, 2011, J Ophthalmic Vis Res, V6, P63
   Diaz JH, 2015, J TRAVEL MED, V22, P116, DOI 10.1111/jtm.12174
   El-Bahnasawy Mamdouh, 2013, J Egypt Soc Parasitol, V43, P41
   Fang ST, 2006, EYE, V20, P1439, DOI 10.1038/sj.eye.6702301
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Garg S, 2005, SURV OPHTHALMOL, V50, P3, DOI 10.1016/j.survophthal.2004.10.001
   Greenlee John E, 2012, Continuum (Minneap Minn), V18, P1271, DOI 10.1212/01.CON.0000423847.40147.06
   Griffith KS, 2007, JAMA-J AM MED ASSOC, V297, P2264, DOI 10.1001/jama.297.20.2264
   GUPTA A, 1992, ACTA OPHTHALMOL, V70, P832, DOI 10.1111/j.1755-3768.1992.tb04896.x
   Harbach RE, 2013, MOSQUITO TAXONOMIC I
   Harding SP, 2006, TROP DOCT, V36, P1, DOI 10.1258/004947506776315781
   Hasbun R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148898
   Hindo H, 2005, J PEDIAT HEMATOL ONC, V27, P659, DOI 10.1097/01.mph.0000188111.04459.6f
   Idris MNA, 1999, E AFR MED J, V76, P417
   Kahloun R, 2015, EYE BRAIN, V7, P59, DOI 10.2147/EB.S69173
   Kantardjiev T, 2007, BRIT J OPHTHALMOL, V91, P1206, DOI 10.1136/bjo.2007.117523
   Kar SK, 2015, TRANSL BIOMED, V6, P29
   KOKERNOT ROBERT H., 1953, CALIFORNIA MED, V79, P73
   Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002
   Larik Ashfaq, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr.12.2011.5378
   Lewallen S, 1999, T ROY SOC TROP MED H, V93, P619, DOI 10.1016/S0035-9203(99)90071-8
   Lim WK, 2004, OPHTHALMOLOGY, V111, P2057, DOI 10.1016/j.ophtha.2004.03.038
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-35
   Mahesh G, 2009, INDIAN J OPHTHALMOL, V57, P148, DOI 10.4103/0301-4738.45508
   Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]
   Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381
   Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355
   Muqit MMK, 2008, BRIT J OPHTHALMOL, V92, P1599, DOI 10.1136/bjo.2007.132902
   Murray KO, 2008, VECTOR-BORNE ZOONOT, V8, P167, DOI 10.1089/vbz.2007.0109
   Murthy KR, 2008, INDIAN J OPHTHALMOL, V56, P329
   Nanyingi Mark O., 2015, Infection Ecology & Epidemiology, V5, P28024, DOI 10.3402/iee.v5.28024
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Otranto D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-41
   PAHO, NUMB REP CAS CHIK FE
   PAHO/ WHO, NUMB REP CAS DENG SE
   PAHO/ WHO, 2017, LAT GLOB SIT REP ZIK
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045
   Price KM, 2007, BRIT J OPHTHALMOL, V91, P6695, DOI 10.1136/bjo.2006.100776
   Priestley Y, 2008, EXPERT REV OPHTHALMO, V3, P279, DOI 10.1586/17469899.3.3.279
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Rao NG, 2008, INDIAN J OPHTHALMOL, V56, P76, DOI 10.4103/0301-4738.37610
   Rueda LM, 2008, HYDROBIOLOGIA, V595, P477, DOI 10.1007/s10750-007-9037-x
   SAVINO DF, 1986, OPHTHALMOLOGY, V93, P1225, DOI 10.1016/S0161-6420(86)33593-0
   SHOPE RE, 1982, B WORLD HEALTH ORGAN, V60, P299
   SIAM AL, 1980, BRIT J OPHTHALMOL, V64, P366, DOI 10.1136/bjo.64.5.366
   Silverman MA, 2013, EMERG INFECT DIS, V19, P194, DOI 10.3201/eid1902.120039
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Tse BC, 2010, OPHTHAL PLAST RECONS, V26, P323, DOI 10.1097/IOP.0b013e3181c563e9
   Venkat H, 2015, MMWR-MORBID MORTAL W, V64, P1349, DOI 10.15585/mmwr.mm6448a5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wakamatsu TH, 2006, EYE, V20, P1088, DOI 10.1038/sj.eye.6702120
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Watts DM, 1997, AM J TROP MED HYG, V56, P661, DOI 10.4269/ajtmh.1997.56.661
   Wesolowska M, 2010, AM J TROP MED HYG, V83, P210, DOI 10.4269/ajtmh.2010.10-0084
   WHO, 2016, WORLD MAL REP 2016 G
   WHO, 2015, GUID TREATM MAL
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Young PR, 2014, MANSONS TROPICAL DIS, P129
NR 81
TC 3
Z9 3
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0026-4075
EI 1930-613X
J9 MIL MED
JI Milit. Med.
PD MAR-APR
PY 2018
VL 183
SU S
BP 450
EP 458
DI 10.1093/milmed/usx183
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA GC0JM
UT WOS:000429463600063
PM 29635625
OA Other Gold
DA 2020-07-08
ER

PT J
AU Lam, ST
   Viganeshwari, SH
   Bhave, AS
   Tan, CWT
   Tambyah, PA
   Soon, D
AF Lam, S. T.
   Viganeshwari, S. H.
   Bhave, A. S.
   Tan, C. W. T.
   Tambyah, P. A.
   Soon, D.
TI Optic Neuritis: A Complication of ZIKA Virus Infection in An Adult
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 10th Congress of the
   Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
   (PACTRIMS)
CY NOV 23-25, 2017
CL Ho Chi Minh City, VIETNAM
SP Pan Asian Comm Treatment & Res Multiple Sclerosis
C1 [Lam, S. T.; Viganeshwari, S. H.; Bhave, A. S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Tan, C. W. T.; Tambyah, P. A.; Soon, D.] Natl Univ Hlth Syst, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD MAR
PY 2018
VL 24
IS 3
MA P-126
BP 423
EP 423
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GB8LI
UT WOS:000429327000173
DA 2020-07-08
ER

PT J
AU Gurung, S
   Reuter, DN
   Martin, A
   Dubaut, J
   Preno, A
   Papin, J
   Myers, D
AF Gurung, Sunam
   Reuter, Darlene N.
   Martin, Ashley
   Dubaut, Jamie
   Preno, Alisha
   Papin, James
   Myers, Dean
TI Cytokine Response to Zika Virus (ZIKV) Infection in Non-Pregnant and
   Pregnant Olive Baboons.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 65th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 06-10, 2018
CL San Diego, CA
SP Soc Reprod Invest
C1 [Gurung, Sunam; Reuter, Darlene N.; Martin, Ashley; Dubaut, Jamie; Preno, Alisha; Papin, James; Myers, Dean] Univ Oklahoma, HSC, Oklahoma City, OK USA.
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NS103772, OD010988]
FX NIH NS103772, OD010988
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2018
VL 25
SU 1
MA O-012
BP 60A
EP 60A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GC6UM
UT WOS:000429928200013
DA 2020-07-08
ER

PT J
AU Lei, J
   Vermillion, M
   Jia, B
   McLane, M
   Feller, M
   Brown, A
   Klein, S
   Burd, I
AF Lei, Jun
   Vermillion, Meghan
   Jia, Bei
   McLane, Michael
   Feller, Mia
   Brown, Amanda
   Klein, Sabra
   Burd, Irina
TI IL-1 Receptor Antagonist Improves Trophoblast Invasion, Endothelial
   Development and ZIKV Sequelae in Offspring.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 65th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 06-10, 2018
CL San Diego, CA
SP Soc Reprod Invest
C1 [Lei, Jun; Vermillion, Meghan; Jia, Bei; McLane, Michael; Feller, Mia; Brown, Amanda; Klein, Sabra; Burd, Irina] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2018
VL 25
SU 1
MA O-011
BP 60A
EP 60A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GC6UM
UT WOS:000429928200012
DA 2020-07-08
ER

PT J
AU Yockey, LJ
   Jurado, KA
   Arora, N
   Millet, A
   Rakib, T
   Milano, KM
   Hastings, AK
   Fikrig, E
   Kong, Y
   Weatherbee, S
   Kliman, HJ
   Coyne, CB
   Iwasaki, A
AF Yockey, Laura J.
   Jurado, Kellie A.
   Arora, Nitin
   Millet, Alon
   Rakib, Tasfia
   Milano, Kristin M.
   Hastings, Andrew K.
   Fikrig, Erol
   Kong, Yong
   Weatherbee, Scott
   Kliman, Harvey J.
   Coyne, Carolyn B.
   Iwasaki, Akiko
TI Type I Interferons Instigate Fetal Demise after Zika Virus Infection.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 65th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 06-10, 2018
CL San Diego, CA
SP Soc Reprod Invest
C1 [Fikrig, Erol; Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD USA.
   [Arora, Nitin; Coyne, Carolyn B.] Univ Pittsburgh, Pittsburgh, PA USA.
   [Yockey, Laura J.; Jurado, Kellie A.; Millet, Alon; Rakib, Tasfia; Milano, Kristin M.; Hastings, Andrew K.; Fikrig, Erol; Kong, Yong; Weatherbee, Scott; Kliman, Harvey J.; Iwasaki, Akiko] Yale Univ, New Haven, CT USA.
RI Iwasaki, Akiko/Z-1591-2019
OI Iwasaki, Akiko/0000-0002-7824-9856
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2018
VL 25
SU 1
MA O-024
BP 64A
EP 64A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GC6UM
UT WOS:000429928200025
DA 2020-07-08
ER

PT J
AU Guzeloglu-Kayisli, O
   Semerci, N
   Larsen, K
   Elzein, C
   Schatz, F
   Kayisli, U
   Lockwood, C
AF Guzeloglu-Kayisli, Ozlem
   Semerci, Nihan
   Larsen, Kellie
   Elzein, Catherine
   Schatz, Frederick
   Kayisli, Umit
   Lockwood, Charles
TI Human Decidual Cells (DCs) Express Proteins Required for ZIKA Virus
   (ZIKV) Cell Entry and Are Permissive for ZIKV Infection.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 65th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 06-10, 2018
CL San Diego, CA
SP Soc Reprod Invest
C1 [Guzeloglu-Kayisli, Ozlem; Semerci, Nihan; Larsen, Kellie; Elzein, Catherine; Schatz, Frederick; Kayisli, Umit; Lockwood, Charles] Univ S Florida, Morsani Coll Med, Tampa, FL USA.
FU Florida Department of Health [7ZK23]
FX Supported by Florida Department of Health (#7ZK23).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2018
VL 25
SU 1
MA O-148
BP 106A
EP 106A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GC6UM
UT WOS:000429928200149
DA 2020-07-08
ER

PT J
AU Liang, B
   Kumar, A
   Giri, R
   Mysorekar, IU
AF Liang, Brooke
   Kumar, Ankur
   Giri, Rajanish
   Mysorekar, Indira U.
TI Hydroxychloroquine Treatment Inhibits ZIKV Infection in Placenta by
   Blocking ZIKV NS2B-NS3 Protease Activity
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 65th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 06-10, 2018
CL San Diego, CA
SP Soc Reprod Invest
C1 [Kumar, Ankur; Giri, Rajanish] Indian Inst Technol, Mandi, India.
   [Liang, Brooke; Mysorekar, Indira U.] Washington Univ, SOM, St Louis, MO USA.
RI Giri, Rajanish/Q-6530-2018
OI Giri, Rajanish/0000-0002-2046-836X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2018
VL 25
SU 1
MA O-147
BP 106A
EP 106A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GC6UM
UT WOS:000429928200148
DA 2020-07-08
ER

PT J
AU Gurung, S
   Singleton, K
   Martin, A
   Dubaut, J
   Preno, A
   Papin, J
   Myers, D
AF Gurung, Sunam
   Singleton, Krista
   Martin, Ashley
   Dubaut, Jamie
   Preno, Alisha
   Papin, James
   Myers, Dean
TI Zika Virus (ZIKV) Infection during the First, Second and Third
   Trimesters in the Pregnant Olive Baboon.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 65th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 06-10, 2018
CL San Diego, CA
SP Soc Reprod Invest
C1 [Gurung, Sunam; Singleton, Krista; Martin, Ashley; Dubaut, Jamie; Preno, Alisha; Papin, James; Myers, Dean] Univ Oklahoma, HSC, Oklahoma City, OK USA.
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NS103772, OD010988]
FX NIH NS103772, OD010988
NR 0
TC 0
Z9 0
U1 1
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2018
VL 25
SU 1
MA T-060
BP 129A
EP 129A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GC6UM
UT WOS:000429928200220
DA 2020-07-08
ER

PT J
AU Collier, ARY
   Barouch, DH
AF Collier, Ai-ris Y.
   Barouch, Dan H.
TI Maternal Immune Response to Zika Virus.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 65th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 06-10, 2018
CL San Diego, CA
SP Soc Reprod Invest
C1 [Collier, Ai-ris Y.; Barouch, Dan H.] BIDMC, Boston, MA USA.
RI Barouch, Dan/Y-3918-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2018
VL 25
SU 1
MA T-163
BP 163A
EP 164A
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GC6UM
UT WOS:000429928200323
DA 2020-07-08
ER

PT J
AU Walker, CL
   Merriam, A
   Ohuma, EO
   Dighe, MK
   Gale, M
   Rajagopal, L
   Papageorghiou, A
   Gyamfi-Bannerman, C
   Waldorf, KMA
AF Walker, Christie L.
   Merriam, Audrey
   Ohuma, Eric O.
   Dighe, Manjiri K.
   Gale, Michael, Jr.
   Rajagopal, Lakshmi
   Papageorghiou, Aris
   Gyamfi-Bannerman, Cynthia
   Waldorf, Kristina M. Adams
TI Femur-Sparing Pattern of Abnormal Fetal Growth after Possible Zika Virus
   Infection.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 65th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 06-10, 2018
CL San Diego, CA
SP Soc Reprod Invest
C1 [Merriam, Audrey; Gyamfi-Bannerman, Cynthia] Columbia Univ, Med Ctr, New York, NY USA.
   [Ohuma, Eric O.; Papageorghiou, Aris] Univ Oxford, Oxford, England.
   [Walker, Christie L.; Dighe, Manjiri K.; Gale, Michael, Jr.; Rajagopal, Lakshmi; Waldorf, Kristina M. Adams] Univ Washington, Seattle, WA 98195 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2018
VL 25
SU 1
MA F-029
BP 192A
EP 192A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GC6UM
UT WOS:000429928200409
DA 2020-07-08
ER

PT J
AU Dubaut, JP
   Gurung, S
   Lindgren, MC
   Husain, S
   Zavy, MT
   Myers, DA
   Papin, JF
AF Dubaut, Jamie P.
   Gurung, Sunam
   Lindgren, Mark C.
   Husain, Sanam
   Zavy, Michael T.
   Myers, Dean A.
   Papin, James F.
TI Zika Virus (ZIKV) Infects Male Reproductive Organs and Sheds in Semen of
   Olive Baboons.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 65th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 06-10, 2018
CL San Diego, CA
SP Soc Reprod Invest
C1 [Dubaut, Jamie P.; Gurung, Sunam; Lindgren, Mark C.; Husain, Sanam; Zavy, Michael T.; Myers, Dean A.; Papin, James F.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2018
VL 25
SU 1
MA F-060
BP 201A
EP 202A
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GC6UM
UT WOS:000429928200440
DA 2020-07-08
ER

PT J
AU Gurung, S
   Reuter, DN
   Preno, A
   Papin, J
   Myers, DA
AF Gurung, Sunam
   Reuter, Darlene N.
   Preno, Alisha
   Papin, James
   Myers, Dean A.
TI Vertical Transfer of Zika Virus (ZIKV) at Mid-Gestation Disrupts Normal
   Development in the Cerebral Cortex in the Olive Baboon (Papio anubis).
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 65th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 06-10, 2018
CL San Diego, CA
SP Soc Reprod Invest
C1 [Gurung, Sunam; Reuter, Darlene N.; Preno, Alisha; Papin, James; Myers, Dean A.] Univ Oklahoma HSC, Oklahoma City, OK USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2018
VL 25
SU 1
MA S-094
BP 283A
EP 283A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GC6UM
UT WOS:000429928200691
DA 2020-07-08
ER

PT J
AU Kuri-Morales, PA
   Correa-Morales, F
   Gonzalez-Acosta, C
   Moreno-Garcia, M
   Davalos-Becerril, E
   Benitez-Alva, JI
   Peralta-Rodriguez, J
   Salazar-Bueyes, V
   Gonzalez-Roldan, JF
AF Kuri-Morales, Pablo A.
   Correa-Morales, Fabian
   Gonzalez-Acosta, Cassandra
   Moreno-Garcia, Miguel
   Davalos-Becerril, Eduardo
   Ismael Benitez-Alva, Jose
   Peralta-Rodriguez, Jorge
   Salazar-Bueyes, Victor
   Gonzalez-Roldan, Jesus F.
TI Efficacy of 13 Commercial Household Aerosol Insecticides Against Aedes
   aegypti (Diptera: Culicidae) From Morelos, Mexico
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; aerosol; community participation; household insecticide;
   Mexico
ID DENGUE; DELTAMETHRIN; CHIKUNGUNYA; PYRETHROIDS; RESISTANCE; REPELLENCY;
   DISEASES
AB In Mexico, Aedes aegypti (L.) (Diptera: Culicidae) is the primary vector of Dengue, Zika, and Chikungunya viruses. Control programs include community participation using personal protection such as household aerosol insecticides. In both, urban or rural areas, the use of aerosol insecticides is a common practice to avoiding mosquito biting. Thus, information on the efficacy of commercial products must be available. This study reports the efficacy of 13 household aerosol insecticides against Ae. aegypti from an endemic dengue area in Mexico. To test each insecticide, six netting cages, containing 10 non-blood fed female mosquitoes each one, were placed in different locations inside a bedroom. Readings at 30 min and 24 h after exposure were recorded. No products showed 100% mortality after 30 min of exposure. Only three products killed the 100% of the individuals 24 h after exposure. Results showed a high mortality variance among insecticides. Location in the room also impacts the insecticide efficacy. Mosquitoes located inside cabinets or with behind an obstacle (preventing an accurate insecticide exposure) showed lower mortalities. Products and spraying methods could and should be improved.
C1 [Kuri-Morales, Pablo A.] Secretaria Salud Mexico, Lieja 7, Mexico City 06600, DF, Mexico.
   [Correa-Morales, Fabian; Gonzalez-Acosta, Cassandra; Moreno-Garcia, Miguel; Davalos-Becerril, Eduardo; Ismael Benitez-Alva, Jose; Salazar-Bueyes, Victor; Gonzalez-Roldan, Jesus F.] Ctr Nacl Programas Prevent & Control Enfermda, Benjamin Franklin 132, Mexico City 11800, DF, Mexico.
   [Moreno-Garcia, Miguel; Peralta-Rodriguez, Jorge] Ctr Reg Control Vectores Panchimalco, Unidad Bioensayo, Serv Salud Morelos, Emiliano Zapata 95, Jojutla 62900, Morelos, Mexico.
RP Gonzalez-Roldan, JF (corresponding author), Ctr Nacl Programas Prevent & Control Enfermda, Benjamin Franklin 132, Mexico City 11800, DF, Mexico.
EM jesus.gonzalez@salud.gob.mx
OI Gonzalez Acosta, Cassandra/0000-0003-2682-908X; Correa Morales,
   Fabian/0000-0002-6193-1242; MORENO-GARCIA, MIGUEL/0000-0001-6733-9007
CR Lorono-Pino MA, 2014, TROP MED INT HEALTH, V19, P1267, DOI 10.1111/tmi.12364
   Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005
   Rivera-Avila RC, 2014, SALUD PUBLICA MEXICO, V56, P402
   Chareonviriyaphap T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-280
   Flores AE, 2013, J ECON ENTOMOL, V106, P959, DOI 10.1603/EC12284
   Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940, DOI 10.4269/ajtmh.2008.79.940
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Ikeda Y., 2006, 13 INT S APPL LAS TE, P12
   Khadri MS, 2009, SE ASIAN J TROP MED, V40, P1226
   Kongmee M, 2004, J MED ENTOMOL, V41, P1055, DOI 10.1603/0022-2585-41.6.1055
   Kuri-Morales PA, 2017, J MED ENTOMOL, V54, P1305, DOI 10.1093/jme/tjx076
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Mongkalangoon P, 2009, J VECTOR ECOL, V34, P217, DOI [10.1111/j.1948-7134.2009.00029.x, 10.3376/038.034.0207]
   Osaka Ken, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P484
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Ramesh A, 2001, J ENVIRON MONITOR, V3, P191, DOI 10.1039/b007303m
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277
   Sarwar Muhammad, 2015, INT J MAT CHEM PHYS, V1, P116
   Siller Q, 2011, J AM MOSQUITO CONTR, V27, P357, DOI 10.2987/11-6149.1
   WHO, 2009, WHOHTMNTDWHOPES20093
NR 22
TC 2
Z9 2
U1 1
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAR
PY 2018
VL 55
IS 2
BP 417
EP 422
DI 10.1093/jme/tjx212
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA GB8IQ
UT WOS:000429320000019
PM 29228197
DA 2020-07-08
ER

PT J
AU Chimelli, L
   Pone, SM
   Avvad-Portari, E
   Vasconcelos, ZFM
   Zin, AA
   Cunha, DP
   Thompson, NR
   Moreira, MEL
   Wiley, CA
   Pone, MVD
AF Chimelli, Leila
   Pone, Sheila Moura
   Avvad-Portari, Elyzabeth
   Meira Vasconcelos, Zilton Farias
   Zin, Andrea Araujo
   Cunha, Daniela Prado
   Thompson, Nathalia Raposo
   Lopes Moreira, Maria Elisabeth
   Wiley, Clayton A.
   da Silva Pone, Marcos Vinicius
TI Persistence of Zika Virus After Birth: Clinical, Virological,
   Neuroimaging, and Neuropathological Documentation in a 5-Month Infant
   With Congenital Zika Syndrome
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Arthrogryposis; Calcification; Hydrocephalus; Microcephaly;
   Neuropathology; RT-qPCR; Zika virus
ID INFECTION; POSTMORTEM; BRAIN
AB During the Zika epidemic in Brazil, a baby was born at term with microcephaly and arthrogryposis. The mother had Zika symptoms at 10 weeks of gestation. At 17 weeks, ultrasound showed cerebral malformation and ventriculomegaly. At 24 weeks, the amniotic fluid contained ZIKV RNA and at birth, placenta and maternal blood were also positive using RT-qPCR. At birth the baby urine contained ZIKV RNA, whereas CSF at birth and urine at 17 days did not. Seizures started at 6 days. EEG was abnormal and CT scan showed cerebral atrophy, calcifications, lissencephaly, ventriculomegaly, and cerebellar hypoplasia. Bacterial sepsis at 2 months was treated. A sudden increase in head circumference occurred at 4 months necessitating ventricle-peritoneal shunt placement. At 5 months, the infant died with sepsis due to bacterial meningitis. Neuropathological findings were as severe as some of those found in neonates who died soon after birth, including hydrocephalus, destructive lesions/calcification, gliosis, abnormal neuronal migration, dysmaturation of nerve cells, hypomyelination, loss of descending axons, and spinal motor neurons. ZIKV RNA was detected only in frozen brain tissue using RT-qPCR, but infected cells were not detected by in situ hybridization. Progressive gliosis and microgliosis in the midbrain may have contributed to aqueduct compression and subsequent hydrocephalus. The etiology of progressive disease after in utero infection is not clear and requires investigation.
C1 [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
   [Pone, Sheila Moura; Thompson, Nathalia Raposo; da Silva Pone, Marcos Vinicius] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Pediat Infect Dis, Rio De Janeiro, Brazil.
   [Avvad-Portari, Elyzabeth] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Pathol, Rio De Janeiro, Brazil.
   [Meira Vasconcelos, Zilton Farias; Zin, Andrea Araujo; Cunha, Daniela Prado; Lopes Moreira, Maria Elisabeth] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Clin Res Unit, Rio De Janeiro, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, Pittsburgh, PA USA.
RP Chimelli, L (corresponding author), State Inst Brain, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Vasconcelos, Zilton/AAD-5784-2019; da Silva Pone, Marcos
   Vinicius/N-1285-2019; Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Vasconcelos, Zilton/0000-0002-2193-2224; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Moura Pone, Sheila/0000-0002-6246-8915
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Ochieng' N, 2015, J NEUROSURG-PEDIATR, V15, P150, DOI 10.3171/2014.10.PEDS14178
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Siebert JR, 2007, POTTERS PATHOLOGY FE, P695
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
NR 16
TC 15
Z9 15
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD MAR
PY 2018
VL 77
IS 3
BP 193
EP 198
DI 10.1093/jnen/nlx116
PG 6
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA GB3IH
UT WOS:000428949800002
PM 29346650
OA Bronze
DA 2020-07-08
ER

PT J
AU Cella, E
   Giovanetti, M
   Milano, T
   Fogolari, M
   Garilli, F
   Alexiev, I
   Bazzardi, R
   Salemi, M
   Alcantara, LCJ
   Angeletti, S
   Pascarella, S
   Ciccozzi, M
AF Cella, Eleonora
   Giovanetti, Marta
   Milano, Teresa
   Fogolari, Marta
   Garilli, Francesco
   Alexiev, Ivailo
   Bazzardi, Riccardo
   Salemi, Marco
   Alcantara, Luiz Carlos Junior
   Angeletti, Silvia
   Pascarella, Stefano
   Ciccozzi, Massimo
TI Mayaro virus infection, the next epidemic wave after Zika? Evolutionary
   and structural analysis
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Mayaro virus; Proteins; Evolutionary analysis
ID B-CELL EPITOPES; CHIKUNGUNYA VIRUS; PREDICTION; SEQUENCE; EMERGENCE;
   OUTBREAK; AMERICA; DISEASE; SURFACE; BRAZIL
AB Objective: To evaluate the evolution of the pathogen Mayaro virus, causing Mayaro fever (a mosquito-borne disease) and to perform selective pressure analysis and homology modelling. Methods: Nine different datasets were built, one for each protein (from protein C to non-structural protein 4) and the last one for the complete genome. Selective pressure and homology modelling analyses were applied. Results: Two main clades (A and B) were pointed in the maximum likelihood tree. The clade A included five Brazilian sequences sampled from 1955 to 2015. The Brazilian sequence sampled in 2014 significantly clustered with the Haitian sequence sampled in 2015. The clade B included the remaining 27 sequences sampled in the Central and Southern America from 1957 to 2013. Selective pressure analysis revealed several sites under episodic diversifying selection in envelope surface glycoprotein E1, non-structural protein 1 and nonstructural protein 3 with a posterior probability P <= 0.01. Homology modelling showed different sites modified by selective pressure and some protein-protein interaction sites at high interaction propensity. Conclusion: Maximum likelihood analysis confirmed the Mayaro virus previous circulation in Haiti and the successful spread to the Caribbean and USA. Selective pressure analysis revealed a strong presence of negatively selected sites, suggesting a probable purging of deleterious polymorphisms in functional genes. Homology model showed the position 31, under selective pressure, located in the edge of the ADP-ribose binding site predicting to possess a high potential of protein-protein interaction and suggesting the possible chance for a protective vaccine, thus preventing Mayaro virus urbanization as with Chikungunya virus.
C1 [Cella, Eleonora] Sapienza Univ, Publ Hlth & Infect Dis, Rome, Italy.
   [Cella, Eleonora; Fogolari, Marta; Angeletti, Silvia; Ciccozzi, Massimo] Univ Campus Biomed Rome, Unit Clin Lab Sci, Via Alvaro del Portillo 200, I-00125 Rome, Italy.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Milano, Teresa; Pascarella, Stefano] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy.
   [Garilli, Francesco] Univ Campus Biomed Rome, Dept Med, Rome, Italy.
   [Alexiev, Ivailo] Natl Ctr Infect & Parasit Dis, Natl Reference Lab HIV, Sofia, Bulgaria.
   [Bazzardi, Riccardo] Expt Zooprophylact Inst Sardinia, Dept Food Hyg, Sassari, Italy.
   [Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
RP Cella, E; Angeletti, S; Ciccozzi, M (corresponding author), Univ Campus Biomed Rome, Unit Clin Lab Sci, Via Alvaro del Portillo 200, I-00125 Rome, Italy.
EM Eleonora.cella@yahoo.it; s.angeletti@unicampus.it; ciccozzi@iss.it
RI Cella, Eleonora/J-9961-2016; Bazzardi, Riccardo/G-3191-2019; BAZZARDI,
   RICCARDO/M-2103-2019; Giovanetti, Marta/AAK-7408-2020; Fogolari,
   Marta/X-1945-2019
OI Cella, Eleonora/0000-0002-7870-9744; Bazzardi,
   Riccardo/0000-0001-5528-6892; BAZZARDI, RICCARDO/0000-0001-5528-6892;
   Alcantara, Luiz/0000-0002-6769-9931; Alexiev, Ivailo/0000-0002-3186-1124
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Gouandijka-Vasilache I, 2014, EMERG INFECT DIS, V20, P1254, DOI 10.3201/eid2007.131839
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lavergne A, 2006, VIRUS RES, V117, P283, DOI 10.1016/j.virusres.2005.11.006
   Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381
   Liang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-302
   Lo Presti A, 2016, INFECT GENET EVOL, V41, P270, DOI 10.1016/j.meegid.2016.04.006
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   McPherson RL, 2017, P NATL ACAD SCI USA, V114, P1666, DOI 10.1073/pnas.1621485114
   MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993
   Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Potocnakova L, 2016, J IMMUNOL RES, DOI 10.1155/2016/6760830
   Powers A, 2011, VIRUS TAXONOMY, P1103
   Rack JGM, 2016, ANNU REV BIOCHEM, V85, P431, DOI 10.1146/annurev-biochem-060815-014935
   ROBINSON DM, 1976, MIL MED, V141, P163
   Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014
   Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Schroedinger LLC, 2015, PYMOL MOL GRAPH SYST
   SIEVERS F, 2014, CURR PROTOC BIOINFOR, V48, P3, DOI DOI 10.1002/0471250953.BI0313S48
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199
   Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15]
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Yao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045152
NR 57
TC 1
Z9 1
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAR
PY 2018
VL 11
IS 3
BP 194
EP 201
DI 10.4103/1995-7645.228433
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GB1VD
UT WOS:000428837700003
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Carbajo, AE
   Rubio, A
   Viani, MJ
   Colombo, MR
AF Carbajo, Anibal E.
   Rubio, Alejandra
   Viani, Maria J.
   Colombo, Maria R.
TI The largest dengue outbreak in Argentina and spatial analyses of dengue
   cases in relation to a control program in a district with sylvan and
   urban environments
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Aedes aegypti; Vector-borne diseases; Vector control; Dengue epidemic
ID LOWER DELTA; MOSQUITOS; PATTERNS; ISLANDS; FEVER; CITY; ZIKA
AB Objective: To analyze the largest outbreak of dengue in Argentina in the municipality of Tigre during 2016, through detailed spatial analyses of the occurrence of cases in relation to demographic factors and vector control actions. Methods: Detailed and georreferenced data on dengue cases with laboratory results (NS1 or IgM) were analyzed. The occurrences of imported and autochthonous cases by census tract were modeled using demographic variables (population by age class, proportion of foreigners, proportion with university grade, proportion of males), dwelling variables (number of homes, proportion of dwellings with latrine, number of dwellings, proportion of houses, proportion of flats, proportion of slums) and census tract area as explanatory variables. The probability of occurrence of autochthonous and imported cases was modeled separately. The spatio-temporal occurrence of cases was studied in relation to focal and perifocal control actions (involving education campaigns, removal of Aedes aegypti breeding sites and exhaustive insecticide spraying) to assess the efficiency in stopping autochthonous cases spreading. Results: All autochthonous cases occurred in the urban environment with no sylvan cases. The majority of the imported cases registered came from Paraguay and Northeastern Argentina. The age structure of imported and autochthonous cases did not differ from the age structure of the municipality, while that of the negative cases did. When studied spatially, the occurrence of imported cases by census tract was mildly associated with a higher proportion of foreign population and more people at active age, while occurrence of autochthonous cases was not significantly associated with any of the studied variables. For census tracts with laboratory confirmed results, the models showed higher probability of autochthonous cases related to higher population density and population age structure. The clustering of autochthonous cases was generally mild, with prevailing isolated cases and a weak spread inside the municipality. The biggest outbreak focus was associated with a delay in the focal vector control. Conclusions: Results confirmed the virus pressure coming from neighboring countries and related to population movement by workers. All autochthonous cases occurred in the urban environment with no sylvan cases. The susceptibility of residents to dengue may be similar among age classes and the laboratory tests were performed more frequently in the younger. Autochthonous cases incidence was low and spatio-temporal clustering of cases weak, suggesting that control measures were effective when no delay occurred in their application.
C1 [Carbajo, Anibal E.; Rubio, Alejandra] Univ Nacl Gen San Martin, Inst Invest & Ingn Ambiental, Lab Ecol Enfermedades Transmitidas Vectores, Buenos Aires, DF, Argentina.
   [Carbajo, Anibal E.; Rubio, Alejandra] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.
   [Viani, Maria J.; Colombo, Maria R.] Secretaria Polit Sanitaria & Desarrollo Humano, Buenos Aires, DF, Argentina.
RP Carbajo, AE (corresponding author), Univ Nacl Gen San Martin, Inst Invest & Ingn Ambiental, Lab Ecol Enfermedades Transmitidas Vectores, Buenos Aires, DF, Argentina.; Carbajo, AE (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.
EM acarbajo@unsam.edu.ar
RI Carbajo, Anibal Eduardo/AAF-3405-2020
FU Consejo Nacional de Investigacion Cientificas y Tecnicas [PIP
   112-201301-00038]; Fondo para la Investigacion Cientifica y Tecnologica
   [PICT-2014-3217]
FX This study was partially supported by Consejo Nacional de Investigacion
   Cientificas y Tecnicas (PIP 112-201301-00038) and Fondo para la
   Investigacion Cientifica y Tecnologica (PICT-2014-3217).
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carbajo AE, 2015, MEM I OSWALDO CRUZ, V110, P259, DOI 10.1590/0074-02760150005
   Carbajo AE, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-26
   Cardo MV, 2015, J ASIA-PAC ENTOMOL, V18, P727, DOI 10.1016/j.aspen.2015.09.002
   Davis CE, 1986, MODERN STAT METHODS, P140
   Duncombe J, 2012, AM J TROP MED HYG, V86, P753, DOI 10.4269/ajtmh.2012.11-0650
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   Gil JF, 2016, ACTA TROP, V158, P24, DOI 10.1016/j.actatropica.2016.02.003
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Kandus P, 2004, WETLANDS, V24, P620, DOI 10.1672/0277-5212(2004)024[0620:VPACAI]2.0.CO;2
   Kandus P, LANDSCAPE PATTERNS B
   Loetti V, 2007, J VECTOR ECOL, V32, P358, DOI 10.3376/1081-1710(2007)32[358:SADAPO]2.0.CO;2
   Lopez-Gatell H, 2015, NEGLECT TROP DIS, P203, DOI 10.1007/978-3-7091-1422-3_11
   McCullagh P., 1989, GEN LINEAR MODELS
   Ministry of Health, MIN HLTH B INT VIG
   National institute of statistics and census, POP DWELL NAT CENS
   OIM, MIGR PROF ARG
   PAHO and WHO, EP AL YELL FEV
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Pilger D., 2010, TROPIKA, V1, P1
   R Development Core Team, 2014, R LANG ENV STAT COMP
   Seidahmed O. M. E., 2012, Eastern Mediterranean Health Journal, V18, P1217
   Seijo A, 2009, MEDICINA-BUENOS AIRE, V69, P593
   Seijo A, 2009, ARCH ARGENT PEDIATR, V107, P387, DOI 10.1590/S0325-00752009000500002
   Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tantawichien T, 2012, PAEDIATR INT CHILD H, V32, P22, DOI 10.1179/2046904712Z.00000000049
   Tittarelli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111017
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   World Health Organization (WHO) and the Special Programme for Research and Training in Tropical diseases (TDR), DENG GUID DIAGN TREA
   Yung CF, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1662-4
   Zuur Alain F., 2009, P1
NR 41
TC 2
Z9 2
U1 0
U2 5
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAR
PY 2018
VL 11
IS 3
BP 227
EP 234
DI 10.4103/1995-7645.228438
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GB1VD
UT WOS:000428837700008
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Broughton, DE
   Schaeffer, S
   Halabi, J
   Caine, E
   Govero, J
   Diamond, M
   Moley, KH
AF Broughton, D. E.
   Schaeffer, S.
   Halabi, J.
   Caine, E.
   Govero, J.
   Diamond, M.
   Moley, K. H.
TI ZIKA VIRUS CAUSES ACUTE OOPHORITIS MEDIATED BY T LYMPHOCYTES IN A MOUSE
   MODEL
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the Pacific-Coast-Reproductive-Society (PCRS)
CY MAR 21-25, 2018
CL Indian Wells, CA
SP Pacific Coast Reprod Soc
C1 [Broughton, D. E.; Schaeffer, S.; Halabi, J.; Moley, K. H.] Washington Univ, Sch Med, Dept Ob Gyn, Ctr Reprod Hlth Sci, St Louis, MO USA.
   [Caine, E.; Govero, J.; Diamond, M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU  [R01 HD065435];  [R01HD083895];  [R01 AI073755];  [R01 AI104972 9]
FX R01 HD065435, R01HD083895 (Moley) R01 AI073755, R01 AI104972 9 (Diamond)
CR Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD MAR
PY 2018
VL 109
IS 3
SU S
MA O-2
BP E4
EP E5
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FZ8WS
UT WOS:000427891800003
DA 2020-07-08
ER

PT J
AU Arluck, JC
   Mayhew, AC
AF Arluck, Jessica C.
   Mayhew, Allison C.
TI Preconception Care for the General Ob/Gyn
SO CLINICAL OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE preconception counseling; reproductive life plan; family planning
ID CLINICAL CONTENT; UNITED-STATES; ZIKA VIRUS; FOLIC-ACID; PREGNANCY;
   SUPPLEMENTATION; PREVENTION; OUTCOMES; IRON
AB Preconception counseling is an important aspect of the care of reproductive-aged women. Asking each woman with each interaction her wishes regarding pregnancy allows the health care provider to investigate her history. The areas to review include environmental toxins, nutrition, genetics, substance abuse, medical conditions, infectious diseases, and psychosocial issues. Then preconception counseling can be individualized. The goal is to decrease or eliminate risks that can cause detriments to the patient or her future pregnancies.
C1 [Arluck, Jessica C.; Mayhew, Allison C.] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.
RP Arluck, JC (corresponding author), 69 Jesse Hill Dr, Atlanta, GA USA.
EM jarluck@emory.edu
CR Agrawal P, 2015, B WORLD HEALTH ORGAN, V93, P135, DOI 10.2471/BLT.14.148627
   Allen D, 2017, MATERN CHILD HLTH J, V21, P387, DOI 10.1007/s10995-017-2283-2
   American College of Obstetricians and Gynecologists, 2011, OBSTET GYNECOL, V118, P383
   Breiding M. J., 2015, INTIMATE PARTNER VIO
   Breiding MJ, 2014, MMWR SURVEILL SUMM, V63, P1
   CDC/ATSDR Preconception Care Network Group, 2006, MMWR, V55
   Cogswell ME, 2003, AM J CLIN NUTR, V78, P773
   Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214
   Coonrod DV, 2008, AM J OBSTET GYNECOL, V199, pS296, DOI 10.1016/j.ajog.2008.08.062
   Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558
   Floyd RL, 2008, AM J OBSTET GYNECOL, V199, pS333, DOI 10.1016/j.ajog.2008.09.018
   Gabbe SG, 2012, OBSTET NORMAL PROBLE, P106
   Gardiner PM, 2008, AM J OBSTET GYNECOL, V199, pS345, DOI 10.1016/j.ajog.2008.10.049
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Koren G, 2004, CMAJ, V169, P209
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   McDiarmid MA, 2008, AM J OBSTET GYNECOL, V199, pS357, DOI 10.1016/j.ajog.2008.10.044
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Moos MK, 2008, AM J OBSTET GYNECOL, V199, pS280, DOI 10.1016/j.ajog.2008.08.060
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rink B, 2017, OBSTET GYNECOL, V129, pE41
   Robbins CL, 2014, MMWR SURVEILL SUMM, V63, P1
   Rolf C, 2001, EXP CLIN ENDOCR DIAB, V109, P68, DOI 10.1055/s-2001-14825
   Siega-Riz AM, 2006, AM J OBSTET GYNECOL, V194, P512, DOI 10.1016/j.ajog.2005.08.011
   Viswanathan M, 2017, JAMA-J AM MED ASSOC, V317, P190, DOI 10.1001/jama.2016.19193
   Wald NJ, 2004, NEW ENGL J MED, V350, P101, DOI 10.1056/NEJMp038186
   Wang C, 2017, AM J OBSTET GYNECOL, V216, P340, DOI 10.1016/j.ajog.2017.01.037
   Willett WC, 2001, NEW ENGL J MED, V345, P1819, DOI 10.1056/NEJMcp010710
NR 29
TC 3
Z9 3
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-9201
EI 1532-5520
J9 CLIN OBSTET GYNECOL
JI Clin. Obstet. Gynecol.
PD MAR
PY 2018
VL 61
IS 1
BP 62
EP 71
DI 10.1097/GRF.0000000000000338
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GA6XN
UT WOS:000428478100007
PM 29319589
DA 2020-07-08
ER

PT J
AU Holtzman, M
   Golden, WC
   Sheffield, JS
AF Holtzman, Meghan
   Golden, William C.
   Sheffield, Jeanne S.
TI Zika Virus Infection in the Pregnant Woman
SO CLINICAL OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE Zika virus; pregnancy; congenital Zika syndrome
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; INFANTS; TRANSMISSION; BRAZIL;
   ASSOCIATION; EXPOSURE; BIRTH
AB Zika virus is a single-stranded RNA virus from the Flaviviridae family. Transmission is typically from the bite of an infected mosquito though mother-to-child, sexual and blood donation transmissions can occur. Although maternal symptoms are uncommon and rarely severe, the consequences of congenital infections are devastating. The emergence of congenital Zika syndrome is a world-wide public health crisis. The Centers for Disease Control and Prevention, ACOG, and SMFM have developed algorithms for screening and managing women exposure to and diagnosed with Zika virus infection. Prevention is the mainstay of infection control as there is currently no vaccine or therapy available.
C1 [Holtzman, Meghan; Sheffield, Jeanne S.] Johns Hopkins Sch Med, Dept Gynecol & Obstetrics, Phipps 203, Baltimore, MD 21287 USA.
   [Golden, William C.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA.
RP Sheffield, JS (corresponding author), Johns Hopkins Sch Med, Dept Gynecol & Obstetrics, Phipps 203, Baltimore, MD 21287 USA.
EM jsheffi2@jhmi.edu
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   [Anonymous], 2016, MMWR-MORBID MORTAL W, P65, DOI 10.15585/mmwr.mm6518e
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Centers for Disease Control and Prevention, US ZIK PREGN REG
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Franca GV, 2016, LANCET
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jimenez A, 2017, TRANSFUSION, V57, P2077, DOI 10.1111/trf.14252
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Pan American Health Organization World Health Organization, 2015, WHO EP AL NEUR SYNDR
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rabe IB, 2016, MORB MORTAL WKLY REP, V65
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shao Q, 2017, AFRICAN ZIKA VIRUS M
   Wang LL, 2017, SCI REP UK, V7
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 46
TC 4
Z9 4
U1 0
U2 18
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-9201
EI 1532-5520
J9 CLIN OBSTET GYNECOL
JI Clin. Obstet. Gynecol.
PD MAR
PY 2018
VL 61
IS 1
BP 177
EP 185
DI 10.1097/GRF.0000000000000343
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GA6XN
UT WOS:000428478100017
PM 29319591
DA 2020-07-08
ER

PT J
AU Kurani, S
   Theel, E
   Greenberg-Worisek, A
AF Kurani, Shaheen
   Theel, Elitza
   Greenberg-Worisek, Alexandra
TI Diagnostic Testing for Zika: Observing Rapid Translation During a Public
   Health Emergency
SO CTS-CLINICAL AND TRANSLATIONAL SCIENCE
LA English
DT Article
ID VIRUS
C1 [Kurani, Shaheen; Greenberg-Worisek, Alexandra] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN 55905 USA.
   [Theel, Elitza] Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN USA.
   [Greenberg-Worisek, Alexandra] Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA.
RP Greenberg-Worisek, A (corresponding author), Mayo Clin, Grad Sch Biomed Sci, Rochester, MN 55905 USA.; Greenberg-Worisek, A (corresponding author), Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA.
EM greenberg.alexandra@mayo.edu
RI Kurani, Shaheen/AAL-2614-2020
OI Kurani, Shaheen/0000-0003-2366-7505
FU National Center for Advancing Translational Sciences (NCATS)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Advancing Translational
   Sciences (NCATS) [uL1 TR000135]
FX This publication was supported by Grant Number uL1 TR000135 from the
   National Center for Advancing Translational Sciences (NCATS). Its
   contents are solely the responsibility of the authors and do not
   necessarily represent the official views of the NIH.
CR Cohen J., 2016, US OFFICIALS WELCOME
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   FDA, 2017, EM US AUTH
   Fox M., 2016, 1 COMMERCIAL ZIKA VI
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Krow-Lucal E.R., 2017, ESTIMATED INCUBATION
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   National Institutes of Health, 2016, TEST INV IN ZIK VACC
   Rosen M., 2017, DNA MAY OFFER RAPID
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
NR 10
TC 4
Z9 4
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1752-8054
EI 1752-8062
J9 CTS-CLIN TRANSL SCI
JI CTS-Clin. Transl. Sci.
PD MAR
PY 2018
VL 11
IS 2
BP 103
EP 105
DI 10.1111/cts.12529
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA GA4RH
UT WOS:000428317700003
PM 29194962
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aziz, A
   Alshehri, MA
   Panneerselvam, C
   Murugan, K
   Trivedi, S
   Mahyoub, JA
   Hassan, MM
   Maggi, F
   Sut, S
   Dall'Acqua, S
   Canale, A
   Benelli, G
AF Aziz, Al Thabiani
   Alshehri, Mohammed Ali
   Panneerselvam, Chellasamy
   Murugan, Kadarkarai
   Trivedi, Subrata
   Mahyoub, Jazem A.
   Hassan, Mo'awia Mukhtar
   Maggi, Filippo
   Sut, Stefania
   Dall'Acqua, Stefano
   Canale, Angelo
   Benelli, Giovanni
TI The desert wormwood (Artemisia herba-alba) - From Arabian folk medicine
   to a source of green and effective nanoinsecticides against mosquito
   vectors
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Artemisia herba-alba; LC-DAD-MS; H-1 NMR; Antibacterial activity;
   Dengue; Green synthesis; Larvicide; Malaria; Pesticide; Zika virus
ID SYNTHESIZED SILVER NANOPARTICLES; ECO-FRIENDLY TOOL; AEDES-AEGYPTI;
   CULEX-QUINQUEFASCIATUS; ZIKA VIRUS; GOLD NANOPARTICLES; ANTIBACTERIAL
   ACTIVITY; ANOPHELES-STEPHENSI; ESSENTIAL OILS; LEAF EXTRACT
AB The development of eco-friendly and effective insecticides is crucial for public health worldwide. Herein, we focused on the desert wormwood (Artemisia herba-alba), a plant widely used in Arabian traditional medicine, as a source of green nanoinsecticides against mosquito vectors, as well as growth inhibitors to be employed against microbial pathogens. Ag nanoparticles (AgNPs) fabricated with the A. herba-albs extract were tested on Indian and Saudi Arabian strains of Anopheles, Aedes and Culex mosquitoes. The chemical profile of the A. herba-alba extract was determined by LC-DAD-MS and H-1 NMR studies. Then, AgNPs were studied using UV-vis spectroscopy, XRD, FTIR spectroscopy, TEM, and EDX analyses. Artemisia herba-alba-synthesized AgNPs showed high larvicidal toxicity against mosquitoes from both Indian and Saudi Arabian strains. LC50 of AgNPs against Indian strains was 9.76 mu g/ml for An. stephensi, 10.70 mu g/ml for Ae. aegypti and 11.43 mu g/ml for Cx. quinquefasciatus, whereas against Saudi Arabian strains it was 33.58 mu g/ml for Ae. aegypti and 38.06 mu g/ml for Cx. pipiens. In adulticidal experiments, A. herba-alba extract showed LC50 ranging from 293.02 to 450 mu g/ml, while AgNP LC50 ranged from 8.22 to 27.39 mu g/ml. Further, low doses of the AgNPs inhibited the growth of selected microbial pathogens. Overall, A. herba-alba can be further considered as a source of phytochemicals, with special reference to saponins, for effective and prompt fabrication of AgNPs with relevant insecticidal and bactericidal activity against species of high public health importance.
C1 [Aziz, Al Thabiani; Alshehri, Mohammed Ali; Panneerselvam, Chellasamy; Trivedi, Subrata; Hassan, Mo'awia Mukhtar] Univ Tabuk, Fac Sci, Biol Dept, Tabuk, Saudi Arabia.
   [Murugan, Kadarkarai] Bharathiar Univ, Sch Life Sci, Div Entomol, Dept Zool, Coimbatore 641046, Tamil Nadu, India.
   [Murugan, Kadarkarai] Thiruvalluvar Univ, Vellore 632115, Tamil Nadu, India.
   [Mahyoub, Jazem A.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia.
   [Mahyoub, Jazem A.] IBB Univ, Ibb, Yemen.
   [Maggi, Filippo] Univ Camerino, Sch Pharm, Camerino, Italy.
   [Sut, Stefania] Univ Padua, Dipartimento Agron Anim Alimenti Risorse Nat & Am, Via Univ 16, I-35020 Legnaro, PD, Italy.
   [Dall'Acqua, Stefano] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via Marzolo 5, Padua, Italy.
   [Canale, Angelo; Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] Scuola Super Sant Anna, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Panneerselvam, C (corresponding author), Univ Tabuk, Fac Sci, Biol Dept, Tabuk, Saudi Arabia.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Benelli, G (corresponding author), Scuola Super Sant Anna, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
EM cpselva@ymail.com; benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013; Murugan, Kadarkarai/AAP-3937-2020
OI Benelli, Giovanni/0000-0001-8971-6010; Panneerselvam,
   Chellasamy/0000-0003-3994-8141
FU Deanship of Scientific Research (DSR), University of Tabuk, Tabuk,
   Kingdom of Saudi Arabia [S-0068-1437]
FX The authors are grateful to the Deanship of Scientific Research (DSR),
   University of Tabuk, Tabuk, Kingdom of Saudi Arabia, Project No.
   S-0068-1437, for providing financial support.
CR Abinaya M, 2018, J TRACE ELEM MED BIO, V45, P93, DOI 10.1016/j.jtemb.2017.10.002
   AlQahtani FS, 2017, J ASIA-PAC ENTOMOL, V20, P157, DOI 10.1016/j.aspen.2016.12.004
   Amel D., 2007, INT J BIOSCI, V10
   Amerasan D, 2016, J PEST SCI, V89, P249, DOI 10.1007/s10340-015-0675-x
   Arancon NQ, 2007, CROP PROT, V26, P29, DOI 10.1016/j.cropro.2006.03.013
   ARNAULT C, 1985, EXPERIENTIA, V41, P1074, DOI 10.1007/BF01952151
   Athanassiou CG, 2018, J PEST SCI, V91, P1, DOI 10.1007/s10340-017-0898-0
   Aziz AT, 2016, ASIAN PAC J TROP BIO, V6, P390, DOI 10.1016/j.apjtb.2015.12.017
   Baghbani-Arani F, 2017, J PHOTOCH PHOTOBIO B, V173, P640, DOI 10.1016/j.jphotobiol.2017.07.003
   BAILEY C, 1981, ECON BOT, V35, P145, DOI 10.1007/BF02858682
   Barbouche N., 2001, Biotechnologie, Agronomie, Societe et Environnement, V5, P85
   Belhattab R, 2014, ARAB J CHEM, V7, P243, DOI 10.1016/j.arabjc.2012.04.042
   Benelli G., 2018, NAT PROD RES
   Benelli G, 2018, ENV SCI POLLUT RES
   Benelli G, 2018, IND CROP PROD, V112, P668, DOI 10.1016/j.indcrop.2017.12.062
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, J KING SAUD UNIV SCI, V29, P424, DOI 10.1016/j.jksus.2016.08.006
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Borase HP, 2017, BIOPROC BIOSYST ENG, V40, P1437, DOI 10.1007/s00449-017-1801-3
   Bourgou S, 2017, FOOD RES INT, V99, P702, DOI 10.1016/j.foodres.2017.06.009
   Chaieb I., 2007, J BIOL SCI, V7
   CHAIEB I., 2010, TUNISIAN J PLANT PRO, V5, P39
   Chandramohan B., 2016, PARASITOLOGY RES MON, P8
   Chapagain B. P., 2011, BIORESOURCE TECHNOL, V99, P1165
   Cheah SX, 2013, PARASITOL RES, V112, P3275, DOI 10.1007/s00436-013-3506-0
   Clifford MN, 2008, FOOD CHEM, V106, P379, DOI 10.1016/j.foodchem.2007.05.081
   Clifford MN, 2006, PHYTOCHEM ANALYSIS, V17, P384, DOI 10.1002/pca.935
   Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q
   Dakal TC, 2016, FRONT MICROBIOL, V7, DOI 10.7389/fmicb.2016.01831
   Derwich E., 2009, Electronic Journal of Environmental, Agricultural and Food Chemistry, V8, P1202
   Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Divya M, 2018, J PHOTOCH PHOTOBIO B, V178, P211, DOI 10.1016/j.jphotobiol.2017.11.008
   Dobrucka R., 2016, IRAN J SCI TECHNOL A
   Elumalai D., 2015, ENG AGR ENV FOOD, V1
   Elumalai Devan, 2017, Parasite Epidemiol Control, V2, P15, DOI 10.1016/j.parepi.2017.09.001
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Ikbal C, 2006, Commun Agric Appl Biol Sci, V71, P489
   Ishwarya R, 2018, J PHOTOCH PHOTOBIO B, V178, P249, DOI 10.1016/j.jphotobiol.2017.11.006
   Jeeva K, 2014, IND CROP PROD, V52, P714, DOI 10.1016/j.indcrop.2013.11.037
   Jinu U., 2018, J PHOTOCH PHOTOBIO B, V178, P496
   Kalimuthu K, 2017, PROCESS SAF ENVIRON, V109, P82, DOI 10.1016/j.psep.2017.03.027
   Kamal M., 2007, INT J PHARM, V3
   Khaled JM, 2017, J CLUST SCI, V28, P3009, DOI 10.1007/s10876-017-1271-4
   Khalili H, 2017, J CLUST SCI, V28, P1617, DOI 10.1007/s10876-017-1172-6
   Khater H. F., 2012, Pharmacologia, V3, P641
   Khater H. F., 2017, NATURAL REMEDIES FIG, P3
   Kovendan K, 2016, J ASIA-PAC ENTOMOL, V19, P1001, DOI 10.1016/j.aspen.2016.09.001
   Kovendan K, 2012, PARASITOL RES, V110, P195, DOI 10.1007/s00436-011-2469-2
   Kumar P, 2012, NANO BIOMED ENG, p[4, 12], DOI DOI 10.5101/NBE.V4I1.P12-16
   Laid M, 2008, PHYTOCHEM LETT, V1, P85, DOI 10.1016/j.phytol.2008.04.002
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Madhiyazhagan P, 2017, J APPL PHYCOL, V29, P649, DOI 10.1007/s10811-016-0953-x
   Mahyoub JA, 2017, J CLUST SCI, V28, P565, DOI 10.1007/s10876-016-1127-3
   Malaikozhundan B, 2016, BIOCATAL AGR BIOTECH, V8, P189, DOI 10.1016/j.bcab.2016.09.007
   MARCO JA, 1994, J NAT PROD, V57, P939, DOI 10.1021/np50109a010
   Mohamed AEHH, 2010, REC NAT PROD, V4, P1
   Mukherjee P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075103
   Murugan K, 2017, HYDROBIOLOGIA, V797, P335, DOI 10.1007/s10750-017-3196-1
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Murugan K, 2015, PARASITOL RES, V114, P4087, DOI 10.1007/s00436-015-4638-1
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Nalini M., 2017, EGYPT J BASIC APPL S, V4
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nicoletti M, 2012, PARASITOL RES, V111, P205, DOI 10.1007/s00436-012-2819-8
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Panneerselvam C, 2013, PARASITOL RES, V112, P679, DOI 10.1007/s00436-012-3185-2
   Panneerselvam C, 2012, PARASITOL RES, V111, P2241, DOI 10.1007/s00436-012-3073-9
   Patil S., 2014, AM J ETHNOMED, V1, P174
   Pavela R, 2017, IND CROP PROD, V109, P603, DOI 10.1016/j.indcrop.2017.09.013
   Pavela R, 2017, IND CROP PROD, V97, P338, DOI 10.1016/j.indcrop.2016.12.046
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Rajaganesh R, 2016, RES VET SCI, V109, P40, DOI 10.1016/j.rvsc.2016.09.012
   Rasheed T, 2017, COLLOID SURFACE B, V158, P408, DOI 10.1016/j.colsurfb.2017.07.020
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Salah SM, 2005, J ETHNOPHARMACOL, V99, P145, DOI 10.1016/j.jep.2005.01.031
   SALEH NAM, 1987, PHYTOCHEMISTRY, V26, P3059, DOI 10.1016/S0031-9422(00)84593-8
   Saratale RG, 2018, ARTIF CELL NANOMED B, V46, P211, DOI 10.1080/21691401.2017.1337031
   Seddiek SA, 2011, J MED PLANTS RES, V5, P3946
   Sharifian Iman, 2012, Biharean Biologist, V6, P90
   Sharma G, 2014, PARASITOL RES, V113, P197, DOI 10.1007/s00436-013-3644-4
   Singh M, 2008, DIG J NANOMATER BIOS, V3, P115
   Sinha S., 2009, J APPL BIOSCI, V19, P1113
   Srinivasan K, 2017, B MATER SCI, V40, P1455, DOI 10.1007/s12034-017-1486-x
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Suganya P, 2017, J PHOTOCH PHOTOBIO B, V173, P404, DOI 10.1016/j.jphotobiol.2017.06.004
   Sujitha V, 2017, AQUAT TOXICOL, V188, P100, DOI 10.1016/j.aquatox.2017.04.015
   Sundararajan B, 2017, J TRACE ELEM MED BIO, V43, P187, DOI 10.1016/j.jtemb.2017.03.008
   Suresh U., 2017, PHYSL MOL PLANT PATH
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Thaya R, 2018, MICROB PATHOGENESIS, V114, P17, DOI 10.1016/j.micpath.2017.11.011
   TODD GW, 1971, ANN ENTOMOL SOC AM, V64, P718, DOI 10.1093/aesa/64.3.718
   Vadivalagan C, 2017, ACTA TROP, V169, P43, DOI 10.1016/j.actatropica.2017.01.020
   Vernin G, 1995, DEV FOOD SCI, V37, P147
   Vijayakumar M, 2013, IND CROP PROD, V41, P235, DOI 10.1016/j.indcrop.2012.04.017
   Wiesman Z, 2006, FITOTERAPIA, V77, P420, DOI 10.1016/j.fitote.2006.05.012
   World Health Organization, 1981, WHOVBC81807
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   YASHPHE J, 1979, J PHARM SCI, V68, P924, DOI 10.1002/jps.2600680742
   Younsi F, 2017, CHEM BIODIVERS, V14, DOI 10.1002/cbdv.201700017
   Zyoud SH, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0534-2
NR 118
TC 10
Z9 10
U1 1
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD MAR
PY 2018
VL 180
BP 225
EP 234
DI 10.1016/j.jphotobiol.2018.02.012
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA GA7BY
UT WOS:000428490800026
PM 29459314
DA 2020-07-08
ER

PT J
AU Wong, G
   Gao, GF
AF Wong, Gary
   Gao, George F.
TI Did ZIKV evolve to be more dangerous? A new clue towards neurovirulence
SO NATIONAL SCIENCE REVIEW
LA English
DT Editorial Material
C1 [Wong, Gary; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Guangdong Key Lab Diag & Treatment Emerging Infec, Shenzhen, Peoples R China.
   [Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
RP Gao, GF (corresponding author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Guangdong Key Lab Diag & Treatment Emerging Infec, Shenzhen, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
EM gaof@im.ac.cn
CR Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 6
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2095-5138
EI 2053-714X
J9 NATL SCI REV
JI Natl. Sci. Rev.
PD MAR
PY 2018
VL 5
IS 2
BP 120
EP +
DI 10.1093/nsr/nwy027
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA9CB
UT WOS:000428637600002
OA Other Gold
DA 2020-07-08
ER

PT J
AU Pattnaik, A
   Palermo, N
   Sahoo, BR
   Yuan, Z
   Hu, DY
   Annamalai, AS
   Vu, HLX
   Correas, I
   Prathipati, PK
   Destache, CJ
   Li, QS
   Osorio, FA
   Pattnaik, AK
   Xiang, SH
AF Pattnaik, Aryamav
   Palermo, Nicholas
   Sahoo, Bikash R.
   Yuan, Zhe
   Hu, Duoyi
   Annamalai, Arun S.
   Vu, Hiep L. X.
   Correas, Ignacio
   Prathipati, Pavan Kumar
   Destache, Christopher J.
   Li, Qingsheng
   Osorio, Fernando A.
   Pattnaik, Asit K.
   Xiang, Shi-hua
TI Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika
   virus replication through in silico screening
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE In silico screening; Zika virus (ZIKV); RNA-dependent-RNA polymerase
   (RdRp); Non-nucleoside inhibitor (NNI); TPB
ID PUBLIC-HEALTH EMERGENCY; GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS;
   CRYSTAL-STRUCTURE; DRUG DISCOVERY; NS5 PROTEIN; MOUSE MODEL; INFECTION;
   THERAPEUTICS; PATHOGENESIS
AB Zika virus (ZIKV), an emerging arbovirus, has become a major human health concern globally due to its association with congenital abnormalities and neurological diseases. Licensed vaccines or antivirals against ZIKV are currently unavailable. Here, by employing a structure-based approach targeting the ZIKV RNA-dependent RNA polymerase (RdRp), we conducted in silico screening of a library of 100,000 small molecules and tested the top ten lead compounds for their ability to inhibit the virus replication in cell-based in vitro assays. One compound, 3-chloro-N-[({4-[4-(2-thienylcarbonyl)-1-piperazinyliphenyl)amino)carbonothioyl]-1-benzothiophene-2-carboxamide (TPB), potently inhibited ZIKV replication at sub-micromolar concentrations. Molecular docking analysis suggests that TPB binds to the catalytic active site of the RdRp and therefore likely blocks the viral RNA synthesis by an allosteric effect. The IC50 and the CC50 of TPB in Vero cells were 94 nM and 19.4 pM, respectively, yielding a high selective index of 206. In in vivo studies using immunocompetent mice, TPB reduced ZIKV viremia significantly, indicating TPB as a potential drug candidate for ZIKV infections.
C1 [Pattnaik, Aryamav; Sahoo, Bikash R.; Hu, Duoyi; Annamalai, Arun S.; Correas, Ignacio; Osorio, Fernando A.; Pattnaik, Asit K.; Xiang, Shi-hua] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA.
   [Palermo, Nicholas] Univ Nebraska, Holland Comp Ctr, Lincoln, NE 68583 USA.
   [Yuan, Zhe; Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.
   [Vu, Hiep L. X.] Univ Nebraska, Dept Anim Sci, Lincoln, NE 68583 USA.
   [Prathipati, Pavan Kumar; Destache, Christopher J.] Creighton Univ, Sch Pharm & Hlth Profess, Omaha, NE 68178 USA.
   [Vu, Hiep L. X.; Destache, Christopher J.; Li, Qingsheng; Osorio, Fernando A.; Pattnaik, Asit K.; Xiang, Shi-hua] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA.
RP Pattnaik, AK; Xiang, SH (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Sch Vet Med & Biomed Sci, Morrison Ctr 337,4240 Fair St, Lincoln, NE 68583 USA.
EM apattnaik2@unl.edu; sxiang2@unl.edu
RI Pattnaik, Asit K./X-1531-2019; Annamalai, Arun
   Saravanakumar/AAB-7352-2020; Prathipati, Pavan Kumar/I-2530-2019;
   Destache, Christopher/A-7537-2009; Yuan, Zhe/H-1169-2018; Vu,
   Hiep/AAA-1655-2019; Correas, Ignacio/I-6884-2018
OI Pattnaik, Asit K./0000-0002-9581-6787; Annamalai, Arun
   Saravanakumar/0000-0002-4892-4291; Prathipati, Pavan
   Kumar/0000-0002-2463-3350; Destache, Christopher/0000-0001-7923-3939;
   Yuan, Zhe/0000-0002-8674-9287; Vu, Hiep/0000-0001-8084-4358; Correas,
   Ignacio/0000-0001-8504-9804; Pattnaik, Aryamav/0000-0002-8325-2216
FU University of Nebraska-Lincoln; Nebraska Research Initiative
FX This work was supported by funds provided to A.K.P. from the University
   of Nebraska-Lincoln. The virtual screens of the compound library were
   completed utilizing the Holland Computing Center of the University of
   Nebraska, which receives support from the Nebraska Research Initiative.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Avelino-Silva VI, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30843-1
   Baronti C, 2014, GENOME ANNOUNC, V2
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Che PL, 2009, INT J CLIN EXP MED, V2, P363
   Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137
   Omura S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1825-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Roos RP, 2016, JAMA NEUROL, V73, P1395, DOI 10.1001/jamaneurol.2016.3677
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Salam AP, 2017, ANN INTERN MED, V166, P725, DOI [10.7326/M16-2530, 10.7326/m16-2530]
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yu J., 2017, VIRUSES, V9, pe165
   Yuan Z, 2016, J VIROL, V90, P7728, DOI 10.1128/JVI.00860-16
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 55
TC 12
Z9 13
U1 3
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2018
VL 151
BP 78
EP 86
DI 10.1016/j.antiviral.2017.12.016
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GA7BK
UT WOS:000428489400012
PM 29274845
DA 2020-07-08
ER

PT J
AU Chan, SY
   Wang, LF
   Ng, L
   Mani, S
   Kam, YW
   Selvam, P
   Chew, KL
   Yan, B
   Tambyah, PA
   Yong, EL
AF Chan, S-Y
   Wang, L. F.
   Ng, L.
   Mani, S.
   Kam, Y-W
   Selvam, P.
   Chew, K. L.
   Yan, B.
   Tambyah, P. A.
   Yong, E. L.
TI Challenges in serological screening for recent Zika infections in
   pregnancy: Results of a hospital-based cohort in dengue-endemic
   Singapore
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Meeting Abstract
C1 [Chan, S-Y; Selvam, P.; Yong, E. L.] Natl Univ Singapore, Obstet & Gynaecol, Singapore, Singapore.
   [Wang, L. F.; Mani, S.] Duke NUS Med Sch, Emerging Infect Dis Programme, Singapore, Singapore.
   [Ng, L.; Kam, Y-W] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.
   [Chew, K. L.; Yan, B.] Natl Univ Singapore Hosp, Lab Med, Singapore, Singapore.
   [Tambyah, P. A.] Natl Univ Singapore Hosp, Med, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD MAR
PY 2018
VL 125
SU 1
SI SI
MA IEP6753
BP 113
EP 113
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GA0OG
UT WOS:000428013200239
DA 2020-07-08
ER

PT J
AU O'Rourke, K
   Murphy, T
   Srinivas, SK
   Pegues, DA
AF O'Rourke, Kathleen
   Murphy, Teresa
   Srinivas, Sindhu K.
   Pegues, David A.
TI Preparing for Emerging Infectious Diseases in the Perinatal Population
SO JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING
LA English
DT Article
DE Ebola virus disease (EVD); emerging infections; global viral threat;
   isolation; rapid QI cycle
ID VIRUS-DISEASE; PREGNANCY; EBOLA; METAANALYSIS; OUTCOMES
AB The unprecedented scale of the 2014-2015 Ebola virus outbreak in West Africa and the recent emergence and rapid spread of Zika virus infection and resultant neonatal sequelae show that the geographic range, spread, and effect of emerging infections are unpredictable. Lessons learned from analyzing the response of an academic medical center to care for pregnant women with suspected or confirmed Ebola virus disease can help health care professionals address future threats from emerging infections.
C1 [O'Rourke, Kathleen] Hosp Univ Penn, Labor & Delivery Perinatal Evaluat Ctr, Ravdin 7,3400 Spruce St, Philadelphia, PA 19104 USA.
   [Murphy, Teresa] Hosp Univ Penn, Nursing Resources & Operat, Ravdin 7,3400 Spruce St, Philadelphia, PA 19104 USA.
   [Srinivas, Sindhu K.] Hosp Univ Penn, Obstet Serv, Ravdin 7,3400 Spruce St, Philadelphia, PA 19104 USA.
   [Srinivas, Sindhu K.] Hosp Univ Penn, Dept Obstet & Gynecol, Qual & Safety, Ravdin 7,3400 Spruce St, Philadelphia, PA 19104 USA.
   [Pegues, David A.] Hosp Univ Penn, Healthcare Epidemiol Infect Prevent & Control, Qual & Safety, Ravdin 7,3400 Spruce St, Philadelphia, PA 19104 USA.
RP O'Rourke, K (corresponding author), Hosp Univ Penn, Ravdin 7,3400 Spruce St, Philadelphia, PA 19104 USA.
EM kathleen.orourke@uphs.upenn.edu
RI amsalu, ribka/G-8780-2019
CR Baud D, 2011, CLIN MICROBIOL INFEC, V17, P1312, DOI 10.1111/j.1469-0691.2011.03604.x
   Black BO, 2015, OBSTET MED, V8, P108, DOI 10.1177/1753495X15597354
   Brainard J, 2016, INT J EPIDEMIOL, V45, P102, DOI 10.1093/ije/dyv307
   Caluwaerts S, 2016, CLIN INFECT DIS, V62, P903, DOI 10.1093/cid/civ1024
   Centers for Disease Control and Prevention, 2017, EB OUTBR CHRON
   Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Mertz D, 2017, VACCINE, V35, P521, DOI 10.1016/j.vaccine.2016.12.012
   Muehlenbachs A, 2017, J INFECT DIS, V215, P64, DOI 10.1093/infdis/jiw206
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   World Health Organization, 2017, EB OUTBR 2014 2015
NR 13
TC 1
Z9 1
U1 4
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0884-2175
EI 1552-6909
J9 JOGNN-J OBST GYN NEO
JI JOGNN
PD MAR
PY 2018
VL 47
IS 2
BP 245
EP 253
DI 10.1016/j.jogn.2017.06.005
PG 9
WC Nursing; Obstetrics & Gynecology
SC Nursing; Obstetrics & Gynecology
GA FZ3XW
UT WOS:000427525700017
PM 28736265
DA 2020-07-08
ER

PT J
AU Delet, J
   Cabie, A
   Merle, S
   Volumenie, JL
   Monthieux, A
AF Delet, J.
   Cabie, A.
   Merle, S.
   Volumenie, J. -L.
   Monthieux, A.
TI Knowledge, attitudes and practices of pregnant women in Martinique in
   the immediate aftermath of the Zika virus outbreak
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Article
DE Zika virus; Pregnancy; Health education; Information; Martinique
ID ULTRASOUND; HEALTH
AB Introduction: The WHO and the HCSP recognize the Zika virus as a public health problem of international concern primarily because of the foetal risks. During the epidemic in Martinique, several modifications to the normal obstetrical follow-up were set up and information had to be delivered to pregnant women about these modifications, the attitudes to prevent infection and the signs motivating additional visits. The objective of our work was to evaluate the knowledge, attitudes and practices of pregnant women in Martinique about the risks associated with Zika infection during pregnancy in the immediate aftermath of the epidemic.
   Materials and methods: A descriptive cross-sectional survey was conducted from February to May 2017. It took place through an anonymous and standardized face-to-face questionnaire. The questions dealt with the pregnant women general knowledge about the virus, information disseminated by media on this subject, the potential risks, the protective measures taken and the monitoring throughout the pregnancy in case of infection.
   Results: The total sample consisted of 297 pregnant women. Despite a weak adherence to individual and domestic protection recommendations, we found a good level of knowledge about Zika virus from pregnant women in Martinique. The fetal risk in case of maternal infection was known for 96.6% of those surveyed, individual protective measures were followed by 64.6% of women, 77.0% knew where to go in case of suspected infection, and 79.4% reported that the modifications in follow-up mainly concerned ultrasound monitoring.
   Conclusion: The awareness campaign on zika virus had a significant impact on population's knowledge and main practical information was correctly captured. The information did not spill excessive fear. Nevertheless, modification of individual behavior appeared harder to obtain. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Delet, J.; Cabie, A.] CHU Martinique, Ctr Invest Clin 1424, Martinique, France.
   [Cabie, A.] CHU Martinique, Serv Malad Infect, Martinique, France.
   [Merle, S.] CHU Martinique, Delegat Rech Clin & Innovat, Martinique, France.
   [Delet, J.; Volumenie, J. -L.; Monthieux, A.] CHU Martinique, Serv Gynecol Obstet, Martinique, France.
RP Monthieux, A (corresponding author), CHU Ft France, Maison Mere Femme & Enfant, Rue Coup Main, Martinique, France.
EM alice.monthieux@chu-martinique.fr
OI Cabie, Andre/0000-0003-0117-3061
CR [Anonymous], 2012, NET INT COMM SOURC I, V3
   Bakshy Eytan, 2012, ROLE SOCIAL NETWORKS
   CFEF, 2016, AID EX ECH CAS RISQ
   Cire Antilles Guyane, 2016, SURV VIR ZIK ANT GUY
   Conseil National Professionnel de Gynecologie et Obstetrique, 2016, VIR ZIKA FEMM ENC AG
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Gustave J, 2016, B VEILLE SANITAI DEC, P36
   HCSP, 2016, INF VIR ZIK INSCR LI
   HCSP, PRIS CHARG MED PERS
   HCSP, 2015, COLL AV RAPP
   Inpes, 2011, COMM PRESS CONTR FRA
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Nhan TX, 2015, VIROLOGIE, V19, P225, DOI 10.1684/vir.2015.0622
   OMS, 2016, PRIS CHARG GROSS CON
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Viossat P, 2014, GYNECOL OBSTET FERTI, V42, P51, DOI 10.1016/j.gyobfe.2013.11.004
NR 18
TC 1
Z9 2
U1 2
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-2115
EI 1872-7654
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD MAR
PY 2018
VL 222
BP 70
EP 74
DI 10.1016/j.ejogrb.2018.01.010
PG 5
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FY9UZ
UT WOS:000427213700012
PM 29353134
DA 2020-07-08
ER

PT J
AU Howells, M
AF Howells, Michaela
TI Zika: From the Brazilian Backlands to Global Threat
SO AMERICAN JOURNAL OF HUMAN BIOLOGY
LA English
DT Book Review
C1 [Howells, Michaela] Univ N Carolina, Dept Anthropol, Wilmington, NC 28403 USA.
RP Howells, M (corresponding author), Univ N Carolina, Dept Anthropol, Wilmington, NC 28403 USA.
CR DINIZ D, ZIKA BRAZILIAN BACKL
NR 1
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-0533
EI 1520-6300
J9 AM J HUM BIOL
JI Am. J. Hum. Biol.
PD MAR-APR
PY 2018
VL 30
IS 2
AR e23081
DI 10.1002/ajhb.23081
PG 2
WC Anthropology; Biology
SC Anthropology; Life Sciences & Biomedicine - Other Topics
GA FZ0CB
UT WOS:000427233300009
DA 2020-07-08
ER

PT J
AU Asad, H
   Carpenter, DO
AF Asad, Hina
   Carpenter, David O.
TI Effects of climate change on the spread of zika virus: a public health
   threat
SO REVIEWS ON ENVIRONMENTAL HEALTH
LA English
DT Review
DE Aedes aegypti; climate change; dengue; El Nino; global warming;
   microcephaly; natural disasters; urbanization; vector-borne diseases
ID VECTOR-BORNE DISEASES; INFECTIOUS-DISEASES; EL-NINO; EPIDEMIOLOGY;
   TRANSMISSION; RISK; DISCOVERY; MOSQUITOS; DENGUE; TRAVEL
AB Zika is a vector-borne viral disease transmitted to humans primarily by Aedes aegypti mosquitoes. The increased climate instability has contributed to the emergence of infections carried by mosquitoes like dengue, chikungunya and zika. While infection with the zika virus is not new, the recent epidemic of microcephaly in Brazil and other countries in South America resulting from the infection of pregnant women with the zika virus raise a number of serious public health concerns. These include the question of how climate change affects the range of zika vectors, what can we do to shorten the length of mosquito season, how and why the symptoms of zika infection have changed and what can be done to reduce the burden of human disease from this infection? Another important question that needs to be answered is what are the factors that caused the zika virus to leave the non-human primates and/or other mammals and invade the human population?
C1 [Asad, Hina; Carpenter, David O.] SUNY Albany, Inst Hlth & Environm, Rensselaer, NY 12144 USA.
RP Carpenter, DO (corresponding author), SUNY Albany, Inst Hlth & Environm, Rensselaer, NY 12144 USA.
EM dcarpenter@albany.edu
RI amsalu, ribka/G-8780-2019
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   [Anonymous], CBC NEWS WORLD
   [Anonymous], INDEPENDENT NEWS
   [Anonymous], DAWN NEWS
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Balbus JM, 2013, ENVIRON TOXICOL CHEM, V32, P62, DOI 10.1002/etc.2046
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Cable J, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0088
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for disease control and prevention, CDC ZIK VIR CLIN EV
   Centers for disease control and prevention, CDC ZIK VIR ZIK TRAV
   Centers for disease control and prevention, CDC ZIK VIR TRANSM Z
   Chang AY, 2014, HEALTH HUM RIGHTS, V16, P93
   Climate Central, CLIM CENTR INF MOR M
   Diem JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177937
   Doss CGP, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0234-6
   Eisenberg JNS, 2006, P NATL ACAD SCI USA, V103, P19460, DOI 10.1073/pnas.0609431104
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ho LL, 2017, HEALTH SECUR, V15, P185, DOI 10.1089/hs.2016.0106
   Hribar LJ, 2010, J VECTOR ECOL, V35, P339, DOI 10.1111/j.1948-7134.2010.00092.x
   Igbinosa Irogue I, 2017, Am Fam Physician, V95, P507
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jia PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2071-2
   Khawar W, 2017, CUREUS, V9, DOI 10.7759/cureus.1099
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Klein RS, 2017, CELL HOST MICROBE, V22, P9, DOI 10.1016/j.chom.2017.06.015
   Lafferty KD, 2016, F1000RES, V5, pF1000
   Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068512
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006245, 10.1590/s1518-8787.2016050006245]
   Liu H, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.109
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Matysiak A, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8947067
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Mier-y-Teran-Romero L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005683
   Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389
   Ozkurt Z, 2017, EURASIAN J MED, V49, P142, DOI 10.5152/eurasianjmed.2017.17147
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   Vonesch N, 2016, ANN I SUPER SANITA, V52, P397, DOI 10.4415/ANN_16_03_11
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wu XX, 2016, ENVIRON INT, V86, P14, DOI 10.1016/j.envint.2015.09.007
   Yang Y Tony, 2016, Prev Med Rep, V4, P444, DOI 10.1016/j.pmedr.2016.07.011
   Zhou HD, 2016, VIROL SIN, V31, P357, DOI 10.1007/s12250-016-3821-6
NR 62
TC 5
Z9 5
U1 3
U2 82
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0048-7554
EI 2191-0308
J9 REV ENVIRON HEALTH
JI Rev. Environ. Health
PD MAR
PY 2018
VL 33
IS 1
BP 31
EP 42
DI 10.1515/reveh-2017-0042
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FY1IM
UT WOS:000426565400003
PM 29500926
DA 2020-07-08
ER

PT J
AU Pinato, L
   Ribeiro, EM
   Leite, RFP
   Lopes, TF
   Pessoa, ALS
   Campos, LMG
   Piffer, GE
   Souza, ALDM
   Giacheti, CM
AF Pinato, Luciana
   Ribeiro, Erlane M.
   Leite, Rebeka F. P.
   Lopes, Thayse F.
   Pessoa, Andre L. S.
   Guissoni Campos, Leila M.
   Piffer, Giovanna E.
   Souza, Ana L. D. M.
   Giacheti, Celia M.
TI Sleep findings in Brazilian children with congenital Zika syndrome
SO SLEEP
LA English
DT Article
DE neurodevelopment; Zika virus; microcephaly; sleep habits
ID VIRUS-INFECTION; YOUNG-CHILDREN; INFANTS; DISORDERS; MELATONIN;
   SPECTRUM; BEHAVIOR; INTERVENTIONS; ARCHITECTURE; DISTURBANCE
AB Study Objectives: Zika virus infection during pregnancy may result in congenital Zika syndrome (CZS), whose characteristics are being described.
   Methods: The aim of the present study was to investigate the sleep characteristics of 136 infants and toddlers (88 with CZS and 48 with typical development [TD], age and gender matched, 60% girls and 40% boys in both groups) using the Brief Infant Sleep Questionnaire. The ages of children in both groups ranged from 5 to 24 months (CZS 15.9 +/- 0.4 vs. TD 15.8 +/- 1.0 months, p = 0.90).
   Results: The results show that 34.1% of CZS and 2% of TD children were defined as poor sleepers, 15% of CZS and 2% of TD children remained awake at night for a period longer than 1 hr, and 24% of CZS and 2% of TD children slept less than 9 hr. The CZS group showed shorter total sleep time (CZS 11.24 +/- 2.6 vs. TD 12.02 +/- 1.9 hr, p = 0.03) and shorter nocturnal sleep duration than the TD group (CZS 8.2 +/- 0.2 vs. TD 9.4 +/- 0.2 hr, p = 0.0002). In contrast to the control group (p = 0.02, r = -0.34), in the CZS group, no correlation was found between age and nocturnal wakefulness. Future studies should explore these data in relation to the development and maturation of the central nervous system of these children.
   Conclusions: Considering the well-known consequences of poor sleep quality on health in several populations, the presence of sleep disorders should be considered in CZS using multidisciplinary treatments.
C1 [Pinato, Luciana; Souza, Ana L. D. M.; Giacheti, Celia M.] Sao Paulo State Univ UNESP, Marilia, SP, Brazil.
   [Ribeiro, Erlane M.; Leite, Rebeka F. P.; Lopes, Thayse F.; Pessoa, Andre L. S.] Albert Sabin Childrens Hosp, Fortaleza, Ceara, Brazil.
   [Ribeiro, Erlane M.] Christus Univ Ctr, Fortaleza, Ceara, Brazil.
   [Guissoni Campos, Leila M.; Piffer, Giovanna E.] Univ Marilia UNIMAR, Marilia, SP, Brazil.
   [Pessoa, Andre L. S.] State Univ Ceara UECE, Fortaleza, Ceara, Brazil.
   CAVIVER, Fortaleza, Ceara, Brazil.
RP Pinato, L (corresponding author), Av Hygino Muzzi Filho 737, Mirante Marilia, SP, Brazil.
EM lpinato@marilia.unesp.br
RI Giacheti, Celia M/I-4863-2012; Pinato, luciana/A-8314-2018
OI Giacheti, Celia M/0000-0001-9691-4672; Guissoni Campos, Leila
   Maria/0000-0002-2344-4750; Pinato, luciana/0000-0001-7788-9205
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [11/51495-4]
FX This work was supported by FAPESP (11/51495-4) funding grant to L.P.
CR ANDERS TF, 1992, PEDIATRICS, V90, P554
   ARMSTRONG KL, 1994, MED J AUSTRALIA, V161, P202, DOI 10.5694/j.1326-5377.1994.tb127383.x
   Begum Esmot ara, 2006, J Circadian Rhythms, V4, P11, DOI 10.1186/1740-3391-4-11
   Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Fadini CC, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00347, 10.3389/fnhum.2015.00347]
   Galland BC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014908
   Gelman VS, 2001, AUST J PSYCHOL, V53, P18, DOI 10.1080/00049530108255117
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hoppenbrouwers T, 2005, SLEEP, V28, P1428, DOI 10.1093/sleep/28.11.1428
   Horner Richard L, 2017, Continuum (Minneap Minn), V23, P955, DOI 10.1212/CON.0000000000000495
   Ivanenko A, 2009, CHILD ADOL PSYCH CL, V18, P839, DOI 10.1016/j.chc.2009.04.005
   Juca E, 2018, CHILD NERV SYST, V34, P101, DOI 10.1007/s00381-017-3636-2
   Kahn A, 1996, J CLIN NEUROPHYSIOL, V13, P184, DOI 10.1097/00004691-199605000-00002
   KATARIA S, 1987, J PEDIATR-US, V110, P642, DOI 10.1016/S0022-3476(87)80571-1
   Kortum F, 2011, J MED GENET, V48, P396, DOI 10.1136/jmg.2010.087528
   Kuhn BR, 2000, CHILD FAM BEHAV THER, V22, P33, DOI 10.1300/J019v22n02_03
   Malow BA, 2006, SLEEP, V29, P1563, DOI 10.1093/sleep/29.12.1563
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meltzer LJ, 2017, J CHILD HEALTH CARE, V21, P301, DOI 10.1177/1367493517712064
   Mindell JA, 2009, SLEEP, V32, P599, DOI 10.1093/sleep/32.5.599
   Montemitro E, 2008, SLEEP, V31, P47, DOI 10.1093/sleep/31.1.47
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Nunes ML, 2014, CLIN NEUROPHYSIOL, V125, P1121, DOI 10.1016/j.clinph.2013.10.049
   Nunes ML, 2012, SLEEP SCI, V5, P89
   O'Brien LM, 2004, SLEEP, V27, P279, DOI 10.1093/sleep/27.2.279
   Owens JA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e51
   Owens JL, 1999, SLEEP MED REV, V3, P281
   Ozkurt Z, 2017, EURASIAN J MED, V49, P142, DOI 10.5152/eurasianjmed.2017.17147
   Pandi-Perumal SR, 2008, PROG NEUROBIOL, V85, P335, DOI 10.1016/j.pneurobio.2008.04.001
   Peever JH, 2007, SLEEP AND PAIN, P1
   Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414
   Santoro SD, 2016, PHYSIOL BEHAV, V159, P14, DOI 10.1016/j.physbeh.2016.03.010
   Bonan KCSD, 2015, ARQ NEURO-PSIQUIAT, V73, P147, DOI 10.1590/0004-282X20140214
   Smith L, 2017, BEHAV SLEEP MED, V26, P1
   Urfer-Maurer N, 2017, SLEEP MED, V38, P64, DOI 10.1016/j.sleep.2017.07.010
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   World Health Organization, 2016, 1 M INT HLTH REG 200
   ZUCKERMAN B, 1987, PEDIATRICS, V80, P664
   Zuculo GM, 2017, CHRONOBIOL INT, V34, P527, DOI 10.1080/07420528.2017.1308375
   Zuculo GM, 2014, CODAS, V26, P447, DOI 10.1590/2317-1782/20140201435
NR 46
TC 6
Z9 6
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
EI 1550-9109
J9 SLEEP
JI Sleep
PD MAR
PY 2018
VL 41
IS 3
AR UNSP zsy009
DI 10.1093/sleep/zsy009
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FY8NZ
UT WOS:000427123100008
PM 29325155
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Boujnan, M
   Duits, AJ
   Koppelman, MHGM
AF Boujnan, Mohamed
   Duits, Ashley J.
   Koppelman, Marco H. G. M.
TI Zika virus RNA polymerase chain reaction on the utility channel of a
   commercial nucleic acid testing system
SO TRANSFUSION
LA English
DT Article
ID REVERSE TRANSCRIPTION-PCR; MOLECULAR-DETECTION; BLOOD-DONORS;
   CHIKUNGUNYA; DENGUE; TRANSMISSION; INFECTION; DONATIONS
AB BACKGROUNDSeveral countries have implemented safety strategies to reduce the risk of Zika virus (ZIKV) transmission through blood transfusion. These strategies have included nucleic acid amplification testing (NAT) of blood donations. In this study, a new real-time polymerase chain reaction (PCR) assay including internal control for the detection of ZIKV on the cobas omni Utility Channel (UC) on the cobas 6800 system is presented.
   STUDY DESIGN AND METHODSPCR conditions and primer/probe concentrations were optimized on the LightCycler 480 instrument. Optimized conditions were transferred to the cobas omni UC on the cobas 6800 system. Subsequently, the limit of detection (LOD) in plasma and urine, genotype inclusivity, specificity, cross-reactivity, and clinical sensitivity were determined.
   RESULTSThe 95% LOD of the ZIKV PCR assay on the cobas 6800 system was 23.0 IU/mL (95% confidence interval [CI], 16.5-37.5) in plasma and 24.5 IU/mL (95% CI, 13.4-92.9) in urine. The assay detected African and Asian lineages of ZIKV. The specificity was 100%. The clinical concordance between the newly developed ZIKV PCR assay and the investigational Roche cobas Zika NAT test was 83% (24/29).
   CONCLUSIONSWe developed a sensitive ZIKV PCR assay on the cobas omni UC on the cobas 6800 system. The assay can be used for large-scale screening of blood donations for ZIKV or for testing of blood donors returning from areas with ZIKV to avoid temporal deferral. This study also demonstrates that the cobas omni UC on the cobas 6800 system can be used for in-house-developed PCR assays.
C1 [Boujnan, Mohamed; Koppelman, Marco H. G. M.] Natl Screening Lab Sanquin NSS, Sanquin Blood Supply Fdn, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.
   [Duits, Ashley J.] Biomed & Hlth Res Inst, Willemstad, Curacao.
   [Duits, Ashley J.] Red Cross Blood Bank Fdn, Willemstad, Curacao.
RP Koppelman, MHGM (corresponding author), Natl Screening Lab Sanquin NSS, Sanquin Blood Supply Fdn, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.
EM m.koppelman@sanquin.nl
FU Roche Molecular Diagnostics
FX This study was supported by Roche Molecular Diagnostics (Provided UC
   reagents)
CR [Anonymous], 2016, REV REC RED RISK ZIK
   [Anonymous], 2016, TARG PROD PROF BETT
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Lieshout-Krikke RW, 2013, VOX SANG, V104, P12, DOI 10.1111/j.1423-0410.2012.01631.x
   Lieshout-Krikke RW, 2015, TRANSFUSION, V55, P79, DOI 10.1111/trf.12783
   Massad E, 2016, GLOBAL HLTH ACTION, V9
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pisani G, 2016, TRANSFUS MED HEMOTH, V43, P158, DOI 10.1159/000446219
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Slenczka W, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0019-2016
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
NR 36
TC 3
Z9 3
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2018
VL 58
IS 3
BP 641
EP 648
DI 10.1111/trf.14460
PG 8
WC Hematology
SC Hematology
GA FY8WD
UT WOS:000427145100008
PM 29322525
OA Bronze
DA 2020-07-08
ER

PT J
AU Laughhunn, A
   Huang, YJS
   Vanlandingham, DL
   Lanteri, MC
   Stassinopoulos, A
AF Laughhunn, Andrew
   Huang, Yan-Jang S.
   Vanlandingham, Dana L.
   Lanteri, Marion C.
   Stassinopoulos, Adonis
TI Inactivation of chikungunya virus in blood components treated with
   amotosalen/ultraviolet A light or amustaline/glutathione
SO TRANSFUSION
LA English
DT Article
ID PATHOGEN INACTIVATION; UNITED-STATES; PHOTOCHEMICAL INACTIVATION;
   PLATELET COMPONENTS; DENGUE VIRUS; PUERTO-RICO; TRANSFUSION; EPIDEMIC;
   INFECTION; RISK
AB BACKGROUNDChikungunya virus, a mosquito-borne arbovirus, often co-circulates with the Zika, dengue, and yellow fever viruses in Aedes mosquito-infested areas where cases of arbovirus transfusion-transmitted infections have been reported. Building on past experience to help maintain the availability of safe components during major outbreaks of chikungunya virus in La Reunion, Italy, and Thailand and of Zika virus in the Pacific, the Caribbean, and the Americas, pathogen inactivation is a mitigation strategy to reduce the risk of transfusion-transmitted infection. Inactivation of chikungunya virus was investigated for platelets in 100% plasma using amotosalen/ultraviolet A light, and in red blood cells using amustaline/glutathione.
   STUDY DESIGN AND METHODSPlatelets in 100% plasma and red blood cells (RBCs) were spiked with chikungunya virus. Infectious chikungunya virus titers were measured in contaminated blood products before and after treatment with amotosalen/ultraviolet A light for platelets in 100% plasma and after treatment with amustaline/glutathione for RBCs. Viral infectivity was quantified by plaque assay.
   RESULTSThe mean chikungunya virus infectivity titers before inactivation were 6.50 log(10) plaque-forming units/mL for platelets in 100% plasma and 7.60 log(10) plaque-forming units/mL for RBCs. No infectivity was detected after amotosalen/ultraviolet A light or amustaline/glutathione treatment, corresponding to greater than 6.5 log(10) plaque-forming units/mL and greater than 7.1 log(10) plaque-forming units/mL of inactivation, respectively.
   CONCLUSIONRobust levels of chikungunya virus inactivation were achieved for platelets in 100% plasma and for RBC components. The licensed amotosalen/ultraviolet A light technology and the amustaline/glutathione pathogen-reduction system under development may provide an opportunity for comprehensive mitigation of the risk of chikungunya virus transfusion-transmitted infection by plasma, platelets, and RBCs.
C1 [Laughhunn, Andrew; Lanteri, Marion C.; Stassinopoulos, Adonis] Cerus Corp, 2550 Stanwell Dr, Concord, CA 94520 USA.
   [Huang, Yan-Jang S.; Vanlandingham, Dana L.] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
   [Huang, Yan-Jang S.; Vanlandingham, Dana L.] Kansas State Univ, Dept Diagnost Med Pathobiolgoy, Manhattan, KS 66506 USA.
RP Stassinopoulos, A (corresponding author), Cerus Corp, 2550 Stanwell Dr, Concord, CA 94520 USA.
EM adonis@cerus.com
CR Appassakij H, 2014, TRANSFUSION, V54, P1945, DOI 10.1111/trf.12575
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   CORDEL H, 2006, EUROSURVEILLANCE, V11, P2944
   Faddy HM, 2016, VOX SANG, V111, P235, DOI 10.1111/vox.12414
   Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519
   Faddy HM, 2015, TRANSFUSION, V55, P824, DOI 10.1111/trf.12899
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Gay N, 2014, B VEILLE SANITAIRE S, P33
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Henschler R, 2011, TRANSFUS MED HEMOTH, V38, P33, DOI 10.1159/000324458
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Huang YJS, 2015, VECTOR-BORNE ZOONOT, V15, P674, DOI 10.1089/vbz.2015.1795
   Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937
   Jain M, 2008, TROP DOCT, V38, P70, DOI 10.1258/td.2007.070019
   Kalantri SP, 2006, NATL MED J INDIA, V19, P315
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krastinova E, 2006, EURO SURVEILL S34, V11, P3030
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Marks DC, 2017, VOX SANG SS1, V112, P148
   Montgomery SP, 2006, TRANSFUSION, V46, P2038, DOI 10.1111/j.1537-2995.2006.01030.x
   Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Nakkhara P, 2013, T ROY SOC TROP MED H, V107, P789, DOI 10.1093/trstmh/trt083
   Oei W, 2013, TRANSFUSION, V53, P1421, DOI 10.1111/j.1537-2995.2012.03941.x
   Paty MC, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.28.20856
   Petersen LR, 2010, TRANSFUS MED REV, V24, P15, DOI 10.1016/j.tmrv.2009.09.002
   Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3
   Ramachandra RT, 1964, CURR SCI, V33, P235
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Rasongles P, 2009, TRANSFUSION, V49, P1083, DOI 10.1111/j.1537-2995.2009.02111.x
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189
   SHAH KV, 1965, INDIAN J MED RES, V53, P610
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   TOMORI O, 1981, AM J TROP MED HYG, V30, P855, DOI 10.4269/ajtmh.1981.30.855
   Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325
   Tsetsarkin KA, 2013, AM J TROP MED HYG, V88, P1163, DOI 10.4269/ajtmh.12-0603
   Vanlandingham DL, 2013, TRANSFUSION, V53, P284, DOI 10.1111/j.1537-2995.2012.03717.x
   Warner E., 2006, Morbidity and Mortality Weekly Report, V55, P1040
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
NR 48
TC 9
Z9 9
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2018
VL 58
IS 3
BP 748
EP 757
DI 10.1111/trf.14442
PG 10
WC Hematology
SC Hematology
GA FY8WD
UT WOS:000427145100020
PM 29322519
OA Other Gold
DA 2020-07-08
ER

PT J
AU Sigfrid, L
   Eckerle, I
   Papa, A
   Horby, P
   Koopmans, M
   Reusken, C
AF Sigfrid, L.
   Eckerle, I.
   Papa, A.
   Horby, P.
   Koopmans, M.
   Reusken, C.
TI Strengthening preparedness for (re-) emerging arboviruses in Europe
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Editorial Material
ID ZIKA VIRUS
C1 [Sigfrid, L.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.
   [Eckerle, I.] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.
   [Papa, A.] Aristotle Univ Thessaloniki, Dept Microbiol, Thessaloniki, Greece.
   [Horby, P.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.
   [Koopmans, M.; Reusken, C.] Erasmus Univ, Med Ctr, Dept Virosci, WHO Collaborating Ctr Arboviruses & Viral Haemorr, Rotterdam, Netherlands.
   [Eckerle, I.] Univ Hosp Geneva, Div Infect Dis, Geneva Ctr Emerging Viral Dis, Geneva, Switzerland.
RP Sigfrid, L (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.
EM louise.sigfrid@gmail.com
RI Sigfrid, Louise/AAM-1364-2020; Koopmans, Marion/Y-9170-2019
OI Sigfrid, Louise/0000-0003-2764-1177; Koopmans,
   Marion/0000-0002-5204-2312
FU European CommissionEuropean Commission Joint Research Centre [602525]
FX This work forms part of the PREPARE (Platform for European Preparedness
   against (re-)emerging epidemics funded by the European Commission under
   grant number 602525.
CR Aradaib IE, 2010, EMERG INFECT DIS, V16, P837, DOI 10.3201/eid1605.091815
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Charrel RN, 2005, EMERG INFECT DIS, V11, P1657, DOI 10.3201/eid1111.050869
   Cleton N, 2012, J CLIN VIROL
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004073
   Eckerle I, 2018, CLIN MICROBIOL INFEC, V24, P240, DOI 10.1016/j.cmi.2018.01.007
   Elata AT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-303
   European Centre for Disease Prevention and Control (ECDC), 2017, CLUST AUT CHIK CAS I
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gurbuz Y, 2009, INT J INFECT DIS, V13, P105
   Jacquot M, 1864, P BIOL SCI, V2017, P284
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2016, CLIN MICROBIOL INFEC, V22, P494, DOI 10.1016/j.cmi.2016.03.032
   Musso D, 2016, TRANSFUSION, V56, P3143, DOI 10.1111/trf.13861
   Papa A, 2017, J MED VIROL, V89, P1315, DOI 10.1002/jmv.24803
   Reusken CB, 2018, CLIN MICROBIOL INFEC, V24, P221, DOI 10.1016/j.cmi.2017.12.010
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   Sigfrid L, 2018, CLIN MICROBIOL INFEC, V24, P229, DOI 10.1016/j.cmi.2017.05.029
   Wernike K, 2014, PREV VET MED, V116, P423, DOI 10.1016/j.prevetmed.2014.03.021
NR 20
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAR
PY 2018
VL 24
IS 3
BP 219
EP 220
DI 10.1016/j.cmi.2018.02.001
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FX9KG
UT WOS:000426417300004
PM 29496185
OA Bronze
DA 2020-07-08
ER

PT J
AU Reusken, CB
   Ieven, M
   Sigfrid, L
   Eckerle, I
   Koopmans, M
AF Reusken, C. B.
   Ieven, M.
   Sigfrid, L.
   Eckerle, I.
   Koopmans, M.
TI Laboratory preparedness and response with a focus on arboviruses in
   Europe
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Review
DE Diagnostics; Emerging diseases; Laboratory preparedness; Microbiology
ID WEST NILE VIRUS; QUALITY-CONTROL ASSESSMENT; LINKED IMMUNOSORBENT
   ASSAYS; ZIKA VIRUS; CHIKUNGUNYA VIRUS; ENCEPHALITIS-VIRUS; SEROLOGICAL
   DIAGNOSIS; DENGUE; INFECTIONS; DISEASES
AB Background: The global health burden of arboviruses is continuously rising, which results in increasing pressure on local and ( inter) national laboratory infrastructures. Timely and accurate diagnosis of cases is one of the main pillars for public health and clinical responses to an arbovirus emergence.
   Aims and sources: This narrative review aims to summarize recent advances and to identify needs in laboratory preparedness and response activities, with a focus on viruses transmitted by arthropods in Europe. The review is based on evidence extracted from PubMed searches, Public Health and clinical laboratory experiences from the authors and the authors' opinions substantiated by peer-reviewed scientific literature.
   Content: We illustrate the importance of inter-epidemic laboratory preparedness activities to ensure adequate Public Health and clinical responses. We describe the status of arbovirus endemicity and emergence in Europe thereby highlighting the need for preparedness for these viruses. We discuss the components and pitfalls of an adequate laboratory preparedness and response and the broader context of the current landscape of international research, clinical and laboratory preparedness networks. The complexity of arbovirus laboratory preparedness and response is described.
   Implications: Outbreak preparedness plans need to look beyond national reference laboratories, to include first-line responding onsite hospital laboratories and plans for strengthening of such local capacity and capability as required depending on the nature of the outbreak. In particular, the diagnosis of arbovirus infections is complicated by the existence of geographic overlap of circulation of numerous arboviruses, the overlap in clinical manifestation between many arboviruses and other aetiologies and the existence of cross-reactivity between related arboviruses in serology testing. Inter-epidemic preparedness activities need strong national and international networks addressing these issues. However, the current mushrooming of European preparedness networks requires governance to bring the European preparedness and response to a next level. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Reusken, C. B.; Koopmans, M.] Erasmus Univ, Med Ctr, WHO Collaborating Ctr Arboviruses & Viral Haemorr, Dept Virosci, Rotterdam, Netherlands.
   [Ieven, M.] Antwerp Univ Hosp, Dept Med Microbiol, Antwerp, Belgium.
   [Ieven, M.] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Antwerp, Belgium.
   [Sigfrid, L.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [Eckerle, I.] Univ Klinikum Bonn, Inst Virol, Bonn, Germany.
RP Reusken, CB (corresponding author), Erasmus MC, Dept Virosci, Wytemaweg 80, Rotterdam, Netherlands.
EM C.Reusken@erasmusmc.nl
RI Sigfrid, Louise/AAM-1364-2020; Koopmans, Marion/Y-9170-2019
OI Sigfrid, Louise/0000-0003-2764-1177; Koopmans,
   Marion/0000-0002-5204-2312
FU European CommissionEuropean Commission Joint Research Centre [602525];
   EU H
FX This work was funded by the European Commission under H2020 grant number
   602525 (PREPARE).; Dr. Reusken reports grants from EU H2020, during the
   conduct of the study.
CR Aarestrup FM, 2016, TRENDS MICROBIOL, V24, P241, DOI 10.1016/j.tim.2016.01.009
   Adouchief S, 2016, REV MED VIROL, V26, P221, DOI 10.1002/rmv.1876
   Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16
   Allering L, 2012, EUROSURVEILLANCE, P17
   [Anonymous], 2016, GOVT DISTRIBUTE 3 5
   Bakonyi T, 2017, EUROSURVEILLANCE, P22
   Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005
   Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245
   Braks M, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00280
   Brown L, 2014, PUBLIC HEALTH, V128, P29, DOI 10.1016/j.puhe.2013.09.006
   Caclar D, 2016, AVESUNN EUROPE 2016, V2017, P22
   Calzolari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063978
   Cassadou S, 2014, EUROSURVEILLANCE, P19
   CBD Convention on Biological Diversity, 2014, NAG PROT ACC BEN SHA
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Charrel RN, 2016, B WHO
   Chaskopoulou A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1736-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004073
   COMPARE, 2016, COLL MAN PLATF DET A
   Cusi MG, 2011, EXPERT REV ANTI-INFE, V9, P799, DOI [10.1586/eri.11.54, 10.1586/ERI.11.54]
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   de Sousa R, 2014, J CLIN VIROL, V59, P4, DOI 10.1016/j.jcv.2013.10.030
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Domingo C, 2017, PLOS ONE, V7
   Domingo C, 2010, PLOS NEGLECT TROP D, P4
   Donoso Mantke O, 2005, Euro Surveill, V10, P102
   Drew TW, 2017, VACCINE, V35, P5990, DOI 10.1016/j.vaccine.2017.07.109
   ECDC, 2010, TECHN REP COR FUNCT
   ECDC, 2016, RAP RISK CRIM CONG H
   ECDC, 2017, ECDC TOOL PRIOR INF
   ECDC, 2017, ECDC RAP RISK ASS CL
   ECDC, 2017, RAP RISK ASS CLUST A
   ECDC, 2017, DIS LAB NETW
   ECDC, 2017, ZIK VIR SAF SUBST HU
   ECDC, 2017, RAP RISK ASS ZIK VIR
   ECDC, 2017, ECDC PUBL HLTH TRAIN
   Ellerbrok H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005570
   EMERGE, 2016, EM JA EFF RESP HIGHL
   Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869
   ERINHA, 2017, EUR RES INFR HIGHL P
   Escadafal C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002244
   Escadafal C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001706
   Escadafal C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001607
   Estrada-Pena A, 2012, VECTOR-BORNE ZOONOT, V12, P743, DOI 10.1089/vbz.2011.0767
   Estrada-Pena A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00064
   Estrada-Pena A, 2012, EMERG INFECT DIS, V18, P179, DOI 10.3201/eid1801.111040
   European Centre for Disease Prevention and Control (ECDC), 2016, EX VECT MOSQ MAPS
   European Centre for Disease Prevention and Control (ECDC), 2017, RAP RISK ASS YELL FE
   EuroStat, 2015, TOUR STAT TOP DEST
   EVAg, 2015, EUR VIR ARCH GOES GL
   EVD-LabNet, 2016, EUR EXP LAB NEWT EM
   EVD-LabNet, 2017, EVD LABNET DIAGN DIR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandez-Garcia MD, 2012, EUROSURVEILLANCE, V2014, P19
   Garigliany M, 2017, INFECT GENET EVOL, V48, P116, DOI 10.1016/j.meegid.2016.12.023
   GIDEON, 2017, GID WORLDS PREM GLOB
   GLOPID-R, 2017, GLOPID R GLOP R MAK
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Graring NV, 2002, FAO ANIMAL HLTH MANU, P61
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Grunow R, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00199
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hoch T, 2016, EXP APPL ACAROL, V68, P347, DOI 10.1007/s10493-015-9937-9
   Huber K, 2014, PARASITOL RES, V113, P3195, DOI 10.1007/s00436-014-3983-9
   Huzly D, 2016, EUROSURVEILLANCE, P21
   Jacobsen S, 2016, J CLIN VIROL, V76, P55, DOI 10.1016/j.jcv.2016.01.008
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Krause G, 2008, EUROSURVEILLANCE, P13
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lemmer A, 2004, J CLIN VIROL, V30, P291, DOI 10.1016/j.jcv.2003.11.002
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lindsey NP, 2016, EPIDEMIOL INFECT, V144, P3170, DOI 10.1017/S0950268816001138
   Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753
   Mantke OD, 2004, J CLIN VIROL, V29, P105, DOI 10.1016/S1386-6532(03)00110-0
   Mantke OD, 2007, J CLIN VIROL, V38, P73, DOI 10.1016/j.jcv.2006.09.001
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Mogling R, 2017, EUROSURVEILLANCE, P22
   Moratelli R, 2015, MEM I OSWALDO CRUZ, V110, P1, DOI 10.1590/0074-02760150048
   Niedrig M, 2009, CLIN MICROBIOL INFEC, V15, P880, DOI 10.1111/j.1469-0691.2009.02851.x
   Niedrig M, 2007, J CLIN VIROL, V38, P260, DOI 10.1016/j.jcv.2006.12.013
   Nikolay B, 2015, T ROY SOC TROP MED H, V109, P609, DOI 10.1093/trstmh/trv066
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Olival KJ, 2017, ECOHEALTH, V14, P1, DOI 10.1007/s10393-017-1220-6
   Palmer S, 2005, BMJ-BRIT MED J, V331, P1256, DOI 10.1136/bmj.331.7527.1256
   PANDEM, 2017, PAND PAND RISK EM MA
   Pas SD, 2015, J CLIN VIROL, V69, P81, DOI 10.1016/j.jcv.2015.05.022
   Paz-Bailey G, 2017, N ENGL J MED
   Platono A, 2012, EUROSURVEILLANCE, P17
   PREPARE, 2015, PLATF EUR PREP RE EM
   Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011
   Reusken CB, 2018, EUROSURVEILLANCE
   Reusken C, 2015, J CLIN VIROL, V62, P124, DOI 10.1016/j.jcv.2014.11.007
   Reusken CBEM, 2013, J TRAVEL MED, V20, P44, DOI 10.1111/j.1708-8305.2012.00670.x
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rijks JM, 2016, 2016 EURO SURVEILL, P21
   Rizzoli A, 2015, EUROSURVEILLANCE, P20
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Sambri V, 2013, VIRUSES-BASEL, V5, P2329, DOI 10.3390/v5102329
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Shu V, 2017, EUROSURVEILLANCE, P22
   Sigfrid L, 2018, CLIN MICROBIOL INFEC, V24, P229, DOI 10.1016/j.cmi.2017.05.029
   Simon-Loriere E, 2017, NEW ENGL J MED, V376, P1483, DOI 10.1056/NEJMc1701600
   Steinhagen K, 2016, EUROSURVEILLANCE, P21
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Tilslon-Lunel NL, 2017, VIRUSES, P9
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Tonteri E, 2015, EUROSURVEILLANCE, P20
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Vilibic-Cavlek T, 2014, INFECTION, V42, P689, DOI 10.1007/s15010-014-0625-1
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 2016, POL STAT DAT SHAR WO
   WHO, 2017, DENG WHO200017
   WHO, 2015, POL OUTBR SIM EX
   WHO, 2017, R D BLUEPR LIST PRIO
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   World Bank, 2012, PEOPL PATH OUR PLAN
   WORLD HEALTH ORGANIZATION, 2009, DENGUE: GUIDELINES FOR DIAGNOSIS, TREATMENT, PREVENTION AND CONTROL, P91
   World Health Organization, 2015, DEV GLOB NORMS SHAR
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   World Health Organization W, 2016, TECHNICAL REPORT
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   ZAPI, 2017, ZOON ANT PREP INT
NR 138
TC 9
Z9 9
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAR
PY 2018
VL 24
IS 3
BP 221
EP 228
DI 10.1016/j.cmi.2017.12.010
PG 8
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FX9KG
UT WOS:000426417300005
PM 29274465
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Sigfrid, L
   Reusken, C
   Eckerle, I
   Nussenblatt, V
   Lipworth, S
   Messina, J
   Kraemer, M
   Ergonul, O
   Papa, A
   Koopmans, M
   Horby, P
AF Sigfrid, L.
   Reusken, C.
   Eckerle, I.
   Nussenblatt, V.
   Lipworth, S.
   Messina, J.
   Kraemer, M.
   Ergonul, O.
   Papa, A.
   Koopmans, M.
   Horby, P.
TI Preparing clinicians for (re-) emerging arbovirus infectious diseases in
   Europe
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Review
DE Arboviruses; Arthropod-borne viruses; Clinical presentation;
   Epidemiology; Risk factors
ID CONGO HEMORRHAGIC-FEVER; MOSQUITO AEDES-ALBOPICTUS; TOSCANA VIRUS; ZIKA
   VIRUS; DENGUE VIRUS; SEPTEMBER 2010; GREECE; TRANSMISSION; RIBAVIRIN;
   OUTBREAK
AB Background: Arthropod-borne virus (Arbovirus) infections are considered an emerging threat for Europe, with an increase in cases in recent decades. The increase in global travel and trade has contributed to the introduction of vectors and viruses into new geographical areas. Tropical arboviruses such as dengue and chikungunya have re-emerged causing local, sporadic outbreaks ignited by travel-imported cases. The recent Zika virus outbreak in the Americas highlighted a need to strengthen preparedness for (re-) emerging arbovirus infections globally.
   Aims: To strengthen preparedness for the early identification of (re-) emerging arbovirus outbreaks in Europe and highlight areas for research.
   Sources: An evidence review of published and grey literature together with consultations with European arbovirus experts.
   Content: This paper presents an overview of endemic and travel-imported arboviruses of clinical significance in Europe. The overview includes syndromic presentation, risk factors for infection and risk of transmission as well as an update on treatments and vaccinations and surveillance notifications and reporting. The paper also presents predictive modelled risks of further geographical expansion of vectors and viruses.
   Implications: There are a range of arboviruses of clinical significance to Europe. There has been an increase in notifications of endemic and travel-imported arbovirus cases in recent years and an increased geographical range of vectors and viruses. The heterogeneity in surveillance reporting indicates a risk for the early identification of (re-) emerging outbreaks. The data presented show a need to strengthen preparedness for (re-) emerging arbovirus infections and a need for research into neglected arboviruses, risks of non-vector transmission and effective therapeutics and vaccinations. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Sigfrid, L.; Lipworth, S.; Horby, P.] Univ Oxford, Trop Med & Global Hlth, Oxford, England.
   [Sigfrid, L.] Brighton & Sussex Med Sch, Publ Hlth, Brighton, E Sussex, England.
   [Reusken, C.; Koopmans, M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Eckerle, I.] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.
   [Nussenblatt, V.] Univ Antwerp, Lab Med Microbiol, Antwerp, Belgium.
   [Messina, J.] Univ Oxford, Sch Geog & Environm, Sch Interdisciplinary Area Studies, Oxford, England.
   [Kraemer, M.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, M.] Harvard Med Sch, Boston, MA USA.
   [Kraemer, M.] Boston Childrens Hosp, Boston, MA USA.
   [Ergonul, O.] Koc Univ, Sch Med, Istanbul, Turkey.
   [Papa, A.] Aristotle Univ Thessaloniki, Dept Microbiol, Thessaloniki, Greece.
RP Sigfrid, L (corresponding author), Univ Oxford, Ctr Trop Med, Platform European Preparedness Reemerging Epidem, NDM Res Bldg,Old Rd Campus, Oxford OX3 7FZ, England.
EM louise.sigfrid@gmail.com
RI Sigfrid, Louise/AAM-1364-2020; Koopmans, Marion/Y-9170-2019
OI Sigfrid, Louise/0000-0003-2764-1177; Koopmans,
   Marion/0000-0002-5204-2312; Ergonul, Onder/0000-0003-1935-9235; Horby,
   Peter/0000-0002-9822-1586; Lipworth, Sam/0000-0001-5872-9214
FU European CommissionEuropean Commission Joint Research Centre [602525];
   National Institute of Child Health and Human DevelopmentUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [T32HD040128]
FX This work forms part of the PREPARE (Platform for European Preparedness
   against (re-)emerging epidemics funded by the European Commission under
   grant number 602525.; MUGK is supported by a Training Grant from the
   National Institute of Child Health and Human Development, T32HD040128.
CR Anagnostou V, 2013, CLIN MICROBIOL INFEC, V19, P566, DOI 10.1111/j.1469-0691.2012.03957.x
   Anagnostou V, 2013, TRAVEL MED INFECT DI, V11, P98, DOI 10.1016/j.tmaid.2012.11.006
   Angelini R, 2007, EUROSURVEILLANCE, V12
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ballart C, 2012, ACTA TROP, V122, P155, DOI 10.1016/j.actatropica.2011.11.011
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Calzolari M., 2014, EUROSURVEILLANCE, V19
   Canada. Phao, CRIM CONG HAEM FEV V
   Celikbas AK, 2014, EMERG INFECT DIS, V20, P477, DOI 10.3201/eid2003.131353
   Charrel R., 2014, TOSCANA VIRUS INFECT
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Charrel Remi N, 2012, World J Virol, V1, P135, DOI 10.5501/wjv.v1.i5.135
   Charrel RN, 2005, EMERG INFECT DIS, V11, P1657, DOI 10.3201/eid1111.050869
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004073
   ClinicalTrialsgov, 2016, CHIK VACC
   ClinicalTrialsgov, 2015, CELG MOD TREATM AD P
   ClinicalTrialsgov, 2016, DENG VACC
   ClinicalTrialsgov. Zika vaccination, 2016, ZIK VACC
   Cusi Maria G, 2010, Open Virol J, V4, P22, DOI 10.2174/1874357901004020022
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Danielova V, 2008, INT J MED MICROBIOL, V298, P68, DOI 10.1016/j.ijmm.2008.02.005
   Delisle E, 2014, CHIKUNGUNYA OUTBREAK, P20
   Dokuzoguz B, 2013, CLIN INFECT DIS, V57, P1270, DOI 10.1093/cid/cit527
   Donoso Mantke O., 2008, EUROSURVEILLANCE, V13
   ECDC, 2012, EP SIT W NIL VIR INF
   ECDC, 2016, EP UPD W NIL VIR TRA
   ECDC, DENG FEV FACTSH HLTH
   ECDC, 2016, ANN EP REP 2016 DENG
   ECDC, DENG FEV
   ECDC, SINDB DEV FACTSH HLT
   ECDC, 2016, RAP RISK ASS ZIK VIR
   ECDC, PHLEB SAND FIL
   ECDC, 2016, EP UPD OUTBR ZIK VIR
   ECDC, 2016, ANN EP REP TICK BORN
   ECDC, CHIK FACTSH HLTH PRO
   ECDC, W NIL VIR FACTSH HLT
   ECDC, 2016, PLEB MAPS
   ECDC, TICK BORN ENC FACTSH
   ECDC, 2009, CONS CRIM CONG HAEM
   ECDC, W NIL FEV EU CAS DEF
   ECDC, 2015, CHIK RISK ASS
   ECDC, EM THREAT MOSQ BORN
   ECDC, 2016, ANN EP REP CHIK FEV
   ECDC, 2016, ZIK EP 2014 ONW EP S
   ECDC, CRIM CONG HAEM FEV F
   ECDC, 2016, ZIK VIR FACTSH HLTH
   ECDC, 2016, ANN EP REP CRIM CONG
   ECDC, 2016, ZIK VIR CAS DEF
   ECDC, 2016, W NIL FEV
   ECDC, 2016, TICK MAPS
   ECDC, IX RIC
   ECDC, 2016, RAP RISK ASS CRIM CO
   ECDC European Centre for disease prevention and control, HYAL MARG
   Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2
   Ergonul O, 2008, ANTIVIR RES, V78, P125, DOI 10.1016/j.antiviral.2007.11.002
   Es-Sette N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0826-1
   European Centre for Disease Prevention and Control, 2016, ANN EP REP W NIL FEV
   European Centre for Disease Prevention and Control (ECDC), 2014, ANN EP REP EM VECT B
   European Directorate for the Quality of Medicines & HealthCare, 2015, GUIDE PREPARATION US
   Fischer M, INFECT DIS RELATED T
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Graaf J, 2016, EUROSURVEILLANCE, V21
   Guner R, 2014, VECTOR-BORNE ZOONOT, V14, P601, DOI 10.1089/vbz.2013.1546
   Gupta RK, 2016, J CLIN EXP HEPATOL, V6, P59, DOI 10.1016/j.jceh.2016.01.005
   Heinz F, 2015, EUROSURVEILLANCE, V20
   Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8
   Jungbauer C, 2015, J CLIN VIROL, V64, P16, DOI 10.1016/j.jcv.2015.01.003
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Leblebicioglu H, 2016, ANTIVIR RES, V126, P21, DOI 10.1016/j.antiviral.2015.12.003
   Louis C, 2012, EMERG INFECT DIS, V18, P78, DOI 10.3201/eid1801.110191
   Maltezou HC, 2010, EUROSURVEILLANCE, V15, P48
   Maroli M, 2008, TROP MED INT HEALTH, V13, P256, DOI [10.1111/j.1365-3156.2007.01998.x, 10.1111/j.1365-3156.2007.01998]
   Messina JP, 2015, T ROY SOC TROP MED H, V109, P503, DOI 10.1093/trstmh/trv050
   Papa A, 2016, J MED VIROL, V88, P769, DOI 10.1002/jmv.24400
   Papa A, 2014, INTERVIROLOGY, V57, P393, DOI 10.1159/000363505
   Papa A, 2014, EMERG INFECT DIS, V20, P1417, DOI 10.3201/eid2008.140248
   Papa A, 2010, TRAVEL MED INFECT DI, V8, P302, DOI 10.1016/j.tmaid.2010.09.002
   Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113
   Public Health England, 2016, MOSQ NAT SURV
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.21.30238
   Rizzo C, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.37.30340
   Scholte EJ, 2008, MED VET ENTOMOL, V22, P352, DOI 10.1111/j.1365-2915.2008.00763.x
   Seixas G, 2013, MEM I OSWALDO CRUZ, V108, P3, DOI 10.1590/0074-0276130386
   Shrestha P, 2016, B WHO
   Smit R, 2012, VACCINE, V30, P6301, DOI 10.1016/j.vaccine.2012.07.083
   Soares-Weiser K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-207
   Staples J, INFECT DIS RELATED T
   Tomashek K, INFECT DIS RELATED T
   Twgobsa WNV., 2012, EU SAT M WORK GROUP
   WHO, 2011, VACC TICK BORN ENC
   WHO, 2011, W NIL VIR INF WNV EU
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   World Health Organization, 2016, IMM VACC BIOL
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Ze-Ze L, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.38.30024
   Zhang F, 2014, CORTICOSTEROIDS DENG
NR 101
TC 10
Z9 10
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAR
PY 2018
VL 24
IS 3
BP 229
EP 239
DI 10.1016/j.cmi.2017.05.029
PG 11
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FX9KG
UT WOS:000426417300006
PM 28648861
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Eckerle, I
   Briciu, VT
   Ergonul, O
   Lupse, M
   Papa, A
   Radulescu, A
   Tsiodras, S
   Tsitou, C
   Drosten, C
   Nussenblatt, VR
   Reusken, CB
   Sigfrid, LA
   Beeching, NJ
AF Eckerle, I.
   Briciu, V. T.
   Ergonul, O.
   Lupse, M.
   Papa, A.
   Radulescu, A.
   Tsiodras, S.
   Tsitou, C.
   Drosten, C.
   Nussenblatt, V. R.
   Reusken, C. B.
   Sigfrid, L. A.
   Beeching, N. J.
TI Emerging souvenirs-clinical presentation of the returning traveller with
   imported arbovirus infections in Europe
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Arbovirus; Chikungunya virus; Dengue fever; Imported febrile illness;
   Travel-imported illness; Zika virus
ID ZIKA VIRUS; CHIKUNGUNYA VIRUS; DENGUE; SPREAD; FEVER; SYMPTOMS;
   EPIDEMIC; OUTBREAK; DISEASES; SEROTYPE
AB Background: Arboviruses are an emerging group of viruses that are causing increasing health concerns globally, including in Europe. Clinical presentation usually consists of a nonspecific febrile illness that may be accompanied by rash, arthralgia and arthritis, with or without neurological or haemorrhagic syndromes. The range of differential diagnoses of other infectious and noninfectious aetiologies is broad, presenting a challenge for physicians. While knowledge of the geographical distribution of pathogens and the current epidemiological situation, incubation periods, exposure risk factors and vaccination history can help guide the diagnostic approach, the nonspecific and variable clinical presentation can delay final diagnosis.
   Aims and sources: This narrative review aims to summarize the main clinical and laboratory-based findings of the three most common imported arboviruses in Europe. Evidence is extracted from published literature and clinical expertise of European arbovirus experts.
   Content: We present three cases that highlight similarities and differences between some of the most common travel-related arboviruses imported to Europe. These include a patient with chikungunya virus infection presenting in Greece, a case of dengue fever in Turkey and a travel-related case of Zika virus infection in Romania.
   Implications: Early diagnosis of travel-imported cases is important to reduce the risk of localized outbreaks of tropical arboviruses such as dengue and chikungunya and the risk of local transmission from body fluids or vertical transmission. Given the global relevance of arboviruses and the continuous risk of (re) emerging arbovirus events, clinicians should be aware of the clinical syndromes of arbovirus fevers and the potential pitfalls in diagnosis. (C) 2018 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Eckerle, I.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany.
   [Briciu, V. T.; Lupse, M.; Radulescu, A.] Univ Med & Pharm Iuliu Hatieganu, Cluj Napoca, Romania.
   [Ergonul, O.] Koc Univ, Sch Med, Istanbul, Turkey.
   [Papa, A.] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, Thessaloniki, Greece.
   [Tsiodras, S.] Univ Athens, Sch Med, Athens, Greece.
   [Tsitou, C.] Corfu Gen Hosp, Corfu, Greece.
   [Drosten, C.] Charite, Inst Virol, Berlin, Germany.
   [Nussenblatt, V. R.] Univ Hosp Antwerp, Lab Med Microbiol, Antwerp, Belgium.
   [Reusken, C. B.] Erasmus MC, Virosci, Rotterdam, Netherlands.
   [Sigfrid, L. A.] Univ Oxford, Ctr Trop Med, Oxford, England.
   [Beeching, N. J.] Royal Liverpool Univ Hosp, Trop & Infect Dis Unit, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.
RP Eckerle, I (corresponding author), Inst Virol, Sigmund Freud Str 25, D-53127 Bonn, Germany.
EM eckerle@virology-bonn.de
RI Lupse, Mihaela/I-5995-2017; TSIODRAS, SOTIRIOS/AAD-8273-2019; Sigfrid,
   Louise/AAM-1364-2020; Lupse, Mihaela/AAN-3740-2020
OI TSIODRAS, SOTIRIOS/0000-0002-0463-4321; Sigfrid,
   Louise/0000-0003-2764-1177; Ergonul, Onder/0000-0003-1935-9235;
   Beeching, Nicholas/0000-0002-7019-8791
FU European CommissionEuropean Commission Joint Research Centre [602525];
   Hellenic Centre for Disease Control and Prevention; Ministry of
   HealthMinistry of Health - Turkey; National Institute for Health
   Research Health Protection Research Unit (NIHR HPRU) in Emerging and
   Zoonotic Infections; University of Liverpool, Liverpool School of
   Tropical Medicine; Public Health England (PHE)
FX This work forms part of the PREPARE project (Platform for European
   Preparedness against (Re)emerging Epidemics), funded by the European
   Commission under grant 602525. The National Reference Centre for
   Arboviruses in Greece is financially supported by the Hellenic Centre
   for Disease Control and Prevention, Ministry of Health. LS and NJB are
   members of the European Society of Clinical Microbiology and Infectious
   Diseases Study Group for Infections in Travellers and Migrants. NJB is
   partially supported by the National Institute for Health Research Health
   Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic
   Infections, a partnership between the University of Liverpool, Liverpool
   School of Tropical Medicine and Public Health England (PHE). The views
   expressed are those of the authors and not necessarily those of their
   respective institutions, the NIHR, the NHS, PHE or Ministries of Health.
   All authors report no conflicts of interest relevant to this review.
CR Alves MJ, 2013, EUROSURVEILLANCE, V18, P2
   Andries AC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1551-x
   Angelini R, 2007, Euro Surveill, V12
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Beltran-Silva SL, 2016, REV MED HOSP GEN MEX
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Centers for Disease Control and Prevention, 2017, ZIK PREGN COUPL TRYI
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   COBRA C, 1995, AM J EPIDEMIOL, V142, P1204, DOI 10.1093/oxfordjournals.aje.a117579
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   Cordel N, 2017, JAMA DERMATOL, V153, P326, DOI 10.1001/jamadermatol.2016.5442
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Eckerle I, 2015, EMERG INFECT DIS, V21, P175, DOI 10.3201/eid2101.141145
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Freour T., 2016, EURO SURVEILL, V21
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grande AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004888
   Grossi PA, 2017, NEW MICROBIOL, V40
   Gyawali N, 2017, MICROBES INFECT, V19, P388, DOI 10.1016/j.micinf.2017.05.002
   Gyawali N, 2016, AUST NZ J PUBL HEAL, V40, P596, DOI 10.1111/1753-6405.12582
   Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jaenisch T, 2014, EMERG INFECT DIS, P20
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Rodriguez-Morales AJ, 2016, ARTHRIT CARE RES, V68, P1849, DOI 10.1002/acr.22900
   Sanchez-Seco MP, 2001, J VIROL METHODS, V95, P153, DOI 10.1016/S0166-0934(01)00306-8
   Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X
   Schmidt-Chanasit J, 2010, EUROSURVEILLANCE, V15, P2
   Scholte EJ, 2008, MED VET ENTOMOL, V22, P352, DOI 10.1111/j.1365-2915.2008.00763.x
   Sigfrid L, 2018, CLIN MICROBIOL INFEC, V24, P229, DOI 10.1016/j.cmi.2017.05.029
   Sousa CA, 2012, EUROSURVEILLANCE, V17, P15
   Succo T, 2016, EUROSURVEILLANCE, V26, P21
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Travel Health Pro, 2017, ZIK VIR UPD ADV TRAV
   US Centers for Disease Control and Prevention, ZIK VIR WHAT CLIN NE
   van Aalst M, 2017, TRAVEL MED INFECT DI, V15, P8, DOI 10.1016/j.tmaid.2017.01.004
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, DENG SEV DENG FACT S
   World Health Organization, CHIK FACT SHEET
NR 55
TC 4
Z9 4
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAR
PY 2018
VL 24
IS 3
BP 240
EP 245
DI 10.1016/j.cmi.2018.01.007
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FX9KG
UT WOS:000426417300007
PM 29339224
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Monteiro, LMC
   Cruz, GND
   Fontes, JM
   Salles, TRDS
   Boechat, MCB
   Monteiro, AC
   Moreira, MEL
AF Costa Monteiro, Lucia Maria
   de Oliveira Cruz, Glaura Nisya
   Fontes, Juliana Marin
   Dias Saad Salles, Tania Regina
   Bastos Boechat, Marcia Cristina
   Monteiro, Ana Carolina
   Lopes Moreira, Maria Elizabeth
TI Neurogenic bladder findings in patients with Congenital Zika Syndrome: A
   novel condition
SO PLOS ONE
LA English
DT Article
ID VIRUS-INFECTION; NEUROPATHIC BLADDER; MEDICAL-TREATMENT; URINARY-TRACT;
   CHILDREN; BRAZIL; COUNTRIES; INFANTS
AB Introduction
   Congenital Zika Syndrome ( CZS) has been associated with microcephaly and other central nervous system abnormalities including areas that have been implicated in the control of the lower urinary tract. As such, this descriptive case series has aimed to investigate whether CZS is linked with neurogenic bladder. Identifying such an association is paramount in the effort to recognize CZS complications that have putative treatment options that could mitigate the impact of CZS in infected children.
   Methods
   Following IRB approval, urological assessment was performed in all patients referred to our clinic between June 2016 and May 2017 who presented with confirmed CZS-associated microcephaly. The research protocol consisted of obtaining clinical history, laboratory tests, lower and upper urinary tract ultrasounds, as well as a diagnostic urodynamic evaluation. ZIKA virus infection was previously confirmed by maternal history and positive PCR in babies and mothers. Microcephaly and other central nervous system abnormalities were established based on neurological assessment and associated imaging of the central nervous system ( CT head and/or Brain MRI).
   Results
   Twenty-two consecutive CZS patients were tested and confirmed to have neurogenic bladder. Of the 22 patients assessed, 21 presented with an overactive bladder combined with reduced bladder capacity and elevated detrusor filling pressures. Clinically significant increases in postvoid residual ( PVR) were confirmed in 40% of cases while a urinary tract infection ( UTI) was identified in 23% of cases.
   Conclusion
   Neurogenic bladder, a known treatable health condition, was confirmed in 100% of patients tested in this study, most presenting with high-risk urodynamic patterns known to lead to renal damage when left untreated. Follow up studies are necessary to provide further insight onto long-term disease progression and to investigate the response to standard therapies for neurogenic bladder. Nonetheless, we emphasize the importance of proactive management of neurogenic bladder and prompt referral so as to help mitigate CZS disease burden for patients and their families.
C1 [Costa Monteiro, Lucia Maria; de Oliveira Cruz, Glaura Nisya; Fontes, Juliana Marin] Fiocruz MS, Dept Pediat Urodynam & Dysfunct Voiding, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Dias Saad Salles, Tania Regina] Fiocruz MS, Dept Pediat Neurol, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Bastos Boechat, Marcia Cristina] Fiocruz MS, Dept Pediat Radiol & Imagining, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Monteiro, Ana Carolina] Univ Calif Los Angeles, Dept Internal Med, Los Angeles, CA USA.
   [Lopes Moreira, Maria Elizabeth] Fiocruz MS, Dept Neonatol, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
RP Monteiro, LMC (corresponding author), Fiocruz MS, Dept Pediat Urodynam & Dysfunct Voiding, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
EM lucia@iff.fiocruz.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Monteiro, Lucia Maria
   Costa/O-7903-2014
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Monteiro, Lucia
   Maria Costa/0000-0002-7612-7249; costa monteiro,
   ana/0000-0002-1501-4435; Marin Fontes, Juliana/0000-0003-4098-7324
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPES (Brazil)CAPES [440580/2016-1]; National Plan to Prevent
   and Combat ZIKA (MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS) [14/2016];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX The research is funded by a grant from CNPq and CAPES (Brazil), process
   number 440580/2016-1, from the National Plan to Prevent and Combat ZIKA
   (MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit/ No 14/2016 - Prevencao e Com
   bate ao virus Zika). Lucia M Costa Monteiro is the grant coordinator.
   Maria Elizabeth Lopes Moreira is funded by FAPERJ.
CR Bauer SB, 2015, NEUROUROL URODYNAM, V34, P640, DOI 10.1002/nau.22783
   Bauer SB, 2012, NEUROUROL URODYNAM, V31, P610, DOI 10.1002/nau.22247
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Costa Monteiro LM, 2017, CRITERIA EVALUATE NE
   Costa Monteiro LM, 2017, J PEDIAT RIO J
   de Groat W. C., 2014, COMPREHENSIVE PHYSL, P327
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dik P, 2006, EUR UROL, V49, P908, DOI 10.1016/j.eururo.2005.12.056
   Drzewiecki BA, 2011, J UROLOGY, V186, P1190, DOI 10.1016/j.juro.2011.02.2692
   Filler G, 2012, INT UROL NEPHROL, V44, P817, DOI 10.1007/s11255-010-9894-5
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Gostin LO, 2016, LANCET INFECT DIS, V16, P1099, DOI 10.1016/S1473-3099(16)30332-2
   Kari JA, 2006, PEDIATR NEPHROL, V21, P517, DOI 10.1007/s00467-006-0034-5
   Lehnert T, 2012, INT UROL NEPHROL, V44, P335, DOI 10.1007/s11255-011-0030-y
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   MCGUIRE EJ, 1981, J UROLOGY, V126, P205, DOI 10.1016/S0022-5347(17)54449-3
   McKibben MJ, 2015, UROL CLIN N AM, V42, P527, DOI 10.1016/j.ucl.2015.05.006
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Olandoski KP, 2011, CLINICS, V66, P189, DOI 10.1590/S1807-59322011000200002
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rodriguez-Ruiz M, 2016, ACTAS UROL ESP, V40, P37, DOI [10.1016/j.acuroe.2015.11.005, 10.1016/j.acuro.2015.06.002]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   STEINHARDT GF, 1988, J UROLOGY, V140, P1293, DOI 10.1016/S0022-5347(17)42028-3
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Verpoorten C, 2008, PEDIATR NEPHROL, V23, P717, DOI 10.1007/s00467-007-0691-z
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 30
TC 8
Z9 8
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 1
PY 2018
VL 13
IS 3
AR e0193514
DI 10.1371/journal.pone.0193514
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX8RR
UT WOS:000426363200059
PM 29494684
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Villamil-Gomez, WE
   Ramirez-Vallejo, E
   Rodriguez-Morales, AJ
AF Villamil-Gomez, Wilmer E.
   Ramirez-Vallejo, Eduardo
   Rodriguez-Morales, Alfonso J.
TI Cardiac Compromise in Zika Virus Infection
SO MAYO CLINIC PROCEEDINGS
LA English
DT Letter
C1 [Villamil-Gomez, Wilmer E.] Hosp Univ Sincelejo, Sincelejo, Sucre, Colombia.
   [Ramirez-Vallejo, Eduardo; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Pereira, Risaralda, Colombia.
RP Villamil-Gomez, WE (corresponding author), Hosp Univ Sincelejo, Sincelejo, Sucre, Colombia.
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1
   Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   Hidalgo-Zambrano DM, 2016, REV PANAM INFECTOL, V18, P13
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Villannil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P510, DOI 10.1016/j.tmaid.2016.06.004
NR 5
TC 3
Z9 3
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD MAR
PY 2018
VL 93
IS 3
BP 393
EP 394
DI 10.1016/j.mayocp.2017.12.006
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA FY1FU
UT WOS:000426558100023
PM 29397953
OA Bronze
DA 2020-07-08
ER

PT J
AU Schwartzmann, PV
   Simoes, MV
   Figueiredo, LTM
AF Schwartzmann, Pedro V.
   Simoes, Marcus Vinicius
   Moraes Figueiredo, Luiz Tadeu
TI In Reply-Cardiac Compromise in Zika Virus Infection
SO MAYO CLINIC PROCEEDINGS
LA English
DT Letter
C1 [Schwartzmann, Pedro V.; Simoes, Marcus Vinicius; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Med Sch Ribeirao Preto, Cardiol Ctr, Internal Med Dept, Sao Paulo, Brazil.
RP Schwartzmann, PV (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Cardiol Ctr, Internal Med Dept, Sao Paulo, Brazil.
CR Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Villamil-Gomez WE, 2018, MAYO CLIN P
NR 2
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD MAR
PY 2018
VL 93
IS 3
BP 394
EP 395
DI 10.1016/j.mayocp.2017.12.007
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA FY1FU
UT WOS:000426558100024
PM 29395352
OA Bronze
DA 2020-07-08
ER

PT J
AU Christian, KM
   Song, HJ
   Ming, GL
AF Christian, Kimberly M.
   Song, Hongjun
   Ming, Guo-li
TI A previously undetected pathology of Zika virus infection
SO NATURE MEDICINE
LA English
DT Editorial Material
ID BRAIN; NEUROGENESIS
AB In a nonhuman primate model of Zika virus infection, structural and cellular pathology deficits that could have a long-lasting impact on neural development and neurocognitive function are detected in offspring of infected mothers.
C1 [Christian, Kimberly M.] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.
   [Christian, Kimberly M.] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.
   [Song, Hongjun] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA USA.
RP Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.
EM gming@pennmedicine.upenn.edu
OI Ming, Guo-li/0000-0002-2517-6075
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI131130]; NINDS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R35 NS097370]
CR Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134
   Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
NR 12
TC 1
Z9 1
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD MAR
PY 2018
VL 24
IS 3
BP 258
EP 259
DI 10.1038/nm.4510
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA FY3EN
UT WOS:000426700900006
PM 29509754
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Pereira, AM
   Monteiro, DLM
   Werner, H
   Daltro, P
   Fazecas, T
   Guedes, B
   Tonni, G
   Peixoto, AB
   Araujo, E
AF Pereira, Alessandra Mendelski
   Maia Monteiro, Denise Leite
   Werner, Heron
   Daltro, Pedro
   Fazecas, Tatiana
   Guedes, Bianca
   Tonni, Gabriele
   Peixoto, Alberto Borges
   Araujo Junior, Edward
TI Zika virus and pregnancy in Brazil: What happened?
SO JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION
LA English
DT Review
DE Zika virus; intrauterine infection; microcephaly; ultrasound; magnetic
   resonance imaging
ID WEST-NILE; INFECTION; TRANSMISSION; BRAIN; FETAL; BIRTH; ASSOCIATION;
   STANDARDS; RESPONSES; OUTBREAK
AB The recent epidemic of Zika virus (ZIKV) infection in Central and South America is one of the most serious global public health emergencies since the Ebola outbreak in West Africa. In Brazil, especially in the north, northeast, and southeast parts of the country, the ZIKV outbreak is a cause of concern for pregnant women because ZIKV intrauterine infection has been found to be associated with multiple brain malformations and microcephaly. In Brazil, the number of newborns with confirmed microcephaly per year recorded during the ZIKV outbreak, has been approximately 15 times greater than previously reported. Considering that the infection is self-limiting and symptomatic, it is usually diagnosed at the time of routine prenatal scan, especially in the third trimester. In other cases, the disease is detected after childbirth through neuroimaging. This study provides an insight into the history and evolution of ZIKV in Brazil, including current knowledge concerning the transmission, diagnosis, and pathogenesis of the infection. In addition, this review describes the pre-and postnatal neuroimaging findings obtained using ultrasound, magnetic resonance imaging, and computed tomography.
C1 [Pereira, Alessandra Mendelski; Maia Monteiro, Denise Leite] Univ Estado Rio De Janeiro, Dept Obstet & Gynecol, Rio De Janeiro, Brazil.
   [Werner, Heron; Daltro, Pedro; Fazecas, Tatiana; Guedes, Bianca] Clin Diagnost Imagem, Dept Radiol, Rio De Janeiro, Brazil.
   [Tonni, Gabriele] Guastalla Civil Hosp, Dept Obstet & Gynecol, Reggio Emilia, Italy.
   [Peixoto, Alberto Borges] Univ Uberaba, Mario Palmerio Univ Hosp, Uberaba, Brazil.
   [Araujo Junior, Edward] Univ Fed Sao Paulo, Paulista Sch Med, Dept Obstet, Sao Paulo, Brazil.
RP Araujo, E (corresponding author), Univ Fed Sao Paulo, Paulista Sch Med, Dept Obstet, Sao Paulo, Brazil.
EM araujojred@terra.com.br
RI Werner, Heron/W-1578-2019; amsalu, ribka/G-8780-2019; Tonni,
   Gabriele/AAM-9842-2020; Junior, Edward Araujo/E-1228-2012
OI Junior, Edward Araujo/0000-0002-6145-2532
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude, 2017, B EPID SECR VIG SAUD, P47
   Ministerio da Saude (BR), 2017, B EPID SECR VIG SAUD, V48
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 48
TC 3
Z9 4
U1 0
U2 11
PU GALENOS YAYINCILIK
PI FINDIKZADE
PA ERKAN MOR, MOLLA GURANI CAD 21-1, FINDIKZADE, ISTANBUL 34093, TURKEY
SN 1309-0399
EI 1309-0380
J9 J TURK-GER GYNECOL A
JI J. Turk.-Ger. Gynecol. Assoc.
PD MAR
PY 2018
VL 19
IS 1
BP 39
EP 47
DI 10.4274/jtgga.2017.0072
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FX9OT
UT WOS:000426433200009
PM 29503261
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hendrixson, DT
   Newland, JG
AF Hendrixson, David Taylor
   Newland, Jason G.
TI Zika Virus Infection in Children
SO INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
LA English
DT Article
DE Arthropod-borne disease; Congenital Infection; Flavivirus; Microcephaly;
   Vertical transmission; Zika virus
ID UPDATE INTERIM GUIDANCE; MALE SEXUAL TRANSMISSION; UNITED-STATES;
   BIRTH-DEFECTS; PUERTO-RICO; INFANTS; BRAZIL; OUTBREAK; BRAIN;
   ASSOCIATION
AB Zika virus is a mosquito-borne Flavivirus responsible for symptomatic and asymptomatic infections in humans. Zika was first identified in Africa as a cause of sporadic febrile illness. Beginning in 2015, Zika virus infection was identified in Brazil and linked with several symptomatic infections. Notably, congenital infections were observed with marked neurologic abnormalities. Diagnosis relies on the detection of Zika virus by real-time polymerase chain reaction or by the presence of anti-Zika antibodies. Treatment of this viral illness remains supportive; however, proactive screening and interventions are indicated in the treatment of infants with symptomatic congenital infection.
C1 [Hendrixson, David Taylor; Newland, Jason G.] Washington Univ, Div Infect Dis, Dept Pediat, St Louis Childrens Hosp, Campus Box 8116,1 Childrens Pl, St Louis, MO 63110 USA.
RP Hendrixson, DT (corresponding author), Washington Univ, Div Infect Dis, Dept Pediat, St Louis Childrens Hosp, Campus Box 8116,1 Childrens Pl, St Louis, MO 63110 USA.
EM dthendrixson@wustl.edu
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Masuzaki H, 2004, CLIN CHEM, V50, P1709, DOI 10.1373/clinchem.2004.036517
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2017, N ENGL J MED
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   United States Food and Drug Administration, 2017, COB ZIK BL 125653 0
   United States Food and Drug Administration, 2016, GUID IND REV REC RED
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 68
TC 1
Z9 1
U1 0
U2 13
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0891-5520
EI 1557-9824
J9 INFECT DIS CLIN N AM
JI Infect. Dis. Clin. North Am.
PD MAR
PY 2018
VL 32
IS 1
BP 215
EP +
DI 10.1016/j.idc.2017.10.003
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FX5SP
UT WOS:000426140200016
PM 29406975
DA 2020-07-08
ER

PT J
AU Ramanathan, M
   Majzoub, K
   Rao, DS
   Neela, PH
   Zarnegar, BJ
   Mondal, S
   Roth, JG
   Gai, H
   Kovalski, JR
   Siprashvili, Z
   Palmer, TD
   Carette, JE
   Khavari, PA
AF Ramanathan, Muthukumar
   Majzoub, Karim
   Rao, Deepti S.
   Neela, Poornima H.
   Zarnegar, Brian J.
   Mondal, Smarajit
   Roth, Julien G.
   Gai, Hui
   Kovalski, Joanna R.
   Siprashvili, Zurab
   Palmer, Theo D.
   Carette, Jan E.
   Khavari, Paul A.
TI RNA-protein interaction detection in living cells
SO NATURE METHODS
LA English
DT Article
ID BINDING PROTEINS; MESSENGER-RNAS; BIOTIN LIGASE; PLATFORM; PROTEOMICS;
   INSIGHTS; AFFINITY; ELEMENTS; CAPTURE
AB RNA-protein interactions play numerous roles in cellular function and disease. Here we describe RNA-protein interaction detection (RaPID), which uses proximity-dependent protein labeling, based on the BirA* biotin ligase, to rapidly identify the proteins that bind RNA sequences of interest in living cells. RaPID displays utility in multiple applications, including in evaluating protein binding to mutant RNA motifs in human genetic disorders, in uncovering potential post-transcriptional networks in breast cancer, and in discovering essential host proteins that interact with Zika virus RNA. To improve the BirA*-labeling component of RaPID, moreover, a new mutant BirA* was engineered from Bacillus subtilis, termed BASU, that enables > 1,000-fold faster kinetics and > 30-fold increased signal-to-noise ratio over the prior standard Escherichia coli BirA*, thereby enabling direct study of RNA-protein interactions in living cells on a timescale as short as 1 min.
C1 [Ramanathan, Muthukumar; Rao, Deepti S.; Neela, Poornima H.; Zarnegar, Brian J.; Mondal, Smarajit; Kovalski, Joanna R.; Siprashvili, Zurab; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA.
   [Majzoub, Karim; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.
   [Roth, Julien G.; Gai, Hui; Palmer, Theo D.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.
   [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA.
RP Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA.; Khavari, PA (corresponding author), Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA.
EM khavari@stanford.edu
RI Rao, Deepti/K-2594-2019; Roth, Julien/AAF-3254-2019
OI Rao, Deepti/0000-0003-2190-7157; Roth, Julien/0000-0002-7560-3258;
   Carette, Jan/0000-0002-5187-8070; Majzoub, Karim/0000-0001-7345-6840;
   Palmer, Theo/0000-0002-6266-1862
FU US VA Office of Research and Development; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [AR49737, AR43799]; National Center For Research ResourcesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Research Resources (NCRR) [S10RR027425]
FX We thank C. Adams, R. Leib and Vincent Coates Foundation Mass
   Spectrometry Laboratory, Stanford University Mass Spectrometry for help
   with mass spectrometry. We also thank P. Oikonomou and S. Tavazoie for
   providing position weight matrixes. We thank A. Fire, H. Chang, J.
   Elias, P. Sarnow, R. Flynn, J. Quinn, A. Bhaduri, A. Rubin and M. Kay
   for presubmission review. We thank L. Morcom and P. Bernstein for expert
   administrative assistance and members of the Khavari lab for helpful
   discussions. This work was supported by the US VA Office of Research and
   Development, by NIH AR49737, and NIH AR43799 (P.A.K.). The project
   described was supported by Award Number S10RR027425 from the National
   Center For Research Resources. The content is solely the responsibility
   of the authors and does not necessarily represent the official views of
   the National Center for Research Resources or the National Institutes of
   Health.
CR Allerson CR, 1999, J BIOL CHEM, V274, P26439, DOI 10.1074/jbc.274.37.26439
   Austin RJ, 2002, J AM CHEM SOC, V124, P10966, DOI 10.1021/ja026610b
   Buenrostro JD, 2014, NAT BIOTECHNOL, V32, P562, DOI 10.1038/nbt.2880
   Butter F, 2009, P NATL ACAD SCI USA, V106, P10626, DOI 10.1073/pnas.0812099106
   Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031
   Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095
   Edwards JM, 2013, NUCLEIC ACIDS RES, V41, P7153, DOI 10.1093/nar/gkt470
   Galloway KE, 2013, SCIENCE, V341, P1358, DOI 10.1126/science.1235005
   Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088
   Hardy RJ, 1998, J NEUROSCI RES, V54, P46, DOI 10.1002/(SICI)1097-4547(19981001)54:1<46::AID-JNR6>3.0.CO;2-H
   Henke SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096757
   Hoistad M, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.009.2009
   Janowski R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11032
   Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   Kim DI, 2016, MOL BIOL CELL, V27, P1188, DOI 10.1091/mbc.E15-12-0844
   Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111
   Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179
   Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776
   Li ZH, 2011, RNA BIOL, V8, P305, DOI 10.4161/rna.8.2.15391
   Matia-Gonzalez AM, 2017, METHODS, V118, P93, DOI 10.1016/j.ymeth.2016.10.005
   McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443
   Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557
   Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443
   Oikonomou P, 2014, CELL REP, V7, P281, DOI 10.1016/j.celrep.2014.03.001
   Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]
   Parker BJ, 2011, GENOME RES, V21, P1929, DOI 10.1101/gr.112516.110
   Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011
   Ramanathan M., 2018, PROTOCOL EXCHANGE
   Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i
   Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265
   Rogell B, 2017, RNA, V23, P1290, DOI 10.1261/rna.060798.117
   Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098
   Schlundt A, 2014, NAT STRUCT MOL BIOL, V21, P671, DOI 10.1038/nsmb.2855
   Sharma A, 2014, CIRC RES, V115, P556, DOI 10.1161/CIRCRESAHA.115.303810
   Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06
   Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456
   Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]
   Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8
   Zheng XX, 2016, METHODS MOL BIOL, V1421, P35, DOI 10.1007/978-1-4939-3591-8_4
NR 45
TC 53
Z9 53
U1 7
U2 67
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1548-7091
EI 1548-7105
J9 NAT METHODS
JI Nat. Methods
PD MAR
PY 2018
VL 15
IS 3
BP 207
EP +
DI 10.1038/NMETH.4601
PG 9
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA FX7WV
UT WOS:000426303200017
PM 29400715
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ritchie, SA
   van den Hurk, AF
   Smout, MJ
   Staunton, KM
   Hoffmann, AA
AF Ritchie, Scott A.
   van den Hurk, Andrew F.
   Smout, Michael J.
   Staunton, Kyran M.
   Hoffmann, Ary A.
TI Mission Accomplished? We Need a Guide to the 'Post Release' World of
   Wolbachia for Aedes-borne Disease Control
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID CYTOPLASMIC INCOMPATIBILITY; BLOCKS DENGUE; MOSQUITO; AEGYPTI;
   INFECTION; VECTOR; ESTABLISHMENT; STRAIN; TRANSMISSION; POPULATIONS
AB Historically, sustained control of Aedes aegypti, the vector of dengue, chikungunya, yellow fever, and Zika viruses, has been largely ineffective. Subsequently, two novel 'rear and release' control strategies utilizing mosquitoes infected with Wolbachia are currently being developed and deployed widely. In the incompatible insect technique, male Aedes mosquitoes, infected with Wolbachia, suppress populations through unproductive mating. In the transinfection strategy, both male and female Wolbachia-infected Ae. aegypti mosquitoes rapidly infect the wild population with Wolbachia, blocking virus transmission. It is critical to monitor the long-term stability of Wolbachia in host populations, and also the ability of this bacterium to continually inhibit virus transmission. Ongoing release and monitoring programs must be future-proofed should political support weaken when these vectors are successfully controlled.
C1 [Ritchie, Scott A.; Staunton, Kyran M.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia.
   [Ritchie, Scott A.; Smout, Michael J.; Staunton, Kyran M.] James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia.
   [van den Hurk, Andrew F.] Queensland Govt, Dept Hlth, Publ Hlth Virol, Forens & Sci Serv, 39 Kessels Rd, Coopers Plains, Qld 4108, Australia.
   [Hoffmann, Ary A.] Univ Melbourne, Inst Bio21, Sch Biosci, Melbourne, Vic 3010, Australia.
RP Ritchie, SA (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia.; Ritchie, SA (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia.
EM scott.ritchie@jcu.edu.au
RI Staunton, Kyran/W-2263-2019; van den Hurk, Andrew/X-9831-2019; Hoffmann,
   Ary/R-2972-2019
OI Staunton, Kyran/0000-0001-6812-3320; van den Hurk,
   Andrew/0000-0001-6262-831X; Hoffmann, Ary/0000-0001-9497-7645; Smout,
   Michael/0000-0001-6937-0112
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Arimoto H, 2015, J AM MOSQUITO CONTR, V31, P384, DOI 10.2987/moco-31-04-384-387.1
   Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann A. A., 1997, INFLUENTIAL PASSENGE
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004765
   Jacups SP, 2013, J MED ENTOMOL, V50, P344, DOI 10.1603/ME12043
   Khoshmanesh A, 2017, ANAL CHEM, V89, P5285, DOI 10.1021/acs.analchem.6b04827
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Leclercq S, 2016, P NATL ACAD SCI USA, V113, P15036, DOI 10.1073/pnas.1608979113
   Lee SF, 2012, APPL ENVIRON MICROB, V78, P4740, DOI 10.1128/AEM.00069-12
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lindsay SW, 2017, B WORLD HEALTH ORGAN, V95, P607, DOI 10.2471/BLT.16.189688
   Lounibos LP, 2016, J MED ENTOMOL, V53, P1385, DOI 10.1093/jme/tjw122
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Marris E, 2017, NATURE, V548, P17, DOI 10.1038/548017a
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Muzari MO, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005286
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Rasic G, 2015, EVOL APPL, V8, P901, DOI 10.1111/eva.12301
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Ritchie S, 2014, AUSTRAL ENTOMOL, V53, P363, DOI 10.1111/aen.12127
   Ritchie SA, 2017, J INFECT DIS, V215, pS103, DOI 10.1093/infdis/jiw575
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Schmidt T. L., 2017, BIORXIV
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Segoli M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003294
   Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004759
   Sinkins SP, 1995, EXP PARASITOL, V81, P284, DOI 10.1006/expr.1995.1119
   Terradas G, 2017, CURR OPIN INSECT SCI, V22, P37, DOI 10.1016/j.cois.2017.05.005
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yeap HL, 2016, HEREDITY, V116, P265, DOI 10.1038/hdy.2015.97
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
NR 63
TC 28
Z9 28
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD MAR
PY 2018
VL 34
IS 3
BP 217
EP 226
DI 10.1016/j.pt.2017.11.011
PG 10
WC Parasitology
SC Parasitology
GA FX6RQ
UT WOS:000426213900008
PM 29396201
DA 2020-07-08
ER

PT J
AU Simkins, J
   Anjan, S
   Morillas-Rodriguez, JA
   Greissman, SR
   Abbo, LM
   Camargo, JF
   Ruiz, P
   Vianna, R
   Guerra, G
   Salama, S
   Morris, MI
AF Simkins, J.
   Anjan, S.
   Morillas-Rodriguez, J. A.
   Greissman, S. R.
   Abbo, L. M.
   Camargo, J. F.
   Ruiz, P.
   Vianna, R.
   Guerra, G.
   Salama, S.
   Morris, M. I.
TI Screening for Zika virus in deceased organ donors in Florida
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Article
DE clinical research; practice; donors and donation: donor evaluation;
   epidemiology; infection and infectious agents - viral; infectious
   disease
ID UNITED-STATES; PUERTO-RICO; AUGUST 2016; TRANSMISSION; INFECTION;
   SPECIMENS; COLOMBIA; DISEASE; URINE
AB Zika virus (ZIKV) cases have been detected across the United States (US) and locally acquired cases have been reported in Florida. Currently, there are no ZIKV screening guidelines and no data on the incidence among organ donors in the US. This retrospective study was conducted at Jackson Memorial-Miami Transplant Institute. Positive ZIKV tests in local deceased organ donors were investigated from 6/2016 to 1/2017. We evaluated demographics and risk factors for ZIKV infection among organ donors and transplant outcomes among recipients of donors with positive ZIKV testing. One hundred forty-two donors were analyzed. Ten percent had traveled to ZIKV-endemic countries and 19% had outdoor occupations. Only 3% had positive ZIKV IGG. None had a positive ZIKV IGM or PCR. ZIKV-positive donors were more likely to have traveled to ZIKV-endemic countries (50% vs. 9%, P=.05). The kidneys from a ZIKV-positive donor were transplanted in our hospital with no 6-month rejection, graft failure, or death in the recipients. Our study demonstrated a low prevalence of ZIKV among deceased donors in our community. Despite local ZIKV transmission, ZIKV was more common in donors who traveled to ZIKV-endemic countries. This cohort demonstrated excellent outcomes in recipients of ZIKV IGG-positive donors. However, larger studies are needed.
   This study demonstrates a low prevalence of Zika virus among local deceased organ donors in a hospital located in Miami and that Zika virus is more common in donors who traveled to endemic countries for Zika.
C1 [Simkins, J.; Anjan, S.; Abbo, L. M.; Camargo, J. F.; Morris, M. I.] Univ Miami, Miller Sch Med, Div Infect Dis, Dept Med, Miami, FL 33136 USA.
   [Morillas-Rodriguez, J. A.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.
   [Greissman, S. R.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Ruiz, P.; Vianna, R.; Salama, S.] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA.
   [Guerra, G.] Univ Miami, Miller Sch Med, Div Nephrol, Dept Med, Miami, FL 33136 USA.
RP Simkins, J (corresponding author), Univ Miami, Miller Sch Med, Div Infect Dis, Dept Med, Miami, FL 33136 USA.
EM jsimkins@med.miami.edu
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Borena W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178175
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CDC, ZIK VIR DIS US 2015
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Cleto Thais Lira, 2016, Pediatr Neurol, V65, pe1, DOI 10.1016/j.pediatrneurol.2016.08.011
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Florida Health Department, ZIK VIR
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hahn MB, 2016, J MED ENTOMOL, V53
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Kotton CN, 2016, TRANSPLANTATION, V100, P970, DOI 10.1097/TP.0000000000001179
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Nelson B, 2016, PLOS CURR, V8
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   The Centers for Disease Control and Prevention (CDC), ZIK PROT OUTD WORK
NR 29
TC 7
Z9 7
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD MAR
PY 2018
VL 18
IS 3
BP 731
EP 736
DI 10.1111/ajt.14582
PG 6
WC Surgery; Transplantation
SC Surgery; Transplantation
GA FW8YP
UT WOS:000425623200026
PM 29116671
OA Bronze
DA 2020-07-08
ER

PT J
AU Kovendan, K
   Chandramohan, B
   Govindarajan, M
   Jebanesan, A
   Kamalakannan, S
   Vincent, S
   Benelli, G
AF Kovendan, Kalimuthu
   Chandramohan, Balamurugan
   Govindarajan, Marimuthu
   Jebanesan, Arulsamy
   Kamalakannan, Siva
   Vincent, Savariar
   Benelli, Giovanni
TI Orchids as Sources of Novel Nanoinsecticides? Efficacy of Bacillus
   sphaericus and Zeuxine gracilis-Fabricated Silver Nanoparticles Against
   Dengue, Malaria and Filariasis Mosquito Vectors
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Biosafety; DLS; FTIR; Yellow fever; SEM; TEM; XRD; Zika virus
ID CULEX-QUINQUEFASCIATUS DIPTERA; AEDES-AEGYPTI DIPTERA;
   ANOPHELES-STEPHENSI; LEAF EXTRACT; BACTERIAL INSECTICIDE; MEDIATED
   BIOSYNTHESIS; PREDATION EFFICIENCY; ADULTICIDAL ACTIVITY; LARVICIDAL
   ACTIVITY; OVICIDAL ACTIVITY
AB Mosquitoes are the most critical group of insects in the context of public health, since they transmit key parasites and pathogens, causing millions of deaths annually. Insecticides from natural products may boost the effectiveness of vector control programs. In this study, we tested silver nanoparticles (AgNPs) fabricated using the leaf extract of the orchid Zeuxine gracilis as reducing agent, and the microbial pesticide Bacillus sphaericus, against the mosquitoes Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus. The synthesis of AgNP was confirmed analyzing the excitation of surface Plasmon resonance using ultraviolet-visible (UV-Vis) spectrophotometry. SEM and TEM showed the irregular shapes of AgNPs. EDX spectroscopy, FTIR spectroscopy, X-ray diffraction and dynamic light scattering analysis were carried out. AgNPs were highly effective against the larvae of An. stephensi (LC50 = 8.48 A mu g/mL), Ae. aegypti (LC50 = 10.39 A mu g/mL) and Cx. quinquefasciatus (LC50 = 13.21 A mu g/mL), respectively. Combined treatments testing B. sphaericus with AgNPs were also effective against An. stephensi (LC50 = 12.32 A mu g/mL), Ae. aegypti (LC50 = 14.78 A mu g/mL) and Cx. quinquefasciatus (LC50 = 19.19 A mu g/mL). Overall, this study suggests that the orchid-synthesized AgNPs can be a rapid, environmentally safer bio-pesticide to be used in synergy with B. sphaericus to control mosquito vectors.
C1 [Kovendan, Kalimuthu; Chandramohan, Balamurugan; Kamalakannan, Siva] Bharathiar Univ, Sch Life Sci, Div Entomol, Dept Zool, Coimbatore 641046, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Kovendan, Kalimuthu; Jebanesan, Arulsamy] Annamalai Univ, Div Vector Biol, Dept Zool, Annamalainagar 608002, Tamil Nadu, India.
   [Vincent, Savariar] Loyola Coll, PG Res & Dept Adv Zool & Biotechnol, Ctr Environm Res & Dev, LIFE, Chennai 600034, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] Scuola Super Sant Anna, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Kovendan, K (corresponding author), Bharathiar Univ, Sch Life Sci, Div Entomol, Dept Zool, Coimbatore 641046, Tamil Nadu, India.; Kovendan, K (corresponding author), Annamalai Univ, Div Vector Biol, Dept Zool, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Benelli, G (corresponding author), Scuola Super Sant Anna, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
EM gokulloyo@yahoo.co.in; benelli.giovanni@gmail.com
RI /V-9095-2019; GOVINDARAJAN, MARIMUTHU/A-8070-2019; Kalimuthu,
   Kovendan/V-6519-2017
OI /0000-0001-8996-8437; GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931;
   Kalimuthu, Kovendan/0000-0003-1239-525X
FU Science Engineering Research Board (SERB), Department of Science and
   Technology (DST), Govt. of India, New Delhi [PDF/2017/001581]
FX The authors are thankful to Science Engineering Research Board (SERB),
   Department of Science and Technology (DST), Govt. of India, New Delhi
   (PDF/2017/001581) for providing financial support for the present work.
CR Abraham A., 1981, INTRO ORCHIDS, P533
   Amerasan D, 2012, PARASITOL RES, V111, P1953, DOI 10.1007/s00436-012-3042-3
   Ankamwar B, 2005, SYNTH REACT INORG M, V35, P19, DOI 10.1081/SIM-200047527
   Ankanna S, 2010, DIG J NANOMATER BIOS, V5, P369
   Bankar A, 2010, COLLOID SURFACE B, V80, P45, DOI 10.1016/j.colsurfb.2010.05.029
   Bar H, 2009, COLLOID SURFACE A, V348, P212, DOI 10.1016/j.colsurfa.2009.07.021
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bernhard L, 2003, ALTERN APPROACH PHYS, V89, P743, DOI DOI 10.1016/S0031-9406(05)60500-7
   Chandramohan B, 2016, ASIAN PAC J TROP BIO, V6, P472, DOI 10.1016/j.apjtb.2015.11.013
   Cheah SX, 2013, PARASITOL RES, V112, P3275, DOI 10.1007/s00436-013-3506-0
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Dubey SP, 2010, PROCESS BIOCHEM, V45, P1065, DOI 10.1016/j.procbio.2010.03.024
   Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Geetha I, 2012, PEST MANAG SCI, V68, P1447, DOI 10.1002/ps.3324
   Ghorbani HR, 2013, J NANOSTRUCTURE CHEM, V3, DOI 10.1186/2193-8865-3-29
   Govindarajan M, 2017, J CLUST SCI, V28, P15, DOI 10.1007/s10876-016-1035-6
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2014, PARASITOL RES, V113, P1435, DOI 10.1007/s00436-014-3784-1
   Govindarajan M, 2012, PARASITOL RES, V110, P1607, DOI 10.1007/s00436-011-2669-9
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Hooker J. D., 1895, CENTURY INDIAN ORCHI
   KALFON A, 1984, J GEN MICROBIOL, V130, P893
   Karthik L, 2011, PARASITOL RES, V108, P1447, DOI 10.1007/s00436-010-2193-3
   Kovendan K., 2009, INT C GLOB WARM BIOD, P62
   Kovendan K, 2016, J ASIA-PAC ENTOMOL, V19, P1001, DOI 10.1016/j.aspen.2016.09.001
   Kovendan K, 2013, PARASITOL RES, V112, P1205, DOI 10.1007/s00436-012-3252-8
   Kovendan K, 2012, PARASITOL RES, V110, P195, DOI 10.1007/s00436-011-2469-2
   Kovendan K, 2011, PARASITOL RES, V109, P1251, DOI 10.1007/s00436-011-2368-6
   Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008
   Kumar V, 2010, J CHEM TECHNOL BIOT, V85, P1301, DOI 10.1002/jctb.2427
   Luz C, 2007, J MED ENTOMOL, V44, P799, DOI 10.1603/0022-2585(2007)44[799:OAOEHO]2.0.CO;2
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Mahitha B, 2011, DIG J NANOMATER BIOS, V6, P135
   Meisch V., 1990, J AM MOSQUITO CONTR, V6, P496
   Mohanpuria P, 2008, J NANOPART RES, V10, P507, DOI 10.1007/s11051-007-9275-x
   Mukherjee P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075103
   Munusamy R. G., 2016, Asian Pacific Journal of Tropical Disease, V6, P468, DOI 10.1016/S2222-1808(16)61070-8
   Murugan K., 2017, ENV SCI POLLUT RES
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Murugan K, 2012, PARASITOL RES, V111, P1757, DOI 10.1007/s00436-012-3021-8
   Muthukumar T., 2012, ANALES BIOL, V33, P127
   Nagajyothi PC, 2013, MATER LETT, V108, P160, DOI 10.1016/j.matlet.2013.06.095
   Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001
   Noghabi MP, 2017, J MOL STRUCT, V1146, P499, DOI 10.1016/j.molstruc.2017.05.145
   Oz E., 2007, 4 EUR MOSQ CONTR ASS, P11
   Panneerselvam C, 2013, PARASITOL RES, V112, P679, DOI 10.1007/s00436-012-3185-2
   Panneerselvam C, 2012, PARASITOL RES, V111, P2241, DOI 10.1007/s00436-012-3073-9
   Rajaganesh R, 2016, RES VET SCI, V109, P40, DOI 10.1016/j.rvsc.2016.09.012
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Reegan Appadurai Daniel, 2015, Osong Public Health Res Perspect, V6, P64, DOI 10.1016/j.phrp.2014.08.009
   Sathyavathi R, 2010, ADV SCI LETT, V3, P138, DOI 10.1166/asl.2010.1099
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shrivastava S, 2010, NANO-MICRO LETT, V2, P164, DOI 10.1007/BF03353636
   SONG JY, 2009, BIOPROC BIOSYST ENG, V44, P1133
   Soni N, 2014, ANN MICROBIOL, V64, P1099, DOI 10.1007/s13213-013-0749-z
   STERN WL, 1993, BOT J LINN SOC, V113, P161, DOI 10.1111/j.1095-8339.1993.tb00336.x
   Su TY, 1998, J AM MOSQUITO CONTR, V14, P204
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Subramaniam J, 2012, SAUDI J BIOL SCI, V19, P503, DOI 10.1016/j.sjbs.2012.07.003
   Suresh U., 2017, PHYSIOL MOL PLANT P, Vxxx, P1
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Thirunavoukkarasu M, 2013, SPECTROCHIM ACTA A, V116, P424, DOI 10.1016/j.saa.2013.07.033
   Velayutham K, 2013, ASIAN PAC J TROP MED, V6, P95, DOI 10.1016/S1995-7645(13)60002-4
   Vincent S, 2017, J CLUST SCI, V28, P37, DOI 10.1007/s10876-016-1038-3
   Vivek R, 2012, PROCESS BIOCHEM, V47, P2405, DOI 10.1016/j.procbio.2012.09.025
   *WHO, 2005, WHOCDSWHOPESGCDPP200
   WHO, 2010, WKLY EPIDEMIOL REC, V85, P365
   Wirth M. C., 2001, MOSQ CONTROL RES
   World Health Organization, 2014, WHO JAP ENC
   World Health Organization, 1981, WHOVBC81807
   Xu HX, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.246802
   Yang TC, 2009, J VECTOR ECOL, V34, P148, DOI [10.1111/j.1948-7134.2009.00018.x, 10.3376/038.034.0118]
   Zaheer Z, 2017, J MOL LIQ, V242, P1035, DOI 10.1016/j.molliq.2017.07.123
NR 83
TC 3
Z9 3
U1 1
U2 18
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD MAR
PY 2018
VL 29
IS 2
BP 345
EP 357
DI 10.1007/s10876-018-1331-4
PG 13
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA FW8TB
UT WOS:000425608200015
DA 2020-07-08
ER

PT J
AU Aubry, M
   Teissier, A
   Huart, M
   Merceron, S
   Vanhomwegen, J
   Mapotoeke, M
   Mariteragi-Helle, T
   Roche, C
   Vial, AL
   Teururai, S
   Sicard, S
   Paulous, S
   Despres, P
   Manuguerra, JC
   Mallet, HP
   Imrie, A
   Musso, D
   Deparis, X
   Cao-Lormeau, V
AF Aubry, Maite
   Teissier, Anita
   Huart, Michael
   Merceron, Sebastien
   Vanhomwegen, Jessica
   Mapotoeke, Mihiau
   Mariteragi-Helle, Teheipuaura
   Roche, Claudine
   Vial, Anne-Laure
   Teururai, Sylvianne
   Sicard, Sebastien
   Paulous, Sylvie
   Despres, Philippe
   Manuguerra, Jean-Claude
   Mallet, Henri-Pierre
   Imrie, Allison
   Musso, Didier
   Deparis, Xavier
   Cao-Lormeau, Van-Mai
TI Seroprevalence of Dengue and Chikungunya Virus Antibodies, French
   Polynesia, 2014-2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB We investigated dengue and chikungunya virus antibody seroprevalence in French Polynesia during 2014-2015. Dengue virus seroprevalence was approximate to 60% among schoolchildren and >83% among the general population; chikungunya virus seroprevalence was <3% before and 76% after Zika virus emergence (2013). Dengue virus herd immunity may affect Zika virus infection and pathogenesis.
C1 [Aubry, Maite; Teissier, Anita; Mariteragi-Helle, Teheipuaura; Teururai, Sylvianne; Musso, Didier; Cao-Lormeau, Van-Mai] Aix Marseille Univ, IRD, AP HM, SSA,VITROME,IHU Mediterranee Infect, Marseille, France.
   [Aubry, Maite; Teissier, Anita; Mapotoeke, Mihiau; Mariteragi-Helle, Teheipuaura; Roche, Claudine; Teururai, Sylvianne; Musso, Didier; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Papeete, French Polynesi, France.
   [Huart, Michael; Sicard, Sebastien; Deparis, Xavier] Ctr Epidemiol & Sante Publ Armees, Marseille, France.
   [Huart, Michael; Sicard, Sebastien; Deparis, Xavier] Unite Mixte Rech Sci Econ & Sociales Sante & Trai, Marseille, France.
   [Merceron, Sebastien] Inst Stat Polynesie Francaise, Papeete, France.
   [Merceron, Sebastien] Inst Natl Stat & Etud Econ, St Clotilde, La Reunion, France.
   [Vanhomwegen, Jessica; Paulous, Sylvie; Manuguerra, Jean-Claude] Inst Pasteur, Paris, France.
   [Mapotoeke, Mihiau; Vial, Anne-Laure; Mallet, Henri-Pierre] Direct Sante Polynesie Francaise, Papeete, France.
   [Vial, Anne-Laure] Direct Dept Cohes Sociale & Protect Populat, Yonne, France.
   [Despres, Philippe] Univ Reunion, St Clotilde, France.
   [Imrie, Allison] Univ Western Australia, Perth, WA, Australia.
RP Aubry, M (corresponding author), Inst Louis Malarde, POB 30, F-98713 Tahiti, French Polynesi, France.
EM maubry@ilm.pf
RI Musso, Didier/AAO-8178-2020; Imrie, Allison/AAH-2421-2019; Musso,
   Didier/P-7809-2016; Cao-Lormeau, Van-Mai/H-4879-2018
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Aubry,
   Maite/0000-0002-9913-5794
FU Contrat de Projet Etat-Pays [7331/MSS/DSP]; French Government
   Investissement d'Avenir Programme (Labex Integrative Biology of Emerging
   Infectious Diseases)French National Research Agency (ANR)
   [ANR-10-LABX-62-IBEID]
FX This study received grants from the Contrat de Projet Etat-Pays
   (convention no. 7331/MSS/DSP du 31/08/12 modifiee) and from the French
   Government Investissement d'Avenir Programme (Labex Integrative Biology
   of Emerging Infectious Diseases grant no. ANR-10-LABX-62-IBEID).
CR Andrade DV, 2017, VIRUS RES
   Aubry M, 2017, EUROSURVEILLANCE, V22, P14, DOI 10.2807/1560-7917.ES.2017.22.14.30505
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Clapham HE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005926
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   Singh Narendra, 2005, Pac Health Dialog, V12, P111
NR 15
TC 15
Z9 16
U1 0
U2 7
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAR
PY 2018
VL 24
IS 3
BP 558
EP 561
DI 10.3201/eid2403.171149
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FW5QK
UT WOS:000425371700020
PM 29460745
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Food and Drug Administration Panel Recommends Zika Testing of Donated
   Blood Be Relaxed
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 1
PY 2018
VL 66
IS 5
BP I
EP II
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FW5UW
UT WOS:000425385600003
DA 2020-07-08
ER

PT J
AU Rahman, SU
   Yao, XT
   Li, XC
   Chen, DK
   Tao, SH
AF Rahman, Siddiq Ur
   Yao, Xiaoting
   Li, Xiangchen
   Chen, Dekun
   Tao, Shiheng
TI Analysis of codon usage bias of Crimean-Congo hemorrhagic fever virus
   and its adaptation to hosts
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Crimean-Congo hemorrhagic fever virus; Bunyaviridae; Hyalomma; Codon
   usage bias; Evolution
ID DETAILED COMPARATIVE-ANALYSIS; NUCLEOTIDE COMPOSITION; ZIKA VIRUS;
   EVOLUTION; PATTERNS; SELECTION; GENOMES; DEOPTIMIZATION; EPIDEMIOLOGY;
   CHALLENGES
AB Crimean-Congo hemorrhagic fever virus (CCHFV) is a negative-sense, single stranded RNA virus with a three-segmented genome that belongs to the genus Nairovirus within the family Bunyaviridae. CCHFV uses Hyalomma ticks as a vector to infect humans with a wide range of clinical signs, from asymptomatic to Zika-like syndrome. Despite significant progress in genomic analyses, the influences of viral relationships with different hosts on overall viral fitness, survival, and evading the host's immune systems remain unknown. To better understand the evolutionary characteristics of CCHFV, we performed a comprehensive analysis of the codon usage pattern in 179 CCHFV strains by calculating the relative synonymous codon usage (RSCU), effective number of codons (ENC), codon adaptation index (CAI), and other indicators. The results indicate that the codon usage bias of CCHFV is relatively low. Several lines of evidence support the hypothesis that a translation selection factor is shaping codon usage pattern in this virus. A correspondence analysis (CA) showed that other factors, such as base composition, aromaticity, and hydrophobicity may also be involved in shaping the codon usage pattern of CCHFV. Additionally, the results from a comparative analysis of RSCU between CCHFV and its hosts suggest that CCHFV tends to evolve codon usage patterns that are comparable to those of its hosts. Furthermore, the selection pressures from Homo sapiens, Bos taurus, and Ovis aries on the CCHFV RSCU patterns were dominant when compared with selection pressure from Hyalomma spp. vectors. Taken together, both natural selection and mutation pressure are important for shaping the codon usage pattern of CCHFV. We believe that such findings will assist researchers in understanding the evolution of CCHFV and its adaptation to its hosts.
C1 [Rahman, Siddiq Ur; Yao, Xiaoting; Li, Xiangchen; Tao, Shiheng] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.
   [Rahman, Siddiq Ur; Yao, Xiaoting; Li, Xiangchen; Chen, Dekun; Tao, Shiheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.
   [Chen, Dekun] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.
RP Tao, SH (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Chen, DK; Tao, SH (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Chen, DK (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.
EM chendekun163@163.com; shihengt@nwsuaf.edu.cn
RI Rahman, Siddiq Ur/AAP-1706-2020
CR Al-Saif M, 2012, MOL THER, V20, P954, DOI 10.1038/mt.2012.29
   ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990
   Aragones L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000797
   Aslam S, 2016, BIOMED REP, V4, P15, DOI 10.3892/br.2015.545
   Athey J, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1793-7
   Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006
   Bertolotti-Ciarlet A, 2005, J VIROL, V79, P6152, DOI 10.1128/JVI.79.10.6152-6161.2005
   BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358
   Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006
   Butenko A. M., 2007, P99, DOI 10.1007/978-1-4020-6106-6_9
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905
   Chamberlain J, 2005, J GEN VIROL, V86, P3337, DOI 10.1099/vir.0.81213-0
   Chen H, 2014, PLOS ONE, V9
   Cheng X., 2013, PLOS ONE, V8
   Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   Cristina J, 2015, VIRUS RES, V196, P87, DOI 10.1016/j.virusres.2014.11.005
   Das B, 2013, INFECT GENET EVOL, V16, P401, DOI 10.1016/j.meegid.2013.03.016
   Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790
   Dorn A, 2008, CURR OPIN MOL THER, V10, P10
   Duan XK, 2015, INT J MOL SCI, V16, P11996, DOI 10.3390/ijms160611996
   Elliott R. M., 2017, REV ARTICLE MOL BIOL, P501
   European Centre for Disease Prevention and Control, 2016, FACTSH HLTH PROF CRI
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Ghosh S, 2014, J VECTOR DIS, V51, P259
   Goni N, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-263
   Greenacre M.J., 1984, THEORY APPL CORRES A
   Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079
   Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442
   Hewson R, 2004, J GEN VIROL, V85, P3059, DOI 10.1099/vir.0.80121-0
   HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307
   Hu CY, 2014, GENE, V545, P5, DOI 10.1016/j.gene.2014.05.018
   Hu JS, 2011, INFECT GENET EVOL, V11, P2098, DOI 10.1016/j.meegid.2011.08.025
   Costafreda MI, 2014, J VIROL, V88, P5029, DOI 10.1128/JVI.00087-14
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Jung SK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-340
   Karniychuk UU, 2016, VIRUS RES, V223, P73, DOI 10.1016/j.virusres.2016.06.015
   Kattoor JJ, 2015, INFECT GENET EVOL, V34, P17, DOI 10.1016/j.meegid.2015.06.018
   Kumar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154376
   Lara-Ramirez EE, 2014, BIOMED RES INT, DOI 10.1155/2014/851425
   Leblebicioglu H, 2016, ANTIVIR RES, V126, P21, DOI 10.1016/j.antiviral.2015.12.003
   Leblebicioglu H, 2010, INT J ANTIMICROB AG, V36, pS43, DOI 10.1016/j.ijantimicag.2010.06.020
   Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201
   Liu H., 2017, GENOMICS
   Liu XS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-68
   Ma JJ, 2013, J ANIM VET ADV, V12, P88
   Ma MX, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/409386
   Ma YP, 2015, J FISH DIS, V38, P665, DOI 10.1111/jfd.12316
   Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030178
   Metanat M., 2016, CCHF REEMEGING DIS C
   Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06
   Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4
   Novembre JA., 2000, AMINO ACIDS, V2, P1390, DOI DOI 10.1093/0XF0RDJ0URNALS.M0LBEV.A004201
   Papa A., 2002, CHINA, V8
   Pena D. J., 2009, VIRUS HOST COEVOLUTI, P4
   Peyrefitte C, 2015, REV SCI TECH OIE, V34, P391
   Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65
   Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38
   Rabadan R, 2006, J VIROL, V80, P11887, DOI 10.1128/JVI.01414-06
   Rahman SU, 2017, GENES GENOM, V39, P855, DOI 10.1007/s13258-017-0549-0
   RoyChoudhury S, 2010, VIRUS RES, V148, P31, DOI 10.1016/j.virusres.2009.11.018
   Schubert AM, 2010, INFECT GENET EVOL, V10, P129, DOI 10.1016/j.meegid.2009.11.004
   Serres-Giardi L, 2012, PLANT CELL, V24, P1379, DOI 10.1105/tpc.111.093674
   Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1
   Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305
   SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737
   Shayan S, 2015, LABMEDICINE, V46, P180, DOI 10.1309/LMN1P2FRZ7BKZSCO
   Simmonds Peter, 2012, BMC Res Notes, V5, P50, DOI 10.1186/1756-0500-5-50
   Singh NK, 2016, VIRUS RES, V221, P58, DOI 10.1016/j.virusres.2016.05.008
   Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z
   van Hemert F, 2016, J GEN VIROL, V97, P2608, DOI 10.1099/jgv.0.000579
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Wang H, 2016, INT J ELECTROCHEM, DOI 10.1155/2016/4261012
   Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z
   Weaver S. C., 2006, EVOLUTIONARY INFLUEN
   WHO, 2013, CRIM CONG HAEM FEV F
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP
   Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Wu YQ, 2015, GENES-BASEL, V6, P1125, DOI 10.3390/genes6041125
   Yurievna N., 2016, INT J INFECT DIS, V45, P109
   Zhou J, 2013, SCI WORLD J, DOI 10.1155/2013/603130
   Zhou JH, 2012, VIRUS GENES, V44, P475, DOI 10.1007/s11262-012-0731-z
NR 86
TC 3
Z9 3
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD MAR
PY 2018
VL 58
BP 1
EP 16
DI 10.1016/j.meegid.2017.11.027
PG 16
WC Infectious Diseases
SC Infectious Diseases
GA FW4VV
UT WOS:000425314100001
PM 29198972
DA 2020-07-08
ER

PT J
AU Sapkal, GN
   Yadav, PD
   Vegad, MM
   Viswanathan, R
   Gupta, N
   Mourya, DT
AF Sapkal, Gajanan N.
   Yadav, Pragya D.
   Vegad, Mahendra M.
   Viswanathan, Rajlakshmi
   Gupta, Nivedita
   Mourya, Devendra T.
TI First laboratory confirmation on the existence of Zika virus disease in
   India
SO JOURNAL OF INFECTION
LA English
DT Letter
C1 [Sapkal, Gajanan N.; Viswanathan, Rajlakshmi] Natl Inst Virol, Diagnost Virol Grp, Microbial Containment Complex,Sus Rd, Pune 411021, Maharashtra, India.
   [Yadav, Pragya D.] Natl Inst Virol, Maximum Containment Lab, Microbial Containment Complex,Sus Rd, Pune 411021, Maharashtra, India.
   [Vegad, Mahendra M.] BJ Med Coll, Dept Microbiol, 2nd Floor,Civil Hosp Campus, Ahmadabad 380016, Gujarat, India.
   [Gupta, Nivedita] Indian Council Med Res, Minist Hlth & Family Welf, Dept Hlth Res, New Delhi 110029, India.
   [Mourya, Devendra T.] Natl Inst Virol, 20-A,Ambedkar Rd, Pune 411001, Maharashtra, India.
RP Mourya, DT (corresponding author), Natl Inst Virol, 20-A,Ambedkar Rd, Pune 411001, Maharashtra, India.
EM directorniv@gmail.com
FU Indian Council of Medical Research, New Delhi, IndiaIndian Council of
   Medical Research (ICMR)
FX Finance support was provided from Indian Council of Medical Research,
   New Delhi, India.
CR [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
NR 7
TC 7
Z9 7
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD MAR
PY 2018
VL 76
IS 3
BP 314
EP 317
DI 10.1016/j.jinf.2017.09.020
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA FW5JO
UT WOS:000425353000012
PM 28988896
OA Bronze
DA 2020-07-08
ER

PT J
AU Turato, ER
   Lima, DD
   Amaral, EM
   Surita, FGC
   Milanez, HMBPM
   Lajos, GJ
AF Turato, E. R.
   Lima, D. D.
   Amaral, E. M.
   Surita, F. G. C.
   Milanez, H. M. B. P. M.
   Lajos, G. J.
TI Maria - portrait of a Brazilian pregnant woman awaiting zika test
   results and her psychological expectations: Case report from a
   university obstetric public service
SO EUROPEAN PSYCHIATRY
LA English
DT Meeting Abstract
C1 [Turato, E. R.; Lima, D. D.; Amaral, E. M.; Surita, F. G. C.; Milanez, H. M. B. P. M.; Lajos, G. J.] UNICAMP State Univ Campinas, Med Psychol & Psychiat, Lab Clin Qualitat Res, Campinas, SP, Brazil.
RI Lima, Daniela Dantas/B-2004-2017; Surita, Fernanda Garanhani/H-9575-2012
OI Lima, Daniela Dantas/0000-0001-6712-0240; Surita, Fernanda
   Garanhani/0000-0003-4335-0337
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0924-9338
EI 1778-3585
J9 EUR PSYCHIAT
JI Eur. Psychiat.
PD MAR
PY 2018
VL 48
SU S
MA EV0964
BP S565
EP S566
PG 2
WC Psychiatry
SC Psychiatry
GA HO9BQ
UT WOS:000461256107174
DA 2020-07-08
ER

PT J
AU Valega-Mackenzie, W
   Rios-Soto, KR
AF Valega-Mackenzie, Wencel
   Rios-Soto, Karen R.
TI Can Vaccination Save a Zika Virus Epidemic?
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Zika virus; Epidemic model; Vaccination; Epidemiology
ID SEXUAL TRANSMISSION; DYNAMICS; OUTBREAK; MODELS
AB Zika virus (ZIKV) is a vector-borne disease that has rapidly spread during the year 2016 in more than 50 countries around the world. If a woman is infected during pregnancy, the virus can cause severe birth defects and brain damage in their babies. The virus can be transmitted through the bites of infected mosquitoes as well as through direct contact from human to human (e.g., sexual contact and blood transfusions). As an intervention for controlling the spread of the disease, we study a vaccination model for preventing Zika infections. Although there is no formal vaccine for ZIKV, The National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health) has launched a vaccine trial at the beginning of August 2016 to control ZIKV transmission, patients who received the vaccine are expected to return within 44 weeks to determine if the vaccine is safe. Since it is important to understand ZIKV dynamics under vaccination, we formulate a vaccination model for ZIKV spread that includes mosquito as well as sexual transmission. We calculate the basic reproduction number of the model to analyze the impact of relatively, perfect and imperfect vaccination rates. We illustrate several numerical examples of the vaccination model proposed as well as the impact of the basic reproduction numbers of vector and sexual transmission and the effect of vaccination effort on ZIKV spread. Results show that high levels of sexual transmission create larger cases of infection associated with the peak of infected humans arising in a shorter period of time, even when a vaccine is available in the population. However, a high level of transmission of Zika from vectors to humans compared with sexual transmission represents that ZIKV will take longer to invade the population providing a window of opportunities to control its spread, for instance, through vaccination.
C1 [Valega-Mackenzie, Wencel; Rios-Soto, Karen R.] Univ Puerto Rico, Dept Math Sci, Mayaguez, PR 00681 USA.
RP Rios-Soto, KR (corresponding author), Univ Puerto Rico, Dept Math Sci, Mayaguez, PR 00681 USA.
EM wencel.valega@upr.edu; karen.rios3@upr.edu
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Andraud M, 2013, MATH BIOSCI, V244, P22, DOI 10.1016/j.mbs.2013.04.001
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Brauer Fred, 2016, Infect Dis Model, V1, P79, DOI 10.1016/j.idm.2016.08.001
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Cushing JM, 2016, J THEOR BIOL, V404, P295, DOI 10.1016/j.jtbi.2016.06.017
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lee S, 2010, J THEOR BIOL, V265, P136, DOI 10.1016/j.jtbi.2010.04.003
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007
   Pereira RC, 2015, VACCINE, V33, P4261, DOI 10.1016/j.vaccine.2015.03.077
   Raimundo SM, 2015, COMPUT MATH METHOD M, DOI 10.1155/2015/482091
   Saad-Roy CM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2076-z
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   World Health Organization, 2016, SAUDI MED J, V37, P1166
   World Health Organization, 2016, SAUDI MED J, V37, P334
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
NR 26
TC 1
Z9 1
U1 0
U2 41
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD MAR
PY 2018
VL 80
IS 3
BP 598
EP 625
DI 10.1007/s11538-018-0393-7
PG 28
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA FW4TV
UT WOS:000425308400006
PM 29359251
DA 2020-07-08
ER

PT J
AU Rocha, RF
   Del Sarto, JL
   Marques, RE
   Costa, VV
   Teixeira, MM
AF Rocha, Rebeca Froes
   Del Sarto, Juliana Lemos
   Marques, Rafael Elias
   Costa, Vivian Vasconcelos
   Teixeira, Mauro Martins
TI Host target-based approaches against arboviral diseases
SO BIOLOGICAL CHEMISTRY
LA English
DT Review
DE arboviruses; chikungunya virus; dengue virus; host target; immune
   response; Zika virus
ID DENGUE-VIRUS-INFECTION; ANTIBODY-DEPENDENT ENHANCEMENT; MATERNAL IMMUNE
   ACTIVATION; HUMAN PLACENTAL TROPHOBLASTS; PLACEBO-CONTROLLED TRIAL; ZIKA
   VIRUS; CHIKUNGUNYA VIRUS; RHEUMATOID-ARTHRITIS; ANTIVIRAL RESPONSES;
   FRENCH-POLYNESIA
AB In the 20th century, socioeconomic and environmental changes facilitated the reintroduction of mosquitoes in developing cities, resulting in the reinsertion of mosquito-borne viral diseases and the dispersal of their causative agents on a worldwide scale. Recurrent outbreaks of arboviral diseases are being reported, even in regions without a previous history of arboviral disease transmission. Of note, arboviral infections represented approximately 30% of all emerging vector-borne diseases in the last decade. Therapeutic strategies against infectious viral diseases include the use of different classes of molecules that act directly on the pathogen and/or act by optimizing the host immune response. Drugs targeting the virus usually provide amelioration of symptoms by suppressing and controlling the infection. However, it is limited by the short-window of effectiveness, ineffectiveness against latent viruses, development of drug-resistant mutants and toxic side effects. Disease may also be a consequence of an excessive, uncontrolled or misplaced inflammatory response, treatments that interfere in host immune response are interesting options and can be used isolated or in combination with virus-targeted therapies. The use of host-targeted therapies requires specific knowledge regarding host immune patterns that may trigger dengue virus (DENV), chikungunya virus (CHIKV) or Zika virus (ZIKV) disease.
C1 [Rocha, Rebeca Froes; Del Sarto, Juliana Lemos; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Rocha, Rebeca Froes; Del Sarto, Juliana Lemos; Costa, Vivian Vasconcelos; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Biol Sci, Res Ctr Drug Dev, BR-31270901 Belo Horizonte, MG, Brazil.
   [Marques, Rafael Elias] LNBio, Brazilian Biosci Natl Lab, CNPEM, BR-13083970 Campinas, SP, Brazil.
   [Costa, Vivian Vasconcelos] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Teixeira, MM (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.; Teixeira, MM (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Res Ctr Drug Dev, BR-31270901 Belo Horizonte, MG, Brazil.
EM mmtex.ufmg@gmail.com
RI Costa, Vivian VVC/I-2499-2018; Marques, Rafael Elias/R-4890-2016;
   Teixeira, Mauro M/A-4587-2008; de Paiva Froes Rocha, Rebeca/B-2477-2018
OI Costa, Vivian VVC/0000-0002-0175-642X; Marques, Rafael
   Elias/0000-0002-6949-0947; Teixeira, Mauro M/0000-0002-6944-3008; de
   Paiva Froes Rocha, Rebeca/0000-0002-5678-4006
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Andrade DV, 2017, VIRUS RES
   Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Ballendine SA, 2015, PROG NEURO-PSYCHOPH, V57, P155, DOI 10.1016/j.pnpbp.2014.11.002
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chang Z, 2014, ARTHRITIS RHEUMATOL, V66, P3227, DOI 10.1002/art.38811
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chen WQ, 2015, J VIROL, V89, P581, DOI 10.1128/JVI.02034-14
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Cohen S, 2002, ARTHRITIS RHEUM, V46, P614, DOI 10.1002/art.10141
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Costa VV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001663
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598
   de Lamballerie X., 2015, CURACHIK TRIAL EFFIC
   De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049
   Trugilho MRD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006385
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duijster JW, 2016, ZIKA VIRUS INFECT 18
   Fagundes CT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001449
   Flipse J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29201
   Forger F, 2016, EXPERT REV CLIN IMMU, V12, P937, DOI 10.1080/1744666X.2016.1184973
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   FREEDMAN A, 1960, ANN RHEUM DIS, V19, P243, DOI 10.1136/ard.19.3.243
   Freitas Rodrigo Pegado, 2017, TDCS ITS THERAPEUTIC
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Gallegos KM, 2016, J INFECT DIS, V214, P1192, DOI 10.1093/infdis/jiw358
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gasque P, 2015, VECTOR-BORNE ZOONOT, V15, P241, DOI 10.1089/vbz.2014.1710
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guabiraba R, 2013, EUR J IMMUNOL, V43, P1529, DOI 10.1002/eji.201243229
   Guabiraba R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015680
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a030700
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HARINASUTA C, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P332
   Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, P1
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Journel I, 2017, MMWR-MORBID MORTAL W, V66, P172, DOI 10.15585/mmwr.mm6606a4
   Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279
   Khan M, 2010, J MED VIROL, V82, P817, DOI 10.1002/jmv.21663
   Kim JH, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0656-x
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leviton A, 2011, EARLY HUM DEV, V87, P325, DOI 10.1016/j.earlhumdev.2011.01.043
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Mahalingam S, 2017, LANCET INFECT DIS, V17, P686, DOI 10.1016/S1473-3099(17)30340-7
   Marques RE, 2015, IMMUNOLOGY, V145, P583, DOI 10.1111/imm.12476
   Marques RE, 2013, EXPERT OPIN THER TAR, V17, P1439, DOI 10.1517/14728222.2013.837886
   Marques RE, 2014, DENGUE, V6, P1, DOI [10.4199/c00103ed1v01y201402isp049, DOI 10.4199/C00103ED1V01Y201402ISP049]
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   MODI WS, 1990, HUM GENET, V84, P185
   Mosa C, 2014, INT J INFECT DIS, V23, P25, DOI 10.1016/j.ijid.2013.11.021
   Musso D., 2014, EUROSURVEILLANCE, V19
   NAHMIAS AJ, 1971, AM J OBSTET GYNECOL, V110, P825, DOI 10.1016/0002-9378(71)90580-1
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Peng MH, 2017, ANTIVIR RES, V143, P176, DOI 10.1016/j.antiviral.2017.03.026
   Plummer E, 2015, J VIROL, V89, P5592, DOI 10.1128/JVI.00028-15
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ravichandran R, 2008, J INFECT DEV COUNTR, V2, P140, DOI 10.3855/T2.2.140
   Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020
   Renneson J, 2011, AM J PATHOL, V179, P1872, DOI 10.1016/j.ajpath.2011.06.023
   Rong L, 2010, CRIT REV IMMUNOL, V30, P131, DOI 10.1615/CritRevImmunol.v30.i2.30
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Ruiz Silva M., 2016, SCI REP, V6, P28538
   Rulli NE, 2011, J INFECT DIS, V204, P1026, DOI 10.1093/infdis/jir470
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Schwarz TF, 2016, LANCET, V388, P1881, DOI 10.1016/S0140-6736(16)31807-4
   Sharma S. K., 2017, EFFICACY STARTING ME
   Simin C. A. D., 2008, GROWTH LAKELAND, V23, P1
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Skorpen CG, 2016, ANN RHEUM DIS, V75, P795, DOI 10.1136/annrheumdis-2015-208840
   Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007
   Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106
   Srirangan S, 2010, THER ADV MUSCULOSKEL, V2, P247, DOI 10.1177/1759720X10378372
   STEPHEN EL, 1977, J INFECT DIS, V136, P122, DOI 10.1093/infdis/136.1.122
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Teng TS, 2015, J INFECT DIS, V211, P1925, DOI 10.1093/infdis/jiv049
   Terzian A. C. B., 2017, CLIN INFECT DIS, V48, P324
   Nguyen THT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002592
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328
   Woolf NK, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-26
   World Health Organization (WHO), 2016, QUEST ANSW DENG VACC
   WORM M, 1993, MELANOMA RES, V3, P29, DOI 10.1097/00008390-199304000-00005
   Yusof MYM, 2013, DRUGS, V73, P341, DOI 10.1007/s40265-013-0018-2
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zlokovic BV, 2010, NAT MED, V16, P1370, DOI 10.1038/nm1210-1370
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
   Zuiki M, 2017, NEUROSCI LETT, V653, P296, DOI 10.1016/j.neulet.2017.06.004
NR 135
TC 1
Z9 1
U1 1
U2 25
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1431-6730
EI 1437-4315
J9 BIOL CHEM
JI Biol. Chem.
PD MAR
PY 2018
VL 399
IS 3
BP 203
EP 217
DI 10.1515/hsz-2017-0236
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FV7EW
UT WOS:000424747200001
PM 29145171
DA 2020-07-08
ER

PT J
AU Mondolfi, AEP
   Perez, MH
   Blohm, G
   Marquez, M
   Mendoza, AM
   Hernandez-Pereira, CE
   Escalona, MA
   Colatosti, AL
   DeArocha, JR
   Morales, AJR
AF Paniz Mondolfi, A. E.
   Perez, M. Hernandez
   Blohm, G.
   Marquez, M.
   Mogollon Mendoza, A.
   Hernandez-Pereira, C. E.
   Escalona, M. A.
   Lodeiro Colatosti, A.
   Rothe DeArocha, J.
   Rodriguez Morales, A. J.
TI Generalized pustular psoriasis triggered by Zika virus infection
SO CLINICAL AND EXPERIMENTAL DERMATOLOGY
LA English
DT Article
AB Zika virus is an emerging arbovirus, which is expanding in epidemic proportions through tropical and subtropical areas of the world. Although Zika is linked to a number of congenital and neurological complications, there is scarce knowledge on the impact of ZIKV infection in human skin. We report the case of a 68-year old woman who presented with generalized pustular psoriasis after a preceding and otherwise uneventful episode of ZIKV infection. Based on recent experimental data on the biology of ZIKV infection in the cutaneous environment, we speculate that ZIKV may have directly triggered the development of generalized pustular psoriasis by stimulation of keratinocyte-derived mediators of inflammation and a polyfunctional T-cell driven immune reaction in the cutaneous milieu.
C1 [Paniz Mondolfi, A. E.] Hosp Int Barquisimeto, Dept Trop Med & Infect Dis, Ave Intercomunal Barquisimeto Cabudare, Barquisimeto 3023, Lara, Venezuela.
   [Paniz Mondolfi, A. E.] IVSS, Dept Hlth, Caracas, Venezuela.
   [Perez, M. Hernandez] Tufts Med Ctr, Miraca Life Sci Res Inst, Dept Dermatopathol, Boston, MA USA.
   [Blohm, G.] Univ Florida, Coll Liberal Arts & Sci, Dept Biol, Gainesville, FL USA.
   [Marquez, M.; Mogollon Mendoza, A.; Hernandez-Pereira, C. E.; Escalona, M. A.; Lodeiro Colatosti, A.] Infect Dis Res Incubator, Barquisimeto, Lara, Venezuela.
   [Marquez, M.; Mogollon Mendoza, A.; Hernandez-Pereira, C. E.; Escalona, M. A.; Lodeiro Colatosti, A.] Zoonosis & Emerging Pathogens Reg Collaborat Netw, Barquisimeto, Lara, Venezuela.
   [Marquez, M.; Mogollon Mendoza, A.; Hernandez-Pereira, C. E.] Univ Centroccident Lisandro Alvarado, Coll Med, Hlth Sci Dept, Barquisimeto, Lara, Venezuela.
   [Lodeiro Colatosti, A.] Inst Salud Publ Estado Bolivar, Wonken Rural Clin, Ciudad Bolivar, Bolivar, Venezuela.
   [Rothe DeArocha, J.] Hosp Cent Antonio Maria Pineda, Psoriasis Unit, Barquisimeto, Lara, Venezuela.
   [Rodriguez Morales, A. J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
RP Mondolfi, AEP (corresponding author), Hosp Int Barquisimeto, Dept Trop Med & Infect Dis, Ave Intercomunal Barquisimeto Cabudare, Barquisimeto 3023, Lara, Venezuela.
EM albertopaniz@yahoo.com
RI Lodeiro, Carlos/B-4793-2013; Lodeiro, Adriana/AAF-9019-2020
OI Lodeiro, Carlos/0000-0001-5582-5446; Lodeiro,
   Adriana/0000-0001-9410-2347; Escalona Rodriguez,
   Maria/0000-0002-3089-9083
CR Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Fry L, 2007, CLIN DERMATOL, V25, P606, DOI 10.1016/j.clindermatol.2007.08.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ito T, 2000, EUR J DERMATOL, V10, P226
   Jiyad Z, 2015, CLIN EXP DERMATOL, V40, P146, DOI 10.1111/ced.12493
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Seetharam KA, 2011, J DERMATOL, V38, P1033, DOI 10.1111/j.1346-8138.2011.01200.x
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Zampetti A, 2010, CASE REP DERMATOL, V2, P183, DOI 10.1159/000321012
NR 11
TC 3
Z9 3
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0307-6938
EI 1365-2230
J9 CLIN EXP DERMATOL
JI Clin. Exp. Dermatol.
PD MAR
PY 2018
VL 43
IS 2
BP 171
EP 174
DI 10.1111/ced.13294
PG 4
WC Dermatology
SC Dermatology
GA FU8NB
UT WOS:000424108600010
PM 29027743
OA Bronze
DA 2020-07-08
ER

PT J
AU Smith, LB
   Kasai, S
   Scott, JG
AF Smith, Leticia B.
   Kasai, Shinji
   Scott, Jeffrey G.
TI Voltage-sensitive sodium channel mutations S989P+V1016G in Aedes aegypti
   confer variable resistance to pyrethroids, DDT and oxadiazines
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE Vssc; pyrethroid resistance; oxadiazine insecticides; sodium channel;
   DDT
ID KNOCK-DOWN-RESISTANCE; BLATTELLA-GERMANICA; MUSCA-DOMESTICA; INSECTICIDE
   RESISTANCE; DIPTERA-CULICIDAE; CROSS-RESISTANCE; ZIKA VIRUS; HOUSE-FLY;
   KDR; INDOXACARB
AB BACKGROUNDAedes aegypti is a vector of several important human pathogens. Control efforts rely primarily on pyrethroid insecticides for adult mosquito control, especially during disease outbreaks. A. aegypti has developed resistance nearly everywhere it occurs and insecticides are used. An important mechanism of resistance is due to mutations in the voltage-sensitive sodium channel (Vssc) gene. Two mutations, in particular, S989P + V1016G, commonly occur together in parts of Asia.
   RESULTSWe have created a strain (KDR:ROCK) that contains the Vssc mutations S989P + V1016G as the only mechanism of pyrethroid resistance within the genetic background of Rockefeller (ROCK), a susceptible lab strain. We created KDR:ROCK by crossing the pyrethroid-resistant strain Singapore with ROCK followed by four backcrosses with ROCK and Vssc S989P + V1016G genotype selections. We determined the levels of resistance conferred to 17 structurally diverse pyrethroids, the organochloride DDT, and oxadiazines (VSSC blockers) indoxacarb (proinsecticide) and DCJW (the active metabolite of indoxacarb). Levels of resistance to the pyrethroids were variable, ranging from 21- to 107-fold, but no clear pattern between resistance and chemical structure was observed. Resistance is inherited as an incompletely recessive trait. KDR:ROCK had a > 2000-fold resistance to DDT, 37.5-fold cross-resistance to indoxacarb and 13.4-fold cross-resistance to DCJW.
   CONCLUSIONEtofenprox (and DDT) should be avoided in areas where Vssc mutations S989P + V1016G exist at high frequencies. We found that pyrethroid structure cannot be used to predict the level of resistance conferred by kdr. These results provide useful information for resistance management and for better understanding pyrethroid interactions with VSSC. (c) 2017 The Authors. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
C1 [Smith, Leticia B.; Kasai, Shinji; Scott, Jeffrey G.] Cornell Univ, Dept Entomol, 6134 Comstock Hall, Ithaca, NY 14853 USA.
   [Kasai, Shinji] Natl Inst Infect Dis, Dept Med Entomol, Tokyo, Japan.
RP Scott, JG (corresponding author), Cornell Univ, Dept Entomol, 6134 Comstock Hall, Ithaca, NY 14853 USA.
EM jgs5@cornell.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; Griswold Endowment
   fund provided by the Department of Entomology at Cornell University
FX The authors would like to thank C. Sears and S. Fortna for technical
   assistance. This research was supported by the National Institutes of
   Health (to JGS) and Griswold Endowment fund provided by the Department
   of Entomology at Cornell University (to LBS).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chang C, 2012, PESTIC BIOCHEM PHYS, V104, P136, DOI 10.1016/j.pestbp.2012.06.003
   Crow JF, 1970, INTRO THEORY POPULAT
   Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170
   Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   FARNHAM AW, 1977, PESTIC SCI, V8, P631, DOI 10.1002/ps.2780080607
   Finney D.T., 1971, PROBIT ANAL
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GRANT DF, 1989, PESTIC BIOCHEM PHYS, V33, P132, DOI 10.1016/0048-3575(89)90004-7
   Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994
   Jiang DX, 2015, INSECT BIOCHEM MOLEC, V66, P88, DOI 10.1016/j.ibmb.2015.09.011
   Kasai S, 1998, ARCH INSECT BIOCHEM, V37, P47, DOI 10.1002/(SICI)1520-6327(1998)37:1&lt;47::AID-ARCH6&gt;3.0.CO;2-S
   Kasai S, 2017, ACTA HORTIC, V1169, P87
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Khan HAA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-146
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Lapied B, 2001, BRIT J PHARMACOL, V132, P587, DOI 10.1038/sj.bjp.0703853
   Lee RML, 2014, TROP BIOMED, V31, P670
   Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z
   Milani R., 1957, Rivista di Parassitologia Roma, V18, P199
   Miyazaki M, 1996, MOL GEN GENET, V252, P61, DOI 10.1007/BF02173205
   N'Guessan R, 2007, J MED ENTOMOL, V44, P270, DOI 10.1603/0022-2585(2007)44[270:EOIAOI]2.0.CO;2
   NARAHASHI T, 1971, B WORLD HEALTH ORGAN, V44, P337
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   NOLAN J, 1977, PESTIC SCI, V8, P484, DOI 10.1002/ps.2780080508
   OMER SM, 1980, MOSQ NEWS, V40, P200
   Oxborough RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055781
   Prapanthadara L., 2005, Dengue Bulletin, V29, P183
   PRASITTISUK C, 1977, PESTIC SCI, V8, P527, DOI 10.1002/ps.2780080516
   Raymond M., 1985, Cahiers O.R.S.T.O.M., Serie Entomologie Medicale et Parasitologie, V23, P117
   Scott J. G., 1990, PESTICIDE RESISTANCE, P39
   SCOTT JG, 1994, COMP BIOCHEM PHYS B, V109, P191, DOI 10.1016/0305-0491(94)90002-7
   SCOTT JG, 1981, PESTIC BIOCHEM PHYS, V16, P21, DOI 10.1016/0048-3575(81)90068-7
   Shono T, 2004, PESTIC BIOCHEM PHYS, V80, P106, DOI 10.1016/j.pestbp.2004.06.004
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325
   Sun H, 2016, INSECT MOL BIOL, V25, P126, DOI 10.1111/imb.12206
   Tsagkarakou A, 2009, INSECT MOL BIOL, V18, P583, DOI 10.1111/j.1365-2583.2009.00900.x
   WHO, 2012, DENGUE B
   Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204
   Wing KD, 1998, ARCH INSECT BIOCHEM, V37, P91, DOI 10.1002/(SICI)1520-6327(1998)37:1&lt;91::AID-ARCH11&gt;3.0.CO;2-5
   Wing KD, 2000, CROP PROT, V19, P537, DOI 10.1016/S0261-2194(00)00070-3
   World Health Organization, DENG SEV DENG
   World Health Organization, YELLOW FEVER
   World Health Organization, 2006, PESTICIDES THEIR APP
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   Yadav R, 2011, GLOBAL INSECTICIDE U
   YAMASAKI T., 1962, Japanese Journal of Applied Entomology and Zoology, V6, P293, DOI 10.1303/jjaez.6.293
NR 52
TC 11
Z9 11
U1 1
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD MAR
PY 2018
VL 74
IS 3
BP 737
EP 745
DI 10.1002/ps.4771
PG 9
WC Agronomy; Entomology
SC Agriculture; Entomology
GA FU3UM
UT WOS:000423777600026
PM 29064635
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lamb, LE
   Bartolone, SN
   Tree, MO
   Conway, MJ
   Rossignol, J
   Smith, CP
   Chancellor, MB
AF Lamb, Laura E.
   Bartolone, Sarah N.
   Tree, Maya O.
   Conway, Michael J.
   Rossignol, Julien
   Smith, Christopher P.
   Chancellor, Michael B.
TI Rapid Detection of Zika Virus in Urine Samples and Infected Mosquitos by
   Reverse Transcription-Loop-Mediated Isothermal Amplification
SO SCIENTIFIC REPORTS
LA English
DT Article
ID IMAGE-ANALYSIS; PLATFORM; DISEASE; RNA; PCR
AB Infection with Zika virus (ZIKV) is of growing concern since infection is associated with the development of congenital neurological disease. Quantitative reverse transcription PCR (qRT-PCR) has been the standard for ZIKV detection; however, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) may allow for faster and cheaper testing. Studies have suggested that ZIKV detection in urine is more sensitive and has a longer window of detection compared to serum and saliva. The objective of this study was to develop a urine diagnostic test that could be completed in under 30 minutes. Urine samples spiked with ZIKV or dengue virus were tested using RT-LAMP as well as by conventional quantitative qRT-PCR. These techniques were then validated using crude lysates made from ZIKV infected mosquitoes in addition to urine and serum samples from ZIKV infected patients. RT-LAMP specifically detected ZIKV in urine and serum for ZIKV infected patients and crude mosquito lysates. This test was performed in under 30 minutes and did not require RNA extraction from urine nor mosquitos. This approach could be used for monitoring of exposed individuals, especially pregnant women, couples wanting to conceive, or individuals with suspicious symptoms as well as surveillance of mosquito populations.
C1 [Lamb, Laura E.; Bartolone, Sarah N.; Chancellor, Michael B.] Beaumont Hlth Syst, Dept Urol, Royal Oak, MI 48073 USA.
   [Lamb, Laura E.; Chancellor, Michael B.] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48309 USA.
   [Tree, Maya O.; Conway, Michael J.; Rossignol, Julien] Cent Michigan Univ, Coll Med, Fdn Sci, Mt Pleasant, MI 48859 USA.
   [Rossignol, Julien] Cent Michigan Univ, Field Neurosci Lab Restorat Neurol, Mt Pleasant, MI 48859 USA.
   [Rossignol, Julien] Cent Michigan Univ, Program Neurosci, Mt Pleasant, MI 48859 USA.
   [Smith, Christopher P.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA.
RP Lamb, LE (corresponding author), Beaumont Hlth Syst, Dept Urol, Royal Oak, MI 48073 USA.; Lamb, LE (corresponding author), Oakland Univ, William Beaumont Sch Med, Rochester, MI 48309 USA.
EM laura.lamb@beaumont.org
RI Rossignol, Julien/I-1013-2019; amsalu, ribka/G-8780-2019
OI Rossignol, Julien/0000-0002-8662-0547; Bartolone,
   Sarah/0000-0001-9040-7055; Lamb, Laura/0000-0003-0386-4165
FU Maureen and Ronald Hirsch family; Field Neurosciences Institute, St.
   Mary's of Michigan
FX We would like to thank Clinica La Esperanza, Copan Ruinas, Hondoras. We
   acknowledge the Infectious Disease group at Beaumont for use of their
   imaging system. We also thank Dr. Bernadette Zwaans for her critical
   review of manuscript and support and Elijah Ward for technical
   assistance. This work was supported by the Maureen and Ronald Hirsch
   family philanthropic contribution and Field Neurosciences Institute, St.
   Mary's of Michigan. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x
   Gandasegui J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003963
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Interim Guidance for Zika Virus Testing of Urine - United States, 2016, INTERIM GUIDANCE ZIK
   Lamb LE, 2016, INT UROL NEPHROL, V48, P1961, DOI 10.1007/s11255-016-1406-9
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Lee JR, 2014, IMMUNOL REV, V258, P218, DOI 10.1111/imr.12159
   Miranda KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096094
   Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Paz-Bailey G, 2017, NEW ENGLAND J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tanner NA, 2012, BIOTECHNIQUES, V53, P81, DOI 10.2144/0000113902
   Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
NR 26
TC 11
Z9 12
U1 1
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 28
PY 2018
VL 8
AR 3803
DI 10.1038/s41598-018-22102-5
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX7IM
UT WOS:000426262400056
PM 29491389
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Basu, R
   Zhai, LK
   Contreras, A
   Tumban, E
AF Basu, Rupsa
   Zhai, Lukai
   Contreras, Alice
   Tumban, Ebenezer
TI Immunization with phage virus-like particles displaying Zika virus
   potential B-cell epitopes neutralizes Zika virus infection of monkey
   kidney cells
SO VACCINE
LA English
DT Article
DE Zika virus; Vaccine; B-cell epitopes; Bacteriophage virus-like
   particles; Neutralization; PRNT; Protection
ID MOUSE MODEL; ENVELOPE GLYCOPROTEIN; CROSS-REACTIVITY; PEPTIDE VACCINES;
   HUMAN-ANTIBODIES; DENGUE VIRUS; FLAVIVIRUS
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that has re-emerged and is associated with many debilitating clinical manifestations. Research is currently being conducted to develop a prophylactic vaccine against the virus; however, there has not been any licensed ZIKV vaccine. Recent studies have identified potential B-cell epitopes (amino acids 241-259, 294-315, 317-327, 346-361, 377-388 and 421-437) on the envelope protein of ZIKV, which could be explored to develop peptide vaccines against ZIKV infection. Nevertheless, the immunogenicity of these epitopes has never been assessed. Here, we displayed these epitopes on highly immunogenic bacteriophage virus-like particles (VLPs; MS2, PP7 and Q beta) platforms and assessed their immunogenicity in mice. Mice immunized with a mixture of VLPs displaying ZIKV envelope B-cell epitopes elicited anti-ZIKV antibodies. Although, immunized mice were not protected against a high challenge dose of ZIKV, sera- albeit at low titers-from immunized mice neutralized (in vitro) a low dose of ZIKV. Taken together, these results show that these epitopes are B-cell epitopes and they are immunogenic when displayed on a Q beta VLP platform. Furthermore, the results also show that immunization with VLPs displaying a single B-cell epitope minimally reduces ZIKV infection whereas immunization with a mixture of VLPs displaying a combination of the B-cell epitopes neutralizes ZIKV infection. Thus, immunization with a mixture of VLPs displaying multiple ZIKV B-cell epitopes is a good strategy to enhance ZIKV neutralization. Published by Elsevier Ltd.
C1 [Basu, Rupsa; Zhai, Lukai; Contreras, Alice; Tumban, Ebenezer] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA.
RP Tumban, E (corresponding author), Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA.
EM etumban@mtu.edu
RI Basu, Rupsa/V-2531-2019
OI Basu, Rupsa/0000-0002-6336-0842
FU Michigan Technological University - United States
FX We would like to thank Dr. Robert Tesh (World Reference Center for
   Emerging Viruses and Arboviruses at the University of Texas Medical
   Branch in Galveston) for providing us with ZIKV MR-766. We would also
   like to thank Julianne Peabody for her comments and Owen Mills for
   helping with TEM. This study was supported by a start-up fund from
   Michigan Technological University - United States.
CR Aliota MT, 2017, ANTIVIRAL RES
   Badawi MM, 2016, AM J BIOMED RES, V4, P46
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   BRUNSWICK M, 1988, J IMMUNOL, V140, P3364
   Caldeira JD, 2010, VACCINE, V28, P4384, DOI 10.1016/j.vaccine.2010.04.049
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   CDC, 2017, CONG ZIK SYNDR OTH B
   Chackerian B, 2008, J IMMUNOL, V180, P5816, DOI 10.4049/jimmunol.180.9.5816
   Chackerian B, 2011, J MOL BIOL, V409, P225, DOI 10.1016/j.jmb.2011.03.072
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dey S, 2017, COMPUT BIOL CHEM, V68, P143, DOI 10.1016/j.compbiolchem.2017.03.002
   DINTZIS RZ, 1985, J IMMUNOL, V135, P423
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515
   Milich DR, 1997, P NATL ACAD SCI USA, V94, P14648, DOI 10.1073/pnas.94.26.14648
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Mishra B, 2016, J POSTGRAD MED, V62, P249, DOI 10.4103/0022-3859.191006
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shawan M. M. A. K., 2014, INDIAN J PHARM BIOL, V2, P44
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Slingluff CL, 2011, CANCER J, V17, P343, DOI 10.1097/PPO.0b013e318233e5b2
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tumban E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049751
   Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310
   Tyler M, 2014, VACCINE, V32, P4267, DOI 10.1016/j.vaccine.2014.06.054
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wang JZ, 2016, BRAIN DEV
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 45
TC 9
Z9 9
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD FEB 28
PY 2018
VL 36
IS 10
BP 1256
EP 1264
DI 10.1016/j.vaccine.2018.01.056
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FX6UV
UT WOS:000426223700003
PM 29395533
DA 2020-07-08
ER

PT J
AU Ghosh, D
AF Ghosh, Debosree
TI Zika virus - a global emergency
SO CURRENT SCIENCE
LA English
DT Editorial Material
C1 [Ghosh, Debosree] Govt Gen Degree Coll, Dept Physiol, Medinipur 721149, India.
RP Ghosh, D (corresponding author), Govt Gen Degree Coll, Dept Physiol, Medinipur 721149, India.
EM ghoshdebosree@gmail.com
NR 0
TC 1
Z9 1
U1 0
U2 4
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD FEB 25
PY 2018
VL 114
IS 4
BP 725
EP 725
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX1CW
UT WOS:000425786600019
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Shi, YC
   Li, SH
   Wu, Q
   Sun, L
   Zhang, JJ
   Pan, N
   Wang, QH
   Bi, YH
   An, J
   Lu, XC
   Gao, GF
   Wang, XQ
AF Shi, Yingchao
   Li, Shihua
   Wu, Qian
   Sun, Le
   Zhang, Junjing
   Pan, Na
   Wang, Qihui
   Bi, Yuhai
   An, Jing
   Lu, Xuancheng
   Gao, George Fu
   Wang, Xiaoqun
TI Vertical Transmission of the Zika Virus Causes Neurological Disorders in
   Mouse Offspring
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INFECTION; BRAIN; CELLS; EMERGENCE; INFANTS; NEURONS; DENGUE; BRAZIL;
   LEADS
AB The association between Zika virus (ZIKV) infection and congenital malformations such as microcephaly in infants is a public health emergency. Although various in vivo and in vitro models are used for ZIKV research, few animal models are available for resolving the effects of maternal ZIKV infection on neonatal development. Here, we established an immunocompetent mouse model via intrauterine inoculation. Our results confirmed that ZIKV, but not dengue virus, infection caused spontaneous abortions, brain malformations, ocular abnormalities, spinal cord defects and paralysis in mouse offspring. Aside from microcephaly and hippocampal dysplasia, eye abnormalities, including microphthalmia, thinner optic nerves, damaged retinae, and deficient visual projection, were also observed following ZIKV infection. Moreover, ZIKV-infected offspring showed a loss of alpha motor neurons in the spinal cord and cerebellar malformation, which may cause paralysis. ZIKV also impaired adult neurogenesis in neonatal mice. Due to its intact immunity, our rodent model can be used to systematically evaluate the impact of ZIKV on embryonic and neonatal development and to explore potential therapies.
C1 [Shi, Yingchao; Wu, Qian; Sun, Le; Zhang, Junjing; Pan, Na; Wang, Xiaoqun] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.
   [Li, Shihua; Wang, Qihui; Bi, Yuhai; Gao, George Fu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Shi, Yingchao; Wu, Qian; Sun, Le; Pan, Na; Wang, Xiaoqun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [An, Jing; Wang, Xiaoqun] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.
   [Gao, George Fu] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.
   [Gao, George Fu] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
   [An, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100069, Peoples R China.
   [Gao, George Fu] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China.
   [Lu, Xuancheng] Chinese Ctr Dis Control & Prevent, Lab Anim Ctr, Beijing 102206, Peoples R China.
RP Wang, XQ (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.; Wang, XQ (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Wang, XQ (corresponding author), Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.; Gao, GF (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China.
EM gaof@im.ac.cn; xiaoqunwang@ibp.ac.cn
FU National Basic Research Program of ChinaNational Basic Research Program
   of China [2014CB964600, 2017YFA0103303]; Zika Special Project of the
   MOST Reform and Development Project; National Key Plan for Scientific
   Research and Development of China [2016YFD0500304]; Chinese Academy of
   SciencesChinese Academy of Sciences [XDA16020601]; National Natural
   Science Foundation of China (NSFC)National Natural Science Foundation of
   China [31371100, 91732301, 31671072]; STCSMScience & Technology
   Commission of Shanghai Municipality (STCSM) [16JC1420500]
FX We thank members from Gao lab and Wang lab for suggestion and
   discussion. This work was supported by National Basic Research Program
   of China (2014CB964600, 2017YFA0103303), the Zika Special Project of the
   MOST Reform and Development Project, the National Key Plan for
   Scientific Research and Development of China (2016YFD0500304), the
   Strategic Priority Research Program of the Chinese Academy of Sciences
   (XDA16020601), the National Natural Science Foundation of China (NSFC)
   (31371100, 91732301 to X.W., 31671072 to Q.W) and the Grants of Shanghai
   Brain-Intelligence Project from STCSM (16JC1420500). G.F.G. is a leading
   principal investigator of the NSFC Innovative Research Group (81621091).
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2014, EURO SURVEILL, V19
   Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Euler T, 2016, NATURE, V535, P45, DOI 10.1038/nature18454
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028
   Lazarov O, 2016, PROG NEUROBIOL, V138, P1, DOI 10.1016/j.pneurobio.2015.12.006
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MAYER RF, 1981, NEUROSCIENCE, V6, P725, DOI 10.1016/0306-4522(81)90156-1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moser MB, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021808
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2014, EURO SURVEILL, V19
   Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   STRYKER MP, 1986, J NEUROSCI, V6, P2117
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Toda T., 2017, CELL TISSUE RES
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura L. O., 2017, J AAPOS
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang S, 2014, P NATL ACAD SCI USA, V111, pE3110, DOI 10.1073/pnas.1323342111
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 55
TC 8
Z9 9
U1 2
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 23
PY 2018
VL 8
AR 3541
DI 10.1038/s41598-018-21894-w
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX2YI
UT WOS:000425934200029
PM 29476066
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Luo, SY
   Cui, WH
   Li, C
   Ling, F
   Fu, T
   Liu, QY
   Ren, JP
   Sun, JM
AF Luo, Shuying
   Cui, Weihong
   Li, Chan
   Ling, Feng
   Fu, Tao
   Liu, Qiyong
   Ren, Jiangping
   Sun, Jimin
TI Seroprevalence of dengue IgG antibodies in symptomatic and asymptomatic
   individuals three years after an outbreak in Zhejiang Province, China
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Seroprevalence; Antibody; Duration
ID VIRUS-INFECTION; DEPENDENT ENHANCEMENT; ZIKA VIRUS; FEVER
AB Background: Cross-reacting antibodies enhanced dengue infection in humans and antibody dependent enhancement (ADE) have been proposed as early mechanisms underlying DHF/DSS. However, the duration of dengue IgG antibodies in the body as well as factors associated with said duration remain unclear.
   Methods: Blood samples from 59 dengue symptomatic persons and 48 asymptomatic individuals were collected. Study participant demographic information (including age in 2009, gender, and place of residence) were also collected. Serum samples were tested for dengue specific IgG by Panbio dengue IgG indirect enzyme-linked immunosorbent assay (ELISA). Chi-square tests and logistic regression analysis of dengue IgG antibodies seroprevalence divided by gender, age groups, and symptomatic or asymptomatic infection were conducted using the Statistical Package for the Social Sciences.
   Results: Overall, 70 (65.42%) blood samples were seropositive for dengue IgG antibodies with similar seroprevalences found when dividing by gender and different age groups. However, seroprevalence of dengue IgG antibodies in samples from dengue symptomatic persons was significantly higher than that in samples from asymptomatic individuals (96.61% vs 27.08%) according to multivariable logistic regression analysis, the odds ratio (OR) of the factor was 76.731.
   Conclusions: Dengue IgG antibodies were detectable in samples from most individuals three years after infection. Dengue symptomatic persons had a higher dengue IgG prevalence compared to asymptomatic individuals.
C1 [Li, Chan; Ling, Feng; Ren, Jiangping; Sun, Jimin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.
   [Luo, Shuying; Fu, Tao] Yiwu Municipal Ctr Dis Control & Prevent, Yiwu, Peoples R China.
   [Cui, Weihong] Yantai Municipal Ctr Dis Control & Prevent, Yantai, Peoples R China.
   [Liu, Qiyong; Sun, Jimin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.
RP Sun, JM (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.; Sun, JM (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.
EM jmsun@cdc.zj.cn
FU National Basic Research Program of China (973 Program)National Basic
   Research Program of China [2012CB955504]; Medical Research Program of
   Zhejiang Province [2015RCA005]
FX This work was supported by the National Basic Research Program of China
   (973 Program) (Grant Number 2012CB955504), the Medical Research Program
   of Zhejiang Province (2015RCA005).
CR Ang LW, 2015, EPIDEMIOL INFECT, V143, P1585, DOI 10.1017/S0950268814002507
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chen B, 2015, LANCET, V385, P1621, DOI 10.1016/S0140-6736(15)60793-0
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Gabor JJ, 2016, TRAVEL MED INFECT DI, V14, P26, DOI 10.1016/j.tmaid.2016.01.005
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Imrie A, 2007, VIRAL IMMUNOL, V20, P672, DOI 10.1089/vim.2007.0050
   Jamjoom Ghazi A, 2016, Virology (Auckl), V7, P1, DOI [10.4137/VRT.S34187, 10.4137/vrt.s34187]
   Jeewandara C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144799
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   Lau L, 2015, J CLIN VIROL, V69, P63, DOI 10.1016/j.jcv.2015.06.003
   Mazaba-Liwewe ML, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-135
   Ministry of Health of the People's Republic of China, 2008, DIAGN CRIT DENG FEV, P1
   Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Shah PS, 2017, J VECTOR DIS, V54, P172
   Soghaier MA, 2014, J INFECT PUBLIC HEAL, V7, P54, DOI 10.1016/j.jiph.2013.07.008
   Sun JM, 2012, VIRAL IMMUNOL, V25, P456, DOI 10.1089/vim.2012.0039
   Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396
   Tun MMN, 2016, BIORESEARCH OPEN ACC, V5, P188, DOI 10.1089/biores.2016.0016
   Vairo F, 2014, EMERG INFECT DIS, V20, P465, DOI 10.3201/eid2003.130150
   Vongpunsawad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180560
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114
NR 27
TC 3
Z9 4
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 23
PY 2018
VL 18
AR 92
DI 10.1186/s12879-018-3000-5
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA FX4UK
UT WOS:000426073600004
PM 29471783
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kakooza-Mwesige, A
   Mohammed, AH
   Kristensson, K
   Juliano, SL
   Lutwama, JJ
AF Kakooza-Mwesige, Angelina
   Mohammed, Abdul H.
   Kristensson, Krister
   Juliano, Sharon L.
   Lutwama, Julius J.
TI Emerging Viral Infections in Sub-Saharan Africa and the Developing
   Nervous System: A Mini Review
SO FRONTIERS IN NEUROLOGY
LA English
DT Review
DE developing nervous system; emerging viruses; Ebola virus; Chikungunya
   virus; West Nile virus; Zika virus; neurological disorders; sub-Saharan
   Africa
ID WEST-NILE-VIRUS; ZIKA VIRUS; AEDES-AEGYPTI; CHIKUNGUNYA FEVER;
   CARBON-DIOXIDE; ANIMAL-MODELS; EBOLA-VIRUS; CHILDREN; MOSQUITO; ILLNESS
AB The global public health concern is heightened over the increasing number of emerging viruses, i.e., newly discovered or previously known that have expanded into new geographical zones. These viruses challenge the health-care systems in sub-Saharan Africa (SSA) countries from which several of them have originated and been transmitted by insects worldwide. Some of these viruses are neuroinvasive, but have been relatively neglected by neuroscientists. They may provide experiments by nature to give a time window for exposure to a new virus within sizeable, previously non-infected human populations, which, for instance, enables studies on potential long-term or late-onset effects on the developing nervous system. Here, we briefly summarize studies on the developing brain by West Nile, Zika, and Chikungunya viruses, which are mosquito-borne and have spread worldwide out of SSA. They can all be neuroinvasive, but their effects vary from malformations caused by prenatal infections to cognitive disturbances following perinatal or later infections. We also highlight Ebola virus, which can leave surviving children with psychiatric disturbances and cause persistent infections in the non-human primate brain. Greater awareness within the neuroscience community is needed to emphasize the menace evoked by these emerging viruses to the developing brain. In particular, frontline neuroscience research should include neuropediatric follow-up studies in the field on long-term or late-onset cognitive and behavior disturbances or neuropsychiatric disorders. Studies on pathogenetic mechanisms for viral-induced perturbations of brain maturation should be extended to the vulnerable periods when neurocircuit formations are at peaks during infancy and early childhood.
C1 [Kakooza-Mwesige, Angelina] Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda.
   [Kakooza-Mwesige, Angelina] Mulago Hosp, Kampala, Uganda.
   [Mohammed, Abdul H.] Linnaeus Univ, Dept Psychol, Vaxjo, Sweden.
   [Kristensson, Krister] Karolinska Inst, Dept Neurosci, Stockholm, Sweden.
   [Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Anat Physiol & Genet, Bethesda, MD 20814 USA.
   [Lutwama, Julius J.] Uganda Virus Res Inst, Arbovirol Lab, Entebbe, Uganda.
RP Kakooza-Mwesige, A (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda.; Kakooza-Mwesige, A (corresponding author), Mulago Hosp, Kampala, Uganda.
EM akakooza246@gmail.com
RI Juliano, Sharon/AAO-1030-2020
FU DELTAS Africa Initiative grant [DEL-15-011]; Wellcome TrustWellcome
   Trust [107742/Z/15/Z]; UK government
FX AK-M was supported through the DELTAS Africa Initiative grant #
   DEL-15-011 to THRiVE-2. The DELTAS Africa Initiative is a funding scheme
   of the Accelerating Excellence in Science in Africa (AESA) with funding
   from the Wellcome Trust grant # 107742/Z/15/Z and the UK government.
CR Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Barzon L, 2015, EXPERT REV ANTI-INFE, V13, P1373, DOI 10.1586/14787210.2015.1083859
   BIDLINGMAYER WL, 1980, B ENTOMOL RES, V70, P321, DOI 10.1017/S0007485300007604
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Dalman C, 2008, AM J PSYCHIAT, V165, P59, DOI 10.1176/appi.ajp.2007.07050740
   DAVIS EE, 1976, J COMP PHYSIOL, V105, P43, DOI 10.1007/BF01380052
   DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Etard JF, 2017, LANCET INFECT DIS, V17, P545, DOI 10.1016/S1473-3099(16)30516-3
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gaensbauer JT, 2014, PEDIATRICS, V134, pE642, DOI 10.1542/peds.2014-0498
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360
   Han HJ, 2015, VIRUS RES, V205, P1, DOI 10.1016/j.virusres.2015.05.006
   Hanzlik E, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060047
   Hasbun R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148898
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4
   Kihara M, 2014, NEGLECTED TROPICAL D, P369
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Kleinschmidt-DeMasters BK, 2015, BRAIN PATHOL, V25, P625, DOI 10.1111/bpa.12280
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Kristensson K, 2011, NAT REV NEUROSCI, V12, P345, DOI 10.1038/nrn3029
   Larsen T, 2007, J INFECT DIS, V196, pS323, DOI 10.1086/520589
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Maximova OA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004980
   McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Newton C, 2014, NEGLECTED TROPICAL D, P355
   Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pastula DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005410
   PAUL JR, 1971, HIST POLIOMYELITIS
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277
   Pridjian G, 2016, BIRTH DEFECTS RES A, V106, P716, DOI 10.1002/bdra.23523
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Riabinina O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13010
   Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Samaan Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158364
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shives KD, 2017, J NEUROIMMUNOL, V308, P102, DOI 10.1016/j.jneuroim.2017.03.006
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   Smith JC, 2014, J INFECTION, V69, pS70, DOI 10.1016/j.jinf.2014.07.019
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212
   van Breugel F, 2015, CURR BIOL, V25, P2123, DOI 10.1016/j.cub.2015.06.046
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   WHO, 2017, WHO DIS OUTBR YEAR
   Wilmshurst JM, 2014, CURR OPIN HIV AIDS, V9, P533, DOI 10.1097/COH.0000000000000101
   Wilson CA, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0391-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5
   Zeng XK, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.113
NR 74
TC 1
Z9 1
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD FEB 23
PY 2018
VL 9
AR 82
DI 10.3389/fneur.2018.00082
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FX3SD
UT WOS:000425991700001
PM 29527187
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saisawang, C
   Kuadkitkan, A
   Auewarakul, P
   Smith, DR
   Ketterman, AJ
AF Saisawang, Chonticha
   Kuadkitkan, Atichat
   Auewarakul, Prasert
   Smith, Duncan R.
   Ketterman, Albert J.
TI Glutathionylation of dengue and Zika NS5 proteins affects
   guanylyltransferase and RNA dependent RNA polymerase activities
SO PLOS ONE
LA English
DT Article
ID CAPPING ENZYME; VIRUS; DOMAIN; ENTRY; ASSAY
AB It has been estimated for dengue infection that the global population at risk is 3.5 billion people, which makes dengue an important public health problem. The causative agents of dengue are dengue viruses. For dengue virus replication, the dengue virus NS5 protein is of special importance as it has several enzyme activities important for viral replication. Previous reports of phosphorylation and SUMOylation of dengue NS5 have shown these protein modifications have important consequences for NS5 functions. In this report we identify glutathionylation, another reversible post translation modification that impacts on NS5 enzyme activity. Using dengue virus infected cells we employed specific antibodies and mass spectrometry to identify 3 cysteine residues of NS5 protein as being glutathionylated. Glutathionylation is a post translational protein modification where glutathione is covalently attached to a cysteine residue. We showed glutathionylation occurs on 3 conserved cysteine residues of dengue NS5. Then we generated two flavivirus recombinant full length proteins, dengue NS5 and Zika NS5, to characterize two of the NS5 enzyme activities, namely, guanylyltransferase and RNA-dependent RNA polymerase activities. We show glutathionylation of dengue and Zika NS5 affects enzyme activities of the two flavivirus proteins. The data suggests that glutathionylation is a general feature of the flavivirus NS5 protein and the modification has the potential to modulate several of the NS5 enzyme functions.
C1 [Saisawang, Chonticha; Kuadkitkan, Atichat; Smith, Duncan R.; Ketterman, Albert J.] Mahidol Univ, Inst Mol Biosci, Salaya Campus, Salaya, Nakhon Pathom, Thailand.
   [Auewarakul, Prasert] Mahidol Univ, Fac Med, Dept Microbiol, Siriraj Hosp, Bangkok, Thailand.
RP Ketterman, AJ (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus, Salaya, Nakhon Pathom, Thailand.
EM albertketterman@yahoo.com
RI Smith, Duncan R/C-6891-2011
OI Smith, Duncan R/0000-0002-6592-9852
FU Thailand Research FundThailand Research Fund (TRF) [TRG5980012,
   IRG5780009]; Mahidol University; National Science and Technology
   Development Agency [P-16-50685]
FX This work was supported by the Thailand Research Fund (TRG5980012)(CS)
   and the Thailand Research Fund (IRG5780009)(AJK), and grants from
   Mahidol University (AJK, DRS) and The National Science and Technology
   Development Agency (P-16-50685)(DRS). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Anand SK, 2013, ADV VIROL, V2013, DOI 10.1155/2013/738794
   Atasheva S, 2010, J VIROL, V84, P10004, DOI 10.1128/JVI.01151-10
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cavrini F, 2009, J INFECT DEV COUNTR, V3, P744, DOI 10.3855/jidc.169
   CONG PJ, 1993, J BIOL CHEM, V268, P7256
   Geiss BJ, 2011, J BIOMOL SCREEN, V16, P852, DOI 10.1177/1087057111412183
   Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250
   Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368
   Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037
   Hanh TDN, 2013, ANAL BIOCHEM, V434, P284, DOI 10.1016/j.ab.2012.11.019
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Alcaraz-Estrada SL, 2010, FUTURE VIROL, V5, P575, DOI 10.2217/FVL.10.49
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P7511, DOI 10.1093/nar/gkw551
   Russell P. K., 1980, CHEM ANTIGENIC STRUC
   Su CI, 2016, J VIROL, V90, P4308, DOI 10.1128/JVI.00223-16
   Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361
   Weaver SC, 2005, ARCH VIROL, P33
   Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Zhang J, 2014, ADV CANCER RES, V122, P143, DOI 10.1016/B978-0-12-420117-0.00004-9
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
NR 38
TC 5
Z9 5
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2018
VL 13
IS 2
AR e0193133
DI 10.1371/journal.pone.0193133
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX1SB
UT WOS:000425831000037
PM 29470500
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stefanik, M
   Formanova, P
   Bily, T
   Vancova, M
   Eyer, L
   Palus, M
   Salat, J
   Braconi, CT
   Zanotto, PMD
   Gould, EA
   Ruzek, D
AF Stefanik, Michal
   Formanova, Petra
   Bily, Tomas
   Vancova, Marie
   Eyer, Ludek
   Palus, Martin
   Salat, Jiri
   Braconi, Carla Torres
   Zanotto, Paolo M. de A.
   Gould, Ernest A.
   Ruzek, Daniel
TI Characterisation of Zika virus infection in primary human astrocytes
SO BMC NEUROSCIENCE
LA English
DT Article
DE Zika virus; Flavivirus; Astrocyte; Luminex; Immune response; Electron
   tomography
ID MENINGOENCEPHALITIS; PATHOGENESIS; REPLICATION; CELLS
AB Background: The recent Zika virus (ZIKV) outbreak has linked ZIKV with microcephaly and other central nervous system pathologies in humans. Astrocytes are among the first cells to respond to ZIKV infection in the brain and are also targets for virus infection. In this study, we investigated the interaction between ZIKV and primary human brain cortical astrocytes (HBCA).
   Results: HBCAs were highly sensitive to representatives of both Asian and African ZIKV lineages and produced high viral yields. The infection was associated with limited immune cytokine/chemokine response activation; the highest increase of expression, following infection, was seen in CXCL-10 (IP-10), interleukin-6, 8, 12, and CCL5 (RANTES). Ultrastructural changes in the ZIKV-infected HBCA were characterized by electron tomography (ET). ET reconstructions elucidated high-resolution 3D images of the proliferating and extensively rearranged endoplasmic reticulum (ER) containing viral particles and virus-induced vesicles, tightly juxtaposed to collapsed ER cisternae.
   Conclusions: The results confirm that human astrocytes are sensitive to ZIKV infection and could be a source of proinflammatory cytokines in the ZIKV-infected brain tissue.
C1 [Stefanik, Michal; Formanova, Petra; Eyer, Ludek; Palus, Martin; Salat, Jiri; Ruzek, Daniel] Vet Res Inst, Dept Virol, Hudcova 70, Brno 62100, Czech Republic.
   [Bily, Tomas; Vancova, Marie; Eyer, Ludek; Palus, Martin; Ruzek, Daniel] Czech Acad Sci, Inst Parasitol, Biol Ctr, Branisovska 31, Ceske Budejovice 37005, Czech Republic.
   [Bily, Tomas; Vancova, Marie] Univ South Bohemia, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic.
   [Braconi, Carla Torres; Zanotto, Paolo M. de A.] Univ Sao Paulo, Lab Mol Evolut & Bioinformat, Dept Microbiol, Inst Microbiol Sci, BR-05508000 Sao Paulo, Brazil.
   [Gould, Ernest A.] Aix Marseille Univ, EHESP French Sch Publ Hlth, IRD French Inst Res Dev, EPV UMR D Emergence Pathol Virales 190, Marseille, France.
RP Ruzek, D (corresponding author), Vet Res Inst, Dept Virol, Hudcova 70, Brno 62100, Czech Republic.
EM ruzekd@paru.cas.cz
RI Eyer, Ludek/U-4883-2018; Salat, Jiri/F-6295-2019; Ruzek,
   Daniel/G-9275-2014; Palus, Martin/N-1263-2017; Vancova,
   Marie/G-8347-2014; Braconi, Carla T./B-3320-2014; de A. Zanotto, Paolo
   M./B-9286-2019
OI Eyer, Ludek/0000-0001-7761-0702; Ruzek, Daniel/0000-0003-4655-2380;
   Palus, Martin/0000-0002-4279-7092; Braconi, Carla
   T./0000-0002-5370-8980; de A. Zanotto, Paolo M./0000-0002-8167-0625;
   Bily, Tomas/0000-0003-1450-1693; Salat, Jiri/0000-0002-9915-8953;
   Vancova, Marie/0000-0003-0678-8268
FU Czech Science FoundationGrant Agency of the Czech Republic [16-20054S,
   17-02196S]; Ministry of Education, Youth, and Sports of the Czech
   Republic, under the NPU I program [LO1218]; Project "FIT" (Pharmacology,
   Immunotherapy, nanoToxicology) - European Regional Development Fund;
   National Subvention for the Development of Research Organizations [RVO:
   61388963]; European Virus Archive Goes Global project from the European
   Union's Horizon research and innovation program [653316]; Ministry of
   Education, Youth, and Sports of the Czech RepublicMinistry of Education,
   Youth & Sports - Czech Republic [LM2015062]; Technology Agency of the
   Czech Republic [TE01020118]
FX This work was supported by the Czech Science Foundation (Grants
   16-20054S and 17-02196S); the Ministry of Education, Youth, and Sports
   of the Czech Republic, under the NPU I program (Grant LO1218); by
   Project "FIT" (Pharmacology, Immunotherapy, nanoToxicology), which was
   funded by the European Regional Development Fund; the National
   Subvention for the Development of Research Organizations (Grant RVO:
   61388963); and the European Virus Archive Goes Global project, which has
   received funding from the European Union's Horizon 2020 research and
   innovation program (Grant 653316). The Laboratory of EM supported by the
   Ministry of Education, Youth, and Sports of the Czech Republic
   (LM2015062 Czech-BioImaging) and Technology Agency of the Czech Republic
   (TE01020118).
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bily T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10745
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912
   Palus M, 2015, J MED VIROL, V87, P885, DOI 10.1002/jmv.24140
   Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
NR 25
TC 13
Z9 13
U1 1
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2202
J9 BMC NEUROSCI
JI BMC Neurosci.
PD FEB 20
PY 2018
VL 19
AR 5
DI 10.1186/s12868-018-0407-2
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA FX4XK
UT WOS:000426081900001
PM 29463209
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Akhoundi, M
   Jourdain, F
   Chandre, F
   Delaunay, P
   Roiz, D
AF Akhoundi, Mohammad
   Jourdain, Frederic
   Chandre, Fabrice
   Delaunay, Pascal
   Roiz, David
TI Effectiveness of a field trap barrier system for controlling Aedes
   albopictus: a "removal trapping" strategy
SO PARASITES & VECTORS
LA English
DT Article
DE Vector control; Removal method; Trap barrier system; CO2 baited trap;
   Aedes albopictus
ID BG-SENTINEL; TIGER MOSQUITO; VECTOR CONTROL; FLIES DIPTERA; DENGUE;
   SEPTEMBER; FRANCE; CHIKUNGUNYA; MANAGEMENT; CULICIDAE
AB Background: Aedes aegypti and Aedes albopictus are the main vectors for the transmission of several viral pathogens, in particular, dengue, Zika and chikungunya. In the absence of vaccines and treatment, control of Aedes mosquitoes is the only means of keeping these diseases in check. Aedes control is difficult, and it is, therefore, necessary to evaluate the efficacy of novel control methods, particularly those targeting adult and exophilic Ae. albopictus populations.
   Methods: We carried out the first evaluation of the effectiveness of a field trap barrier system, i.e. a "removal trapping" outdoor control strategy for Ae. albopictus in southern France.
   Results: The removal trapping control strategy is an effective system, able to reduce to almost zero the biting rate of the tiger mosquito in and around houses with traps installed. This strategy has the advantage of being a non-chemical method, which is environmentally friendly and does not affect non-target fauna. Nevertheless, it has several constraints including the cost of the CO2 required for the system to function. However, the system could be optimized by reducing the costs and combining it with other control strategies within the framework of integrated vector management.
   Conclusions: We provide the first evidence of the effectiveness of this trap barrier system, which is based on the combined effect of (i) removing adult mosquitoes living in the area, and (ii) hampering the migration of mosquitoes from outside into the treated area. Further investigation is needed to understand its efficacy for other species, other locations and at-risk communities, and to evaluate its application for reducing the prevalence of dengue, Zika and chikungunya diseases.
C1 [Akhoundi, Mohammad; Delaunay, Pascal] CHU Nice, Hop Archet, Serv Parasitol Mycol, Nice, France.
   [Akhoundi, Mohammad; Chandre, Fabrice; Delaunay, Pascal; Roiz, David] Univ Montpellier, MIVEGEC, CNRS5290, UMR IRD224, Montpellier, France.
   [Jourdain, Frederic; Chandre, Fabrice] Ctr Natl Expertise Vecteurs, Montpellier, France.
RP Akhoundi, M (corresponding author), CHU Nice, Hop Archet, Serv Parasitol Mycol, Nice, France.; Akhoundi, M (corresponding author), Univ Montpellier, MIVEGEC, CNRS5290, UMR IRD224, Montpellier, France.
EM m.akhoundi@yahoo.com
RI Roiz, David/F-2082-2011; Chandre, Fabrice/Q-3429-2019
OI Roiz, David/0000-0002-5819-3648; Chandre, Fabrice/0000-0002-1994-9705;
   Jourdain, Frederic/0000-0001-6485-8952
FU IRD; CNEV; CHU-Nice; HBM distribution
FX This study was funded by IRD, CNEV, CHU-Nice and HBM distribution. HBM
   distribution had no role in study design, data collection, data analysis
   and writing of the article.
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.39.30361
   Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008
   Boubidi SC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1881-y
   Bouzid M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005176
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Chandel K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005235
   Abramides GC, 2011, T ROY SOC TROP MED H, V105, P281, DOI 10.1016/j.trstmh.2011.01.003
   DAY JF, 1994, AM J TROP MED HYG, V50, P126, DOI 10.4269/ajtmh.1994.50.126
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Delaunay P, 2007, Med Trop (Mars), V67, P310
   Delaunay P, 2009, ARCH PEDIATRIE, V16, pS66, DOI 10.1016/S0929-693X(09)75304-7
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   EID, 2007, SURV MOUST AED ALB F
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Englbrecht C, 2015, J AM MOSQUITO CONTR, V31, P16, DOI 10.2987/14-6444.1
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Jourdain F, 2015, TRANSFUS CLIN BIOL, V22, P101, DOI 10.1016/j.tracli.2015.06.001
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2
   Kline DL, 1998, J VECTOR ECOL, V23, P171
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Laveissiere C, 1988, SERIE LUTTE ANTIVECT, P91
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   MORRIS KRS, 1949, B ENTOMOL RES, V39, P491, DOI 10.1017/S0007485300022598
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   MULLA M S, 1990, Bulletin of the Society for Vector Ecology, V15, P156
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pombi M, 2014, ITALY PARASIT VECTOR, V7, P580, DOI DOI 10.1186/S13071-014-0580-9
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   RUGG D, 1982, J ECON ENTOMOL, V75, P857, DOI 10.1093/jee/75.5.857
   Smith JP, 2010, J AM MOSQUITO CONTR, V26, P43, DOI 10.2987/09-5941.1
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   VALE GA, 1985, B ENTOMOL RES, V75, P219, DOI 10.1017/S0007485300014309
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   WALL WJ, 1980, ENVIRON ENTOMOL, V9, P371, DOI 10.1093/ee/9.4.371
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x
NR 43
TC 3
Z9 3
U1 0
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 20
PY 2018
VL 11
AR 101
DI 10.1186/s13071-018-2691-1
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FW7QQ
UT WOS:000425519700005
PM 29463300
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Faiq, MA
   Kumar, A
   Singh, HN
   Pareek, V
   Kumar, P
AF Faiq, Muneeb A.
   Kumar, Ashutosh
   Singh, Himanshu N.
   Pareek, Vikas
   Kumar, Pavan
TI Commentary: A Possible Mechanism of Zika Virus Associated Microcephaly:
   Imperative Role of Retinoic Acid Response Element (RARE) Consensus
   Sequence Repeats in the Viral Genome
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Editorial Material
DE endogenous retroviruses; retinoic acid signaling; retrovirus; reverse
   transcriptase; RNA virus; zika virus
ID RNA; INHIBITION; RETROVIRUS; DNA
C1 [Faiq, Muneeb A.] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.
   [Faiq, Muneeb A.] All India Inst Med Sci, Dept Anat, Lab Mol Reprod & Genet, New Delhi, India.
   [Faiq, Muneeb A.] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Med Biotechnol Lab, New Delhi, India.
   [Faiq, Muneeb A.; Kumar, Ashutosh; Singh, Himanshu N.; Pareek, Vikas; Kumar, Pavan] Etiol Elus Disorders Res Network, New Delhi, India.
   [Kumar, Ashutosh; Kumar, Pavan] All India Inst Med Sci, Dept Anat, New Delhi, India.
   [Singh, Himanshu N.] Inst Genom & Integrat Biol, Funct Genom Unit, New Delhi, India.
   [Singh, Himanshu N.] All India Inst Med Sci, Dept Biochem, New Delhi, India.
   [Pareek, Vikas] Natl Brain Res Ctr, Computat Neurosci & Neuroimaging Div, Manesar, India.
RP Faiq, MA (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.; Faiq, MA (corresponding author), All India Inst Med Sci, Dept Anat, Lab Mol Reprod & Genet, New Delhi, India.; Faiq, MA (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Med Biotechnol Lab, New Delhi, India.; Faiq, MA (corresponding author), Etiol Elus Disorders Res Network, New Delhi, India.
EM muneeb1983@gmail.com
RI Singh, Himanshu N/K-1760-2016
OI Singh, Himanshu N/0000-0003-4111-5165; Pareek,
   Vikas/0000-0001-8985-4982; Kumar, Ashutosh/0000-0003-1589-9568
CR Berkhout B, 1999, J VIROL, V73, P2365, DOI 10.1128/JVI.73.3.2365-2375.1999
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111
   Diamond MS, 2003, IMMUNOL CELL BIOL, V81, P196, DOI 10.1046/j.1440-1711.2003.01157.x
   Geuking MB, 2009, SCIENCE, V323, P393, DOI 10.1126/science.1167375
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876
   Kumar A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00403
   Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003
   Li W, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8201
   Lopez-Denman AJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010014
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   Moon SL, 2012, CURR OPIN MICROBIOL, V15, P500, DOI 10.1016/j.mib.2012.04.009
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Tyagi R, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0347-4
   Weiss RA, 1997, NATURE, V390, P235, DOI 10.1038/36740
NR 17
TC 1
Z9 1
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 20
PY 2018
VL 9
AR 190
DI 10.3389/fmicb.2018.00190
PG 3
WC Microbiology
SC Microbiology
GA FW7NM
UT WOS:000425510800001
PM 29515529
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zanini, F
   Pu, SY
   Bekerman, E
   Einav, S
   Quake, SR
AF Zanini, Fabio
   Pu, Szu-Yuan
   Bekerman, Elena
   Einav, Shirit
   Quake, Stephen R.
TI Single-cell transcriptional dynamics of flavivirus infection
SO ELIFE
LA English
DT Article
ID DENGUE VIRUS-INFECTION; GENE-EXPRESSION; RNA-SEQ; PATHWAY; TARGET;
   REPLICATION; DEGRADATION; INHIBITION; EFFICIENT; MEDIATORS
AB Dengue and Zika viral infections affect millions of people annually and can be complicated by hemorrhage and shock or neurological manifestations, respectively. However, a thorough understanding of the host response to these viruses is lacking, partly because conventional approaches ignore heterogeneity in virus abundance across cells. We present viscRNA-Seq (virus-inclusive single cell RNA-Seq), an approach to probe the host transcriptome together with intracellular viral RNA at the single cell level. We applied viscRNA-Seq to monitor dengue and Zika virus infection in cultured cells and discovered extreme heterogeneity in virus abundance. We exploited this variation to identify host factors that show complex dynamics and a high degree of specificity for either virus, including proteins involved in the endoplasmic reticulum translocon, signal peptide processing, and membrane trafficking. We validated the viscRNA-Seq hits and discovered novel proviral and antiviral factors. viscRNA-Seq is a powerful approach to assess the genome-wide virus-host dynamics at single cell level.
C1 [Zanini, Fabio; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
   [Pu, Szu-Yuan; Bekerman, Elena; Einav, Shirit] Stanford Univ, Dept Med, Div Infect Dis, Sch Med, Stanford, CA 94305 USA.
   [Pu, Szu-Yuan; Bekerman, Elena; Einav, Shirit] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.
   [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.
   [Quake, Stephen R.] Chan Zuckerberg Biohub, San Francisco, CA USA.
RP Zanini, F; Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Quake, SR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.; Quake, SR (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA USA.
EM fabio.zanini@stanford.edu; quake@stanford.edu
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [1U19 A110966201, 5T32AI007502]; Stanford Bio-X; Stanford Institute for
   Immunity, Transplantation, and Infection; European Molecular Biology
   OrganizationEuropean Molecular Biology Organization (EMBO); Child Health
   Research Institute; Lucile Packard Foundation for Children's Health;
   Stanford Clinical and Translational Science Award [UL1 TR000093]
FX National Institute of Allergy and Infectious Diseases 1U19 A110966201
   Shirit Einav; Stanford Bio-X Shirit Einav; Stanford Institute for
   Immunity, Transplantation, and Infection Shirit Einav; European
   Molecular Biology Organization ALTF 269-2016 Fabio Zanini; Child Health
   Research Institute Szu-Yuan Pu; Lucile Packard Foundation for Children's
   Health Szu-Yuan Pu; Stanford Clinical and Translational Science Award
   UL1 TR000093 Szu-Yuan Pu; National Institute of Allergy and Infectious
   Diseases 5T32AI007502 Elena Bekerman; The funders had no role in study
   design, data collection and interpretation, or the decision to submit
   the work for publication.
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Becerra A, 2009, J MED VIROL, V81, P1403, DOI 10.1002/jmv.21538
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Conceicao TM, 2010, J INFECTION, V60, P65, DOI 10.1016/j.jinf.2009.10.003
   CORNER LC, 1987, CAN J MICROBIOL, V33, P863, DOI 10.1139/m87-151
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11
   FAYE O, 2013, VIROL J, P311
   Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396
   Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086
   Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5
   Guo JT, 2003, J VIROL, V77, P10769, DOI 10.1128/JVi.77.20.10769-10779.2003
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   HEIT AM, 2005, J VIROL, V79, P13218
   Hillesheim A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-29
   Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   Judith D, 2013, EMBO REP, V14, P534, DOI 10.1038/embor.2013.51
   Kumar A, 2008, J VIROL, V82, P2813, DOI 10.1128/JVI.02498-07
   Kwon YJ, 2014, ANTIVIR RES, V110, P20, DOI 10.1016/j.antiviral.2014.07.006
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Li R, 2011, J VIROL, V85, P2138, DOI 10.1128/JVI.02313-10
   Liew KJL, 2006, J VIROL METHODS, V131, P47, DOI 10.1016/j.jviromet.2005.07.003
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   McKinney W., 2011, PANDAS FDN PYTHON LI
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138
   Moni MA, 2017, J INFECT DIS, V216, P703, DOI 10.1093/infdis/jix327
   Moreno-Altamirano MMB, 2004, SCAND J IMMUNOL, V60, P631, DOI 10.1111/j.0300-9475.2004.01519.x
   MOYER S, 2017, J OPEN RES SOFTWARE, V2
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Ng CL, 2010, EXP CELL RES, V316, P2113, DOI 10.1016/j.yexcr.2010.04.010
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200
   Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604
   Russell AB, 2018, ELIFE, V7, DOI 10.7554/eLife.32303
   Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105
   Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060
   Sessions OM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002107
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522
   Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779
   van der Maaten L, 2008, J MACH LEARN RES, V9, P2579
   van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37
   Waskom M., 2014, SEABORN V0 5 0
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 60
TC 31
Z9 31
U1 0
U2 7
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD FEB 16
PY 2018
VL 7
AR e32942
DI 10.7554/eLife.32942
PG 21
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FX4SN
UT WOS:000426068600001
PM 29451494
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Afsahi, S
   Lerner, MB
   Goldstein, JM
   Lee, J
   Tang, XL
   Bagarozzi, DA
   Pan, D
   Locascio, L
   Walker, A
   Barron, F
   Goldsmith, BR
AF Afsahi, Savannah
   Lerner, Mitchell B.
   Goldstein, Jason M.
   Lee, Joo
   Tang, Xiaoling
   Bagarozzi, Dennis A., Jr.
   Pan, Deng
   Locascio, Lauren
   Walker, Amy
   Barron, Francie
   Goldsmith, Brett R.
TI Novel graphene-based biosensor for early detection of Zika virus
   infection
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Graphene; Biosensor; Zika; Field effect biosensing; FEB
AB We have developed a cost-effective and portable graphene-enabled biosensor to detect Zika virus with a highly specific immobilized monoclonal antibody. Field Effect Biosensing (FEB) with monoclonal antibodies covalently linked to graphene enables real-time, quantitative detection of native Zika viral (ZIKV) antigens. The percent change in capacitance in response to doses of antigen (ZIKV NS1) coincides with levels of clinical significance with detection of antigen in buffer at concentrations as low as 450 pM. Potential diagnostic applications were demonstrated by measuring Zika antigen in a simulated human serum. Selectivity was validated using Japanese Encephalitis NS1, a homologous and potentially cross-reactive viral antigen. Further, the graphene platform can simultaneously provide the advanced quantitative data of nonclinical biophysical kinetics tools, making it adaptable to both clinical research and possible diagnostic applications. The speed, sensitivity, and selectivity of this first-of-its-kind graphene-enabled Zika biosensor make it an ideal candidate for development as a medical diagnostic test.
C1 [Afsahi, Savannah; Lerner, Mitchell B.; Pan, Deng; Locascio, Lauren; Walker, Amy; Barron, Francie; Goldsmith, Brett R.] Nanomed Diagnost Inc, 6185 Cornerstone Court East Suite 110, San Diego, CA 92121 USA.
   [Goldstein, Jason M.; Lee, Joo; Tang, Xiaoling; Bagarozzi, Dennis A., Jr.] Ctr Dis Control & Prevent, Reagent & Diagnost Serv Branch, Div Sci Resources, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd NE, Atlanta, GA 30333 USA.
RP Goldsmith, BR (corresponding author), Nanomed Diagnost Inc, 6185 Cornerstone Court East Suite 110, San Diego, CA 92121 USA.
EM brgoldsmith@nanomedicaldiagnostics.com
CR Afsahi S.J., 2017, MRS ADV, P1
   Centers for Disease Control, 2017, ZIK VIR CAS COUNTS U
   Clinical Laboratory Standards Institute, 2012, EP15A225 NCCLS CLIN
   Esfandiar A, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4827811
   Food and Drug Administration, 2016, COMMUNICATION
   Gao N, 2016, P NATL ACAD SCI USA, V113, P14633, DOI 10.1073/pnas.1625010114
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kybert NJ, 2014, NANO RES, V7, P95, DOI 10.1007/s12274-013-0376-9
   Ladhani S.N., 2016, ARCH DIS CHILD
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lerner M.B., 2016, SENSOR ACTUAT B-CHEM, P1
   Lerner MB, 2014, NANO LETT, V14, P2709, DOI 10.1021/nl5006349
   Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675
   Liu BW, 2013, ANAL CHEM, V85, P10045, DOI 10.1021/ac4024654
   Lu Y., 2010, APPL PHYS LETT, V97
   Lu Y, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3678024
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Peterson L., 2016, NEW ENGL J MED
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sironi M., 2016, PLOS NEGLECT TROP D, V10, P1
   Xu X, 2016, PLOS CURR, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Zhu SE, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802799
NR 24
TC 70
Z9 70
U1 11
U2 131
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD FEB 15
PY 2018
VL 100
BP 85
EP 88
DI 10.1016/j.bios.2017.08.051
PG 4
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA FN7GV
UT WOS:000416187600012
PM 28865242
OA Other Gold
DA 2020-07-08
ER

PT J
AU Dodson, BL
   Pujhari, S
   Rasgon, JL
AF Dodson, Brittany L.
   Pujhari, Sujit
   Rasgon, Jason L.
TI Vector competence of selected North American Anopheles and Culex
   mosquitoes for Zika virus
SO PEERJ
LA English
DT Article
DE Arbovirus; Vector-borne; Vector competence; Infection; Dissemination;
   Transmission
ID WEST-NILE-VIRUS; VALLEY FEVER VIRUS; UNITED-STATES; TRANSMISSION;
   INFECTION; PACIFIC; PIPIENS; DENGUE; WAVE
AB Zika virus (ZIKV) is a vector-borne flavivirus that has caused recent outbreaks associated with serious disease in infants and newborns in the Americas. Aedes mosquitoes are the primary vectors for ZIKV, but little is known about the diversity of mosquitoes that can transmit ZIKV in North America. We chose three abundant North American mosquito species (Anopheles freeborni, Anopheles quadrimaculatus, and Culex tarsalis) and one known vector species (Aedes aegypti), fed them blood meals supplemented with a recent outbreak ZIKV strain, and tested bodies, legs, and saliva for infectious ZIKV. ZIKV was able to infect, disseminate, and be transmitted by Aedes aegypti. However, Anopheles freeborni, Anopheles quadrimaculatus, and Culex tarsalis were unable to be infected. We conclude that these species are unlikely to be involved in ZIKV transmission in North America. However, we should continue to examine the ability for other mosquito species to potentially act as ZIKV vectors in North America.
C1 [Rasgon, Jason L.] Penn State Univ, Ctr Infect Dis Dynam, Dept Entomol, University Pk, PA 16802 USA.
   Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.
RP Rasgon, JL (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, Dept Entomol, University Pk, PA 16802 USA.
EM jlr54@psu.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI128918, R01AI116636]
FX This research was funded by NIH grants R21AI128918 and R01AI116636 to
   Jason L. Rasgon. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AITKEN THG, 1977, MOSQ NEWS, V37, P130
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Centers for Disease Control and Prevention, 2017, ZIK VIR PREV
   Centres for Disease Control and Prevention, 2017, WORLD MAP AR RISK ZI
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Dodson BL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-199
   Dodson BL, 2011, VECTOR-BORNE ZOONOT, V11, P1493, DOI 10.1089/vbz.2011.0662
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manguin S, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P1, DOI 10.5772/3392
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Pujhari S, 2016, PEERJ PREPRINTS, V4, DOI [10.7287/peerj.preprints.1781v1, DOI 10.7287/PEERJ.PREPRINTS.1781V1]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Turell MJ, 2014, J AM MOSQUITO CONTR, V30, P253, DOI 10.2987/14-6441R.1
   Turell MJ, 2008, J AM MOSQUITO CONTR, V24, P502, DOI 10.2987/08-5791.1
   Venkatesan M, 2010, MOL ECOL, V19, P1573, DOI 10.1111/j.1365-294X.2010.04577.x
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 2017, ZIK SIT REP
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
NR 44
TC 10
Z9 10
U1 0
U2 12
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD FEB 15
PY 2018
VL 6
AR e4324
DI 10.7717/peerj.4324
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FW5MT
UT WOS:000425362200004
PM 29472998
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Spencer, JL
   Lahon, A
   Tran, LL
   Arya, RP
   Kneubehl, AR
   Vogt, MB
   Xavier, D
   Rowley, DR
   Kimata, JT
   Rico-Hesse, RR
AF Spencer, Jennifer L.
   Lahon, Anismrita
   Tran, Linda L.
   Arya, Ravi P.
   Kneubehl, Alexander R.
   Vogt, Megan B.
   Xavier, Daniela
   Rowley, David R.
   Kimata, Jason T.
   Rico-Hesse, Rebecca R.
TI Replication of Zika Virus in Human Prostate Cells: A Potential Source of
   Sexually Transmitted Virus
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; prostate; sexual transmission
ID TRANSMISSION; RNA; INFECTION; CONTACT
AB Background. While Zika virus (ZIKV) is mainly transmitted by mosquitoes, numerous cases of sexual transmission have been reported during recent outbreaks. Little is known about which host cell types or entry factors aid in mediating this sexual transmission.
   Methods. In this study, we investigated ZIKV cell tropism by infecting 2 types of human prostate cells with 3 contemporary ZIKV isolates from persons infected in the Americas. We used real-time quantitative polymerase chain reaction and immunofluorescence analyses to measure infection and flow cytometry to detect entry factor expression.
   Results. Here we show that ZIKV infects, replicates, and produces infectious virus in prostate stromal mesenchymal stem cells, epithelial cells, and organoids made with a combination of these cells. We also show that prostate cells express several well-characterized flavivirus attachment factors. In contrast, dengue virus does not infect or does not replicate in these prostate cells, although it is known to use similar receptors.
   Conclusions. Our results indicate that ZIKV favors infection of stromal cells more so than epithelial cells in organoids, possibly indicating a preference for stem cells in general. Overall, these results suggest that ZIKV replication occurs in the human prostate and can account for ZIKV secretion in semen, thus leading to sexual transmission.
C1 [Spencer, Jennifer L.; Lahon, Anismrita; Arya, Ravi P.; Kneubehl, Alexander R.; Vogt, Megan B.; Kimata, Jason T.; Rico-Hesse, Rebecca R.] Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza,MS 385, Houston, TX 77030 USA.
   [Tran, Linda L.; Rowley, David R.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
   [Tran, Linda L.; Vogt, Megan B.] Baylor Coll Med, Integrat Mol & Biomed Sci Program, Houston, TX 77030 USA.
   [Xavier, Daniela] Baylor Coll Med, Genom & RNA Profiling Core, Houston, TX 77030 USA.
RP Rico-Hesse, RR (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza,MS 385, Houston, TX 77030 USA.
EM Rebecca.rico-hesse@bcm.edu
RI ARYA, RAVI/AAF-4108-2020
OI ARYA, RAVI/0000-0001-9255-610X
FU Baylor College of Medicine (BCM); National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01 AI098715, R01 AI099483]; BCM Pathology and
   Histology Core [NCI-CA125123]; BCM Integrated Microscopy Core
   [NCI-CA125123, NIDDK-56338-13/15, RP150578]; BCM Cytometry and Cell
   Sorting Core [NIAID P30A1036211, NCI P30CA125123, NCRR S10RR024574]; BCM
   Genomic and RNA Profiling Core [NCI-CA125123, NIDDK-DK56338]
FX This work was supported by Baylor College of Medicine (BCM), the
   National Institutes of Health (grants R01 AI098715, R01 AI099483 to R.
   R.-H.), the BCM Pathology and Histology Core (grant NCI-CA125123], the
   BCM Integrated Microscopy Core (grants NCI-CA125123, NIDDK-56338-13/15,
   and RP150578), the BCM Cytometry and Cell Sorting Core (grants NIAID
   P30A1036211, NCI P30CA125123 and NCRR S10RR024574), and the BCM Genomic
   and RNA Profiling Core (grants NIDDK-DK56338 and NCI-CA125123).
CR Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102
   Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Dunn GP, 2005, CANCER RES, V65, P3447, DOI 10.1158/0008-5472.CAN-04-4316
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111
   Lahon A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005019
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Meyer AS, 2015, CELL SYST, V1, P25, DOI 10.1016/j.cels.2015.06.002
   Mota J, 2009, J VIROL, V83, P8638, DOI 10.1128/JVI.00581-09
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P1
NR 43
TC 14
Z9 15
U1 1
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD FEB 15
PY 2018
VL 217
IS 4
BP 538
EP 547
DI 10.1093/infdis/jix436
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FW5WD
UT WOS:000425389100005
PM 28968863
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Martin-Acebes, MA
   Saiz, JC
   de Oya, NJ
AF Martin-Acebes, Miguel A.
   Saiz, Juan-Carlos
   Jimenez de Oya, Nereida
TI Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Editorial Material
DE Zika virus; dengue virus; West Nile virus; antibody-dependent
   enhancement (ADE); vaccines
ID DENGUE HEMORRHAGIC-FEVER; VIRUS-INFECTION; CROSS-REACTIVITY; IN-VITRO;
   PATHOGENESIS; REPLICATION; IMMUNITY; DISEASE; HUMANS; BRAZIL
C1 [Martin-Acebes, Miguel A.; Saiz, Juan-Carlos; Jimenez de Oya, Nereida] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain.
RP de Oya, NJ (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain.
EM jdeoya@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014; Jimenez de Oya,
   Nereida/K-8470-2016; de Oya, Nereida Jimenez/T-6449-2019
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; Jimenez de Oya,
   Nereida/0000-0003-3129-813X; de Oya, Nereida Jimenez/0000-0003-3129-813X
FU INIAInstituto de Investigacion Agropecuaria (INIA) [E-RTA2017-0003-C02,
   E-RTA2013-00013-C04, RTA-2015-00009, ZIKA-BIO-2016-01]; Comunidad de
   Madrid/FEDERComunidad de Madrid [S2013/ABI-2906];  [AGL2014-56518JIN]
FX This work was supported in part by grants E-RTA2017-0003-C02,
   E-RTA2013-00013-C04, RTA-2015-00009, and ZIKA-BIO-2016-01 from INIA, and
   S2013/ABI-2906 (PLATESA) from Comunidad de Madrid/FEDER to J-CS, and
   AGL2014-56518JIN to MM-A.
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15
   Halstead SB, 2014, ANTIBODY FC: LINKING ADAPTIVE AND INNATE IMMUNITY, P333
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Khurram M, 2014, J INFECT PUBLIC HEAL, V7, P489, DOI 10.1016/j.jiph.2014.05.005
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Soo KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154760
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Vazquez-Calvo A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.68
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 31
TC 16
Z9 16
U1 1
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD FEB 15
PY 2018
VL 8
AR 44
DI 10.3389/fcimb.2018.00044
PG 4
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FW2SH
UT WOS:000425154300002
PM 29497604
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ducheyne, E
   Minh, NNT
   Haddad, N
   Bryssinckx, W
   Buliva, E
   Simard, F
   Malik, MR
   Charlier, J
   De Waele, V
   Mahmoud, O
   Mukhtar, M
   Bouattour, A
   Hussain, A
   Hendrickx, G
   Roiz, D
AF Ducheyne, Els
   Nhu Nguyen Tran Minh
   Haddad, Nabil
   Bryssinckx, Ward
   Buliva, Evans
   Simard, Frederic
   Malik, Mamunur Rahman
   Charlier, Johannes
   De Waele, Valerie
   Mahmoud, Osama
   Mukhtar, Muhammad
   Bouattour, Ali
   Hussain, Abdulhafid
   Hendrickx, Guy
   Roiz, David
TI Current and future distribution of Aedes aegypti and Aedes albopictus
   (Diptera: Culicidae) in WHO Eastern Mediterranean Region
SO INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS
LA English
DT Article
DE Aedes; Aedes aegypti; Aedes albopictus; Distribution; Chikungunya;
   Dengue; Spatial model; Surveillance; Yellow fever; Zika
ID CLIMATE-CHANGE; MOSQUITO; INVASION; VIRUS; TIGER
AB Background: Aedes-borne diseases as dengue, zika, chikungunya and yellow fever are an emerging problem worldwide, being transmitted by Aedes aegypti and Aedes albopictus. Lack of up to date information about the distribution of Aedes species hampers surveillance and control. Global databases have been compiled but these did not capture data in the WHO Eastern Mediterranean Region (EMR), and any models built using these datasets fail to identify highly suitable areas where one or both species may occur. The first objective of this study was therefore to update the existing Ae. aegypti (Linnaeus, 1762) and Ae. albopictus (Skuse, 1895) compendia and the second objective was to generate species distribution models targeted to the EMR. A final objective was to engage the WHO points of contacts within the region to provide feedback and hence validate all model outputs.
   Methods: The Ae. aegypti and Ae. albopictus compendia provided by Kraemer et al. (Sci Data 2: 150035, 2015; Dryad Digit Repos, 2015) were used as starting points. These datasets were extended with more recent species and disease data. In the next step, these sets were filtered using the Koppen-Geiger classification and the Mahalanobis distance. The occurrence data were supplemented with pseudo-absence data as input to Random Forests. The resulting suitability and maximum risk of establishment maps were combined into hard-classified maps per country for expert validation.
   Results: The EMR datasets consisted of 1995 presence locations for Ae. aegypti and 2868 presence locations for Ae. albopictus. The resulting suitability maps indicated that there exist areas with high suitability and/or maximum risk of establishment for these disease vectors in contrast with previous model output. Precipitation and host availability, expressed as population density and night-time lights, were the most important variables for Ae. aegypti. Host availability was the most important predictor in case of Ae. albopictus. Internal validation was assessed geographically. External validation showed high agreement between the predicted maps and the experts' extensive knowledge of the terrain.
   Conclusion: Maps of distribution and maximum risk of establishment were created for Ae. aegypti and Ae. albopictus for the WHO EMR. These region-specific maps highlighted data gaps and these gaps will be filled using targeted monitoring and surveillance. This will increase the awareness and preparedness of the different countries for Aedes borne diseases.
C1 [Ducheyne, Els; Bryssinckx, Ward; Charlier, Johannes; De Waele, Valerie; Hendrickx, Guy] Avia GIS, Zoersel, Belgium.
   [Nhu Nguyen Tran Minh; Buliva, Evans; Malik, Mamunur Rahman] WHO, Reg Off Eastern Mediterranean, Cairo, Egypt.
   [Haddad, Nabil] Lebanese Univ, Fac Publ Hlth, Lab Immunol & Vector Borne Dis, Fanar, Lebanon.
   [Simard, Frederic; Roiz, David] IRD CNRS UM, MIVEGEC Lab, Montpellier, France.
   [Mahmoud, Osama] Minist Hlth, Directorate Gen Dis Surveillance & Control, Muscat, Oman.
   [Mukhtar, Muhammad] Directorate Malaria Control, Islamabad, Pakistan.
   [Bouattour, Ali] Inst Pasteur Tunis, Tunis, Tunisia.
   [Hussain, Abdulhafid] Minist Hlth, Vector Control Focal Point, Puntland, Somalia.
RP Ducheyne, E (corresponding author), Avia GIS, Zoersel, Belgium.
EM educheyne@avia-gis.com
RI Roiz, David/F-2082-2011; SIMARD, Frederic/J-9489-2016; Charlier,
   Johannes/AAC-8990-2019
OI Roiz, David/0000-0002-5819-3648; SIMARD, Frederic/0000-0002-2871-5329; 
FU WHO Regional Office for the Eastern MediterraneanWorld Health
   Organization; project InvaCosts [ANR-14-CE02-0021-01]
FX This work was supported by the WHO Regional Office for the Eastern
   Mediterranean. The work was supported partially by the project InvaCosts
   (ANR-14-CE02-0021-01). Field work in Lebanon was supported by the WHO
   National Bureau (LEB1409860).
CR Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bennouna A, 2017, MED VET ENTOMOL, V31, P102, DOI 10.1111/mve.12194
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Breiman L, 2001, MACH LEARN, V45, P261, DOI 10.1023/A:1017934522171
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Cunze S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162116
   Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   European Center for Disease Control and Prevention, 2013, ENV RISK MAPP AED AL
   European Centre for Disease Control, 2009, DEV AED ALB RISK MAP
   Habib RR, 2010, ECOHEALTH, V7, P156, DOI 10.1007/s10393-010-0330-1
   Haddad N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-300
   HOLSTEIN M, 1967, B WORLD HEALTH ORGAN, V36, P541
   Humphrey JM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005194
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kraemer MUG, 2015, DRYAD DIGIT REPOS
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x
   Mellander C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139779
   Minh NNT, 2016, E MEDITERR HEALTH J, V22, P350
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rubel F, 2017, METEOROL Z, V26, P115, DOI 10.1127/metz/2016/0816
   Sallam MF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1646-7
   Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408
   Senay SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071218
   Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
NR 30
TC 26
Z9 27
U1 6
U2 25
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-072X
J9 INT J HEALTH GEOGR
JI Int. J. Health Geogr.
PD FEB 14
PY 2018
VL 17
AR 4
DI 10.1186/s12942-018-0125-0
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FW7OB
UT WOS:000425512300001
PM 29444675
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, XF
   Dong, HL
   Wang, HJ
   Huang, XY
   Qiu, YF
   Ji, X
   Ye, Q
   Li, CF
   Liu, Y
   Deng, YQ
   Jiang, T
   Cheng, G
   Zhang, FC
   Davidson, AD
   Song, YJ
   Shi, PY
   Qin, CF
AF Li, Xiao-Feng
   Dong, Hao-Long
   Wang, Hong-Jiang
   Huang, Xing-Yao
   Qiu, Ye-Feng
   Ji, Xue
   Ye, Qing
   Li, Chunfeng
   Liu, Yang
   Deng, Yong-Qiang
   Jiang, Tao
   Cheng, Gong
   Zhang, Fu-Chun
   Davidson, Andrew D.
   Song, Ya-Jun
   Shi, Pei-Yong
   Qin, Cheng-Feng
TI Development of a chimeric Zika vaccine using a licensed live-attenuated
   flavivirus vaccine as backbone
SO NATURE COMMUNICATIONS
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; TETRAVALENT DENGUE VACCINE; YELLOW-FEVER
   VACCINE; STRAIN SA14-14-2; T-CELL; PROTECTION; CHALLENGE; EFFICACY;
   RHESUS; MODEL
AB The global spread of Zika virus (ZIKV) and its unexpected association with congenital defects necessitates the rapid development of a safe and effective vaccine. Here we report the development and characterization of a recombinant chimeric ZIKV vaccine candidate (termed ChinZIKV) that expresses the prM-E proteins of ZIKV using the licensed Japanese encephalitis live-attenuated vaccine SA14-14-2 as the genetic backbone. ChinZIKV retains its replication activity and genetic stability in vitro, while exhibiting an attenuation phenotype in multiple animal models. Remarkably, immunization of mice and rhesus macaques with a single dose of ChinZIKV elicits robust and long-lasting immune responses, and confers complete protection against ZIKV challenge. Significantly, female mice immunized with ChinZIKV are protected against placental and fetal damage upon ZIKV challenge during pregnancy. Overall, our study provides an alternative vaccine platform in response to the ZIKV emergency, and the safety, immunogenicity, and protection profiles of ChinZIKV warrant further clinical development.
C1 [Li, Xiao-Feng; Dong, Hao-Long; Wang, Hong-Jiang; Huang, Xing-Yao; Ji, Xue; Ye, Qing; Li, Chunfeng; Deng, Yong-Qiang; Jiang, Tao; Song, Ya-Jun; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Li, Xiao-Feng; Ye, Qing; Zhang, Fu-Chun; Qin, Cheng-Feng] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
   [Wang, Hong-Jiang] 306th Hosp PLA, Dept Infect Control, Beijing 100101, Peoples R China.
   [Qiu, Ye-Feng] Acad Mil Med Sci, Lab Anim Ctr, Beijing 100071, Peoples R China.
   [Li, Chunfeng] Chinese Acad Med Sci, Ctr Syst Med, Inst Basic Med Sci, Beijing 100005, Peoples R China.
   [Li, Chunfeng] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Liu, Yang; Cheng, Gong] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Beijing 100084, Peoples R China.
   [Davidson, Andrew D.] Univ Bristol, Fac Biomed Sci, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Qin, CF (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
EM qincf@bmi.ac.cn
RI Song, Yajun/F-3714-2011; Qin, Cheng-Feng/I-6839-2019; Tao,
   Jiang/AAE-6623-2019; Li, Chunfeng/S-3185-2019
OI Song, Yajun/0000-0002-6628-2747; Qin, Cheng-Feng/0000-0002-0632-2807;
   Tao, Jiang/0000-0003-1908-2926; Li, Chunfeng/0000-0001-8883-9078
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81661148054, 31770190, 31470265]; National Science
   and Technology Major Project of China [2017ZX09101005, 2017ZX10304402,
   2017ZX10305501-003]; Municipal Healthcare Joint-Innovation Major Project
   of Guangzhou [201704020229]; NSFCNational Natural Science Foundation of
   China [81522025]; Innovative Research Group [81621005]; UK Academy of
   Medical Sciences; NSFC of ChinaNational Natural Science Foundation of
   China [81661130162]; Beijing Nova ProgramBeijing Municipal Science &
   Technology Commission [2016110]; National Key Research and Development
   Project of China [2016YFC1201000, 2016ZX10004001-008]
FX We thank Dr. Bo Zhang (Wuhan Institute of Virology, CAS) and Professor
   Jing An (Capital Medical University) for critical reagents and
   insightful discussion. This work was supported by the National Natural
   Science Foundation of China (numbers 81661148054, 31770190, and
   31470265), the National Science and Technology Major Project of China
   (numbers 2017ZX09101005, 2017ZX10304402, and 2017ZX10305501-003) and the
   Municipal Healthcare Joint-Innovation Major Project of Guangzhou (number
   201704020229). C.F.Q. was supported by the NSFC Excellent Young
   Scientist Fund (number 81522025), Innovative Research Group (number
   81621005), and Newton Advanced Fellowship from the UK Academy of Medical
   Sciences and the NSFC of China (number 81661130162). X.F.L. was
   supported by Beijing Nova Program (number 2016110). G.C. was supported
   by the National Key Research and Development Project of China
   (2016YFC1201000 and 2016ZX10004001-008).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430
   Bista MB, 2001, LANCET, V358, P791, DOI 10.1016/S0140-6736(01)05967-0
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004828
   Chokephaibulkit K, 2016, EXPERT REV VACCINES, V15, P153, DOI 10.1586/14760584.2016.1123097
   Chuang YC, 2011, CYTOKINE, V54, P222, DOI 10.1016/j.cyto.2011.01.013
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   ECKELS KH, 1988, VACCINE, V6, P513, DOI 10.1016/0264-410X(88)90103-X
   Gaudinski MR, 2017, LANCET
   Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530
   Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Gunther VJ, 2011, VACCINE, V29, P3895, DOI 10.1016/j.vaccine.2011.03.038
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Harenberg A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004830
   Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Kumar R, 2009, NEW ENGL J MED, V360, P1465, DOI 10.1056/NEJMc0808664
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li SH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-64
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Li XF, 2013, J GEN VIROL, V94, P2700, DOI 10.1099/vir.0.059436-0
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2015, VACCINE, V33, P62, DOI 10.1016/j.vaccine.2014.10.004
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Osorio JE, 2016, EXPERT REV VACCINES, V15, P497, DOI 10.1586/14760584.2016.1128328
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SUMIYOSHI H, 1995, J INFECT DIS, V171, P1144, DOI 10.1093/infdis/171.5.1144
   Tebas P, 2017, N ENGL J MED
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Wang HJ, 2014, VACCINE, V32, P949, DOI 10.1016/j.vaccine.2013.12.050
   Watson AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005786
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yu YX, 2010, VACCINE, V28, P3635, DOI 10.1016/j.vaccine.2010.02.105
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang NN, 2016, HUM VACC IMMUNOTHER, V12, P3107, DOI 10.1080/21645515.2016.1219004
NR 69
TC 33
Z9 35
U1 0
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 14
PY 2018
VL 9
AR 673
DI 10.1038/s41467-018-02975-w
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FW0MK
UT WOS:000424989000003
PM 29445153
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abramov, DM
   Saad, T
   Gomes, SC
   Silva, DDE
   Araujo, I
   Moreira, MEL
   Lazarev, VV
AF Abramov, Dimitri Marques
   Saad, Tania
   Gomes-Junior, Saint-Clair
   de Souza e Silva, Daniel
   Araujo, Izabel
   Lopes Moreira, Maria Elizabeth
   Lazarev, Vladimir V.
TI Auditory brainstem function in microcephaly related to Zika virus
   infection
SO NEUROLOGY
LA English
DT Article
ID SENSORINEURAL HEARING-LOSS; HYPOPLASIA; CEREBELLUM; CHILDREN; FETUSES;
   INFANTS
AB ObjectiveTo study the effect of prenatal Zika virus (ZV) infection on brainstem function reflected in brainstem auditory evoked potentials (BAEPs).MethodsIn a cross-sectional study in 19 children (12 girls) with microcephaly related to ZV infection, aged between 12 and 62 weeks, the brainstem function was examined through BAEPs. The latencies of wave peaks I, III, and V of the left and right ears (n = 37) were standardized according to normative data, and compared between them by 2-tailed t test. The confounding variables (cephalic perimeter at the born and chronological age) were correlated with the normalized latencies using Pearson test.ResultsAll patients showed, in general, clear waveforms, with latencies within 3 SDs of the normative values. However, statistically increased latencies of waves I and III (I > III, p = 0.031) were observed, relative to wave V (p < 0.001), the latter being closer to respective normative value. The latency of wave I was observed to increase with age (r = 0.45, p = 0.005). The waves, in turn, did not depend on cephalic perimeter.ConclusionsThese results are consistent with the functional normality of the brainstem structure and its lack of correlation with microcephaly, suggesting that the disruption produced by the ZV infection does not act in the cell proliferation phase, but mostly in the processes of neuronal migration and differentiation in the telencephalon.
C1 [Abramov, Dimitri Marques; Saad, Tania; de Souza e Silva, Daniel; Araujo, Izabel; Lazarev, Vladimir V.] Minist Hlth, Lab Neurobiol & Clin Neurophysiol, Natl Inst Women Children & Adolescents, Hlth Fernandes Figueira,Oswaldo Cruz Fdn FIOCRUZ, Rio De Janeiro, Brazil.
   [Gomes-Junior, Saint-Clair; Lopes Moreira, Maria Elizabeth] Minist Hlth, Unit Clin Res, Natl Inst Women Children & Adolescents, Hlth Fernandes Figueira,Oswaldo Cruz Fdn FIOCRUZ, Rio De Janeiro, Brazil.
RP Lazarev, VV (corresponding author), Minist Hlth, Lab Neurobiol & Clin Neurophysiol, Natl Inst Women Children & Adolescents, Hlth Fernandes Figueira,Oswaldo Cruz Fdn FIOCRUZ, Rio De Janeiro, Brazil.
EM vlad.v@iname.com
RI Junior, Clair Gomes/W-8940-2019; Junior, Clair Gomes/F-7579-2012;
   Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Junior, Clair Gomes/0000-0002-1554-943X; Junior, Clair
   Gomes/0000-0002-1554-943X; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294
FU National Council for Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico)National Council
   for Scientific and Technological Development (CNPq)
FX Study funded by the National Council for Scientific and Technological
   Development (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico).
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   [Anonymous], 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P1
   Basel-Vanagaite L, 2010, PEDIATR NEUROL, V43, P7, DOI 10.1016/j.pediatrneurol.2010.02.015
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Celesia GG, 2011, NIEDERMEYERS ELECTRO, P976
   Chiappa Keith H., 1997, P199
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   da Cunha AJLA, 2016, PEDIATR INFECT DIS J, V36, P1
   Das Piyali, 2010, Indian J Physiol Pharmacol, V54, P376
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Guha R, 2017, PEDIATR NEUROL, V70, P81, DOI 10.1016/j.pediatrneurol.2017.01.012
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Kenna MA, 2015, OTOLARYNG CLIN N AM, V48, P933, DOI 10.1016/j.otc.2015.07.011
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Legatt AD, 2012, AMINOFFS ELECTRODIAG, P519
   Levy SR, 1997, EVOKED POTENTIALS CL, P271
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Marrs GS, 2012, J PHYSIOL-LONDON, V590, P2391, DOI 10.1113/jphysiol.2011.226886
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Morzaria S, 2004, INT J PEDIATR OTORHI, V68, P1193, DOI 10.1016/j.ijporl.2004.04.013
   Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194
   Nakamura K, 2012, J CHILD NEUROL, V27, P218, DOI 10.1177/0883073811416239
   Olusanya BO, 2013, ANN AFR MED, V12, P98, DOI 10.4103/1596-3519.112399
   Pan American Health Organization/ World Health Organization, 2016, GUID SURV ZIK VIR DI
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001
   Rajab A, 2007, AM J MED GENET A, V143A, P2761, DOI 10.1002/ajmg.a.31955
   Ramalho Rocha YR, 2016, PLOS CURR OUTBREAKS
   Saenz M, 2014, HEARING RES, V307, P42, DOI 10.1016/j.heares.2013.07.016
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
NR 40
TC 4
Z9 4
U1 1
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD FEB 13
PY 2018
VL 90
IS 7
BP E606
EP E614
DI 10.1212/WNL.0000000000004974
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA FZ7VS
UT WOS:000427813200009
PM 29352094
DA 2020-07-08
ER

PT J
AU Atieh, T
   El Ayoubi, MD
   Aubry, F
   Priet, S
   de Lamballerie, X
   Nougairede, A
AF Atieh, Therese
   El Ayoubi, Miriam Diala
   Aubry, Fabien
   Priet, Stephane
   de Lamballerie, Xavier
   Nougairede, Antoine
TI Haiku: New paradigm for the reverse genetics of emerging RNA viruses
SO PLOS ONE
LA English
DT Article
ID VACCINES; SYSTEMS; ZIKA
AB Reverse genetics is key technology for producing wild-type and genetically modified viruses. The ISA (Infectious Subgenomic Amplicons) method is a recent versatile and user-friendly reverse genetics method to rescue RNA viruses. The main constraint of its canonic protocol was the requirement to produce (e.g., by DNA synthesis or fusion PCR) 5' and 3' modified genomic fragments encompassing the human cytomegalovirus promoter (pCMV) and the hepatitis delta virus ribozyme/simian virus 40 polyadenylation signal (HDR/SV40pA), respectively. Here, we propose the ultimately simplified "Haiku" designs in which terminal pCMV and HDR/SV40pA sequences are provided as additional separate DNA amplicons. This improved procedure was successfully applied to the rescue of a wide range of viruses belonging to genera Flavivirus, Alphavirus and Enterovirus in mosquito or mammalian cells using only standard PCR amplification techniques and starting from a variety of original materials including viral RNAs extracted from cell supernatant media or animal samples. We also demonstrate that, in specific experimental conditions, the presence of the HDR/SV40pA is not necessary to rescue the targeted viruses. These ultimately simplified "Haiku" designs provide an even more simple, rapid, versatile and cost-effective tool to rescue RNA viruses since only generation of overlapping amplicons encompassing the entire viral genome is now required to generate infectious virus. This new approach may completely modify our capacity to obtain infectious RNA viruses.
C1 [Atieh, Therese; El Ayoubi, Miriam Diala; Aubry, Fabien; Priet, Stephane; de Lamballerie, Xavier; Nougairede, Antoine] Aix Marseille Univ, UMR Emergence Pathol Virales EPV, IRD 190, Inserm 1207,EHESP,IHU Mediterranee Infect, Marseille, France.
RP Nougairede, A (corresponding author), Aix Marseille Univ, UMR Emergence Pathol Virales EPV, IRD 190, Inserm 1207,EHESP,IHU Mediterranee Infect, Marseille, France.
EM antoine.nougairede@univ-amu.fr
RI Priet, Stephane/N-7952-2017
OI Priet, Stephane/0000-0001-7102-3654
FU French "Agence Nationale de la Recherche"French National Research Agency
   (ANR) [ANR-14-CE14-0001]; European Virus Archive goes global project
   (EVAg); European Virus Archive goes global project (European Union
   Horizon programme) [653316]
FX This work was supported by the French "Agence Nationale de la Recherche"
   (grant agreement no. ANR-14-CE14-0001) and the European Virus Archive
   goes global project (EVAg; European Union Horizon 2020 programme under
   grant agreement no. 653316; http://www.european-virus-archive.com/). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Atieh T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14522-6
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Aubry F, 2013, GENOME ANNOUNCEMENTS, V1
   Aubry F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138703
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Bradley T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15711
   Conzelmann KK, 2004, CURR TOP MICROBIOL, V283, P1
   de Fabritus L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159564
   LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993
   Mire CE, 2015, NATURE, V520, P688, DOI 10.1038/nature14428
   Nougairede A, 2014, J CLIN VIROL, V61, P118, DOI 10.1016/j.jcv.2014.05.022
   Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172
   Pijlman GP, 2015, BIOTECHNOL J, V10, P659, DOI 10.1002/biot.201400427
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   Tan CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162771
NR 18
TC 1
Z9 2
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 13
PY 2018
VL 13
IS 2
AR e0193069
DI 10.1371/journal.pone.0193069
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FW1TV
UT WOS:000425083400067
PM 29438402
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lo, D
   Park, B
AF Lo, Derek
   Park, Briton
TI Modeling the spread of the Zika virus using topological data analysis
SO PLOS ONE
LA English
DT Article
AB Zika virus (ZIKV), a disease spread primarily through the Aedes aegypti mosquito, was identified in Brazil in 2015 and was declared a global health emergency by the World Health Organization (WHO). Epidemiologists often use common state-level attributes such as population density and temperature to determine the spread of disease. By applying techniques from topological data analysis, we believe that epidemiologists will be able to better predict how ZIKV will spread. We use the Vietoris-Rips filtration on high-density mosquito locations in Brazil to create simplicial complexes, from which we extract homology group generators. Previously epidemiologists have not relied on topological data analysis to model disease spread. Evaluating our model on ZIKV case data in the states of Brazil demonstrates the value of these techniques for the improved assessment of vector-borne diseases.
C1 [Lo, Derek; Park, Briton] Yale Univ, Dept Stat, New Haven, CT 06520 USA.
   [Lo, Derek] Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA.
   [Park, Briton] Yale Univ, Dept Math, New Haven, CT 06520 USA.
RP Lo, D (corresponding author), Yale Univ, Dept Stat, New Haven, CT 06520 USA.; Lo, D (corresponding author), Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA.
EM derektlo@gmail.com
CR Andrew J, 2016, POTENTIAL IMPACTS 21, P1573
   [Anonymous], 2014, IBGE EST EST RES POP
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Castro, 2016, BIORXIV056648
   CDC, 2016, ZIK VIR
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   ECDC, 2016, CURR ZIK TRANSM
   Edelsbrunner H., 2010, COMPUTATIONAL TOPOLO
   FAO, 2010, FAOCLIM NET X 203 MN
   Fasy B, 2016, TDA STAT TOOLS TOPOL
   Gao, 2016, SCI REPORTS, P28070
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kraemer MUG, 2015, DRYAD DIGITAL REPOSI
   NEWBOLD P, 1983, J FORECASTING, V2, P23, DOI 10.1002/for.3980020104
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x
   Winer JB, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/793024
   Zhang, 2016, BIORXIV066456
NR 23
TC 4
Z9 4
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 13
PY 2018
VL 13
IS 2
AR e0192120
DI 10.1371/journal.pone.0192120
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FW1TV
UT WOS:000425083400013
PM 29438377
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Marques, ETA
   Burke, DS
AF Marques, Ernesto T. A.
   Burke, Donald S.
TI Tradition and innovation in development of a Zika vaccine
SO LANCET
LA English
DT Editorial Material
ID VIRUS
C1 [Marques, Ernesto T. A.; Burke, Donald S.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA.
   [Marques, Ernesto T. A.; Burke, Donald S.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Marques, Ernesto T. A.] FIOCRUZ Pernambuco, Dept Virol & Expt Therapeut, Inst Aggeu Magalhaes, Recife, PE, Brazil.
RP Marques, ETA (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA.; Marques, ETA (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.; Marques, ETA (corresponding author), FIOCRUZ Pernambuco, Dept Virol & Expt Therapeut, Inst Aggeu Magalhaes, Recife, PE, Brazil.
EM marques@pitt.edu
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
CR [Anonymous], 2017, LANCET INFECT DIS, V17, P1003, DOI 10.1016/S1473-3099(17)30534-0
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Gaudinski MR, 2017, LANCET
   Maciel M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003693
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Modjarrad K, 2017, LANCET
   PARDOLL DM, 1995, IMMUNITY, V3, P165, DOI 10.1016/1074-7613(95)90085-3
   Paules CI, 2017, JAMA-J AM MED ASSOC, V317, P691, DOI 10.1001/jama.2016.21079
   Salk JE, 1955, AM J PUBLIC HEALTH N, V45, P151, DOI 10.2105/AJPH.45.2.151
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
NR 12
TC 2
Z9 2
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 10
PY 2018
VL 391
IS 10120
BP 516
EP 517
DI 10.1016/S0140-6736(17)33107-0
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA FV5VB
UT WOS:000424649400006
PM 29217377
OA Bronze
DA 2020-07-08
ER

PT J
AU Gaudinski, MR
   Houser, KV
   Morabito, KM
   Hu, ZH
   Yamshchikov, G
   Rothwell, RS
   Berkowitz, N
   Mendoza, F
   Saunders, JG
   Novik, L
   Hendel, CS
   Holman, LA
   Gordon, IJ
   Cox, JH
   Edupuganti, S
   McArthur, MA
   Rouphael, NG
   Lyke, KE
   Cummings, GE
   Sitar, S
   Bailer, RT
   Foreman, BM
   Burgomaster, K
   Pelc, RS
   Gordon, DN
   DeMaso, CR
   Dowd, KA
   Laurencot, C
   Schwartz, RM
   Mascola, JR
   Graham, BS
   Pierson, TC
   Ledgerwood, JE
   Chen, GL
AF Gaudinski, Martin R.
   Houser, Katherine V.
   Morabito, Kaitlyn M.
   Hu, Zonghui
   Yamshchikov, Galina
   Rothwell, Ro Shauna
   Berkowitz, Nina
   Mendoza, Floreliz
   Saunders, Jamie G.
   Novik, Laura
   Hendel, Cynthia S.
   Holman, LaSonji A.
   Gordon, Ingelise J.
   Cox, Josephine H.
   Edupuganti, Srilatha
   McArthur, Monica A.
   Rouphael, Nadine G.
   Lyke, Kirsten E.
   Cummings, Ginny E.
   Sitar, Sandra
   Bailer, Robert T.
   Foreman, Bryant M.
   Burgomaster, Katherine
   Pelc, Rebecca S.
   Gordon, David N.
   DeMaso, Christina R.
   Dowd, Kimberly A.
   Laurencot, Carolyn
   Schwartz, Richard M.
   Mascola, John R.
   Graham, Barney S.
   Pierson, Theodore C.
   Ledgerwood, Julie E.
   Chen, Grace L.
CA VRC 319 Study Team
   VRC 320 Study Team
TI Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine
   candidates in healthy adults: randomised, open-label, phase 1 clinical
   trials
SO LANCET
LA English
DT Article
ID WEST-NILE-VIRUS; NEUTRALIZING ANTIBODY; INFECTION; TRANSMISSION; BRAZIL;
   PATHOGENESIS; TRANSFUSION; OUTBREAK; AMERICA; FEVER
AB Background The Zika virus epidemic and associated congenital infections have prompted rapid vaccine development. We assessed two new DNA vaccines expressing premembrane and envelope Zika virus structural proteins.
   Methods We did two phase 1, randomised, open-label trials involving healthy adult volunteers. The VRC 319 trial, done in three centres, assessed plasmid VRC5288 (Zika virus and Japanese encephalitis virus chimera), and the VRC 320, done in one centre, assessed plasmid VRC5283 (wild-type Zika virus). Eligible participants were aged 18-35 years in VRC19 and 18-50 years in VRC 320. Participants were randomly assigned 1: 1 by a computer-generated randomisation schedule prepared by the study statistician. All participants received intramuscular injection of 4 mg vaccine. In VRC 319 participants were assigned to receive vaccinations via needle and syringe at 0 and 8 weeks, 0 and 12 weeks, 0, 4, and 8 weeks, or 0, 4, and 20 weeks. In VRC 320 participants were assigned to receive vaccinations at 0, 4, and 8 weeks via single-dose needle and syringe injection in one deltoid or split-dose needle and syringe or needle-free injection with the Stratis device (Pharmajet, Golden, CO, USA) in each deltoid. Both trials followed up volunteers for 24 months for the primary endpoint of safety, assessed as local and systemic reactogenicity in the 7 days after each vaccination and all adverse events in the 28 days after each vaccination. The secondary endpoint in both trials was immunogenicity 4 weeks after last vaccination. These trials are registered with ClinicalTrials.gov, numbers NCT02840487 and NCT02996461.
   Findings VRC 319 enrolled 80 participants (20 in each group), and VRC 320 enrolled 45 participants (15 in each group). One participant in VRC 319 and two in VRC 320 withdrew after one dose of vaccine, but were included in the safety analyses. Both vaccines were safe and well tolerated. All local and systemic symptoms were mild to moderate. In both studies, pain and tenderness at the injection site was the most frequent local symptoms (37 [46%] of 80 participants in VRC 319 and 36 [80%] of 45 in VRC 320) and malaise and headache were the most frequent systemic symptoms (22 [27%] and 18 [22%], respectively, in VRC 319 and 17 [38%] and 15 [33%], respectively, in VRC 320). For VRC5283, 14 of 14 (100%) participants who received split-dose vaccinations by needle-free injection had detectable positive antibody responses, and the geometric mean titre of 304 was the highest across all groups in both trials.
   Interpretation VRC5283 was well tolerated and has advanced to phase 2 efficacy testing.
C1 [Gaudinski, Martin R.; Houser, Katherine V.; Morabito, Kaitlyn M.; Yamshchikov, Galina; Rothwell, Ro Shauna; Berkowitz, Nina; Mendoza, Floreliz; Saunders, Jamie G.; Novik, Laura; Hendel, Cynthia S.; Holman, LaSonji A.; Gordon, Ingelise J.; Cox, Josephine H.; Sitar, Sandra; Bailer, Robert T.; Laurencot, Carolyn; Schwartz, Richard M.; Mascola, John R.; Graham, Barney S.; Ledgerwood, Julie E.; Chen, Grace L.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Hu, Zonghui] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Foreman, Bryant M.; Burgomaster, Katherine; Pelc, Rebecca S.; Gordon, David N.; DeMaso, Christina R.; Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Edupuganti, Srilatha; Rouphael, Nadine G.] Emory Sch Med, Emory Vaccine Ctr, Dept Med, Div Infect Dis,Hope Clin, Decatur, GA USA.
   [McArthur, Monica A.; Lyke, Kirsten E.; Cummings, Ginny E.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
RP Chen, GL (corresponding author), NIAID, Vaccine Res Ctr, Clin Trials Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM grace.chen@nih.gov
RI Graham, Barney S./AAC-5898-2019; McArthur, Monica/AAD-9682-2019
OI Graham, Barney S./0000-0001-8112-0853; Pelc,
   Rebecca/0000-0001-5080-4945; Morabito, Kaitlyn/0000-0002-4849-4690;
   Gaudinski, Martin/0000-0002-3743-5281; Cox,
   Josephine/0000-0003-1301-7373
FU Intramural Research Program of the Vaccine Research Center, National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health
FX Intramural Research Program of the Vaccine Research Center, National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health.
CR ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   BUKOWSKI JF, 1989, J VIROL, V63, P5086, DOI 10.1128/JVI.63.12.5086-5091.1989
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7
   Liang HB, 2016, CELL MOL IMMUNOL, V13, P36, DOI 10.1038/cmi.2015.76
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06
   Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Pierson TC, 2014, ANNU REV VIROL, V1, P375, DOI 10.1146/annurev-virology-031413-085453
   Sarwar UN, 2015, J INFECT DIS, V211, P549, DOI 10.1093/infdis/jiu511
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sheets RL, 2006, TOXICOL SCI, V91, P620, DOI 10.1093/toxsci/kfj170
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
NR 31
TC 80
Z9 81
U1 3
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 10
PY 2018
VL 391
IS 10120
BP 552
EP 562
DI 10.1016/S0140-6736(17)33105-7
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA FV5VB
UT WOS:000424649400032
PM 29217376
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Modjarrad, K
   Lin, L
   George, SL
   Stephenson, KE
   Eckels, KH
   De La Barrera, RA
   Jarman, RG
   Sondergaard, E
   Tennant, J
   Ansel, JL
   Mills, K
   Koren, M
   Robb, ML
   Barrett, J
   Thompson, J
   Kosel, AE
   Dawson, P
   Hale, A
   Tan, CS
   Walsh, SR
   Meyer, KE
   Brien, J
   Crowell, TA
   Blazevic, A
   Mosby, K
   Larocca, RA
   Abbink, P
   Boyd, M
   Bricault, CA
   Seaman, MS
   Basil, A
   Walsh, M
   Tonwe, V
   Hoft, DF
   Thomas, SJ
   Barouch, DH
   Michael, NL
AF Modjarrad, Kayvon
   Lin, Leyi
   George, Sarah L.
   Stephenson, Kathryn E.
   Eckels, Kenneth H.
   De La Barrera, Rafael A.
   Jarman, Richard G.
   Sondergaard, Erica
   Tennant, Janice
   Ansel, Jessica L.
   Mills, Kristin
   Koren, Michael
   Robb, Merlin L.
   Barrett, Jill
   Thompson, Jason
   Kosel, Alison E.
   Dawson, Peter
   Hale, Andrew
   Tan, C. Sabrina
   Walsh, Stephen R.
   Meyer, Keith E.
   Brien, James
   Crowell, Trevor A.
   Blazevic, Azra
   Mosby, Karla
   Larocca, Rafael A.
   Abbink, Peter
   Boyd, Michael
   Bricault, Christine A.
   Seaman, Michael S.
   Basil, Anne
   Walsh, Melissa
   Tonwe, Veronica
   Hoft, Daniel F.
   Thomas, Stephen J.
   Barouch, Dan H.
   Michael, Nelson L.
TI Preliminary aggregate safety and immunogenicity results from three
   trials of a purified inactivated Zika virus vaccine candidate: phase 1,
   randomised, double-blind, placebo-controlled clinical trials
SO LANCET
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; PROTECTIVE EFFICACY; INFECTION; PREGNANCY
AB Background A safe, effective, and rapidly scalable vaccine against Zika virus infection is needed. We developed a purified formalin-inactivated Zika virus vaccine (ZPIV) candidate that showed protection in mice and non-human primates against viraemia after Zika virus challenge. Here we present the preliminary results in human beings.
   Methods We did three phase 1, placebo-controlled, double-blind trials of ZPIV with aluminium hydroxide adjuvant. In all three studies, healthy adults were randomly assigned by a computer-generated list to receive 5 mu g ZPIV or saline placebo, in a ratio of 4:1 at Walter Reed Army Institute of Research, Silver Spring, MD, USA, or of 5:1 at Saint Louis University, Saint Louis, MO, USA, and Beth Israel Deaconess Medical Center, Boston, MA, USA. Vaccinations were given intramuscularly on days 1 and 29. The primary objective was safety and immunogenicity of the ZPIV candidate. We recorded adverse events and Zika virus envelope microneutralisation titres up to day 57. These trials are registered at ClinicalTrials.gov, numbers NCT02963909, NCT02952833, and NCT02937233.
   Findings We enrolled 68 participants between Nov 7, 2016, and Jan 25, 2017. One was excluded and 67 participants received two injections of Zika vaccine (n=55) or placebo (n=12). The vaccine caused only mild to moderate adverse events. The most frequent local effects were pain (n=40 [60%]) or tenderness (n=32 [47%]) at the injection site, and the most frequent systemic reactogenic events were fatigue (29 [43%]), headache (26 [39%]), and malaise (15 [22%]). By day 57, 52 (92%) of vaccine recipients had seroconverted (micro-neutralisation titre >= 1:10), with peak geometric mean titres seen at day 43 and exceeding protective thresholds seen in animal studies.
   Interpretation The ZPIV candidate was well tolerated and elicited robust neutralising antibody titres in healthy adults.
C1 [Modjarrad, Kayvon; Lin, Leyi; Eckels, Kenneth H.; De La Barrera, Rafael A.; Jarman, Richard G.; Sondergaard, Erica; Mills, Kristin; Koren, Michael; Thomas, Stephen J.; Michael, Nelson L.] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [George, Sarah L.; Tennant, Janice; Meyer, Keith E.; Blazevic, Azra; Mosby, Karla; Hoft, Daniel F.] St Louis Univ, Sch Med, Dept Internal Med, Div Infect Dis Allergy & Immunol, St Louis, MO USA.
   [Brien, James] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA.
   [George, Sarah L.; Hoft, Daniel F.] St Louis VA Med Ctr, St Louis, MO USA.
   [Stephenson, Kathryn E.; Ansel, Jessica L.; Tan, C. Sabrina; Walsh, Stephen R.; Larocca, Rafael A.; Abbink, Peter; Boyd, Michael; Bricault, Christine A.; Seaman, Michael S.; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, E CLS 1043, Boston, MA 02115 USA.
   [Stephenson, Kathryn E.; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA.
   [Robb, Merlin L.; Crowell, Trevor A.; Basil, Anne; Walsh, Melissa; Tonwe, Veronica] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA.
   [Barrett, Jill; Thompson, Jason; Kosel, Alison E.; Dawson, Peter] Emmes Corp, Rockville, MD USA.
   [Hale, Andrew] Univ Vermont, Med Ctr, Burlington, VT USA.
   [Hale, Andrew] Larner Coll Med, Burlington, VT USA.
RP Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, E CLS 1043, Boston, MA 02115 USA.; Michael, NL (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.
EM dbarouch@bidmc.harvard.edu; nelson.l.michael2.mil@mail.mil
RI Crowell, Trevor/W-3904-2019; Barouch, Dan/Y-3918-2019
OI Crowell, Trevor/0000-0001-5947-265X; Stephenson,
   Kathryn/0000-0002-3440-4105
FU Department of the Army; Department of the DefenseUnited States
   Department of Defense; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID)
FX Departments of the Army and Defense and National Institute of Allergy
   and Infectious Diseases.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muthumani K, VIVO PROTECTION ZIKV
   Pardi N., 2017, NATURE
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Plotkin SA, 2001, VACCINE, V19, P3311, DOI 10.1016/S0264-410X(01)00073-1
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   US Food and Drug Administration, 2017, TITL 21 FOOD DRUGS
NR 26
TC 70
Z9 71
U1 1
U2 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 10
PY 2018
VL 391
IS 10120
BP 563
EP 571
DI 10.1016/S0140-6736(17)33106-9
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA FV5VB
UT WOS:000424649400033
PM 29217375
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU da Silva, MB
   Santos, RCR
   Freire, PTC
   Caetano, EWS
   Freire, VN
AF Bezerra da Silva, M.
   Santos, R. C. R.
   Freire, P. T. C.
   Caetano, E. W. S.
   Freire, V. N.
TI Vibrational Properties of Bulk Boric Acid 2A and 3T Polymorphs and Their
   Two-Dimensional Layers: Measurements and Density Functional Theory
   Calculations
SO JOURNAL OF PHYSICAL CHEMISTRY A
LA English
DT Article
ID MOLECULAR-CRYSTALS; ORTHOBORIC ACID; DFT CALCULATIONS; SPECTRA;
   FREQUENCIES; APPROXIMATION; GAS
AB Boric acid (H3BO3) is being used effectively nowadays in traps/baits for the management of Aedes aegypti L. and Aedes albopictus Skuse species of mosquitoes, which are the main spreading vectors worldwide for diseases such as malaria, dengue, and zika. Previously, we published results on the structural, electronic, and optical properties of its molecular triclinic H3BO3-2A and trigonal H3BO3-3T polymorphs within the framework of density functional theory (DFT). Because of the renewed importance of these materials, the focus of this work is on the vibrational properties of the bulk boric acid 2A and 3T polymorphs. We measured the infrared and Raman spectra of the former, which was accompanied and interpreted through state-of-the-art DFT calculations, supplemented by computa-tions regarding the H3BO3 molecule and two-dimensional layersba sed on the bulk structures. We identify/assign their normal as in-and out-of-plane motions and molecular vibrations, unveiling a nice agreement between the DFT level of theory employed and our improved spectroscopic measurements in the wavenumber ranges of 400-2000 cm(-1) (infrared) and 0-1500 cm(-1) (Raman). We show that a dispersion-corrected DFT functional within the generalized gradient approximation (GGA) can be very accurate in describing the vibrational properties of the boric acid polymorphs. Besides, several issues left open/not clearly resolved in previously published works on the vibrational mode assignments of the bulk and 2D sheets of boric acid are explained satisfactorily. Finally, phonon dispersions and associated densities of states were also evaluated for each polymorph along with their temperature-dependent DFT-calculated entropy, enthalpy, free energy, heat capacity, and Debye temperature. In particular, our DFT calculations suggest a possible way to differentiate the 2A and 3T boric acid polymorphs through Raman spectroscopy and heat capacity measurements.
C1 [Bezerra da Silva, M.; Santos, R. C. R.; Freire, P. T. C.; Freire, V. N.] Univ Fed Ceara, Dept Fis, Caixa Postal 6030, BR-60440900 Fortaleza, CE, Brazil.
   [Santos, R. C. R.; Freire, V. N.] Univ Fed Ceara, Dept Quim Analit & Fis Quim, BR-60440554 Fortaleza, CE, Brazil.
   [Caetano, E. W. S.] Inst Fed Educ Ciencia & Tecnol Ceara, DEMEL, Campus Fortaleza, BR-60040531 Fortaleza, CE, Brazil.
RP da Silva, MB (corresponding author), Univ Fed Ceara, Dept Fis, Caixa Postal 6030, BR-60440900 Fortaleza, CE, Brazil.
RI de Tarso Cavalcante Freire, Paulo/C-5229-2013; Santos, Regina C.
   R./N-1418-2018; Caetano, Ewerton WS/A-2284-2015; BEZERRA DA SILVA,
   MAURICELIO/M-8997-2017
OI de Tarso Cavalcante Freire, Paulo/0000-0002-2321-3709; Santos, Regina C.
   R./0000-0002-6943-366X; Caetano, Ewerton WS/0000-0002-1021-6927; BEZERRA
   DA SILVA, MAURICELIO/0000-0001-7941-3956
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq); Brazilian Research
   Agency CNPqNational Council for Scientific and Technological Development
   (CNPq); CNPqNational Council for Scientific and Technological
   Development (CNPq) [307843/2013-0, 140898/2016-6]
FX V.N.F., P.T.C.F., and E.W.S.C. are researchers from the Brazilian
   National Research Council (CNPq) and acknowledge the financial support
   received during the development of this work from Brazilian Research
   Agency CNPq. E.W.S.C. and M.B.d.S. received financial support from CNPq
   projects 307843/2013-0 and 140898/2016-6, respectively. E.W.S.C. and
   P.T.C.F. also acknowledge PRONEX CNPq/FUNCAP.
CR Aliatis I, 2015, J RAMAN SPECTROSC, V46, P501, DOI 10.1002/jrs.4670
   Ananthakrishnan R., 1937, Proceedings of the Indian Academy of Sciences, Section A, V5, P200
   ANDREWS L, 1992, J CHEM PHYS, V97, P7203, DOI 10.1063/1.463545
   Araujo-Filho AA, 2017, J SOLID STATE CHEM, V250, P68, DOI 10.1016/j.jssc.2017.03.017
   Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515
   Bedoya-Martinez N, 2017, J PHYS CHEM LETT, V8, P3690, DOI 10.1021/acs.jpclett.7b01634
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   BETHELL DE, 1955, T FARADAY SOC, V51, P9, DOI 10.1039/tf9555100009
   da Silva MB, 2016, CRYST GROWTH DES, V16, P6631, DOI 10.1021/acs.cgd.6b01297
   Neto JRB, 2014, J RAMAN SPECTROSC, V45, P801, DOI 10.1002/jrs.4559
   Bloino J, 2010, J CHEM THEORY COMPUT, V6, P1256, DOI 10.1021/ct9006772
   BROADHEAD P, 1971, J MOL STRUCT, V10, P157, DOI 10.1016/0022-2860(71)87074-6
   Civalleri B, 2008, CRYSTENGCOMM, V10, P405, DOI 10.1039/b715018k
   Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075
   Costa SN, 2016, J PHYS CHEM A, V120, P5752, DOI 10.1021/acs.jpca.6b05436
   DORSET DL, 1992, ACTA CRYSTALLOGR A, V48, P562, DOI 10.1107/S010876739200206X
   DURIG JR, 1968, J MOL STRUCT, V2, P19, DOI 10.1016/0022-2860(68)85002-1
   Ennis C, 2017, MON NOT R ASTRON SOC, V471, P4265, DOI 10.1093/mnras/stx1736
   Erdemir A, 1996, SURF COAT TECH, V86-7, P507, DOI 10.1016/S0257-8972(96)02984-2
   Farfan-Garcia ED, 2016, TOXICOL LETT, V258, P115, DOI 10.1016/j.toxlet.2016.06.018
   Grimme S, 2016, CHEM REV, V116, P5105, DOI 10.1021/acs.chemrev.5b00533
   Hetmanczyk J, 2016, J RAMAN SPECTROSC, V47, P591, DOI 10.1002/jrs.4863
   HORNIG DF, 1957, J CHEM PHYS, V26, P637, DOI 10.1063/1.1743360
   Krishnan K., 1963, P INDIAN ACAD SCI, V60, P103
   LIN JS, 1993, PHYS REV B, V47, P4174, DOI 10.1103/PhysRevB.47.4174
   Medvedev EF, 2007, GLASS CERAM+, V64, P42, DOI 10.1007/s10717-007-0010-y
   Milman V, 2010, J MOL STRUC-THEOCHEM, V954, P22, DOI 10.1016/j.theochem.2009.12.040
   Mitra S.M., 1938, Indian Journal of Physics, V12, P9
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nielsen FH, 2014, J TRACE ELEM MED BIO, V28, P383, DOI 10.1016/j.jtemb.2014.06.023
   OGDEN JS, 1988, J CHEM SOC DALTON, P1645, DOI 10.1039/dt9880001645
   PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048
   Rotaru P, 2010, THERMOCHIM ACTA, V506, P8, DOI 10.1016/j.tca.2010.04.006
   Scorei RI, 2011, BIOL TRACE ELEM RES, V143, P1223, DOI 10.1007/s12011-011-8972-6
   Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r
   Segall MD, 2002, J PHYS-CONDENS MAT, V14, P2717, DOI 10.1088/0953-8984/14/11/301
   SERVOSS RR, 1957, J CHEM PHYS, V26, P1175, DOI 10.1063/1.1743486
   Shuvalov R. R., 2003, ACTA CRYSTALLOGR C, V34, DOI [10.1002/chin.200339006, DOI 10.1002/CHIN.200339006]
   Shuvalov RR, 2003, ACTA CRYSTALLOGR C, V59, pI47, DOI 10.1107/S0108270103009685
   Sibaev M, 2015, J PHYS CHEM A, V119, P13107, DOI 10.1021/acs.jpca.5b11386
   Silva AM, 2015, J PHYS CHEM A, V119, P11791, DOI 10.1021/acs.jpca.5b08784
   Silva AM, 2013, CRYST GROWTH DES, V13, P4844, DOI 10.1021/cg401016v
   Tian SX, 1999, J MOL STRUC-THEOCHEM, V469, P223, DOI 10.1016/S0166-1280(99)00085-8
   Tkatchenko A, 2015, ADV FUNCT MATER, V25, P2054, DOI 10.1002/adfm.201403029
   Tkatchenko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073005
   Van Troeye B, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.144304
   Venkateswaran CS, 1937, NATURE, V140, P151, DOI 10.1038/140151b0
   Zachariasen W. H., 1934, Z KRIST-CRYST MATER, V88, P1
   ZACHARIASEN WH, 1954, ACTA CRYSTALLOGR, V7, P305, DOI 10.1107/S0365110X54000886
   ZAKI K, 1995, CHEM PHYS LETT, V236, P184, DOI 10.1016/0009-2614(95)00172-Z
NR 54
TC 5
Z9 5
U1 2
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5639
J9 J PHYS CHEM A
JI J. Phys. Chem. A
PD FEB 8
PY 2018
VL 122
IS 5
BP 1312
EP 1325
DI 10.1021/acsjpca.7b10083
PG 14
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA FW0AZ
UT WOS:000424954700017
PM 29328646
DA 2020-07-08
ER

PT J
AU Barrera, R
   Amador, M
   Munoz, J
   Acevedo, V
AF Barrera, Roberto
   Amador, Manuel
   Munoz, Jorge
   Acevedo, Veronica
TI Integrated vector control of Aedes aegypti mosquitoes around target
   houses
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Zika; Vector control; AGO traps; Mosquitoes
ID ZIKA VIRUS TRANSMISSION; DIPTERA-CULICIDAE; PUERTO-RICO; DENGUE CONTROL;
   PERSISTENCE; INFECTION; DISPERSAL; OVITRAPS; SIZE; RNA
AB Background: The developing fetuses of pregnant women are at high risk of developing serious birth defects following Zika virus infections. We applied an Integrated Vector Control (IVC) approach using source reduction, larviciding, and mass trapping with non-insecticidal sticky traps to protect targeted houses by reducing the density of female Aedes aegypti mosquitoes.
   Methods: We tested the hypothesis that Ae. aegypti density could be reduced to below three female mosquitoes/trap/week around a target house in the center of a circular area with a 150 m radius using IVC. Two non-adjacent areas within the same neighbourhood were selected and randomly designated as the treatment or control areas. Sentinel Autocidal Gravid Ovitraps (SAGO traps) were placed in each study area and were sampled weekly from May to November, during the 2016 Zika epidemic in Puerto Rico. The experimental design was longitudinal with pre- and post-IVC treatment observations between treatment and control areas, and a partial cross-over design, where IVC was applied to the original control area after 2 months to determine if Ae. aegypti density converged to levels observed in the treatment area. Pools of female Ae. aegypti mosquitoes were analyzed by RT-PCR to detect Zika, dengue and chikungunya virus RNA.
   Results: Overall, pre-treatment mosquito densities in the inner (0-50 m; 15.6 mosquitoes/trap/week), intermediate (50-100 m; 18.1) and outer rings (100-150 m; 15.6) were reduced after treatment to 2.8, 4.1, and 4.3 in the inner, middle, and outer rings, respectively. Density at the target house in the treatment area changed from 27.7 mosquitoes/trap/week before IVC to 2.1 after IVC (92.4% reduction), whereas after treating the original control area (cross-over) density changed from 22.4 to 3.5 (84.3% reduction). Vector reductions were sustained in both areas after IVC. Zika virus was detected in Ae. aegypti, but the low incidence of the virus precluded assessing the impact of IVC on Zika transmission during the study.
   Conclusions: Applying IVC to circular areas that were surrounded by untreated areas significantly decreased the number of mosquitoes around target houses located in the center. Gravid Ae. aegypti females in the center of the 150 m areas fell below threshold levels that possibly protect against novel invading arboviruses, such as chikungunya and Zika.
C1 [Barrera, Roberto; Amador, Manuel; Acevedo, Veronica] Ctr Dis Control & Prevent, Entomol & Ecol Act, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
   [Munoz, Jorge] Ctr Dis Control & Prevent, Mol Diagnost Lab, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
RP Barrera, R (corresponding author), Ctr Dis Control & Prevent, Entomol & Ecol Act, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
EM amz9@cdc.gov
RI amsalu, ribka/G-8780-2019
FU Division of Vector Borne Diseases, Centers for Disease Control and
   Prevention
FX Funding was provided by the Division of Vector Borne Diseases, Centers
   for Disease Control and Prevention.
CR Bangs MJ, 2007, J MED ENTOMOL, V44, P163, DOI 10.1603/0022-2585(2007)44[163:PODVRI]2.0.CO;2
   Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrera R, 2009, AM J TROP MED HYG, V81, P100, DOI 10.4269/ajtmh.2009.81.100
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   FDA, TRIOPL REAL TIM RT P
   Hills Susan L, 2002, Commun Dis Intell Q Rep, V26, P596
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Maciel-de-Freitas R, 2010, MED VET ENTOMOL, V24, P74, DOI 10.1111/j.1365-2915.2009.00851.x
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Mavale M, 2012, AM J TROP MED HYG, V86, P178, DOI 10.4269/ajtmh.2012.11-0236
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Vazquez-Prokopec G, 2010, PLOS NEGL TROP DIS, V4
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
NR 25
TC 5
Z9 5
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 8
PY 2018
VL 11
AR 88
DI 10.1186/s13071-017-2596-4
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FV7SC
UT WOS:000424784300002
PM 29422087
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Singh, RK
   Dhama, K
   Khandia, R
   Munjal, A
   Karthik, K
   Tiwari, R
   Chakraborty, S
   Malik, YS
   Bueno-Mari, R
AF Singh, Raj K.
   Dhama, Kuldeep
   Khandia, Rekha
   Munjal, Ashok
   Karthik, Kumaragurubaran
   Tiwari, Ruchi
   Chakraborty, Sandip
   Malik, Yashpal S.
   Bueno-Mari, Ruben
TI Prevention and Control Strategies to Counter Zika Virus, a Special Focus
   on Intervention Approaches against Vector Mosquitoes-Current Updates
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Zika virus; Zika fever; mosquito management; prevention; vector control;
   arbovirus
ID TRANSMISSION-BLOCKING VACCINES; AEDES-AEGYPTI DIPTERA; PUBLIC-HEALTH
   EMERGENCY; MESSENGER-RNA VACCINES; DENGUE VECTOR; BORNE DISEASES;
   MESOCYCLOPS-THERMOCYCLOPOIDES; ENHANCING IMMUNOGENICITY;
   TOXORHYNCHITES-SPLENDENS; SILVER NANOPARTICLES
AB Zika virus (ZIKV) is the most recent intruder that acquired the status of global threat creating panic and frightening situation to public owing to its rapid spread, attaining higher virulence and causing complex clinical manifestations including microcephaly in newborns and Guillain Barre Syndrome. Alike other flaviviruses, the principal mode of ZIKV transmission is by mosquitoes. Advances in research have provided reliable diagnostics for detecting ZIKV infection, while several drug/therapeutic targets and vaccine candidates have been identified recently. Despite these progresses, currently there is neither any effective drug nor any vaccine available against ZIKV. Under such circumstances and to tackle the problem at large, control measures of which mosquito population control need to be strengthened following appropriate mechanical, chemical, biological and genetic control measures. Apart from this, several other known modes of ZIKV transmission which have gained importance in recent past such as intrauterine, sexual intercourse, and blood-borne spread need to be checked and kept under control by adopting appropriate precautions and utmost care during sexual intercourse, blood transfusion and organ transplantation. The virus inactivation by pasteurization, detergents, chemicals, and filtration can effectively reduce viral load in plasma-derived medicinal products. Added to this, strengthening of the surveillance and monitoring of ZIKV as well as avoiding travel to Zika infected areas would aid in keeping viral infection under check. Here, we discuss the salient advances in the prevention and control strategies to combat ZIKV with a focus on highlighting various intervention approaches against the vector mosquitoes of this viral pathogen along with presenting an overview regarding human intervention measures to counter other modes of ZIKV transmission and spread. Additionally, owing to the success of vaccines for a number of infections globally, a separate section dealing with advances in ZIKV vaccines and transmission blocking vaccines has also been included.
C1 [Singh, Raj K.] Indian Vet Res Inst, ICAR, Bareilly, Uttar Pradesh, India.
   [Dhama, Kuldeep] Indian Vet Res Inst, ICAR, Div Pathol, Bareilly, Uttar Pradesh, India.
   [Khandia, Rekha; Munjal, Ashok] Barkatullah Univ, Dept Biochem & Genet, Bhopal, India.
   [Karthik, Kumaragurubaran] Tamil Nadu Vet & Anim Sci Univ, Cent Univ Lab, Chennai, Tamil Nadu, India.
   [Tiwari, Ruchi] UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vig, Coll Vet Sci, Dept Vet Microbiol & Immunol, Mathura, India.
   [Chakraborty, Sandip] Coll Vet Sci & Anim Husb, Dept Vet Microbiol, Agartala, India.
   [Malik, Yashpal S.] Indian Vet Res Inst, ICAR, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.
   [Bueno-Mari, Ruben] Dept Invest & Desarrollo I D, Labs Lokim, Valencia, Spain.
RP Dhama, K (corresponding author), Indian Vet Res Inst, ICAR, Div Pathol, Bareilly, Uttar Pradesh, India.; Malik, YS (corresponding author), Indian Vet Res Inst, ICAR, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.
EM kdhama@rediffmail.com; malikyps@gmail.com
RI Dhama, Kuldeep/B-7852-2015; Malik, Yashpal Singh/AAI-2259-2019
OI Dhama, Kuldeep/0000-0001-7469-4752; 
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Adalja Amesh, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.1c39ec05a743d41ee39391ed0f2ed8d3
   Adeosun C., 2016, J PATHOL PEST MANAG, V3, P53
   AhbiRami R, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu042
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Alfonso-Parra C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004451
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Alphey L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003909
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Anbu P, 2016, NAT PROD RES, V30, P2077, DOI 10.1080/14786419.2015.1114935
   Anholeti MC, 2015, MEM I OSWALDO CRUZ, V110, P629, DOI 10.1590/0074-02760150103
   Anogwih JA, 2015, BIOL CONTROL, V81, P31, DOI 10.1016/j.biocontrol.2014.11.001
   Anwar A, 2005, VIROLOGY, V332, P66, DOI 10.1016/j.virol.2004.11.022
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1
   Ashfaq UA, 2016, VIRAL IMMUNOL, V29, P436, DOI 10.1089/vim.2016.0033
   Asif A, 2017, VIRAL IMMUNOL, V30, P682, DOI 10.1089/vim.2017.0046
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10218, DOI 10.1007/s11356-016-8146-3
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Brown MD, 1996, J AM MOSQUITO CONTR, V12, P414
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2015, CURR OPIN VIROL, V10, P63, DOI 10.1016/j.coviro.2015.01.006
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chang KS, 2018, AM J TROP MED HYG, V98, P166, DOI 10.4269/ajtmh.17-0587
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Chitti Sai V., 2016, VirusDisease, V27, P211, DOI 10.1007/s13337-016-0317-9
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Coutinho-Abreu IV, 2010, MEM I OSWALDO CRUZ, V105, P1, DOI 10.1590/S0074-02762010000100001
   Cu Y, 2013, VACCINES, V1, P367, DOI 10.3390/vaccines1030367
   Cunha-Neto E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00640
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Darbro JM, 2009, AM J TROP MED HYG, V80, P992, DOI 10.4269/ajtmh.2009.80.992
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   Dhalia R, 2009, AN ACAD BRAS CIENC, V81, P663, DOI 10.1590/S0001-37652009000400005
   Dhama K., 2013, INT J CURR RES, V5, P1942
   Dhiman RC, 2010, PARASITOL RES, V106, P763, DOI 10.1007/s00436-010-1767-4
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   Farcet MR, 2017, TRANSFUSION, V57, P797, DOI 10.1111/trf.13953
   Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Fotin-Mleczek M, 2011, J IMMUNOTHER, V34, P1, DOI 10.1097/CJI.0b013e3181f7dbe8
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franco LD, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0395-z
   Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Ghosh Anupam, 2005, Turkish Journal of Biology, V29, P167
   GOLDBERG LJ, 1977, MOSQ NEWS, V37, P355
   Goodsell JA, 1999, CONSERV BIOL, V13, P921, DOI 10.1046/j.1523-1739.1999.98237.x
   Govindarajan M, 2016, ENZYME MICROB TECH, V95, P155, DOI 10.1016/j.enzmictec.2016.05.005
   Govindarajan M, 2016, ENVIRON SCI POLLUT R, V23, P23228, DOI 10.1007/s11356-016-7568-2
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Griffin L, 2014, J VECTOR ECOL, V39, P197, DOI 10.1111/j.1948-7134.2014.12087.x
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hirano M, 1998, REV TOXICOL, V2, P357
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006
   Jaber S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1763-3
   Jiang DB, 2015, VACCINE, V33, P3367, DOI 10.1016/j.vaccine.2015.05.007
   Kalimuthu K, 2014, HYDROBIOLOGIA, V741, P113, DOI 10.1007/s10750-013-1745-9
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kant R, 2013, J VECTOR DIS, V50, P1
   Kaslow DC, 1997, INT J PARASITOL, V27, P183, DOI 10.1016/S0020-7519(96)00148-8
   Kay BH, 2010, AM J TROP MED HYG, V82, P822, DOI 10.4269/ajtmh.2010.09-0503
   Kennedy RB, 2016, EBIOMEDICINE, V13, P29, DOI 10.1016/j.ebiom.2016.10.016
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kline MW, 2016, JAMA PEDIATR, V170, P309, DOI 10.1001/jamapediatrics.2016.0429
   Kollars T. M., 2016, IOSR J DENT MED SCI, V15, P104, DOI [10.9790/0853-150907104107, DOI 10.9790/0853-150907104107]
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Kuhnel D, 2017, TRANSFUSION, V57, P802, DOI 10.1111/trf.13964
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Kumar PM, 2012, PARASITOL RES, V111, P609, DOI 10.1007/s00436-012-2876-z
   Kumar S, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00147
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Li YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18848
   Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931
   Londono-Renteria B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1802-0
   Lu Yang, 2003, Discov Med, V3, P54
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Mathivanan T, 2010, J VECTOR DIS, V47, P178
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Mischke CC, 2016, J WORLD AQUACULT SOC, V47, P212, DOI 10.1111/jwas.12243
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Mourya DT, 2016, INDIAN J MED RES, V143, P553, DOI 10.4103/0971-5916.187103
   MULLA MS, 1986, J AM MOSQUITO CONTR, V2, P314
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Munjal A, 2017, INT J PHARMACOL, V13, P667, DOI 10.3923/ijp.2017.667.676
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Murugan K, 2013, PHYTOPARASITICA, V41, P307, DOI 10.1007/s12600-013-0291-3
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67
   Nathiya V., 2015, INT J MODN RES REVS, V3, P630
   Neelakanta G, 2015, ARCH IMMUNOL THER EX, V63, P169, DOI 10.1007/s00005-014-0324-8
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0377
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Phukon H.K., 2013, Advances in Bioresearch, V4, P22
   Pierre DYS, 2014, J MOSQ RES, V4, P5, DOI DOI 10.5376/JMR.2014.04.0002
   Prabhu K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P124, DOI 10.1016/S2221-1691(11)60009-9
   Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073
   Ramkumar G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158088
   Ramkumar G, 2015, PARASITOL RES, V114, P167, DOI 10.1007/s00436-014-4173-5
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Reegan Appadurai Daniel, 2015, Osong Public Health Res Perspect, V6, P64, DOI 10.1016/j.phrp.2014.08.009
   Richards SL, 2017, J ENVIRON HEALTH, V79, P8
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rodriguez SD, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew117
   Rossi P, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0888-0
   Sandipan Gupta, 2013, Bioscience Discovery, V4, P89
   Sankar S, 2017, BIOINFORMATION, V13, P366, DOI 10.6026/97320630013366
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   Sarwar M., 2015, INT J PREVENTIVE MED, V1, P232
   Schaper S, 2006, REV BIOL TROP, V54, P843
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Singh RK, 2017, VET QUART, V37, P98, DOI 10.1080/01652176.2017.1309474
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Sluydts V, 2016, LANCET INFECT DIS, V16, P1169, DOI 10.1016/S1473-3099(16)30148-7
   Snetselaar J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-200
   Souza TM, 2011, J MED ENTOMOL, V48, P846, DOI 10.1603/ME10205
   Specter M, 2012, NEW YORKER
   SUAREZ MF, 1992, J AM MOSQUITO CONTR, V8, P409
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tennyson Samuel, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1130
   Tham HW, 2014, VIRUSES-BASEL, V6, P5028, DOI 10.3390/v6125028
   Tiago PV, 2014, CIENC RURAL, V44, P645, DOI 10.1590/S0103-84782014000400012
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Unlu I, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2034-7
   Uragayala S, 2015, INDIAN J MED RES, V142, P64, DOI 10.4103/0971-5916.176624
   van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340
   Vasquez AM, 2016, AM J TRANSPLANT, V16, P2487, DOI 10.1111/ajt.13941
   Veljkovic Veljko, 2016, F1000Res, V5, P190, DOI 10.12688/f1000research.8102.2
   Vest KG, 2017, DISASTER MED PUBLIC, V11, P163, DOI 10.1017/dmp.2016.105
   Von Seidlein L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002219
   Vythilingam I, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01452
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walton WE, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P261
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587
   Weterings R, 2015, J VECTOR ECOL, V40, P230, DOI 10.1111/jvec.12158
   Whitehead S.S., 2017, Patent No. [WO201715651A1, 2017156511A1]
   *WHO, 1997, WHOCTDWHOPES972
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Wilson F., 1960, COMMONWEALTH I BIOL, P80
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zuharah WF, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev115
NR 195
TC 12
Z9 12
U1 0
U2 29
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 8
PY 2018
VL 9
AR 87
DI 10.3389/fmicb.2018.00087
PG 22
WC Microbiology
SC Microbiology
GA FV3GI
UT WOS:000424455600001
PM 29472902
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Darwish, NT
   Sekaran, SD
   Alias, Y
   Khor, SM
AF Darwish, Nadiya T.
   Sekaran, Shamala D.
   Alias, Yatimah
   Khor, Sook Mei
TI Immunofluorescence-based biosensor for the determination of dengue virus
   NS1 in clinical samples
SO JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
LA English
DT Article
DE Optical; Immunosensor; Immunofluorescence; Dengue virus; NS1
ID LINKED-IMMUNOSORBENT-ASSAY; ANTIBODY; FLUORESCENCE; ANTIGEN;
   IMMUNOSENSOR; IMMUNOASSAY; FEVER; GOLD; NANOPARTICLES; DIAGNOSTICS
AB The sharp increase in incidence of dengue infection has necessitated the development of methods for the rapid diagnosis of this deadly disease. Here we report the design and development of a reliable, sensitive, and specific optical immunosensor for the detection of the dengue nonstructural protein 1 (NS1) biomarker in clinical samples obtained during early stages of infection. The present optical NS1 immunosensor comprises a biosensing surface consisting of specific monoclonal NS1 antibody for immunofluorescence-based NS1 antigen determination using fluorescein isothiocyanate (FITC) conjugated to IgG antibody. The linear range of the optical immunosensor was from 15 - 500 ngmL(-1), with coefficient of determination (R-2) of 0.92, high reproducibility (the relative standard deviation obtained was 2%), good stability for 21 days at 4 degrees, and low detection limit (LOD) at 15 ng mL(-1). Furthermore, the optical immunosensor was capable of detecting NS1 analytes in plasma specimens from patients infected with the dengue virus, with low cross - reaction with plasma specimens containing the Japanese encephalitis virus (AV) and Zika virus. No studies have been performed on the reproducibility and cross -reactivity regarding NS1 specificity, which is thus a limitation for optical NS1 immunosensors. In contrast, the present study addressed these limitations carefully where these two important experiments were conducted to showcase the robustness of our newly developed optical-based fluorescence immunosensor, which can be practically used for direct NS1 determination in any untreated clinical sample. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Darwish, Nadiya T.; Alias, Yatimah; Khor, Sook Mei] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 50603, Malaysia.
   [Sekaran, Shamala D.] Univ Malaya, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.
   [Alias, Yatimah; Khor, Sook Mei] Univ Malaya, UMCiL, Kuala Lumpur 50603, Malaysia.
RP Khor, SM (corresponding author), Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 50603, Malaysia.
EM naomikhor@um.edu.my
RI Devi, Shamala Devi/B-9735-2010; Khor, Sook Mei/E-6117-2015; Sekaran,
   Shamala Devi/B-8482-2008; ALIAS, YATIMAH/C-1074-2010
OI Devi, Shamala Devi/0000-0002-0478-0425; Khor, Sook
   Mei/0000-0001-6050-0195; Sekaran, Shamala Devi/0000-0002-0478-0425; 
FU University of Malaya Research Grant [UMRG] [RP012C-14SUS]; Fundamental
   Research Grant Scheme [FRGS] from the Ministry of Higher Education of
   Malaysia [MOHE] [FP041-2016]; University of Malaya Postgraduate Research
   Grant [PG120-2012B]
FX This work was financially supported by the University of Malaya Research
   Grant [UMRG] [RP012C-14SUS], the Fundamental Research Grant Scheme
   [FRGS] from the Ministry of Higher Education of Malaysia [MOHE]
   [FP041-2016], and a University of Malaya Postgraduate Research Grant
   [PG120-2012B].
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Atias D, 2009, SENSOR ACTUAT B-CHEM, V140, P206, DOI 10.1016/j.snb.2009.03.044
   Baeumner AJ, 2002, ANAL CHEM, V74, P1442, DOI 10.1021/ac015675e
   Bertok T, 2013, ANAL CHEM, V85, P7324, DOI 10.1021/ac401281t
   Camara AR, 2013, OPT EXPRESS, V21, P27023, DOI 10.1364/OE.21.027023
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Cheng C, 2016, SENSOR ACTUAT B-CHEM, V227, P283, DOI 10.1016/j.snb.2015.12.057
   Damodaran Vinod B, 2016, Biomater Res, V20, P18, DOI 10.1186/s40824-016-0064-4
   Darwish NT, 2015, APPL SURF SCI, V325, P91, DOI 10.1016/j.apsusc.2014.10.167
   Darwish NT, 2016, J ELECTROCHEM SOC, V163, pB19, DOI 10.1149/2.0471603jes
   Darwish NT, 2018, SENSOR ACTUAT B-CHEM, V255, P3316, DOI 10.1016/j.snb.2017.09.159
   Darwish NT, 2015, TRAC-TREND ANAL CHEM, V67, P45, DOI 10.1016/j.trac.2015.01.005
   Dinsmore MJ, 2008, J ELECTROANAL CHEM, V617, P71, DOI 10.1016/j.jelechem.2008.01.018
   Dodeigne C, 2000, TALANTA, V51, P415, DOI 10.1016/S0039-9140(99)00294-5
   Gan SD, 2013, J INVEST DERMATOL, V133, pE10, DOI 10.1038/jid.2013.287
   Granger D, 2017, DIAGN MICR INFEC DIS, V88, P120, DOI 10.1016/j.diagmicrobio.2017.03.015
   Gunda NSK, 2013, BIOMED MICRODEVICES, V15, P959, DOI 10.1007/s10544-013-9787-3
   Guo LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32755
   He SF, 2017, FOOD CHEM, V227, P33, DOI 10.1016/j.foodchem.2017.01.060
   Hosseini S, 2014, EUR POLYM J, V60, P14, DOI 10.1016/j.eurpolymj.2014.08.010
   Huang A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40772
   Huang CH, 2013, J MICROBIOL IMMUNOL, V46, P358, DOI 10.1016/j.jmii.2012.07.011
   Iswardy E, 2017, BIOSENS BIOELECTRON, V95, P174, DOI 10.1016/j.bios.2017.04.011
   Jiang XS, 2008, BIOSENS BIOELECTRON, V23, P1577, DOI 10.1016/j.bios.2008.01.035
   Kato F, 2016, ANTIVIR RES, V131, P141, DOI 10.1016/j.antiviral.2016.04.014
   Khoo MM, 2016, SENSOR ACTUAT B-CHEM, V224, P683, DOI 10.1016/j.snb.2015.10.085
   Kostomoiri M, 2015, ARCH BIOCHEM BIOPHYS, V567, P83, DOI 10.1016/j.abb.2014.12.027
   Kumbhat S, 2010, J PHARMACEUT BIOMED, V52, P255, DOI 10.1016/j.jpba.2010.01.001
   Linares EM, 2013, BIOSENS BIOELECTRON, V41, P180, DOI 10.1016/j.bios.2012.08.005
   Luna DMN, 2015, SENSOR ACTUAT B-CHEM, V220, P565, DOI 10.1016/j.snb.2015.05.067
   Mallat E, 2001, TRAC-TREND ANAL CHEM, V20, P124, DOI 10.1016/S0165-9936(00)00082-0
   Navakul K, 2016, NANOMEDICINE, V13, P549
   Peterson AW, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-35
   Pirich CL, 2017, BIOSENS BIOELECTRON, V92, P47, DOI 10.1016/j.bios.2017.01.068
   Qin D., 2007, J BIOMED BIOTECHNOL, V2007, P9
   Rai V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042346
   Ranzoni A, 2015, ANAL CHEM, V87, P6150, DOI 10.1021/acs.analchem.5b00762
   Raposo M., 2007, MODERN RES ED TOPICS, V1, P758
   Ruan CM, 2002, ANAL CHEM, V74, P4814, DOI 10.1021/ac025647b
   Saleem W, 2016, BIOSENS BIOELECTRON, V86, P522, DOI 10.1016/j.bios.2016.07.009
   Saudi M, 2016, EUR J MED CHEM, V121, P158, DOI 10.1016/j.ejmech.2016.05.043
   Serra B, 2002, BIOSENS BIOELECTRON, V17, P217, DOI 10.1016/S0956-5663(01)00269-X
   Sharma A, 2010, THIN SOLID FILMS, V519, P1213, DOI 10.1016/j.tsf.2010.08.071
   Shenoy B., 2014, PEDIAT INFECT DIS, V6, P110, DOI DOI 10.1016/J.PID.2014.08.002
   Stemmer A, 2008, HISTOCHEM CELL BIOL, V130, P807, DOI 10.1007/s00418-008-0506-8
   Tian SY, 2017, J IMMUNOL METHODS, V451, P78, DOI 10.1016/j.jim.2017.09.002
   Vaschenko S, 2016, PROCEDIA ENGINEER, V140, P57, DOI 10.1016/j.proeng.2015.08.1111
   Vira S, 2010, ANAL BIOCHEM, V402, P146, DOI 10.1016/j.ab.2010.03.036
   Wong WR, 2016, BIOSENS BIOELECTRON, V78, P132, DOI 10.1016/j.bios.2015.11.030
   Wu SJL, 2001, J CLIN MICROBIOL, V39, P2794, DOI 10.1128/JCM.39.8.2794-2798.2001
   Yenchitsomanus Pa-Thai, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P228
NR 51
TC 7
Z9 8
U1 4
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0731-7085
EI 1873-264X
J9 J PHARMACEUT BIOMED
JI J. Pharm. Biomed. Anal.
PD FEB 5
PY 2018
VL 149
BP 591
EP 602
DI 10.1016/j.jpba.2017.11.064
PG 12
WC Chemistry, Analytical; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA FV1IV
UT WOS:000424315700076
PM 29197806
DA 2020-07-08
ER

PT J
AU Kiely, P
   Wood, EM
   Cheng, AC
AF Kiely, Philip
   Wood, Erica M.
   Cheng, Allen C.
TI Emerging infectious disease agents and blood safety in Australia:
   spotlight on Zika virus
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT Letter
C1 [Kiely, Philip] Australian Red Cross Blood Serv, Melbourne, Vic, Australia.
   [Kiely, Philip; Wood, Erica M.; Cheng, Allen C.] Monash Univ, Melbourne, Vic, Australia.
   [Cheng, Allen C.] Alfred Hlth, Melbourne, Vic, Australia.
RP Kiely, P (corresponding author), Australian Red Cross Blood Serv, Melbourne, Vic, Australia.; Kiely, P (corresponding author), Monash Univ, Melbourne, Vic, Australia.
EM pkiely@redcrossblood.org.au
RI Wood, Erica/I-1956-2014
OI Wood, Erica/0000-0001-7527-2340
CR Department of Health, 2017, SUMM INF OV ACQ VECT
   Kiely P, 2017, MED J AUSTRALIA, V206, P455, DOI 10.5694/mja16.00833
NR 2
TC 0
Z9 0
U1 0
U2 1
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
EI 1326-5377
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD FEB 5
PY 2018
VL 208
IS 2
DI 10.5694/mja17.00612
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GA1WG
UT WOS:000428107700017
PM 29553691
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Emerging infectious disease agents and blood safety in Australia:
   spotlight on Zika virus
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT Letter
EM wviroj@yahoo.com
CR Kiely P, 2017, MED J AUSTRALIA, V206, P455, DOI 10.5694/mja16.00833
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P1099, DOI 10.1016/j.apjtm.2016.10.004
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 0
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
EI 1326-5377
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD FEB 5
PY 2018
VL 208
IS 2
DI 10.5694/mja17.00532
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GA1WG
UT WOS:000428107700016
PM 29385979
DA 2020-07-08
ER

PT J
AU Sabalza, M
   Yasmin, R
   Barber, CA
   Castro, T
   Malamud, D
   Kim, BJ
   Zhu, H
   Montagna, RA
   Abrams, WR
AF Sabalza, Maite
   Yasmin, Rubina
   Barber, Cheryl A.
   Castro, Talita
   Malamud, Daniel
   Kim, Beum Jun
   Zhu, Hui
   Montagna, Richard A.
   Abrams, William R.
TI Detection of Zika virus using reverse-transcription LAMP coupled with
   reverse dot blot analysis in saliva
SO PLOS ONE
LA English
DT Article
ID SQUAMOUS-CELL CARCINOMA; INFECTIOUS-DISEASES; MOLECULAR-DETECTION;
   IDENTIFICATION; EMERGENCE; SPREAD; STATES; DNA
AB In recent years, there have been increasing numbers of infectious disease outbreaks that spread rapidly to population centers resulting from global travel, population vulnerabilities, environmental factors, and ecological disasters such as floods and earthquakes. Some examples of the recent outbreaks are the Ebola epidemic in West Africa, Middle East respiratory syndrome coronavirus (MERS-Co) in the Middle East, and the Zika outbreak through the Americas. We have created a generic protocol for detection of pathogen RNA and/or DNA using loop-mediated isothermal amplification (LAMP) and reverse dot-blot for detection (RDB) and processed automatically in a microfluidic device. In particular, we describe how a microfluidic assay to detect HIV viral RNA was converted to detect Zika virus (ZIKV) RNA. We first optimized the RT-LAMP assay to detect ZIKV RNA using a benchtop isothermal amplification device. Then we implemented the assay in a microfluidic device that will allow analyzing 24 samples simultaneously and automatically from sample introduction to detection by RDB technique. Preliminary data using saliva samples spiked with ZIKV showed that our diagnostic system detects ZIKV RNA in saliva. These results will be validated in further experiments with well-characterized ZIKV human specimens of saliva. The described strategy and methodology to convert the HIV diagnostic assay and platform to a ZIKV RNA detection assay provides a model that can be readily utilized for detection of the next emerging or re-emerging infectious disease.
C1 [Sabalza, Maite; Barber, Cheryl A.; Castro, Talita; Malamud, Daniel; Abrams, William R.] NYU, Coll Dent, Dept Basic Sci, New York, NY 10003 USA.
   [Yasmin, Rubina; Kim, Beum Jun; Zhu, Hui; Montagna, Richard A.] Rheonix Inc, Ithaca, NY USA.
   [Castro, Talita] Univ Sao Paulo, Sch Dent, Stomatol Dept, Sao Paulo, SP, Brazil.
   [Malamud, Daniel] NYU, Sch Med, Dept Med, New York, NY USA.
RP Sabalza, M (corresponding author), NYU, Coll Dent, Dept Basic Sci, New York, NY 10003 USA.
EM ms10129@nyu.edu
RI KIM, BEUM JUN/G-6829-2011; Abrams, William R/A-5782-2008
OI KIM, BEUM JUN/0000-0003-1797-5026; Malamud, Daniel/0000-0002-9094-4122
FU National Institute of Dental and Craniofacial Research of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Dental & Craniofacial Research (NIDCR) [R44DE024456,
   3R44DE024456-03S1]
FX Research reported in this publication was supported by the National
   Institute of Dental and Craniofacial Research of the National Institutes
   of Health under Award Numbers R44DE024456 and 3R44DE024456-03S1. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health. Four of the authors (Richard Montagna, Rubina Yasmin, Beum Jun
   Kim and Hui Zhu) are employees of Rheonix, Inc. Rheonix, Inc. provided
   support in the form of salaries for authors RM, RY, BJK and HZ, but did
   not have any additional role in the study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. The
   specific roles of these authors are articulated in the "author
   contributions" section.
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brierley L, 2016, AM NAT, V187, pE53, DOI 10.1086/684391
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   CDC, 2016, CAS COUNTS US 2016
   Centers for Disease Control and Prevention (CDC), 2017, WORLD MAP AR RISK ZI
   Chen Z, 2016, J AIDS CLIN RES, V7, P1
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Cone EJ, 2002, J ANAL TOXICOL, V26, P541, DOI 10.1093/jat/26.8.541
   Corstjens Paul L A M, 2012, J Am Dent Assoc, V143, p12S
   de Souza M, 2017, MYCOPATHOLOGIA, V182, P625, DOI 10.1007/s11046-017-0129-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DeSantis AS, 2015, PSYCHOSOM MED, V77, P6, DOI 10.1097/PSY.0000000000000131
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duz MB, 2016, CELL ONCOL, V39, P187, DOI 10.1007/s13402-015-0259-z
   FDA, EM US AUTH 2017
   Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664
   Finger F, 2016, P NATL ACAD SCI USA, V113, P6421, DOI 10.1073/pnas.1522305113
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Hajosi-Kalcakosz S, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0392-z
   Hutchins SS, 2009, AM J PUBLIC HEALTH, V99, pS243, DOI 10.2105/AJPH.2009.164814
   Javaid Mohammad A, 2016, J Oral Biol Craniofac Res, V6, P66, DOI 10.1016/j.jobcr.2015.08.006
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Lau YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138694
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Maffert P, 2017, EUR J CLIN MICROBIOL, V36, P1717, DOI 10.1007/s10096-017-3013-9
   Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004
   Mangili A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.IOL5-0009-2015
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martins D, 2015, BIOSENS BIOELECTRON, V72, P87, DOI 10.1016/j.bios.2015.04.063
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Miocevic O, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00133
   Modak Sayli S, 2016, Infect Dis (Auckl), V9, P1, DOI [10.4137/IDRT.S32162, 10.4137/idrt.s32162]
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415
   Nakata Y, 2015, J MATH BIOL, V70, P1411, DOI 10.1007/s00285-014-0801-z
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   PAHO, 2017, COUNTR TERR AUT TRAN
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Sabalza M, 2017, JOVE-J VIS EXP, DOI 10.3791/56784
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Septfons A, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.32.30315
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Spizz G, 2015, ARCH PATHOL LAB MED, V139, P805, DOI 10.5858/arpa.2014-0059-OA
   Spizz G, 2012, POINT CARE, V11, P42, DOI 10.1097/POC.0b013e318222e184
   Tang HK, 2013, MOL MED REP, V7, P761, DOI 10.3892/mmr.2012.1254
   Triunfol M, 2016, LANCET INFECT DIS, V16, P527, DOI 10.1016/S1473-3099(16)30015-9
   WILSON ME, 1995, EMERG INFECT DIS, V1, P39, DOI 10.3201/eid0102.950201
   Wilson ME, 2003, J APPL MICROBIOL, V94, p1S
   Yadav S, 2016, J CLIN DIAGN RES, V10, pDM1, DOI 10.7860/JCDR/2016/19170.8133
   Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 59
TC 13
Z9 14
U1 3
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 5
PY 2018
VL 13
IS 2
AR e0192398
DI 10.1371/journal.pone.0192398
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FU8KH
UT WOS:000424101400058
PM 29401479
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chinmai, P
   Chirasani, VR
   Rahman, MH
   Ahsan, M
   Revanasiddappa, PD
   Senapati, S
AF Chinmai, Pindi
   Chirasani, Venkat Reddy
   Rahman, Mohammad Homaidur
   Ahsan, Mohd
   Revanasiddappa, Prasanna Diddige
   Senapati, Sanjib
TI How Zika Sustains High Temperatures: Insights from Atomic Simulations
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 62nd Annual Meeting of the Biophysical-Society
CY FEB 17-21, 2018
CL San Francisco, CA
SP Biophys Soc
C1 [Chinmai, Pindi; Chirasani, Venkat Reddy; Rahman, Mohammad Homaidur; Ahsan, Mohd; Revanasiddappa, Prasanna Diddige; Senapati, Sanjib] Indian Inst Technol, Biotechnol, Madras, Tamil Nadu, India.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB 2
PY 2018
VL 114
IS 3
SU 1
MA 1669-Pos
BP 337A
EP 337A
PG 1
WC Biophysics
SC Biophysics
GA GD4CL
UT WOS:000430450000183
DA 2020-07-08
ER

PT J
AU Moore, AFT
   Koculi, E
AF Moore, Anthony F. T.
   Koculi, Eda
TI Discovery of Zika NS5 Polymerase Inhibitors
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 62nd Annual Meeting of the Biophysical-Society
CY FEB 17-21, 2018
CL San Francisco, CA
SP Biophys Soc
C1 [Moore, Anthony F. T.; Koculi, Eda] Univ Cent Florida, Chem, Orlando, FL 32816 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB 2
PY 2018
VL 114
IS 3
SU 1
MA 2057-Pos
BP 416A
EP 416A
DI 10.1016/j.bpj.2017.11.2307
PG 1
WC Biophysics
SC Biophysics
GA GD4CL
UT WOS:000430450000571
OA Bronze
DA 2020-07-08
ER

PT J
AU Rawle, R
   Webster, E
   Boxer, S
   Kasson, P
AF Rawle, Robert
   Webster, Elizabeth
   Boxer, Steven
   Kasson, Peter
TI Kinetic Models of Zika Virus Membrane Fusion
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 62nd Annual Meeting of the Biophysical-Society
CY FEB 17-21, 2018
CL San Francisco, CA
SP Biophys Soc
C1 [Rawle, Robert; Kasson, Peter] Univ Virginia, Mol Phys & Biol Phys, Charlottesville, VA USA.
   [Webster, Elizabeth; Boxer, Steven] Stanford Univ, Stanford, CA 94305 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB 2
PY 2018
VL 114
IS 3
SU 1
MA 3000-Pos
BP 604A
EP 604A
DI 10.1016/j.bpj.2017.11.3304
PG 1
WC Biophysics
SC Biophysics
GA GD5RC
UT WOS:000430563300021
OA Bronze
DA 2020-07-08
ER

PT J
AU de Caires, LC
   Goulart, E
   Melo, U
   Araujo, BSH
   Alvizi, L
   Schanoski, AS
   de Oliveira, DF
   Kobayashi, GS
   Griesi-Oliveira, K
   Musso, CM
   Amaral, M
   dasilva, LF
   Astray, RM
   Suarez-Patino, SF
   Ventini, DC
   da Silva, SG
   Yamamoto, GL
   Ezquina, S
   Naslavsky, MS
   Silva, KTA
   Weinmann, K
   Van der Linden, V
   Van der Linden, H
   de Oliveira, JMR
   Arrais, NRM
   Melo, A
   Figueiredo, T
   Santos, S
   Meira, JCG
   Passos, SD
   de Almeida, RP
   Bispo, AJ
   Cavalheiro, E
   Kalil, J
   Cunha-Neto, E
   Nakaya, H
   Santos, RA
   Ferreira, LCD
   Verjovski-Almeida, S
   Ho, PL
   Passos-Bueno, MR
   Zatz, M
AF de Caires, Luiz Carlos, Jr.
   Goulart, Ernesto
   Melo, UiraSouto
   Henrique Araujo, Bruno Silva
   Alvizi, Lucas
   Schanoski, Alessandra Soares
   de Oliveira, Danyllo Felipe
   Kobayashi, Gerson Shigeru
   Griesi-Oliveira, Karina
   Musso, Camila Manso
   Amaral, MuriloSena
   dasilva, Lucas Ferreira
   Astray, Renato Mancini
   Suarez-Patino, Sandra Fernanda
   Ventini, Daniella Cristina
   da Silva, Sergio Gomes
   Yamamoto, Guilherme Lopes
   Ezquina, Suzana
   Naslavsky, Michel Satya
   Alves Silva, Kayque Telles
   Weinmann, Karina
   Van der Linden, Vanessa
   Van der Linden, Helio
   Ricardo de Oliveira, Joao Mendes
   Maria Arrais, Nivia Rodrigues
   Melo, Adriana
   Figueiredo, Thalita
   Santos, Silvana
   Goes Meira, Joanna Castro
   Passos, Saulo Duarte
   de Almeida, Roque Pacheco
   Bispo, Ana JovinaBarreto
   Cavalheiro, EsperAbrao
   Kalil, Jorge
   Cunha-Neto, Edecio
   Nakaya, Helder
   Santos, Robert Andreata
   de Souza Ferreira, Luis Carlos
   Verjovski-Almeida, Sergio
   Ho, Paulo Lee
   Passos-Bueno, Maria Rita
   Zatz, Mayana
TI Discordant congenital Zika syndrome twins show differential in vitro
   viral susceptibility of neural progenitor cells
SO NATURE COMMUNICATIONS
LA English
DT Article
ID VIRUS-INFECTION; STEM-CELLS; MENTAL-RETARDATION; GENETIC-VARIANTS;
   SEQUENCING DATA; ASSOCIATION; IDENTIFICATION; FLAVIVIRUSES; INTEGRATION;
   EXPRESSION
AB Congenital Zika syndrome (CZS) causes early brain development impairment by affecting neural progenitor cells (NPCs). Here, we analyze NPCs from three pairs of dizygotic twins discordant for CZS. We compare by RNA-Seq the NPCs derived from CZS-affected and CZS-unaffected twins. Prior to Zika virus (ZIKV) infection the NPCs from CZS babies show a significantly different gene expression signature of mTOR and Wnt pathway regulators, key to a neurodevelopmental program. Following ZIKV in vitro infection, cells from affected individuals have significantly higher ZIKV replication and reduced cell growth. Whole-exome analysis in 18 affected CZS babies as compared to 5 unaffected twins and 609 controls excludes a monogenic model to explain resistance or increased susceptibility to CZS development. Overall, our results indicate that CZS is not a stochastic event and depends on NPC intrinsic susceptibility, possibly related to oligogenic and/or epigenetic mechanisms.
C1 [de Caires, Luiz Carlos, Jr.; Goulart, Ernesto; Melo, UiraSouto; Alvizi, Lucas; de Oliveira, Danyllo Felipe; Kobayashi, Gerson Shigeru; Griesi-Oliveira, Karina; Musso, Camila Manso; Yamamoto, Guilherme Lopes; Ezquina, Suzana; Naslavsky, Michel Satya; Alves Silva, Kayque Telles; Weinmann, Karina; Figueiredo, Thalita; Passos-Bueno, Maria Rita; Zatz, Mayana] Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Res Ctr, Dept Genet & Evolutionary Biol, BR-05508900 Sao Paulo, SP, Brazil.
   [Henrique Araujo, Bruno Silva] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, BR-13083970 Campinas, SP, Brazil.
   [Henrique Araujo, Bruno Silva; Cavalheiro, EsperAbrao] Fed Univ Sao Paulo Univ UNIFESP EPM, Dept Neurol & Neurosurg, Neurosci Lab, BR-04039002 Sao Paulo, SP, Brazil.
   [Schanoski, Alessandra Soares; Amaral, MuriloSena; Astray, Renato Mancini; Suarez-Patino, Sandra Fernanda; Ventini, Daniella Cristina; Kalil, Jorge; Verjovski-Almeida, Sergio; Ho, Paulo Lee] Butantan Inst, BR-05503900 Sao Paulo, SP, Brazil.
   [Griesi-Oliveira, Karina; da Silva, Sergio Gomes] Albert Einstein Hosp, BR-05652900 Sao Paulo, SP, Brazil.
   [dasilva, Lucas Ferreira; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508900 Sao Paulo, SP, Brazil.
   [da Silva, Sergio Gomes] Univ Mogi das Cruzes, BR-08780911 Mogi Das Cruzes, SP, Brazil.
   [Van der Linden, Vanessa] AACD, BR-50080810 Recife, PE, Brazil.
   [Van der Linden, Helio] Rehabil Ctr Dr Henrique Santillo, BR-74653230 Goiania, Go, Brazil.
   [Ricardo de Oliveira, Joao Mendes] Fed Univ Pernambuco UFPE, Neuropsychiat Dept, BR-50670901 Recife, PE, Brazil.
   [Ricardo de Oliveira, Joao Mendes] Fed Univ Pernambuco UFPE, KeizoAsami Lab, BR-50670901 Recife, PE, Brazil.
   [Maria Arrais, Nivia Rodrigues] Fed Univ Rio Grande Norte UFRN, Dept Pediat, BR-59010180 Natal, RN, Brazil.
   [Melo, Adriana] ISEA, BR-58400220 Campina Grande, PB, Brazil.
   [Figueiredo, Thalita] Paraiba State Univ UEPB, Dept Biol, BR-58429500 Campina Grande, PB, Brazil.
   [Goes Meira, Joanna Castro] Fed Univ Bahia UFBA, BR-40170115 Salvador, BA, Brazil.
   [Passos, Saulo Duarte] Med Sch Jundiai, Infect Pediat Lab, BR-13202550 Jundiai, SP, Brazil.
   [de Almeida, Roque Pacheco; Bispo, Ana JovinaBarreto] Fed Univ Sergipe UFS, Div Immunol, BR-49100000 Aracaju, SP, Brazil.
   [de Almeida, Roque Pacheco; Bispo, Ana JovinaBarreto] Fed Univ Sergipe UFS, Mol Biol Lab, BR-49100000 Aracaju, SP, Brazil.
   [Cunha-Neto, Edecio] Univ Sao Paulo, Fac Med, Heart Inst, BR-05403900 Sao Paulo, SP, Brazil.
   [Nakaya, Helder] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508900 Sao Paulo, SP, Brazil.
   [Santos, Robert Andreata; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Vaccine Dev Lab, BR-05508900 Sao Paulo, SP, Brazil.
RP Zatz, M (corresponding author), Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Res Ctr, Dept Genet & Evolutionary Biol, BR-05508900 Sao Paulo, SP, Brazil.
EM mayazatz@usp.br
RI Zatz, Mayana/M-5338-2015; Araujo, Bruno/B-8741-2013; KALIL,
   JORGE/C-8029-2012; Verjovski-Almeida, Sergio/E-4082-2012; Schanoski,
   Alessandra/H-8144-2014; da Silva, Sergio Gomes/F-1847-2013; Araujo,
   Bruno/P-9975-2019; Cunha-Neto, Edecio/B-4157-2009; Melo, Adriana S
   O/H-5650-2016; Cavalheiro, Esper A/I-3084-2016; Nakaya,
   Helder/A-1397-2010; Goulart, Ernesto/AAC-3713-2020; Naslavsky,
   Michel/L-1772-2015; Kobayashi, Gerson Shigeru/AAB-9113-2019; Astray,
   Renato Mancini/N-6627-2013; Verjovski-Almeida, Sergio/AAI-2728-2020;
   Kobayashi, Gerson/H-4017-2013; Passos-Bueno, Maria Rita/I-6796-2016;
   Nakaya, Helder/AAF-1738-2020; Amaral, Murilo S/G-5769-2013
OI Zatz, Mayana/0000-0003-3970-8025; Araujo, Bruno/0000-0003-0012-4217;
   KALIL, JORGE/0000-0001-8415-4274; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Schanoski, Alessandra/0000-0002-6514-8458;
   da Silva, Sergio Gomes/0000-0002-9650-809X; Araujo,
   Bruno/0000-0003-0012-4217; Cunha-Neto, Edecio/0000-0002-3699-3345;
   Cavalheiro, Esper A/0000-0002-0854-3582; Nakaya,
   Helder/0000-0001-5297-9108; Naslavsky, Michel/0000-0002-9068-1713;
   Kobayashi, Gerson Shigeru/0000-0002-6520-5774; Astray, Renato
   Mancini/0000-0002-6983-5298; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Kobayashi, Gerson/0000-0002-6520-5774;
   Passos-Bueno, Maria Rita/0000-0002-9248-3008; Nakaya,
   Helder/0000-0001-5297-9108; Santos, Silvana/0000-0002-5252-0206; VAN DER
   LINDEN JUNIOR, HELIO/0000-0002-3123-2264; Passos,
   Saulo/0000-0002-0908-2677; Alves Telles Silva,
   Kayque/0000-0002-2994-609X; Alexandrasmello@gmail.com,
   Alexandra/0000-0002-7996-873X; Goulart, Ernesto/0000-0001-9526-8701
FU FAPESP (CEPID)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2013/08028-1]; FAPESP (INCT) [14/50931-3]; FAPESP (Thematic
   grant) [2014/03620-2]; CNPq (INCT)National Council for Scientific and
   Technological Development (CNPq) [465355/2014-5]; AACD (Recife-PE);
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [440770/2016-5]
FX This study was supported by grants from FAPESP (CEPID number
   2013/08028-1 and INCT number 14/50931-3 to M.Z. and Thematic grant
   number 2014/03620-2 to S.V.-A.) and CNPq (INCT number 465355/2014-5 to
   M.Z.); Luiz Carlos de Caires Junior is a fellow of FAPESP
   (2017/16283-2); Ernesto Goulart is a fellow of FAPESP (2015/14821-1);
   Bruno Araujo is a fellow of FAPESP (2014/08049-1); Vanessa van der
   Linden Mota is supported by AACD (Recife-PE); Joao Ricardo de Oliveira
   is supported by CNPq (440770/2016-5). We are extremely grateful to Dr.
   S. Raia, D. Bertola, M. Vibranoski, P. Cunha, E.L. Durigon, W. Cumpady,
   P. Zanotto, C.R.S. Maia, A.N. Melo, M.T.A.L. Bezerra, D.A.M. de Araujo,
   A. Tanuri, R.S. de Aguiar, and T.R. Gollop for scientific discussions
   and sample collections. L. Suzuki and E. Amaro-Junior for helping with
   CT analysis. N. Lourenco, and M. Aguena for technical support in exome
   sequencing and MLPA assay.
CR Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003
   Araujo B. H. S., 2017, MOL NEUROBIOL
   Barbier A, 2013, PEDIATRICS, V131, pE1158, DOI 10.1542/peds.2011-3846
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109
   Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013
   Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Alves RPD, 2016, CLIN VACCINE IMMUNOL, V23, P460, DOI 10.1128/CVI.00081-16
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   Hou PS, 2013, NUCLEIC ACIDS RES, V41, P7753, DOI 10.1093/nar/gkt567
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089
   Jehee FS, 2011, EUR J MED GENET, V54, pE425, DOI 10.1016/j.ejmg.2011.03.007
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Joubert PE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005091
   Kassai H, 2014, CELL REP, V7, P1626, DOI 10.1016/j.celrep.2014.04.048
   Kortum F, 2011, J MED GENET, V48, P396, DOI 10.1136/jmg.2010.087528
   Kumamoto T, 2017, DEV GROWTH DIFFER, V59, P258, DOI 10.1111/dgd.12367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
   Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293
   Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 45
TC 11
Z9 12
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 2
PY 2018
VL 9
AR 475
DI 10.1038/s41467-017-02790-9
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FU7VL
UT WOS:000424060700001
PM 29396410
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Feng, WJ
   Liu, HK
   Kawauchi, D
AF Feng, Weijun
   Liu, Hai-Kun
   Kawauchi, Daisuke
TI CRISPR-engineered genome editing for the next generation neurological
   disease modeling
SO PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
LA English
DT Review
DE Neurological disorder; Brain tumor; Mouse model; CRISPR; Cas9
ID ONE-STEP GENERATION; ZIKA VIRUS; CHROMOSOMAL REARRANGEMENTS; CEREBRAL
   ORGANOIDS; WIDE SPECIFICITIES; BRAIN-DEVELOPMENT; GENE-EXPRESSION;
   MAMMALIAN BRAIN; ANIMAL-MODELS; KNOCKIN MICE
AB Neurological disorders often occur because of failure of proper brain development and/or appropriate maintenance of neuronal circuits. In order to understand roles of causative factors (e.g. genes, cell types) in disease development, generation of solid animal models has been one of straight-forward approaches. Recent next generation sequencing studies on human patient-derived clinical samples have identified various types of recurrent mutations in individual neurological diseases. While these discoveries have prompted us to evaluate impact of mutated genes on these neurological diseases, a feasible but flexible genome editing tool had remained to be developed. An advance of genome editing technology using the clustered regularly interspaced short palindromic repeats (CRISPR) with the CRISPR-associated protein (Cas) offers us a tremendous potential to create a variety of mutations in the cell, leading to "next generation" disease models carrying disease-associated mutations. We will here review recent progress of CRISPR-based brain disease modeling studies and discuss future requirement to tackle current difficulties in usage of these technologies.
C1 [Feng, Weijun; Liu, Hai-Kun] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Mol Neurogenet, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.
   [Kawauchi, Daisuke] German Canc Res Ctr, Div Pediat Neurooncol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.
RP Kawauchi, D (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.
EM d.kawauchi@dkfz.de
OI liu, hai-kun/0000-0003-3338-4066
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [KA
   4472/1-1, LI 2140/1-1]
FX This study was supported by the Deutsche Forschungsgemeinschaft (KA
   4472/1-1 for D.K., LI 2140/1-1 for H-K.L.).
CR Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36
   Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021
   Bender S, 2016, NAT MED, V22, P1314, DOI 10.1038/nm.4204
   Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006
   Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051
   Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034
   Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936
   Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113
   Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]
   Chen FY, 2015, DEVELOPMENT, V142, P3601, DOI 10.1242/dev.118836
   Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038
   Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728
   Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Davidson BL, 2007, NEURON, V53, P781, DOI 10.1016/j.neuron.2007.02.020
   De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772
   Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033
   Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895
   Feng WJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14758
   Fontebasso AM, 2014, NAT GENET, V46, P462, DOI 10.1038/ng.2950
   Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019
   Gronych J, 2011, J CLIN INVEST, V121, P1344, DOI 10.1172/JCI44656
   Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909
   Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019
   Han JX, 2014, RNA BIOL, V11, P829, DOI 10.4161/rna.29624
   Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015
   He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064
   Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2
   Heinzen EL, 2015, ANNU REV NEUROSCI, V38, P47, DOI 10.1146/annurev-neuro-071714-034136
   Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199
   Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927
   Imaizumi Y, 2014, J NEUROCHEM, V129, P388, DOI 10.1111/jnc.12625
   Incontro S, 2014, NEURON, V83, P1051, DOI 10.1016/j.neuron.2014.07.043
   Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828
   Kalebic N, 2016, EMBO REP, V17, P338, DOI 10.15252/embr.201541715
   Kawauchi D, 2006, DEVELOPMENT, V133, P1113, DOI 10.1242/dev.02283
   Kawauchi D, 2008, DEV BIOL, V322, P345, DOI 10.1016/j.ydbio.2008.08.005
   Kc R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32048
   Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325
   Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609
   Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115
   Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]
   Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620
   Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526
   Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592
   Komor AC, 2016, CELL
   Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946
   Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136
   Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466
   Lackner DH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10237
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766
   Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056
   Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006
   Llaguno SRA, 2015, CANCER CELL, V28, P429, DOI 10.1016/j.ccell.2015.09.007
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902
   Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Malkin D, 2011, CANCER, V2, P475, DOI [10.1177/1947601911413466, DOI 10.1177/1947601911413466]
   Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190
   McDowell K, 2012, NEUROBIOL DIS, V46, P597, DOI 10.1016/j.nbd.2011.12.040
   Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mohankumar KM, 2015, NAT GENET, V47, P878, DOI 10.1038/ng.3323
   Monteys AM, 2017, MOL THER, V25, P12, DOI 10.1016/j.ymthe.2016.11.010
   More SV, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091447
   Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658
   Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560
   Nakajima K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34703
   Narita Y, 2002, CANCER RES, V62, P6764
   Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011
   Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729
   Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027
   Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379
   Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410
   Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310
   Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002
   Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109
   Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382
   Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491
   Paul PJ, 2016, ONCOGENE, V35, P6235, DOI 10.1038/onc.2016.159
   Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993
   Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554
   Platt RJ, 2017, CELL REP, V19, P335, DOI 10.1016/j.celrep.2017.03.052
   Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014
   Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753
   Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022
   Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413
   ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064
   Saba R, 2003, J NEUROSCI, V23, P1987
   Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439
   Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6
   Schmid-Burgk JL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12338
   Schwartzentruber J, 2012, NATURE, V482, P226, DOI 10.1038/nature10833
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]
   Shinmyo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20611
   Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227
   Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011
   Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939
   Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655
   Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024
   Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565
   Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012
   Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055
   Tai DJC, 2016, NAT NEUROSCI, V19, P517, DOI 10.1038/nn.4235
   Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630
   Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632
   Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964
   Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28
   Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117
   Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908
   Tu ZC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0031-x
   Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004
   Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198
   Varley JM, 2003, HUM MUTAT, V21, P313, DOI 10.1002/humu.10185
   Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159
   Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834
   Walters BJ, 2016, FRONT GENET, V6, DOI 10.3389/fphys.2015.00362
   Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025
   Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1
   Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
   Weber J., 2015, P NATL ACAD SCI US, V112
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938
   Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102
   Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889
   Xu XH, 2017, STEM CELL REP, V8, P619, DOI 10.1016/j.stemcr.2017.01.022
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589
   Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022
   Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017
   Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240
   Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431
   Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737
   Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038
   Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004
   Zuckermann M, 2017, BRIEF FUNCT GENOMICS, V16, P25, DOI 10.1093/bfgp/elw021
   Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391
NR 152
TC 5
Z9 6
U1 2
U2 247
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-5846
EI 1878-4216
J9 PROG NEURO-PSYCHOPH
JI Prog. Neuro-Psychopharmacol. Biol. Psychiatry
PD FEB 2
PY 2018
VL 81
BP 459
EP 467
DI 10.1016/j.pnpbp.2017.05.019
PG 9
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA FM3JN
UT WOS:000414901100050
PM 28536069
DA 2020-07-08
ER

PT J
AU Bailey, DB
   Ventura, LO
AF Bailey, Donald B., Jr.
   Ventura, Liana O.
TI The Likely Impact of Congenital Zika Syndrome on Families:
   Considerations for Family Supports and Services
SO PEDIATRICS
LA English
DT Article
ID FRAGILE-X-SYNDROME; DEVELOPMENTAL-DISABILITIES; VIRUS-INFECTION; MEDICAL
   COMPLEXITY; YOUNG-CHILDREN; UNITED-STATES; HEALTH; OUTCOMES;
   INTERVENTION; INFANTS
AB Congenital Zika virus infection has obvious implications for infants, and considerable research has addressed the nature and consequences of congenital Zika syndrome (CZS). Children with classic CZS meet the criteria for "children with medical complexity," and ongoing research is required to understand the range of needs and optimal treatment options. Far less attention has been given to the consequences of CZS for families, which are both immediate and lifelong. Although families of children with CZS have much in common with families of other children with disabilities, at least 4 features of CZS have special family implications: (1) the severity of the impact on children with obvious abnormalities at birth, coupled with the anticipation of a lifetime of caregiving and economic burdens; (2) uncertainty about the unfolding consequences, both for obviously affected children and for exposed children with no symptoms at birth; (3) a lack of specialized professional knowledge about the course of the disease or treatment options; and (4) social isolation, a lack of social or community supports, and potential stigma. Supporting families will require a family-centered approach to services, extensive care coordination, access to evolving new information, ongoing surveillance, formal and informal supports, and individualized child and family services.
C1 [Bailey, Donald B., Jr.] RTI Int, 3040 E Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA.
   [Ventura, Liana O.] Altino Ventura Fdn, Recife, PE, Brazil.
RP Bailey, DB (corresponding author), RTI Int, 3040 E Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA.
EM dbailey@rti.org
RI Ventura, Liana Vieira O/N-6151-2018
OI Ventura, Liana Vieira O/0000-0001-6529-6883
FU RTI International; Eunice Kennedy Shriver National Institute of Child
   Health and Human Development of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [R01HD093572]
FX Supported in part by internal funding from RTI International, and in
   part by the Eunice Kennedy Shriver National Institute of Child Health
   and Human Development of the National Institutes of Health under Award
   Number R01HD093572. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   National Institutes of Health (NIH).
CR Abbeduto L, 2004, AM J MENT RETARD, V109, P237, DOI 10.1352/0895-8017(2004)109<237:PWACIM>2.0.CO;2
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Bailey DB, 2008, AM J MED GENET A, V146A, P720, DOI 10.1002/ajmg.a.32240
   Bailey DB, 2007, PEDIATRICS, V120, pE992, DOI 10.1542/peds.2006-2775
   Bailey DB, 2006, J EARLY INTERVENTION, V28, P227, DOI 10.1177/105381510602800401
   Bailey DB, 2012, J DEV BEHAV PEDIATR, V33, P705, DOI 10.1097/DBP.0b013e318272dcbc
   Bailey DB, 2011, J EARLY INTERVENTION, V33, P6, DOI 10.1177/1053815111399441
   Bailey DB, 2010, AJIDD-AM J INTELLECT, V115, P447, DOI 10.1352/1944-7558-115.6.447
   Bailey DB, 2005, INT ISSUE EARLY INTE, P151
   Bailey DB, 2009, J PEDIATR PSYCHOL, V34, P648, DOI 10.1093/jpepsy/jsn032
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Boshoff K, 2016, CHILD CARE HLTH DEV, V42, P784, DOI 10.1111/cch.12383
   Cohen E, 2011, PEDIATRICS, V127, P529, DOI 10.1542/peds.2010-0910
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Crnic KA, 2017, CHILD DEV, V88, P436, DOI 10.1111/cdev.12740
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   Eckhoff RP, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4202
   Edelstein H, 2017, CHILD CARE HLTH DEV, V43, P323, DOI 10.1111/cch.12430
   Epley PH, 2011, J EARLY INTERVENTION, V33, P201, DOI 10.1177/1053815111425929
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Glader L, 2016, DEV MED CHILD NEUROL, V58, P1116, DOI 10.1111/dmcn.13201
   Gooding JS, 2011, SEMIN PERINATOL, V35, P20, DOI 10.1053/j.semperi.2010.10.004
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Kizakevich PN, 2014, ANN REV CYBERTHERAPY, V12, P35, DOI 10.3233/978-1-61499-401-5-35
   Kline MW, 2016, JAMA PEDIATR, V170, P309, DOI 10.1001/jamapediatrics.2016.0429
   Lindly OJ, 2016, J DEV BEHAV PEDIATR, V37, P712, DOI 10.1097/DBP.0000000000000363
   Lindo EJ, 2016, FAM RELAT, V65, P207, DOI 10.1111/fare.12185
   Mastal MF, 2007, PROF CASE MANAG, V12, P27
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   Ouyang LJ, 2014, RES DEV DISABIL, V35, P1518, DOI 10.1016/j.ridd.2014.04.009
   Parry O, 2004, FAM PRACT, V21, P131, DOI 10.1093/fampra/cmh203
   Peer JW, 2014, J POLICY PRACT INTEL, V11, P92, DOI 10.1111/jppi.12072
   Raspa M, 2014, AJIDD-AM J INTELLECT, V119, P33, DOI 10.1352/1944-7558-119.1.33
   Raspa M, 2010, EXCEPT CHILDREN, V76, P496, DOI 10.1177/001440291007600407
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Singer GHS, 2007, MENT RETARD DEV D R, V13, P357, DOI 10.1002/mrdd.20175
   Timmermans S, 2010, J HEALTH SOC BEHAV, V51, P408, DOI 10.1177/0022146510386794
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Warren SF, 2017, J AUTISM DEV DISORD, V47, P768, DOI 10.1007/s10803-016-2999-7
NR 43
TC 14
Z9 15
U1 0
U2 2
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD FEB
PY 2018
VL 141
SU 2
BP S180
EP S187
DI 10.1542/peds.2017-2038G
PG 8
WC Pediatrics
SC Pediatrics
GA HG1SC
UT WOS:000454739100006
PM 29437051
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Broussard, CS
   Shapiro-Mendoza, CK
   Peacock, G
   Rasmussen, SA
   Mai, CT
   Petersen, EE
   Galang, RR
   Newsome, K
   Reynolds, MR
   Gilboa, SM
   Boyle, CA
   Moore, CA
AF Broussard, Cheryl S.
   Shapiro-Mendoza, Carrie K.
   Peacock, Georgina
   Rasmussen, Sonja A.
   Mai, Cara T.
   Petersen, Emily E.
   Galang, Romeo R.
   Newsome, Kimberly
   Reynolds, Megan R.
   Gilboa, Suzanne M.
   Boyle, Coleen A.
   Moore, Cynthia A.
TI Public Health Approach to Addressing the Needs of Children Affected by
   Congenital Zika Syndrome
SO PEDIATRICS
LA English
DT Article
ID VIRUS-INFECTION; BIRTH-DEFECTS; UNITED-STATES; PUERTO-RICO; PREGNANCY;
   INFANTS; UPDATE; MANIFESTATIONS; OUTBREAK; EXPOSURE
AB We have learned much about the short-term sequelae of congenital Zika virus (ZIKV) infection since the Centers for Disease Control and Prevention activated its ZIKV emergency response in January 2016. Nevertheless, gaps remain in our understanding of the full spectrum of adverse health outcomes related to congenital ZIKV infection and how to optimize health in those who are affected. To address the remaining knowledge gaps, support affected children so they can reach their full potential, and make the best use of available resources, a carefully planned public health approach in partnership with pediatric health care providers is needed. An essential step is to use population-based data captured through surveillance systems to describe congenital Zika syndrome. Another key step is using collected data to investigate why some children exhibit certain sequelae during infancy and beyond, whereas others do not, and to describe the clustering of anomalies and the timing of when these anomalies occur, among other research questions. The final critical step in the public health framework for congenital Zika syndrome is an intervention strategy with evidence-based best practices for longer-term monitoring and care. Adherence to recommended evaluation and management procedures for infants with possible congenital ZIKV infection, including for those with less obvious developmental and medical needs at birth, is essential. It will take many years to fully understand the effects of ZIKV on those who are congenitally infected; however, the lifetime medical and educational costs as well as the emotional impact on affected children and families are likely to be substantial.
C1 [Broussard, Cheryl S.; Peacock, Georgina; Mai, Cara T.; Galang, Romeo R.; Newsome, Kimberly; Reynolds, Megan R.; Gilboa, Suzanne M.; Boyle, Coleen A.; Moore, Cynthia A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Hwy NE,MS E-86, Atlanta, GA 30341 USA.
   [Shapiro-Mendoza, Carrie K.; Petersen, Emily E.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA.
   [Rasmussen, Sonja A.] Ctr Dis Control & Prevent, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA USA.
RP Broussard, CS (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Hwy NE,MS E-86, Atlanta, GA 30341 USA.
EM cbroussard@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Centers for Disease Control and Prevention, ZIK VIR 2017 CAS COU
   Centers for Disease Control and Prevention, CDC NEWSR CDC I NAC
   Centers for Disease Control and Prevention, EV INF POSS CONG ZIK
   Centers for Disease Control and Prevention, ZIK PREGN ADD RES HE
   Centers for Disease Control and Prevention, CDC US ZIK PREGN REG
   Centers for Disease Control and Prevention, ZIK VIR TRANSM
   Centers for Disease Control and Prevention, TRAV HLTH WORLD MAP
   CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Early Childhood Technical Assistance Center, EARL INT PROGR INF C
   Gelber SE, 2017, BJOG-INT J OBSTET GY, V124, P550, DOI 10.1111/1471-0528.14388
   Gilboa SM, 2017, BIRTH DEFECTS RES, V109, P372, DOI 10.1002/bdr2.1007
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   NANCARROW SA, 2013, HUM RESOUR HEALTH, V11
   National Center for Education in Maternal and Child Health; Georgetown University, BRIGHT FUT
   National Institutes of Health, NIH LAUNCH LARG STUD
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   Patient-Centered Primary Care Collaborative, DEF MED HOM
   Rasmussen SA, 2005, AM J PUBLIC HEALTH, V95, P1942, DOI 10.2105/AJPH.2004.054957
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   SEVER JL, 1985, REV INFECT DIS, V7, pS164
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   World Health Organization, 2016, STAT 5 M EM COMM INT
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 36
TC 4
Z9 4
U1 0
U2 1
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD FEB
PY 2018
VL 141
SU 2
BP S146
EP S153
DI 10.1542/peds.2017-2038C
PG 8
WC Pediatrics
SC Pediatrics
GA HG1SC
UT WOS:000454739100002
PM 29437047
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU MacDonald, PDM
   Holden, EW
AF MacDonald, Pia D. M.
   Holden, E. Wayne
TI Zika and Public Health: Understanding the Epidemiology and Information
   Environment
SO PEDIATRICS
LA English
DT Article
ID UNITED-STATES; SEXUAL TRANSMISSION; VIRUS-INFECTION; DISEASE; HISTORY;
   TWITTER; CRISIS
AB Because Zika is a newly emerging infectious disease with little previous information known about it, there are many epidemiologic and clinical questions. The complexity of providing care to those who are at risk for infection or are already infected with Zika in this evidencescarce environment cannot be understated. In this article, we provide an overview of the Zika virus (ZIKV) in the context of public health and pediatric health care. A broad public health focus is used to provide relevant information for addressing important questions about the epidemic and to facilitate communication with patients, parents, and caregivers within the current information environment. We explore issues regarding the epidemiology of the virus (including why ZIKV outbreaks are occurring), what has changed since the sporadic case reports before the outbreaks, why the true incidence is difficult to estimate, why attack rates vary by population and geography, and why the association between Zika and congenital Zika syndrome and Guillain-Barre syndrome have only come to light recently. Additionally, challenges related to the current information environment, traditional and informal information sources about the ZIKV, and examples of Zika public health communication campaigns are discussed. Importantly, we review the existing findings regarding the US population's Zika-related knowledge, attitudes, beliefs, and behavior by highlighting variations and gaps. We conclude by identifying related research questions that remain critical.
C1 [MacDonald, Pia D. M.; Holden, E. Wayne] RTI Int, Res Triangle Pk, NC USA.
RP MacDonald, PDM (corresponding author), RTI Int, 2150 Shattuck Ave,Suite 800, Berkeley, CA 94704 USA.
EM pmacdonald@rti.org
OI Holden, Emery/0000-0001-8114-082X
FU RTI International
FX Supported by internal funding from RTI International.
CR Abramson D., 2016, 1 NYU COLL GLOB PUBL
   [Anonymous], 2017, LANCET, V389, P573, DOI 10.1016/S0140-6736(17)30325-2
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Avery EJ, 2017, PUBLIC RELAT REV, V43, P468, DOI 10.1016/j.pubrev.2017.02.018
   Barzon L., 2016, EURO SURVEILL, V21
   Basch Corey H, 2017, J Prev Med Public Health, V50, P133, DOI 10.3961/jpmph.16.107
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2017, ZIK VIR POT RANG US
   Centers for Disease Control and Prevention, 2017, ZIK VIR SEX TRANSM P
   Centers for Disease Control and Prevention, 2017, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention, 2017, ZIK VIR OUTC PREGN L
   Centres for Disease Control and Prevention, 2017, WORLD MAP AR RISK ZI
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2017, CURR ZIK TRANSM
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   Kaiser Family Foundation, 2016, WHAT DOES PUBL KNOW
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Leslie TE, 2017, GLOBAL HEALTH ACTION, V10, DOI [1, 10.1080/16549716.2017.1350394]
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   NORC at the University of Chicago, 2016, ZIKA VIRUS GAPS AM K
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prue CE, 2017, MMWR-MORBID MORTAL W, V66, P909, DOI 10.15585/mmwr.mm6634a4
   Roos RP, 2016, JAMA NEUROL, V73, P1395, DOI 10.1001/jamaneurol.2016.3677
   RTI International, 2016, PROC EV REP DET ZIK
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Venkatraman A, 2016, TRAVEL MED INFECT DI, V14, P421, DOI 10.1016/j.tmaid.2016.05.018
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   WHO, 2008, INT HLTH REG
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, EM ON YEAR ZIK OUTBR
NR 54
TC 5
Z9 5
U1 2
U2 4
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD FEB
PY 2018
VL 141
SU 2
BP S137
EP S145
AR e20172038
DI 10.1542/peds.2017-2038B
PG 9
WC Pediatrics
SC Pediatrics
GA HG1SC
UT WOS:000454739100001
PM 29437046
OA Bronze
DA 2020-07-08
ER

PT J
AU Pessoa, A
   van der Linden, V
   Yeargin-Allsopp, M
   Carvalho, MDCG
   Ribeiro, EM
   Braun, KV
   Durkin, MS
   Pastula, DM
   Moore, JT
   Moore, CA
AF Pessoa, Andre
   van der Linden, Vanessa
   Yeargin-Allsopp, Marshalyn
   Costa Gomes Carvalho, Maria Durce
   Ribeiro, Erlane Marques
   Braun, Kim Van Naarden
   Durkin, Maureen S.
   Pastula, Daniel M.
   Moore, Jazmyn T.
   Moore, Cynthia A.
TI Motor Abnormalities and Epilepsy in Infants and Children With Evidence
   of Congenital Zika Virus Infection
SO PEDIATRICS
LA English
DT Article
ID CEREBRAL-PALSY; DEVELOPMENTAL-DISABILITIES; NUTRITIONAL-STATUS; BRAZIL;
   CYTOMEGALOVIRUS; PREVALENCE; HEALTH; COSTS; RUBELLA; BORN
AB Initial reports of congenital Zika virus (ZIKV) infection focused on microcephaly at birth with severe brain anomalies; the phenotype has broadened to include microcephaly that develops after birth and neurodevelopmental sequelae. In this narrative review, we summarize medical literature describing motor abnormalities and epilepsy in infants with evidence of congenital ZIKV infection and provide information on the impact of these conditions. Specific scenarios are used to illustrate the complex clinical course in infants with abnormalities that are consistent with congenital Zika syndrome. A search of the English-language medical literature was done to identify motor abnormalities and epilepsy in infants with evidence of congenital ZIKV infection by using Medline and PubMed, Embase, Scientific Electronic Library Online, Scopus, the OpenGrey Repository, and the Grey Literature Report in Public Health. Search terms included "Zika" only and "Zika" in combination with any of the following terms: "epilepsy", "seizure", "motor", and "cerebral palsy". Clinical features of motor abnormalities and epilepsy in these children were reviewed. Thirty-six publications were identified; 8 were selected for further review. Among infants with clinical findings that are consistent with congenital Zika syndrome, 54% had epilepsy and 100% had motor abnormalities. In these infants, impairments that are consistent with diagnoses of cerebral palsy and epilepsy occur frequently. Pyramidal and extrapyramidal motor abnormalities were notable for their early development and co-occurrence. Prompt identification of potential disabilities enables early intervention to improve the quality of life for affected children. Long-term studies of developmental outcomes and interventions in children with congenital ZIKV infection are needed.
C1 [Pessoa, Andre; Ribeiro, Erlane Marques] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Pessoa, Andre] Univ Estadual Ceara, Dept Pediat & Neurol, Fortaleza, Ceara, Brazil.
   [van der Linden, Vanessa] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [van der Linden, Vanessa] Hosp Barao Lucena, Recife, PE, Brazil.
   [Yeargin-Allsopp, Marshalyn; Braun, Kim Van Naarden; Moore, Jazmyn T.; Moore, Cynthia A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Costa Gomes Carvalho, Maria Durce] Univ Pernambuco, Osvaldo Cruz Univ Hosp, Recife, PE, Brazil.
   [Durkin, Maureen S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA.
   [Pastula, Daniel M.] Univ Colorado, Dept Neurol, Denver, CO USA.
   [Pastula, Daniel M.] Univ Colorado, Dept Med Infect Dis, Denver, CO USA.
   [Pastula, Daniel M.] Univ Colorado, Dept Epidemiol, Denver, CO USA.
RP Yeargin-Allsopp, M (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway NE,Mail Stop E-86, Atlanta, GA 30341 USA.
EM mxy1@cdc.gov
RI Pastula, Daniel M./M-1325-2019
OI Pastula, Daniel M./0000-0001-9342-4459
FU US government
FX Supported by the US government.
CR AICARDI J, 1990, DEV MED CHILD NEUROL, V32, P191
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Ali MAS, 2014, EPILEPSY RES, V108, P576, DOI 10.1016/j.eplepsyres.2013.12.014
   Alves Lucas Victor, 2016, Rev. Bras. Saude Mater. Infant., V16, pS27, DOI 10.1590/1806-9304201600s100003
   [Anonymous], 2015, NON TRADITIONAL REF
   ARAGAO MDV, 2016, BMJ BRIT MED J, V353
   Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B
   Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003
   Barbosa Vanessa Maziero, 2007, Pediatr Phys Ther, V19, P28, DOI 10.1097/PEP.0b013e31802f65f9
   Beghi E, 2005, PHARMACOECONOMICS, V23, P27, DOI 10.2165/00019053-200523010-00003
   Benfer KA, 2013, PEDIATRICS, V131, pE1553, DOI 10.1542/peds.2012-3093
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Botelho Ana Carla Gomes, 2016, Rev. Bras. Saude Mater. Infant., V16, P39, DOI 10.1590/1806-9304201600s100004
   BOYLE CA, 1994, PEDIATRICS, V93, P399
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Braun KV, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2872
   Bruck I, 2001, ARQ NEURO-PSIQUIAT, V59, P35, DOI 10.1590/S0004-282X2001000100008
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Cans C, 2002, DEV MED CHILD NEUROL, V44, P633
   Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x
   Carlsson M, 2003, DEV MED CHILD NEUROL, V45, P371, DOI 10.1017/S0012162203000719
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P57
   CHANTLER JK, 1995, LAB INVEST, V72, P334
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, p574D
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Cheeran MCJ, 2005, J NEUROSCI RES, V82, P839, DOI 10.1002/jnr.20682
   Christensen D, 2014, DEV MED CHILD NEUROL, V56, P59, DOI 10.1111/dmcn.12268
   Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Cramer JA, 2014, EPILEPSY BEHAV, V32, P135, DOI 10.1016/j.yebeh.2014.01.016
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Dakovic I, 2014, EUR J PAEDIATR NEURO, V18, P618, DOI 10.1016/j.ejpn.2014.04.007
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DESMOND MM, 1978, J PEDIATR-US, V93, P584, DOI 10.1016/S0022-3476(78)80892-0
   Fisher RS, 2015, CURR OPIN NEUROL, V28, P130, DOI 10.1097/WCO.0000000000000174
   Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Garcia J, 2016, DEV MED CHILD NEUROL, V58, P1057, DOI 10.1111/dmcn.13091
   GRAHAM HK, 2016, NAT REV DIS PRIMERS, V2
   Gururaj AK, 2003, SEIZURE-EUR J EPILEP, V12, P110, DOI 10.1016/S1059131102002558
   Hadjipanayis A, 1997, DEV MED CHILD NEUROL, V39, P659
   Hagglund G, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-150
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Herrera-Anaya E, 2016, DEV MED CHILD NEUROL, V58, P936, DOI 10.1111/dmcn.13108
   Himmelmann K, 2009, ARCH DIS CHILD, V94, P921, DOI 10.1136/adc.2008.144014
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Hundozi-Hysenaj H, 2008, J PEDIATR NEUROL, V6, P43
   Hunter RM, 2015, EPILEPSIA, V56, P1056, DOI 10.1111/epi.13015
   Kancherla V, 2012, RES DEV DISABIL, V33, P832, DOI 10.1016/j.ridd.2011.12.001
   Knierim J, 1997, NON TRADITIONAL REF
   Kwong KL, 1998, PEDIATR NEUROL, V19, P31, DOI 10.1016/S0887-8994(98)00011-3
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leandro CG, 2016, DEV MED CHILD NEUROL, V58, P893, DOI 10.1111/dmcn.13134
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   NELSON KB, 1982, PEDIATRICS, V69, P529
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Olusanya BO, 2011, J DEV BEHAV PEDIATR, V32, P476, DOI 10.1097/DBP.0b013e318221b8c5
   Pastula DM, 2017, JAMA NEUROL, V74, P631, DOI 10.1001/jamaneurol.2017.0215
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Riechmann J, 2015, EPILEPSIA, V56, P1388, DOI 10.1111/epi.13089
   Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sellier E, 2012, EUR J PAEDIATR NEURO, V16, P48, DOI 10.1016/j.ejpn.2011.10.003
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Smithers-Sheedy H, 2014, DEV MED CHILD NEUROL, V56, P846, DOI 10.1111/dmcn.12467
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trabacca A, 2016, J MULTIDISCIP HEALTH, V9, DOI 10.2147/JMDH.S88782
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Wimalasundera Neil, 2016, Pract Neurol, V16, P184, DOI 10.1136/practneurol-2015-001184
   Wirrell EC, 2011, EPILEPSY RES, V95, P110, DOI 10.1016/j.eplepsyres.2011.03.009
   World Health Organization, 2016, PSYCH SUPP PREGN WOM
   Yeargin-Allsopp M, 2008, CAPUTE ACCARDOS NEUR
   Yeargin-Allsopp M, 2008, PEDIATRICS, V121, P547, DOI 10.1542/peds.2007-1270
   Yoon D, 2009, EPILEPSIA, V50, P2186, DOI 10.1111/j.1528-1167.2009.02159.x
   ZAUSMER E, 1971, PEDIATRICS, V47, P16
NR 101
TC 25
Z9 25
U1 0
U2 5
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD FEB
PY 2018
VL 141
SU 2
BP S167
EP S179
DI 10.1542/peds.2017-2038F
PG 13
WC Pediatrics
SC Pediatrics
GA HG1SC
UT WOS:000454739100005
PM 29437050
OA Bronze
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Ventura, LO
AF Ventura, Camila V.
   Ventura, Liana O.
TI Ophthalmologic Manifestations Associated With Zika Virus Infection
SO PEDIATRICS
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; VISUAL IMPAIRMENT; MACULAR ATROPHY;
   LOW-VISION; INFANTS; CHILDREN; STATES; BIRTH
AB Vision plays an important role in the development of communication, social interaction, spatial awareness, and the motor skills needed to explore the environment. In the past 2 years, researchers have described the broad spectrum of clinical features that comprise congenital Zika syndrome (CZS). The ocular manifestations are considered 1 important pillar of this new entity. The most characteristic ophthalmic findings include chorioretinal scars and focal pigmentary changes seen in the macular region. Since these findings were first reported, other researchers have validated and extended them, leading to a more complete picture of the spectrum of ocular manifestations related to CZS. In this article, we summarize the current knowledge on the ocular implications of CZS and emphasize the importance of early rehabilitation to enhance visual performance in affected children.
C1 Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
RP Ventura, CV (corresponding author), Altino Ventura Fdn, R Soledade 170, BR-50070040 Recife, PE, Brazil.
EM camilaventuramd@gmail.com
RI Ventura, Camila V/N-2654-2018; Ventura, Liana Vieira O/N-6151-2018
OI Ventura, Camila V/0000-0002-2927-4684; Ventura, Liana Vieira
   O/0000-0001-6529-6883
FU Eunice Kennedy Shriver National Institute Of Child Health & Human
   Development of the National Institutes of Health [R01HD093572]; National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA
FX Preparation of this manuscript was supported in part by the Eunice
   Kennedy Shriver National Institute Of Child Health & Human Development
   of the National Institutes of Health under Award Number R01HD093572. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health. Funded by the National Institutes of Health (NIH).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   ARAGAO MDV, 2016, BMJ BRIT MED J, V353
   Brandao AD, 2017, ARQ BRAS OFTALMOL, V80, P59, DOI 10.5935/0004-2749.20170016
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Chen D, 2015, PARENTS THEIR INFANT
   Coats DK, 2000, J AAPOS, V4, P110, DOI 10.1067/mpa.2000.103870
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DROSTE PJ, 1991, OPHTHALMOLOGY, V98, P1513
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Huo R, 1999, BRIT J OPHTHALMOL, V83, P670, DOI 10.1136/bjo.83.6.670
   Hyvarinen L, DELAYED VISUAL DEV D
   JAN JE, 1993, J VISUAL IMPAIR BLIN, V87, P101
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Report S, 2017, ZIK VIR MICR GUILL B
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 51
TC 13
Z9 13
U1 0
U2 0
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD FEB
PY 2018
VL 141
SU 2
BP S161
EP S166
DI 10.1542/peds.2017-2038E
PG 6
WC Pediatrics
SC Pediatrics
GA HG1SC
UT WOS:000454739100004
PM 29437049
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Wheeler, AC
AF Wheeler, Anne C.
TI Development of Infants With Congenital Zika Syndrome: What Do We Know
   and What Can We Expect?
SO PEDIATRICS
LA English
DT Article
ID AUTISM SPECTRUM DISORDER; VIRUS-INFECTION; MATERNAL INFECTION; FETAL;
   OUTCOMES; BRAZIL; CHILDREN; BRAIN; ASSOCIATION; IMPAIRMENT
AB The association between Zika virus infection during pregnancy and severe birth defects in infants has led to worldwide attention focused on the mechanisms of the disease and the prevention of future exposure. Surveillance efforts around the world continue with the goal of identifying and monitoring all potentially exposed women and their newborns. For infants who were born with congenital Zika syndrome (CZS) and their families, an uncertain future awaits. As infants who were born with CZS during the most recent outbreak enter their second year of life, new developments in the outcomes of the condition continue to unfold, providing some insight into the likely long-term sequalae. In this article, I review the literature on emerging findings regarding the impact of CZS on the developing infant and provide some predictions regarding the long-term outcomes and lifetime needs of these children and their families.
C1 [Wheeler, Anne C.] RTI Int, 3040 E Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA.
RP Wheeler, AC (corresponding author), RTI Int, 3040 E Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA.
EM acwheeler@rti.org
FU RTI International; Eunice Kennedy Shriver National Institute Of Child
   Health & Human Development of the National Institutes of Health
   [R01HD093572]; National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA
FX Supported by RTI International. Preparation of this manuscript was
   supported in part by the Eunice Kennedy Shriver National Institute Of
   Child Health & Human Development of the National Institutes of Health
   under Award Number R01HD093572. The content is solely the responsibility
   of the authors and does not necessarily represent the official views of
   the National Institutes of Health. Funded by the National Institutes of
   Health (NIH).
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y
   Baptista T, 2016, BMJ-BRIT MED J, V353, pi2194
   Barton MA, 2016, CAN MED ASSOC J, V188, pE118, DOI 10.1503/cmaj.160179
   Belluck P, 2017, NY TIMES
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Blacher J, 2016, J INTELL DISABIL RES, V60, P399, DOI 10.1111/jir.12294
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361
   Butchart M, 2017, REV J AUTISM DEV DIS, V4, P118, DOI 10.1007/s40489-016-0101-1
   Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939
   Centers for Disease Control and Prevention, 2017, ZIK VIR CAS COUNTS U
   CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741
   Chu A, 2017, NEOREVIEWS, V18, pe44
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Do B, 2017, OPHTHAL PHYSL OPT, V37, P212, DOI 10.1111/opo.12350
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   GULLAND A, 2016, BMJ BRIT MED J, V352
   Houwen S, 2016, RES DEV DISABIL, V53-54, P19, DOI 10.1016/j.ridd.2016.01.012
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jiang HY, 2016, BRAIN BEHAV IMMUN, V58, P165, DOI 10.1016/j.bbi.2016.06.005
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Leal Mariana de Carvalho, 2016, Braz J Otorhinolaryngol, DOI 10.1016/j.bjorl.2016.06.001
   Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194
   Molnar Z, 2016, NAT REV NEUROL, V12, P315, DOI 10.1038/nrneurol.2016.71
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morano S., 2017, AUTISM DEV LANGUAGE, V2, P1, DOI DOI 10.1177/2396941516688399
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Porter S, 2017, INFANT YOUNG CHILD, V30, P17, DOI 10.1097/IYC.0000000000000084
   Reilly M, 2017, J DEV BEHAV PEDIATR, V38, P65, DOI 10.1097/DBP.0000000000000382
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
   Werner H, 2017, J OBSTET GYNAECOL CA, V39, P1150, DOI 10.1016/j.jogc.2017.05.013
   WHO, 2016, SCREEN ASS MAN NEON
NR 55
TC 14
Z9 14
U1 0
U2 0
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD FEB
PY 2018
VL 141
SU 2
BP S154
EP S160
DI 10.1542/peds.2017-2038D
PG 7
WC Pediatrics
SC Pediatrics
GA HG1SC
UT WOS:000454739100003
PM 29437048
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Benelli, G
AF Benelli, Giovanni
TI Gold nanoparticles - against parasites and insect vectors
SO ACTA TROPICA
LA English
DT Review
DE Cryptosporidium; Dengue; Filariasis; Helminths; Malaria; Leishmania;
   Mosquitoes; Nanosynthesis; Sandflies; Schistosoma; Toxoplasma;
   Trypanosoma; Zika virus
ID TOXOPLASMA-GONDII; GREEN SYNTHESIS; LEAF EXTRACT; IN-VITRO; LEISHMANIA;
   MALARIA; SILVER; AMPLIFICATION; ASSAY; TOXICITY
AB Nanomaterials are currently considered for many biological, biomedical and environmental purposes, due to their outstanding physical and chemical properties. The synthesis of gold nanoparticles (Au NPs) is of high interest for research in parasitology and entomology, since these nanomaterials showed promising applications, ranging from detection techniques to drug development, against a rather wide range of parasites of public health relevance, as well as on insect vectors. Here, I reviewed current knowledge about the bioactivity of Au NPs on selected insect species of public health relevance, including major mosquito vectors, such as Aedes aegypti, Anopheles stephensi and Culex quinquefasciatus. The toxicity of Au NPs against helminths was reviewed, covering Schistosoma mansoni trematodes as well as Raillietina cestodes. Furthermore, I summarized the information available on the antiparasitic role of Au NPs in the fight against malaria, leishmaniosis, toxoplasmosis, trypanosomiasis, cryptosporidiosis, and microsporidian parasites affecting human and animals health. Besides, I examined the employ of Au NPs as biomarkers, tools for diagnostics and adjuvants for the induction of transmission blocking immunity in malaria vaccine research. In the final section, major challenges and future outlooks for further research are discussed, with special reference to the pressing need of further knowledge about the effect of Au NPs on other arthropod vectors, such as ticks, tsetse flies, tabanids, sandflies and blackflies, and related ecotoxicology assays.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] Scuola Super Sant Anna, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010
CR Adeyemi OS, 2014, BBA-GEN SUBJECTS, V1840, P701, DOI 10.1016/j.bbagen.2013.10.038
   Ahmad A, 2015, RSC ADV, V5, P73793, DOI 10.1039/c5ra13206a
   Akhoundi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004349
   Alharbi NS, 2017, J CLUST SCI, V28, P507, DOI 10.1007/s10876-016-1130-8
   Andreadou M, 2014, J MICROBIOL METH, V96, P56, DOI 10.1016/j.mimet.2013.10.011
   Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701
   Athanassiou CG, 2018, J PEST SCI, V91, P1, DOI 10.1007/s10340-017-0898-0
   Balalakshmi C, 2017, J PHOTOCH PHOTOBIO B, V173, P598, DOI 10.1016/j.jphotobiol.2017.06.040
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Barboza CG, 2012, EXP PARASITOL, V130, P152, DOI 10.1016/j.exppara.2011.10.015
   Benelli G., 2017, ENV SCI POLLUT RES
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, IND CROP PROD, V103, P19, DOI 10.1016/j.indcrop.2017.03.032
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Borase HP, 2017, BIOPROC BIOSYST ENG, V40, P1437, DOI 10.1007/s00449-017-1801-3
   Casals E, 2008, TRAC-TREND ANAL CHEM, V27, P672, DOI 10.1016/j.trac.2008.06.004
   CDC, 2017, PAR TOX TOX INF
   Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8
   Chu X, 2005, J IMMUNOL METHODS, V301, P77, DOI 10.1016/j.jim.2005.03.005
   Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008
   Dantas-Torres F, 2014, ACTA TROP, V137, P67, DOI 10.1016/j.actatropica.2014.04.034
   Das P, 2017, J CLUST SCI, V28, P2269, DOI 10.1007/s10876-017-1224-y
   Das S, 2013, COLLOID SURFACE B, V107, P27, DOI 10.1016/j.colsurfb.2013.01.061
   Deng H, 2012, ANAL CHEM, V84, P1253, DOI 10.1021/ac201713t
   Dkhil MA, 2017, SAUDI J BIOL SCI, V24, P1418, DOI 10.1016/j.sjbs.2016.12.017
   Dkhil MA, 2016, PARASITOL RES MG, V8, P191, DOI 10.1007/978-3-319-25292-6_10
   Dkhil MA, 2015, INT J NANOMED, V10, P7467, DOI 10.2147/IJN.S97622
   Dkhil MA, 2015, PARASITOL RES, V114, P3711, DOI 10.1007/s00436-015-4600-2
   Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f
   Dubey JP, 2016, PARASITOL RES, V115, P1627, DOI 10.1007/s00436-015-4900-6
   Eger I, 2012, J MICROBIOL METH, V91, P101, DOI 10.1016/j.mimet.2012.07.013
   Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6
   Feigin V., 2016, LANCET, V388, P1459, DOI DOI 10.1016/S0140-6736(15)01119-8
   Ferry JL, 2009, NAT NANOTECHNOL, V4, P441, DOI [10.1038/NNANO.2009.157, 10.1038/nnano.2009.157]
   Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004
   Garcia-Negrete CA, 2015, ANALYST, V140, P3082, DOI [10.1039/C4AN01643B, 10.1039/c4an01643b]
   Ghosh S, 2015, J NANOMATER, V2015, P161
   Gopinath K, 2016, MICROB PATHOGENESIS, V101, P1, DOI 10.1016/j.micpath.2016.10.011
   Guirgis BSS, 2012, ANAL BIOANAL CHEM, V402, P1019, DOI 10.1007/s00216-011-5489-y
   Gulka CP, 2014, ACS APPL MATER INTER, V6, P6257, DOI 10.1021/am501452k
   Hemingway J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002380
   Hempelmann E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-232
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Ilari A, 2012, AMINO ACIDS, V42, P803, DOI 10.1007/s00726-011-0997-9
   Javier DJ, 2009, J CLIN MICROBIOL, V47, P4060, DOI 10.1128/JCM.00807-09
   Jebali A, 2015, COLLOID SURFACE B, V129, P107, DOI 10.1016/j.colsurfb.2015.03.029
   Jebali A, 2013, TOXICOL IN VITRO, V27, P1896, DOI 10.1016/j.tiv.2013.06.002
   Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8
   Jeon W, 2013, ANAL BIOCHEM, V439, P11, DOI 10.1016/j.ab.2013.03.032
   Judy JD, 2011, ENVIRON SCI TECHNOL, V45, P776, DOI 10.1021/es103031a
   Kamte SLN, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070737
   Kar PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084693
   Karthik L, 2013, NANOMED-NANOTECHNOL, V9, P951, DOI 10.1016/j.nano.2013.02.002
   Karthika V, 2017, J PHOTOCH PHOTOBIO B, V167, P189, DOI 10.1016/j.jphotobiol.2017.01.008
   Kevric I, 2015, DERMATOL CLIN, V33, P579, DOI 10.1016/j.det.2015.03.018
   Kumar R, 2015, VACCINE, V33, P5064, DOI 10.1016/j.vaccine.2015.08.025
   Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206
   Lallawmawma H, 2015, ENVIRON SCI POLLUT R, V22, P17753, DOI 10.1007/s11356-015-5001-x
   Liu Q, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0902-6
   McKerr C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125955
   Mossallam SF, 2014, EXP PARASITOL, V144, P14, DOI 10.1016/j.exppara.2014.06.002
   Murugan K, 2017, HYDROBIOLOGIA, V797, P335, DOI 10.1007/s10750-017-3196-1
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Nagagi YP, 2017, J VECTOR DIS, V54, P16
   Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nash MA, 2012, ACS NANO, V6, P6776, DOI 10.1021/nn3015008
   Natera S, 2007, INT J ANTIMICROB AG, V29, P637, DOI 10.1016/j.ijantimicag.2007.01.004
   Niazi A, 2013, MOL DIAGN THER, V17, P363, DOI 10.1007/s40291-013-0044-5
   Opiro R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005485
   Papasani MR, 2012, NANOMED-NANOTECHNOL, V8, P804, DOI 10.1016/j.nano.2012.01.008
   Parween S, 2011, VACCINE, V29, P2451, DOI 10.1016/j.vaccine.2011.01.014
   Pavela R, 2017, IND CROP PROD, V97, P338, DOI 10.1016/j.indcrop.2016.12.046
   Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046
   Petrelli R, 2017, PARASITOL INT, V66, P146, DOI 10.1016/j.parint.2017.01.001
   Pissuwan D, 2007, NANO LETT, V7, P3808, DOI 10.1021/nl072377+
   Pissuwan D, 2011, J CONTROL RELEASE, V149, P65, DOI 10.1016/j.jconrel.2009.12.006
   Pissuwan D, 2009, SMALL, V5, P1030, DOI 10.1002/smll.200801018
   Rai M, 2017, INT J PHARMACEUT, V526, P254, DOI 10.1016/j.ijpharm.2017.04.042
   Rivas L, 2015, NANO RES, V8, P3704, DOI 10.1007/s12274-015-0870-3
   Rocha A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-5
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Saleh M, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0668-x
   Sannella AR, 2008, FEBS LETT, V582, P844, DOI 10.1016/j.febslet.2008.02.028
   Sattarahmady N, 2016, SENSOR ACTUAT B-CHEM, V235, P723, DOI 10.1016/j.snb.2016.05.023
   Sazgarnia A, 2013, INT J HYPERTHER, V29, P79, DOI 10.3109/02656736.2012.758875
   Sharma MK, 2010, ANALYST, V135, P608, DOI 10.1039/b918880k
   Sharon M., 2010, J PHYTOL, V2, P83
   Shaw APM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003624
   Soni N, 2012, PARASITOL RES, V110, P175, DOI 10.1007/s00436-011-2467-4
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Suebsing R, 2013, J APPL MICROBIOL, V114, P1254, DOI 10.1111/jam.12160
   Suganthy N., 2017, ENV SCI POLLUT RES
   Suganya P, 2017, J PHOTOCH PHOTOBIO B, V173, P404, DOI 10.1016/j.jphotobiol.2017.06.004
   Thiruppathiraja C, 2011, BIOSENS BIOELECTRON, V26, P4624, DOI 10.1016/j.bios.2011.05.006
   Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471
   Unrine JM, 2012, ENVIRON SCI TECHNOL, V46, P9753, DOI 10.1021/es3025325
   Vieites M, 2009, J INORG BIOCHEM, V103, P1300, DOI 10.1016/j.jinorgbio.2009.02.011
   Vijayakumar S, 2017, MICROB PATHOGENESIS, V102, P173, DOI 10.1016/j.micpath.2016.11.029
   Wang H, 2004, BIOSENS BIOELECTRON, V19, P701, DOI 10.1016/S0956-5663(03)00265-3
   Ward M, 2017, PARASITOL RES, V116, P839, DOI 10.1007/s00436-016-5352-3
   Weigum SE, 2013, J PARASITOL, V99, P923, DOI 10.1645/12-132.1
NR 106
TC 55
Z9 55
U1 6
U2 126
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2018
VL 178
BP 73
EP 80
DI 10.1016/j.actatropica.2017.10.021
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FU1YB
UT WOS:000423644300011
PM 29092797
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, JQ
   Deng, CL
   Gu, DY
   Li, X
   Shi, L
   He, JA
   Zhang, QY
   Zhang, B
   Ye, HQ
AF Li, Jia-Qi
   Deng, Cheng-Lin
   Gu, Dayong
   Li, Xiao
   Shi, Lei
   He, Jian'an
   Zhang, Qiu-Yan
   Zhang, Bo
   Ye, Han-Qing
TI Development of a replicon cell line-based high throughput antiviral
   assay for screening inhibitors of Zika virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Flavivirus; Zika virus; Luciferase; Antiviral screening; Replicon cell
   line
ID INFECTION; IDENTIFICATION; REPLICATION
AB Zika virus (ZIKV) is an important emerging human pathogen associated with microcephaly, Guillain-Barre syndrome and meningoencephalitis. Developing rapid and reliable HTS assay is important for ZIKV drug discovery. Here, we constructed a dicistronic ZIKV replicon (ZIKV-Pac-Rluc-Rep) that contained the Renilla luciferase (Rluc) reporter gene separated from the puromycin N-acetyl-transferase (Pac) selectable marker by a short peptide cleavage site. A clonal replicon cell line stably expressing high level of ZIKV replicon was established by selection with puromycin. By optimizing cell number, compound concentration and incubation time, a robust replicon cell-based HTS assay was developed with a calculated Z' value of > 0.5. The fully optimized assay was further validated using several known flavivirus replication inhibitors. Altogether, the replicon cell-based HTS assay developed in this study will facilitate the discovery of antiviral compounds against ZIKV.
C1 [Li, Jia-Qi; Deng, Cheng-Lin; Li, Xiao; Zhang, Qiu-Yan; Zhang, Bo; Ye, Han-Qing] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Hubei, Peoples R China.
   [Li, Jia-Qi; Li, Xiao; Zhang, Qiu-Yan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Gu, Dayong; Shi, Lei; He, Jian'an] Shenzhen Acad Inspect & Quarantine, Shenzhen Int Travel Healthcare Ctr, Cent Lab Hlth Quarantine, Guangzhou 518033, Guangdong, Peoples R China.
RP Zhang, B; Ye, HQ (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China.
EM zhangbo@wh.iov.cn; yehq@wh.iov.cn
OI Zhang, Bo/0000-0002-8895-3679; gu, dayong/0000-0002-9547-8474
FU National Key Research and Development Program of China [2016YFD0500400,
   2016YFC1200400]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81572003]; Shenzhen science and
   technology program [CXZZ20150504163004339]
FX We thank the Core Facility and Technical Support, Wuhan Institute of
   Virology and Wuhan Key Laboratory on Emerging Infectious Diseases and
   Biosafety for helpful supports during the course of the work. This work
   was supported by the National Key Research and Development Program of
   China (2016YFD0500400, 2016YFC1200400), the National Natural Science
   Foundation of China (81572003) and Shenzhen science and technology
   program (CXZZ20150504163004339).
CR Alcaraz-Estrada Sofia L, 2013, Methods Mol Biol, V1030, P283, DOI 10.1007/978-1-62703-484-5_22
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Elshabrawy HA, 2014, J VIROL, V88, P4353, DOI 10.1128/JVI.03050-13
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847
   Kato F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050122
   Li QJ, 2009, ANTIVIR RES, V83, P267, DOI 10.1016/j.antiviral.2009.06.004
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Morrey JD, 2002, ANTIVIR RES, V55, P107, DOI 10.1016/S0166-3542(02)00013-X
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   PERCY N, 1994, J VIROL, V68, P4486, DOI 10.1128/JVI.68.7.4486-4492.1994
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shi PY, 2002, VIROLOGY, V296, P219, DOI 10.1006/viro.2002.1453
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tiong-Yip CL, 2014, ANTIVIR RES, V101, P75, DOI 10.1016/j.antiviral.2013.11.003
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zhang B, 2008, J VIROL, V82, P7047, DOI 10.1128/JVI.00654-08
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
NR 26
TC 11
Z9 11
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD FEB
PY 2018
VL 150
BP 148
EP 154
DI 10.1016/j.antiviral.2017.12.017
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FW1SC
UT WOS:000425078700017
PM 29288699
DA 2020-07-08
ER

PT J
AU Dourado, ME
AF Dourado, Mario Emilio
TI Guillain, Barraquer and I
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE history of medicine; autoimmune diseases of the nervous system;
   Guillain-Barre syndrome; polyradiculoneuropathy; Zika virus infection
ID ZIKA VIRUS OUTBREAK; BARRE-SYNDROME; BRAZIL
AB The year 2016 was the centennial anniversary of the recognition of the Guillain-Barre syndrome, which was first described by George Guillain, Jean-Alexandre Barre and Andre Strohl. In celebration of the centennial, this historical review describes aspects of the contributions of Guillain and the Spanish neurologist, Barraquer-Bordas and a brief account of the Fourth International Neurological Congress, which brought together Guillain and Barraquer-Bordas. There were many outstanding Brazilian physicians at that meeting. Finally, the author describes his interaction with Barraquer-Bordas and provides an account of his influence in shaping a generation of Brazilian neurologists, including himself.
C1 [Dourado, Mario Emilio] Hosp Univ Onofre Lopes, Natal, RN, Brazil.
RP Dourado, ME (corresponding author), Rua Nilo Pecanha 620, BR-59012300 Natal, RN, Brazil.
EM medourado@ufrnet.br
CR Aarli JA, 2014, HIST WORLD FEDERATIO
   [Anonymous], 1949, J NEUROL NEUROSUR PS, V12, P77
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Lange O., 1957, ARQ NEURO-PSIQUIAT, V15, P91
   Maranhao P, 2015, ARQ NEURO-PSIQUIAT, V73, P140, DOI 10.1590/0004-282X20140215
   Pritchard J, 2004, LANCET, V363, P2186, DOI 10.1016/S0140-6736(04)16512-4
   RUTZ-LARA R, 1952, Arq Neuropsiquiatr, V10, P127
   Sociedad Espanola de Neurologia, 2010, EXP LB BORD SOC ESP
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 11
TC 0
Z9 0
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD FEB
PY 2018
VL 76
IS 2
BP 113
EP 116
DI 10.1590/0004-282X20170177
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FX9TT
UT WOS:000426450500011
PM 29489966
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Affonso, RS
   Lima, JA
   Lessa, BM
   Caetano, JVO
   Obara, MT
   Nobrega, AB
   Nepovimova, E
   Musilek, K
   Kuca, K
   Slana, GBCA
   Franca, TCC
AF Affonso, Raphael S.
   Lima, Joselia A.
   Lessa, Bruno M.
   Caetano, Joao V. O.
   Obara, Marcos T.
   Nobrega, Andrea B.
   Nepovimova, Eugenie
   Musilek, Kamil
   Kuca, Kamil
   Slana, Glaucia B. C. A.
   Franca, Tanos C. C.
TI Quantification through TLC-densitometric analysis, repellency and
   anticholinesterase activity of the homemade extract of Indian cloves
SO BIOMEDICAL CHROMATOGRAPHY
LA English
DT Article
DE Aedes aegypti; anticholinesterase; eugenol; insect repellent; Syzygium
   aromaticum L
ID SYZYGIUM-AROMATICUM; ESSENTIAL OIL; INSECT REPELLENTS;
   ACETYLCHOLINESTERASE; SIMILARITIES; ANTIOXIDANT; INHIBITION; VALIDATION;
   COMPONENTS; TOXICITY
AB The rise of the mosquitoes-transmitted diseases, like dengue, zika and chikungunya in Brazil in the last years has increased concerns on protection against mosquitoes bites. However, the prohibitive prices of the commercially available repellents for the majority of the Brazilian population has provoked a search for cheaper solutions, like the use of the homemade ethanolic extract of Indian clove (Syzygium aromaticumL.) as repellent, which has been reported as quite efficient by the local press. In order to verify this, we performed here the quantification of the main components of this extract through high-performance thin-layer chromatography (HPTLC)-densitometry and evaluated its efficiency as a repellent and its acetylcholinesterase(AChE) inhibition capacity. Our results have proved HPTLC-densitometry as an efficient and appropriate method for this quantification and confirmed the repellency activity, as well as its capacity of AChE inhibition.
C1 [Affonso, Raphael S.; Lima, Joselia A.; Franca, Tanos C. C.] Mil Inst Engn, Lab Mol Modeling Appl Chem & Biol Def, Rio De Janeiro, Brazil.
   [Lessa, Bruno M.; Nobrega, Andrea B.; Slana, Glaucia B. C. A.] Biodivers Chem Lab, Phytomed Agroecol Platform, Rio De Janeiro, Brazil.
   [Caetano, Joao V. O.] Anhanguera Coll Brasilia, Brasilia, DF, Brazil.
   [Obara, Marcos T.] Univ Brasilia, Nucleus Trop Med Brazil, Brasilia, DF, Brazil.
   [Nepovimova, Eugenie; Musilek, Kamil; Kuca, Kamil] Univ Hradec Kralove, Dept Chem, Fac Sci, Rokitanskeho 62, Hradec Kralove 50003, Czech Republic.
   [Musilek, Kamil] Univ Hosp, Biomed Res Ctr, Sokolska 581, Hradec Kralove 50005, Czech Republic.
   [Slana, Glaucia B. C. A.] Natl Inst Intellectual Property, Rio De Janeiro, RJ, Brazil.
   [Franca, Tanos C. C.] Univ Hradec Kralove, Fac Informat & Management, Ctr Basic & Appl Res, Hradec Kralove, Czech Republic.
RP Franca, TCC (corresponding author), Mil Inst Engn, Lab Mol Modeling Appl Chem & Biol Def, Rio De Janeiro, Brazil.
EM tanosfranca@gmail.com
RI Kuca, Kamil/D-1396-2011; Lima, Joselia A/M-2720-2016; Franca, Tanos
   Celmar Costa/I-9519-2012; Musilek, Kamil/G-4258-2018
OI Kuca, Kamil/0000-0001-9664-1109; Lima, Joselia A/0000-0002-2076-1144;
   Franca, Tanos Celmar Costa/0000-0002-6048-8103; Musilek,
   Kamil/0000-0002-7504-4062
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); CAPESCAPES; Ministry of Health of the
   Czech RepublicMinistry of Health, Czech Republic [16-34390A]; University
   Hradec Kralove (Faculty of Science) [2201/2017]; Excellence Project FIM
FX The authors wish to thank the Brazilian financial agencies CNPq, FAPERJ
   and CAPES for financial support and the Military Institute of
   Engineering for the physical infrastructure and working space. This work
   was supported by the Ministry of Health of the Czech Republic (No.
   16-34390A) and by University Hradec Kralove (Faculty of Science, No.
   2201/2017). This paper was also supported by the Excellence Project FIM.
CR Abd-Ella A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126406
   Abdel-Rahman A, 2004, J TOXICOL ENV HEAL A, V67, P163, DOI 10.1080/15287390490264802
   Abou-Donia MB, 2004, PHARMACOL BIOCHEM BE, V77, P253, DOI 10.1016/j.pbb.2003.10.018
   Affonso RD, 2012, REV VIRTUAL QUIM, V4, P146, DOI 10.5935/1984-6835.20120012
   Affonso RD, 2013, J BRAZIL CHEM SOC, V24, P473, DOI 10.5935/0103-5053.20130059
   Affonso RS, 2014, REV VIRTUAL QUIM, V6, P1316, DOI 10.5935/1984-6835.20140086
   Alma MH, 2007, BIORESOURCES, V2, P265
   Annegowda HV, 2013, FOOD ANAL METHOD, V6, P715, DOI 10.1007/s12161-012-9470-y
   [Anonymous], 2009, GUID EFF TEST MOSQ R
   AOAC, 2017, OFF METH AN AOAC INT
   Belal TS, 2014, J ASS ARAB U BASIC A, DOI [10.1016/j.jaubas.2014.06.004, DOI 10.1016/J.JAUBAS.2014.06.004]
   CLEM JR, 1993, ANN PHARMACOTHER, V27, P289, DOI 10.1177/106002809302700305
   Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47
   Dwivedi V, 2011, ASIAN PAC J CANCER P, V12, P1989
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Evans W. C., 2002, TREASE EVANS PHARM
   Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131
   Fu YJ, 2007, PHYTOTHER RES, V21, P989, DOI 10.1002/ptr.2179
   Gao Xueyan, 2009, Zhongguo Zhong Yao Za Zhi, V34, P2695
   Ghani S., 2015, BIOCHEMISTRY-US, V5, P22
   Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063
   International Council for Harmonisation (ICH), 2005, VAL AN PROC TEXT MET
   Kafle L, 2013, J ECON ENTOMOL, V106, P131, DOI 10.1603/EC12230
   Khan MSA, 2009, LETT APPL MICROBIOL, V49, P354, DOI 10.1111/j.1472-765X.2009.02666.x
   Kim HM, 1998, J ETHNOPHARMACOL, V60, P125, DOI 10.1016/S0378-8741(97)00143-8
   Kong X., 2014, CURRENT OPINION COMP, V1, P8, DOI DOI 10.7178/COCAM.7
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Lee KG, 2001, FOOD CHEM, V74, P443, DOI 10.1016/S0308-8146(01)00161-3
   Lima JA, 2009, PHARMACOL BIOCHEM BE, V92, P508, DOI 10.1016/j.pbb.2009.01.024
   LIPSCOMB JW, 1992, ANN EMERG MED, V21, P315, DOI 10.1016/S0196-0644(05)80896-0
   Minz S, 2015, BIOMED CHROMATOGR, V29, P1473, DOI 10.1002/bmc.3444
   Musthafa KS, 2016, FLAVOUR FRAG J, V31, P448, DOI 10.1002/ffj.3336
   Pathak SB, 2004, CHROMATOGRAPHIA, V60, P241, DOI 10.1365/s10337-004-0373-y
   Prashar A, 2006, CELL PROLIFERAT, V39, P241, DOI 10.1111/j.1365-2184.2006.00384.x
   Quinn G. P., 2002, EXPT DESIGN DATA ANA
   R Core Team, 2015, R LANG ENV STAT COMP
   Rana IS, 2011, BRAZ J MICROBIOL, V42, P1269, DOI 10.1590/S1517-83822011000400004
   SCHAEFER C, 1992, REPROD TOXICOL, V6, P175, DOI 10.1016/0890-6238(92)90120-I
   Shabir GA, 2003, J CHROMATOGR A, V987, P57, DOI 10.1016/S0021-9673(02)01536-4
   SRIVASTAVA KC, 1991, PROSTAG LEUKOTR ESS, V42, P73, DOI 10.1016/0952-3278(91)90070-L
   TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816
   Viuda-Martos M, 2010, FLAVOUR FRAG J, V25, P13, DOI 10.1002/ffj.1951
   Wiesner J, 2007, J ENZYM INHIB MED CH, V22, P417, DOI 10.1080/14756360701421294
NR 43
TC 3
Z9 3
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-3879
EI 1099-0801
J9 BIOMED CHROMATOGR
JI Biomed. Chromatogr.
PD FEB
PY 2018
VL 32
IS 2
AR e4096
DI 10.1002/bmc.4096
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA FT8LJ
UT WOS:000423404000045
DA 2020-07-08
ER

PT J
AU Cordel, N
   Hebert, V
   Rua, AV
   Herrmann-Storck, C
AF Cordel, N.
   Hebert, V.
   Rua, A. Vega
   Herrmann-Storck, C.
TI In vivo Zika virus detection in human skin
SO BRITISH JOURNAL OF DERMATOLOGY
LA English
DT Letter
ID INFECTION
C1 [Cordel, N.] Pointe A Pitre Univ Hosp, Dermatol & Internal Med Unit, Pointe a Pitre, Guadeloupe, France.
   [Cordel, N.] Univ French West Indies Fouillole, Pointe a Pitre, Guadeloupe, France.
   [Cordel, N.] UNIROUEN Normandy Univ, INSERM, U1234, Rouen, France.
   [Hebert, V.] Rouen Univ Hosp, Dept Dermatol, Rouen, France.
   [Rua, A. Vega] Inst Pasteur Guadeloupe, Pointe a Pitre, Guadeloupe, France.
   [Herrmann-Storck, C.] Microbiol Lab, Pointe a Pitre, Guadeloupe, France.
RP Cordel, N (corresponding author), Pointe A Pitre Univ Hosp, Dermatol & Internal Med Unit, Pointe a Pitre, Guadeloupe, France.; Cordel, N (corresponding author), Univ French West Indies Fouillole, Pointe a Pitre, Guadeloupe, France.; Cordel, N (corresponding author), UNIROUEN Normandy Univ, INSERM, U1234, Rouen, France.
EM nadege.cordel@chu-guadeloupe.fr
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   [Anonymous], ZIK SIT REP ZIK VIR
   Cordel N, 2017, JAMA DERMATOL, V153, P326, DOI 10.1001/jamadermatol.2016.5442
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Paz-Bailey G, 2017, N ENGL J MED
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Shrestha P, 2016, B WHO
NR 8
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-0963
EI 1365-2133
J9 BRIT J DERMATOL
JI Br. J. Dermatol.
PD FEB
PY 2018
VL 178
IS 2
BP E108
EP E110
DI 10.1111/bjd.16096
PG 3
WC Dermatology
SC Dermatology
GA FW0TW
UT WOS:000425009400002
PM 29078002
DA 2020-07-08
ER

PT J
AU Monaghan, AJ
   Sampson, KM
   Steinhoff, DF
   Ernst, KC
   Ebi, KL
   Jones, B
   Hayden, MH
AF Monaghan, Andrew J.
   Sampson, K. M.
   Steinhoff, D. F.
   Ernst, K. C.
   Ebi, K. L.
   Jones, B.
   Hayden, M. H.
TI The potential impacts of 21st century climatic and population changes on
   human exposure to the virus vector mosquito Aedes aegypti
SO CLIMATIC CHANGE
LA English
DT Article
ID GLOBAL DISTRIBUTION; DENGUE-FEVER; STEGOMYIA AEGYPTI; CHIKUNGUNYA;
   DIPTERA; TEMPERATURE; COMPETITION; CULICIDAE; MODELS; SYSTEM
AB The mosquito Aedes (Ae). aegypti transmits the viruses that cause dengue, chikungunya, Zika and yellow fever. We investigate how choosing alternate emissions and/or socioeconomic pathways may modulate future human exposure to Ae. aegypti. Occurrence patterns for Ae. aegypti for 2061-2080 are mapped globally using empirically downscaled air temperature and precipitation projections from the Community Earth System Model, for the Representative Concentration Pathway (RCP) 4.5 and 8.5 scenarios. Population growth is quantified using gridded global population projections consistent with two Shared Socioeconomic Pathways (SSPs), SSP3 and SSP5. Change scenarios are compared to a 1950-2000 reference period. A global land area of 56.9 M km(2) is climatically suitable for Ae. aegypti during the reference period, and is projected to increase by 8 % (RCP4.5) to 13 % (RCP8.5) by 2061-2080. The annual average number of people exposed globally to Ae. aegypti for the reference period is 3794 M, a value projected to statistically significantly increase by 298-460 M (8-12 %) by 2061-2080 if only climate change is considered, and by 4805-5084 M (127-134 %) for SSP3 and 2232-2483 M (59-65 %) for SSP5 considering both climate and population change (lower and upper values of each range represent RCP4.5 and RCP8.5 respectively). Thus, taking the lower-emissions RCP4.5 pathway instead of RCP8.5 may mitigate future human exposure to Ae. aegypti globally, but the effect of population growth on exposure will likely be larger. Regionally, Australia, Europe and North America are projected to have the largest percentage increases in human exposure to Ae. aegypti considering only climate change.
C1 [Monaghan, Andrew J.; Sampson, K. M.; Steinhoff, D. F.; Hayden, M. H.] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.
   [Ernst, K. C.] Univ Arizona, Coll Publ Hlth, Tucson, AZ 85724 USA.
   [Ebi, K. L.] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA.
   [Jones, B.] CUNY, CUNY Inst Demog Res, New York, NY 10010 USA.
RP Monaghan, AJ (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.
EM monaghan@ucar.edu
FU National Science FoundationNational Science Foundation (NSF)
   [GEO-1010204]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [IR01AI091843]; National Science FoundationNational Science Foundation
   (NSF)
FX This research was supported by the National Science Foundation
   (GEO-1010204) and the National Institutes of Health (IR01AI091843). The
   National Center for Atmospheric Research is sponsored by the National
   Science Foundation. The SSP data is available on request from Bryan
   Jones; other data sources are cited within. Lars Eisen of the Centers
   for Disease Control and Prevention provided invaluable guidance.
CR Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bouzid M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-781
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Capinha C, 2014, ECOHEALTH, V11, P420, DOI 10.1007/s10393-014-0918-y
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Centre for International Earth Science Information Network (CIESIN) Columbia University; and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503
   Ebi KL, 2014, INT J ENV RES PUB HE, V11, P30, DOI 10.3390/ijerph110100030
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Ernst KC, 2015, EMERG INFECT DIS, V21, P320, DOI 10.3201/eid2102.141035
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   Hurrell JW, 2013, B AM METEOROL SOC, V94, P1339, DOI 10.1175/BAMS-D-12-00121.1
   Jiang L., 2015, GLOBAL ENVIRON CHANG, V42, P193, DOI DOI 10.1016/J.GLOENVCHA.2015.03.008
   Kay JE, 2015, B AM METEOROL SOC, V96, P1333, DOI 10.1175/BAMS-D-13-00255.1
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Koenraadt CJM, 2008, J MED ENTOMOL, V45, P28, DOI 10.1603/0022-2585(2008)45[28:FEOROC]2.0.CO;2
   Kroeger A, 2006, LANCET, V368, P2193, DOI 10.1016/S0140-6736(06)69873-5
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Lucio PS, 2013, J VECTOR ECOL, V38, P20, DOI 10.1111/j.1948-7134.2013.12005.x
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Marsha A, 2016, CLIMATE CHANGE INFLU
   MOGI M, 1988, MED VET ENTOMOL, V2, P319, DOI 10.1111/j.1365-2915.1988.tb00203.x
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333
   O'Neill BC, 2016, CLIM CHANG UNPUB
   O'Neill BC, 2017, GLOBAL ENVIRON CHANG, V42, P169, DOI 10.1016/j.gloenvcha.2015.01.004
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551
   Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rogers DJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0562
   Samir KC, 2017, GLOBAL ENVIRON CHANG, V42, P181, DOI 10.1016/j.gloenvcha.2014.06.004
   Sanderson BM, 2018, CLIMATIC CHANGE, V146, P303, DOI 10.1007/s10584-015-1567-z
   TABACHNICK WJ, 1979, GENET RES, V34, P215, DOI 10.1017/S0016672300019467
   Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1
   Thomas SJ, 2015, NEW ENGL J MED, V372, P172, DOI 10.1056/NEJMe1413146
   van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P1, DOI [10.1007/s10584-011-0157-y, 10.1007/s10584-011-0152-3, 10.1007/s10584-011-0148-z]
   Williams CR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-447
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xu YY, 2018, CLIMATIC CHANGE, V146, P393, DOI 10.1007/s10584-015-1565-1
NR 55
TC 19
Z9 21
U1 2
U2 35
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0165-0009
EI 1573-1480
J9 CLIMATIC CHANGE
JI Clim. Change
PD FEB
PY 2018
VL 146
IS 3-4
SI SI
BP 487
EP 500
DI 10.1007/s10584-016-1679-0
PG 14
WC Environmental Sciences; Meteorology & Atmospheric Sciences
SC Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences
GA FW2GC
UT WOS:000425120000015
PM 29610543
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Adachi, K
   Nielsen-Saines, K
AF Adachi, Kristina
   Nielsen-Saines, Karin
TI Zika clinical updates: implications for pediatrics
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
DE congenital Zika syndrome; pediatric Zika infection; Zika virus
ID GUILLAIN-BARRE-SYNDROME; DISTRICT-OF-COLUMBIA; JANUARY 1-JULY 31;
   RIO-DE-JANEIRO; VIRUS-INFECTION; UNITED-STATES; INTERIM GUIDANCE; SEXUAL
   TRANSMISSION; CHIKUNGUNYA VIRUS; PREGNANT-WOMEN
AB Purpose of review
   Zika virus (ZIKV), a mosquito-borne flavivirus, has gained recognition over the past few years as an important new cause of congenital infection. As a result, it is critical that pediatricians understand its epidemiology, clinical presentation, clinical sequelae, and management.
   Recent findings
   The recent ZIKV epidemiology, clinical presentation of acute infection in children and complications, perinatal infection, and congenital infection will be summarized in this ZIKV review. This will be followed by a brief summary on ZIKV diagnosis, management, treatment, and prevention.
   Summary
   The field of clinical research in ZIKV has rapidly evolved over recent months. It is critical that pediatricians continue to stay up-to-date with the continuously evolving understanding of the clinical aspects of ZIKV to ensure optimal identification and management of affected infants and children. Given the recent changes in Centers for Disease Control and Prevention guidelines to limit screening of asymptomatic pregnant women in the United States with possible ZIKV exposure, comprehensive ZIKV clinical knowledge becomes even more crucial.
C1 [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Dept Pediat, 10833 Le Conte Ave MDCC 22-442, Los Angeles, CA 90095 USA.
RP Adachi, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Dept Pediat, 10833 Le Conte Ave MDCC 22-442, Los Angeles, CA 90095 USA.
EM kadachi@mednet.ucla.edu
FU Thrasher Research Fund [20164370]
FX K.A. was supported in part by grant 20164370 from the Thrasher Research
   Fund.
CR ABBASI J, 2016, JAMA J AM MED ASSOC, V316, P1249
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Aiken ARA, 2016, TIME MAGAZINE
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   [Anonymous], 2017, ZIKA CASES US CUMULA
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Asadi-Pooya AA, 2016, SEIZURE-EUR J EPILEP, V43, P13, DOI 10.1016/j.seizure.2016.10.011
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2014, EURO SURVEILL, V19
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Blohm GM, 2017, GENOME ANNOUNC, P5
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Bryson Y, 2017, CURR OPIN PEDIATR, V29, P94, DOI 10.1097/MOP.0000000000000453
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   CDC, 2015, CDC ACC EV REL MICR
   CDC, 2016, CDC SUPP TEX INV POS
   CDC, 2016, ZIK VIR DIS US 2015
   CDC, 2016, CAS DEF
   CDC, 2016, CDC RESP ZIKA ZIK VI
   CDC, 2016, CDC GUID US LAB TEST
   CDC, 2016, ALL COUNTR TERR ACT
   CDC, ZIK TRAV INF
   CDC, HEALTHC EXP ZIK INF
   Centers for Disease Control, 2016, ZIK VIR DIS ZIK VIR
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Chen L, 2017, NEW ENGL J MED, V376, P400, DOI 10.1056/NEJMc1610614
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Chow A, 2017, EMERG INFECT DIS, V23, P677, DOI 10.3201/eid2304.161716
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Farahnik B, 2016, J AM ACAD DERMATOL, V74, P1286, DOI 10.1016/j.jaad.2016.02.1232
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandez-Salas I, 2016, CURR OPIN INFECT DIS, V29, P467, DOI 10.1097/QCO.0000000000000304
   da Silva IRF, 2016, NEUROLOGY, V87, pE180, DOI 10.1212/WNL.0000000000003024
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T., 2016, EURO SURVEILL, V21
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gabaglia CR, 2017, CURR OPIN PEDIATR, V29, P107, DOI 10.1097/MOP.0000000000000446
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Gostin LO, 2016, LANCET INFECT DIS, V16, P1099, DOI 10.1016/S1473-3099(16)30332-2
   Grossi-Soyster EN, 2017, CURR OPIN PEDIATR, V29, P102, DOI 10.1097/MOP.0000000000000449
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal MC, 2016, BRAZ J OTORHINOLARYN
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4298
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2016, CLIN MICROBIOL INFEC, V22, P494, DOI 10.1016/j.cmi.2016.03.032
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30317-8
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   NIH, 2016, NIH NIH BEG TEST INV
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   PAHO, 2017, ZIK CAS CONG SYNDR A
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Purpura LJ, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30330-9
   Quanquin N, 2017, CURR OPIN PEDIATR, V29, P114, DOI 10.1097/MOP.0000000000000441
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Ramalho FS, 2017, CLIN INFECT DIS, V65, P687, DOI 10.1093/cid/cix374
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sacramento CQ, 2016, BIORXIV
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Septfons A, 2016, EURO SURVEILL, V21
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Sun L., 2016, WASHINGTON POST
   Sun LH, WASHINGTON POST
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   van der Linden V, 2017, ZIKA IN FOCUS
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Weitzel T, 2016, AM J TROP MED HYG, V95, P255, DOI 10.4269/ajtmh.16-0096
   WHO, 2016, HIST ZIK VIR
   WHO, 2016, ZIK VIR FACT SHEET
   WHO, 2016, TABL 1 COUNTR TERR H
   WHO: Media Centre, 2005, WHO STAT 1 M INT HLT
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2016, ZIK VIR COMPL
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Yung CF, 2016, CLIN INFECT DIS, V63, P708, DOI 10.1093/cid/ciw355
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zea-Vera AF, 2017, LUPUS, V26, P890, DOI 10.1177/0961203316671816
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
   Zucker J, 2017, EMERG INFECT DIS, V23, P1047, DOI 10.3201/eid2306.162029
   PUBLIC HLTH EMERGENC
NR 203
TC 3
Z9 3
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8703
EI 1531-698X
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD FEB
PY 2018
VL 30
IS 1
BP 105
EP 116
DI 10.1097/MOP.0000000000000582
PG 12
WC Pediatrics
SC Pediatrics
GA FU7PP
UT WOS:000424045000016
PM 29176498
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Rey, FA
   Stiasny, K
   Vaney, MC
   Dellarole, M
   Heinz, FX
AF Rey, Felix A.
   Stiasny, Karin
   Vaney, Marie-Christine
   Dellarole, Mariano
   Heinz, Franz X.
TI The bright and the dark side of human antibody responses to
   flaviviruses: lessons for vaccine design
SO EMBO REPORTS
LA English
DT Review
DE antibody neutralization; antibody-dependent enhancement; flavivirus
   structure; particle heterogeneity; vaccine design
ID WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; TETRAVALENT DENGUE VACCINE;
   HUMAN MONOCLONAL-ANTIBODIES; ENVELOPE DOMAIN III; YELLOW-FEVER VIRUS;
   ZIKA VIRUS; DEPENDENT ENHANCEMENT; MEDIATED NEUTRALIZATION; STRUCTURAL
   BASIS
AB Zika and dengue viruses belong to the Flavivirus genus, a close group of antigenically related viruses that cause significant arthropod- transmitted diseases throughout the globe. Although infection by a given flavivirus is thought to confer lifelong protection, some of the patient's antibodies cross-react with other flaviviruses without cross-neutralizing. The original antigenic sin phenomenon may amplify such antibodies upon subsequent heterologous flavivirus infection, potentially aggravating disease by antibody-dependent enhancement (ADE). The most striking example is provided by the four different dengue viruses, where infection by one serotype appears to predispose to more severe disease upon infection by a second one. A similar effect was postulated for sequential infections with Zika and dengue viruses. In this review, we analyze the molecular determinants of the dual antibody response to flavivirus infection or vaccination in humans. We highlight the role of conserved partially cryptic epitopes giving rise to cross-reacting and poorly neutralizing, ADE-prone antibodies. We end by proposing a strategy for developing an epitope-focused vaccine approach to avoid eliciting undesirable antibodies while focusing the immune system on producing protective antibodies only.
C1 [Rey, Felix A.; Vaney, Marie-Christine; Dellarole, Mariano] Inst Pasteur, Virol Dept, Struct Virol Unit, Paris, France.
   [Rey, Felix A.; Vaney, Marie-Christine; Dellarole, Mariano] CNRS, UMR 3569, Paris, France.
   [Stiasny, Karin; Heinz, Franz X.] Med Univ Vienna, Ctr Virol, Vienna, Austria.
RP Rey, FA (corresponding author), Inst Pasteur, Virol Dept, Struct Virol Unit, Paris, France.; Rey, FA (corresponding author), CNRS, UMR 3569, Paris, France.; Heinz, FX (corresponding author), Med Univ Vienna, Ctr Virol, Vienna, Austria.
EM felix.rey@pasteur.fr; franz.x.heinz@meduniwien.ac.at
OI Rey, Felix/0000-0002-9953-7988; Stiasny, Karin/0000-0002-1902-8674
FU French ANRFrench National Research Agency (ANR) [ANR-13-ISV8-0002-01];
   Institut Pasteur; CNRSCentre National de la Recherche Scientifique
   (CNRS); LABEX IBEID; Austrian Science Fund FWFAustrian Science Fund
   (FWF)
FX FAR, MCV, and MD acknowledge support from the French ANR (grant
   ANR-13-ISV8-0002-01), Institut Pasteur, CNRS, and the LABEX IBEID. FXH
   and KS acknowledge support from the Austrian Science Fund FWF.
CR Acosta EG, 2016, EXPERT REV VACCINES, V15, P467, DOI 10.1586/14760584.2016.1121814
   Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P442
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhardwaj S, 2001, J VIROL, V75, P4002, DOI 10.1128/JVI.75.8.4002-4007.2001
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Burton DR, 2001, CURR TOP MICROBIOL, V260, P109
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   CASALS J, 1954, J EXP MED, V99, P429, DOI 10.1084/jem.99.5.429
   CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005
   Chaichana P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092173
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   Chan KR, 2011, P NATL ACAD SCI USA, V108, P12479, DOI 10.1073/pnas.1106568108
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Cohen J., 2017, SCIENCE
   Collins ND, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0566-9
   Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Silva AM, 2017, COLD SPRING HARB PER
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   desAlwis R, 2014, PLOS PATHOG, V10
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   ECDC, 2017, 1 UPDATE        0413
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Finlay CJ, 1881, NEW ORL MED SURG J, V18, P601
   Gan ES, 2017, EXPERT REV ANTI-INFE, V15, P111, DOI 10.1080/14787210.2017.1254550
   GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   GOLLINS SW, 1986, NATURE, V321, P244, DOI 10.1038/321244a0
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Guy B, 2017, EXPERT REV VACCINES, V16, P671, DOI 10.1080/14760584.2017.1335201
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Halstead SB, 2017, PLOTKINS VACCINES, P511
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Haslwanter D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006643
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001
   Hombach J., 2017, PLOTKINS VACCINES, P1080
   Hss AS, 2013, VACCINE, V31, P5814, DOI 10.1016/j.vaccine.2013.10.013
   Igonet S, 2012, CELL, V151, P1634, DOI 10.1016/j.cell.2012.11.041
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000672
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Khetarpal N, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-15
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Laoprasopwattana K, 2005, J INFECT DIS, V192, P510, DOI 10.1086/431520
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022
   Mukherjee S, 2011, J VIROL, V85, P12067, DOI 10.1128/JVI.05559-11
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2014, ANNU REV VIROL, V1, P375, DOI 10.1146/annurev-virology-031413-085453
   Pierson TC, 2015, PROG MOL BIOL TRANSL, V129, P141, DOI 10.1016/bs.pmbts.2014.10.005
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   PORTERFIELD JS, 1954, T ROY SOC TROP MED H, V48, P261, DOI 10.1016/0035-9203(54)90074-7
   PORTERFIELD JS, 1986, ADV VIRUS RES, V31, P335, DOI 10.1016/S0065-3527(08)60268-7
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Reed W, 1900, Public Health Pap Rep, V26, P37
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rothman AL, 2016, J INFECT DIS, V214, P825, DOI 10.1093/infdis/jiw068
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Serafin IL, 2001, ARCH VIROL, V146, P2469, DOI 10.1007/s007050170017
   Sirivichayakul C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-48
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531
   Smith SA, 2016, J VIROL, V90, P780, DOI 10.1128/JVI.01805-15
   Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Staples JE, 2017, PLOTKINS VACCINES, P1181
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453
   Tsouchnikas G, 2015, J VIROL, V89, P7970, DOI 10.1128/JVI.00938-15
   VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003
   Wines BD, 2000, J IMMUNOL, V164, P5313, DOI 10.4049/jimmunol.164.10.5313
   Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659
   Xu MH, 2016, J VIROL, V90, P11122, DOI 10.1128/JVI.01096-16
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 158
TC 56
Z9 58
U1 4
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD FEB
PY 2018
VL 19
IS 2
BP 206
EP 224
DI 10.15252/embr.201745302
PG 19
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA FU9HK
UT WOS:000424166400007
PM 29282215
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Aggarwal, A
   Garg, N
AF Aggarwal, Anju
   Garg, Neha
TI Newer Vaccines against Mosquito-borne Diseases
SO INDIAN JOURNAL OF PEDIATRICS
LA English
DT Review
DE Mosquito-borne diseases; Vaccines; Children
ID JAPANESE ENCEPHALITIS VACCINE; WEST NILE VIRUS; IMMUNIZATION PRACTICES;
   ADVISORY-COMMITTEE; DOUBLE-BLIND; IMMUNOGENICITY; SAFETY; LIVE;
   CHILDREN; RECOMMENDATIONS
AB Mosquitos are responsible for a number of protozoal and viral diseases. Malaria, dengue, Japanese encephalitis (JE) and chikungunya epidemics occur commonly all over the world, leading to marked mortality and morbidity in children. Zika, Yellow fever and West Nile fever are others requiring prevention. Environmental control and mosquito bite prevention are useful in decreasing the burden of disease but vaccination has been found to be most cost-effective and is the need of the hour. RTS, S/AS01 vaccine is the first malaria vaccine being licensed for use against P. falciparum malaria. Dengvaxia (CYD-TDV) against dengue was licensed first in Mexico in 2015. A Vero-cell derived, inactivated and alum-adjuvanted JE vaccine based on the SA14-14-2 strain was approved in 2009 in North America, Australia and various European countries. It can be used from 2 mo of age. In India, immunization is carried out in endemic regions at 1 y of age. Another inactivated Vero-cell culture derived Kolar strain, 821564XY, JE vaccine is being used in India. Candidate vaccines against dengue, chikungunya and West Nile fever are been discussed. A continued research and development of new vaccines are required for controlling these mosquito-borne diseases.
C1 [Aggarwal, Anju; Garg, Neha] Univ Coll Med Sci, Dept Pediat, New Delhi 110095, India.
   [Aggarwal, Anju; Garg, Neha] Guru Tegh Bahadur Hosp, New Delhi 110095, India.
RP Aggarwal, A (corresponding author), Univ Coll Med Sci, Dept Pediat, New Delhi 110095, India.; Aggarwal, A (corresponding author), Guru Tegh Bahadur Hosp, New Delhi 110095, India.
EM aanju67@gmail.com
RI Aggarwal, Anju/I-7512-2019
CR [Anonymous], HLTH AGD 4 8 JAP ENC
   Bocchini JA, 2013, MMWR-MORBID MORTAL W, V62, P898
   Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384
   Caraballo H., 2014, EMERG MED PRACT, V16, P23
   Caraballo Hector, 2014, Emerg Med Pract, V16, P1
   Centers for Disease Control and Prevention, VACC INF STAT YELL F
   Centers for Disease Control and Prevention, JAP ENC
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Edelman R, 2007, CLIN INFECT DIS, V45, pS56, DOI 10.1086/518148
   Erasmus JH, NAT MED
   Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Godoi IP, 2017, J COMP EFFECT RES, V6, P165, DOI 10.2217/cer-2016-0045
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091
   Joint Technical Expert Group on Malaria Vaccines World Health Organization, 2015, BACKGR PAP RTS S AS0
   Kwon HJ, 2015, J KOREAN MED SCI, V30, P612, DOI 10.3346/jkms.2015.30.5.612
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   Nasveld PE, 2010, HUM VACCINES, V6, P906, DOI 10.4161/hv.6.11.12854
   NUSSENZWEIG R, 1969, MIL MED, V134, P1176
   Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13
   Pierce KK, 2017, J INFECT DIS, V215, P52, DOI 10.1093/infdis/jiw501
   Poore EA, 2017, VACCINE, V35, P283, DOI 10.1016/j.vaccine.2016.11.080
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Melo FIR, 2017, PEDIATR INFECT DIS J, V36, P602, DOI 10.1097/INF.0000000000001542
   Sanchayan K, 2016, CEYLON MED J, V61, P99, DOI 10.4038/cmj.v61i3.8344
   Sricharoenchai S, 2017, PEDIATR INFECT DIS J, V36, pE45, DOI 10.1097/INF.0000000000001395
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   W.H.O, CHIK
   Wang SY, 2015, HUM VACC IMMUNOTHER, V11, P1418, DOI 10.1080/21645515.2015.1011996
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   WHO, DENGUE
   World Health Organization, YELLOW FEVER
   World Health Organization, QUEST ANSW RTS S ASO
   World Health Organization Strategic Advisory Group of Experts (SAGE) on Immunization, BACKGR PAP DENG VACC
   World Hlth Org, 2017, VACCINE, V35, P1200, DOI 10.1016/j.vaccine.2016.10.070
NR 36
TC 6
Z9 6
U1 1
U2 12
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0019-5456
EI 0973-7693
J9 INDIAN J PEDIATR
JI Indian J. Pediatr.
PD FEB
PY 2018
VL 85
IS 2
BP 117
EP 123
DI 10.1007/s12098-017-2383-4
PG 7
WC Pediatrics
SC Pediatrics
GA FY1IK
UT WOS:000426565200008
PM 28560654
DA 2020-07-08
ER

PT J
AU Brugman, VA
   Hernandez-Triana, LM
   Medlock, JM
   Fooks, AR
   Carpenter, S
   Johnson, N
AF Brugman, Victor A.
   Hernandez-Triana, Luis M.
   Medlock, Jolyon M.
   Fooks, Anthony R.
   Carpenter, Simon
   Johnson, Nicholas
TI The Role of Culex pipiens L. (Diptera: Culicidae) in Virus Transmission
   in Europe
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE Culex pipiens; West Nile virus; transmission; molestus; arbovirus; host
   preference
ID WEST-NILE-VIRUS; POTENTIAL MOSQUITO VECTORS; MOLESTUS FORSKAL DIPTERA;
   HOST-FEEDING PATTERNS; BLOOD MEAL ANALYSIS; SINDBIS VIRUS; ZIKA VIRUS;
   ANOPHELES-PLUMBEUS; USUTU-VIRUS; PHYLOGENETIC-RELATIONSHIPS
AB Over the past three decades, a range of mosquito-borne viruses that threaten public and veterinary health have emerged or re-emerged in Europe. Mosquito surveillance activities have highlighted the Culex pipiens species complex as being critical for the maintenance of a number of these viruses. This species complex contains morphologically similar forms that exhibit variation in phenotypes that can influence the probability of virus transmission. Critical amongst these is the choice of host on which to feed, with different forms showing different feeding preferences. This influences the ability of the mosquito to vector viruses and facilitate transmission of viruses to humans and domestic animals. Biases towards blood-feeding on avian or mammalian hosts have been demonstrated for different Cx. pipiens ecoforms and emerging evidence of hybrid populations across Europe adds another level of complexity to virus transmission. A range of molecular methods based on DNA have been developed to enable discrimination between morphologically indistinguishable forms, although this remains an active area of research. This review provides a comprehensive overview of developments in the understanding of the ecology, behaviour and genetics of Cx. pipiens in Europe, and how this influences arbovirus transmission.
C1 [Brugman, Victor A.] Evolut Biotechnol, Colworth Sci Pk, Sharnbrook MK44 1LZ, Beds, England.
   [Brugman, Victor A.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England.
   [Hernandez-Triana, Luis M.; Fooks, Anthony R.; Johnson, Nicholas] Anim & Plant Hlth Agcy, Woodham Lane, Addlestone KT15 3NB, Surrey, England.
   [Medlock, Jolyon M.] Publ Hlth England, Salisbury SP4 0JG, Wilts, England.
   [Medlock, Jolyon M.] Hlth Protect Res Unit Emerging Infect & Zoonoses, Salisbury SP4 0JG, Wilts, England.
   [Fooks, Anthony R.] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Liverpool L69 7BE, Merseyside, England.
   [Carpenter, Simon] Pirbright Inst, Ash Rd, Woking GU24 0NF, Surrey, England.
   [Johnson, Nicholas] Univ Surrey, Fac Hlth & Med, Guildford GU2 7XH, Surrey, England.
RP Johnson, N (corresponding author), Anim & Plant Hlth Agcy, Woodham Lane, Addlestone KT15 3NB, Surrey, England.; Johnson, N (corresponding author), Univ Surrey, Fac Hlth & Med, Guildford GU2 7XH, Surrey, England.
EM vab@evolutionbiotech.com; Luis.Hernandez-Triana@apha.gsi.gov.uk;
   jolyon.medlock@phe.gov.uk; tony.fooks@apha.gsi.gov.uk;
   Simon.Carpenter@pirbright.ac.uk; Nick.Johnson@apha.gsi.gov.uk
RI Carpenter, Simon/C-2718-2013
OI Carpenter, Simon/0000-0001-5775-045X; Brugman,
   Victor/0000-0003-3476-9646
FU UK Department for Environment, Food and Rural AffairsDepartment for
   Environment, Food & Rural Affairs (DEFRA); Scottish Government [SE4113];
   Welsh Government [SE4113]
FX This study was funded by the UK Department for Environment, Food and
   Rural Affairs and the Scottish and Welsh Governments through grant
   SE4113.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Adouchief S, 2016, REV MED VIROL, V26, P221, DOI 10.1002/rmv.1876
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Allan SA, 2006, J MED ENTOMOL, V43, P225, DOI 10.1603/0022-2585(2006)043[0225:LEOAOF]2.0.CO;2
   Almeida APG, 2010, VECTOR-BORNE ZOONOT, V10, P673, DOI 10.1089/vbz.2009.0245
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Amraoui F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-83
   Andreadis TG, 2012, J AM MOSQUITO CONTR, V28, P137, DOI 10.2987/8756-971X-28.4s.137
   Aranda Carlos, 2000, European Mosquito Bulletin, V8, P7
   Atyame CM, 2011, MOL BIOL EVOL, V28, P2761, DOI 10.1093/molbev/msr083
   Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028
   Balenghien T, 2006, J MED ENTOMOL, V43, P936, DOI 10.1603/0022-2585(2006)43[936:HBAHBA]2.0.CO;2
   Beck Matthias, 2003, European Mosquito Bulletin, V14, P21
   Becker N, 2012, J AM MOSQUITO CONTR, V28, P53, DOI 10.2987/8756-971X-28.4s.53
   Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604
   Becker N, 2008, PARASITOL RES, V103, pS19, DOI 10.1007/s00436-008-1210-2
   Beji M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2265-7
   Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161
   Bernasconi MV, 2000, INSECT MOL BIOL, V9, P67, DOI 10.1046/j.1365-2583.2000.00158.x
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Borstler J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1597-z
   Borstler J, 2014, J VECTOR ECOL, V39, P204, DOI 10.1111/j.1948-7134.2014.12088.x
   Boukraa S, 2016, PREV VET MED, V124, P58, DOI 10.1016/j.prevetmed.2015.12.013
   Boukraa S, 2015, J VECTOR ECOL, V40, P398, DOI 10.1111/jvec.12180
   Bourguet D, 1998, J AM MOSQUITO CONTR, V14, P390
   Bozicic-Lothrop B., 1996, Acta Entomologica Serbica, V1, P31
   Bravo-Barriga D, 2017, J VECTOR ECOL, V42, P136, DOI 10.1111/jvec.12248
   Brown L, 2014, PUBLIC HEALTH, V128, P29, DOI 10.1016/j.puhe.2013.09.006
   Brugman VA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2098-4
   Brugman VA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2360-9
   Brustolin M, 2016, MED VET ENTOMOL, V30, P166, DOI 10.1111/mve.12164
   Bunning ML, 2002, EMERG INFECT DIS, V8, P380
   Busula AO, 2017, J INFECT DIS, V216, P291, DOI 10.1093/infdis/jix214
   Byrne K, 1999, HEREDITY, V82, P7, DOI 10.1038/sj.hdy.6884120
   Cabre O, 2006, EMERG INFECT DIS, V12, P1958
   Cadar D, 2017, EUROSURVEILLANCE, V22, P9, DOI [10.2807/1560-7917.es.2017.22.14.30501, 10.2807/1560-7917.ES.2017.22.14.30501]
   Cadar D, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.4.30452
   Calzolari M., 2015, PLOS ONE, V10
   Calzolari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063978
   Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324
   Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7
   Cancrini G, 2006, J MED ENTOMOL, V43, P574, DOI 10.1603/0022-2585(2006)43[574:NVODIR]2.0.CO;2
   Capelli G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-188
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Cernescu C, 2000, J INFECT DIS, V181, P710, DOI 10.1086/315225
   Ciota AT, 2011, J AM MOSQUITO CONTR, V27, P21, DOI 10.2987/8756-971X-27.1.21
   Cornel AJ, 2003, J MED ENTOMOL, V40, P36, DOI 10.1603/0022-2585-40.1.36
   Cornet S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-179
   Cornet S, 2013, ECOL LETT, V16, P323, DOI 10.1111/ele.12041
   Culverwell C. L., 2017, MED VET ENTOMOL
   Curtotti A., 2009, THESIS
   Danabalan R, 2012, J AM MOSQUITO CONTR, V28, P68, DOI 10.2987/8756-971X-28.0.68
   DANIELOVA V, 1984, FOLIA PARASIT, V31, P379
   de Boer JG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08978-9
   Dekoninck W, 2011, J MED ENTOMOL, V48, P924, DOI 10.1603/ME10235
   Di Luca M., 2016, PLOS ONE, V11
   DOBROTWO.NV, 1967, B WORLD HEALTH ORGAN, V37, P251
   Duron O, 2011, HEREDITY, V106, P986, DOI 10.1038/hdy.2010.146
   EDMAN JD, 1987, INSECT SCI APPL, V8, P617, DOI 10.1017/S1742758400022694
   Eiden M, 2014, VECTOR-BORNE ZOONOT, V14, P220, DOI 10.1089/vbz.2013.1354
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869
   Eritja R., 2000, European Mosquito Bulletin, V8, P10
   ESPMARK A, 1984, AM J TROP MED HYG, V33, P1203, DOI 10.4269/ajtmh.1984.33.1203
   European Centre for Disease Prevention and Control, 2016, AED ALB FACTSH EXP
   Fall G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006078
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002
   Ferraguti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066237
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Fonseca DM, 2000, MOL ECOL, V9, P1803, DOI 10.1046/j.1365-294x.2000.01070.x
   Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247
   Fortuna C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1067-z
   Fritz ML, 2015, MED VET ENTOMOL, V29, P115, DOI 10.1111/mve.12096
   Fros JJ, 2015, ONE HEALTH, V1, P31, DOI 10.1016/j.onehlt.2015.08.002
   Fyodorova MV, 2006, J MED ENTOMOL, V43, P552, DOI 10.1603/0022-2585(2006)43[552:EOPWNV]2.0.CO;2
   Gibson G, 2006, CURR BIOL, V16, P1311, DOI 10.1016/j.cub.2006.05.053
   Gomes B, 2013, INFECT GENET EVOL, V16, P218, DOI 10.1016/j.meegid.2013.02.006
   Gomes B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-93
   Gomes B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-262
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gratz NG, 2006, VECTOR-AND RODENT-BORNE DISEASES OF EUROPE AND NORTH AMERICA: THEIR DISTRIBUTION AND PUBLIC HEALTH BURDEN, P1, DOI 10.2277/ 0521854474
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Gunay F, 2015, ACTA TROP, V143, P112, DOI 10.1016/j.actatropica.2014.10.013
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268
   Han LL, 1999, J INFECT DIS, V179, P230, DOI 10.1086/314566
   Harbach R.E, MOSQUITO TAXONOMIC I
   Harbach Ralph E., 2007, European Mosquito Bulletin, V23, P1
   Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10
   HARBACH RE, 1985, P ENTOMOL SOC WASH, V87, P1
   HARBACH RE, 1984, P ENTOMOL SOC WASH, V86, P521
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hernandez-Triana LM, 2017, ZOOTAXA, V4250, P67, DOI 10.11646/zootaxa.4250.1.5
   Hesson JC, 2014, MED VET ENTOMOL, V28, P179, DOI 10.1111/mve.12024
   Hesson JC, 2015, J VECTOR ECOL, V40, P158, DOI 10.1111/jvec.12145
   Hesson JC, 2015, EMERG INFECT DIS, V21, P875, DOI 10.3201/eid2105.141577
   Hesson JC, 2011, VECTOR-BORNE ZOONOT, V11, P1383, DOI 10.1089/vbz.2011.0630
   Heym EC, 2017, TROP MED INT HEALTH, V22, P103, DOI 10.1111/tmi.12805
   Huang SM, 2009, VECTOR-BORNE ZOONOT, V9, P637, DOI 10.1089/vbz.2008.0146
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7
   Hulden L., 2014, ZOOKEYS
   Ibanez-Justicia A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0865-7
   JAENSON TGT, 1986, B ENTOMOL RES, V76, P375, DOI 10.1017/S0007485300014863
   Jalili N., 2000, European Mosquito Bulletin, V6, P20
   Jhumur US, 2006, J MED ENTOMOL, V43, P1164, DOI 10.1603/0022-2585(2006)43[1164:NACROC]2.0.CO;2
   Jost H, 2011, AM J TROP MED HYG, V84, P241, DOI 10.4269/ajtmh.2011.10-0483
   Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301
   Kassim NFA, 2012, J VECTOR ECOL, V37, P162, DOI 10.1111/j.1948-7134.2012.00213.x
   Kaufmann C, 2012, PARASITOLOGY, V139, P248, DOI 10.1017/S0031182011001764
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Kent RJ, 2007, J MED ENTOMOL, V44, P50, DOI 10.1603/0022-2585(2007)44[50:GDBCPF]2.0.CO;2
   Keyghobadi N, 2004, MOL ECOL NOTES, V4, P20, DOI 10.1046/j.1471-8286.2003.00557.x
   Kilpatrick AM, 2007, AM J TROP MED HYG, V77, P667, DOI 10.4269/ajtmh.2007.77.667
   Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082
   Korkmaz S., 2017, TURKISH J PARASITOL, V40, P199
   Kothera L, 2010, J MED ENTOMOL, V47, P805, DOI 10.1603/ME10031
   LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487
   Lafri I, 2017, COMP IMMUNOL MICROB, V50, P8, DOI 10.1016/j.cimid.2016.11.005
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Luhken R, 2015, J MED ENTOMOL, V52, P932, DOI 10.1093/jme/tjv070
   Lundstrom JO, 2010, VECTOR-BORNE ZOONOT, V10, P889, DOI 10.1089/vbz.2009.0069
   Lundstrom JO, 1999, J VECTOR ECOL, V24, P1
   LUNDSTROM JO, 1990, AM J TROP MED HYG, V43, P534, DOI 10.4269/ajtmh.1990.43.534
   LUNDSTROM JO, 1990, J MED ENTOMOL, V27, P561, DOI 10.1093/jmedent/27.4.561
   Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x
   MALKOVA D, 1972, ACTA VIROL, V16, P93
   MANI P, 1998, SELEZIONE VET, V8, P749
   Manley R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134453
   Margarita Y, 2006, ACTA PARASITOL, V1, P59
   Martinez -de la Puente J., 2016, MALARIA J, V15, P589, DOI DOI 10.1186/S12936-016-1643-5
   Martinez-de la Puente J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0571-0
   Martinez-de la Puente J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-109
   Martinez-de la Puente J, 2012, J MED ENTOMOL, V49, P1419, DOI 10.1603/ME12081
   Mauer DJ, 1999, J MED ENTOMOL, V36, P503, DOI 10.1093/jmedent/36.4.503
   Medlock JM, 2007, EPIDEMIOL INFECT, V135, P466, DOI 10.1017/S0950268806007047
   Medlock JM, 2015, B ENTOMOL RES, V25, P1
   Medlock JM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0751-3
   Medlock JM, 2014, J VECTOR ECOL, V39, P249, DOI 10.1111/jvec.12099
   MELNICK JL, 1951, P SOC EXP BIOL MED, V77, P661, DOI 10.3181/00379727-77-18884
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Munoz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039549
   Munoz J, 2011, J MED ENTOMOL, V48, P956, DOI 10.1603/ME11016
   Nelms BM, 2013, J MED ENTOMOL, V50, P773, DOI 10.1603/ME12280
   Nicolescu Gabriela, 2002, European Mosquito Bulletin, V13, P17
   Nikolay B, 2015, T ROY SOC TROP MED H, V109, P609, DOI 10.1093/trstmh/trv066
   ONYEKA JOA, 1987, B ENTOMOL RES, V77, P99, DOI 10.1017/S0007485300011585
   Osorio HC, 2014, MED VET ENTOMOL, V28, P103, DOI 10.1111/mve.12020
   Osorio HC, 2012, J MED ENTOMOL, V49, P717, DOI 10.1603/ME11184
   Pakalniskis S., 2006, New and Rare for Lithuania Insect Species Records and Descriptions, V18, P16
   Papa A, 2011, CLIN MICROBIOL INFEC, V17, P1176, DOI 10.1111/j.1469-0691.2010.03438.x
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040
   Petric D, 2017, MOL CELL PROBE, V31, P28, DOI 10.1016/j.mcp.2016.10.011
   Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0
   Radrova J, 2013, J MED ENTOMOL, V50, P1097, DOI 10.1603/ME13029
   Rappole JH, 2003, J APPL MICROBIOL, V94, p47S
   Reusken CBEM, 2010, J VECTOR ECOL, V35, P210, DOI 10.1111/j.1948-7134.2010.00050.x
   Ribeiro H., 1988, Actas do Congresso Iberico de Entomologia, V3, P233
   Rizzoli A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0831-4
   Rogozi E., 2012, P E SOV BIOL INT CHA
   Roiz D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-333
   Roiz D, 2012, J VECTOR ECOL, V37, P20, DOI 10.1111/j.1948-7134.2012.00196.x
   Rudolf I, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2399-7
   Rudolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071832
   Russell RC, 2012, J AM MOSQUITO CONTR, V28, P24, DOI 10.2987/8756-971X-28.4s.24
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Sanders CJ, 2017, J APPL ECOL, V54, P1429, DOI 10.1111/1365-2664.12875
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Savini G, 2012, VET MICROBIOL, V158, P267, DOI 10.1016/j.vetmic.2012.02.018
   Schaffner Francis, 1998, European Mosquito Bulletin, V2, P1
   Schonenberger AC, 2016, MED VET ENTOMOL, V30, P39, DOI 10.1111/mve.12155
   Schuffenecker I, 2005, EMERG INFECT DIS, V11, P306, DOI 10.3201/eid1102.040817
   SERVICE MW, 1968, J ZOOL, V156, P313
   SERVICE MW, 1969, B ENTOMOL RES, V59, P161, DOI 10.1017/S000748530000314X
   SERVICE MW, 1971, B ENTOMOL RES, V60, P653, DOI 10.1017/S0007485300042401
   SERVICE MW, 1971, J HYG-CAMB, V69, P105, DOI 10.1017/S0022172400021318
   Shaikevich EV, 2010, COMP CYTOGENET, V4, P161, DOI 10.3897/compcytogen.v4i2.45
   Shaikevich EV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1333-8
   Shaikevich EV, 2014, ENTOMOL REV, V94, P35, DOI DOI 10.1134/S0013873814010047
   Shaikevich EV, 2007, EUROPEAN MOSQUITO B, V23, P25
   Sieg M, 2017, VECTOR-BORNE ZOONOT, V17, P662, DOI 10.1089/vbz.2016.2096
   Silver JB., 2007, MOSQUITO ECOLOGY FIE
   Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282
   Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Snow Keith, 2006, European Mosquito Bulletin, V21, P1
   Snow Keith, 1999, European Mosquito Bulletin, V3, P14
   Sotelo E, 2011, J GEN VIROL, V92, P2512, DOI 10.1099/vir.0.033829-0
   Sulesco TM, 2013, J AM MOSQUITO CONTR, V29, P98, DOI 10.2987/12-6311R.1
   Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Tamas B, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.72
   TAYLOR RM, 1955, AM J TROP MED HYG, V4, P844, DOI 10.4269/ajtmh.1955.4.844
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Toth S., 2012, European Mosquito Bulletin, P30
   Townroe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095325
   van Niekerk S, 2015, EMERG INFECT DIS, V21, P2225, DOI 10.3201/eid2112.150132
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0705-9
   Verhulst NO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-200
   Versteirt V, 2012, J MED ENTOMOL, V49, P1226, DOI 10.1603/ME11170
   VINOGRADOVA EB, 2000, PENSOFT SERIES PARAS, V2, P250
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Vogels CBF, 2017, J EXP BIOL, V220, P3598, DOI 10.1242/jeb.164186
   Vogels CBF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05185-4
   Vogels CBF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166959
   Vogels CBF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1677-0
   Vogels CBF, 2015, VECTOR-BORNE ZOONOT, V15, P619, DOI 10.1089/vbz.2015.1820
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Weitzel T, 2015, PARASITOL RES, V114, P289, DOI 10.1007/s00436-014-4193-1
   Weitzel Thomas, 2011, European Mosquito Bulletin, V29, P22
   Weitzel T, 2009, J AM MOSQUITO CONTR, V25, P6, DOI 10.2987/08-5699.1
   WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872
   Yssouf A, 2014, PARASITOL RES, V113, P2375, DOI 10.1007/s00436-014-3876-y
   Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12
   Zittra C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1495-4
NR 224
TC 14
Z9 15
U1 2
U2 19
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB
PY 2018
VL 15
IS 2
AR 389
DI 10.3390/ijerph15020389
PG 30
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FY3LM
UT WOS:000426721400214
PM 29473903
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Leta, S
   Beyene, TJ
   De Clercq, EM
   Amenu, K
   Kraemer, MUG
   Revie, CW
AF Leta, Samson
   Beyene, Tariku Jibat
   De Clercq, Eva M.
   Amenu, Kebede
   Kraemer, Moritz U. G.
   Revie, Crawford W.
TI Global risk mapping for major diseases transmitted by Aedes aegypti and
   Aedes albopictus
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Arboviral diseases; Chikungunya;
   Dengue; RVF; Yellow fever; Zika
ID RIFT-VALLEY FEVER; ZIKA VIRUS; YELLOW-FEVER; CHIKUNGUNYA; DENGUE;
   TRANSMISSION; MOSQUITOS; WOLBACHIA; OUTBREAK; DIPTERA
AB Objectives: The objective of this study was to map the global risk of the major arboviral diseases transmitted by Aedes aegypti and Aedes albopictus by identifying areas where the diseases are reported, either through active transmission or travel-related outbreaks, as well as areas where the diseases are not currently reported but are nonetheless suitable for the vector.
   Methods: Data relating to five arboviral diseases (Zika, dengue fever, chikungunya, yellow fever, and Rift Valley fever (RVF)) were extracted from some of the largest contemporary databases and paired with data on the known distribution of their vectors, A. aegypti and A. albopictus. The disease occurrence data for the selected diseases were compiled from literature dating as far back as 1952 to as recent as 2017. The resulting datasets were aggregated at the country level, except in the case of the USA, where state-level data were used. Spatial analysis was used to process the data and to develop risk maps.
   Results: Out of the 250 countries/territories considered, 215 (86%) are potentially suitable for the survival and establishment of A. aegypti and/or A. albopictus. A. albopictus has suitability foci in 197 countries/territories, while there are 188 that are suitable for A. aegypti. There is considerable variation in the suitability range among countries/territories, but many of the tropical regions of the world provide high suitability over extensive areas. Globally, 146 (58.4%) countries/territories reported at least one arboviral disease, while 123 (49.2%) reported more than one of the above diseases. The overall numbers of countries/territories reporting autochthonous vector-borne occurrences of Zika, dengue, chikungunya, yellow fever, and RVF, were 85, 111, 106, 43, and 39, respectively.
   Conclusions: With 215 countries/territories potentially suitable for the most important arboviral disease vectors and more than half of these reporting cases, arboviral diseases are indeed a global public health threat. The increasing proportion of reports that include multiple arboviral diseases highlights the expanding range of their common transmission vectors. The shared features of these arboviral diseases should motivate efforts to combine interventions against these diseases. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Leta, Samson; Beyene, Tariku Jibat; Amenu, Kebede] Addis Ababa Univ, Coll Vet Med, POB 34, Bishoftu, Ethiopia.
   [De Clercq, Eva M.] Catholic Univ Louvain, FNRS, George Lemaitre Inst Earth & Climate Res, Pl Louis Pasteur 3, B-1348 Louvain, Belgium.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Revie, Crawford W.] Univ Prince Edward Isl, Dept Hlth Management, Charlottetown, PE, Canada.
RP Leta, S (corresponding author), Addis Ababa Univ, Coll Vet Med, POB 34, Bishoftu, Ethiopia.
EM samson.leta@aau.edu.et
RI ; Beyene, Tariku Jibat/A-6875-2017; Revie, Crawford/B-5002-2011; Ejeta,
   Kebede Amenu/E-6876-2018
OI De Clercq, Eva/0000-0002-0578-9771; Beyene, Tariku
   Jibat/0000-0002-7474-1966; Leta, Samson/0000-0003-4792-5978; Revie,
   Crawford/0000-0002-5018-0340; Ejeta, Kebede Amenu/0000-0002-0985-2950
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32 HD040128]
CR AITKEN THG, 1979, AM J TROP MED HYG, V28, P119, DOI 10.4269/ajtmh.1979.28.119
   Al-Hazmi M, 2003, CLIN INFECT DIS, V36, P245, DOI 10.1086/345671
   Alto BW, 2006, ECOLOGY PARASITE VEC
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P905
   Charrel RN, 2014, CLIN MICROBIOL INFEC, V20, P662, DOI 10.1111/1469-0691.12694
   Cianci D, 2015, J MED ENTOMOL, V52, P329, DOI 10.1093/jme/tjv026
   Clements ACA, 2007, PREV VET MED, V82, P72, DOI 10.1016/j.prevetmed.2007.05.006
   DAVIS M, 2016, MEM I O CRUZ, V10, P1, DOI DOI 10.1007/978-3-319-41842-1_1
   Demir T, 2016, FOLIA MICROBIOL, V61, P523, DOI 10.1007/s12223-016-0467-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2017, CURR ZIK TRANSM
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Hafiz MY, 2016, INFECT DRUG RESIST, V9, DOI 10.2147/IDR.S108057
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Li Y, 2014, PLOS NEGL TROP DIS, V8
   Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x
   Lover AA, 2016, LANCET INFECT DIS, V16, P1331, DOI 10.1016/S1473-3099(16)30462-5
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   Millichap J Gordon, 2016, Pediatr Neurol Briefs, V30, P8, DOI 10.15844/pedneurbriefs-30-1-7
   Mlacker S, 2016, INT J DERMATOL, V55, P1369, DOI 10.1111/ijd.13399
   Mohamed M, 2010, AM J TROP MED HYG, V83, P22, DOI 10.4269/ajtmh.2010.09-0318
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009
   Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2
   Mweya CN, 2013, INFECT ECOL EPIDEMIO, V3
   Nanyingi Mark O., 2015, Infection Ecology & Epidemiology, V5, P28024, DOI 10.3402/iee.v5.28024
   Norwood PF, 2015, REV SCI TECH OIE, V34, P479, DOI 10.20506/rst.34.2.2373
   Ortiz-Martinez Yeimer, 2017, F1000Res, V6, P398, DOI 10.12688/f1000research.11280.2
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033
   QGIS Development Team, 2009, QGIS GEOGR INF SYST
   RAO TR, 1973, B WORLD HEALTH ORGAN, V48, P615
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   WHO, 2017, CIK FACTSH
   WHO, 2017, WHAT IS DENG
   World Health Organisation, 2016, YELL FEV SIT REP
   World Health Organization, 2016, RIFT VALL FEV FACT S
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization, 2014, GLOB BRIEF VECT BORN
NR 67
TC 68
Z9 72
U1 5
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2018
VL 67
BP 25
EP 35
DI 10.1016/j.ijid.2017.11.026
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA FX1XQ
UT WOS:000425849400006
PM 29196275
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Lustig, Y
   Cotar, AI
   Ceianu, CS
   Castilletti, C
   Zelena, H
   Burdino, E
   van Tienen, C
   Avsic, T
   Aarons, E
   Reusken, C
AF Lustig, Yaniv
   Cotar, Ani Ioana
   Ceianu, Cornelia S.
   Castilletti, Concetta
   Zelena, Hana
   Burdino, Elisa
   van Tienen, Carla
   Avsic, Tatjana
   Aarons, Emma
   Reusken, Chantal
TI Lack of Zika virus antibody response in confirmed patients in
   non-endemic countries
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Letter
ID ASSAY
C1 [Lustig, Yaniv] Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Natl Ctr Zoonot Viruses Lab, Ramat Gan, Israel.
   [Cotar, Ani Ioana; Ceianu, Cornelia S.] Cantacuzino Natl Inst Res, Bucharest, Romania.
   [Castilletti, Concetta] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
   [Zelena, Hana] Inst Publ Hlth, Ostrava, Czech Republic.
   [Zelena, Hana] Univ Def, Fac Mil Hlth Sci, Hradec Kralove, Czech Republic.
   [Burdino, Elisa] Amedeo di Savoia Hosp, Lab Microbiol & Virol, Turin, Italy.
   [van Tienen, Carla; Reusken, Chantal] Erasmus MC, Dept Virosci, WHO Collaborating Ctr Arbovirus & Haemorrhag, Fever Reference & Res, Rotterdam, Netherlands.
   [Avsic, Tatjana] Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.
   [Aarons, Emma] Publ Hlth England Porton, Rare & Imported Pathogens Lab, Salisbury, Wilts, England.
RP Lustig, Y (corresponding author), Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Natl Ctr Zoonot Viruses Lab, Ramat Gan, Israel.
EM yaniv.lustig@sheba.health.gov.il
RI Castilletti, Concetta/AAA-8408-2019; Castilletti, Concetta/B-6545-2016
OI Castilletti, Concetta/0000-0001-9819-236X; Castilletti,
   Concetta/0000-0001-9819-236X; AVSIC ZUPANC, TATJANA/0000-0001-6243-0688
CR Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EURO SURVEILL, V21
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Park MS, 2016, IMMUNE NETW, V16, P261, DOI 10.4110/in.2016.16.5.261
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Steinhagen K, 2016, EURO SURVEILL, V21
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
NR 15
TC 6
Z9 6
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD FEB-MAR
PY 2018
VL 99-100
BP 31
EP 34
DI 10.1016/j.jcv.2017.12.007
PG 4
WC Virology
SC Virology
GA FX0PI
UT WOS:000425747400006
PM 29289815
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Lourenco-de-Oliveira, R
   Marques, JT
   Sreenu, VB
   Nten, CA
   Aguiar, ERGR
   Varjak, M
   Kohl, A
   Failloux, AB
AF Lourenco-de-Oliveira, Ricardo
   Marques, Joao T.
   Sreenu, Vattipally B.
   Nten, Celestine Atyame
   Guimaraes Rocha Aguiar, Eric Roberto
   Varjak, Margus
   Kohl, Alain
   Failloux, Anna-Bella
TI Culex quinquefasciatus mosquitoes do not support replication of Zika
   virus
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE mosquito; Culex spp; mosquitoes; Zika virus; transmission; replication
ID AEDES-AEGYPTI; PIPIENS COMPLEX; WOLBACHIA; COMPETENCE; BRAZIL;
   TRANSMISSION; INHIBITION; VECTORS; DISEASE; STRAIN
AB The rapid spread of Zika virus (ZIKV) in the Americas raised many questions about the role of Culex quinquefasciatus mosquitoes in transmission, in addition to the key role played by the vector Aedes aegypti. Here we analysed the competence of Cx. quinquefasciatus (with or without Wolbachia endosymbionts) for a ZIKV isolate. We also examined the induction of RNA interference pathways after viral challenge and the production of small virus-derived RNAs. We did not observe any infection nor such small virus-derived RNAs, regardless of the presence or absence of Wolbachia. Thus, Cx. quinquefasciatus does not support ZIKV replication and Wolbachia is not involved in producing this phenotype. In short, these mosquitoes are very unlikely to play a role in transmission of ZIKV.
C1 [Lourenco-de-Oliveira, Ricardo; Nten, Celestine Atyame; Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.
   [Lourenco-de-Oliveira, Ricardo] Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Marques, Joao T.; Guimaraes Rocha Aguiar, Eric Roberto] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, 6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Sreenu, Vattipally B.; Varjak, Margus; Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Nten, Celestine Atyame] Univ Reunion Isl, CNRS 9192, UMR PIMIT Proc Infect Milieu Insulaire Trop, INSERM,U1187,IRD 249, St Clotilde, Reunion, France.
RP Failloux, AB (corresponding author), Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.; Kohl, A (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
EM alain.Kohl@glasgow.ac.uk; anna-bella.failloux@pasteur.fr
RI Aguiar, Eric/T-5076-2019; Aguiar, Eric RGR/L-7989-2018; Marques, Joao
   T/F-7683-2012
OI Aguiar, Eric/0000-0002-8143-5756; Aguiar, Eric RGR/0000-0002-8143-5756;
   Marques, Joao T/0000-0002-3457-3320; Varjak, Margus/0000-0003-2608-5148;
   Vattipally, Bala Sreenu/0000-0001-6673-4697
FU European Union's Horizon research and innovation programme under
   ZIKAlliance grant [734548]; European Union's Horizon research and
   innovation programme under Marie Sklodowska-Curie grant [661232];
   CAPES-COFECUB programme grantCAPES [799-14]; Fundacao Carlos Chagas
   Filho de Amparoa Pesquisa do Estado do Rio de Janeiro grant
   [E-26/201.335/2016]; UK Medical Research CouncilMedical Research Council
   UK (MRC) [MC_UU_12014]
FX This study was partially supported by the European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant agreement no.
   734548 (A.K., A.B.F., J.M., R.L.O.) and under Marie Sklodowska-Curie
   grant agreement no. 661232 (M.V.). Moreover, the project received
   support under the CAPES-COFECUB programme grant agreement no, 799-14
   (A.B.F., R.L.O.), and the Fundacao Carlos Chagas Filho de Amparoa
   Pesquisa do Estado do Rio de Janeiro grant agreement no.
   E-26/201.335/2016 (R.L.O.). This work was also funded by the UK Medical
   Research Council (MC_UU_12014) (A.K.).
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Atyame CM, 2011, MOL BIOL EVOL, V28, P2761, DOI 10.1093/molbev/msr083
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Caragata EP, 2016, FUTURE MICROBIOL, V11, P1499, DOI 10.2217/fmb-2016-0177
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Demir T, 2016, FOLIA MICROBIOL, V61, P523, DOI 10.1007/s12223-016-0467-6
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Donald Claire L, 2012, Insects, V3, P511, DOI 10.3390/insects3020511
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GEORGHIOU GP, 1966, B WORLD HEALTH ORGAN, V35, P691
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Aguiar ERGR, 2016, NUCLEIC ACIDS RES, V44, P3477, DOI 10.1093/nar/gkw044
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hang J, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01644-15
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew035
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li CX, 2015, ELIFE, V4, DOI 10.7554/eLife.05378
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005511
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Parrish NF, 2015, RNA, V21, P1691, DOI 10.1261/rna.052092.115
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Richard V, 2017, ACTA TROP, V173, P200, DOI 10.1016/j.actatropica.2017.04.036
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354
   Sinkins SP, 2013, FUTURE MICROBIOL, V8, P1249, DOI 10.2217/fmb.13.95
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   YEN JH, 1973, J INVERTEBR PATHOL, V22, P242, DOI 10.1016/0022-2011(73)90141-9
NR 63
TC 12
Z9 12
U1 0
U2 5
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD FEB
PY 2018
VL 99
IS 2
BP 258
EP 264
DI 10.1099/jgv.0.000949
PG 7
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GE2AU
UT WOS:000431018700012
PM 29076805
OA Other Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Cheng, F
   da Silva, SR
   Huang, IC
   Jung, JU
   Gao, SJ
AF Cheng, Fan
   da Silva, Suzane Ramos
   Huang, I-Chueh
   Jung, Jae U.
   Gao, Shou-Jiang
TI Suppression of Zika Virus Infection and Replication in Endothelial Cells
   and Astrocytes by PKA Inhibitor PKI 14-22
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; inhibitor; PKI 14-22; PKA; endothelial cells; astrocytes
ID PROTEIN-KINASE; BRAIN; ACTIVATION; PATHWAY; BIOLOGY; AMPK;
   IDENTIFICATION; BRAZIL; MODEL
AB The recent outbreak of Zika virus (ZIKV), a reemerging flavivirus, and its associated neurological disorders, such as Guillain-Barre (GB) syndrome and microcephaly, have generated an urgent need to develop effective ZIKV vaccines and therapeutic agents. Here, we used human endothelial cells and astrocytes, both of which represent key cell types for ZIKV infection, to identify potential inhibitors of ZIKV replication. Because several pathways, including the AMP-activated protein kinase (AMPK), protein kinase A (PKA), and mitogen-activated protein kinase (MAPK) signaling pathways, have been reported to play important roles in flavivirus replication, we tested inhibitors and agonists of these pathways for their effects on ZIKV replication. We identified the PKA inhibitor PKI 14-22 (PKI) to be a potent inhibitor of ZIKV replication. PKI effectively suppressed the replication of ZIKV from both the African and Asian/ American lineages with a high efficiency and minimal cytotoxicity. While ZIKV infection does not induce PKA activation, endogenous PKA activity is essential for supporting ZIKV replication. Interestingly, in addition to PKA, PKI also inhibited another unknown target(s) to block ZIKV replication. PKI inhibited ZIKV replication at the postentry stage by preferentially affecting negative-sense RNA synthesis as well as viral protein translation. Together, these results have identified a potential inhibitor of ZIKV replication which could be further explored for future therapeutic application.
   IMPORTANCE There is an urgent need to develop effective vaccines and therapeutic agents against Zika virus (ZIKV) infection, a reemerging flavivirus associated with neurological disorders, including Guillain-Barre (GB) syndrome and microcephaly. By screening for inhibitors of several cellular pathways, we have identified the PKA inhibitor PKI 14-22 (PKI) to be a potent inhibitor of ZIKV replication. We show that PKI effectively suppresses the replication of all ZIKV strains tested with minimal cytotoxicity to human endothelial cells and astrocytes, two key cell types for ZIKV infection. Furthermore, we show that PKI inhibits ZIKV negative-sense RNA synthesis and viral protein translation. This study has identified a potent inhibitor of ZIKV infection which could be further explored for future therapeutic application.
C1 [Cheng, Fan; da Silva, Suzane Ramos; Huang, I-Chueh; Jung, Jae U.; Gao, Shou-Jiang] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
   [Gao, Shou-Jiang] Shantou Univ, Med Coll, Lab Human Virol & Oncol, Shantou, Guangdong, Peoples R China.
RP Gao, SJ (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.; Gao, SJ (corresponding author), Shantou Univ, Med Coll, Lab Human Virol & Oncol, Shantou, Guangdong, Peoples R China.
EM shoujiag@usc.edu
RI Gao, Shou-Jiang/B-8641-2012
OI Gao, Shou-Jiang/0000-0001-6194-1742
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [CA096512, CA124332, CA132637,
   CA213275, CA177377, DE025465, CA197153]
FX This work was supported by grants from the NIH (CA096512, CA124332,
   CA132637, CA213275, CA177377, DE025465, and CA197153) to S.-J. Gao.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Albarnaz JD, 2014, ANTIVIR RES, V111, P82, DOI 10.1016/j.antiviral.2014.09.004
   Bhattacharya D, 2009, J VIROL, V83, P9195, DOI 10.1128/JVI.00271-09
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Ceballos-Olvera I, 2010, VIROLOGY, V396, P30, DOI 10.1016/j.virol.2009.10.019
   Cheng F, 2015, J VIROL, V89, P9262, DOI 10.1128/JVI.01098-15
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1657, DOI 10.1002/jmv.24582
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   GLASS DB, 1989, J BIOL CHEM, V264, P8802
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kumar R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30490
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee YR, 2008, AM J INFECT DIS, V4, P32, DOI 10.3844/ajidsp.2008.32.40
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011
   Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807
   Moser TS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002661
   Oehler E, 2014, EURO SURVEILL, V19
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rousset CI, 2015, J NEUROCHEM, V133, P242, DOI 10.1111/jnc.13034
   Saeedi BJ, 2013, WIRES RNA, V4, P723, DOI 10.1002/wrna.1191
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Zhang NN, 2016, HUM VACC IMMUNOTHER, V12, P3107, DOI 10.1080/21645515.2016.1219004
   Zhang Q, 2012, J VIROL, V86, P1544, DOI 10.1128/JVI.00688-11
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 57
TC 19
Z9 19
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2018
VL 92
IS 4
AR UNSP e02019-17
DI 10.1128/JVI.02019-17
PG 17
WC Virology
SC Virology
GA FU1AG
UT WOS:000423580900036
PM 29212931
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Kim, YH
   Lee, J
   Kim, YE
   Chong, CK
   Pinchemel, Y
   Reisdorfer, F
   Coelho, JB
   Dias, RF
   Bae, PK
   Gusmao, ZPM
   Ahn, HJ
   Nam, HW
AF Kim, Yeong Hoon
   Lee, Jihoo
   Kim, Young-Eun
   Chong, Chom-Kyu
   Pinchemel, Yanaihara
   Reisdoerfer, Francis
   Coelho, Joyce Brito
   Dias, Ronaldo Ferreira
   Bae, Pan Kee
   Maia Gusmao, Zuinara Pereira
   Ahn, Hye-Jin
   Nam, Ho-Woo
TI Development of a Rapid Diagnostic Test Kit to Detect IgG/IgM Antibody
   against Zika Virus Using Monoclonal Antibodies to the Envelope and
   Non-structural Protein 1 of the Virus
SO KOREAN JOURNAL OF PARASITOLOGY
LA English
DT Article
DE Zika; flavivirus; diagnostics; RDT; monoclonal antibody; envelope; NS1;
   cross reaction
ID DISEASE; ASSAY; BRAZIL; TRANSMISSION; MICRONESIA; MOSQUITOS; OUTBREAK;
   ANTIGEN; THREAT; SALIVA
AB We developed a Rapid Diagnostic Test (RDT) kit for detecting IgG/IgM antibodies against Zika virus (ZIKV) using monoclonal antibodies to the envelope (E) and non-structural protein 1 (NS1) of ZIKV. These proteins were produced using baculovirus expression vector with Sf9 cells. Monoclonal antibodies J2G7 to NS1 and J5E1 to E protein were selected and conjugated with colloidal gold to produce the Zika IgG/IgM RDT kit (Zika RDT). Comparisons with ELISA, plaque reduction neutralization test (PRNT), and PCR were done to investigate the analytical sensitivity of Zika RDT, which resulted in 100% identical results. Sensitivity and specificity of Zika RDT in a field test was determined using positive and negative samples from Brazil and Korea. The diagnostic accuracy of Zika RDT was fairly high; sensitivity and specificity for IgG was 99.0 and 99.3%, respectively, while for IgM it was 96.7 and 98.7%, respectively. Cross reaction with dengue virus was evaluated using anti-Dengue Mixed Titer Performance Panel (PVD201), in which the Zika RDT showed cross-reactions with DENV in 16.7% and 5.6% in IgG and IgM, respectively. Cross reactions were not observed with West Nile, yellow fever, and hepatitis C virus infected sera. Zika RDT kit is very simple to use, rapid to assay, and very sensitive, and highly specific. Therefore, it would serve as a choice of method for point-of-care diagnosis and large scale surveys of ZIKV infection under clinical or field conditions worldwide in endemic areas.
C1 [Kim, Yeong Hoon] Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul 06591, South Korea.
   [Lee, Jihoo; Kim, Young-Eun; Chong, Chom-Kyu] GenBody Inc, Cheonan 31116, South Korea.
   [Pinchemel, Yanaihara; Reisdoerfer, Francis; Coelho, Joyce Brito; Dias, Ronaldo Ferreira] Bahiafarma, Simoes Filho, BA, Brazil.
   [Bae, Pan Kee] BioNano Hlth Guard Res Ctr, Daejeon 34141, South Korea.
   [Maia Gusmao, Zuinara Pereira] Lacen Ba, Lab Cent, Salvador, BA, Brazil.
   [Ahn, Hye-Jin; Nam, Ho-Woo] Catholic Univ Korea, Coll Med, Dept Parasitol, Seoul 06591, South Korea.
RP Nam, HW (corresponding author), Catholic Univ Korea, Coll Med, Dept Parasitol, Seoul 06591, South Korea.
EM howoo@catholic.ac.kr
FU Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) - Korean Government (MSIP)Ministry of Food & Drug
   Safety (MFDS) [2016M3A9B6919217]
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF) funded by the Korean
   Government (MSIP) (no. 2016M3A9B6919217).
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chong CK, 2011, KOREAN J PARASITOL, V49, P207, DOI 10.3347/kjp.2011.49.3.207
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4
   Galfre G, 1981, Methods Enzymol, V73, P3
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EURO SURVEILL, V21
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Paz-Bailey G, 2017, N ENGL J MED
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   To KKW, 2015, MICROBES INFECT, V17, P84, DOI 10.1016/j.micinf.2014.11.007
   To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 40
TC 10
Z9 11
U1 2
U2 5
PU KOREAN SOC PARASITOLOGY, SEOUL NATL UNIV COLL MEDI
PI SEOUL
PA DEPT PARASITOLOGY, SEOUL, 00000, SOUTH KOREA
SN 0023-4001
EI 1738-0006
J9 KOREAN J PARASITOL
JI Korean J. Parasitol.
PD FEB
PY 2018
VL 56
IS 1
BP 61
EP 70
DI 10.3347/kjp.2018.56.1.61
PG 10
WC Parasitology
SC Parasitology
GA FY5LJ
UT WOS:000426869400009
PM 29529852
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Ribeiro, GS
   Kikuti, M
   Tauro, LB
   Nascimento, LCJ
   Cardoso, CW
   Campos, GS
   Ko, AI
   Weaver, SC
   Reis, MG
   Kitron, U
AF Ribeiro, Guilherme Sousa
   Kikuti, Mariana
   Tauro, Laura B.
   Nascimento, Leile Camila J.
   Cardoso, Cristiane W.
   Campos, Gubio S.
   Ko, Albert I.
   Weaver, Scott C.
   Reis, Mitermayer G.
   Kitron, Uriel
CA Salvador Arboviral Res Grp
TI Does immunity after Zika virus infection cross-protect against dengue?
SO LANCET GLOBAL HEALTH
LA English
DT Letter
C1 [Ribeiro, Guilherme Sousa; Kikuti, Mariana; Tauro, Laura B.; Nascimento, Leile Camila J.; Ko, Albert I.; Reis, Mitermayer G.; Kitron, Uriel] Fundacao Oswaldo Cruz, BR-40296710 Salvador, BA, Brazil.
   [Ribeiro, Guilherme Sousa; Kikuti, Mariana; Campos, Gubio S.; Reis, Mitermayer G.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Cardoso, Cristiane W.] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Univ, New Haven, CT USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, BR-40296710 Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Ribeiro, Guilherme/B-6624-2008; Paploski, Igor AD/D-7015-2014; Ko,
   Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020; Kikuti,
   Mariana/G-2313-2017; Araujo, Joselio M G/B-5502-2013; sardi, silvia
   ines/P-9349-2016
OI Ribeiro, Guilherme/0000-0002-6798-2059; Paploski, Igor
   AD/0000-0002-3689-2042; Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Kikuti, Mariana/0000-0001-8119-7236;
   Araujo, Joselio M G/0000-0003-3548-2786; sardi, silvia
   ines/0000-0002-2002-8436; Cardoso, Cristiane/0000-0001-5432-1174
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [550160/2010-8, 400830/2013-2, 440891/2016-7]; Bahia Foundation
   for Research Support [PNX0010/2011, PPP0055/2011, JCB0020/2013,
   PET0026/2013, APP0044/2016, PET0022/2016]; Coordination for the
   Improvement of Higher Education Personnel, Brazilian Ministry of
   Education [440891/2016-7]; Federal University of Bahia [PROPI/2011,
   PROPI/2013, PRODOC/2013]; Oswaldo Cruz Foundation; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [D43 TW010540, U01 AI088752, R01
   TW009504, R01 AI121207]
FX We thank the municipal and state surveillance and laboratory staff. This
   study was supported by the Brazilian National Council for Scientific and
   Technological Development (grant 550160/2010-8 to MGR, grants
   400830/2013-2 and 440891/2016-7 to GSR; and scholarships to IADP, LBT,
   UK, MGR, and GSR); the Bahia Foundation for Research Support (grant
   PNX0010/2011 to MGR, grants PPP0055/2011, JCB0020/2013, PET0026/2013,
   APP0044/2016, and PET0022/2016 to GSR, and scholarship to MMOS and ROA);
   the Coordination for the Improvement of Higher Education Personnel,
   Brazilian Ministry of Education (grant 440891/2016-7 to GSR and
   scholarship to MK); the Federal University of Bahia (grants: PROPI/2011,
   PROPI/2013, and PRODOC/2013 to GSR); the Oswaldo Cruz Foundation
   (scholarship to: AMK, MMOS, AST, and JSC); and National Institutes of
   Health (grants D43 TW010540, U01 AI088752, R01 TW009504, R01 AI121207 to
   AIK).
CR Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Teixeira  M G, 2001, Rev Soc Bras Med Trop, V34, P269
NR 5
TC 24
Z9 24
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD FEB
PY 2018
VL 6
IS 2
BP E140
EP E141
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FT3NR
UT WOS:000423054400011
PM 29389533
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lathrop, E
   Romero, L
   Hurst, S
   Bracero, N
   Zapata, LB
   Frey, MT
   Rivera, MI
   Berry-Bibee, EN
   Honein, MA
   Monroe, J
   Jamieson, DJ
AF Lathrop, Eva
   Romero, Lisa
   Hurst, Stacey
   Bracero, Nabal
   Zapata, Lauren B.
   Frey, Meghan T.
   Rivera, Maria I.
   Berry-Bibee, Erin N.
   Honein, Margaret A.
   Monroe, Judith
   Jamieson, Denise J.
TI The Zika Contraception Access Network: a feasibility programme to
   increase access to contraception in Puerto Rico during the 2016-17 Zika
   virus outbreak
SO LANCET PUBLIC HEALTH
LA English
DT Article
ID UNITED-STATES; WOMEN; PREGNANCY; DISEASE; NEEDS; YOUNG; LARC
AB Background Prevention of unintended pregnancy is a primary strategy to reduce adverse pregnancy and birth outcomes related to Zika virus infection. The Zika Contraception Access Network (Z-CAN) aimed to build a network of health-care providers offering client-centred contraceptive counselling and the full range of reversible contraception at no cost to women in Puerto Rico who chose to prevent pregnancy during the 2016-17 Zika virus outbreak. Here, we describe the Z-CAN programme design, implementation activities, and baseline characteristics of the first 21 124 participants.
   Methods Z-CAN was developed by establishing partnerships between federal agencies, territorial health agencies, private corporations, and domestic philanthropic and non-profit organisations in the continental USA and Puerto Rico. Private donations to the National Foundation for the Centers for Disease Control and Prevention (CDCF) secured a supply of reversible contraceptive methods (including long-acting reversible contraception), made available to non-sterilised women of reproductive age at no cost through provider reimbursements and infrastructure supported by the CDCF. To build capacity in contraception service provision, doctors and clinic staff from all public health regions and nearly all municipalities in Puerto Rico were recruited into the programme. All providers completed 1 day of comprehensive training in contraception knowledge, counselling, and initiation and management, including the insertion and removal of long-acting reversible contraceptives (LARCs). Z-CAN was announced through health-care providers, word of mouth, and a health education campaign. Descriptive characteristics of programme providers and participants were recorded, and we estimated the factors associated with choosing and receiving a LARC method. As part of a Z-CAN programme monitoring plan, participants were invited to complete a patient satisfaction survey about whether they had obtained free, same-day access to their chosen contraceptive method after receiving comprehensive counselling, their perception of the quality of care they had received, and their satisfaction with their chosen method and services.
   Findings Between May 4, 2016, and Aug 15, 2017, 153 providers in the Z-CAN programme provided services to 21 124 women. 20 110 (95%) women received same-day provision of a reversible contraceptive method. Whereas only 767 (4%) women had used a LARC method before Z-CAN, 14 259 (68%) chose and received a LARC method at their initial visit. Of the women who received a LARC method, 10 808 (76%) women had used no method or a least effective method of contraception (ie, condoms or withdrawal) before their Z-CAN visit. Of the 3489 women who participated in a patient satisfaction survey, 3068 (93%) of 3294 women were very satisfied with the services received, and 3216 (93%) of 3478 women reported receiving the method that they were most interested in after receiving counselling. 2382 (78%) of 3040 women rated their care as excellent or very good.
   Interpretation Z-CAN was designed as a short-term response for rapid implementation of reversible contraceptive services in a complex emergency setting in Puerto Rico and has served more than 21 000 women. This model could be replicated or adapted as part of future emergency preparedness and response efforts.
C1 [Lathrop, Eva; Berry-Bibee, Erin N.; Jamieson, Denise J.] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30303 USA.
   [Romero, Lisa; Hurst, Stacey; Zapata, Lauren B.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA.
   [Lathrop, Eva; Frey, Meghan T.; Rivera, Maria I.; Honein, Margaret A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Bracero, Nabal] Univ Puerto Rico, Area Ctr Med, San Juan, PR 00936 USA.
   [Bracero, Nabal] Amer Coll Obstetricians & Gynecologists, Puerto Rico Sect, San Juan, PR USA.
   [Bracero, Nabal] Puerto Rico Obstet & Gynecol, San Juan, PR USA.
   [Monroe, Judith] Ctr Dis Control & Prevent, Natl Fdn, Atlanta, GA USA.
RP Lathrop, E (corresponding author), Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30303 USA.
EM elathro@emory.edu
OI Jamieson, Denise/0000-0003-2597-1201
FU National Foundation for the Centers for Disease Control and Prevention
FX National Foundation for the Centers for Disease Control and Prevention.
CR Biggs MA, 2015, CONTRACEPTION, V91, P167, DOI 10.1016/j.contraception.2014.10.009
   BORING CC, 1988, FERTIL STERIL, V49, P973
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   CDC, CDCS WORLD MAP AR RI
   CDC, PUBLIC HLTH ETHICS
   Curtis KM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6504a1
   Dehlendorf C, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.173
   Ellington SR, 2013, J WOMENS HEALTH, V22, P189, DOI 10.1089/jwh.2012.4178
   Gubrium AC, 2016, AM J PUBLIC HEALTH, V106, P18, DOI 10.2105/AJPH.2015.302900
   Gutierrez N, 2011, ARCH INTERN MED, V171, P1579, DOI 10.1001/archinternmed.2011.305
   Harper CC, 2015, LANCET, V386, P562, DOI 10.1016/S0140-6736(14)62460-0
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Higgins JA, 2016, AM J PUBLIC HEALTH, V106, P1932, DOI 10.2105/AJPH.2016.303393
   Kavanaugh ML, 2017, CONTRACEPTION, DOI [10.1016/i.contraception.2017.10.003, DOI 10.1016/I.CONTRACEPTION.2017.10.003]
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   McNicholas C, 2014, CLIN OBSTET GYNECOL, V57, P635, DOI 10.1097/GRF.0000000000000070
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   PBS, 2001, PEOPL EV PUERT RIC P
   Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Ricketts S, 2014, PERSPECT SEX REPRO H, V46, P125, DOI 10.1363/46e1714
   Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Tyler CP, 2012, OBSTET GYNECOL, V119, P762, DOI 10.1097/AOG.0b013e31824aca39
   UNHCR, 2010, INT FIELD MAN REPR H
NR 26
TC 18
Z9 20
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2468-2667
J9 LANCET PUBLIC HEALTH
JI Lancet Public Health
PD FEB
PY 2018
VL 3
IS 2
BP E91
EP E99
DI 10.1016/S2468-2667(18)30001-X
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FW8NJ
UT WOS:000425592500011
PM 29371100
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Temmerman, M
   Nally, C
AF Temmerman, Marleen
   Nally, Cora
TI Z-CAN: prevention of unintended pregnancy in an emergency setting
SO LANCET PUBLIC HEALTH
LA English
DT Editorial Material
ID ZIKA
C1 [Temmerman, Marleen; Nally, Cora] Aga Khan Univ, Nairobi, Kenya.
   [Temmerman, Marleen] Univ Ghent, Ghent, Belgium.
RP Temmerman, M (corresponding author), Aga Khan Univ, Nairobi, Kenya.; Temmerman, M (corresponding author), Univ Ghent, Ghent, Belgium.
EM marleen.temmerman@aku.edu
CR Darney BG, 2017, OBSTET GYNECOL, V129, P638, DOI [10.1097/AOG.0000000000001914, 10.1097/aog.0000000000001914]
   Dehlendorf C, 2017, CONTRACEPTION, V95, P1, DOI 10.1016/j.contraception.2016.08.013
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Lathrop E, 2018, LANCET PUB HLTH
   McNeil Jr Donald G., 2016, NY TIMES
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
NR 8
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2468-2667
J9 LANCET PUBLIC HEALTH
JI Lancet Public Health
PD FEB
PY 2018
VL 3
IS 2
BP E59
EP E60
DI 10.1016/S2468-2667(18)30005-7
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FW8NJ
UT WOS:000425592500005
PM 29371101
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schuler-Faccini, L
   Roehe, P
   Zimmer, ER
   Quincozes-Santos, A
   de Assis, AM
   Lima, EOC
   Guimares, JA
   Victora, C
   Neto, VM
   Souza, DO
AF Schuler-Faccini, Lavinia
   Roehe, Paulo
   Zimmer, Eduardo R.
   Quincozes-Santos, Andre
   de Assis, Adriano M.
   Cirne Lima, Elizabeth Obino
   Guimares, Jorge Almeida
   Victora, Cesar
   Neto, Vivaldo Moura
   Souza, Diogo O.
TI ZIKA Virus and Neuroscience: the Need for a Translational Collaboration
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE ZIKV; Microcephaly; Translational research; Brazil
ID DENGUE VIRUS; INFECTION; BRAZIL; AMERICA; POTENT
AB Zika virus (ZIKV) has become a major challenge for scientists and health agencies. ZIKV's involvement with human fetal microcephaly and Guillain-Barr, syndrome and its transmission through Aedes africanus and Aedes aegypti mosquitos highlighted the epidemiological and neurological risks associated to ZIKV infection. In 2013, ZIKV arrives in Brazil but the first outbreak in the country was reported in 2015. Here, we used the Web of Science as a search tool for comparing the evolution of world and Brazilian scientific research on dengue virus (DENV)-also present in mosquito-, ZIKV and microcephaly. The association between ZIKV and microcephaly was only evidenced in 2015. Interestingly, Brazil and the USA are the responsible for most of these reports. Furthermore, the level of double-counted articles indicates a high degree of international collaborative effort in studying ZIKV and microcephaly. The ZIKV research clearly requires multidisciplinary expertise including epidemiologic, clinical, virological, and neurochemical backgrounds. This letter intends to emphasize the need of multidisciplinary studies and put forward some as yet unanswered questions in attempting to contribute to the understanding of this multifaceted health problem. In line with this, we recently constituted a collaborative and multidisciplinary taskforce encompassing eight Brazilian scientific institutions of excellence, The ZIKV translational research taskforce. This taskforce comprises a vast international network of collaborators and welcomes additional collaborators. We intend to advance fast in terms of mechanisms, which can potentially contribute to treat or halt ZIKV spreading around the world.
C1 [Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Dept Genet, Inst Biosci, Porto Alegre, RS, Brazil.
   [Roehe, Paulo] Univ Fed Rio Grande do Sul, Lab Virol, Microbiol Immunobiol & Parasitol, Porto Alegre, RS, Brazil.
   [Zimmer, Eduardo R.; Quincozes-Santos, Andre; de Assis, Adriano M.; Souza, Diogo O.] Univ Fed Rio Grande do Sul, Dept Biochem, ICBS, 2600 Ramiro Barcelos St, BR-90035003 Porto Alegre, RS, Brazil.
   [Zimmer, Eduardo R.] Pontif Catholic Univ Rio Grande do Sul PUCRS, Brain Inst BraIns Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Cirne Lima, Elizabeth Obino] Hosp Clin Porto Alegre, Embryol & Cell Differentiat Lab, Porto Alegre, RS, Brazil.
   [Guimares, Jorge Almeida] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Guimares, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Lab Biochem Pharmacol, Porto Alegre, RS, Brazil.
   [Victora, Cesar] Univ Fed Pelotas, Postgrad Program Epidemiol, Int Ctr Equ Hlth, Rua Marechal Deodoro, Pelotas, Brazil.
   [Neto, Vivaldo Moura] Secretaria Estadual Saude Rio de Janeiro, Inst Estadual Cerebro Paulo Niemeyer, Rio De Janeiro, Brazil.
RP Souza, DO (corresponding author), Univ Fed Rio Grande do Sul, Dept Biochem, ICBS, 2600 Ramiro Barcelos St, BR-90035003 Porto Alegre, RS, Brazil.
EM diogo@ufrgs.br
RI de Assis, Adriano/H-2606-2013; Zimmer, Eduardo R Rigon/I-2932-2015;
   Victora, Cesar Gomes/Y-2455-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013;
   Guimaraes, Jorge Almeida/V-2196-2019; Quincozes-Santos,
   Andre/AAO-2714-2020; Cirne-Lima, Elizabeth Obino/N-9796-2018; Souza,
   Diogo/J-8894-2014
OI de Assis, Adriano/0000-0002-1953-7831; Zimmer, Eduardo R
   Rigon/0000-0002-5349-0053; Victora, Cesar Gomes/0000-0002-2465-2180;
   SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Souza,
   Diogo/0000-0002-4322-0404; Quincozes-Santos, Andre/0000-0001-8611-4890
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR)
   [440763/2016-9]
CR Aguiar DP, 2014, DEVELOPMENT, V141, P2494, DOI 10.1242/dev.101790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frost JL, 2016, TRENDS CELL BIOL, V26, P587, DOI 10.1016/j.tcb.2016.02.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Le Douarin N, 1999, DEV CELL BIOL SERIES, V36
   Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 22
TC 5
Z9 5
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD FEB
PY 2018
VL 55
IS 2
BP 1551
EP 1555
DI 10.1007/s12035-017-0429-2
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA FW8YX
UT WOS:000425624000053
PM 28185126
DA 2020-07-08
ER

PT J
AU Walter, LT
   Higa, GSV
   Ikebara, JM
   Vedovello, D
   Salvador, FS
   Takada, SH
   Kinjo, ER
   Whalley, BJ
   Speranca, MA
   Kihara, AH
AF Walter, Lais Takata
   Vilar Higa, Guilherme Shigueto
   Ikebara, Juliane Midori
   Vedovello, Danila
   Salvador, Felipe Scassi
   Takada, Silvia Honda
   Kinjo, Erika Reime
   Whalley, Benjamin J.
   Speranca, Marcia Aparecida
   Kihara, Alexandre Hiroaki
TI Evaluation of Possible Consequences of Zika Virus Infection in the
   Developing Nervous System
SO MOLECULAR NEUROBIOLOGY
LA English
DT Review
DE Neurodevelopment; Disease; Infection; Virulence; Microcephaly
ID ENDOPLASMIC-RETICULUM STRESS; GAP-JUNCTION PROTEINS; DENGUE VIRUS;
   CELL-CYCLE; DIFFERENTIAL EXPRESSION; STRUCTURAL BASIS; CONNEXIN43;
   MIGRATION; AUTOPHAGY; GROWTH
AB The Zika virus (ZIKV) outbreak that occurred in the northeast of Brazil in 2015 led to alarming numbers of babies born with microcephaly in this region. Since then, several studies have evaluated the relationship between ZIKV infection and development of the malformation although the specific mechanistic interaction between ZIKV and human physiological processes that ultimately manifest as microcephaly remains debated. Importantly, most current studies did not consider the specificities of the biology and life cycle of ZIKV. As a consequence, specificities of the infection on the developing central nervous system (CNS) were frequently disregarded. In order to begin to address this important gap in our knowledge, we have collated and critically reviewed the existing evidence in this area to identify any emerging consensus on this topic and thereafter describe possible mechanisms by which ZIKV infection could interfere with specific processes of CNS development, such as neuronal proliferation, and the complex interactions of immature neurons with radial glial cells. With this, we were able to present the current knowledge on this important topic in the neurobiology field.
C1 [Walter, Lais Takata; Vilar Higa, Guilherme Shigueto; Ikebara, Juliane Midori; Takada, Silvia Honda; Kinjo, Erika Reime; Kihara, Alexandre Hiroaki] Univ Fed ABC, Ctr Matemat Comp & Cognicao, Nucleo Cognicao & Sistemas Complexos, Sao Bernardo Do Campo, SP, Brazil.
   [Vilar Higa, Guilherme Shigueto; Kihara, Alexandre Hiroaki] Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol & Biofis, Sao Paulo, SP, Brazil.
   [Vedovello, Danila; Speranca, Marcia Aparecida] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Bernardo Do Campo, SP, Brazil.
   [Salvador, Felipe Scassi] Univ Sao Paulo, Lab Virol, Inst Med Trop, Sao Paulo, SP, Brazil.
   [Whalley, Benjamin J.] Univ Reading, Sch Chem Food & Nutr Sci & Pharm, Reading, Berks, England.
RP Kihara, AH (corresponding author), Univ Fed ABC, Ctr Matemat Comp & Cognicao, Nucleo Cognicao & Sistemas Complexos, Sao Bernardo Do Campo, SP, Brazil.; Kihara, AH (corresponding author), Univ Sao Paulo, Dept Fisiol & Biofis, Inst Ciencias Biomed, Sao Paulo, SP, Brazil.
EM alexandrekihara@gmail.com
RI Speranca, Marcia Aparecida/D-2310-2012; Kihara, Alexandre H/C-2458-2012;
   KIHARA, ALEXANDRE HIROAKI/T-9590-2019; Kinjo, Erika R/C-9381-2014;
   Vedovello, Danila/M-5757-2014
OI Speranca, Marcia Aparecida/0000-0002-1178-3747; Kihara, Alexandre
   H/0000-0002-4027-7261; KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261;
   Vedovello, Danila/0000-0001-8585-8206
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/16711-6];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [308608/2014-3]
FX AHK is grateful for grants from Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) (2014/16711-6) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (308608/2014-3).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE
   Adibi J. J., 2016, LANCET
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013
   Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105
   Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chu JJH, 2003, VIROLOGY, V312, P458, DOI 10.1016/S0042-6822(03)00261-7
   Cina C, 2007, J COMP NEUROL, V504, P298, DOI 10.1002/cne.21426
   Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009
   Cucullo L, 2009, MAMMALIAN BRAIN DEVELOPMENT, P53, DOI 10.1007/978-1-60761-287-2_4
   Cugola F. R., 2016, NATURE
   Culjat M, 2016, CLIN INFECT DIS
   Dahm T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8562805
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J., 2016, CELL STEM CELL
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dejnirattisai W, 2016, NAT IMMUNOL
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148
   Diamond MS, 2003, IMMUNOL CELL BIOL, V81, P196, DOI 10.1046/j.1440-1711.2003.01157.x
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007
   Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168
   Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109
   Fushiki S, 2003, J NEUROPATH EXP NEUR, V62, P304, DOI 10.1093/jnen/62.3.304
   Garcez P. P., 2016, SCIENCE
   Garcez P. P., 2016, PEERJ PREPRINTS
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9
   Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners N. W., 2016, CELL REPORTS
   Harris E., 2006, NOVART FDN SYMP, V40, P251
   Harris E, 2006, NOVART FDN SYMP, V277, P251
   Harris E, 2006, NOVART FDN SYMP, V277, P40
   Harris Eva, 2006, Novartis Found Symp, V277, P23, DOI 10.1002/0470058005.ch3
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124
   Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689
   Hindley C, 2012, BIOCHEM J, V444, P375, DOI 10.1042/BJ20112040
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lazear HM, 2016, CELL HOST MICROBE
   Li C, 2016, CELL STEM CELL
   Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297
   Liang Q., 2016, CELL STEM CELL
   Liu XX, 2010, J NEUROSCI, V30, P4197, DOI 10.1523/JNEUROSCI.4187-09.2010
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735
   Matsuuchi L, 2013, BBA-BIOMEMBRANES, V1828, P94, DOI 10.1016/j.bbamem.2012.05.014
   McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971
   McLeod TL, 2001, CELL COMMUN ADHES, V8, P441, DOI 10.3109/15419060109080767
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Mercuri E, 2000, PEDIATRICS, V106, P235, DOI 10.1542/peds.106.2.235
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Montiel JF, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00022
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Nadarajah B, 1997, J NEUROSCI, V17, P3096
   Naus CC, 2016, SEMIN CELL DEV BIOL, V50, P59, DOI 10.1016/j.semcdb.2015.12.008
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nicholson BL, 2014, NAT REV MICROBIOL, V12, P493, DOI 10.1038/nrmicro3288
   Nicol MB, 1999, NEUROPHARMACOLOGY, V38, P49, DOI 10.1016/S0028-3908(98)00166-X
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150
   Oyamada M, 2005, BBA-BIOMEMBRANES, V1719, P6, DOI 10.1016/j.bbamem.2005.11.002
   Petraglia F, 2010, ENDOCR REV, V31, P783, DOI 10.1210/er.2009-0019
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ramos-Castaneda J, 1997, J NEUROVIROL, V3, P435
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shives KD, 2014, J VIROL, V88, P9458, DOI 10.1128/JVI.01323-14
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Song H., 2016, NAT STRUCT MOL BIOL
   Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26
   Stettler K., 2016, SCIENCE
   Szelenyi J, 2001, BRAIN RES BULL, V54, P329, DOI 10.1016/S0361-9230(01)00428-2
   Tang H, 2016, CELL STEM CELL
   Tappe D, 2015, MED MICROBIOL IMMUNO
   Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13
   Tetro JA, 2016, MICROBES INFECT
   Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094
   Verfaillie T, 2010, INT J CELL BIOL, V2010, DOI DOI 10.1155/2010/930509
   Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272
   Vitalis T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00093
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484
   Witteveen JS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00143
   Wu K. Y., 2016, CELL RES
   Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373
   Xu X, 2001, J CELL BIOL, V154, P217, DOI 10.1083/jcb.200105047
   YAMAMOTO T, 1992, DEV BRAIN RES, V66, P165, DOI 10.1016/0165-3806(92)90077-A
   Yawno T, 2009, NEUROSCIENCE, V163, P838, DOI 10.1016/j.neuroscience.2009.07.009
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 118
TC 2
Z9 2
U1 2
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD FEB
PY 2018
VL 55
IS 2
BP 1620
EP 1629
DI 10.1007/s12035-017-0442-5
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA FW8YX
UT WOS:000425624000059
PM 28190239
DA 2020-07-08
ER

PT J
AU Yang, M
   Sun, HY
   Lai, HF
   Hurtado, J
   Chen, Q
AF Yang, Ming
   Sun, Haiyan
   Lai, Huafang
   Hurtado, Jonathan
   Chen, Qiang
TI Plant-produced Zika virus envelope protein elicits neutralizing immune
   responses that correlate with protective immunity against Zika virus in
   mice
SO PLANT BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE Zika virus; vaccine; Plant-made vaccine; envelope protein; neutralizing
   immunity; Plant-made pharmaceutical; Nicotiana benthamiana; antibody
   response; cytokine
ID WEST NILE VIRUS; MONOCLONAL-ANTIBODY; VACCINE; EXPRESSION; CHALLENGE;
   IMMUNOGENICITY; INFECTION; EFFICACY; SYSTEM; CHAIN
AB The global Zika virus (ZIKV) outbreak and its link to foetal and newborn microcephaly and severe neurological complications in adults call for the urgent development of ZIKV vaccines. In response, we developed a subunit vaccine based on the ZIKV envelope (E) protein and investigated its immunogenicity in mice. Transient expression of ZIKV E (zE) resulted in its rapid accumulation in leaves of Nicotiana benthamiana plants. Biochemical analysis revealed that plant-produced ZIKV E (PzE) exhibited specific binding to a panel of monoclonal antibodies that recognize various zE conformational epitopes. Furthermore, PzE can be purified to >90% homogeneity with a one-step Ni2+ affinity chromatography process. PzE are found to be highly immunogenic, as two doses of PzE elicited both potent zE-specific antibody and cellular immune responses in mice. The delivery of PzE with alum induced a mixed Th1/Th2 immune response, as the antigen-specific IgG isotypes were a mixture of high levels of IgG1/IgG2c and splenocyte cultures from immunized mice secreted significant levels of IFN-gamma, IL-4 and IL-6. Most importantly, the titres of zE-specific and neutralizing antibodies exceeded the threshold that correlates with protective immunity against multiple strains of ZIKV. Thus, our results demonstrated the feasibility of plant-produced ZIKV protein antigen as effective, safe and affordable vaccines against ZIKV.
C1 [Yang, Ming; Sun, Haiyan; Lai, Huafang; Chen, Qiang] Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA.
   [Hurtado, Jonathan; Chen, Qiang] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.
RP Chen, Q (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA.; Chen, Q (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.
EM qiang.chen.4@asu.edu
RI Yang, Ming/J-9215-2019
OI chen, qiang/0000-0003-1498-7013
FU Biodesign Institute; National Institute of Allergy and Infectious
   Diseases (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R33AI101329]
FX We thank Dr. M. Diamond of Washington University Medical School for the
   gift of anti-ZIKV E mAbs. We also acknowledge the technical assistance
   of J. Kilbourne for animal studies. The critical reading of the
   manuscript by C. Jugler is appreciated. This work was supported in part
   by a seed grant from the Biodesign Institute and a grant from National
   Institute of Allergy and Infectious Diseases (NIAID) # R33AI101329 to
   QC. The authors declare no conflict of interest.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan HT, 2016, PLANT BIOTECHNOL J, V14, P2190, DOI 10.1111/pbi.12575
   Chen Q., 2016, F1000RES, V5
   Chen Q, 2013, ADV TECH BIOL MED, V1, DOI [10.4172/atbm.1000103, DOI 10.4172/ATBM.1000103]
   Chen Q., 2013, MOL VACCINES, P153, DOI DOI 10.1007/978-3-7091-1419-3_8
   Chen Q., 2008, BIOL ENG, V1, P291, DOI DOI 10.13031/201326854
   Chen Q., 2011, EUROPEAN BIOPHARM RE, V2, P64
   Chen Q, 2016, METHODS MOL BIOL, V1385, P55, DOI 10.1007/978-1-4939-3289-4_4
   Chen Q, 2014, CABI BIOTECH SER, P42, DOI 10.1079/9781780643434.0042
   Chen Q, 2011, TRANSGENIC HORTICULTURAL CROPS: CHALLENGES AND OPPORTUNITIES, P83
   Clarke JL, 2017, PLANT BIOTECHNOL J, V15, P1611, DOI 10.1111/pbi.12743
   Clarke JL, 2013, PLANT MOL BIOL, V83, P33, DOI 10.1007/s11103-013-0081-9
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dent M, 2016, J GEN VIROL, V97, P3280, DOI 10.1099/jgv.0.000635
   Fulton A, 2015, J CHROMATOGR A, V1389, P128, DOI 10.1016/j.chroma.2015.02.013
   Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   He JY, 2014, BIOMED RES INT, DOI 10.1155/2014/952865
   He JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093541
   He JY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/106783
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Jungblut M., 2008, JOVE-J VIS EXP, V22, pe1029, DOI DOI 10.3791/1029
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Kwon KC, 2015, PLANT BIOTECHNOL J, V13, P1017, DOI 10.1111/pbi.12462
   Lai HF, 2014, PLANT BIOTECHNOL J, V12, P1098, DOI 10.1111/pbi.12217
   Lai HF, 2012, PLANT CELL REP, V31, P573, DOI 10.1007/s00299-011-1196-6
   Lai HF, 2012, PLANT BIOTECHNOL J, V10, P95, DOI 10.1111/j.1467-7652.2011.00649.x
   Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521
   Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x
   Liu G, 2015, CLIN VACCINE IMMUNOL, V22, P516, DOI 10.1128/CVI.00770-14
   Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Moyle PM, 2013, CHEMMEDCHEM, V8, P360, DOI 10.1002/cmdc.201200487
   Nandi S, 2016, MABS-AUSTIN, V8, P1456, DOI 10.1080/19420862.2016.1227901
   Pardi N, 2017, METHODS MOL BIOL, V1499, P109, DOI 10.1007/978-1-4939-6481-9_6
   Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053
   Tuse D, 2014, BIOMED RES INT, DOI 10.1155/2014/256135
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 50
TC 22
Z9 22
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7644
EI 1467-7652
J9 PLANT BIOTECHNOL J
JI Plant Biotechnol. J.
PD FEB
PY 2018
VL 16
IS 2
BP 572
EP 580
DI 10.1111/pbi.12796
PG 9
WC Biotechnology & Applied Microbiology; Plant Sciences
SC Biotechnology & Applied Microbiology; Plant Sciences
GA FU0LP
UT WOS:000423542700020
PM 28710796
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chotiwan, N
   Andre, BG
   Sanchez-Vargas, I
   Islam, MN
   Grabowskia, JM
   Hopf-Jannasch, A
   Gough, E
   Nakayasu, E
   Blair, CD
   Belisle, JT
   Hill, CA
   Kuhn, RJ
   Perera, R
AF Chotiwan, Nunya
   Andre, Barbara G.
   Sanchez-Vargas, Irma
   Islam, M. Nurul
   Grabowskia, Jeffrey M.
   Hopf-Jannasch, Amber
   Gough, Erik
   Nakayasu, Ernesto
   Blair, Carol D.
   Belisle, John T.
   Hill, Catherine A.
   Kuhn, Richard J.
   Perera, Rushika
TI Dynamic remodeling of lipids coincides with dengue virus replication in
   the midgut of Aedes aegypti mosquitoes
SO PLOS PATHOGENS
LA English
DT Article
ID YELLOW-FEVER MOSQUITO; INSECT FAT-BODY; MASS-SPECTROMETRY; WEST NILE;
   3-DIMENSIONAL ARCHITECTURE; SPHINGOLIPID METABOLISM;
   QUANTITATIVE-ANALYSIS; MEMBRANE-LIPIDS; AMINO-ACIDS; ACYL-COA
AB We describe the first comprehensive analysis of the midgut metabolome of Aedes aegypti, the primary mosquito vector for arboviruses such as dengue, Zika, chikungunya and yellow fever viruses. Transmission of these viruses depends on their ability to infect, replicate and disseminate from several tissues in the mosquito vector. The metabolic environments within these tissues play crucial roles in these processes. Since these viruses are enveloped, viral replication, assembly and release occur on cellular membranes primed through the manipulation of host metabolism. Interference with this virus infection-induced metabolic environment is detrimental to viral replication in human and mosquito cell culture models. Here we present the first insight into the metabolic environment induced during arbovirus replication in Aedes aegypti. Using high-resolution mass spectrometry, we have analyzed the temporal metabolic perturbations that occur following dengue virus infection of the midgut tissue. This is the primary site of infection and replication, preceding systemic viral dissemination and transmission. We identified metabolites that exhibited a dynamic-profile across early-, mid- and late-infection time points. We observed a marked increase in the lipid content. An increase in glycerophospholipids, sphingolipids and fatty acyls was coincident with the kinetics of viral replication. Elevation of glycerolipid levels suggested a diversion of resources during infection from energy storage to synthetic pathways. Elevated levels of acyl-carnitines were observed, signaling disruptions in mitochondrial function and possible diversion of energy production. A central hub in the sphingolipid pathway that influenced dihydroceramide to ceramide ratios was identified as critical for the virus life cycle. This study also resulted in the first reconstruction of the sphingolipid pathway in Aedes aegypti. Given conservation in the replication mechanisms of several flaviviruses transmitted by this vector, our results highlight biochemical choke points that could be targeted to disrupt transmission of multiple pathogens by these mosquitoes.
C1 [Chotiwan, Nunya; Andre, Barbara G.; Sanchez-Vargas, Irma; Islam, M. Nurul; Blair, Carol D.; Belisle, John T.; Perera, Rushika] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Grabowskia, Jeffrey M.; Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.
   [Grabowskia, Jeffrey M.; Hill, Catherine A.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.
   [Hopf-Jannasch, Amber; Nakayasu, Ernesto] Purdue Univ, Bindley Biosci Ctr, MPF, W Lafayette, IN 47907 USA.
   [Gough, Erik] Purdue Univ, Bindley Biosci Ctr, Computat Life Sci Core, W Lafayette, IN 47907 USA.
   [Hill, Catherine A.; Kuhn, Richard J.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
   [Grabowskia, Jeffrey M.] NIAID, NIH, Rocky Mt Labs, Lab Virol,Biol Vector Borne Viruses Sect, Hamilton, MT USA.
   [Nakayasu, Ernesto] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA USA.
RP Perera, R (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM rushika.perera@colostate.edu
RI Belisle, John T/B-8944-2017; Blair, Carol/D-1357-2019; Nakayasu, Ernesto
   S./AAJ-8374-2020
OI Belisle, John T/0000-0002-2539-2798; Blair, Carol/0000-0002-2803-0354;
   Nakayasu, Ernesto S./0000-0002-4056-2695; Chotiwan,
   Nunya/0000-0003-3214-6605; Islam, M. Nurul/0000-0002-2396-6444; Graham,
   Barbara/0000-0002-4221-1979
FU Boettcher Foundation - Webb Waring Biomedical Research Early Career
   Investigator award; Virus Pathogen Resource (NIAID) award; Office of the
   Vice President for Research and the Department of Microbiology,
   Immunology and Pathology, Colorado State University, Fort Collins,
   Colorado
FX This work was funded by the Boettcher Foundation - Webb Waring
   Biomedical Research Early Career Investigator award to Rushika Perera,
   by the Virus Pathogen Resource
   (http://www.viprbrc.org/brc/home.spg?decorator=vipr) (NIAID) award to
   Richard J. Kuhn (Principle Investigator) and Catherine Hill and Rushika
   Perera (Co-investigators), and by the Office of the Vice President for
   Research and the Department of Microbiology, Immunology and Pathology,
   Colorado State University, Fort Collins, Colorado. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aktepe TE, 2015, VIROLOGY, V484, P241, DOI 10.1016/j.virol.2015.06.015
   Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8
   Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356
   Atella GC, 2002, J EXP BIOL, V205, P3623
   Bakermans AJ, 2013, J INHERIT METAB DIS, V36, P973, DOI 10.1007/s10545-013-9604-4
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Benton HP, 2010, BIOINFORMATICS, V26, P2488, DOI 10.1093/bioinformatics/btq441
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bohdanowicz M, 2013, PHYSIOL REV, V93, P69, DOI 10.1152/physrev.00002.2012
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   BREMER J, 1990, J CLIN CHEM CLIN BIO, V28, P297
   BREZINSKI ME, 1990, P NATL ACAD SCI USA, V87, P6248, DOI 10.1073/pnas.87.16.6248
   Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200
   Butrapet S, 2006, J VIROL METHODS, V131, P1, DOI 10.1016/j.jviromet.2005.06.019
   Canavoso LE, 2004, INSECT BIOCHEM MOLEC, V34, P845, DOI 10.1016/j.ibmb.2004.05.008
   Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Carocci M, 2015, ANTIMICROB AGENTS CH, V59, P85, DOI 10.1128/AAC.04177-14
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Chen YF, 2010, NEUROMOL MED, V12, P306, DOI 10.1007/s12017-010-8132-8
   Cheon HM, 2006, J BIOL CHEM, V281, P8426, DOI 10.1074/jbc.M510957200
   CLARK AJ, 1959, J BIOL CHEM, V234, P2589
   CLAYTON RB, 1964, COMP BIOCHEM PHYSIOL, V11, P333, DOI 10.1016/0010-406X(64)90001-5
   CLAYTON RB, 1964, J LIPID RES, V5, P3
   CLAYTON RB, 1962, NATURE, V195, P1125, DOI 10.1038/1951125a0
   Dawaliby R, 2016, J BIOL CHEM, V291, P3658, DOI 10.1074/jbc.M115.706523
   de Abreu LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098966
   DELIA D, 1995, BLOOD, V85, P359, DOI 10.1182/blood.V85.2.359.bloodjournal852359
   DEUBEL V, 1986, VIROLOGY, V155, P365, DOI 10.1016/0042-6822(86)90200-X
   DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3
   El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003
   Eyster KM, 2007, ADV PHYSIOL EDUC, V31, P5, DOI 10.1152/advan.00088.2006
   Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200
   Fernandis AZ, 2007, CURR OPIN LIPIDOL, V18, P121, DOI 10.1097/MOL.0b013e328082e4d5
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Fullekrug J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00401
   FUNK CD, 1983, BIOCHIM BIOPHYS ACTA, V754, P57
   Fyrst H, 2008, BBA-MOL CELL BIOL L, V1781, P448, DOI 10.1016/j.bbalip.2008.05.005
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Girard YA, 2005, J MED ENTOMOLOGY, V42
   Gower A. K. O., 1955, AUSTR J BIOL SCI, V9, P125, DOI 10.1071/BI9560125
   Gregersen N, 1980, J Inherit Metab Dis, V3, P67, DOI 10.1007/BF02312527
   Guan XL, 2013, DEV CELL, V24, P98, DOI 10.1016/j.devcel.2012.11.012
   Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3
   Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Horvath TD, 2017, FASEB J
   Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731
   Jan JT, 2000, J VIROL, V74, P6425, DOI 10.1128/JVI.74.14.6425-6432.2000
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Khalil SM, 2015, ANAL CHEM, V87, P11309, DOI 10.1021/acs.analchem.5b02781
   Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551
   KLER RS, 1991, J BIOL CHEM, V266, P22932
   KNABB MT, 1986, CIRC RES, V58, P230, DOI 10.1161/01.RES.58.2.230
   KOLLER CN, 1991, J INSECT PHYSIOL, V37, P703, DOI 10.1016/0022-1910(91)90048-5
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   Kraut R, 2011, J NEUROCHEM, V116, P764, DOI 10.1111/j.1471-4159.2010.07022.x
   Krebs KC, 2003, INSECT MOL BIOL, V12, P51, DOI 10.1046/j.1365-2583.2003.00386.x
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   LASSER NL, 1966, J LIPID RES, V7, P403
   LASSER NL, 1966, J LIPID RES, V7, P413
   Laue T, 1999, J CLIN MICROBIOL, V37, P2543, DOI 10.1128/JCM.37.8.2543-2547.1999
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Lin YH, 2014, AGING CELL, V13, P755, DOI 10.1111/acel.12232
   Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0
   Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009
   Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200
   Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Mathews CK, 2013, BIOCHEMISTRY
   Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x
   Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040
   Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009
   Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917
   Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432
   Mishima K, 2004, COLLOID SURFACE B, V33, P185, DOI 10.1016/j.colsurfb.2003.10.004
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Nchoutmboube JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003401
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Pennington JE, 1996, J LIPID RES, V37, P1144
   Perera R, 2015, ARBOVIRUSES MOL BIOL
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573
   Prince JT, 2006, ANAL CHEM, V78, P6140, DOI 10.1021/ac0605344
   REES HH, 1995, EUR J ENTOMOL, V92, P9
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rodriguez-Cuenca S, 2015, BBA-MOL CELL BIOL L, V1851, P40, DOI 10.1016/j.bbalip.2014.09.021
   Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826
   Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3
   Sarri E, 2011, J BIOL CHEM, V286, P28632, DOI 10.1074/jbc.M111.267534
   Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016
   Scheitz CJF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072726
   Schneider-Schaulies Jurgen, 2013, Handb Exp Pharmacol, P321, DOI 10.1007/978-3-7091-1511-4_16
   Schulz H., 2008, BIOCH LIPIDS LIPOPRO
   Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y
   Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027
   Stanley DW, 2006, ENTOMOL EXP APPL, V119, P1, DOI 10.1111/j.1570-7458.2006.00406.x
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504
   Team RC, 2015, R LANG ENV STAT COMP
   Tortoriello G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067865
   Vacaru AM, 2013, J BIOL CHEM, V288, P11520, DOI 10.1074/jbc.M113.460972
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   YANG TK, 1974, LIPIDS, V9, P1009, DOI 10.1007/BF02533827
   Ye YXH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002362
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang GD, 2014, PROG LIPID RES, V53, P108, DOI 10.1016/j.plipres.2013.11.003
   Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003
   Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014
   Ziegler R, 2001, J INSECT PHYSIOL, V47, P623, DOI 10.1016/S0022-1910(00)00158-X
NR 122
TC 28
Z9 28
U1 2
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2018
VL 14
IS 2
AR e1006853
DI 10.1371/journal.ppat.1006853
PG 35
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FY0CH
UT WOS:000426477000018
PM 29447265
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xia, H
   Wang, YJ
   Atoni, E
   Zhang, B
   Yuan, ZM
AF Xia, Han
   Wang, Yujuan
   Atoni, Evans
   Zhang, Bo
   Yuan, Zhiming
TI Mosquito-Associated Viruses in China
SO VIROLOGICA SINICA
LA English
DT Review
DE Mosquito associated viruses; China; Vector; Public health
ID ROSS-RIVER-VIRUS; WEST NILE VIRUS; JAPANESE-ENCEPHALITIS-VIRUS;
   RIFT-VALLEY FEVER; CULEX-FLAVIVIRUS FLAVIVIRIDAE; QINGHAI-TIBET PLATEAU;
   FULL CODING SEQUENCE; SINDBIS-LIKE VIRUS; REPUBLIC-OF-KOREA; TEMBUSU
   VIRUS
AB Mosquitoes are classified into approximately 3500 species and further grouped into 41 genera. Epidemiologically, they are considered to be among the most important disease vectors in the world and they can harbor a wide variety of viruses. Several mosquito viruses are considered to be of significant medical importance and can cause serious public health issues throughout the world. Such viruses are Japanese encephalitis virus (JEV), dengue virus (DENV), chikungunya virus (CHIKV), and Zika virus (ZIKV). Others are the newly recognized mosquito viruses such as Banna virus (BAV) and Yunnan orbivirus (YNOV) with unclear medical significance. The remaining mosquito viruses are those that naturally infect mosquitoes but do not appear to infect humans or other vertebrates. With the continuous development and improvement of mosquito and mosquito-associated virus surveillance systems in China, many novel mosquito-associated viruses have been discovered in recent years. This review aims to systematically outline the history, characteristics, distribution, and/or current epidemic status of mosquito-associated viruses in China.
C1 [Xia, Han; Wang, Yujuan; Atoni, Evans; Zhang, Bo; Yuan, Zhiming] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China.
   [Wang, Yujuan; Atoni, Evans] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Yuan, ZM (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China.
EM yzm@wh.iov.cn
OI Xia, Han/0000-0001-9932-6040
FU Ministry of Science and Technology of ChinaMinistry of Science and
   Technology, China [2013FY113500]
FX This work is supported by the Ministry of Science and Technology of
   China (Science and Technology Basic Work Program 2013FY113500).
CR Adouchief S, 2016, REV MED VIROL, V26, P221, DOI 10.1002/rmv.1876
   Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507
   Attoui H, 2006, J GEN VIROL, V87, P199, DOI 10.1099/vir.0.81294-0
   Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0
   Attoui H, 2005, EMERG INFECT DIS, V11, P1673, DOI 10.3201/eid1111.050868
   Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05
   Brown CM, 1998, TROP ANIM HEALTH PRO, V30, P241, DOI 10.1023/A:1005079229232
   Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905
   Cao YX, 2011, VECTOR-BORNE ZOONOT, V11, P1577, DOI 10.1089/vbz.2010.0262
   Cao ZZ, 2011, EMERG INFECT DIS, V17, P1873, DOI 10.3201/eid1710.101890
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chen J, 2016, BIOSCI TRENDS, V10, P158, DOI 10.5582/bst.2016.01051
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DOHERTY RL, 1968, T ROY SOC TROP MED H, V62, P862, DOI 10.1016/0035-9203(68)90014-X
   Feng Yun, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P528
   FILIPE AR, 1969, AM J TROP MED HYG, V18, P423, DOI 10.4269/ajtmh.1969.18.423
   Fu SH, 2017, SCI CHINA LIFE SCI, V60, P1364, DOI 10.1007/s11427-017-9196-8
   Fu XL, 2016, VIROL SIN, V31, P454, DOI 10.1007/s12250-016-3876-4
   Gao XY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0270-z
   Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624
   Gu Wen, 2012, Chinese Journal of Zoonoses, V28, P695
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Heilman James M, 2014, Open Med, V8, pe105
   Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039
   Huang WL, 1998, J DALI MED COLL, V7, P12
   Huang WL, 2001, ENDEMIC DIS B, V16, P39
   Huang XY, 2014, BIOMED ENVIRON SCI, V27, P894, DOI 10.3967/bes2014.125
   Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7
   Huhtamo E, 2013, J GEN VIROL, V94, P1242, DOI 10.1099/vir.0.051359-0
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Jiang SF, 2010, J MED ENTOMOL, V47, P788, DOI 10.1603/ME08292
   Jiang SF, 2014, J VECTOR ECOL, V39, P78, DOI 10.1111/j.1948-7134.2014.12073.x
   Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87
   Jost H, 2011, AM J TROP MED HYG, V84, P241, DOI 10.4269/ajtmh.2011.10-0483
   KARABATSOS N, 1978, AM J TROP MED HYG, V27, P372
   Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034
   Kono Y, 2000, AM J TROP MED HYG, V63, P94, DOI 10.4269/ajtmh.2000.63.94
   Kurkela S, 2008, EMERG INFECT DIS, V14, P41, DOI 10.3201/eid1401.070510
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x
   Lan DL, 2011, ARCH VIROL, V156, P893, DOI 10.1007/s00705-010-0913-8
   Lauber C, 2012, ARCH VIROL, V157, P1623, DOI 10.1007/s00705-012-1295-x
   Lee JS, 2013, VIROLOGY, V435, P220, DOI 10.1016/j.virol.2012.10.020
   Lei WW, 2017, VET MICROBIOL, V201, P32, DOI 10.1016/j.vetmic.2017.01.003
   Lei WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136257
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231
   Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088738
   Li WJ, 2010, AM J TROP MED HYG, V82, P705, DOI 10.4269/ajtmh.2010.09-0649
   Li WJ, 2014, VECTOR-BORNE ZOONOT, V14, P353, DOI 10.1089/vbz.2013.1351
   Li XF, 2012, J VIROL, V86, P8904, DOI 10.1128/JVI.01289-12
   Li XL, 2013, VECTOR-BORNE ZOONOT, V13, P131, DOI 10.1089/vbz.2012.0995
   Li Xue-Dong, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P730
   Li YY, 2017, BIOMED ENVIRON SCI, V30, P210, DOI 10.3967/bes2017.028
   Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347
   Liang WK, 2015, ARCH VIROL, V160, P2259, DOI 10.1007/s00705-015-2492-1
   Ling Y, 2016, EMERG INFECT DIS, V22, P1317, DOI 10.3201/eid2207.160469
   Liu H, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P1277, DOI 10.3760/cma.j.issn.0254-6450.2016.09.019
   Liu H, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-138
   Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68
   Liu H, 2010, EMERG INFECT DIS, V16, P514, DOI 10.3201/eid1603.091160
   Liu JY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.136
   Lu X, 2014, VIRUS GENES, V48, P15, DOI 10.1007/s11262-013-0991-2
   Lu Z, 2014, EMERG INFECT DIS, V20, P1421, DOI 10.3201/eid2008.131433
   Lu Z, 2011, AM J TROP MED HYG, V85, P442, DOI 10.4269/ajtmh.2011.10-0368
   Lu Z, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-282
   Lu Z, 2009, EMERG INFECT DIS, V15, P306, DOI 10.3201/eid1502.080722
   Lv XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037732
   Lv Zhi, 2011, Bing Du Xue Bao, V27, P71
   Machado DC, 2012, INTERVIROLOGY, V55, P475, DOI 10.1159/000337166
   MCINTOSH BM, 1964, ANN TROP MED PARASIT, V58, P45, DOI 10.1080/00034983.1964.11686213
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Nabeshima T, 2008, EMERG INFECT DIS, V14, P1276, DOI 10.3201/eid1408.080100
   Nemoto M, 2016, ARCH VIROL, V161, P1691, DOI 10.1007/s00705-016-2840-9
   Thuy NT, 2013, VIROLOGY, V444, P337, DOI 10.1016/j.virol.2013.06.030
   O'Guinn ML, 2013, AM J TROP MED HYG, V89, P1023, DOI 10.4269/ajtmh.13-0160
   Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROSEN L, 1981, AM J TROP MED HYG, V30, P1294, DOI 10.4269/ajtmh.1981.30.1294
   Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006
   Russell RC, 2002, ANNU REV ENTOMOL, V47, P1, DOI 10.1146/annurev.ento.47.091201.145100
   Sam IC, 2015, EMERG INFECT DIS, V21, P1683, DOI 10.3201/eid2109.150439
   SCRIMGEOUR EM, 1987, T ROY SOC TROP MED H, V81, P833, DOI 10.1016/0035-9203(87)90045-9
   Seo HJ, 2012, ACTA VIROL, V56, P265, DOI 10.4149/av_2012_03_265
   Shi CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129845
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Shi YX, 2017, VIROL SIN, V32, P253, DOI 10.1007/s12250-017-3949-z
   Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003
   Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405
   Song S, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.80
   Su S, 2016, J INFECTION, V73, P289, DOI 10.1016/j.jinf.2016.06.004
   Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396
   Sun Xiao-hong, 2009, Chinese Journal of Virology, V25, P173
   Sun XH, 2009, VECTOR-BORNE ZOONOT, V9, P623, DOI 10.1089/vbz.2008.0145
   Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083014
   Takhampunya R, 2014, J MED ENTOMOL, V51, P464, DOI 10.1603/ME13033
   Tang Y, 2015, TRANSBOUND EMERG DIS, V62, P209, DOI 10.1111/tbed.12111
   Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P193, DOI 10.1111/tbed.12085
   Tao SJ, 2005, CHINESE MED J-PEKING, V118, P581
   TAYLOR RM, 1955, AM J TROP MED HYG, V4, P844, DOI 10.4269/ajtmh.1955.4.844
   Wang Feng-tian, 2009, Chinese Journal of Virology, V25, P83
   Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0
   Wang HY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-73
   Wang HY, 2009, JPN J INFECT DIS, V62, P331
   Wang Jing-jing, 2008, Virologica Sinica, V23, P31, DOI 10.1007/s12250-008-2891-5
   Wang JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143601
   Wang JL, 2011, AM J TROP MED HYG, V84, P738, DOI 10.4269/ajtmh.2011.10-0294
   Wang W, 2015, EMERG INFECT DIS, V21, P1670, DOI 10.3201/eid2109.150622
   Wang YJ, 2017, VIRUS RES, V240, P130, DOI 10.1016/j.virusres.2017.08.001
   Wang Z.S., 2009, CHIN J PUBLIC HLTH, V25, P769
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Wu D, 2012, EMERG INFECT DIS, V18, P493, DOI 10.3201/eid1803.110034
   Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755
   Xing SZ, 2017, VIROL SIN, V32, P159, DOI 10.1007/s12250-016-3886-2
   Xiong Yiquan, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P1822
   Xu PuTing, 1990, Chinese Journal of Virology, V6, P27
   Yan Ju-Ying, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P1091
   Yan PX, 2011, VIROLOGY, V417, P1, DOI 10.1016/j.virol.2011.06.003
   Yang M. d., 2015, CHINESE J PATHOGEN B, V10, P738
   Ye XuFang, 2012, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V23, P428
   Yu WW, 2014, AM J TROP MED HYG, V91, P109, DOI 10.4269/ajtmh.13-0455
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhai YG, 2008, J GEN VIROL, V89, P1446, DOI 10.1099/vir.0.83607-0
   Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0
   Zhang FC, 2014, INT J INFECT DIS, V27, P4, DOI 10.1016/j.ijid.2014.03.1392
   Zhang HaiLin, 2012, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V23, P377
   Zhang QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042830
   Zhang W, 2017, J GEN VIROL, V98, P2413, DOI 10.1099/jgv.0.000908
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhao Chunsheng, 1997, Chinese Journal of Veterinary Science, V17, P241
   Zhao YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34444
   Zheng K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-8
   Zheng Yayun, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P368
   Zhou G, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P314
   Zhou JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00340-3
   Zuo SQ, 2014, VIRUS RES, V180, P31, DOI 10.1016/j.virusres.2013.12.005
NR 145
TC 20
Z9 20
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD FEB
PY 2018
VL 33
IS 1
BP 5
EP 20
DI 10.1007/s12250-018-0002-9
PG 16
WC Virology
SC Virology
GA GA4GL
UT WOS:000428287700002
PM 29532388
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Kim, JA
   Seong, RK
   Kumar, M
   Shin, OS
AF Kim, Ji-Ae
   Seong, Rak-Kyun
   Kumar, Mukesh
   Shin, Ok Sarah
TI Favipiravir and Ribavirin Inhibit Replication of Asian and African
   Strains of Zika Virus in Different Cell Models
SO VIRUSES-BASEL
LA English
DT Article
DE favipiravir; ribavirin; Zika virus; hNPCs; anti-viral
ID IN-VIVO ACTIVITIES; LETHAL MUTAGENESIS; T-705 FAVIPIRAVIR; ANTIVIRAL
   DRUG; INFECTION; VITRO; SOFOSBUVIR; ORGANOIDS; EFFICACY; NEUROGENESIS
AB Zika virus (ZIKV) has recently emerged as a new public health threat. ZIKV infections have caused a wide spectrum of neurological diseases, such as Guillain-Barre syndrome, myelitis, meningoencephalitis, and congenital microcephaly. No effective therapies currently exist for treating patients infected with ZIKV. Herein, we evaluated the anti-viral activity of favipiravir (T-705) and ribavirin against Asian and African strains of ZIKV using different cell models, including human neuronal progenitor cells (hNPCs), human dermal fibroblasts (HDFs), human lung adenocarcinoma cells (A549) and Vero cells. Cells were treated with favipiravir or ribavirin and effects on ZIKV replication were determined using quantitative real-time PCR and plaque assay. Our results demonstrate that favipiravir or ribavirin treatment significantly inhibited ZIKV replication in a dose-dependent manner. Moreover, favipiravir treatment of ZIKV-infected hNPCs led to reduced cell death, enhanced AKT pathway phosphorylation, and increased expression of anti-apoptotic factor B cell lymphoma 2. In conclusion, our results demonstrate conclusively that favipiravir inhibits ZIKV replication and prevents cell death, and can be a promising intervention for ZIKV-associated disease.
C1 [Kim, Ji-Ae; Seong, Rak-Kyun; Shin, Ok Sarah] Korea Univ, Dept Biomed Sci, Coll Med, Guro Hosp, Seoul 08308, South Korea.
   [Kumar, Mukesh] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96813 USA.
RP Shin, OS (corresponding author), Korea Univ, Dept Biomed Sci, Coll Med, Guro Hosp, Seoul 08308, South Korea.; Kumar, M (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96813 USA.
EM kja0910kr@gmail.com; cyeano66@naver.com; mukesh@hawaii.edu;
   oshin@korea.ac.kr
RI Kumar, Mukesh/AAI-1046-2019; Kumar, Mukesh/N-8814-2015
OI Kumar, Mukesh/0000-0003-0970-4875; Kumar, Mukesh/0000-0003-0970-4875
FU National Research Foundation of Korea (NRF), Ministry of Science, ICT &
   Future Planning [NRF-2016R1C1B2006493]; Centers of Biomedical Research
   Excellence, National Institute of General Medical Sciences
   [P30GM114737]; National Institute of Neurological Disorders and
   StrokeUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R21NS099838]; Office of the Director,
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21OD024896]
FX We would like to thank Ho-Seok Song (Korea University School of
   Medicine) for providing hNPC and Vincent Racaneillo (Columbia
   University, New York, NY, USA) for providing the ZIKV plaque assay
   protocol. This research was supported by the Basic Science Research
   Program of the National Research Foundation of Korea (NRF), Ministry of
   Science, ICT & Future Planning (NRF-2016R1C1B2006493). M.K. is supported
   by a grant (P30GM114737) from the Centers of Biomedical Research
   Excellence, National Institute of General Medical Sciences, grant
   (R21NS099838) from National Institute of Neurological Disorders and
   Stroke, and grant (R21OD024896) from the Office of the Director,
   National Institutes of Health.
CR Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Arias A, 2014, ELIFE, V3, DOI 10.7554/eLife.03679
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baranovich T, 2013, J VIROL, V87, P3741, DOI 10.1128/JVI.02346-12
   Barr KL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004931
   Baz M, 2017, ANTIVIR THER, V22, P613, DOI 10.3851/IMP3180
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   de Mello CPP, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01983-17
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Escribano-Romero E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01400-17, 10.1128/aac.01400-17]
   Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07
   Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Kim JA, 2017, J INVEST DERMATOL, V137, P2101, DOI 10.1016/j.jid.2017.03.041
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Kumar M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-80
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Seong RK, 2017, IMMUNOBIOLOGY, V222, P979, DOI 10.1016/j.imbio.2017.07.002
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Sidwell RW, 2007, ANTIMICROB AGENTS CH, V51, P845, DOI 10.1128/AAC.01051-06
   Takahashi Kazumi, 2003, Antiviral Chemistry & Chemotherapy, V14, P235
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thorne L, 2016, J INFECT DIS, V213, pS27, DOI 10.1093/infdis/jiv280
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Urban N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00396
   Wahane SD, 2014, J NEUROCHEM, V130, P255, DOI 10.1111/jnc.12718
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
NR 55
TC 19
Z9 20
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2018
VL 10
IS 2
AR 72
DI 10.3390/v10020072
PG 15
WC Virology
SC Virology
GA FZ4EN
UT WOS:000427544100022
PM 29425176
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McFadden, MJ
   Mitchell-Dick, A
   Vazquez, C
   Roder, AE
   Labagnara, KF
   McMahon, JJ
   Silver, DL
   Horner, SM
AF McFadden, Michael J.
   Mitchell-Dick, Aaron
   Vazquez, Christine
   Roder, Allison E.
   Labagnara, Kevin F.
   McMahon, John J.
   Silver, Debra L.
   Horner, Stacy M.
TI A Fluorescent Cell-Based System for Imaging Zika Virus Infection in
   Real-Time
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus (ZIKV); NS2B-NS3; NS4B-NS5; reporter; fluorescence; live cell
   imaging; apoptosis
ID REPORTER SYSTEM; IN-VITRO; BRAIN; ORGANOIDS; MICE; LOCALIZATION;
   REPLICATION; APOPTOSIS; TROPISM; STRAIN
AB Zika virus (ZIKV) is a re-emerging flavivirus that is transmitted to humans through the bite of an infected mosquito or through sexual contact with an infected partner. ZIKV infection during pregnancy has been associated with numerous fetal abnormalities, including prenatal lethality and microcephaly. However, until recent outbreaks in the Americas, ZIKV has been relatively understudied, and therefore the biology and pathogenesis of ZIKV infection remain incompletely understood. Better methods to study ZIKV infection in live cells could enhance our understanding of the biology of ZIKV and the mechanisms by which ZIKV contributes to fetal abnormalities. To this end, we developed a fluorescent cell-based reporter system allowing for live imaging of ZIKV-infected cells. This system utilizes the protease activity of the ZIKV non-structural proteins 2B and 3 (NS2B-NS3) to specifically mark virus-infected cells. Here, we demonstrate the utility of this fluorescent reporter for identifying cells infected by ZIKV strains of two lineages. Further, we use this system to determine that apoptosis is induced in cells directly infected with ZIKV in a cell-autonomous manner. Ultimately, approaches that can directly track ZIKV-infected cells at the single cell-level have the potential to yield new insights into the host-pathogen interactions that regulate ZIKV infection and pathogenesis.
C1 [McFadden, Michael J.; Mitchell-Dick, Aaron; Vazquez, Christine; Roder, Allison E.; Labagnara, Kevin F.; McMahon, John J.; Silver, Debra L.; Horner, Stacy M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
   [Silver, Debra L.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.
   [Silver, Debra L.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.
   [Horner, Stacy M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
RP Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.; Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
EM michael.mcfadden@duke.edu; aaron.mitchell.dick@duke.edu;
   christine.vazquez@duke.edu; allison.roder@duke.edu;
   kevin.labagnara@duke.edu; mcmahonjohnj@gmail.com; debra.silver@duke.edu;
   stacy.horner@duke.edu
OI Horner, Stacy/0000-0002-9351-7409; McFadden, Michael/0000-0003-0303-6968
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21NS100545, R21AI129851,
   T32-CA009111]; Hartwell Foundation; Burroughs Wellcome FundBurroughs
   Wellcome Fund; Ford Foundation
FX We thank members of the Horner lab for discussion and reading of the
   manuscript, and the following for reagents and equipment use: Carey
   Medin at the University of Rhode Island, Chris Nicchita at Duke
   University, the Duke Functional Genomics Facility, the Duke Light
   Microscopy Core Facility, Mariano Garcia-Blanco at University of Texas
   Medical Branch, Mehul Suthar at Emory University, and Scott Weaver at
   University of Texas Medical Branch. This work was supported by funds
   from the NIH: R21NS100545 (Stacy M. Horner, Debra L. Silver);
   R21AI129851 (Stacy M. Horner); T32-CA009111 (Michael J. McFadden,
   Allison E. Roder), and the Hartwell Foundation (Debra L. Silver).
   Additional funding sources include the Burroughs Wellcome Fund (Stacy M.
   Horner) and the Ford Foundation (Christine Vazquez).
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   European Centre for Disease Prevention and Control (ECDC), RAP RISK ASS ZIK VIR
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417
   HARTMANN E, 1994, FEBS LETT, V349, P324, DOI 10.1016/0014-5793(94)00693-8
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086
   Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19
   Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lossia OV, 2018, J NEUROVIROL, V24, P52, DOI 10.1007/s13365-017-0589-x
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Medin CL, 2015, J VIROL METHODS, V211, P55, DOI 10.1016/j.jviromet.2014.10.010
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tamura T, 2018, J VIROL, V92, DOI 10.1128/JVI.01582-17
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115
NR 46
TC 2
Z9 2
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2018
VL 10
IS 2
AR 95
DI 10.3390/v10020095
PG 15
WC Virology
SC Virology
GA FZ4EN
UT WOS:000427544100045
PM 29495257
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tabari, D
   Scholl, C
   Hildt, E
   Stingl, JC
AF Tabari, D.
   Scholl, C.
   Hildt, E.
   Stingl, J. C.
TI Effects of Zika virus on gene expression
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Meeting Abstract
CT 84th Annual Meeting of the
   German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology
   (DGPT) / 20th Annual Meeting of the
   Association-of-the-Clinical-Pharmacology-Germany (VKliPha)
CY FEB 26-MAR 01, 2018
CL Gottingen, GERMANY
SP German Soc Expt & Clin Pharmacol & Toxicol, Assoc Clin Pharmacol Germany, Georg August Univ
C1 [Tabari, D.; Scholl, C.; Stingl, J. C.] Bundesinst Arzneimittel & Med Prod, Forsch, Bonn, Germany.
   [Hildt, E.] Paul Ehrlich Inst, Langen, Germany.
RI Hildt, Eberhard/A-1040-2015
CR Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835
NR 2
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD FEB
PY 2018
VL 391
SU 1
MA 64
BP S17
EP S17
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GP7RW
UT WOS:000441104400058
DA 2020-07-08
ER

PT J
AU Morris, MI
   Grossi, P
   Nogueira, ML
   Azevedo, LS
AF Morris, Michele I.
   Grossi, Paolo
   Nogueira, Mauricio L.
   Azevedo, Luiz S.
TI Arboviruses Recommendations for Solid-Organ Transplant Recipients and
   Donors
SO TRANSPLANTATION
LA English
DT Review
ID YELLOW-FEVER VACCINE; CHIKUNGUNYA VIRUS-INFECTION; DENGUE
   HEMORRHAGIC-FEVER; ZIKA VIRUS; CLINICAL-MANIFESTATIONS; SHOCK SYNDROME;
   BLOOD-DONORS; TRANSMISSION; OUTBREAK; EPIDEMIC
C1 [Morris, Michele I.] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA.
   [Grossi, Paolo] Univ Insubria, Sect Infect & Trop Dis, Dept Surg & Morphol Sci, Varese, Italy.
   [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Dept Infect Dis, Sao Jose Do Rio Preto, Brazil.
   [Azevedo, Luiz S.] Univ Sao Paulo, Kidney Transplantat Unit, Hosp Clin, Fac Med, Sao Paulo, Brazil.
RP Azevedo, LS (corresponding author), Hosp Clin Sao Paulo, Unidade Transplante Renal, Ave Eneas de Carvalho Aguiar 255, BR-05403900 Sao Paulo, Brazil.
EM ls.azevedo@terra.com.br
RI Nogueira, Mauricio L/B-7599-2012; GROSSI, PAOLO/A-6158-2013
OI Nogueira, Mauricio L/0000-0003-1102-2419; GROSSI,
   PAOLO/0000-0003-2883-5061
FU Pan American Health organization (PAHO); Ministry of Health of Brazil
FX Funded by a technical cooperation agreement between the Pan American
   Health organization (PAHO) and the Ministry of Health of Brazil.
CR Agencia Nacional de Vigilancia Sanitaria, CRIT TECN GER RISC S
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Azevedo LS, 2012, TRANSPL INFECT DIS, V14, P237, DOI 10.1111/j.1399-3062.2011.00686.x
   Azevedo LS, 2007, TRANSPLANTATION, V84, P792, DOI 10.1097/01.tp.0000280547.91617.25
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Brito Ferreira ML, 2016, C AM ACAD NEUROLOGY
   Brunette GW, 2016, CDC YELLOW BOOK 2016
   Brunette GW, 2016, CDC YELLOW BOOK 2016
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Centers for Disease Control and Prevention, WORLD MAP AR RISK ZI
   Chacko B, 2004, TRANSPLANTATION, V77, P634, DOI 10.1097/01.TP.0000114608.44000.D7
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Control CDC, CHIK VIR 2014 FIN DA
   ControlCDC, CHIK VIR GEOGR DISTR
   Costa SD, 2015, AM J TROP MED HYG, V93, P394, DOI 10.4269/ajtmh.15-0038
   Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Dias LL, 2012, TRANSFUSION, V52, P1667, DOI 10.1111/j.1537-2995.2012.03729.x
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664
   Maia SHF, 2015, REV SOC BRAS MED TRO, V48, P783, DOI 10.1590/0037-8682-0205-2015
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Food and Drug Administration, DON SCREEN REC RED R
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Garcia JHP, 2006, TRANSPLANTATION, V82, P850, DOI 10.1097/01.tp.0000235151.60237.fe
   Gasperina DD, 2015, TRANSPL INFECT DIS, V17, P876, DOI 10.1111/tid.12453
   Girao ES, 2017, TRANSPL P, V49, P2076, DOI 10.1016/j.transproceed.2017.07.004
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gowda R, 2004, EUR J HAEMATOL, V72, P299, DOI 10.1111/j.1600-0609.2004.00218.x
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Kee ACL, 2010, EMERG INFECT DIS, V16, P1038, DOI 10.3201/eid1606.091115
   Limonta D, 2007, J CLIN VIROL, V40, P50, DOI 10.1016/j.jcv.2007.04.024
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D., 2014, EURO SURVEILL, V19
   Nasim A, 2013, TRANSPL INFECT DIS, V15, P516, DOI 10.1111/tid.12114
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Nordin JD, 2013, J TRAVEL MED, V20, P368, DOI 10.1111/jtm.12070
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Park SB, 2008, TRANSPL P, V40, P2431, DOI 10.1016/j.transproceed.2008.07.037
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierrotti LC, 2017, INT J INFECT DIS, V64, P96, DOI 10.1016/j.ijid.2017.09.009
   Prasad N, 2012, TRANSPL INFECT DIS, V14, P163, DOI 10.1111/j.1399-3062.2011.00699.x
   Punzel M, 2014, EMERG INFECT DIS, V20, P1366, DOI 10.3201/eid2008.140508
   Renaud CJ, 2007, NEPHROLOGY, V12, P305, DOI 10.1111/j.1440-1797.2007.00785.x
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2015, PATHOG GLOB HEALTH, V109, P170, DOI 10.1179/2047773215Y.0000000017
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Rothan HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126360
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Saigal S, 2013, LIVER TRANSPLANT, V19, P1413, DOI 10.1002/lt.23755
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Slifka MK, 2013, TRANSPLANTATION, V95, pE59, DOI 10.1097/TP.0b013e31828c6d9e
   Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tan FLS, 2005, NEPHROL DIAL TRANSPL, V20, P447, DOI 10.1093/ndt/gfh601
   Tang KF, 2012, EXPERT REV ANTI-INFE, V10, P895, DOI [10.1586/eri.12.76, 10.1586/ERI.12.76]
   Tangnararatchakit K, 2012, TRANSPL P, V44, P303, DOI 10.1016/j.transproceed.2011.11.025
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Teo D, 2009, TRANSFUSION MED, V19, P66, DOI 10.1111/j.1365-3148.2009.00916.x
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Weerakkody Ranga Migara, 2014, J Med Case Rep, V8, P378, DOI 10.1186/1752-1947-8-378
   WHO, 2015, VACCINE, V33, P76, DOI 10.1016/j.vaccine.2014.05.040
   World Health Organization, ZIK VIR MICR GUILL B
   World Health Organization, ZIK VIR DIS INT CAS
   World Health Organization (WHO) and the Special Programme for Research and Training in Tropical diseases (TDR), DENG GUID DIAGN TREA
   Wyplosz B, 2013, AM J TRANSPLANT, V13, P2458, DOI 10.1111/ajt.12338
   Yax JA, 2009, J TRAVEL MED, V16, P365, DOI 10.1111/j.1708-8305.2009.00336.x
   Yoon IK, 2016, WINTER NEWSLETTER
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 80
TC 7
Z9 8
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD FEB
PY 2018
VL 102
IS 2
SU 2
BP S42
EP S51
DI 10.1097/TP.0000000000002011
PG 10
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA GL1UZ
UT WOS:000436897200006
PM 29381577
DA 2020-07-08
ER

PT J
AU Bello-Lopez, JM
   Castaneda-Garcia, C
   Munoz-Estrada, C
   Machorro-Perez, AJ
AF Bello-Lopez, J. Manuel
   Castaneda-Garcia, Cristina
   Munoz-Estrada, Celerino
   Machorro-Perez, Antonio Jose
TI External quality control program in screening for infectious diseases at
   blood banks in Mexico
SO TRANSFUSION AND APHERESIS SCIENCE
LA English
DT Article
DE External quality control; Blood banks; Infectious markers; Screening;
   Blood donors
ID ZIKA VIRUS; DONORS; PREVALENCE; SEROPREVALENCE; TRANSMISSION;
   TRANSFUSION; ANTIGEN; STATES
AB Introduction: Quality control for the detection of infectious markers in blood banks is a necessary activity to ensure the accuracy of donor screening results. Considering that in Mexico blood safety is one of the goals of the National Action Programs, it is essential to evaluate banks through an External Quality Control Program.
   Objective: To analyze one of the evaluations that showed the greatest participation (2014-2/lot46) of banks in the Mexican Republic in the detection of transfusion-transmitted diseases. Materials and methods: A randomized panel of infectious markers of HIV, HCV, HBV, Treponema pallidum and Trypanosoma cruzi was manufactured under high quality standards. The evaluation criteria for each infectious marker were the identification of false positives and false negative results. Additionally, technologies used to detect infectious markers were requested for each bank.
   Results: Of the 503 banks, only 374 participated in the evaluation. Technologies based on chemiluminescence, immunofluorescence and immunocolorimetry were used to detect viral markers. Even rapid tests for T. pallidum continue to be the methods of choice with 42%. Trypanosoma cruzi was 20% with fast techniques versus 80% with automated tests. Highest incidence of false positives was identified for T. pallidum and HBV, followed by T. cruzi, HIV and HCV. Fourteen (3.74%) false negatives results were identified for T. cruzi, followed by T. pallidum (n = 5/1.33%), HCV (n=4/1.06) and HVB/HIV (n = 2/0.53%).
   Conclusion: False positive results identified for each infectious marker was considered high. This evidence will allow us to focus on areas of opportunity during serologic screening with greater emphasis on good laboratory practices. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Bello-Lopez, J. Manuel; Castaneda-Garcia, Cristina; Munoz-Estrada, Celerino; Machorro-Perez, Antonio Jose] Ctr Nacl Transfus Sanguinea, Ave Othon de Mendizabal 195, Mexico City 07360, DF, Mexico.
   [Bello-Lopez, J. Manuel] Hosp Judrez Mexico, Res Unit Microbiol & Toxicol, Ave Inst Politecn Nacl 5160, Mexico City 07360, DF, Mexico.
RP Bello-Lopez, JM (corresponding author), Hosp Judrez Mexico, Res Unit Microbiol & Toxicol, Ave Inst Politecn Nacl 5160, Mexico City 07360, DF, Mexico.
EM juanmanuelbello81@hotmail.com
CR Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Crowder LA, 2017, TRANSFUSION, V57, P404, DOI 10.1111/trf.13891
   Diario Oficial de la Federacion, NORM OF MEX NOM 253
   Duran Mauricio Beltran, 2003, Rev Panam Salud Publica, V13, P138, DOI 10.1590/S1020-49892003000200015
   Karimi G, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0492-8
   Kumar Alok, 2014, J Educ Health Promot, V3, P11, DOI 10.4103/2277-9531.127568
   Lin H, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.40492
   Memon FA, 2017, PAK J MED SCI, V33, P443, DOI 10.12669/pjms.332.11691
   Moore A, 2001, LANCET, V358, P657, DOI 10.1016/S0140-6736(01)05783-X
   Owusu-Ofori AK, 2011, EMERG INFECT DIS, V17, P2080, DOI 10.3201/eid1711.110985
   Prati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003
   Ries J, 2016, TRANSFUS MED HEMOTH, V43, P415, DOI 10.1159/000446264
   Saez-Alquezar Amadeo, 2015, EJIFCC, V26, P278
   Sáez-Alquézar Amadeo, 2003, Rev Panam Salud Publica, V13, P91, DOI 10.1590/S1020-49892003000200009
   Slavov SN, 2017, J INFECT DEV COUNTR, V11, P277, DOI 10.3855/jidc.8169
   Tafesse Tadesse Bekele, 2017, Human Antibodies, V25, P39, DOI 10.3233/HAB-160304
   Vollmer T, 2014, J CLIN MICROBIOL, V52, P2150, DOI 10.1128/JCM.03578-13
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Yang SG, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014947
NR 19
TC 0
Z9 0
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1473-0502
J9 TRANSFUS APHER SCI
JI Transfus. Apher. Sci.
PD FEB
PY 2018
VL 57
IS 1
BP 97
EP 101
DI 10.1016/j.transci.2018.01.004
PG 5
WC Hematology
SC Hematology
GA GK3PB
UT WOS:000436056500023
PM 29452838
DA 2020-07-08
ER

PT J
AU Chaubal, G
   Sarkale, P
   Kore, P
   Yadav, P
AF Chaubal, Gouri
   Sarkale, Prasad
   Kore, Pravin
   Yadav, Pragya
TI Development of single step RT-PCR for detection of Kyasanur forest
   disease virus from clinical samples
SO HELIYON
LA English
DT Article
DE Infectious disease; Molecular biology; Virology
ID SAUDI-ARABIA; INDIA; FEVER
AB Background: Kyasanur Forest Disease (KFD), a tick borne flavivirus, which was earlier endemic to Karnataka state, India, has been confirmed and detected from neighboring states of Tamil Nadu, Maharashtra, Goa and Kerala states in India. Increased human and vector surveillance therefore becomes essential for the identification of KFD affected regions and control of further spread of the disease. Currently, available KFD detection assays include realtime RT-PCR and nested RT-PCR assays. Here we describe the development of a sensitive single step RT-PCR assay for the detection of KFD viral RNA. This can be easily used in any BSL-2 laboratory for screening of KFD suspected cases or for differential diagnosis of viral hemorrhagic fever panel.
   Method: Three primer sets were designed and checked for sensitivity using known dilutions of KFD viral RNA (Ranging from 106 copies to 10 copies). The primer set (2) was found to be most sensitive was selected and tested for specificity for Kyasanur forest disease virus (KFDV) by testing against zika, dengue, chikungunya, crimean congo hemorrhagic fever (CCHF), yellow fever, japanese encephalitis (JE) and west nile viruses. A total of 104 samples (human, monkey and tick positive and negative samples) were tested using this assay.
   Result: No false positive or false negative results were seen for human, monkey or tick samples. The assay was specific for KFD and could detect upto 100 copies of KFD viral RNA.
   Discussion and conclusion: The previously published sensitive real time RT-PCR assay requires higher cost in terms of reagents and machine setup and technical expertise has been the primary reason for development of this assay. A single step RT-PCR is relatively easy to perform and more cost effective than real time RT-PCR in smaller setups in the absence of Biosafety Level-3 facility. This study reports the development and optimization of single step RT-PCR assay which is more sensitive and less time-consuming than nested RT-PCR and cost effective for rapid diagnosis of KFD viral RNA.
C1 [Chaubal, Gouri; Sarkale, Prasad; Kore, Pravin; Yadav, Pragya] Natl Inst Virol, Maximum Containment Lab, Sus Rd, Pune 410021, Maharashtra, India.
RP Yadav, P (corresponding author), Natl Inst Virol, Maximum Containment Lab, Sus Rd, Pune 410021, Maharashtra, India.
EM hellopragya22@gmail.com
FU Indian Council of Medical Research, National Institute of Virology,
   Pune, Maharashtra, India
FX This work is funded by Indian Council of Medical Research, National
   Institute of Virology, Pune, Maharashtra, India under the Intramural
   project Reagent preparation for highly infectious diseases.
CR Awate P, 2016, J INFECTION, V72, P759, DOI 10.1016/j.jinf.2016.03.006
   Banerjee K, 1988, ARBOVIRUSES EPIDEMIO, P93
   Blow JA, 2004, J VIROL METHODS, V119, P195, DOI 10.1016/j.jviromet.2004.03.015
   Charrel RN, 2001, BIOCHEM BIOPH RES CO, V287, P455, DOI 10.1006/bbrc.2001.5610
   Department of Information & Technology Government of Goa, FEV CAS PAL CONF KYA
   Holbrook MR, 2012, ANTIVIR RES, V96, P353, DOI 10.1016/j.antiviral.2012.10.005
   Mehla R, 2009, EMERG INFECT DIS, V15, P1431, DOI 10.3201/eid1509.080759
   Mourya Devendra T, 2014, WHO South East Asia J Public Health, V3, P8, DOI 10.4103/2224-3151.206890
   Mourya DT, 2013, EMERG INFECT DIS, V19, P1540, DOI 10.3201/eid1909.121884
   Mourya DT, 2012, J VIROL METHODS, V186, P49, DOI 10.1016/j.jviromet.2012.07.019
   Murhekar MV, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0066-9
   Pattnaik P, 2006, REV MED VIROL, V16, P151, DOI 10.1002/rmv.495
   PAVRI K, 1989, REV INFECT DIS, V11, pS854
   Qattan I, 1996, SAUDI EPIDEMIOL B, V3, P1
   Tandale BV, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0044-2
   THIEL HJ, 2005, VIRUS TAXONOMY, P981
   Wang JL, 2009, EMERG INFECT DIS, V15, P326, DOI 10.3201/eid1502.080979
   Work T.H., 1957, INDIAN J MED SCI, V11, P340
   Zaki AM, 1997, T ROY SOC TROP MED H, V91, P179, DOI 10.1016/S0035-9203(97)90215-7
NR 19
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD FEB
PY 2018
VL 4
IS 2
AR e00549
DI 10.1016/j.heliyon.2018.e00549
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GF5UC
UT WOS:000432032300004
PM 29560461
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Piret, J
   Carbonneau, J
   Rheaume, C
   Baz, M
   Boivin, G
AF Piret, Jocelyne
   Carbonneau, Julie
   Rheaume, Chantal
   Baz, Mariana
   Boivin, Guy
TI Predominant role of IPS-1 over TRIF adaptor proteins in early innate
   immune response against Zika virus in mice
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Zika virus; innate immunity; TRIF; IPS-1; interferon; cytokines
ID WEST NILE VIRUS; PLASMACYTOID DENDRITIC CELLS; PATTERN-RECOGNITION
   RECEPTORS; HERPES-SIMPLEX-VIRUS; DENGUE VIRUS; RNA VIRUSES; ANTIVIRAL
   IMMUNITY; VIRAL-INFECTION; RIG-I; INDUCTION
AB Toll-like receptors and RNA helicases are involved in the control of RNA virus infection through production of type I interferons (IFNs). To delineate the relative contributions of these signalling pathways in the innate immune response and the control of Zika virus (ZIKV) pathogenesis, the impact of a deficiency in TRIF and/or IPS-1 adaptor proteins was investigated in mice. Mice were infected intravenously with ZIKV and monitored for clinical signs for 14 days. Groups of mice were sacrificed on days 1, 3 and 7 post-infection (p.i.) and viral RNA was measured by digital droplet PCR in serum, spleen, brain and eyes. Some mice were sacrificed at 12 h p.i. for determination of the levels of IFN-alpha/-beta (ELISA), cytokines/chemokines (Luminex) and total/phosphorylated IRF3 and IRF7 (Western blotting). All groups of mice infected with ZIKV exhibited no clinical signs of infection. However, IPS-1(-/-) and TRIF(-/-)xIPS-1(-/-) mice developed higher viraemia than WT and TRIF-/- groups on days 1, 3 and 7. TRIF(-/-)xIPS-1(-/-) mice presented higher viral RNA levels in spleen, brain and eyes over time than TRIF-/-, IPS-1(-/-) and WT groups. At 12 h, IFN-alpha/-beta and cytokine/chemokine levels in spleen were significantly decreased in IPS-1(-/-) and TRIF(-/-)xIPS-1(-/-) compared to WT and TRIF-/-. On day 1 p.i., IFN-beta levels were significantly reduced in spleen of TRIF(-/-)xIPS-1(-/-) mice compared to all other groups. These data suggest that IPS-1 plays a more important role than TRIF in the early type I IFN response and that both IPS-1 and TRIF are involved at later stages of ZIKV infection.
C1 [Boivin, Guy] CHU Quebec, Res Ctr Infect Dis, Quebec City, PQ, Canada.
   Laval Univ, Quebec City, PQ, Canada.
RP Boivin, G (corresponding author), CHU Quebec, Res Ctr Infect Dis, Quebec City, PQ, Canada.
EM Guy.Boivin@crchudequebec.ulaval.ca
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [148361]
FX This study was supported by a Foundation Grant from the Canadian
   Institutes of Health Research (grant no. 148361 to G. B.). G. B. is the
   holder of the Canada research chair on emerging viruses and antiviral
   resistance.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Bauer J, 2016, J IMMUNOL, V196, P4447, DOI 10.4049/jimmunol.1500383
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799
   Daffis S, 2009, J INNATE IMMUN, V1, P435, DOI 10.1159/000226248
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hey YY, 2012, J CELL MOL MED, V16, P2611, DOI 10.1111/j.1582-4934.2012.01608.x
   Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004
   Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091
   Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Makhluf H, 2015, CRIT REV IMMUNOL, V35, P253, DOI 10.1615/CritRevImmunol.2015014251
   Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660
   Menasria R, 2013, J VIROL, V87, P7301, DOI 10.1128/JVI.00591-13
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 49
TC 6
Z9 6
U1 0
U2 4
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD FEB
PY 2018
VL 99
IS 2
BP 209
EP 218
DI 10.1099/jgv.0.000992
PG 10
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GE2AU
UT WOS:000431018700006
PM 29297844
OA Bronze
DA 2020-07-08
ER

PT J
AU Zmurko, J
   Vasey, DB
   Donald, CL
   Armstrong, AA
   McKee, ML
   Kohl, A
   Clayton, RF
AF Zmurko, Joanna
   Vasey, Douglas B.
   Donald, Claire L.
   Armstrong, Alison A.
   McKee, Marian L.
   Kohl, Alain
   Clayton, Reginald F.
TI Mitigating the risk of Zika virus contamination of raw materials and
   cell lines in the manufacture of biologicals
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE infectivity; cytopathic effect; Zika virus; raw materials; virus
   detection; virological safety of biologicals
ID EPIDEMIOLOGY; THREAT
AB Ensuring the virological safety of biologicals is challenging due to the risk of viral contamination of raw materials and cell banks, and exposure during in-process handling to known and/or emerging viral pathogens. Viruses may contaminate raw materials and biologicals intended for human or veterinary use and remain undetected until appropriate testing measures are employed. The outbreak and expansive spread of the mosquito-borne flavivirus Zika virus (ZIKV) poses challenges to screening human- and animal -derived products used in the manufacture of biologicals. Here, we report the results of an in vitro study where detector cell lines were challenged with African and Asian lineages of ZIKV. We demonstrate that this pathogen is robustly detectable by in vitro assay, thereby providing assurance of detection of ZIKV, and in turn underpinning the robustness of in vitro virology assays in safety testing of biologicals.
C1 [Zmurko, Joanna; Vasey, Douglas B.; Armstrong, Alison A.; McKee, Marian L.; Clayton, Reginald F.] Merck KGaA, BioReliance Serv, Todd Campus,West Scotland Sci Pk, Glasgow G20 OXA, Lanark, Scotland.
   [Donald, Claire L.; Kohl, Alain] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
RP Clayton, RF (corresponding author), Merck KGaA, BioReliance Serv, Todd Campus,West Scotland Sci Pk, Glasgow G20 OXA, Lanark, Scotland.
EM Reginald.Clayton@sial.com
RI Donald, Claire/AAC-7556-2019
OI Donald, Claire/0000-0002-4370-0707
FU UK Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014, MR/N017552/1]
FX This study was partially funded by the UK Medical Research Council
   [(MC_UU_12014) and (MR/N017552/1)] (AK).
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   [Anonymous], 2017, 5 2 4 CELL CULT PROD
   [Anonymous], 2017, 5 2 3 CELL SUBTR PRO
   [Anonymous], 2017, 2 6 16 TEST EXTR AG, P90
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barr KL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004931
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   ECDC, 2016, ZIK VIR SAF SUBST HU
   EMA(CHMP), 2013, GUID ADV AG SAF UR D, V44, P1
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS, V2015, P1
   European Medicines Agency, 1998, ICH TOP Q 5 D QUAL B
   European Medicines Agency, 2010, GUID PLASM DER MED P, V44, P1
   European Medicines Agency, 2000, CPMPICH410600 EUR ME
   FDA, 2010, GUID IND CELL SUBSTR
   FDA, 2016, REV REC RED RISK ZIK
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAHON N, 1973, APPL MICROBIOL, V25, P595, DOI 10.1128/AEM.25.4.595-600.1973
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hoogstfcaal H, 1983, SERO EPIDEMIOLOGICAL, V77, P442
   Howard CR, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.47
   Ilchmann A, 2017, BIOLOGICALS, V49, P28, DOI 10.1016/j.biologicals.2017.07.004
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kinney RM, 2005, J VIROL, V79, P5116, DOI 10.1128/JVI.79.8.5116-5128.2005
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Phillips JA, 2016, WORKPLACE HEALTH SAF, V64, P396, DOI 10.1177/2165079916657109
   PORTERFIELD JS, 1957, NATURE, V180, P1201, DOI 10.1038/1801201b0
   Public Health England, 2013, INTR PHE HEAL WELLB, P5
   Rather IA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00830
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Saker L, 2004, GLOBALIZATION INFECT, P1
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Sheets R., 2000, CENT BIOL EV RES CBE, P1
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
   World Health Organization, 2010, REC EV AN CELL CULT
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 59
TC 0
Z9 0
U1 1
U2 4
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD FEB
PY 2018
VL 99
IS 2
BP 219
EP 229
DI 10.1099/jgv.0.000995
PG 11
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GE2AU
UT WOS:000431018700007
PM 29239715
OA Green Accepted, Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lustig, Y
   Sofer, D
   Hindiyeh, M
   Mendelson, E
AF Lustig, Yaniv
   Sofer, Danit
   Hindiyeh, Musa
   Mendelson, Ella
TI LAMP assay for specific detection of Asian and African lineage Zika
   virus: will it meet the expectations?
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Editorial Material
ID TRANSMISSION
C1 [Lustig, Yaniv; Sofer, Danit; Hindiyeh, Musa; Mendelson, Ella] Minist Hlth, Cent Virol Lab, Tel Hashomer, Israel.
   [Hindiyeh, Musa; Mendelson, Ella] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel.
RP Lustig, Y (corresponding author), Sheba Med Ctr, Natl Ctr Zoonot Viruses Lab, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel.
EM Yaniv.lustig@sheba.health.gov.il
CR Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EURO SURVEILL, V21
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
NR 15
TC 3
Z9 3
U1 0
U2 3
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD FEB
PY 2018
VL 6
IS 3
AR 53
DI 10.21037/atm.2017.11.25
PG 3
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA GD7QA
UT WOS:000430706000016
PM 29610745
OA Green Published
DA 2020-07-08
ER

PT J
AU Randle, J
   Nelder, M
   Sider, D
   Hohenadel, K
AF Randle, Janet
   Nelder, Mark
   Sider, Doug
   Hohenadel, Karin
TI Characterizing the health and information-seeking behaviours of
   Ontarians in response to the Zika virus outbreak
SO CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE
LA English
DT Article
DE Re-emerging infectious disease; Infectious disease outbreaks; Zika
   virus; Health behaviour
ID TRENDS
AB Objectives The purpose of this study is to describe the impact of the 2016 Zika virus (ZIKV) outbreak on the health-seeking and information-seeking behaviours of Ontarians.
   Methods A timeline that included events and announcements from health agencies was constructed to describe the unfolding of the ZIKV outbreak between January 1 and September 30, 2016. In order to gain an understanding of the information and health-seeking behaviours of Ontarians, data from the following sources were collected and analyzed descriptively over time in 1-week intervals: trends in web searches, calls to a provincial telemedicine advice line, test submissions to the provincial laboratory and Zika-related media coverage.
   Results The World Health Organization's declaration that the ZIKV outbreak was a public health emergency of international concern (PHEIC) prompted a surge in media coverage peaking at 165 articles in a 1-week period. Concurrently, the frequency of Zika-related web searches was at its highest over the time period of the study, weekly telemedicine calls requesting Zika-related information were at their highest (177 calls/week) and requests for laboratory testing increased (162 patients submitting specimens/week).
   Conclusions Understanding the public response to novel and re-emerging infectious disease outbreaks as they unfold has the potential to facilitate timely public messaging for disease prevention, enable resource planning and inform effective public health action.
C1 [Randle, Janet] Mt Sinai Hosp, Infect Control Dept, 210-600 Univ Ave, Toronto, ON M5G IX5, Canada.
   [Nelder, Mark] Publ Hlth Ontario, Enter Zoonot & Vector Borne Dis, Toronto, ON, Canada.
   [Sider, Doug] Publ Hlth Ontario, Communicable Dis Emergency Preparedness & Respons, Toronto, ON, Canada.
   [Hohenadel, Karin] Publ Hlth Ontario, Communicable Dis, Toronto, ON, Canada.
RP Randle, J (corresponding author), Mt Sinai Hosp, Infect Control Dept, 210-600 Univ Ave, Toronto, ON M5G IX5, Canada.
EM janetsrandle@gmail.com
CR Attaran A, 2016, LANCET INFECT DIS, V16, P1001, DOI 10.1016/S1473-3099(16)30230-4
   Canadian Tourism Research Institute, 2015, OUTB CAN TRAV TRENDS
   Centers for Disease Control and Prevention, 2016, CDC CONC ZIK CAUS MI
   Centers for Disease Control and Prevention, 2016, 1 FEM MAL SEX TRANSM
   Centers for Disease Control and Prevention, 2016, CDC ISS TRAV GUID RE
   Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244
   Government of Canada, 2016, ZIK VIR INF GLOB UPD
   Government of Canada, 2016, STAT CHIEF PUBL HLTH
   Hogue MCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034314
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Liang B, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2401
   Ministry of Health and Long- Term Care, 2016, STAT CHIEF MED OFF H
   Ontario Ministry of Health and Long- Term Care, 2016, GET MED ADV TEL ONT
   Pang PCI, 2015, HEALTH TECHNOL-GER, V5, P45, DOI 10.1007/s12553-015-0096-0
   Public Health Ontario, 2016, ZIK VIR
   Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Statistics Canada, 2015, TRAV CAN US TOP 15 S
   Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759
   WHO, 2016, WHO PUBL HLTH ADV RE
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK SIT REP
NR 22
TC 0
Z9 0
U1 7
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0008-4263
EI 1920-7476
J9 CAN J PUBLIC HEALTH
JI Can. J. Public Health-Rev. Can. Sante Publ.
PD FEB
PY 2018
VL 109
IS 1
BP 99
EP 107
DI 10.17269/s41997-018-0026-9
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GD2JC
UT WOS:000430324900013
PM 29981066
OA Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, B.
   Wiwanitkit, V.
TI Ocular manifestations of Zika virus: What we should know and what we
   should do
SO JOURNAL FRANCAIS D OPHTALMOLOGIE
LA English
DT Letter
C1 [Joob, B.] Sanitat 1 Med Acad Ctr, Sanitat 1 Rd, Bangkok, Thailand.
   [Wiwanitkit, V.] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Sanitat 1 Rd, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Benzekri R, 2017, J FR OPHTALMOL
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 1
Z9 1
U1 0
U2 0
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0181-5512
EI 1773-0597
J9 J FR OPHTALMOL
JI J. Fr. Ophthamol.
PD FEB
PY 2018
VL 41
IS 2
BP E89
EP E89
DI 10.1016/j.jfo.2017.03.029
PG 1
WC Ophthalmology
SC Ophthalmology
GA FZ4KE
UT WOS:000427560300011
PM 29366587
DA 2020-07-08
ER

PT J
AU Rousseau, A
AF Rousseau, A.
TI Ocular manifestations of Zika virus: What we should know and what we
   should do. Response
SO JOURNAL FRANCAIS D OPHTALMOLOGIE
LA English
DT Letter
C1 [Rousseau, A.] Univ Paris Sud, Serv Ophtalmol, Hop Bicetre, AP HP,DHU Vis & Handicap, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.
   [Rousseau, A.] Commissariat Energie Atom & Energies Alternat, Immunol Infect Virales & Malad Autoimmunes, UMR 1184, F-92265 Fontenay Aux Roses, France.
RP Rousseau, A (corresponding author), Univ Paris Sud, Serv Ophtalmol, Hop Bicetre, AP HP,DHU Vis & Handicap, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.
EM antoine.rousseau@aphp.fr
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0181-5512
EI 1773-0597
J9 J FR OPHTALMOL
JI J. Fr. Ophthamol.
PD FEB
PY 2018
VL 41
IS 2
BP E59
EP E59
DI 10.1016/j.jfo.2017.12.003
PG 1
WC Ophthalmology
SC Ophthalmology
GA FZ4KE
UT WOS:000427560300002
PM 29426761
DA 2020-07-08
ER

PT J
AU McKenna, KC
AF McKenna, Kyle Christopher
TI Use of Aborted Fetal Tissue in Vaccines and Medical Research Obscures
   the Value of All Human Life
SO LINACRE QUARTERLY
LA English
DT Article
DE abortion; ethics; fetal tissue; research; vaccine
ID VARICELLA
AB This opinion addresses the licitness, quasi-benefits, and consequences of using aborted fetal tissue in vaccines and in medical research. The Catholic Church permits temporary use of vaccines generated using aborted fetal tissue to protect children from preventable diseases until alternative vaccines that do not use aborted fetal tissue are available. In medical research, cell lines that were generated from elective abortions should be avoided and alternative cell lines of licit origin utilized. The association between in utero Zika virus infections and microcephaly has increased the demand for fetal tissue to establish causality and to understand disease progression. These studies require extensive oversight as they could directly encourage elective abortions. The consequence of the use of fetal tissue from elective abortions is desensitization of beneficiaries to the original illicit act of abortion thereby obscuring the value of all human life and potentially leading to scandal.
C1 [McKenna, Kyle Christopher] Franciscan Univ Steubenville, Biol, Steubenville, OH 43952 USA.
RP McKenna, KC (corresponding author), Franciscan Univ Steubenville, Biol, Steubenville, OH 43952 USA.
CR American Academy of Pediatrics, 2016, IMM SCHED 2016
   Armour Stephanie, 2015, WALL STREET J
   Bonanni P, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-26
   CDC, 2016, MEASL CAS OUTBR
   Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P279
   Congregation for the Doctrine of the Faith, 2008, INSTRUCTION DIGNITAS
   Congregation for the Doctrine of the Faith, 1987, INSTRUCTION RESPECT
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Gershon AA, 2010, CURR TOP MICROBIOL, V342, P359, DOI 10.1007/82_2010_12
   Glaxo Smith Kline, 2016, VACC HAVRIX PRESCR I
   Hayden EC, 2016, NATURE, V532, P16
   Hobbelen PHF, 2016, J INFECTION, V73, P241, DOI 10.1016/j.jinf.2016.05.008
   INNIS BL, 1994, JAMA-J AM MED ASSOC, V271, P1328, DOI 10.1001/jama.271.17.1328
   Merck, 2016, VACC MMR 2 PRESCR IN
   Merck, 2016, VACC VARIVAX PRESCR
   Merck, 2016, VACC ZOSTAVAX PRESCR
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Paul II John, CATECHISM CATHOLIC C
   Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353
   PLOTKIN SA, 1965, AM J DIS CHILD, V110, P381, DOI 10.1001/archpedi.1965.02090030401007
   Pontifical Academy for Life, 2006, Natl Cathol Bioeth Q, V6, P541
   Seward JF, 2008, J INFECT DIS, V197, pS82, DOI 10.1086/522145
   Smith SL, 2009, J VIROL METHODS, V157, P47, DOI 10.1016/j.jviromet.2008.12.002
   Wong Alvin, 2006, Natl Cathol Bioeth Q, V6, P473
   Workowski Kimberly A., 2006, Morbidity and Mortality Weekly Report, V55, P1
NR 25
TC 0
Z9 0
U1 1
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0024-3639
EI 2050-8549
J9 LINACRE Q
JI Linacre Q.
PD FEB
PY 2018
VL 85
IS 1
BP 13
EP 17
DI 10.1177/0024363918761715
PG 5
WC Medical Ethics
SC Medical Ethics
GA GC7GW
UT WOS:000429962200004
PM 29970932
OA Green Published
DA 2020-07-08
ER

PT J
AU Kniel, KE
   Kumar, D
   Thakur, S
AF Kniel, Kalmia E.
   Kumar, Deepak
   Thakur, Siddhartha
TI Understanding the Complexities of Food Safety Using a "One Health"
   Approach
SO MICROBIOLOGY SPECTRUM
LA English
DT Article
ID ANTIBIOTIC-RESISTANCE GENES; III SECRETION SYSTEM; UNITED-STATES;
   SALMONELLA; PLANT; PATHOGEN; SURVIVAL; GROWTH; MANURE; RISK
AB The philosophy of One Health is growing in concept and clarity. The interdependence of human, animal, and environmental health is the basis for the concept of One Health. One Health is a comprehensive approach to ensure the health of people, animals, and the environment through collaborative efforts. Preharvest food safety issues align with the grand concept of One Health. Imagine any food production system, and immediately, parallel images from One Health emerge: for example, transmission of zoonotic diseases, antibiotic residues, or resistance genes in the environment; environmental and animal host reservoirs of disease; challenges with rearing animals and growing fresh produce on the same farm; application and transport of manure or diseased animals. During a recent celebration of # OneHealthDay, information was shared around the globe concerning scientists dedicated to One Health research systems. An ever-growing trade and global commerce system mixed with our incessant desire for food products during the whole year makes it all the more important to take a global view through the One Health lens to solve these growing challenges. The recent explosion of Zika virus around the globe renewed the need for assessing transmissible diseases through the eyes of One Health. It is not good enough to know how a disease affects the human population without a thorough understanding of the environment and vector reservoirs. If 60 to 75% of infectious diseases affecting humans are of animal origin, the need for better One Health research strategies and overdue solutions is imperative.
C1 [Kniel, Kalmia E.] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA.
   [Kumar, Deepak] Govind Ballabh Pant Univ Agr & Technol, Coll Vet & Anim Sci, Dept Vet Publ Hlth & Epidemiol, Pantnagar 263145, Uttar Pradesh, India.
   [Thakur, Siddhartha] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27607 USA.
RP Kniel, KE (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA.
EM kniel@udel.edu
RI kumar, deepak/D-5893-2011
OI Thakur, Siddhartha/0000-0003-3787-9939
CR Atlas RM, 2013, CURR TOP MICROBIOL, V365, P1, DOI 10.1007/82_2012_223
   Berendsen BJA, 2015, TALANTA, V132, P258, DOI 10.1016/j.talanta.2014.09.022
   Beuchat LR, 2002, MICROBES INFECT, V4, P413, DOI 10.1016/S1286-4579(02)01555-1
   Bleasdale B, 2009, APPL ENVIRON MICROB, V75, P1793, DOI 10.1128/AEM.02033-08
   Bonten M J, 2001, Lancet Infect Dis, V1, P314, DOI 10.1016/S1473-3099(01)00145-1
   Casey JA, 2013, JAMA INTERN MED, V173, P1980, DOI 10.1001/jamainternmed.2013.10408
   D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388
   FDA, 2015, SUMM REP ANT SOLD DI
   Ferro G, 2015, ENVIRON SCI TECHNOL, V49, P11096, DOI 10.1021/acs.est.5b02613
   Fleming-Dutra KE, 2016, JAMA-J AM MED ASSOC, V315, P1864, DOI 10.1001/jama.2016.4151
   Haapalainen M, 2009, MOL PLANT MICROBE IN, V22, P282, DOI 10.1094/MPMI-22-3-0282
   Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009
   HIPPOCRATES, AIRS WATERS PLACES
   Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x
   Kahn L.H., 2016, ONE HLTH POLITICS AN
   King LJ, 2013, MICROBIOL SPECTR, V1, DOI 10.1128/microbiolspec.OH-0012-2012
   Kumar D, 2018, FOODBORNE PATHOG DIS, V15, P210, DOI 10.1089/fpd.2017.2354
   Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1
   Markland SM, 2015, ADV BOT RES, V75, P115, DOI 10.1016/bs.abr.2015.08.002
   McGettigan P, 2017, LANCET GLOB HEALTH, V5, pE1075, DOI 10.1016/S2214-109X(17)30365-0
   Milillo SR, 2008, FOOD MICROBIOL, V25, P698, DOI 10.1016/j.fm.2008.03.003
   Monier JM, 2011, CURR OPIN MICROBIOL, V14, P229, DOI 10.1016/j.mib.2011.04.010
   Nakao JH, 2015, EPIDEMIOL INFECT, V143, P2178, DOI 10.1017/S0950268815000151
   ONeill J., 2016, TACKLING DRUG RESIST
   Parmley EJ, 2013, FOODBORNE PATHOG DIS, V10, P747, DOI 10.1089/fpd.2012.1438
   Perry JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00138
   Plotnikova JM, 2000, PLANT PHYSIOL, V124, P1766, DOI 10.1104/pp.124.4.1766
   Pornsukarom S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164621
   Prithiviraj B, 2005, PLANT J, V42, P417, DOI 10.1111/j.1365-313X.2005.02385.x
   Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641
   Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]
   Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279
   Silva C, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.OH-0020-2013
   Singer AC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01728
   SOBSEY MD, 1980, APPL ENVIRON MICROB, V40, P92, DOI 10.1128/AEM.40.1.92-101.1980
   Taban BM, 2011, ANAEROBE, V17, P286, DOI 10.1016/j.anaerobe.2011.04.004
   Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7
   Wichmann F, 2014, MBIO, V5, DOI 10.1128/mBio.01017-13
   Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003
   Xu J, 2015, CHEMOSPHERE, V119, P1379, DOI 10.1016/j.chemosphere.2014.02.040
   Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110
NR 42
TC 3
Z9 3
U1 2
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD FEB
PY 2018
VL 6
IS 1
AR UNSP PFS-0021-2017
DI 10.1128/microbiolspec.PFS-0021-2017
PG 9
WC Microbiology
SC Microbiology
GA GB9JD
UT WOS:000429389200008
PM 29451115
DA 2020-07-08
ER

PT J
AU Valentine, G
   Seferovic, M
   Murray, K
   Gorchakov, R
   Suter, M
   Berry, R
   Swennes, A
   Fowler, S
   Aagaard, K
AF Valentine, G.
   Seferovic, M.
   Murray, K.
   Gorchakov, R.
   Suter, M.
   Berry, R.
   Swennes, A.
   Fowler, S.
   Aagaard, K.
TI ZIKA VIRUS IS ASSOCIATED WITH FETAL GROWTH RESTRICTION AND A GESTATIONAL
   WINDOW OF SUSCEPTIBILITY IN A MURINE MODEL
SO JOURNAL OF INVESTIGATIVE MEDICINE
LA English
DT Meeting Abstract
CT Southern Regional Meeting of the
   American-Federation-for-Medical-Research (AFMR)
CY FEB 22-24, 2018
CL New Orleans, LA
SP Amer Federat Med Res
C1 [Valentine, G.; Seferovic, M.; Murray, K.; Gorchakov, R.; Suter, M.; Berry, R.; Swennes, A.; Fowler, S.; Aagaard, K.] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1081-5589
EI 1708-8267
J9 J INVEST MED
JI J. Invest. Med.
PD FEB
PY 2018
VL 66
IS 2
MA 511
BP 560
EP 561
DI 10.1136/jim-2017-000697.511
PG 2
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA GB2XK
UT WOS:000428919000524
DA 2020-07-08
ER

PT J
AU Chiesa, V
   Ragni, P
AF Chiesa, Valentina
   Ragni, Pietro
TI Zika Virus and Neurological Disease: Investing in Prevention
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Letter
C1 [Chiesa, Valentina] Univ Parma, Dept Med & Surg, Unit Biomed Biotechnol & Translat Sci, Parma, Italy.
   [Chiesa, Valentina; Ragni, Pietro] Local Hlth Author Reggio Emilia, Clin Governance, Emilia Romagna, Italy.
RP Chiesa, V (corresponding author), Univ Parma, Dept Med & Surg, Unit Biomed Biotechnol & Translat Sci, Parma, Italy.
EM valentina.chiesa@libero.it
RI chiesa, valentina/U-7156-2017
OI chiesa, valentina/0000-0001-6706-6483
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   World Health Organization, 2016, RISK COMM COMM EN ZI
   World Health Organization (WHO), ZIK SIT REP
NR 5
TC 0
Z9 0
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD FEB
PY 2018
VL 12
IS 1
BP 4
EP 5
DI 10.1017/dmp.2017.53
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GA3GA
UT WOS:000428215300004
PM 28803579
OA Bronze
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Zika-Virus-Related Photo Sharing
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Letter
C1 [Yasri, Sora] KMIT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Yasri, S (corresponding author), KMIT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Fung ICH, 2017, DISASTER MED PUBLIC, V11, P656, DOI 10.1017/dmp.2017.23
   Tiggemann M, 2018, J HEALTH PSYCHOL, V23, P1003, DOI 10.1177/1359105316639436
NR 2
TC 0
Z9 0
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD FEB
PY 2018
VL 12
IS 1
BP 5
EP 6
DI 10.1017/dmp.2017.81
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GA3GA
UT WOS:000428215300005
PM 28829013
OA Bronze
DA 2020-07-08
ER

PT J
AU Asokan, GV
   Nama, MMB
   Salman, FJ
   AlGhareeb, ZHA
   Almoosawi, AM
   Al Hammam, RA
   Awadhalla, MS
AF Asokan, G. V.
   Nama, Mariam Mohammed Baqer
   Salman, Feryal Juma
   AlGhareeb, Zainab Habib Ali
   Almoosawi, Ali Moosa
   Al Hammam, Ridha Abdulla
   Awadhalla, Muyssar Sabri
TI Appraisal of the Preparedness of Midwives and Nurses in Bahrain to
   Conduct Early Screening for Zika Virus Infection in Pregnant Women
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE Zika virus; pregnant women; preparedness; midwives; nurses
AB Objective: To appraise the awareness and knowledge levels of midwives and nurses concerning early screening for Zika virus (ZIKV) infection among pregnant women attending health care facilities in Bahrain.
   Methods: This was a cross-sectional, purposely chosen study of Bahraini and expatriate midwives, nurses, and supervisors employed in gynecology/obstetrics and labor wards of Salmanya hospital, a maternity hospital, 4 private hospitals, and health centers in Bahrain. The chosen individuals were invited to participate in a survey on awareness and knowledge of early screening for ZIKV infection.
   Results: Of 266 midwives and nurses employed in the study sites, 170 (64%) consented to participate in the study. Of those who agreed to participate, 76 were midwives and 94 were nurses. Admittedly, 39% of midwives and nurses were unaware of ZIKV infection. The grand mean knowledge score in the study was 39%. Expatriate midwives and nurses scored better than did Bahrainis (P<0.001). The grand mean knowledge scores of evening and night shift duty participants were significantly higher than those of the day duty participants.
   Conclusions: The awareness and knowledge scores of midwives and nurses concerning ZIKV infection were inadequate, which supported our hypothesis. By harnessing modern technology and support systems, lifelong learning can be used as a means to enhance preparedness for public health crises such as ZIKV.
C1 [Asokan, G. V.] Univ Bahrain, Coll Hlth Sci, Publ Hlth Program, POB 32038, Zallaq, Bahrain.
   [Nama, Mariam Mohammed Baqer; Salman, Feryal Juma; AlGhareeb, Zainab Habib Ali; Almoosawi, Ali Moosa] Univ Bahrain, Coll Hlth Sci, Nursing Program, Zallaq, Bahrain.
   [Al Hammam, Ridha Abdulla] Minist Hlth, Salmanya Med Complex, Manama, Bahrain.
   [Awadhalla, Muyssar Sabri] Univ Bahrain, Coll Hlth Sci, WHO Collaborating Ctr Nursing Dev, Nursing Program, Zallaq, Bahrain.
RP Asokan, GV (corresponding author), Univ Bahrain, Coll Hlth Sci, Publ Hlth Program, POB 32038, Zallaq, Bahrain.
EM agvaithinathan@uob.edu.bh
CR [Anonymous], 2016, WHO CALLS COUNTR REG
   Attar N, 2016, NAT REV MICROBIOL, V14, P6
   Bell BP, 2016, AM J PUBLIC HEALTH, V106, P589, DOI 10.2105/AJPH.2016.303124
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Deonae, 2012, BE INSPIRED
   El-Bahnasawy Mamdouh M, 2014, J Egypt Soc Parasitol, V44, P41
   Harris SR, 2013, DEV NEUROREHABIL, V16, P129, DOI 10.3109/17518423.2012.737040
   Kosht Novak Malorie, 2014, J Allied Health, V43, P146
   WHO, HIST ZIK VIR
   World Health Organization, ZIK VIR FACTSH
NR 10
TC 1
Z9 1
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD FEB
PY 2018
VL 12
IS 1
BP 7
EP 13
DI 10.1017/dmp.2017.26
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GA3GA
UT WOS:000428215300006
PM 28724472
DA 2020-07-08
ER

PT J
AU Burkett-Cadena, ND
   Vittor, AY
AF Burkett-Cadena, Nathan D.
   Vittor, Amy Y.
TI Deforestation and vector-borne disease: Forest conversion favors
   important mosquito vectors of human pathogens
SO BASIC AND APPLIED ECOLOGY
LA English
DT Article
DE Deforestation; Vector; Mosquito; Landscape; Land use; Habitat
ID ANOPHELES-GAMBIAE DIPTERA; LAND-USE; COMMUNITY COMPOSITION;
   SPATIAL-DISTRIBUTION; REPRODUCTIVE FITNESS; HABITAT SEGREGATION; LARVAL
   HABITATS; MALARIA VECTOR; CULICIDAE; DARLINGI
AB The global burden of vector-borne diseases accounts for more than 17% of infectious diseases in humans. Rapid global expansion of previously obscure pathogens, such as Zika and chikungunya viruses in recent years highlights the importance of understanding how anthropogenic changes influence emergence and spillover of vector-borne diseases. Deforestation has been identified as one anthropogenic change that influences vector-borne disease prevalence, although contrasting pictures of the effects of deforestation on vector-borne disease transmission have been reported. These conflicting findings are likely attributable to the inherent complexity of vector-borne disease systems, which involve diverse groups of vectors, hosts and pathogens, depending on geography. The current study represents a quantitative exploration of the link between deforestation and mosquitoes, the most important common constituents of vector-borne disease systems. Analysis of data compiled from published field studies for 87 mosquito species from 12 countries revealed that about half of the species (52.9%) were associated with deforested habitats. Of these species that are favored by deforestation, a much larger percentage (56.5%) are confirmed vectors of human pathogens, compared to those negatively impacted by deforestation (27.5%). Moreover, species that serve as vectors of multiple human pathogens were all favored by deforestation, including Anopheles bancroftii, Anopheles darlingi, Anopheles farauti, Anopheles funestus s.l., Anopheles gambiae s.l., Anopheles subpictus, Aedes aegypti, Aedes vigilax, Culex annulirostris, and Culex quinquefasciatus. Our quantitative analysis of vector and non-vector species, demonstrates that the net effect of deforestation favors mosquitoes that serve as vectors of human disease, while the obverse holds true for non-vectors species. These results begin to unify our understanding of the relationship between deforestation and vector mosquitoes, an important step in quantifying how land use change, specifically deforestation, affects human risk of vector-borne disease. (C) 2017 Gesellschaft fur Okologie. Published by Elsevier GmbH. All rights reserved.
C1 [Burkett-Cadena, Nathan D.] Univ Florida, Florida Med Entomol Lab, Vero Beach, FL 32962 USA.
   [Vittor, Amy Y.] Univ Florida, Div Infect Dis & Global Med, Gainesville, FL 32962 USA.
RP Burkett-Cadena, ND (corresponding author), Univ Florida, Entomol & Nematol Dept, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
EM nburkettcadena@ufl.edu
FU  [NIFAFLA-VME-005446]
FX The authors would like to thank T. Tscharntke and T. Schowalter for
   editing the special issue of BAAE and inviting this submission. The
   authors thank P. Lounibos for sharing data (Lounibos 1981) on treehole
   mosquitoes from Kenya. We thank K. Sloyer for producing the map in Fig.
   1. Three anonymous reviewers provided thoughtful criticisms that greatly
   improved the final draft. This work was supported by NIFAFLA-VME-005446.
CR Afrane YA, 2007, AM J TROP MED HYG, V77, P660, DOI 10.4269/ajtmh.2007.77.660
   Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772
   AMERASINGHE FP, 1990, J MED ENTOMOL, V27, P789, DOI 10.1093/jmedent/27.5.789
   Amerasinghe PH, 1999, MED VET ENTOMOL, V13, P124, DOI 10.1046/j.1365-2915.1999.00160.x
   Andrews ES, 2014, J MED ENTOMOL, V51, P1127, DOI 10.1603/ME14058
   Barros FSM, 2015, AM J TROP MED HYG, V93, P939, DOI 10.4269/ajtmh.15-0042
   Bayon G, 2012, SCIENCE, V335, P1219, DOI 10.1126/science.1215400
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Birkinshaw SJ, 2011, HYDROL PROCESS, V25, P1284, DOI 10.1002/hyp.7900
   Brouard O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020129
   Calder I., 2008, UNASYLVAFAO229, V229, P3
   Charlwood JD, 1996, MEM I OSWALDO CRUZ, V91, P391, DOI 10.1590/S0074-02761996000400001
   Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x
   Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769
   Cox J, 2007, AM J TROP MED HYG, V76, P820, DOI 10.4269/ajtmh.2007.76.820
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772
   Futami K, 2008, J MED ENTOMOL, V45, P1050, DOI 10.1603/0022-2585(2008)45[1050:DBIAGD]2.0.CO;2
   Gary RE, 2001, J MED ENTOMOL, V38, P22, DOI 10.1603/0022-2585-38.1.22
   Gonsalves L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064081
   Gottdenker NL, 2014, ECOHEALTH, V11, P619, DOI 10.1007/s10393-014-0941-z
   Gu WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015996
   Hahn MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085725
   HARBACH R E, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P241
   Jackson RR, 2012, MED VET ENTOMOL, V26, P233, DOI 10.1111/j.1365-2915.2011.00986.x
   Jansen CC, 2009, AM J TROP MED HYG, V81, P849, DOI 10.4269/ajtmh.2009.09-0008
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kling LJ, 2007, J VECTOR ECOL, V32, P207, DOI 10.3376/1081-1710(2007)32[207:LMCIDV]2.0.CO;2
   Kroeger I, 2014, J VECTOR ECOL, V39, P103, DOI 10.1111/j.1948-7134.2014.12076.x
   Kweka EJ, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00238
   Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-128
   Le Flohic G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002208
   Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003
   Li Y, 2015, NATURE COMMUNICATION, V6
   Lord JS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004249
   Louca V, 2009, J MED ENTOMOL, V46, P546, DOI 10.1603/033.046.0320
   LOUNIBOS LP, 1981, ECOL ENTOMOL, V6, P129, DOI 10.1111/j.1365-2311.1981.tb00601.x
   Marinotti O, 2013, NUCLEIC ACIDS RES, V41, P7387, DOI 10.1093/nar/gkt484
   Minakawa N, 2005, AM J TROP MED HYG, V73, P157, DOI 10.4269/ajtmh.2005.73.157
   Mullen G.R., 2009, MED VET ENTOMOLOGY
   Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69
   Munga S, 2005, J MED ENTOMOL, V42, P993, DOI 10.1603/0022-2585(2005)042[0993:OSPAEH]2.0.CO;2
   Murrell EG, 2013, OECOLOGIA, V173, P1033, DOI 10.1007/s00442-013-2674-z
   Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13
   Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x
   Neill C, 2006, HYDROL PROCESS, V20, P2563, DOI 10.1002/hyp.6216
   Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/s10393-004-0008-7
   Ohba SY, 2010, J MED ENTOMOL, V47, P783, DOI 10.1603/ME10051
   Overgaard HJ, 2003, LANDSCAPE ECOL, V18, P605, DOI 10.1023/A:1026074910038
   Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251
   Poulin B, 2010, J APPL ECOL, V47, P884, DOI 10.1111/j.1365-2664.2010.01821.x
   Reisen WK, 2008, J VECTOR ECOL, V33, P89, DOI 10.3376/1081-1710(2008)33[89:IOCVOM]2.0.CO;2
   Roberts DR, 2002, J VECTOR ECOL, V27, P21
   Paramo MER, 2015, BIOCONTROL SCI TECHN, V25, P238, DOI 10.1080/09583157.2014.967177
   Samuel PP, 2008, J MED ENTOMOL, V45, P927, DOI 10.1603/0022-2585(2008)45[927:HFPOJE]2.0.CO;2
   Sithiprasasna Ratana, 2005, Int J Health Geogr, V4, P17, DOI 10.1186/1476-072X-4-17
   Steiger DM, 2012, J VECTOR ECOL, V37, P69, DOI 10.1111/j.1948-7134.2012.00201.x
   Stone CM, 2012, AM J TROP MED HYG, V87, P727, DOI 10.4269/ajtmh.2012.12-0123
   Takken W, 2005, WAG UR FRON, V9, P113
   Thongsripong P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002507
   Valle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057519
   Vittor AY, 2009, AM J TROP MED HYG, V81, P5
   Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3
   White BJ, 2011, ANNU REV ECOL EVOL S, V42, P111, DOI 10.1146/annurev-ecolsys-102710-145028
   WHO, 2016, VECT BORN
   WOLDA H, 1981, ECOL ENTOMOL, V6, P99, DOI 10.1111/j.1365-2311.1981.tb00976.x
   Yanoviak SP, 2006, ANN ENTOMOL SOC AM, V99, P1172, DOI 10.1603/0013-8746(2006)99[1172:LUAMCC]2.0.CO;2
   Zohdy S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1164-2
NR 68
TC 13
Z9 13
U1 3
U2 31
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 1439-1791
EI 1618-0089
J9 BASIC APPL ECOL
JI Basic Appl. Ecol.
PD FEB
PY 2018
VL 26
BP 101
EP 110
DI 10.1016/j.baae.2017.09.012
PG 10
WC Ecology
SC Environmental Sciences & Ecology
GA FY7VD
UT WOS:000427070700010
DA 2020-07-08
ER

PT J
AU Garcia, GD
   David, MR
   Martins, AD
   Maciel-de-Freitas, R
   Linss, JGB
   Araujo, SC
   Lima, JBP
   Valle, D
AF Garcia, Gabriela de Azambuja
   David, Mariana Rocha
   Martins, Ademir de Jesus
   Maciel-de-Freitas, Rafael
   Birggitt Linss, Jutta Gerlinde
   Araujo, Simone Costa
   Pereira Lima, Jose Bento
   Valle, Denise
TI The impact of insecticide applications on the dynamics of resistance:
   The case of four Aedes aegypti populations from different Brazilian
   regions
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHITIN SYNTHESIS INHIBITOR; SODIUM-CHANNEL GENE; TEMEPHOS RESISTANCE;
   DIPTERA-CULICIDAE; FIELD POPULATIONS; SUSCEPTIBILITY; CYPERMETHRIN;
   METHOPRENE; LOCALITIES; MECHANISMS
AB Background
   In the tropics, the utilization of insecticides is still an important strategy for controlling Aedes aegypti, the principle vector of dengue, chikungunya and Zika viruses. However, increasing insecticide resistance in Ae. aegypti populations might hinder insecticide efficacy on a long-term basis. It will be important to understand the dynamics and evolution of insecticide resistance by assessing its frequency and the mechanisms by which it occurs.
   Methodology/Principal findings
   The insecticide resistance status of four Brazilian Ae. aegypti populations was monitored. Quantitative bioassays with the major insecticides employed in the country was performed: the adulticide deltamethrin (a pyrethroid-PY) and the larvicides, temephos (an organo-phosphate) and diflubenzuron (a chitin synthesis inhibitor). Temephos resistance was detected in all populations although exhibiting a slight decrease over time probably due to the interruption of field use. All vector populations were susceptible to diflubenzuron, recently introduced in the country to control Ae. aegypti. Resistance against deltamethrin was extremely high in three populations. Molecular assays investigated substitutions in the voltage gated sodium channel (Na-V), the PY target site, at positions 1011, 1016 and 1534. Elevated frequencies of substitutions Val1016lle and Phe1534Cys related to high PY resistance levels were identified. Biochemical assays detected alterations in the activities of two detoxifying enzyme classes related to metabolic resistance, glutathion-S-transferases and esterases. The results obtained were evaluated in the context of both recent insecticide use and the records of dengue incidence in each locality.
   Conclusions/Significance
   The four Ae. aegypti populations evaluated were resistant to the neurotoxic insecticides, temephos and deltamethrin. However, they were still susceptible to diflubenzuron. A probable correlation between adult insect resistance to PY and the domestic application of insecticides is discussed, pointing to the need for awareness measures regarding the correct utilization by citizens. This work aims to contribute to the efficient and rational management of Ae. aegypti control of both larvae and adults.
C1 [Garcia, Gabriela de Azambuja; David, Mariana Rocha; Maciel-de-Freitas, Rafael] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Martins, Ademir de Jesus; Birggitt Linss, Jutta Gerlinde; Araujo, Simone Costa; Pereira Lima, Jose Bento] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, Brazil.
   [Martins, Ademir de Jesus; Maciel-de-Freitas, Rafael; Valle, Denise] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
   [Araujo, Simone Costa] Secretaria Municipal Saude, Gerencia Controle Zoonoses, Belo Horizonte, MG, Brazil.
   [Valle, Denise] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
RP Valle, D (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.; Valle, D (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
EM dvalle@ioc.fiocruz.br
RI Martins, Ademir/W-3251-2019; Martins, Ademir J./B-4117-2009
OI Martins, Ademir/0000-0001-5739-1215; Garcia,
   Gabriela/0000-0002-7400-0367; Rocha David, Mariana/0000-0003-1241-3585;
   Maciel-de-Freitas, Rafael/0000-0002-2198-6492
FU Programa Nacional de Controle da Dengue/Ministerio da Saude (PNCD/MS);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Instituto Nacional de
   Ciencia e Tecnologia-Entomologia Molecular (INCT-EM)
FX This work was supported by the Programa Nacional de Controle da
   Dengue/Ministerio da Saude (PNCD/MS), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and the
   Instituto Nacional de Ciencia e Tecnologia-Entomologia Molecular
   (INCT-EM). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2012, 2 SEM INT AV CONTR Q
   [Anonymous], 2011, 22011IOC FIOCR DIR I
   Belinato TA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-83
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Biber PA, 2006, J AM MOSQUITO CONTR, V22, P408, DOI 10.2987/8756-971X(2006)22[408:LEOSON]2.0.CO;2
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Braga I, 2005, MEM I OSWALDO CRUZ, V100, P435, DOI 10.1590/S0074-02762005000400016
   Braga IA, 2005, J MED ENTOMOL, V42, P830, DOI 10.1603/0022-2585(2005)042[0830:EOMAIG]2.0.CO;2
   Braga IA, 2015, DENGUE TEORIAS PRATI, P61
   Braga Ima Aparecida, 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P347, DOI 10.1590/S0037-86822000000400003
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Macoris MDD, 2007, MEM I OSWALDO CRUZ, V102, P895, DOI 10.1590/S0074-02762007000800001
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Flores AE, 2006, J AM MOSQUITO CONTR, V22, P672, DOI 10.2987/8756-971X(2006)22[672:MOIRIF]2.0.CO;2
   Fontoura NG, 2012, MEM I OSWALDO CRUZ, V107, P387, DOI 10.1590/S0074-02762012000300014
   GEORGHIOU GP, 1987, J MED ENTOMOL, V24, P290, DOI 10.1093/jmedent/24.3.290
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lima J. B. P., 2006, QUANTIFICATION METHO
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Luna JED, 2004, REV SAUDE PUBL, V38, P842, DOI [10.1590/S0034-89102004000600013, 10.1590/s0034-89102004000600013]
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   Martins AJ, 2008, PEST MANAG SCI, V64, P676, DOI 10.1002/ps.1547
   Martins Ademir Jesus, 2013, Evolution Medicine and Public Health, P148, DOI 10.1093/emph/eot012
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   Martins AJ, 2009, AM J TROP MED HYG, V81, P108, DOI 10.4269/ajtmh.2009.81.108
   Mazzari MB, 1995, B DIRECCION MALARIOL, V35, P90
   Ministerio da SaCide, 1999, REUN TECN DISC STAT
   Ministerio da SaCide, 2015, B EPIDEMIOLOGICO
   Ministerio da SaCtde, 2009, 0152009 CGPNCDDIGESS
   Ministerio da Satkle, 2009, REUN DISC AV RES MON
   Ministerio da Saude, 2006, REUN TECN DISC STAT
   Ministerio da SaUde, 2008, 2042008 CGPNCDDIGESS
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2009, DIR NAC PREV CONTR A
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007
   Pethuan S, 2007, TROP BIOMED, V24, P7
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115
   Portal da Prefeitura de Parnamirim, 2015, PORT TRANSP
   Prefeitura Municipal de Santarem, 2013, INF MUN SANT SEMMA C
   Rawlins S C, 1998, Rev Panam Salud Publica, V4, P243
   Raymond M., 1985, Cahiers O.R.S.T.O.M., Serie Entomologie Medicale et Parasitologie, V23, P117
   Rodriguez MM, 2002, J MED ENTOMOL, V39, P882, DOI 10.1603/0022-2585-39.6.882
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Siller Q, 2011, J AM MOSQUITO CONTR, V27, P357, DOI 10.2987/11-6149.1
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Suarez MF, 1988, AM J TROP MED HYG, V55, P257
   Teixeira MG, 2015, DENGUE TEORIAS PRATI, P293
   Valle D., 2015, DENGUE TEORIAS PRATI, P93
   Viana-Medeiros PF, 2011, THESIS
   *WHO, 1981, INSTR DET SUSC RES M
   WHO, 2013, WHOPES REC COMP FORM
   Wirth MC, 1999, J AM MOSQUITO CONTR, V15, P315
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2012, REC INS SPAC SPRAYIN
   WORLD HEALTH ORGANIZATION, 2006, WHOCDSNTDWHOPESGCDPP
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 72
TC 12
Z9 13
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2018
VL 12
IS 2
AR e0006227
DI 10.1371/journal.pntd.0006227
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FZ0RM
UT WOS:000427279700023
PM 29432488
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Inocente, EA
   Shaya, M
   Acosta, N
   Rakotondraibe, LH
   Piermarini, PM
AF Inocente, Edna Alfaro
   Shaya, Marguerite
   Acosta, Nuris
   Rakotondraibe, L. Harinantenaina
   Piermarini, Peter M.
TI A natural agonist of mosquito TRPA1 from the medicinal plant Cinnamosma
   fragrans that is toxic, antifeedant, and repellent to the yellow fever
   mosquito Aedes aegypti
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DRIMANE SESQUITERPENOIDS; COVALENT MODIFICATION; WARBURGIA-UGANDENSIS;
   INHIBITORY-ACTIVITY; BIOLOGICAL-ACTIVITY; CHANNEL ACTIVATION; RENAL
   TUBULES; IN-VITRO; A-C; DROSOPHILA
AB Plants produce various secondary metabolites that offer a potential source of novel insecticides and repellents for the control of mosquito vectors. Plants of the genus Cinnamosma are endemic to, and widely-distributed throughout, the island of Madagascar. The barks of these species are commonly used in traditional medicines for treating a wide range of maladies. The therapeutic nature of the bark is thought to be associated with its enrichment of pungent drimane sesquiterpenes, which elicit antifeedant and toxic effects in some insects. Here we test the hypothesis that a bark extract of Cinnamosma fragrans (CINEX) and its major drimane sesquiterpenes are insecticidal, antifeedant, and repellent to Aedes aegypti, the principal mosquito vector of chikungunya, dengue, yellow fever, and Zika viruses. We demonstrate that CINEX is 1) toxic to larval and adult female mosquitoes, and 2) antifeedant and repellent to adult female mosquitoes. Moreover, we show that cinnamodial (CDIAL), a sesquiterpene dialdehyde isolated from CINEX, duplicates these bioactivities and exhibits similar toxic potency against pyrethroid-susceptible and-resistant strains of Ae. aegypti. Importantly, we show that CDIAL is an agonist of heterologously-expressed mosquito Transient Receptor Potential Al (TRPA1) channels, and the antifeedant activity of CDIAL is dampened in a TRPAl-deficient strain of Ae. aegypti (TRPA1-/-). Intriguingly, TRPA1-/-mosquitoes do not exhibit toxic resistance to CDIAL. The data indicate that modulation of TRPA1 is required for the sensory detection and avoidance of CDIAL by mosquitoes, but not for inducing the molecule's toxicity. Our study suggests that CDIAL may serve as a novel chemical platform for the development of natural product-based insecticides and repellents for controlling mosquito vectors.
C1 [Inocente, Edna Alfaro; Shaya, Marguerite; Acosta, Nuris; Piermarini, Peter M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.
   [Rakotondraibe, L. Harinantenaina] Ohio State Univ, Dept Med Chem, Columbus, OH 43210 USA.
   [Rakotondraibe, L. Harinantenaina] Ohio State Univ, Dept Pharmacognosy, Columbus, OH 43210 USA.
RP Piermarini, PM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.; Rakotondraibe, LH (corresponding author), Ohio State Univ, Dept Med Chem, Columbus, OH 43210 USA.; Rakotondraibe, LH (corresponding author), Ohio State Univ, Dept Pharmacognosy, Columbus, OH 43210 USA.
EM rakotondraibe.1@osu.edu; piermarini.1@osu.edu
OI Rakotondraibe, L. Harinantenaina/0000-0003-2166-4992
FU National Institutes of Health National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI129951]; Ohio State
   University Public Health Preparedness for Infectious Disease Program
   (New Investigator Grant); Ohio Agricultural Research and Development
   Center SEEDS (SEEDS grant) [0HOA1569]; State fund; Federal fund
FX This research was funded by the National Institutes of Health National
   Institute of Allergy and Infectious Diseases (R21AI129951 to PMP and
   LHR), The Ohio State University Public Health Preparedness for
   Infectious Disease Program (New Investigator Grant to PMP and LHR), Ohio
   Agricultural Research and Development Center SEEDS (SEEDS grant
   0HOA1569; oardc.osu.edu/seeds) to PMP, and State and Federal funds
   appropriated to the Ohio Agricultural Research and Development Center of
   The Ohio State University. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002
   Amiguet VT, 2006, J NAT PROD, V69, P1005, DOI 10.1021/np0504863
   ASAKAWA Y, 1988, J CHEM ECOL, V14, P1845, DOI 10.1007/BF01013481
   Calkins TL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137084
   Claudino VD, 2013, MEM I OSWALDO CRUZ, V108, P140, DOI 10.1590/0074-0276108022013002
   Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108
   Corfas RA, 2015, ELIFE, V4, DOI [10.7554/eLife.11751, 10.7554/eLife.11750]
   Du EJ, 2015, MOL CELLS, V38, P911, DOI 10.14348/molcells.2015.0215
   Escalera J, 2008, J BIOL CHEM, V283, P24136, DOI 10.1074/jbc.M710280200
   Estep AS, 2017, J MED ENTOMOL, P1
   Fernandez-Carvajal A., 2015, TRP CHANNELS SENSORY, P41
   Fowler MA, 2013, LIFE SCI, V92, P394, DOI 10.1016/j.lfs.2012.07.029
   Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5
   Gols GJZ, 1996, ENTOMOL EXP APPL, V79, P69, DOI 10.1007/BF00333823
   Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001
   Harinantenaina L, 2008, J NAT PROD, V71, P123, DOI 10.1021/np070474c
   Harinantenaina L, 2007, J NAT PROD, V70, P277, DOI 10.1021/np060435l
   Harinantenaina L, 2006, J NAT PROD, V69, P1193, DOI 10.1021/np0601298
   He DH, 2017, BIOORG MED CHEM LETT, V27, P1754, DOI 10.1016/j.bmcl.2017.02.067
   Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103
   ISMAN MB, 1990, J AGR FOOD CHEM, V38, P1406, DOI 10.1021/jf00096a024
   Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104
   Jansen BJM, 2004, NAT PROD REP, V21, P449, DOI 10.1039/b311170a
   JANSEN BJM, 1991, NAT PROD REP, V8, P309, DOI 10.1039/np9910800309
   Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715
   Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848
   Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107
   KUBO I, 1976, J CHEM SOC CHEM COMM, P1013, DOI 10.1039/c39760001013
   Kwan KY, 2009, J GEN PHYSIOL, V133, P251, DOI 10.1085/jgp.200810146
   Kwon H, 2016, P NATL ACAD SCI USA, V113, P6880, DOI 10.1073/pnas.1520404113
   Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016
   Laursen WJ, 2014, CURR TOP MEMBR, V74, P89, DOI [10.1016/B978-0-12-800181-3.00004-X, 10.1016/B978-0-800181-3.00004-X]
   Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544
   Maekawa E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-10
   MAHMOUD II, 1980, J NAT PROD, V43, P365, DOI 10.1021/np50009a008
   Mathie K, 2017, J AGR FOOD CHEM, V65, P5700, DOI 10.1021/acs.jafc.7b02356
   MEINWALD J, 1978, SCIENCE, V199, P1167, DOI 10.1126/science.199.4334.1167
   Mendes GL, 1998, LIFE SCI, V63, P369, DOI 10.1016/S0024-3205(98)00285-9
   Mendes GL, 2000, J PHARMACOL EXP THER, V292, P164
   Miresmailli S, 2014, TRENDS PLANT SCI, V19, P29, DOI 10.1016/j.tplants.2013.10.002
   Montenegro I, 2013, MOLECULES, V18, P4192, DOI 10.3390/molecules18044192
   NAKANISHI K, 1977, ISRAEL J CHEM, V16, P28
   Pavela R, 2017, S AFR J BOT, V108, P359, DOI 10.1016/j.sajb.2016.08.017
   Peng GD, 2015, CELL REP, V12, P190, DOI 10.1016/j.celrep.2015.06.025
   Pernet R, 1957, PHARMACOPEE MADAGASC, P3
   Piermarini PM, 2011, AM J PHYSIOL-REG I, V301, pR1318, DOI 10.1152/ajpregu.00223.2011
   Piermarini PM, 2009, AM J PHYSIOL-RENAL, V296, pF730, DOI 10.1152/ajprenal.90564.2008
   Pridgeon JW, 2009, J MED ENTOMOL, V46, P335, DOI 10.1603/033.046.0219
   Quero A, 2016, CR CHIM, V19, P1056, DOI 10.1016/j.crci.2016.04.006
   Randrianarivelojosia M, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-25
   Raphemot R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110772
   Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905
   Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0
   Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205
   Rouhier MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100700
   Salgado VL, 2017, J PESTIC SCI, V42, P1, DOI 10.1584/jpestics.D16-104
   Su QX, 2016, NAT PRODUCT BIOPROSP, V6, P31, DOI 10.1007/s13659-015-0083-1
   Swale DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36954
   Szallasi A, 1998, EUR J PHARMACOL, V356, P81, DOI 10.1016/S0014-2999(98)00514-7
   Viana F, 2016, J PHYSIOL-LONDON, V594, P4151, DOI 10.1113/JP270935
   Vriens J, 2008, CURR NEUROPHARMACOL, V6, P79, DOI 10.2174/157015908783769644
   Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x
   Wube AA, 2005, PHYTOCHEMISTRY, V66, P2309, DOI 10.1016/j.phytochem.2005.07.018
   Wube AA, 2006, PLANTA MED, V72, P754, DOI 10.1055/s-2006-931596
   Wube AA, 2010, PHYTOTHER RES, V24, P1468, DOI 10.1002/ptr.3126
   Yang L, 2017, J INSECT PHYSIOL, V96, P35, DOI 10.1016/j.jinsphys.2016.10.011
   Zapata N, 2010, PHYTOPARASITICA, V38, P191, DOI 10.1007/s12600-010-0087-7
NR 67
TC 4
Z9 4
U1 3
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2018
VL 12
IS 2
AR e0006265
DI 10.1371/journal.pntd.0006265
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FZ0RM
UT WOS:000427279700043
PM 29425195
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mehta, R
   Soares, CN
   Medialdea-Carrera, R
   Ellul, M
   da Silva, MTT
   Rosala-Hallas, A
   Jardim, MR
   Burnside, G
   Pamplona, L
   Bhojak, M
   Manohar, R
   da Silva, GAM
   Adriano, MV
   Brasil, P
   Nogueira, RMR
   Dos Santos, CC
   Turtle, L
   de Sequeira, PC
   Brown, DW
   Griffiths, MJ
   de Filippis, AMB
   Solomon, T
AF Mehta, Ravi
   Soares, Cristiane Nascimento
   Medialdea-Carrera, Raquel
   Ellul, Mark
   Texeira da Silva, Marcus Tulius
   Rosala-Hallas, Anna
   Jardim, Marcia Rodrigues
   Burnside, Girvan
   Pamplona, Luciana
   Bhojak, Maneesh
   Manohar, Radhika
   Medeiros da Silva, Gabriel Amorelli
   Adriano, Marcus Vinicius
   Brasil, Patricia
   Ribeiro Nogueira, Rita Maria
   Dos Santos, Carolina Cardoso
   Turtle, Lance
   de Sequeira, Patricia Carvalho
   Brown, David W.
   Griffiths, Michael J.
   Bispo de Filippis, Ana Maria
   Solomon, Tom
TI The spectrum of neurological disease associated with Zika and
   chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; ANTIBODY-DEPENDENT ENHANCEMENT; INFECTION;
   ENCEPHALITIS; MANIFESTATIONS; COLOMBIA
AB Background
   During 2015-16 Brazil experienced the largest epidemic of Zika virus ever reported. This arthropod-borne virus (arbovirus) has been linked to Guillain-Barre syndrome (GBS) in adults but other neurological associations are uncertain. Chikungunya virus has caused outbreaks in Brazil since 2014 but associated neurological disease has rarely been reported here. We investigated adults with acute neurological disorders for Zika, chikungunya and dengue, another arbovirus circulating in Brazil.
   Methods
   We studied adults who had developed a new neurological condition following suspected Zika virus infection between 1st November 2015 and 1st June 2016. Cerebrospinal fluid (CSF), serum, and urine were tested for evidence of Zika, chikungunya, and dengue viruses.
   Results
   Of 35 patients studied, 22 had evidence of recent arboviral infection. Twelve had positive PCR or IgM for Zika, five of whom also had evidence for chikungunya, three for dengue, and one for all three viruses. Five of them presented with GBS; seven had presentations other than GBS, including meningoencephalitis, myelitis, radiculitis or combinations of these syndromes. Additionally, ten patients positive for chikungunya virus, two of whom also had evidence for dengue virus, presented with a similar range of neurological conditions.
   Conclusions
   Zika virus is associated with a wide range of neurological manifestations, including central nervous system disease. Chikungunya virus appears to have an equally important association with neurological disease in Brazil, and many patients had dual infection. To understand fully the burden of Zika we must look beyond GBS, and also investigate for other co-circulating arboviruses, particularly chikungunya.
C1 [Mehta, Ravi; Medialdea-Carrera, Raquel; Ellul, Mark; Turtle, Lance; Griffiths, Michael J.; Solomon, Tom] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Mehta, Ravi; Medialdea-Carrera, Raquel; Ellul, Mark; Turtle, Lance; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Soares, Cristiane Nascimento; Medeiros da Silva, Gabriel Amorelli] Hosp Fed Servidores Estado, Dept Neurol, Rio De Janeiro, Brazil.
   [Ellul, Mark; Bhojak, Maneesh; Manohar, Radhika; Turtle, Lance; Solomon, Tom] Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England.
   [Texeira da Silva, Marcus Tulius] Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Neuroinfeccao, Rio De Janeiro, Brazil.
   [Texeira da Silva, Marcus Tulius] Hosp Clin Niteroi, Dept Neurol, Niteroi, RJ, Brazil.
   [Rosala-Hallas, Anna; Burnside, Girvan] Univ Liverpool, Inst Translat Med, Dept Biostat, Liverpool, Merseyside, England.
   [Jardim, Marcia Rodrigues] Hosp Univ Pedro Ernesto, Dept Neurol, Rio De Janeiro, Brazil.
   [Pamplona, Luciana] Hosp Geral Bonsucesso, Dept Neurol, Rio De Janeiro, Brazil.
   [Adriano, Marcus Vinicius] Hosp Barra Dor, Dept Neurol, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria; Dos Santos, Carolina Cardoso; de Sequeira, Patricia Carvalho; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz, Flavivirus Reference Lab, Rio De Janeiro, Brazil.
   [Brown, David W.] Inst Oswaldo Cruz, Influenza Reference Lab, Rio De Janeiro, Brazil.
   [Brown, David W.] Publ Hlth England, Virus Reference Dept, Natl Infect Serv, London, England.
   [Griffiths, Michael J.] Alder Hey Childrens NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England.
RP Mehta, R; Solomon, T (corresponding author), Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.; Mehta, R; Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.; Solomon, T (corresponding author), Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England.
EM Ravi.mehta@liverpool.ac.uk; tsolomon@liv.ac.uk
RI Burnside, Girvan/AAO-4490-2020
OI Medialdea-Carrera, Raquel/0000-0002-0371-5138; Solomon,
   Tom/0000-0001-7266-6547; Turtle, Lance/0000-0002-0778-1693; Burnside,
   Girvan/0000-0001-7398-1346
FU United Kingdom Medical Research CouncilMedical Research Council UK (MRC)
   [MC_PC_15096]; National Institute for Health Research Health Protection
   Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at the
   University of Liverpool; Public Health England (PHE); Liverpool School
   of Tropical Medicine (LSTM); European Union's Horizon 2020 research and
   innovation program [734584]
FX This work was supported by the United Kingdom Medical Research Council
   (https://www.mrc.ac.uk/, Grant number MC_PC_15096); the National
   Institute for Health Research Health Protection Research Unit (NIHR
   HPRU, http://www.hpruezi.nihr.ac.uk/) in Emerging and Zoonotic
   Infections at the University of Liverpool, in partnership with Public
   Health England (PHE) and Liverpool School of Tropical Medicine (LSTM);
   and the European Union's Horizon 2020 research and innovation program
   under grant agreement No. 734584
   (https://ec.europa.eu/programmes/horizon2020/). The views expressed are
   those of the authors and not necessarily those of the NHS, the NIHR, the
   Department of Health or Public Health England. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   [Anonymous], 2014, SURV DENG ZIK POL FR
   [Anonymous], 2016, PROT VIG RESP OC MIC
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606
   Brazilian Ministry of Health, 2017, EPIDEMIOLOGICAL B
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CDC, 2016, ZIK MAC ELISA INSTR
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Huzly D, 2016, EURO SURVEIL, V21
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mallewa M, 2013, LANCET GLOB HEALTH, V1, pE153, DOI 10.1016/S2214-109X(13)70060-3
   Martins HAL, 2016, J NEUROINFECTIOUS DI, V7
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Molko N, 2017, NEUROLOGY
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Pan American Health Organisation, 2016, CHIK STAT DAT 2016
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2017, N ENGL J MED
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Roze B, 2016, EURO SURVEIL, V21
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Steinhagen K, 2016, EURO SURVEILL, V21
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 39
TC 26
Z9 27
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2018
VL 12
IS 2
AR e0006212
DI 10.1371/journal.pntd.0006212
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FZ0RM
UT WOS:000427279700016
PM 29432457
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Salvo, MA
   Kingstad-Bakke, B
   Salas-Quinchucua, C
   Camacho, E
   Osorio, JE
AF Salvo, Mauricio A.
   Kingstad-Bakke, Brock
   Salas-Quinchucua, Cristhian
   Camacho, Erwin
   Osorio, Jorge E.
TI Zika virus like particles elicit protective antibodies in mice
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PASSIVE-IMMUNIZATION; ENCEPHALITIS-VIRUS; IFN-ALPHA/BETA; MOUSE MODEL;
   AG129 MICE; VACCINE; EFFICACY; INFECTION; BRAZIL; IMMUNOGENICITY
AB Mosquito-borne Zika virus (ZIKV) typically causes a mild and self-limiting illness known as Zika fever. Since its recent emergence in 2014 in the American continent, ZIKV infection during pregnancy has been closely associated with a wide range of congenital abnormalities. To date, no vaccines or antivirals are publicly available. We developed Zika virus-like particles (VLPs) and evaluated their immunogenicity and protective efficacy in mouse models. ZIKV VLPs (ZIKVLPs) formulated with alum were injected into 6-8-week-old interferon deficient AG129 mice as well as wild type BALB/c mice. Control mice received PBS/alum. Animals were challenged with 200 PFU (>1000 AG129 LD50s) of ZIKV strain H/PF/2013. All vaccinated mice survived with no morbidity or weight loss while control animals either died at 9 days post challenge (AG129) or had increased viremia (BALB/c). Neutralizing antibodies were observed in all ZIKVLP vaccinated mice. The role of neutralizing antibodies in protecting mice was demonstrated by passive transfer. Our findings demonstrate the protective efficacy of the ZIKVLP vaccine and highlight the important role that neutralizing antibodies play in protection against ZIKV infection.
C1 [Salvo, Mauricio A.; Kingstad-Bakke, Brock; Salas-Quinchucua, Cristhian; Camacho, Erwin; Osorio, Jorge E.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
RP Osorio, JE (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
EM jorge.osorio@wisc.edu
OI Camacho Burgos, Erwin/0000-0003-2411-1875
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Ariano RE, 2010, CAN MED ASSOC J, V182, P357, DOI 10.1503/cmaj.092127
   Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brewoo JN, 2012, VACCINE, V30, P1513, DOI 10.1016/j.vaccine.2011.11.072
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chiba N, 1999, VACCINE, V17, P1532, DOI 10.1016/S0264-410X(98)00360-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Hennessey MJ, 2016, AM J TROP MED HYG
   Hombach J, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5923
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Lin HH, 2017, BIOTECHNOLOGY ADV
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Merino-Ramos T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108056
   Metz SW, 2016, METHODS MOL BIOL, V1426, P297, DOI 10.1007/978-1-4939-3618-2_27
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Ohtaki N, 2010, VACCINE, V28, P6588, DOI 10.1016/j.vaccine.2010.07.055
   Pan American Health Organization (PAHO) World Health Organization (WHO), 2017, ZIK SUSP CONF CAS RE
   Partidos CD, 2011, VACCINE, V29, P3067, DOI 10.1016/j.vaccine.2011.01.076
   Pijlman GP, 2015, BIOTECHNOL J, V10, P659, DOI 10.1002/biot.201400427
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sarathy VV, 2015, J GEN VIROL, V96, P3035, DOI 10.1099/jgv.0.000246
   Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146
   Tesh RB, 2002, EMERG INFECT DIS, V8, P1392, DOI 10.3201/eid0812.020229
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
   Wang L., 2013, BIOMED RES INT, V2013
   Wang YS, 2012, VACCINE, V30, P2125, DOI 10.1016/j.vaccine.2012.01.040
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 52
TC 15
Z9 15
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2018
VL 12
IS 2
AR e0006210
DI 10.1371/journal.pntd.0006210
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FZ0RM
UT WOS:000427279700014
PM 29401460
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tisseuil, C
   Velo, E
   Bino, S
   Kadriaj, P
   Mersini, K
   Shukullari, A
   Simaku, A
   Rogozi, E
   Caputo, B
   Ducheyne, E
   della Torre, A
   Reiter, P
   Gilbert, M
AF Tisseuil, Clement
   Velo, Enkelejda
   Bino, Silvia
   Kadriaj, Perparim
   Mersini, Kujtim
   Shukullari, Ada
   Simaku, Artan
   Rogozi, Elton
   Caputo, Beniamino
   Ducheyne, Els
   della Torre, Alessandra
   Reiter, Paul
   Gilbert, Marius
TI Forecasting the spatial and seasonal dynamic of Aedes albopictus
   oviposition activity in Albania and Balkan countries
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID INVASIVE MOSQUITOS; CULICIDAE; DIPTERA; SKUSE; TIGER
AB The increasing spread of the Asian tiger mosquito, Aedes albopictus, in Europe and US raises public health concern due to the species competence to transmit several exotic human arboviruses, among which dengue, chikungunya and Zika, and urges the development of suitable modeling approach to forecast the spatial and temporal distribution of the mosquito. Here we developed a dynamical species distribution modeling approach forecasting Ae. albopictus eggs abundance at high spatial (0.01 degree WGS84) and temporal (weekly) resolution over 10 Balkan countries, using temperature times series of Modis data products and altitude as input predictors. The model was satisfactorily calibrated and validated over Albania based observed eggs abundance data weekly monitored during three years. For a given week of the year, eggs abundance was mainly predicted by the number of eggs and the mean temperature recorded in the preceding weeks. That is, results are in agreement with the biological cycle of the mosquito, reflecting the effect temperature on eggs spawning, maturation and hatching. The model, seeded by initial egg values derived from a second model, was then used to forecast the spatial and temporal distribution of eggs abundance over the selected Balkan countries, weekly in 2011, 2012 and 2013. The present study is a baseline to develop an easy-handling forecasting model able to provide information useful for promoting active surveillance and possibly prevention of Ae. albopictus colonization in presently non-infested areas in the Balkans as well as in other temperate regions.
C1 [Tisseuil, Clement; Gilbert, Marius] Univ Libre Bruxelles, Spatial Epidemiol Lab, Brussels, Belgium.
   [Velo, Enkelejda; Bino, Silvia; Kadriaj, Perparim; Simaku, Artan; Rogozi, Elton] Inst Publ Hlth, Control Infect Dis Dept, Tirana, Albania.
   [Mersini, Kujtim] Food Safety & Vet Inst, Natl Vet Epidemiol Unit, Tirana, Albania.
   [Shukullari, Ada] Univ Tirana, Fac Nat Sci, Dept Biol, Tirana, Albania.
   [Caputo, Beniamino; della Torre, Alessandra] Univ Rome Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Ducheyne, Els] European Agroenvironm Hlth Geog Informat Syst, European Econ Interest Grp, Zoersel, Belgium.
   [Reiter, Paul] Inst Pasteur, Insects & Infect Dis Unit, Paris, France.
   [Gilbert, Marius] Fonds Natl Rech Sci, Brussels, Belgium.
RP Velo, E (corresponding author), Inst Publ Hlth, Control Infect Dis Dept, Tirana, Albania.
EM keladikolli@yahoo.com
OI Velo, Enkelejda/0000-0001-7283-2541
FU EUEuropean Union (EU) [FP7-261504 EDENext]
FX This study was partially funded by EU grant FP7-261504 EDENext and is
   catalogued by the EDENext Steering Committee as EDENext399
   (https://www.edenext.eu) and Institute of Public Health, Tirana,
   Albania. The contents of this publication are the sole responsibility of
   the authors and do not necessarily reflect the views of the European
   Commission. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Albieri A, 2010, B INSECTOL, V63, P209
   Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Breheny P., 2014, VISREG VISUALIZATION
   Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cunze S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162116
   EEA, 2013, RAST DAT LAND COV CL
   Erguler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149282
   Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Manica M, 2016, PLOS NEGL TROP DIS
   McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6
   Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Neteler M, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-49
   Patsoula E, 2017, VECTOR-BORNE ZOONOT, V17, P217, DOI 10.1089/vbz.2016.1974
   Roiz D, 2010, VECTOR BORNE ZOO DIS, P10
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800
   Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098
   Romi R, 2008, EUR INFECT DIS, V2, P98
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Simon J., 2015, PSCL CLASSES METHODS
   Toma L, 2003, J AM MOSQUITO CONTR, V19, P19
   Vanwambeke SO, 2007, J MED ENTOMOL, V44, P133, DOI 10.1603/0022-2585(2007)44[133:LALCFI]2.0.CO;2
   Velo E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1501-x
   Vitek CJ, 2006, J AM MOSQUITO CONTR, V22, P609, DOI 10.2987/8756-971X(2006)22[609:FALCOH]2.0.CO;2
   Wickham H., 2015, DPLYR GRAMMAR DATA M
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zamburlini R, 2003, IGIENE ALIMENTI DISI, P8
   Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08
   Zuur A. F., 2012, ZERO INFLATED MODELS
NR 38
TC 3
Z9 3
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2018
VL 12
IS 2
AR e0006236
DI 10.1371/journal.pntd.0006236
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FZ0RM
UT WOS:000427279700029
PM 29432489
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Velazquez-Castro, J
   Anzo-Hernandez, A
   Bonilla-Capilla, B
   Soto-Bajo, M
   Fraguela-Collar, A
AF Velazquez-Castro, Jorge
   Anzo-Hernandez, Andres
   Bonilla-Capilla, Beatriz
   Soto-Bajo, Moises
   Fraguela-Collar, Andres
TI Vector-borne disease risk indexes in spatially structured populations
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID NETWORK MODELS; DYNAMICS; BEHAVIOR; AEGYPTI; DENGUE; TRANSMISSION;
   EMERGENCE; MOVEMENT; SPREAD
AB There are economic and physical limitations when applying prevention and control strategies for urban vector borne diseases. Consequently, there are increasing concerns and interest in designing efficient strategies and regulations that health agencies can follow in order to reduce the imminent impact of viruses like Dengue, Zika and Chikungunya. That includes fumigation, abatization, reducing the hatcheries, picking up trash, information campaigns. A basic question that arise when designing control strategies is about which and where these ones should focus. In other words, one would like to know whether preventing the contagion or decrease vector population, and in which area of the city, is more efficient. In this work, we propose risk indexes based on the idea of secondary cases from patch to patch. Thus, they take into account human mobility and indicate which patch has more chance to be a corridor for the spread of the disease and which is more vulnerable, i.e. more likely to have cases?. They can also indicate the neighborhood where hatchery control will reduce more the number of potential cases. In order to illustrate the usefulness of these indexes, we run a set of numerical simulations in a mathematical model that takes into account the urban mobility and the differences in population density among the areas of a city. If we label by fa particular neighborhood, the transmission risk index (TRi) measures the potential secondary cases caused by a host in that neighborhood. The vector transmission risk index (VTRi) measures the potential secondary cases caused by a vector. Finally, the vulnerability risk index (VRi) measures the potential secondary cases in the neighborhood. Transmission indexes can be used to give geographical priority to some neighborhoods when applying prevention and control measures. On the other hand, the vulnerability index can be useful to implement monitoring campaigns or public health investment.
C1 [Velazquez-Castro, Jorge; Fraguela-Collar, Andres] Benemerita Univ Autonoma Puebla, Fac Ciencias Fis Matemat, Puebla, Mexico.
   [Anzo-Hernandez, Andres; Bonilla-Capilla, Beatriz; Soto-Bajo, Moises] Benemerita Univ Autonoma Puebla, Fac Ciencias Fis Matemat, Catedras CONACYT, Puebla, Mexico.
RP Velazquez-Castro, J (corresponding author), Benemerita Univ Autonoma Puebla, Fac Ciencias Fis Matemat, Puebla, Mexico.
EM jorgevc@fcfm.buap.mx
RI Bonilla-Capilla, Beatriz/M-4974-2019; Velazquez-Castro,
   Jorge/A-9348-2016
OI Bonilla-Capilla, Beatriz/0000-0002-4798-1358; Velazquez-Castro,
   Jorge/0000-0002-7176-2008
FU Universidad Autonoma de Puebla-VIEP [00279, 00463]; CONACYTConsejo
   Nacional de Ciencia y Tecnologia (CONACyT); Laboratorio Nacional de
   Supercomputo del Sureste de Mexico, CONACYT network of national
   laboratories
FX Authors acknowledge Universidad Autonoma de Puebla-VIEP financial
   support through projects 00279 granted to JVC and 00463 granted to AAH,
   call 2017, and also CONACYT financial support of AAH, BBC and MSB
   through "Catedras CONACYT para Jovenes Investigadores 2016" program. The
   authors thankfully acknowledge the computer resources, technical
   expertise and support provided by the Laboratorio Nacional de
   Supercomputo del Sureste de Mexico, CONACYT network of national
   laboratories. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Ames GM, 2011, P ROY SOC B-BIOL SCI, V278, P3544, DOI 10.1098/rspb.2011.0290
   Aparicio JP, 2007, P ROY SOC B-BIOL SCI, V274, P505, DOI 10.1098/rspb.2006.0057
   Apolloni A, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-3
   Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Bichara D, 2016, LETT BIOMATHEMATICS, V3, P140
   Bichara D, 2016, MATH BIOSCI, V281, P128, DOI 10.1016/j.mbs.2016.09.006
   Bichara D, 2015, B MATH BIOL, V77, P2004, DOI 10.1007/s11538-015-0113-5
   Castillo-Chavez C, 2016, P NATL ACAD SCI USA, V113, P14582, DOI 10.1073/pnas.1604994113
   Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028
   Cosner C, 2009, J THEOR BIOL, V258, P550, DOI 10.1016/j.jtbi.2009.02.016
   de Almeida SJ, 2010, MULTIAGENT MODELING
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Esteva L, 2006, J MATH BIOL, V53, P540, DOI 10.1007/s00285-006-0020-3
   Eubank S., 2010, Journal of Biological Dynamics, V4, P446, DOI 10.1080/17513751003778687
   Ferreira CP, 2006, MATH POPUL STUD, V13, P215, DOI 10.1080/08898480600950515
   Gratz NG, 2004, CRITICAL REVIEW OF T
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Jansen Cassie C, 2010, DENGUE VECTOR AEDES
   Keeling M. J., 2008, MODELING INFECT DIS
   Keeling MJ, 2011, NETWORKS EPIDEMIOLOG
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Meyer T., 2016, ENG RISK MANAGEMENT
   Molina C, 2012, J THEOR BIOL, V315, P110, DOI 10.1016/j.jtbi.2012.08.036
   Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925
   Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419
   Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Lima AWS, 2016, J MED ENTOMOL, V53, P343, DOI 10.1093/jme/tjv187
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Sturrock HJW, TACKLING IMPORTED MA, V93, P139
   TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0
   Yang HM, 2011, BIOSYSTEMS, V103, P360, DOI 10.1016/j.biosystems.2010.11.002
NR 35
TC 3
Z9 3
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2018
VL 12
IS 2
AR e0006234
DI 10.1371/journal.pntd.0006234
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FZ0RM
UT WOS:000427279700027
PM 29432455
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Venter, M
AF Venter, Marietjie
TI Assessing the zoonotic potential of arboviruses of African origin
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID WEST-NILE-VIRUS; SOUTH-AFRICA; NEUROLOGIC DISEASE; WESSELSBRON VIRUS;
   CENTRAL-EUROPE; BAGAZA VIRUS; USUTU-VIRUS; SHUNI VIRUS; HORSES;
   TRANSMISSION
AB Several African arboviruses have emerged over the past decade in new regions where they caused major outbreaks in humans and/or animals including West Nile virus, Chikungunya virus and Zika virus. This raise questions regarding the importance of less known zoonotic arboviruses in local epidemics in Africa and their potential to emerge internationally. Syndromic surveillance in animals may serve as an early warning system to detect zoonotic arbovirus outbreaks. Rift Valley fever and Wesselsbronvirus are for example associated with abortion storms in livestock while West Nile-virus, Shuni virus and Middelburg virus causes neurological disease outbreaks in horses and other animals. Death in birds may signal Bagaza virus and Usutu virus outbreaks. This short review summarise data on less known arboviruses with zoonotic potential in Africa.
C1 [Venter, Marietjie] Univ Pretoria, Zoonot Arbo & Resp Virus Program, Dept Med Virol, Fac Hlth, Pretoria, South Africa.
RP Venter, M (corresponding author), Univ Pretoria, Zoonot Arbo & Resp Virus Program, Dept Med Virol, Fac Hlth, Pretoria, South Africa.
EM Marietjie.venter@up.ac.za
RI Venter, Marietjie/P-9604-2016
OI Venter, Marietjie/0000-0003-2696-824X
FU Poliomyelitis Research Foundation of South Africa; National Research
   Foundation; Medical Research councilMedical Research Council UK (MRC);
   Global Disease Detection Programme of the US-CDC [1 U19GH00057102]
FX The arbovirus surveillance and research programme was funded by several
   grants over the years including the Poliomyelitis Research Foundation of
   South Africa, the National Research Foundation, the Medical Research
   council and the Global Disease Detection Programme of the US-CDC (1
   U19GH00057102: Investigation of vector-borne viruses as the cause of
   neurological disease of humans and animals.) Collaboiration agreement
   with the National Institute for Communicable Diseases). This review
   represent the view of the authors and not that of the funders.
CR ACAV: The International Catalog of Arboviruses Including Certain, 2017, ACAV INT CAT ARB INC
   Aguero M, 2011, EMERG INFECT DIS, V17, P1498, DOI 10.3201/eid1708.110077
   Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005
   BARNARD BJH, 1980, ONDERSTEPOORT J VET, V47, P89
   Barzon L., 2015, CLIN MICROBIOL INFEC, V21, pe1121
   BLACKBURN NK, 1980, J HYG-CAMBRIDGE, V85, P1, DOI 10.1017/S0022172400027066
   Bondre VP, 2009, J GEN VIROL, V90, P2644, DOI 10.1099/vir.0.012336-0
   Burt FJ, 2014, FUTURE VIROL, V9, P993, DOI 10.2217/FVL.14.87
   Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021
   Diagne MM, 2017, ONE HEALTH-AMSTERDAM, V3, P23, DOI 10.1016/j.onehlt.2017.02.001
   Drummond R, 2008, VET REC, V162, P763, DOI 10.1136/vr.162.23.763-a
   Forrester NL, 2012, J VIROL, V86, P2729, DOI 10.1128/JVI.05591-11
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Golender N, 2015, EMERG INFECT DIS, V21, P2267, DOI 10.3201/eid2112.150804
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Jupp PG, 1998, J AM MOSQUITO CONTR, V14, P40
   JUPP PG, 1980, ONDERSTEPOORT J VET, V47, P1
   Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x
   Leblond A, 2007, VECTOR-BORNE ZOONOT, V7, P403, DOI 10.1089/vbz.2006.0593
   Lloyed G, 2009, ALPHAVIRUSES
   Lwande OW, 2014, PARASITE VECTOR, P7
   Mackenzie JS, 2013, CURR OPIN VIROL, V3, P170, DOI 10.1016/j.coviro.2013.02.002
   McIntosh B., 1980, EPIDEMIOLOGY ARTHROP
   McINTOSH B. M., 1961, S AFRICAN MED JOUR, V35, P647
   MCINTOSH BM, 1976, J MED ENTOMOL, V12, P637, DOI 10.1093/jmedent/12.6.637
   MCINTOSH BM, 1986, S AFR MED J, P69
   McLean RG, 2001, ANN NY ACAD SCI, V951, P54
   Murray KO, 2011, EPIDEMIOL INFECT, V139, P807, DOI 10.1017/S0950268811000185
   Nanyingi Mark O., 2015, Infection Ecology & Epidemiology, V5, P28024, DOI 10.3402/iee.v5.28024
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Paweska JT, 2015, REV SCI TECH OIE, V34, P375, DOI 10.20506/rst.34.2.2364
   Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Schoub B, 2009, PRINCIPLES PRACTICE
   Storm N, 2014, EPIDEMIOL INFECT, V142, P234, DOI 10.1017/S0950268813000964
   Swanepoel R., 2009, Principles and practice of clinical virology, P699, DOI 10.1002/9780470741405.ch29
   van Eeden C, 2014, EMERG INFECT DIS, V20, P1409, DOI 10.3201/eid2008.131724
   van Eeden C, 2012, EMERG INFECT DIS, V18, P318, DOI 10.3201/eid1802.111403
   van Niekerk S, 2015, EMERG INFECT DIS, V21, P2225, DOI 10.3201/eid2112.150132
   Venter M, 2009, S AFR FAM PRACT, V51, P276, DOI 10.1080/20786204.2009.10873864
   Venter M, 2017, EMERG INFECT DIS, P23
   Venter M, 2009, EMERG INFECT DIS, V15, P877, DOI 10.3201/eid1506.081515
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Were F, 2012, PAEDIATR INT CHILD H, V32, P18, DOI 10.1179/2046904712Z.00000000048
   Weyer J, 2013, VECTOR-BORNE ZOONOT, V13, P330, DOI 10.1089/vbz.2012.1181
   WOLFE MS, 1982, LANCET, V2, P1306
   Zaayman D, 2012, EMERG INFECT DIS, V18, P2051, DOI 10.3201/eid1812.111208
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 53
TC 9
Z9 9
U1 3
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD FEB
PY 2018
VL 28
BP 74
EP 84
DI 10.1016/j.coviro.2017.11.004
PG 11
WC Virology
SC Virology
GA FZ5VV
UT WOS:000427665300013
PM 29216533
DA 2020-07-08
ER

PT J
AU Manglani, M
   McGavern, DB
AF Manglani, Monica
   McGavern, Dorian B.
TI New advances in CNS immunity against viral infection
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; OLFACTORY ENSHEATHING CELLS; EPSTEIN-BARR-VIRUS;
   CD8 T-CELLS; ZIKA VIRUS; CHOROID-PLEXUS; ADOPTIVE IMMUNOTHERAPY; BRAIN;
   MICROGLIA; PATHOGENESIS
AB The central nervous system (CNS) is an immunologically specialized organ where restrictive barrier structures protect the parenchyma from inflammation and infection. This protection is important in preventing damage to non-renewable resident cell populations, such as neurons, responsible for functions ranging from executive to autonomic. Despite these barriers, the CNS can be infected through several entry portals, giving rise to meningitis and encephalitis. Following infection, resident cells recruit peripherally derived immune cells to sites of viral infection. In this review, we discuss recent advances in immune recruitment and entry at barrier structures as well as current immunotherapeutic strategies for the treatment of persistent viral infections.
C1 [Manglani, Monica; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Manglani, Monica] Penn State Coll Med, Med Scientist Training Program, Hershey, PA USA.
RP McGavern, DB (corresponding author), NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
EM mcgavernd@mail.nih.gov
FU National Institute of Neurological Disorders & Stroke (NINDS), National
   Institutes of Health (NIH)
FX This work was supported by the intramural program at the National
   Institute of Neurological Disorders & Stroke (NINDS), National
   Institutes of Health (NIH). We thank Alan Hoofring and Ethan Tyler in
   the NIH Medical Arts Design Section for their help with the
   illustrations.
CR ANDRES KH, 1987, ANAT EMBRYOL, V175, P289, DOI 10.1007/BF00309843
   Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023
   Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
   Balduzzi A, 2011, BONE MARROW TRANSPL, V46, P987, DOI 10.1038/bmt.2010.221
   BALIN BJ, 1986, J COMP NEUROL, V251, P260, DOI 10.1002/cne.902510209
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Baruch K, 2015, EMBO J, V34, P1816, DOI 10.15252/embj.201591468
   Berger DP, 2000, VIROLOGY, V266, P257, DOI 10.1006/viro.1999.0074
   Beyer M, 2016, NAT IMMUNOL, V17, P593, DOI 10.1038/ni.3399
   Billioux BJ, 2017, JAMA NEUROL, V74, P1141, DOI 10.1001/jamaneurol.2017.1460
   Chai QQ, 2015, J VIROL, V89, P870, DOI 10.1128/JVI.02154-14
   Coles JA, 2017, PROG NEUROBIOL, V156, P107, DOI 10.1016/j.pneurobio.2017.05.002
   Conrady CD, 2013, J IMMUNOL, V190, P2807, DOI 10.4049/jimmunol.1203265
   Cupovic J, 2016, IMMUNITY, V44, P622, DOI 10.1016/j.immuni.2015.12.022
   Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Daniels BP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005096
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Drokhlyansky E, 2017, P NATL ACAD SCI USA, V114, pE95, DOI 10.1073/pnas.1618157114
   Durrant DM, 2016, ACS CHEM NEUROSCI, V7, P464, DOI 10.1021/acschemneuro.6b00043
   Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Henderson B, 2017, J PEDIAT INFECT DIS
   Herz J, 2015, J EXP MED, V212, P1153, DOI 10.1084/jem.20142047
   Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Jelcic I, 2016, ANN NEUROL, V79, P404, DOI 10.1002/ana.24574
   Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683
   Kelesidis Theodoros, 2014, BMC Infect Dis, V14, P321, DOI 10.1186/1471-2334-14-321
   Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638
   Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610
   Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144
   Koyanagi N, 2017, J CLIN INVEST, V127, P3784, DOI 10.1172/JCI92931
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Kunis G, 2013, BRAIN, V136, P3427, DOI 10.1093/brain/awt259
   Landis BN, 2010, J NEUROL, V257, P439, DOI 10.1007/s00415-009-5344-7
   Lee H, 2015, MUCOSAL IMMUNOL, V8, P1083, DOI 10.1038/mi.2014.135
   Lei YM, 2017, PROG NEUROBIOL, V157, P230, DOI 10.1016/j.pneurobio.2015.12.007
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lin FC, 2014, CYTOKINE GROWTH F R, V25, P369, DOI 10.1016/j.cytogfr.2014.07.015
   Llovera G, 2017, ACTA NEUROPATHOL
   Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006
   Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136
   McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105
   McGavern DB, 2006, NEUROLOGY, V66, pS59, DOI 10.1212/01.wnl.0000192109.81449.7a
   Miller KD, 2016, NAT REV NEUROSCI, V17, P766, DOI 10.1038/nrn.2016.140
   Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105
   Mori I, 2002, J GEN VIROL, V83, P2109, DOI 10.1099/0022-1317-83-9-2109
   Munster VJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00736
   Nair S, 2015, CURR OPIN IMMUNOL, V36, P47, DOI 10.1016/j.coi.2015.06.011
   Nath A, 2013, ANN NEUROL, V74, P412, DOI 10.1002/ana.23988
   Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240
   Nayak D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003395
   Nazareth L, 2015, J COMP NEUROL, V523, P479, DOI 10.1002/cne.23694
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   OLDSTONE MBA, 1986, NATURE, V321, P239, DOI 10.1038/321239a0
   Pabst R, 2015, VACCINE, V33, P4406, DOI 10.1016/j.vaccine.2015.07.022
   Panni P, 2013, NEUROSCI LETT, V539, P65, DOI 10.1016/j.neulet.2013.01.052
   Pender MP, 2014, MULT SCLER J, V20, P1541, DOI 10.1177/1352458514521888
   Pender MP, 2014, IMMUNOTHERAPY-UK, V6, P659, DOI [10.2217/IMT.14.43, 10.2217/imt.14.43]
   PENDER MP, 2017, CLIN TRANSL IMMUNOL, V6
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Pikor NB, 2017, J IMMUNOL, V198, P1775, DOI 10.4049/jimmunol.1601566
   Pikor NB, 2015, IMMUNITY, V43, P1160, DOI 10.1016/j.immuni.2015.11.010
   Pizzolla A, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6970
   Reinert LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13348
   Riddell J, 2012, NEUROIMAG CLIN N AM, V22, P543, DOI 10.1016/j.nic.2012.05.003
   Rosato PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005028
   Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002
   Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002
   Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939
   Schwerk C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00080
   Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030
   Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Swanson PA, 2015, CURR OPIN VIROL, V11, P44, DOI 10.1016/j.coviro.2014.12.009
   Tian J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159033
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   van den Pol AN, 2014, J VIROL, V88, P3695, DOI 10.1128/JVI.03509-13
   Vincent AJ, 2007, GLIA, V55, P905, DOI 10.1002/glia.20512
   Vincent AJ, 2005, GLIA, V51, P132, DOI 10.1002/glia.20195
   Watanabe R, 2016, NEUROPATHOLOGY, V36, P513, DOI 10.1111/neup.12302
   Wegner KW, 2017, TRENDS PHARMACOL SCI, V38, P202, DOI 10.1016/j.tips.2016.12.005
   Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416
NR 92
TC 9
Z9 9
U1 3
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD FEB
PY 2018
VL 28
BP 116
EP 126
DI 10.1016/j.coviro.2017.12.003
PG 11
WC Virology
SC Virology
GA FZ5VV
UT WOS:000427665300018
PM 29289900
OA Green Published
DA 2020-07-08
ER

PT J
AU Dhama, K
   Karthik, K
   Tiwari, R
   Khandia, R
   Munjal, A
   Chakraborty, S
   Yadav, JP
   Kumar, D
   Latheef, SK
   Saminathan, M
   Malik, YS
   Iqbal, HMN
   Singh, RK
AF Dhama, Kuldeep
   Karthik, Kumaragurubaran
   Tiwari, Ruchi
   Khandia, Rekha
   Munjal, Ashok
   Chakraborty, Sandip
   Yadav, Jay Prakash
   Kumar, Deepak
   Latheef, Shyma K.
   Saminathan, Mani
   Malik, Yashpal Singh
   Iqbal, Hafiz M. N.
   Singh, Raj Kumar
TI ZIKA VIRUS / ZIKA FEVER : A COMPREHENSIVE UPDATE
SO JOURNAL OF EXPERIMENTAL BIOLOGY AND AGRICULTURAL SCIENCES
LA English
DT Review
DE Zika virus; Zika fever; Pathology; Diagnosis; Vaccines; Drugs;
   Treatment; Prevention, control
ID GUILLAIN-BARRE-SYNDROME; MEDIATED ISOTHERMAL AMPLIFICATION;
   TRANSMISSION-BLOCKING VACCINES; ANTIBODY-DEPENDENT ENHANCEMENT; EMERGING
   ARBOVIRAL DISEASE; VECTOR-BORNE DISEASES; TIME RT-PCR; DENGUE VIRUS;
   INHIBITS ZIKA; AEDES-AEGYPTI
AB Zika virus (ZIKV) has attracted global attention after its first large-scale outbreak in Pacific, Micronesian island of Yap (Year 2007). The virus spreads rapidly and owes increased virulence than the ZIKV which appeared nearly six decades ago, where it was associated with sporadic cases and mild illness. The World Health Organization declared ZIKA as a, Public Health Emergency of International Concern" due to severe illness and associated several complications such as neurological disorders, autoimmune disorder, fetal anomalies, impaired central nervous system (CNS) of the fetus, microcephaly in newborns and Guillain Barre'Syndrome (GBS). Recently, this virus has posed a pandemic threat to global human population. The virus is transmitted primarily by a mosquito (Aedes aegypti), whereas, other routes of viral transmission includes monkey bite, coitus and body fluids such as blood, semen, and saliva which needs further confirmaton. Furthermore, implementation of appropriate mechanical, chemical and biological control methodologies can help to avoid mosquito bites and ultimately limit the viral spread. Another potential approach could be the development of ZIKV resistant mosquito strains such as Wolbachia-harboring mosquitoes which can reduce the incidences of ZIKV by lowering the availability of vectors for virus transmission. In-use ZIKV diagnosis relies on serological, molecular and few other advanced detection methods. Nowadays, worldwide researchers and biomedical and pharmaceutical authorities are paying attention on designing and developing effective vaccines, drugs, medicines, and therapeutics to counter this virus. The reasons behind the shift of virus virulence need to be explored by understanding the genetic and molecular characteristics, host-pathogen interactions and immunobiology of the virus, which would help to design effective antiviral drugs, prophylactics, and vaccines. The present review highlights various aspects of ZIKV and its clinical manifestations, progress, and advances in developing effective diagnostics, vaccines and drugs/therapeutics along with adopting suitable prevention and control strategies to tackle this deadly emerging disease.
C1 [Dhama, Kuldeep; Saminathan, Mani] ICAR Indian Vet Res Inst, Div Pathol, Izatnagar 243122, UP, India.
   [Karthik, Kumaragurubaran] Tamil Nadu Vet & Anim Sci Univ, Cent Univ Lab, Madras 600051, Tamil Nadu, India.
   [Tiwari, Ruchi] UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vig, Coll Vet Sci, Dept Vet Microbiol & Immunol, Mathura 281001, UP, India.
   [Khandia, Rekha; Munjal, Ashok] Barkatullah Univ, Dept Biochem & Genet, Bhopal 462026, MP, India.
   [Chakraborty, Sandip] Coll Vet Sci & Anim Husb, Dept Vet Microbiol, Rk Nagar 799008, W Tripura, India.
   [Yadav, Jay Prakash] ICAR Indian Vet Res Inst, Div Vet Publ Hlth, Izatnagar 243122, UP, India.
   [Kumar, Deepak] ICAR Indian Vet Res Inst, Div Vet Biotechnol, Izatnagar 243122, UP, India.
   [Latheef, Shyma K.] ICAR Indian Vet Res Inst, Immunol Sect, Izatnagar 243122, UP, India.
   [Malik, Yashpal Singh] ICAR Indian Vet Res Inst, Div Biol Standardizat, Izatnagar 243122, UP, India.
   [Iqbal, Hafiz M. N.] Tecnol Monterrey, Sch Sci & Engn, Campus Monterrey,Ave Eugenio Garza Sada 2501, Monterrey 64849, NL, Mexico.
   [Singh, Raj Kumar] ICAR Indian Vet Res Inst, Izatnagar 243122, UP, India.
RP Dhama, K (corresponding author), ICAR Indian Vet Res Inst, Div Pathol, Izatnagar 243122, UP, India.; Malik, YS (corresponding author), ICAR Indian Vet Res Inst, Div Biol Standardizat, Izatnagar 243122, UP, India.
EM kdhama@rediffmail.com; malikyps@gmail.com
RI Iqbal, Hafiz M.N./J-5423-2014; Malik, Yashpal Singh/AAI-2259-2019;
   Hossein, Fria/AAC-7149-2019; Dhama, Kuldeep/B-7852-2015
OI Iqbal, Hafiz M.N./0000-0003-4855-2720; Dhama,
   Kuldeep/0000-0001-7469-4752
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Adalja Amesh, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.1c39ec05a743d41ee39391ed0f2ed8d3
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   Alfonso-Parra C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004451
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Alphey L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003909
   Anglero-Rodriguez YI, 2017, FRONTIERS MICROBIOLO
   Anholeti MC, 2015, MEM I OSWALDO CRUZ, V110, P629, DOI 10.1590/0074-02760150103
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Ashfaq UA, 2016, VIRAL IMMUNOL, V29, P436, DOI 10.1089/vim.2016.0033
   Asif A, 2017, VIRAL IMMUNOL, V30, P682, DOI 10.1089/vim.2017.0046
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Awasthi S., 2016, J ANTIVIR ANTIRETROV, V8, P61, DOI DOI 10.4172/JAA.1000E130
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Bonin CRB, 2017, HUM VACC IMMUNOTHER, V13, P484, DOI 10.1080/21645515.2017.1264774
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10218, DOI 10.1007/s11356-016-8146-3
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benzekri R, 2017, J FR OPHTALMOL, V40, P138, DOI 10.1016/j.jfo.2017.01.002
   BESNARD M, 2014, EUROSURVEILLANCE, V19, P13
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Blecher K, 2011, VIRULENCE, V2, P395, DOI 10.4161/viru.2.5.17035
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Bullerdiek J, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0240-1
   Butler T, 2001, Carba-nucleoside analogs for antiviral treatment., Patent No. [US8012942B2, 8012942]
   Byler KG, 2016, PLANTA MED, V82, DOI 10.1055/s-0036-1596272
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   CALVET G, 2016, LANCET INFECT DIS, V16, P653, DOI DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CAOLORMEAU VM, 2016, LANCET, V387, P1531, DOI DOI 10.1016/S0140-6736(16)00562-6
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, REV DIAGN TEST ZIK C
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Chiang C, 2015, J VIROL, V89, P8011, DOI 10.1128/JVI.00845-15
   Chitti Sai V., 2016, VirusDisease, V27, P211, DOI 10.1007/s13337-016-0317-9
   Clark KB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00305
   Conde JN, 2016, J VIROL, V90, P9570, DOI 10.1128/JVI.00912-16
   Contreras D, 2016, JOVE-J VIS EXP, V114
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Coutinho-Abreu IV, 2010, MEM I OSWALDO CRUZ, V105, P1, DOI 10.1590/S0074-02762010000100001
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Wispelaere M, 2017, ANTIVIR RES, V139, P171, DOI 10.1016/j.antiviral.2016.12.017
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delvecchio R, 2016, VIRUSES, V8, pE322
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Devnarain N, 2017, RSC ADV, V7, P47416, DOI 10.1039/c7ra05918c
   Dhama K., 2013, INT J CURR RES, V5, P1942
   Dhama K, 2018, CURR DRUG METAB, V19, P236, DOI 10.2174/1389200219666180129145252
   Dhama K, 2016, RECENT PATENTS INFLA, V10, P105, DOI 10.2174/1872213X10666161226162229
   Dhama K, 2015, J INFECT DEV COUNTR, V9, P441, DOI 10.3855/jidc.6197
   Dhama Kuldeep, 2014, Pak J Biol Sci, V17, P151, DOI 10.3923/pjbs.2014.151.166
   Dhama Kuldeep, 2013, Pak J Biol Sci, V16, P101, DOI 10.3923/pjbs.2013.101.111
   Dhiman RC, 2010, PARASITOL RES, V106, P763, DOI 10.1007/s00436-010-1767-4
   Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x
   Dick GW, 1952, T ROY SOC TROP MED H, V46, P521
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Ding S, 2017, AME MED J, DOI [10.21037/amj.2017.05.22, DOI 10.21037/AMJ.2017.05.22]
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duhaime-Ross A, 2016, THE VERGE
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   DUTRA HLC, 2016, MOSQUITOES, V19, P771, DOI DOI 10.1016/J.CHOM.2016.04.021
   Dyer O., 2016, BMJ-BRIT MED J, V352, pi630
   Dyer O, 2016, BMJ-BRIT MED J, V353, pi3588
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Elgot J, 2016, THE GUARDIAN
   Epelboin S, 2017, HUMAN REPROD UPDATE, V9, P1
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Farcet MR, 2017, TRANSFUSION, V57, P797, DOI 10.1111/trf.13953
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feranchuk S., 2016, VIRTUAL SCREENING IN, DOI 10.1101/060798
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313
   Freire CCDM, 2015, BIORXIV, DOI DOI 10.1101/032839
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   GOULD EA, 1989, J GEN VIROL, V70, P1605, DOI 10.1099/0022-1317-70-6-1605
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govindarajan M, 2016, ENZYME MICROB TECH, V95, P155, DOI 10.1016/j.enzmictec.2016.05.005
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   HALSTEAD SB, 1973, J INFECT DIS, V128, P7, DOI 10.1093/infdis/128.1.7
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMPTON T, 2016, J AM MED ASS, V316, P1755
   Hashem MA, 2017, J YOUNG PHARM, V9, P23, DOI 10.5530/jyp.2017.9.5
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Ibrahim NK, 2016, PAK J MED SCI, V32, P1038, DOI 10.12669/pjms.324.10038
   Iqbal HMN, 2016, RECENT PATENTS INFLA, V10, P86, DOI 10.2174/1872213X10666161213162823
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Junquera Elena C, 2014, Recent Pat Antiinfect Drug Discov, V9, P14
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Kaushik A, 2017, TRENDS BIOTECHNOL, V35, P308, DOI 10.1016/j.tibtech.2016.10.001
   Kawadkar J, 2011, J PHARM CLIN RES, V4, P23
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kelvin AA, 2016, J INFECT DEV COUNTR, V10, P113, DOI 10.3855/jidc.8248
   Kennedy RB, 2011, EBIOMEDICINE, V13, P29
   Kennedy RB, 2011, OMICS, V15, P533, DOI 10.1089/omi.2011.0012
   Khandia R, 2017, INT J PHARMACOL, V13, P370, DOI 10.3923/ijp.2017.370.377
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Koenig KL, 2016, WEST J EMERG MED, V17, P238, DOI 10.5811/westjem.2016.3.30188
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Kollars T. M., 2016, IOSR J DENT MED SCI, V15, P104, DOI [10.9790/0853-150907104107, DOI 10.9790/0853-150907104107]
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Kuhnel D, 2016, TRANSFUSION, V138, P16212
   Kuldeep Dhama, 2014, Research Opinions in Animal and Veterinary Sciences, V4, P353
   Kuldeep Dhama, 2013, Advances in Animal and Veterinary Sciences, V1, P14
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lambe U, 2016, J EXP BIOL AGRIC SCI, V4, P307, DOI 10.18006/2016.4(3S).307.320
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Lazear HM, 2017, CELL HOST MICROBE, V21, P305, DOI 10.1016/j.chom.2017.02.015
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lim L., 2016, BIORXIV, DOI [10.1101/078543, DOI 10.1101/078543]
   Liu SQ, 2018, J MED VIROL, V90, P389, DOI 10.1002/jmv.24970
   Londono-Renteria B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1802-0
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mahalingam S, 2017, LANCET INFECT DIS, V17, P686, DOI 10.1016/S1473-3099(17)30340-7
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Malik Y. S., 2013, South Asian Journal of Experimental Biology, V3, P207
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martins KAO, 2016, VACCINE, V34, P3711, DOI 10.1016/j.vaccine.2016.06.012
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Mehrdad Mohammadpour, 2017, JAPANESE J RADIOLOGY, P1
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Mirza MU, 2016, SCI REP, V6, P37313, DOI [10.1038/srep44633, DOI 10.1038/SREP44633]
   Mittal R, 2018, JAMA OTOLARYNGOL, V144, P3, DOI 10.1001/jamaoto.2017.1798
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molko N, 2017, NEUROLOGY, V88, P1097, DOI 10.1212/WNL.0000000000003697
   MONATH TP, 1980, AM J TROP MED HYG, V29, P624, DOI 10.4269/ajtmh.1980.29.624
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Mukherjee S., 2016, COMMUNIT ACQUIR INFE, V3, P31, DOI [10.4103/2225-6482.184908, DOI 10.4103/2225-6482.184908]
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Munjal A, 2017, INT J PHARMACOL, V13, P667, DOI 10.3923/ijp.2017.667.676
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Musso D, 2014, REV BRASILEIRA HEMAT, V19
   Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nandi S, 2016, MABS-AUSTIN, V8, P1456, DOI 10.1080/19420862.2016.1227901
   Nayak S, 2016, SEMIN REPROD MED, V34, P266, DOI 10.1055/s-0036-1592071
   Neelakanta G, 2015, ARCH IMMUNOL THER EX, V63, P169, DOI 10.1007/s00005-014-0324-8
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pan American Health Organization/ World Health Organization (PAHO/WHO), 2016, REG ZIK EP UPD AM 2
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parham P. E, 2015, PHILOS T ROYAL SOC B, V370
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Passi D, 2017, INT J PREVENTIVE MED, V8, P6
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paz-Bailey G, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJM0A1613108]
   Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Poland GA, 2018, LANCET INFE IN PRESS
   Poland GA, 2013, SEMIN IMMUNOL, V25, P89, DOI 10.1016/j.smim.2013.04.007
   Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032
   Prasad M, 2018, BIOMED PHARMACOTHER, V97, P1521, DOI 10.1016/j.biopha.2017.11.026
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Pyke AT, 2014, PLOS CURRENTS, V6
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rajeswary M, 2018, ENVIRON SCI POLLUT R, V25, P10307, DOI 10.1007/s11356-017-9093-3
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Reegan Appadurai Daniel, 2015, Osong Public Health Res Perspect, V6, P64, DOI 10.1016/j.phrp.2014.08.009
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reveiz L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180220
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rossi P, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0888-0
   Roy A, 2016, BIORXIV
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sanabani SS, 2017, PLOS CURRENT, DOI [10.1371/currents.outbreaks.a7f1db2c7d66c3fc0ea0a774305d319e, DOI 10.1371/CURRENTS.ENTS.OUTBREAKS.A7F1DB2C7D66C3FC0EA0A774305D319E]
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarwar M., 2015, INT J PREVENTIVE MED, V1, P232
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shadgan B, 2016, CURR SPORT MED REP, V15, P298, DOI 10.1249/JSR.0000000000000278
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Shoaib Maria, 2016, J Ayub Med Coll Abbottabad, V28, P210
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Singh RK, 2017, VET QUART, V37, P98, DOI 10.1080/01652176.2017.1309474
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Singh RK, 2015, NAT WORKSH CURR TREN, P1
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Specter M, 2012, THE OSQUITO SOLUTION
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   St George K, 2018, REV MED MICROBIOL, V29, P8, DOI 10.1097/MRM.0000000000000125
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Steinhagen K, 2016, EURO SURVEILL, V21
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Sumathy K, 2017, SCI REPORTS
   Sumita LM, 2016, REV INST MED TROP SP, V58, DOI [10.1590/s1678-9946201658089, 10.1590/S1678-9946201658089]
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Suzuki Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005357
   Sze A, 2017, VIRUSES, V9
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   TANG HL, 2016, CELL STEM CELL, V18, P587, DOI DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Teruya J, 2017, J THORAC CARDIOV SUR, V154, P303, DOI 10.1016/j.jtcvs.2016.11.074
   Tiago PV, 2014, CIENC RURAL, V44, P645, DOI 10.1590/S0103-84782014000400012
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tiwari R, 2018, CURR DRUG METAB, V19, P264, DOI 10.2174/1389200219666180129125436
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torjesen I, 2016, BMJ-BRIT MED J, V352, pi500
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Tuse D, 2014, BIOMED RES INT, DOI 10.1155/2014/256135
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Valero N, 2015, INVEST CLIN, V56, P241
   van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Varghese FS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02227-16, 10.1128/aac.02227-16]
   Veljkovic Veljko, 2016, F1000Res, V5, P190, DOI 10.12688/f1000research.8102.2
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vest KG, 2017, DISASTER MED PUBLIC, V11, P163, DOI 10.1017/dmp.2016.105
   Von Seidlein L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002219
   Vythilingam I, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01452
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170128
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Weterings R, 2015, J VECTOR ECOL, V40, P230, DOI 10.1111/jvec.12158
   WHO, 2016, ZIK SIT REP ZIK VIR
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Xu X, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b, DOI 10.1371/CURRENTS.OUTBREAKS.9AA2E1FB61B0F632F58A098773008C4B]
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 379
TC 3
Z9 3
U1 0
U2 14
PU JOURNAL EXPERIMENTAL BIOLOGY & AGRICULTURAL SCIENCES
PI ALIGARH
PA JOURNAL EXPERIMENTAL BIOLOGY & AGRICULTURAL SCIENCES, ALIGARH, 00000,
   INDIA
SN 2320-8694
J9 J EXP BIOL AGRIC SCI
JI J. Exp. Biol. Agric. Sci.
PD FEB
PY 2018
VL 6
IS 1
BP 1
EP 31
DI 10.18006/2018.6(1).1.31
PG 31
WC Agronomy
SC Agriculture
GA FZ8UP
UT WOS:000427886100001
OA Bronze
DA 2020-07-08
ER

PT J
AU Cao, B
   Sheth, MN
   Mysorekar, IU
AF Cao, Bin
   Sheth, Meghal N.
   Mysorekar, Indira U.
TI To Zika and destroy: an antimalarial drug protects fetuses from Zika
   infection
SO FUTURE MICROBIOLOGY
LA English
DT Editorial Material
DE autophagy; hydroxychloroquine; placenta; pregnancy
ID VIRUS-INFECTION; PREGNANCY; AUTOPHAGY; DISEASES; CELLS
AB Given that HCQ is relatively inexpensive and readily available globally, including in low- and middle-income countries, HCQ may prove to be an ideal therapeutic to treat pregnant women who test positive for ZIKV.
C1 [Cao, Bin; Sheth, Meghal N.; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Cao, Bin; Sheth, Meghal N.; Mysorekar, Indira U.] Washington Univ, Sch Med, Ctr Reprod Hlth Sci, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA.
RP Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave, St Louis, MO 63110 USA.; Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Ctr Reprod Hlth Sci, 660 South Euclid Ave, St Louis, MO 63110 USA.; Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA.
EM imysorekar@wustl.edu
FU National Institutes of Health/Eunice Kennedy Shriver National Institute
   of Child Health and Human Development grant [R01HD091218]
FX This work was supported by National Institutes of Health/Eunice Kennedy
   Shriver National Institute of Child Health and Human Development grant
   R01HD091218 (to IUM). The authors have no other relevant affiliations or
   financial involvement with any organization or entity with a financial
   interest in or financial conflict with the subjectmatter ormaterials
   discussed in the manuscript apart from those disclosed.
CR Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Cao B, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86654
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Costedoat-Chalumeau N, 2003, ARTHRITIS RHEUM, V48, P3207, DOI 10.1002/art.11304
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kaplan YC, 2016, BRIT J CLIN PHARMACO, V81, P835, DOI 10.1111/bcp.12872
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Motta Mario, 2005, J Perinatol, V25, P86, DOI 10.1038/sj.jp.7211208
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   Wang LF, 2015, J INTERF CYTOK RES, V35, P143, DOI 10.1089/jir.2014.0038
NR 17
TC 4
Z9 4
U1 0
U2 2
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0913
EI 1746-0921
J9 FUTURE MICROBIOL
JI Future Microbiol.
PD FEB
PY 2018
VL 13
IS 2
BP 137
EP 139
DI 10.2217/fmb-2017-0213
PG 3
WC Microbiology
SC Microbiology
GA FZ0PR
UT WOS:000427273500001
PM 29302996
OA Bronze
DA 2020-07-08
ER

PT J
AU Smith, DR
   Bocan, TM
AF Smith, Darci R.
   Bocan, Thomas M.
TI Could PET imaging provide insights into Zika virus neurological sequelae
   progression?
SO FUTURE VIROLOGY
LA English
DT Editorial Material
DE FDG; FMISO; molecular imaging; PET; viral bioreporter; Zika virus
C1 [Smith, Darci R.] US Army, Med Res Inst Infect Dis, Virol Div, 1425 Porter St, Ft Detrick, MD 21702 USA.
   [Bocan, Thomas M.] US Army, Med Res Inst Infect Dis, Mol & Translat Sci Div, 1425 Porter St, Ft Detrick, MD 21702 USA.
RP Smith, DR (corresponding author), US Army, Med Res Inst Infect Dis, Virol Div, 1425 Porter St, Ft Detrick, MD 21702 USA.
EM darci.r.smith.ctr@mail.mil
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bocan TM, 2015, MOL IMAGING BIOL, V17, P4, DOI 10.1007/s11307-014-0759-7
   Brader P, 2013, J NUCL MED, V54, P167, DOI 10.2967/jnumed.111.099788
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Clark PM, 2014, P NATL ACAD SCI USA, V111, pE2866, DOI 10.1073/pnas.1410326111
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Kuszpit K, 2017, MOL IMAGING BIOL, DOI [10.1007/s11307-017-1118-1112, DOI 10.1007/S11307-017-1118-1112]
   Lewis DY, 2015, CANCER J, V21, P129, DOI 10.1097/PPO.0000000000000105
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rini JN, 2006, RADIOLOGY, V238, P978, DOI 10.1148/radiol.2382041993
   Sawatzke AB, 2015, PLACENTA, V36, P115, DOI 10.1016/j.placenta.2014.12.009
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 20
TC 0
Z9 0
U1 0
U2 2
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD FEB
PY 2018
VL 13
IS 2
BP 75
EP 78
DI 10.2217/fvl-2017-0137
PG 4
WC Virology
SC Virology
GA FZ1SO
UT WOS:000427357900001
OA Bronze
DA 2020-07-08
ER

PT J
AU Roth, C
   Delgado, FG
   Simon-Loriere, E
   Sakuntabhai, A
AF Roth, Claude
   Delgado, Felix G.
   Simon-Loriere, Etienne
   Sakuntabhai, Anavaj
TI Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine
   Development
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE Zika virus; dengue virus; T cell epitopes; vaccination
ID ANTIBODY-DEPENDENT ENHANCEMENT; HUMAN NEUTRALIZING ANTIBODIES;
   CROSS-REACTIVITY; HEMORRHAGIC-FEVER; PROTECTIVE ROLE; HLA-B; INFECTION;
   EPITOPES; CD4(+); DISEASE
AB Despite numerous efforts to identify the molecular and cellular effectors of the adaptive immunity that induce a long-lasting immunity against dengue or Zika virus infection, the specific mechanisms underlying such protective immunity remain largely unknown. One of the major challenges lies in the high level of dengue virus (DENV) seroprevalence in areas where Zika virus (ZIKV) is circulating. In the context of such a pre-existing DENV immunity that can exacerbate ZIKV infection and disease, and given the lack of appropriate treatment for ZIKV infection, there is an urgent need to develop an efficient vaccine against DENV and ZIKV. Notably, whereas several ZIKV vaccine candidates are currently in clinical trials, all these vaccine candidates have been designed to induce neutralizing antibodies as the primary mechanism of immune protection. Given the difficulty to elicit simultaneously high levels of neutralizing antibodies against the different DENV serotypes, and the potential impact of pre-existing subneutralizing antibodies induced upon DENV infection or vaccination on ZIKV infection and disease, additional or alternative strategies to enhance vaccine efficacy, through T cell immunity, are now being considered. In this review, we summarize recent discoveries about cross-reactive B and T cell responses against DENV and ZIKV and propose guidelines for the development of safe and efficient T cell vaccines targeting both viruses.
C1 [Roth, Claude; Delgado, Felix G.; Simon-Loriere, Etienne; Sakuntabhai, Anavaj] Inst Pasteur, Funct Genet Infect Dis Unit, F-75015 Paris, France.
   [Roth, Claude; Delgado, Felix G.; Simon-Loriere, Etienne; Sakuntabhai, Anavaj] Inst Pasteur, CNRS, UMR Genom Evolut Modelisat & Sante 2000, F-75015 Paris, France.
   [Delgado, Felix G.] Univ El Bosque, Virol Grp, Bogota 110121, Colombia.
RP Roth, C (corresponding author), Inst Pasteur, Funct Genet Infect Dis Unit, F-75015 Paris, France.; Roth, C (corresponding author), Inst Pasteur, CNRS, UMR Genom Evolut Modelisat & Sante 2000, F-75015 Paris, France.
EM claude.roth@pasteur.fr; fdelgadot@unbosque.edu.co;
   etienne.simon-loriere@pasteur.fr; anavaj.sakuntabhai@pasteur.fr
OI , Etienne/0000-0001-8420-7743; Delgado, Felix/0000-0002-1734-6855; Roth,
   Claude/0000-0001-6360-4758
FU Ecole Doctoral BioSPC (Universite Paris Diderot) [679]; Colombian
   Department of Science, Technolomgy and Innovation (COLCIENCIAS) [679];
   "Integrative Biology of Emerging Infectious Diseases" Labex (Laboratoire
   d'excellence) grant ANRFrench National Research Agency (ANR)
   [ANR-10-LABX-62-IBEID]; European Commission Seventh Framework
   ProgramEuropean Union (EU) [282 378]; Prix Duquesne
FX The authors would like to acknowledge the Ecole Doctoral BioSPC
   (Universite Paris Diderot) and the Colombian Department of Science,
   Technolomgy and Innovation (COLCIENCIAS) for the doctoral scholarship
   program (Nb. 679) of F.G.D. The authors acknowledge also support from
   the "Integrative Biology of Emerging Infectious Diseases" Labex
   (Laboratoire d'excellence) grant ANR Num. ANR-10-LABX-62-IBEID (French
   Governement's "Investissements d'Avenir" program), the European
   Commission Seventh Framework Program (PF7/2007-2013) for the DENFREE
   project under Grant Agreement no 282 378 and Prix Duquesne.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Andrade DV, 2017, VIRUS RES
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Clapham HE, 2016, J INFECT DIS, V213, P1428, DOI 10.1093/infdis/jiv759
   Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Dar H, 2016, ASIAN PAC J TROP MED, V9, P822, DOI 10.1016/j.apjtm.2016.07.004
   de Alwis R, 2014, METHODS MOL BIOL, V1138, P27, DOI 10.1007/978-1-4939-0348-1_3
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Forshey BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004398
   Grifoni A, 2017, J VIROL, V91
   Halstead S. B., 2017, CSH PERSPECT BIOL
   HALSTEAD SB, 1973, AM J TROP MED HYG, V22, P365, DOI 10.4269/ajtmh.1973.22.365
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kurane I, 1998, VIROLOGY, V240, P169, DOI 10.1006/viro.1997.8925
   Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   LIVINGSTON PG, 1995, J IMMUNOL, V154, P1287
   Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320
   Malavige GN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020581
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naiyer MM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5296
   Nascimento EJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002497
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Okamoto Y, 1998, J GEN VIROL, V79, P697, DOI 10.1099/0022-1317-79-4-697
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Pacheco O, 2016, N ENGL J MED
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Puschnik A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002274
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Rivino L, 2016, EXPERT REV VACCINES, V15, P443, DOI 10.1586/14760584.2016.1116948
   Rivino L, 2013, J IMMUNOL, V191, P4010, DOI 10.4049/jimmunol.1301507
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Simon-Loriere E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5088
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Waggoner JJ, 2016, J INFECT DIS, V214, P986, DOI 10.1093/infdis/jiw099
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Xu X, 2016, PLOS CURR, V8
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zeng LL, 1996, J VIROL, V70, P3108, DOI 10.1128/JVI.70.5.3108-3117.1996
   Zivny J, 1999, J IMMUNOL, V163, P2754
   Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13
NR 105
TC 3
Z9 3
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB
PY 2018
VL 15
IS 2
AR 385
DI 10.3390/ijerph15020385
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FY3LM
UT WOS:000426721400210
PM 29473899
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Weetman, D
   Kamgang, B
   Badolo, A
   Moyes, CL
   Shearer, FM
   Coulibaly, M
   Pinto, J
   Lambrechts, L
   McCall, PJ
AF Weetman, David
   Kamgang, Basile
   Badolo, Athanase
   Moyes, Catherine L.
   Shearer, Freya M.
   Coulibaly, Mamadou
   Pinto, Joao
   Lambrechts, Louis
   McCall, Philip J.
TI Aedes Mosquitoes and Aedes-Borne Arboviruses in Africa: Current and
   Future Threats
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE Aedes aegypti; Aedes albopictus; Aedes formosus; Zika; dengue;
   chikungunya; yellow fever; vector
ID LASTING INSECTICIDAL NETS; ALBOPICTUS DIPTERA-CULICIDAE;
   YELLOW-FEVER-EPIDEMIC; DENGUE VIRUS; CHIKUNGUNYA VIRUS; ZIKA VIRUS; 1ST
   RECORD; SUSCEPTIBILITY STATUS; VECTOR COMPETENCE; GENETIC DIVERSITY
AB The Zika crisis drew attention to the long-overlooked problem of arboviruses transmitted by Aedes mosquitoes in Africa. Yellow fever, dengue, chikungunya and Zika are poorly controlled in Africa and often go unrecognized. However, to combat these diseases, both in Africa and worldwide, it is crucial that this situation changes. Here, we review available data on the distribution of each disease in Africa, their Aedes vectors, transmission potential, and challenges and opportunities for Aedes control. Data on disease and vector ranges are sparse, and consequently maps of risk are uncertain. Issues such as genetic and ecological diversity, and opportunities for integration with malaria control, are primarily African; others such as ever-increasing urbanization, insecticide resistance and lack of evidence for most control-interventions reflect problems throughout the tropics. We identify key knowledge gaps and future research areas, and in particular, highlight the need to improve knowledge of the distributions of disease and major vectors, insecticide resistance, and to develop specific plans and capacity for arboviral disease surveillance, prevention and outbreak responses.
C1 [Weetman, David; McCall, Philip J.] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
   [Kamgang, Basile] Ctr Res Infect Dis, POB 13501, Yaounde, Cameroon.
   [Badolo, Athanase] Univ Ouaga, LEFA, 1 Pr Joseph Ki Zerbo,03 BP 7021, Ouagadougou, Burkina Faso.
   [Moyes, Catherine L.; Shearer, Freya M.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford OX3 7LF, England.
   [Coulibaly, Mamadou] Univ Sci Tech & Technol Bamako, BP 1805, Bamako, Mali.
   [Pinto, Joao] Univ Nova Lisboa, IHMT, GHTM, Rua Junqueira 100, P-1349008 Lisbon, Portugal.
   [Lambrechts, Louis] Inst Pasteur, Dept Genomes & Genet, Insect Virus Interact, F-75015 Paris, France.
   [Lambrechts, Louis] CNRS, Unite Mixte Rech 2000, F-75015 Paris, France.
RP McCall, PJ (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
EM david.weetman@lstmed.ac.uk; kamgang_d@yahoo.fr; a.badolo@gmail.com;
   clmoyes@well.ox.ac.uk; freya.m.shearer@gmail.com; doudou@icermali.org;
   JPinto@ihmt.unl.pt; louis.lambrechts@pasteur.fr;
   philip.mccall@lstmed.ac.uk
RI Pinto, Joao/C-2208-2012; Coulibaly, Mamadou/AAE-7006-2019; J.,
   Pinto/H-6177-2019; Weetman, David/M-1261-2014
OI Pinto, Joao/0000-0001-8572-7708; J., Pinto/0000-0001-8572-7708; Weetman,
   David/0000-0002-5820-1388; Kamgang, Basile/0000-0002-8883-4557; McCall,
   Philip/0000-0002-0007-3985
FU Wellcome TrustWellcome Trust [204862/Z/16/Z, 108440/Z/15/Z,
   200222/Z/15/Z MiRA]; Agence Nationale de la RechercheFrench National
   Research Agency (ANR) [ANR-16-CE35-0004-01, ANR-17-ERC2-0016-01]; French
   Government's Investissement d'Avenir program Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious DiseasesFrench National
   Research Agency (ANR) [ANR-10-LABX-62-IBEID]; City of Paris Emergence(s)
   program in Biomedical ResearchRegion Ile-de-France; European
   UnionEuropean Union (EU) [734584]; Ecology of Health program of Centre
   National de la Recherche Scientifique (grant AFRICAEDES); WHO/TDR grant
   [RCS-KM 2015 ID235974]; Medical Research CouncilMedical Research Council
   UK (MRC) [MR/M011941/1]; Bill and Melinda Gates FoundationGates
   Foundation [OPP1159078]
FX B.K. is supported by the Wellcome Trust (204862/Z/16/Z). C.L.M. and
   F.M.S. are supported by the Wellcome Trust (108440/Z/15/Z). L.L.
   receives support from the Agence Nationale de la Recherche (grants
   ANR-16-CE35-0004-01 and ANR-17-ERC2-0016-01), the French Government's
   Investissement d'Avenir program Laboratoire d'Excellence Integrative
   Biology of Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID),
   the City of Paris Emergence(s) program in Biomedical Research, the
   European Union's Horizon 2020 research and innovation programme under
   ZikaPLAN grant agreement No. 734584, and the Ecology of Health program
   of Centre National de la Recherche Scientifique (grant AFRICAEDES). A.B.
   is supported by a WHO/TDR grant (RCS-KM 2015 ID235974). P.J.M. receives
   personal support from The Medical Research Council (Grant No.
   MR/M011941/1), Wellcome Trust (200222/Z/15/Z MiRA) and the Bill and
   Melinda Gates Foundation (OPP1159078). We thank Maria Devine for her
   help sourcing new publications that have reported these Aedes species in
   Africa. D.W., C.L.M., J.P. and M.C. would like to thank members of the
   WIN network for fruitful discussions on Aedes insecticide resistance.
CR Abad-Franch F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002213
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Agwu EJ, 2016, ACTA TROP, V161, P18, DOI 10.1016/j.actatropica.2016.05.005
   Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   [Anonymous], GROSS DOM PROD 2016
   Ayorinde A, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev045
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Benallal KE, 2016, ACTA TROP, V164, P411, DOI 10.1016/j.actatropica.2016.09.027
   Bennouna A, 2017, MED VET ENTOMOL, V31, P102, DOI 10.1111/mve.12194
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bosio CF, 1998, AM J TROP MED HYG, V59, P965, DOI 10.4269/ajtmh.1998.59.965
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255
   Chan M, 2016, LANCET, V387, P2165, DOI 10.1016/S0140-6736(16)30620-1
   Chepkorir E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-435
   Crawford JE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0351-0
   Demanou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002950
   Dia I, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-238
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2013, T ROY SOC TROP MED H, V107, P200, DOI 10.1093/trstmh/trs095
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Diallo M, 2005, AM J TROP MED HYG, V73, P445, DOI 10.4269/ajtmh.2005.73.445
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   Diallo M, 2008, T ROY SOC TROP MED H, V102, P493, DOI 10.1016/j.trstmh.2008.02.010
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickson LB, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700585
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   DONPEDRO KN, 1985, ENVIRON POLLUT A, V38, P19, DOI 10.1016/0143-1471(85)90091-1
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   Eastwood G, 2017, AM J TROP MED HYG, V97, P1399, DOI 10.4269/ajtmh.17-0126
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   da Moura AJF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0706-8
   Fiorenzano JM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040398
   Gabor JJ, 2016, TRAVEL MED INFECT DI, V14, P26, DOI 10.1016/j.tmaid.2016.01.005
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gaye A, 2014, TROP MED INT HEALTH, V19, P1355, DOI 10.1111/tmi.12373
   Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Godoi IP, 2017, J COMP EFFECT RES, V6, P165, DOI 10.2217/cer-2016-0045
   Golding N, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0491-4
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grigoraki L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005533
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guindo-Coulibaly N., 2014, EUR J SCI RES, V126, P434
   Haddow A. J., 1977, MED ENTOMOLOGY CENTE, P33
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218, DOI 10.1080/00034983.1948.11685365
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hertz JT, 2016, PATHOG GLOB HEALTH, V110, P108, DOI 10.1080/20477724.2016.1182719
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Horstmann S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149738
   Huber K, 2008, AM J TROP MED HYG, V79, P218, DOI 10.4269/ajtmh.2008.79.218
   Husham A. O., 2010, SUDAN J PUBLIC HLTH, V10, P199
   Jaenisch T, 2014, EMERG INFECT DIS, P20
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   JOHNSON BK, 1982, LANCET, V2, P208
   Kamgang B, 2010, MED VET ENTOMOL, V24, P132, DOI 10.1111/j.1365-2915.2010.00869.x
   Kamgang B, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2408-x
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kampango A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1361-4
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Kigozi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042857
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0
   Konan LY, 2012, VECTOR-BORNE ZOONOT, V12, P325, DOI 10.1089/vbz.2011.0617
   Konan YL, 2014, SANTE PUBLIQUE, V26, P859, DOI 10.3917/spub.146.0859
   Kraemer M. U., 2015, SCI DATA, P2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185
   Lambrechts L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001019
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lindsay SW, 2017, B WORLD HEALTH ORGAN, V95, P607, DOI 10.2471/BLT.16.189688
   Lutomiah J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004981
   Magalhaes T, 2017, VIRUS RES, DOI 10.1016
   MAHAFFY A F, 1954, Bull World Health Organ, V11, P319
   Massangaie M, 2016, AM J TROP MED HYG, V94, P413, DOI 10.4269/ajtmh.15-0543
   Mathias L, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0316-0
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   MATTINGLY PF, 1967, B WORLD HEALTH ORGAN, V36, P552
   MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315
   Mbare O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-94
   MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   MOUCHET J, 1971, B WORLD HEALTH ORGAN, V45, P394
   Mouchet J., 1967, B WORLD HEALTH ORGAN, V36, P569
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Muller GC, 2016, ACTA TROP, V162, P245, DOI 10.1016/j.actatropica.2016.07.008
   Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Ngoagouni C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-175
   Noden BH, 2014, ACTA TROP, V137, P123, DOI 10.1016/j.actatropica.2014.05.010
   Nsoesie E. O., 2016, EUROSURVEILL EUR COM, V21
   Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645
   Oduola A. O., 2016, Animal Research International, V13, P2483
   Ogoma SB, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005455
   Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Patching HMM, 2015, BIG DATA-US, V3, P230, DOI 10.1089/big.2015.0019
   Paupy C, 2012, VECTOR-BORNE ZOONOT, V12, P167, DOI 10.1089/vbz.2011.0736
   Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Pocquet N, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-299
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Powell JR, 2016, SCIENCE, V354, P971, DOI 10.1126/science.aal1717
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Reis S, 2017, ACTA TROP, V171, P86, DOI 10.1016/j.actatropica.2017.03.035
   Rocha HDR, 2015, ACTA TROP, V152, P66, DOI 10.1016/j.actatropica.2015.08.013
   Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333
   Sang R, 2017, J MED ENTOMOL, V54, P460, DOI 10.1093/jme/tjw206
   Sangoro O, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-324
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Seixas G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005799
   SELF LS, 1966, B WORLD HEALTH ORGAN, V34, P960
   Sharp TM, 2013, MMWR-MORBID MORTAL W, V62, P504
   Shearer F., 2018, LANCET GLOB HLTH
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Sluydts V, 2016, LANCET INFECT DIS, V16, P1169, DOI 10.1016/S1473-3099(16)30148-7
   Solomon T, 2001, J INFECTION, V42, P104, DOI 10.1053/jinf.2001.0802
   Special Programme for Research and Training in Tropical Diseases (TDR), 2016, TECHN HDB DENG SURV, P92
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Stoler J, 2014, ACTA TROP, V134, P58, DOI 10.1016/j.actatropica.2014.02.017
   Suzuki Takashi, 2016, Ghana Med J, V50, P136
   Sylla M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000408
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219
   Talla C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1399-3
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1
   Tusting LS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008923.pub2
   Vazeille M, 2013, VECTOR-BORNE ZOONOT, V13, P37, DOI 10.1089/vbz.2012.0982
   Vazquez-Prokopec GM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005656
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Vu DM, 2017, EMERG INFECT DIS, V23, P1915, DOI 10.3201/eid2311.170807
   Wanzirah H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117396
   Ward T, 2017, TROP MED INT HEALTH, V22, P960, DOI 10.1111/tmi.12903
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wetsman N, 2017, NAT MED, V23, P904, DOI 10.1038/nm0817-904
   WHO, 1998, TEST PROC INS RES MO
   WHO, 2017, WORLD MAL REP 2017, P196
   WHO World Health Organization, 2017, GLOB VECT CONTR RESP, P53
   Wilson AL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-446
   World Health Organization, 2014, METH FIELD APR SCI B
   World Health Organization, 2012, GLOB STRAT DENG PREV, P43
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zahouli JBZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189082
NR 169
TC 25
Z9 26
U1 2
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB
PY 2018
VL 15
IS 2
AR 220
DI 10.3390/ijerph15020220
PG 20
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FY3LM
UT WOS:000426721400045
PM 29382107
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Alpuche-Lazcano, SP
   McCullogh, CR
   Del Corpo, O
   Rance, E
   Scarborough, RJ
   Mouland, AJ
   Sagan, SM
   Teixeira, MM
   Gatignol, A
AF Alpuche-Lazcano, Sergio P.
   McCullogh, Craig R.
   Del Corpo, Olivier
   Rance, Elodie
   Scarborough, Robert J.
   Mouland, Andrew J.
   Sagan, Selena M.
   Teixeira, Mauro M.
   Gatignol, Anne
TI Higher Cytopathic Effects of a Zika Virus Brazilian Isolate from Bahia
   Compared to a Canadian-Imported Thai Strain
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; predicted protein structure; qRT-PCR; cytopathicity; viral
   titer
ID GUILLAIN-BARRE-SYNDROME; ENDOTHELIAL-CELLS; INFECTION; AXL;
   TRANSMISSION; EPIDEMIC; TARGET; REPLICATION; MICRONESIA; INHIBITION
AB Zika virus (ZIKV) is an emerging pathogen from the Flaviviridae family. It represents a significant threat to global health due to its neurological and fetal pathogenesis (including microcephaly and congenital malformations), and its rapid dissemination across Latin America in recent years. The virus has spread from Africa to Asia, the Pacific islands and the Americas with limited knowledge about the pathogenesis associated with infection in recent years. Herein, we compared the ability of the Canadian-imported Thai strain PLCal_ZV and the Brazilian isolate HS-2015-BA-01 from Bahia to produce infectious ZIKV particles and cytopathic effects in a cell proliferation assay. We also compared the intracellular viral RNA accumulation of the two strains by quantitative RT-PCR (reverse transcription polymerase chain reaction) analyses. Our observations show that HS-2015-BA-01 is more cytopathic than PLCal_ZV in proliferation assays in Vero, Human Embryonic Kidney HEK 293T and neuroblastoma SH-SY5Y cells. Quantitative RT-PCR shows that the level of viral RNA is higher with HS-2015-BA-01 than with PLCal_ZV in two cell lines, but similar in a neuroblastoma cell line. The two strains have 13 amino acids polymorphisms and we analyzed their predicted protein secondary structure. The increased cytopathicity and RNA accumulation of the Brazilian ZIKV isolate compared to the Thai isolate could contribute to the increased pathogenicity observed during the Brazilian epidemic.
C1 [Alpuche-Lazcano, Sergio P.; McCullogh, Craig R.; Del Corpo, Olivier; Rance, Elodie; Scarborough, Robert J.; Gatignol, Anne] Lady Davis Inst Med Res, Virus Cell Interact Lab, Montreal, PQ H3T 1E2, Canada.
   [Alpuche-Lazcano, Sergio P.; Mouland, Andrew J.] Lady Davis Inst Med Res, RNA Trafficking Lab, Montreal, PQ H3T 1E2, Canada.
   [Alpuche-Lazcano, Sergio P.; Del Corpo, Olivier; Rance, Elodie; Mouland, Andrew J.; Gatignol, Anne] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ H4A 3J1, Canada.
   [McCullogh, Craig R.; Scarborough, Robert J.; Mouland, Andrew J.; Sagan, Selena M.; Gatignol, Anne] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.
   [Sagan, Selena M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.
   [Teixeira, Mauro M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Gatignol, A (corresponding author), Lady Davis Inst Med Res, Virus Cell Interact Lab, Montreal, PQ H3T 1E2, Canada.; Gatignol, A (corresponding author), McGill Univ, Div Expt Med, Dept Med, Montreal, PQ H4A 3J1, Canada.; Gatignol, A (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.
EM sergio.alpuche@mail.mcgill.ca; craig.mccullogh@mail.mcgill.ca;
   olivier.delcorpo@mail.mcgill.ca; elodie.rance@mail.mcgill.ca;
   robert.scarborough@mail.mcgill.ca; andrew.mouland@mcgill.ca;
   selena.sagan@mcgill.ca; mmtex.ufmg@gmail.com; anne.gatignol@mcgill.ca
RI Scarborough, Robert/L-2547-2019; Gatignol, Anne/AAA-6501-2020; Teixeira,
   Mauro M/A-4587-2008
OI Scarborough, Robert/0000-0002-7724-2441; Gatignol,
   Anne/0000-0002-4553-0836; Teixeira, Mauro M/0000-0002-6944-3008; Sagan,
   Selena/0000-0002-8484-3632; Alpuche Lazcano, Sergio
   Paulo/0000-0002-5958-2880
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [HBF-143163, PJT-133050]; Consejo Nacional de Ciencia y
   Tecnologia (CONACYT) (Mexico)Consejo Nacional de Ciencia y Tecnologia
   (CONACyT); Canada Graduate scholarship (CGM); Wares Family post-doctoral
   award; Richard and Edith Strauss Canadian Foundation through the McGill
   University Faculty of Medicine
FX This work was supported by grants HBF-143163 and PJT-133050 from the
   Canadian Institutes of Health Research (to Anne Gatignol). Sergio P.
   Alpuche-Lazcano is supported by a Doctoral fellowship from the Consejo
   Nacional de Ciencia y Tecnologia (CONACYT) (Mexico). Olivier Del Corpo
   was supported by a Canada Graduate scholarship (CGM). Robert J.
   Scarborough was a recipient of the Wares Family post-doctoral award and
   is a recipient of a post-doctoral fellowship from the Richard and Edith
   Strauss Canadian Foundation through the McGill University Faculty of
   Medicine. We thank Marc Fabian (Lady Davis Institute, LDI and McGill
   University, Montreal) for the neuroblastoma SH-SY5Y cell line, Maria
   Petropavlovskaya (LDI and McGill University, Montreal, QC, Canada) for
   the use of the Bio-Rad CFX96 and James Saliba (LDI and McGill
   University, Montreal, QC, Canada) for his technical help in the qRT-PCR
   set up and analysis.
CR Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   CICCARONE V, 1989, CANCER RES, V49, P219
   Clerzius G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-96
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li TY, 2017, BMC MOL BIOL, V18, DOI 10.1186/s12867-017-0086-z
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Relich RF, 2017, CLIN LAB MED, V37, P253, DOI 10.1016/j.cll.2017.01.002
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scarborough RJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.31
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 72
TC 9
Z9 9
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2018
VL 10
IS 2
AR 53
DI 10.3390/v10020053
PG 15
WC Virology
SC Virology
GA FZ4EN
UT WOS:000427544100003
PM 29382068
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Blazquez, AB
   Vazquez-Calvo, A
   Martin-Acebes, MA
   Saiz, JC
AF Blazquez, Ana B.
   Vazquez-Calvo, Angela
   Martin-Acebes, Miguel A.
   Saiz, Juan-Carlos
TI Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus
   Replication
SO VIRUSES-BASEL
LA English
DT Article
DE West Nile virus; viral replication; protein kinase C
ID ATYPICAL PKC; PHOSPHORYLATION; ACTIVATION; APOPTOSIS; INFECTION;
   PATHWAY; TARGET; DENGUE; CELLS; ZETA
AB Flaviviruses are relevant animal and human pathogens that include West Nile virus (WNV), Japanese encephalitis virus, dengue virus, or Zika virus, among others. Currently, no licensed therapy is available to fight flaviviral infections. Protein kinases C (PKCs) constitute a family of multifunctional lipid-dependent isoenzymes that regulate a wide variety of cellular processes (apoptosis, differentiation, proliferation, cellular transformation, motility, adhesion, etc.) being currently considered at the front line of drug development for the treatment of diverse human disorders. PKCs have also been implicated in different steps during viral replication; however, nowadays, results regarding their role in flavivirus replication are controversial. Here we demonstrate that calphostin C and chelerythrine, two broad-PKC inhibitors that target conventional, novel and atypical PKCs, significantly inhibit WNV multiplication in cell culture without affecting cell viability. A reduction of viral yields was observed in treated cells when compared with mock-treated cells. Likewise, immunofluorescence detection of viral enveloped E protein was reduced in treated cells, as was the amount of viral RNA released to the supernatant, mainly in those treated with chelerythrine. On the other hand, two PKC inhibitors specific for conventional and novel isoforms (staurosporine and enzastaurine) did not show any significant effect in WNV multiplication. These results suggested that PKCs, more probably atypical PKCs, are likely involved in WNV multiplication, although both broad-spectrum tested drugs seem to act through different mechanisms, and point to them as potential antiviral candidates for WNV, as well as for other related flaviviruses.
C1 [Blazquez, Ana B.; Vazquez-Calvo, Angela; Martin-Acebes, Miguel A.; Saiz, Juan-Carlos] INIA, Dept Biotechnol, Ctra Coruna Km 7-5, Madrid 28040, Spain.
RP Blazquez, AB (corresponding author), INIA, Dept Biotechnol, Ctra Coruna Km 7-5, Madrid 28040, Spain.
EM blazquez@inia.es; angelavazquezcalvo@gmail.com; martin.mangel@inia.es;
   jcsaiz@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014; Blazquez, Ana/G-9791-2015;
   Vazquez-Calvo, Angela/G-8795-2015
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; Blazquez,
   Ana/0000-0002-0847-0977; Vazquez-Calvo, Angela/0000-0003-3172-2762;
   Saiz, Juan-Carlos/0000-0001-8269-5544
FU INIAInstituto de Investigacion Agropecuaria (INIA) [E-RTA2013-00013-C04,
   RTA2015-009, E-RTA2017-00003-C02]; Comunidad Autonoma de Madrid to
   Juan-Carlos Saiz [P2013/ABI-2906];  [AGL2014-56518-JIN]
FX We thank M. Calvo for technical assistance. The work was supported in
   part by grants E-RTA2013-00013-C04, RTA2015-009, and E-RTA2017-00003-C02
   from INIA, and P2013/ABI-2906 (PLATESA) from the Comunidad Autonoma de
   Madrid to Juan-Carlos Saiz, and AGL2014-56518-JIN to Miguel A.
   Martin-Acebes.
CR Ahmad R, 2007, J MOL BIOL, V367, P25, DOI 10.1016/j.jmb.2006.12.060
   Bhattacharya D, 2008, VIROLOGY, V380, P276, DOI 10.1016/j.virol.2008.07.013
   Bhuvanakantham R, 2010, MICROBES INFECT, V12, P615, DOI 10.1016/j.micinf.2010.04.005
   Blazquez AB, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00296, 10.3389/fmicb.2010.00296]
   Blazquez AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002509
   Blazquez AB, 2010, VIRUS RES, V151, P240, DOI 10.1016/j.virusres.2010.04.009
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208
   Chu JJH, 2006, VIROLOGY, V349, P463, DOI 10.1016/j.virol.2006.01.022
   DE BP, 1995, P NATL ACAD SCI USA, V92, P5204, DOI 10.1073/pnas.92.11.5204
   Dorfman MD, 2017, DIABETES, V66, P920, DOI 10.2337/db16-0482
   Escribano-Romero E, 2013, VACCINE, V31, P4523, DOI 10.1016/j.vaccine.2013.07.071
   Farese RV, 2014, EXPERT OPIN THER TAR, V18, P1163, DOI 10.1517/14728222.2014.944897
   Filone CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015483
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071
   HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3
   Jiang ZM, 2015, J CELL MOL MED, V19, P1085, DOI 10.1111/jcmm.12503
   Keating JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-242
   Kudoh A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-9
   Lanciotti RS, 2001, J CLIN MICROBIOL, V39, P4506, DOI 10.1128/JCM.39.12.4506-4513.2001
   Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Mondal A, 2017, ELIFE, V6, DOI 10.7554/eLife.26910
   Monick MM, 2001, J IMMUNOL, V166, P2681, DOI 10.4049/jimmunol.166.4.2681
   Morozova OV, 1997, VIRUS RES, V49, P9, DOI 10.1016/S0168-1702(96)01433-5
   Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003
   NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0
   Noppakunmongkolchai W, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0494-6
   Nuesch JPF, 2001, J VIROL, V75, P5730, DOI 10.1128/JVI.75.13.5730-5739.2001
   Ratnayake WS, 2017, INT J ONCOL, V51, P1370, DOI 10.3892/ijo.2017.4131
   Reed KE, 1998, J VIROL, V72, P6199, DOI 10.1128/JVI.72.7.6199-6206.1998
   Ringvold H C, 2017, Adv Pharmacol, V78, P203, DOI 10.1016/bs.apha.2016.06.002
   Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Sobhia ME, 2013, EXPERT OPIN THER PAT, V23, P1297, DOI 10.1517/13543776.2013.805205
   Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662
   Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007
   TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2
   Wang WS, 2017, ANTIVIR RES, V140, P1, DOI 10.1016/j.antiviral.2017.01.005
   Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1
   Webb BLJ, 2000, BRIT J PHARMACOL, V130, P1433, DOI 10.1038/sj.bjp.0703452
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Xiao HL, 2013, CELL MOL LIFE SCI, V70, P3057, DOI 10.1007/s00018-012-1192-1
   Yamboliev Ilia A, 2005, BMC Physiol, V5, P9, DOI 10.1186/1472-6793-5-9
   Zhan B, 2013, TUMOR BIOL, V34, P1759, DOI 10.1007/s13277-013-0714-2
   Zhang J, 2017, INT J MOL MED, V40, P1335, DOI 10.3892/ijmm.2017.3144
   Zhu YZ, 2018, BIOL PHARM BULL, V41, P36, DOI 10.1248/bpb.b17-00451
NR 50
TC 1
Z9 1
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2018
VL 10
IS 2
AR 91
DI 10.3390/v10020091
PG 10
WC Virology
SC Virology
GA FZ4EN
UT WOS:000427544100041
PM 29473907
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Simanjuntak, Y
   Liang, JJ
   Chen, SY
   Li, JK
   Lee, YL
   Wu, HC
   Lin, YL
AF Simanjuntak, Yogy
   Liang, Jian-Jong
   Chen, Si-Yu
   Li, Jin-Kun
   Lee, Yi-Ling
   Wu, Han-Chung
   Lin, Yi-Ling
TI Ebselen alleviates testicular pathology in mice with Zika virus
   infection and prevents its sexual transmission
SO PLOS PATHOGENS
LA English
DT Article
ID HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; NITRIC-OXIDE SYNTHASE; OXIDATIVE
   STRESS; MOUSE MODEL; RISK-FACTOR; EXPRESSION; ANTIOXIDANT; INFLAMMATION;
   TESTES; SPERMATOGENESIS
AB Despite the low case fatality, Zika virus (ZIKV) infection has been associated with microcephaly in infants and Guillain-Barre A syndrome. Antiviral and vaccine developments against ZIKV are still ongoing; therefore, in the meantime, preventing the disease transmission is critical. Primarily transmitted by Aedes species mosquitoes, ZIKV also can be sexually transmitted. We used AG129 mice lacking interferon-a/beta and -gamma receptors to study the testicular pathogenesis and sexual transmission of ZIKV. Infection of ZIKV progressively damaged mouse testes, increased testicular oxidative stress as indicated by the levels of reactive oxygen species, nitric oxide, glutathione peroxidase 4, spermatogenesis- associated-18 homolog in sperm and pro-inflammatory cytokines including IL-1 beta, IL-6, and G-CSF. We then evaluated the potential role of the antioxidant ebselen (EBS) in alleviating the testicular pathology with ZIKV infection. EBS treatment significantly reduced ZIKV-induced testicular oxidative stress, leucocyte infiltration and production of pro-inflammatory response. Furthermore, it improved testicular pathology and prevented the sexual transmission of ZIKV in a male-to-female mouse sperm transfer model. EBS is currently in clinical trials for various diseases. ZIKV infection could be on the list for potential use of EBS, for alleviating the testicular pathogenesis with ZIKV infection and preventing its sexual transmission.
C1 [Simanjuntak, Yogy; Liang, Jian-Jong; Chen, Si-Yu; Li, Jin-Kun; Lee, Yi-Ling; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.
   [Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan.
   [Lin, Yi-Ling] Acad Sinica, Genom Res Ctr, Taipei, Taiwan.
RP Simanjuntak, Y; Lin, YL (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Lin, YL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei, Taiwan.
EM yogy@ibms.sinica.edu.tw; yll@ibms.sinica.edu.tw
RI Lin, Yi-Ling/N-7128-2018
OI Lin, Yi-Ling/0000-0002-1838-6410; Simanjuntak, Yogy/0000-0002-8983-0451
FU Academia SinicaAcademia Sinica - Taiwan [106-2101-01-11-01]; Ministry of
   Science and Technology, TaiwanMinistry of Science and Technology, Taiwan
   [MOST 106-0210-01-15-02]
FX This work was supported by Academia Sinica (106-2101-01-11-01) and
   Ministry of Science and Technology, Taiwan (MOST 106-0210-01-15-02). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Agarwal A, 2014, WORLD J MENS HEALTH, V32, P1, DOI 10.5534/wjmh.2014.32.1.1
   Agbulos DS, 2016, CURR PROTOC MICROBIO, V43, pD 4 1
   Aitken RJ, 2008, OXID MED CELL LONGEV, V1, P15, DOI 10.4161/oxim.1.1.6843
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Azad GK, 2014, MOL BIOL REP, V41, P2717, DOI 10.1007/s11033-014-3181-y
   Borchert A, 2006, J BIOL CHEM, V281, P19655, DOI 10.1074/jbc.M601195200
   Bornstein C, 2011, MOL CELL BIOL, V31, P1679, DOI 10.1128/MCB.01072-10
   Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858
   Bromfield JJ, 2014, J ASSIST REPROD GEN, V31, P627, DOI 10.1007/s10815-014-0243-y
   Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davis AS, 2014, J HISTOCHEM CYTOCHEM, V62, P405, DOI 10.1369/0022155414531549
   deMello MAR, 1996, BIOCHEM PHARMACOL, V52, P1703, DOI 10.1016/S0006-2952(96)00520-5
   Demirel I, 2012, AM J NEPHROL, V36, P524, DOI 10.1159/000345351
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Duselis Amanda R, 2007, J Vis Exp, P184, DOI 10.3791/184
   Endale M, 2013, IMMUNOBIOLOGY, V218, P1452, DOI 10.1016/j.imbio.2013.04.019
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gonzalez Michael J, 2014, J Orthomol Med, V29, P154
   Gonzalez MJ, 2016, JOM, V31, P1
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guaiquil VH, 2001, J BIOL CHEM, V276, P40955, DOI 10.1074/jbc.M106878200
   Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674
   Ingold I, 2015, J BIOL CHEM, V290, P14668, DOI 10.1074/jbc.M115.656363
   Kaneko T, 2010, MOL REPROD DEV, V77, P363, DOI 10.1002/mrd.21154
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kim H, 2016, J PHARM PHARMACOL, V68, P406, DOI 10.1111/jphp.12529
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lin YL, 1996, VIRUS RES, V44, P45, DOI 10.1016/0168-1702(96)01343-3
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Matsunaga T, 1999, BIOCHEM BIOPH RES CO, V260, P813, DOI 10.1006/bbrc.1999.0990
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149
   Miyamoto T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00379
   Miyamoto Y, 2011, PLOS ONE, V6
   Morrow CMK, 2007, ANN NY ACAD SCI, V1120, P144, DOI 10.1196/annals.1411.005
   Mostafa T, 2009, ANDROLOGIA, V41, P125, DOI 10.1111/j.1439-0272.2008.00900.x
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367
   Nakamura Y, 2002, J BIOL CHEM, V277, P2687, DOI 10.1074/jbc.M109641200
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Pedrielli P, 2001, J AGR FOOD CHEM, V49, P3034, DOI 10.1021/jf010017g
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rifaioglu MM, 2014, ANDROLOGIA, V46, P1134, DOI 10.1111/and.12204
   Savaskan NE, 2007, FREE RADICAL BIO MED, V43, P191, DOI 10.1016/j.freeradbiomed.2007.03.033
   Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11596
   Turner TT, 2008, J ANDROL, V29, P488, DOI 10.2164/jandrol.108.005132
   Ueno H, 2009, P NATL ACAD SCI USA, V106, P175, DOI 10.1073/pnas.0810325105
   Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393
   Valyi-Nagy T, 2005, HISTOL HISTOPATHOL, V20, P957, DOI 10.14670/HH-20.957
   WHO (World Health Organization), 2010, WHO LABORATORY MANUA
   World Health Organization, 2017, PREV SEX TRANSM ZIK
   WU DL, 2011, JOVE J VIS EXP NOV, DOI DOI 10.3791/3357
   Xing MZ, 2012, ENDOCR-RELAT CANCER, V19, pC7, DOI 10.1530/ERC-11-0360
   Yang CF, 2000, ARCH BIOCHEM BIOPHYS, V380, P319, DOI 10.1006/abbi.2000.1939
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   ZEMBOWICZ A, 1993, J PHARMACOL EXP THER, V267, P1112
NR 65
TC 15
Z9 17
U1 2
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2018
VL 14
IS 2
AR e1006854
DI 10.1371/journal.ppat.1006854
PG 23
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FY0CH
UT WOS:000426477000019
PM 29447264
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McGrath, EL
   Gao, JL
   Wu, P
AF McGrath, Erica L.
   Gao, Junling
   Wu, Ping
TI Zika Virus Infection of Cultured Human Fetal Brain Neural Stem Cells for
   Immunocytochemical Analysis
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Developmental Biology; Issue 132; Neural stem cell; differentiation;
   proliferation; neuron; Zika virus; disease modeling
ID GROWTH; TRANSMISSION
AB Human fetal brain neural stem cells are a unique non-genetically modified model system to study the impact of various stimuli on human developmental neurobiology. Rather than use an animal model or genetically modified induced pluripotent cells, human neural stem cells provide an effective in vitro system to examine the effects of treatments, screen drugs, or examine individual differences. Here, we provide the detailed protocols for methods used to expand human fetal brain neural stem cells in culture with serum-free media, to differentiate them into various neuronal subtypes and astrocytes via different priming procedures, and to freeze and recover these cells. Furthermore, we describe a procedure of using human fetal brain neural stem cells to study Zika virus infection.
C1 [McGrath, Erica L.; Gao, Junling; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.
   [McGrath, Erica L.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA.
   [Wu, Ping] Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China.
RP Wu, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.; Wu, P (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China.
EM piwu@utmb.edu
FU John S. Dunn Foundation; Institute for Human Infections and Immunity of
   the University of Texas Medical Branch
FX This work was supported by funds from the John S. Dunn Foundation and
   the Institute for Human Infections and Immunity of the University of
   Texas Medical Branch (P.W.).
CR [Anonymous], 2016, FACTS MICR
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268
   Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lopez-Garcia I., 2016, BR J PHARM
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mich JK, 2014, ELIFE, V3, DOI 10.7554/eLife.02669
   Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974
NR 17
TC 0
Z9 0
U1 0
U2 5
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD FEB
PY 2018
IS 132
AR e56917
DI 10.3791/56917
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX9UK
UT WOS:000426453400055
PM 29443111
OA Green Published
DA 2020-07-08
ER

PT J
AU Bautista, LE
AF Bautista, Leonelo E.
TI Maternal Zika virus infection and newborn microcephaly-an analysis of
   the epidemiological evidence
SO ANNALS OF EPIDEMIOLOGY
LA English
DT Review
DE Zika virus; Microcephaly; Disease outbreaks; Time series analysis;
   Brazil
ID TIME-SERIES; BIRTH-WEIGHT; BRAZIL; REGRESSION; NIGERIA; SURVEILLANCE;
   STANDARDS; AMERICA; DISEASE; ISSUES
AB Purpose: To evaluate whether existing data and evidence support a causal link between maternal Zika virus (ZIKV) infection and newborn microcephaly.
   Methods: I quantified and compared the prevalence of all and severe microcephaly in Brazil, during and before 2015-2016, to assess whether an outbreak has occurred, used time series analysis to evaluate if the presumed outbreak was linked to a previous outbreak of ZIKV infections, and quantitatively synthesized published data from observational studies testing this association.
   Results: The prevalences of microcephaly in 2015-2016 were similar or lower than background levels (prevalence ratio [PR] for all microcephaly: 0.19; 95% confidence intervals [CI]: 0.17, 0.20). Changes in the number of cases of ZIKV infections at times matching 11-18 weeks of pregnancy were not followed by changes in the number of microcephaly cases (PR for infection at 12 weeks: 1.02; 95% CI: 0.99, 1.05). In observational studies, the prevalence of microcephaly was not significantly increased in newborns of Zika-infected mothers (average PR: 1.30; 95% CI: 0.84, 2.02).
   Conclusions: Existing evidence is insufficient to claim maternal ZIKV infection causes microcephaly. Although a public health response seems sensible, it should be consistent with existing knowledge and consider risks, potential benefits and harm, and competing priorities. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Bautista, Leonelo E.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Populat Hlth Sci, 610 Walnut St,WARF 703, Madison, WI 53726 USA.
RP Bautista, LE (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Populat Hlth Sci, 610 Walnut St,WARF 703, Madison, WI 53726 USA.
EM lebautista@wisc.edu
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Aguilar-Salinas CA, 2002, AM J MED, V113, P569, DOI 10.1016/S0002-9343(02)01314-1
   Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Allard R, 1998, B WORLD HEALTH ORGAN, V76, P327
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Azra Haider Batool, 2006, Curr Probl Pediatr Adolesc Health Care, V36, P178
   Bautista LE., 2017, J PUBLIC HLTH EMERG, V2017
   Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554
   Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092
   Borrell-Carrio F, 2004, ANN FAM MED, V2, P310, DOI 10.1370/afm.80
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazil Ministry of Health, 2015, PUBL HLTH EM OP CTR
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cash RA, 2000, B WORLD HEALTH ORGAN, V78, P1358
   Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776
   Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9
   Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003
   Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECLAMC, 2009, XXXXI REUN AN EST CO
   EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.2307/2335441
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Greenland S, 2000, AM J EPIDEMIOL, V151, P531
   Greenland S, 2007, INT J EPIDEMIOL, V36, P195, DOI 10.1093/ije/dyl289
   Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981
   Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hoover KD, 2003, BRIT J PHILOS SCI, V54, P527, DOI 10.1093/bjps/54.4.527
   Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   Lopez-Camelo JS, 2015, SUMMARY CONCLUSIONS
   Luz AG, 2008, REV BRAS GINECOL OBS, V30, P281, DOI 10.1590/S0100-72032008000600003
   Mattos SD, 2015, B WORLD HEALTH ORGAN, V93, P881, DOI 10.2471/BLT.14.148874
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morgan SL, 2007, ANAL METHOD SOC RES, P1, DOI 10.1017/CBO9780511804564
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   Nazer J, 2011, REV MED CHILE, V139, P72, DOI /S0034-98872011000100010
   O'Driscoll MC, 2010, AM J HUM GENET, V87, P354, DOI 10.1016/j.ajhg.2010.07.012
   Orioli IM, 2011, CAD SAUDE PUBLICA, V27, P1961, DOI 10.1590/S0102-311X2011001000009
   Pan American Health O World Health O, 2015, EP AL INCR MICR NE B
   Pan American Health O World Health O, 2015, EP AL NEUR SYNDR CON
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pearl J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1203
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Pinto VC, 2015, REV BRAS CIR CARDIOV, V30, P219, DOI 10.5935/1678-9741.20150018
   Rainey C, 2016, POLIT ANAL, V24, P339, DOI 10.1093/pan/mpw014
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Royston P, 2007, STATA J, V7, P376, DOI 10.1177/1536867X0700700305
   Russo F., 2007, INT STUDIES PHILOS S, V21, P157, DOI DOI 10.1080/02698590701498084
   Russo F, 2011, EUR J PHILOS SCI, V1, P47, DOI 10.1007/s13194-010-0012-4
   Sadovsky ADI, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0656-0
   Schwartz J, 1996, J EPIDEMIOL COMMUN H, V50, pS3, DOI 10.1136/jech.50.Suppl_1.S3
   SCHWENK CR, 1984, STRATEGIC MANAGE J, V5, P111, DOI 10.1002/smj.4250050203
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Simmins Jr CH, 2016, B WHO
   Siqueira JB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-361
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   SUSSER M, 1991, AM J CLIN NUTR, V53, P1384
   SUSSER M, 1991, AM J EPIDEMIOL, V133, P635, DOI 10.1093/oxfordjournals.aje.a115939
   Tobias A, 1999, STATA TECH B, V8, P33
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   World Health O, 2016, ZIK VIR RES AG
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   Xavier F, 2006, EMERG INFECT DIS, V16, P418
NR 84
TC 2
Z9 2
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1047-2797
EI 1873-2585
J9 ANN EPIDEMIOL
JI Ann. Epidemiol.
PD FEB
PY 2018
VL 28
IS 2
BP 111
EP 118
DI 10.1016/j.annepidem.2017.11.010
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FX6WM
UT WOS:000426228000007
PM 29277550
DA 2020-07-08
ER

PT J
AU Ahmadivand, A
   Gerislioglu, B
   Tomitaka, A
   Manickam, P
   Kaushik, A
   Bhansali, S
   Nair, M
   Pala, N
AF Ahmadivand, Arash
   Gerislioglu, Burak
   Tomitaka, Asahi
   Manickam, Pandiaraj
   Kaushik, Ajeet
   Bhansali, Shekhar
   Nair, Madhavan
   Pala, Nezih
TI Extreme sensitive metasensor for targeted biomarkers identification
   using colloidal nanoparticles-integrated plasmonic unit cells
SO BIOMEDICAL OPTICS EXPRESS
LA English
DT Article
ID TERAHERTZ METAMATERIAL; INDUCED TRANSPARENCY; CHARGE-TRANSFER; SLOW
   LIGHT; TECHNOLOGY; PLATFORM; OPTICS; DARK
AB Engineered terahertz (THz) plasmonic metamaterials have emerged as promising platforms for quick infection diagnosis, cost-effective and real-time pharmacology applications owing to their non-destructive and harmless interaction with biological tissues in both in vivo and in vitro assays. As a recent member of THz metamaterials family, toroidal metamaterials have been demonstrated to be supporting high-quality sharp resonance modes. Here we introduce a THz metasensor based on a plasmonic surface consisting of metamolecules that support ultra-narrow toroidal resonances excited by the incident radiation and demonstrate detection of an ultralow concertation targeted biomarker. The toroidal plasmonic metasurface was designed and optimized through extensive numerical studies and fabricated by standard microfabrication techniques. The surface then functionalized by immobilizing the antibody for virus-envelope proteins (ZIKV-EPs) for selective sensing. We sensed and quantified the ZIKV-EP in the assays by measuring the spectral shifts of the toroidal resonances while varying the concentration. In an improved protocol, we introduced gold nanoparticles (GNPs) decorated with the same antibodies onto the metamolecules and monitored the resonance shifts for the same concentrations. Our studies verified that the presence of GNPs enhances capturing of biomarker molecules in the surrounding medium of the metamaterial. By measuring the shift of the toroidal dipolar momentum (up to Delta omega similar to 0.35 cm(-1)) for different concentrations of the biomarker proteins, we analyzed the sensitivity, repeatability, and limit of detection (LoD) of the proposed toroidal THz metasensor. The results show that up to 100-fold sensitivity enhancement can be obtained by utilizing plasmonic nanoparticles-integrated toroidal metamolecules in comparison to analogous devices. This approach allows for detection of low molecular-weight biomolecules (approximate to 13 kDa) in diluted solutions using toroidal THz plasmonic unit cells. (C) 2018 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
C1 [Ahmadivand, Arash; Gerislioglu, Burak; Pala, Nezih] Florida Int Univ, Dept Elect & Comp Engn, 10555 W Flagler St, Miami, FL 33174 USA.
   [Tomitaka, Asahi; Kaushik, Ajeet; Nair, Madhavan] Florida Int Univ, Herbert Wertheim Coll Med, Ctr Personalized NanoMed, Inst Neurolmmune Pharmacol,Dept Immunol, Miami, FL 33199 USA.
   [Manickam, Pandiaraj; Bhansali, Shekhar] Florida Int Univ, Dept Elect & Comp Engn, Bio MEMS & Microsyst Lab, 10555 W Flagler St, Miami, FL 33174 USA.
   [Manickam, Pandiaraj] Cent Elect Res Inst, CSJR, Electrod & Electrocatal Div, Karaikkudi 630006, Tamil Nadu, India.
RP Ahmadivand, A (corresponding author), Florida Int Univ, Dept Elect & Comp Engn, 10555 W Flagler St, Miami, FL 33174 USA.
EM aahma011@fiu.edu
RI Gerislioglu, Burak/K-7729-2019; Kaushik, Ajeet/K-1289-2018
OI Gerislioglu, Burak/0000-0001-8575-7990; Kaushik,
   Ajeet/0000-0003-4206-1541; Ahmadivand, Arash/0000-0003-0808-8775;
   Tomitaka, Asahi/0000-0002-1234-6047
FU Army Research Laboratory (ARL) Multiscale Multidisciplinary Modelling of
   Electronic Materials (MSME) Collaborative Research Alliance (CRA) [W91
   1NF-12-2-0023]; National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01-DA027049, R01-DA034547, R01-DA037838, R01-DA040537,
   R01-DA042706]
FX Army Research Laboratory (ARL) Multiscale Multidisciplinary Modelling of
   Electronic Materials (MSME) Collaborative Research Alliance (CRA) (Grant
   No. W91 1NF-12-2-0023, Program Manager: Dr. Meredith L. Reed). The
   authors have acknowledge grants R01-DA027049, R01-DA034547,
   R01-DA037838, R01-DA040537, and R01-DA042706 awarded by National
   Institutes of Health (NIH).
CR Ahmadivand A, 2017, IEEE PHOTONIC TECH L, V29, P1860, DOI 10.1109/LPT.2017.2754339
   Ahmadivand A, 2017, J PHYS CHEM C, V121, P19966, DOI 10.1021/acs.jpcc.7b05890
   Ahmadivand A, 2017, ACS SENSORS, V2, P1359, DOI 10.1021/acssensors.7b00478
   Ahmadivand A, 2017, J INFRARED MILLIM TE, V38, P992, DOI 10.1007/s10762-017-0400-3
   Ahmadivand A, 2016, J NANOPART RES, V19, DOI 10.1007/s11051-016-3696-3
   Ahmadivand A, 2016, OPT LETT, V41, P5333, DOI 10.1364/OL.41.005333
   Alu A, 2008, J OPT A-PURE APPL OP, V10, DOI 10.1088/1464-4258/10/9/093002
   Ambrosi A, 2010, ANAL CHEM, V82, P1151, DOI 10.1021/ac902492c
   Amin M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02105
   Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Avasthi DK, 2010, J NANOSCI NANOTECHNO, V10, P2705, DOI 10.1166/jnn.2010.1433
   Avitzour Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045131
   Bao YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11793
   Belgrader P, 1999, SCIENCE, V284, P449, DOI 10.1126/science.284.5413.449
   Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258
   Cai WS, 2007, NAT PHOTONICS, V1, P224, DOI 10.1038/nphoton.2007.28
   Cao C, 2013, ACS NANO, V7, P7583, DOI 10.1021/nn401645t
   Chen JX, 2011, OPT EXPRESS, V19, P5970, DOI 10.1364/OE.19.005970
   Currie LA, 1999, ANAL CHIM ACTA, V391, P127, DOI 10.1016/S0003-2670(99)00105-1
   Edwards B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.153901
   Epstein JR, 2002, ANAL CHIM ACTA, V469, P3, DOI 10.1016/S0003-2670(02)00030-2
   Erwin WR, 2016, J PHYS CHEM C, V120, P29423, DOI 10.1021/acs.jpcc.6b10166
   Espina V, 2004, J IMMUNOL METHODS, V290, P121, DOI 10.1016/j.jim.2004.04.013
   Fan YC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115417
   Fang X, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4870635
   Ferguson B, 2002, NAT MATER, V1, P26, DOI 10.1038/nmat708
   Gan QQ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.256803
   Gupta M, 2016, ADV MATER, V28, P8206, DOI 10.1002/adma.201601611
   Hao JM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165107
   Jung P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4730
   Kabashin AV, 2009, NAT MATER, V8, P867, DOI [10.1038/NMAT2546, 10.1038/nmat2546]
   Kaelberer T, 2010, SCIENCE, V330, P1510, DOI 10.1126/science.1197172
   Kang L, 2015, ADV MATER, V27, P4377, DOI 10.1002/adma.201501930
   Kaushik A, 2017, TRENDS BIOTECHNOL, V35, P308, DOI 10.1016/j.tibtech.2016.10.001
   Khoo IC, 2014, PROG QUANT ELECTRON, V38, P77, DOI 10.1016/j.pquantelec.2014.03.001
   Kim SH, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.035116
   Kravets VG, 2013, NAT MATER, V12, P304, DOI [10.1038/NMAT3537, 10.1038/nmat3537]
   Liu N, 2011, NAT MATER, V10, P631, DOI [10.1038/nmat3029, 10.1038/NMAT3029]
   Liu W, 2015, LASER PHOTONICS REV, V9, P564, DOI 10.1002/lpor.201500102
   Liu W, 2015, OPT LETT, V40, P2293, DOI 10.1364/OL.40.002293
   Luk'yanchuk B, 2010, NAT MATER, V9, P707, DOI [10.1038/NMAT2810, 10.1038/nmat2810]
   Maier SA, 2001, ADV MATER, V13, P1501, DOI 10.1002/1521-4095(200110)13:19<1501::AID-ADMA1501>3.0.CO;2-Z
   Miroshnichenko AE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9069
   Miyamaru F, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.153416
   Muhlig S., 2011, METAMATERIALS, V5, P64, DOI DOI 10.1016/J.METMAT.2011.03.003
   ORDAL MA, 1987, APPL OPTICS, V26, P744, DOI 10.1364/AO.26.000744
   Otsuji T, 2014, IEEE MICROW MAG, V15, P43, DOI 10.1109/MMM.2014.2355712
   Papasimakis N, 2016, NAT MATER, V15, P263, DOI [10.1038/NMAT4563, 10.1038/nmat4563]
   Park SJ, 2017, BIOMED OPT EXPRESS, V8, P3551, DOI 10.1364/BOE.8.003551
   Park SJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04988
   Petschulat J, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.043811
   Radescu EE, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035601
   Ren MX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1805
   Rusling JF, 2010, ANALYST, V135, P2496, DOI 10.1039/c0an00204f
   Savinov V, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205112
   Seco-Martorell C, 2013, OPT EXPRESS, V21, P17800, DOI 10.1364/OE.21.017800
   Siegel PH, 2004, IEEE T MICROW THEORY, V52, P2438, DOI 10.1109/TMTT.2004.835916
   Son J.H., 2014, TERAHERTZ BIOMEDICAL
   Spaldin NA, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/43/434203
   Sreekanth KV, 2016, NAT MATER, V15, P621, DOI [10.1038/NMAT4609, 10.1038/nmat4609]
   Tang C, 2016, EEE PHOTON J, V8, P1
   Wang JQ, 2013, OPT EXPRESS, V21, P25159, DOI 10.1364/OE.21.025159
   Wu CH, 2012, NAT MATER, V11, P69, DOI [10.1038/NMAT3161, 10.1038/nmat3161]
   Wurtz GA, 2011, NAT NANOTECHNOL, V6, P106, DOI 10.1038/nnano.2010.278
   Xie LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08671
   Xu WD, 2016, ACS PHOTONICS, V3, P2308, DOI 10.1021/acsphotonics.6b00463
   Yahiaoui R, 2016, IEEE SENS J, V16, P2484, DOI 10.1109/JSEN.2016.2521708
   Yan SH, 2016, INT CONF MANIP MANU, P327, DOI 10.1109/3M-NANO.2016.7824992
   Yasuda H, 2008, JPN J APPL PHYS, V47, P1632, DOI 10.1143/JJAP.47.1632
   Zeng BB, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4899132
   Zhang S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047401
   Zheludev NI, 2012, NAT MATER, V11, P917, DOI [10.1038/NMAT3431, 10.1038/nmat3431]
   Zhu L, 2012, OPT EXPRESS, V20, P4494, DOI 10.1364/OE.20.004494
   Zouhdi S., 2008, METAMATERIALS PLASMO
NR 74
TC 37
Z9 37
U1 1
U2 18
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 2156-7085
J9 BIOMED OPT EXPRESS
JI Biomed. Opt. Express
PD FEB 1
PY 2018
VL 9
IS 2
BP 373
EP 386
DI 10.1364/BOE.9.000373
PG 14
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA FX2VZ
UT WOS:000425923300002
PM 29552379
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Willenbrink, TJ
   Elston, DM
AF Willenbrink, Tyler J.
   Elston, Dirk M.
TI What's Eating You? Sand Flies
SO CUTIS
LA English
DT Article
ID DIPTERA PSYCHODIDAE; LUTZOMYIA-SHANNONI; CUTANEOUS LEISHMANIASIS; VIRUS;
   VECTORS; RECORDS; TRANSMISSION; SANDFLIES; FEVER; STATE
AB As thousands of Americans descended upon Brazil for the Olympic games in the summer of 2016, the mosquito-borne Zika virus became a source of great concern among the countless athletes and travelers in Rio. As is often the case, the media frenzy that ensued drew travelers' attention away from a lesser known flying vector that often carries with it grave consequences. The Phlebotominae, commonly known as sand flies, are biting insects known for their ability to transmit the protozoa Leishmania as well as a number of other viruses and bacteria. As the impact of sand flies continues to grow in the United States and worldwide, knowledge of the vector is important for proper treatment and prevention of the diseases they carry.
C1 [Willenbrink, Tyler J.] Spartanburg Reg Med Ctr, Transit Year Program, Spartanburg, SC USA.
   [Elston, Dirk M.] Med Univ South Carolina, Dept Dermatol & Dermatol Surg, Charleston, SC USA.
RP Willenbrink, TJ (corresponding author), Transit Year Program, 101 E Wood St, Spartanburg, SC 29303 USA.
EM T.J.Willenbrink@gmail.com
CR Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x
   Alkan C, 2013, ANTIVIR RES, V100, P54, DOI 10.1016/j.antiviral.2013.07.005
   Alves VR, 2012, REV BRAS ENTOMOL, V56, P220, DOI 10.1590/S0085-56262012005000020
   Blazes DL, 2013, EMERG INFECT DIS, V19, P1111, DOI 10.3201/eid1907.121718
   Centers for Disease Control and Prevention, 2016, CDC HLTH INFORM INT
   Chadha MS, 2005, AM J TROP MED HYG, V73, P566, DOI 10.4269/ajtmh.2005.73.566
   Charrel RN, 2009, VECTOR-BORNE ZOONOT, V9, P519, DOI 10.1089/vbz.2008.0131
   Claborn DM, 2010, J GLOB INFECT DIS, V2, P127, DOI 10.4103/0974-777X.62866
   Claborn DM, 2009, MIL MED, V174, P1203, DOI 10.7205/MILMED-D-00-4309
   Clarke CF, 2013, AM J TROP MED HYG, V88, P157, DOI 10.4269/ajtmh.2012.11-0717
   Collao X, 2010, AM J TROP MED HYG, V83, P760, DOI 10.4269/ajtmh.2010.09-0697
   COMER JA, 1990, AM J TROP MED HYG, V42, P483, DOI 10.4269/ajtmh.1990.42.483
   DAROSA APAT, 1984, INTERVIROLOGY, V21, P38
   Douvoyiannis M, 2014, CLIN INFECT DIS, V59, pE73, DOI 10.1093/cid/ciu386
   DURDEN LA, 2002, MED VET ENTOMOLOGY
   Eremeeva ME, 2007, NEW ENGL J MED, V356, P2381, DOI 10.1056/NEJMoa065987
   Ergen EN, 2015, CUTIS, V96, pE22
   European Centre for Disease Prevention and Control, PHLEB SAND FLIES FAC
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331
   Gonzalez C, 2011, AM J TROP MED HYG, V85, P839, DOI 10.4269/ajtmh.2011.10-0452
   Haddow AD, 2008, J VECTOR ECOL, V33, P393, DOI 10.3376/1081-1710-33.2.393
   Hashiguchi Yoshihisa, 2016, Trop Med Health, V44, P2, DOI 10.1186/s41182-016-0002-0
   Hennings C, 2015, CUTIS, V95, P208
   Herwaldt BL, CDC YELLOW BOOK
   Lawyer PG, 2000, MED ENTOMOLOGY
   LEWIS DJ, 1971, B WORLD HEALTH ORGAN, V44, P535
   Minnick MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002919
   Minter L, 2009, J MED ENTOMOL, V46, P965, DOI 10.1603/033.046.0432
   Pech-May A, 2010, MED VET ENTOMOL, V24, P150, DOI 10.1111/j.1365-2915.2010.00870.x
   Perich MJ, 2003, MED VET ENTOMOL, V17, P205, DOI 10.1046/j.1365-2915.2003.00427.x
   PERICH MJ, 1995, AM J TROP MED HYG, V52, P485, DOI 10.4269/ajtmh.1995.52.485
   Price DC, 2011, J MED ENTOMOL, V48, P476, DOI 10.1603/ME10170
   Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1
   ROBERT LL, 1995, J AM MOSQUITO CONTR, V11, P195
   Schaut RG, 2015, EMERG INFECT DIS, V21, P2209, DOI 10.3201/eid2112.141167
   Shaw J, 2007, MEM I OSWALDO CRUZ, V102, P541, DOI 10.1590/S0074-02762007000500001
   Sudeep AB, 2014, INDIAN J MED RES, V139, P769
   Tetreault GE, 2001, J AM MOSQUITO CONTR, V17, P23
   Vasilakis N, 2013, VIROLOGY, V444, P80, DOI 10.1016/j.virol.2013.05.035
   Weng JL, 2012, J MED ENTOMOL, V49, P1460, DOI 10.1603/ME12105
   Wolff K, 2013, FITZPATRICKS COLOR A
   Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1
   YOUNG DG, 1984, MOSQ NEWS, V44, P263
   Zhioua E, 2010, J GEN VIROL, V91, P1275, DOI 10.1099/vir.0.019240-0
NR 44
TC 1
Z9 1
U1 1
U2 6
PU QUADRANT HEALTHCOM INC
PI PARSIPPANY
PA 7 CENTURY DRIVE, STE 302, PARSIPPANY, NJ 07054-4603 USA
SN 0011-4162
EI 2326-6929
J9 CUTIS
JI Cutis
PD FEB
PY 2018
VL 101
IS 2
BP 109
EP +
PG 4
WC Dermatology
SC Dermatology
GA FW9EE
UT WOS:000425637700007
DA 2020-07-08
ER

PT J
AU Stockwell, S
AF Stockwell, Serena
TI The CDC Updates Guidelines for Congenital Zika
SO AMERICAN JOURNAL OF NURSING
LA English
DT News Item
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Griffin I, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2044
NR 2
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0002-936X
EI 1538-7488
J9 AM J NURS
JI Am. J. Nurs.
PD FEB
PY 2018
VL 118
IS 2
BP 14
EP 14
PG 1
WC Nursing
SC Nursing
GA FV0NT
UT WOS:000424254100008
PM 29369860
DA 2020-07-08
ER

PT J
AU Ishtiaq, F
AF Ishtiaq, Farah
TI A Call to Introduce Structured Zika Surveillance in India
SO TRENDS IN PARASITOLOGY
LA English
DT Editorial Material
ID VIRUS; AFRICA
AB India has the climatic conditions conducive to year-round transmission of Zika virus, and a structured disease surveillance program should be implemented to prevent an outbreak. Such a program should (i) start screening before an outbreak arises; (ii) collect baseline data to assess future disease risk and monitor potential birth defects; and (iii) provide new insights into the ecology of the disease and inform public health policy following the one health concept.
C1 [Ishtiaq, Farah] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.
RP Ishtiaq, F (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.
EM fishtiaq@iisc.ac.in
OI Ishtiaq, Farah/0000-0002-6762-7014
FU Wellcome Trust/DBT India Alliance Fellowship [IA/I(S)/12/2/500629]
FX This work was supported by Wellcome Trust/DBT India Alliance Fellowship
   (IA/I(S)/12/2/500629).
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Okia N O, 1971, East Afr Med J, V48, P725
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211
   Wetsman N, 2017, NAT MED, V23, P904, DOI 10.1038/nm0817-904
NR 13
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD FEB
PY 2018
VL 34
IS 2
BP 92
EP 95
DI 10.1016/j.pt.2017.10.008
PG 5
WC Parasitology
SC Parasitology
GA FW7HK
UT WOS:000425492300002
PM 29153262
OA Green Published
DA 2020-07-08
ER

PT J
AU Veater, J
   Wong, N
   Lai, FY
   Stephenson, I
   Wiselka, M
   Tang, JLW
AF Veater, James
   Wong, Nicholas
   Lai, Florence Y.
   Stephenson, Iain
   Wiselka, Martin
   Tang, Julian W.
TI Cost effectiveness of screening for dengue infection in a UK teaching
   hospital
SO JOURNAL OF INFECTION
LA English
DT Letter
DE Dengue; Screening; Serology; PCR; Cost-effectiveness
ID CLINICAL-FEATURES; ZIKA
C1 [Veater, James; Wong, Nicholas; Tang, Julian W.] Univ Hosp Leicester NHS Trust, Clin Microbiol, Leicester, Leics, England.
   [Lai, Florence Y.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.
   [Lai, Florence Y.] Glenfield Hosp, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England.
   [Stephenson, Iain; Wiselka, Martin] Univ Hosp Leicester NHS Trust, Infect Dis Unit, Leicester, Leics, England.
   [Stephenson, Iain; Wiselka, Martin; Tang, Julian W.] Univ Leicester, Infect, Immun, Inflammat, Leicester, Leics, England.
RP Tang, JLW (corresponding author), Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Clin Microbiol, Level 5 Sandringham Bldg,Infirm Sq, Leicester LE1 5WW, Leics, England.
EM julian.tang@uhl-tr.nhs.uk
OI Tang, Julian/0000-0002-4963-1028
CR Chia PY, 2017, J INFECTION, V74, P611, DOI 10.1016/j.jinf.2017.03.007
   Rare and Imported Pathogens Laboratory (RIPL), SPEC REF GUID SERV U
   Thanachartwet V, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1150-2
   Wong N, 2017, J INFECTION, V74, P616, DOI 10.1016/j.jinf.2017.03.004
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yong YK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1226-4
NR 6
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD FEB
PY 2018
VL 76
IS 2
BP 214
EP 217
DI 10.1016/j.jinf.2017.09.006
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA FW5JI
UT WOS:000425352300014
PM 28919345
DA 2020-07-08
ER

PT J
AU Goo, L
   DeMaso, CR
   Pelc, RS
   Ledgerwood, JE
   Graham, BS
   Kuhn, RJ
   Pierson, TC
AF Goo, Leslie
   DeMaso, Christina R.
   Pelc, Rebecca S.
   Ledgerwood, Julie E.
   Graham, Barney S.
   Kuhn, Richard J.
   Pierson, Theodore C.
TI The Zika virus envelope protein glycan loop regulates virion
   antigenicity
SO VIROLOGY
LA English
DT Article
DE Zika virus; Antigenicity; Fusion loop; Antibodies
ID ANTIBODY-MEDIATED NEUTRALIZATION; BORNE ENCEPHALITIS-VIRUS; DENGUE
   VIRUS; STRUCTURAL BASIS; GLYCOPROTEIN; INFECTION; POTENT; TRANSMISSION;
   VACCINATION; EMERGENCE
AB Because antibodies are an important component of flavivirus immunity, understanding the antigenic structure of flaviviruses is critical. Compared to dengue virus (DENV), the loop containing the single N-linked glycosylation site on Zika virus (ZIKV) envelope (E) proteins extends further towards the DII fusion loop (DII-FL) on neighboring E proteins within E dimers on mature viruses. Although ZIKV is poorly neutralized by DII-FL antibodies, we demonstrated significantly increased neutralization sensitivity of ZIKV particles incorporating the DENV glycan loop. Increased neutralization sensitivity was independent of E protein glycosylation: ZIKV lacking E protein glycans remained poorly neutralized, whereas ZIKV loop chimeras with or without an E protein glycan were potently neutralized. ZIKV particles lacking the E protein glycan were capable of infecting Raji cells expressing the lectin DC-SIGNR, suggesting the prM glycan of partially mature particles can facilitate entry. Our study provides insight into the determinants of ZIKV E protein function and antigenicity.
C1 [Goo, Leslie; DeMaso, Christina R.; Pelc, Rebecca S.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Ledgerwood, Julie E.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Kuhn, Richard J.] Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.
   [Kuhn, Richard J.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
   [Goo, Leslie] Chan Zuckerberg Biohub, San Francisco, CA USA.
   [Pelc, Rebecca S.] North Carolina Dept Hlth & Human Serv, North Carolina State Lab Publ Hlth, Raleigh, NC USA.
RP Pierson, TC (corresponding author), NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM piersontc@mail.nih.gov
RI Graham, Barney S./AAC-5898-2019
OI Graham, Barney S./0000-0001-8112-0853; Pelc, Rebecca/0000-0001-5080-4945
FU intramural research program of the Division of Intramural Research and
   Vaccine Research Center; National Institutes of Allergy and Infectious
   Diseases, National Institutes of Health and NIAID [AI073755]
FX This study was funded by the intramural research program of the Division
   of Intramural Research and Vaccine Research Center, National Institutes
   of Allergy and Infectious Diseases, National Institutes of Health and
   NIAID grant AI073755 (RJK). We thank Dr. Michael Diamond for kindly
   providing mAbs ZV-13, ZV-48, and ZV-67, and members of the Pierson lab
   for helpful comments on the manuscript.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Markoff L, 2000, VACCINE, V18, P26, DOI 10.1016/S0264-410X(00)00038-4
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 62
TC 23
Z9 23
U1 1
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD FEB
PY 2018
VL 515
BP 191
EP 202
DI 10.1016/j.virol.2017.12.032
PG 12
WC Virology
SC Virology
GA FV8TS
UT WOS:000424860300019
PM 29304471
OA Bronze
DA 2020-07-08
ER

PT J
AU Schmitt, K
   Charlins, P
   Veselinovic, M
   Kinner-Bibeau, L
   Hu, S
   Curlin, J
   Remling-Mulder, L
   Olson, KE
   Aboellail, T
   Akkina, R
AF Schmitt, Kimberly
   Charlins, Paige
   Veselinovic, Milena
   Kinner-Bibeau, Lauren
   Hu, Shuang
   Curlin, James
   Remling-Mulder, Leila
   Olson, Ken E.
   Aboellail, Tawfik
   Akkina, Ramesh
TI Zika viral infection and neutralizing human antibody response in a BLT
   humanized mouse model
SO VIROLOGY
LA English
DT Article
DE Zika viral infection and immune response in BLT mice; Anti-Zika viral
   antibodies in BLT humanized mice; Zika viral tropism to human cells in
   BLT mice; Zika Infection of human myeloid cells, B cells and HSC;
   Immmunoprecipitation of Zika viral proteins; Zika viral pathogenesis in
   humanized mice; Hu-Mouse model for Zika viral infection; Animal model
   for Zika virus; Neutralizing antibodies to Zika virus in hu-mice
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; IMMUNE-SYSTEM; DENGUE VIRUS;
   MICE; VACCINE; BRAZIL; MICRONESIA; PROGRESS; RHESUS
AB Many murine and non-human primate animal models have been recently developed to understand Zika viral pathogenesis. However, a major limitation with these models is the inability to directly examine the human specific immune response. Here, we utilized a BLT humanized mouse model endowed with a transplanted human immune system. Plasma viremia could be detected within 48 h after viral challenge and viremia persisted for as long as 220 days in some mice. Neutralizing human antibody was detected in infected mice and mouse sera showed reactivity with the viral envelope and capsid proteins in a radio-immunoprecipitation assay. Human monocytes/macrophages, B cells and hematopoietic stem cells in the bone marrow were found to be virus infected. These data establish that BLT mice are permissive for Zika viral infection and are capable of generating viral-specific human immune responses thus providing a human surrogate model for future testing of vaccine and antiviral therapeutic candidates.
C1 [Schmitt, Kimberly; Charlins, Paige; Veselinovic, Milena; Kinner-Bibeau, Lauren; Curlin, James; Remling-Mulder, Leila; Olson, Ken E.; Aboellail, Tawfik; Akkina, Ramesh] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Hu, Shuang] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.
RP Akkina, R (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM akkina@colostate.edu
RI Aboellail, Tawfik/AAB-8990-2019
FU NIH, USAUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1 AI100845, RO1 AI120021]
FX Work reported here was supported in part by the NIH, USA grants RO1
   AI100845 and RO1 AI120021 to R. A. We would like to thank Rushika Perera
   and Nunya Chotiwan for providing Zika viral stocks and reagents, Brian
   Foy for the Zika human antisera and Molly Price for technical
   assistance.
CR Akkina R, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0003-2012
   Akkina R, 2013, CURR OPIN IMMUNOL, V25, P403, DOI 10.1016/j.coi.2013.03.009
   Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007
   AKKINA RK, 1994, BLOOD, V84, P1393
   AKKINA RK, 1987, J VIROL, V61, P2217, DOI 10.1128/JVI.61.7.2217-2224.1987
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Denton PW, 2011, AIDS REV, V13, P135
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005
   Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005
   Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Paz-Bailey G, 2017, N ENGL J MED
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seung E, 2013, J INFECT DIS, V208, pS155, DOI 10.1093/infdis/jit448
   Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933
   Vesnaver TV, 2017, BJOG-INT J OBSTET GY, V124, P521, DOI 10.1111/1471-0528.14423
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wege AK, 2008, CURR TOP MICROBIOL, V324, P149
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   World Health Organization (WHO), 2016, 3 M EM COMM EC REG M
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 51
TC 15
Z9 15
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD FEB
PY 2018
VL 515
BP 235
EP 242
DI 10.1016/j.virol.2017.12.026
PG 8
WC Virology
SC Virology
GA FV8TS
UT WOS:000424860300023
PM 29310105
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Lee, BH
   Jo, S
   Choi, MK
   Kim, MH
   Choi, JB
   Kim, MK
AF Lee, Byung Ho
   Jo, Soojin
   Choi, Moon-ki
   Kim, Min Hyeok
   Choi, Jae Boong
   Kim, Moon Ki
TI Normal mode analysis of Zika virus
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE Zika virus; Glycosylation site; Normal mode analysis; Elastic network
   model; Symmetry constrained elastic network; model
ID ELASTIC NETWORK MODEL; DENGUE VIRUS; MATURATION; DYNAMICS; TRANSITIONS;
   MORPHOLOGY; RESOLUTION; OUTBREAK; SYMMETRY; BRAZIL
AB In recent years, Zika virus (ZIKV) caused a new pandemic due to its rapid spread and close relationship with microcephaly. As a result, ZIKV has become an obvious global health concern. Information about the fundamental viral features or the biological process of infection remains limited, despite considerable efforts. Meanwhile, the icosahedral shell structure of the mature ZIKV was recently revealed by cryoelectron microscopy. This structural information enabled us to simulate ZIKV. In this study, we analyzed the dynamic properties of ZIKV through simulation from the mechanical viewpoint. We performed normal mode analysis (NMA) for a dimeric structure of ZIKV consisting of the envelope proteins and the membrane proteins as a unit structure. By analyzing low-frequency normal modes, we captured intrinsic vibrational motions and defined basic vibrational properties of the unit structure. Moreover, we also simulated the entire shell structure of ZIKV at the reduced computational cost, similar to the case of the unit structure, by utilizing its icosahedral symmetry. From the NMA results, we can not only comprehend the putative dynamic fluctuations of ZIKV but also verify previous inference such that highly mobile glycosylation sites would play an important role in ZIKV. Consequently, this theoretical study is expected to give us an insight on the underlying biological functions and infection mechanism of ZIKV. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Lee, Byung Ho; Jo, Soojin; Choi, Moon-ki; Choi, Jae Boong; Kim, Moon Ki] Sungkyunkwan Univ, Sch Mech Engn, Suwon 16419, South Korea.
   [Kim, Min Hyeok] Korea Inst Adv Study, Seoul 02455, South Korea.
   [Choi, Jae Boong; Kim, Moon Ki] Sungkyunkwan Univ, SKKU Adv Inst Nanotechnol SAINT, Suwon 16419, South Korea.
RP Kim, MK (corresponding author), Sungkyunkwan Univ, Sch Mech Engn, Suwon 16419, South Korea.
EM mkkim@me.skku.ac.kr
FU Pioneer Research Center Program [2012-0009579]; Basic Science Research
   Program through the National Research Foundation of Korea - Ministry of
   Education, Science and Technology [2015R1D1A1A01057280]
FX This research was supported by the Pioneer Research Center Program
   (2012-0009579) and the Basic Science Research Program
   (2015R1D1A1A01057280) through the National Research Foundation of Korea
   funded by the Ministry of Education, Science and Technology. None of the
   authors has any conflicts of interest with respect to the material
   contained in this manuscript.
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2016, RAP RISK ASS ZIK VIR
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Fuglebakk E, 2015, BBA-GEN SUBJECTS, V1850, P911, DOI 10.1016/j.bbagen.2014.09.021
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Heinz FX, 2001, CURR OPIN MICROBIOL, V4, P450, DOI 10.1016/S1369-5274(00)00234-4
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Hsieh YC, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00085
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   Kim MK, 2006, INT J CONTROL AUTOM, V4, P382
   Kim MK, 2003, J STRUCT BIOL, V143, P107, DOI 10.1016/S1047-8477(03)00126-6
   Kim MK, 2002, J MOL GRAPH MODEL, V21, P151, DOI 10.1016/S1093-3263(02)00143-2
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lee H, 2014, PROTEIN SCI, V23, P703, DOI 10.1002/pro.2454
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   May ER, 2012, J PHYS CHEM B, V116, P8604, DOI 10.1021/jp300005g
   May ER, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.188101
   McHugh D, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00162
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Rader AJ, 2005, STRUCTURE, V13, P413, DOI 10.1016/j.str.2004.12.015
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tama F, 2005, J MOL BIOL, V345, P299, DOI 10.1016/j.jmb.2004.10.054
   Tama F, 2004, J STRUCT BIOL, V147, P315, DOI 10.1016/j.jsb.2004.03.002
   Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005
   van Vlijmen HWT, 2005, J MOL BIOL, V350, P528, DOI 10.1016/j.jmb.2005.03.028
   Yang Z, 2009, BIOPHYS J, V96, P4438, DOI 10.1016/j.bpj.2009.03.016
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 43
TC 4
Z9 4
U1 3
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
EI 1476-928X
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD FEB
PY 2018
VL 72
BP 53
EP 61
DI 10.1016/j.compbiolchem.2018.01.004
PG 9
WC Biology; Computer Science, Interdisciplinary Applications
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA FW1TH
UT WOS:000425081800007
PM 29414097
DA 2020-07-08
ER

PT J
AU Dufort, E
   White, J
AF Dufort, Elizabeth
   White, Jennifer
TI Pre-Zika Microcephaly in Brazil: Closer to the Elusive Baseline and New
   Questions Raised
SO PEDIATRICS
LA English
DT Editorial Material
ID PREVALENCE
C1 [Dufort, Elizabeth; White, Jennifer] New York State Dept Hlth, Div Epidemiol, Corning Tower Room 503,Empire State Plaza, Albany, NY 12237 USA.
   [Dufort, Elizabeth] Albany Med Coll, Dept Pediat, Albany, NY 12208 USA.
RP Dufort, E (corresponding author), New York State Dept Hlth, Div Epidemiol, Corning Tower Room 503,Empire State Plaza, Albany, NY 12237 USA.
EM elizabeth.dufort@health.ny.gov
CR Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   Graham KA, 2017, MMWR-MORBID MORTAL W, V66, P125, DOI 10.15585/mmwr.mm6605a1
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Latin American Collaborative Study of Congenital Malformations, ECLAM FIN DOC REG RE
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
   Simmins CH, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171223, DOI 10.2471/BLT.16.171223]
   Van Beneden CA, 2013, INFECTIOUS DISEASE SURVEILLANCE, 2ND EDITION, P95
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WHO, 2016, SCREEN ASS MAN NEON
NR 11
TC 1
Z9 1
U1 0
U2 0
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD FEB
PY 2018
VL 141
IS 2
AR e20173811
DI 10.1542/peds.2017-3811
PG 2
WC Pediatrics
SC Pediatrics
GA FV8EJ
UT WOS:000424817500046
PM 29305392
OA Bronze
DA 2020-07-08
ER

PT J
AU Silva, AA
   Barbieri, MA
   Alves, MT
   Carvalho, CA
   Batista, RF
   Ribeiro, MR
   Lamy, F
   Lamy, ZC
   Cardoso, VC
   Cavalli, RC
   Simoes, VM
   Bettiol, H
AF Silva, Antonio A.
   Barbieri, Marco A.
   Alves, Maria T.
   Carvalho, Carolina A.
   Batista, Rosangela F.
   Ribeiro, Marizelia R.
   Lamy-Filho, Fernando
   Lamy, Zeni C.
   Cardoso, Viviane C.
   Cavalli, Ricardo C.
   Simoes, Vanda M.
   Bettiol, Heloisa
TI Prevalence and Risk Factors for Microcephaly at Birth in Brazil in 2010
SO PEDIATRICS
LA English
DT Article
ID HEAD CIRCUMFERENCE; ZIKA VIRUS; GROWTH; PREGNANCY; STANDARDS
AB OBJECTIVES: To estimate the baseline prevalence and risk factors for microcephaly at birth before the Zika virus epidemic in 2 Brazilian cities.
   METHODS: We used population-based data from the Brazilian Ribeirao Preto (RP) and Sao Luis (SL) birth cohort studies of 2010 that included hospital deliveries by resident mothers. The final sample was 7376 live births in RP and 4220 in SL. Gestational age was based on the date of the mother's last normal menstrual period or obstetric ultrasonography, if available. Microcephaly at birth was classified according to the criteria of the International Fetal and Newborn Growth Consortium for the 21st Century and the Brazilian Ministry of Health. Risk factors for microcephaly, proportionate and disproportionate microcephaly, and severe microcephaly were estimated in a hierarchized logistic regression model.
   RESULTS: According to the International Fetal and Newborn Growth Consortium for the 21st Century definition, the prevalence of microcephaly (> 2 SDs below the mean for gestational age and sex) was higher in SL (3.5%) than in RP (2.5%). The prevalence of severe microcephaly (> 3 SDs below the mean) was higher in SL (0.7%) than in RP (0.5%). Low maternal schooling, living in consensual union or without a companion, maternal smoking during pregnancy, primiparity, vaginal delivery, and intrauterine growth restriction were consistently associated with microcephaly. The number of cases of microcephaly is grossly underestimated, with an underreporting rate of similar to 90%.
   CONCLUSIONS: The prevalence of severe microcephaly was much higher than expected in both cities. Our findings suggest that microcephaly was endemic in both municipalities before the circulation of the Zika virus.
C1 [Silva, Antonio A.; Alves, Maria T.; Carvalho, Carolina A.; Batista, Rosangela F.; Lamy, Zeni C.; Simoes, Vanda M.] Univ Fed Maranhao, Dept Publ Hlth, Sao Luis, Brazil.
   [Ribeiro, Marizelia R.; Lamy-Filho, Fernando] Univ Fed Maranhao, Dept Med 3, Sao Luis, Brazil.
   [Barbieri, Marco A.; Cardoso, Viviane C.; Bettiol, Heloisa] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Puericulture & Pediat, Ribeirao Preto, Brazil.
   [Cavalli, Ricardo C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
RP Silva, AA (corresponding author), Univ Fed Maranhao, Dept Publ Hlth, Ctr 155, Rua Barao Itapary, BR-65020070 Sao Luis, Maranhao, Brazil.
EM aamouradasilva@gmail.com
RI Silva, Antonio A M/B-5410-2009; Simoes, Vanda Maria
   Ferreira/M-4126-2016; Lamy, Zeni Carvalho/AAP-6494-2020; Batista,
   Rosangela Fernandes Lucena/G-6808-2016; FILHO, FERNANDO
   LAMY/I-3633-2013; Cavalli, Ricardo C/G-2405-2012
OI Silva, Antonio A M/0000-0003-4968-5138; Simoes, Vanda Maria
   Ferreira/0000-0001-8351-1348; Batista, Rosangela Fernandes
   Lucena/0000-0002-1529-0165; 
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research
   Foundation)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2008-53593-0]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (Brazilian National Research Council) [471923/2011-7,
   561058/2010-5]; Fundacao de Amparo a Pesquisa e ao Desenvolvimento
   Cientifico e Tecnologico do Maranhao (Maranhao State Research
   Foundation) [0035/2008, 00356/11, 01362-11]
FX Supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao
   Paulo Research Foundation), grant 2008-53593-0; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (Brazilian National Research
   Council), grants 471923/2011-7 and 561058/2010-5; and Fundacao de Amparo
   a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao
   (Maranhao State Research Foundation), grants 0035/2008, 00356/11 and
   01362-11.
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Ayinde OA, 2004, ANN AFR MED, V3, P126
   Bhide P, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.172080, DOI 10.2471/BLT.16.172080]
   Brasil Ministerio da Saude, PROT VIG RESP OC MIC
   Brasil Ministerio da Saude, EST VIT NASC VIV
   Brasil Ministerio da Saude, 47 BRAS MIN SAUD CTR
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cohen E, 2015, NEONATOLOGY, V108, P269, DOI 10.1159/000438451
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27
   European Centre for Disease Prevention and Control, RAP RISK ASS MICR BR
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   International Fetal and Newborn Growth Consortium for the, INTERGROWTH 21 NEWB
   Kallen K, 2000, EARLY HUM DEV, V58, P197, DOI 10.1016/S0378-3782(00)00077-3
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Latin American Collaborative Study of Congenital Malformations, ECLAM FIN DOC REG RE
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   da Silva AAM, 2015, CAD SAUDE PUBLICA, V31, P1437, DOI 10.1590/0102-311X00100314
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Simmins CH, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171223, DOI 10.2471/BLT.16.171223]
   Souza S W, 1976, Arch Dis Child, V51, P624
   VARGAS GC, 1975, CLIN PEDIATR, V14, P751, DOI 10.1177/000992287501400811
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   WHO, 2016, SCREEN ASS MAN NEON
   World Health Organization Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA
NR 32
TC 11
Z9 11
U1 0
U2 5
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD FEB
PY 2018
VL 141
IS 2
AR e20170589
DI 10.1542/peds.2017-0589
PG 10
WC Pediatrics
SC Pediatrics
GA FV8EJ
UT WOS:000424817500004
PM 29305391
OA Bronze
DA 2020-07-08
ER

PT J
AU Ma, JL
   Zhang, XX
   Soloveva, V
   Warren, T
   Guo, F
   Wu, S
   Lu, HG
   Guo, J
   Su, Q
   Shen, HL
   Solon, E
   Comunale, MA
   Mehta, A
   Guo, JT
   Bavari, S
   Du, YM
   Block, TM
   Chang, JH
AF Ma, Julia
   Zhang, Xuexiang
   Soloveva, Veronica
   Warren, Travis
   Guo, Fang
   Wu, Shuo
   Lu, Huagang
   Guo, Jia
   Su, Qing
   Shen, Helen
   Solon, Eric
   Comunale, Mary Ann
   Mehta, Anand
   Guo, Ju-Tao
   Bavari, Sina
   Du, Yanming
   Block, Timothy M.
   Chang, Jinhong
TI Enhancing the antiviral potency of ER alpha-glucosidase inhibitor
   IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID N-ALKYLDEOXYNOJIRIMYCIN DERIVATIVES; EBOLA-VIRUS; T-705 FAVIPIRAVIR;
   ZIKA VIRUS; DENGUE; INFECTION; EFFICACY; IMINOSUGAR; CELGOSIVIR;
   DEOXYNOJIRIMYCIN
AB Targeting host functions essential for viral replication has been considered as a broad spectrum and resistance refractory antiviral approach. However, only a few host functions have, thus far, been validated as broad-spectrum antiviral targets in vivo. ER alpha-glucosidases I and II have been demonstrated to be essential for the morphogenesis of many enveloped viruses, including members from four families of viruses causing hemorrhagic fever. In vivo antiviral efficacy of various iminosugar-based ER a-glucosidase inhibitors has been reported in animals infected with Dengue, Japanese encephalitis, Ebola, Marburg and influenza viruses. Herein, we established Huh7.5-derived cell lines with ER a-glucosidase I or II knockout using CRISPR/Cas9 and demonstrated that the replication of Dengue, Yellow fever and Zika viruses was reduced by only 1-2 logs in the knockout cell lines. The results clearly indicate that only a partial suppression of viral replication can possibly be achieved with a complete inhibition of ER-alpha-glucosidases I or II by their inhibitors. We therefore explore to improve the antiviral efficacy of a lead iminosugar IHVR-19029 through combination with another broad-spectrum antiviral agent, favipiravir (T-705). Indeed, combination of IHVR-19029 and T-705 synergistically inhibited the replication of Yellow fever and Ebola viruses in cultured cells. Moreover, in a mouse model of Ebola virus infection, combination of sub-optimal doses of IHVR-19029 and T-705 significantly increased the survival rate of infected animals. We have thus proved the concept of combinational therapeutic strategy for the treatment of viral hemorrhagic fevers with broad spectrum host- and viral-targeting antiviral agents.
C1 [Ma, Julia; Zhang, Xuexiang; Guo, Fang; Wu, Shuo; Lu, Huagang; Guo, Jia; Su, Qing; Guo, Ju-Tao; Du, Yanming; Block, Timothy M.; Chang, Jinhong] Hepatitis B Fdn, Baruch S Blumberg Inst, 3805 Old Easton Rd, Doylestown, PA 18902 USA.
   [Soloveva, Veronica; Warren, Travis; Bavari, Sina] USAMRIID, Ft Detrick, MD USA.
   [Shen, Helen; Solon, Eric] QPS LLC, Newark, DE USA.
   [Comunale, Mary Ann; Mehta, Anand] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.
RP Chang, JH (corresponding author), Hepatitis B Fdn, Baruch S Blumberg Inst, 3805 Old Easton Rd, Doylestown, PA 18902 USA.
EM jinhong.chang@bblumberg.org
RI Bavari, Sina/L-3642-2019
OI Bavari, Sina/0000-0001-8424-5635
FU National Institutes of Health, USAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI104636];
   Unither Virology, LLC; Commonwealth of Pennsylvania through the
   Hepatitis B Foundation
FX We thank Dr. Richard R. Drake at Medical University of South Carolina
   for providing technical support. A cDNA clone of serotype 2 dengue
   virus, pACYC177-NGC-DENV-2, was a gift from Dr. Pei-Yong Shi at
   University of Texas Medical Branch. A cDNA clone of Yellow fever virus
   17D strain, pACNR/FLYF-17Dx, was a gift from Dr. Charles M. Rice at
   Rockefeller University. This work was supported by grant from the
   National Institutes of Health, USA (AI104636), Unither Virology, LLC,
   and the Commonwealth of Pennsylvania through the Hepatitis B Foundation.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Alonzi DS, 2017, BIOCHEM SOC T, V45, P571, DOI 10.1042/BST20160182
   Baz M, 2017, ANTIVIR THER, V22, P613, DOI 10.3851/IMP3180
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Caputo AT, 2016, P NATL ACAD SCI USA, V113, pE4630, DOI 10.1073/pnas.1604463113
   Chang JH, 2015, ANTIVIR THER, V20, P257, DOI 10.3851/IMP2907
   Chang JH, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.77
   Chang JH, 2013, ANTIVIR RES, V99, P251, DOI 10.1016/j.antiviral.2013.06.011
   Chang JH, 2013, ANTIVIR RES, V98, P432, DOI 10.1016/j.antiviral.2013.03.023
   Chang JH, 2011, ANTIVIR RES, V92, P369, DOI 10.1016/j.antiviral.2011.08.003
   Chang JH, 2011, ANTIVIR RES, V89, P26, DOI 10.1016/j.antiviral.2010.11.002
   Chang JH, 2009, ANTIMICROB AGENTS CH, V53, P1501, DOI 10.1128/AAC.01457-08
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   Du YM, 2013, BIOORG MED CHEM LETT, V23, P4258, DOI 10.1016/j.bmcl.2013.04.052
   Du YM, 2013, BIOORG MED CHEM LETT, V23, P2172, DOI 10.1016/j.bmcl.2013.01.108
   Durantel D, 2009, CURR OPIN INVEST DR, V10, P860
   Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708
   FISCHL MA, 1994, J ACQ IMMUN DEF SYND, V7, P139
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198
   Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2
   Gowen BB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002614
   Guo F, 2016, J VIROL, V90, P10774, DOI 10.1128/JVI.01253-16
   Guo F, 2014, ANTIVIR RES, V107, P56, DOI 10.1016/j.antiviral.2014.04.010
   Guo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042583
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Lennemann NJ, 2015, J INFECT DIS, V212, pS204, DOI 10.1093/infdis/jiv201
   Lennemann NJ, 2014, MBIO, V5, DOI 10.1128/mBio.00862-13
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Ma J, 2017, ACS MED CHEM LETT, V8, P157, DOI 10.1021/acsmedchemlett.6b00332
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Oestereich L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002804
   Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014
   Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004
   Plummer E, 2015, J VIROL, V89, P5592, DOI 10.1128/JVI.00028-15
   Prichard M N, 1996, Antivir Ther, V1, P9
   Qu XW, 2011, ANTIMICROB AGENTS CH, V55, P1036, DOI 10.1128/AAC.01319-10
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   Smither SJ, 2014, ANTIVIR RES, V104, P153, DOI 10.1016/j.antiviral.2014.01.012
   Stavale EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121662
   Sun W, 2017, ANTIVIR RES, V137, P165, DOI 10.1016/j.antiviral.2016.11.017
   Sun W, 2016, DRUG DISCOV TODAY, V21, P1189, DOI 10.1016/j.drudis.2016.05.015
   SUNKARA PS, 1987, BIOCHEM BIOPH RES CO, V148, P206, DOI 10.1016/0006-291X(87)91096-5
   Nguyen THT, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005389
   Tyrrell BE, 2017, CRIT REV MICROBIOL, V43, P521, DOI 10.1080/1040841X.2016.1242868
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Warfield KL, 2017, ANTIVIR RES, V138, P22, DOI 10.1016/j.antiviral.2016.11.019
   Warfield KL, 2016, ANTIVIR RES, V129, P93, DOI 10.1016/j.antiviral.2016.03.001
   WARFIELD KL, 2016, VIRUSES, V8
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   Westover JB, 2016, ANTIVIR RES, V126, P62, DOI 10.1016/j.antiviral.2015.12.006
   Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005
   Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664
   Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   XU HT, 2017, SCI REP UK, V7
   Yu WQ, 2012, J MED CHEM, V55, P6061, DOI 10.1021/jm300171v
NR 70
TC 8
Z9 9
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD FEB
PY 2018
VL 150
BP 112
EP 122
DI 10.1016/j.antiviral.2017.12.008
PG 11
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FW1SC
UT WOS:000425078700013
PM 29253498
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Luthra, P
   Liang, J
   Pietzsch, CA
   Khadka, S
   Edwards, MR
   Wei, SG
   De, S
   Posner, B
   Bukreyev, A
   Ready, JM
   Basler, CF
AF Luthra, Priya
   Liang, Jue
   Pietzsch, Colette A.
   Khadka, Sudip
   Edwards, Megan R.
   Wei, Shuguang
   De, Sampriti
   Posner, Bruce
   Bukreyev, Alexander
   Ready, Joseph M.
   Basler, Christopher F.
TI A high throughput screen identifies benzoquinoline compounds as
   inhibitors of Ebola virus replication
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Antiviral; Ebola virus; Filovirus; Marburg virus; Vesicular stomatitis
   virus; Zika virus
ID REVERSE GENETICS SYSTEMS; MYCOPHENOLIC-ACID; ANTIVIRAL ACTIVITY; T-705
   FAVIPIRAVIR; POTENT ACTIVITY; MARBURG-VIRUS; DENGUE VIRUS; DRUG;
   TRANSCRIPTION; INFECTION
AB Ebola virus (EBOV) is an enveloped negative-sense, single-stranded RNA virus of the filovirus family that causes severe disease in humans. Approved therapies for EBOV disease are lacking. EBOV RNA synthesis is carried out by a virus-encoded complex with RNA-dependent RNA polymerase activity that is required for viral propagation. This complex and its activities are therefore potential antiviral targets. To identify potential lead inhibitors of EBOV RNA synthesis, a library of small molecule compounds was screened against a previously established assay of EBOV RNA synthesis, the EBOV minigenome assay (MGA), in 384 well microplate format. The screen identified 56 hits that inhibited EBOV MGA activity by more than 70% while exhibiting less than 20% cell cytotoxicity. Inhibitory chemical scaffolds included angelicin derivatives, derivatives of the antiviral compound GSK983 and benzoquinolines. Structure-activity relationship (SAR) studies of the benzoquinoline scaffold produced similar to 50 analogs and led to identification of an optimized compound, SW456, with a submicromolar IC50 in the EBOV MGA and antiviral activity against infectious EBOV in cell culture. The compound was also active against a MGA for another deadly filovirus, Marburg virus. It also exhibited antiviral activity towards a negative sense RNA virus from the rhabdovirus family, vesicular stomatitis virus, and a positive-sense RNA virus, Zika virus. Overall, these data demonstrate the potential of the EBOV MGA to identify anti-EBOV compounds and identifies the benzoquinoline series as a broad-spectrum antiviral lead.
C1 [Luthra, Priya; Khadka, Sudip; Edwards, Megan R.; De, Sampriti; Basler, Christopher F.] Georgia State Univ, Inst Biomed Sci, Ctr Microbial Pathogenesis, Atlanta, GA 30303 USA.
   [Liang, Jue; Wei, Shuguang; Posner, Bruce; Ready, Joseph M.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX USA.
   [Pietzsch, Colette A.; Bukreyev, Alexander] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Bukreyev, Alexander] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Bukreyev, Alexander] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA.
RP Basler, CF (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Microbial Pathogenesis, Atlanta, GA 30303 USA.
EM cbasler@gsu.edu
OI khadka, sudip/0000-0002-5551-0417; Basler,
   Christopher/0000-0003-4195-425X
FU Basler [U19 AI109664]
FX This work was supported by U19 AI109664 (Basler) to CFB, AB and JMR. CFB
   is Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis.
   We thank Anwu Zhou (UT Southwestern) for data mining and analysis and
   Benjamin R tenOever (Icahn School of Medicine at Mount Sinai) for
   providing the VSV-GFP virus.
CR Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1
   ANDO K, 1968, J ANTIBIOT, V21, P649, DOI 10.7164/antibiotics.21.649
   Cardile AP, 2017, ANNU REV PHARMACOL, V57, P329, DOI 10.1146/annurev-pharmtox-010716-105055
   Cho HJ, 2013, ANTIVIR RES, V100, P75, DOI 10.1016/j.antiviral.2013.07.009
   Connor JH, 2007, VIROLOGY, V362, P109, DOI 10.1016/j.virol.2006.12.026
   Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Dolnik O, 2008, CELL MOL LIFE SCI, V65, P756, DOI 10.1007/s00018-007-7406-2
   Edwards MR, 2015, ACS INFECT DIS, V1, P380, DOI 10.1021/acsinfecdis.5b00053
   Gong ZJ, 1999, J VIRAL HEPATITIS, V6, P229, DOI 10.1046/j.1365-2893.1999.00163.x
   Gudmundsson KS, 2009, BIOORG MED CHEM LETT, V19, P3489, DOI 10.1016/j.bmcl.2009.05.003
   Gudmundsson KS, 2009, BIOORG MED CHEM LETT, V19, P4110, DOI 10.1016/j.bmcl.2009.06.001
   Harvey R, 2009, ANTIVIR RES, V82, P1, DOI 10.1016/j.antiviral.2008.12.015
   Herrmann ML, 2000, IMMUNOPHARMACOLOGY, V47, P273, DOI 10.1016/S0162-3109(00)00191-0
   Hoenen T, 2011, ANTIVIR RES, V91, P195, DOI 10.1016/j.antiviral.2011.06.003
   Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Jasenosky LD, 2010, ANTIMICROB AGENTS CH, V54, P3007, DOI 10.1128/AAC.00138-10
   Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200
   Khiar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02776-z
   Liu JG, 2014, BBA-GEN SUBJECTS, V1840, P1051, DOI 10.1016/j.bbagen.2013.11.006
   Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395
   Lucas-Hourani M, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00383-17, 10.1128/aac.00383-17]
   Lucas-Hourani M, 2015, J MED CHEM, V58, P5579, DOI 10.1021/acs.jmedchem.5b00606
   Madelain V, 2015, ANTIVIR RES, V123, P70, DOI 10.1016/j.antiviral.2015.08.015
   Messaoudi I, 2015, NAT REV MICROBIOL, V13, P663, DOI 10.1038/nrmicro3524
   Muhlberger E, 2007, FUTURE VIROL, V2, P205, DOI 10.2217/17460794.2.2.205
   Muhlberger E, 1998, J VIROL, V72, P8756
   Muhlberger E, 1999, J VIROL, V73, P2333
   Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014
   PLANTEROSE DN, 1969, J GEN VIROL, V4, P629, DOI 10.1099/0022-1317-4-4-629
   Pokhrel L, 2012, BIOORG MED CHEM LETT, V22, P3480, DOI 10.1016/j.bmcl.2012.03.084
   Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014
   Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015
   Smither SJ, 2014, ANTIVIR RES, V104, P153, DOI 10.1016/j.antiviral.2014.01.012
   Spengler JR, 2016, EMERG INFECT DIS, V22, P956, DOI [10.3201/eid2206.160021, 10.32032/eid2206.160021]
   Stuyver Lieven J, 2002, Antivir Chem Chemother, V13, P345
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048
   Uebelhoer LS, 2014, ANTIVIR RES, V106, P86, DOI 10.1016/j.antiviral.2014.03.018
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yeh JY, 2010, J MED CHEM, V53, P1519, DOI 10.1021/jm901570x
   Yeh S, 2015, NEW ENGL J MED, V373, P1982, DOI 10.1056/NEJMc1510459
   Zeng XK, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.113
   Zhang T, 2017, BIOORG MED CHEM LETT, V27, P2364, DOI 10.1016/j.bmcl.2017.04.028
NR 49
TC 15
Z9 15
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD FEB
PY 2018
VL 150
BP 193
EP 201
DI 10.1016/j.antiviral.2017.12.019
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FW1SC
UT WOS:000425078700022
PM 29294299
DA 2020-07-08
ER

PT J
AU Li, Z
   Sakamuru, S
   Huang, RL
   Brecher, M
   Koetzner, CA
   Zhang, J
   Chen, HY
   Qin, CF
   Zhang, QY
   Zhou, J
   Kramer, LD
   Xia, MH
   Li, HM
AF Li, Zhong
   Sakamuru, Srilatha
   Huang, Ruili
   Brecher, Matthew
   Koetzner, Cheri A.
   Zhang, Jing
   Chen, Haiying
   Qin, Cheng-feng
   Zhang, Qing-Yu
   Zhou, Jia
   Kramer, Laura D.
   Xia, Menghang
   Li, Hongmin
TI Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the
   flavivirus NS2B-NS3 protease
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Flavivirus; Zika virus; Dengue virus; Antiviral; Protease inhibitor;
   Erythrosin B
ID ZIKA VIRUS-INFECTION; DRUG DISCOVERY; TRANSMISSION; BRAIN; ORGANOIDS;
   EXPOSURE; TARGETS; CELLS; MICE
AB Many flaviviruses, such as Zika virus (ZIKV), Dengue virus (DENV1-4) and yellow fever virus (YFV), are significant human pathogens. Infection with ZIKV, an emerging mosquito-borne flavivirus, is associated with increased risk of microcephaly in newborns and Guillain-Barre syndrome and other complications in adults. Currently, specific therapy does not exist for any flavivirus infections. In this study, we found that erythrosin B, an FDA-approved food additive, is a potent inhibitor for flaviviruses, including ZIKV and DENV2. Erythrosin B was found to inhibit the DENV2 and ZIKV NS2B-NS3 proteases with IC50 in low micromolar range, via a noncompetitive mechanism. Erythrosin B can significantly reduce titers of representative flaviviruses, DENV2, ZIKV, YFV, JEV, and WNV, with micromolar potency and with excellent cytotoxicity profile. Erythrosin B can also inhibit ZIKV replication in ZIKV-relevant human placental and neural progenitor cells. As a pregnancy category B food additive, erythrosin B may represent a promising and easily developed therapy for management of infections by ZIKV and other flaviviruses.
C1 [Li, Zhong; Brecher, Matthew; Koetzner, Cheri A.; Zhang, Jing; Zhang, Qing-Yu; Kramer, Laura D.; Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12208 USA.
   [Sakamuru, Srilatha; Huang, Ruili; Xia, Menghang] Natl Ctr Adv Translat Sci, NIH, Bethesda, MD 20892 USA.
   [Chen, Haiying; Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Chem Biol Program, Galveston, TX 77555 USA.
   [Qin, Cheng-feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zhang, Qing-Yu; Kramer, Laura D.; Li, Hongmin] Univ Albany, Sch Publ Hlth, Dept Biomed Sci, POB 509,Empire State Plaza, Albany, NY 12201 USA.
RP Li, HM (corresponding author), New York State Dept Hlth, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12208 USA.
EM Hongmin.li@health.ny.gov
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Zhou, Jia/0000-0002-2811-1090; Li,
   Zhong/0000-0002-1039-7000; Li, Hongmin/0000-0002-8684-5308; Brecher,
   Matthew/0000-0003-1151-2290
FU NIH Biodefense and Emerging Infectious Disease training grant
   [AI055429]; Wadsworth Center flavivirus drug discovery seed funding;
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI133219, AI134568, AI131669,
   DA038446]; Intramural Research Program of NCATS, NIH; NSFC Excellent
   Young Scientist [81522025]; Innovative Research Group [81621005];
   National Key Research and Development Project of China [2016YFD0500304];
   National Science and Technology Major Project of China [2017ZX09101005];
   Newton Advanced Fellowship from the UK Academy of Medical Sciences
   [NAF003\1003]; NSFC of ChinaNational Natural Science Foundation of China
   [81661130162]
FX We thank J. Tang at the Wadsworth Center Tissue Culture Core facility
   for help with cell culture and K. McClive-Reed for helpful suggestions.
   We also thank other core facilities at the Wadsworth Center, including
   the Applied Genomic Technologies Core for DNA sequencing, the Advanced
   Light Microscopy Core for immunofluorescence imaging, and the Tissue
   Culture Core for media. M.B. was partially supported by the NIH
   Biodefense and Emerging Infectious Disease training grant AI055429. This
   work was partially supported by the Wadsworth Center flavivirus drug
   discovery seed funding (H.L., N.B, and L.D.K.), by NIH grants AI133219,
   AI134568, and AI131669 (H.L., Q.Y.Z., and L.D.K.), by NIH grant DA038446
   (J.Z.), and by the Intramural Research Program of NCATS, NIH (M.X.).
   C.F.Q. was supported by the NSFC Excellent Young Scientist (No.
   81522025), Innovative Research Group (No. 81621005), the National Key
   Research and Development Project of China (No.2016YFD0500304), the
   National Science and Technology Major Project of China
   (No.2017ZX09101005), and the Newton Advanced Fellowship from the UK
   Academy of Medical Sciences (NAF003\1003) and the NSFC of China (No.
   81661130162).
CR (ANS) E.P.o.F.A.a.N.S.a.t.F, 2011, EFSA J
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Brecher Matthew, 2013, Virologica Sinica, V28, P326, DOI 10.1007/s12250-013-3390-x
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076900
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li Z, 2017, VIRAL PROTEASES AND THEIR INHIBITORS, P163, DOI 10.1016/B978-0-12-809712-0.00007-1
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   LIN GHY, 1986, MUTAGENESIS, V1, P253, DOI 10.1093/mutage/1.4.253
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   POULSEN E, 1993, FOOD ADDIT CONTAM, V10, P315, DOI 10.1080/02652039309374154
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Schrodinger L., 2016, SMALL MOL DRUG DISC
   Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tanaka T, 2001, FOOD CHEM TOXICOL, V39, P447, DOI 10.1016/S0278-6915(00)00163-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 44
TC 15
Z9 15
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD FEB
PY 2018
VL 150
BP 217
EP 225
DI 10.1016/j.antiviral.2017.12.018
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FW1SC
UT WOS:000425078700024
PM 29288700
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Vermillion, MS
   Klein, SL
AF Vermillion, Meghan S.
   Klein, Sabra L.
TI Pregnancy and infection: using disease pathogenesis to inform vaccine
   strategy
SO NPJ VACCINES
LA English
DT Review
ID RESPIRATORY SYNCYTIAL VIRUS; CONGENITAL CYTOMEGALOVIRUS-INFECTION;
   INACTIVATED INFLUENZA VACCINE; ACELLULAR PERTUSSIS-VACCINE; IMMUNIZATION
   PRACTICES ACIP; NONHUMAN PRIMATE MODEL; HERPES-SIMPLEX-VIRUS;
   HEPATITIS-E VIRUS; ZIKA VIRUS; ADVISORY-COMMITTEE
AB Vaccination is the mainstay of preventative medicine for many infectious diseases. Pregnant women, unborn fetuses, and neonates represent three at-risk populations that can be simultaneously protected by strategic vaccination protocols. Because the pathogenesis of different infectious microbes varies based on tissue tropism, timing of infection, and host susceptibility, the goals of immunization are not uniform across all vaccines. Mechanistic understanding of infectious disease pathogenesis and immune responses is therefore essential to inform vaccine design and the implementation of appropriate immunization protocols that optimize protection of pregnant women, fetuses, and neonates.
C1 [Vermillion, Meghan S.; Klein, Sabra L.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
   [Vermillion, Meghan S.] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA.
RP Klein, SL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
EM Sklein2@jhu.edu
FU Johns Hopkins Fisher Center Discovery Program
FX The authors thank the Johns Hopkins Fisher Center Discovery Program for
   funding.
CR Adachi K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9315757
   Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106
   [Anonymous], 1996, MMWR Recomm Rep, V45, P1
   Arav-Boger R, 2006, J INFECT DIS, V194, P464, DOI 10.1086/505427
   Arav-Boger R, 2015, INFECT DIS CLIN N AM, V29, P401, DOI 10.1016/j.idc.2015.05.009
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Avanzini MA, 1998, ACTA PAEDIATR, V87, P180, DOI 10.1080/08035259850157633
   Avgil M, 2006, REPROD TOXICOL, V21, P436, DOI 10.1016/j.reprotox.2004.11.014
   Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004
   Baker SF, 2013, J VIROL, V87, P8591, DOI 10.1128/JVI.01081-13
   Barber A, 2017, MMWR-MORBID MORTAL W, V66, P56, DOI 10.15585/mmwr.mm6602a4
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bialas KM, 2015, P NATL ACAD SCI USA, V112, P13645, DOI 10.1073/pnas.1511526112
   Black BO, 2015, OBSTET MED, V8, P108, DOI 10.1177/1753495X15597354
   Blanco JCG, 2017, VACCINE, V35, P3951, DOI 10.1016/j.vaccine.2017.06.009
   Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027
   Calvert A, 2017, CURR OPIN INFECT DIS, V30, P268, DOI 10.1097/QCO.0000000000000372
   Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P279
   Chao AS, 2017, TAIWAN J OBSTET GYNE, V56, P37, DOI 10.1016/j.tjog.2016.08.007
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Choi KY, 2016, J VIROL, V90, P7902, DOI 10.1128/JVI.00283-16
   Chu HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152015
   Clark RL, 2009, REPROD TOXICOL, V28, P285, DOI 10.1016/j.reprotox.2009.05.002
   Cox B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.37
   Cromer D, 2017, LANCET PUBLIC HEALTH, V2, pE367, DOI 10.1016/S2468-2667(17)30103-2
   Sa GRDE, 2011, J INFECT DIS, V204, pS722, DOI 10.1093/infdis/jir408
   Damman A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0145-8
   De Paschale Massimo, 2016, World J Virol, V5, P97, DOI 10.5501/wjv.v5.i3.97
   De Santis Marco, 2012, Infect Dis Obstet Gynecol, V2012, P430585, DOI 10.1155/2012/430585
   Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303
   Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608
   Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eberhardt CS, 2017, CLIN INFECT DIS, V64, P1129, DOI 10.1093/cid/cix046
   Ely JS, 2000, AM FAM PHYSICIAN, V61, P3065
   Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384
   Emery VC, 2002, J INFECT DIS, V185, P1723, DOI 10.1086/340653
   ESMONDE TF, 1989, THORAX, V44, P812, DOI 10.1136/thx.44.10.812
   Forbes RL, 2012, THORAX, V67, P209, DOI 10.1136/thoraxjnl-2011-200708
   Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gall SA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.024
   Garcia-Sastre A, 2013, CURR OPIN VIROL, V3, P210, DOI 10.1016/j.coviro.2013.02.001
   Garg R, 2016, VACCINE, V34, P261, DOI 10.1016/j.vaccine.2015.11.029
   GARTY BZ, 1994, CLIN DIAGN LAB IMMUN, V1, P667, DOI 10.1128/CDLI.1.6.667-669.1994
   Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738
   Gershon AA, 2013, CLIN MICROBIOL REV, V26, P728, DOI 10.1128/CMR.00052-13
   GITTER M, 1986, VET REC, V118, P575, DOI 10.1136/vr.118.21.575
   Glenn GM, 2015, VACCINE, V33, P6488, DOI 10.1016/j.vaccine.2015.08.039
   Gomes AC, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5010006
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffiths P, 2013, VACCINE, V31, pB197, DOI 10.1016/j.vaccine.2012.10.074
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507
   Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1
   Healy CM, 2013, CLIN INFECT DIS, V56, P539, DOI 10.1093/cid/cis923
   Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173
   HULKA JF, 1964, OBSTET GYNECOL, V23, P830
   Investigators A. I., 2010, BMJ-BRIT MED J, V340, pc1279
   Irving SA, 2013, OBSTET GYNECOL, V121, P159, DOI [10.1097/AOG.0b013e318279f56f, http://10.1097/AOG.0b013e318279f56f]
   Jamieson DJ, 2014, OBSTET GYNECOL, V124, P1005, DOI 10.1097/AOG.0000000000000533
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Jones GJB, 2014, VACCINE, V32, P3977, DOI 10.1016/j.vaccine.2014.05.018
   Joshi SS, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0302-8
   Katsura H, 2012, VACCINE, V30, P6027, DOI 10.1016/j.vaccine.2012.07.059
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Khandaker G, 2014, VACCINE, V32, P6746, DOI 10.1016/j.vaccine.2014.10.021
   Kharbanda EO, 2013, OBSTET GYNECOL, V122, P659, DOI 10.1097/AOG.0b013e3182a1118a
   Khoshnood B, 2006, PEDIATR INFECT DIS J, V25, P41, DOI 10.1097/01.inf.0000195636.43584.bb
   Khrustalev VV, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00044
   KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0
   Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x
   KHUROO MS, 1995, LANCET, V345, P1025, DOI 10.1016/S0140-6736(95)90761-0
   Kovacs SD, 2015, DRUG SAFETY, V38, P165, DOI 10.1007/s40264-014-0261-9
   Krain LJ, 2014, AM J TROP MED HYG, V90, P365, DOI 10.4269/ajtmh.13-0265
   Kumar RM, 2001, EUR J OBSTET GYN R B, V100, P9, DOI 10.1016/S0301-2115(01)00448-1
   Kwon YM, 2014, ANTIVIR RES, V104, P1, DOI 10.1016/j.antiviral.2014.01.008
   Lago EG, 2016, CUREUS, V8, DOI 10.7759/cureus.525
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P175, DOI 10.1111/j.1471-0528.2010.02749.x
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]
   Lanzieri TM, 2015, CLIN VACCINE IMMUNOL, V22, P245, DOI 10.1128/CVI.00697-14
   Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x
   Ledger WJ, 2008, CURR OPIN OBSTET GYN, V20, P120, DOI 10.1097/GCO.0b013e3282f734db
   Lee C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004790.pub2
   Leuridan E, 2011, PEDIATR INFECT DIS J, V30, P608, DOI 10.1097/INF.0b013e3182093814
   Li AM, 2005, ARCH DIS CHILD-FETAL, V90, pF461, DOI 10.1136/adc.2005.075309
   Li SW, 2015, CURR OPIN VIROL, V11, P130, DOI 10.1016/j.coviro.2015.04.003
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Loubet P, 2014, EXPERT OPIN DRUG SAF, V13, P1709, DOI 10.1517/14740338.2014.977252
   Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Masic A, 2013, J VIROL, V87, P10114, DOI 10.1128/JVI.01348-13
   Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1
   McAllister SC, 2014, EXPERT REV VACCINES, V13, P1349, DOI 10.1586/14760584.2014.932694
   McLean HQ, 2013, MMWR RECOMM REP, V62, P1
   Meharry PM, 2014, MATERN CHILD HLTH J, V18, P1205, DOI 10.1007/s10995-013-1352-4
   Metcalf CJE, 2012, EPIDEMIOL INFECT, V140, P2290, DOI 10.1017/S0950268812000131
   MILLER E, 1982, LANCET, V2, P781
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moro PL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.050
   Moskosky S. B., 2011, Morbidity and Mortality Weekly Report, V60, P1
   Moyer TJ, 2016, J CLIN INVEST, V126, P799, DOI 10.1172/JCI81083
   MURRAY DL, 1979, J CLIN MICROBIOL, V10, P184, DOI 10.1128/JCM.10.2.184-187.1979
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K. G. B., 2016, NPJ VACCIN, V1, P1272
   Mutsaerts E, 2016, EXPERT REV VACCINES, V15, P1055, DOI 10.1080/14760584.2016.1192473
   Natama HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02173-6
   Nelson JM, 2016, J PERINATOL, V36, P411, DOI 10.1038/jp.2015.189
   Newcomer BW, 2015, THERIOGENOLOGY, V83, P360, DOI 10.1016/j.theriogenology.2014.09.028
   Nicoara C, 1999, CLIN DIAGN LAB IMMUN, V6, P868, DOI 10.1128/CDLI.6.6.868-871.1999
   Nogales A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010020
   Nordin JD, 2014, VACCINE, V32, P4985, DOI 10.1016/j.vaccine.2014.07.017
   Nosten F, 2006, CURR DRUG SAF, V1, P1, DOI 10.2174/157488606775252584
   Organization W. H, 2006, WEEKLY EPIDEMIOLOGIC, V81, P197
   Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Plachter B, 2016, MED MICROBIOL IMMUN, V205, P537, DOI 10.1007/s00430-016-0472-z
   Planitzer CB, 2011, TRANSPLANTATION, V92, P267, DOI 10.1097/TP.0b013e318224115e
   Plotkin SA, 2011, EXPERT REV VACCINES, V10, P981, DOI [10.1586/ERV.11.72, 10.1586/erv.11.72]
   Powell TJ, 2012, J VIROL, V86, P13397, DOI 10.1128/JVI.01820-12
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Racicot K, 2017, J CLIN INVEST, V127, P1591, DOI 10.1172/JCI87490
   Rai R., INDIAN J PEDIAT
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023
   RODRIGUES IMX, 2014, BMC INFECT DIS, V14
   Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/revreprod/4.2.81
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   SARVAS H, 1993, J CLIN IMMUNOL, V13, P145, DOI 10.1007/BF00919271
   Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131
   Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1
   Shi LM, 2005, INT J DEV NEUROSCI, V23, P299, DOI 10.1016/j.ijdevneu.2004.05.005
   Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003
   Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030
   Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0
   Smith MA, 2003, INFECT IMMUN, V71, P1574, DOI 10.1128/IAI.71.3.1574-1579.2003
   Sperling RS, 2012, OBSTET GYNECOL, V119, P631, DOI 10.1097/AOG.0b013e318244ed20
   Stockman LJ, 2004, EMERG INFECT DIS, V10, P1689, DOI 10.3201/eid1009.040244
   Suzano CES, 2006, VACCINE, V24, P1421, DOI 10.1016/j.vaccine.2005.09.033
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Perez-Gracia MT, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1929
   Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0
   Thwaites CL, 2015, LANCET, V385, P362, DOI 10.1016/S0140-6736(14)60236-1
   Toback SL, 2012, INFLUENZA OTHER RESP, V6, P44, DOI 10.1111/j.1750-2659.2011.00266.x
   Tobin NH, 2013, IMMUNOL REV, V254, P143, DOI 10.1111/imr.12074
   Uraki R, 2013, J VIROL, V87, P7874, DOI 10.1128/JVI.00076-13
   Van Damme P, 2017, HUM VACC IMMUNOTHER, V13, P972, DOI 10.1080/21645515.2016.1274473
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Victor ST, 2012, J VIROL, V86, P4123, DOI 10.1128/JVI.06232-11
   Vodkin I, 2014, Minerva Gastroenterol Dietol, V60, P205
   Walker Deborah K., 2011, Morbidity and Mortality Weekly Report, V60, P1078
   Walls T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009536
   Weston WM, 2011, VACCINE, V29, P1017, DOI 10.1016/j.vaccine.2010.11.057
   Wheeler SM, 2015, EMERG INFECT DIS, V21, P1951, DOI 10.3201/eid2111.150497
   White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0
   WHO, 2017, WHO VACC PIP TRACK
   Wolfe B, 2017, MBIO, V8, DOI 10.1128/mBio.01938-16
   WONG SY, 1994, CLIN INFECT DIS, V18, P853, DOI 10.1093/clinids/18.6.853
   Wujcicka W, 2014, EUR J CLIN MICROBIOL, V33, P703, DOI 10.1007/s10096-013-2017-3
   Wynn JL, 2010, CLIN PERINATOL, V37, P307, DOI 10.1016/j.clp.2010.04.001
   YANG M, 2017, BMC PREGNANCY CHILDB, V17
   Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6
   Zucker I, 2017, NEUROSCI BIOBEHAV R, V77, P107, DOI 10.1016/j.neubiorev.2017.03.005
NR 170
TC 8
Z9 8
U1 0
U2 3
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD FEB 1
PY 2018
VL 3
AR UNSP 6
DI 10.1038/s41541-017-0042-4
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FW0RV
UT WOS:000425003900001
PM 29423318
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Casale, TB
   Teng, MN
   Morano, JP
   Unnasch, T
   Lockwood, CJ
AF Casale, Thomas B.
   Teng, Michael N.
   Morano, Jamie P.
   Unnasch, Thomas
   Lockwood, Charles J.
TI Zika virus: An emerging infectious disease with serious perinatal and
   neurologic complications
SO JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
LA English
DT Article
DE Zika; dengue; chikungunya; emerging infectious diseases; Guillain-Barre
   syndrome; microcephaly; vaccine; flavivirus
ID MALE SEXUAL TRANSMISSION; CROSS-REACTIVITY; PROTECTIVE EFFICACY; DENGUE
   VIRUS; VACCINE; RNA; ENHANCEMENT; PROSPECTS; OUTBREAK; AMERICA
AB Zika virus (ZIKV) is a flavivirus that is primarily transmitted by Aedes aegypti, the mosquito vector also important in transmission of the flaviviruses responsible for dengue fever, yellow fever, and chikungunya. Because of occurrence in the same geographic regions, serologic cross-reactivity, and similar but often less severe clinical manifestations, such as dengue and chikungunya infections, ZIKV infection likely has gone undetected, misdiagnosed, or both for many years. ZIKV is somewhat unique among flaviviruses in its ability to also be transmitted through sexual contact, nonsexual body fluids, and perinatally. The relatively recent detection of the link between ZIKV infection and Guillain-Barre syndrome and fetal neurological defects, including microcephaly, has prompted intense efforts aimed at the development of new and specific diagnostic tests. Infection with ZIKV has been postulated to lead to a more severe clinical course from other structurally related viruses, especially dengue, and vice versa because of a phenomenon termed antibody-dependent enhancement. Inactivated whole virus, DNA, RNA, and vectored vaccine approaches to prevent ZIKV infection are in development, as are treatments for active disease that are safe in pregnant women. Here we summarize the important epidemiologic and clinical features of ZIKV infection, as well as the progress and challenges in developing rapid point-of-care diagnostic tests and vaccines to prevent disease. We used electronic databases to identify relevant published data regarding ZIKV MeSH searches.
C1 [Casale, Thomas B.] Univ S Florida, Dept Internal Med, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA.
   [Casale, Thomas B.] Univ S Florida, Dept Pediat, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA.
   [Teng, Michael N.] Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA.
   [Morano, Jamie P.] Univ S Florida, Div Infect Dis & Int Med, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA.
   [Unnasch, Thomas] Univ S Florida, Dept Global Hlth, Coll Publ Hlth, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA.
   [Lockwood, Charles J.] Univ S Florida, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA.
RP Casale, TB (corresponding author), Univ S Florida, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA.
EM tbcasale@health.usf.edu
RI amsalu, ribka/G-8780-2019
FU Florida Department of Health Zika Research Grants
FX Supported by Florida Department of Health Zika Research Grants (to
   T.B.C., M.N.T., and C.J.L.).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Andrade DV, 2017, VIRUS RES
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bozzo J, 2017, EXPERT REV ANTI-INFE, V15, P585, DOI 10.1080/14787210.2017.1328278
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   CDC, 2016, ZIK CAS COUNTS
   CDC, 2017, ZIK CAS COUNTS
   CDC, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, TRIOPL REAL TIM RT P
   Centers for Disease Control and Prevention, 2016, ZIKV CAS COUNTS US
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dempsey LA, 2017, NAT IMMUNOL, V18, P603, DOI 10.1038/ni.3762
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Flores MS, 2016, CLEV CLIN J MED, V83, P1, DOI 10.3949/ccjm.83a.16027
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Mo Y, 2016, BRIT MED BULL, V119, P25, DOI 10.1093/bmb/ldw023
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Sanabani SS, 2017, PLOS CURR, V9
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Ulmer JB, 2012, VACCINE, V30, P4414, DOI 10.1016/j.vaccine.2012.04.060
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   US Food and Drug Administration, EM US AUTH
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 73
TC 3
Z9 3
U1 0
U2 15
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0091-6749
EI 1097-6825
J9 J ALLERGY CLIN IMMUN
JI J. Allergy Clin. Immunol.
PD FEB
PY 2018
VL 141
IS 2
BP 482
EP 490
DI 10.1016/j.jaci.2017.11.029
PG 9
WC Allergy; Immunology
SC Allergy; Immunology
GA FV2PQ
UT WOS:000424410800003
PM 29273403
OA Bronze
DA 2020-07-08
ER

PT J
AU Narayanan, N
   Lacy, CR
   Cruz, JE
   Nahass, M
   Karp, J
   Barone, JA
   Hermes-DeSantis, ER
AF Narayanan, Navaneeth
   Lacy, Clifton R.
   Cruz, Joseph E.
   Nahass, Meghan
   Karp, Jonathan
   Barone, Joseph A.
   Hermes-DeSantis, Evelyn R.
TI Disaster Preparedness: Biological Threats and Treatment Options
SO PHARMACOTHERAPY
LA English
DT Review
DE biological threats; biological disasters; emerging infections;
   bioterrorism; infectious diseases
ID EBOLA-VIRUS; UNITED-STATES; ZIKA VIRUS; SEXUAL TRANSMISSION; PRACTICE
   GUIDELINES; RING VACCINATION; IMMUNE GLOBULIN; ANTHRAX; EFFICACY;
   MANAGEMENT
AB Biological disasters can be natural, accidental, or intentional. Biological threats have made a lasting impact on civilization. This review focuses on agents of clinical significance, bioterrorism, and national security, specifically Category A agents (anthrax, botulism, plague, tularemia, and smallpox), as well as briefly discusses other naturally emerging infections of public health significance, Ebola virus (also a Category A agent) and Zika virus. The role of pharmacists in disaster preparedness and disaster response is multifaceted and important. Their expertise includes clinical knowledge, which can aid in drug information consultation, patient-specific treatment decision making, and development of local treatment plans. To fulfill this role, pharmacists must have a comprehensive understanding of medical countermeasures for these significant biological threats across all health care settings. New and reemerging infectious disease threats will continue to challenge the world. Pharmacists will be at the forefront of preparedness and response, sharing knowledge and clinical expertise with responders, official decision makers, and the general public.
C1 [Narayanan, Navaneeth; Lacy, Clifton R.; Cruz, Joseph E.; Barone, Joseph A.; Hermes-DeSantis, Evelyn R.] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharm Practice & Adm, Piscataway, NJ USA.
   [Narayanan, Navaneeth; Barone, Joseph A.; Hermes-DeSantis, Evelyn R.] Robert Wood Johnson Univ Hosp, Dept Pharm, New Brunswick, NJ USA.
   [Narayanan, Navaneeth; Lacy, Clifton R.] Rutgers Robert Wood Johnson Med Sch, Piscataway, NJ USA.
   [Lacy, Clifton R.] Rutgers Sch Commun & Informat, New Brunswick, NJ USA.
   [Cruz, Joseph E.] Englewood Hosp & Med Ctr, Dept Pharm, Englewood, NJ USA.
   [Nahass, Meghan] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA.
   [Barone, Joseph A.] Univ Vermont, Burlington, VT USA.
RP Narayanan, N (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA.
EM navan12@pharmacy.rutgers.edu
OI Cruz, Joseph/0000-0002-8083-8692; Narayanan,
   Navaneeth/0000-0001-5071-9193
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adalja AA, 2015, NEW ENGL J MED, V372, P954, DOI 10.1056/NEJMra1409755
   Anantpadma M, 2016, ANTIMICROB AGENTS CH, V60, P4471, DOI 10.1128/AAC.00543-16
   Andrei G, 2010, VIRUSES-BASEL, V2, P2803, DOI 10.3390/v2122803
   [Anonymous], 2015, J AM PHARM ASSOC, V55, P364, DOI 10.1331/JAPhA.2015.15529
   [Anonymous], 2000, MMWR Recomm Rep, V49, P1
   [Anonymous], 2003, Am J Health Syst Pharm, V60, P1993
   Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P299
   Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926
   Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059
   Athamna A, 2004, J ANTIMICROB CHEMOTH, V54, P424, DOI 10.1093/jac/dkh258
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bai CQ, 2016, CLIN INFECT DIS, V63, P1288, DOI 10.1093/cid/ciw571
   Bishop BM, 2015, ANN PHARMACOTHER, V49, P196, DOI 10.1177/1060028014561227
   Booth MG, 2010, LANCET, V375, P1345, DOI 10.1016/S0140-6736(10)60573-9
   Borio LL, 2015, MANDELL DOUGLAS BENN, P178
   Bower WA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr6404a1
   Bradley JS, 2014, PEDIATRICS, V133, pE1411, DOI 10.1542/peds.2014-0563
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cangene Corp, 2017, BAT BOT ANT HEPT A B
   Cangene Corp, 2015, ANTHR ANTHR IMM GLOB
   Center for Disease Control and Prevention, 2017, BIOT AG DIS CAT A
   Center for Disease Control and Prevention, 2017, PAND INFL PLAN
   Center for Disease Control and Prevention, 2017, PREV MOSQ BIT
   Center for Disease Control and Prevention, 2015, PLAGUE
   Cohen J, 2016, SCIENCE, V353, P529, DOI 10.1126/science.353.6299.529
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330
   Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af
   Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Elusys, 2016, ANTH OB PACK INS
   Emergent BioDefense Operations Lansing LLC, 2015, BIOTHR ANTHR VACC AB
   Fagan RP, 2011, CLIN INFECT DIS, V52, P585, DOI 10.1093/cid/ciq240
   FDA, 2015, PROD DEV AN RUL GUID
   Frieden TR, 2015, EMERG INFECT DIS, V21, P1897, DOI 10.3201/eid2111.150949
   Geisbert TW, 2015, MANDELL DOUGLAS BENN, P1995
   GlaxoSmithKline, 2016, RAX PACK INS
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hanczaruk M, 2014, EMERG INFECT DIS, V20, P322, DOI 10.3201/eid2002.120921
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127
   Hendricks Katherine A, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2002.130687
   Hill SE, 2013, ANN PHARMACOTHER, V47, DOI 10.1345/aph.1R646
   Hodowanec A, 2015, MANDELL DOUGLAS BENN, P2763
   Hou AW, 2017, ANN PHARMACOTHER, V51, P908, DOI 10.1177/1060028017713029
   Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281
   Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353
   Jorgenson D, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-74
   Katharios-Lanwermeyer S, 2016, CLIN INFECT DIS, V62, P1537, DOI 10.1093/cid/ciw184
   Khabbaz R., 2015, MANDELL DOUGLAS BENN, V1, P158, DOI [10.1016/B978-1-4557-4801-3.00014-X, DOI 10.1016/B978-1-4557-4801-3.00014-X]
   Kool JL, 2005, CLIN INFECT DIS, V40, P1166, DOI 10.1086/428617
   Kretzschmar M, 2004, EMERG INFECT DIS, V10, P832, DOI 10.3201/eid1005.030419
   Kwit N, 2015, MMWR-MORBID MORTAL W, V64, P918, DOI 10.15585/mmwr.mm6433a6
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Martin GF, 2015, MANDELL DOUGLAS BENN, P2391
   Mead PS, 2015, PRINCIPLES PRACTICE, P2607
   MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702
   Meyerhoff A, 2004, CLIN INFECT DIS, V39, P303, DOI 10.1086/421491
   Migone TS, 2015, ANTIMICROB AGENTS CH, V59, P1145, DOI 10.1128/AAC.04606-14
   Migone TS, 2009, NEW ENGL J MED, V361, P135, DOI 10.1056/NEJMoa0810603
   Miller AD, 2011, NEW ENGL J MED, V364, P2560, DOI 10.1056/NEJMc1105155
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morens DM, 2008, LANCET INFECT DIS, V8, P710, DOI 10.1016/S1473-3099(08)70256-1
   Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819
   Mucker EM, 2013, ANTIMICROB AGENTS CH, V57, P6246, DOI 10.1128/AAC.00977-13
   Mwengee W, 2006, CLIN INFECT DIS, V42, P614, DOI 10.1086/500137
   Mytle N, 2013, ANTIMICROB AGENTS CH, V57, P5684, DOI 10.1128/AAC.00458-13
   Nalca A, 2010, DRUG DES DEV THER, V4, P71
   Nelson C, 2013, MMWR-MORBID MORTAL W, V62, P963
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Olson VA, 2014, ANTIMICROB AGENTS CH, V58, P5570, DOI 10.1128/AAC.02814-14
   Penn RL, 2015, MANDELL DOUGLAS BENN, P2590
   Petersen BW, 2015, MMWR RECOMM REP, V64, P1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reardon S, 2014, NATURE, V514, P544, DOI 10.1038/514544a
   Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6
   Rolfes MA, 2017, ESTIMATED INFLUENZA
   Runfola JK, 2015, MMWR-MORBID MORTAL W, V64, P429
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Smolinski M.S., 2003, MICROBIAL THREATS HL
   Spengler JR, 2016, EMERG INFECT DIS, V22, P956, DOI [10.3201/eid2206.160021, 10.32032/eid2206.160021]
   Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702
   Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]
   Taubenberger JK, 2006, EMERG INFECT DIS, V12, P1
   Tebas P, 2017, N ENGL J MED
   Treanor J, 2015, PRINCIPLES PRACTICE, P2000
   Trost LC, 2015, ANTIVIR RES, V117, P115, DOI 10.1016/j.antiviral.2015.02.007
   Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   USAMIIRD, 2014, MED MAN BIOL CAS HDB
   Wheelis M, 2002, EMERG INFECT DIS, V8, P971, DOI 10.3201/eid0809.010536
   WHO, 2016, EB SIT REP
   Woodard LJ, 2010, J AM PHARM ASSOC, V50, P158, DOI 10.1331/JAPhA.2010.09187
   World Health Organization, 1979, GLOB
   Wright Jennifer Gordon, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Yamamoto BJ, 2016, ANTIMICROB AGENTS CH, V60, P5787, DOI 10.1128/AAC.00972-16
   Zhu FC, 2017, LANCET, V389, P621, DOI [10.1016/S0140-6736(16)32617-4, 10.1016/s0140-6736(16)32617-4]
   Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0
   Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322
NR 101
TC 5
Z9 6
U1 1
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0277-0008
EI 1875-9114
J9 PHARMACOTHERAPY
JI Pharmacotherapy
PD FEB
PY 2018
VL 38
IS 2
BP 217
EP 234
DI 10.1002/phar.2068
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FV8KS
UT WOS:000424836400010
PM 29236288
OA Bronze
DA 2020-07-08
ER

PT J
AU Watson-Brown, P
   Viennet, E
   Hoad, VC
   Flower, RLP
   Faddy, HM
AF Watson-Brown, Peter
   Viennet, Elvina
   Hoad, Veronica C.
   Flower, Robert L. P.
   Faddy, Helen M.
TI Is Zika virus a potential threat to the Australian Blood Supply?
SO AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
LA English
DT Letter
ID TRANSMISSION; DONATIONS
C1 [Watson-Brown, Peter; Faddy, Helen M.] Univ Queensland, Sch Med, Brisbane, Qld, Australia.
   [Watson-Brown, Peter; Viennet, Elvina; Flower, Robert L. P.; Faddy, Helen M.] Australian Red Cross Blood Serv, Res & Dev, 44 Musk Ave, Kelvin Grove, Qld 4059, Australia.
   [Hoad, Veronica C.] Australian Red Cross Blood Serv, Clin Serv & Res, Perth, WA, Australia.
RP Viennet, E (corresponding author), Australian Red Cross Blood Serv, Res & Dev, 44 Musk Ave, Kelvin Grove, Qld 4059, Australia.
EM eviennet@redcrossblood.org.au
RI Flower, Robert/N-3680-2017; Viennet, Elvina/D-9032-2017; Viennet,
   Elvina/M-5818-2019
OI Viennet, Elvina/0000-0002-1418-1426; Viennet,
   Elvina/0000-0002-1418-1426; Faddy, Helen/0000-0002-3446-8248
FU Australian governmentsAustralian Government
FX We thank laboratories and health departments in the states and
   territories of Australia who produced and collected the notification
   data used in this study. Australian governments fund the Australian Red
   Cross Blood Service to provide blood, blood products and services to the
   Australian community. We thank R.J. Harley and C.R. Seed for critically
   reviewing the manuscript.
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Australian Red Cross Blood Service, 2016, TRANSFUSION NEWS
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Boadle A, 2016, REUTERS
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Department of Health, 2016, ZIK VIR NOT ZIK VIR
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Kiely P, 2017, MED J AUSTRALIA, V206, P455, DOI 10.5694/mja16.00833
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   National Notifiable Diseases Surveillance System, 2017, NUMB NOT DENG VIR IN
   Viennet E, 2016, PLOS CURR, V8
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
NR 16
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1326-0200
EI 1753-6405
J9 AUST NZ J PUBL HEAL
JI Aust. N. Z. Publ. Health
PD FEB
PY 2018
VL 42
IS 1
BP 104
EP 105
DI 10.1111/1753-6405.12697
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FV0AD
UT WOS:000424217400020
PM 28749569
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Obenauer, J
   Rubsamen, N
   Castell, S
   Hoodgarzadeh, M
   Klett-Tammen, CJ
   Mikolajczyk, RT
   Karch, A
AF Obenauer, Julie
   Ruebsamen, Nicole
   Castell, Stefanie
   Hoodgarzadeh, Mahrrouz
   Klett-Tammen, Carolina J.
   Mikolajczyk, Rafael T.
   Karch, Andre
TI Perceptions of Zika virus risk in Germany in 2016
SO EUROPEAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID SEXUAL TRANSMISSION; OUTBREAK
AB Risks associated with Zika virus (ZIKV) transmission in the Americas have been discussed widely in the media as several European athletes declined to participate in the 2016 Summer Olympic Games. Since risk perceptions of individuals in unaffected areas are unknown, we assessed the risk perceptions of ZIKV and related behaviour in Lower Saxony, Germany, with a specific focus on pregnant women and their partners.
   In May 2016, we surveyed 1,037 participants aged 15-69 years of an online panel (addressing hygiene and preventive behaviour regarding infections) in Lower Saxony with respect to their risk perceptions related to ZIKV. We additionally included 26 expectant parents who were recruited at antenatal preparation courses in Braunschweig and Hannover between May and July 2016.
   Six hundred fifty-five (69.1%) of the panel participants had ever heard about ZIKV. About 8% of the study participants reported to be concerned about ZIKV. Pregnant women had the highest odds of reporting concern about ZIKV (OR: 6.24; 95% CI: 2.94-13.26, reference: non-pregnant women). The vast majority of participants (79%) would travel to the Olympics if they won a free trip; this proportion was lower in currently pregnant women (46%). Risk perceptions towards ZIKV were considerably lower than those towards Ebola during the 2014 epidemic.
   This study showed that fear of contracting ZIKV is not a major deterrent for travelling to high-risk areas. Pregnant women are appropriately concerned about the risk of ZIKV. Studies modelling the further spread of ZIKV need to account for these results.
C1 [Obenauer, Julie] East Tennessee State Univ, Dept Epidemiol & Biostat, Johnson City, TN USA.
   [Ruebsamen, Nicole; Castell, Stefanie; Hoodgarzadeh, Mahrrouz; Klett-Tammen, Carolina J.; Mikolajczyk, Rafael T.; Karch, Andre] Helmholtz Ctr Infect Res, Dept Epidemiol, Inhoffenstr 7, D-38124 Braunschweig, Germany.
   [Ruebsamen, Nicole; Hoodgarzadeh, Mahrrouz; Karch, Andre] PhD Programme Epidemiol, Braunschweig, Germany.
   [Klett-Tammen, Carolina J.; Mikolajczyk, Rafael T.] Hannover Med Sch, Hannover, Germany.
   [Mikolajczyk, Rafael T.; Karch, Andre] German Ctr Infect Res DZIF, Hannover Braunschweig Site, Braunschweig, Germany.
   [Mikolajczyk, Rafael T.] Martin Luther Univ Halle Wittenberg, Med Fac, Halle, Saale, Germany.
RP Karch, A (corresponding author), Helmholtz Ctr Infect Res, Dept Epidemiol, Inhoffenstr 7, D-38124 Braunschweig, Germany.
EM andre.karch@helmholtz-hzi.de
RI Karch, Andre/D-6973-2017; Rubsamen, Nicole/S-2460-2019; amsalu,
   ribka/G-8780-2019
OI Karch, Andre/0000-0003-3014-8543; Rubsamen, Nicole/0000-0003-2198-5577; 
FU Helmholtz Centre for Infection Research
FX This study was funded by intramural funds of the Helmholtz Centre for
   Infection Research and did not receive external funding.
CR [Anonymous], EP UPD OUTBR ZIK VIR
   Attaran A, PODIUM WHY PUBLIC HL
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Figueiras A, 1998, STAT MED, V17, P2099, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2099::AID-SIM905>3.0.CO;2-6
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Kmietowicz Z, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3233
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Porst R, 2014, FRAGEBOGEN ARBEITSBU, P189, DOI [10.1007/978-3-658-02118-4_15, DOI 10.1007/978-3-658-02118-4_15]
   Prati G, 2016, RISK ANAL, V36, P2000, DOI 10.1111/risa.12537
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Robert Koch-Institute, 2016, EPIDEMIOL B, V20, P179
   Rubsamen N, 2017, EMERG THEMES EPIDEMI, V14, DOI 10.1186/s12982-017-0058-2
   Rubsamen N, 2015, EMERG INFECT DIS, V21, P1012, DOI 10.3201/eid2106.150013
   StataCorp, 2011, STAT STAT SOFTW REL
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   World Health Organization, ZIK VIR TECHN REP IN
   World Health Organization Regional Office for Europe, FREQ ASK QUEST ZIK V
NR 19
TC 1
Z9 1
U1 5
U2 12
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1101-1262
EI 1464-360X
J9 EUR J PUBLIC HEALTH
JI Eur. J. Public Health
PD FEB
PY 2018
VL 28
IS 1
BP 139
EP 144
DI 10.1093/eurpub/ckx092
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FU8SR
UT WOS:000424126000024
PM 29106547
OA Bronze
DA 2020-07-08
ER

PT J
AU Micewicz, ED
   Khachatoorian, R
   French, SW
   Ruchala, P
AF Micewicz, Ewa D.
   Khachatoorian, Ronik
   French, Samuel W.
   Ruchala, Piotr
TI Identification of novel small-molecule inhibitors of Zika virus
   infection
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Antivirals; Zika inhibitors; Zika virus; Plaque assay; Screening
ID A(2A) RECEPTOR ANTAGONISTS; SEXUAL TRANSMISSION; ANTIVIRAL ACTIVITY;
   NS2B-NS3 PROTEASE; BROAD-SPECTRUM; POTENT; RADIOLIGAND; BRAZIL; BRAIN;
   SOLUBILITY
AB The recent re-emergence of Zika virus (ZIKV), a member of the Flaviviridae family, has become a global emergency and a serious public health threat worldwide. ZIKV infection causes severe neuroimmunopathology and is particularly harmful to the developing fetuses of infected pregnant women causing various developmental abnormalities. Currently, there are no effective methods of preventing or treating ZIKV infection, and new treatment options are urgently needed. Therefore, we have used an in vitro plaque assay to screen a limited proprietary library of small organic compounds and identified highly bioactive leads, with the most active analogs showing activity in low picomolar range. Identified "hits" possess certain common structural features that can be used in the design of the next generation(s) of ZIKV inhibitors. Collectively, our findings suggest that identified compounds represent excellent template(s) for the development of inexpensive and orally available anti-Zika drugs. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Micewicz, Ewa D.] Univ Calif Los Angeles, Dept Radiat Oncol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [Khachatoorian, Ronik; French, Samuel W.] Univ Calif Los Angeles, Dept Pathol & Lab Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [French, Samuel W.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [French, Samuel W.] Univ Calif Los Angeles, UCLA AIDS Inst, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [Ruchala, Piotr] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA.
   [Ruchala, Piotr] Jane & Terry Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, 760 Westwood Plaza, Los Angeles, CA 90024 USA.
RP Ruchala, P (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA.
EM pruchala@mednet.ucla.edu
OI RUCHALA, PIOTR/0000-0002-5574-2779
FU Department of Pathology and Laboratory Medicine
FX This project was partially supported by funds from the Department of
   Pathology and Laboratory Medicine (SWF). The authors thank
   Vaithilingaraja Arumugaswami for providing the virus and guidance, Asim
   Dasgupta for providing critical resources and guidance, Ren Sun for
   providing guidance, and Anthony Buzzanco, Danyang Gong, Deisy Contreras
   and Gustavo Garcia Jr. for technical assistance.
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Borrmann T, 2009, J MED CHEM, V52, P3994, DOI 10.1021/jm900413e
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267
   Hauser RA, 2011, LANCET NEUROL, V10, P221, DOI 10.1016/S1474-4422(11)70012-6
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hodgson RA, 2009, J PHARMACOL EXP THER, V330, P294, DOI 10.1124/jpet.108.149617
   Jacobson KA, 1997, NEUROPHARMACOLOGY, V36, P1157, DOI 10.1016/S0028-3908(97)00104-4
   Kalk P, 2007, BRIT J PHARMACOL, V1025, P151
   KRAUSE W, 1990, EUR J CLIN PHARMACOL, V38, P71, DOI 10.1007/BF00314807
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007
   Lunniss CJ, 2009, BIOORG MED CHEM LETT, V19, P1380, DOI 10.1016/j.bmcl.2009.01.045
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, P61
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohamed HA, 2011, J MED CHEM, V54, P495, DOI 10.1021/jm100842v
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Muller Christa E, 2007, Recent Pat CNS Drug Discov, V2, P1, DOI 10.2174/157488907779561772
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Neustadt BR, 2007, BIOORG MED CHEM LETT, V17, P1376, DOI 10.1016/j.bmcl.2006.11.083
   Ohsawa F, 1998, JPN J PHARMACOL, V77, P147, DOI 10.1254/jjp.77.147
   Perry M. J., 1998, Cell Biochemistry and Biophysics, V29, P113, DOI 10.1007/BF02737831
   RAEBURN D, 1994, BRIT J PHARMACOL, V113, P1423, DOI 10.1111/j.1476-5381.1994.tb17156.x
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01417
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Saiz J.C., 2017, ANTIMICROB AGENTS CH, P61
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Soares dO-S, 2016, RADIOLOGY, V281, P203
   Stewart M, 2004, BIOCHEM PHARMACOL, V68, P305, DOI 10.1016/j.bcp.2004.03.026
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Vesnaver TV, 2017, BJOG-INT J OBSTET GY, V124, P521, DOI 10.1111/1471-0528.14423
   Wang P, 1997, BIOCHEM BIOPH RES CO, V234, P320, DOI 10.1006/bbrc.1997.6636
   Weyler S, 2006, CHEMMEDCHEM, V1, P891, DOI 10.1002/200600066
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yates L., 2006, Autonomic & Autacoid Pharmacology, V26, P191, DOI 10.1111/j.1474-8673.2006.00372.x
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zhao Y, 2003, J PHARMACOL EXP THER, V305, P565, DOI 10.1124/jpet.102.47407
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 65
TC 8
Z9 10
U1 1
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD FEB 1
PY 2018
VL 28
IS 3
BP 452
EP 458
DI 10.1016/j.bmcl.2017.12.019
PG 7
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA FV0XU
UT WOS:000424285600042
PM 29258771
DA 2020-07-08
ER

PT J
AU de Araujo, TVB
   Ximenes, RAA
   Miranda, DB
AF de Araujo, T. V. B.
   Ximenes, R. A. A.
   Miranda-Filho, D. B.
TI Association between microcephaly, Zika virus infection, and other risk
   factors in Brazil: final report of a case-control study (vol 18, 2017)
SO LANCET INFECTIOUS DISEASES
LA English
DT Correction
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
NR 1
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD FEB
PY 2018
VL 18
IS 2
BP 139
EP 139
DI 10.1016/S1473-3099(18)30001-X
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA FU4HL
UT WOS:000423814000017
OA Bronze
DA 2020-07-08
ER

PT J
AU Salam, AP
   Horby, P
AF Salam, Alex P.
   Horby, Peter
TI Isolation of viable Zika virus from spermatozoa
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID SPERM
C1 [Salam, Alex P.] Univ Oxford, United Kingdom Publ Hlth Rapid Support Team, Oxford OX3 7BN, England.
   [Horby, Peter] Univ Oxford, Epidem Dis Res Grp, Wellcome Ctr Human Genet, Oxford OX3 7BN, England.
RP Salam, AP (corresponding author), Univ Oxford, United Kingdom Publ Hlth Rapid Support Team, Oxford OX3 7BN, England.
EM alex.salam@ndm.ox.ac.uk
CR Choi JK, 2015, CRYOBIOLOGY, V71, P350, DOI 10.1016/j.cryobiol.2015.08.012
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   Toshimori K, 2009, ADV ANAT EMBRYOL CEL, V204, P5
NR 4
TC 5
Z9 5
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD FEB
PY 2018
VL 18
IS 2
BP 144
EP 144
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA FU4HL
UT WOS:000423814000025
PM 29412962
OA Bronze
DA 2020-07-08
ER

PT J
AU Faddy, HM
   Tran, TV
   Hoad, VC
   Seed, CR
   Viennet, E
   Chan, HT
   Harley, R
   Hewlett, E
   Hall, RA
   Bielefeldt-Ohmann, H
   Flower, RLP
   Prow, NA
AF Faddy, Helen M.
   Tran, Thu V.
   Hoad, Veronica C.
   Seed, Clive R.
   Viennet, Elvina
   Chan, Hiu-Tat
   Harley, Robert
   Hewlett, Elise
   Hall, Roy A.
   Bielefeldt-Ohmann, Helle
   Flower, Robert L. P.
   Prow, Natalie A.
TI Ross River virus in Australian blood donors: possible implications for
   blood transfusion safety
SO TRANSFUSION
LA English
DT Article
ID TROPICAL NORTHERN AUSTRALIA; BARMAH FOREST VIRUSES; EPIDEMIC
   POLYARTHRITIS; DENGUE VIREMIA; INFECTION; TRANSMISSION; QUEENSLAND;
   PLATELET; DISEASE; ARBOVIRUSES
AB BACKGROUNDEmerging transfusion-transmissible pathogens, including arboviruses such as West Nile, Zika, dengue, and Ross River viruses, are potential threats to transfusion safety. The most prevalent arbovirus in humans in Australia is Ross River virus (RRV); however, prevalence varies substantially around the country. Modeling estimated a yearly risk of 8 to 11 potentially RRV-viremic fresh blood components nationwide. This study aimed to measure the occurrence of RRV viremia among donors who donated at Australian collection centers located in areas with significant RRV transmission during one peak season.
   STUDY DESIGN AND METHODSPlasma samples were collected from donors (n=7500) who donated at the selected collection centers during one peak season. Viral RNA was extracted from individual samples, and quantitative reverse transcription-polymerase chain reaction was performed.
   RESULTSRegions with the highest rates of RRV transmission were not areas where donor centers were located. We did not detect RRV RNA among 7500 donations collected at the selected centers, resulting in a zero risk estimate with a one-sided 95% confidence interval of 0 to 1 in 2019 donations.
   CONCLUSIONOur results suggest that the yearly risk of collecting a RRV-infected blood donation in Australia is low and is at the lower range of previous risk modeling. The majority of Australian donor centers were not in areas known to be at the highest risk for RRV transmission, which was not taken into account in previous models based on notification data. Therefore, we believe that the risk of RRV transfusion transmission in Australia is acceptably low and appropriately managed through existing risk management, including donation restrictions and recall policies.
C1 [Faddy, Helen M.; Tran, Thu V.; Viennet, Elvina; Hewlett, Elise; Flower, Robert L. P.] Australian Red Cross Blood Serv, Res & Dev, Brisbane, Qld, Australia.
   [Faddy, Helen M.] Univ Queensland, Sch Med, Brisbane, Qld, Australia.
   [Hoad, Veronica C.; Seed, Clive R.; Chan, Hiu-Tat; Harley, Robert] Australian Red Cross Blood Serv, Clin Serv & Res, Brisbane, Qld, Australia.
   [Hewlett, Elise; Hall, Roy A.; Bielefeldt-Ohmann, Helle] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.
   [Prow, Natalie A.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
RP Faddy, HM (corresponding author), 44 Musk Ave, Kelvin Grove, Qld, Australia.
EM hfaddy@redcrossblood.org.au
RI Viennet, Elvina/M-5818-2019; Flower, Robert/N-3680-2017; Viennet,
   Elvina/D-9032-2017
OI Viennet, Elvina/0000-0002-1418-1426; Viennet,
   Elvina/0000-0002-1418-1426; Chan, Hiu Tat/0000-0002-3169-9884; Faddy,
   Helen/0000-0002-3446-8248
FU Australian governmentsAustralian Government
FX We thank Blood Service Donor Services and Manufacturing staff,
   especially: K. Lever, T. McCartin, S. Mckenzie, L. Halgath, K. Myers, T.
   Watt, A. Monteagle, E. Thompson, S. Mungwana, S. Morrow, and C. Angelino
   for assisting with sample collection; J. Fryk for assisting with sample
   testing; C. Harrington, P. Diaz, and G. Shuttleworth for providing data;
   A. Keller, A. Pyke, S. Hall-Mendelin, D. Smith, and G. Chidlow for
   technical advice; and K. Knope, A. Keller, D. Warrilow, and R. Allcock
   for critically reviewing this manuscript. We also thank the laboratories
   and health departments in the states and territories of Australia that
   produced and collected the notification data used in this study. The
   Australian governments fund the Australian Red Cross Blood Service to
   provide blood, blood products, and services to the Australian community.
CR Alter HJ, 2007, SEMIN HEMATOL, V44, P32, DOI 10.1053/j.seminhematol.2006.09.016
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Barton AJ, 2017, J EQUINE VET SCI, V51, P34, DOI 10.1016/j.jevs.2016.12.010
   Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122
   Chidlow G, 2010, J CLIN MICROBIOL, V48, P862, DOI 10.1128/JCM.01435-09
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   DOHERTY R. L., 1963, AUSTRALIAN J SCI, V26, P183
   Dunstan RA, 2008, AUST NZ J PUBL HEAL, V32, P354, DOI 10.1111/j.1753-6405.2008.00254.x
   Faddy H, 2015, ECOHEALTH, V12, P347, DOI 10.1007/s10393-014-1005-0
   Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519
   Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664
   Flies EJ, 2016, J MED ENTOMOL, V53, P902, DOI 10.1093/jme/tjw035
   Gatton ML, 2005, AM J TROP MED HYG, V72, P792, DOI 10.4269/ajtmh.2005.72.792
   Hall RA, 2011, ROSS RIVER VIRUS MOL, P349
   Hii J., 1997, Papua New Guinea Medical Journal, V40, P14
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Hyland CA, 2014, PRENATAL DIAG, V34, P56, DOI 10.1002/pd.4253
   Jacups SP, 2008, TROP MED INT HEALTH, V13, P943, DOI 10.1111/j.1365-3156.2008.02095.x
   Jacups SP, 2008, VECTOR-BORNE ZOONOT, V8, P283, DOI 10.1089/vbz.2007.0152
   Jansen CC, 2009, J AM MOSQUITO CONTR, V25, P272, DOI 10.2987/09-5908.1
   Kay BH, 2007, AM J TROP MED HYG, V76, P417, DOI 10.4269/ajtmh.2007.76.417
   Knope K, 2013, COMMUN DIS INTELL, V37, pE1
   Koolhof IS, 2017, EPIDEMIOL INFECT, V145, P656, DOI 10.1017/S0950268816002739
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lau C, 2017, INT J INFECT DIS, V57, P73, DOI 10.1016/j.ijid.2017.01.041
   Mackenzie JS, 1996, MED J AUSTRALIA, V164, P90, DOI 10.5694/j.1326-5377.1996.tb101357.x
   Montgomery SP, 2006, TRANSFUSION, V46, P2038, DOI 10.1111/j.1537-2995.2006.01030.x
   Mood AM, 2001, INTRO THEORY STAT
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Old JM, 2005, J WILDLIFE DIS, V41, P611, DOI 10.7589/0090-3558-41.3.611
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   ROSEN L, 1981, AM J TROP MED HYG, V30, P1294, DOI 10.4269/ajtmh.1981.30.1294
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Seed CR, 2016, VOX SANG, V110, P317, DOI 10.1111/vox.12372
   Shang G, 2012, VOX SANG, V102, P185, DOI 10.1111/j.1423-0410.2011.01536.x
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Sutherland MR, 2016, TRANSFUSION, V56, P1129, DOI 10.1111/trf.13454
   TESH RB, 1981, T ROY SOC TROP MED H, V75, P426, DOI 10.1016/0035-9203(81)90112-7
   Tong SL, 2004, TROP MED INT HEALTH, V9, P298, DOI 10.1046/j.1365-3156.2003.01175.x
   Yu WW, 2014, AM J TROP MED HYG, V91, P109, DOI 10.4269/ajtmh.13-0455
NR 40
TC 5
Z9 5
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD FEB
PY 2018
VL 58
IS 2
BP 485
EP 492
DI 10.1111/trf.14472
PG 8
WC Hematology
SC Hematology
GA FV2KJ
UT WOS:000424395000030
PM 29350414
OA Bronze
DA 2020-07-08
ER

PT J
AU Sato, K
   Misawa, N
   Takeuchi, JS
   Kobayashi, T
   Izumi, T
   Aso, H
   Nagaoka, S
   Yamamoto, K
   Kimura, I
   Konno, Y
   Nakano, Y
   Koyanagi, Y
AF Sato, Kei
   Misawa, Naoko
   Takeuchi, Junko S.
   Kobayashi, Tomoko
   Izumi, Taisuke
   Aso, Hirofumi
   Nagaoka, Shumpei
   Yamamoto, Keisuke
   Kimura, Izumi
   Konno, Yoriyuki
   Nakano, Yusuke
   Koyanagi, Yoshio
TI Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz
   to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized
   Mouse Model
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE HIV-1; SIVcpz; cross-species transmission; humanized mouse; viral
   evolution
ID HIV-1 GROUP-N; DEFICIENCY-SYNDROME AIDS; EBOLA-VIRUS; SWISS-MODEL;
   INFECTIOUS-DISEASES; MAXIMUM-LIKELIHOOD; ACCESSORY PROTEINS; NONPANDEMIC
   HIV-1; GENETIC DIVERSITY; WILD CHIMPANZEES
AB Human immunodeficiency virus type 1 (HIV-1), the causative agent of AIDS, originated from simian immunodeficiency virus from chimpanzees (SIVcpz), the precursor of the human virus, approximately 100 years ago. This indicates that HIV-1 has emerged through the cross-species transmission of SIVcpz from chimpanzees to humans. However, it remains unclear how SIVcpz has evolved into pandemic HIV-1 in humans. To address this question, we inoculated three SIVcpz strains (MB897, EK505, and MT145), four pandemic HIV-1 strains (NL4-3, NLCSFV3, JRCSF, and AD8), and two nonpandemic HIV-1 strains (YBF30 and DJO0131). Humanized mice infected with SIVcpz strain MB897, a virus phylogenetically similar to pandemic HIV-1, exhibited a peak viral load comparable to that of mice infected with pandemic HIV-1, while peak viral loads of mice infected with SIVcpz strain EK505 or MT145 as well as nonpandemic HIV-1 strains were significantly lower. These results suggest that SIVcpz strain MB897 is preadapted to humans, unlike the other SIVcpz strains. Moreover, viral RNA sequencing of MB897-infected humanized mice identified a nonsynonymous mutation in env, a G413R substitution in gp120. The infectivity of the gp120 G413R mutant of MB897 was significantly higher than that of parental MB897. Furthermore, we demonstrated that the gp120 G413R mutant of MB897 augments the capacity for viral replication in both in vitro cell cultures and humanized mice. Taken together, this is the first experimental investigation to use an animal model to demonstrate a gain-of-function evolution of SIVcpz into pandemic HIV-1.
   IMPORTANCE From the mid-20th century, humans have been exposed to the menace of infectious viral diseases, such as severe acute respiratory syndrome coronavirus, Ebola virus, and Zika virus. These outbreaks of emerging/reemerging viruses can be triggered by cross-species viral transmission from wild animals to humans, or zoonoses. HIV-1, the causative agent of AIDS, emerged by the cross-species transmission of SIVcpz, the HIV-1 precursor in chimpanzees, around 100 years ago. However, the process by which SIVcpz evolved to become HIV-1 in humans remains unclear. Here, by using a hematopoietic stem cell-transplanted humanized-mouse model, we experimentally recapitulate the evolutionary process of SIVcpz to become HIV-1. We provide evidence suggesting that a strain of SIVcpz, MB897, preadapted to infect humans over other SIVcpz strains. We further demonstrate a gain-of-function evolution of SIVcpz in infected humanized mice. Our study reveals that pandemic HIV-1 has emerged through at least two steps: preadaptation and subsequent gain-of-function mutations.
C1 [Sato, Kei; Misawa, Naoko; Takeuchi, Junko S.; Kobayashi, Tomoko; Izumi, Taisuke; Nakano, Yusuke; Koyanagi, Yoshio] Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Kyoto, Japan.
   [Sato, Kei; Misawa, Naoko; Izumi, Taisuke; Aso, Hirofumi; Nagaoka, Shumpei; Yamamoto, Keisuke; Kimura, Izumi; Konno, Yoriyuki; Nakano, Yusuke; Koyanagi, Yoshio] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Biosyst Sci, Lab Syst Virol, Kyoto, Japan.
   [Sato, Kei] Japan Sci & Technol Agcy, CREST, Saitama, Japan.
   [Aso, Hirofumi] Kyoto Univ, Fac Pharmaceut Sci, Kyoto, Japan.
   [Nagaoka, Shumpei; Konno, Yoriyuki] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.
   [Yamamoto, Keisuke] Kyoto Univ, Grad Sch Med, Kyoto, Japan.
   [Kimura, Izumi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan.
   [Takeuchi, Junko S.] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.
   [Kobayashi, Tomoko] Tokyo Univ Agr, Dept Anim Sci, Lab Anim Hlth, Fac Agr, Atsugi, Kanagawa, Japan.
   [Izumi, Taisuke] Frederick Natl Lab Canc Res, Frederick, MD USA.
RP Sato, K (corresponding author), Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Kyoto, Japan.; Sato, K (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Dept Biosyst Sci, Lab Syst Virol, Kyoto, Japan.; Sato, K (corresponding author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.
EM ksato@virus.kyoto-u.ac.jp
RI Izumi, Taisuke/J-5607-2014
OI Izumi, Taisuke/0000-0002-9694-1459; Sato, Kei/0000-0003-4431-1380;
   Izumi, Taisuke/0000-0001-8193-0813
FU Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [J-PRIDE 17fm0208006h0001];
   CREST, Japan Science and Technology Agency (JST)Japan Science &
   Technology Agency (JST)Core Research for Evolutional Science and
   Technology (CREST); Health Labor Sciences Research grant from the
   Ministry of Health, Labour, and Welfare (MHLW) [26361601]; Japan Society
   for the Promotion of Science (JSPS)Ministry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of Science [15K07166]; JSPSMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of Science [16KT0111]; Ministry of Education, Culture, Sports,
   Science, and Technology (MEXT)Ministry of Education, Culture, Sports,
   Science and Technology, Japan (MEXT); Takeda Science FoundationTakeda
   Science Foundation (TSF); Sumitomo Foundation; Imai Memorial Trust;
   Ichiro Kanehara Foundation; Kanae Foundation; Suzuken Memorial
   Foundation; Uehara Memorial FoundationUehara Memorial Foundation;
   Mochida Memorial Foundation for Medical and Pharmaceutical Research;
   Salt Science Research Foundation; Smoking Research Foundation; Chube Ito
   Foundation; Fordays Self-Reliance Support in Japan; Mishima Kaiun
   Memorial FoundationMishima Kaiun Memorial Foundation; Tobe Maki
   Scholarship Foundation; NIH/NIAIDUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [5P30 AI028697]; 
   [16H06429];  [16K21723];  [17H05813];  [24115008]
FX This study was supported in part by grant J-PRIDE 17fm0208006h0001 from
   the Japan Agency for Medical Research and Development (AMED) (to K.S.),
   by a grant from CREST, Japan Science and Technology Agency (JST) (to
   K.S.), by Health Labor Sciences Research grant 26361601 from the
   Ministry of Health, Labour, and Welfare (MHLW) (to K.S.), by
   grant-in-aid for scientific research C 15K07166 from the Japan Society
   for the Promotion of Science (JSPS) (to K.S.), by Scientific Research B
   (Generative Research Fields) grant 16KT0111 from the JSPS (to K.S.), by
   Scientific Research on Innovative Areas grants 16H06429, 16K21723,
   17H05813 (to K.S.), and 24115008, and by grants from the Ministry of
   Education, Culture, Sports, Science, and Technology (MEXT) (to Y.K.),
   the Takeda Science Foundation (to K.S.), the Sumitomo Foundation (to
   K.S.), the Imai Memorial Trust (to K.S.), the Ichiro Kanehara Foundation
   (to K.S.), the Kanae Foundation (to K.S.), the Suzuken Memorial
   Foundation (to K.S.), the Uehara Memorial Foundation (to K.S.), the
   Mochida Memorial Foundation for Medical and Pharmaceutical Research (to
   K.S.), the Salt Science Research Foundation (to K.S.), the Smoking
   Research Foundation (to K.S.), the Chube Ito Foundation (to K.S.),
   Fordays Self-Reliance Support in Japan (to K.S.), the Mishima Kaiun
   Memorial Foundation (to K.S.), the Tobe Maki Scholarship Foundation (to
   K.S.), and the JSPS Core-to-Core Program, A, Advanced Research Networks
   (to Y.K.). The UCLA CFAR Gene and Cellular Therapy Core Facility is
   funded through NIH/NIAID grant 5P30 AI028697.
CR ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986
   An DS, 2007, CLIN VACCINE IMMUNOL, V14, P391, DOI 10.1128/CVI.00403-06
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Ayouba A, 2000, AIDS, V14, P2623, DOI 10.1097/00002030-200011100-00033
   BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Bibollet-Ruche F, 2012, J CLIN INVEST, V122, P1644, DOI 10.1172/JCI61429
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   D'arc M, 2015, P NATL ACAD SCI USA, V112, pE1343, DOI 10.1073/pnas.1502022112
   de Sousa JD, 2012, VIRUSES-BASEL, V4, P1950, DOI 10.3390/v4101950
   Delaugerre C, 2011, LANCET, V378, P1894, DOI 10.1016/S0140-6736(11)61457-8
   Etienne L, 2013, CELL HOST MICROBE, V14, P85, DOI 10.1016/j.chom.2013.06.002
   Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010
   Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739
   Gaddis NC, 2004, J VIROL, V78, P12041, DOI 10.1128/JVI.78.21.12041-12046.2004
   GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823
   Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130
   GILDEN RV, 1986, LANCET, V1, P678
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Greenwood EJD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005146
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Ikeda H, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0252-2
   Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207
   Iwami S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12256
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531
   Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Kirchhoff F, 2004, J VIROL, V78, P6864, DOI 10.1128/JVI.78.13.6864-6874.2004
   Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004
   Kluge SF, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-32
   KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751
   Letko M, 2013, J VIROL, V87, P11861, DOI 10.1128/JVI.01944-13
   Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008
   Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185
   Ministry of Education Culture Sports Science and Technology Japan, 2006, GUID PROP COND AN EX
   Mwaengo DM, 1998, J VIROL, V72, P8976, DOI 10.1128/JVI.72.11.8976-8987.1998
   Nakano Y, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006348
   Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553
   Nie CY, 2009, VIROLOGY, V394, P64, DOI 10.1016/j.virol.2009.08.011
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08
   Roques P, 2004, AIDS, V18, P1371, DOI 10.1097/01.aids.0000125990.86904.28
   Sato K, 2008, J VIROL, V82, P1021, DOI 10.1128/JVI.01044-07
   Sato K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004453
   Sato K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003812
   Sato K, 2012, J VIROL, V86, P5000, DOI 10.1128/JVI.07062-11
   Sato K, 2011, EXP BIOL MED, V236, P977, DOI 10.1258/ebm.2011.010294
   Sato K, 2011, BLOOD, V117, P5663, DOI 10.1182/blood-2010-09-305979
   Sato K, 2010, J VIROL, V84, P9546, DOI 10.1128/JVI.00823-10
   Sato K, 2010, VACCINE, V28, pB32, DOI 10.1016/j.vaccine.2009.10.154
   Sauter D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003093
   Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004
   Sharp PM, 2008, NATURE, V455, P605, DOI 10.1038/455605a
   Sharp PM, 2010, PHILOS T R SOC B, V365, P2487, DOI 10.1098/rstb.2010.0031
   Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939
   Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017
   Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612
   Soper A, 2017, EXP BIOL MED, V242, P850, DOI 10.1177/1535370217697384
   Suzuki Y, 1999, J VIROL, V73, P316, DOI 10.1128/JVI.73.1.316-324.1999
   Takehisa J, 2009, J VIROL, V83, P1635, DOI 10.1128/JVI.02311-08
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191
   Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490
   Vallari A, 2010, AIDS RES HUM RETROV, V26, P109, DOI 10.1089/aid.2009.0178
   Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001
   Van Heuverswyn F, 2007, VIROLOGY, V368, P155, DOI 10.1016/j.virol.2007.06.018
   Wain LV, 2007, MOL BIOL EVOL, V24, P1853, DOI 10.1093/molbev/msm110
   Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002
   Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009
   Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390
   Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024
   Yamada E, 2015, VIRUSES-BASEL, V7, P1373, DOI 10.3390/v7031373
   Yang SJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-78
   Yuan Z, 2016, J VIROL, V90, P7728, DOI 10.1128/JVI.00860-16
   Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012
NR 79
TC 8
Z9 8
U1 2
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2018
VL 92
IS 4
AR UNSP e01905-17
DI 10.1128/JVI.01905-17
PG 21
WC Virology
SC Virology
GA FU1AG
UT WOS:000423580900031
PM 29212937
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ding, FY
   Fu, JY
   Jiang, D
   Hao, MM
   Lin, G
AF Ding, Fangyu
   Fu, Jingying
   Jiang, Dong
   Hao, Mengmeng
   Lin, Gang
TI Mapping the spatial distribution of Aedes aegypti and Aedes albopictus
SO ACTA TROPICA
LA English
DT Article
DE Global distribution; Aedes aegypti; Aedes albopictus; Multidisciplinary
   datasets; Machine learning models
ID ZIKA VIRUS; CHIKUNGUNYA VIRUS; DIPTERA; CULICIDAE; SPREAD; PATTERNS;
   MOSQUITO; CLIMATE; VECTOR; COMPETENCE
AB Mosquito-borne infectious diseases, such as Rift Valley fever, Dengue, Chikungunya and Zika, have caused mass human death with the transnational expansion fueled by economic globalization. Simulating the distribution of the disease vectors is of great importance in formulating public health planning and disease control strategies. In the present study, we simulated the global distribution of Aedes aegypti and Aedes albopictus at a 5 x 5 km spatial resolution with high-dimensional multidisciplinary datasets and machine learning methods Three relatively popular and robust machine learning models, including support vector machine (SVM), gradient boosting machine (GBM) and random forest (RF), were used. During the fine-tuning process based on training datasets of A. aegypti and A. albopictus, RF models achieved the highest performance with an area under the curve (AUC) of 0.973 and 0.974, respectively, followed by GBM (AUC of 0.971 and 0.972, respectively) and SVM (AUC of 0.963 and 0.964, respectively) models. The simulation difference between RF and GBM models was not statistically significant (p > 0.05) based on the validation datasets, whereas statistically significant differences (p < 0.05) were observed for RF and GBM simulations compared with SVM simulations. From the simulated maps derived from RF models, we observed that the distribution of A. albopictus was wider than that of A. aegypti along a latitudinal gradient. The discriminatory power of each factor in simulating the global distribution of the two species was also analyzed. Our results provided fundamental information for further study on disease transmission simulation and risk assessment.
C1 [Ding, Fangyu; Fu, Jingying; Jiang, Dong; Hao, Mengmeng; Lin, Gang] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China.
   [Ding, Fangyu; Fu, Jingying; Jiang, Dong; Hao, Mengmeng] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China.
RP Jiang, D (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China.
EM dingfy.14s@igsnrr.ac.cn; fujy@igsnrr.ac.cn; jiangd@igsnrr.ac.cn;
   haomm.16b@igsnrr.ac.cn; ling@lreis.ac.cn
FU Ministry of Science and Technology of ChinaMinistry of Science and
   Technology, China [2016YFC1201300]
FX This research was supported and funded by the Ministry of Science and
   Technology of China (2016YFC1201300). We are grateful to all the data
   providers. We also appreciate editors and reviewers for their
   constructive comments and suggestions.
CR Alpaydin E, 2014, ADAPT COMPUT MACH LE, P1
   Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0
   Bargielowski IE, 2015, INFECT GENET EVOL, V36, P456, DOI 10.1016/j.meegid.2015.08.016
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Breiman L., 2007, RANDOM FORESTS CLASS, P2
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Center for International Earth Science Information Network - CIESIN - Columbia University, 2016, GLOB SUMM LAND SURF
   CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P651
   CIESIN (Center for International Earth Science Information Network-Columbia University), 2016, GRIDD POP WORLD VERS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dutta P., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P173
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hirotsugu U., 2010, AGGLOMERATION INDEX
   HORNBY JA, 1994, J AM MOSQUITO CONTR, V10, P397
   Hsieh YH, 2013, TROP MED INT HEALTH, V18, P830, DOI 10.1111/tmi.12105
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516
   LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434
   Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397
   Liu Z., 2017, EMERG INFECT DIS
   Martens WJM, 1998, ENVIRON HEALTH PERSP, V106, P241, DOI 10.2307/3433924
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   Nelson A., 2008, ESTIMATED TRAVEL TIM
   Nihei N, 2014, GEOSPATIAL HEALTH, V8, P417, DOI 10.4081/gh.2014.30
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Pal M, 2004, FUTURE GENER COMP SY, V20, P1215, DOI 10.1016/j.future.2003.11.011
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   PredPsych Koul A., 2017, PREDIC APPROACHES PS
   Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325
   Ridgeway G., 2006, R PACKAGE VERSION, V1, P55
   Romero-Vivas CME, 2005, J AM MOSQUITO CONTR, V21, P15, DOI 10.2987/8756-971X(2005)21[15:IORBAA]2.0.CO;2
   Roslan MA, 2013, J AM MOSQUITO CONTR, V29, P328, DOI 10.2987/13-6363.1
   Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102755
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Thu H.M., 1998, EFFECT TEMPERATURE H
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110
NR 56
TC 18
Z9 18
U1 2
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2018
VL 178
BP 155
EP 162
DI 10.1016/j.actatropica.2017.11.020
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FU1YB
UT WOS:000423644300025
PM 29191515
DA 2020-07-08
ER

PT J
AU Mead, PS
   Hills, SL
   Brooks, JT
AF Mead, Paul S.
   Hills, Susan L.
   Brooks, John T.
TI Zika virus as a sexually transmitted pathogen
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE condoms; flavivirus; human; pregnancy; semen; sexual transmission; Zika
   virus
ID FEMALE GENITAL-TRACT; APRIL 2016; UNITED-STATES; MOUSE MODEL;
   TRANSMISSION; INFECTION; SEMEN; PREGNANCY; WOMEN; PERSISTENCE
AB Purpose of review
   Zika virus has recently emerged from an obscure mosquito-borne pathogen to an international public health concern. It is the first viral agent newly demonstrated to cause birth defects in several decades, and it is the only arbovirus now known to be transmitted sexually. The purpose of this review is to provide an overview of current understanding of sexual transmission of Zika virus and its possible clinical and public health consequences.
   Recent findings
   Sexual transmission of Zika virus has been reported from at least 13 countries without simultaneous mosquito-borne transmission; it is undoubtedly also occurring in countries with active arthropod transmission. Most published cases involve transmission from symptomatically infected men to women partners. Nevertheless, transmission from a symptomatic man to another man, from a symptomatic woman to a man, and from an asymptomatic man to a woman has also been reported. Sexual transmission has occurred before symptom onset, during illness, and after resolution of the source partner's symptoms. With the exception of a woman who developed symptomatic infection 44 days after onset of her husband's illness, nearly all instances reported to date have occurred within 20 days of the source partner's illness. Zika virus RNA has been detected in semen, saliva, blood, urine, and vaginal and cervical secretions; the length of time during which RNA can be detected varies widely across different body fluids but is especially lengthy in semen. Although semen has been found to contain ZIKV RNA for more than 180 days after illness onset, only a small proportion of samples with detectable RNA yield replicative virus whenever cultured.
   Summary
   Public health agencies have promulgated interim recommendations to prevent sexual transmission of Zika virus; however, much remains unknown regarding the duration of contagiousness and risk factors for transmission. Given the risk for birth defects, the greatest concern is for transmission of the virus to women who are pregnant or attempting to become pregnant. To prevent sexual transmission in general, couples are advised to use condoms or not have sex for at least 6 months from the start of the male partner's symptoms or the date he was diagnosed with Zika or after he has returned from an area with risk of ZIKV infection. Women who have symptomatic ZIKV infection or have traveled to an area of risk are advised to use condoms or avoid sex for 8 weeks from the start of the woman's symptoms or the date she was diagnosed with Zika or after the woman returns from the area of risk.
C1 [Mead, Paul S.; Hills, Susan L.] Ctr Dis Control & Prevent CDC, Div Vector Borne Dis, NCEZID, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Brooks, John T.] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Ft Collins, CO 80521 USA.
RP Mead, PS (corresponding author), Ctr Dis Control & Prevent CDC, Div Vector Borne Dis, NCEZID, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM pmead@cdc.gov
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   CDC, 2017, ZIK VIR SEX TRANSM P
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HELLER CG, 1963, SCIENCE, V140, P184, DOI 10.1126/science.140.3563.184
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Pan American Health Organization, 2017, ZIK VIR INF
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   WHO, 2016, PREV SEX TRANSM ZIK
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   World Health Organization, 2017, SIT REP 2017
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 51
TC 33
Z9 33
U1 0
U2 25
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD FEB
PY 2018
VL 31
IS 1
BP 39
EP 44
DI 10.1097/QCO.0000000000000414
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA FU7OI
UT WOS:000424041200006
PM 29176348
DA 2020-07-08
ER

PT J
AU Ferreira-de-Lima, VH
   Lima-Camara, TN
AF Ferreira-de-Lima, Victor Henrique
   Lima-Camara, Tamara Nunes
TI Natural vertical transmission of dengue virus in Aedes aegypti and Aedes
   albopictus: a systematic review
SO PARASITES & VECTORS
LA English
DT Review
DE Vertical transmission; Dengue; Chikungunya; Zika; Aedes; Vectors
ID TRANS-OVARIAL TRANSMISSION; POLYMERASE CHAIN-REACTION; ZIKA VIRUS;
   DIPTERA-CULICIDAE; POPULATIONS; CHIKUNGUNYA; INFECTION; STATE;
   GENERATIONS; OUTBREAK
AB Dengue is of great concern in various parts of the world, especially in tropical and subtropical countries where the mosquito vectors Aedes aegypti and Aedes albopictus are present. The transmission of this virus to humans, by what is known as horizontal transmission, occurs through the bite of infected females of one or other of the two mosquito species. Furthermore, an infected female or male parent, by what is known as vertical transmission, can transfer this arbovirus to some part of their offspring. Considering that vertical transmission may represent an important strategy for maintaining the circulation of arboviruses in nature, the verification of this phenomenon worldwide is extremely important and necessary to better understand its dynamic. In the present study, we conducted a literature review of the presence of natural vertical transmission of dengue virus in Ae. aegypti and Ae. albopictus worldwide. Searches were conducted in MEDLINE, sciELO and Lilacs and all the studies published in Portuguese, English and Spanish were read, evaluated and organized by mosquito species, serotype and the location at which the samples were collected. Forty-two studies were included in accordance with the exclusion criteria and methodology. The presence of natural vertical transmission in Ae. aegypti and Ae. albopictus was most clearly evidenced by dengue virus in endemic countries, especially in those in South America and Asia. Despite several African countries being considered endemic for dengue, there is a lack of publications on this subject on that continent, which highlights the importance of conducting studies there. Furthermore, the finding of natural vertical transmission in Ae. albopictus in countries where this species is not yet incriminated as a vector is of great concern as it demonstrates the circulation of this virus in populations of Ae. albopictus and alerts to the possibility of some other mosquito species playing a role in the transmission dynamics of this arbovirus. Parallel to this, the small number of studies of natural vertical transmission of chikungunya and Zika virus in the world may be explained by the recent entry of these arboviruses into most of the countries concerned.
C1 [Ferreira-de-Lima, Victor Henrique] Univ Sao Paulo, Inst Trop Med, Postgrad Program, Ave Dr Eneas de Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
   [Lima-Camara, Tamara Nunes] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Ave Dr Arnaldo 715, BR-03178200 Sao Paulo, SP, Brazil.
RP Lima-Camara, TN (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Ave Dr Arnaldo 715, BR-03178200 Sao Paulo, SP, Brazil.
EM limacamara@usp.br
RI Ferreira de Lima, Victor Henrique/H-6013-2018
OI Ferreira de Lima, Victor Henrique/0000-0002-3897-4420
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2016/12140-0, 2017/12434-6]
FX This research was financially supported by: Grant No. 2016/12140-0, Sao
   Paulo Research Foundation (FAPESP); Grant No. 2017/12434-6, Sao Paulo
   Research Foundation (FAPESP).
CR Ahmad Rohani, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P138
   Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56
   Arunachalam N, 2008, INDIAN J MED RES, V127, P395
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cabezas César, 2015, Rev. perú. med. exp. salud publica, V32, P191
   Cabral CM, 2017, EPIDEMIOL SERV SAUDE, V26, P245, DOI [10.5123/S1679-49742017000200002, 10.5123/s1679-49742017000200002]
   Calderon-Arguedas O, 2015, J VECTOR ECOL, V40, P184, DOI 10.1111/jvec.12149
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cecilio AB, 2004, SOC PATH, V9, P57, DOI DOI 10.17525/VRRJ0URNAL.V9I2.231
   Cecilio SG, 2015, J VECTOR ECOL, V40, P71, DOI 10.1111/jvec.12134
   Chen CF, 2010, VECTOR-BORNE ZOONOT, V10, P1017, DOI 10.1089/vbz.2008.0069
   Clements AN., 2012, BIOL MOSQUITOES TRAN, P125
   Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858
   CRUZ LCT, 2015, REV SOC BRAS MED TRO, V48, P18, DOI DOI 10.1590/0037-8682-0264-2014
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   Das Bina Pani, 2008, Journal of Communicable Diseases, V40, P155
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   dos Santos TP, 2017, ACTA TROP, V176, P140, DOI 10.1016/j.actatropica.2017.07.014
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Edillo FE, 2015, J VECTOR ECOL, V40, P282, DOI 10.1111/jvec.12166
   Espinosa M, 2014, REV INST MED TROP SP, V56, P165, DOI 10.1590/S0036-46652014000200013
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2007, FIELDS VIROLOGY, P1154
   Gunther J, 2007, INTERVIROLOGY, V50, P347, DOI 10.1159/000107272
   Gurugama Padmalal, 2010, Indian J Dermatol, V55, P68, DOI 10.4103/0019-5154.60357
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Higgs S, 1996, BIOL DIS VECTORS, P167
   HULL B, 1984, AM J TROP MED HYG, V33, P1248, DOI 10.4269/ajtmh.1984.33.1248
   Hutamai Songwut, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P448
   Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x
   ILKAL MA, 1991, INDIAN J MED RES-A, V93, P174
   Jain J, 2016, ACTA TROP, V162, P46, DOI 10.1016/j.actatropica.2016.06.004
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   KHIN MM, 1983, AM J TROP MED HYG, V32, P590, DOI 10.4269/ajtmh.1983.32.590
   Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Lee H. L., 2005, Dengue Bulletin, V29, P106
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006245, 10.1590/s1518-8787.2016050006245]
   Martinez NE, 2014, J AM MOSQUITO CONTR, V30, P143, DOI 10.2987/14-6402.1
   Mulyatno KC, 2012, JPN J INFECT DIS, V65, P274, DOI 10.7883/yoken.65.274
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pessanha José Eduardo Marques, 2011, Rev. Soc. Bras. Med. Trop., V44, P103, DOI 10.1590/S0037-86822011000100023
   Pinheiro VCS, 2005, MEM I OSWALDO CRUZ, V100, P833, DOI 10.1590/S0074-02762005000800003
   Prefeitura do Municipio de Sao Paulo, 2015, INF TECN DENG CHIK Z
   Romero-Vivas CME, 1998, MED VET ENTOMOL, V12, P284, DOI 10.1046/j.1365-2915.1998.00117.x
   ROSEN L, 1987, CR ACAD SCI III-VIE, V304, P347
   Sanchez-Rodriguez OS, 2014, SOUTHWEST ENTOMOL, V39, P459, DOI 10.3958/059.039.0307
   SERUFO JC, 1993, MEM I OSWALDO CRUZ, V88, P503, DOI 10.1590/S0074-02761993000300025
   SHROYER DA, 1990, J AM MOSQUITO CONTR, V6, P312
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   TEIXEIRA MG, 1999, INF EPIDEMIOL SUS, V8, P5, DOI DOI 10.5123/S0104-16731999000400002
   Thenmozhi V, 2007, JPN J INFECT DIS, V60, P245
   Thongrungkiat S, 2011, J VECTOR ECOL, V36, P147, DOI 10.1111/j.1948-7134.2011.00151.x
   VDC Shields, 2017, BIOL CONTROL PEST VE
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   WATTS DM, 1985, J MED ENTOMOL, V22, P261, DOI 10.1093/jmedent/22.3.261
   Westaway E. G., 1997, P147
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeidler Julianna Dias, 2008, Rev. Saúde Pública, V42, P986, DOI 10.1590/s0034-89102008000600002
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, P34
NR 69
TC 24
Z9 24
U1 0
U2 16
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 1
PY 2018
VL 11
AR 77
DI 10.1186/s13071-018-2643-9
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FU5IA
UT WOS:000423885200003
PM 29391071
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Song, G
   Rho, HS
   Pan, JB
   Ramos, P
   Yoon, KJ
   Medina, FA
   Lee, EM
   Eichinger, D
   Ming, GL
   Munoz-Jordan, JL
   Tang, HL
   Pino, I
   Song, HJ
   Qian, J
   Zhu, H
AF Song, Guang
   Rho, Hee-Sool
   Pan, Jianbo
   Ramos, Pedro
   Yoon, Ki-Jun
   Medina, Freddy A.
   Lee, Emily M.
   Eichinger, Daniel
   Ming, Guo-li
   Munoz-Jordan, Jorge L.
   Tang, Hengli
   Pino, Ignacio
   Song, Hongjun
   Qian, Jiang
   Zhu, Heng
TI Multiplexed Biomarker Panels Discriminate Zika and Dengue Virus
   Infection in Humans
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID PROTEIN MICROARRAY; IDENTIFICATION; DIAGNOSIS; ANTIBODIES; DISEASE
AB Zika virus (ZIKV) and dengue virus (DENV) are closely related flaviviruses that cause widespread, acute febrile illnesses, notably microcephaly for fetuses of infected pregnant women. Detecting the viral cause of these illnesses is paramount to determine risks to patients, counsel pregnant women, and help fight outbreaks. A combined diagnostic algorithm for ZIKV and DENV requires Reverse transcription polymerase chain reaction (RT-PCR) and IgM antibody detection. RT-PCR differentiates between DENV and ZIKV infections during the acute phases of infection, but differentiation based on IgM antibodies is currently nearly impossible in endemic areas. We have developed a ZIKV/DENV protein array and tested it with serum samples collected from ZIKV- and DENV-infected patients and healthy subjects in Puerto Rico. Our analyses reveal a biomarker panel that are capable of discriminating ZIKV and DENV infections with high accuracy, including Capsid protein from African ZIKV strain MR766, and other 5 pair of proteins (NS1, NS2A, NS3, NS4B and NS5) from ZIKV and DENV respectively. Both sensitivity and specificity of the test for ZIKV from DENV are around 90%. We propose that the ZIKV/DENV protein array will be used in future studies to discriminate patients infected with ZIKV from DENV.
C1 [Song, Guang; Rho, Hee-Sool; Zhu, Heng] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.
   [Pan, Jianbo; Qian, Jiang] Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.
   [Ramos, Pedro; Eichinger, Daniel; Pino, Ignacio] CDI Labs Inc, Mayaguez, PR 00682 USA.
   [Yoon, Ki-Jun; Ming, Guo-li; Song, Hongjun] Johns Hopkins Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Yoon, Ki-Jun; Ming, Guo-li; Song, Hongjun] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Medina, Freddy A.; Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, Dengue Branch, San Juan, PR 00920 USA.
   [Lee, Emily M.; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
   [Ming, Guo-li; Song, Hongjun] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Ming, Guo-li; Song, Hongjun] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.
   [Ming, Guo-li; Song, Hongjun] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.
   [Ming, Guo-li; Song, Hongjun] Univ Penn, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA.
RP Zhu, H (corresponding author), Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.
EM hzhu4@jhmi.edu
RI Yoon, Ki-Jun/S-8170-2018; Pan, Jianbo/M-6708-2018; amsalu,
   ribka/G-8780-2019; Song, guang/I-6224-2019
OI Pan, Jianbo/0000-0001-6014-8160; Song, guang/0000-0002-7630-716X; Yoon,
   Ki-Jun/0000-0003-2985-2541; Ming, Guo-li/0000-0002-2517-6075
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01GM111514, U19AI131130, R35NS097370,
   R37NS047344]; FSU Zika seed funding
FX This work was partially supported by NIH grants R01GM111514 (to H.Z &J.
   Q.), U19AI131130 (to G-I.M, & H.T.), R35NS097370 (to G-I.M.),
   R37NS047344 (to H-j.S.), and FSU Zika seed funding (to H.T.).
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, P65, DOI 10.15585/mmwr.mm6518e
   Hu CJ, 2017, MOL CELL PROTEOMICS, V16, P147, DOI 10.1074/mcp.M116.061002
   Huang W, 2012, BIOCHEM BIOPH RES CO, V418, P241, DOI 10.1016/j.bbrc.2012.01.001
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Mohammed H, 2012, TRANSFUSION, V52, P1652, DOI 10.1111/j.1537-2995.2011.03492.x
   Organization  P. A. H., DENGUE GUIDELINES PA
   Pan JB, 2017, MOL CELL PROTEOMICS, V16, P2069, DOI 10.1074/mcp.RA117.000212
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qi H, 2017, MOL CELL PROTEOMICS, V16, P288, DOI 10.1074/mcp.M116.064873
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   U. S. Food and Drug Administration, EM AUTH
   Vermeulen N, 2011, INFLAMM BOWEL DIS, V17, P1291, DOI 10.1002/ibd.21508
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191
   Zhu J, 2009, J VIROL, V83, P5219, DOI 10.1128/JVI.02378-08
NR 21
TC 6
Z9 6
U1 1
U2 9
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD FEB
PY 2018
VL 17
IS 2
BP 349
EP 356
DI 10.1074/mcp.RA117.000310
PG 8
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA FU8GN
UT WOS:000424091400011
PM 29141913
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Diamond, MS
   Coyne, CB
AF Diamond, Michael S.
   Coyne, Carolyn B.
TI Closing in on a Zika virus vaccine
SO NATURE REVIEWS IMMUNOLOGY
LA English
DT Editorial Material
ID PROTECTION
AB Over the past 2 years, Zika virus (ZIKV) has emerged as a pathogen capable of causing devastating congenital malformations in the developing fetus and significant neurological disease in adults. In 2017, substantial progress has been made towards the development, immunological analysis and preclinical evaluation of vaccine platforms to prevent the pathologies associated with ZIKV infection.
C1 [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA.
   [Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
EM mdiamond@wustl.edu; coynec2@pitt.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
NR 11
TC 6
Z9 6
U1 0
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1733
EI 1474-1741
J9 NAT REV IMMUNOL
JI Nat. Rev. Immunol.
PD FEB
PY 2018
VL 18
IS 2
BP 89
EP +
DI 10.1038/nri.2017.132
PG 2
WC Immunology
SC Immunology
GA FU0NY
UT WOS:000423548800010
PM 29199280
DA 2020-07-08
ER

PT J
AU Lossia, OV
   Conway, MJ
   Tree, MO
   Williams, RJ
   Goldthorpe, SC
   Srinageshwar, B
   Dunbar, GL
   Rossignol, J
AF Lossia, Olivia V.
   Conway, Michael J.
   Tree, Maya O.
   Williams, Robert J.
   Goldthorpe, Stacy C.
   Srinageshwar, Bhairavi
   Dunbar, Gary L.
   Rossignol, Julien
TI Zika virus induces astrocyte differentiation in neural stem cells
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Zika virus; Neuropathogenesis; Neural stem cell; Astrocyte; Neuron;
   Differentiation
ID HUMAN CYTOMEGALOVIRUS-INFECTION; BRAIN; HSV-1; LEADS
AB Zika virus (ZIKV) is a rapidly emerging flavivirus that has been associated with a number of congenital neurological manifestations. Here, we show that ZIKV replicated efficiently in mouse neural stem cells (mNSCs). ZIKV infection caused a cytopathic effect without affecting cell viability, yet led to a significant decrease in the number of proteins secreted into mNSC supernatants. A gene expression array of neural stem cell progenitor and differentiation markers suggested that infection reduced the number of neuronal and oligodendrocyte progenitors while increasing the number of astrocyte progenitors. Infection in astrocytes increased transcription of key genes involved in the antiviral response. These data provide molecular and cellular evidence that ZIKV significantly alters neural development in the vertebrate host and that astrocyte differentiation may be a protective response that limits neuropathogenesis.
C1 [Lossia, Olivia V.; Conway, Michael J.; Tree, Maya O.; Williams, Robert J.; Goldthorpe, Stacy C.; Rossignol, Julien] Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA.
   [Lossia, Olivia V.; Srinageshwar, Bhairavi; Dunbar, Gary L.; Rossignol, Julien] Cent Michigan Univ, Program Neurosci, Mt Pleasant, MI 48859 USA.
   [Lossia, Olivia V.; Srinageshwar, Bhairavi; Dunbar, Gary L.; Rossignol, Julien] Cent Michigan Univ, Field Neurosci Lab Restorat Neurol, Mt Pleasant, MI 48859 USA.
   [Dunbar, Gary L.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA.
   [Dunbar, Gary L.] St Marys Michigan Field Neurosci Inst, Saginaw, MI 48604 USA.
RP Conway, MJ (corresponding author), Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA.
EM michael.conway@cmich.edu
RI Srinageshwar, Bhairavi/K-8754-2019; Rossignol, Julien/I-1013-2019
OI Srinageshwar, Bhairavi/0000-0002-8763-545X; Rossignol,
   Julien/0000-0002-8662-0547
FU College of Medicine, Field Neurosciences Institute; John G. Kulhavi
   Professorship in Neuroscience at CMU
FX We thank Tonya Colpitts at the University of South Carolina School of
   Medicine for helping our team develop the experimental aims for this
   project. Support for this project was provided by the College of
   Medicine, Field Neurosciences Institute, and the John G. Kulhavi
   Professorship in Neuroscience at CMU.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Belzile JP, 2014, J VIROL, V88, P4021, DOI 10.1128/JVI.03492-13
   Calvet G., 2016, LANCET INFECT DIS
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020
   Fauci AS, 2016, N ENGL J MED
   Garcez P. P., 2016, SCIENCE
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Kosugi I, 1998, ACTA NEUROPATHOL, V96, P239, DOI 10.1007/s004010050890
   Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583
   Lazear HM, 2016, CELL HOST MICROBE
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XJ, 2015, J VIROL, V89, P6792, DOI 10.1128/JVI.00351-15
   Liu ZJ, 2013, NEUROL RES, V35, P755, DOI 10.1179/016164113X13703372991516
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Nocon AL, 2014, J VIROL, V88, P679, DOI 10.1128/JVI.02094-13
   Rossi SL, 2016, AM J TROP MED HYG
   Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402
   Tang H, 2016, ZIKA VIRUS INFECTS H, P1
   Tsutsui Y, 2008, PATHOL INT, V58, P257, DOI 10.1111/j.1440-1827.2008.02221.x
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 22
TC 11
Z9 11
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD FEB
PY 2018
VL 24
IS 1
BP 52
EP 61
DI 10.1007/s13365-017-0589-x
PG 10
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA FU3DD
UT WOS:000423729400005
PM 29063515
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Hydrocephalus associated to congenital Zika syndrome and shunting
SO CHILDS NERVOUS SYSTEM
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Joob Beuy, 2017, Pediatr Neurol, V68, pe1, DOI 10.1016/j.pediatrneurol.2016.11.009
   Juca E, 2017, CHILDS NERV SYST
   Visagan R, 2017, BMJ CASE REP, V11, P2017
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, CHILD NERV SYST, V32, P1349, DOI 10.1007/s00381-016-3102-6
NR 5
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD FEB
PY 2018
VL 34
IS 2
BP 183
EP 183
DI 10.1007/s00381-017-3656-y
PG 1
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FT8IA
UT WOS:000423394800002
PM 29143115
OA Bronze
DA 2020-07-08
ER

PT J
AU Juca, E
   Pessoa, A
   Cavalcanti, LP
AF Juca, Eduardo
   Pessoa, Andre
   Cavalcanti, Luciano Pamplona
TI Reply to the letter by Joob and Wiwanitkit regarding our article on
   congenital Zika syndrome and hydrocephalus
SO CHILDS NERVOUS SYSTEM
LA English
DT Letter
C1 [Juca, Eduardo; Pessoa, Andre] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Juca, Eduardo] Ctr Univ Christus Unichristus, Fortaleza, Ceara, Brazil.
   [Juca, Eduardo] Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil.
   [Pessoa, Andre] Univ Estadual Ceara UECE, Fortaleza, Ceara, Brazil.
   [Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Fortaleza, Ceara, Brazil.
RP Juca, E (corresponding author), Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.; Juca, E (corresponding author), Ctr Univ Christus Unichristus, Fortaleza, Ceara, Brazil.; Juca, E (corresponding author), Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil.
EM eduardojuca@gmail.com
RI Juca, Eduardo/AAF-7029-2019; Cavalcanti, Luciano/N-4391-2015
OI Juca, Eduardo/0000-0003-3269-2577; Cavalcanti,
   Luciano/0000-0002-3440-1182
CR Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Joob B, 2017, CHILDS NERV SYST
   Juca E, 2017, CHILDS NERV SYST
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ribeiro EM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0107-x
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 9
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD FEB
PY 2018
VL 34
IS 2
BP 185
EP 186
DI 10.1007/s00381-017-3683-8
PG 2
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FT8IA
UT WOS:000423394800003
PM 29209886
DA 2020-07-08
ER

PT J
AU Zorec, R
   Parpura, V
   Verkhratsky, A
AF Zorec, R.
   Parpura, V.
   Verkhratsky, A.
TI Astroglial vesicular network: evolutionary trends, physiology and
   pathophysiology
SO ACTA PHYSIOLOGICA
LA English
DT Review
DE astrocyte; endocytosis; exocytosis; intellectual deficiency;
   neurodegeneration; vesicle network
ID BLOOD-BRAIN-BARRIER; INSULIN-DEGRADING ENZYME; TICK-BORNE ENCEPHALITIS;
   UNCONVENTIONAL SECRETORY PATHWAY; CULTURED RAT ASTROCYTES; HUMAN
   CEREBRAL-CORTEX; VESICLE MOBILITY; ALZHEIMERS-DISEASE; FUSION PORE;
   MULTIPLE-SCLEROSIS
AB Intracellular organelles, including secretory vesicles, emerged when eukaryotic cells evolved some 3 billion years ago. The primordial organelles that evolved in Archaea were similar to endolysosomes, which developed, arguably, for specific metabolic tasks, including uptake, metabolic processing, storage and disposal of molecules. In comparison with prokaryotes, cell volume of eukaryotes increased by several orders of magnitude and vesicle traffic emerged to allow for communication between distant intracellular locations. Lysosomes, first described in 1955, a prominent intermediate of endo- and exocytotic pathways, operate virtually in all eukaryotic cells including astroglia, the most heterogeneous type of homeostatic glia in the central nervous system. Astrocytes support neuronal network activity in particular through elaborated secretion, based on a complex intracellular vesicle network dynamics. Deranged homeostasis underlies disease and astroglial vesicle traffic contributes to the pathophysiology of neurodegenerative (Alzheimer's disease, Huntington's disease), neurodevelopmental diseases (intellectual deficiency, Rett's disease) and neuroinfectious (Zika virus) disorders. This review addresses astroglial cell-autonomous vesicular traffic network, as well as its into primary and secondary vesicular network defects in diseases, and considers this network as a target for developing new therapies for neurological conditions.
C1 [Zorec, R.; Verkhratsky, A.] Univ Ljubljana, Lab Neuroendocrinol & Mol Cell Physiol, Inst Pathophysiol, Ljubljana, Slovenia.
   [Zorec, R.; Verkhratsky, A.] BIOMEDICAL, Celica, Ljubljana, Slovenia.
   [Parpura, V.] Univ Alabama Birmingham, Dept Neurobiol, Civitan Int Res Ctr, Birmingham, AL USA.
   [Parpura, V.] Univ Alabama Birmingham, Ctr Glial Biol Med, Evelyn F McKnight Brain Inst, Atom Force Microscopy & Nanotechnol Labs, Birmingham, AL USA.
   [Verkhratsky, A.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.
   [Verkhratsky, A.] Basque Fdn Sci, Achucarro Ctr Neurosci, IKERBASQUE, Bilbao, Spain.
   [Verkhratsky, A.] Univ Basque Country UPV EHU, Dept Neurosci, Leioa, Spain.
   [Verkhratsky, A.] CIBERNED, Leioa, Spain.
RP Zorec, R (corresponding author), Univ Ljubljana, Fac Med, SI-1000 Ljubljana, Slovenia.
EM robert.zorec@mf.uni-lj.si
RI Verkhratsky, Alexei/J-4527-2013
OI Verkhratsky, Alexei/0000-0003-2592-9898
FU Slovenian Research Agency (ARRS)Slovenian Research Agency - Slovenia [P3
   310, J3 6790, J3 6789, J3 7605]; CipKeBip; COST ActionEuropean
   Cooperation in Science and Technology (COST) [BM1002]; EU COST
   ActionEuropean Union (EU)European Cooperation in Science and Technology
   (COST) [CM1207-GLISTEN]; National Institutes of Health (The Eunice
   Kennedy Shriver National Institute of Child Health and Human Development
   Award) [HD078678]
FX This work was supported by Grants P3 310, J3 6790, J3 6789 and J3 7605
   from the Slovenian Research Agency (ARRS), CipKeBip, COST Action BM1002,
   EU COST Action CM1207-GLISTEN (to RZ). VP's work is supported by the
   National Institutes of Health (The Eunice Kennedy Shriver National
   Institute of Child Health and Human Development Award HD078678 to VP).
CR Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575
   Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613
   Barber M, 2015, CURR BIOL, V25, P2466, DOI 10.1016/j.cub.2015.08.028
   Barois N, 1998, J CELL SCI, V111, P1791
   Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137
   Bergersen LH, 2012, CEREB CORTEX, V22, P1690, DOI 10.1093/cercor/bhr254
   Bernacki J, 2008, PHARMACOL REP, V60, P600
   Bianchi V, 2009, HUM MOL GENET, V18, P105, DOI 10.1093/hmg/ddn321
   Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163
   Bowser DN, 2007, P NATL ACAD SCI USA, V104, P4212, DOI 10.1073/pnas.0607625104
   BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366
   Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248
   Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033
   Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020
   Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034
   Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6
   Burkovetskaya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095023
   Carmignoto G, 2010, BRAIN RES REV, V63, P138, DOI 10.1016/j.brainresrev.2009.11.007
   Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P7, DOI 10.1099/00207713-52-1-7
   Chakraborti S, 2016, CYTOSKELETON, V73, P521, DOI 10.1002/cm.21290
   Chauhan A, 2014, NEUROSCI RES, V88, P16, DOI 10.1016/j.neures.2014.08.013
   Chou JY, 2015, J INHERIT METAB DIS, V38, P511, DOI 10.1007/s10545-014-9772-x
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Chun J, 2011, DISCOV MED, V12, P213
   D'Adamo P, 2002, HUM MOL GENET, V11, P2567, DOI 10.1093/hmg/11.21.2567
   D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487
   de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847
   Delepine C, 2016, HUM MOL GENET, V25, P146, DOI 10.1093/hmg/ddv464
   Di Malta C, 2012, AUTOPHAGY, V8, P1871, DOI 10.4161/auto.22184
   Dienel GA, 2016, J NEUROCHEM, V138, P14, DOI 10.1111/jnc.13630
   Ding FF, 2013, CELL CALCIUM, V54, P387, DOI 10.1016/j.ceca.2013.09.001
   Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009
   Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389
   DUVE CD, 1955, BIOCHEM J, V60, P604
   Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546
   ESSNER E, 1961, J BIOPHYS BIOCHEM CY, V9, P773, DOI 10.1083/jcb.9.4.773
   Flasker A, 2013, MOL CELL ENDOCRINOL, V376, P136, DOI 10.1016/j.mce.2013.06.012
   FOOTE SL, 1983, PHYSIOL REV, V63, P844
   FROHMAN EM, 1988, P NATL ACAD SCI USA, V85, P1292, DOI 10.1073/pnas.85.4.1292
   Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144
   Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020
   Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841
   Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1
   Gucek A, 2016, CELL MOL LIFE SCI, V73, P3719, DOI 10.1007/s00018-016-2213-2
   Hakim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086178
   Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599
   Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x
   Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528
   HECHTMAN P, 1993, DNA CELL BIOL, V12, P651, DOI 10.1089/dna.1993.12.651
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Held H, 1909, MON PSYCHIATR NEUROL, V26, P360
   Hong Y, 2016, J NEUROSCI, V36, P8790, DOI 10.1523/JNEUROSCI.0168-16.2016
   Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516
   ITOH H, 1984, BRAIN DEV-JPN, V6, P467, DOI 10.1016/S0387-7604(84)80029-7
   Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111/j.1365-2141.2004.05351.x
   Jones VC, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.89
   Jorgacevski J, 2017, J NEUROSCI RES, V95, P2152, DOI 10.1002/jnr.24051
   Jorgacevski J, 2011, J NEUROSCI, V31, P9055, DOI 10.1523/JNEUROSCI.0185-11.2011
   Jorgacevski J, 2010, MOL MEMBR BIOL, V27, P65, DOI 10.3109/09687681003597104
   Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849
   Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003
   Kreft M, 2004, GLIA, V46, P437, DOI 10.1002/glia.20018
   Kreft M, 2003, J NEUROPHYSIOL, V90, P218, DOI 10.1152/jn.01025.2002
   Kreft M, 1997, PFLUG ARCH EUR J PHY, V434, P212, DOI 10.1007/s004240050387
   Kreft M, 2016, J NEUROCHEM, V137, P880, DOI 10.1111/jnc.13561
   Krzan M, 2003, J NEUROSCI, V23, P1580
   Lasic E, 2016, J NEUROCHEM, V139, P309, DOI 10.1111/jnc.13754
   Lasic E, 2016, J NEUROCHEM, V138, P909, DOI 10.1111/jnc.13715
   Laureys G, 2010, PROG NEUROBIOL, V91, P189, DOI 10.1016/j.pneurobio.2010.01.011
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214
   Luckasson R, 2001, MENT RETARD, V39, P47, DOI 10.1352/0047-6765(2001)039<0047:NDACIM>2.0.CO;2
   Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011
   Malarkey EB, 2011, J PHYSIOL-LONDON, V589, P4271, DOI 10.1113/jphysiol.2011.210435
   Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007
   Marignier R, 2008, MULT SCLER, V14, P440, DOI 10.1177/1352458507084595
   MARTIN DL, 1992, GLIA, V5, P81, DOI 10.1002/glia.440050202
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mills EA, 2015, P NATL ACAD SCI USA, V112, P10509, DOI 10.1073/pnas.1506486112
   Milosevic M, 2013, CELL CALCIUM, V54, P17, DOI 10.1016/j.ceca.2013.03.005
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moody LR, 2017, J BIOL CHEM, V292, P5814, DOI 10.1074/jbc.M116.772020
   Mukherjee S, 1997, PHYSIOL REV, V77, P759
   MURPHY S, 1988, GLIA, V1, P241, DOI 10.1002/glia.440010402
   Nageotte J, 1910, CR SOC BIOL, V68, P1068
   Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008
   NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967
   Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200
   Pangrsic T, 2006, J NEUROCHEM, V99, P514, DOI 10.1111/j.1471-4159.2006.04042.x
   PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0
   Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x
   Parpura V, 2010, NEUROCHEM INT, V57, P451, DOI 10.1016/j.neuint.2010.02.007
   Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008
   Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014
   Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1
   Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013
   Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152
   Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015
   Ponath G, 2017, BRAIN, V140, P399, DOI 10.1093/brain/aww298
   Potokar M, 2005, BIOCHEM BIOPH RES CO, V329, P678, DOI 10.1016/j.bbrc.2005.02.030
   Potokar M, 2008, GLIA, V56, P135, DOI 10.1002/glia.20597
   Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x
   Potokar M, 2017, MOL NEUROBIOL, V54, P2458, DOI 10.1007/s12035-016-9834-1
   Potokar M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071121
   Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219
   Potokar M, 2013, INT J MOL SCI, V14, P11238, DOI 10.3390/ijms140611238
   Potokar M, 2013, GLIA, V61, P917, DOI 10.1002/glia.22485
   Potokar M, 2012, GLIA, V60, P594, DOI 10.1002/glia.22293
   Potokar M, 2011, HISTOL HISTOPATHOL, V26, P277, DOI 10.14670/HH-26.277
   Potokar M, 2010, GLIA, V58, P1208, DOI 10.1002/glia.21000
   Potokar M, 2009, BIOCHEM BIOPH RES CO, V390, P1192, DOI 10.1016/j.bbrc.2009.10.119
   Prada CE, 2013, DEV DISABIL RES REV, V17, P226, DOI 10.1002/ddrr.1116
   Prebil M, 2011, GLIA, V59, P903, DOI 10.1002/glia.21161
   Rao KVR, 2016, NEUROSCIENCE, V323, P195, DOI 10.1016/j.neuroscience.2015.05.061
   Rituper B, 2013, NAT PROTOC, V8, P1169, DOI 10.1038/nprot.2013.069
   Rose CR, 2016, GLIA, V64, P1611, DOI 10.1002/glia.22964
   Rusakov DA, 2011, NEUROSCIENTIST, V17, P513, DOI 10.1177/1073858410387304
   Ruzek D, 2008, VIRUS RES, V137, P142, DOI 10.1016/j.virusres.2008.05.013
   Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565
   Shahzad R, 2016, J INORG BIOCHEM, V162, P319, DOI 10.1016/j.jinorgbio.2016.02.027
   Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276
   Son SM, 2016, AUTOPHAGY, V12, P784, DOI 10.1080/15548627.2016.1159375
   Son SM, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0054-3
   Soos JM, 1998, J IMMUNOL, V161, P5959
   Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447
   Spang A, 2013, ARCHAEA, V2013, DOI 10.1155/2013/202358
   Sreetama SC, 2016, CELL DEATH DIFFER, V23, P596, DOI 10.1038/cdd.2015.124
   Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728
   Stenovec M, 2011, ACTA PHYSIOL, V203, P457, DOI 10.1111/j.1748-1716.2011.02337.x
   Stenovec M, 2007, EXP CELL RES, V313, P3809, DOI 10.1016/j.yexcr.2007.08.020
   Stenovec M, 2016, MOL NEUROBIOL, V53, P6882, DOI 10.1007/s12035-015-9562-y
   Stenovec M, 2016, GLIA, V64, P317, DOI 10.1002/glia.22931
   STRAUS W, 1964, J CELL BIOL, V20, P497, DOI 10.1083/jcb.20.3.497
   Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037
   Takai Y, 2001, PHYSIOL REV, V81, P153
   Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284
   TAOCHENG JH, 1987, J NEUROSCI, V7, P3293
   Tasdemir-Yilmaz OE, 2014, GENE DEV, V28, P20, DOI 10.1101/gad.229518.113
   Tech K, 2015, TRANSL PEDIATR, V4, P12, DOI 10.3978/j.issn.2224-4336.2015.01.03
   Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010
   Trkov S, 2012, GLIA, V60, P1406, DOI 10.1002/glia.22361
   Turner G, 1996, AM J HUM GENET, V58, P1109
   Tvarusko W, 1999, P NATL ACAD SCI USA, V96, P7950, DOI 10.1073/pnas.96.14.7950
   Vardjan N, 2016, GLIA, V64, P1034, DOI 10.1002/glia.22981
   Vardjan N, 2015, NEUROCHEM RES, V40, P2414, DOI 10.1007/s11064-015-1545-x
   Vardjan N, 2015, CELL TRANSPLANT, V24, P599, DOI 10.3727/096368915X687750
   Vardjan N, 2014, ADV NEUROBIOL, V11, P81, DOI 10.1007/978-3-319-08894-5_5
   Vardjan N, 2014, GLIA, V62, P566, DOI 10.1002/glia.22626
   Vardjan N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-144
   Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147
   Vekrellis K, 2000, J NEUROSCI, V20, P1657
   Verkhratsky A, 1998, PHYSIOL REV, V78, P99
   Verkhratsky A, 2016, PHILOS T R SOC LON B, V371
   Verkhratsky A, 2016, EMBO J, V35, P239, DOI 10.15252/embj.201592705
   Verkhratsky A, 2016, CURR OPIN PHARMACOL, V26, P74, DOI 10.1016/j.coph.2015.09.011
   Verkhratsky A, 2016, NEUROBIOL DIS, V85, P254, DOI 10.1016/j.nbd.2015.03.025
   Verkhratsky A, 2014, BIOCHEM SOC T, V42, P1291, DOI 10.1042/BST20140107
   Verkhratsky A, 2010, NEUROCHEM INT, V57, P332, DOI 10.1016/j.neuint.2010.02.002
   Verkhratsky A, 2009, MOL NEUROBIOL, V39, P190, DOI 10.1007/s12035-009-8063-2
   Vindedal GF, 2016, MOL CELL NEUROSCI, V77, P47, DOI 10.1016/j.mcn.2016.10.004
   Vyas JM, 2007, J IMMUNOL, V178, P7199, DOI 10.4049/jimmunol.178.11.7199
   Wei F, 2017, LIFE SCI, V182, P29, DOI 10.1016/j.lfs.2017.05.028
   WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576
   WOLBURG H, 1994, J CELL SCI, V107, P1347
   Wubbolts R, 1999, J CELL SCI, V112, P785
   Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224
   Zorec R, 2016, NEUROSCIENCE, V323, P67, DOI 10.1016/j.neuroscience.2015.02.033
   Zorec R, 2017, NORADRENERGIC SIGNALING AND ASTROGLIA, P1, DOI 10.1016/B978-0-12-805088-0.00001-3
   Zorec R, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00056
   Zorec R, 2012, ASN NEURO, V4, P103, DOI 10.1042/AN20110061
NR 176
TC 14
Z9 14
U1 1
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1748-1708
EI 1748-1716
J9 ACTA PHYSIOL
JI Acta Physiol.
PD FEB
PY 2018
VL 222
IS 2
AR UNSP e12915
DI 10.1111/apha.12915
PG 18
WC Physiology
SC Physiology
GA FT7XY
UT WOS:000423367700004
PM 28665546
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Frenkel, LD
   Gomez, F
   Sabahi, F
AF Frenkel, L. D.
   Gomez, F.
   Sabahi, F.
TI The pathogenesis of microcephaly resulting from congenital infections:
   why is my baby's head so small?
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Review
ID ZIKA VIRUS-INFECTION; CELL-MEDIATED-IMMUNITY; HEMATOPOIETIC STEM-CELLS;
   GUILLAIN-BARRE-SYNDROME; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS;
   CYTOMEGALOVIRUS-INFECTION; TOXOPLASMA-GONDII; PREGNANT-WOMEN;
   PERIPHERAL-BLOOD
AB The emergence of Zika-virus-associated congenital microcephaly has engendered renewed interest in the pathogenesis of microcephaly induced by infectious agents. Three of the original "TORCH" agents are associated with an appreciable incidence of congenital microcephaly: cytomegalovirus, rubella virus, and Toxoplasma gondii. The pathology of congenital microcephaly is characterized by neurotropic infectious agents that involve the fetal nervous system, leading to brain destruction with calcifications, microcephaly, sensorineural hearing loss, and ophthalmologic abnormalities. The inflammatory reaction induced by these four agents has an important role in pathogenesis. The potential role of "strain differences" in pathogenesis of microcephaly by these four pathogens is examined. Specific epidemiologic factors, such as first and early second trimester maternal infection, and the manifestations of congenital infection in the infant, shed some light on the pathogenesis. Immune aspects of normal pregnancy and their role in congenital infections is examined. In this review, we integrate all these findings to create a unified hypothesis of the pathogenesis of congenital microcephaly induced by these infectious agents.
C1 [Frenkel, L. D.] Univ Illinois, Coll Med, Dept Pediat, Rockford, IL 61107 USA.
   [Frenkel, L. D.] Univ Illinois, Coll Med, Dept Microbiol, Rockford, IL 61107 USA.
   [Frenkel, L. D.] St Peters Univ Hosp, Childrens Hosp, Dept Pediat, Div Immunol Allergy & Infect Dis, New Brunswick, NJ 08901 USA.
   [Gomez, F.] Rocky Vista Univ, Dept Specialty Med, Sch Osteopath Med, Parker, CO USA.
   [Sabahi, F.] Tarbiat Modares Univ, Dept Virol, Fac Basic Med Sci, Tehran, Iran.
RP Frenkel, LD (corresponding author), Univ Illinois, Coll Med, Dept Pediat, Rockford, IL 61107 USA.; Frenkel, LD (corresponding author), Univ Illinois, Coll Med, Dept Microbiol, Rockford, IL 61107 USA.; Frenkel, LD (corresponding author), St Peters Univ Hosp, Childrens Hosp, Dept Pediat, Div Immunol Allergy & Infect Dis, New Brunswick, NJ 08901 USA.
EM lfrenkel@uic.edu
CR Abernathy E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-32
   Abrahams VM, 2004, AM J REPROD IMMUNOL, V51, P275, DOI 10.1111/j.1600-0897.2004.00156.x
   Adams KM, 2006, MED INTELL UNIT, P244
   Adiga R, 2016, J MED VIROL, V88, P1821, DOI 10.1002/jmv.24615
   Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663
   ALFORD CA, 1964, NEW ENGL J MED, V271, P1275, DOI 10.1056/NEJM196412172712501
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Amodio G, 2013, HUM IMMUNOL, V74, P406, DOI 10.1016/j.humimm.2012.11.031
   Anderson K S, 1996, J Am Optom Assoc, V67, P273
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   BALE JF, 1984, ARCH NEUROL-CHICAGO, V41, P310, DOI 10.1001/archneur.1984.04050150092023
   Bale JF, 2011, SWAIMANS PEDIATRIC N, P1262
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605
   Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55
   BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007
   Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Borzychowski AM, 2005, EUR J IMMUNOL, V35, P3054, DOI 10.1002/eji.200425929
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Britt WJ, 2017, J VIROL, V91, DOI 10.1128/JVI.02392-16
   Britt WJ, 2016, REMINGTON KLEINS INF, P724
   Burny Wivine, 2004, Expert Rev Anti Infect Ther, V2, P881, DOI 10.1586/14789072.2.6.881
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Carlson Amanda, 2010, Rev Obstet Gynecol, V3, P172
   CAUDA R, 1987, J MED VIROL, V23, P41, DOI 10.1002/jmv.1890230106
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crack PJ, 2007, IMMUNOL CELL BIOL, V85, P476, DOI 10.1038/sj.icb.7100103
   Cupurdija K, 2004, AM J REPROD IMMUNOL, V51, P117, DOI 10.1046/j.8755-8920.2003.00128.x
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Darmochwal-Kolarz D, 2012, J REPROD IMMUNOL, V93, P75, DOI 10.1016/j.jri.2012.01.006
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   DESMOND MM, 1969, AM J DIS CHILD, V118, P30, DOI 10.1001/archpedi.1969.02100040032005
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   DUDGEON JA, 1969, AM J DIS CHILD, V118, P35, DOI 10.1001/archpedi.1969.02100040037007
   DUDGEON JA, 1967, ARCH DIS CHILD, V42, P110, DOI 10.1136/adc.42.222.110
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elbez-Rubinstein A, 2009, J INFECT DIS, V199, P280, DOI 10.1086/595793
   Elenkov IJ, 2001, J CLIN ENDOCR METAB, V86, P4933, DOI 10.1210/jc.86.10.4933
   ELLIOTT GB, 1962, ARCH DIS CHILD, V37, P34, DOI 10.1136/adc.37.191.34
   Elsheikha HM, 2010, FEMS MICROBIOL REV, V34, P532, DOI 10.1111/j.1574-6976.2010.00215.x
   Erlebacher A, 2007, J CLIN INVEST, V117, P1399, DOI 10.1172/JCI28214
   Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003
   Ernerudh J, 2011, AM J REPROD IMMUNOL, V66, P31, DOI 10.1111/j.1600-0897.2011.01049.x
   Faas MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00298
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Fornara C, 2011, J CLIN IMMUNOL, V31, P1054, DOI 10.1007/s10875-011-9577-8
   FRENKEL JK, 1974, B NEW YORK ACAD MED, V50, P182
   FRENKEL LD, 1980, PEDIATRICS, V66, P763
   FRENKEL LD, 1982, COMPR IMMUNOL, V9, P135
   Gardner L, 2003, BIOL REPROD, V69, P1438, DOI 10.1095/biolreprod.103.017574
   GEISELHART A, 1995, AM J REPROD IMMUNOL, V33, P315, DOI 10.1111/j.1600-0897.1995.tb00900.x
   Gilbert R, 2001, EPIDEMIOL INFECT, V127, P113, DOI 10.1017/S095026880100560X
   Gonzalez RMS, 2014, J INNATE IMMUN, V6, P685, DOI 10.1159/000362367
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gregg NM, 1941, T OPHTHALMOL SOC AUS, V3, P35
   Guglietta S, 2007, MICROBES INFECT, V9, P127, DOI 10.1016/j.micinf.2006.10.017
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002
   HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445
   Heikkinen J, 2003, CLIN EXP IMMUNOL, V131, P498, DOI 10.1046/j.1365-2249.2003.02092.x
   Ho M, 2008, MED MICROBIOL IMMUN, V197, P65, DOI 10.1007/s00430-007-0066-x
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Houser BL, 2011, J IMMUNOL, V186, P2633, DOI 10.4049/jimmunol.1003153
   Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152
   Jones JL, 2010, AM J TROP MED HYG, V82, P464, DOI 10.4269/ajtmh.2010.09-0664
   Jun Y, 2000, J IMMUNOL, V164, P805, DOI 10.4049/jimmunol.164.2.805
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   KOPPE JG, 1989, INT OPHTHALMOL, V13, P387, DOI 10.1007/BF02306486
   Kumar VK, 2015, ROBBINS COTRAN PATHO, P186
   Kylat RI, 2006, EUR J PEDIATR, V165, P773, DOI 10.1007/s00431-006-0172-6
   La Rosa C, 2012, FUTURE VIROL, V7, P279, DOI 10.2217/FVL.12.8
   Lago EG, 2007, CLIN RADIOL, V62, P1004, DOI 10.1016/j.crad.2007.05.001
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Lilleri D, 2007, J INFECT DIS, V195, P1062, DOI 10.1086/512245
   Lindsay DS, 2011, PARASITOLOGY, V138, P1829, DOI 10.1017/S0031182011001478
   Lissauer D, 2011, HUM REPROD, V26, P3355, DOI 10.1093/humrep/der327
   Liu HY, 2014, J INTERF CYTOK RES, V34, P394, DOI 10.1089/jir.2013.0062
   Lo CP, 2008, NEUROIMAG CLIN N AM, V18, P119, DOI 10.1016/j.nic.2007.12.002
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Martinez-Torres AO, 2009, J CLIN MICROBIOL, V47, P158, DOI 10.1128/JCM.00469-08
   McAuley JB, 2014, J PEDIAT INF DIS SOC, V3, pS30, DOI 10.1093/jpids/piu077
   McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330
   McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971
   McLeod R, 2006, CLIN INFECT DIS, V42, P1383, DOI 10.1086/501360
   MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   MILLER E, 1982, LANCET, V2, P781
   Mjosberg J, 2009, J IMMUNOL, V183, P759, DOI 10.4049/jimmunol.0803654
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509
   NAHMIAS AJ, 1971, PEDIATR RES, V5, P405, DOI 10.1203/00006450-197108000-00144
   Nancy P, 2014, INT J DEV BIOL, V58, P189, DOI 10.1387/ijdb.140054ae
   Nelson JL, 2002, TRENDS MOL MED, V8, P109, DOI 10.1016/S1471-4914(01)02269-9
   NUMAZAKI Y, 1970, AM J EPIDEMIOL, V91, P410, DOI 10.1093/oxfordjournals.aje.a121151
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Peyron F, 2016, INFECT DIS FETUS NEW, P949
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Quicke KM, 2013, VIRUSES-BASEL, V5, P2643, DOI 10.3390/v5112643
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reef SE, 2016, REMINGTON KLEINS INF, P894
   Revello MG, 2006, J INFECT DIS, V193, P269, DOI 10.1086/498872
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11
   Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11
   Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023
   ROLAPLESZCZYNSKI M, 1977, J INFECT DIS, V135, P386, DOI 10.1093/infdis/135.3.386
   Ross SA, 2011, J INFECT DIS, V204, P1003, DOI 10.1093/infdis/jir457
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   RUNMARKER B, 1995, BRAIN, V118, P253, DOI 10.1093/brain/118.1.253
   SABAHI F, 1995, AM J REPROD IMMUNOL, V33, P381, DOI 10.1111/j.1600-0897.1995.tb00907.x
   SABAHI F, 1993, J IMMUNOL, V150, pA101
   Saito S, 1999, CLIN EXP IMMUNOL, V117, P550
   Salaun B, 2007, EUR J IMMUNOL, V37, P3311, DOI 10.1002/eji.200737744
   Sappenfield Elisabeth, 2013, Infect Dis Obstet Gynecol, V2013, P752852, DOI 10.1155/2013/752852
   Schneider AD, 2017, CLADISTICS, V33, P1, DOI 10.1111/cla.12178
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   Slavuljica I, 2015, CELL MOL IMMUNOL, V12, P180, DOI 10.1038/cmi.2014.51
   Sobanski V, 2013, AM J RESP CRIT CARE, V187, P1143, DOI 10.1164/rccm.201209-1635LE
   Spector DH, 2014, J INFECT DIS, V209, P1497, DOI 10.1093/infdis/jiu092
   St John MA, 2000, ANN TROP PAEDIATR, V20, P231
   STAGNO S, 1982, Clinical Obstetrics and Gynecology, V25, P563, DOI 10.1097/00003081-198209000-00014
   STARR SE, 1979, J INFECT DIS, V140, P500, DOI 10.1093/infdis/140.4.500
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stokowski LA, 2016, MORE MICROCEPHALY CO
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882
   Szekeres-Bartho Julia, 2002, Int Rev Immunol, V21, P471, DOI 10.1080/08830180215017
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teles A, 2013, AM J REPROD IMMUNOL, V69, P331, DOI 10.1111/aji.12067
   THONG YH, 1973, NEW ENGL J MED, V289, P604, DOI 10.1056/NEJM197309202891203
   Tilburgs T, 2010, PLACENTA, V31, pS82, DOI 10.1016/j.placenta.2010.01.007
   Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737
   Trundley A, 2004, TISSUE ANTIGENS, V63, P1, DOI 10.1111/j.1399-0039.2004.00170.x
   Ueda K, 2016, VACCINE, V34, P1971, DOI 10.1016/j.vaccine.2015.10.010
   Vacca P, 2010, P NATL ACAD SCI USA, V107, P11918, DOI 10.1073/pnas.1001749107
   Valdes V, 2011, ARCH PEDIATRIE, V18, P761, DOI 10.1016/j.arcped.2011.04.011
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van Egmond A, 2016, J REPROD IMMUNOL, V113, P1, DOI 10.1016/j.jri.2015.09.073
   van Lier RAW, 2003, NAT REV IMMUNOL, V3, P931, DOI 10.1038/nri1228
   van Nieuwenhoven ALV, 2002, FERTIL STERIL, V77, P1032, DOI 10.1016/S0015-0282(02)02976-X
   van Nieuwenhoven ALV, 2008, HYPERTENS PREGNANCY, V27, P207, DOI 10.1080/10641950701885006
   Vega-Sanchez R, 2010, J REPROD IMMUNOL, V84, P100, DOI 10.1016/j.jri.2009.08.002
   Vogel G, 2016, SCIENCE
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D
   Weisblum Y, 2016, J VIROL, V91
   Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004
   Wilczynski JR, 2003, EUR J OBSTET GYN R B, V109, P8, DOI 10.1016/S0301-2115(02)00350-0
   Williams PJ, 2009, J REPROD IMMUNOL, V82, P24, DOI 10.1016/j.jri.2009.08.001
   Wilson CB, 1981, OBSTET GYNECOL SURV, V36, P436
   Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049
   Xiao J, 2015, ACTA PHYSIOL, V213, P828, DOI 10.1111/apha.12458
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yamamoto AY, 2011, PEDIATR INFECT DIS J, V30, P1043, DOI 10.1097/INF.0b013e31822d9640
   Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Yuan TM, 2010, J NEUROIMMUNOL, V229, P16, DOI 10.1016/j.jneuroim.2010.08.008
NR 187
TC 6
Z9 7
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD FEB
PY 2018
VL 37
IS 2
BP 209
EP 226
DI 10.1007/s10096-017-3111-8
PG 18
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FT4VA
UT WOS:000423152100002
PM 28980148
DA 2020-07-08
ER

PT J
AU Liu, QY
   Xu, WB
   Lu, S
   Jiang, JF
   Zhou, JP
   Shao, ZJ
   Liu, XB
   Xu, L
   Xiong, YW
   Zheng, H
   Jin, S
   Jiang, H
   Cao, WC
   Xu, JG
AF Liu, Qiyong
   Xu, Wenbo
   Lu, Shan
   Jiang, Jiafu
   Zhou, Jieping
   Shao, Zhujun
   Liu, Xiaobo
   Xu, Lei
   Xiong, Yanwen
   Zheng, Han
   Jin, Sun
   Jiang, Hai
   Cao, Wuchun
   Xu, Jianguo
TI Landscape of emerging and re-emerging infectious diseases in China:
   impact of ecology, climate, and behavior
SO FRONTIERS OF MEDICINE
LA English
DT Review
DE infectious disease profile; emerging infectious diseases; influence
   factor
ID HEPATITIS-E VIRUS; HUMAN ADENOVIRUS; ZIKA VIRUS; NEISSERIA-MENINGITIDIS;
   GUANGDONG PROVINCE; GENOTYPE DIVERSITY; HEMORRHAGIC-FEVER; COV
   INFECTION; YELLOW-FEVER; IDENTIFICATION
AB For the past several decades, the infectious disease profile in China has been shifting with rapid developments in social and economic aspects, environment, quality of food, water, housing, and public health infrastructure. Notably, 5 notifiable infectious diseases have been almost eradicated, and the incidence of 18 additional notifiable infectious diseases has been significantly reduced. Unexpectedly, the incidence of over 10 notifiable infectious diseases, including HIV, brucellosis, syphilis, and dengue fever, has been increasing. Nevertheless, frequent infectious disease outbreaks/events have been reported almost every year, and imported infectious diseases have increased since 2015. New pathogens and over 100 new genotypes or serotypes of known pathogens have been identified. Some infectious diseases seem to be exacerbated by various factors, including rapid urbanization, large numbers of migrant workers, changes in climate, ecology, and policies, such as returning farmland to forests. This review summarizes the current experiences and lessons from China in managing emerging and re-emerging infectious diseases, especially the effects of ecology, climate, and behavior, which should have merits in helping other countries to control and prevent infectious diseases.
C1 [Liu, Qiyong; Lu, Shan; Shao, Zhujun; Liu, Xiaobo; Xu, Lei; Xiong, Yanwen; Zheng, Han; Jiang, Hai; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.
   [Xu, Wenbo] Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
   [Jiang, Jiafu; Cao, Wuchun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zhou, Jieping; Jin, Sun] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing 100094, Peoples R China.
   [Zhou, Jieping; Jin, Sun] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing 100094, Peoples R China.
   [Zhou, Jieping; Jin, Sun] Beijing Normal Univ, Beijing 100094, Peoples R China.
RP Xu, JG (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.
EM xujianguo@icdc.cn
RI Zheng, Han/AAH-6977-2019
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [L1522033, 81290340, 81290345]; National Key
   Research and Development Program of China [2016YFC1201903]
FX This work was supported by grants from the National Natural Science
   Foundation of China (Nos. L1522033, 81290340, and 81290345) and the
   National Key Research and Development Program of China (No.
   2016YFC1201903). We thank the two anonymous reviewers for the
   improvement of this study. We also extend our gratitude to Dr. Hualiang
   Lin and Prof. Xinhe Lai for the revision and discussion.
CR Blasdell KR, 2016, ELIFE, V5, DOI 10.7554/eLife.13135
   Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612
   Chen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121375
   Chen XP, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.008
   Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9
   Deng C, 1993, Zhonghua Liu Xing Bing Xue Za Zhi, V14, P78
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Ding ZS, 1982, CHIN J EPIDEMIOL, V3, P80
   Dong X, 2014, TICKS TICK-BORNE DIS, V5, P727, DOI 10.1016/j.ttbdis.2014.05.011
   Du PC, 2017, EMERG INFECT DIS, V23, P204, DOI 10.3201/eid2302.160297
   Enserink M, 2003, SCIENCE, V301, P294, DOI 10.1126/science.301.5631.294
   Fang LQ, 2015, LANCET INFECT DIS, V15, P1467, DOI 10.1016/S1473-3099(15)00177-2
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   Hu Xiaoshu, 2000, Zhonghua Yufang Yixue Zazhi, V34, P150
   Huang GH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110781, 10.137]
   HUNG T, 1984, LANCET, V1, P1139, DOI 10.1016/S0140-6736(84)91391-6
   Jia N, 2014, EMERG INFECT DIS, V20, P866, DOI 10.3201/eid2005.130995
   Jia N, 2013, NEW ENGL J MED, V369, P1176, DOI 10.1056/NEJMc1303625
   Jiang JF, 2015, LANCET INFECT DIS, V15, P196, DOI 10.1016/S1473-3099(14)71046-1
   Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lai SJ, 2017, EMERG INFECT DIS, V23, P184, DOI 10.3201/eid2302.151710
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Li H, 2015, LANCET INFECT DIS, V15, P663, DOI 10.1016/S1473-3099(15)70051-4
   Li K, 2015, VIROLOGY, V476, P37, DOI 10.1016/j.virol.2014.11.026
   Li X, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2170-2
   Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332
   Lin HL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004919
   Lin HL, 2014, INT J BIOMETEOROL, V58, P1031, DOI 10.1007/s00484-013-0688-1
   Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065585
   Lin HL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-130
   Ling Y, 2016, EMERG INFECT DIS, V22, P1317, DOI 10.3201/eid2207.160469
   Liu Ai-Ying, 2014, Glob J Health Sci, V7, P249, DOI 10.5539/gjhs.v7n3p249
   Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273
   Liu P, 2012, INFECT GENET EVOL, V12, P428, DOI 10.1016/j.meegid.2012.01.017
   Liu W, 2016, LANCET INFECT DIS, V16, P1226, DOI 10.1016/S1473-3099(16)30401-7
   Liu W, 2016, ANN INTERN MED, V164, P641, DOI 10.7326/M15-2572
   Liu YZ, 2010, AUSTRALAS MED J, V3, P375, DOI 10.4066/AMJ.2010.310
   Lu JH, 2016, ONE HEALTH, V2, P99, DOI 10.1016/j.onehlt.2016.07.001
   Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395
   Lu QB, 2014, INFLUENZA OTHER RESP, V8, P302, DOI 10.1111/irv.12232
   Lu Z, 2014, EMERG INFECT DIS, V20, P1421, DOI 10.3201/eid2008.131433
   Lu Z, 2009, EMERG INFECT DIS, V15, P306, DOI 10.3201/eid1502.080722
   Luo HM, 2013, NEW ENGL J MED, V369, P1981, DOI 10.1056/NEJMoa1303368
   Mei YF, 2003, J GEN VIROL, V84, P2061, DOI 10.1099/vir.0.19178-0
   Meng Q, 2013, INFECT GENET EVOL, V16, P275, DOI 10.1016/j.meegid.2013.02.018
   Meng XL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.137
   Ni XB, 2014, CLIN MICROBIOL INFEC, V20, P808, DOI 10.1111/1469-0691.12532
   Ning HQ, 2007, VET MICROBIOL, V121, P125, DOI 10.1016/j.vetmic.2006.11.006
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760
   Pang Bo, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P123
   Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6
   Qu M, 2003, J CLIN MICROBIOL, V41, P2306, DOI 10.1128/JCM.41.6.2306-2310.2003
   Sang SW, 2015, INFECT GENET EVOL, V32, P178, DOI 10.1016/j.meegid.2015.03.005
   Shao ZJ, 2006, LANCET, V367, P419, DOI 10.1016/S0140-6736(06)68141-5
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Shi Q, 2016, PRION, V10, P484, DOI 10.1080/19336896.2016.1229731
   Song T, 2015, WEST PAC SURVEILL RE, V6, P33, DOI [10.5365/wpsar.2015.6.4.001, 10.5365/WPSAR.2015.6.4.001]
   Stone R, 2010, SCIENCE, V328, P559, DOI 10.1126/science.328.5978.559-a
   Tan NX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019648
   Tong MX, 2015, INT J ENV RES PUB HE, V12, P11025, DOI 10.3390/ijerph120911025
   Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09
   Wang H Y, 1989, Zhonghua Liu Xing Bing Xue Za Zhi, V10, P270
   Wang LF, 2016, J INFECTION, V73, P377, DOI 10.1016/j.jinf.2016.07.003
   Wang M, 2005, EMERG INFECT DIS, V11, P1860, DOI 10.3201/eid1112.041293
   Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675
   Wu J, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21158
   Wu ZY, 2001, HEALTH POLICY PLANN, V16, P41, DOI 10.1093/heapol/16.1.41
   Xia Ning-shao, 2011, Xiamen Daxue Xuebao (Ziran Kexue Ban), V50, P431
   Xiang B, 2017, J INFECTION, V74, P328, DOI 10.1016/j.jinf.2017.01.004
   Xiao JP, 2015, INT J ENV RES PUB HE, V12, P14055, DOI 10.3390/ijerph121114055
   Xiong YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036144
   Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369
   Xu Jian-guo, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P417
   Xu Jianguo, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P114
   Xu JG, 2013, LANCET, V381, P1815, DOI 10.1016/S0140-6736(13)60950-2
   Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114
   Yan Y C, 1982, Zhonghua Liu Xing Bing Xue Za Zhi, V3, P197
   Yang SG, 2017, LANCET INFECT DIS, V17, P716, DOI 10.1016/S1473-3099(17)30227-X
   Yang WZ, 2011, WEST PAC SURVEILL RE, V2, P10, DOI [10.5365/wpsar.2010.1.1.009, 10.5365/WPSAR.2010.1.1.009]
   Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232
   Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09
   Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370
   Yu D, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P300
   Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
   Zeng Y, 1992, Arch AIDS Res, V6, P1
   Zhang JZ, 1996, ACTA VIROL, V40, P215
   Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626
   Zhang N, 2014, J CLIN MICROBIOL, V52, P1119, DOI 10.1128/JCM.02669-13
   Zhang S, 2010, INT J GYNECOL OBSTET, V109, P194, DOI 10.1016/j.ijgo.2010.01.002
   Zhang T C, 1985, Zhonghua Liu Xing Bing Xue Za Zhi, V6, P26
   Zhang W, 2010, EMERG INFECT DIS, V16, P1630, DOI 10.3201/eid1610.100873
   Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94
   Zhang YZ, 2016, CURR OPIN VIROL, V16, P126, DOI 10.1016/j.coviro.2016.02.006
   Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804
   Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209
   Zhang Z F, 1989, Zhonghua Liu Xing Bing Xue Za Zhi, V10, P261
   Zhu BQ, 2015, EMERG INFECT DIS, V21, P925, DOI 10.3201/eid2106.140687
NR 100
TC 7
Z9 9
U1 10
U2 42
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2095-0217
EI 2095-0225
J9 FRONT MED-PRC
JI Front. Med.
PD FEB
PY 2018
VL 12
IS 1
SI SI
BP 3
EP 22
DI 10.1007/s11684-017-0605-9
PG 20
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA FV7SB
UT WOS:000424784200002
PM 29368266
OA Green Published
DA 2020-07-08
ER

PT J
AU Harburguer, L
   Gonzalez, PV
   Audino, PG
   Zerba, E
   Masuh, H
AF Harburguer, Laura
   Gonzalez, Paula V.
   Gonzalez Audino, Paola
   Zerba, Eduardo
   Masuh, Hector
TI N-substituted methyl maleamates as larvicidal compounds against Aedes
   aegypti (Diptera: Culicidae)
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Aedes aegypti; Larvae; Larvicide; Maleamates
ID PHENYLALKYL-MALEIMIDES; VECTOR CONTROL; RESISTANCE; INSECTICIDES;
   TEMEPHOS; PYRIPROXYFEN; METHOPRENE; STABILITY; MECHANISM; LARVAE
AB Severe human arboviral diseases can be transmitted by the mosquito Aedes aegypti (L.), including dengue, chikungunya, zika, and yellow fever. The use of larvicides in containers that can result as potential breeding places and cannot be eliminated is the main alternative in control programs. However, their continuous and widespread use caused an increase in insecticide-resistant populations of this mosquito. The aim of this study was to evaluate the effect of three N-substituted methyl maleamates as larvicides on Ae. aegypti, the N-propyl methyl maleamate (PMM), N-butyl methyl maleamate (BMM), and N-hexyl methyl maleamate (HMM). These compounds could have a different mode of action from those larvicides known so far. We evaluated the larva mortality after 1 and 24 h of exposure and we found that mortality was fast and occurs within the first 60 min. HMM was slightly more effective with LC50 values of 0.7 and 0.3 ppm for 1 and 24 h of exposure and LC95 of 11 and 3 ppm. Our results demonstrate that N-substituted methyl maleamates have insecticidal properties for the control of Ae. aegypti larvae. These compounds could become useful alternatives to traditional larvicides after studying their insecticidal mechanism as well as their toxicity towards non target organisms.
C1 [Harburguer, Laura; Gonzalez, Paula V.; Gonzalez Audino, Paola; Zerba, Eduardo; Masuh, Hector] Consejo Nacl Invest Cient & Tecn, Ctr Invest Plagas & Insecticidas CIPEIN, UNIDEF, CITEDEF, JB LaSalle 4397, RA-1603 Buenos Aires, DF, Argentina.
   [Gonzalez Audino, Paola; Zerba, Eduardo; Masuh, Hector] Univ Nacl San Martin, 3IA, Buenos Aires, DF, Argentina.
RP Harburguer, L; Masuh, H (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Invest Plagas & Insecticidas CIPEIN, UNIDEF, CITEDEF, JB LaSalle 4397, RA-1603 Buenos Aires, DF, Argentina.; Masuh, H (corresponding author), Univ Nacl San Martin, 3IA, Buenos Aires, DF, Argentina.
EM lharburguer@citedef.gob.ar; pgonzalez@citedef.gob.ar;
   pgonzalezaudino@citedef.gob.ar; ezerba@live.com.ar;
   hmasuh@citedef.gob.ar
RI Harburguer, Laura/L-2043-2019; Gonzalez, Paula/L-2041-2019
CR Audino PG, 1997, PESTIC SCI, V49, P339, DOI 10.1002/(SICI)1096-9063(199704)49:4&lt;339::AID-PS523&gt;3.0.CO;2-R
   Bisset J, 2005, PROTOCOLO DETERMINAR
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410
   Cornel AJ, 2002, PEST MANAG SCI, V58, P791, DOI 10.1002/ps.521
   Dame DA, 1998, J AM MOSQUITO CONTR, V14, P200
   DELICASTRO SA, 1993, COMP BIOCHEM PHYS C, V104, P43, DOI 10.1016/0742-8413(93)90108-W
   Frazier JL, 1985, CHEM SENSES FLAVOR, V1, P271
   Gonzalez PV, 2015, J MED ENTOMOL, V52, P1315, DOI 10.1093/jme/tjv136
   GRATZ NG, 1994, AM J TROP MED HYG, V50, P11
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   Lopez SN, 2005, ARZNEIMITTELFORSCH, V55, P123
   Ma W, 2010, J ECON ENTOMOL, V103, P158, DOI 10.1603/EC09122
   Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020
   MEHTA NB, 1960, J ORG CHEM, V25, P1012, DOI 10.1021/jo01076a038
   Morita H., 1985, COMPREHENSIVE INSECT, P133
   Nunes JPM, 2015, CHEM COMMUN, V51, P10624, DOI 10.1039/c5cc03557k
   Patil CD, 2012, PARASITOL RES, V110, P1841, DOI 10.1007/s00436-011-2708-6
   Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2
   PICOLLO MI, 1993, ACTA TROP, V52, P297, DOI 10.1016/0001-706X(93)90014-3
   Pilger D, 2010, TROPIKA
   Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2
   Seccacini E, 2008, J AM MOSQUITO CONTR, V24, P608, DOI 10.2987/5738.1
   Shah RM, 2015, PESTIC BIOCHEM PHYS, V119, P67, DOI 10.1016/j.pestbp.2015.02.003
   Sortino M, 2008, BIOORGAN MED CHEM, V16, P560, DOI 10.1016/j.bmc.2007.08.030
   Stenersen J, 2004, CHEM PESTICIDES MODE, P16
   Tikar SN, 2009, PARASITOL RES, V105, P57, DOI 10.1007/s00436-009-1362-8
   WHO, 1999, BAC THUR ENV HLTH CR
   World Health Organization, 2008, PYR DRINK WAT US VEC
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6
   Zentz F, 2002, FARMACO, V57, P421, DOI 10.1016/S0014-827X(02)01217-X
NR 32
TC 1
Z9 1
U1 0
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD FEB
PY 2018
VL 117
IS 2
BP 611
EP 615
DI 10.1007/s00436-017-5729-y
PG 5
WC Parasitology
SC Parasitology
GA FT2JW
UT WOS:000422968700030
PM 29290037
DA 2020-07-08
ER

PT J
AU Gibelin, N
   Romero, J
   Gregoire, V
   Kaidomar, M
AF Gibelin, N.
   Romero, J.
   Gregoire, V.
   Kaidomar, M.
TI Miller Fisher syndrome associated with a Zika virus infection
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Letter
DE electromyography; Miller Fisher syndrome; polyradiculoneuritis; public
   health; Zika virus
C1 [Gibelin, N.; Romero, J.; Gregoire, V.; Kaidomar, M.] Frejus St Raphael Hosp, Dept Neurol, Fresnes, France.
RP Gibelin, N (corresponding author), Bonnet Hosp, 240 Ave St Lambert, F-83600 Fresnes, France.
EM gibelin.nathalie@yahoo.fr
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   World Health Organization, ZIK VIR MICR GUILL B
NR 5
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD FEB
PY 2018
VL 25
IS 2
BP E20
EP E21
DI 10.1111/ene.13514
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FT2KR
UT WOS:000422971000003
PM 29356259
DA 2020-07-08
ER

PT J
AU Jurado, KA
   Yockey, LJ
   Wong, PW
   Lee, S
   Huttner, AJ
   Iwasaki, A
AF Jurado, Kellie A.
   Yockey, Laura J.
   Wong, Patrick W.
   Lee, Sarah
   Huttner, Anita J.
   Iwasaki, Akiko
TI Antiviral CD8 T cells induce Zika-virus-associated paralysis in mice
SO NATURE MICROBIOLOGY
LA English
DT Article
ID NEURONAL TISSUES; INFECTION; BRAIN; PATHOGENESIS; ANTIBODY; ACCESS;
   MODEL
AB Zika virus (ZIKV) is an emerging, mosquito-borne RNA virus. The rapid spread of ZIKV within the Americas has unveiled microcephaly(1) and Guillain-Barre syndrome(2,3) as ZIKV-associated neurological complications. Recent reports have also indicated other neurological manifestations to be associated with ZIKV, including myelitis(4), meningoencephalitis(5) and fatal encephalitis(6). Here, we investigate the neuropathogenesis of ZIKV infection in type I interferon receptor IFNAR knockout (Ifnar1(-/-)) mice, an infection model that exhibits high viral burden within the central nervous system. We show that systemic spread of ZIKV from the site of infection to the brain requires Ifnar1 deficiency in the haematopoietic compartment. However, spread of ZIKV within the central nervous system is supported by Ifnar1-deficient non-haematopoietic cells. Within this context, ZIKV infection of astrocytes results in breakdown of the blood-brain barrier and a large influx of CD8(+) effector T cells. We also find that antiviral activity of CD8(+) T cells within the brain markedly limits ZIKV infection of neurons, but, as a consequence, instigates ZIKV-associated paralysis. Taken together, our study uncovers mechanisms underlying ZIKV neuropathogenesis within a susceptible mouse model and suggests blood-brain barrier breakdown and T-cell-mediated neuropathology as potential underpinnings of ZIKV-associated neurological complications in humans.
C1 [Jurado, Kellie A.; Yockey, Laura J.; Wong, Patrick W.; Lee, Sarah; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.
   [Huttner, Anita J.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.
   [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM akiko.iwasaki@yale.edu
RI Iwasaki, Akiko/Z-1591-2019
OI Iwasaki, Akiko/0000-0002-7824-9856
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1R21AI131284,
   T32GM007205, 4T32AI007019-41]; Burroughs Wellcome Postdoctoral
   Enrichment Program
FX The authors thank A.N. van den Pol for providing anti-ZIKV rat serum,
   and H. Dong and Y. Kumamoto for animal care and technical assistance,
   respectively. This study was in part supported by the National
   Institutes of Health (1R21AI131284 to A.I., T32GM007205 to L.J.Y. and
   4T32AI007019-41 to K.A.J.). A.I. is an investigator of the Howard Hughes
   Medical Institute. K.A.J. is a recipient of the Burroughs Wellcome
   Postdoctoral Enrichment Program.
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cormier SA, 2014, J VIROL, V88, P9350, DOI 10.1128/JVI.00818-14
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Iijima N, 2016, NATURE, V533, P552, DOI 10.1038/nature17979
   Iwasaki A, 2017, TRENDS MOL MED, V23, P227, DOI 10.1016/j.molmed.2017.01.004
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 23
TC 33
Z9 33
U1 0
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD FEB
PY 2018
VL 3
IS 2
BP 141
EP 147
DI 10.1038/s41564-017-0060-z
PG 7
WC Microbiology
SC Microbiology
GA FT2PM
UT WOS:000422987500007
PM 29158604
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Jurado, KA
   Yockey, LJ
   Wong, PW
   Lee, S
   Huttner, AJ
   Iwasaki, A
AF Jurado, Kellie A.
   Yockey, Laura J.
   Wong, Patrick W.
   Lee, Sarah
   Huttner, Anita J.
   Iwasaki, Akiko
TI Antiviral CD8 T cells induce Zika-virus-associated paralysis in mice
   (vol 3, pg 141, 2018)
SO NATURE MICROBIOLOGY
LA English
DT Correction
CR Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
NR 1
TC 0
Z9 0
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD FEB
PY 2018
VL 3
IS 2
BP 255
EP 255
DI 10.1038/s41564-017-0101-7
PG 1
WC Microbiology
SC Microbiology
GA FT2PM
UT WOS:000422987500021
OA Bronze
DA 2020-07-08
ER

PT J
AU Mathis, S
   Duval, F
   Sole, G
   Tourdias, T
   Le Masson, G
AF Mathis, Stephane
   Duval, Fanny
   Sole, Guilhem
   Tourdias, Thomas
   Le Masson, Gwendal
TI CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY-CAUSING
   MYELOPATHY
SO MUSCLE & NERVE
LA English
DT Editorial Material
DE arboviruses; ganglionopathy; Guillain-Barre syndrome; sensory
   neuronopathy; Zika virus
ID GUILLAIN-BARRE-SYNDROME; ZIKA VIRUS-INFECTION; POLYNEUROPATHY
C1 [Mathis, Stephane; Duval, Fanny; Sole, Guilhem; Le Masson, Gwendal] CHU Bordeaux, Dept Neurol, Nerve Muscle Unit, Pellegrin Hosp, Pl Amelie Raba Leon, F-33000 Bordeaux, France.
   [Tourdias, Thomas] CHU Bordeaux, Dept Neuroradiol, Pellegrin Hosp, Bordeaux, France.
   [Tourdias, Thomas] Univ Bordeaux, INSERM, U1215, Bordeaux, France.
RP Mathis, S (corresponding author), CHU Bordeaux, Dept Neurol, Nerve Muscle Unit, Pellegrin Hosp, Pl Amelie Raba Leon, F-33000 Bordeaux, France.
EM stephane.mathis@chu-bordeaux.fr
RI Tourdias, Thomas/K-1209-2019
OI Tourdias, Thomas/0000-0002-7151-6325
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Camdessanche JP, 2009, BRAIN, V132, P1723, DOI 10.1093/brain/awp136
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Garcia RU, 2013, ARQ NEURO-PSIQUIAT, V71, P465, DOI 10.1590/0004-282X20130063
   Gwathmey KG, 2016, MUSCLE NERVE, V53, P8, DOI 10.1002/mus.24943
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
NR 10
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD FEB
PY 2018
VL 57
IS 2
BP E102
EP E103
DI 10.1002/mus.25756
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FS7GA
UT WOS:000419964700002
PM 28786217
DA 2020-07-08
ER

PT J
AU Martinez, ARM
   Costa, MCAM
   Novaes, MAC
   Lima, HC
   Nucci, A
   Franca, MC
AF Muro Martinez, Alberto Rolim
   Machado Costa, Marcela Camara
   Caires Novaes, Marco Antonio
   Lima, Humberto Castro
   Nucci, Anamarli
   Franca, Marcondes C., Jr.
TI A NOVEL PHENOTYPE OF ZIKA VIRUS-RELATED NEUROLOGICAL DISEASE: SENSORY
   NEURONOPATHY
SO MUSCLE & NERVE
LA English
DT Editorial Material
DE arboviruses; ganglionopathy; Guillain-Barre syndrome; sensory
   neuronopathy; Zika virus
ID GUILLAIN-BARRE-SYNDROME; POLYNEUROPATHY; INFECTION
C1 [Muro Martinez, Alberto Rolim; Nucci, Anamarli; Franca, Marcondes C., Jr.] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil.
   [Machado Costa, Marcela Camara; Caires Novaes, Marco Antonio; Lima, Humberto Castro] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
RP Martinez, ARM (corresponding author), Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil.
OI DE CASTRO LIMA FILHO, HUMBERTO/0000-0002-2688-6319
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [13/01766-7, 2014/197867];
   Coordenaco de Aperfeicoamento de Pessoal de Nivel Superior
FX In conclusion, ZIKV should be included in the list of infectious
   etiologies that may trigger acute/subacute SN. The authors received
   funding from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant
   13/01766-7 and 2014/197867) and Coordenaco de Aperfeicoamento de Pessoal
   de Nivel Superior.
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Camdessanche JP, 2009, BRAIN, V132, P1723, DOI 10.1093/brain/awp136
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Garcia RU, 2013, ARQ NEURO-PSIQUIAT, V71, P465, DOI 10.1590/0004-282X20130063
   Gwathmey KG, 2016, MUSCLE NERVE, V53, P8, DOI 10.1002/mus.24943
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
NR 10
TC 4
Z9 4
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD FEB
PY 2018
VL 57
IS 2
BP E100
EP E101
DI 10.1002/mus.25958
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FS7GA
UT WOS:000419964700001
PM 28877553
OA Bronze
DA 2020-07-08
ER

PT J
AU Golnar, AJ
   Kading, RC
   Hamer, GL
AF Golnar, A. J.
   Kading, R. C.
   Hamer, G. L.
TI Quantifying the potential pathways and locations of Rift Valley fever
   virus entry into the United States
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE arboviruses; Emerging Disease; modelling; mosquitoes; prevention and
   control; Rift Valley fever; vector biology
ID MOSQUITOS DIPTERA-CULICIDAE; WEST-NILE; AEDES-ALBOPICTUS; CULEX-PIPIENS;
   VECTOR; OUTBREAK; SPREAD; POPULATION; ISOLATIONS; ANTIBODIES
AB The global invasion of West Nile virus, chikungunya virus and Zika virus in the past two decades suggests an increasing rate of mosquito-borne virus (arbovirus) dispersal. Rift Valley fever virus (RVFV) is an arbovirus identified as a high-consequence threat to the United States (USA) because of the severe economic and health consequences associated with disease. Numerous studies demonstrate that the USA is receptive to RVFV transmission based on the widespread presence of competent mosquito species and vertebrate species. In this study, the potential pathways and locations of RVFV entry into the USA were quantitatively estimated to support a priori surveillance and RVFV prevention strategies. International movement data, ecological data and epidemiological data were combined to estimate the number of RVFV-infected mosquitoes entering the USA. Results suggest infected humans travelling by plane pose the highest risk of importing RVFV into the USA, followed by the unintentional transport of infected adult mosquitoes by ship and airplane. Furthermore, New York, New York, Washington DC, Atlanta, Georgia, and Houston, Texas, are implicated as the most likely regions of RVFV entry. Results are interpreted and discussed to support the prediction and mitigation of RVFV spread to the USA.
C1 [Golnar, A. J.; Hamer, G. L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
   [Kading, R. C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
RP Hamer, GL (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
EM ghamer@tamu.edu
RI Kading, Rebekah/E-5633-2017
OI Kading, Rebekah/0000-0002-4996-915X
FU NSF Graduate Research Fellowship ProgramNational Science Foundation
   (NSF) [1252521]; Department of Entomology, Texas AM University
FX NSF Graduate Research Fellowship Program, Grant/Award Number: #1252521;
   Department of Entomology, Texas A&M University.
CR ABBITT B, 1981, J AM VET MED ASSOC, V179, P1397
   Ba Y, 2012, J AM MOSQUITO CONTR, V28, P170, DOI 10.2987/12-5725.1
   Barker CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002515
   Basili M, 2015, J ECON SURV, V29, P896, DOI 10.1111/joes.12075
   Basio R. G., 1970, Philippine Entomologist, V1, P407
   Bird BH, 2016, ANTIVIR RES, V132, P274, DOI 10.1016/j.antiviral.2016.07.005
   Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Britch S. C., 2007, EMERG INFECT DIS, V13, pe1, DOI [10.3201/eid1308.070551, DOI 10.3201/EID1308.070551]
   CARNEIRO de MENDONCA F, 1947, Bol Oficina Sanit Panam, V26, P22
   CITES, CITES TRAD STAT DER
   CRAVEN RB, 1988, J AM MOSQUITO CONTR, V4, P138
   Diallo M, 2005, MED VET ENTOMOL, V19, P119, DOI 10.1111/j.0269-283X.2005.00564.x
   Dobbs TT, 2004, FLA ENTOMOL, V87, P65, DOI 10.1653/0015-4040(2004)087[0065:CAAAPF]2.0.CO;2
   Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629
   Durand J., 2001, MED TROPICALE REV CO, V62, P291
   Evans A, 2008, EPIDEMIOL INFECT, V136, P1261, DOI 10.1017/S0950268807009806
   EVANS BURTON R., 1963, MOSQUITO NEWS, V23, P9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fenichel EP, 2010, BIOL INVASIONS, V12, P2877, DOI 10.1007/s10530-010-9734-7
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   GARGAN TP, 1988, AM J TROP MED HYG, V38, P440, DOI 10.4269/ajtmh.1988.38.440
   Golnar AJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003163
   Hanafi HA, 2011, ACTA TROP, V119, P119, DOI 10.1016/j.actatropica.2011.04.018
   Haneche F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.18.30222
   Hartley D., 2011, EMERG INFECT DIS, V17, P1
   Hatcher MJ, 2012, FUNCT ECOL, V26, P1275, DOI 10.1111/j.1365-2435.2012.02031.x
   Hethcote HW, 2009, MATH UNDERSTANDING I, P1
   HIGHTON RB, 1970, B WORLD HEALTH ORGAN, V42, P334
   Jeanmaire EM, 2011, VECTOR-BORNE ZOONOT, V11, P395, DOI 10.1089/vbz.2009.0249
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Jupp PG, 2002, MED VET ENTOMOL, V16, P245, DOI 10.1046/j.1365-2915.2002.00371.x
   Kakani S, 2010, GEOSPATIAL HEALTH, V5, P33, DOI 10.4081/gh.2010.185
   Kasari TR, 2008, JAVMA-J AM VET MED A, V232, P514, DOI 10.2460/javma.232.4.514
   Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103
   Kilpatrick AM, 2006, CONSERV BIOL, V20, P1224, DOI 10.1111/j.1523-1739.2006.00423.x
   Kompas T., 2015, POLICY BRIEF BUDGETI
   LAIRD M, 1994, J AM MOSQUITO CONTR, V10, P14
   LAIRD MARSHALL, 1952, JOUR AVIATION MED, V23, P280
   LEMAITRE A, 1983, MOSQ NEWS, V43, P21
   LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434
   LINTHICUM KJ, 2008, VECTOR BORNE DIS UND, P78
   Lord CC, 2006, J MED ENTOMOL, V43, P623, DOI 10.1603/0022-2585(2006)43[623:RBHVAV]2.0.CO;2
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X
   MORVAN J, 1992, T ROY SOC TROP MED H, V86, P675, DOI 10.1016/0035-9203(92)90187-H
   Nie Wei-Zhong, 2004, Medical Entomology and Zoology, V55, P333
   Oda T, 2002, J MED ENTOMOL, V39, P185, DOI 10.1603/0022-2585-39.1.185
   Peterson AT, 2015, J VECTOR ECOL, V40, P191, DOI 10.1111/jvec.12151
   Powers AM, 2015, J GEN VIROL, V96, P1, DOI 10.1099/vir.0.070136-0
   ProMed mail, 2014, INV MOSQ US CAL
   Rolin AI, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.81
   SMITHBURN KC, 1949, J IMMUNOL, V62, P213
   Spielman A., 2002, MOSQUITO STORY MANS
   Takahashi S., 1984, COMMERCE SPREAD PEST
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tatem AJ, 2014, INT HEALTH, V6, P5, DOI 10.1093/inthealth/ihu006
   Turell MJ, 2015, J MED ENTOMOL, V52, P1111, DOI 10.1093/jme/tjv093
   Turell MJ, 2013, J MED ENTOMOL, V50, P1111, DOI 10.1603/ME13049
   Turell MJ, 2008, J AM MOSQUITO CONTR, V24, P502, DOI 10.2987/08-5791.1
   Turell MJ, 2002, J MED ENTOMOL, V39, P248, DOI 10.1603/0022-2585-39.1.248
   TURELL MJ, 1985, AM J TROP MED HYG, V34, P1211, DOI 10.4269/ajtmh.1985.34.1211
   UNComtrade, 2015, UN COMM TRAD STAT DA
   UNEP WCMC, 2014, CITES TRADE STATISTI
   Zeller HG, 1997, AM J TROP MED HYG, V56, P265, DOI 10.4269/ajtmh.1997.56.265
NR 66
TC 9
Z9 9
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD FEB
PY 2018
VL 65
IS 1
BP 85
EP 95
DI 10.1111/tbed.12608
PG 11
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA FS4JD
UT WOS:000419755700041
PM 28191786
OA Other Gold
DA 2020-07-08
ER

PT J
AU Silva, LEI
   Paula, AR
   Ribeiro, A
   Butt, TM
   Silva, CP
   Samuels, RI
AF Silva, L. E. I.
   Paula, A. R.
   Ribeiro, A.
   Butt, T. M.
   Silva, C. P.
   Samuels, R. I.
TI A new method of deploying entomopathogenic fungi to control adult Aedes
   aegypti mosquitoes
SO JOURNAL OF APPLIED ENTOMOLOGY
LA English
DT Article
DE attraction; biological control; dengue; traps; vector; zika
ID MALARIA VECTORS; SURVIVAL; ANISOPLIAE; DELIVERY; DEVICE
AB A new system for deployment of fungus-impregnated black cloths was tested against Aedes aegypti. A PET trap was placed in a test chamber to evaluate attractiveness to female A.aegypti with black cloths covered in adhesive film or adhesive film only for 24 and 48hr. Traps with fungus (Metarhizium anisopliae and Beauveria bassiana)-impregnated black cloths were tested against female mosquitoes for different time periods (3h to 48hr) in the chambers. Traps were then tested under intradomicile conditions against sucrose and blood-fed insects. Experiments were carried out to ascertain the minimum number of PET traps need to be deployed per test room and to test the effect of different periods of exposure to traps. Exposing the insects for 24 and 48hr to a PET trap with adhesive film + black cloth resulted in higher rates of trapped mosquitoes (38.6% and 68%, respectively) when compared with adhesive film only (6% and 12.6%, respectively). Both fungal species were effective at reducing survival rates when mosquitoes were exposed to traps for 24hr or 48hr. Lower exposure times did not significantly alter survival rates when compared to controls. The results showed that five traps or three traps per room were equally effective in reducing mosquito survival rates when testing both fungal species. The results for sucrose-fed insects showed significant reductions in survival when exposed to M.ansiopliae or B.bassiana for 24, 48 or 120hr when compared to control survival, with the lowest survival rates seen following 48- or 120-hr exposures. Survival of blood-fed mosquitoes exposed to fungus-impregnated traps for 48hr was not significantly different to the controls; however, longer exposure times significantly reduced survival rates. PET traps could be an effective system for deploying fungus-impregnated cloths in residences, facilitating cooperation of volunteers and reducing distribution time.
C1 [Silva, L. E. I.; Paula, A. R.; Ribeiro, A.; Samuels, R. I.] Univ Estadual Norte Fluminense, Dept Entomol & Plant Pathol, Campos Dos Goytacazes, Brazil.
   [Butt, T. M.] Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales.
   [Silva, C. P.] Univ Fed Santa Catarina, Dept Bioquim, Florianopolis, SC, Brazil.
RP Samuels, RI (corresponding author), Univ Estadual Norte Fluminense, Dept Entomol & Plant Pathol, Campos Dos Goytacazes, Brazil.
EM richardiansamuels@gmail.com
RI Samuels, Richard/I-2108-2019; Samuels, Richard I/R-6042-2017
OI Samuels, Richard/0000-0003-1814-2456; Samuels, Richard
   I/0000-0003-1814-2456; Silva, Carlos/0000-0001-5112-7050; Butt,
   Tariq/0000-0002-8789-9543
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES [BEX
   1720/14-7]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado
   do Rio de JaneiroCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [E-26/102.353/2013,
   E26/201.359/2016, E-26/110.617/2012]
FX Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Grant/Award
   Number: BEX 1720/14-7; Fundacao Carlos Chagas Filho de Amparo a Pesquisa
   do Estado do Rio de Janeiro, Grant/Award Number: E-26/102.353/2013,
   E26/201.359/2016 and E-26/110.617/2012
CR Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591
   CDC, 2016, CDC CONCL ZIK CAUS M
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   de Paula AR, 2008, BIOCONTROL SCI TECHN, V18, P1017, DOI 10.1080/09583150802509199
   Farenhorst M, 2008, AM J TROP MED HYG, V78, P910, DOI 10.4269/ajtmh.2008.78.910
   George J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062632
   HECHT OTTO, 1963, ENTOMOL EXPTL ET APPL, V6, P63, DOI 10.1111/j.1570-7458.1963.tb00603.x
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18
   de Santos EMM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-195
   Ministerio da Saude, 2015, B EP SECR VIG SAUD M, V46, P44
   Mmbando AS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1013-8
   Mnyone LL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-87
   Mnyone LL, 2011, PARASITOL RES, V108, P317, DOI 10.1007/s00436-010-2064-y
   Mnyone LL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-246
   Okech BA, 2003, J MED ENTOMOL, V40, P657, DOI 10.1603/0022-2585-40.5.657
   Paula AR, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-256
   Paula AR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-91
   Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639
   Scott TW, 1997, AM J TROP MED HYG, V57, P235, DOI 10.4269/ajtmh.1997.57.235
   Snetselaar J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-200
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
NR 22
TC 5
Z9 5
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0931-2048
EI 1439-0418
J9 J APPL ENTOMOL
JI J. Appl. Entomol.
PD FEB
PY 2018
VL 142
IS 1-2
BP 59
EP 66
DI 10.1111/jen.12402
PG 8
WC Entomology
SC Entomology
GA FS5JK
UT WOS:000419830900008
OA Bronze
DA 2020-07-08
ER

PT J
AU Pugliese, A
   Gumel, AB
   Milner, FA
   Velasco-Hernandez, JX
AF Pugliese, Andrea
   Gumel, Abba B.
   Milner, Fabio A.
   Velasco-Hernandez, Jorge X.
TI SEX-BIASED PREVALENCE IN INFECTIONS WITH HETEROSEXUAL, DIRECT, AND
   VECTOR-MEDIATED TRANSMISSION: A THEORETICAL ANALYSIS
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT International Conference on Mathematical and Computational Epidemiology
   of Infectious Diseases - The Interplay between Models and Public Health
   Policies (Erice MathCompEpi)
CY AUG 30-SEP 05, 2015
CL Erice, ITALY
DE Epidemic model; heterosexual transmission; vector transmission;
   sex-biased prevalence; Zika epidemic mode
ID ZIKA VIRUS; EPIDEMIC
AB Three deterministic Kermack-McKendrick-type models for studying the transmission dynamics of an infection in a two-sex closed population are analyzed here. In each model it is assumed that infection can be transmitted through heterosexual contacts, and that there is a higher probability of transmission from one sex to the other than vice versa. The study is focused on understanding whether and how this bias in transmission reflects in sex differences in final attack ratios (i.e. the fraction of individuals of each sex that eventually gets infected). In the first model, where the other two transmission modes are not considered, the attack ratios (fractions of the population of each sex that will eventually be infected) can be obtained as solutions of a system of two nonlinear equations, that has a unique solution if the net reproduction number exceeds unity. It is also shown that the ratio of attack ratios depends solely on the ratio of gender-specific susceptibilities and on the basic reproductive number of the epidemic R-0, and that the gender-specific final attack-ratio is biased in the same direction as the gender-specific susceptibilities. The second model allows also for infection transmission through direct, non-sexual, contacts. In this case too, an analytical expression is derived from which the attack ratios can be obtained. The qualitative results are similar to those obtained for the previous model, but another important parameter for determining the value of the ratio between the attack ratios in the two sexes is obtained, the relative weight of direct vs. heterosexual transmission (namely, rho). Quantitatively, the ratio of final attack ratios generally will not exceed 1.5, if non-sexual transmission accounts for most transmission events (rho >= 0.6) and the ratio of gender-specific susceptibilities is not too large (say, 5 at most).
   The third model considers vector-borne, instead of direct transmission. In this case, we were not able to find an analytical expression for the final attack ratios, but used instead numerical simulations. The results on final attack ratios are actually quite similar to those obtained with the second model. It is interesting to note that transient patterns can differ from final attack ratios, as new cases will tend to occur more often in the more susceptible sex, while later depletion of susceptibles may bias the ratio in the opposite direction. The analysis of these simple models, despite their lack of realism, can help in providing insight into, and assessment of, the potential role of gender-specific transmission in infections with multiple modes of transmission, such as Zika virus (ZIKV), by gauging what can be expected to be seen from epidemiological reports of new cases, disease incidence and seroprevalence surveys.
C1 [Pugliese, Andrea] Univ Trento, Dipartimento Matemat, Via Sommarive 14, I-38123 Povo, TN, Italy.
   [Gumel, Abba B.; Milner, Fabio A.] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ 85281 USA.
   [Velasco-Hernandez, Jorge X.] Univ Nacl Autonoma Mexico, Inst Matemat, Ciudad Univ, Ciudad De Mexico 04510, DF, Mexico.
RP Pugliese, A (corresponding author), Univ Trento, Dipartimento Matemat, Via Sommarive 14, I-38123 Povo, TN, Italy.
EM andrea.pugliese@unitn.it; agumel@asu.edu; milner@asu.edu;
   jx.velasco@im.unam.mx
RI Velasco-Hernandez, Jorge/A-5391-2008; Pugliese, Andrea/E-1905-2011
OI Velasco-Hernandez, Jorge/0000-0002-5604-7719; Pugliese,
   Andrea/0000-0002-3512-8560; Gumel, Abba/0000-0002-8413-1248
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fos PJ, 2011, EPIDEMIOLOGY FDN SCI
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Miller Joel C, 2017, Infect Dis Model, V2, P35, DOI 10.1016/j.idm.2016.12.003
   Pellissier R., 1954, B SOC PATHOL EXOT, V47, P228
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Ross Ronald, 1911, PREVENTION MALARIA
   Lopes WDZ, 2013, VET PARASITOL, V195, P47, DOI 10.1016/j.vetpar.2012.12.056
   Zhang Q, 2017, P NATL ACAD SCI
NR 21
TC 2
Z9 2
U1 0
U2 104
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PD FEB
PY 2018
VL 15
IS 1
SI SI
BP 125
EP 140
DI 10.3934/mbe.2018005
PG 16
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA FI5CU
UT WOS:000411999900006
PM 29161829
OA Other Gold
DA 2020-07-08
ER

PT J
AU Platt, DJ
   Smith, AM
   Arora, N
   Diamond, MS
   Coyne, CB
   Miner, JJ
AF Platt, Derek J.
   Smith, Amber M.
   Arora, Nitin
   Diamond, Michael S.
   Coyne, Carolyn B.
   Miner, Jonathan J.
TI Zika virus-related neurotropic flaviviruses infect human placental
   explants and cause fetal demise in mice
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; STRUCTURAL BASIS; POWASSAN
   VIRUS; UNITED-STATES; MAYARO-VIRUS; DISEASE; CHIKUNGUNYA; ANTIBODIES;
   PREGNANCY
AB Although Zika virus (ZIKV) infection in pregnant women can cause placental damage, intrauterine growth restriction, microcephaly, and fetal demise, these disease manifestations only became apparent in the context of a large epidemic in the Americas. We hypothesized that ZIKV is not unique among arboviruses in its ability to cause congenital infection. To evaluate this, we tested the capacity of four emerging arboviruses [West Nile virus (WNV), Powassan virus (POWV), chikungunya virus (CHIKV), and Mayaro virus (MAYV)] from related (flavivirus) and unrelated (alphavirus) genera to infect the placenta and fetus in immunocompetent, wild-type mice. Although all four viruses caused placental infection, only infection with the neurotropic flaviviruses (WNV and POWV) resulted in fetal demise. WNV and POWV also replicated efficiently in second-trimester human maternal (decidua) and fetal (chorionic villi and fetal membrane) explants, whereas CHIKV and MAYV replicated less efficiently. In mice, RNA in situ hybridization and histopathological analysis revealed that WNV infected the placenta and fetal central nervous system, causing injury to the developing brain. In comparison, CHIKV and MAYV did not cause substantive placental or fetal damage despite evidence of vertical transmission. On the basis of the susceptibility of human maternal and fetal tissue explants and pathogenesis experiments in immunocompetent mice, other emerging neurotropic flaviviruses may share with ZIKV the capacity for transplacental transmission, as well as subsequent infection and injury to the developing fetus.
C1 [Platt, Derek J.; Diamond, Michael S.; Miner, Jonathan J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Smith, Amber M.; Diamond, Michael S.; Miner, Jonathan J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Arora, Nitin; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA.
   [Arora, Nitin; Coyne, Carolyn B.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
   [Diamond, Michael S.; Miner, Jonathan J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
RP Miner, JJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Miner, JJ (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Miner, JJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
EM miner@wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Platt, Derek/0000-0003-0766-4590;
   Arora, Nitin/0000-0001-6840-4333
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [K08 AR070918, R21 EY027870, R01
   HD075665, R01AI081759, R01 AI073755, R01 AI104972, R01 HD091218, R25
   GM103757, U19 AI083019]; Mid-America Transplant Foundation; Children's
   Discovery Institute; Rheumatology Research Foundation; Burroughs
   Wellcome Fund Investigators in Pathogenesis of Infectious Disease Award;
   Washington University Chancellor's Graduate Fellowship Program
FX The Miner laboratory is supported by grants from the NIH (K08 AR070918
   and R21 EY027870), Mid-America Transplant Foundation, Children's
   Discovery Institute, and the Rheumatology Research Foundation. The Coyne
   laboratory is supported by grants from the NIH (R01 HD075665 and
   R01AI081759) and the Burroughs Wellcome Fund Investigators in
   Pathogenesis of Infectious Disease Award. The Diamond Laboratory is
   supported by grants from the NIH (R01 AI073755, R01 AI104972, U19
   AI083019, and R01 HD091218). D.J.P. is supported by the Washington
   University Chancellor's Graduate Fellowship Program and the NIH
   Initiative for Maximizing Student Development (R25 GM103757).
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   ANDERSEN A A, 1970, Infection and Immunity, V2, P320
   ANDERSEN AA, 1975, INFECT IMMUN, V12, P1173, DOI 10.1128/IAI.12.5.1173-1183.1975
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   BURNS KF, 1950, P SOC EXP BIOL MED, V75, P621, DOI 10.3181/00379727-75-18285
   Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Cervantes DT, 2015, EMERG INFECT DIS, V21, P681, DOI 10.3201/eid2104.141178
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ebel GD, 1999, EMERG INFECT DIS, V5, P570, DOI 10.3201/eid0504.990423
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   FUJISAKI Y, 1976, NATL I ANIM HEALTH Q, V16, P97
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Grivard P, 2007, PATHOL BIOL, V55, P490, DOI 10.1016/j.patbio.2007.07.002
   Icheku V., 2017, J MOL PATHOL EPIDEMI, V2, pS1
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Julander JG, 2005, ANTIVIR RES, V65, P79, DOI 10.1016/j.antiviral.2004.10.005
   Karthiga V, 2016, J PEDIATR NEUROSCI, V11, P223, DOI 10.4103/1817-1745.193369
   Levi T, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0556
   Lindahl J, 2012, TROP ANIM HEALTH PRO, V44, P239, DOI 10.1007/s11250-011-0005-0
   MATHUR A, 1981, INFECT IMMUN, V34, P26, DOI 10.1128/IAI.34.1.26-29.1981
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Nishioka SD, 1998, TROP MED INT HEALTH, V3, P29, DOI 10.1046/j.1365-3156.1998.00164.x
   Nofchissey RA, 2013, AM J TROP MED HYG, V88, P1159, DOI 10.4269/ajtmh.12-0586
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Pedersen K, 2017, AM J TROP MED HYG, V97, P319, DOI 10.4269/ajtmh.17-0180
   Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070
   Piantadosi A, 2016, CLIN INFECT DIS, V62, P707, DOI 10.1093/cid/civ1005
   Pridjian G, 2016, BIRTH DEFECTS RES A, V106, P716, DOI 10.1002/bdra.23523
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 56
TC 36
Z9 36
U1 0
U2 9
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JAN 31
PY 2018
VL 10
IS 426
AR eaao7090
DI 10.1126/scitranslmed.aao7090
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA FU3LX
UT WOS:000423754100005
PM 29386359
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Mohr, EL
   Block, LN
   Newman, CM
   Stewart, LM
   Koenig, M
   Semler, M
   Breitbach, ME
   Teixeira, LBC
   Zeng, XK
   Weiler, AM
   Barry, GL
   Thoong, TH
   Wiepz, GJ
   Dudley, DM
   Simmons, HA
   Mejia, A
   Morgan, TK
   Salamat, MS
   Kohn, S
   Antony, KM
   Aliota, MT
   Mohns, MS
   Hayes, JM
   Schultz-Darken, N
   Schotzko, ML
   Peterson, E
   Capuano, S
   Osorio, JE
   O'Connor, SL
   Friedrich, TC
   O'Connor, DH
   Golos, TG
AF Mohr, Emma L.
   Block, Lindsey N.
   Newman, Christina M.
   Stewart, Laurel M.
   Koenig, Michelle
   Semler, Matthew
   Breitbach, Meghan E.
   Teixeira, Leandro B. C.
   Zeng, Xiankun
   Weiler, Andrea M.
   Barry, Gabrielle L.
   Thoong, Troy H.
   Wiepz, Gregory J.
   Dudley, Dawn M.
   Simmons, Heather A.
   Mejia, Andres
   Morgan, Terry K.
   Salamat, M. Shahriar
   Kohn, Sarah
   Antony, Kathleen M.
   Aliota, Matthew T.
   Mohns, Mariel S.
   Hayes, Jennifer M.
   Schultz-Darken, Nancy
   Schotzko, Michele L.
   Peterson, Eric
   Capuano, Saverio, III
   Osorio, Jorge E.
   O'Connor, Shelby L.
   Friedrich, Thomas C.
   O'Connor, David H.
   Golos, Thaddeus G.
TI Ocular and uteroplacental pathology in a macaque pregnancy with
   congenital Zika virus infection
SO PLOS ONE
LA English
DT Article
ID VAGINAL SECRETIONS; DENGUE VIRUS; RHESUS; INFANTS; URINE; BIRTH;
   DIAGNOSIS; COLOBOMA; GENETICS; TYLOSIN
AB Congenital Zika virus (ZIKV) infection impacts fetal development and pregnancy outcomes. We infected a pregnant rhesus macaque with a Puerto Rican ZIKV isolate in the first trimester. The pregnancy was complicated by preterm premature rupture of membranes (PPROM), intraamniotic bacterial infection and fetal demise 49 days post infection (gestational day 95). Significant pathology at the maternal-fetal interface included acute chorioamnionitis, placental infarcts, and leukocytoclastic vasculitis of the myometrial radial arteries. ZIKV RNA was disseminated throughout fetal tissues and maternal immune system tissues at necropsy, as assessed by quantitative RT-PCR for viral RNA. Replicating ZIKV was identified in fetal tissues, maternal uterus, and maternal spleen by fluorescent in situ hybridization for viral replication intermediates. Fetal ocular pathology included a choroidal coloboma, suspected anterior segment dysgenesis, and a dysplastic retina. This is the first report of ocular pathology and prolonged viral replication in both maternal and fetal tissues following congenital ZIKV infection in a rhesus macaque. PPROM followed by fetal demise and severe pathology of the visual system have not been described in macaque congenital ZIKV infection previously. While this case of ZIKV infection during pregnancy was complicated by bacterial infection with PPROM, the role of ZIKV on this outcome cannot be precisely defined, and further nonhuman primate studies will determine if increased risk for PPROM or other adverse pregnancy outcomes are associated with congenital ZIKV infection.
C1 [Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.
   [Block, Lindsey N.; Newman, Christina M.; Stewart, Laurel M.; Koenig, Michelle; Semler, Matthew; Breitbach, Meghan E.; Dudley, Dawn M.; Salamat, M. Shahriar; Mohns, Mariel S.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA.
   [Teixeira, Leandro B. C.; Aliota, Matthew T.; Osorio, Jorge E.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI USA.
   [Zeng, Xiankun] US Army, Med Res Inst Infect Dis, Frederick, MD USA.
   [Mohr, Emma L.; Weiler, Andrea M.; Barry, Gabrielle L.; Thoong, Troy H.; Wiepz, Gregory J.; Simmons, Heather A.; Mejia, Andres; Hayes, Jennifer M.; Schultz-Darken, Nancy; Schotzko, Michele L.; Peterson, Eric; Capuano, Saverio, III; Friedrich, Thomas C.; O'Connor, David H.; Golos, Thaddeus G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
   [Morgan, Terry K.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA.
   [Morgan, Terry K.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
   [Kohn, Sarah] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA.
   [Antony, Kathleen M.; Golos, Thaddeus G.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA.
RP Mohr, EL (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.; Golos, TG (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.; Golos, TG (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.; Golos, TG (corresponding author), Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA.
EM emohr@uwhealth.org; golos@primate.wisc.edu
RI amsalu, ribka/G-8780-2019; Teixeira, Leandro B C/H-9272-2015
OI Teixeira, Leandro B C/0000-0001-9960-678X; Zeng, Xiankun
   (Kevin)/0000-0003-3526-8755; Aliota, Matthew/0000-0002-6902-9149
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21 HD091163-01, R01
   AI116382-01A1S1, P51 0D011106, T32 AI55397]; Pediatric Infectious
   Diseases Society;  [P51 OD011106]
FX This study was supported by the National Institutes of Health (R21
   HD091163-01, R01 AI116382-01A1S1, P51 0D011106, T32 AI55397) and the
   Pediatric Infectious Diseases Society. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. Opinions, interpretations, conclusions,
   and recommendations are those of the author (X. Zeng) and are not
   necessarily endorsed by the U.S. Army.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184
   Aid M, 2017, CELL
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Arragain L, 2016, J PEDIAT INF DIS SOC
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Blackwood RS, 2008, COMPARATIVE MED, V58, P81
   BLANKENSHIP TN, 1993, CELL TISSUE RES, V272, P227, DOI 10.1007/BF00302728
   Bondarenko GI, 2007, J IMMUNOL, V179, P8042, DOI 10.4049/jimmunol.179.12.8042
   BUNTON TE, 1986, VET PATHOL, V23, P431, DOI 10.1177/030098588602300413
   Carlson J, 2007, AM J DERMATOPATH, V29, P32, DOI 10.1097/01.dad.0000245198.80847.ff
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Centers for Disease Control and Prevention, PREGN WOM AN LAB EV
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Churchill A, 1996, BRIT J OPHTHALMOL, V80, P669, DOI 10.1136/bjo.80.7.669
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DOYLE L, 1991, J MED PRIMATOL, V20, P409
   Driggers KW, 2016, NEW ENGLAND J MED
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Enders AC, 2007, PLACENTA, V28, P794, DOI 10.1016/j.placenta.2006.11.001
   Franca GV, 2016, LANCET
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494
   GRIBNAU AAM, 1985, ADV ANAT EMBRYOL CEL, V91, pUR7
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Iannetta M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.34.30600
   Ji LW, 2014, J VET PHARMACOL THER, V37, P312, DOI 10.1111/jvp.12092
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Landais A, 2017, J NEUROLOGICAL SCI
   LIN CCL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1651, DOI 10.1001/archopht.1984.01040031341023
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOLOGY
   Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moore CA, 2016, JAMA PEDIAT
   Morgan TK, 2016, AM J PERINAT, V33, P258, DOI 10.1055/s-0035-1570379
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508
   Onwochei BC, 2000, SURV OPHTHALMOL, V45, P175, DOI 10.1016/S0039-6257(00)00151-X
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2017, NEW ENGLAND J MED
   Pereira BB de Souza, 2017, TRANSPLANT INFECT DI
   *PREV, 2017, OUTCOMES OF PREGNANC
   Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reis LM, 2011, CURR OPIN OPHTHALMOL, V22, P314, DOI 10.1097/ICU.0b013e328349412b
   Romero R, 2015, J MATERN-FETAL NEO M, V28, P1394, DOI 10.3109/14767058.2014.958463
   Russo FB, 2017, CELLULAR MICROBIOLOG
   RUTANEN EM, 1993, CLIN CHIM ACTA, V214, P73, DOI 10.1016/0009-8981(93)90304-M
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Souto I Oliveira, 2016, ENFERMEDADES INFECCI
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tarantal A. F., 2005, ULTRASOUND IMAGING R
   TARANTAL AF, 1988, ANAT REC, V222, P177, DOI 10.1002/ar.1092220210
   Turmel J. M., 2016, LANCET, V6736, P30775, DOI DOI 10.1016/S0140-6736(16)30775-9
   Van den Bossche D, 2015, EUR J CLIN MICROBIOL, V34, P1361, DOI 10.1007/s10096-015-2359-0
   van der Eijk AA, 2016, NEW ENGLAND J MED
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x
   Waldorf KM Adams, 2016, NATURE MED
   Wong CW, 2017, RETINAL CASES BRIEF
   Yanoff MS, 2015, J W OCULAR PATHOLOGY
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIAT
NR 85
TC 26
Z9 26
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 30
PY 2018
VL 13
IS 1
AR e0190617
DI 10.1371/journal.pone.0190617
PG 28
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FU1NX
UT WOS:000423617800010
PM 29381706
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lum, FM
   Couderc, T
   Chia, BS
   Ong, RY
   Her, Z
   Chow, A
   Leo, YS
   Kam, YW
   Renia, L
   Lecuit, M
   Ng, LFP
AF Lum, Fok-Moon
   Couderc, Therese
   Chia, Bing-Shao
   Ong, Ruo-Yan
   Her, Zhisheng
   Chow, Angela
   Leo, Yee-Sin
   Kam, Yiu-Wing
   Renia, Laurent
   Lecuit, Marc
   Ng, Lisa F. P.
TI Antibody-mediated enhancement aggravates chikungunya virus infection and
   disease severity
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DEPENDENT ENHANCEMENT; DENGUE VIRUS; CROSS-REACTIVITY; GENE-EXPRESSION;
   T-CELLS; MACROPHAGES; EPIDEMIC; REPLICATION; SUPPRESSION; MECHANISMS
AB The arthropod-transmitted chikungunya virus (CHIKV) causes a flu-like disease that is characterized by incapacitating arthralgia. The re-emergence of CHIKV and the continual risk of new epidemics have reignited research in CHIKV pathogenesis. Virus-specific antibodies have been shown to control virus clearance, but antibodies present at sub-neutralizing concentrations can also augment virus infection that exacerbates disease severity. To explore this occurrence, CHIKV infection was investigated in the presence of CHIKV-specific antibodies in both primary human cells and a murine macrophage cell line, RAW264.7. Enhanced attachment of CHIKV to the primary human monocytes and B cells was observed while increased viral replication was detected in RAW264.7 cells. Blocking of specific Fc receptors (Fc gamma Rs) led to the abrogation of these observations. Furthermore, experimental infection in adult mice showed that animals had higher viral RNA loads and endured more severe joint inflammation in the presence of sub-neutralizing concentrations of CHIKV-specific antibodies. In addition, CHIKV infection in 11 days old mice under enhancing condition resulted in higher muscles viral RNA load detected and death. These observations provide the first evidence of antibody-mediated enhancement in CHIKV infection and pathogenesis and could also be relevant for other important arboviruses such as Zika virus.
C1 [Lum, Fok-Moon; Chia, Bing-Shao; Ong, Ruo-Yan; Her, Zhisheng; Kam, Yiu-Wing; Renia, Laurent; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore.
   [Lum, Fok-Moon; Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117596, Singapore.
   [Couderc, Therese; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, F-75015 Paris, France.
   [Couderc, Therese; Lecuit, Marc] INSERM, U1117, F-75015 Paris, France.
   [Chow, Angela; Leo, Yee-Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore 308433, Singapore.
   [Lecuit, Marc] Paris Descartes Univ, Sorbonne Paris Cite, Necker Enfants Malad Univ Hosp, Inst Imagine,AP HP,Div Infect Dis & Trop Med, F-75743 Paris, France.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
   [Chia, Bing-Shao] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
   [Ong, Ruo-Yan] Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland.
   [Her, Zhisheng] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.
RP Lum, FM; Ng, LFP (corresponding author), ASTAR, Singapore Immunol Network, Singapore 138648, Singapore.; Lum, FM; Ng, LFP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117596, Singapore.; Ng, LFP (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
EM lum_fok_moon@immunol.a-star.edu.sg; lisa_ng@immunol.a-star.edu.sg
RI Lecuit, Marc/J-4073-2013; Lecuit, Marc/M-4126-2019
OI Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; Lum,
   Fok Moon/0000-0002-5645-7048; Ng, Lisa/0000-0003-4071-5222; Chia, Bing
   Shao/0000-0003-0101-5805
FU EU project FP7-ICRES [261202]; LabEx IBEID; Institut Pasteur;
   InsermInstitut National de la Sante et de la Recherche Medicale (Inserm)
FX We acknowledge the study participants and healthy volunteers for
   providing the plasma and blood samples. We would also like to express
   our gratitude to the research staffs and clinical staffs from CDC/TTSH
   for patient enrolment, study coordination, and collection of patient
   samples. We would also want to thank Martial Jaume (Hong Kong University
   Pasteur Research Center) for providing the transformed ST486 cell lines.
   We would also like to thank Andres Merits for providing the Zs-Green
   tagged CHIKV infectious clone and the rabbit anti-CHIKV nsP2 polyclonal
   antibodies. In addition, we express our gratitude to the SIgN Flow
   Cytometry core and to Kenneth Low and Adeline Lin for their technical
   assistance. We thank P. Bergeat, Director of the Laboratoire Francais du
   Fractionnement et des Biotechnologies, for his support. This project was
   funded in part by the EU project FP7-ICRES (grant no. 261202), and LabEx
   IBEID, Institut Pasteur and Inserm. Lastly, we are grateful to Kai-Er
   Eng for editing of the manuscript. The sponsors were not involved in the
   design of the study, gathering of the data, analysis or drafting of the
   manuscript.
CR Angelini R, 2007, EUROSURVEILLANCE, V12
   Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161
   Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07
   Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0
   Chua K B, 2010, Med J Malaysia, V65, P277
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Hallengard D, 2014, J VIROL, V88, P13333, DOI 10.1128/JVI.01926-14
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   HAWKES RA, 1964, AUST J EXP BIOL MED, V42, P465
   Her ZS, 2015, EMBO MOL MED, V7, P24, DOI 10.15252/emmm.201404459
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   HOHDATSU T, 1994, ARCH VIROL, V139, P273, DOI 10.1007/BF01310791
   Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11
   Kam YW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003445
   Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033
   Kumarasamy V, 2006, Med J Malaysia, V61, P221
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   LaLinn M, 1996, J GEN VIROL, V77, P407, DOI 10.1099/0022-1317-77-3-407
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013
   Lee WWL, 2015, J VIROL, V89, P7893, DOI 10.1128/JVI.00998-15
   Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lidbury BA, 2000, J VIROL, V74, P8376, DOI 10.1128/JVI.74.18.8376-8381.2000
   Liu HT, 2008, IMMUNOL LETT, V117, P70, DOI 10.1016/j.imlet.2007.12.012
   Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304
   Mahalingam S, 2002, P NATL ACAD SCI USA, V99, P13819, DOI 10.1073/pnas.202415999
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   MORENS DM, 1990, J GEN VIROL, V71, P2909, DOI 10.1099/0022-1317-71-12-2909
   Nakayama E, 2011, J INFECT DIS, V204, pS978, DOI 10.1093/infdis/jir334
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   Ng KW, 2009, SINGAP MED J, V50, P785
   Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486
   OCHIAI H, 1992, J MED VIROL, V36, P217, DOI 10.1002/jmv.1890360312
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Pierson TC, 2010, CELL HOST MICROBE, V7, P85, DOI 10.1016/j.chom.2010.02.004
   Plaskon NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007468
   Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923
   PORTERFIELD JS, 1981, NATURE, V290, P542, DOI 10.1038/290542a0
   Ravi V, 2006, Indian J Med Microbiol, V24, P83
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   ROBINSON WE, 1988, LANCET, V1, P790
   Rolph MS, 2011, J INFECT DIS, V204, P489, DOI 10.1093/infdis/jir271
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Sallie R, 2004, MED HYPOTHESES, V63, P515, DOI 10.1016/j.mehy.2004.02.050
   Seneviratne SL, 2006, BMJ-BRIT MED J, V333, P1220, DOI 10.1136/bmj.39051.725729.3A
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Suhrbier A, 2003, TRENDS IMMUNOL, V24, P165, DOI 10.1016/S1471-4906(03)00065-6
   Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15
   Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177
   Triggiani M, 2007, J ALLERGY CLIN IMMUN, V119, P472, DOI 10.1016/j.jaci.2006.09.027
   Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325
   Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018
   Watanaveeradej V, 2006, EMERG INFECT DIS, V12, P1770, DOI 10.3201/eid1211.051560
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004
   Zuniga EI, 2015, ANNU REV VIROL, V2, P573, DOI 10.1146/annurev-virology-100114-055226
NR 72
TC 14
Z9 14
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 30
PY 2018
VL 8
AR 1860
DI 10.1038/s41598-018-20305-4
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT9YR
UT WOS:000423508900031
PM 29382880
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Koma, T
   Veljkovic, V
   Anderson, DE
   Wang, LF
   Rossi, SL
   Shan, C
   Shi, PY
   Beasley, DW
   Bukreyeva, N
   Smith, JN
   Hallam, S
   Huang, C
   von Messling, V
   Paessler, S
AF Koma, Takaaki
   Veljkovic, Veljko
   Anderson, Danielle E.
   Wang, Lin-Fa
   Rossi, Shannan L.
   Shan, Chao
   Shi, Pei-Yong
   Beasley, David W.
   Bukreyeva, Natalya
   Smith, Jeanon N.
   Hallam, Steven
   Huang, Cheng
   von Messling, Veronika
   Paessler, Slobodan
TI Zika virus infection elicits auto-antibodies to C1q
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; NEPHRITIS; ANTIBODIES; VACCINE; MODEL
AB Zika virus (ZIKV) causes mostly asymptomatic infection or mild febrile illness. However, with an increasing number of patients, various clinical features such as microcephaly, Guillain-Barre syndrome and thrombocytopenia have also been reported. To determine which host factors are related to pathogenesis, the E protein of ZIKV was analyzed with the Informational Spectrum Method, which identifies common information encoded by primary structures of the virus and the respective host protein. The data showed that the ZIKV E protein and the complement component C1q cross-spectra are characterized by a single dominant peak at the frequency F = 0.338, suggesting similar biological properties. Indeed, C1q-specific antibodies were detected in sera obtained from mice and monkeys infected with ZIKV. As C1q has been known to be involved not only in immunity, but also in synaptic organization and different autoimmune diseases, a ZIKV-induced anti-C1q antibody response may contribute to the neurological complications. These findings might also be exploited for the design of safe and efficacious vaccines in the future.
C1 [Koma, Takaaki; Rossi, Shannan L.; Bukreyeva, Natalya; Smith, Jeanon N.; Hallam, Steven; Huang, Cheng; Paessler, Slobodan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Koma, Takaaki; Rossi, Shannan L.; Bukreyeva, Natalya; Smith, Jeanon N.; Hallam, Steven; Huang, Cheng; Paessler, Slobodan] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Veljkovic, Veljko] Biomed Protect, Galveston, TX USA.
   [Anderson, Danielle E.; Wang, Lin-Fa; von Messling, Veronika] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
   [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX USA.
   [Beasley, David W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA.
   [von Messling, Veronika] Paul Ehrlich Inst, Vet Med Div, Langen, Germany.
   [Koma, Takaaki] Tokushima Univ, Dept Microbiol, Grad Sch Med Sci, Tokushima, Japan.
RP Paessler, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Paessler, S (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM slpaessl@utmb.edu
FU JSPS Postdoctoral Fellowship for Research AbroadMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science; Singapore Ministry of Health's National
   Medical Research Council under Zika Response Research FundMinistry of
   Health-SingaporeNational Medical Research Council, Singapore
   [NMRC/ZRRF/0002/2016]; University of Texas Medical Branch (UTMB) startup
   award; University of Texas STARs Award; CDC grant [SCON2016-01353]; UTMB
   CTSAUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR-001439]; Robert J. Kleberg, Jr.
   and Helen C. Kleberg Foundation
FX T.K. was supported by in part by a JSPS Postdoctoral Fellowship for
   Research Abroad. D.E.A and L.-F.W.'s research is supported by the
   Singapore Ministry of Health's National Medical Research Council under
   its Zika Response Research Fund (NMRC/ZRRF/0002/2016). P.-Y.S. lab was
   supported by University of Texas Medical Branch (UTMB) startup award,
   University of Texas STARs Award, CDC grant for the Western Gulf Center
   of Excellence for Vector-Borne Diseases, Pan American Health
   Organization grant SCON2016-01353, and UTMB CTSA UL1TR-001439. Sera from
   WNV-infected mice were generated on studies funded by the Robert J.
   Kleberg, Jr. and Helen C. Kleberg Foundation.
CR Beirao P, 2017, BMJ CASE REPORTS, V2017
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Friedrich BM, 2016, VACCINE, V34, P5479, DOI 10.1016/j.vaccine.2016.09.044
   Gunnarsson I, 2002, J RHEUMATOL, V29, P693
   HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512
   Horvath L, 2001, CLIN EXP RHEUMATOL, V19, P667
   Kallenberg CGM, 2008, AUTOIMMUN REV, V7, P612, DOI 10.1016/j.autrev.2008.06.006
   Kouser L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00317
   Madhukaran SP, 2016, IMMUNOBIOLOGY, V221, P1273, DOI 10.1016/j.imbio.2016.06.002
   Martins RD, 2015, HUM VACC IMMUNOTHER, V11, P2183, DOI 10.1080/21645515.2015.1022700
   McMahon AW, 2007, VACCINE, V25, P1727, DOI 10.1016/j.vaccine.2006.11.027
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Putzu GA, 2000, J NEUROL SCI, V174, P16, DOI 10.1016/S0022-510X(99)00328-7
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saadoun D, 2006, CLIN EXP IMMUNOL, V145, P308, DOI 10.1111/j.1365-2249.2006.03153.x
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   SIEGERT CEH, 1993, ANN RHEUM DIS, V52, P851, DOI 10.1136/ard.52.12.851
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Troedson C, 2013, LUPUS, V22, P639, DOI 10.1177/0961203313486950
   VELJKOVIC V, 1973, PHYS LETT A, VA 45, P41, DOI 10.1016/0375-9601(73)90497-0
   VELJKOVIC V, 1972, PHYS REV LETT, V29, P105, DOI 10.1103/PhysRevLett.29.105
   Veljkovic V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00135
   Yuzaki M, 2017, CURR OPIN NEUROBIOL, V45, P9, DOI 10.1016/j.conb.2017.02.002
NR 27
TC 6
Z9 8
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 30
PY 2018
VL 8
AR 1882
DI 10.1038/s41598-018-20185-8
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT9YR
UT WOS:000423508900053
PM 29382894
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carrillo-Hernandez, MY
   Ruiz-Saenz, J
   Villamizar, LJ
   Gomez-Rangel, SY
   Martinez-Gutierrez, M
AF Yelitza Carrillo-Hernandez, Marlen
   Ruiz-Saenz, Julian
   Jaimes Villamizar, Lucy
   Yebrail Gomez-Rangel, Sergio
   Martinez-Gutierrez, Marlen
TI Co-circulation and simultaneous co-infection of dengue, chikungunya, and
   zika viruses in patients with febrile syndrome at the
   Colombian-Venezuelan border
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue virus; Chikungunya virus; Zika virus; Co-infection;
   Co-circulation
ID CLINICAL PRESENTATION; INFECTION; DIAGNOSTICS; PREVALENCE; EPIDEMIC;
   BAHIA; DELHI; RATES; AREA
AB Background: In Colombia, the dengue virus (DENV) has been endemic for decades, and with the recent entry of the chikungunya virus (CHIKV) (2014) and the Zika virus (ZIKV) (2015), health systems are overloaded because the diagnosis of these three diseases is based on clinical symptoms, and the three diseases share a symptomatology of febrile syndrome. Thus, the objective of this study was to use molecular methods to identify their co-circulation as well as the prevalence of co-infections, in a cohort of patients at the Colombian-Venezuelan border.
   Methods: A total of 157 serum samples from patients with febrile syndrome consistent with DENV were collected after informed consent and processed for the identification of DENV (conventional PCR and real-time PCR), CHIKV (conventional PCR), and ZIKV (real-time PCR). DENV-positive samples were serotyped, and some of those positive for DENV and CHIKV were sequenced.
   Results: Eighty-two patients were positive for one or more viruses: 33 (21.02%) for DENV, 47 (29.94%) for CHIKV, and 29 (18.47%) for ZIKV. The mean age range of the infected population was statistically higher in the patients infected with ZIKV (29.72 years) than in those infected with DENV or CHIKV (21.09 years). Both co-circulation and co-infection of these three viruses was found. The prevalence of DENV/CHIKV, DENV/ZIKV, and CHIKV/ZIKV co-infection was 7.64%, 6.37%, and 5.10%, with attack rates of 14.90, 12.42, and 9.93 cases per 100,000 inhabitants, respectively. Furthermore, three patients were found to be co-infected with all three viruses (prevalence of 1.91%), with an attack rate of 4.96 cases per 100,000 inhabitants.
   Conclusion: Our results demonstrate the simultaneous co-circulation of DENV, CHIKV, ZIKV and their co-infections at the Colombian-Venezuelan border. Moreover, it is necessary to improve the differential diagnosis in patients with acute febrile syndrome and to study the possible consequences of this epidemiological overview of the clinical outcomes of these diseases in endemic regions.
C1 [Yelitza Carrillo-Hernandez, Marlen; Ruiz-Saenz, Julian; Martinez-Gutierrez, Marlen] Univ Cooperat Colombia, Grp Invest Ciencias Anim GRICA, Calle 30A, Bucaramanga 3351, Colombia.
   [Yelitza Carrillo-Hernandez, Marlen; Yebrail Gomez-Rangel, Sergio] Univ Santander UDES, Fac Ciencias Salud, Programa Bacteriol & Lab Clin, Grp Invest Manejo Clin CLINIUDES, Bucaramanga, Colombia.
   [Yelitza Carrillo-Hernandez, Marlen] Univ Santander, Invest Enfermedades Infecciosas, Bucaramanga, Colombia.
   [Yelitza Carrillo-Hernandez, Marlen] Univ Antioquia, Ciencias Basicas Biomed, Medellin, Colombia.
   [Jaimes Villamizar, Lucy] ESE Jorge Cristo Sahium Hosp, Lab Clin, Norte De Santander, Cucuta, Colombia.
RP Martinez-Gutierrez, M (corresponding author), Univ Cooperat Colombia, Grp Invest Ciencias Anim GRICA, Calle 30A, Bucaramanga 3351, Colombia.
EM marlen.martinezg@campusucc.edu.co
RI Ruiz-Saenz, Julian/Q-5085-2019
OI Ruiz-Saenz, Julian/0000-0002-1447-1458; Martinez-Gutierrez,
   Marlen/0000-0002-9429-0058; Carrillo Hernandez,
   Marlen/0000-0001-9572-2302
FU CONADI of the Universidad Cooperativa de Colombia-Convocatoria
   Sostenibilidad;  [1882-2017]
FX This work was funded by CONADI of the Universidad Cooperativa de
   Colombia-Convocatoria Sostenibilidad 2014 and Grant 1882-2017. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Adiga R, 2016, J MED VIROL, V88, P1821, DOI 10.1002/jmv.24615
   Alarcón-Cruz Ángela P, 2016, Rev. salud pública, V18, P1, DOI 10.15446/rsap.v18n3.55425
   Diaz-Quinonez JA, 2016, EMERG INFECT DIS, V22, P937, DOI 10.3201/eid2205.160190
   Alvis-Guzman N, 2015, COLOMB MEDICA, V46, P3, DOI 10.25100/cm.v46i1.1487
   Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Arroyave E, 2013, BIOMEDICA, V33, P99, DOI 10.7705/biomedica.v33i0.734
   Berger S, 2016, CHIKUNGUNYA ZIKA GLO, P121
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carabali M, 2017, INT J INFECT DIS, V58, P27, DOI 10.1016/j.ijid.2017.02.016
   Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Díaz-Quijano Fredi, 2008, Rev. salud pública, V10, P250
   Dirlikov E., 2016, MMWR MORB MORTAL WKL, V65
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Arcila VG, 2015, REV ARGENT MICROBIOL, V47, P78, DOI 10.1016/j.ram.2015.01.001
   Gomez S, 2008, DENGUE B, V32, P126
   Gomez-Calderon C, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1562-1
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gutierrez G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002385
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Laiton-Donato K, 2016, BIOMEDICA, V36, P25, DOI 10.7705/biomedica.v36i0.2990
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martinez-Gutierrez M, 2014, CURARE, V1, P39
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Mattar S, 2014, INT J INFECT DIS, V25, P201, DOI 10.1016/j.ijid.2014.03.1396
   Mercado M, 2016, EURO SURVEILL, P21
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Ocazionez Raquel E, 2007, Rev. salud pública, V9, P262, DOI 10.1590/S0124-00642007000200010
   Ocazionez-Jimenez RE, 2013, BIOMEDICA, V33, P22, DOI 10.7705/biomedica.v33i0.717
   Omarjee R, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.13.20753
   Organization WH, 2009, AL P DENG GUID DIAGN
   Pacheco O, 2016, N ENGL J MED
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pfeffer M, 2002, J VET MED B, V49, P49, DOI 10.1046/j.1439-0450.2002.00535.x
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Ramachandran V. G., 2016, VirusDisease, V27, P183, DOI 10.1007/s13337-016-0314-z
   Rodas JD, 2016, AM J TROP MED HYG, V95, P639, DOI 10.4269/ajtmh.16-0091
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Rodriguez-Morales AJ, 2016, ARTHRIT CARE RES, V68, P1849, DOI 10.1002/acr.22900
   Rodríguez-Villamarín Flor R, 2014, Rev. salud pública, V16, P597, DOI 10.15446/rsap.v16n4.46259
   Romero-Vega Liliana, 2014, Rev. Saúde Pública, V48, P899, DOI [10.1590/S0034-8910.2014048005321, 10.1590/s0034-8910.2014048005321]
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Salas-Benito JS, 2015, J IMMUNOL RES, DOI 10.1155/2015/873404
   Paiva MHS, 2017, GENET MOL BIOL, V40, P597, DOI [10.1590/1678-4685-GMB-2016-0312, 10.1590/1678-4685-gmb-2016-0312]
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Saswat T, 2015, INFECT GENET EVOL, V35, P134, DOI 10.1016/j.meegid.2015.08.006
   Singh P, 2012, EPIDEMIOL INFECT, V140, P1337, DOI 10.1017/S0950268811001671
   Soares CN, 2008, ARQ NEURO-PSIQUIAT, V66, P234, DOI 10.1590/S0004-282X2008000200018
   Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   WHO P, 2015, INF VIR ZIK 7 MAY 20
   WHO P, 2014, AL EP FIEBR CHIK DEN
   Wilder-Smith A, 2016, LANCET INFECT DIS, V16, P629, DOI 10.1016/S1473-3099(16)00076-1
   Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 77
TC 44
Z9 45
U1 2
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 30
PY 2018
VL 18
AR 61
DI 10.1186/s12879-018-2976-1
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA FU3FS
UT WOS:000423736800003
PM 29382300
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xia, HJ
   Luo, HL
   Shan, C
   Muruato, AE
   Nunes, BTD
   Medeiros, DBA
   Zou, J
   Xie, XP
   Giraldo, MI
   Vasconcelos, PFC
   Weaver, SC
   Wang, T
   Rajsbaum, R
   Shi, PY
AF Xia, Hongjie
   Luo, Huanle
   Shan, Chao
   Muruato, Antonio E.
   Nunes, Bruno T. D.
   Medeiros, Daniele B. A.
   Zou, Jing
   Xie, Xuping
   Giraldo, Maria Isabel
   Vasconcelos, Pedro F. C.
   Weaver, Scott C.
   Wang, Tian
   Rajsbaum, Ricardo
   Shi, Pei-Yong
TI An evolutionary NS1 mutation enhances Zika virus evasion of host
   interferon induction
SO NATURE COMMUNICATIONS
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE VIRUS; I INTERFERON; RIG-I; STIMULATED GENES;
   PROTEIN; PATHOGENESIS; IMMUNITY; RECOGNITION; INHIBITION
AB Virus-host interactions determine an infection outcome. The Asian lineage of Zika virus (ZIKV), responsible for the recent epidemics, has fixed a mutation in the NS1 gene after 2012 that enhances mosquito infection. Here we report that the same mutation confers NS1 to inhibit interferon-beta induction. This mutation enables NS1 binding to TBK1 and reduces TBK1 phosphorylation. Engineering the mutation into a pre-epidemic ZIKV strain debilitates the virus for interferon-beta induction; reversing the mutation in an epidemic ZIKV strain invigorates the virus for interferon-beta induction; these mutational effects are lost in IRF3-knockout cells. Additionally, ZIKV NS2A, NS2B, NS4A, NS4B, and NS5 can also suppress interferon-beta production through targeting distinct components of the RIG-I pathway; however, for these proteins, no antagonistic difference is observed among various ZIKV strains. Our results support the mechanism that ZIKV has accumulated mutation(s) that increases the ability to evade immune response and potentiates infection and epidemics.
C1 [Xia, Hongjie; Shan, Chao; Muruato, Antonio E.; Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Zou, Jing; Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Luo, Huanle; Muruato, Antonio E.; Giraldo, Maria Isabel; Weaver, Scott C.; Wang, Tian; Rajsbaum, Ricardo] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Vasconcelos, Pedro F. C.] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil.
   [Vasconcelos, Pedro F. C.] Para State Univ, Dept Pathol, Belem, Para, Brazil.
   [Weaver, Scott C.; Rajsbaum, Ricardo; Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Wang, Tian; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Wang, Tian] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI Vasconcelos, Pedro/AAH-3142-2019; Rajsbaum, Ricardo/AAD-4775-2020; Xia,
   Hongjie/M-9241-2019; Weaver, Scott C/D-6490-2011; Xie,
   Xuping/AAD-7406-2019
OI Xia, Hongjie/0000-0002-2520-7038; Weaver, Scott C/0000-0001-8016-8556; 
FU University of Texas Medical Branch (UTMB) startup award; University of
   Texas STARs Award; CDC grant; Pan American Health Organization grant
   [SCON2016-01353]; Kleberg Foundation Award; UTMB CTSAUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR-001439]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI127744, AI120942,
   AI099123]; NIH from ORWH [K12HD052023]; NICHDUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD); NIH/NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21 AI132479-01]; CAPESCAPES;
   CNPq from the Ministry of Science and Technology of Brazil
   [440405/2016-5, 303999/2016-0]; Ministry of HealthMinistry of Health -
   Turkey
FX We thank Slobodan Paessler at University of Texas Medical Branch (UTMB)
   for providing Irf3<SUP>-/-</SUP> mice. We also thank other colleagues at
   UTMB for helpful discussions and support during the course of this
   study. P.-Y.S. lab was supported by University of Texas Medical Branch
   (UTMB) startup award, University of Texas STARs Award, CDC grant for the
   Western Gulf Center of Excellence for Vector-Borne Diseases, Pan
   American Health Organization grant SCON2016-01353, the Kleberg
   Foundation Award, UTMB CTSA UL1TR-001439, and NIH grant AI127744. This
   research was also partially supported by NIH grants AI120942 and
   AI099123 to S.C.W and T.W., respectively. R.R. lab is supported by NIH
   grants K12HD052023 from ORWH and NICHD, and NIH/NIAID R21 AI132479-01.
   P.F.C.V. was supported by projects of CAPES (Zika Fast-Track) and CNPq
   grants 440405/2016-5 and 303999/2016-0 from the Ministry of Science and
   Technology of Brazil and by the Ministry of Health.
CR Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bharaj P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005880
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CLEARY CM, 1994, J BIOL CHEM, V269, P18747
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Huang C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002933
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Petersen LR, 2016, NEW ENGL J MED, V374, P1981
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2017, METHODS MOL BIOL, V1602, P47, DOI 10.1007/978-1-4939-6964-7_4
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 63
TC 71
Z9 73
U1 1
U2 26
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 29
PY 2018
VL 9
AR 414
DI 10.1038/s41467-017-02816-2
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT8VS
UT WOS:000423431900001
PM 29379028
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Delaney, A
   Mai, C
   Smoots, A
   Cragan, J
   Ellington, S
   Langlois, P
   Breidenbach, R
   Fornoff, J
   Dunn, J
   Yazdy, M
   Scotto-Rosato, N
   Sweatlock, J
   Fox, D
   Palacios, J
   Forestieri, N
   Leedom, V
   Smiley, M
   Nance, A
   Lake-Burger, H
   Romitti, P
   Fall, C
   Prado, MV
   Barton, J
   Bryan, JM
   Arias, W
   Brown, SV
   Kimura, J
   Mann, S
   Martin, B
   Orantes, L
   Taylor, A
   Nahabedian, J
   Akosa, A
   Song, ZW
   Martin, S
   Ramlal, R
   Shapiro-Mendoza, C
   Isenburg, J
   Moore, CA
   Gilboa, S
   Honein, MA
AF Delaney, Augustina
   Mai, Cara
   Smoots, Ashley
   Cragan, Janet
   Ellington, Sascha
   Langlois, Peter
   Breidenbach, Rebecca
   Fornoff, Jane
   Dunn, Julie
   Yazdy, Mahsa
   Scotto-Rosato, Nancy
   Sweatlock, Joseph
   Fox, Deborah
   Palacios, Jessica
   Forestieri, Nina
   Leedom, Vinita
   Smiley, Mary
   Nance, Amy
   Lake-Burger, Heather
   Romitti, Paul
   Fall, Carrie
   Prado, Miguel Valencia
   Barton, Jerusha
   Bryan, J. Michael
   Arias, William
   Brown, Samara Viner
   Kimura, Jonathan
   Mann, Sylvia
   Martin, Brennan
   Orantes, Lucia
   Taylor, Amber
   Nahabedian, John
   Akosa, Amanda
   Song, Ziwei
   Martin, Stacey
   Ramlal, Roshan
   Shapiro-Mendoza, Carrie
   Isenburg, Jennifer
   Moore, Cynthia A.
   Gilboa, Suzanne
   Honein, Margaret A.
TI Population-Based Surveillance of Birth Defects Potentially Related to
   Zika Virus Infection-15 States and U. S. Territories, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID PREGNANCY
C1 [Delaney, Augustina; Mai, Cara; Smoots, Ashley; Cragan, Janet; Ellington, Sascha; Taylor, Amber; Nahabedian, John; Akosa, Amanda; Song, Ziwei; Ramlal, Roshan; Isenburg, Jennifer; Moore, Cynthia A.; Gilboa, Suzanne; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Langlois, Peter; Breidenbach, Rebecca] Texas Dept State Hlth Serv, Austin, TX USA.
   [Fornoff, Jane] Illinois Dept Publ Hlth, Springfield, IL 62761 USA.
   [Dunn, Julie; Yazdy, Mahsa] Massachusetts Dept Publ Hlth, Boston, MA 02111 USA.
   [Scotto-Rosato, Nancy; Sweatlock, Joseph] New Jersey Dept Hlth, Trenton, NJ USA.
   [Fox, Deborah; Palacios, Jessica] New York State Dept Hlth, Albany, NY 12237 USA.
   [Forestieri, Nina] North Carolina Dept Hlth & Human Serv, Raleigh, NC USA.
   [Leedom, Vinita; Smiley, Mary] South Carolina Dept Hlth & Environm Control, Columbia, SC 29201 USA.
   [Nance, Amy] Utah Dept Hlth, Salt Lake City, UT 84116 USA.
   [Lake-Burger, Heather] Florida Dept Hlth, Tallahassee, FL USA.
   [Romitti, Paul; Fall, Carrie] Univ Iowa, Iowa City, IA 52242 USA.
   [Prado, Miguel Valencia] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Barton, Jerusha; Bryan, J. Michael] Georgia Dept Publ Hlth, Atlanta, GA USA.
   [Arias, William; Brown, Samara Viner] Rhode Isl Dept Hlth, Providence, RI 02908 USA.
   [Kimura, Jonathan; Mann, Sylvia] Hawaii Dept Hlth, Pearl City, HI USA.
   [Martin, Brennan; Orantes, Lucia] Vermont Dept Hlth, Burlington, VT USA.
   [Martin, Stacey] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Shapiro-Mendoza, Carrie] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
RP Ellington, S (corresponding author), CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM zikaMCH@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782
CR CDC, 2016, GUID TRAV TEST PREGN
   CDC, 2016, ZIK VIR 2016 CAS COU
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   Gilboa SM, 2017, BIRTH DEFECTS RES, V109, P372, DOI 10.1002/bdr2.1007
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
NR 9
TC 27
Z9 27
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JAN 26
PY 2018
VL 67
IS 3
BP 91
EP 96
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FT9BZ
UT WOS:000423448300002
PM 29370151
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Gaya, M
   Barral, P
   Burbage, M
   Aggarwal, S
   Montaner, B
   Navia, AW
   Aid, M
   Tsui, C
   Maldonado, P
   Nair, U
   Ghneim, K
   Fallon, PG
   Sekaly, RP
   Barouch, DH
   Shalek, AK
   Bruckbauer, A
   Strid, J
   Batista, FD
AF Gaya, Mauro
   Barral, Patricia
   Burbage, Marianne
   Aggarwal, Shweta
   Montaner, Beatriz
   Navia, Andrew Warren
   Aid, Malika
   Tsui, Carlson
   Maldonado, Paula
   Nair, Usha
   Ghneim, Khader
   Fallon, Padraic G.
   Sekaly, Rafick-Pierre
   Barouch, Dan H.
   Shalek, Alex K.
   Bruckbauer, Andreas
   Strid, Jessica
   Batista, Facundo D.
TI Initiation of Antiviral B Cell Immunity Relies on Innate Signals from
   Spatially Positioned NKT Cells
SO CELL
LA English
DT Article
ID KILLER T-CELLS; LYMPH-NODES; IN-VIVO; ANTIBODY-RESPONSES; IL-4
   PRODUCTION; COGNATE HELP; ANTIGEN; ACTIVATION; MICE; INFECTION
AB B cells constitute an essential line of defense from pathogenic infections through the generation of class-switched antibody-secreting cells (ASCs) in germinal centers. Although this process is known to be regulated by follicular helper T(TfH) cells, the mechanism by which B cells initially seed germinal center reactions remains elusive. We found that NKT cells, a population of innate-like T lymphocytes, are critical for the induction of B cell immunity upon viral infection. The positioning of NKT cells at the interfollicular areas of lymph nodes facilitates both their direct priming by resident macrophages and the localized delivery of innate signals to antigen-experienced B cells. Indeed, NKT cells secrete an early wave of IL-4 and constitute up to 70% of the total IL-4-producing cells during the initial stages of infection. Importantly, the requirement of this innate immunity arm appears to be evolutionarily conserved because early NKT and IL-4 gene signatures also positively correlate with the levels of neutralizing antibodies in Zika-virus-infected macaques. In conclusion, our data support a model wherein a pre-TfH wave of IL-4 secreted by interfollicular NKT cells triggers the seeding of germinal center cells and serves as an innate link between viral infection and B cell immunity.
C1 [Gaya, Mauro; Navia, Andrew Warren; Nair, Usha; Barouch, Dan H.; Shalek, Alex K.; Batista, Facundo D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
   [Gaya, Mauro; Barral, Patricia; Burbage, Marianne; Aggarwal, Shweta; Montaner, Beatriz; Tsui, Carlson; Maldonado, Paula; Bruckbauer, Andreas; Batista, Facundo D.] Francis Crick Inst, London NW1A 1AT, England.
   [Barral, Patricia] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 9RT, England.
   [Navia, Andrew Warren; Shalek, Alex K.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Navia, Andrew Warren; Shalek, Alex K.] Broad Inst, Cambridge, MA 02142 USA.
   [Aid, Malika; Barouch, Dan H.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Ghneim, Khader; Sekaly, Rafick-Pierre] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Fallon, Padraic G.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland.
   [Strid, Jessica] Imperial Coll London, Div Immunol & Inflammat, Dept Med, London W12 0NN, England.
   [Batista, Facundo D.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
   [Batista, Facundo D.] Harvard Med Sch, HMS Ctr Immune Imaging, Boston, MA 02115 USA.
RP Gaya, M; Batista, FD (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Gaya, M; Batista, FD (corresponding author), Francis Crick Inst, London NW1A 1AT, England.; Batista, FD (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; Batista, FD (corresponding author), Harvard Med Sch, HMS Ctr Immune Imaging, Boston, MA 02115 USA.
EM contact@maurogaya.com; fbatista1@mgh.harvard.edu
RI Fallon, Padraic/Y-2711-2019; Barouch, Dan/Y-3918-2019; Shalek,
   Alex/Y-2434-2019
OI Fallon, Padraic/0000-0002-8401-7293; Shalek, Alex/0000-0001-5670-8778;
   Barral, Patricia/0000-0003-4324-8973; Montaner,
   Beatriz/0000-0001-9877-7317
FU Francis Crick Institute from Cancer Research UK [FC001035]; United
   Kingdom Medical Research CouncilMedical Research Council UK (MRC)
   [FC001035]; Wellcome TrustWellcome Trust [FC001035]; Center for HIV/AIDS
   Vaccine Immunology and Immunogen Discovery of the NIH [UM1AI100663];
   Phillip T. and Susan M. Ragon Institute Foundation; Bill and Melinda
   Gates Foundation Innovation Award [228966]
FX We thank the flow cytometry facility for technical support and the
   biological resource unit for the breeding of animals and assistance with
   the generation of CD1d-floxed animals (at the Francis Crick and Ragon
   Institutes). We thank Kathrin Kirsch for the maintenance of mouse
   colonies. We thank Neil Rogers and Caetano Reis e Sousa for the
   provision of MyD88<SUP>-/-</SUP>, TLR7<SUP>-/-</SUP>, CD11c-Cre, and
   Lyz2-Cre mice and for scientific discussions. We thank Michael Reth for
   the Mb1-Cre strain. We thank Mark Wilson for the IL-4-GFP reporter mice.
   We thank Andrew McKenzie for the IL-33R<SUP>-/</SUP>-bone marrow. We
   thank Samuel W. Kazer and Sanjay M. Prakadan for assistance with RNA-seq
   analysis. We thank Adolfo Garcia-Sastre for the NS1-GFP virus. We thank
   Paul Thomas for the PR8-OTII virus. We thank Daniel Lingwood for the HA
   trimer. We thank the NIH Tetramer Core Facility for the provision of
   labeled CD1d tetramers. We thank all members of the Lymphocyte
   Interaction Laboratory for critical reading of the manuscript and
   scientific discussions. This work was supported by the Francis Crick
   Institute, which receives its core funding from Cancer Research UK
   (FC001035), the United Kingdom Medical Research Council (FC001035), the
   Wellcome Trust (FC001035), the Center for HIV/AIDS Vaccine Immunology
   and Immunogen Discovery of the NIH (UM1AI100663), the Phillip T. and
   Susan M. Ragon Institute Foundation, and Bill and Melinda Gates
   Foundation Innovation Award 228966 (to F.D.B.).
CR Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0
   Artiaga BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23593
   Bai L, 2013, P NATL ACAD SCI USA, V110, P16097, DOI 10.1073/pnas.1303218110
   Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105
   Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853
   Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454
   Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369
   Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007
   Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166
   De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264
   Dufort FJ, 2007, J IMMUNOL, V179, P4953, DOI 10.4049/jimmunol.179.8.4953
   Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104
   Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300
   Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016
   Hagglof T, 2016, NAT IMMUNOL, V17, P1407, DOI 10.1038/ni.3583
   Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023
   Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016
   Ishikawa H, 2010, VIROLOGY, V407, P325, DOI 10.1016/j.virol.2010.08.030
   Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021
   King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172
   King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313
   Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096
   Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105
   Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731
   Leite-De-Moraes MC, 2001, J IMMUNOL, V166, P945, DOI 10.4049/jimmunol.166.2.945
   Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107
   Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006
   Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8
   Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706
   Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703
   Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715
   Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108
   Sagoo P, 2016, NAT MED, V22, P64, DOI 10.1038/nm.4016
   Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192
   Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015
   Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015
   Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103
   Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069
   Turqueti-Neves A, 2014, EUR J IMMUNOL, V44, P2130, DOI 10.1002/eji.201344203
   Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
   Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554
   Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505
NR 44
TC 52
Z9 54
U1 0
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD JAN 25
PY 2018
VL 172
IS 3
BP 517
EP +
DI 10.1016/j.cell.2017.11.036
PG 37
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA FT9BS
UT WOS:000423447600012
PM 29249358
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abdalla, LF
   Santos, JHA
   Barreto, RTJ
   Souza, EME
   D'Assuncao, FF
   Borges, MA
   Nascimento, VA
   da Silva, GAV
   de Souza, VC
   Ramasawmy, R
   Campi-Azevedo, AC
   Coelho-dos-Reis, JG
   Antonelli, LRD
   Teixeira-Carvalho, A
   Martins, OA
   Naveca, FG
AF Abdalla, Ligia Fernandes
   Abdalla Santos, Joao Hugo
   Jales Barreto, Renata Teodora
   Martins e Souza, Erick
   D'Assuncao, Fabricio Fonseca
   Borges, Marcio Aurelio
   Nascimento, Valdinete Alves
   Villarouco da Silva, George Allan
   de Souza, Victor Costa
   Ramasawmy, Rajendranath
   Campi-Azevedo, Ana Carolina
   Coelho-dos-Reis, Jordana Graziela
   do Vale Antonelli, Lis Ribeiro
   Teixeira-Carvalho, Andrea
   Martins-Filho, Olindo Assis
   Naveca, Felipe Gomes
TI Atrial fibrillation in a patient with Zika virus infection
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Arboviruses; Atrial fibrillation; Cardiac disorders
ID JANUARY 2016; TRANSMISSION; CHIKUNGUNYA; EPIDEMIC; MICRONESIA; OUTBREAK;
   DISEASE; SALIVA; STATES; BRAZIL
AB Background: Zika virus is an emerging arbovirus of the family Flaviviridae and genus Flavivirus that until 2007 was restricted to a few cases of mild illness in Africa and Asia.
   Case presentation: We report a case of atrial fibrillation disclosed during an acute Zika virus infection in a 49-year-old man. Different biological samples were analyzed for the molecular diagnosis of Zika by real-time PCR, however only the saliva specimen was positive. The patient's wife tested positive in the serum sample, although she was an asymptomatic carrier. Moreover, a complete overview of patient's biomarkers, including cytokines, chemokines, and growth-factors levels, was analyzed and compared to gender and age matching non-infected controls, as well as other Zika infected patients, considering the 95% CI of the mean values. Elevated levels of CXCL8, CCL11, CCL2, CXCL10, IL-1 beta, IL-6, TNF-alpha, IFN-gamma, IL-17, IL-1Ra, IL-4, IL-9, FGF-basic, PDGF, G-CSF, and GM-CSF were observed in the Atrial fibrillation patient, in contrast to uninfected controls. Furthermore, increased levels of CCL5, IL-1 beta, TNF-alpha, IFN-gamma, IL-9, G-CSF, and GM-CSF were observed only in the atrial fibrillation patient, when compared to other Zika patients.
   Conclusions: To our knowledge, this is the first description of this type of cardiac disorder in Zika patients which may be considered another atypical manifestation during Zika virus infection.
C1 [Abdalla, Ligia Fernandes; Villarouco da Silva, George Allan; Ramasawmy, Rajendranath; Naveca, Felipe Gomes] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [Abdalla, Ligia Fernandes; D'Assuncao, Fabricio Fonseca] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Abdalla Santos, Joao Hugo; Martins e Souza, Erick] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Abdalla Santos, Joao Hugo; Jales Barreto, Renata Teodora; Borges, Marcio Aurelio] Hosp Adventista Manaus, Manaus, Amazonas, Brazil.
   [Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz Amazonia, Inst Leonidas & Maria Diane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz MS, Inst Oswaldo Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, Brazil.
   [Villarouco da Silva, George Allan; Ramasawmy, Rajendranath] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Ramasawmy, Rajendranath] Univ Nilton Lins, Manaus, Amazonas, Brazil.
   [Campi-Azevedo, Ana Carolina; Coelho-dos-Reis, Jordana Graziela; do Vale Antonelli, Lis Ribeiro; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis] Fiocruz Minas, Inst Rene Rachou, Belo Horizonte, MG, Brazil.
   [Naveca, Felipe Gomes] Fiocruz Amazonia, Inst Leonidas & Maria Diane, Programa Posgrad Biol Int Patogenohospediro, Manaus, Amazonas, Brazil.
RP Naveca, FG (corresponding author), Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Fiocruz Amazonia, Inst Leonidas & Maria Diane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
EM felipe.naveca@fiocruz.br
RI Naveca, Felipe/H-1130-2012; Ramasawmy, Rajendranath/V-4926-2019;
   Antonelli, Lis/R-4910-2019
OI Naveca, Felipe/0000-0002-2888-1060; Antonelli, Lis/0000-0002-4969-8812;
   Souza, Victor Costa de/0000-0002-3869-1519; Nascimento,
   Valdinete/0000-0002-7786-4718; Campi-Azevedo, Ana
   Carolina/0000-0001-6306-3605
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [440856/2016-7, 440682/2016-9]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES [88881.130825/2016-00,
   88887.130823/2016-00, 88881.130829/2016-01]; Financiadora de Estudos e
   ProjetosCiencia Tecnologia e Inovacao (FINEP) [TED264/16]
FX FGN is funded by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (http://www.cnpq.br, grant 440856/2016-7) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br,
   grants 88881.130825/2016-00 and 88887.130823/2016-00). OAMF is funded by
   the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (http://www.cnpq.br, grant 440682/2016-9); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br,
   grant 88881.130829/2016-01) and Financiadora de Estudos e Projetos
   (http://www.finep.gov.br, grant TED264/16). The funders had no role in
   study design, data collection and analysis, decision to publish or
   preparation of the manuscript.
CR Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Hadi HAR, 2010, J INFLAMM RES, V3, P75, DOI 10.2147/JIR.S10095
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuo HJ, 2017, J MICROBIOL IMMUNOL
   Kushawaha Anurag, 2009, Cases J, V2, P7147, DOI 10.1186/1757-1626-2-7147
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Naveca FG, 2017, BIORXIV
   OBEYESEKERE I, 1972, BRIT HEART J, V34, P821
   PAHO, 2015, 17 PAHO, P1
   Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Ratanacharoensiri A, 2017, J RES PHARM PRACT, V6, P1, DOI 10.4103/2279-042X.200984
   Saldarriaga G. Clara, 2013, Rev. Colomb. Cardiol., V20, P366
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 33
TC 7
Z9 7
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JAN 25
PY 2018
VL 15
AR 23
DI 10.1186/s12985-018-0938-2
PG 6
WC Virology
SC Virology
GA FU2LY
UT WOS:000423682900001
PM 29370812
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tai, WB
   He, L
   Wang, YF
   Sun, SH
   Zhao, GY
   Luo, CM
   Li, P
   Zhao, HY
   Fremont, DH
   Li, F
   Jiang, SB
   Zhou, YS
   Du, LY
AF Tai, Wanbo
   He, Lei
   Wang, Yufei
   Sun, Shihun
   Zhao, Guangyu
   Luo, Chuming
   Li, Pei
   Zhao, Haiyan
   Fremont, Daved H.
   Li, Fang
   Jiang, Shibo
   Zhou, Yusen
   Du, Lanying
TI Critical neutralizing fragment of Zika virus EDIII elicits
   cross-neutralization and protection against divergent Zika viruses
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID RECEPTOR-BINDING DOMAIN; VACCINE CANDIDATE; DENGUE VIRUS; INFECTION;
   ANTIBODY; BRAZIL; ENHANCEMENT; REACTIVITY; PROTEIN; MICE
AB Zika virus (ZIKV) infection remains a serious health threat due to its close association with congenital Zika syndrome (CZS), which includes microcephaly and other severe birth defects. As no vaccines are available for human use, continuous effort is needed to develop effective and safe vaccines to prevent ZIKV infection. In this study, we constructed three recombinant proteins comprising, respectively, residues 296-406 (E296-406), 298-409 (E298-409), and 301-404 (E301-404) of ZIKV envelope (E) protein domain III (EDIII) fused with a C-terminal Fc of human IgG. Our results demonstrated that E298-409 induced the highest titer of neutralizing antibodies against infection with nine ZIKV strains isolated from different hosts, countries, and time periods, and it maintained long-term anti-ZIKV immunogenicity to induce neutralizing antibodies. Pups born to mice immunized with E298-409 were fully protected against lethal challenge with two epidemic human ZIKV strains, 2015/Honduras (R103451) and 2015/Colombia (FLR). Passive transfer of anti-E298-409 mouse sera protected pups born to naive mice, as well as type I interferon receptor-deficient adult A129 mice, from lethal challenge with human ZIKV strains R103451 and FLR, and this protection was positively correlated with neutralizing antibodies. These data suggest that the critical neutralizing fragment (i.e., a fragment that can induce highly potent neutralizing antibodies against divergent ZIKV strains) of ZIKV EDIII is a good candidate for development as an effective and safe ZIKV subunit vaccine to protect pregnant mothers and their fetuses against ZIKV infection. The E298-409-specific antibodies can be used for passive immunization to prevent ZIKV infection in newborns or immunocompromised adults.
C1 [Tai, Wanbo; Wang, Yufei; Jiang, Shibo; Du, Lanying] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
   [Tai, Wanbo; Sun, Shihun; Zhao, Guangyu; Li, Pei; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [He, Lei; Zhou, Yusen] Guangxi Med Univ, Grad Sch, Nanning 530021, Guangxi, Peoples R China.
   [Luo, Chuming; Li, Fang] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.
   [Zhao, Haiyan; Fremont, Daved H.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Educ, Shanghai Med Coll, Shanghai 200032, Peoples R China.
   [Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Hlth, Shanghai Med Coll, Shanghai 200032, Peoples R China.
   [Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200032, Peoples R China.
RP Jiang, SB; Du, LY (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.; Zhou, YS (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
EM sjiang@nybc.org; yszhou@bmi.ac.cn; ldu@nybc.org
RI amsalu, ribka/G-8780-2019; Jiang, Shibo/L-4500-2014; Tai,
   Wanbo/G-3838-2018
OI Tai, Wanbo/0000-0002-9864-8993
FU New York Blood Center [NYB000414, NYB000475, NYB000486]
FX This study was supported by intramural funds of the New York Blood
   Center (NYB000414, NYB000475, and NYB000486). The ZIKV strains (FLR,
   R103451, PAN2015, PAN2016, PRVABC59, PLCal_ZV, IbH 30656, MEX 2-81, and
   MR 766) used in this study were obtained from BEI Resources.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dittmer DP, 2016, SCIENCE, V353, P1375, DOI 10.1126/science.aai8117
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Du LY, 2008, J IMMUNOL, V180, P948, DOI 10.4049/jimmunol.180.2.948
   Du LY, 2017, EXPERT REV VACCINES, V16, P951, DOI 10.1080/14760584.2017.1363648
   Du LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13473
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Ma CQ, 2014, VACCINE, V32, P6170, DOI 10.1016/j.vaccine.2014.08.086
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Medin CL, 2017, ARCH PATHOL LAB MED, V141, P33, DOI 10.5858/arpa.2016-0409-RA
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Reynolds M. R., 2016, MMWR-MORBID MORTAL W, V66, P366, DOI DOI 10.15585/MMWR.MM6613E1
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tai WB, 2017, J VIROL, V91, DOI 10.1128/JVI.01651-16
   Tai WB, 2016, VIROLOGY, V499, P375, DOI 10.1016/j.virol.2016.10.005
   Tebas P, 2017, N ENGL J MED
   Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 41
TC 22
Z9 24
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 24
PY 2018
VL 7
AR 7
DI 10.1038/s41426-017-0007-8
PG 13
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FU5ED
UT WOS:000423875000002
PM 29362446
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xie, DY
   Liu, ZY
   Nian, QG
   Zhu, L
   Wang, N
   Deng, YQ
   Zhao, H
   Ji, X
   Li, XF
   Wang, XX
   Shi, PY
   Qin, CF
AF Xie, Dong-Yang
   Liu, Zhong-Yu
   Nian, Qing-Gong
   Zhu, Ling
   Wang, Nan
   Deng, Yong-Qiang
   Zhao, Hui
   Ji, Xue
   Li, Xiao-Feng
   Wang, Xiangxi
   Shi, Pei-Yong
   Qin, Cheng-Feng
TI A single residue in the alpha B helix of the E protein is critical for
   Zika virus thermostability
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
C1 [Xie, Dong-Yang; Liu, Zhong-Yu; Nian, Qing-Gong; Deng, Yong-Qiang; Zhao, Hui; Ji, Xue; Li, Xiao-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Xie, Dong-Yang; Qin, Cheng-Feng] Anhui Med Univ, Hefei 230032, Anhui, Peoples R China.
   [Zhu, Ling; Wang, Nan; Wang, Xiangxi] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100101, Peoples R China.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Pharmacol & Toxicol, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Qin, CF (corresponding author), Anhui Med Univ, Hefei 230032, Anhui, Peoples R China.
EM qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Liu, Zhong-Yu/0000-0001-7385-5681
FU National Key Research and Development Project of China [2016YFD0500304];
   National Science and Technology Major Project of China [2017ZX09101005,
   2017ZX10304402]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [31770190, U170220023, 81661130162,
   81661148054]; NSFCNational Natural Science Foundation of China
   [81522025]; Innovative Research Group [81621005]; Academy of Medical
   Sciences, UK
FX This work was supported by the National Key Research and Development
   Project of China (No. 2016YFD0500304), the National Science and
   Technology Major Project of China (No. 2017ZX09101005 and No.
   2017ZX10304402), and the National Natural Science Foundation of China
   (No. 31770190, No. U170220023, No. 81661130162 and No. 81661148054).
   C.F.Q. was supported by the NSFC Excellent Young Scientist (No.
   81522025), the Innovative Research Group (No. 81621005), and the Newton
   Advanced Fellowship from the Academy of Medical Sciences, UK.
CR Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Rincon V, 2014, STRUCTURE, V22, P1560, DOI 10.1016/j.str.2014.08.019
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stobart CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13916
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
NR 8
TC 2
Z9 2
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 24
PY 2018
VL 7
AR 5
DI 10.1038/s41426-017-0006-9
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FU5ED
UT WOS:000423875000004
PM 29362473
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Calvet, GA
   Kara, EO
   Giozza, SP
   Botto-Menezes, CHA
   Gaillard, P
   Franca, RFD
   de Lacerda, MVG
   Castilho, MD
   Brasil, P
   de Sequeira, PC
   de Mello, MB
   Bermudez, XPD
   Modjarrad, K
   Meurant, R
   Landoulsi, S
   Benzaken, AS
   de Filippis, AMB
   Broutet, NJN
AF Calvet, Guilherme Amaral
   Kara, Edna Oliveira
   Giozza, Silvana Pereira
   Aguiar Botto-Menezes, Camila Helena
   Gaillard, Philippe
   de Oliveira Franca, Rafael Freitas
   Guimaraes de lacerda, Marcus Vinicius
   Castilho, Marcia da Costa
   Brasil, Patricia
   de Sequeira, Patricia Carvalho
   de Mello, Maeve Brito
   Diaz Bermudez, Ximena Pamela
   Modjarrad, Kayvon
   Meurant, Robyn
   Landoulsi, Sihem
   Benzaken, Adele Schwartz
   Bispo de Filippis, Ana Maria
   Nicole Broutet, Nathalie Jeanne
CA ZIKABRA Study Team
TI Study on the persistence of Zika virus (ZIKV) in body fluids of patients
   with ZIKV infection in Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Arbovirus; Flavivirus; Zika virus; Body fluids; Persistence; Rt-Pcr;
   Emerging infectious diseases
ID SEXUAL TRANSMISSION; EPIDEMIC; STATES; RNA
AB Background: Zika virus (ZIKV) has been identified in several body fluids of infected individuals. In most cases, it remained detected in blood from few days to 1 week after the onset of symptoms, and can persist longer in urine and in semen. ZIKV infection can have dramatic consequences such as microcephaly and Guillain-Barre syndrome. ZIKV sexual transmission has been documented. A better understanding of ZIKV presence and persistence across biologic compartments is needed to devise rational measures to prevent its transmission.
   Methods: This observational cohort study will recruit non-pregnant participants aged 18 years and above with confirmed ZIKV infection [positive reverse transcriptase-polymerase chain reaction (RT-PCR) test in blood and/or urine]: symptomatic men and women in ZIKV infection acute phase, and their symptomatic or asymptomatic household/sexual infected contacts. Specimens of blood, urine, semen, vaginal secretion/menstrual blood, rectal swab, oral fluids, tears, sweat, urine and breast milk (if applicable) will be collected at pre-established intervals and tested for ZIKV RNA presence by RT-PCR, other co-infection (dengue, Chikungunya, HIV, hepatitis B and C, syphilis), antibody response (including immunoglobulins M and G), plaque reduction neutralization test (if simultaneously positive for ZIKV and dengue), and ZIKV culture and RNA sequencing. Data on socio-demographic characteristics and comorbidities will be collected in parallel. Participants will be followed up for 12 months.
   Discussion: This prolonged longitudinal follow-up of ZIKV infected persons with regular biologic testing and data collection will offer a unique opportunity to investigate the presence and persistence of ZIKV in various biologic compartments, their clinical and immunological correlates as well as the possibility of ZIKV reactivation/reinfection over time. This valuable information will substantially contribute to the body of knowledge on ZIKV infection and serve as a base for the development of more effective recommendation on the prevention of ZIKV transmission.
C1 [Calvet, Guilherme Amaral; Brasil, Patricia] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, RJ, Brazil.
   [Kara, Edna Oliveira; Gaillard, Philippe; Meurant, Robyn; Landoulsi, Sihem; Nicole Broutet, Nathalie Jeanne] WHO, Geneva, Switzerland.
   [Giozza, Silvana Pereira; Benzaken, Adele Schwartz] Minist Hlth Brazil, Secretary Hlth Surveillance, Dept STI AIDS & Viral Hepatitis, Brasilia, DF, Brazil.
   [Aguiar Botto-Menezes, Camila Helena; Guimaraes de lacerda, Marcus Vinicius; Castilho, Marcia da Costa; Benzaken, Adele Schwartz] Trop Med Fdn Doctor Heitor Vieira Dourado FMT HVD, Manaus, Amazonas, Brazil.
   [de Oliveira Franca, Rafael Freitas] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [de Sequeira, Patricia Carvalho; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Flavivirus Lab, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [de Mello, Maeve Brito] Pan Amer Hlth Org, WHO, Dept Communicable Dis & Hlth Anal, Washington, DC USA.
   [Diaz Bermudez, Ximena Pamela] Univ Brasilia, Publ Hlth Dept, Pan Amer Hlth Org, WHO, Brasilia, DF, Brazil.
   [Modjarrad, Kayvon] Walter Reed Army Inst Res, Silver Spring, MD USA.
RP Calvet, GA (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, RJ, Brazil.
EM guilherme.calvet@ini.fiocruz.br
RI Gaillard, Philippe/E-7256-2019; amsalu, ribka/G-8780-2019; Calvet,
   Guilherme/G-6959-2013
OI Calvet, Guilherme/0000-0002-3545-5238; Trautmann,
   Lydie/0000-0002-3012-0009; Thorson, Anna/0000-0002-8703-6561
FU Brazilian Ministry of Health; World Health OrganizationWorld Health
   Organization; UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of
   Research, Development and Research Training in Human Reproduction (HRP)
   from the WHO; Wellcome TrustWellcome Trust; Walter Reed Army Institute
   of Research
FX Funding was provided by the Brazilian Ministry of Health, the World
   Health Organization, the UNDP-UNFPA-UNICEF-WHO-World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP) from the WHO, the Wellcome Trust and Walter Reed Army
   Institute of Research.
CR [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ognjan A, 2002, JAMA-J AM MED ASSOC, V288, P1976
   Pan American Health Organization World Health Organization, 2015, NEUR SYNDR CONG MALF
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Prefeitura do Rio de Janeiro, CLIN FAM NOV RED AT
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   WHO Emergencies, 2016, ZIK SIT REP
   WHO Interim Guidance, 2016, BREASTF CONT ZIK VIR
   WHO Media Center, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, FACT SHEET
NR 35
TC 12
Z9 12
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 22
PY 2018
VL 18
AR 49
DI 10.1186/s12879-018-2965-4
PG 17
WC Infectious Diseases
SC Infectious Diseases
GA FT4GR
UT WOS:000423112300001
PM 29357841
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pliego, EP
   Velazquez-Castro, J
   Eichhorn, MP
   Collar, AF
AF Pliego, Emilene Pliego
   Velazquez-Castro, Jorge
   Eichhorn, Markus P.
   Collar, Andres Fraguela
TI Increased efficiency in the second-hand tire trade provides opportunity
   for dengue control
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE Aedes; Vertical transmission; Diapause; Reservoirs; Transportation;
   Mobility; Metapopulations
ID AEDES-AEGYPTI; VERTICAL TRANSMISSION; ZIKA VIRUS; MOSQUITOS; RISK
AB Dengue fever is increasing in geographical range, spread by invasion of its vector mosquitoes. The trade in second-hand tires has been implicated as a factor in this process because they act as mobile reservoirs of mosquito eggs and larvae. Regional transportation of tires can create linkages between rural areas with dengue and disease-free urban areas, potentially giving rise to outbreaks even in areas with strong local control measures. In this work we sought to model the dynamics of mosquito transportation via the tire trade, in particular to predict its role in causing unexpected dengue outbreaks through vertical transmission of the virus across generations of mosquitoes. We also aimed to identify strategies for regulating the trade in second-hand tires, improving disease control. We created a mathematical model which captures the dynamics of dengue between rural and urban areas, taking into account the movement and storage time of tires, and mosquito diapause. We simulate a series of scenarios in which a mosquito population is introduced to a dengue-free area via movement of tires, either as single or multiple events, increasing the likelihood of a dengue outbreak. A persistent disease state can be induced regardless of whether urban conditions for an outbreak are met, and an existing endemic state can be enhanced by vector input. Finally we assess the potential for regulation of tire processing as a means of reducing the transmission of dengue fever using a specific case study from Puerto Rico. Our work demonstrates the importance of the second-hand tire trade in modulating the spread of dengue fever across regions, in particular its role in introducing dengue to disease-free areas. We propose that reduction of tire storage time and control of their movement can play a crucial role in containing dengue outbreaks. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Pliego, Emilene Pliego; Velazquez-Castro, Jorge; Collar, Andres Fraguela] Benemerita Univ Autonoma Puebla, Fac Ciencias Fis Matemat, Ave San Claudio & 18 Sur, Puebla, Mexico.
   [Eichhorn, Markus P.] Univ Nottingham, Sch Life Sci, Univ Pk, Nottingham NG7 2RD, England.
RP Velazquez-Castro, J (corresponding author), Benemerita Univ Autonoma Puebla, Fac Ciencias Fis Matemat, Ave San Claudio & 18 Sur, Puebla, Mexico.
EM emilene.pliego@alumno.buap.mx; jorge.velazquezcastro@correo.buap.mx;
   markus.eichhorn@nottingham.ac.uk; fraguela@fcfm.buap.mx
RI Eichhorn, Markus/L-5027-2013; Velazquez-Castro, Jorge/A-9348-2016
OI Eichhorn, Markus/0000-0002-3381-0822; Velazquez-Castro,
   Jorge/0000-0002-7176-2008
FU SAL-MCMSC; CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT);
   SEP-PRODEP [DSA/103.5/15/7449]
FX Carlos Castillo-Chavez and Anuj Mubayi made helpful comments on an early
   version of the manuscript. We are grateful for support from the
   SAL-MCMSC to participate in MTBI where part of this work was developed,
   and from CONACyT and SEP-PRODEP Grant DSA/103.5/15/7449 (Mexican
   agencies).
CR A. D. S, 2014, MAN NEUM PUERT RIC
   Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   Belli A, 2015, J MED ENTOMOL, V52, P713, DOI 10.1093/jme/tjv049
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bengis RH, 2004, REV SCI TECH OIE, V23, P497
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brauer F., 2008, MATH EPIDEMIOLOGY MA
   BrisenoGarcia B, 1996, EMERG INFECT DIS, V2, P133, DOI 10.3201/eid0202.960210
   Cantanhede A., 2002, ORGAN PANAM
   Christophers S. S. R., 1960, AEDES AEGYPTI 1 YELL
   Cook G. C., 2008, TROPICAL DIS
   Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6
   Esteva L, 2003, J MATH BIOL, V46, P31, DOI 10.1007/s00285-002-0168-4
   Esteva L, 2000, MATH BIOSCI, V167, P51, DOI 10.1016/S0025-5564(00)00024-9
   Esteva L, 2006, J MATH BIOL, V53, P540, DOI 10.1007/s00285-006-0020-3
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Garcia-Rivera E. J., 2006, DENGUE VIRUS
   GOTELLI NJ, 1995, PRIMER ECOLOGY
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Gunther J, 2007, INTERVIROLOGY, V50, P347, DOI 10.1159/000107272
   Higa Y, 2010, J AM MOSQUITO CONTR, V26, P1, DOI 10.2987/09-5945.1
   Honorio NA, 2006, MEM I OSWALDO CRUZ, V101, P225, DOI 10.1590/S0074-02762006000200017
   Juliano SA, 2007, J AM MOSQUITO CONTR, V23, P265, DOI 10.2987/8756-971X(2007)23[265:PD]2.0.CO;2
   Kouri G, 1998, EMERG INFECT DIS, V4, P89
   LEVIN SA, 2009, PRINCETON GUIDE ECOL
   LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237
   Loreau M, 2010, MONOGRAPHS POPULATIO
   MacArthur R. H., 2016, THEORY ISLAND BIOGEO
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Murillo D., 2014, BIOL LETT, V1, P249, DOI DOI 10.1080/23737867.2014.11414484
   Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Thompson RCA, 2000, INT J PARASITOL, V30, P1259, DOI 10.1016/S0020-7519(00)00127-2
   World Health Organization, 2014, STAT ART PREV CONTR
   World Health Organization, 2009, RES DIS POV
   Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2
NR 42
TC 3
Z9 3
U1 0
U2 17
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD JAN 21
PY 2018
VL 437
BP 126
EP 136
DI 10.1016/j.jtbi.2017.10.025
PG 11
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA FO9RG
UT WOS:000417228400014
PM 29079324
DA 2020-07-08
ER

PT J
AU Mesci, P
   Macia, A
   Moore, SM
   Shiryaev, SA
   Pinto, A
   Huang, CT
   Tejwani, L
   Fernandes, IR
   Suarez, NA
   Kolar, MJ
   Montefusco, S
   Rosenberg, SC
   Herai, RH
   Cugola, FR
   Russo, FB
   Sheets, N
   Saghatelian, A
   Shresta, S
   Momper, JD
   Neto, JLS
   Corbett, KD
   Beltrao-Braga, PCB
   Terskikh, AV
   Muotri, AR
AF Mesci, Pinar
   Macia, Angela
   Moore, Spencer M.
   Shiryaev, Sergey A.
   Pinto, Antonella
   Huang, Chun-Teng
   Tejwani, Leon
   Fernandes, Isabella R.
   Suarez, Nicole A.
   Kolar, Matthew J.
   Montefusco, Sandro
   Rosenberg, Scott C.
   Herai, Roberto H.
   Cugola, Fernanda R.
   Russo, Fabiele B.
   Sheets, Nicholas
   Saghatelian, Alan
   Shresta, Sujan
   Momper, Jeremiah D.
   Siqueira-Neto, Jair L.
   Corbett, Kevin D.
   Beltrao-Braga, Patricia C. B.
   Terskikh, Alexey V.
   Muotri, Alysson R.
TI Blocking Zika virus vertical transmission
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HEPATITIS-C-VIRUS; MULTIPLE SEQUENCE ALIGNMENT; SOFOSBUVIR; MODEL;
   BIRTH; RISK; INHIBITORS; INFECTION; PREGNANCY; INFANTS
AB The outbreak of the Zika virus (ZIKV) has been associated with increased incidence of congenital malformations. Although recent efforts have focused on vaccine development, treatments for infected individuals are needed urgently. Sofosbuvir (SOF), an FDA-approved nucleotide analog inhibitor of the Hepatitis C (HCV) RNA-dependent RNA polymerase (RdRp) was recently shown to be protective against ZIKV both in vitro and in vivo. Here, we show that SOF protected human neural progenitor cells (NPC) and 3D neurospheres from ZIKV infection-mediated cell death and importantly restored the antiviral immune response in NPCs. In vivo, SOF treatment post-infection (p.i.) decreased viral burden in an immunodeficient mouse model. Finally, we show for the first time that acute SOF treatment of pregnant dams p.i. was well-tolerated and prevented vertical transmission of the virus to the fetus. Taken together, our data confirmed SOF-mediated sparing of human neural cell types from ZIKV-mediated cell death in vitro and reduced viral burden in vivo in animal models of chronic infection and vertical transmission, strengthening the growing body of evidence for SOF anti-ZIKV activity.
C1 [Mesci, Pinar; Macia, Angela; Moore, Spencer M.; Tejwani, Leon; Fernandes, Isabella R.; Suarez, Nicole A.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Dept Cellular & Mol Med,Dept Pediat,Stem Cell Pro, La Jolla, CA 92037 USA.
   [Shiryaev, Sergey A.; Pinto, Antonella; Huang, Chun-Teng; Terskikh, Alexey V.] Sanford Burnham Prebys Med Discovery Inst, 10901N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Kolar, Matthew J.; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Montefusco, Sandro; Siqueira-Neto, Jair L.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Ctr Discovery & Innovat Parasit Dis, 9500 Gilman Dr,MC 0755, La Jolla, CA 92093 USA.
   [Rosenberg, Scott C.; Corbett, Kevin D.] Ludwig Inst Canc Res, San Diego Branch, 9500 Gilman Dr,MC 2385, La Jolla, CA 92093 USA.
   [Rosenberg, Scott C.] Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr,MC 2385, La Jolla, CA 92093 USA.
   [Herai, Roberto H.] Pontificia Univ Catolica Parana PUCPR, Sch Med, Grad Program Hlth Sci, Curitiba, Parana, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Stem Cell & Dis Modeling, BR-05508000 Sao Paulo, SP, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, SP, Brazil.
   [Sheets, Nicholas; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Momper, Jeremiah D.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
RP Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Dept Cellular & Mol Med,Dept Pediat,Stem Cell Pro, La Jolla, CA 92037 USA.; Terskikh, AV (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901N Torrey Pines Rd, La Jolla, CA 92037 USA.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Stem Cell & Dis Modeling, BR-05508000 Sao Paulo, SP, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br; terskikh@sbpdiscovery.org; muotri@ucsd.edu
RI Siqueira-Neto, Jair L/D-6040-2012; Beltrao-Braga, Patricia C
   B/D-6450-2013; Terskikh, Alexey/U-8407-2019
OI Siqueira-Neto, Jair L/0000-0001-9574-8174; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; Kolar, Matthew/0000-0001-8054-9121; Mesci,
   Pinar/0000-0003-3402-5671; Corbett, Kevin/0000-0001-5854-2388; herai,
   roberto/0000-0001-9885-2735; Moore, Spencer/0000-0001-9811-9007; Macia
   Ortega, Angela/0000-0001-8735-0916
FU California Institute for Regenerative MedicineCalifornia Institute for
   Regenerative Medicine [DISC2-09649]; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [U19MH107367]; NGO "The tooth fairy project"; NARSAD
   Independent Investigator GrantNARSAD; International Rett syndrome
   foundation (IRSF) mentored training fellowship; NARSAD Young
   Investigator GrantNARSAD; Autism Science Foundation; Rett Syndrome
   Research Trust (RSRT); Ludwig Institute for Cancer Research;  [F30
   DK112604]
FX This work was supported by grants from the California Institute for
   Regenerative Medicine (DISC2-09649), the National Institutes of Health
   through the U19MH107367, the NGO "The tooth fairy project", and an
   NARSAD Independent Investigator Grant to A.R.M. M.J.K. is funded by F30
   DK112604 grant. Dr. Mesci has an International Rett syndrome foundation
   (IRSF) mentored training fellowship. Dr. Macia has an NARSAD Young
   Investigator Grant and Spencer M. Moore is supported by a grant from the
   Autism Science Foundation and Rett Syndrome Research Trust (RSRT).
   K.D.C. acknowledges support from the Ludwig Institute for Cancer
   Research. We thank Mary Braxtan, Buddy Charbono, Francisco Beltran,
   Hilda Clarke and the SBP Animal Facility Core for their help with animal
   experiments. We also like to thank E. Durigon and his group for the
   ZKV2015 aliquots, and P. Vasconcelos for providing a lyophilized ZKV2015
   seed. Dr. Mesci and Dr. Macia drew the mouse schematics in the
   manuscript.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Balakrishnan A., 2013, GENOME ANNOUNC, V1, P4
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bhatia HK, 2014, J PHARMACOL PHARMACO, V5, P278, DOI 10.4103/0976-500X.142464
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G., 2016, LANCET INFE IN PRESS, V3099
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Chailangkarn T, 2016, NATURE, V536, P338, DOI 10.1038/nature19067
   Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439
   Cugola FR, 2016, NATURE, P1
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Elfiky AA, 2013, PROTEIN J, V32, P75, DOI 10.1007/s10930-013-9462-9
   Ellis C., 2013, PHARM REV S
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gentile I, 2015, EXPERT OPIN DRUG DIS, V10, P1363, DOI 10.1517/17460441.2015.1094051
   Gilead Sciences I., 2013, HIGHL PRESCR INF
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Jackowiak P, 2014, INFECT GENET EVOL, V21, P67, DOI 10.1016/j.meegid.2013.10.021
   KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   LINDENBACH BD, 2007, FIELDS VIROLOGY
   Lu L, 2007, J GEN VIROL, V88, P1519, DOI 10.1099/vir.0.82820-0
   Mandelbrot L, 2015, CLIN INFECT DIS, V61, P1715, DOI 10.1093/cid/civ578
   Marchetto M. C, 2016, MOL PSYCHIAT
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mesci P., 2017, HUM MOL GENET
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pasternak B, 2010, JAMA-J AM MED ASSOC, V304, P859, DOI 10.1001/jama.2010.1206
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Retallack H., 2016, P NATL ACAD SCI USA, V113
   Rezk MR, 2015, J PHARMACEUT BIOMED, V114, P97, DOI 10.1016/j.jpba.2015.05.006
   Reznik S. E., 2016, J INFECT DIS, V55
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Singha H, 2013, ARCH VIROL, V158, P113, DOI 10.1007/s00705-012-1474-9
   Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Toussaint-Miller KA, 2015, ANN PHARMACOTHER, V49, P1015, DOI 10.1177/1060028015592015
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu D, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001628
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J., 2016, ANTIVIRAL R IN PRESS, V55
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 73
TC 19
Z9 20
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 19
PY 2018
VL 8
AR 1218
DI 10.1038/s41598-018-19526-4
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT1JJ
UT WOS:000422891000048
PM 29352135
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Britch, SC
   Linthicum, KJ
   Aldridge, RL
   Breidenbaugh, MS
   Latham, MD
   Connelly, PH
   Rush, MJE
   Remmers, JL
   Kerce, JD
   Silcox, CA
AF Britch, Seth C.
   Linthicum, Kenneth J.
   Aldridge, Robert L.
   Breidenbaugh, Mark S.
   Latham, Mark D.
   Connelly, Peter H.
   Rush, Mattie J. E.
   Remmers, Jennifer L.
   Kerce, Jerry D.
   Silcox, Charles A.
CA US Navy Entomology Ctr Ex
TI Aerial ULV control of Aedes aegypti with naled (Dibrom) inside simulated
   rural village and urban cryptic habitats
SO PLOS ONE
LA English
DT Article
ID LOW-VOLUME APPLICATIONS; MOSQUITO-CONTROL; THERMAL FOG; ZIKA VIRUS;
   INSECTICIDE; THAILAND; DIPTERA; DENGUE; TRANSMISSION; PERFORMANCE
AB We conducted aerial fixed wing ultra low volume (ULV) spray trials with naled to investigate penetration of exposed and simulated cryptic habitat within opened buildings, partially sealed buildings, and outdoor locations targeting sentinel adult Aedes aegypti mosquitoes in north central Florida. Mortality was observed in open and closed buildings and outdoors, even in mosquitoes placed in cryptic habitats. Observations on the impact of building type, mosquito exposure method such as placement in cryptic habitat, and spray nozzle size on mosquito mortality are described and analyzed.
C1 [Britch, Seth C.; Linthicum, Kenneth J.; Aldridge, Robert L.; Rush, Mattie J. E.] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
   [Breidenbaugh, Mark S.; Remmers, Jennifer L.] Youngstown Air Reserve Stn, Aerial Spray Branch, 910 Airlift Wing,757 Airlift Squadron, Vienna, OH USA.
   [Latham, Mark D.] Manatee Cty Mosquito Control Dist, West Palmetto, FL USA.
   [Connelly, Peter H.; Silcox, Charles A.] AMVAC Environm Prod, Newport Beach, CA USA.
   [Kerce, Jerry D.] Camp Blanding Joint Training Ctr, Starke, FL USA.
   [US Navy Entomology Ctr Ex] US Navy, Entomol Ctr Excellence, Naval Air Stn, Jacksonville, FL USA.
RP Britch, SC (corresponding author), ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
EM seth.britch@ars.usda.gov
RI Aldridge, Robert L./J-9828-2019
OI Aldridge, Robert L./0000-0001-7656-365X
FU US Department of Agriculture, Agricultural Research ServiceUnited States
   Department of Agriculture (USDA) [NP-104, 6036-32000-050-00D];
   Department of Defense Deployed Warfighter Protection Program Project
   [6036-32000-050-671]; US Department of Defense (DOD) Deployed
   War-Fighter Protection Program (DWFP)
FX Funding from the US Department of Agriculture, Agricultural Research
   Service NP-104, Project 6036-32000-050-00D and the Department of Defense
   Deployed Warfighter Protection Program Project 6036-32000-050-671. AMVAC
   Environmental Products provided support in the form of salaries for
   authors (PHC and CAS) and provided Dibrom. The specific roles of these
   authors are articulated in the "author contributions" section. The
   funders did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; The membership of the US Navy Entomology Center of
   Excellence Team was (alphabetically) Hanayo Arimoto, Christopher
   Dooling, Carl Doud, Kevin Justice, Jennifer Knapp, Marcus McDonough,
   Peter Nunn, Dominick Spatola, Paulo Torresalvarado, Brent Turnwall,
   Matthew Yans. We thank Bryan Smith and Christopher Swain
   (USDA-ARS-CMAVE) for expert production of insectary specimens for this
   study. This research was supported by the US Department of Agriculture
   (USDA)-Agricultural Research Service and the US Department of Defense
   (DOD) Deployed War-Fighter Protection Program (DWFP). Mention of trade
   names or commercial products in this publication is solely for the
   purpose of providing specific information and does not imply
   recommendation or endorsement by the USDA, the DOD, the US Navy, the US
   Air Force, the Florida Army National Guard, or the DWFP. The USDA is an
   equal opportunity provider and employer.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   AFREHNUAMAH K, 1988, INSECT SCI APPL, V9, P629, DOI 10.1017/S1742758400005129
   Aldridge RL, 2012, J AM MOSQUITO CONTR, V28, P65, DOI 10.2987/11-6195.1
   Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724
   BILANIN AJ, 1989, T ASAE, V32, P327
   Bonds JAS, 2009, J AM MOSQUITO CONTR, V25, P474, DOI 10.2987/09-5882.1
   Breidenbaugh M, 2009, ARMY MED DEP J   JUL, P1
   Britch SC, 2011, J MED ENTOMOL, V48, P1145, DOI 10.1603/ME11025
   Britch SC, 2010, J AM MOSQUITO CONTR, V26, P183, DOI 10.2987/09-5948.1
   Burkett DA, 1996, J AM MOSQUITO CONTR, V12, P380
   Chaskopoulou A, 2011, J AM MOSQUITO CONTR, V27, P414, DOI 10.2987/11-6177.1
   Chen Y. S., 1984, Journal of the Florida Anti-Mosquito Association, V55, P46
   Clark G. G., 1989, Arbovirus research in Australia. Proceedings Fifth Symposium, August 28-September 1, 1989, Brisbane, Australia., P192
   Conlon J. M., 1990, Journal of the Florida Anti-Mosquito Association, V61, P19
   Cooper JF, 1996, CROP PROT, V15, P249, DOI 10.1016/0261-2194(95)00113-1
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Farooq M, 2013, J AM MOSQUITO CONTR, V29, P389, DOI 10.2987/13-6333.1
   Fritz BK, 2008, AGRICULTURAL ENGINEE
   FUKUTO T. R., 1971, Pesticides in the environment. Volume 1, Part I., V1, P145
   GRATZ NG, 1991, J AM MOSQUITO CONTR, V7, P353
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hudson J E, 1986, Bull Pan Am Health Organ, V20, P294
   Jokanovic M, 2001, TOXICOLOGY, V166, P139, DOI 10.1016/S0300-483X(01)00463-2
   Koenraadt CJM, 2007, J MED ENTOMOL, V44, P65, DOI 10.1603/0022-2585(2007)44[65:SATPIT]2.0.CO;2
   Kramer LD, 2017, INNOVATIVE APPROACH
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   LOFGREN CS, 1970, B WORLD HEALTH ORGAN, V42, P15
   Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745
   Matthews G. A., 1996, Pesticide Outlook, V7, P24
   Merk W., 1971, WHOVBC71317
   Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601
   NEWHART K, 2006, ENV FATE MALATHION
   Phanthumachinda B, 1976, WHOVBC76651117
   Ponlawat A, 2017, J AM MOSQUITO CONTR, V33, P116, DOI 10.2987/16-6594.1
   Reiter P., 1992, Journal of the American Mosquito Control Association, V8, P315
   Reiter P, 1989, ARB RES AUSTR P 5 S, P192
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   SUNDARAM A, 1991, J ENVIRON SCI HEAL B, V26, P115, DOI 10.1080/03601239109372727
   Teske ME, 1999, ASAE CSAE SCGR ANN I
   Travis BV, 1968, P 55 ANN M NEW JERS, V55, P122
   United States of America Department of Health and Human Services Centers for Disease Control and Prevention, 1987, EFF AER APPL DIBR 14
   WHO Pesticide Evaluation Scheme (WHOPES) Communicable Disease Control Prevention and Eradication, 2003, SPAC SPRAY APPL INS
   Wooster M. T., 1989, Journal of the Florida Anti-Mosquito Association, V60, P62
NR 44
TC 3
Z9 3
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 19
PY 2018
VL 13
IS 1
AR e0191555
DI 10.1371/journal.pone.0191555
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT1QM
UT WOS:000422911300113
PM 29352307
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Singh, RK
   Dhama, K
   Karthik, K
   Tiwari, R
   Khandia, R
   Munjal, A
   Iqbal, HMN
   Malik, YS
   Bueno-Mari, R
AF Singh, Raj K.
   Dhama, Kuldeep
   Karthik, Kumaragurubaran
   Tiwari, Ruchi
   Khandia, Rekha
   Munjal, Ashok
   Iqbal, Hafiz M. N.
   Malik, Yashpal S.
   Bueno-Mari, Ruben
TI Advances in Diagnosis, Surveillance, and Monitoring of Zika Virus: An
   Update
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Zika virus; Zika fever; diagnosis; surveillance; monitoring
ID LINKED IMMUNOSORBENT ASSAYS; WHOLE-BLOOD SPECIMENS; NEUROIMAGING
   FINDINGS; MOLECULAR DIAGNOSIS; PROLONGED DETECTION; DENGUE VIRUSES; RNA
   DETECTION; 1ST REPORT; RT-PCR; INFECTION
AB Zika virus (ZIKV) is associated with numerous human health-related disorders, including fetal microcephaly, neurological signs, and autoimmune disorders such as Guillain-Barre syndrome (GBS). Perceiving the ZIKA associated losses, in 2016, the World Health Organization (WHO) declared it as a global public health emergency. In consequence, an upsurge in the research on ZIKV was seen around the globe, with significant attainments over developing several effective diagnostics, drugs, therapies, and vaccines countering this life-threatening virus at an early step. State-of-art tools developed led the researchers to explore virus at the molecular level, and in-depth epidemiological investigations to understand the reason for increased pathogenicity and different clinical manifestations. These days, ZIKV infection is diagnosed based on clinical manifestations, along with serological and molecular detection tools. As, isolation of ZIKV is a tedious task; molecular assays such as reverse transcription-polymerase chain reaction (RT-PCR), real-time qRT-PCR, loop-mediated isothermal amplification (LAMP), lateral flow assays (LFAs), biosensors, nucleic acid sequence-based amplification (NASBA) tests, strand invasion-based amplification tests and immune assays like enzyme-linked immunosorbent assay (ELISA) are in-use to ascertain the ZIKV infection or Zika fever. Herein, this review highlights the recent advances in the diagnosis, surveillance, and monitoring of ZIKV. These new insights gained from the recent advances can aid in the rapid and definitive detection of this virus and/or Zika fever. The summarized information will aid the strategies to design and adopt effective prevention and control strategies to counter this viral pathogen of great public health concern.
C1 [Singh, Raj K.] Indian Vet Res Inst, ICAR, Bareilly, Uttar Pradesh, India.
   [Dhama, Kuldeep] Indian Vet Res Inst, ICAR, Div Pathol, Bareilly, Uttar Pradesh, India.
   [Karthik, Kumaragurubaran] Tamil Nadu Vet & Anim Sci Univ, Cent Univ Lab, Chennai, Tamil Nadu, India.
   [Tiwari, Ruchi] UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vig, Coll Vet Sci, Dept Vet Microbiol & Immunol, Mathura, India.
   [Khandia, Rekha; Munjal, Ashok] Barkatullah Univ, Dept Biochem & Genet, Bhopal, India.
   [Iqbal, Hafiz M. N.] Tecnol Monterrey, Sch Engn & Sci, Monterrey, Mexico.
   [Malik, Yashpal S.] Indian Vet Res Inst, ICAR, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.
   [Bueno-Mari, Ruben] Dept Invest & Desarrollo I D, Labs Lokim, Valencia, Spain.
RP Singh, RK (corresponding author), Indian Vet Res Inst, ICAR, Bareilly, Uttar Pradesh, India.; Dhama, K (corresponding author), Indian Vet Res Inst, ICAR, Div Pathol, Bareilly, Uttar Pradesh, India.
EM rks_virology@rediffmail.com; kdhama@rediffmail.com
RI Dhama, Kuldeep/B-7852-2015; Malik, Yashpal Singh/AAI-2259-2019; Iqbal,
   Hafiz M.N./J-5423-2014
OI Dhama, Kuldeep/0000-0001-7469-4752; Iqbal, Hafiz
   M.N./0000-0003-4855-2720
CR Abd El Wahed Ahmed, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.a7f1db2c7d66c3fc0ea0a774305d319e
   Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Adegoke O, 2017, BIOSENS BIOELECTRON, V94, P513, DOI 10.1016/j.bios.2017.03.046
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Araujo E, 2017, CURR OPIN OBSTET GYN, V29, P95, DOI 10.1097/GCO.0000000000000345
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Basile AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075670
   Bedin F, 2017, J MED VIROL, V89, P1520, DOI 10.1002/jmv.24806
   Bergquist R, 2011, MEM I OSWALDO CRUZ, V106, P892, DOI 10.1590/S0074-02762011000700016
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Brault AC, 2016, AM J TROP MED HYG, V94, P1187, DOI 10.4269/ajtmh.16-0277
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chan JF, 2016, EMERG MICROBES INFEC, V5
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Cordeiro M. T., 2017, ZIKA IN FOCUS, P9
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dhama Kuldeep, 2014, Pak J Biol Sci, V17, P151, DOI 10.3923/pjbs.2014.151.166
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Frankel MB, 2017, J VIROL METHODS, V246, P117, DOI 10.1016/j.jviromet.2017.05.002
   Fung Isaac Chun-Hai, 2017, Disaster Med Public Health Prep, V11, P656, DOI 10.1017/dmp.2017.23
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gu SH, 2017, VIRUS GENES, V53, P918, DOI 10.1007/s11262-017-1500-9
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hancock WT, 2017, MMWR-MORBID MORTAL W, V66, P299, DOI 10.15585/mmwr.mm6611a5
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jacob JA, 2016, JAMA-J AM MED ASSOC, V315, P1097, DOI 10.1001/jama.2016.1219
   Jiang QS, 2017, ADV BIOSYST, V1, DOI 10.1002/adbi.201700096
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Karthik K, 2014, METHODSX, V1, P137, DOI 10.1016/j.mex.2014.08.009
   Kawadkar J, 2011, J PHARM CLIN RES, V4, P23
   Kelvin AA, 2016, J INFECT DEV COUNTR, V10, P113, DOI 10.3855/jidc.8248
   Khandia R, 2017, INT J PHARMACOL, V13, P370, DOI 10.3923/ijp.2017.370.377
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kruger RP, 2016, CELL, V164, P585, DOI 10.1016/j.cell.2016.01.040
   Kuldeep Dhama, 2013, Advances in Animal and Veterinary Sciences, V1, P14
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lamb LE, 2016, INT UROL NEPHROL, V48, P1961, DOI 10.1007/s11255-016-1406-9
   Lambe U, 2016, J EXP BIOL AGRIC SCI, V4, P307, DOI 10.18006/2016.4(3S).307.320
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miller E, 2017, J NEUROL SCI, V375, P367, DOI 10.1016/j.jns.2017.02.029
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONATH TP, 1980, AM J TROP MED HYG, V29, P624, DOI 10.4269/ajtmh.1980.29.624
   Morrissey J., 2017, ADV PHOTONICS 2017 I
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Munjal A, 2017, INT J PHARMACOL, V13, P667, DOI 10.3923/ijp.2017.667.676
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, EUROSURVEILLANCE, V19, P14, DOI DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Nikolay A, 2018, VACCINE, V36, P3140, DOI 10.1016/j.vaccine.2017.03.018
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   NOVOTNY J, 1992, ACTA VIROL, V36, P483
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Pessoa R, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.30.30302
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Pyzocha NJ, 2017, CURR SPORT MED REP, V16, P109, DOI 10.1249/JSR.0000000000000346
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rafiei N, 2016, MED J AUSTRALIA, V204, P186, DOI 10.5694/mja15.01275
   Ratcliff RM, 2007, CURR ISSUES MOL BIOL, V9, P87
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V18, P57, DOI 10.1016/j.tmaid.2017.05.004
   Rodriguez-Morales AJ, 2017, INFECTION, V45, P93, DOI 10.1007/s15010-016-0948-1
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Sakudo A, 2016, MOL MED REP, V14, P697, DOI 10.3892/mmr.2016.5330
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Saraswati TE, 2012, CARBON, V50, P1253, DOI 10.1016/j.carbon.2011.10.044
   Shadgan B, 2016, CURR SPORT MED REP, V15, P298, DOI 10.1249/JSR.0000000000000278
   Shan C., 2017, J CLIN MICROBIOL, DOI [10.1128/JCM.00975-17, DOI 10.1128/JCM.00975-17]
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Singh R.K., 2015, CURRENT TRENDS FUTUR, P1, DOI DOI 10.2118/175057-MS
   Singh RK, 2017, VET QUART, V37, P98, DOI 10.1080/01652176.2017.1309474
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Sumita LM, 2016, REV INST MED TROP SP, V58, DOI [10.1590/s1678-9946201658089, 10.1590/S1678-9946201658089]
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Troncoso A, 2016, ASIAN PAC J TROP BIO, V6, P520, DOI 10.1016/j.apjtb.2016.04.004
   van den Hurk R, 2015, SENSORS-BASEL, V15, P14045, DOI 10.3390/s150614045
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilson HL, 2017, J CLIN MICROBIOL, V55, P3104, DOI [10.1128/JCM.00673-17, 10.1128/jcm.00673-17]
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Yadav S, 2016, J TRANSL INTERN MED, V4, P42, DOI 10.1515/jtim-2016-0009
   Yang Y, 2017, VIROL SIN, V32, P199, DOI 10.1007/s12250-017-3958-y
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Zaghloul H, 2014, WORLD J HEPATOL, V6, P916, DOI 10.4254/wjh.v6.i12.916
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zaytseva NV, 2004, ANAL BIOANAL CHEM, V380, P46, DOI 10.1007/s00216-004-2724-9
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 158
TC 19
Z9 20
U1 5
U2 24
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 19
PY 2018
VL 8
AR UNSP 2677
DI 10.3389/fmicb.2017.02677
PG 17
WC Microbiology
SC Microbiology
GA FT2EB
UT WOS:000422951500001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hirsch, AJ
   Roberts, VHJ
   Grigsby, PL
   Haese, N
   Schabel, MC
   Wang, XJ
   Lo, JO
   Liu, Z
   Kroenke, CD
   Smith, JL
   Kelleher, M
   Broeckel, R
   Kreklywich, CN
   Parkins, CJ
   Denton, M
   Smith, P
   DeFilippis, V
   Messer, W
   Nelson, JA
   Hennebold, JD
   Grafe, M
   Colgin, L
   Lewis, A
   Ducore, R
   Swanson, T
   Legasse, AW
   Axthelm, MK
   MacAllister, R
   Moses, AV
   Morgan, TK
   Frias, AE
   Streblow, DN
AF Hirsch, Alec J.
   Roberts, Victoria H. J.
   Grigsby, Peta L.
   Haese, Nicole
   Schabel, Matthias C.
   Wang, Xiaojie
   Lo, Jamie O.
   Liu, Zheng
   Kroenke, Christopher D.
   Smith, Jessica L.
   Kelleher, Meredith
   Broeckel, Rebecca
   Kreklywich, Craig N.
   Parkins, Christopher J.
   Denton, Michael
   Smith, Patricia
   DeFilippis, Victor
   Messer, William
   Nelson, Jay A.
   Hennebold, Jon D.
   Grafe, Marjorie
   Colgin, Lois
   Lewis, Anne
   Ducore, Rebecca
   Swanson, Tonya
   Legasse, Alfred W.
   Axthelm, Michael K.
   MacAllister, Rhonda
   Moses, Ashlee V.
   Morgan, Terry K.
   Frias, Antonio E.
   Streblow, Daniel N.
TI Zika virus infection in pregnant rhesus macaques causes placental
   dysfunction and immunopathology
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; NONHUMAN PRIMATE; BLOOD-FLOW; SEXUAL
   TRANSMISSION; MODEL; CELLS; ASTROCYTES; UPDATE; GROWTH; BRAZIL
AB Zika virus (ZIKV) infection during pregnancy leads to an increased risk of fetal growth restriction and fetal central nervous system malformations, which are outcomes broadly referred to as the Congenital Zika Syndrome (CZS). Here we infect pregnant rhesus macaques and investigate the impact of persistent ZIKV infection on uteroplacental pathology, blood flow, and fetal growth and development. Despite seemingly normal fetal growth and persistent fetal-placenta-maternal infection, advanced non-invasive in vivo imaging studies reveal dramatic effects on placental oxygen reserve accompanied by significantly decreased oxygen permeability of the placental villi. The observation of abnormal oxygen transport within the placenta appears to be a consequence of uterine vasculitis and placental villous damage in ZIKV cases. In addition, we demonstrate a robust maternal-placental-fetal inflammatory response following ZIKV infection. This animal model reveals a potential relationship between ZIKV infection and uteroplacental pathology that appears to affect oxygen delivery to the fetus during development.
C1 [Hirsch, Alec J.; Haese, Nicole; Kreklywich, Craig N.; Parkins, Christopher J.; Denton, Michael; Smith, Patricia; DeFilippis, Victor; Nelson, Jay A.; Moses, Ashlee V.; Streblow, Daniel N.] Oregon Hlth & Sci Univ, Vaccine & Gene Inst, 505 NW 185th Ave, Beaverton, OR 97006 USA.
   [Hirsch, Alec J.; Haese, Nicole; Smith, Jessica L.; Broeckel, Rebecca; Kreklywich, Craig N.; DeFilippis, Victor; Nelson, Jay A.; Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Moses, Ashlee V.; Streblow, Daniel N.] ONPRC, Div Pathobiol & Immunol, 505 NW 185th Ave, Beaverton, OR 97006 USA.
   [Roberts, Victoria H. J.; Grigsby, Peta L.; Kelleher, Meredith; Hennebold, Jon D.; Frias, Antonio E.] ONPRC, Div Reprod & Dev Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.
   [Grigsby, Peta L.; Lo, Jamie O.; Hennebold, Jon D.; Morgan, Terry K.; Frias, Antonio E.] OHSU, Dept Obstet & Gynecol, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Schabel, Matthias C.; Wang, Xiaojie; Liu, Zheng; Kroenke, Christopher D.] OHSU, Adv Imaging Res Ctr, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Schabel, Matthias C.] Univ Utah, Dept Radiol, Utah Ctr Adv Imaging Res, 201 Presidents Circle, Salt Lake City, UT 84112 USA.
   [Messer, William] OHSU, Dept Mol Microbiol & Immunol, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Messer, William] OHSU, Div Infect Dis, Dept Med, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Grafe, Marjorie] OHSU, Neuropathol, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Colgin, Lois; Lewis, Anne; Ducore, Rebecca] ONPRC, Div Comparat Med, Pathol Serv Unit, 505 NW 185th Ave, Beaverton, OR 97006 USA.
   [MacAllister, Rhonda] ONPRC, Div Comparat Med, Clin Serv Unit, 505 NW 185th Ave, Beaverton, OR 97006 USA.
   [Morgan, Terry K.] OHSU, Dept Pathol, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.
RP Hirsch, AJ; Streblow, DN (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Inst, 505 NW 185th Ave, Beaverton, OR 97006 USA.; Hirsch, AJ; Streblow, DN (corresponding author), ONPRC, Div Pathobiol & Immunol, 505 NW 185th Ave, Beaverton, OR 97006 USA.; Frias, AE (corresponding author), ONPRC, Div Reprod & Dev Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.; Frias, AE (corresponding author), OHSU, Dept Obstet & Gynecol, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.
EM hirschal@ohsu.edu; friasa@ohsu.edu; streblow@ohsu.edu
RI Schabel, Matthias C./H-4647-2019; Haese, Nicole/AAN-4551-2020; Kelleher,
   Meredith Anne/L-2317-2019
OI Kelleher, Meredith Anne/0000-0002-5313-004X; Hennebold,
   Jon/0000-0002-6760-3733
FU Oregon National Primate Research Center (ONPRC) [P51 OD011092];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA;  [R21-HD091032];  [R01-HD086331]
FX The work presented in this manuscript was supported by the Oregon
   National Primate Research Center (ONPRC) P51 OD011092 NIH Core Grant as
   well as R21-HD091032 (D.N.S.) and R01-HD086331 (A.E.F.). Veterinarian
   and husbandry staff at the ONPRC provided excellent care for the animals
   used in this study. We thank Jessica Gaffney for technical assistance on
   this project.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Acharya G, 2007, ULTRASOUND OBST GYN, V29, P401, DOI 10.1002/uog.3977
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Arraut AME, 2013, REPROD SCI, V20, P33, DOI 10.1177/1933719112459224
   BENIRSCHKE K, 1983, J EXP ZOOL, V228, P385, DOI 10.1002/jez.1402280221
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Carlson J, 2007, AM J DERMATOPATH, V29, P32, DOI 10.1097/01.dad.0000245198.80847.ff
   Chavez-Galan L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00263
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2167
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferrazzi E, 2000, ULTRASOUND OBST GYN, V16, P432, DOI 10.1046/j.1469-0705.2000.00208.x
   Frias AE, 2015, MAGN RESON MED, V73, P1570, DOI 10.1002/mrm.25264
   Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hashima JN, 2010, REPROD SCI, V17, P760, DOI 10.1177/1933719110370490
   Hayward CE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00028
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kiserud T, 2000, AM J OBSTET GYNECOL, V182, P147, DOI 10.1016/S0002-9378(00)70504-7
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lo JO, 2018, REPROD SCI, V25, P64, DOI 10.1177/1933719117699704
   Lo JO, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.042
   LUSTER AD, 1987, MOL CELL BIOL, V7, P3723, DOI 10.1128/MCB.7.10.3723
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messaoudi I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002343
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morgan TK, 2016, AM J PERINAT, V33, P258, DOI 10.1055/s-0035-1570379
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nazar ASMI, 1997, J NEUROIMMUNOL, V77, P116, DOI 10.1016/S0165-5728(97)00070-2
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   NYLAND TG, 1984, J CLIN ULTRASOUND, V12, P387, DOI 10.1002/jcu.1870120703
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Osuna CE, 2017, NAT MED, V23, P264, DOI 10.1038/nm0217-264b
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Perret C, 2005, J INFECTION, V51, P287, DOI 10.1016/j.jinf.2004.10.003
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roberts VHJ, 2012, PLACENTA, V33, P73, DOI 10.1016/j.placenta.2011.10.003
   Roberts VHJ, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.001
   Roberts VHJ, 2014, FASEB J, V28, P2466, DOI 10.1096/fj.13-245472
   Schabel MC, 2016, MAGN RESON MED, V76, P1551, DOI 10.1002/mrm.26052
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tarantal Alice F., 2005, P317, DOI 10.1016/B978-012080261-6/50020-9
   VANGURI P, 1994, J IMMUNOL, V152, P1411
   VANGURI P, 1995, J NEUROIMMUNOL, V56, P35, DOI 10.1016/0165-5728(94)00131-7
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang XJ, 2017, J NEUROSCI, V37, P1971, DOI 10.1523/JNEUROSCI.3157-16.2017
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
NR 68
TC 59
Z9 61
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 17
PY 2018
VL 9
AR 263
DI 10.1038/s41467-017-02499-9
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS8HD
UT WOS:000422650500014
PM 29343712
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, L
   Wu, JT
AF Wang, Lin
   Wu, Joseph T.
TI Characterizing the dynamics underlying global spread of epidemics
SO NATURE COMMUNICATIONS
LA English
DT Article
ID EBOLA-VIRUS DISEASE; INTERNATIONAL SPREAD; ZIKA VIRUS; TRANSMISSION;
   LIBERIA; NETWORK; COMPLEX; MODELS; COUNTY; IMPACT
AB Over the past few decades, global metapopulation epidemic simulations built with worldwide air-transportation data have been the main tool for studying how epidemics spread from the origin to other parts of the world (e.g., for pandemic influenza, SARS, and Ebola). However, it remains unclear how disease epidemiology and the air-transportation network structure determine epidemic arrivals for different populations around the globe. Here, we fill this knowledge gap by developing and validating an analytical framework that requires only basic analytics from stochastic processes. We apply this framework retrospectively to the 2009 influenza pandemic and 2014 Ebola epidemic to show that key epidemic parameters could be robustly estimated in real-time from public data on local and global spread at very low computational cost. Our framework not only elucidates the dynamics underlying global spread of epidemics but also advances our capability in nowcasting and forecasting epidemics.
C1 [Wang, Lin; Wu, Joseph T.] Univ Hong Kong, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Li Ka Shing Fac Med, 7 Sassoon Rd, Pokfulam 999077, Hong Kong, Peoples R China.
RP Wu, JT (corresponding author), Univ Hong Kong, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Li Ka Shing Fac Med, 7 Sassoon Rd, Pokfulam 999077, Hong Kong, Peoples R China.
EM joewu@hku.hk
RI Wang, Lin/B-4145-2013; Wu, Joseph Tsz Kei/C-4450-2009
OI Wang, Lin/0000-0002-5371-2138; Wu, Joseph Tsz Kei/0000-0002-3155-5987
FU National Institute of General Medical Sciences Models of Infectious
   Disease Agent Study (MIDAS) Informatics Services Group [1U24GM110707];
   Harvard Center for Communicable Disease Dynamics from the National
   Institute of General Medical Sciences MIDAS Initiative [U54GM088558];
   Area of Excellence Scheme of the Hong Kong University Grants Committee
   [AoE/M-12/06]; Research Grants Council Collaborative Research FundHong
   Kong Research Grants Council [CityU8/CRF/12G]; Health and Medical
   Research Fund from the Government of the Hong Kong Special
   Administrative Region [HKS-15-E03, HKS-17-E13]
FX We thank M. Lipsitch, B. J. Cowling, J. M. Read, K. Leung, H. Choi and
   Y. Zhang for helpful discussions. We thank C. K. Lam for assistance in
   data processing and technical support. We thank the Official Airline
   Guide, Center for International Earth Science Information Network at
   Columbia University, and World Health Organization (WHO) for providing
   their databases. This research was conducted in part using the research
   computing facilities and advisory services offered by Information
   Technology Services, The University of Hong Kong; and was done in part
   on the Olympus High Performance Compute Cluster at the Pittsburgh
   Supercomputing Center at Carnegie Mellon University, which is supported
   by National Institute of General Medical Sciences Models of Infectious
   Disease Agent Study (MIDAS) Informatics Services Group Grant
   1U24GM110707. This research was supported by Harvard Center for
   Communicable Disease Dynamics from the National Institute of General
   Medical Sciences MIDAS Initiative (Grant No. U54GM088558), Area of
   Excellence Scheme of the Hong Kong University Grants Committee (Grant
   No. AoE/M-12/06), Research Grants Council Collaborative Research Fund
   (Grant No. CityU8/CRF/12G), and a commissioned grant from the Health and
   Medical Research Fund from the Government of the Hong Kong Special
   Administrative Region (Grant Nos. HKS-15-E03, HKS-17-E13). The content
   is solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institute of General
   Medical Sciences, the National Institutes of Health. The funding bodies
   had no role in study design, data collection and analysis, preparation
   of the manuscript, or the decision to publish.
CR [Anonymous], EB DAT STAT
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106
   Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45
   Barthelemy M, 2010, J THEOR BIOL, V267, P554, DOI 10.1016/j.jtbi.2010.09.015
   Bobashev G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003154
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Center for International Earth Science Information Network-CIESIN-Columbia University, 2017, DOC GRIDD POP WORLD
   Center for International Earth Science Information Network-CIESIN-Columbia University, 2017, GRIDD POP WORLD VERS
   Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467
   Chevalier MS, 2014, MMWR-MORBID MORTAL W, V63, P1087
   Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436
   Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103
   Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212
   Cover T. M., 2006, ELEMENTS INFORM THEO
   DOXSEYWHITFIELD E, 2015, PAP APPL GEOGR, V0001
   Fasina FO, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.40.20920
   Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Gautreau A, 2008, J THEOR BIOL, V251, P509, DOI 10.1016/j.jtbi.2007.12.001
   Gignoux E, 2015, EMERG INFECT DIS, V21, P2265, DOI 10.3201/eid2112.150756
   Gilks W.R., 1996, MARKOV CHAIN MONTE C
   Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9
   Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876
   Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497
   Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101
   Keeling M.J., 2007, MODELING INFECT DIS
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Kirsch TD, 2017, HEALTH POLICY PLANN, V32, P205, DOI 10.1093/heapol/czw113
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004403
   Lipsitch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006895
   Newman M. E. J., 2010, NETWORKS INTRO
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Poletto, 2014, EUROSURVEILLANCE, V19, P8
   Poletto C, 2014, EUROSURVEILLANCE, V19, P13
   Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x
   Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695
   Ross S. M., 1996, STOCHASTIC PROCESSES
   RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1
   Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867
   Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194
   Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165
   Tomba GS, 2008, MATH BIOSCI, V214, P70, DOI 10.1016/j.mbs.2008.02.009
   Vespignani A, 2012, NAT PHYS, V8, P32
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174
   Wu JT, 2016, LANCET, V388, P2904, DOI 10.1016/S0140-6736(16)31838-4
   Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085
   Yang W, 2015, P NATL ACAD SCI USA, V112, P2723, DOI 10.1073/pnas.1415012112
   Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 55
TC 54
Z9 54
U1 7
U2 54
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 15
PY 2018
VL 9
AR 218
DI 10.1038/s41467-017-02344-z
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS8GD
UT WOS:000422647600015
PM 29335536
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vicenti, I
   Boccuto, A
   Giannini, A
   Dragoni, F
   Saladini, F
   Zazzi, M
AF Vicenti, Ilaria
   Boccuto, Adele
   Giannini, Alessia
   Dragoni, Filippo
   Saladini, Francesco
   Zazzi, Maurizio
TI Comparative analysis of different cell systems for Zika virus (ZIKV)
   propagation and evaluation of anti-ZIKV compounds in vitro
SO VIRUS RESEARCH
LA English
DT Article
DE Zika virus; Yield reduction assay; Plaque assay; qRT-PCR; Sofosbuvir;
   Viral replication kinetics
ID GUILLAIN-BARRE-SYNDROME; YELLOW-FEVER; INFECTION; SOFOSBUVIR;
   INHIBITORS; SCREEN; BRAZIL; ANTIVIRALS; FLAVIVIRUS; EMERGENCE
AB A strong correlation between Zika virus (ZIKV) infection and severe neurological disease in newborns and occasionally adults has emerged in the Brazilian outbreak. Efficient human cell-based assays are required to test candidate inhibitors of ZIKV replication. The aim of this work was to investigate ZIKV propagation and quantification in different cell lines. The human (U87, A549, Huh7), mosquito (C6/36) and monkey (VERO E6) cell lines tested were all permissive to ZIKV infection. When assessed by plaque forming units (PFU) in three different target cell lines, the maximal production of ZIKV was achieved in Huh7 at day 3 post-infection (6.38 +/- 0.44 log(10) PFU/ml). The C6/36 cell line showed a low and slow production of virus when compared with other cell lines. A549 readout cells generated a larger number of plaques compared to Huh7 but not to VERO E6 cells. ZIKV PFU and RNA titers showed the highest correlation when Huh7 and A549 were used as the producer and readout cells, respectively. Also, U87 cells produced ZIKV RNA titers which were highly correlated with PFU independently from the readout cell line. Using the best virus-cell system, sofosbuvir and ribavirin EC50 were 1.2 mu M and 1.1 mu M when measured through plaque assay, and 4.2 mu M and 5.2 mu M when measured by quantitative real time PCR (qRT-PCR), respectively. In summary, ZIKV can efficiently infect different human cell lines and rapidly reach peak viral titers. Overall, A549 cells appear to be as efficient as the VERO E6 gold standard for plaque assay allowing the use of human, rather than simian, cells for evaluating candidate anti-ZIKV compounds by the reference assay. The possibility to replace the labor-intensive plaque assay with the more rapid and easy to-perform qRT-PCR is appealing and warrants further investigation.
C1 [Vicenti, Ilaria; Boccuto, Adele; Giannini, Alessia; Dragoni, Filippo; Saladini, Francesco; Zazzi, Maurizio] Univ Siena, Med Biotechnol Dept, Siena, Italy.
RP Vicenti, I (corresponding author), Univ Siena, Dept Med Biotechnol, Policlin Santa Maria Alle Scotte, Viale Bracci 16, I-53100 Siena, Italy.
EM ilariavicenti@gmail.com
RI Saladini, Francesco/D-5837-2015; Vicenti, Ilaria/AAP-9663-2020; Zazzi,
   Maurizio/K-3422-2018
OI Saladini, Francesco/0000-0002-9934-377X; Zazzi,
   Maurizio/0000-0002-0344-6281; vicenti, ilaria/0000-0002-4306-2960
FU Project UNAVIR "A novel strategy to combat multiple viral diseases with
   one antiviral agent"
FX This work was partially supported by the Project UNAVIR "A novel
   strategy to combat multiple viral diseases with one antiviral agent"
   (Bando FAS Salute 2014 Region Toscana). The funding sources had no
   involvement in study design; in the collection, analysis and
   interpretation of data; in the writing of the report; and in the
   decision to submit the article for publication.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Agbulos D. S., 2016, CURR PROTOCOLS MICRO
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Baronti C, 2014, GENOME ANNOUNC, V2
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Chutaputti A, 2000, J GASTROEN HEPATOL, V15, pE156, DOI 10.1046/j.1440-1746.2000.02114.x
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Shah A, 2016, NEUROTOX RES, V30, P131, DOI 10.1007/s12640-016-9635-3
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zamree I, 2005, Trop Biomed, V22, P217
NR 48
TC 10
Z9 11
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JAN 15
PY 2018
VL 244
SI SI
BP 64
EP 70
DI 10.1016/j.virusres.2017.11.003
PG 7
WC Virology
SC Virology
GA FW8IM
UT WOS:000425575400008
PM 29113824
DA 2020-07-08
ER

PT J
AU Gurumayum, S
   Brahma, R
   Naorem, LD
   Muthaiyan, M
   Gopal, J
   Venkatesan, A
AF Gurumayum, Sanathoi
   Brahma, Rahul
   Naorem, Leimarembi Devi
   Muthaiyan, Mathavan
   Gopal, Jeyakodi
   Venkatesan, Amouda
TI ZikaBase: An integrated ZIKV- Human Interactome Map database
SO VIROLOGY
LA English
DT Article
DE Zika virus; RNA-Seq; DEGs; ZIKV-Human protein interactome map
ID MOLECULAR INTERACTION DATABASE; VIRUS-INFECTION; NEURAL PROGENITORS;
   CELLS; PROTEINS; RESOURCE; TRANSMISSION; RECEPTORS; CYTOSCAPE; NETWORKS
AB Re-emergence of ZIKV has caused infections in more than 1.5 million people. The molecular mechanism and pathogenesis of ZIKV is not well explored due to unavailability of adequate model and lack of publically accessible resources to provide information of ZIKV-Human protein interactome map till today. This study made an attempt to curate the ZIKV-Human interaction proteins from published literatures and RNA-Seq data. 11 direct interaction, 12 associated genes are retrieved from literatures and 3742 Differentially Expressed Genes (DEGs) are obtained from RNA-Seq analysis. The genes have been analyzed to construct the ZIKV-Human Interactome Map. The importance of the study has been illustrated by the enrichment analysis and observed that direct interaction and associated genes are enriched in viral entry into host cell. Also, ZIKV infection modulates 32% signal and 27% immune system pathways. The integrated database, ZikaBase has been developed to help the virology research community and accessible at https://test5.bicpu.edu.in.
C1 [Gurumayum, Sanathoi; Brahma, Rahul; Naorem, Leimarembi Devi; Muthaiyan, Mathavan; Venkatesan, Amouda] Pondicherry Univ, Ctr Bioinformat, Kalapet 605014, Puducherry, India.
   [Gopal, Jeyakodi] Vector Control Res Ctr, Med Complex, Indira Nagar 605006, Puducherry, India.
RP Venkatesan, A (corresponding author), Pondicherry Univ, Sch Life Sci, Ctr Bioinformat, Pondicherry 605014, India.
EM amouda@yahoo.com
RI Brahma, Rahul/M-3084-2019; muthaiyan, mathavan/J-3202-2016; Brahma,
   Rahul/J-7752-2018
OI Brahma, Rahul/0000-0003-1802-3430; muthaiyan,
   mathavan/0000-0002-4885-203X; Brahma, Rahul/0000-0003-1802-3430;
   Gurumayum, Sanathoi/0000-0002-6295-6783; devi, naorem
   leimarembi/0000-0002-2454-2862
CR Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001
   Akira S., 2004, NATURE, V4, P88
   Ako-Adjei D, 2015, NUCLEIC ACIDS RES, V43, pD566, DOI 10.1093/nar/gku1126
   Andrews S, 2010, BABRAHAM BIOINFORMA
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Blankenberg D., 2010, CURR PROTOC MOL S89
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bruford E., 2008, NUCL ACIDS RES S1, V36
   Calderone A, 2015, NUCLEIC ACIDS RES, V43, pD588, DOI 10.1093/nar/gku830
   Chang W., 2017, SHINY WEB APPL FRAME
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira-Szejnfeld P. Soares, 2016, RADIOLOGY
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guirimand T, 2015, NUCLEIC ACIDS RES, V43, pD583, DOI 10.1093/nar/gku1121
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988
   Karyala P., 2016, PLOS NEGLECT TROP D, V10, P1
   Kwofie SK, 2011, INFECT GENET EVOL, V11, P1971, DOI 10.1016/j.meegid.2011.09.001
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Maglott D., 2011, NUCL ACIDS RES S1, V39
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Moghadam SRJ, 2016, ASIAN PAC J TROP BIO, V6, P989, DOI 10.1016/j.apjtb.2016.09.007
   Mossenta M., 2016, BIOCHEM BIOPH RES CO, P1
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pickett BE, 2012, VIRUSES-BASEL, V4, P3209, DOI 10.3390/v4113209
   Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113
   Richard A. S, 2017, P NATL ACAD SCI USA
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y
   von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034
   Wickham H., 2009, GGPLOT2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 54
TC 3
Z9 3
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JAN 15
PY 2018
VL 514
BP 203
EP 210
DI 10.1016/j.virol.2017.11.007
PG 8
WC Virology
SC Virology
GA FT2XV
UT WOS:000423010200022
PM 29197720
OA Bronze
DA 2020-07-08
ER

PT J
AU de Souza, WV
   de Albuquerque, MDPM
   Vazquez, E
   Bezerra, LCA
   Mendes, ADG
   Lyra, TM
   de Araujo, TVB
   de Oliveira, ALS
   Braga, MC
   Ximenes, RAD
   Miranda, DD
   Silva, APDSC
   Rodrigues, L
   Martelli, CMT
AF de Souza, Wayner Vieira
   Pessoa Militao de Albuquerque, Maria de Fatima
   Vazquez, Enrique
   Albuquerque Bezerra, Luciana Caroline
   Gouveia Mendes, Antonio da Cruz
   Lyra, Tereza Maciel
   Barreto de Araujo, Thalia Velho
   Sa de Oliveira, Andre Luiz
   Braga, Maria Cynthia
   de Alencar Ximenes, Ricardo Arraes
   Miranda-Filho, Democrito de Barros
   de Santana Cabral Silva, Amanda Priscila
   Rodrigues, Laura
   Turchi Martelli, Celina Maria
TI Microcephaly epidemic related to the Zika virus and living conditions in
   Recife, Northeast Brazil
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Zika; Ecological study; Socio-economic; Brazil
ID INFECTIOUS-DISEASES; INTERVENTIONS; HISTORY; HEALTH; NEEDS
AB Background: Starting in August 2015, there was an increase in the number of cases of neonatal microcephaly in Northeast Brazil. These findings were identified as being an epidemic of microcephaly related to Zika virus (ZIKV) infection. The present study aims to analyse the spatial distribution of microcephaly cases in Recife (2015-2016), which is in Northeast Brazil, and its association with the living conditions in this city.
   Methods: This was an ecological study that used data from reported cases of microcephaly from the State Health Department of Pernambuco (August 2015 to July 2016). The basic spatial unit of analysis was the 94 districts of Recife. The case definition of microcephaly was: neonates with a head circumference of less than the cut-off point of -2 standard deviations below the mean value from the established Fenton growth curve. As an indicator of the living conditions of the 94 districts, the percentage of heads of households with an income of less than twice the minimum wage was calculated. The districts were classified into four homogeneous strata using the K-means clustering algorithm. We plotted the locations of each microcephaly case over a layer of living conditions.
   Results: During the study period, 347 microcephaly cases were reported, of which 142 (40.9%) fulfilled the definition of a microcephaly case. Stratification of the 94 districts resulted in the identification of four strata. The highest stratum in relation to the living conditions presented the lowest prevalence rate of microcephaly, and the overall difference between this rate and the rates of the other strata was statistically significant. The results of the Kruskal-Wallis test demonstrated that there was a strong association between a higher prevalence of microcephaly and poor living conditions. After the first 6 months of the study period, there were no microcephaly cases recorded within the population living in the richest socio-economic strata.
   Conclusion: This study showed that those residing in areas with precarious living conditions had a higher prevalence of microcephaly compared with populations with better living conditions.
C1 [de Souza, Wayner Vieira; Pessoa Militao de Albuquerque, Maria de Fatima; Gouveia Mendes, Antonio da Cruz; Lyra, Tereza Maciel; Sa de Oliveira, Andre Luiz; Braga, Maria Cynthia; de Santana Cabral Silva, Amanda Priscila; Turchi Martelli, Celina Maria] FIOCRUZ PE, Aggeu Magalhaes Res Ctr, Ave Prof Moraes Rego,S-N Cidade Univ, BR-50740465 Recife, PE, Brazil.
   [Vazquez, Enrique] Pan Amer Hlth Org, Setor Embaixadas Norte, Lote 19, BR-70800400 Brasilia, DF, Brazil.
   [Albuquerque Bezerra, Luciana Caroline] Pernambuco State Hlth Dept, Rua Dona Maria Augusta Nogueira,519, BR-50751530 Recife, PE, Brazil.
   [Barreto de Araujo, Thalia Velho; de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Ave Prof Moares Rego,1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes; Miranda-Filho, Democrito de Barros] Univ Pernambuco, Ave Agamenon Magalhaes,S-N, BR-50110001 Recife, PE, Brazil.
   [Rodrigues, Laura] London Sch Hyg & Trop Med, Keppel St, London, England.
   [Turchi Martelli, Celina Maria] Univ Fed Goias, Ave Esperanca,S-N,Campus Samambaia, BR-74690900 Goiania, Go, Brazil.
RP de Souza, WV (corresponding author), FIOCRUZ PE, Aggeu Magalhaes Res Ctr, Ave Prof Moraes Rego,S-N Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM wayner@cpqam.fiocruz.br
RI Souza, Wayner V/H-3798-2013
OI Turchi Martelli, Celina Maria/0000-0002-2491-0688; Souza,
   Wayner/0000-0002-0939-9332
FU Brazilian Ministry of Health and Pan American Health Organization
FX The Brazilian Ministry of Health and Pan American Health Organization
   funded this study.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1
   Banco Central Do Brasil, 2014, RES CONV
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Bermudez-Tamayo C, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0198-6
   Braga C, 1997, J Pediatr (Rio J), V73, P95
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Censo, 2010, IBGE CENS 2010
   De Albuquerque MFPM, 1993, CAD SAUDE PUBLICA, V9, P487
   de Souza WV, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00017216
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Instituto Brasileiro de Geografia e Estatistica, 2016, SIRGAS PROJ GEOC REF
   Instituto Brasileiro de Geografia e Estatistica, 2016, IBGE CID INF PERN RE
   Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011
   Ministerio da Saude (BR), 2015, MIN SAUD CONF REL EN
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Netto MJ, 2016, ACTA TROP, V163, P54, DOI 10.1016/j.actatropica.2016.07.006
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regis L, 2009, AN ACAD BRAS CIENC, V81, P655, DOI 10.1590/S0001-37652009000400004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Steffens I, 2014, EUROSURVEILLANCE, P74
   Velho T, 2016, ASS ZIKA VIRUS INFEC, P1356
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 28
TC 24
Z9 25
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 12
PY 2018
VL 18
AR 130
DI 10.1186/s12889-018-5039-z
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FT0PD
UT WOS:000422828800002
PM 29329574
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reynolds, CJ
   Suleyman, OM
   Ortega-Prieto, AM
   Skelton, JK
   Bonnesoeur, P
   Blohm, A
   Carregaro, V
   Silva, JS
   James, EA
   Maillere, B
   Dorner, M
   Boyton, RJ
   Altmann, DM
AF Reynolds, C. J.
   Suleyman, O. M.
   Ortega-Prieto, A. M.
   Skelton, J. K.
   Bonnesoeur, P.
   Blohm, A.
   Carregaro, V.
   Silva, J. S.
   James, E. A.
   Maillere, B.
   Dorner, M.
   Boyton, R. J.
   Altmann, D. M.
TI T cell immunity to Zika virus to immunodominant epitopes that show
   cross-reactivity with other Flaviviruses
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUS; CD4(+); INFECTION; RECOGNIZE
AB Zika virus (ZIKV) Infection has several outcomes from asymptomatic exposure to rash, conjunctivitis, Guillain-Barre syndrome or congenital Zika syndrome. Analysis of ZIKV immunity is confounded by the fact that several related Flaviviruses infect humans, including Dengue virus 1-4, West Nile virus and Yellow Fever virus. HLA class II restricted T cell cross-reactivity between ZIKV and other Flaviviruses infection(s) or vaccination may contribute to protection or to enhanced immunopathology. We mapped immunodominant, HLA class II restricted, CD4 epitopes from ZIKV Envelope (Env), and Non-structural (NS) NS1, CD4 cells responded to homologous sequences from other viruses, including DENV1-4,WNV or YFV. However, cross-reactive responses could confer immune deviation - the response to the Env DENV4 p1 epitope in HLA-DR1 resulted in IL-17A immunity, often associated with exacerbated immunopathogenesis. This conservation of recognition across Flaviviruses, may encompass protective and/or pathogenic components and poses challenges to characterization of ZIKV protective components and poses challenges to characterization of ZIKV protective immunity.
C1 [Reynolds, C. J.; Suleyman, O. M.; Ortega-Prieto, A. M.; Skelton, J. K.; Blohm, A.; Dorner, M.; Boyton, R. J.; Altmann, D. M.] Imperial Coll London, Dept Med, London, England.
   [Bonnesoeur, P.; Maillere, B.] CEA Saclay, Inst Frederic Joliot, Gif Sur Yvette, France.
   [Carregaro, V.; Silva, J. S.] Univ Sao Paulo, Dept Biochem & Immunol, Ribeirao Preto, Brazil.
   [James, E. A.] Benaroya Res Inst Virginia Mason, Seattle, WA USA.
RP Boyton, RJ; Altmann, DM (corresponding author), Imperial Coll London, Dept Med, London, England.
EM r.boyton@imperial.ac.uk; d.altmann@imperial.ac.uk
RI Carregaro, Vanessa/D-2913-2012; Ortega-Prieto, Ana Maria/M-6431-2019;
   James, Eddie/V-4929-2019; Silva, Joao S/A-4484-2008
OI Ortega-Prieto, Ana Maria/0000-0002-9023-0103; James,
   Eddie/0000-0002-7217-5729; Silva, Joao S/0000-0002-3410-3927; Carregaro,
   Vanessa/0000-0002-8435-0766; Dorner, Marcus/0000-0003-0321-4226
FU Laboratory of Excellence in research on Medication and Innovative
   Therapeutics (LERMIT); Imperial NIHR Biomedical Research CentreNational
   Institute for Health Research (NIHR); NIHR Imperial BRC multi-parameter
   flow cytometry and confocal imaging facility, Hammersmith Campus;
   Wellcome TrustWellcome Trust [104771/Z/14/Z]; NIH NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [HHSN272201400049C, UWSC9568]; ERC Starter grant [637304]; MRC- Newton
   Welcome Trust/FAPESP Zika Rapid Response Project [ZK/16-104]
FX The authors acknowledge the support of the NIHR Imperial BRC
   multi-parameter flow cytometry and confocal imaging facility,
   Hammersmith Campus. The authors wish to thank W. W. Kwok for help with
   study design and critically reading and commenting on the manuscript.
   This work was supported by MRC- Newton Welcome Trust/FAPESP Zika Rapid
   Response Project ZK/16-104 (DMA, RJB, JS, VC and WWK) and by NIH NIAID
   award number: HHSN272201400049C, Subcontract number: UWSC9568 (DMA, RJB,
   WWK). BM is supported by Laboratory of Excellence in research on
   Medication and Innovative Therapeutics (LERMIT). MD is supported by
   Wellcome Trust Investigator award (104771/Z/14/Z), ERC Starter grant
   (637304). RJB and MD were supported by the Imperial NIHR Biomedical
   Research Centre. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ascough S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004085
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Centers for Disease Control and Prevention, 2017, ZIK CAS US
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DYER O, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J707
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hunziker L, 2002, J EXP MED, V196, P1039, DOI 10.1084/jem.20012045
   James EA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005375
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259
   Kim JH, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0656-x
   Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mattapallil MJ, 2011, J IMMUNOL, V187, P1977, DOI 10.4049/jimmunol.1101247
   Musson JA, 2014, J IMMUNOL, V193, P6041, DOI 10.4049/jimmunol.1402273
   Nascimento EJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002497
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8
   Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476
   Pagliari C, 2016, J CLIN VIROL, V75, P16, DOI 10.1016/j.jcv.2015.12.005
   Panning M, 2017, EBIOMEDICINE, V16, P12, DOI 10.1016/j.ebiom.2017.01.045
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quigley KJ, 2015, AM J RESP CRIT CARE, V191, P1250, DOI 10.1164/rccm.201411-1995OC
   Reynolds C, 2015, J IMMUNOL, V194, P4814, DOI 10.4049/jimmunol.1402862
   Reynolds CJ, 2014, IMMUNOLOGY, V143, P438, DOI 10.1111/imm.12327
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   ROEHRIG JT, 1994, VIROLOGY, V198, P31, DOI 10.1006/viro.1994.1005
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shorter SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149582
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Till SJ, 2014, THORAX, V69, P335, DOI 10.1136/thoraxjnl-2013-204324
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
NR 39
TC 20
Z9 21
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 12
PY 2018
VL 8
AR 672
DI 10.1038/s41598-017-18781-1
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS6YX
UT WOS:000419945400113
PM 29330423
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fukutani, KF
   Kasprzykowski, JI
   Paschoal, AR
   Gomes, MD
   Barral, A
   de Oliveira, CI
   Ramos, PIP
   de Queiroz, ATL
AF Fukutani, Kiyoshi Ferreira
   Kasprzykowski, Jose Irahe
   Paschoal, Alexandre Rossi
   Gomes, Matheus de Souza
   Barral, Aldina
   de Oliveira, Camila, I
   Pereira Ramos, Pablo Ivan
   Lopo de Queiroz, Artur Trancoso
TI Meta-Analysis of Aedes Aegypti Expression Datasets: Comparing Virus
   Infection and Blood-Fed Transcriptomes to Identify Markers of Virus
   Presence
SO FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
LA English
DT Article
DE Aedes aegypti; alimentation; blood-feeding; meta-analysis;
   transcriptomics; vector-borne diseases; virus infection
AB The mosquito Aedes aegypti (L.) is vector of several arboviruses including dengue, yellow fever, chikungunya, and more recently zika. Previous transcriptomic studies have been performed to elucidate altered pathways in response to viral infection. However, the intrinsic coupling between alimentation and infection were unappreciated in these studies. Feeding is required for the initial mosquito contact with the virus and these events are highly dependent. Addressing this relationship, we reinterrogated datasets of virus-infected mosquitoes with two different diet schemes (fed and unfed mosquitoes), evaluating the metabolic cross-talk during both processes. We constructed coexpression networks with the differentially expressed genes of these comparison: virus-infected versus blood-fed mosquitoes and virus-infected versus unfed mosquitoes. Our analysis identified one module with 110 genes that correlated with infection status (representing similar to 0.7% of the A. aegypti genome). Furthermore, we performed a machine-learning approach and summarized the infection status using only four genes (AAEL012128, AAEL014210, AAEL002477, and AAEL005350). While three of the four genes were annotated as hypothetical proteins, AAEL012128 gene is a membrane amino acid transporter correlated with viral envelope binding. This gene alone is able to discriminate all infected samples and thus should have a key role to discriminate viral infection in the A. aegypti mosquito. Moreover, validation using external datasets found this gene as differentially expressed in four transcriptomic experiments. Therefore, these genes may serve as a proxy of viral infection in the mosquito and the others 106 identified genes provides a framework to future studies.
C1 [Fukutani, Kiyoshi Ferreira; Kasprzykowski, Jose Irahe; Barral, Aldina; de Oliveira, Camila, I; Pereira Ramos, Pablo Ivan; Lopo de Queiroz, Artur Trancoso] Fundacao Oswaldo Cruz FIOCRUZ, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Kasprzykowski, Jose Irahe; Lopo de Queiroz, Artur Trancoso] Fundacao Oswaldo Cruz FIOCRUZ, Postgrad Program Biotechnol Hlth & Invest, Salvador, BA, Brazil.
   [Paschoal, Alexandre Rossi] Univ Tecnol Fed Parana, UTFPR, Campus Cornell Procopio, Cornell Procopio, Brazil.
   [Gomes, Matheus de Souza] Univ Fed Uberlandia, Patos De Minas, Brazil.
   [Barral, Aldina; de Oliveira, Camila, I] Univ Fed Bahia, Sch Med, Postgrad Program Hlth Sci, Salvador, BA, Brazil.
   [Lopo de Queiroz, Artur Trancoso] Univ Estadual Feira de Santana, Postgrad Program Appl Computat, Feira De Santana, Brazil.
   [Fukutani, Kiyoshi Ferreira] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil.
RP Fukutani, KF; de Queiroz, ATL (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Goncalo Moniz, Salvador, BA, Brazil.; de Queiroz, ATL (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Postgrad Program Biotechnol Hlth & Invest, Salvador, BA, Brazil.; de Queiroz, ATL (corresponding author), Univ Estadual Feira de Santana, Postgrad Program Appl Computat, Feira De Santana, Brazil.; Fukutani, KF (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil.
EM ferreirafk@gmail.com; arturqueiroz@bahia.fiocruz.br
RI Ramos, Pablo I. Pereira/H-6276-2019; de Oliveira, Camila I/B-4358-2009;
   Paschoal, Alexandre Rossi Rossi/I-4074-2013; Fukutani,
   Kiyoshi/T-1630-2019
OI Ramos, Pablo I. Pereira/0000-0002-9075-7861; de Oliveira, Camila
   I/0000-0002-7868-5164; Paschoal, Alexandre Rossi
   Rossi/0000-0002-8887-0582; de Queiroz, Artur Trancoso
   Lopo/0000-0003-4908-9993; Fukutani, Kiyoshi/0000-0003-2223-0918
FU Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)
   [JCB0004/2013]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/03491-6]; CNPq-Grant Edital Universal MCTI/CNPQ/Universal14/2014
   [454505/2014-0]
FX AQ acknowledges financial support from Fundacao de Amparo a Pesquisa do
   Estado da Bahia (FAPESB process no. JCB0004/2013). KF was supported by
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP no.
   2017/03491-6). AP acknowledges financial support from CNPq-Grant Edital
   Universal MCTI/CNPQ/Universal14/2014 (Process No.: 454505/2014-0).
CR Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356
   Bae HG, 2005, J CLIN VIROL, V33, P274, DOI 10.1016/j.jcv.2004.12.001
   Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bonizzoni M, 2012, G3-GENES GENOM GENET, V2, P103, DOI 10.1534/g3.111.001107
   Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82
   Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985
   Boudko DY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9546
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Chen Y, 2012, DEV COMP IMMUNOL, V38, P88, DOI 10.1016/j.dci.2012.04.007
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Davis TJ, 2016, J MED ENTOMOL, V53, P273, DOI 10.1093/jme/tjv201
   Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248
   Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200
   Espindola MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145261
   Evans AM, 2009, J EXP BIOL, V212, P3263, DOI 10.1242/jeb.029553
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   Hansen IA, 2011, J BIOL CHEM, V286, P10803, DOI 10.1074/jbc.M110.179739
   Helt AM, 2005, J VIROL, V79, P13218, DOI 10.1128/JVI.79.21.13218-13230.2005
   Ito K, 2008, P NATL ACAD SCI USA, V105, P7523, DOI 10.1073/pnas.0711841105
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kerpedjiev P, 2015, BIOINFORMATICS, V31, P3374, DOI 10.1093/bioinformatics/btv372
   Kogelman LJA, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-57
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Langfelder P, 2012, J STAT SOFTW, V46, P1
   Leming MT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1128
   Lorenzo MG, 2014, J BRAZIL CHEM SOC, V25, P1799, DOI 10.5935/0103-5053.20140202
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Medeiros MCI, 2016, AM J TROP MED HYG, V95, P1121, DOI 10.4269/ajtmh.16-0236
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Pan Y, 2012, J ETHNOPHARMACOL, V143, P586, DOI 10.1016/j.jep.2012.07.024
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Pradier S, 2012, REV SCI TECH OIE, V31, P829
   Ptitsyn AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-153
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sathler-Avelar R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004302
   Seixas G, 2013, MEM I OSWALDO CRUZ, V108, P3, DOI 10.1590/0074-0276130386
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800
   Umesh A, 2003, J EXP BIOL, V206, P2241, DOI 10.1242/jeb.00430
   WANG H, 1991, NATURE, V352, P729, DOI 10.1038/352729a0
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Wickham H., 2016, ELEGANT GRAPHICS DAT
   World Health Organization, 2015, GLOB STRAT DENG PREV
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 57
TC 6
Z9 6
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-4185
J9 FRONT BIOENG BIOTECH
JI Front. Bioeng. Biotechnol.
PD JAN 11
PY 2018
VL 5
AR 84
DI 10.3389/fbioe.2017.00084
PG 13
WC Biotechnology & Applied Microbiology; Multidisciplinary Sciences
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA GO7MB
UT WOS:000440249200001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jorfi, M
   D'Avanzo, C
   Kim, DY
   Irimia, D
AF Jorfi, Mehdi
   D'Avanzo, Carla
   Kim, Doo Yeon
   Irimia, Daniel
TI Three-Dimensional Models of the Human Brain Development and Diseases
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE 3D culture; biomaterials; disease modeling; microfluidics; organoids
ID FAMILIAL ALZHEIMERS-DISEASE; MICROFLUIDIC CULTURE PLATFORM;
   CELL-MATERIAL INTERACTIONS; PLURIPOTENT STEM-CELLS;
   CENTRAL-NERVOUS-SYSTEM; IN-VITRO MODELS; AMYLOID-BETA; CEREBRAL
   ORGANOIDS; ZIKA VIRUS; PHOTODEGRADABLE HYDROGELS
AB Deciphering the human brain pathophysiology remains one of the greatest challenges of the 21st century. Neurological disorders represent a significant proportion of diseases burden; however, the complexity of the brain physiology makes it challenging to model its diseases. Simple in vitro models have been very useful for precise measurements in controled conditions. However, existing models are limited in their ability to replicate complex interactions between various cells in the brain. Studying human brain requires sophisticated models to reconstitute the tangled architecture and functions of brain cells. Recently, advances in the development of three-dimensional (3D) brain cell culture models have begun to recapitulate various aspects of the human brain physiology in vitro and replicate basic disease processes of Alzheimer's disease, amyotrophic lateral sclerosis, and microcephaly. In this review, we discuss the progress, advantages, limitations, and future directions of 3D cell culture systems for modeling the human brain development and diseases.
C1 [Jorfi, Mehdi; Irimia, Daniel] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Engn Med, Charlestown, MA 02129 USA.
   [D'Avanzo, Carla; Kim, Doo Yeon] Harvard Med Sch, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA 02129 USA.
RP Jorfi, M; Irimia, D (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Engn Med, Charlestown, MA 02129 USA.
EM mjorfi@mgh.harvard.edu; dirimia@mgh.harvard.edu
RI Irimia, Daniel/S-5404-2019
OI Irimia, Daniel/0000-0001-7347-2082; Jorfi, Mehdi/0000-0003-4724-6190
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NS045776, AG048080,
   AG15379, AG014713]; Cure Alzheimer's Fund; BrightFocus
   FoundationBrightFocus Foundation
FX This work was supported by the National Institutes of Health (NS045776,
   AG048080, AG15379, and AG014713), Cure Alzheimer's Fund, and BrightFocus
   Foundation.
CR Adler M, 2010, LAB CHIP, V10, P388, DOI 10.1039/b920401f
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Alge DL, 2013, NAT MATER, V12, P950, DOI 10.1038/nmat3794
   An J, 2008, BLOOD, V112, P2787, DOI 10.1182/blood-2008-02-141630
   Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001
   Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974
   Bae BI, 2013, SCIENCE, V342, P200, DOI 10.1126/science.1245812
   Bershteyn M, 2013, CELL, V155, P19, DOI 10.1016/j.cell.2013.09.010
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Bigler RL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00676-w
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Boers SN, 2016, EMBO REP, V17, P938, DOI 10.15252/embr.201642613
   Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018
   Bredenoord AL, 2017, SCIENCE, V355, DOI 10.1126/science.aaf9414
   Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158
   Camos S, 2010, MOLECULES, V15, P9104, DOI 10.3390/molecules15129104
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Cauchemez S, 2016, LANCET, V388, P338, DOI 10.1016/S0140-6736(16)31017-0
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavaliere F., 2016, STEM CELLS INT, V2016, P6
   Cavaliere F, 2010, J NEUROSCI METH, V188, P205, DOI 10.1016/j.jneumeth.2010.02.008
   Chambers SM, 2013, CELL STEM CELL, V13, P377, DOI 10.1016/j.stem.2013.09.010
   Cho HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15222
   Cho HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01823
   Choi SH, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0139-7
   Choi Se Hoon, 2015, US Neurol, V11, P102
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Choi YJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01921
   Choi YJ, 2013, BIOMATERIALS, V34, P2938, DOI 10.1016/j.biomaterials.2013.01.038
   Chokshi TV, 2010, LAB CHIP, V10, P2758, DOI 10.1039/c004658b
   Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558
   Chwalek K, 2015, NAT PROTOC, V10, P1362, DOI 10.1038/nprot.2015.091
   Cohen MS, 2011, P NATL ACAD SCI USA, V108, P11246, DOI 10.1073/pnas.1012401108
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   D'Avanzo C, 2015, BIOESSAYS, V37, P1139, DOI 10.1002/bies.201500063
   D'Avanzo C, 2015, FASEB J, V29, P3335, DOI 10.1096/fj.15-271015
   Daschil N, 2015, NEUROBIOL AGING, V36, P1333, DOI 10.1016/j.neurobiolaging.2014.12.027
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Dauth S, 2017, J NEUROPHYSIOL, V117, P1320, DOI 10.1152/jn.00575.2016
   Daviaud N, 2013, EXP NEUROL, V248, P429, DOI 10.1016/j.expneurol.2013.07.012
   De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228
   De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Deosarkar SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142725
   Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720
   Ehrbar M, 2007, BIOMACROMOLECULES, V8, P3000, DOI 10.1021/bm070228f
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Eriksson C, 2003, EXP NEUROL, V184, P615, DOI 10.1016/S0014-4886(03)00271-1
   Espuny-Camacho I, 2017, NEURON, V93, P1066, DOI 10.1016/j.neuron.2017.02.001
   Fan YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep25062
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Frigerio CS, 2016, ANNU REV NEUROSCI, V39, P57, DOI 10.1146/annurev-neuro-070815-014015
   GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0
   Gao YD, 2016, MICROSYST NANOENG, V2, DOI 10.1038/micronano.2015.45
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045
   Giandomenico SL, 2017, CURR OPIN CELL BIOL, V44, P36, DOI 10.1016/j.ceb.2017.01.001
   Gjorevski N., 2016, NATURE, P539
   Gjorevski N, 2014, DEVELOPMENT, V141, P1794, DOI 10.1242/dev.101048
   Glass RI, 2015, NATURE, V527, pS150, DOI 10.1038/nature16027
   Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Guan A, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0045
   Guerrero-Cazares H, 2009, METHODS MOL BIOL, V568, P73, DOI 10.1007/978-1-59745-280-9_6
   Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Healy S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36410
   Hellwig S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14624
   Herland A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150360
   Hofmann F, 2006, J PHYSIOLOGY-PARIS, V99, P125, DOI 10.1016/j.jphysparis.2005.12.005
   HONEGGER P, 1979, NATURE, V282, P305, DOI 10.1038/282305a0
   Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086
   Hutter-Schmid Bianca, 2015, Front Cell Dev Biol, V3, P52, DOI 10.3389/fcell.2015.00052
   Imaizumi Y, 2014, J NEUROCHEM, V129, P388, DOI 10.1111/jnc.12625
   Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225
   Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821
   Jaderstad LM, 2010, REGEN MED, V5, P901, DOI 10.2217/RME.10.80
   Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a
   Jennings C, 2016, NAT NEUROSCI, V19, P1123, DOI 10.1038/nn.4362
   Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153
   Jeong GS, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0109-y
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Joseph JV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145393
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935
   Kanagasabapathi TT, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036010
   Kato-Negishi M, 2010, BIOMATERIALS, V31, P8939, DOI 10.1016/j.biomaterials.2010.08.008
   Kelava I, 2016, DEV BIOL, V420, P199, DOI 10.1016/j.ydbio.2016.06.037
   Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001
   Kilic O, 2016, LAB CHIP, V16, P4152, DOI 10.1039/c6lc00946h
   Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112
   Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j
   Kim HJ, 2012, ACS CHEM NEUROSCI, V3, P433, DOI 10.1021/cn3000026
   Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065
   Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Koch P, 2012, AM J PATHOL, V180, P2404, DOI 10.1016/j.ajpath.2012.02.012
   Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009
   Kreutz F, 2011, NEUROCHEM INT, V59, P648, DOI 10.1016/j.neuint.2011.06.007
   Kunze A, 2013, INTEGR BIOL-UK, V5, P964, DOI 10.1039/c3ib40022k
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003
   Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199
   Lee HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163072
   Lee J, 2016, EXPERT REV GASTROENT, V10, P883, DOI 10.1080/17474124.2016.1200466
   Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121
   Li HC, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601013
   Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106
   Lo JF, 2010, LAB CHIP, V10, P2394, DOI 10.1039/c004660d
   Lu X, 2012, J NEUROSCI METH, V209, P35, DOI 10.1016/j.jneumeth.2012.05.021
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MP, 2012, NATURE, V482, P477, DOI 10.1038/482477a
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Majumdar D, 2011, J NEUROSCI METH, V196, P38, DOI 10.1016/j.jneumeth.2010.12.024
   Marton RM, 2016, CELL STEM CELL, V19, P145, DOI 10.1016/j.stem.2016.07.017
   Mason JO, 2016, NEUROSCIENCE, V334, P105, DOI 10.1016/j.neuroscience.2016.07.048
   Mauleon G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043309
   Meinhardt A, 2014, STEM CELL REP, V3, P987, DOI 10.1016/j.stemcr.2014.09.020
   Menon S, 2015, DEV CELL, V35, P698, DOI 10.1016/j.devcel.2015.11.022
   Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006
   Millet LJ, 2012, TRENDS NEUROSCI, V35, P752, DOI 10.1016/j.tins.2012.09.001
   Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268
   Moser KV, 2003, EUR J NEUROSCI, V18, P85, DOI 10.1046/j.1460-9568.2003.02728.x
   Moser KV, 2004, BRAIN RES, V1017, P53, DOI 10.1016/j.brainres.2004.05.013
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI [10.1038/NMAT3766, 10.1038/nmat3766]
   Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064
   Naik P, 2012, J PHARM SCI-US, V101, P1337, DOI 10.1002/jps.23022
   Nakao Y, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3580753
   Nasu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053024
   Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016
   Neto E, 2016, J NEUROSCI, V36, P11573, DOI 10.1523/JNEUROSCI.1748-16.2016
   Oppegard SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006891
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Park HS, 2013, IEEE ENG MED BIO, P2833, DOI 10.1109/EMBC.2013.6610130
   Park JW, 2013, LAB CHIP, V13, P509, DOI 10.1039/c2lc41081h
   Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316
   Park J, 2015, LAB CHIP, V15, P141, DOI 10.1039/c4lc00962b
   Parmar M, 2002, MOL CELL NEUROSCI, V21, P645, DOI 10.1006/mcne.2002.1204
   Parmar M, 2003, MOL CELL NEUROSCI, V24, P741, DOI 10.1016/S1044-7431(03)00239-2
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Passier R, 2016, CELL STEM CELL, V18, P309, DOI [10.1016/j.stem.2016.02.011, 10.1016/j.stem.2016.02.013]
   Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007
   Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c
   Pinto MJ, 2016, J CELL BIOL, V212, P789, DOI 10.1083/jcb.201509039
   Polinkovsky M, 2009, LAB CHIP, V9, P1073, DOI 10.1039/b816191g
   Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012
   Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j
   Prasanthi RPJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026420
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Quadrato G, 2016, NAT MED, V22, P1220, DOI 10.1038/nm.4214
   Ranga A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5324
   Ranga A., 2016, P NATL ACAD SCI USA, P3529
   Ravula SK, 2007, J NEUROSCI METH, V159, P78, DOI 10.1016/j.jneumeth.2006.06.022
   Richard MJP, 2010, J NEUROSCI METH, V190, P20, DOI 10.1016/j.jneumeth.2010.04.017
   Rosales AM, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.12
   Samson AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33746
   Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425
   Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005
   Schultz KM, 2015, P NATL ACAD SCI USA, V112, pE3757, DOI 10.1073/pnas.1511304112
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873
   Shi MJ, 2013, LAB CHIP, V13, P3008, DOI 10.1039/c3lc50249j
   Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518
   Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74
   Shuler ML, 2014, P NATL ACAD SCI USA, V111, P13682, DOI 10.1073/pnas.1414484111
   Skardal A., 2016, DRUG DISCOV TODAY
   Skolimowski M, 2010, LAB CHIP, V10, P2162, DOI 10.1039/c003558k
   Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299
   Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030
   Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490
   Takeshita Y, 2015, CLIN EXPT NEUROIMMUN, V6, P351
   Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111
   Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801
   Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777
   Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v
   Taylor AM, 2010, CURR OPIN NEUROBIOL, V20, P640, DOI 10.1016/j.conb.2010.07.011
   Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009
   Taylor AM, 2013, J NEUROSCI, V33, P5584, DOI 10.1523/JNEUROSCI.2944-12.2013
   Tibbitt MW, 2015, P NATL ACAD SCI USA, V112, P14444, DOI 10.1073/pnas.1516247112
   Tibbitt MW, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004804
   Tonnesen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017560
   Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X
   Ullrich C, 2011, J NEUROSCI METH, V201, P131, DOI 10.1016/j.jneumeth.2011.07.021
   Urich E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01500
   Uzel SGM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501429
   Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033
   Vu LT, 2015, TISSUE ENG PART B-RE, V21, P67, DOI [10.1089/ten.teb.2013.0782, 10.1089/ten.TEB.2013.0782]
   Wang JY, 2009, LAB CHIP, V9, P644, DOI 10.1039/b813495b
   Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402
   Wilhelm I, 2014, MOL PHARMACEUT, V11, P1949, DOI 10.1021/mp500046f
   Wolff A, 2015, J PHARM SCI-US, V104, P2727, DOI 10.1002/jps.24329
   World Health Organization, 2006, NEUR DIS PUBL HLTH C
   Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394
   Yang C, 2016, P NATL ACAD SCI USA, V113, pE4439, DOI 10.1073/pnas.1609731113
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Yi Y, 2015, TRENDS BIOTECHNOL, V33, P762, DOI 10.1016/j.tibtech.2015.09.007
   Zhang DW, 2014, BIOMATERIALS, V35, P1420, DOI 10.1016/j.biomaterials.2013.11.028
   Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067
   Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003
   Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114
NR 212
TC 15
Z9 15
U1 7
U2 40
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JAN 10
PY 2018
VL 7
IS 1
AR UNSP 1700723
DI 10.1002/adhm.201700723
PG 20
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA FS3IO
UT WOS:000419674600009
PM 28845922
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Miller, JR
   Koren, S
   Dilley, KA
   Puri, V
   Brown, DM
   Harkins, DM
   Thibaud-Nissen, F
   Rosen, B
   Chen, XG
   Tu, Z
   Sharakhov, IV
   Sharakhova, MV
   Sebra, R
   Stockwell, TB
   Bergman, NH
   Sutton, GG
   Phillippy, AM
   Piermarini, PM
   Shabman, RS
AF Miller, Jason R.
   Koren, Sergey
   Dilley, Kari A.
   Puri, Vinita
   Brown, David M.
   Harkins, Derek M.
   Thibaud-Nissen, Francoise
   Rosen, Benjamin
   Chen, Xiao-Guang
   Tu, Zhijian
   Sharakhov, Igor V.
   Sharakhova, Maria V.
   Sebra, Robert
   Stockwell, Timothy B.
   Bergman, Nicholas H.
   Sutton, Granger G.
   Phillippy, Adam M.
   Piermarini, Peter M.
   Shabman, Reed S.
TI Analysis of the Aedes albopictus C6/36 genome provides insight into cell
   line utility for viral propagation
SO GIGASCIENCE
LA English
DT Article
DE Aedes albopictus; C6/36; cell line; genome assembly
ID YELLOW-FEVER MOSQUITO; DE-NOVO IDENTIFICATION; POTASSIUM KIR CHANNELS;
   FUNCTIONAL-CHARACTERIZATION; ANOPHELES-GAMBIAE; MALARIA VECTOR;
   SEQUENCE; AEGYPTI; CHROMOSOME; ALIGNMENT
AB Background: The 50-year-old Aedes albopictus C6/36 cell line is a resource for the detection, amplification, and analysis of mosquito-borne viruses including Zika, dengue, and chikungunya. The cell line is derived from an unknown number of larvae from an unspecified strain of Aedes albopictus mosquitoes. Toward improved utility of the cell line for research in virus transmission, we present an annotated assembly of the C6/36 genome. Results: The C6/36 genome assembly has the largest contig N50 (3.3 Mbp) of any mosquito assembly, presents the sequences of both haplotypes for most of the diploid genome, reveals independent null mutations in both alleles of the Dicer locus, and indicates a male-specific genome. Gene annotation was computed with publicly available mosquito transcript sequences. Gene expression data from cell line RNA sequence identified enrichment of growth-related pathways and conspicuous deficiency in aquaporins and inward rectifier K+ channels. As a test of utility, RNA sequence data from Zika-infected cells were mapped to the C6/36 genome and transcriptome assemblies. Host subtraction reduced the data set by 89%, enabling faster characterization of nonhost reads. Conclusions: The C6/36 genome sequence and annotation should enable additional uses of the cell line to study arbovirus vector interactions and interventions aimed at restricting the spread of human disease.
C1 [Miller, Jason R.; Dilley, Kari A.; Puri, Vinita; Brown, David M.; Harkins, Derek M.; Sutton, Granger G.; Piermarini, Peter M.; Shabman, Reed S.] J Craig Venter Inst, 9714 Med Ctr Dr, Rockville, MD 20850 USA.
   [Miller, Jason R.] Shepherd Univ, Coll Nat Sci & Math, Shepherdstown, WV 25443 USA.
   [Koren, Sergey; Phillippy, Adam M.] NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, Bethesda, MD 20892 USA.
   [Thibaud-Nissen, Francoise] NCBI, NLM, NIH, 45 Ctr Dr, Bethesda, MD 20894 USA.
   [Rosen, Benjamin] USDA, 10300 Baltimore Ave,Bldg 306 Barc East, Beltsville, MD 20705 USA.
   [Chen, Xiao-Guang] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Pathogen Biol, Guangzhou 510515, Guangdong, Peoples R China.
   [Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA USA.
   [Tu, Zhijian; Sharakhov, Igor V.; Sharakhova, Maria V.] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA USA.
   [Sharakhov, Igor V.; Sharakhova, Maria V.] Virginia Tech, Dept Entomol, Blacksburg, VA USA.
   [Sharakhov, Igor V.; Sharakhova, Maria V.] Tomsk State Univ, Lab Ecol Genet & Environm Protect, Tomsk, Russia.
   [Sebra, Robert] Icahn Sch Med Mt Sinai, New York, NY 10029 USA.
   [Stockwell, Timothy B.; Bergman, Nicholas H.] NBACC, Ft Detrick, MD 21702 USA.
   [Piermarini, Peter M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.
   [Shabman, Reed S.] ATCC, 217 Perry Pkwy, Gaithersburg, MD 20877 USA.
RP Miller, JR (corresponding author), J Craig Venter Inst, 9714 Med Ctr Dr, Rockville, MD 20850 USA.
EM jmill02@shepherd.edu
RI Phillippy, Adam M/U-5731-2018; Koren, Sergey/AAE-8314-2019; Sharakhov,
   Igor/B-1972-2008
OI Phillippy, Adam M/0000-0003-2983-8934; Sharakhov,
   Igor/0000-0003-0752-3747; Miller, Jason/0000-0002-6912-2925; Stockwell,
   Timothy/0000-0002-3595-4539; Koren, Sergey/0000-0002-1472-8962; Brown,
   David/0000-0002-5524-7276
FU Department of Homeland Security (DHS)United States Department of
   Homeland Security (DHS) [HSHQDC-15-C-B0059]; National Nature Science
   Foundation of ChinaNational Natural Science Foundation of China [81 420
   108 024]; Natural Science Foundation of Guangdong ProvinceNational
   Natural Science Foundation of Guangdong Province [2014A030312016];
   National Institute of Allergy and Infectious Diseases (NIAIDP) grant
   [AI123338]; Intramural Research Program of the National Human Genome
   Research Institute, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Human Genome Research Institute (NHGRI); Intramural
   Research Program of the National Institutes of Health, National Library
   of MedicineUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Library of Medicine (NLM);
   DHS Science and Technology Directorate (ST) [HSHQDC-07-C-00020]
FX JCVI staff was supported by Department of Homeland Security (DHS)
   contract HSHQDC-15-C-B0059. X.G.C. was supported by the National Nature
   Science Foundation of China (81 420 108 024) and the Natural Science
   Foundation of Guangdong Province (2014A030312016). Z.T. was supported by
   National Institute of Allergy and Infectious Diseases (NIAIDP) grant
   AI123338. P.M.P. was supported by state and federal funds appropriated
   to the Ohio Agricultural Research and Development Center (OARDC) of the
   Ohio State University. S.K. and A.M.P. were supported by the Intramural
   Research Program of the National Human Genome Research Institute,
   National Institutes of Health. F.T.N. was supported by the Intramural
   Research Program of the National Institutes of Health, National Library
   of Medicine. N.H.B. and T.S. were supported under contract No.
   HSHQDC-07-C-00020 awarded by the DHS Science and Technology Directorate
   (S&T) for the management and operation of the NBACC, a Federally Funded
   Research and Development Center. The views and conclusions contained in
   this document are those of the authors and should not be interpreted as
   representing the official policies, either expressed or implied, of the
   DHS or S&T. In no event shall the DHS, NBACC, S&T, or Battelle National
   Biodefense Institute have any responsibility or liability for any use,
   misuse, inability to use, or reliance upon the information contained
   herein. DHS does not endorse any products or commercial services
   mentioned in this publication.
CR Acland A, 2013, NUCLEIC ACIDS RES, V41, pD8, DOI 10.1093/nar/gks1189
   Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064
   Alexander DH, 2016, QUIVER FAQ
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   [Anonymous], 2017, PAC BIOSC GEN CONS
   ATCC, 2017, CRL1660TM ATCC
   Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Chen SX, 2004, VIROLOGY, V318, P123, DOI 10.1016/j.virol.2003.09.013
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]
   CHIPLONKAR JM, 1983, EXPERIENTIA, V39, P608, DOI 10.1007/BF01971121
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Daly GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129059
   Drake LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07795
   Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578
   Dritsou V, 2015, PATHOG GLOB HEALTH, V109, P207, DOI 10.1179/2047773215Y.0000000031
   Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327
   Eleftherianos I, 2011, P NATL ACAD SCI USA, V108, P12024, DOI 10.1073/pnas.1108926108
   Esquivel CJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1784
   FERRARI JA, 1989, EVOLUTION, V43, P895, DOI 10.1111/j.1558-5646.1989.tb05187.x
   Avila-Bonilla RG, 2017, VIRUS RES, V232, P139, DOI 10.1016/j.virusres.2017.03.005
   GenomeWiki, 2017, MIN STEPS LIFTOVER
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Goubert C, 2015, GENOME BIOL EVOL, V7, P1192, DOI 10.1093/gbe/evv050
   Hall AB, 2016, P NATL ACAD SCI USA, V113, pE2114, DOI 10.1073/pnas.1525164113
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hall AB, 2014, GENOME BIOL EVOL, V6, P179, DOI 10.1093/gbe/evu002
   Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273
   Hammond S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-67
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100
   Jiao WB, 2017, CURR OPIN PLANT BIOL, V36, P64, DOI 10.1016/j.pbi.2017.02.002
   Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202
   Koren S., 2017, ARROW GRID
   Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116
   Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu K, 2016, BIOL CELL, V108, P294, DOI 10.1111/boc.201600030
   Liu K, 2011, P NATL ACAD SCI USA, V108, P6062, DOI 10.1073/pnas.1102629108
   Lu ZY, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq036
   Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18
   MATTHEWS TC, 1980, ANN ENTOMOL SOC AM, V73, P739, DOI 10.1093/aesa/73.6.739
   Miller J, 2017, SUPPORTING DATA ANAL
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15
   Myers G., 2017, DAMASKER
   NCBI, 2017, NCBI EUK GEN ANN PIP
   NCBI, 2017, NCBI AED AEG ANN REL
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Overend G, 2015, INSECT BIOCHEM MOLEC, V67, P47, DOI 10.1016/j.ibmb.2015.05.007
   Paterson A, 2005, VIROLOGY, V337, P253, DOI 10.1016/j.virol.2005.04.037
   Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/NMETH.3454, 10.1038/nmeth.3454]
   Piermarini PM, 2015, INSECT BIOCHEM MOLEC, V67, P59, DOI 10.1016/j.ibmb.2015.06.006
   Piermarini PM, 2013, INSECT BIOCHEM MOLEC, V43, P75, DOI 10.1016/j.ibmb.2012.09.009
   Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Raphemot R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110772
   Raphemot R, 2014, INSECT BIOCHEM MOLEC, V51, P10, DOI 10.1016/j.ibmb.2014.05.002
   Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905
   Rouhier MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100700
   Rouhier MF, 2014, INSECT BIOCHEM MOLEC, V48, P91, DOI 10.1016/j.ibmb.2014.03.003
   Seo JS, 2016, NATURE, V538, P243, DOI 10.1038/nature20098
   Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351
   SINGH KRP, 1967, CURR SCI INDIA, V36, P506
   Sork VL, 2016, G3-GENES GENOM GENET, V6, P3485, DOI 10.1534/g3.116.030411
   Swale DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36954
   Tsujimoto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075888
   Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153
   WAGH UV, 1984, CYTOMETRY, V5, P403, DOI 10.1002/cyto.990050418
   Walenz B., 2017, CANU RELEASES
   Walker T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-382
   Weisenfeld NI, 2017, GENOME RES, V27, P757, DOI 10.1101/gr.214874.116
   WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X
   Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932
   Yang L, 2017, J INSECT PHYSIOL, V98, P141, DOI 10.1016/j.jinsphys.2016.12.005
   Yang ZX, 2017, COMP BIOCHEM PHYS B, V204, P35, DOI 10.1016/j.cbpb.2016.11.003
NR 84
TC 11
Z9 12
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2047-217X
J9 GIGASCIENCE
JI GigaScience
PD JAN 10
PY 2018
VL 7
IS 3
DI 10.1093/gigascience/gix135
PG 13
WC Biology; Multidisciplinary Sciences
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA GB0WH
UT WOS:000428770500001
PM 29329394
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, WB
   Li, G
   Wu, D
   Luo, Z
   Pan, P
   Tian, MF
   Wang, YC
   Xiao, F
   Li, AX
   Wu, KL
   Liu, XH
   Rao, L
   Liu, F
   Liu, YL
   Wu, JG
AF Wang, Wenbiao
   Li, Geng
   Wu, De
   Luo, Zhen
   Pan, Pan
   Tian, Mingfu
   Wang, Yingchong
   Xiao, Feng
   Li, Aixin
   Wu, Kailang
   Liu, Xiaohong
   Rao, Lang
   Liu, Fang
   Liu, Yingle
   Wu, Jianguo
TI Zika virus infection induces host inflammatory responses by facilitating
   NLRP3 inflammasome assembly and interleukin-1 beta secretion
SO NATURE COMMUNICATIONS
LA English
DT Article
ID EMERGENCE; RNA; RECOGNITION; RECEPTORS; IMMUNITY; PROTEIN; DEATH; LEADS
AB Zika virus (ZIKV) infection is a public health emergency and host innate immunity is essential for the control of virus infection. The NLRP3 inflammasome plays a key role in host innate immune responses by activating caspase-1 to facilitate interleukin-1 beta (IL-1 beta) secretion. Here we report that ZIKV stimulates IL-1 beta secretion in infected patients, human PBMCs and macrophages, mice, and mice BMDCs. The knockdown of NLRP3 in cells and knockout of NLRP3 in mice inhibit ZIKV-mediated IL-1 beta secretion, indicating an essential role for NLRP3 in ZIKV-induced IL-1 beta activation. Moreover, ZIKV NS5 protein is required for NLRP3 activation and IL-1 beta secretion by binding with NLRP3 to facilitate the inflammasome complex assembly. Finally, ZIKV infection in mice activates IL-1 beta secretion, leading to inflammatory responses in the mice brain, spleen, liver, and kidney. Thus we reveal a mechanism by which ZIKV induces inflammatory responses by facilitating NLRP3 inflammasome complex assembly and IL-1 beta activation.
C1 [Wang, Wenbiao; Pan, Pan; Tian, Mingfu; Wang, Yingchong; Xiao, Feng; Li, Aixin; Wu, Kailang; Liu, Fang; Liu, Yingle; Wu, Jianguo] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.
   [Wang, Wenbiao; Pan, Pan; Tian, Mingfu; Wang, Yingchong; Xiao, Feng; Li, Aixin; Wu, Kailang; Liu, Fang; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.
   [Wang, Wenbiao; Luo, Zhen; Liu, Yingle; Wu, Jianguo] Jinan Univ, Inst Med Microbiol, Guangzhou 510632, Guangdong, Peoples R China.
   [Li, Geng; Liu, Xiaohong] Guangzhou Univ Chinese Med, Sch Chinese Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.
   [Wu, De] Ctr Dis Control & Prevent Guangdong, Inst Pathogen Microbiol, Guangzhou 510006, Guangdong, Peoples R China.
   [Rao, Lang] Wuhan Univ, Sch Phys & Technol, Wuhan 430072, Hubei, Peoples R China.
RP Liu, F; Liu, YL; Wu, JG (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.; Liu, F; Liu, YL; Wu, JG (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.; Liu, YL; Wu, JG (corresponding author), Jinan Univ, Inst Med Microbiol, Guangzhou 510632, Guangdong, Peoples R China.
EM liufung@whu.edu.cn; mvlwu@whu.edu.cn; jwu@whu.edu.cn
RI Li, Aixin/AAO-7926-2020; Rao, Lang/H-4666-2017
OI Li, Aixin/0000-0002-3158-0170; Rao, Lang/0000-0001-5010-0729; Zhen,
   Luo/0000-0002-1142-2845; Liu, Xiaohong/0000-0003-4795-3039
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81730061, 31230005, 81471942, 31200134, 31270206];
   National Mega Project on Major Infectious Disease Prevention
   [2017ZX10103005]; Major Program of Guangdong Natural Science Foundation
   of China [S201230006598]
FX This work was supported by National Natural Science Foundation of China
   (No. 81730061, 31230005, 81471942, 31200134, and 31270206); the National
   Mega Project on Major Infectious Disease Prevention (No.
   2017ZX10103005); and the Major Program of Guangdong Natural Science
   Foundation of China (No. S201230006598). We thank Dr. Cheng-Feng Qin of
   the Beijing Institute of Microbiology and Epidemiology, China for the
   gift of 129/Sv/Ev mice (A129 mice) deficient in IFN-alpha/beta
   receptors; Dr. Di Wang of Zhejiang University School of Medicine, China
   for kindly providing C57BL/6 NLRP3<SUP>-/-</SUP> mice; Dr Takaji Wakita
   of the National Institute of Infectious Diseases, Japan for the gift of
   hepatitis C virus genotype 2a strain JFH-1; and Dr. Pei-Yong Shi of the
   University of Texas Medical Branch, USA for the gift of the infectious
   cDNA clone of ZIKV.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005
   Bassil F, 2016, P NATL ACAD SCI USA, V113, P9593, DOI 10.1073/pnas.1609291113
   Chen WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092154
   Chuang YT, 2011, BLOOD, V117, P960, DOI 10.1182/blood-2010-08-303115
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DINARELLO CA, 1977, P NATL ACAD SCI USA, V74, P4624, DOI 10.1073/pnas.74.10.4624
   Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032
   Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710
   FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141
   Shrivastava G, 2016, IMMUNOL RES, V64, P1101, DOI 10.1007/s12026-016-8873-z
   Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Wang HB, 2013, PROTEIN CELL, V4, P565, DOI 10.1007/s13238-013-3905-0
   Wang WB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 54
TC 46
Z9 48
U1 1
U2 24
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 9
PY 2018
VL 9
AR 106
DI 10.1038/s41467-017-02645-3
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS3CY
UT WOS:000419658100006
PM 29317641
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Braack, L
   de Almeida, APG
   Cornel, AJ
   Swanepoel, R
   De Jager, C
AF Braack, Leo
   Paulo Gouveia de Almeida, A.
   Cornel, Anthony J.
   Swanepoel, Robert
   De Jager, Christiaan
TI Mosquito-borne arboviruses of African origin: review of key viruses and
   vectors
SO PARASITES & VECTORS
LA English
DT Review
DE Africa; Mosquito-borne arboviruses; Vector mosquitoes; Zoonoses; Global
   health threats
ID WEST-NILE-VIRUS; RIFT-VALLEY FEVER; AEDES-AEGYPTI DIPTERA; ONYONG-NYONG
   FEVER; NATURAL VERTICAL TRANSMISSION; FATAL NEUROLOGIC DISEASE; HITHERTO
   UNKNOWN AGENT; SOUTH-CENTRAL UGANDA; YELLOW-FEVER; INSECTICIDE
   RESISTANCE
AB Key aspects of 36 mosquito-borne arboviruses indigenous to Africa are summarized, including lesser or poorly-known viruses which, like Zika, may have the potential to escape current sylvatic cycling to achieve greater geographical distribution and medical importance. Major vectors are indicated as well as reservoir hosts, where known. A series of current and future risk factors is addressed. It is apparent that Africa has been the source of most of the major mosquito-borne viruses of medical importance that currently constitute serious global public health threats, but that there are several other viruses with potential for international challenge. The conclusion reached is that increased human population growth in decades ahead coupled with increased international travel and trade is likely to sustain and increase the threat of further geographical spread of current and new arboviral disease.
C1 [Braack, Leo; Cornel, Anthony J.] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa.
   [Paulo Gouveia de Almeida, A.] Univ Nova Lisboa, Inst Higiene & Med Trop, Lisbon, Portugal.
   [Paulo Gouveia de Almeida, A.] Univ Pretoria, Dept Med Virol, Pretoria, South Africa.
   [Cornel, Anthony J.] Univ Calif Davis, Dept Entomol & Nematol, Kearney Agr Ctr, Mosquito Control Res Lab, Parlier, CA USA.
   [Swanepoel, Robert] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa.
   [De Jager, Christiaan] Univ Pretoria, Fac Hlth Sci, Pretoria, South Africa.
RP Braack, L (corresponding author), Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa.
EM leo.braack@up.ac.za
RI de almeida, antonio paulo gouveia/I-2541-2012
OI de almeida, antonio paulo gouveia/0000-0003-0751-4488; de Jager,
   Christiaan/0000-0002-3743-1715
CR Abilio AP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-110
   AITKEN THG, 1979, AM J TROP MED HYG, V28, P119, DOI 10.4269/ajtmh.1979.28.119
   Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Andreadis TG, 2012, J AM MOSQUITO CONTR, V28, P137, DOI 10.2987/8756-971X-28.4s.137
   Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56
   Antipa C, 1984, Virologie, V35, P5
   Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Attoui H, 2007, J GEN VIROL, V88, P3078, DOI 10.1099/vir.0.83076-0
   BAQAR S, 1993, AM J TROP MED HYG, V48, P757, DOI 10.4269/ajtmh.1993.48.757
   BEATY BJ, 1980, AM J TROP MED HYG, V29, P125, DOI 10.4269/ajtmh.1980.29.125
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Berthet N, 2016, VECTOR-BORNE ZOONOT, V16, P139, DOI 10.1089/vbz.2015.1830
   Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0
   Bongaarts J, 2009, PHILOS T R SOC B, V364, P2985, DOI 10.1098/rstb.2009.0137
   Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144
   BOORMAN J. P. T., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P383, DOI 10.1016/0035-9203(58)90053-1
   Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05
   Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030
   Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410
   Brown CR, 2011, ORNITHOLOGICAL MONOG, V71
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Brummer-Korvenkontio M, 2002, EPIDEMIOL INFECT, V129, P335, DOI 10.1017/S0950268802007409
   BRUMMERKORVENKONTIO M, 1975, MED BIOL, V53, P279
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Burt FJ, 2014, FUTURE VIROL, V9, P993, DOI 10.2217/FVL.14.87
   Burt FJ, 2002, EMERG INFECT DIS, V8, P820, DOI 10.3201/eid0808.020027
   Cadar D, 2014, EMERG INFECT DIS, V20, P1771, DOI 10.3201/eid2010.140909
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Cantile C, 2000, EQUINE VET J, V32, P31, DOI 10.2746/042516400777612080
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Centers for Disease Control and Prevention, 2017, RIFT VALL FEV
   Centers for Disease Control and Prevention, 2017, YELL FEV BRAZ
   Centers for Disease Control and Prevention, 2016, COUNTR HAV CURR EV Z
   Centers for Disease Control & Prevention, 2016, HAS CHIK VIR BEEN FO
   Centres for Disease Control and Prevention, KAM VIR
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chompoosri J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1505-6
   Christian KA, 2017, HEALTH SECUR, V15, P1
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   D'Antonio M., 2001, MOSQUITO NATURAL HIS
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   Davidson I, 2015, ISR J VET MED, V70, P3
   DESOUZA M, 1991, J AM MOSQUITO CONTR, V7, P118
   Dhar-Chowdhury P, 2016, AM J TROP MED HYG, V94, P1223, DOI 10.4269/ajtmh.15-0639
   Diallo M, 2005, AM J TROP MED HYG, V73, P445, DOI 10.4269/ajtmh.2005.73.445
   Diallo M, 2000, AM J TROP MED HYG, V62, P151, DOI 10.4269/ajtmh.2000.62.151
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Digoutte J.-P., 1980, Medecine Tropicale, V40, P523
   DIGOUTTE J-P, 1972, Bulletin de la Societe de Pathologie Exotique, V65, P751
   Dilcher M, 2013, VIRUS GENES, V46, P162, DOI 10.1007/s11262-012-0825-7
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Eiden M, 2014, EMERG INFECT DIS, V20, P2174, DOI 10.3201/eid2012.140787
   Elliott RM, 2009, CLIN MICROBIOL INFEC, V15, P510, DOI 10.1111/j.1469-0691.2009.02849.x
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869
   Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860
   Escobar LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1403-y
   Fall G, 2016, VECTOR-BORNE ZOONOT, V16, P781, DOI 10.1089/vbz.2016.1967
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218
   Fontenille D, 1997, T ROY SOC TROP MED H, V91, P533, DOI 10.1016/S0035-9203(97)90013-4
   Forrester NL, 2012, J VIROL, V86, P2729, DOI 10.1128/JVI.05591-11
   Fros JJ, 2015, ONE HEALTH, V1, P31, DOI 10.1016/j.onehlt.2015.08.002
   Garigliany MM, 2014, VET J, V199, P191, DOI 10.1016/j.tvjl.2013.10.017
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   GERMAIN M, 1982, B I PASTEUR, V80, P315
   Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004
   Gokhale M. D., 2001, Journal of Communicable Diseases, V33, P212
   Golender N, 2015, EMERG INFECT DIS, V21, P2267, DOI 10.3201/eid2112.150804
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gould EA, 2001, ADV VIRUS RES, V57, P71, DOI 10.1016/S0065-3527(01)57001-3
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   GRIST NR, 1993, J INFECTION, V27, P1, DOI 10.1016/0163-4453(93)93418-4
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Groseth A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003147
   Groseth A, 2012, J VIROL, V86, P13846, DOI 10.1128/JVI.02644-12
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   GUBLER DJ, 1970, MOSQ NEWS, V30, P201
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   GUBLER DJ, 1998, PATHOLOGY EMERGING I, V2, P43
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Gudo ES, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005001
   Gudo ES, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005052
   Gudo ES, 2016, EMERG INFECT DIS, V22, P915, DOI 10.3201/eid2205.151002
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   HADDOW A. J., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P517, DOI 10.1016/0035-9203(60)90025-0
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218, DOI 10.1080/00034983.1948.11685365
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hernandez-Triana LM, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00271
   Hesson JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162005
   Hien DS., 1975, ACTA PARASITOL POL, V23, P395
   Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Horne KM, 2014, VIRUSES-BASEL, V6, P4373, DOI 10.3390/v6114373
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   IHS, 2017, 5 TRENDS SHAP MAR IN
   Intergovernmental Panel on Climate Change, 2014, CLIMATE CHANGE 2014
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Jia PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2071-2
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Jupp P.G., 1996, MOSQUITOES SO AFRICA
   Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x
   JUPP PG, 1992, J AM MOSQUITO CONTR, V8, P321
   JUPP PG, 1976, J MED ENTOMOL, V12, P647, DOI 10.1093/jmedent/12.6.647
   Jupp PG, 2004, INFECT DIS LIVESTOCK
   Karabatsos N., 1985, INT CATALOGUE ARBOVI
   Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364
   Knudsen A. B., 1995, Parassitologia (Rome), V37, P91
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P145
   KOKERNOT R. H., 1960, S AFRICAN MED JOUR, V34, P871
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P71
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P81
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P103
   KOKERNOT RH, 1961, ANN TROP MED PARASIT, V55, P73, DOI 10.1080/00034983.1961.11686021
   KOKERNOT RH, 1958, AM J TROP MED HYG, V7, P579, DOI 10.4269/ajtmh.1958.7.579
   KOKERNOT RH, 1962, AM J TROP MED HYG, V11, P683, DOI 10.4269/ajtmh.1962.11.683
   KOKERNOT RH, 1960, AM J TROP MED HYG, V9, P62, DOI 10.4269/ajtmh.1960.9.62
   KOKERNOT RH, 1962, AM J TROP MED HYG, V11, P678, DOI 10.4269/ajtmh.1962.11.678
   KOKERNOT RH, 1961, AM J TROP MED HYG, V10, P383, DOI 10.4269/ajtmh.1961.10.383
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6
   Kollars Jr TM, 2016, INT J MED, V4, P70, DOI DOI 10.14419/IJM.V4I2.5922
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kurkela S, 2008, EMERG INFECT DIS, V14, P41, DOI 10.3201/eid1401.070510
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanciotti RS, 1998, VIROLOGY, V252, P258, DOI 10.1006/viro.1998.9437
   LEAKE CJ, 1992, PARASITOL TODAY, V8, P123, DOI 10.1016/0169-4758(92)90279-B
   Lecollinet S, 2016, EMERG INFECT DIS, V22, P2225, DOI 10.3201/eid2212.161272
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434
   Lucey D, 2016, JAMA-J AM MED ASSOC, V315, P2661, DOI 10.1001/jama.2016.6606
   Lutomiah J, 2014, VECTOR-BORNE ZOONOT, V14, P656, DOI 10.1089/vbz.2013.1564
   Lutwama JJ, 1999, AM J TROP MED HYG, V61, P158, DOI 10.4269/ajtmh.1999.61.158
   Lutwama Julius J, 2002, Afr Health Sci, V2, P24
   Mahy B.W., 2009, DICT VIROLOGY
   Malkinson M, 2002, CURR TOP MICROBIOL, V267, P309
   Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700
   Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112
   McIntosh B, 1980, THESIS
   McINTOSH B. M., 1961, S AFRICAN MED JOUR, V35, P647
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P63, DOI 10.1016/0035-9203(61)90041-4
   McIntosh B M, 1972, J S Afr Vet Med Assoc, V43, P391
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P192, DOI 10.1016/0035-9203(61)90025-6
   MCINTOSH BM, 1980, S AFR MED J, V58, P127
   MCINTOSH BM, 1976, J MED ENTOMOL, V12, P637, DOI 10.1093/jmedent/12.6.637
   MCINTOSH BM, 1976, S AFR J SCI, V72, P295
   MCINTOSH BM, 1976, J MED ENTOMOL, V12, P645, DOI 10.1093/jmedent/12.6.645
   McIntosh BM, 1960, S AFR J MED SCI, V23, P33
   Meegan JM., 1994, HDB ZOONOSES B, P111
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Monath TP, 1989, ARBOVIRUSES EPIDEMIO, V5, P139
   Monath TP, 2001, ENCY ARTHROPOD TRANS, P571
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   MORVAN JM, 1994, T ROY SOC TROP MED H, V88, P205, DOI 10.1016/0035-9203(94)90297-6
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Murgue B, 2001, EMERG INFECT DIS, V7, P692
   Mutebi JP, 2002, MICROBES INFECT, V4, P1459, DOI 10.1016/S1286-4579(02)00028-X
   Nakoune E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005082
   Nelms BM, 2013, J MED ENTOMOL, V50, P371, DOI 10.1603/ME12264
   Nikolay B, 2012, AM J TROP MED HYG, V86, P993, DOI 10.4269/ajtmh.2012.11-0509
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28
   Norris LC, 2011, J VECTOR ECOL, V36, P411, DOI 10.1111/j.1948-7134.2011.00182.x
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140
   Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022
   Olivia Lwande Wesula, 2015, Infection Ecology & Epidemiology, V5, P29853, DOI 10.3402/iee.v5.29853
   Ortiz-Martinez Yeimer, 2017, F1000Res, V6, P398, DOI 10.12688/f1000research.11280.2
   Pachler K, 2013, INFECT GENET EVOL, V20, P124, DOI 10.1016/j.meegid.2013.08.015
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Patsoula E, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2450682
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Pedro SA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005167
   Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033
   Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386
   Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Poulakou G, 2016, INTENS CARE MED, V42, P2055, DOI 10.1007/s00134-016-4580-4
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Pringle C. R., 1996, The Bunyaviridae., P189
   Protopopoff N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-149
   Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x
   Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   ROBIN Y, 1978, ANN INST PASTEUR MIC, VA129, P239
   ROSEN L, 1988, AM J TROP MED HYG, V39, P123, DOI 10.4269/ajtmh.1988.39.123
   Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441
   Sall AA, 1999, J VIROL, V73, P8196, DOI 10.1128/JVI.73.10.8196-8200.1999
   Sam IC, 2015, VECTOR-BORNE ZOONOT, V15, P223, DOI 10.1089/vbz.2014.1680
   Sanders EJ, 1999, J INFECT DIS, V180, P1436, DOI 10.1086/315073
   Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319
   Schaffner F, 2008, DEV AEDES ALBOPICTUS
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Singh AK, 2016, DEF LIFE SCI J, V1, P184
   SMITHBURN K. C., 1959, S AFRICAN MED JOUR, V33, P959
   SMITHBURN K. C, 1959, S AFRICAN MED JOUR, V33, P555
   SMITHBURN KC, 1946, AM J TROP MED, V26, P189
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130, DOI 10.3181/00379727-77-18700
   Smithburn KC, 1944, J IMMUNOL, V49, P141
   Smithburn KC, 1940, AM J TROP MED, V20, P71
   Smithburn KC, 1941, AM J TROP MED HYG, V21, P75
   Soper L., 1977, 355 PAN AM HLTH ORG
   SOTA T, 1992, OECOLOGIA, V90, P353, DOI 10.1007/BF00317691
   Sudeep AB, 2013, INDIAN J MED RES, V138, P257
   Swanepoel R, 1998, ZOONOSES, P459
   Swanepoel R., 2004, INFECT DIS LIVESTOCK
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   TAYLOR RM, 1955, AM J TROP MED HYG, V4, P844, DOI 10.4269/ajtmh.1955.4.844
   Tchetgna HDS, 2017, VECTOR-BORNE ZOONOT, V17, P447, DOI 10.1089/vbz.2016.2068
   Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474
   Townson H, 2008, T ROY SOC TROP MED H, V102, P308, DOI 10.1016/j.trstmh.2007.11.013
   Tricou V, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.01078-14
   TRPIS M, 1972, B WORLD HEALTH ORGAN, V47, P433
   TRPIS M, 1973, B WORLD HEALTH ORGAN, V48, P447
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tukei P. M., 1972, Cahiers ORSTOM, Serie Entomologie Medicale et Parasitologie, V10, P159
   UN, 2014, STESASERA352 UN POP
   United Nations, 2013, WORLD POP PROSP 2012
   van Eeden C, 2014, EMERG INFECT DIS, V20, P1409, DOI 10.3201/eid2008.131724
   van Eeden C, 2012, EMERG INFECT DIS, V18, P318, DOI 10.3201/eid1802.111403
   van Niekerk S, 2015, EMERG INFECT DIS, V21, P2225, DOI 10.3201/eid2112.150132
   vanEeden C, 2014, THESIS
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vazquez A, 2011, EUROSURVEILLANCE, V16, P22
   Venter M, 2011, EMERG INFECT DIS, V17, P1534, DOI 10.3201/eid1708.101794
   Venter M, 2010, VECTOR-BORNE ZOONOT, V10, P659, DOI 10.1089/vbz.2009.0230
   Venter M, 2009, EMERG INFECT DIS, V15, P877, DOI 10.3201/eid1506.081515
   Vest KG, 2016, DISASTER MED PUBLIC, V10, P707, DOI 10.1017/dmp.2016.43
   Vogels CBF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166959
   Vonesch N, 2016, ANN I SUPER SANITA, V52, P397, DOI 10.4415/ANN_16_03_11
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   WEISS K. E., 1956, ONDERSTEPOORT JOUR VET RES, V27, P183
   WHO, YELL FEV BRAZ
   Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602
   WILLIAMS M. C., 1965, ARCH GESAMTE VIRUSFORSCH, V15, P422, DOI 10.1007/BF01241769
   WILLIAMS M C, 1964, East Afr Med J, V41, P271
   WILLIAMS MC, 1964, ANN TROP MED PARASIT, V58, P367, DOI 10.1080/00034983.1964.11686258
   Williams RAJ, 2012, AFR J MICROBIOL RES, V6, P1966, DOI 10.5897/AJMR11.479
   WOLFE MS, 1982, LANCET, V2, P1306
   WOODRUFF AW, 1978, BRIT MED J, V1, P956, DOI 10.1136/bmj.1.6118.956
   WORTH CB, 1961, AM J TROP MED HYG, V10, P583, DOI 10.4269/ajtmh.1961.10.583
   Yanola J, 2015, ACTA TROP, V149, P232, DOI 10.1016/j.actatropica.2015.06.011
   Zeller HG, 1996, B SOC PATHOL EXOT, V89, P12
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 282
TC 42
Z9 44
U1 7
U2 37
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JAN 9
PY 2018
VL 11
AR 29
DI 10.1186/s13071-017-2559-9
PG 26
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FS3MG
UT WOS:000419685400004
PM 29316963
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU MacFadden, A
   O'Donoghue, Z
   Silva, PAGC
   Chapman, EG
   Olsthoorn, RC
   Sterken, MG
   Pijlman, GP
   Bredenbeek, PJ
   Kieft, JS
AF MacFadden, Andrea
   O'Donoghue, Zoe
   Silva, Patricia A. G. C.
   Chapman, Erich G.
   Olsthoorn, Rene C.
   Sterken, Mark G.
   Pijlman, Gorben P.
   Bredenbeek, Peter J.
   Kieft, Jeffrey S.
TI Mechanism and structural diversity of exoribonuclease-resistant RNA
   structures in flaviviral RNAs
SO NATURE COMMUNICATIONS
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; SUBGENOMIC RNA; MESSENGER-RNA;
   CAPILLARY-ELECTROPHORESIS; BORNE FLAVIVIRUSES; HOST ADAPTATION; ROBUST
   ANALYSIS; MOSQUITO CELLS; RIBOSOMAL-RNA; INTERFERENCE
AB Flaviviruses such as Yellow fever, Dengue, West Nile, and Zika generate disease-linked viral noncoding RNAs called subgenomic flavivirus RNAs. Subgenomic flavivirus RNAs result when the 5'-3' progression of cellular exoribonuclease Xrn1 is blocked by RNA elements called Xrn1-resistant RNAs located within the viral genome's 3'-untranslated region that operate without protein co-factors. Here, we show that Xrn1-resistant RNAs can halt diverse exoribonucleases, revealing a mechanism in which they act as general mechanical blocks that ` brace' against an enzyme's surface, presenting an unfolding problem that confounds further enzyme progression. Further, we directly demonstrate that Xrn1-resistant RNAs exist in a diverse set of flaviviruses, including some specific to insects or with no known arthropod vector. These Xrn1-resistant RNAs comprise two secondary structural classes that mirror previously reported phylogenic analysis. Our discoveries have implications for the evolution of exoribonuclease resistance, the use of Xrn1-resistant RNAs in synthetic biology, and the development of new therapies.
C1 [MacFadden, Andrea; O'Donoghue, Zoe; Chapman, Erich G.; Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.
   [Silva, Patricia A. G. C.; Bredenbeek, Peter J.] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2333 ZA Leiden, Netherlands.
   [Olsthoorn, Rene C.] Leiden Univ, Leiden Inst Chem, Einsteinweg 55, NL-2333 CC Leiden, Netherlands.
   [Sterken, Mark G.; Pijlman, Gorben P.] Wageningen Univ, Lab Virol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.
   [Sterken, Mark G.] Wageningen Univ, Lab Nematol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.
   [Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, RNA BioSci Initiat, Aurora, CO 80045 USA.
   [Chapman, Erich G.] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA.
RP Kieft, JS (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.; Kieft, JS (corresponding author), Univ Colorado, Denver Sch Med, RNA BioSci Initiat, Aurora, CO 80045 USA.
EM Jeffrey.Kieft@ucdenver.edu
OI Kieft, Jeffrey/0000-0002-3718-1891
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R35GM118070, T32AI052066, K99GM115757]
FX The authors thank current and former Kieft Lab members for thoughtful
   discussions and technical assistance. The expression vector for RNase J1
   was a gift of Ciaran Condon, the expression vectors for Dxo1 and Xrn1
   were gifts of Liang Tong, and the expression vector for RppH was a gift
   of Joel Belasco. This work was supported by NIH grant R35GM118070 to
   J.S.K., NIH training grant T32AI052066 to Z.O., and NIH K99GM115757 to
   E.G.C. J.S.K. was an Early Career Scientist of the Howard Hughes Medical
   Institute.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   BREDENBEEK PJ, 1993, J VIROL, V67, P6439, DOI 10.1128/JVI.67.11.6439-6446.1993
   Chang JH, 2012, NAT STRUCT MOL BIOL, V19, P1011, DOI 10.1038/nsmb.2381
   Chang JH, 2011, NAT STRUCT MOL BIOL, V18, P270, DOI 10.1038/nsmb.1984
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Cordero P, 2014, METHODS MOL BIOL, V1086, P53, DOI 10.1007/978-1-62703-667-2_4
   Dorleans A, 2011, STRUCTURE, V19, P1252, DOI 10.1016/j.str.2011.06.018
   Fields B.N., 2013, FIELDS VIROLOGY
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Iwakawa HO, 2008, J VIROL, V82, P10162, DOI 10.1128/JVI.01027-08
   Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004
   Jones CI, 2012, WIRES RNA, V3, P455, DOI 10.1002/wrna.1109
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Kim H, 2013, NUCLEIC ACIDS RES, V41, pW492, DOI 10.1093/nar/gkt501
   Kladwang W, 2014, BIOCHEMISTRY-US, V53, P3063, DOI 10.1021/bi5003426
   Lamiable A, 2012, COMPUT BIOL CHEM, V37, P1, DOI 10.1016/j.compbiolchem.2011.11.001
   Lee S, 2015, BIOINFORMATICS, V31, P2808, DOI 10.1093/bioinformatics/btv282
   Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106
   Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004
   Liu R, 2010, BIOCHEM BIOPH RES CO, V391, P1099, DOI 10.1016/j.bbrc.2009.12.030
   Liu Y, 2014, VIROLOGY, V448, P15, DOI 10.1016/j.virol.2013.09.016
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moon SL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004708
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   NAEVE CW, 1978, J VIROL, V25, P535, DOI 10.1128/JVI.25.2.535-545.1978
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Sambrook J, 1989, MOL CLONING LAB MANU, V1, P626
   Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Silva PAGC, 2007, J GEN VIROL, V88, P1738, DOI 10.1099/vir.0.82811-0
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   TAKEDA H, 1978, J GEN VIROL, V38, P281, DOI 10.1099/0022-1317-38-2-281
   Urosevic N, 1997, J GEN VIROL, V78, P23, DOI 10.1099/0022-1317-78-1-23
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   VLACHAKIS D, 2013, PEERJ, V1
   WENGLER G, 1978, VIROLOGY, V89, P423, DOI 10.1016/0042-6822(78)90185-X
   Yoon S, 2011, BIOINFORMATICS, V27, P1798, DOI 10.1093/bioinformatics/btr277
NR 52
TC 19
Z9 20
U1 1
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 9
PY 2018
VL 9
AR 119
DI 10.1038/s41467-017-02604-y
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS3CY
UT WOS:000419658100018
PM 29317714
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chatrin, C
   Talapatra, SK
   Canard, B
   Kozielski, F
AF Chatrin, Chatrin
   Talapatra, Sandeep K.
   Canard, Bruno
   Kozielski, Frank
TI The structure of the binary methyltransferase-SAH complex from Zika
   virus reveals a novel conformation for the mechanism of mRNA capping
SO ONCOTARGET
LA English
DT Article
DE zika virus; flavivirus; methyltransferase; methylation; mRNA capping
ID CRYSTAL-STRUCTURE; NS5 METHYLTRANSFERASE; CAPPED RNAS; RECOGNITION;
   DOMAIN; METHYLATION; INTERFACE
AB Zika virus, a flavivirus like Dengue and West Nile viruses, poses a significant risk as a pathogen in the category of emerging infectious diseases. Zika infections typically cause nonspecific, mild symptoms, but can also manifest as a neurological disorder like Guillain-Barre syndrome. Infection in pregnant women is linked to microcephaly in newborn infants. The methyltransferase domain of the non-structural protein 5 is responsible for two sequential methylations of the 5'-RNA cap. This is crucial for genome stability, efficient translation, and escape from the host immune response. Here we present the crystal structures of the Zika methyltransferase domain in complex with the methyl-donor SAM and its by-product SAH. The methyltransferase-SAH binary complex presents a new conformation of a "closed" or "obstructed" state that would restrict the binding of new RNA for capping. The combination and comparison of our new structures with recently published Zika methyltransferase structures provide a first glimpse into the structural mechanism of Zika virus mRNA capping.
C1 [Chatrin, Chatrin; Talapatra, Sandeep K.; Kozielski, Frank] UCL, Dept Pharmaceut & Biol Chem, Sch Pharm, London WC1N 1AX, England.
   [Canard, Bruno] Aix Marseille Univ, CNRS, AFMB UMR7257, Marseille, France.
RP Kozielski, F (corresponding author), UCL, Dept Pharmaceut & Biol Chem, Sch Pharm, London WC1N 1AX, England.
EM f.kozielski@ucl.ac.uk
RI amsalu, ribka/G-8780-2019
OI Canard, Bruno/0000-0003-4924-1991; , Chatrin/0000-0002-5666-3175
FU PharmAlliance; Indonesian Endowment Fund for Education
FX We are grateful to PharmAlliance for financial support. C.C. received a
   scholarship from the Indonesian Endowment Fund for Education.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Assenberg R, 2007, J GEN VIROL, V88, P2228, DOI 10.1099/vir.0.82757-0
   Barzon L, 2016, FEMS MICROBIOL LETT, P363
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, P91
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07
   Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Hercik K, 2017, ARCH VIROL
   Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jain R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01756-7
   Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liu Lihui, 2010, Front Biol (Beijing), V5, P286
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Narayanan K, 2013, BBA-GENE REGUL MECH, V1829, P732, DOI 10.1016/j.bbagrm.2012.12.003
   Oh SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005444
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020
   Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Zhang C, 2016, BIOCH BIOPHYS RES CO
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
NR 46
TC 3
Z9 4
U1 1
U2 7
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD JAN 9
PY 2018
VL 9
IS 3
BP 3160
EP 3171
DI 10.18632/oncotarget.23223
PG 12
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA FS3GU
UT WOS:000419669600018
PM 29423037
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Carrington, LB
   Tran, BCN
   Le, NTH
   Luong, TTH
   Nguyen, TT
   Nguyen, PT
   Nguyen, CVV
   Nguyen, HTC
   Vu, TT
   Vo, LT
   Le, DT
   Vu, NT
   Nguyen, GT
   Luu, HQ
   Dang, AD
   Hurst, TP
   O'Neill, SL
   Tran, VT
   Kien, DTH
   Nguyen, NM
   Wolbers, M
   Wills, B
   Simmons, CP
AF Carrington, Lauren B.
   Bich Chau Nguyen Tran
   Nhat Thanh Hoang Le
   Tai Thi Hue Luong
   Truong Thanh Nguyen
   Phong Thanh Nguyen
   Chau Van Vinh Nguyen
   Huong Thi Cam Nguyen
   Trung Tuan Vu
   Long Thi Vo
   Dui Thi Le
   Nhu Tuyet Vu
   Giang Thi Nguyen
   Hung Quoc Luu
   Anh Duc Dang
   Hurst, Timothy P.
   O'Neill, Scott L.
   Vi Thuy Tran
   Duong Thi Hue Kien
   Nguyet Minh Nguyen
   Wolbers, Marcel
   Wills, Bridget
   Simmons, Cameron P.
TI Field-and clinically derived estimates of Wolbachia-mediated blocking of
   dengue virus transmission potential in Aedes aegypti mosquitoes
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE w/Mel Wolbachia; dengue virus; Aedes aegypti mosquito; extrinsic
   incubation period; virus transmission
ID DIPTERA-CULICIDAE; LARVAL DENSITY; ZIKA VIRUS; INFECTION; SIZE;
   TEMPERATURE; COMPETENCE; VACCINE; POPULATIONS; PLASMODIUM
AB The wMel strain of Wolbachia can reduce the permissiveness of Aedes aegypti mosquitoes to disseminated arboviral infections. Here, we report that wMel-infected Ae. aegypti (Ho Chi Minh City background), when directly blood-fed on 141 viremic dengue patients, have lower dengue virus (DENV) transmission potential and have a longer extrinsic incubation period than their wild-type counterparts. The wMel-infected mosquitoes that are field-reared have even greater relative resistance to DENV infection when fed on patient-derived viremic blood meals. This is explained by an increased susceptibility of field-reared wild-type mosquitoes to infection than laboratory-reared counterparts. Collectively, these field- and clinically relevant findings support the continued careful field-testing of wMel introgression for the biocontrol of Ae. aegypti-born arboviruses.
C1 [Carrington, Lauren B.; Bich Chau Nguyen Tran; Nhat Thanh Hoang Le; Trung Tuan Vu; Long Thi Vo; Dui Thi Le; Nhu Tuyet Vu; Giang Thi Nguyen; Vi Thuy Tran; Duong Thi Hue Kien; Nguyet Minh Nguyen; Wolbers, Marcel; Wills, Bridget; Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Dist 5, Ho Chi Minh City, Vietnam.
   [Carrington, Lauren B.; Simmons, Cameron P.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.
   [Tai Thi Hue Luong; Truong Thanh Nguyen; Phong Thanh Nguyen; Chau Van Vinh Nguyen; Huong Thi Cam Nguyen] Hosp Trop Dis, Dist 5, Ho Chi Minh City, Vietnam.
   [Hung Quoc Luu; Anh Duc Dang] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam.
   [Hurst, Timothy P.; O'Neill, Scott L.; Simmons, Cameron P.] Monash Univ, Inst Vector Borne Dis, Melbourne, Vic 3168, Australia.
RP Carrington, LB (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Dist 5, Ho Chi Minh City, Vietnam.; Carrington, LB (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.
EM lbcarrington@gmail.com
RI O'Neill, Scott L/B-3568-2009
OI O'Neill, Scott L/0000-0002-4131-3615; Simmons, Cameron
   P./0000-0002-9039-7392; Carrington, Lauren Bree/0000-0001-9273-7912;
   Nguyen, Nguyet/0000-0002-5960-7849
FU Wellcome Trust (UK)Wellcome Trust; National Health and Medical Research
   Council (Australia)National Health and Medical Research Council of
   Australia
FX We thank the patients and their families for their participation in this
   study; the staff of the HTD; and Huynh Anh Huy, Huynh Le Phuong Thuy,
   Nguyen Thi Van Thuy, Huynh Thi Xuan Trang, Huynh Thi Thuy Van, and Vu Ty
   Hang for providing outstanding technical assistance. The field staff
   based in Nha Trang, particularly Luong Ngo Dong Vien and Tran Nguyen Bao
   Duy, provided weekly collections of both eggs and larvae; this work
   could not have been done without them. This work was supported by the
   Wellcome Trust (UK) and the National Health and Medical Research Council
   (Australia).
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Beserra EB, 2009, NEOTROP ENTOMOL, V38, P847, DOI 10.1590/S1519-566X2009000600020
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Buckner EA, 2016, J MED ENTOMOL, V53, P91, DOI 10.1093/jme/tjv145
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hugo LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002669
   Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kho EA, 2016, J MED ENTOMOL, V53, P894, DOI 10.1093/jme/tjw029
   Kien DTH, 2011, J VIROL METHODS, V177, P168, DOI 10.1016/j.jviromet.2011.08.002
   Koella JC, 1999, J EVOLUTION BIOL, V12, P760, DOI 10.1046/j.1420-9101.1999.00071.x
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Linenberg I, 2016, SCI REP-UK, V6, DOI 10.1038/srep38230
   Mitchell-Foster K, 2012, J VECTOR ECOL, V37, P221, DOI 10.1111/j.1948-7134.2012.00220.x
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Muturi EJ, 2012, J VECTOR ECOL, V37, P154, DOI 10.1111/j.1948-7134.2012.00212.x
   Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x
   NASCI RS, 1986, ENVIRON ENTOMOL, V15, P874, DOI 10.1093/ee/15.4.874
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Olivera-Botello G, 2016, J INFECT DIS, V214, P994, DOI 10.1093/infdis/jiw297
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Price DP, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0863-9
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sumanochitrapon W, 1998, AM J TROP MED HYG, V58, P283, DOI 10.4269/ajtmh.1998.58.283
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
NR 40
TC 27
Z9 27
U1 3
U2 42
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 9
PY 2018
VL 115
IS 2
BP 361
EP 366
DI 10.1073/pnas.1715788115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS3MQ
UT WOS:000419686400055
PM 29279375
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Azevedo, RSS
   de Sousa, JR
   Araujo, MTF
   Martins, AJ
   de Alcantara, BN
   Araujo, FMC
   Queiroz, MGL
   Cruz, ACR
   Vasconcelos, BHB
   Chiang, JO
   Martins, LC
   Casseb, LMN
   da Silva, EV
   Carvalho, VL
   Vasconcelos, BCB
   Rodrigues, SG
   Oliveira, CS
   Quaresma, JAS
   Vasconcelos, PFC
AF Azevedo, Raimunda S. S.
   de Sousa, Jorge R.
   Araujo, Marialva T. F.
   Martins Filho, Arnaldo J.
   de Alcantara, Bianca N.
   Araujo, Fernanda M. C.
   Queiroz, Maria G. L.
   Cruz, Ana C. R.
   Baldez Vasconcelos, Beatriz H.
   Chiang, Jannifer O.
   Martins, Livia C.
   Casseb, Livia M. N.
   da Silva, Eliana V.
   Carvalho, Valeria L.
   Baldez Vasconcelos, Barbara C.
   Rodrigues, Sueli G.
   Oliveira, Consuelo S.
   Quaresma, Juarez A. S.
   Vasconcelos, Pedro F. C.
TI In situ immune response and mechanisms of cell damage in central nervous
   system of fatal cases microcephaly by Zika virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID T-CELLS; INFECTION; EPIDEMIC; BIOLOGY
AB Zika virus (ZIKV) has recently caused a pandemic disease, and many cases of ZIKV infection in pregnant women resulted in abortion, stillbirth, deaths and congenital defects including microcephaly, which now has been proposed as ZIKV congenital syndrome. This study aimed to investigate the in situ immune response profile and mechanisms of neuronal cell damage in fatal Zika microcephaly cases. Brain tissue samples were collected from 15 cases, including 10 microcephalic ZIKV-positive neonates with fatal outcome and five neonatal control flavivirus-negative neonates that died due to other causes, but with preserved central nervous system (CNS) architecture. In microcephaly cases, the histopathological features of the tissue samples were characterized in three CNS areas (meninges, perivascular space, and parenchyma). The changes found were mainly calcification, necrosis, neuronophagy, gliosis, microglial nodules, and inflammatory infiltration of mononuclear cells. The in situ immune response against ZIKV in the CNS of newborns is complex. Despite the predominant expression of Th2 cytokines, other cytokines such as Th1, Th17, Treg, Th9, and Th22 are involved to a lesser extent, but are still likely to participate in the immunopathogenic mechanisms of neural disease in fatal cases of microcephaly caused by ZIKV.
C1 [Azevedo, Raimunda S. S.; de Sousa, Jorge R.; Cruz, Ana C. R.; Chiang, Jannifer O.; Martins, Livia C.; Casseb, Livia M. N.; da Silva, Eliana V.; Carvalho, Valeria L.; Rodrigues, Sueli G.; Oliveira, Consuelo S.; Vasconcelos, Pedro F. C.] Inst Evandro Chagas, Dept Arbovirol & Febres Hemorrag, Ananindeua, Para, Brazil.
   [de Alcantara, Bianca N.] Inst Evandro Chagas, Programa Posgrad Virol, Ananindeua, Para, Brazil.
   [Araujo, Marialva T. F.; Martins Filho, Arnaldo J.] Inst Evandro Chagas, Dept Pathol, Ananindeua, Para, Brazil.
   [Araujo, Fernanda M. C.] SES Ceara, Lab Cent Saude Publ, Fortaleza, Ceara, Brazil.
   [Queiroz, Maria G. L.] SES Rio Grande do Norte, Lab Cent Saude Publ, Natal, RN, Brazil.
   [Cruz, Ana C. R.; Baldez Vasconcelos, Barbara C.; Oliveira, Consuelo S.; Quaresma, Juarez A. S.; Vasconcelos, Pedro F. C.] Univ Estado Para, Belem, Para, Brazil.
   [Baldez Vasconcelos, Beatriz H.; Quaresma, Juarez A. S.] Univ Fed Para, Nucleo Med Trop, Belem, Para, Brazil.
RP Vasconcelos, PFC (corresponding author), Inst Evandro Chagas, Dept Arbovirol & Febres Hemorrag, Ananindeua, Para, Brazil.; Vasconcelos, PFC (corresponding author), Univ Estado Para, Belem, Para, Brazil.
EM pedrovasconcelos@iec.pa.gov.br
RI Filho, Arnaldo Jorge Martins/AAJ-2779-2020; Azevedo,
   Raimunda/T-4656-2019; QUARESMA, JUAREZ ANTONIO SIMOES/F-8390-2012;
   Vasconcelos, Pedro/AAH-3142-2019; Cruz, Ana Cecilia Ribeiro/V-9276-2019;
   amsalu, ribka/G-8780-2019; Quaresma, Juarez AS/M-4190-2014
OI Filho, Arnaldo Jorge Martins/0000-0001-9153-1234; Azevedo,
   Raimunda/0000-0003-1932-9976; QUARESMA, JUAREZ ANTONIO
   SIMOES/0000-0002-6267-9966; Quaresma, Juarez AS/0000-0002-6267-9966
CR Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Beltran D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00192
   Biswas SM, 2009, J GEN VIROL, V90, P818, DOI 10.1099/vir.0.008045-0
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Agostino PM, 2012, ACTA NEUROPATHOL, V124, P599, DOI 10.1007/s00401-012-1018-0
   Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93
   Graham JB, 2014, J IMMUNOL, V192, P683, DOI 10.4049/jimmunol.1202153
   Gupta N, 2014, EUR J IMMUNOL, V44, P1363, DOI 10.1002/eji.201343701
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Huang Z, 2015, SCAND J IMMUNOL, V82, P370, DOI 10.1111/sji.12326
   Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larena M, 2013, EUR J IMMUNOL, V43, P1789, DOI 10.1002/eji.201243152
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Maximova OA, 2009, J HISTOCHEM CYTOCHEM, V57, P973, DOI 10.1369/jhc.2009.954180
   Miao E, 2013, IMMUNOL REV, V243, P206
   Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603
   Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Patkai J, 2001, PEDIATR RES, V50, P222, DOI 10.1203/00006450-200108000-00010
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Quaresma JAS, 2005, ACTA TROP, V94, P116, DOI 10.1016/j.actatropica.2005.03.003
   Retallack H., 2016, ZIKA VIRUS HUMAN PLA
   Shrestha B, 2012, J VIROL, V86, P8937, DOI 10.1128/JVI.00673-12
   Srivastava R, 2012, INFLAMM RES, V61, P381, DOI 10.1007/s00011-011-0423-5
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Wang PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044153
   Winkelmann E. R., 2016, F1000RES, V5
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 44
TC 21
Z9 21
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 8
PY 2018
VL 8
AR 1
DI 10.1038/s41598-017-17765-5
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS0CK
UT WOS:000419441300001
PM 29311619
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barata, G
   Shores, K
   Alperin, JP
AF Barata, Germana
   Shores, Kenneth
   Alperin, Juan Pablo
TI Local chatter or international buzz? Language differences on posts about
   Zika research on Twitter and Facebook
SO PLOS ONE
LA English
DT Article
ID HEALTH; NETWORKS
AB Background
   When the Zika virus outbreak became a global health emergency in early 2016, the scientific community responded with an increased output of Zika-related research. This upsurge in research naturally made its way into academic journals along with editorials, news, and reports. However, it is not yet known how or whether these scholarly communications were distributed to the populations most affected by Zika.
   Methodology/Principal findings
   To understand how scientific outputs about Zika reached global and local audiences, we collected Tweets and Facebook posts that linked to Zika-related research in the first six months of 2016. Using a language detection algorithm, we found that up to 90% of Twitter and 76% of Facebook posts are in English. However, when none of the authors of the scholarly article are from English-speaking countries, posts on both social media are less likely to be in English. The effect is most pronounced on Facebook, where the likelihood of posting in English is between 11 and 16% lower when none of the authors are from English-speaking countries, as compared to when some or all are. Similarly, posts about papers written with a Brazilian author are 13% more likely to be in Portuguese on Facebook than when made on Twitter.
   Conclusions/Significance
   Our main conclusion is that scholarly communication on Twitter and Facebook of Zika-related research is dominated by English, despite Brazil being the epicenter of the Zika epidemic. This result suggests that scholarly findings about the Zika virus are unlikely to be distributed directly to relevant populations through these popular online mediums. Nevertheless, there are differences between platforms. Compared to Twitter, scholarly communication on Facebook is more likely to be in the language of an author's country. The Zika outbreak provides a useful case-study for understanding how scientific outputs are communicated to relevant populations. Our results suggest that Facebook is a more effective channel than Twitter, if communication is desired to be in the native language of the affected country. Further research should explore how local media D such as governmental websites, newspapers and magazines, as well as television and radio D disseminate scholarly publication.
C1 [Barata, Germana] State Univ Campinas Unicamp, Lab Adv Studies Journalism, Campinas, SP, Brazil.
   [Barata, Germana; Alperin, Juan Pablo] Simon Fraser Univ, Sch Publishing, Scholarly Commun Lab, Vancouver, BC, Canada.
   [Shores, Kenneth] Univ Penn, Grad Sch Educ, Philadelphia, PA 19104 USA.
RP Alperin, JP (corresponding author), Simon Fraser Univ, Sch Publishing, Scholarly Commun Lab, Vancouver, BC, Canada.
EM juan@alperin.ca
OI Alperin, Juan Pablo/0000-0002-9344-7439
FU Sao Paulo State Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2016/14173-2]; Social Sciences
   and Humanities Research Council of CanadaSocial Sciences and Humanities
   Research Council of Canada (SSHRC) [435-2016-1029]
FX This research was supported by the Sao Paulo State Research Foundation
   (FAPESP) through a scholarship abroad research grant (2016/14173-2) to
   GB and by the Social Sciences and Humanities Research Council of Canada
   through an Insight Grant (435-2016-1029) to JPA. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Albuquerque PC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005132
   Annesley T, 2017, CLIN CHEM, P63
   [Anonymous], 2017, BIBLIOTECA DIGITAL Z
   Belling L, 2014, DISCOURSE CONTEXT ME, V4-5, P74, DOI 10.1016/j.dcm.2014.03.002
   Bruns A, 2013, AM BEHAV SCI, V57, P871, DOI 10.1177/0002764213479374
   Carvalho MS, 2016, FUNDACAO O CRUZ, P32
   Dredze M, 2012, IEEE INTELL SYST, V27, P81, DOI 10.1109/MIS.2012.76
   Eleta I, 2014, COMPUT HUM BEHAV, V41, P424, DOI 10.1016/j.chb.2014.05.005
   FINEP, 2016, FIN VAI INV 230 MILH
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Google Trends, 2017, GOOGLE TRENDS
   Hernandez D., 2013, WIRED
   Lefebvre RC, 2013, CIRCULATION, P127
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   McNab C, 2009, B WORLD HEALTH ORGAN, V87, P566, DOI 10.2471/BLT.09.066712
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   PAHO, 2017, REG ZIK EP UPD
   Pirmez C, 2016, MEM I OSWALDO CRUZ, V111, P285, DOI 10.1590/0074-02760160001
   Reuters Institute, 2016, REUT I DIG NEWS REP
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Statista, 2017, NUMB MONTHL ACT TWIT
   Statista, 2017, NUMB ACT TWITT US LE
   Statista, 2017, LEAD COUNTR BAS NUMB
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Strehl L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155148
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Van Noorden R, 2014, NATURE, V512, P126, DOI 10.1038/512126a
   Weerkamp W, 2011, WEBSCI CONFERENCE 20
   Wellcome Trust, 2016, SHAR DAT ZIK OTH GLO
   WHO, 2017, ZIK SIT REP
   WHO, 2015, WHO DEV GLOB NORMS S
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
NR 34
TC 5
Z9 5
U1 4
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 5
PY 2018
VL 13
IS 1
AR e0190482
DI 10.1371/journal.pone.0190482
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FR9OU
UT WOS:000419403800055
PM 29304110
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Borges, ALV
   Moreau, C
   Burke, A
   dos Santos, OA
   Chofakian, CB
AF Vilela Borges, Ana Luiza
   Moreau, Caroline
   Burke, Anne
   dos Santos, Osmara Alves
   Chofakian, Christiane Borges
TI Women's reproductive health knowledge, attitudes and practices in
   relation to the Zika virus outbreak in northeast Brazil
SO PLOS ONE
LA English
DT Article
ID FAMILY-PLANNING-SERVICES; 2002 NATIONAL-SURVEY; CONTRACEPTIVE FAILURE;
   ABORTION; EPIDEMIC; GROWTH; TRENDS
AB Objectives
   To assess knowledge, pregnancy attitudes and contraceptive practices in relation to the Zika virus outbreak in Brazil.
   Methods
   We interviewed 526 women 18 to 49 years old in primary health services in a Northeastern capital of Brazil, in 2016. They provided information about their knowledge of Zika transmission and health consequences, their receipt of counseling related to sexual and perinatal transmission of Zika, their pregnancy intentions and reassessment of contraceptive options in the context of the Zika virus outbreak.
   Results
   Awareness about Zika congenital syndrome was high, but knowledge about sexual transmission was low. Few women had changed pregnancy intentions or contraceptive practices in response to Zika. Pregnant women were more likely to access counseling about family planning, condom use and pregnancy postponement due to Zika virus than non-pregnant women, which may suggest that health system responses followed pregnancy occurrence.
   Conclusions
   We observed missed opportunities for prevention of perinatal transmission of Zika virus through behavioral change, including effective contraception to prevent pregnancy and condoms to prevent perinatal transmission, as a complement to vector control.
C1 [Vilela Borges, Ana Luiza; dos Santos, Osmara Alves; Chofakian, Christiane Borges] Univ Sao Paulo, Sch Nursing, Dept Publ Hlth Nursing, Sao Paulo, Brazil.
   [Moreau, Caroline; Burke, Anne] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA.
   [Moreau, Caroline] Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Dept Gynecol & Obstet, Baltimore, MD USA.
   [Burke, Anne] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Gender Sexual & Reprod Hlth, Le Kremlin Bicetre, France.
RP Borges, ALV (corresponding author), Univ Sao Paulo, Sch Nursing, Dept Publ Hlth Nursing, Sao Paulo, Brazil.
EM alvilela@usp.br
RI Moreau, Caroline/A-8989-2019; Chofakian, Christiane Borges do
   Nascimento/S-2179-2017; santos, osmara/AAH-6719-2020; Borges,
   Ana/C-5196-2012
OI Moreau, Caroline/0000-0002-8637-6249; Chofakian, Christiane Borges do
   Nascimento/0000-0002-5953-3296; Borges, Ana/0000-0002-2807-1762
FU Sao Paulo Research Foundation/FapespFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/02447-5]; National Council for
   Scientific and Technological Development/CNPqNational Council for
   Scientific and Technological Development (CNPq) [440577/2014-4]
FX The establishment of the study was supported by Sao Paulo Research
   Foundation/Fapesp (grant 2014/02447-5) and National Council for
   Scientific and Technological Development/CNPq (grant 440577/2014-4).
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Baum P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064416
   Brazilian Market Research Association - ABEP, 2016, BRAZ CRIT 2015 SOC C
   Ferreira DAD, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2025-8
   [Departamento de Acoes Programaticas Estrategicas Secretaria de Atencao a Sade Brasil. Ministerio da Sade], 2016, PROT AT SAUD RESP OC
   [Departamento de Ciencia e Tecnologia Secretaria de Ci6ncia Tecnologia e Insumos Estrategicos Brazil. Ministerio da Sade], 2008, REL FIN PNDS 2006 PE
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Hall J. A., 2016, J FAMILY PLANNING RE, V42, P3
   Heilborn ML, 2009, CAD SAUDE PUBLICA, V25, pS269, DOI 10.1590/S0102-311X2009001400009
   Kost K, 2008, CONTRACEPTION, V77, P10, DOI 10.1016/j.contraception.2007.09.013
   Martins-MeloI FR, 2014, REV SAUDE PUBL, V48, P508, DOI 10.1590/S0034-8910.2014048004878
   Rasanathan JJK, 2017, AM J PUBLIC HEALTH, V107, P525, DOI 10.2105/AJPH.2017.303658
   [Secretaria de Vigilancia em Saude Brasil. Ministerio da Saude], 2017, SECR VIG SAUD B EP M
   Tavares MP, 2016, CONTRACEPTION, V94, P109, DOI 10.1016/j.contraception.2016.04.006
   Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
   Vaughan B, 2008, CONTRACEPTION, V78, P271, DOI 10.1016/j.contraception.2008.05.007
   Vieira Elisabeth Meloni, 2011, Rev. bras. epidemiol., V14, P556, DOI 10.1590/S1415-790X2011000400003
   Viellas EF, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00126013
   Borges ALV, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0087-7
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 22
TC 10
Z9 10
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 3
PY 2018
VL 13
IS 1
AR e0190024
DI 10.1371/journal.pone.0190024
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FR6OK
UT WOS:000419185200036
PM 29298358
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, YJ
   Xu, JB
   Zhong, DB
   Zhang, H
   Yang, WQ
   Zhou, GF
   Su, XH
   Wu, Y
   Wu, K
   Cai, SW
   Yan, GY
   Chen, XG
AF Li, Yiji
   Xu, Jiabao
   Zhong, Daibin
   Zhang, Hong
   Yang, Wenqiang
   Zhou, Guofa
   Su, Xinghua
   Wu, Yang
   Wu, Kun
   Cai, Songwu
   Yan, Guiyun
   Chen, Xiao-Guang
TI Evidence for multiple-insecticide resistance in urban Aedes albopictus
   populations in southern China
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes albopictus; Insecticide resistance; Biochemical assay; Kdr;
   Urbanization; Guangzhou
ID DENGUE VECTORS; PYRETHROID RESISTANCE; DIPTERA-CULICIDAE;
   SPATIAL-DISTRIBUTION; SRI-LANKA; AEGYPTI; SUSCEPTIBILITY; GENE; DDT; KDR
AB Background: Aedes albopictus (Skuse) is an invasive mosquito that has become an important vector of chikungunya, dengue and Zika viruses. In the absence of specific antiviral therapy or a vaccine, vector management is the sole method available for reducing Aedes-induced disease morbidity. Determining the resistance status of Ae. albopictus to insecticides and exploring the resistance mechanisms is essential for future vector control planning.
   Methods: Aedes albopictus larvae and pupae were sampled from six sites (two sites each from urban, suburban and rural) in Guangzhou. The resistance bioassays were conducted against Bacillus thuringiensis israelensis (Bti): deltamethrin, propoxur and malathion for larvae; and deltamethrin, DDT, propoxur and malathion for adults. P450 monooxygenase (P450s), glutathione S-transferase (GSTs) and carboxylesterase (COEs) activities of adult mosquitoes were measured. Mutations at the knockdown resistance (kdr) gene were analyzed, and the association between kdr mutations and phenotypic resistance was tested.
   Results: Adult bioassays revealed varied susceptibility against DDT, deltamethrin and propoxur in the six Ae. albopictus populations. Significantly lower mortality rates were found in urban populations than suburban and rural populations. Urban mosquito populations showed resistance against DDT, deltamethrin and propoxur, while one rural population was resistant to DDT. All populations tested were susceptible to malathion. Larval bioassays results indicated that all populations of Ae. albopictus were sensitive to the larvicide Bti and malathion. Resistance to deltamethrin and propoxur was common in larval populations. The F1534S and F1534 L mutations were found to be significantly associated with deltamethrin resistance. Biochemical assays indicated elevated detoxification enzyme activities in the field mosquito populations.
   Conclusions: Aedes albopictus populations in Guangzhou, especially in urban areas, have developed resistance to the commonly used insecticides, primarily DDT and deltamethrin. This finding calls for resistance management and developing counter measures to mitigate the spread of resistance.
C1 [Li, Yiji; Xu, Jiabao; Zhang, Hong; Yang, Wenqiang; Su, Xinghua; Wu, Yang; Wu, Kun; Yan, Guiyun; Chen, Xiao-Guang] Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.
   [Li, Yiji] Hainan Med Univ, Key Lab Translat Med Trop Dis, Minist Educ, Haikou, Hainan, Peoples R China.
   [Li, Yiji] Hainan Med Univ, Dept Pathogen Biol, Haikou, Hainan, Peoples R China.
   [Zhong, Daibin; Zhou, Guofa; Yan, Guiyun] Univ Calif Irvine, Sch Med, Program Publ Hlth, Irvine, CA 92717 USA.
   [Cai, Songwu] Ctr Dis Control & Prevent Guangdong Prov, Dept Vector Control, Guangzhou, Guangdong, Peoples R China.
RP Yan, GY; Chen, XG (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.; Yan, GY (corresponding author), Univ Calif Irvine, Sch Med, Program Publ Hlth, Irvine, CA 92717 USA.
EM guiyuny@uci.edu; xgchen2001@hotmail.com
OI Wu, Yang/0000-0002-1207-5566
FU National Key R&D Program of China [2016YFC1200500, 2017YFC1201000];
   National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China [81371845, 81420108024, 81528013]; Natural Science
   Foundation of Guangdong ProvinceNational Natural Science Foundation of
   Guangdong Province [2014A030312016, 2016A020251001]; Guangzhou Synergy
   Innovation Key Program for Health [201508020263, 201605030010]; National
   Institutes of Health, USAUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI083202, D43
   TW009527]
FX This study was supported by the grants from the National Key R&D Program
   of China (2016YFC1200500, 2017YFC1201000), the National Nature Science
   Foundation of China (81371845, 81420108024, 81528013), the Natural
   Science Foundation of Guangdong Province (2014A030312016,
   2016A020251001), the Guangzhou Synergy Innovation Key Program for Health
   (201508020263, 201605030010) and the National Institutes of Health, USA
   (R01 AI083202 and D43 TW009527).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Cai Song-wu, 2006, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V17, P274
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Chang XL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002889
   Chen HY, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0125-x
   Chuaycharoensuk T, 2011, J VECTOR ECOL, V36, P204, DOI 10.1111/j.1948-7134.2011.00158.x
   Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288
   Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111
   Dharshini Sangaralingam, 2011, Tropical Medicine and Health, V39, P47, DOI 10.2149/tmh.2010-19
   Ehnholm C, 1986, Methods Enzymol, V129, P716
   Finney D.T., 1971, PROBIT ANAL
   Gao Jian-rong, 2014, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V25, P483
   Guo FengYing, 2002, Acta Parasitologica et Medica Entomologica Sinica, V9, P50
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Hosokawa M, 2002, CURRENT PROTOCOLS TO, V10
   Huang L, 2016, EUR J CLIN MICROBIOL, V35, P269, DOI 10.1007/s10096-015-2540-5
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Karunaratne SHPP, 2013, PESTIC BIOCHEM PHYS, V107, P98, DOI 10.1016/j.pestbp.2013.05.011
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kawada H, 2010, JPN J INFECT DIS, V63, P19
   Kushwah RBS, 2015, J VECTOR DIS, V52, P95
   Lee RML, 2014, TROP BIOMED, V31, P670
   Lei L., 2012, THESIS
   Li Chun-Yan, 2013, Zhonghua Nan Ke Xue, V19, P487
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745
   MOUCHET J, 1972, B WORLD HEALTH ORGAN, V46, P675
   Muthusamy R, 2015, J VECTOR DIS, V52, P159
   NENG W, 1992, J AM MOSQUITO CONTR, V8, P394
   Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83
   Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102755
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619
   WESSON DM, 1990, J AM MOSQUITO CONTR, V6, P258
   WHO, 2013, TEST PROC INREMO
   WHO, 2016, MON MAN INS RES AED
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
   Yan Ju-Ying, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P1091
   Yebakima A, 2004, J MED ENTOMOL, V41, P718, DOI 10.1603/0022-2585-41.4.718
   Yiguan W, 2017, CHINA J EC ENTOMOL, V110, P239, DOI DOI 10.1093/JEE/T0W254
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055475
NR 54
TC 12
Z9 16
U1 0
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JAN 3
PY 2018
VL 11
AR 4
DI 10.1186/s13071-017-2581-y
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FR7GK
UT WOS:000419235500003
PM 29298700
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schultz, MJ
   Connor, JH
   Frydman, HM
AF Schultz, Michaela J.
   Connor, John H.
   Frydman, Horacio M.
TI Group B Wolbachia Strain-Dependent Inhibition of Arboviruses
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE arbovirus; Wolbachia; vector control; emerging viruses; Zika virus;
   dengue virus
ID AEDES-ALBOPICTUS DIPTERA; DENGUE VIRUS; ZIKA VIRUS; NATIVE WOLBACHIA;
   BLOCKS DENGUE; HOST; TRANSMISSION; PATHWAY; RESISTANCE; CULICIDAE
AB Mosquito-borne viruses, including Zika virus (ZIKV) and dengue virus (DENV), are global threats that continue to infect millions annually. Historically, efforts to combat the spread of these diseases have sought to eradicate the mosquito population. This has had limited success. Recent efforts to combat the spread of these diseases have targeted the mosquito population and the mosquito's ability to transmit viruses by altering the mosquito's microbiome. The introduction of particular strains of Wolbachia bacteria into mosquitos suppresses viral growth and blocks disease transmission. This novel strategy is being tested worldwide to reduce DENV and has early indications of success. The Wolbachia genus comprised divergent strains that are divided in major phylogenetic clades termed supergroups. All Wolbachia field trials currently utilize supergroup A Wolbachia in Aedes aegypti mosquitos to limit virus transmission. Here we discuss our studies of Wolbachia strains not yet used in virus control strategies but that show strong potential to reduce ZIKV replication. These strains are important opportunities in the search for novel tools to reduce the levels of mosquito-borne viruses and provide additional models for mechanistic studies.
C1 [Schultz, Michaela J.; Frydman, Horacio M.] Boston Univ, Dept Biol, 5 Cummington Mall, Boston, MA 02215 USA.
   [Schultz, Michaela J.; Connor, John H.; Frydman, Horacio M.] Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA.
   [Connor, John H.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.
RP Frydman, HM (corresponding author), Boston Univ, Dept Biol, 5 Cummington Mall, Boston, MA 02215 USA.; Connor, JH (corresponding author), Boston Univ, Dept Microbiol, 620 Albany St, Boston, MA 02118 USA.; Connor, JH (corresponding author), Boston Univ, NEIDL, 620 Albany St, Boston, MA 02118 USA.
EM jhconnor@bu.edu; hfrydman@bu.edu
RI Schultz, Michaela/AAP-1140-2020
OI Connor, John/0000-0002-8867-7256
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356
   Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7
   Dandalo LC, 2017, T ROY SOC TROP MED H, V111, P38, DOI 10.1093/trstmh/trx013
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Hedges LM, 2012, APPL ENVIRON MICROB, V78, P6773, DOI 10.1128/AEM.01650-12
   HERTIG M., 1936, Parasitology, V28, P453, DOI 10.1017/S0031182000022666
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Mazzon M, 2014, CELL MICROBIOL, V16, P1493, DOI 10.1111/cmi.12340
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Raquin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125066
   Rodriguez SD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-211
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Shaikevich E V, 2014, Genetika, V50, P1390
   Sharp Tyler M, 2017, Curr Epidemiol Rep, V4, P11, DOI 10.1007/s40471-017-0095-y
   Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Yamada H, 2014, J MED ENTOMOL, V51, P811, DOI 10.1603/ME13223
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Ye YXH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066482
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
NR 50
TC 4
Z9 4
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD JAN
PY 2018
VL 37
IS 1
BP 2
EP 6
DI 10.1089/dna.2017.4025
EA JAN 2018
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA FS6KY
UT WOS:000419331500001
PM 29297702
OA Green Published
DA 2020-07-08
ER

PT J
AU Wasik, D
   Mulchandani, A
   Yates, MV
AF Wasik, Daniel
   Mulchandani, Ashok
   Yates, Marylynn V.
TI Point-of-Use Nanobiosensor for Detection of Dengue Virus NS1 Antigen in
   Adult Aedes aegypti: A Potential Tool for Improved Dengue Surveillance
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID DIPTERA-CULICIDAE; CARBON NANOTUBES; PROTEIN NS1; IMMUNOSENSOR;
   QUANTIFICATION; TRANSMISSION; SPECIFICITY; TRANSISTORS; RECOGNITION;
   CHIKUNGUNYA
AB Dengue virus (DENY) and its primary mosquito vectors Aedes spp. have spread to every continent except Antarctica, causing outbreaks and autochthonous transmission in previously disease-free regions. Recently, the spread of other arboviruses carried by invasive Aedes spp., such as Chikungunya and Zika, seem to be following similar trends as DENY and have renewed interest in monitoring and modeling arboviruses within mosquito vectors. Unfortunately, current commercially available detection methods are designed for the diagnosis of DENY in humans or are too expensive and complex for sustainable monitoring. We report a novel electronic nanobiosensor utilizing a single-walled carbon nanotube networks chemiresistor transducer functionalized with antidengue NS1 monoclonal antibodies for rapid detection of the.dengue nonstructural protein 1 (NS1). NS1 is a highly conserved protein secreted at high concentrations during viral replication and is a biomarker for DENY infection. NS1 was successfully detected in spiked adult Aedes aegypti homogenate over a broad dynamic range with high sensitivity and selectivity. The biosensor is compatible with "gold-standard" adult mosquito field-collection protocols and generates electronic data that can be readily stored or wirelessly transmitted. Thus, it has potential for remote and real-time monitoring of wild mosquito populations.
C1 [Wasik, Daniel; Yates, Marylynn V.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.
   [Mulchandani, Ashok] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.
   [Mulchandani, Ashok] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.
RP Mulchandani, A (corresponding author), Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.; Mulchandani, A (corresponding author), Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.
EM adani@engr.ucr.edu
RI Mulchandani, Ashok/R-6130-2019
OI Wasik, Daniel/0000-0002-8877-6107
FU UCR AES (Agricultural Experiment Station); USDA Hatch Grant
   [CA-R-ENS-7772-H]; National Science FoundationNational Science
   Foundation (NSF) [1606181]
FX We thank Dr. Peter Atkinson and Michael Han for providing A. aegypti
   mosquitoes and Thien-Toan Tran for coding and fabricating the Arduino
   control unit and the LabVIEW interface. We acknowledge the financial
   support of UCR AES (Agricultural Experiment Station), USDA Hatch Grant
   (CA-R-ENS-7772-H), and National Science Foundation (1606181).
CR Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634
   Althouse BM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001928
   Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886
   Anker M., 2004, CORVAL C
   Antunes P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16145
   Armstrong P. M., 2011, JOVE-J VIS EXP, P2889
   Bai L, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-10
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Camara AR, 2013, OPT EXPRESS, V21, P27023, DOI 10.1364/OE.21.027023
   Cavalcanti IT, 2012, BIOCHEM ENG J, V67, P225, DOI 10.1016/j.bej.2012.06.016
   Cecchetto J, 2015, SENSOR ACTUAT B-CHEM, V213, P150, DOI 10.1016/j.snb.2015.02.068
   Centers for Disease, 2001, MMWR-MORBID MORTAL W, V50, P57
   Chartuprayoon N, 2015, BIOSENS BIOELECTRON, V63, P432, DOI 10.1016/j.bios.2014.07.043
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Dias ACMS, 2013, BIOSENS BIOELECTRON, V44, P216, DOI 10.1016/j.bios.2012.12.033
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Durbin AP, 2013, VIROLOGY, V439, P34, DOI 10.1016/j.virol.2013.01.018
   Figueiredo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07865
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Garcia-Aljaro C, 2010, BIOSENS BIOELECTRON, V26, P1437, DOI 10.1016/j.bios.2010.07.077
   Gruner G, 2006, ANAL BIOANAL CHEM, V384, P322, DOI 10.1007/s00216-005-3400-4
   Gubler D. J., 2011, ASIA PAC J MOL BIOL, V3, P111
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gunda NSK, 2013, BIOMED MICRODEVICES, V15, P959, DOI 10.1007/s10544-013-9787-3
   Kim JP, 2009, BIOSENS BIOELECTRON, V24, P3372, DOI 10.1016/j.bios.2009.04.048
   Linares EM, 2013, BIOSENS BIOELECTRON, V41, P180, DOI 10.1016/j.bios.2012.08.005
   Muller DA, 2012, J VIROL METHODS, V183, P90, DOI 10.1016/j.jviromet.2012.03.033
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Parkash O, 2014, DIAGNOSTICS, V4, P165, DOI 10.3390/diagnostics4040165
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pirich CL, 2017, BIOSENS BIOELECTRON, V92, P47, DOI 10.1016/j.bios.2017.01.068
   Ramasamy R, 2016, J VECTOR DIS, V53, P91
   Ramnani P, 2016, CHEMOSPHERE, V143, P85, DOI 10.1016/j.chemosphere.2015.04.063
   Ramnani P, 2013, ANAL CHEM, V85, P8061, DOI 10.1021/ac4018346
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Sharp TM, 2015, EMERG INFECT DIS, V21, P1311, DOI 10.3201/eid2108.150368
   Silva MMS, 2015, J CHEM TECHNOL BIOT, V90, P194, DOI 10.1002/jctb.4305
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sinawang PD, 2016, BIOSENS BIOELECTRON, V77, P400, DOI 10.1016/j.bios.2015.09.048
   Stefansson S., 2012, J NANOTECHNOL, V2012, P1
   Sylvestre G, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-155
   Tai DF, 2005, ANAL CHEM, V77, P5140, DOI 10.1021/ac0504060
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028
   Voge NV, 2013, AM J TROP MED HYG, V88, P260, DOI 10.4269/ajtmh.2012.12-0477
   Wasik D, 2017, BIOSENS BIOELECTRON, V91, P811, DOI 10.1016/j.bios.2017.01.017
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Wong WR, 2016, BIOSENS BIOELECTRON, V78, P132, DOI 10.1016/j.bios.2015.11.030
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 52
TC 12
Z9 12
U1 3
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD JAN 2
PY 2018
VL 90
IS 1
BP 679
EP 684
DI 10.1021/acs.analchem.7b03407
PG 6
WC Chemistry, Analytical
SC Chemistry
GA FR9US
UT WOS:000419419200039
PM 29182305
DA 2020-07-08
ER

PT J
AU Villegas, LEM
   Campolina, TB
   Barnabe, NR
   Orfano, AS
   Chaves, BA
   Norris, DE
   Pimenta, PFP
   Secundino, NFC
AF Villegas, Luis E. M.
   Campolina, Thais B.
   Barnabe, Nilton R.
   Orfano, Alessandra S.
   Chaves, Barbara A.
   Norris, Douglas E.
   Pimenta, Paulo F. P.
   Secundino, Nagila F. C.
TI Zika virus infection modulates the bacterial diversity associated with
   &ITAedes aegypti&IT as revealed by metagenomic analysis
SO PLOS ONE
LA English
DT Article
ID GUT MICROBIOTA; BETA-DIVERSITY; SEQUENCING DATA; MOSQUITOS; ECOLOGY;
   VECTOR; ENVIRONMENT; CULICIDAE; INSIGHTS; INSECTS
AB Zika is a re-emerging infection that has been considered a major threat to global public health. Currently at least 100 countries are at risk of Zika virus(ZIKV) transmission. Aedes aegypti is the main mosquito vector in the Americas. This vector is exposed to, and interacts symbiotically with a variety of microorganisms in its environment, which may result in the formation of a lifetime association. Here, the unknown effect that ZIKV exerts on the dynamic bacterial community harbored by this mosquito vector was investigated using a metagenomic analysis of its microbiota. Groups of Ae. aegypti were experimentally fed on sugar, blood and blood mixed with ZIKV, and held for 3 to 7 days after blood meal and eggs development respectively. The infected groups were processed by qPCR to confirm the presence of ZIKV. All groups were analyzed by metagenomics (Illumina Hiseq Sequencing) and 16S rRNA amplicon sequences were obtained to create bacterial taxonomic profiles. A core microbiota and exclusive bacterial taxa were identified that incorporate 50.5% of the predicted reads from the dataset, with 40 Gram-negative and 9 Gram-positive families. To address how ZIKV invasion may disturb the ecological balance of the Ae. aegypti microbiota, a CCA analysis coupled with an explanatory matrix was performed to support the biological interpretation of shifts in bacterial signatures. Two f-OTUs appeared as potential biomarkers of ZIKV infection: Rhodobacteraceae and Desulfuromonadaceae. Coincidentally, both f-OTUs were exclusively present in the ZIKV-infected blood-fed and ZIKVinfected gravid groups. In conclusion, this study shows that bacterial symbionts act as biomarkers of the insect physiological states and how they respond as a community when ZIKV invades Ae. aegypti. Basic knowledge of local haematophagous vectors and their associated microbiota is relevant when addressing transmission of vector-borne infectious diseases in their regional surroundings.
C1 [Villegas, Luis E. M.; Campolina, Thais B.; Barnabe, Nilton R.; Orfano, Alessandra S.; Pimenta, Paulo F. P.; Secundino, Nagila F. C.] Rene Rachou Res Ctr FIOCRUZ, Lab Med Entomol, Belo Horizonte, MG, Brazil.
   [Chaves, Barbara A.; Pimenta, Paulo F. P.] Trop Med Fdn Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Norris, Douglas E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA.
RP Secundino, NFC (corresponding author), Rene Rachou Res Ctr FIOCRUZ, Lab Med Entomol, Belo Horizonte, MG, Brazil.
EM nagila@cpqrr.fiocruz.br
RI Pimenta, Paulo/AAH-1502-2020; Secundino, Nagila/AAM-4553-2020; Villegas,
   Luis/AAG-2655-2019
OI Norris, Douglas/0000-0002-4631-2777; Martinez Villegas, Luis
   Eduardo/0000-0002-9628-4081
FU Minas Gerais State Research Support Foundation [00240-13, APQ 03002-16,
   00242-12]; Amazonas State Research Support (FAPEAM); Brazilian agency:
   Foundation of the Institute Oswaldo Cruz (FIOCRUZ); Brazilian Council
   for Science and Technological Development CNPq [308849/2015-9,
   305512/2014-5]; Brazilian Council for Science and Technological
   Development CNPq-INCT de Entomologia Molecular [465678/2014-9];
   INCT-Instituto Nacional de Ciencia e Tecnologia-Entomologia Molecular;
   Brazilian agency: Amazonas State Research Support (FAPEAM); Brazilian
   agency: Brazilian Council for Scientific and Technological Development
   (CNPq/MS/CAPES/DECIT); Brazilian Council for Science and Technological
   Development CNPq/ DECIT [440615/2016]; Brazilian agency: INCT-Instituto
   Nacional de Ciencia e Tecnologia-Entomologia Molecular; Programme
   Science without Borders; Brazilian agency: Minas Gerais State Research
   Support Foundation (FAPEMIG); Brazilian Council for Science and
   Technological Development CNPq (Science Without Borders [400704/2014-5];
   Foundation of the Institute Oswaldo Cruz (FIOCRUZ); Brazilian agency:
   Programme Science without Borders
FX This study was funded by the following: Minas Gerais State Research
   Support Foundation (00240-13) Paulo Pimenta, www.fapemig.br; Minas
   Gerais State Research Support Foundation (APQ 03002-16) Paulo Pimenta,
   www.fapemig.br; Brazilian Council for Science and Technological
   Development CNPq/ DECIT (440615/2016) Paulo Pimenta, www.cnpq.br;
   Brazilian Council for Science and Technological Development CNPq
   (308849/2015-9) Paulo Pimenta, www.cnpq.br; Brazilian Council for
   Science and Technological Development CNPq (Science Without Borders
   (400704/2014-5) Nagila Secundino, www.cnpq.br; Brazilian Council for
   Science and Technological Development CNPq (305512/2014-5) Nagila
   Secundino, www.cnpq.br; Brazilian Council for Science and Technological
   Development CNPq-INCT de Entomologia Molecular (465678/2014-9) Nagila
   Secundino, www.inctem.bioqmed.ufrj. br; Minas Gerais State Research
   Support Foundation (00242-12) Nagila Secundino, www.fapemig.br. This
   work was also funded in part by the Foundation of the Institute Oswaldo
   Cruz (FIOCRUZ), Programme Science without Borders, INCT-Instituto
   Nacional de Ciencia e Tecnologia-Entomologia Molecular, and Amazonas
   State Research Support (FAPEAM). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.& para;& para;This study was partially
   funded by the following Brazilian agencies: Foundation of the Institute
   Oswaldo Cruz (FIOCRUZ), Brazilian Council for Scientific and
   Technological Development (CNPq/MS/CAPES/DECIT), Programme Science
   without Borders, INCT-Instituto Nacional de Ciencia e
   Tecnologia-Entomologia Molecular, Minas Gerais State Research Support
   Foundation (FAPEMIG) and Amazonas State Research Support (FAPEAM).
CR Abraham NM, 2017, P NATL ACAD SCI USA, V114, pE781, DOI 10.1073/pnas.1613422114
   Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P249
   Audsley MD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005426
   BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226
   Brooks AW, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000225
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Champion CJ, 2017, FREE RADICAL BIO MED, V105, P79, DOI 10.1016/j.freeradbiomed.2016.11.031
   Christian N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00869
   Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   Secundino NFC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2286-2
   Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203
   David MR, 2016, MEM I OSWALDO CRUZ, V111, P577, DOI 10.1590/0074-02760160238
   De Roy K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2392
   Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416
   Douglas AE, 2011, CELL HOST MICROBE, V10, P359, DOI 10.1016/j.chom.2011.09.001
   Duguma D, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00387-16, 10.1128/msphere.00387-16]
   Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025
   Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104
   Gendrin M, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P525, DOI 10.5772/55107
   Gimonneau G, 2014, INFECT GENET EVOL, V28, P715, DOI 10.1016/j.meegid.2014.09.029
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Kelly PH, 2017, MBIO, V8, DOI [10.1128/mBio.01121-16, 10.1128/mbio.01121-16]
   Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]
   Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210
   Lacey LA., 1997, MANUAL TECHNIQUES IN, P409
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141
   Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008
   Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133
   Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06
   Manda H, 2007, MED VET ENTOMOL, V21, P103, DOI 10.1111/j.1365-2915.2007.00672.x
   Manguin S, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P549, DOI 10.5772/55610
   Mason MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077287
   Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146
   Novakova E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00526
   Nyasembe VO, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-234
   Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x
   Oulas A, 2015, BIOINFORM BIOL INSIG, V9, P75, DOI 10.4137/BBI.S12462
   Paliy O, 2016, MOL ECOL, V25, P1032, DOI 10.1111/mec.13536
   Pierre Legendre, 2012, NUMERICAL ECOLOGY
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x
   Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a
   Saldana MA, 2017, MEM I OSWALDO CRUZ, V112, P81, DOI 10.1590/0074-02760160373
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Segata N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24207
   Tchioffo MT, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01500
   Team Rs., 2015, RSTUDIO INT DEV R
   Tremblay J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00771
   Villegas LM, 2014, MEM I OSWALDO CRUZ, V109, P672, DOI 10.1590/0074-0276140194
   Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767
   Wong ACN, 2015, APPL ENVIRON MICROB, V81, P6232, DOI 10.1128/AEM.01442-15
   Yang B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0992-y
NR 59
TC 13
Z9 14
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 2
PY 2018
VL 13
IS 1
AR e0190352
DI 10.1371/journal.pone.0190352
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FR5JA
UT WOS:000419101600096
PM 29293631
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fraiz, LD
   de Roche, A
   Mauro, C
   Catallozzi, M
   Zimet, GD
   Shapiro, GK
   Rosenthal, SL
AF Fraiz, Lauren Dapena
   de Roche, Ariel
   Mauro, Christine
   Catallozzi, Marina
   Zimet, Gregory D.
   Shapiro, Gilla K.
   Rosenthal, Susan L.
TI US pregnant women's knowledge and attitudes about behavioral strategies
   and vaccines to prevent Zika acquisition
SO VACCINE
LA English
DT Article
DE Zika; Pregnancy; Behavioral prevention; Vaccination; Knowledge
ID SEXUAL TRANSMISSION; HPV VACCINATION; VIRUS
AB Introduction: Zika virus infection during pregnancy can cause significant infant morbidity. Little is known about pregnant women's attitudes regarding behavioral strategies and hypothetical vaccination to prevent Zika infections and sequelae.
   Methods: Pregnant women across the United States (N = 362) completed an online questionnaire regarding attitudes about Zika, including six behavioral prevention strategies (i.e., abstaining from sex, using condoms, not traveling to an area with Zika, their partner not traveling into an area with Zika, using mosquito repellant, wearing long pants and sleeves) and vaccination.
   Results: Most women (91%) were married living with the baby's father, 65% were non-Hispanic White, and 71% had been pregnant. Seventy-four percent were worried about Zika, while 30% thought they were knowledgeable about Zika. The mean knowledge score was 5.0 out of 8 (SD = 2.09), and the mean behavioral strategies score was 4.9 out of 12 (SD = 3.7) with a range of 0 (none would be hard to do) to 12 (all would be hard to do). In a multivariable model, having had a sexually transmitted infection, living/traveling in an area with Zika, and worrying about Zika were significantly related to reporting behavioral strategies as hard to do. Seventy-two percent would be willing to be vaccinated. In the multivariable model, living/traveling in an area with Zika, believing they knew a lot about Zika, worrying about Zika, and considering Zika vaccine development as important were significantly associated with willingness to get vaccinated.
   Conclusions: Pregnant women were worried about Zika, yet had gaps in their factual knowledge. Most women reported they would get vaccinated if a vaccine was available. Pregnant women who reported themselves as vulnerable (being worried, having lived in or traveled to a Zika area) were more likely to view behavioral strategies as hard to do and to accept vaccination. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Fraiz, Lauren Dapena; de Roche, Ariel; Catallozzi, Marina; Rosenthal, Susan L.] Columbia Univ, Med Ctr, Coll Phys & Surg, 622 W 168th St, New York, NY 10032 USA.
   [Mauro, Christine; Catallozzi, Marina; Rosenthal, Susan L.] Columbia Univ, Med Coll, Mailman Sch Publ Hlth, 722 W 168th St, New York, NY 10032 USA.
   [Catallozzi, Marina; Rosenthal, Susan L.] New York Presbyterian Hosp, 622 W 168th St, New York, NY 10032 USA.
   [Zimet, Gregory D.] Indiana Univ, Sch Med, Dept Pediat, 410 West 10th St,Suite 1001, Indianapolis, IN 46202 USA.
   [Shapiro, Gilla K.] McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada.
   [Shapiro, Gilla K.] Rush Univ, Med Ctr, Dept Behav Sci, 1645 West Jackson Blvd,Ste 400, Chicago, IL 60612 USA.
RP Rosenthal, SL (corresponding author), Columbia Univ, Med Ctr, Morgan Stanley Childrens Hosp NewYork Presbyteria, New York, NY 10027 USA.
EM lad2177@cumc.columbia.edu; ad3107@cumc.columbia.edu;
   cmm2212@cumc.columbia.edu; mc2840@cumc.columbia.edu; gzimet@iu.edu;
   gilla.shapiro@mail.mcgill.ca; slr2154@cumc.columbia.edu
OI Mauro, Christine/0000-0001-6065-8128
FU National Institutes of Health National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21-R33AI098654]; Vanier
   Canada Graduate Scholarship; Queen Elizabeth II Diamond Jubilee
   Scholarship programs
FX National Institutes of Health National Institute of Allergy and
   Infectious Diseases R21-R33AI098654, Vanier Canada Graduate Scholarship,
   and Queen Elizabeth II Diamond Jubilee Scholarship programs.
CR Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Brewer N, 2007, ANN BEHAV MED, V5, P3
   Centers for Disease Control and Prevention, 2016, HPV VACC COV MAPS
   Centers for Disease Control and Prevention, 2017, CDC PROV DAT
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   D'Angelo DV, 2017, MMWR-MORBID MORTAL W, V66, P574, DOI 10.15585/mmwr.mm6622a2
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hofstetter AM, 2014, EXPERT REV VACCINES, V13, P1013, DOI 10.1586/14760584.2014.933076
   Kasting ML, 2016, HUM VACC IMMUNOTHER, V12, P1435, DOI 10.1080/21645515.2016.1141158
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Marlow LAV, 2009, J ADOLESCENT HEALTH, V44, P446, DOI 10.1016/j.jadohealth.2008.09.011
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   [National HPV Vaccination Coverage National (Australia)], 2015, HPV 3 DOS VACC COV F
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Paz-Bailey G, 2017, N ENGL J MED
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Rosenstock IM, 1988, HLTH ED, V15, P174
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Webb PM, 1999, J ADOLESCENT HEALTH, V25, P320, DOI 10.1016/S1054-139X(99)00066-X
   World Health Organization, 2016, WHO RES AG 2016 ZIK
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
NR 33
TC 7
Z9 8
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JAN 2
PY 2018
VL 36
IS 1
BP 165
EP 169
DI 10.1016/j.vaccine.2017.11.021
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FR9RS
UT WOS:000419411400024
PM 29157958
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Samuel, G
   DiBartolo-Cordovano, R
   Taj, I
   Merriam, A
   Lopez, JM
   Torres, C
   Lantigua, RA
   Morse, S
   Chang, BP
   Gyamfi-Bannerman, C
   Thakur, KT
AF Samuel, Gregory
   DiBartolo-Cordovano, Rianna
   Taj, Insiya
   Merriam, Audrey
   Lopez, Jean M.
   Torres, Caroline
   Lantigua, Rafael A.
   Morse, Steven
   Chang, Bernard P.
   Gyamfi-Bannerman, Cynthia
   Thakur, Kiran T.
TI A survey of the knowledge, attitudes and practices on Zika virus in new
   York City
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Zika virus; Health promotion; Maternal health
AB Background: Over 900 travel-associated Zika virus cases have been identified in New York City (NYC), New York. A survey was administered in NYC adapted from the Knowledge, Attitudes, and Practices (KAP) survey on Zika virus developed by the World Health Organization (WHO).
   Methods: A standardized, self-administered, anonymous questionnaire was administered to a convenience sample in Manhattan and the Bronx from June 30th, 2016 to October 21st, 2016. Responses were grouped into six domains based on the content and structure of the questions and were summarized using descriptive statistics or converted into a continuous knowledge score and assessed for associations with pregnancy status and travel history using linear regression.
   Results: There were 224 respondents with a mean age of 33 (SD +/- 11.6) with 77% (170/224) female and 24% (51/224) pregnant. The majority (98% (213/217)) were unable to identify all of the symptoms associated with acute Zika virus infection and all modes of transmission (97% (213/219)). Most participants (85% (187/219)) identified mosquitoes as a mode of transmission. 95% (116/122) reported an association between Zika virus and microcephaly. The most concerning aspect of Zika virus in 46% (91/200) was the risk of disabilities to babies, and risk of sexual transmission (25% (49/200)). When asked what precautions pregnant persons should to reduce the risk of transmission when traveling to a Zika endemic region, only 27% (50/185) identified using condoms during intercourse or refraining from intercourse while pregnant. Knowledge of Zika transmission is significantly positively associated with pregnancy status, but not with travel history.
   Conclusion: Our results indicate an overall poor understanding of Zika virus symptoms and possible complications, transmission modes, and current recommended prevention guidelines. Pregnancy is positively associated with Knowledge of Zika Transmission, but not other knowledge scores. Reported travel history to Zika endemic regions is not significantly associated with Zika knowledge. There is a need for implementing future public health interventions that particularly focus on protection against Zika transmission, that Zika is sexually transmitted, and risks that the Guillain-Barre Syndrome poses a risk to adults.
C1 [Samuel, Gregory; Lopez, Jean M.; Thakur, Kiran T.] Columbia Univ, Dept Neurol, Med Ctr, 177 Ft Washington Ave, New York, NY 10032 USA.
   [DiBartolo-Cordovano, Rianna; Taj, Insiya; Morse, Steven] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA.
   [Merriam, Audrey; Torres, Caroline; Gyamfi-Bannerman, Cynthia] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY USA.
   [Lantigua, Rafael A.] Columbia Univ, Med Ctr, Dept Internal Med, New York, NY USA.
   [Chang, Bernard P.] Columbia Univ, Med Ctr, Dept Emergency Med, New York, NY USA.
RP Thakur, KT (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, 177 Ft Washington Ave, New York, NY 10032 USA.
EM ktt2115@cumc.columbia.edu
RI Chang, Bernard P./AAI-1139-2019
OI CHANG, BERNARD/0000-0001-8800-7140
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Centers for Disease Control and Prevention, 2016, PREGN WOM PROT YOURS
   Centers for Disease Control and Prevention, 2016, ZIK CAS REP US
   Centers for Disease Control and Prevention, 2016, ZIK VIR CLIN GUID HE
   Centers for Disease Control and Prevention, 2016, ZIK VIR HEALTHC PROV
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Petersen E. E., 2016, MMWR MORB MORTAL WKL, P65
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   WHO, 2016, HIST ZIK VIR
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
NR 11
TC 15
Z9 15
U1 1
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 2
PY 2018
VL 18
AR 98
DI 10.1186/s12889-017-4991-3
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FR6VY
UT WOS:000419205400002
PM 29291723
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT B
AU Santos, DAA
   Teixeira, LE
   Alberti, AM
   Furtado, V
   Rodrigues, JJPC
AF Santos, Diego A. A.
   Teixeira, Luiz E.
   Alberti, Antonio M.
   Furtado, Vasco
   Rodrigues, Joel J. P. C.
BE Perkovic, T
   Milanovic, Z
   Vukojevic, K
   Rodrigues, JJPC
   Nizetic, S
   Patrono, L
   Solic, P
TI Sensitivity and Noise Evaluation of an Optoelectronic Sensor for
   Mosquitoes Monitoring
SO 2018 3RD INTERNATIONAL CONFERENCE ON SMART AND SUSTAINABLE TECHNOLOGIES
   (SPLITECH)
LA English
DT Proceedings Paper
CT 3rd International Conference on Smart and Sustainable Technologies
   (SpliTech)
CY JUN 26-29, 2018
CL Split, CROATIA
SP IEEE, IEEE Commun Soc, Fac Elect Engn Mech Engn & Naval Architecture, Univ Split, Fac Elect Engn Mech Engn & Naval Architecture, IEEE Croatia Sect, IEEE Commun Soc, Croatia Chapter
DE Optoelectronic sensors; Internet of Things; electronic insect traps;
   mosquito; Aedes aegypti
ID AEGYPTI DIPTERA-CULICIDAE; FLIGHT-TONE; INSECTS; FREQUENCY
AB Mosquitoes play a biological role of significant impact on public health, being vectors of several diseases transmission. In particular, the Aedes aegypti mosquito is a vector of potentially fatal diseases such as Dengue, Zika, Chikungunya, and Yellow Fever. The studies progress on these insects biological properties is fundamental for the improvement of more accurate mosquitoes detection sensors. Therefore, the optoelectronic sensors for flying insects detection and classification taking into account the fundamental wingbeat frequency of several insects species database available in the literature. Also, the optoelectronic approach is capable to perform insect sensing without needing uninterrupted data recording. This functionality is essential to reduce the sensor's power consumption and enable the construction of a low-power device ready for an Internet of Things (IoT) scenario. In this regard, this paper aims to design and deploy an optoelectronic sensor module to validate the optoelectronic sensor operating principle and evaluate the main optical interference sources. Thus, it is possible to determine the best sensor's operating bandwidths for an optimal signal-to-noise ratio and efficiency.
C1 [Santos, Diego A. A.; Teixeira, Luiz E.; Alberti, Antonio M.; Rodrigues, Joel J. P. C.] Natl Inst Telecommun Inatel, Santa Rita Do Sapucai, MG, Brazil.
   [Furtado, Vasco; Rodrigues, Joel J. P. C.] Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil.
   [Rodrigues, Joel J. P. C.] Inst Telecomunicacoes, Aveiro, Portugal.
RP Santos, DAA (corresponding author), Natl Inst Telecommun Inatel, Santa Rita Do Sapucai, MG, Brazil.
EM diego.amorim@mtel.inatel.br; luizteixeira@gec.inatel.br;
   alberti@inatel.br; vasco@unifor.br; joeljr@ieee.org
RI Rodrigues, Joel J. P. C./A-8103-2013
OI Rodrigues, Joel J. P. C./0000-0001-8657-3800
FU FCT - Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for
   Science and Technology [UID/EEA/50008/2013]; FinepCiencia Tecnologia e
   Inovacao (FINEP) [01.14.0231.00]; Centro de Referencia em
   Radiocomunicacoes - CRR project of the Instituto Nacional de
   Telecomunicacoes; Brazilian National Council for Research and
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq) [309335/2017-5]; Minas Gerais State Agency for
   Research and Development (FAPMIG) [TEC - APQ-03283-17]
FX This work was supported by the National Funding from the FCT - Fundacao
   para a Ciencia e a Tecnologia through the UID/EEA/50008/2013 Project; by
   Finep, with resources from Funttel, Grant No. 01.14.0231.00, under the
   Centro de Referencia em Radiocomunicacoes - CRR project of the Instituto
   Nacional de Telecomunicacoes (Inatel), Brazil; by Finatel through the
   Inatel Smart Campus project; by Brazilian National Council for Research
   and Development (CNPq) via Grant No. 309335/2017-5; and by Minas Gerais
   State Agency for Research and Development (FAPMIG) via Grant No. TEC -
   APQ-03283-17.
CR Arthur BJ, 2014, J ACOUST SOC AM, V135, P933, DOI 10.1121/1.4861233
   Batista G. E. A. P. A., 2011, Proceedings of the 2011 Tenth International Conference on Machine Learning and Applications (ICMLA 2011), P364, DOI 10.1109/ICMLA.2011.145
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cator LJ, 2011, J MED ENTOMOL, V48, P941, DOI 10.1603/ME11019
   Chen YP, 2014, J INSECT BEHAV, V27, P657, DOI 10.1007/s10905-014-9454-4
   MOORE A, 1986, J ECON ENTOMOL, V79, P1703, DOI 10.1093/jee/79.6.1703
   Ouyang TH, 2015, COMPUT ELECTRON AGR, V118, P47, DOI 10.1016/j.compag.2015.08.021
   Potamitis I, 2017, ROBOTICS, V6, DOI 10.3390/robotics6030019
   Potamitis I, 2016, IEEE SENS J, V16, P6053, DOI 10.1109/JSEN.2016.2574762
   Potamitis I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140474
   Potamitis I, 2015, IEEE SENS J, V15, P4621, DOI 10.1109/JSEN.2015.2424924
   Ravi P., 2016, P 7 ANN S COMP DEV, P3
   Silva D. F., 2011, J INTELLIGENT ROBOTI, V80, P313
   SOTAVALTA O, 1952, NATURE, V170, P1057, DOI 10.1038/1701057a0
   Vega-Almeida R. L., 2018, SCIENTOMETRICS, P1
   Villarreal SM, 2017, J MED ENTOMOL, V54, P1116, DOI 10.1093/jme/tjx079
   World Health Organization, 2014, GLOB BRIEF VECT BORN
NR 17
TC 0
Z9 0
U1 1
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-953-290-083-5
PY 2018
BP 23
EP 27
PG 5
WC Computer Science, Interdisciplinary Applications; Engineering,
   Electrical & Electronic
SC Computer Science; Engineering
GA BO1XF
UT WOS:000502791400005
DA 2020-07-08
ER

PT B
AU de Lima, TFM
AF Melo de Lima, Tiago Franca
GP ACM
TI A Game-based Platform to Tackle a Public Health Problem
SO PROCEEDINGS OF THE 2018 ANNUAL SYMPOSIUM ON COMPUTER-HUMAN INTERACTION
   IN PLAY COMPANION EXTENDED ABSTRACTS (CHI PLAY 2018)
LA English
DT Proceedings Paper
CT 5th ACM SIGCHI Annual Symposium on Computer-Human Interaction in Play
   (CHI PLAY)
CY OCT 28-31, 2018
CL Melbourne, AUSTRALIA
SP Assoc Comp Machinery, ACM SIGCHI
DE Serious games; gamification; Aedes aegypti; dengue; awareness; vector
   surveillance; public health; crowdsourcing; VGI
ID DENGUE; IMPACT; METAANALYSIS; WORLD
AB A global public health concern, mosquito-borne diseases have their transmission dynamics affected by individual behaviors. For instance, improper storage of water may generate breeding sites for the Aedes aegypti mosquito, the vector of dengue, zika, chikungunya and urban yellow fever viruses. Vector control is essential to prevent disease outbreaks. Since most of the Aedes foci are in or near people's homes, population awareness should be part of public health policies. Our research goal is to investigate the design and application of games and gamification to tackle a public health problem. We propose a game-based platform to promote awareness and behavioral changes integrated with a gamification-based system to support entomological surveillance through volunteered contributions. Expected results include the release and evaluation of a game-based platform to support public health actions based on education, and population engagement in vector control.
C1 [Melo de Lima, Tiago Franca] UFOP, Dept Comp & Syst, Joao Monlevade, MG, Brazil.
RP de Lima, TFM (corresponding author), UFOP, Dept Comp & Syst, Joao Monlevade, MG, Brazil.
EM tiagofml@gmail.com
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); UFMG;
   UFOP
FX The PhD supervisor for this work is Prof. Dr. Clodoveu Augusto Davis
   Jr., from the Computer Science Department of the Universidade Federal de
   Minas Gerais (UFMG), Brazil. We acknowledge the support from CNPq and
   FAPEMIG, Brazilian agencies in charge of fostering research and
   development, and our universities, UFOP and UFMG.
CR Al-Muhandis N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001278
   Aleven Vincent, 2010, Proceedings of the Third IEEE International Conference on Digital Game and Intelligent Toy Enhanced Learning (DIGITEL 2010), P69, DOI 10.1109/DIGITEL.2010.55
   Alvarado N., 2012, P INT C FDN DIG GAM, P121, DOI [10.1145/2282338.2282364, DOI 10.1145/2282338.2282364]
   Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x
   Bellotti Francesco, 2010, INT J EMERGING TECHN, V5, DOI [10.3991/ijet.v5iSI3.1500, DOI 10.3991/IJET.V5ISI3.1500]
   Boulos MNK, 2011, INT J HEALTH GEOGR, V10, DOI [10.1186/1476-072x-10-67, 10.1186/1476-072X-10-67]
   Connolly TM, 2012, COMPUT EDUC, V59, P661, DOI 10.1016/j.compedu.2012.03.004
   De Lope RP, 2017, INT CONF GAMES VIRTU, P63, DOI 10.1109/VS-GAMES.2017.8055812
   Deterding S, 2011, P 15 INT AC MINDTREK, V15, P9, DOI DOI 10.1145/2181037.2181040
   Deterding S., 2011, CHI EA, P2425, DOI DOI 10.1145/1979742.1979575
   Edwards EA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012447
   Freifeld CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000376
   Godoi IP, 2017, J COMP EFFECT RES, V6, P165, DOI 10.2217/cer-2016-0045
   Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Hamari J, 2014, P ANN HICSS, P3025, DOI 10.1109/HICSS.2014.377
   Hay SI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001413
   Hunicke Robin, 2004, P AAAI WORKSH CHALL, V4
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Jansen Cassie C, 2010, DENGUE VECTOR AEDES
   Johnson Daniel, 2016, Internet Interv, V6, P89, DOI 10.1016/j.invent.2016.10.002
   Kitchenham B., 2007, TECHNICAL REPORT
   Lima T., 2017, 2017 IEEE 5 INT C SE, P1, DOI DOI 10.1109/SEGAH.2017.7939294
   Lima Tiago, 2018, P INT C ENT COMP IFI, DOI [10.1007/978-3-319-99426-0_3, DOI 10.1007/978-3-319-99426-0_3]
   Looyestyn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173403
   Lwin MO, 2014, ACTA TROP, V130, P100, DOI 10.1016/j.actatropica.2013.09.021
   Marfisi-Schottman I, 2010, PROCEEDINGS OF THE 4TH EUROPEAN CONFERENCE ON GAMES BASED LEARNING, P226
   Michael D. R., 2005, SERIOUS GAMES GAMES
   Pai HH, 2006, J ENVIRON HEALTH, V68, P35
   Pang T, 2016, LANCET INFECT DIS, V16, P880, DOI 10.1016/S1473-3099(16)30167-0
   Pereira de Aguiar Michelle, 2018, Design, User Experience, and Usability. Theory and Practice. 7th International Conference, DUXU 2018 Held as Part of HCI International 2018. Proceedings: LNCS 10918, P165, DOI 10.1007/978-3-319-91797-9_13
   Petersen K., 2008, P 12 INT C EV ASS SO, P68, DOI DOI 10.1142/S0218194007003112
   Pinelle D, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1453
   Porta M, 2014, DICT EPIDEMIOLOGY
   Prensky M., 2006, DONT BOTHER ME MOM I
   Seixas LD, 2016, COMPUT HUM BEHAV, V58, P48, DOI 10.1016/j.chb.2015.11.021
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Susi T., 2007, SERIOUS GAMES OVERVI
   Swaddiwudhipong W., 1992, SHOCK, V5, P1
   Tsekleves E, 2016, BRIT J EDUC TECHNOL, V47, P164, DOI 10.1111/bjet.12223
   Whitehead SS, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028811
   Wilder-Smith A, 2016, J INFECT DIS, V214, P1796, DOI 10.1093/infdis/jiw341
   Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363
   Winn B., 2008, HDB RES EFFECTIVE EL, P1010, DOI DOI 10.4018/978-1-59904-808-6.CH058
   Wouters P, 2013, J EDUC PSYCHOL, V105, P249, DOI 10.1037/a0031311
NR 46
TC 0
Z9 0
U1 1
U2 1
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-5968-9
PY 2018
BP 17
EP 25
DI 10.1145/3270316.3270605
PG 9
WC Computer Science, Cybernetics; Computer Science, Information Systems;
   Computer Science, Software Engineering
SC Computer Science
GA BO1RC
UT WOS:000502121400004
DA 2020-07-08
ER

PT B
AU Srivastava, A
   Kaushik, V
AF Srivastava, Arpit
   Kaushik, Vikas
BE Varadwaj, PK
   Tiwary, US
   Sanjeev, BS
TI Computational Drug Discovery Approach for Drug Design against Zika Virus
SO 2018 INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND SYSTEMS BIOLOGY
   (BSB)
LA English
DT Proceedings Paper
CT International Conference on Bioinformatics and Systems Biology (BSB)
CY OCT 26-28, 2018
CL Indian Inst Informat Technol Allahabad, Allahabad, INDIA
SP IEEE Comp Soc, IEEE Signal Proc Soc, Comp Soc India, Schrodinger, Agrigenome, Sci & Engn Res Board
HO Indian Inst Informat Technol Allahabad
DE HTS; ZIKV; Virtual screening; Polymerase; NS5
AB High Throughput Virtual Screening of various candidate molecules to predict the possibility for acting as inhibitors against NS5 protein of Zika Virus is done in this work. The ontology of NS5 protein of ZIKV is to replicate its viral RNA by enzyme RNA Dependent RNA polymerase and mechanize its viral RNA modification functionality by methyltransferase. Objective of the current study is to screen out potential inhibitor and design drug against NS5 protein which is largely encoded with above 600 amino acids having two subunits. This work will present a valuable opportunity to scientific community for the prediction of efficient novel therapeutic remedies for controlling Zika. The screened ligand could be used as a potential inhibitor against ZIKV.
C1 [Srivastava, Arpit; Kaushik, Vikas] Lovely Profess Univ, Sch Bioengn & Biosci, Phagwara, Punjab, India.
RP Srivastava, A (corresponding author), Lovely Profess Univ, Sch Bioengn & Biosci, Phagwara, Punjab, India.
EM arpit.tech003@gmail.com; vikas.14664@lpu.co.in
RI Kaushik, Vikas/AAG-2963-2020
OI SRIVASTAVA, ARPIT/0000-0002-1525-5626
CR Abagyan R., 2000, NUCL ACIDS RES
   [Anonymous], 2015, ZIK VIR INF OUTBR BR, P3
   [Anonymous], 2017, ILL SEQ TECHN INTR N
   Dang J., 2016, ZIKA VIRUS DEPLETES, P4
   Dina S., 2005, NUCL ACID RES
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Nguyen MH, 2015, EXPERT OPIN PHARMACO
   Sahoo M., 2016, GENOMICS INFORM
   Sikka Veronica, 2016, J GLOBAL INFECT DIS, V15
   Stefano F., 2016, COMPUTATIONAL UNPUB
   Symptoms Diagnosis & Treatment Zika virus, 2016, SCIENCE, P70
   THIEL HJ, 2005, VIRUS TAXONOMY, P981
   Vincent B. C, 2010, ACTA CRYSTALLOGER D
   Wishart DS, DRUG BANK DATABASE 5
NR 15
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5386-6434-6
PY 2018
BP 119
EP 122
PG 4
WC Biotechnology & Applied Microbiology; Mathematical & Computational
   Biology
SC Biotechnology & Applied Microbiology; Mathematical & Computational
   Biology
GA BO0YQ
UT WOS:000493979500026
DA 2020-07-08
ER

PT J
AU Sookaromdee, P
   Wiwanitkit, V
AF Sookaromdee, Pathoom
   Wiwanitkit, Viroj
TI Homosexual and Zika virus infection: Is it a new start of new problem
   for gay
SO INDIAN JOURNAL OF SEXUALLY TRANSMITTED DISEASES AND AIDS
LA English
DT Letter
ID SEXUAL TRANSMISSION
C1 [Sookaromdee, Pathoom] TWS Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
RP Sookaromdee, P (corresponding author), TWS Med Ctr, Bangkok, Thailand.
EM pathumsook@gmail.com
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   MCCARTHY M, 2016, BMJ-BRIT MED J, V352, P1042
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
NR 7
TC 1
Z9 1
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2589-0557
EI 2589-0565
J9 INDIAN J SEX TRANSM
JI Indian J. Sex Transm. Dis. AIDS
PD JAN-JUN
PY 2018
VL 39
IS 1
BP 61
EP 62
DI 10.4103/ijstd.IJSTD_65_16
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA IR8ZA
UT WOS:000481730300013
PM 30187030
OA Green Published
DA 2020-07-08
ER

PT S
AU Guths, R
   Telles, GP
   Walter, MEMT
   Almeida, NF
AF Guths, Rogerio
   Telles, Guilherme P.
   Walter, Maria Emilia M. T.
   Almeida, Nalvo F.
BE Peixoto, N
   Silveira, M
   Ali, HH
   Maciel, C
   VanDenBroek, EL
TI A Heuristic for the Live Parsimony Problem
SO BIOMEDICAL ENGINEERING SYSTEMS AND TECHNOLOGIES (BIOSTEC 2017)
SE Communications in Computer and Information Science
LA English
DT Proceedings Paper
CT 10th International Joint Conference on Biomedical Engineering Systems
   and Technologies (BIOSTEC)
CY FEB 21-23, 2017
CL Porto, PORTUGAL
DE Phylogeny; Character state phylogeny; Live phylogeny Parsimony;
   Algorithms
ID EVOLUTION; TREES
AB Live Phylogeny generalizes the phylogeny theory by admitting living ancestors among the taxonomic objects. This theory suits cases of fast-evolving species like virus, and phylogenies of non-biological objects like documents, images and database records. In character-based live phylogeny, the input is a matrix with n objects and m characters, such each position i, j keeps the state of character j for the object i. The output is a tree where the input objects are represented as leaves or internal nodes labeled with a string of m symbols, representing the state of the characters. The goal is to obtain a tree with the minimal number of state changes along the edges, considering all characters, called the most parsimonious tree. In this paper we analyze problems related to most parsimonious tree using Live Phylogeny. We propose an improvement to a previously presented branch-and-bound algorithm and also a new heuristic for the problem. We present the results of experiments with a set of 20 Zika virus genome sequences, comparing the performance of our heuristic.
C1 [Guths, Rogerio; Almeida, Nalvo F.] Univ Fed Mato Grosso do Sul, Sch Comp, Campo Grande, Brazil.
   [Telles, Guilherme P.] Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil.
   [Walter, Maria Emilia M. T.] Univ Brasilia, Dept Comp Sci, Brasilia, DF, Brazil.
RP Almeida, NF (corresponding author), Univ Fed Mato Grosso do Sul, Sch Comp, Campo Grande, Brazil.
EM r.guths@ufms.br; gpt@ic.unicamp.br; mariaemilia@unb.br;
   nalvo@facom.ufms.br
RI Walter, Maria Emilia/A-8000-2015
OI Walter, Maria Emilia/0000-0001-6822-931X; Almeida,
   Nalvo/0000-0001-5615-1746
FU FundectFundect [TO141/2016, TO 007/2015]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [305857/2013-4,
   473221/2013-6, 310685/2015-0, 308524/2015-2]; CAPESCAPES [3377/2013]
FX RG and NFA thank Fundect grants TO141/2016 and TO 007/2015. NFA also
   thanks CNPq grants 305857/2013-4, 473221/2013-6 and CAPES grant
   3377/2013. GPT acknowledges CNPq grant 310685/2015-0. MEMT thanks CNPq
   grant 308524/2015-2.
CR Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019
   Cuadros AM, 2007, IEEE CONF VIS ANAL, P99, DOI 10.1109/VAST.2007.4389002
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Felsenstein J, 2004, INFERRING PHYLOGENIE
   FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116
   Goeffon A., 2011, HEURISTIC METHODS PH, P579
   GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P10015, DOI 10.1073/pnas.87.24.10015
   Guths R, 2017, PROCEEDINGS OF THE 10TH INTERNATIONAL JOINT CONFERENCE ON BIOMEDICAL ENGINEERING SYSTEMS AND TECHNOLOGIES, VOL 3: BIOINFORMATICS, P184, DOI 10.5220/0006219001840189
   HENDY MD, 1982, MATH BIOSCI, V59, P277, DOI 10.1016/0025-5564(82)90027-X
   Jones N. C., 2004, INTRO BIOINFORMATICS, V2004
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Paiva JGS, 2011, IEEE T VIS COMPUT GR, V17, P2459, DOI 10.1109/TVCG.2011.212
   SANKOFF D, 1975, SIAM J APPL MATH, V28, P35, DOI 10.1137/0128004
   Setubal J. C., 1997, INTRO MOL COMPUTATIO, V1997
   Telles GP, 2013, J COMPUT BIOL, V20, P30, DOI 10.1089/cmb.2012.0219
   Yan M., 2003, TRCS200353 U NEW MEX
NR 17
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1865-0929
EI 1865-0937
BN 978-3-319-94806-5; 978-3-319-94805-8
J9 COMM COM INF SC
PY 2018
VL 881
BP 248
EP 267
DI 10.1007/978-3-319-94806-5_14
PG 20
WC Engineering, Biomedical; Mathematical & Computational Biology
SC Engineering; Mathematical & Computational Biology
GA BN2LD
UT WOS:000476867700014
DA 2020-07-08
ER

PT B
AU Jawahir, WN
   Yussof, HW
   Man, M
   Hitam, MS
   Hamid, AAKA
   Awalludin, EA
   Aezwani, W
   Abu Bakar, W
AF Jawahir, Wan Nural
   Yussof, Hj Wan
   Man, Mustafa
   Hitam, Muhammad Suzuri
   Hamid, Abdul Aziz K. Abdul
   Awalludin, Ezmamarul Afreen
   Aezwani, Wan
   Abu Bakar, Wan
GP Assoc Comp Machinery
TI Wavelet-based Auto-Counting Tool of Aedes Eggs
SO 2018 INTERNATIONAL CONFERENCE ON SENSORS, SIGNAL AND IMAGE PROCESSING
   (SSIP 2018)
LA English
DT Proceedings Paper
CT International Conference on Sensors, Signal and Image Processing (SSIP)
CY OCT 12-14, 2018
CL Prague, CZECH REPUBLIC
SP Int Acad Comp Technol
DE Aedes; eggs counting; Gabor wavelets
AB Aedes aegypti mosquito species are an important vector of many viruses including dengue and Zika. Preventing or reducing the virus transmission depends entirely on controlling the mosquito vectors. To facilitate a vector control operation, a new image processing tool is developed for counting Aedes eggs so that fecundity estimation can be done automatically replacing the manual counting that requires a lot of efforts and time-consuming. The proposed tool is based on Gabor wavelets to produce a response map that can ease the thresholding process. We test the proposed tool of Aedes eggs counting by comparing with ICount and EggCounter which is freely available on the Internet. The results showed that the proposed method is promising for a reliable estimation of Aedes eggs.
C1 [Jawahir, Wan Nural; Yussof, Hj Wan; Man, Mustafa; Hitam, Muhammad Suzuri; Hamid, Abdul Aziz K. Abdul] Univ Malaysia Terengganu, Sch Informat & Appl Math, Kuala Nerus 21030, Terengganu, Malaysia.
   [Awalludin, Ezmamarul Afreen] Univ Malaysia Terengganu, Sch Fisheries & Aquaculture Sci, Kuala Nerus 21030, Terengganu, Malaysia.
   [Aezwani, Wan; Abu Bakar, Wan] Univ Sultan Zainal Abidin, Fac Informat & Comp, Kuala Nerus 21030, Terengganu, Malaysia.
RP Jawahir, WN (corresponding author), Univ Malaysia Terengganu, Sch Informat & Appl Math, Kuala Nerus 21030, Terengganu, Malaysia.
EM wannurwy@umt.edu.my; mustafaman@umt.edu.my; suzuri@umt.edu.my;
   abdulazizkah@umt.edu.my; e.afreen@umt.edu.my; wanaezwani@unisza.edu.my
RI Man, Mustafa/AAG-5475-2019
OI Man, Mustafa/0000-0003-4071-721X
FU Ministry of Education Malaysia; Universiti Malaysia Terengganu [59430]
FX We acknowledge Ministry of Education Malaysia and Universiti Malaysia
   Terengganu for sponsoring this project through FRGS 2016/1 Vot. 59430
   and Matching Grant Project between University-Industry, respectively.
CR Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   da Silva MGNM, 2011, IEEE ENG MED BIO, P6810, DOI 10.1109/IEMBS.2011.6091679
   Dembo E, 2014, J MED ENTOMOL, V51, P831, DOI 10.1603/ME13112
   Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8
   Gaburro J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1870-1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Mains JW, 2008, J AM MOSQUITO CONTR, V24, P496, DOI 10.2987/5740.1
   Mollahosseini A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-122
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Poulin B, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030313
   Seng Chang Moh, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P543
   Wilson A., 2017, OJIN ONLINE J ISSUES, V22
   YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472
NR 13
TC 1
Z9 1
U1 0
U2 0
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-6620-5
PY 2018
BP 56
EP 59
DI 10.1145/3290589.3290594
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Imaging Science & Photographic Technology
SC Engineering; Instruments & Instrumentation; Imaging Science &
   Photographic Technology
GA BN2BY
UT WOS:000475843500011
DA 2020-07-08
ER

PT B
AU Nerghes, A
   Kerkhof, P
   Hellsten, I
AF Nerghes, Adina
   Kerkhof, Peter
   Hellsten, Iina
GP Assoc Comp Machinery
TI Early Public Responses to the Zika-Virus on YouTube: Prevalence of and
   Differences Between Conspiracy Theory and Informational Videos
SO WEBSCI'18: PROCEEDINGS OF THE 10TH ACM CONFERENCE ON WEB SCIENCE
LA English
DT Proceedings Paper
CT 10th ACM Conference on Web Science (WebSci)
CY MAY 27-30, 2018
CL Amsterdam, NETHERLANDS
SP Assoc Comp Machinery, ACM SIGWEB
DE Zika-virus; YouTube; Informational and Conspiracy Theory Videos; Topic
   Modeling; Semantic Networks
ID HPV VACCINE COVERAGE; SOCIAL MEDIA
AB In this paper, we analyze the content of the most popular videos posted on YouTube in the first phase of the Zika-virus outbreak in 2016, and the user responses to those videos. More specifically, we examine the extent to which informational and conspiracy theory videos differ in terms of user activity (number of comments, shares, likes and dislikes), and the sentiment and content of the user responses. Our results show that 12 out of the 35 videos in our data set focused on conspiracy theories, but no statistical differences were found in the number of user activity and sentiment between the two types of videos. The content of the user responses shows that users respond differently to sub-topics related to Zika-virus. The implications of the results for future online health promotion campaigns are discussed.
C1 [Nerghes, Adina] KNAW Humanities Cluster, Amsterdam, Netherlands.
   [Kerkhof, Peter] Vrije Univ Amsterdam, Amsterdam, Netherlands.
   [Hellsten, Iina] Univ Amsterdam, Amsterdam, Netherlands.
RP Nerghes, A (corresponding author), KNAW Humanities Cluster, Amsterdam, Netherlands.
EM adina.nerghes@dh.huc.knaw.nl; p.kerkhof@vu.nl; i.r.hellsten@uva.nl
OI Nerghes, Adina/0000-0002-8483-4357
CR Abramowitz S, 2017, J HEALTH COMMUN, V22, P59, DOI 10.1080/10810730.2016.1209599
   Atlani-Duault L, 2015, CULT MED PSYCHIAT, V39, P43, DOI 10.1007/s11013-014-9410-y
   Basch CH, 2015, DISASTER MED PUBLIC, V9, P531, DOI 10.1017/dmp.2015.77
   Basch Corey H, 2015, J MED INTERNET RES C, V1, P1
   Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Briones R, 2012, HEALTH COMMUN, V27, P478, DOI 10.1080/10410236.2011.610258
   Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113
   Douglas KM, 2017, CURR DIR PSYCHOL SCI, V26, P538, DOI 10.1177/0963721417718261
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Dunn AG, 2017, VACCINE, V35, P3033, DOI 10.1016/j.vaccine.2017.04.060
   Espinola Maria, 2016, Disaster Health, V3, P102, DOI 10.1080/21665044.2016.1263141
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Gruhl D., 2004, P 13 INT C WORLD WID, P491, DOI DOI 10.1145/988672.988739
   Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1
   Hossler EW, 2008, ARCH DERMATOL, V144, P1395, DOI 10.1001/archderm.144.10.1395
   Keelan J, 2007, JAMA-J AM MED ASSOC, V298, P2482, DOI 10.1001/jama.298.21.2482
   Klonoff EA, 1999, PREV MED, V28, P451, DOI 10.1006/pmed.1999.0463
   Madathil KC, 2015, HEALTH INFORM J, V21, P173, DOI 10.1177/1460458213512220
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nagpal SJS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1251-9
   Oliver JE, 2014, JAMA INTERN MED, V174, P817, DOI 10.1001/jamainternmed.2014.190
   Popping R, 2003, SOC SCI INFORM, V42, P91, DOI 10.1177/0539018403042001798
   Porter AJ, 2014, J COMPUT-MEDIAT COMM, V19, P1024, DOI 10.1111/jcc4.12065
   Reintjes R, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0151258, 10.1371/journal.pone.0]
   Rieder Bernhard, 2015, YOUTUBE DATA TOOLS
   Singh AG, 2012, J RHEUMATOL, V39, P899, DOI 10.3899/jrheum.111114
   Syed-Abdul S, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2237
   Thellier M, 2013, PLANT BIOLOGY, V15, P1, DOI 10.1111/j.1438-8677.2012.00674.x
   Van Eck N.J., 2013, VOSVIEWER MANUAL
   Venables W. N., 2002, MODERN APPL STAT S
   Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559
   Walther JB, 2010, HUM COMMUN RES, V36, P469, DOI 10.1111/j.1468-2958.2010.01384.x
   Wasserman S., 1994, SOCIAL NETWORK ANAL, V24
   Yoo JH, 2012, HEALTH COMMUN, V27, P86, DOI 10.1080/10410236.2011.569003
   Zollo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138740
NR 36
TC 1
Z9 1
U1 2
U2 3
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-5563-6
PY 2018
BP 127
EP 133
DI 10.1145/3201064.3201086
PG 7
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BN1PH
UT WOS:000474785000015
OA Green Published
DA 2020-07-08
ER

PT J
AU Bayat, H
   Naderi, F
   Khan, AH
   Memarnejadian, A
   Rahimpour, A
AF Bayat, Hadi
   Naderi, Fatemeh
   Khan, Amjad Hayat
   Memarnejadian, Arash
   Rahimpour, Azam
TI The Impact of CRISPR-Cas System on Antiviral Therapy
SO ADVANCED PHARMACEUTICAL BULLETIN
LA English
DT Review
DE CRISPR-Cas; Antiviral therapy; Genome editing; Latent viruses; Delivery
   system
ID HEPATITIS-B-VIRUS; ZIKA VIRUS; GUIDE RNAS; GENE; DNA; REPLICATION;
   PROTEIN; INHIBITION; MUTATIONS; EXCISION
AB Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein nuclease (Cas) is identified as an adaptive immune system in archaea and bacteria. Type II of this system, CRISPR-Cas9, is the most versatile form that has enabled facile and efficient targeted genome editing. Viral infections have serious impacts on global health and conventional antiviral therapies have not yielded a successful solution hitherto. The CRISPR-Cas9 system represents a promising tool for eliminating viral infections. In this review, we highlight 1) the recent progress of CRISPR-Cas technology in decoding and diagnosis of viral outbreaks, 2) its applications to eliminate viral infections in both pre-integration and provirus stages, and 3) various delivery systems that are employed to introduce the platform into target cells.
C1 [Bayat, Hadi; Rahimpour, Azam] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Tissue Engn & Appl Cell Sci, Tehran, Iran.
   [Bayat, Hadi] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran.
   [Naderi, Fatemeh] Islamic Azad Univ, Tehran Med Sci Branch, Dept Mol Genet, Tehran, Iran.
   [Khan, Amjad Hayat] Univ Sains Malaysia, Inst Res Mol Med INFORMM, George Town, Malaysia.
   [Memarnejadian, Arash] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran.
RP Rahimpour, A (corresponding author), Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Tissue Engn & Appl Cell Sci, Tehran, Iran.
EM rahimpour@sbmu.ac.ir
RI Memarnejadian, Arash/I-3979-2019
OI Memarnejadian, Arash/0000-0003-4005-8787; Bayat,
   Hadi/0000-0003-4069-3529; Khan, Dr. Amjad Hayat/0000-0003-3656-5727
FU School of Advanced Technologies in Medicine, Shahid Beheshti University
   of Medical Sciences
FX Authors wish to thank School of Advanced Technologies in Medicine,
   Shahid Beheshti University of Medical Sciences for its support.
CR Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020
   Bayat H, 2018, CURR MICROBIOL, V75, P107, DOI 10.1007/s00284-017-1406-8
   Bayat H, 2017, J MICROBIOL BIOTECHN, V27, P207, DOI 10.4014/jmb.1607.07005
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908
   Chen SQ, 2017, J VIROL, V91, DOI [10.1128/JVI.02465-16, 10.1128/jvi.02465-16]
   Chen X, 2016, MOL THER, V24, P447, DOI 10.1038/mt.2015.164
   Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27
   Chou YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36921
   Dorningues P, 2015, J GEN VIROL, V96, P3236, DOI 10.1099/jgv.0.000283
   Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454
   Haworth KG, 2017, CYTOTHERAPY, V19, P1325, DOI 10.1016/j.jcyt.2017.05.013
   Ho YK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005102
   Hopcraft SE, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00009-15
   Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577
   Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111
   Hu Z, 2014, BIOMED RES INT, DOI 10.1155/2014/612823
   Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080
   Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41
   Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555
   Kanda T, 2016, J VIROL, V90, P4383, DOI 10.1128/JVI.00060-16
   Karimova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13734
   Kennedy EM, 2015, VIROLOGY, V479, P213, DOI 10.1016/j.virol.2015.02.024
   Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001
   Lao YH, 2018, ADV SCI, V5, DOI 10.1002/advs.201700540
   Lebbink RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41968
   Levasseur A, 2016, NATURE, V531, P249, DOI 10.1038/nature17146
   Lin CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34531
   Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159
   Liu ZP, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0174-2
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741
   Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112
   Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833
   Satou Y, 2016, P NATL ACAD SCI USA, V113, P3054, DOI 10.1073/pnas.1423199113
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Seeger C, 2016, MOL THER, V24, P1258, DOI 10.1038/mt.2016.94
   Senis E, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw805
   Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030
   van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111
   Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042
   Wollebo HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136046
   Xiong X, 2016, ANNU REV GENOM HUM G, V17, P131, DOI 10.1146/annurev-genom-083115-022258
   Xu XL, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0600-9
   Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111
   Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012
   Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471
   Yu L, 2015, ONCOTARGETS THER, V8, P37, DOI 10.2147/OTT.S64092
   Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zou Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01554-1
NR 55
TC 2
Z9 2
U1 0
U2 1
PU TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES
PI TABRIZ
PA DANESHGHAH ST, TABRIZ, REPUBLIC ISLAMIC 51664-14766, IRAN
SN 2228-5881
EI 2251-7308
J9 ADV PHARM BULL
JI Adv. Pharm. Bull.
PY 2018
VL 8
IS 4
BP 591
EP 597
AR PMID 30607331
DI 10.15171/apb.2018.067
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IG5DA
UT WOS:000473822500006
PM 30607331
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bonilla-Soto, LA
AF Bonilla-Soto, Luis A.
TI Zika Virus in the Americas: An Environmental Health Perspective
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE ZIKV; Aedes aegypti; Americas
ID WEST-NILE-VIRUS; AEDES-AEGYPTI; SEXUAL TRANSMISSION; INTERIM GUIDELINES;
   UNITED-STATES; PREGNANT-WOMEN; YELLOW-FEVER; EMERGENCE; MOSQUITOS;
   EPIDEMIC
AB Phylogenetic studies suggest that ZIKV may have been introduced to Brazil, and therefore to the Americas, in 2014 during the World Spring Canoe Championship held in the city of Rio de Janeiro. Since then the virus has spread across Latin America, Caribbean, and North America. It seems clear that Aedes aegypti and, to a lesser extent, Aedes albopictus are the main vectors of the pathogen. ZIKV infection symptoms are similar to other flaviviruses such as a dengue infection and therefore can be easily confounded. Currently, the ZIKV maintains two life cycles. The first, and the original one is the sylvatic/enzootic cycle that occurs in Africa. The second life cycle is the suburban-urban transmission cycle that emerged through natural evolution. ZIKV has gained the ability to maintain this human-endemic cycle in urban and suburban areas. ZIKV has never been isolated from non-primates, so it is not clear whether other species can act as reservoir hosts. Several reports have been made of non-vector ZIKV transmission including breast-milk feeding, blood transfusion, sexual intercourse, saliva, urine, and physical contact (sweat, tears). A major global concern with ZIKV infection is the reported increase in cases of microcephaly and Guillain-Barre Syndrome (GBS) in the Americas after the recent ZIKV outbreak. Currently, there is no available vaccine for ZIKV. Therefore, prevention of ZIKV infection must be emphasized by local public health authorities promoting collective responsibility and engagement for integrated vector management through environmental management, biological control, and as a last resource chemical control.
C1 [Bonilla-Soto, Luis A.] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Environm Hlth, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
RP Bonilla-Soto, LA (corresponding author), Univ Puerto Rico, Grad Sch Publ Hlth, Dept Environm Hlth, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
EM luis.bonilla1@upr.edu
CR Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Costa AA, 2017, J MED ENTOMOL, V54, P670, DOI 10.1093/jme/tjw222
   [Anonymous], 1967, World Health Organ Tech Rep Ser, V369, P1
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bennett SN, 2014, MOL BIOL EVOL, V31, P574
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, OUTC PREGN LAB EV PO
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2007, FIELDS VIROLOGY, P1155
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Hsu WS, 2013, J ENVIRON SCI HEAL B, V48, P1014, DOI 10.1080/03601234.2013.816613
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li R, 2017, RADIOLOGY INFECT DIS, V20, P1
   Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nhan T-X, 2014, REV FRANCOPH LAB, V467, P45
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   PAHO, 2016, ZIK SUSP CONF CAS RE
   PAHO / WHO, 2017, ZIK EP UPD
   Pan American Health Organization, 2016, EP AL NEUR SYNDR CON
   Pan American Health Organization (PAHO)/ World Health Organization (WHO), 2016, ZIK EP UPD
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Shapiro R, 2012, J PEDIATR NURS, V27, P346, DOI 10.1016/j.pedn.2011.03.011
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vandenbogaert M, 2014, 63 AM SOC TROP MED H
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Weaver SC, 2005, ARCH VIROL, P33
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, BIOL CONTROL
   WHO, CHEM CONTR
   WHO, ENV MANAGEMENT
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
NR 86
TC 0
Z9 0
U1 0
U2 3
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S5
EP S14
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900002
PM 30576572
DA 2020-07-08
ER

PT J
AU Davila-Castrodad, NM
   Reyes-Bou, Z
   Correa-Rivas, M
   Perez-Berenguer, JL
   Di-Pasquale, L
   Garcia-Garcia, I
AF Davila-Castrodad, Nicolle M.
   Reyes-Bou, Zayhara
   Correa-Rivas, Maria
   Perez-Berenguer, Juan L.
   Di-Pasquale, Lorena
   Garcia-Garcia, Ines
TI First Autopsy of a Newborn with Congenital Zika Syndrome in Puerto Rico
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Microcephaly; Calcifications; Malformations; Contractures; Zika virus
ID VIRUS
AB We report on the first autopsy performed on a neonate with congenital Zika syndrome in Puerto Rico. A term male was born to a mother with confirmed Zika virus infection; he had a prenatal diagnosis of microcephaly and multiple cerebral calcifications, among other anomalies, and a normal male karyotype (determined by amniocentesis). He required neonatal resuscitation at birth and died at 2 days of age. At autopsy, his head circumference was only 1.5 standard deviations below the mean, not fulfilling the criteria for microcephaly. He presented scissor legs, clenched and hyperflexed hands, and multiple contractures (arthrogryposis). The central nervous system findings were consistent with Zika encephalopathy: ventriculomegaly, lissencephaly, and severe encephalic degeneration with numerous dystrophic calcifications, among other findings. These anomalies were most likely secondary to congenital ZV infection. Although prenatally diagnosed with microcephaly, he did not fulfill the criteria after birth, which fact indicates the need for reassessment of the definition of microcephaly as it applies to patients exposed prenatally to the ZV.
C1 [Davila-Castrodad, Nicolle M.; Garcia-Garcia, Ines] Univ Puerto Rico, Sch Med, Dept Pediat, Neonatol Sect, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
   [Reyes-Bou, Zayhara; Garcia-Garcia, Ines] Univ Puerto Rico, Dept Pediat, Neonatol Sect, Med Sci Campus, San Juan, PR 00936 USA.
   [Correa-Rivas, Maria; Perez-Berenguer, Juan L.; Di-Pasquale, Lorena] Univ Puerto Rico, Dept Pathol, Med Sci Campus, San Juan, PR 00936 USA.
   [Correa-Rivas, Maria; Perez-Berenguer, Juan L.; Di-Pasquale, Lorena] Univ Puerto Rico, Lab Med, Med Sci Campus, San Juan, PR 00936 USA.
RP Garcia-Garcia, I (corresponding author), Univ Puerto Rico, Sch Med, Dept Pediat, Neonatol Sect, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
EM Ines.garcia@upr.edu
CR Centers for Disease Control and Prevention, 2017, ZIK VIR
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Departamento de Salud de Puerto Rico, 2017, SEMANA, P29
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 7
TC 2
Z9 2
U1 1
U2 1
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S81
EP S84
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900013
PM 30576583
DA 2020-07-08
ER

PT J
AU Esquilin-Rivera, IO
   Reyes-Baez, G
   Perez-Torres, R
AF Esquilin-Rivera, Ines O.
   Reyes-Baez, Gloria
   Perez-Torres, Raul
TI Ethical Issues during Zika Epidemic in Puerto Rico and the Americas
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Zika; Ethical issues; Puerto Rico; Americas
ID VIRUS-INFECTION; INFANTS; BIRTH
AB The Zika virus epidemic and the possible devastating teratogenic effects of the virus represent a challenge. Health authorities have the responsibility to create programs that provide adequate preventive, medical and psychological services to the affected population. The estimated risk of microcephaly in infants of mothers infected with Zika virus is 1 to 13% when the infection occurs in the first trimester of pregnancy. There is insufficient data to estimate the risk of microcephaly when infection occurs in the second or third trimester. Pregnant women and those in reproductive age are advised to avoid traveling to places where there is local transmission of the Zika virus. Human rights advocates have requested, comprehensive sexual and reproductive health services that include expanded access to contraceptive methods including emergency contraception and safe abortion services. These strategies created a debate between the abortion rights and the right of the disabled. The discussion rests on the assumption that there are lives that are not worth living. Most people focus on the most severely affected patients, but few consider that the spectrum of disabilities associated with congenital Zika infection is broad. The rights of children with disabilities and their dignity as individuals should be respected.
C1 [Esquilin-Rivera, Ines O.; Reyes-Baez, Gloria] Univ Puerto Rico, Sch Med, Dept Pediat, Med Sci Campus, San Juan, PR 00936 USA.
   [Perez-Torres, Raul] Univ Puerto Rico, Sch Med, Dept Ophthalmol, Med Sci Campus, San Juan, PR 00936 USA.
RP Esquilin-Rivera, IO (corresponding author), POB 5067, San Juan, PR 00936 USA.
EM ines.esquilin@upr.edu
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   American College of Obstetricians and Gynecologists, 2016, ACOG ZIK VIR RES SUM
   [Anonymous], 2017, INF SEM ENF ARB
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   CARRICK P, 1985, MED ETHICS ANTIQUITY
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Veatch RM, 2012, BASICS BIOETHICS, P362
NR 10
TC 0
Z9 0
U1 1
U2 1
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S41
EP S44
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900006
PM 30576576
DA 2020-07-08
ER

PT J
AU Gely-Rojas, L
   Garcia-Fragoso, L
   Negron, J
   Deynes, D
   Zorrilla, CD
   Garcia-Garcia, I
AF Gely-Rojas, Leticia
   Garcia-Fragoso, Lourdes
   Negron, Juanita
   Deynes, Daymara
   Zorrilla, Carmen D.
   Garcia-Garcia, Ines
TI Congenital Zika Syndrome in Puerto Rico, Beyond Microcephaly, A
   Multiorgan Approach
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Lissencephaly; Calcifications; Double-ring sign; Macular stippling
ID VIRUS
AB Objective: Zika virus (ZIKV) infection was identified in Puerto Rico on December 2015, and the outbreak encouraged us to characterize clinical manifestations and laboratory findings of intrauterine exposed infants.
   Methods: Retrospective medical record review of infants born to mothers with confirmed ZIKV infection during pregnancy was performed from January 2016-June 2017. We included patients admitted to UPH Neonatal Intensive Care Unit or referred for follow-up at UPH High Risk Clinics. The database was approved by the University of Puerto Rico, Medical Sciences Campus, IRB.
   Results: 191 infants born to ZIKV positive mothers during pregnancy were identified. Normal head sonogram was found in 93% of the normo-cephalic infants. Ocular findings were reported in 50% of the patients with microcephaly and 31% of the normo-cephalics. Fifteen newborns (7.8%) presented with microcephaly, of which 73% showed calcifications in head sonogram, and had severe anomalies on brain MRI. Auditory brainstem response test was performed on all newborns, 80% were within normal limits.
   Conclusion: Among the group of infants born to mothers with Zika positive test 4% had microcephaly. Of concern to us is the fact that 31% of normo-cephalic infants had ocular manifestations and 7% of them had findings on head sonogram. While microcephaly is the severest form of Congenital Zika Syndrome, ocular manifestations might characterize the spectrum of disease. These findings reiterate the importance of detailed neonatal evaluations of exposed infants.
C1 [Gely-Rojas, Leticia; Garcia-Fragoso, Lourdes; Garcia-Garcia, Ines] Univ Puerto Rico, Neonatol Sect, Dept Pediat, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
   [Negron, Juanita] Univ Puerto Rico, Dept Pediat, Med Sci Campus, San Juan, PR 00936 USA.
   Univ Puerto Rico, Med Sci Campus, San Juan, PR 00936 USA.
   [Zorrilla, Carmen D.] Univ Puerto Rico, Dept Obstet & Gynecol, Med Sci Campus, San Juan, PR 00936 USA.
RP Garcia-Garcia, I (corresponding author), Univ Puerto Rico, Neonatol Sect, Dept Pediat, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
EM ines.garcia@upr.edu
CR [Anonymous], 2017, SEMANA, P20
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   CDC, 2015, CHIK VIR SURV CONTR
   CDC, 2016, ZIK VIR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   GILBERT SF, 2000, DEV BIOL
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
NR 11
TC 1
Z9 1
U1 1
U2 1
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S73
EP S76
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900011
PM 30576581
DA 2020-07-08
ER

PT J
AU Gely-Rojas, L
   Perez, R
   Garcia-Fragoso, L
   Garcia-Garcia, I
AF Gely-Rojas, Leticia
   Perez, Raul
   Garcia-Fragoso, Lourdes
   Garcia-Garcia, Ines
TI Association of Zika Virus Exposure in Utero with Ocular Phenotypes in a
   Group of Newborns in Puerto Rico
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Macular stippling; Double-ring sign; Microcephaly; Normocephalic
ID INFANTS; CHILD
AB Objective: After the outbreak in January 2016, researchers in Brazil reported the first cases of ophthalmic abnormalities in infants with microcephaly and presumed Zika virus (ZIKV) intrauterine infection. Screening for ocular lesions in all newborns exposed to ZIKV prenatally has been emphasized because of a chorioretinal macular scar found in a number normocephalic patient exposed to ZIKV.
   Methods: A retrospective review of the medical records of infants born to mothers found to be ZIKV-positive during their pregnancies (January 2016-July 2017) was performed. We included all newborns and infants admitted to the NICU and/or receiving ambulatory care at the high-riskclinics at the University Pediatric Hospital, San Juan, Puerto Rico. The creation of this database was approved by the IRB of the University of Puerto Rico, Medical Sciences Campus.
   Results: Records from 234 newborns born to Zika-positive mothers were identified. The ophthalmic evaluations of 95 patients were available. Sixty-three of them had normal findings (66 %). Twelve of the 95 patients had microcephaly (12.6% of the cohort). Of the microcephalic group, half had normal ophthalmological findings. Of the normocephalic group (83/95), almost 31% had ocular findings: a small optic nerve in 3%, a double-ring sign in 10%, macular stippling in 8 %, mottling in 4%, an oval optic nerve in 2%, a tilted nerve in 1%, and blunted foveal reflex in 1%.
   Conclusion: We report herein ZIKV-associated ophthalmologic findings, similar to those published, in 34% of the infants with suspected/confirmed ZIKV fetal exposure. These data underline the importance of ocular examination in patients with suspected congenital Zika but without other findings on physical exam.
C1 [Gely-Rojas, Leticia; Garcia-Fragoso, Lourdes; Garcia-Garcia, Ines] Univ Puerto Rico, Neonatol Sect, Dept Pediat, Med Sci Campus, San Juan, PR 00936 USA.
   [Perez, Raul] Univ Puerto Rico, Dept Ophthalmol, Med Sci Campus, San Juan, PR 00936 USA.
RP Garcia-Garcia, I (corresponding author), UPR Sch Med, Dept Pediat, Neonatol Sect, POB 365067, San Juan, PR 00936 USA.
EM ines.garcia@upr.edu
CR Ashina H, 2017, JAMA OPHTHALMOL, V135, P331, DOI 10.1001/jamaophthalmol.2017.0043
   Departamento de Salud de Puerto Rico, 2017, INF SEM ENF ARB ARBO
   Gilbert SF, 2000, DEV BIOL, P359
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Santos A, 1998, RETINAL PIGMENT EPIT, P307
   Spiess Karina, 2017, Ophthalmol Retina, V1, P256, DOI 10.1016/j.oret.2016.10.010
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 12
TC 1
Z9 1
U1 2
U2 2
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S77
EP S80
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900012
PM 30576582
DA 2020-07-08
ER

PT J
AU Major, CG
   Dirlikov, E
   Medina, NA
   Lugo-Robles, R
   Matos, D
   Munoz-Jordan, J
   Colon-Sanchez, C
   Garcia-Negron, M
   Olivero-Segarra, M
   Malave-Gonzalez, G
   Thomas, DL
   Luciano, CA
   Waterman, SH
   Sejvar, J
   Sharp, TM
   Rivera-Garcia, B
AF Major, Chelsea G.
   Dirlikov, Emilio
   Medina, Nicole A.
   Lugo-Robles, Roberta
   Matos, Desiree
   Munoz-Jordan, Jorge
   Colon-Sanchez, Candimar
   Garcia-Negron, Myriam
   Olivero-Segarra, Marangely
   Malave-Gonzalez, Graciela
   Thomas, Dana L.
   Luciano, Carlos A.
   Waterman, Stephen H.
   Sejvar, James
   Sharp, Tyler M.
   Rivera-Garcia, Brenda
TI Implementation and Evaluation of Guillain-Barre Syndrome Surveillance in
   Puerto Rico during the 2016 Zika Virus Epidemic
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Guillain-Barre syndrome; Surveillance; Puerto Rico; Zika virus
ID CASE SERIES; TRANSMISSION; INFECTION
AB Objective: Guillain-Barre syndrome (GBS) is an uncommon autoimmune disorder that follows infection or vaccination, and increased incidence has been reported during Zika virus (ZIKV) transmission. During the 2016 ZIKV epidemic, the Puerto Rico Department of Health (PRDH) implemented the Enhanced GBS Surveillance System (EGBSSS). Here, we describe EGBSSS implementation and evaluate completeness, validity, and timeliness.
   Methods: GBS cases were identified using passive surveillance and discharge diagnostic code for GBS. Completeness was evaluated by capture-recapture methods. Sensitivity and positive predictive value (PPV) for confirmed GBS cases were calculated for both case identification methods. Median time to completion of key time steps were compared by quarter (Q1-4) and hospital size.
   Results: A total of 122 confirmed GBS cases with onset of neurologic illness in 2016 were identified. Capture-recapture methodology estimated that four confirmed GBS cases were missed by both identification methods. Identification of cases by diagnostic code had a higher sensitivity than passive surveillance (89% vs. 80%), but a lower PPV (60% vs. 72%). There was a significant decrease from Q1 to Q3 in median time from hospital admission to case reporting (11 days vs. 2 days, p = 0.032) and from Q2 to Q3 in median time from specimen receipt to arbovirus laboratory test reporting (35 days vs. 26 days, p = 0.004).
   Conclusion: EGBSSS provided complete, valid, and increasingly timely surveillance data, which guided public health action and supported healthcare providers during the ZIKV epidemic. This evaluation provides programmatic lessons for GBS surveillance and emergency response surveillance.
C1 [Major, Chelsea G.; Medina, Nicole A.; Matos, Desiree; Munoz-Jordan, Jorge; Colon-Sanchez, Candimar; Waterman, Stephen H.; Sejvar, James; Sharp, Tyler M.] US Ctr Dis Control & Prevent CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, San Juan, PR USA.
   [Major, Chelsea G.] US CDC, Off State Tribal Local & Terr Support, San Juan, PR USA.
   [Dirlikov, Emilio; Lugo-Robles, Roberta; Rivera-Garcia, Brenda] PRDH, Off Epidemiol & Res, San Juan, PR USA.
   [Dirlikov, Emilio] US CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, San Juan, PR USA.
   [Garcia-Negron, Myriam] PRDH, Biol & Chem Emergencies Lab, Off Publ Hlth Preparedness & Response, San Juan, PR USA.
   [Garcia-Negron, Myriam; Olivero-Segarra, Marangely; Malave-Gonzalez, Graciela] PRDH, Publ Hlth Lab, San Juan, PR USA.
   [Thomas, Dana L.] US CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, San Juan, PR USA.
   [Thomas, Dana L.; Waterman, Stephen H.; Sharp, Tyler M.] US PHS, Commissioned Corps, San Juan, PR USA.
   [Luciano, Carlos A.] Univ Puerto Rico, Neurol Sect, Med Sci Campus, San Juan, PR 00936 USA.
RP Major, CG (corresponding author), 1324 Calle Canada, San Juan, PR 00920 USA.
EM cmajor@cdc.gov
OI Dirlikov, Emilio/0000-0003-4631-2643
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U54MD007587]
FX Dr. Luciano was supported by grant U54MD007587 from the National
   Institutes of Health (NIH). There were no other sources of support for
   this work.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Alcalde-Cabero E, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0598-z
   Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Balavoine S, 2017, AM J TROP MED HYG, V97, P356, DOI 10.4269/ajtmh.15-0753
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chao A, 2001, STAT MED, V20, P3123, DOI 10.1002/sim.996.abs
   Chapman CJ, 1951, U CALIFORNIA PUBL ST, Vl, P131
   Cheng Q, 2000, ACTA NEUROL SCAND, V101, P104, DOI 10.1034/j.1600-0404.2000.101002104.x
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH Z
   Food and Drug Administration. Zika Virus Emergency Use Authorization, 2016, ZIK VIR EM US AUTH T
   Giambrone GP, 2013, EMERG INFECT DIS, V19, P1956, DOI 10.3201/eid1912.130643
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   KOOBATIAN TJ, 1991, ANN NEUROL, V30, P618, DOI 10.1002/ana.410300418
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Pan American Health Organization World Health Organization, 2015, NEUR SYNDR CONG MALF
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Salinas JL, 2017, J NEUROL SCI, V377, P102, DOI 10.1016/j.jns.2017.04.006
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Suryapranata FST, 2016, AM J TROP MED HYG, V94, P1380, DOI 10.4269/ajtmh.15-0070
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tomashek KM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005025
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 31
TC 1
Z9 1
U1 0
U2 0
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S85
EP S92
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900014
PM 30576584
DA 2020-07-08
ER

PT J
AU Medina-Cucurella, E
   Acevedo-Canabal, J
   De Leon-Arbucias, J
   Martinez-Torres, R
   Cruzado-Ramos, G
   Romaguera, J
AF Medina-Cucurella, Evaristo
   Acevedo-Canabal, Jorge
   De Leon-Arbucias, Jeidiel
   Martinez-Torres, Rafael
   Cruzado-Ramos, Gustavo
   Romaguera, Josefina
TI Zika-prevention Knowledge among Hispanic Women Living in Puerto Rico: A
   Cross-sectional Study
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Zika virus; Knowledge; Practices; Zika virus infection; Hispanic women
ID VIRUS-INFECTION; INFANTS; BIRTH
AB Objective: To describe the level of knowledge about Zika virus exposure, symptoms, complications, and transmission prevention in Hispanic women living in Puerto Rico.
   Methods: A sample of 168 women aged 21 to 64 at the general community, consented to complete a self-administered questionnaire of 112 questions from October 2016 to July 2017.
   Results: A univariate analysis showed that the participating women recognized that the Zika virus was transmitted through mosquito bites (95.2%), sexual intercourse (78.0%), and from a mother to her fetus (41.1%); participants also believed that other, incorrect, routes of transmission were plausible. Regarding their knowledge of Zika infection prevention, the participants' correct answers included the following: using mosquito repellent (94.1%), eliminating standing water (83.9%), and using condoms (83.3%). When asked about fetal risks associated with Zika, they believed that the fetus would not develop normally (75.6%), would be born with a disability (69.6%), or would experience nervous system problems (54.2%). Only 22.6% of the participants had taken precautions to prevent pregnancy during the Zika outbreak, of which 65.8% reported that they had used condoms during all sexual relationships.
   Conclusion: There is a need to educate the general population about the Zika virus to reduce the misconceptions about disease prevention and transmission as well as about the complications associated with Zika during pregnancy. Awareness efforts should emphasize the prevention of infections during pregnancy and the use of available contraceptive methods.
C1 [Medina-Cucurella, Evaristo; De Leon-Arbucias, Jeidiel; Cruzado-Ramos, Gustavo; Romaguera, Josefina] San Juan City Hosp, Dept Obstet & Gynecol, San Juan, PR USA.
   [Acevedo-Canabal, Jorge; Romaguera, Josefina] Univ Puerto Rico, Dept Obstet & Gynecol, Med Sci Campus, San Juan, PR 00936 USA.
   [Martinez-Torres, Rafael] Univ Puerto Rico, Endowed Hlth Serv Res Ctr, Med Sci Campus, San Juan, PR 00936 USA.
RP Romaguera, J (corresponding author), Univ Puerto Rico, Dept Obstet & Gynecol, Sch Med, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
EM Josefina.romaguera@upr.edu
RI CANABAL, JORGE M ACEVEDO/AAD-5823-2019
OI CANABAL, JORGE M ACEVEDO/0000-0003-2153-3415
FU UPR School of Medicine Endowed Health Services Research Center from the
   National Center for Minority Health and Health Disparities, National
   Institutes of Health (NCMHD-NIH) [5S21MD000242, 5S21MD000138]
FX This study was supported by the UPR School of Medicine Endowed Health
   Services Research Center, Grants 5S21MD000242 and 5S21MD000138, from the
   National Center for Minority Health and Health Disparities, National
   Institutes of Health (NCMHD-NIH). Its contents are sole the
   responsibility of the authors and do not necessarily represent the
   official views of NCMHDNIH.
CR [Anonymous], 2016, CDC CONCL ZIK CAUS M
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, PREV TRANSM
   Centers for Disease Control and Prevention, SYMPT TEST TREATM
   D'Angelo DV, 2017, MMWR-MORBID MORTAL W, V66, P574, DOI 10.15585/mmwr.mm6622a2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Puerto Rico Department of Health, 2016, CAS SOSP ARBOV
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
NR 13
TC 0
Z9 0
U1 1
U2 1
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S51
EP S56
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900008
PM 30576578
DA 2020-07-08
ER

PT J
AU Nazario-Pietri, G
   Bonilla-Soto, LA
   Nazario, CM
AF Nazario-Pietri, Gloria
   Bonilla-Soto, Luis A.
   Nazario, Cruz Maria
TI The Role of Research in Policy and Practice: The Zika Phenomena in
   Puerto Rico
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE University of Puerto Rico; Zika; Evidence-based policymaking; Political
   economy of epidemics
AB On April 19, 2017, the 37th Medical Sciences Campus Annual Research and Education Forum opened with the discussion panel The role of research in policy and practice: The Zika phenomena in Puerto Rico, with Dr. Cruz M. Nazario Delgado, Dr. Carmen D. Zorrilla and Dr. Luis A. Bonilla Soto. In this article, we critically examine the public policy process of the Zika epidemic in Puerto Rico, as presented by authors Nazario and Bonilla. We argue that policymaking and the public health responses to confront the Zika epidemic in Puerto Rico took place in a political environment where different US and local actors operated to advance their goals and vision, undermining the role of knowledge, evidence and past experiences. We propose a bottom to top preventive and community empowerment approach to control the vector. This model must be built on successful policy implementation experiences with epidemics in the Island and strengthened by evidence, international guidelines and ethical principles.
C1 [Nazario-Pietri, Gloria] Univ Puerto Rico, Dept Ecol Sci, Sch Dent Med, Med Sci Campus, San Juan, PR 00936 USA.
   [Bonilla-Soto, Luis A.] Univ Puerto Rico, Dept Environm Hlth, Grad Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.
   [Nazario, Cruz Maria] Univ Puerto Rico, Dept Biostat & Epidemiol, Grad Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.
RP Nazario-Pietri, G (corresponding author), Univ Puerto Rico, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
EM gloria.nazario@upr.edu
CR [Anonymous], 2016, INF SEM ENF ARB ARBO
   [Anonymous], 2016, INF SEM ENF ARB VIR
   Berridge V, 2010, LANCET, V375, P798, DOI 10.1016/S0140-6736(10)60334-0
   Bodenheimer T.S., 2012, UNDERSTANDING HLTH P
   Bogenschneider K, 2011, EVIDENCE-BASED POLICYMAKING: INSIGHTS FROM POLICY-MINDED RESEARCHERS AND RESEARCH-MINDED POLICYMAKERS, P1
   Bonilla L., 2017, 37 MED SCI CAMP ANN
   Cauchemez S, 2016, LANCET
   Centers for Disease Control and Prevention, 2016, INF AER SPRAYING
   Centers for Disease Control and Prevention Unites States of Department of Health and Human services, CRIS EM RISK COMM
   Hanney Stephen R, 2003, Health Res Policy Syst, V1, P2, DOI 10.1186/1478-4505-1-2
   Jones A., 2016, CNN
   LEE C, 2010, ENV HLTH GLOBAL LOCA, P222
   Martin JA, 2016, NCHS DATA BRIEF, V126, P124
   McNeil DG, 2016, REUTERS
   Meiburg SA, 2010, ENV HLTH GLOBAL LOCA, P1063
   Mosco V., 2009, POLITICAL EC COMMUNI
   Nazario CM, 2017, 37 MED SCI CAMP ANN
   Nolen S., 2016, GLOBE MAIL
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RIGAUPEREZ JG, 2005, PAN AM J PUBLIC HLTH, V17, P282
   Steenbuysen J., 2016, SQUARE ONE      0401
   Sun L., 2016, WASHINGTON POST
   Waitzkin H., 2011, MED PUBLIC HLTH END
   Washington Post, 2016, WASHINGTON POST
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization, 2016, DIR GEN SUMM OUTC EM
NR 26
TC 0
Z9 0
U1 0
U2 0
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S33
EP S40
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900005
PM 30576575
DA 2020-07-08
ER

PT J
AU Rabionet, SE
   Zorrilla, CD
   Rivera-Vinas, JI
   Guerra-Sanchez, Y
AF Rabionet, Silvia E.
   Zorrilla, Carmen D.
   Rivera-Vinas, Juana, I
   Guerra-Sanchez, Yeney
TI Pregnancy and Zika: The Quest for Quality Care and Reproductive Justice
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE ZIKV; Pregnancy; Reproductive justice; Group Prenatal Care; Puerto Rico
ID VIRUS; HEALTH; RIGHTS
AB On February 1, 2016, the World Health Organization (WHO) declared the ZIKV virus outbreak a Public Health Emergency of International Concern (PHEIC). Pregnant women and their infants, are vulnerable to the impact of this vector-borne illness ( mosquito) and sexually transmitted viral infection. The uncertainty surrounding the possibility of congenital anomalies due to ZIKV infection during pregnancy bring a renewed debate about the rights of women to control their reproductive decisions. Current strategies, resources and services aimed at prevention priorities fall short of responding to a clear framework regarding sexual reproductive health, rights and justice. A comprehensive approach to reproduction, in times of Zika, needs to empower women of reproductive age and their families to make decisions and to act on those decisions.
   This paper highlights the contributions of the Maternal-Infant Studies Center (CEMI-Spanish Acronym) in close collaboration with the Department of Obstetrics and Gynecology of the University of the Puerto Rico School of Medicine and the University Hospital in providing comprehensive health care to pregnant women with ZIKV or at risk of ZIKV, at the very onset of the epidemic. CEMI approaches the care of pregnant women from a reproductive justice perspective, integrating clinical services, education, research, and advocacy. Transformacion Prenatal (Centering Group Prenatal Care, GPC) currently implemented at the Puerto Rico University Hospital High Risk Clinics has been pivotal to achieve this aim. Based on the health professionals' experiences and women's testimonies, we articulate a set of principles and key actions that would benefit women, their family and children.
C1 [Rabionet, Silvia E.] Univ Puerto Rico, Nova Southeastern Univ, Coll Pharm, Med Sci Campus, San Juan, PR 00936 USA.
   [Rabionet, Silvia E.] Univ Puerto Rico, Nova Southeastern Univ, Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.
   [Zorrilla, Carmen D.; Rivera-Vinas, Juana, I] Univ Puerto Rico, Dept Obstet & Gynecol, Sch Med, Med Sci Campus, San Juan, PR 00936 USA.
   [Guerra-Sanchez, Yeney] Nova Southeastern Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA.
RP Rabionet, SE (corresponding author), POB 365067, San Juan, PR 00936 USA.
EM silvia.rabionet@upr.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [UM1 AI069415]
CR Aiken ARA, 2016, BJOG, V124, P546
   Allen G., LIVING ZIKA PUERTO R
   [Anonymous], 2017, ZIK EP REP PUERT RIC
   [Anonymous], REPROD HLTH
   [Anonymous], 2014, POL REC ICPD 2014 SE
   [Anonymous], 2016, ZIKA ACTIVE PREGNANC
   Belluck P, 2017, NY TIMES
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   D'Angelo DV, 2016, MMWR-MORBID MORTAL W, V22, P574
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Diniz SG, 2012, REPROD HEALTH MATTER, V20, P94, DOI 10.1016/S0968-8080(12)40657-7
   Moron AF, 2017, BJOG-INT J OBSTET GY, V124, P549, DOI 10.1111/1471-0528.14387
   Meireles JFF, 2017, PSYCHOL HEALTH, V32, P798, DOI 10.1080/08870446.2017.1307369
   Velez ACG, 2016, REPROD HEALTH MATTER, V24, P57, DOI 10.1016/j.rhm.2016.11.008
   Guo Fangjian, 2017, Prev Med Rep, V7, P26, DOI 10.1016/j.pmedr.2017.05.003
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482
   Langer A, 2016, STUD FAMILY PLANN, V47, P179, DOI 10.1111/j.1728-4465.2016.00058.x
   Munjal A, 2017, FRONT MICROBIOL, V10, P389
   Novick G, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.026
   Ross L., WHAT IS REPROD JUSTI
   Rowley RA, 2016, MATERN CHILD HLTH J, V20, P1, DOI 10.1007/s10995-015-1802-2
   Zorrilla C, 2017, 1 INT C ZIK VIR
   Zorrilla C, 2016, OBSTET GYNECOL INT J, P5
   Zorrilla C, 2017, MOJWH, P5
   Zorrilla CD, 2017, SOURCE J OBSTET GYNA, V1, P1
NR 27
TC 1
Z9 1
U1 1
U2 4
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S45
EP S50
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900007
PM 30576577
DA 2020-07-08
ER

PT J
AU Ramos-Rossy, J
   Flores, J
   Otero-Dominguez, Y
   Torres-Palacios, J
   Rodriguez-Cintron, W
AF Ramos-Rossy, Javier
   Flores, Juan
   Otero-Dominguez, Yomayra
   Torres-Palacios, Jose
   Rodriguez-Cintron, William
TI Hypoxemic Respiratory Failure Secondary to Zika Virus Infection
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Zika Virus; Respiratory Failure; Viral Syndrome
AB An 80-year-old man experienced general weakness, myalgias, arthralgias, fever, chills, and diarrhea for one week. He had hypotension and tachycardia. He also had leukocytosis, thrombocytopenia, increased creatinine levels, elevated liver enzymes, elevated creatine phosphokinase (CPK) levels, and metabolic acidosis with hypoxemia, for which he was admitted to the Intensive Care Unit (ICU). His chest x-ray showed decreased lung volumes. Ceftriaxone and levofloxacin were empirically started to cover leptospirosis and community acquired pneumonia, respectively. The patient continued with clinical deterioration and the antibiotic therapy was changed to linezolid, cefepime, and doxycycline. He required endotracheal intubation and mechanical ventilation support due to progressive hypoxemic respiratory failure. A bronchoscopy showed no evidence of bacterial infectious process. The patient developed clinical improvement with successful extubation afterwards (4 days after initial intubation). He was later discharged home with physical therapies. A serum specimen was tested with real-time polymerase chain reaction (RT-PCR) technique, producing a positive result only for Zika virus. Confirmatory molecular diagnostic testing was performed at the Center for Disease Control (CDC).
C1 [Ramos-Rossy, Javier; Flores, Juan; Otero-Dominguez, Yomayra; Torres-Palacios, Jose; Rodriguez-Cintron, William] VA Caribbean Healthcare Syst, 10Casia St, San Juan, PR 00921 USA.
RP Rodriguez-Cintron, W (corresponding author), VA Caribbean Healthcare Syst, 10Casia St, San Juan, PR 00921 USA.
EM William@prmail.net
CR Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
NR 5
TC 0
Z9 0
U1 0
U2 0
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S99
EP S101
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900017
PM 30576587
DA 2020-07-08
ER

PT J
AU Reyes-Medina, YN
   Andino-Figueroa, PC
   Abrams-Maldonado, XM
   Pineiro-Delgado, ZN
   Pizarro-Miller, K
   Subervi-Vazquez, AM
   Concepcion-Rivera, OJ
   Coriano-Diaz, N
   Davila-Santiago, L
   De Jesus-Rodriguez, LD
   Diaz-Ortiz, YI
   Figueroa-Carrasquillo, PN
   Figueroa-Cosme, D
   Gomez-Garay, J
   Irizarry-Flores, JC
   Marquez-Muniz, M
   Rios-Motta, R
   Millan-Perez, LI
   Pena-Orellana, M
AF Reyes-Medina, Yaritza N.
   Andino-Figueroa, Paola C.
   Abrams-Maldonado, Xiovette M.
   Pineiro-Delgado, Zydnia N.
   Pizarro-Miller, Kevin
   Subervi-Vazquez, Alisha M.
   Concepcion-Rivera, Omar J.
   Coriano-Diaz, Natalia
   Davila-Santiago, Loriann
   De Jesus-Rodriguez, Luz D.
   Diaz-Ortiz, Yanire, I
   Figueroa-Carrasquillo, Paola N.
   Figueroa-Cosme, Darinelys
   Gomez-Garay, Janice
   Irizarry-Flores, Jessica C.
   Marquez-Muniz, Myrellis
   Rios-Motta, Ruth
   Millan-Perez, Liza, I
   Pena-Orellana, Marisol
TI A Cross-Sectional Survey of the Zika Virus and its Prevention: The
   Knowledge, Thoughts, and Beliefs of a Community of Residents in Caguas,
   Puerto Rico
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Zika; community; Risk perception; Preventive behaviors; Emerging disease
ID DENGUE PREVENTION; RISK PERCEPTION; HEALTH; PARTICIPATION; HUMANS;
   THREAT; MODEL
AB Objective: The objective of this study was to explore the knowledge, thoughts, and beliefs regarding the Zika virus and its prevention in a community of residents in the municipality of Caguas, Puerto Rico, and elicit their concerns and perceptions of risk.
   Methods: A quantitative, non-experimental, descriptive, cross-sectional correlational study was conducted in a community in Caguas, Puerto Rico. A structured questionnaire was administered to a sample of 158 residents, aged 21 and older, who participated voluntarily. The data were analyzed using SPSS version 17 via univariate and bivariate analysis.
   Results: Of 158 surveyed, 64.6% were women; with a population average of 53.85 years. Of the respondents who believed that they would be affected in some way if they were infected by the Zika virus, over half (52.3%) felt that the virus represented a significant threat to their emotional stability. Of those who perceived emotional threat, 39.5% (n=32) continued to study after completing high school (X-2 =9.217, p=0.027), 57.9% (n=55) had private health insurance (X-2 =6.325; p=0.042), and 67.9% (n=55) reported it was little or unlikely to become infected (X-2 =6.783; p=0.034). Out of those concerned, 57.4% (n=54) considered Zika very or extremely severe (X-2 =22.827, p<0.001) and 98.9% (n=93) clean the house surroundings as a preventive measure (X-2 = 4.951, p=0.026). Lack of interest was the most common reason identified for not complying with preventive actions by the residents (89.2%).
   Conclusion: The underestimation both of the risk concerning the Zika virus and of its consequences was evident. This study reaffirms the need to develop a network that effectively and constantly communicates risk estimates, doing so while addressing the specific needs within the communities served by that network. Community interventions aimed at improving the benefits of and reducing the risks associated with and the perceived barriers to preventive behaviors are needed.
C1 [Reyes-Medina, Yaritza N.; Andino-Figueroa, Paola C.; Abrams-Maldonado, Xiovette M.; Pineiro-Delgado, Zydnia N.; Pizarro-Miller, Kevin; Subervi-Vazquez, Alisha M.; Concepcion-Rivera, Omar J.; Coriano-Diaz, Natalia; Davila-Santiago, Loriann; De Jesus-Rodriguez, Luz D.; Diaz-Ortiz, Yanire, I; Figueroa-Carrasquillo, Paola N.; Figueroa-Cosme, Darinelys; Gomez-Garay, Janice; Irizarry-Flores, Jessica C.; Marquez-Muniz, Myrellis; Millan-Perez, Liza, I; Pena-Orellana, Marisol] Univ Puerto Rico, Dept Hlth Serv Adm, Grad Sch Publ Hlth, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
RP Pena-Orellana, M (corresponding author), Univ Puerto Rico, Dept Hlth Serv Adm, Grad Sch Publ Hlth, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
EM marisol.pena@upr.edu
CR Alarcón-Cruz Ángela P, 2016, Rev. salud pública, V18, P1, DOI 10.15446/rsap.v18n3.55425
   Alicke MD, 2010, PSYCHOL SCI, V21, P174, DOI 10.1177/0956797609357718
   American Community Survey-USCB, 2017, AM COMM SURV 2015 20
   Bae BJ, 2010, THESIS
   Barrera R, 2016, BIOMEDICA, V36, P454, DOI 10.7705/biomedica.v36i3.2892
   BECKER MH, 1974, HEALTH EDUC QUART, V2, P409, DOI 10.1177/109019817400200407
   Carmona G, 2016, INTERFACE-BOTUCATU, V20, P839, DOI 10.1590/1807-57622015.0322
   Carro- Perez EH, 2016, REV PSICOL CIENC COM, V7, P20
   Centers for Disease Control and Prevention, 2017, ZIKA VIR
   de Zwart O, 2007, EMERG INFECT DIS, V13, P290, DOI 10.3201/eid1302.060303
   de Zwart O, 2009, INT J BEHAV MED, V16, P30, DOI 10.1007/s12529-008-9008-2
   Delcid Morazan AF, 2017, ARCH MED, V13, P5
   Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470
   DiLorenzo T, 2006, J BEHAV MED, V29, P37, DOI 10.1007/s10865-005-9039-y
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Elsinga J, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2371-6
   Hernandez R., 2010, METODOLOGIA INVESTIG, P76
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Lennon J. L., 2005, Dengue Bulletin, V29, P217
   Liang B, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2401
   Maguina- Vargas C., 2016, REV MED HERED, V27, P3
   Mendez-Lazaro P, 2014, INT J ENV RES PUB HE, V11, P9409, DOI 10.3390/ijerph110909409
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Nunez-Cardona MT, 2008, J BIOL RES-THESSALON, V9, P17
   Ojala M, 2017, LOCAL ENVIRON, V22, P172, DOI 10.1080/13549839.2016.1185097
   Ong CW, 2016, INTERN MED J, V46, P525, DOI 10.1111/imj.13059
   Pardo-Turriago Rodrigo, 2016, Rev. colomb. anestesiol., V44, P86
   PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Puerto Rico Department of Health, 2016, INF SAL PUERT RIC
   Reuter T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022130
   Rios-González Carlos Miguel, 2016, Rev Cient Cienc Méd, V19, P33
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   Shepperd JA, 2017, CONSCIOUS COGN, V50, P69, DOI 10.1016/j.concog.2016.07.004
   SPSS Inc, REL 2008 SPSS STAT W
   Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P10, DOI 10.1179/2046904712Z.00000000047
   Toledo-Romani ME, 2006, SALUD PUBLICA MEXICO, V48, P39, DOI 10.1590/s0036-36342006000100007
   Torres M., 2006, U RAFAEL LANDIVAR, V2, P1
   Torres-Castro Marco Antonio, 2016, Rev. biomédica, V27, P1
   Claro PAV, 2016, REV CHIL PEDIATR-CHI, V87, P79, DOI 10.1016/j.rchipe.2016.02.005
   Vilagut Gemma, 2005, Gac Sanit, V19, P135, DOI 10.1157/13074370
   Von Seidlein L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002219
   Vong S, 2014, B WORLD HEALTH ORGAN, V92, P303, DOI 10.2471/BLT.13.125989
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
NR 45
TC 1
Z9 1
U1 1
U2 1
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S57
EP S65
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900009
PM 30576579
DA 2020-07-08
ER

PT J
AU Rigau-Perez, JG
AF Rigau-Perez, Jose G.
TI Zika in Puerto Rico, 2016-2017: II Perspectives on Epidemic Surveillance
   and Control, Health Communication, Outcomes and Lessons
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Arbovirus infections; Dibrom; Epidemics; Health communication;
   Microcephaly; Public health surveillance; Puerto Rico; Zika
AB The social reaction to the Zika epidemic in Puerto Rico reached a confrontational climax regarding aerial fumigation with an organophosphate insecticide. The public drama has obscured multiple simultaneous controversies. This and a companion paper, based mostly on print and digital news reports, provide a context and description of the major controversies and examine the outcomes and their lessons for the protection of the public's health. Part II covers the questions on disease surveillance (what is going on?); health communication and epidemic control (what is an epidemic? is there a way to control an epidemic transmitted by Aedes aegypti?), and the outcomes and lessons from the debates.
C1 [Rigau-Perez, Jose G.] Acad Puertorriquena Hist, San Juan, PR 00926 USA.
   [Rigau-Perez, Jose G.] Univ Puerto Rico, Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.
   [Rigau-Perez, Jose G.] Univ Puerto Rico, Sch Med, Med Sci Campus, San Juan, PR 00936 USA.
RP Rigau-Perez, JG (corresponding author), Acad Puertorriquena Hist, San Juan, PR 00926 USA.; Rigau-Perez, JG (corresponding author), Univ Puerto Rico, Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.; Rigau-Perez, JG (corresponding author), Univ Puerto Rico, Sch Med, Med Sci Campus, San Juan, PR 00936 USA.
EM jos.rigau@gmail.com
CR Acevedo E, 2016, VOCERO          1227, P20
   Acosta E., 2016, VISITANTE       0807, P14
   Alvarado Leon GE, 2016, ND              0329, P16
   [Anonymous], 2017, ND              0606, P16
   [Anonymous], 2016, ND              0903, P15
   [Anonymous], 2016, ND              0925
   [Anonymous], 2017, ARBOV REPORTED CONFI, P14
   [Anonymous], 2016, ND              0219, P4
   [Anonymous], 2016, ND              0212, P28
   [Anonymous], 2016, ARBOV WEEKS, P27
   [Anonymous], 2016, ND              0523, P16
   [Anonymous], 2016, ND              0703, P32
   [Anonymous], 2017, ND              1020, P12
   [Anonymous], 2016, ND              0830, P16
   [Anonymous], 2016, ND S            0212
   [Anonymous], 2016, CLARIDAD, P3
   [Anonymous], 2016, ND              0216, P20
   [Anonymous], 2016, ND              0924, P12
   [Anonymous], 2016, ND              0217, P28
   [Anonymous], 2016, METRO, P2
   [Anonymous], 2016, ND              0127, P32
   [Anonymous], 2016, ND              0708, P12
   [Anonymous], 2016, ND              0626, P46
   [Anonymous], 2016, ND              1029, P6
   [Anonymous], 2016, ND              0811, P22
   [Anonymous], 2017, ND              1023, P6
   [Anonymous], 2016, ND              0902, P30
   [Anonymous], 2016, ND              0305, P12
   [Anonymous], 2017, EPIDEMIOLOGY MONITOR
   [Anonymous], 2016, ND              1012, P12
   [Anonymous], 2016, ND              0319, P20
   [Anonymous], 2016, ND              0813, P14
   [Anonymous], 2016, ND              0124, P4
   [Anonymous], 2016, ARBOV REPORTED CONFI, P35
   [Anonymous], 2016, ND              0220, P30
   [Anonymous], 2016, ND              0805, P10
   [Anonymous], 2016, ND              0219, P1
   [Anonymous], 2017, ND              1008, P20
   [Anonymous], 2016, VOCERO          0202, P12
   [Anonymous], 2016, VOCERO          0720, P16
   [Anonymous], 2017, ND              1026, P18
   [Anonymous], 2016, VOCERO          0830, P10
   Badrena M., 2016, ND              0714, P55
   Banuchi R, 2016, ND              0721, P28
   Banuchi R., 2016, ND              0714, P21
   Banuchi R., 2016, ND              0620, P14
   Banuchi R., 2016, ND              0708, P12
   Branswell H, 2017, STAT
   Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025
   Burwell S, 2016, ND              0710, P51
   CANIZARES ED, 2016, ND              0711, P22
   Cardona JJ., 2016, CB              0707, P24
   Caro Gonzalez L, 2016, ND              0712, P19
   Caro Gonzalez L, 2016, ND              0118, P12
   Caro Gonzalez L, 2016, ND              0722, P6
   Caro Gonzalez L., 2016, ND              0716, P26
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Cobian M, 2016, ND              0312, P14
   Correa Velazquez M, 2016, VOCERO          0715, P4
   Cortes Chico R, 2016, ND              0130, P10
   Cortes Chico R., 2016, ND              0709, P12
   Cortes Chico R, 2016, ND              0630, P21
   Cortes Chico R, 2016, ND              0626, P46
   Cortes Chico R., 2016, ND              0703, P32
   Cortes Chico R, 2016, ND              0730, P8
   Cortes Chico R, 2016, ND              0630, P20
   Cotto C, 2016, CLARIDAD, P4
   Delgado JA, 2016, ND              0304, P14
   Delgado JA., 2016, ND              0714, P20
   Delgado JA, ND              1004, P10
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dunn C., 2016, VOCERO          0715, P3
   Espinosa M., 2009, EPIDEMIC INVASIONS Y, p[63, 120]
   Figueroa Cancel A, 2016, ND              0708, P21
   Figueroa Cancel A, 2016, ND              0712, P18
   Figueroa Cancel A, 2016, ND              0629, P21
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Gonzalez J., 2016, ND              0805, P37
   GONZALEZ LI, 2016, ND              0721, P10
   Greer SL, 2017, AM J PUBLIC HEALTH, V107, P861, DOI 10.2105/AJPH.2017.303772
   Guadalupe H, 2016, METRO, P9
   Hernandez JA, 2017, CB              0622, P10
   Hernandez JA, 2017, CB              0406, P13
   Hernandez JA., 2016, CB              0811, P12
   Hoffman SJ, 2018, AM J PUBLIC HEALTH, V108, P329, DOI [10.2105/ajph.2017.304245, 10.2105/AJPH.2017.304245]
   Interlandi J., 2016, CONSUMER REPORTS
   Irizarry Alvarez F, 2016, PRIMERA HORA    0723, P4
   Joglar RL, 2016, ND              0722, P53
   Kahneman Daniel, 2011, THINKING FAST SLOW
   KASTURE H, 2016, VOCERO          0718, P3
   KHAN GZ, 2016, ND              0713, P20
   Kopp E., 2016, KAISER HLTH NEWS
   KUBLERROSS E, 1969, DEATH DYING
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lluberas Manuel F., 2016, PUBLIC HLTH ENTOMOLO, P52
   Lopez Alicea K., 2016, ND              0905, P4
   Lopez C, 2016, ND              0806, P10
   Lopez Caban C, 2016, ND              0813, P14
   Lopez Caban C., 2016, ND              0924, P12
   Martinez Maldonado M, 2016, HISTERIA ZIKA
   Massol Deya A, 2016, CLARIDAD, P8
   McNeill JR, 2010, MOSQUITO EMPIRES ECO, P306
   Melendez-Ackerman E, 2016, CLARIDAD, P7
   Minelli Perez S., 2017, ND              0703, P27
   Minelli Perez S, 2016, ND              1230
   Montero M, 2016, ND              0717, P44
   Nazario CM, 2016, MICROCEFALIA JUSTIFI
   Neustadt RE, 1978, SWINE FLU AFFAIR DEC, P86
   Ortiz BA., 2016, ND              0630, P65
   Pabon Roca L, 2016, WKAQ AM         0720, P9
   PAM, 2016, ND              0706, P12
   PAM, 2016, ND              0201, P18
   PAM, 2016, ND              0928, P24
   PAM, 2016, ND              0213, P28
   PAM, 2016, ND              0709, P13
   PAM, 2016, ND              0723, P6
   PAM, 2016, ND              0724, P18
   PAM, 2016, ND              0725, P18
   PAM, 2016, ND              0526, P10
   PAM, 2016, N               0808, P22
   PAM, 2016, ND              0801, P10
   PAM, 2016, ND              0129, P4
   Perevislov S. N., 2017, NOV OGNEUPORY, P42, DOI DOI 10.17073/1683-4518-2017-10-42-47
   Perez S, 2016, ND              0712, P40
   Perez Soler A, 2016, CLARIDAD, P7
   Porta M, 2014, DICT EPIDEMIOLOGY, P93
   Public Health Leadership Society, 2002, PRINC ETH PRACT PUBL, p[4, 8]
   Quintero LM, 2016, VOCERO          0720, P4
   Rigau-Perez JG, 2002, AM J TROP MED HYG, V67, P355, DOI 10.4269/ajtmh.2002.67.355
   Rigau-Perez JG, 2016, ND              0720, P54
   Rigau-Perez JG, 2016, ND              0815, V15, P46
   Rigau-Perez JG, 2014, ND              1001, P69
   Rigau-Perez JG, 2018, P R HLTH SCI J S, pS5
   Rios Orlandi E, 2016, ND              0814, P63
   Rivera Arguinzoni A, 2016, ND              0709, P12
   Rivera Arguinzoni A, 2016, ND              0712
   Rivera Arguinzoni A, 2016, ND              0711
   Rivera Clemente Y, 2016, VOCERO          0801, P7
   Rivera Clemente Y., 2016, VOCERO          0930, P17
   Rosenberg Charles E., 1992, EXPLAINING EPIDEMICS, P278
   Ruiz G., 2016, ND              0914, P10
   Ruiz Kuilan G., 2016, ND              0707, P21
   Ruiz Kuilan G., 2016, ND              0706, P10
   Rullan J., 2016, ND              0630, P63
   Santiago Medina R, 2016, ND              0706, P50
   Santiago Vargas VM, 2016, ND              0710, P54
   Schoene Roura P, 2017, CB              0727, P2
   Soucheray S, 2016, CIDRAP NEWS     0712
   Suarez Torres L., 2017, CB              0713, P6
   TAUXE RV, 1985, JAMA-J AM MED ASSOC, V254, P237, DOI 10.1001/jama.254.2.237
   Thaler Richard H., 2009, NUDGE IMPROVING DECI
   Trigo B, 2016, ND              0712, P39
   Vega AL, 2016, ND              0703, P50
   Velazquez R., 2016, ND              0707, P35
   WATTS J, 2016, GUARDIAN WEEKLY, P91, DOI DOI 10.1007/978-3-319-27833-9_6
   Zorrilla CD, 2017, NEW ENGL J MED, V377, P1801, DOI 10.1056/NEJMp1713196
NR 156
TC 1
Z9 1
U1 0
U2 0
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S24
EP S32
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900004
PM 30576574
DA 2020-07-08
ER

PT J
AU Rigau-Perez, JG
AF Rigau-Perez, Jose G.
TI Zika in Puerto Rico, 2016-2017: I Perspectives on the Social Crisis and
   Health Care Concerns
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Arbovirus infections; Dibrom; Economic concerns; Epidemics;
   Microcephaly; Public health surveillance; Puerto Rico; Religious belief;
   Zika
ID UNITED-STATES; INTERIM GUIDELINES; INCREASING ACCESS; VIRUS-INFECTION;
   BIRTH-DEFECTS; TRANSMISSION; EPIDEMIC; OUTBREAK; CONTRACEPTION;
   TERRITORIES
AB The social reaction to the Zika epidemic in Puerto Rico reached a confrontational climax regarding aerial fumigation with an organophosphate insecticide. The public drama has obscured multiple simultaneous controversies. This and a companion paper, based mostly on print and digital news reports, provide a context and description of the major controversies and examine the outcomes and their lessons for the protection of the public's health. Part I describes the social and sanitary environment, the first three months of the epidemic, and the debates related to religious, demographic, economic, political, and health care concerns.
C1 [Rigau-Perez, Jose G.] Acad Puertorriquena Hist, San Juan, PR 00926 USA.
   [Rigau-Perez, Jose G.] Univ Puerto Rico, Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.
   [Rigau-Perez, Jose G.] Univ Puerto Rico, Sch Med, Med Sci Campus, San Juan, PR 00936 USA.
RP Rigau-Perez, JG (corresponding author), Acad Puertorriquena Hist, San Juan, PR 00926 USA.; Rigau-Perez, JG (corresponding author), Univ Puerto Rico, Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.; Rigau-Perez, JG (corresponding author), Univ Puerto Rico, Sch Med, Med Sci Campus, San Juan, PR 00936 USA.
EM jos.rigau@gmail.com
CR Aguiar Torres JR, 2016, ND              0718, P38
   Alvarado Leon GE, 2016, ND              0827, P14
   Alvarado Leon GE, 2016, ND              0908, P26
   Alvarado Leon GE, ND              0910, P20
   Amador J., 2015, MED NATION BUILDING, P68
   [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013
   [Anonymous], 2016, ND              0219, P4
   [Anonymous], 2017, ARBOV WEEKS, P1
   [Anonymous], 2016, ND              0129, P34
   [Anonymous], 2016, ND              0814
   [Anonymous], 2016, ND              0727, P10
   [Anonymous], 2016, VISITANTE       0228, P6
   [Anonymous], 2016, ND              0309, p[1, 4]
   [Anonymous], 2016, ND              0830, P16
   [Anonymous], 2016, CLARIDAD, P3
   [Anonymous], 2016, ND              0826, P4
   [Anonymous], 2016, CLARIDAD, P3
   [Anonymous], 2016, ND              1001, P26
   [Anonymous], 2016, ND              1013, P69
   [Anonymous], 2016, ND, P10
   [Anonymous], 2016, ND              0216, P20
   [Anonymous], 2016, ND              1013, P20
   [Anonymous], 2016, ND              0217, P28
   [Anonymous], 2016, VISITANTE       0221, P14
   [Anonymous], 2016, METRO, P2
   [Anonymous], 2016, CB              0512, P4
   [Anonymous], 2016, ND              0824, P12
   [Anonymous], 2016, ND              0317, P22
   [Anonymous], ND              0131, P44
   [Anonymous], 2017, ND              0428
   [Anonymous], 2016, ND              1030
   [Anonymous], 2017, ND              0821, P1
   [Anonymous], 2017, ND              0917, P14
   [Anonymous], 2016, ND              0223, P24
   [Anonymous], 2018, ARBOV WEEK
   [Anonymous], 2016, EMERGING EPIDEMIC
   [Anonymous], 2016, ND              0821
   [Anonymous], 2016, ELNUEVODIA      0502
   [Anonymous], 2016, ND              0603, P36
   [Anonymous], 2016, ND              0303, P17
   [Anonymous], 2016, VOCERO          0501
   [Anonymous], 2009, GALENUS, V2, P26
   [Anonymous], ND              0803, P12
   [Anonymous], 2016, ND, P17
   [Anonymous], 2016, VISITANTE       0904, P14
   Banuchi R, 2016, ND              1015, P24
   Banuchi R, 2016, ND              1022, P16
   Bauza N, 2016, ND              0305, P12
   Bauza N, 2016, ND              0319, V19, P20
   Bauza N, 2016, ND              0206, P8
   Branswell, 2017, FEUD ERUPTED CDC PUE
   Branswell H, 2017, STAT
   Caro Gonzalez L, 2016, ND              0118, P12
   Cobian M, 2016, ND              0120, P16
   Cobian M, 2016, ND              0219, P6
   Colon Rivera J, 2014, PROYECTO EXPLOTACION, P7
   CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801
   Cortes Chico R, 2016, ND              1029, P6
   Costa D., 2016, CB              1222, P23
   Costa Mandry O, 1971, APUNTES HIST M UNPUB, P306
   Cotto C, 2016, CLARIDAD, P4
   Davila Calero MS, 2017, CB              0727, P12
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Delgado JA, 2016, ND              0507, P79
   Delgado JA, 2016, ND              0304, P14
   Delgado JA., 2016, ND              0209, P15
   Delgado JA, 2016, ND              0426, P8
   Dominguez Cristobal CM, 2000, PANORAMA HIST FOREST, P570
   Fajardo R, 2016, CB              0602, P4
   FEREBEE SH, 1957, AM REV TUBERC PULM, V76, P942
   Figueroa Cancel A, 2016, ND              0506, P100
   Figueroa Cancel A, 2017, ND              0419, P16
   Franki R, 2017, OB GYN NEWS MDE 0324
   FREIS ED, 1982, BRIT J CLIN PHARMACO, V13, P67
   FRIEDEN TR, 2016, ND              0308, P39
   Garcia BE, 2016, VOCERO          0927, P29
   Garcia C, 2016, ND              0506, P100
   Gomez Alvarez S, 2016, VOCERO          0210, P8
   Gonzalez J., 2016, ND              0805, P37
   Hernandez JA, 2017, CB              0622, P10
   Hernandez Perez M, 2016, ND              0310, P16
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Brosco JH, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2095
   Jimenez C, 2016, CB              0526, P4
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Lopez Alicea K., 2017, ND              0918, P23
   Lopez Alicea K, 2018, ND              0206, P18
   Lopez Caban C, 2016, ND              0813, P14
   Lopez RL, 2016, METRO, P14
   Maldonado Rios A, 2016, ND              0505, P94
   McNeil Jr DG, 2016, NY TIMES, pA1
   Melendez Garcia L., 2017, METRO, P5
   Melendez Garcia L, 2016, METRO, P2
   Montero, 2016, ND              0911, P52
   Morales Mendez B., 2016, ND              0707, P30
   Narvaez MM, 2016, ND              0506, P61
   NICHD IVIG Study Group, 1991, NEW ENGL J MED, V325, P74
   Ortiz Serrano K, 2016, METRO, P4
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Otero CA., 2016, VOCERO          0422, P3
   Otero Durant JM, 2016, VOCERO          0102, P9
   PAM, 2017, ND              0406, P22
   PAM, 2016, ND              0907, P14
   PAM, 2016, ND              1014, P16
   PAM, 2017, ND              0808, P10
   PAM, 2016, ND              0102, P26
   PAM, 2016, ND              0211, P10
   PAM, 2017, ND              0809, P47
   PAM, 2016, ND              0205, P4
   PAM, 2016, ND              0812, P4
   PAM, 2016, ND              0427, P24
   PAM, 2016, ND              0307, P10
   PAM, 2017, ND              1010, P16
   PAM, 2017, ND              0405, P4
   PAM, 2016, ND              0228, P26
   PAM, 2017, ND              0331, P20
   PAM, 2016, ND              0210, P24
   PAM, 2016, ND              0707, P20
   PAM, 2017, ND              1024, P10
   PAM, ND, V25, P14
   PAM, 2017, ND              0330, P16
   PAM, 2016, ND              1210, P14
   PAM, 2016, ND              0128, P12
   PAM, 2016, ND              1224, P4
   PAM, 2017, ND              0621, P28
   PAM, 2017, ND              0228, P18
   PAM, 2017, ND              0405, P6
   PAM, 2016, ND              0514, P16
   PAM, 2016, ND              0927, P10
   PAM, 2016, ND              0117, P6
   PAM, 2016, ND              0829, P18
   PAM, 2016, ND              0310, P17
   PAM, 2016, ND              0202, P6
   PAM, 2016, ND              0126, P14
   PAM, 2016, ND              0414, P14
   PAM, 2016, ND              1020, P10
   PAM, 2016, ND              0308, P22
   PAM, 2016, ND              1203, P4
   PAM, 2017, ND              0609, P24
   PAM, 2016, ND              0508, P20
   PAM, 2016, ND              0127, P4
   PAM, 2017, CAP AC BOR ENFR ZIK, P12
   PAM, 2016, ND              0129, P4
   PAM, 2016, ND, P5
   PAM, 2016, ND              0804, P10
   PAM, 2017, ND              0324, P20
   PAM. Reforma de Salud, 2017, ND              0817, P4
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pillot Ortiz V, 2016, ND              0504, P84
   Quintero LM., 2016, VOCERO          0202, P12
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P20
   Reina P., 2016, ND              0819, P55
   Rigau-Perez JG, 2005, REV PANAM SALUD PUBL, V17, P282, DOI 10.1590/S1020-49892005000400012
   Rigau-Perez JG, 2008, SOJOURN TROPICAL MED, p[147, 150, 201, 205]
   Rigau-Perez JG, 2018, P R HEALTH SCI J, V37, pS24
   Rivera Clemente Y, 2016, VOCERO          1013, P10
   Rivera Cruz Y., 2016, ND              1225, P12
   Rivera Cruz Y, 2016, ND              0825, P37
   Rivera Cruz Y., 2016, ND              1225
   Rivera Cruz Y, 2017, ND              0716
   Rodrigues LC, 2017, AM J PUBLIC HEALTH, V107, P831, DOI 10.2105/AJPH.2017.303792
   Rodriguez RA, 2016, ND              0505, P94
   RODRIGUEZ Y, 2017, CB              0406, P13
   Rodriguez-Castro F, 2017, CB              0824, P15
   Rodriguez-Diaz CE, 2017, INT J INFECT DIS, V65, P144, DOI 10.1016/j.ijid.2017.07.017
   Rosario F., 2016, ND              0209, P14
   Rosat Rosa C, 2016, ND              0928, P82
   Ruiz Kuilan G., 2016, ND              0530, P20
   Rullan J., 2017, ND              0404, P35
   Saker Jimenez G, 2017, ND              1029, P22
   Sanchez Fournier JA, 2016, ND              0507, P78
   Santoni J, 2016, ND              0510, P41
   Seipp C., 1983, COLONIALISM CATHOLIC, P105
   Osorio-De-Castro CGS, 2017, AM J PUBLIC HEALTH, V107, P960, DOI 10.2105/AJPH.2017.303705
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shokooh-Valle F, 2016, ZIKA NARRATIVE PUERT
   SIFONTES J E, 1955, Bol Asoc Med P R, V47, P58
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Sun LH, 2017, WASHINGTON POST
   Temmerman M, 2018, LANCET PUBLIC HEALTH, V3, pE59, DOI 10.1016/S2468-2667(18)30005-7
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Torres Valcarcel AR, 2017, ND              0620, P40
   Trujillo-Pagan Nicole, 2013, MODERN COLONIZATION
   US Census Bureau, 2011 2015 AM COMM SU
   US Department of Veterans Affairs Office of Public Health and Environmental Hazards, AG OR HERB TESTS STO
   Valencia Prado M., 2016, COMMUNICATION
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, P65
   Velazquez A, 2016, ND              0709, P49
   Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664
   Wolff J., 2017, ND              0212, P10
   Wooden C., 2016, ZIKA OUTBREAK CONTRA
   World Travel & Tourism Council, 2017, TRAV TOUR EC IMP 201, P2
   YU KT, 2016, ND              0220, P30
   Zika Montero M., 2016, ND              0207, P56
   Zorrilla Carmen D, 2007, P R Health Sci J, V26, P329
   Zorrilla CD., 2017, ND              0827
NR 198
TC 0
Z9 0
U1 0
U2 0
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S15
EP S23
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900003
PM 30576573
DA 2020-07-08
ER

PT J
AU Rivera-Concepcion, JR
   Betancourt, JP
   Cerra, J
   Reyes, E
AF Rivera-Concepcion, Joel R.
   Betancourt, Jean P.
   Cerra, Javier
   Reyes, Edgardo
TI The Zika Virus: An Association to Guillain-Barre Syndrome in the United
   States - A Case Report
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE ZIKA; Guillain-Barre; Zika and Guillain-Barre
AB Case of a 37 year-old Puerto Rican male with no past medical history who was admitted to the hospital after developing paresthesia in the upper and lower extremities with associated skin rash, weakness, and dysautonomia. After rigorous analysis of the clinical patterns, neurologic manifestations, laboratory workups, CSF analysis, and nerve conduction studies we conclude the existence of a strong relationship between the Zika virus and the Guillain-Barre syndrome. The patient recovered promptly and his response to treatment was excellent.
C1 [Rivera-Concepcion, Joel R.; Betancourt, Jean P.; Reyes, Edgardo] Univ Puerto Rico, Dept Med, Med Sci Campus, San Juan, PR 00936 USA.
   [Cerra, Javier] Univ Puerto Rico, Dept Med, Vet Affairs Caribbean Healthcare Syst, Med Sci Campus, San Juan, PR 00936 USA.
RP Rivera-Concepcion, JR (corresponding author), POB 10613, San Juan, PR 00922 USA.
EM Joel.rivera2@upr.edu
CR Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Blum JD, 2016, N ENG J MED
   Gordon PH, 2001, ARCH NEUROL-CHICAGO, V58, P913, DOI 10.1001/archneur.58.6.913
   Gupta Deepak, 2008, J Clin Neuromuscul Dis, V10, P42, DOI 10.1097/CND.0b013e31818e9510
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Yadegari S, 2014, IRAN J NEUROL, V13, P138
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 9
TC 2
Z9 2
U1 0
U2 0
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S93
EP S95
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900015
PM 30576585
DA 2020-07-08
ER

PT J
AU Tobar, P
   Vega, M
   Ordonez, C
   Rivera, L
   Landivar, J
   Zambrano, H
AF Tobar, Pool
   Vega, Marcela
   Ordonez, Cathy
   Rivera, Lisette
   Landivar, Jose
   Zambrano, Hector
TI Detection of Zika Virus and Human Papilloma Virus in Cervical Cytology
   Samples using Two Real Time PCR Based Techniques in Ecuadorian Women
   diagnosed with ASCUS
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Article
DE Zika; HPV; ASCUS
ID TRANSMISSION; PATHOGENESIS; CELLS
AB Objective: Atypical Squamous Cells of Undetermined Significance(ASCUS) is the most reported result on pap smears. It is most commonly related to Human Papillomavirus (HPV) infections. However, other pathogens (EBV, Chlamydia) have been reported on cervical samples with abnormal results. Zika virus(ZIKV) has been found to induce cellular abnormalities on different tissues and its presence has been identified on genital secretions.
   Methods: Two real-time PCR has been made on cervical samples from the gynecological service of a third level hospital on Guayaquil-Ecuador. This work was part of a bigger study of ZIKV presence on different body fluids.
   Results: From 89 samples obtained, 19 received an ASCUS result. From these 5 were positive for ZIKV and 5 were positive for HPV, there were no co-infections.
   Conclusion: Given the presence of ZIKV RNA and the absence of HPV DNA on cervical samples diagnosed as ASCUS, it might be plausible that ZIKV could be a triggering factor for the induction of cellular changes observed on these cells.
C1 [Tobar, Pool; Vega, Marcela; Ordonez, Cathy; Rivera, Lisette; Landivar, Jose; Zambrano, Hector] Univ Ghent, Luis Vernaza Hosp, Mol Biol Dept, Int Ctr Reprod Hlth, Ghent, Belgium.
RP Zambrano, H (corresponding author), Univ Ghent, Luis Vernaza Hosp, Mol Biol Dept, Int Ctr Reprod Hlth, Ghent, Belgium.
EM hzambrano@jbgye.org.ec
CR Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davey DD, 2004, ARCH PATHOL LAB MED, V128, P1224
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Herfs M, 2012, P NATL ACAD SCI USA, V109, P10516, DOI 10.1073/pnas.1202684109
   HOFLINGLIMA AL, 2011, ARVO ANNU MEET ABSTR, V2011
   Khenchouche A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-340
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Pirog EC, 2004, ARCH PATHOL LAB MED, V128, P527
   Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114
   Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500
   The American College of Obstetricians and Gynecologist, 2016, OBSTET GYNECOL, V128, P111
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
NR 17
TC 1
Z9 1
U1 0
U2 0
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S96
EP S98
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900016
PM 30576586
DA 2020-07-08
ER

PT J
AU Wojna, V
AF Wojna, Valerie
TI ZIKA VIRUS The Puerto Rican Experience
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Editorial Material
C1 [Wojna, Valerie] Univ Puerto Rico, PI NeuroAIDS Program, Neurol, Med Sci Campus, San Juan, PR 00925 USA.
RP Wojna, V (corresponding author), Univ Puerto Rico, PI NeuroAIDS Program, Neurol, Med Sci Campus, San Juan, PR 00925 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S3
EP S4
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900001
PM 30576571
DA 2020-07-08
ER

PT J
AU Zorrilla, CD
   Rivera-Vinas, JI
   Pujols, AD
   Garcia-Garcia, I
   Rabionet, SE
   Mosquera, AM
AF Zorrilla, Carmen D.
   Rivera-Vinas, Juana, I
   De la Vega Pujols, Albert
   Garcia-Garcia, Ines
   Rabionet, Silvia E.
   Mosquera, Ana M.
TI The Zika Virus Infection in Pregnancy: Review and Implications for
   Research and Care of Women and Infants in Affected Areas
SO PUERTO RICO HEALTH SCIENCES JOURNAL
LA English
DT Review
DE Zika; Pregnancy; Women
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; BIRTH-DEFECTS; SEXUAL
   TRANSMISSION; SURVEILLANCE; TERRITORIES; EXPOSURE; BRAZIL; FETAL
AB The world has encountered a new and serious epidemic which has disproportionately affected fetuses and infants. What makes the Zika virus (ZIKV) epidemic such a threat in our times, is that a whole generation can be affected by birth defects caused by a seemingly innocuous maternal infection, which in most cases go unnoticed and undiagnosed. Spreading to over 80 countries and affecting millions, it is associated with severe birth defects known as congenital Zika syndrome (CZS), which include fetal brain development abnormalities (microcephaly and brain calcifications), retinal abnormalities, and contractures and hypertonia of the extremities. Testing strategies are challenging because of the lack of symptoms and cross-reactivity with other viral infections. Obstetrical complications include fetal loss and the need for an emergency cesarean delivery. The rate of CZS has been described as ranging from 5 to 6% among cohorts in the US, reaching 11% for 1st trimester exposure. Prolonged viremia during pregnancy has been documented in a few cases, reaching 89 days after the onset of symptoms in one case and 109 days after such onset in another. If the ZIKV can infect, multiply in, and persist in diverse placental cells, then movement across the placenta, the fetal brain, and the maternal peripheral blood is possible. There is a sense of urgency, and we need safe and effective vaccines and treatments, particularly for pregnant women. If we do not expand testing and develop methods for early diagnosis and treatment, thousands of infants will be exposed to a neurotropic virus that causes severe birth defects and that could also affect the lives of those who form the next generation.
C1 [Zorrilla, Carmen D.; Rivera-Vinas, Juana, I; De la Vega Pujols, Albert] Univ Puerto Rico, Sch Med, Dept Obstet & Gynecol, Med Sci Campus, San Juan, PR 00936 USA.
   [Garcia-Garcia, Ines] Univ Puerto Rico, Sch Med, Dept Pediat, Med Sci Campus, San Juan, PR 00936 USA.
   [Rabionet, Silvia E.] Univ Puerto Rico, Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.
   [Rabionet, Silvia E.] Nova Southeastern Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA.
   [Mosquera, Ana M.] Maternal Infant Studies Ctr CEMI, POB 365067, San Juan, PR 00936 USA.
RP Zorrilla, CD (corresponding author), Univ Puerto Rico, Sch Med, Dept Obstet & Gynecol, Med Sci Campus, San Juan, PR 00936 USA.; Mosquera, AM (corresponding author), Maternal Infant Studies Ctr CEMI, POB 365067, San Juan, PR 00936 USA.
EM carmen.zorrilla@upr.edu
FU NIAID, NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [5UM1AI069415-12]; NIMH, NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [5R25MH083617-10]
FX The author/s has/have no conflict/s of interest/s to disclose. Dr.
   Zorrilla is funded by the following Research Grants: NIAID, NIH:
   5UM1AI069415-12 (Zorrilla, PI), NIMH, NIH: 5R25MH083617-10 (Zorrilla,
   PI)
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Allard A, 2017, P NATL ACAD SCI USA, V114, P8969, DOI 10.1073/pnas.1703073114
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Center for Disease and Control and Prevention, 2017, SYMPT
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   D'Angelo DV, 2017, MMWR-MORBID MORTAL W, V66, P574, DOI 10.15585/mmwr.mm6622a2
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Departamento de Salud, 2016, SIST VIG ACT ZIK EMB
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erbelding E, 2017, J INFECT DIS, V216, pS991, DOI 10.1093/infdis/jix492
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Mai CT, 2013, BIRTH DEFECTS RES A, V97, P709, DOI 10.1002/bdra.23198
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morens DM, 2017, J INFECT DIS, V216, pS857, DOI 10.1093/infdis/jix383
   Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   National Institute of Health, 2016, NIH LAUNCH LARG STUD
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan American Health Organization/ World Health Organization, 2017, REG ZIK EP UPD AM JU
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sifferlin A., 2016, BRAZIL UNCOVERED POS
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   WHO, 2017, SIT REP
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organization, 2017, HIST ZIK VIR
   World Health Organization, 2016, WHOS RESP ZIK VIR IT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 45
TC 1
Z9 1
U1 1
U2 2
PU UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS
PI SAN JUAN
PA OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA
SN 0738-0658
J9 P R HEALTH SCI J
JI P. R. Health Sci. J.
PY 2018
VL 37
SI SI
BP S66
EP S72
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6EN
UT WOS:000471769900010
PM 30576580
DA 2020-07-08
ER

PT S
AU Arista-Jalife, A
   Sanchez, A
   Nakano, M
   Tunnermann, H
   Perez-Meana, H
   Shouno, H
AF Arista-Jalife, Antonio
   Sanchez, Aalejandra
   Nakano, Mariko
   Tunnermann, Henrik
   Perez-Meana, Hector
   Shouno, Hayaru
BE Fujita, H
   HerreraViedma, E
TI Deep Learning Employed in the Recognition of the Vector that Spreads
   Dengue, Chikungunya and Zika Viruses
SO NEW TRENDS IN INTELLIGENT SOFTWARE METHODOLOGIES, TOOLS AND TECHNIQUES
   (SOMET_18)
SE Frontiers in Artificial Intelligence and Applications
LA English
DT Proceedings Paper
CT 17th International Conference on New Trends in Intelligent Software
   Methodology Tools, and Techniques (SoMeT)
CY SEP 26-28, 2018
CL Granada, SPAIN
DE Aedes mosquito; Vector identification; Convolutional Neural Networks;
   Deep Learning; Entomology; Dengue; Chikungunya; Zika; Transfer Learning;
   Data Augmentation
ID NEURAL-NETWORKS
AB In this paper, a novel Deep Neural Network topology is presented with the objective of recognizing the Aedes aegypti and Aedes albopictus mosquito in their larvarian stage, which are the vectors that cause Dengue, Chikungunya, Zika and Yellow Fever outbreaks. This solution allows to determine if a sample image is a larva of the Aedes aegypti or Aedes albopictus mosquito with an accuracy of 91.28%, a true positive rate of 94.18% and a true negative rate of 88.37%. This Deep Neural Network topology allows the implementation of fast and accurate preventive measures in under-developed countries and isolated areas where a trained specialist might not be available.
C1 [Arista-Jalife, Antonio; Sanchez, Aalejandra; Nakano, Mariko; Perez-Meana, Hector] Inst Politecn Nacl, ESIME Culhuacan, Mexico City, DF, Mexico.
   [Tunnermann, Henrik; Shouno, Hayaru] Univ Electrocommun, Tokyo, Japan.
RP Nakano, M (corresponding author), Ave Sta Ana 1000, Mexico City 09080, DF, Mexico.
EM mnakano@ipn.mx
CR Banerjee AK, 2008, COMPUT BIOL CHEM, V32, P442, DOI 10.1016/j.compbiolchem.2008.07.020
   Byttebier B, 2014, J MED ENTOMOL, V51, P97, DOI 10.1603/ME13066
   Centers for Disease Control and Prevention, 2017, SURV CONTR AED AEG A
   Centers for Disease Control and Protection, EST RANG AED AEG AED
   Gaburro J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1870-1
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Halstead SB, 2016, J PEDIAT-BRAZIL, V92, P429, DOI 10.1016/j.jped.2016.06.004
   Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386
   Lawrence S., 1997, P 14 NAT C ART INT A, P540
   Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Michael A, 2013, NEURAL NETWORKS DEEP, P2056
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2014, EUROSURVEILLANCE J, V19
   Ouyang WL, 2013, IEEE I CONF COMP VIS, P2056, DOI 10.1109/ICCV.2013.257
   Patterson Jessica, 2016, W J EMERGENCY MED, V17
   Schirmer DA, 2016, SEMIN REPROD MED, V34, P261, DOI 10.1055/s-0036-1592069
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162
   Simonyan K., 2014, ARXIV14091556
   Srivastava N, 2014, J MACH LEARN RES, V15, P1929
   Tsai PJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2606-6
   Winskill P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-68
   World Health Organization, 2016, DENG VACC WHO POS PA, V91, P349
   Yosinski J, 2014, ADV NEURAL INFORM PR, P3320, DOI DOI 10.1109/IJCNN.2016.7727519
   Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53
   2016, CELL STEM CELL, V18, P587, DOI DOI 10.1016/J.STEM.2016.02.016
   2001, CLIMATE CHANGE, V48, P441
   2017, NATURE, V542, P115, DOI DOI 10.1038/NATURE21056
   2014, IEEE ACCESS, V2, P514, DOI DOI 10.1109/ACCESS.2014.2325029
NR 31
TC 0
Z9 0
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0922-6389
EI 1879-8314
BN 978-1-61499-900-3; 978-1-61499-899-0
J9 FRONT ARTIF INTEL AP
PY 2018
VL 303
BP 108
EP 120
DI 10.3233/978-1-61499-900-3-108
PG 13
WC Computer Science, Artificial Intelligence; Computer Science, Software
   Engineering
SC Computer Science
GA BM6XD
UT WOS:000467457200009
DA 2020-07-08
ER

PT S
AU Alves, LN
   Abalo, AA
   Argondizzo, APC
   Rocha, HF
   Silva, D
   Cortez, CM
   Missailidis, S
AF Alves, L. N.
   Abalo, A. A.
   Argondizzo, A. P. C.
   Rocha, H. F.
   Silva, D.
   Cortez, C. M.
   Missailidis, S.
BE Simos, TE
   Kalogiratou, Z
   Monovasilis, T
TI Selection and Evaluation of the Binding of Aptamers Against NS5 Zika
   Virus Using Fluorescence Spectroscopy
SO INTERNATIONAL CONFERENCE OF COMPUTATIONAL METHODS IN SCIENCES AND
   ENGINEERING 2018 (ICCMSE-2018)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference of Computational Methods in Sciences and
   Engineering (ICCMSE)
CY MAR 14-18, 2018
CL Thessaloniki, GREECE
SP European Soc Computat Methods Sci & Engn
AB The Zika virus (ZIKV) is an Arbovirus belonging to the family Flaviviridae, genus Flavivirus, whose transmission occurs mainly by bites of mosquitoes of the genus Aedes. Although clinical manifestations of the disease are usually mild, increasing evidence is associated with ZIKV infection with increased congenital neurological abnormalities and neuropathic disorders. The laboratory diagnosis of the infection is based on molecular tests and viral isolation since serological tests usually present cross - reaction with other Flaviviruses. A promising solution for rapid and early diagnosis of infection is the development of nucleic acid aptamers capable of specifically interacting, recognizing infectious agents or detecting antibodies. Following this premise, this study aims to identify specific aptamers for NS5 protein of ZIKV, in order to use them in serological tests.
C1 [Alves, L. N.; Abalo, A. A.; Rocha, H. F.] Biomanguinhos FIOCRUZ, Lab Tecnol Anticorpos Monoclonais, Ave Brasil,4365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Argondizzo, A. P. C.] Biomanguinhos FIOCRUZ, Lab Tecnol Recombinante, Ave Brasil,4365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Silva, D.; Cortez, C. M.] Univ Estado Rio De Janeiro, Dept Matemat Aplicada, 524,Maracana, BR-20550900 Rio De Janeiro, RJ, Brazil.
   [Missailidis, S.] Fiocruz MS, Biomanguinhos, Desenvolvimento Tecnol, Edificio Rocha Lima,Ave Brasil,4365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Missailidis, S (corresponding author), Fiocruz MS, Biomanguinhos, Desenvolvimento Tecnol, Edificio Rocha Lima,Ave Brasil,4365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM sotiris.missailidis@bio.fiocruz.br
RI CORTEZ, CELIA MARTINS/X-3247-2018; Argondizzo, Ana Paula C/D-5880-2017
OI CORTEZ, CELIA MARTINS/0000-0002-7857-1167; Silva,
   Dilson/0000-0001-9726-2442
CR Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franco LD, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0395-z
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Missailidis Sotiris, 2004, Methods Mol Biol, V248, P431
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Simmons SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037938
   Wang W, 2018, NATURE COMMUNICATION, V106, P1
   Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199
   2017, GENE, V628, P117, DOI DOI 10.1016/J.GENE.2017.07.049
   2016, CELL HOST MICROBE, V19, P882, DOI DOI 10.1016/J.CHOM.2016.05.009
   2016, EMERG INFECT DIS, V22, P1185, DOI DOI 10.3201/EID2207.151990
   2016, VIRUS DIS, V27, P111, DOI DOI 10.1007/S13337-016-0307-Y
NR 12
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1766-3
J9 AIP CONF PROC
PY 2018
VL 2040
AR 100005
DI 10.1063/1.5079160
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Multidisciplinary Sciences
SC Computer Science; Engineering; Science & Technology - Other Topics
GA BM7JO
UT WOS:000467966400109
DA 2020-07-08
ER

PT S
AU Morais, LM
   Alves, LN
   Argondizzo, APC
   Rocha, HF
   Silva, D
   Valdez, ECN
   Filippis, AMB
   Missailidis, S
AF Morais, L. M.
   Alves, L. N.
   Argondizzo, A. P. C.
   Rocha, H. F.
   Silva, D.
   Valdez, E. C. N.
   Filippis, A. M. B.
   Missailidis, S.
BE Simos, TE
   Kalogiratou, Z
   Monovasilis, T
TI DNA Aptamer as Molecular Tool for ZIKV NS1 Protein Detection
SO INTERNATIONAL CONFERENCE OF COMPUTATIONAL METHODS IN SCIENCES AND
   ENGINEERING 2018 (ICCMSE-2018)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference of Computational Methods in Sciences and
   Engineering (ICCMSE)
CY MAR 14-18, 2018
CL Thessaloniki, GREECE
SP European Soc Computat Methods Sci & Engn
AB The Zika virus (ZIKV) is an Arbovirus belonging to the family Flaviviridae, genus Flavivirus, whose transmission occurs mainly by bites of of Aedes aegypti mosquitoes. Although clinical manifestations of the disease are usually mild, increasing evidence is associated with ZIKV infection with increased congenital neurological abnormalities and neuropathic disorders. The laboratory diagnosis of the infection is based on molecular tests and viral isolation since serological tests usually present cross-reaction with other Flaviviruses. A promising solution for rapid and early diagnosis of infection is the development of nucleic acid aptamers capable of specifically interacting, recognizing infectious agents or detecting antibodies. Following this premise, this study aims to identify specific aptamers for NS1 protein of ZIKV, in order to use them in serological tests.
C1 [Morais, L. M.] Biomanguinhos Fiocruz, Lab Tecnol Virol, Edificio Rocha Lima,Ave Brasil,4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Alves, L. N.; Rocha, H. F.] Biomanguinhos Fiocruz, Lab Tecnol Anticorpos Monoclonais, Pavilhao Rockfeller,Ave Brasil,4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Argondizzo, A. P. C.] Biomanguinhos Fiocruz, Lab Tecnol Recombinante, Pavilhao Rockfeller,Ave Brasil,4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Silva, D.; Valdez, E. C. N.] Univ Estado Rio De Janeiro, Dept Matemat Aplicada, R Sao Francisco Xavier,524, BR-20550900 Rio De Janeiro, RJ, Brazil.
   [Filippis, A. M. B.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Ave Brasil,4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Missailidis, S.] Fiocruz MS, Biomanguinhos, Desenvolvimento Tecnol, Edificio Rocha Lima,Ave Brasil,4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Missailidis, S (corresponding author), Fiocruz MS, Biomanguinhos, Desenvolvimento Tecnol, Edificio Rocha Lima,Ave Brasil,4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM sotiris.missailidis@bio.fiocruz.br
RI Argondizzo, Ana Paula C/D-5880-2017
OI Silva, Dilson/0000-0001-9726-2442
CR Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Li X-F, 2016, SCI CHINA LIFE SCI, V59, P2012
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Zhou J, 2016, NAT REV D D
   2011, P NATL ACAD SCI USA, V108, P8003, DOI DOI 10.1073/PNAS.1017338108
   2016, ANTIVIR RES, V130, P7, DOI DOI 10.1016/J.ANTIVIRAL.2016.02.014
   2014, SCIENCE, V343, P881, DOI DOI 10.1126/SCIENCE.1247749
   2017, INT J PHARMACEUT, V525, P334, DOI DOI 10.1016/J.IJPHARM.2017.03.086
   1990, J VIROL, V64, P4356
   2016, VIRUSDISEASE, V27, P111, DOI DOI 10.1007/S13337-016-0307-Y
   2015, REV MED VIROL, V25, P205, DOI DOI 10.1002/RMV.1835
   2016, ONCOTARGET, V7, P1344
   2016, A LITERATURE REVIEW, V22, P1185, DOI DOI 10.3201/EID2207.151990
   2013, ANTIVIR RES, V98, P192, DOI DOI 10.1016/J.ANTIVIRAL.2013.03.008
NR 17
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1766-3
J9 AIP CONF PROC
PY 2018
VL 2040
AR 100007
DI 10.1063/1.5079162
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Multidisciplinary Sciences
SC Computer Science; Engineering; Science & Technology - Other Topics
GA BM7JO
UT WOS:000467966400111
DA 2020-07-08
ER

PT S
AU Silva, GCD
   Peltonen, LM
   Pruinelli, L
   Shishido, HY
   Eler, GJ
AF de Souza Silva, Geovanna Cristine
   Peltonen, Laura-Maria
   Pruinelli, Lisiane
   Shishido, Henrique Yoshikazu
   Eler, Gabrielle Jacklin
BE Rotegard, AK
   Skiba, DJ
   Barbosa, S
   Alcazar, AGD
TI Technologies to Combat Aedes Mosquitoes: A Model Based on Smart City
SO NURSING INFORMATICS 2018: ICT TO IMPROVE QUALITY AND SAFETY AT THE POINT
   OF CARE
SE Studies in Health Technology and Informatics
LA English
DT Proceedings Paper
CT 14th International Congress on Nursing and Allied Health Informatics
   (NI)
CY JUN, 2018
CL Mexican Med Informat Assoc NI, Guadalajara, MEXICO
SP Int Med Informat Assoc Nursing Informat Special Interest Grp, Mexican Minist Hth, Federat Med Informat Latin Amer & Caribbean
HO Mexican Med Informat Assoc NI
DE Mosquito control; Aedes; Technology
ID ZIKA VIRUS; IDENTIFICATION; SURVEILLANCE; AEGYPTI
AB Aedes aegypti and Aedes albopictus mosquitoes are responsible for the transmission of diseases such as dengue fever, yellow fever, chikungunya fever, zika virus fever, some of which can cause irreversible central nervous system problems and death. This study investigates what technologies are being used for combatting and monitoring the Aedes mosquitoes and to propose joining these technologies into a single and complete solution using the Smart Cities concept. A search for newscasts on Google and mobile apps in app stores were performed to identify technological solutions for combat to Aedes mosquitoes. Also, a model for joint technology was proposed. Results identified the following technologies: 170 software, two sensors, two drones, one electronic device, ten mosquito traps/lures, seven biological tools, six biotechnologies, and eight chemical formulations. Technological resources and adoption of preventive measures by the population could be a useful method for the mosquito control. Examples include a georeferenced model for identification and examination of larvae, application of chemical/biological products, real-time mapping, sending of educational materials via email or social media for the population, and alerts to health professionals in the zones of combat/risk. In combination, these technologies may indicate a better solution to the current problem.
C1 [de Souza Silva, Geovanna Cristine; Eler, Gabrielle Jacklin] Fed Inst Parana, Nursing Technician Course Collegiate, Londrina, Parana, Brazil.
   [Peltonen, Laura-Maria] Univ Turku, Dept Nursing Sci, Turku, Finland.
   [Pruinelli, Lisiane] Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA.
   [Shishido, Henrique Yoshikazu] Fed Technol Univ Parana, Dept Comp, Cornelio Procopio, Parana, Brazil.
RP Eler, GJ (corresponding author), Joao XXIII St 600, BR-86060370 Londrina, Parana, Brazil.
EM gabrielle.eler@ifpr.edu.br
RI Eler, Gabrielle Jacklin/C-9696-2015
OI Eler, Gabrielle Jacklin/0000-0001-9906-1265
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barbosa IR, 2017, EPIDEMIOL SERV SAUDE, V26, P629, DOI 10.5123/S1679-49742017000300020
   Boger R. A., 2016, AGU FALL M
   Brasil. S. de Vigilancia em Saude, 2016, B EPIDEMIOLOGICO, V57
   Brasil. S. de Vigilancia em Saude, 2017, 57 MIN SAUD, V57
   Brasil. S. de Vigilancia em Saude Levantamento Rapido de Indices para Aedes Aegypti (LIRAa) para vigilancia entomologica do Aedes aegypti no, 2013, TECHNICAL REPORT
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Chiarella J. M., 2016, REV FACULDADE CIENCI, V18, P123
   Jian SW, 2017, HEALTH SECUR, V15, P144, DOI 10.1089/hs.2016.0107
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Malaquias R., 2017, GV EXECUTIVO, V16, P18
   Ortiz-Martinez Y., 2017, F1000RESEARCH, V6
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Sareen S, 2017, ENTERP INF SYST-UK, V11, P1436, DOI 10.1080/17517575.2016.1277558
   Segata Jean, 2017, Horiz. antropol., V23, P19, DOI 10.1590/s0104-71832017000200002
   Sood SK, 2017, COMPUT IND, V91, P33, DOI 10.1016/j.compind.2017.05.006
   Vasconcelos P. F. C., 2015, REV PANAMAZ SAUDE, V2, P9
NR 19
TC 0
Z9 0
U1 1
U2 2
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0926-9630
EI 1879-8365
BN 978-1-61499-872-3; 978-1-61499-871-6
J9 STUD HEALTH TECHNOL
PY 2018
VL 250
BP 129
EP 133
DI 10.3233/978-1-61499-872-3-129
PG 5
WC Computer Science, Interdisciplinary Applications; Nursing
SC Computer Science; Nursing
GA BM7OE
UT WOS:000468219900050
PM 29857404
DA 2020-07-08
ER

PT S
AU McGillivray, P
   Clarke, D
   Meyerson, W
   Zhang, J
   Lee, D
   Gu, MT
   Kumar, S
   Zhou, H
   Gerstein, M
AF McGillivray, Patrick
   Clarke, Declan
   Meyerson, William
   Zhang, Jing
   Lee, Donghoon
   Gu, Mengting
   Kumar, Sushant
   Zhou, Holly
   Gerstein, Mark
BE Altman, RB
   Levitt, M
TI Network Analysis as a Grand Unifier in Biomedical Data Science
SO ANNUAL REVIEW OF BIOMEDICAL DATA SCIENCE, VOL 1
SE Annual Review of Biomedical Data Science
LA English
DT Article; Book Chapter
DE network analysis; molecular interaction; systems biology;
   cross-disciplinary research; network medicine
ID PROTEIN-INTERACTION NETWORKS; COMMUNITY STRUCTURE; MOLECULAR NETWORKS;
   STRUCTURAL INSIGHTS; CYSTIC-FIBROSIS; ZIKA VIRUS; COMPLEX;
   TRANSCRIPTION; REVEALS; GENOME
AB Biomedical data scientists study many types of networks, ranging from those formed by neurons to those created by molecular interactions. People often criticize these networks as uninterpretable diagrams termed hairballs; however, here we show that molecular biological networks can be interpreted in several straightforward ways. First, we can break down a network into smaller components, focusing on individual pathways and modules. Second, we can compute global statistics describing the network as a whole. Third, we can compare networks. These comparisons can be within the same context (e.g., between two gene regulatory networks) or cross-disciplinary (e.g., between regulatory networks and governmental hierarchies). The latter comparisons can transfer a formalism, such as that for Markov chains, from one context to another or relate our intuitions in a familiar setting (e.g., social networks) to the relatively unfamiliar molecular context. Finally, key aspects of molecular networks are dynamics and evolution, i.e., how they evolve over time and how genetic variants affect them. By studying the relationships between variants in networks, we can begin to interpret many common diseases, such as cancer and heart disease.
C1 [McGillivray, Patrick; Clarke, Declan; Zhang, Jing; Kumar, Sushant; Zhou, Holly; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.
   [Meyerson, William; Zhang, Jing; Lee, Donghoon; Gu, Mengting; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA.
   [Gu, Mengting; Gerstein, Mark] Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA.
RP Gerstein, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.; Gerstein, M (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA.; Gerstein, M (corresponding author), Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA.
EM mark@gersteinlab.org
RI Lee, Donghoon/AAH-2252-2020; Gu, Mengting/I-5832-2014
OI Lee, Donghoon/0000-0003-0453-6059; Gu, Mengting/0000-0003-1684-0146
CR Alberts B, 2008, MOL BIOL CELL
   Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300
   Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102
   Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651
   Bai H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003595
   Bashashati A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r124
   Baumstark R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10105
   Benson AR, 2016, SCIENCE, V353, P163, DOI 10.1126/science.aad9029
   Bergthaler A, 2017, NAT IMMUNOL, V18, P481, DOI 10.1038/ni.3727
   Bhardwaj N, 2011, PROTEIN SCI, V20, P1745, DOI 10.1002/pro.710
   Bhardwaj N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001014
   Bird Lucy, 2017, Nat Rev Immunol, V17, P216, DOI 10.1038/nri.2017.31
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005
   Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748
   Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643
   Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407
   Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122
   Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111
   Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830
   Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209
   Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564
   Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385
   Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420
   Cowen L, 2017, NAT REV GENET, V18, P551, DOI 10.1038/nrg.2017.38
   Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222
   Creixell P, 2015, CELL, V163, P187, DOI 10.1016/j.cell.2015.08.057
   Creixell P, 2015, CELL, V163, P202, DOI 10.1016/j.cell.2015.08.056
   Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016
   Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2
   Dempfle A, 2008, EUR J HUM GENET, V16, P1164, DOI 10.1038/ejhg.2008.106
   Donetti L, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10012
   Drost M, 2010, HUM MUTAT, V31, P247, DOI 10.1002/humu.21180
   Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45
   Erlich Y, 2015, GENOME RES, V25, P1411, DOI 10.1101/gr.191692.115
   Erten S, 2011, J COMPUT BIOL, V18, P1561, DOI 10.1089/cmb.2011.0154
   Falco MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39709
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543
   Fu Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0480-5
   Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642
   Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245
   Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495
   Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104
   Grechkin M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004888
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811
   Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949
   Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288
   Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102
   Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489
   GUNTHARD HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI DOI 10.1001/JAMA.2016.8900
   Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555
   Hassabis D, 2017, NEURON, V95, P245, DOI 10.1016/j.neuron.2017.06.011
   Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005
   Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049
   Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]
   Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366
   Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361
   Jiang P, 2015, P NATL ACAD SCI USA, V112, P7731, DOI 10.1073/pnas.1424272112
   Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092
   Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609
   Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115
   Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587
   Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886
   Kim J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00900
   Kim MS, 2010, BIOESSAYS, V32, P505, DOI 10.1002/bies.200900169
   Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16
   Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174
   Kim YA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004747
   Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412
   Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008
   Krishnan A, 2016, NAT NEUROSCI, V19, P1454, DOI 10.1038/nn.4353
   Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386
   Kumar S, 2016, NUCLEIC ACIDS RES, V44, P10062, DOI 10.1093/nar/gkw927
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Lanchantin J, 2016, ARXIV160501133CSLG
   Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031
   Leeper NJ, 2012, CIRCULATION, V125, P3220, DOI 10.1161/CIRCULATIONAHA.111.033878
   Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168
   Leiserson MDM, 2013, CURR OPIN GENET DEV, V23, P602, DOI 10.1016/j.gde.2013.09.003
   Letai A, 2017, NAT MED, V23, P1028, DOI 10.1038/nm.4389
   Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917
   Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782
   Magnusdottir S, 2017, NAT BIOTECHNOL, V35, P81, DOI 10.1038/nbt.3703
   Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100
   Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043
   Marx V, 2015, NATURE, V524, P503, DOI 10.1038/524503a
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Mazza A, 2016, BIOINFORMATICS, V32, P271, DOI 10.1093/bioinformatics/btw263
   Mohamed S, 2017, JAMA-J AM MED ASSOC, V318, P132, DOI 10.1001/jama.2017.8036
   Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870
   Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Nakka P, 2016, GENETICS, V204, P783, DOI 10.1534/genetics.116.188391
   Navlakha S., 2014, JR SOC INTERFACE, V11, P96
   Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103
   Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026113
   Nocedal I, 2015, COLD SH Q B, V80, P265, DOI 10.1101/sqb.2015.80.027557
   Orsini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9627
   Park YJ, 2015, NAT BIOTECHNOL, V33, P825, DOI 10.1038/nbt.3313
   Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6
   Pearl J., 1982, P NAT C ART INT, P133, DOI DOI 10.1038/4580
   Peter IS, 2012, P NATL ACAD SCI USA, V109, P16434, DOI 10.1073/pnas.1207852109
   Piel FB, 2017, NEW ENGL J MED, V376, P1561, DOI 10.1056/NEJMra1510865
   Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018
   Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343
   Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436
   Przulj N, 2016, SCIENCE, V353, P123, DOI 10.1126/science.aah3449
   Qin Q, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005403
   Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101
   Ramachandran S, 2012, P NATL ACAD SCI USA, V109, P13362, DOI 10.1073/pnas.1210906109
   Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693
   Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595
   Ronhovde P, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016109
   Rose AS, 2015, NUCLEIC ACIDS RES, V43, pW576, DOI 10.1093/nar/gkv402
   Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609
   Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4
   Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104
   Ruffalo M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004595
   Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532
   Saxena P, 2016, P NATL ACAD SCI USA, V113, P1244, DOI 10.1073/pnas.1514383113
   Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454
   Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-177
   Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176
   Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172
   Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421
   Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050
   Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1
   Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764
   Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029
   Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195
   Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894
   Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114
   Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488
   Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293
   TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545
   Tu S, 2013, NUCLEUS-AUSTIN, V4, P89, DOI 10.4161/nucl.23986
   Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265
   Varadhachary GR, 2014, NEW ENGL J MED, V371, P757, DOI 10.1056/NEJMra1303917
   Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896
   Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]
   Wang DF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004132
   Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097
   Wu ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10073
   Yan KK, 2016, CELL SYST, V2, P147, DOI 10.1016/j.cels.2016.02.014
   Yan KK, 2010, P NATL ACAD SCI USA, V107, P9186, DOI 10.1073/pnas.0914771107
   Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981
   Zahiri J, 2013, CURR GENOMICS, V14, P397, DOI 10.2174/1389202911314060004
   Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958
   Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503
NR 156
TC 5
Z9 5
U1 0
U2 1
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 2574-3414
J9 ANNU REV BIOMED DA S
JI Annu. Rev. Biomed. Data Sci.
PY 2018
VL 1
BP 153
EP 180
DI 10.1146/annurev-biodatasci-080917-013444
PG 28
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA BM6KJ
UT WOS:000466876200008
DA 2020-07-08
ER

PT S
AU Nagata, LP
   Irwin, CR
   Hu, WG
   Evans, DH
AF Nagata, Les P.
   Irwin, Chad R.
   Hu, Wei-gang
   Evans, David H.
BE Patel, TR
   Vanmarle, G
TI Vaccinia-based vaccines to biothreat and emerging viruses
SO BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, VOL 34, ISSUE 1
SE Biotechnology & Genetic Engineering Reviews
LA English
DT Review
CT Alberta Virology Conference
CY JUN 01-02, 2017
CL Univ Alberta, Alberta, CANADA
HO Univ Alberta
DE Vaccinia; vaccines; emerging infectious diseases; biological threat
   viruses; vaccinia-vectored vaccines; modified vaccinia Ankara
ID X 10(8) TCID50; SMALLPOX VACCINE; STRAIN MVA; IMMUNOGENICITY; SAFETY;
   DELETION; VECTORS; NYVAC; IMVAMUNE; EVASION
AB The past few years have seen a rash of emerging viral diseases, including the Ebola crisis in West Africa, the pandemic spread of chikungunya, and the recent explosion of Zika in South America. Vaccination is the most reliable and cost-effective method of control of infectious diseases, however, there is often a long delay in production and approval in getting new vaccines to market. Vaccinia was the first vaccine developed for the successful eradication of smallpox and has properties that make it attractive as a universal vaccine vector. Vaccinia can cause severe complications, particularly in immune suppressed recipients that would limit its utility, but nonreplicating and attenuated strains have been developed. Modified vaccinia Ankara is nonreplicating in human cells and can be safely given to immune suppressed individuals. Vaccinia has recently been modified for use as an oncolytic treatment for cancer therapy. These new vaccinia vectors are replicating; but have been attenuated and could prove useful as a universal vaccine carrier as many of these are in clinical trials for cancer therapy. This article reviews the development of a universal vaccinia vaccine platform for emerging diseases or biothreat agents, based on nonreplicating or live attenuated vaccinia viruses.
C1 [Nagata, Les P.; Hu, Wei-gang] Suffield Res Ctr, Def R&D Canada, Biothreat Def Sect, Ralston, AB, Canada.
   [Nagata, Les P.; Irwin, Chad R.; Evans, David H.] Univ Alberta, Med Microbiol & Immunol, Edmonton, AB, Canada.
RP Nagata, LP (corresponding author), Suffield Res Ctr, Def R&D Canada, Biothreat Def Sect, Ralston, AB, Canada.; Nagata, LP (corresponding author), Univ Alberta, Med Microbiol & Immunol, Edmonton, AB, Canada.
EM lnagata@ualberta.ca
RI Evans, David/M-1912-2016
OI Evans, David/0000-0001-5871-299X
CR Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Baur K, 2010, J VIROL, V84, P8743, DOI 10.1128/JVI.00604-10
   Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0
   Cottingham MG, 2013, VACCINE, V31, P4247, DOI 10.1016/j.vaccine.2013.03.021
   Eldi P, 2017, MOL THER, V25, P2332, DOI 10.1016/j.ymthe.2017.06.017
   Gomez CE, 2013, EXPERT REV VACCINES, V12, P1395, DOI 10.1586/14760584.2013.845531
   Ferrier-Rembert A, 2008, VACCINE, V26, P1794, DOI 10.1016/j.vaccine.2007.12.059
   Frey SE, 2014, VACCINE, V32, P2732, DOI 10.1016/j.vaccine.2014.02.043
   Fuerst T. R., 1989, MOL CELL BIOL, V7, P2538
   FUERST TR, 1989, P NATL ACAD SCI USA, V86, P2549, DOI 10.1073/pnas.86.8.2549
   Garcia-Arriaza J, 2015, J VIROL, V89, P8525, DOI 10.1128/JVI.01265-15
   Garcia-Arriaza J, 2014, HUM VACC IMMUNOTHER, V10, P2235, DOI 10.4161/hv.28974
   Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13
   Garcia-Arriaza J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066894
   Greenberg RN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138348
   Griffin DE, 2013, FIELDS VIROLOGY, P651
   Haddad D, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00096
   Harrop R, 2006, ADV DRUG DELIVER REV, V58, P931, DOI 10.1016/j.addr.2006.05.005
   Hu W.-G., 2017, PROTECTIVE EFF UNPUB
   Irwin CR, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00229
   Jackson SS, 2005, J VIROL, V79, P6554, DOI 10.1128/JVI.79.10.6554-6559.2005
   Jonker Emile F F, 2013, Ther Adv Vaccines, V1, P144, DOI 10.1177/2051013613498954
   Kibler KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025674
   Lauer KB, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00298-16
   MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375
   McCart JA, 2001, CANCER RES, V61, P8751
   Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Nagata L. P., 2017, ALB VIR C EDM CAN
   Noyce RS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188453
   Pabakaran M., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0107316, DOI 10.1371/JOURNAL.PONE.0107316]
   Potts KG, 2017, EMBO MOL MED, V9, P638, DOI 10.15252/emmm.201607296
   Raengsakulrach B, 1999, AM J TROP MED HYG, V60, P343, DOI 10.4269/ajtmh.1999.60.343
   Ramsauer K, 2016, J INFECT DIS, V214, pS500, DOI 10.1093/infdis/jiw369
   Russell TA, 2014, IMMUNOL CELL BIOL, V92, P466, DOI 10.1038/icb.2014.10
   Sanchez-Sampedro L, 2015, VIRUSES-BASEL, V7, P1726, DOI 10.3390/v7041726
   Schafer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024505
   Schweneker M, 2017, J VIROL, V91, DOI [10.1128/JVI.00343-17, 10.1128/jvi.00343-17]
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0
   Sumner RP, 2016, VACCINE, V34, P4827, DOI 10.1016/j.vaccine.2016.08.002
   Sutter Gerd, 2003, Current Drug Targets - Infectious Disorders, V3, P263, DOI 10.2174/1568005033481123
   TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B
   Tree JA, 2016, HUM VACC IMMUNOTHER, V12, P1795, DOI 10.1080/21645515.2015.1134070
   Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06
   Valkenburg SA, 2014, P NATL ACAD SCI USA, V111, P5676, DOI 10.1073/pnas.1403684111
   van den Doel P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003101
   Vellozzi C, 2005, CLIN INFECT DIS, V41, P689, DOI 10.1086/432584
   Veyer DL, 2017, IMMUNOL LETT, V186, P68, DOI 10.1016/j.imlet.2017.03.015
   Vollmar J, 2006, VACCINE, V24, P2065, DOI 10.1016/j.vaccine.2005.11.022
   von Krempelhuber A, 2010, VACCINE, V28, P1209, DOI 10.1016/j.vaccine.2009.11.030
   Weber C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003684
   Weger-Lucarelli J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002970
   Wennier ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073511
   Wyatt LS, 2017, MBIO, V8, DOI 10.1128/mBio.00790-17
   Yao XD, 2003, J VIROL, V77, P7281, DOI 10.1128/JVI.77.13.7281-7290.2003
   2011, CURRENT GENE THERAPY, V11, P189
NR 57
TC 5
Z9 5
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
SN 0264-8725
J9 BIOTECHNOL GENET ENG
JI Biotechnol. Genet. Eng. Rev.
PY 2018
VL 34
IS 1
BP 107
EP 121
DI 10.1080/02648725.2018.1471643
PG 15
WC Biotechnology & Applied Microbiology; Substance Abuse; Genetics &
   Heredity; Virology
SC Biotechnology & Applied Microbiology; Substance Abuse; Genetics &
   Heredity; Virology
GA BM6GE
UT WOS:000466545200007
PM 29779454
DA 2020-07-08
ER

PT J
AU Mottin, M
   Borba, JVVB
   Melo, CC
   Neves, BJ
   Muratov, E
   Torres, PHM
   Braga, RC
   Perryman, A
   Ekins, S
   Andrade, CH
AF Mottin, Melina
   Verde Bastos Borba, Joyce Villa
   Melo-Filho, Cleber Camilo
   Neves, Bruno Junior
   Muratov, Eugene
   Monteiro Torres, Pedro Henrique
   Braga, Rodolpho Campos
   Perryman, Alexander
   Ekins, Sean
   Andrade, Carolina Horta
TI Computational drug discovery for the Zika virus
SO BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Review
DE Zika; Flavivirus; Antiviral; Computer-assisted drug design; Virtual
   screening; Drug discovery
ID MOLECULAR-DYNAMICS SIMULATIONS; FINGERPRINT SIMILARITY SEARCH;
   PHARMACOPHORE MODELS; INHIBITORS; DOCKING; PROTEIN; LIGAND; SHAPE;
   IDENTIFICATION; DESIGN
AB Few Zika virus (ZIKV) outbreaks had been reported since its first detection in 1947, until the recent epidemics occurred in South America (2014/2015) and expeditiously became a global public health emergency. This arbovirus reached 0.5-1.3 million cases of ZIKV infection in Brazil in 2015 and rapidly spread in new geographic areas such as the Americas. Despite the mild symptoms of the Zika fever, the major concern is related to the related severe neurological disorders, especially microcephaly in newborns. Advances in ZIKV drug discovery have been made recently and constitute promising approaches to ZIKV treatment. In this review, we summarize current computational drug discovery efforts and their applicability to discovery of anti-ZIKV drugs. Lastly, we present successful examples of the use of computational approaches to ZIKV drug discovery.
C1 [Mottin, Melina; Verde Bastos Borba, Joyce Villa; Melo-Filho, Cleber Camilo; Neves, Bruno Junior; Braga, Rodolpho Campos; Andrade, Carolina Horta] Univ Fed Goias, Fac Pharm, Lab Mol Modeling & Drug Design LabMol, Goiania, Go, Brazil.
   [Neves, Bruno Junior] Univ Ctr Anapolis UniEVANGELICA, Lab Cheminformat, Anapolis, Go, Brazil.
   [Muratov, Eugene] Univ N Carolina, Eshelman Sch Pharm, Lab Mol Modeling, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA.
   [Muratov, Eugene] Odessa Natl Polytech Univ, Dept Chem Technol, Odessa, Ukraine.
   [Monteiro Torres, Pedro Henrique] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Perryman, Alexander] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA.
   [Ekins, Sean] Collaborat Pharmaceut Inc, 840 Main Campus Dr,Lab 3510, Raleigh, NC USA.
   [Andrade, Carolina Horta] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut Microbiol & Immunol, Lab Trop Dis, Campinas, SP, Brazil.
RP Andrade, CH (corresponding author), Univ Fed Goias, Fac Farm, Lab Modelagem Mol & Desenho Farmacos, Goiania, Go, Brazil.
EM carolhandrade@gmail.com
RI Neves, Bruno J./E-6295-2016; Torres, Pedro Henrique
   Monteiro/C-7657-2015; Braga, Rodolpho C/A-9655-2011; Mottin,
   Melina/D-8700-2016; Borba, Joyce V. B./S-7813-2018; Camilo Melo-Filho,
   Cleber/V-1119-2018; Andrade, Carolina/C-3960-2014
OI Torres, Pedro Henrique Monteiro/0000-0002-0945-1495; Braga, Rodolpho
   C/0000-0003-3814-3464; Mottin, Melina/0000-0003-0878-9029; Borba, Joyce
   V. B./0000-0002-2663-5173; Camilo Melo-Filho,
   Cleber/0000-0003-0056-6971; Andrade, Carolina/0000-0003-0101-1492
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEG; FAPESPFundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP); CNPq/FAPEG DCR [300508/2017-4]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [1U01CA207160]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [400760/2014-2]; FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/023539]
FX The authors would like to thank Brazilian funding agencies, CNPq, CAPES,
   FAPEG and FAPESP for grants and fellowships. This work was partially
   supported by the CNPq/FAPEG DCR (Grant 300508/2017-4). EM thanks the
   financial support from NIH (grant 1U01CA207160) and CNPq (grant
   400760/2014-2). CHA thanks the FAPESP Visiting Researcher Program (grant
   2017/023539). CHA is Research Fellow in productivity of CNPq. We kindly
   acknowledge all our collaborators on the OpenZika project
   (http://openzika.ufg.br), the wonderful ongoing support and
   encouragement of the IBM World Community Grid team, and the community of
   volunteers who donate their computer time.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Amato AA, 2012, J BIOL CHEM, V287, P28169, DOI 10.1074/jbc.M111.332106
   Baker NC, 2018, DRUG DISCOV TODAY, V23, P661, DOI 10.1016/j.drudis.2018.01.018
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bernardes A, 2013, J MOL BIOL, V425, P2878, DOI 10.1016/j.jmb.2013.05.010
   Braga RC, 2013, CURR TOP MED CHEM, V13, P1127, DOI 10.2174/1568026611313090010
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Caporuscio F, 2011, CURR MED CHEM, V18, P2543, DOI 10.2174/092986711795933669
   Cereto-Massague A, 2015, METHODS, V71, P58, DOI 10.1016/j.ymeth.2014.08.005
   Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285
   Childers MC, 2017, MOL SYST DES ENG, V2, P9, DOI [10.1039/c6me00083e, 10.1039/C6ME00083E]
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins S., 2016, F1000RESEARCH, V5, P1
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Ekins Sean, 2016, F1000Res, V5, P275
   Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016
   Ferreira LG, 2015, MOLECULES, V20, P13384, DOI 10.3390/molecules200713384
   Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051
   Frimayanti Neni, 2011, In Silico Biology, V11, P29, DOI 10.3233/ISB-2012-0442
   Glaab E, 2016, BRIEF BIOINFORM, V17, P352, DOI 10.1093/bib/bbv037
   Gomes MN, 2017, MOLECULES, V22, DOI 10.3390/molecules22081210
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Harris R, 2008, PROTEINS, V70, P1506, DOI 10.1002/prot.21645
   Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Kalyaanamoorthy S, 2011, DRUG DISCOV TODAY, V16, P831, DOI 10.1016/j.drudis.2011.07.006
   Kar S, 2013, EXPERT OPIN DRUG DIS, V8, P245, DOI 10.1517/17460441.2013.761204
   Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549
   Koes DR, 2014, J COMPUT CHEM, V35, P1824, DOI 10.1002/jcc.23690
   Kortagere S, 2009, TRENDS PHARMACOL SCI, V30, P138, DOI 10.1016/j.tips.2008.12.001
   LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lionta E, 2014, CURR TOP MED CHEM, V14, P1923, DOI 10.2174/1568026614666140929124445
   Macalino SJY, 2015, ARCH PHARM RES, V38, P1686, DOI 10.1007/s12272-015-0640-5
   March-Vila E, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00298
   Melo CC, 2016, J CHEM INF MODEL, V56, P1357, DOI 10.1021/acs.jcim.6b00055
   Mortier J, 2012, CURR TOP MED CHEM, V12, P1935, DOI 10.2174/156802612804547371
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Muegge I, 2016, EXPERT OPIN DRUG DIS, V11, P137, DOI 10.1517/17460441.2016.1117070
   Murray CW, 2010, CURR OPIN STRUC BIOL, V20, P497, DOI 10.1016/j.sbi.2010.04.003
   Musyoka TM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23690
   Neves BJ, 2016, J MED CHEM, V59, P7075, DOI 10.1021/acs.jmedchem.5b02038
   Neves BJ, 2016, EXPERT OPIN DRUG DIS, V11, P557, DOI 10.1080/17460441.2016.1178230
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pirhadi S, 2013, CURR TOP MED CHEM, V13, P1036, DOI 10.2174/1568026611313090006
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Reynolds CH, 2014, CURR PHARM DESIGN, V20, P3380, DOI 10.2174/138161282020140528105532
   Ricci CG, 2016, BIOCHEMISTRY-US, V55, P5180, DOI 10.1021/acs.biochem.6b00398
   Ripphausen P, 2011, DRUG DISCOV TODAY, V16, P372, DOI 10.1016/j.drudis.2011.02.011
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Salsbury FR, 2010, CURR OPIN PHARMACOL, V10, P738, DOI 10.1016/j.coph.2010.09.016
   Tanrikulu Y, 2013, DRUG DISCOV TODAY, V18, P358, DOI 10.1016/j.drudis.2013.01.007
   Todeschini R., 2000, HDB MOL DESCRIPTORS, DOI [10.1002/9783527613106, DOI 10.1002/9783527613106]
   Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061
   Vapnik V. N., 2000, NATURE STAT LEARNING
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vuorinen A, 2015, METHODS, V71, P113, DOI 10.1016/j.ymeth.2014.10.013
   Wahid B, 2016, ASIAN PAC J TROP MED, V9, P723, DOI 10.1016/j.apjtm.2016.06.019
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang SY, 2010, DRUG DISCOV TODAY, V15, P444, DOI 10.1016/j.drudis.2010.03.013
   Zauhar RJ, 2013, J COMPUT AID MOL DES, V27, P1009, DOI 10.1007/s10822-013-9698-7
   Zhu T, 2013, J MED CHEM, V56, P6560, DOI 10.1021/jm301916b
NR 67
TC 1
Z9 1
U1 1
U2 1
PU UNIV SAO PAULO, CONJUNTO QUIMICAS
PI SAO PAULO
PA SERVICO PUBLICACOES E CIRCULACAO, CAIXA POSTAL 66083, SAO PAULO, 00000,
   BRAZIL
SN 1984-8250
EI 2175-9790
J9 BRAZ J PHARM SCI
JI Braz. J. Pharm. Sci.
PY 2018
VL 54
SI SI
AR UNSP e01002
DI 10.1590/s2175-97902018000001002
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HT1DR
UT WOS:000464304700002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Francis, L
   Hunte, SA
   Valadere, AM
   Polson-Edwards, K
   Asin-Oostburg, V
   Hospedales, CJ
AF Francis, Lorraine
   Hunte, Shelly-Ann
   Valadere, Ann Marie
   Polson-Edwards, Karen
   Asin-Oostburg, Virginia
   Hospedales, C. James
TI Zika virus outbreak in 19 English- and Dutch-speaking Caribbean
   countries and territories, 2015-2016
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Communicable diseases; emerging; epidemics; Zika virus; Caribbean region
ID AEDES-AEGYPTI
AB Surveillance for Zika virus was enhanced in the English- and Dutch-speaking Caribbean following emergence of the virus in Brazil in May 2015. The first autochthonous case of Zika in the Caribbean was reported by Suriname in November 2015, and the virus subsequently spread rapidly throughout the region. Caribbean Public Health Agency (CARPHA) member states (CMS) reported clinically suspected cases of Zika and submitted serum specimens to the agency for laboratory investigation. A patient was considered a confirmed case if Zika virus was detected by real-time reverse transcription-polymerase chain reaction (RT-PCR) assay or serological test. Due to the documented link between 1) Zika virus and congenital syndrome, and 2) Zika virus and Guillain-Barre syndrome (GBS), data on both of these disease outcomes were extracted from country and regional reports. This special report describes the epidemiology of laboratory-confirmed Zika cases reported to CARPHA, including links with both congenital syndrome and GBS, for 19 English- and Dutch-speaking Caribbean countries during the epidemic period (1 October 2015-29 December 2016).
C1 [Francis, Lorraine; Polson-Edwards, Karen; Asin-Oostburg, Virginia; Hospedales, C. James] Caribbean Publ Hlth Agcy, Div Surveillance Dis Prevent & Control, Communicable Dis & Emergency Response Dept, Port Of Spain, Trinidad Tobago.
   [Hunte, Shelly-Ann] Caribbean Publ Hlth Agcy, Div Policy Planning & Res, Port Of Spain, Trinidad Tobago.
   [Valadere, Ann Marie] Caribbean Publ Hlth Agcy, Div Surveillance Dis Prevent & Control, Lab Serv & Networks Dept, Port Of Spain, Trinidad Tobago.
RP Francis, L (corresponding author), Caribbean Publ Hlth Agcy, Div Surveillance Dis Prevent & Control, Communicable Dis & Emergency Response Dept, Port Of Spain, Trinidad Tobago.
EM francilo@carpha.org
CR BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caribbean Community, 2011, AGR EST CAR PUBL HLT
   Caribbean Community, 2018, MEMB STAT ASS MEMB
   Caribbean Public Health Agency, 2018, WHAT WE DO LAB SERV
   Caribbean Public Health Agency, 2018, CAR PUBL HLTH AF REP
   Caribbean Public Health Agency, 2015, CARPHA ZIK UPD
   Caribbean Public Health Agency, 2015, ZIK VIR REACH CAR CO
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chadee DD, 1998, J AM MOSQUITO CONTR, V14, P5
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Olowokure B, 2014, LANCET INFECT DIS, V14, P1039, DOI 10.1016/S1473-3099(14)70948-X
   Pan American Health Organization, 2015, ZIK CAS CONG SYNDR A
   Pan American Health Organization, 2016, ZIK RES CAS DEF
   Pan American Health Organization, 2015, ZIK VIR INF EP UPD
   Pan American Health Organization, 2015, ALG DET ZIK VIR ZIKV
   Pan American Health Organization, 2017, SUMM REG OUTL COUNTR
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   SOPER F L, 1952, Bol Oficina Sanit Panam, V32, P197
NR 31
TC 1
Z9 1
U1 0
U2 0
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2018
VL 42
AR UNSP e120
DI 10.26633/RPSP.2018.120
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HR6JN
UT WOS:000463257000023
PM 31093148
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tesla, B
   Demakovsky, L
   Mordecai, E
   Ryan, S
   Bonds, M
   Ngonghala, C
   Brindley, M
   Murdock, C
AF Tesla, Blanka
   Demakovsky, Leah
   Mordecai, Erin
   Ryan, Sadie
   Bonds, Matthew
   Ngonghala, Calistus
   Brindley, Melinda
   Murdock, Courtney
TI TEMPERATURE DRIVES ZIKA VIRUS TRANSMISSION: EVIDENCE FROM EMPIRICAL AND
   MATHEMATICAL MODELS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Tesla, Blanka; Demakovsky, Leah; Brindley, Melinda; Murdock, Courtney] Univ Georgia, Athens, GA 30602 USA.
   [Mordecai, Erin] Stanford Univ, Stanford, CA 94305 USA.
   [Ryan, Sadie; Ngonghala, Calistus] Univ Florida, Gainesville, FL USA.
   [Bonds, Matthew] Harvard Univ, Cambridge, MA 02138 USA.
RI Ryan, Sadie Jane/H-7488-2019
OI Ryan, Sadie Jane/0000-0002-4308-6321
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 69
BP 23
EP 23
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602070
DA 2020-07-08
ER

PT J
AU Cudjoe, N
   Noel, T
   Krystostik, A
   Waechter, R
   Phillip, S
   Mapp-Alexander, V
   Grossi-Soyster, EN
   Suresh, P
   Lee, J
   Mitchell, G
   Macpherson, C
   LaBeaud, AD
AF Cudjoe, Nikita
   Noel, Trevor
   Krystostik, Amy
   Waechter, Randall
   Phillip, Sherice
   Mapp-Alexander, Veronica
   Grossi-Soyster, Elysee
   Suresh, Priyanka
   Lee, Justin
   Mitchell, George
   Macpherson, Calum
   LaBeaud, A.
TI ZIKA AND DENGUE VIRUS INFECTIONS IN PREGNANT MOTHERS IN GRENADA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Cudjoe, Nikita; Noel, Trevor; Waechter, Randall; Macpherson, Calum] Windward Isl Res & Educ Fdn, St Georges, Grenada.
   [Krystostik, Amy; Grossi-Soyster, Elysee; Suresh, Priyanka; LaBeaud, A.] Stanford Univ, Dept Pediat, Div Infect Dis, Stanford, CA 94305 USA.
   [Phillip, Sherice; Mapp-Alexander, Veronica] St Georges Univ, St Georges, Grenada.
   [Lee, Justin] Stanford Univ, Qualitat Sci Unit, Stanford, CA 94305 USA.
   [Mitchell, George] Minist Hlth, St Georges, Grenada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 157
BP 49
EP 50
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602158
DA 2020-07-08
ER

PT J
AU Ortega-Lopez, LD
   Pondeville, E
   Kohl, A
   Leon-Villalba, RL
   Pazmino, MV
   Torres, S
   Ferguson, H
AF Ortega-Lopez, Leonardo
   Pondeville, Emilie
   Kohl, Alain
   Leon-Villalba, Renato
   Pazmino, Mauro
   Torres, Sergio
   Ferguson, Heather
TI ABUNDANCE AND BEHAVIOR OF <it>AEDES AEGYPTI</it> IN TWO CITIES WITH HIGH
   TRANSMISSION OF ZIKA AND DENGUE IN ECUADOR
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Ortega-Lopez, Leonardo; Ferguson, Heather] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.
   [Pondeville, Emilie; Kohl, Alain] Univ Glasgow, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Leon-Villalba, Renato; Torres, Sergio] Univ San Francisco Quito, Lab Entomol Med & Med Trop, Quito, Ecuador.
   [Pazmino, Mauro] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 164
BP 51
EP 52
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602165
DA 2020-07-08
ER

PT J
AU Kimata, Y
   Borus, P
   Hunsperger, E
   Tigoi, C
   Chepkorir, E
   Waihenya, R
   Sang, R
AF Kimata, Yvonne
   Borus, Peter
   Hunsperger, Elizabeth
   Tigoi, Caroline
   Chepkorir, Edith
   Waihenya, Rebecca
   Sang, Rosemary
TI DETECTION OF DENGUE AND ZIKA VIRUS ANTIBODIES AMONG SUSPECTED MEASLES
   CASES IN KENYA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Kimata, Yvonne; Waihenya, Rebecca] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya.
   [Borus, Peter; Sang, Rosemary] Kenya Govt Med Res Ctr, Nairobi, Kenya.
   [Hunsperger, Elizabeth] Ctr Dis Control & Prevent, Nairobi, Kenya.
   [Tigoi, Caroline; Chepkorir, Edith] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 184
BP 57
EP 58
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602185
DA 2020-07-08
ER

PT J
AU Maurer, MJ
   Ferreira, J
   Grossi-Soyster, E
   LaBeaud, D
AF Maurer, Michael
   Ferreira, Jose
   Grossi-Soyster, Elysse
   LaBeaud, Desiree
TI DECREASED INCIDENCE OF DENGUE, CHIKUNGUNYA, AND ZIKA INFECTIONS IN
   CHILDREN THROUGHOUT BELO HORIZONTE, BRAZIL: SURPRISING FINDINGS FROM A
   PILOT PROJECT IN A REFERRAL EMERGENCY DEPARTMENT IN 2017
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Maurer, Michael; Grossi-Soyster, Elysse; LaBeaud, Desiree] Stanford Univ, Palo Alto, CA 94304 USA.
   [Ferreira, Jose] Fac Saude & Ecol Humana, Vespasiano, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 181
BP 57
EP 57
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602182
DA 2020-07-08
ER

PT J
AU Clinton, JL
   Tran, LL
   Vogt, MB
   Rowley, DR
   Kimata, JT
   Rico-Hesse, RR
AF Clinton, Jennifer
   Tran, Linda
   Vogt, Megan
   Rowley, David
   Kimata, Jason
   Rico-Hesse, Rebecca
TI ZIKA VIRUS UPREGULATES INTERFERONS AND PRO-INFLAMMATORY CYTOKINES IN
   HUMAN PROSTATE CELLS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Clinton, Jennifer; Tran, Linda; Vogt, Megan; Rowley, David; Kimata, Jason; Rico-Hesse, Rebecca] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 207
BP 64
EP 65
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602208
DA 2020-07-08
ER

PT J
AU Herrington, J
   Squiers, L
   Kelly, B
   Bann, C
   Becker-Dreps, S
   Stamm, L
   Johnson, M
   McCormack, L
AF Herrington, James
   Squiers, Linda
   Kelly, Bridget
   Bann, Carla
   Becker-Dreps, Sylvia
   Stamm, Lola
   Johnson, Mihaela
   McCormack, Lauren
TI ZIKA VIRUS PREVENTION: US TRAVELERS' KNOWLEDGE, RISK PERCEPTIONS, AND
   BEHAVIORAL INTENTIONS - A NATIONAL SURVEY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Herrington, James; Becker-Dreps, Sylvia; Stamm, Lola] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Squiers, Linda; Kelly, Bridget; Bann, Carla; Johnson, Mihaela; McCormack, Lauren] RTI Int, Res Triangle Pk, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 205
BP 64
EP 64
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602206
DA 2020-07-08
ER

PT J
AU Nyataya, JN
   Waitumbi, J
   Buddhdev, N
   Awinda, G
   Kanyara, L
   Irura, Z
   Konongoi, L
   Ofula, V
   Sang, R
AF Nyataya, Josphat
   Waitumbi, John
   Buddhdev, Neha
   Awinda, George
   Kanyara, Lucy
   Irura, Zephania
   Konongoi, Limbaso
   Ofula, Victor
   Sang, Rosemary
TI ZIKA VIRUS SCREENING IN THE KENYAN OLYMPIC TEAM ATTENDING THE 2016
   OLYMPIC GAMES IN BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Nyataya, Josphat; Waitumbi, John; Buddhdev, Neha; Awinda, George; Kanyara, Lucy; Irura, Zephania; Konongoi, Limbaso; Ofula, Victor; Sang, Rosemary] Kenya Govt Med Res Ctr, Med Res Unit, Kisumu, Kenya.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 206
BP 64
EP 64
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602207
DA 2020-07-08
ER

PT J
AU Chua, CL
   Sitam, FT
   Chan, YF
   Andu, ESGS
   Rovie-Ryan, JJ
   Verasahib, K
   Sam, IC
AF Chua, Chong-Long
   Sitam, Frankie
   Chan, Yoke
   Andu, Eva
   Rovie-Ryan, Jeffrine
   Verasahib, Khebir
   Sam, I-Ching
TI ZIKA VIRUS IN LONG-TAILED MACAQUES, PENINSULAR MALAYSIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Chua, Chong-Long; Chan, Yoke; Andu, Eva; Sam, I-Ching] Univ Malaya, Kuala Lumpur, Malaysia.
   [Sitam, Frankie; Rovie-Ryan, Jeffrine] Dept Wildlife & Natl Pk Peninsular Malaysia, Kuala Lumpur, Malaysia.
   [Verasahib, Khebir] Natl Publ Hlth Lab, Sungai Buloh, Malaysia.
RI Chan, Yoke Fun/B-5351-2010; Sam, Jamal I-Ching/B-8688-2010
OI Chan, Yoke Fun/0000-0001-7089-0510; Sam, Jamal
   I-Ching/0000-0002-1296-7898
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 209
BP 65
EP 65
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602210
DA 2020-07-08
ER

EF